PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	RP	EM	RI	OI	FU	FX	CR	NR	TC	Z9	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	D2	PG	WC	SC	GA	UT	PM
J	Sakata, R; Kokubu, T; Mifune, Y; Inui, A; Nishimoto, H; Fujioka, H; Kuroda, R; Kurosaka, M				Sakata, Ryosuke; Kokubu, Takeshi; Mifune, Yutaka; Inui, Atsuyuki; Nishimoto, Hanako; Fujioka, Hiroyuki; Kuroda, Ryosuke; Kurosaka, Masahiro			A new bioabsorbable cotton-textured synthetic polymer scaffold for osteochondral repair	INTERNATIONAL ORTHOPAEDICS			English	Article						Osteochondral repair; Cotton-textured; Synthetic polymer; Scaffold; PLG	AUTOLOGOUS CHONDROCYTE TRANSPLANTATION; ARTICULAR-CARTILAGE REPAIR; MESENCHYMAL STEM-CELLS; FULL-THICKNESS DEFECTS; IN-VIVO; GROWTH-FACTOR; RABBIT MODEL; CANINE MODEL; IMPLANTATION; REGENERATION	Purpose We have previously reported that a cylindrical bioabsorbable synthetic polymer scaffold made of poly (DL-lactide-co-glycolide) (PLG) can be used to repair osteochondral defects without using cultured cells in a rabbit model. This cylindrical scaffold has a solid and pre-formed design, which limits its widespread application. Therefore, we created a cotton-textured PLG scaffold, which would be superior to other scaffolds in terms of plastic property and operability. The purpose of the present study was to examine the efficacy of the cotton-textured PLG scaffold in the repair of osteochondral defects. Methods Cotton-textured PLG scaffolds were prepared using the electrospinning method and used to repair osteochondral defects produced on the right femoral condyle in 36 rabbits. As a control, the defect was left untreated. The outcomes of repair were examined histologically at postoperative weeks four, eight, and 12. Results In the untreated control group, the surface of the defect remained concave and the regenerated cartilaginous tissue partially covered the articular surface even at postoperative week 12. In the scaffold group, cartilaginous tissue covered the surface of the defect at postoperative week four, and the surface was smooth and the cartilaginous tissue was well regenerated and integrated with the native cartilage at postoperative week 12. Conclusions The cotton-textured PLG scaffold could repair the osteochondral defect with good outcomes similar to those previously reported for the cylindrical scaffold, with its characteristic advantages of better plasticity and operability. We conclude that the cotton-textured PLG scaffold has potential for clinical application in comminuted osteochondral injury.	[Sakata, Ryosuke; Kokubu, Takeshi; Mifune, Yutaka; Inui, Atsuyuki; Nishimoto, Hanako; Kuroda, Ryosuke; Kurosaka, Masahiro] Kobe Univ, Grad Sch Med, Dept Orthopaed Surg, Chuo Ku, Kobe, Hyogo 6500017, Japan; [Fujioka, Hiroyuki] Hyogo Univ Hlth Sci, Sch Rehabil, Chuo Ku, Kobe, Hyogo 6508530, Japan	Kokubu, T (reprint author), Kobe Univ, Grad Sch Med, Dept Orthopaed Surg, Chuo Ku, 7-5-1 Kusunoki Cho, Kobe, Hyogo 6500017, Japan.	koku@med.kobe-u.ac.jp					Reddi AH, 2011, TISSUE ENG PART B-RE, V17, P301, DOI [10.1089/ten.TEB.2011.0141, 10.1089/ten.teb.2011.0141]; Fortier LA, 2011, CLIN ORTHOP RELAT R, V469, P2706, DOI 10.1007/s11999-011-1857-3; WAKITANI S, 1994, J BONE JOINT SURG AM, V76A, P579; Hangody L, 2003, J BONE JOINT SURG AM, V85A, P25; Liu YC, 2006, TISSUE ENG, V12, P3405, DOI 10.1089/ten.2006.12.3405; Steinert A, 2003, J ORTHOPAED RES, V21, P1090, DOI 10.1016/S0736-0266(03)00100-1; Igarashi T, 2010, J BIOMED MATER RES A, V94A, P844, DOI 10.1002/jbm.a.32762; Pulkkinen HJ, 2010, OSTEOARTHR CARTILAGE, V18, P1077, DOI 10.1016/j.joca.2010.05.004; Asawa Y, 2012, CELL TRANSPLANT, V21, P1431, DOI 10.3727/096368912X640574; Kon E, 2009, AM J SPORT MED, V37, P33, DOI 10.1177/0363546508323256; BRITTBERG M, 1994, NEW ENGL J MED, V331, P889, DOI 10.1056/NEJM199410063311401; Tamai N, 2005, OSTEOARTHR CARTILAGE, V13, P405, DOI 10.1016/j.joca.2004.12.014; Marcacci M, 2007, KNEE SURG SPORT TR A, V15, P610, DOI 10.1007/s00167-006-0265-9; Tokuhara Y, 2010, INT ORTHOP, V34, P761, DOI 10.1007/s00264-009-0818-x; Heng BC, 2004, STEM CELLS, V22, P1152, DOI 10.1634/stemcells.2004-0062; Sakata R, 2012, J ORTHOP RES, V30, P252, DOI 10.1002/jor.21502; Ikeda R, 2009, INT ORTHOP, V33, P821, DOI 10.1007/s00264-008-0532-0; Igarashi T, 2012, J BIOMED MATER RES A, V100A, P180, DOI 10.1002/jbm.a.33248; Toyokawa N, 2010, ARTHROSCOPY, V26, P375, DOI 10.1016/j.arthro.2009.08.006; Loken S, 2008, KNEE SURG SPORT TR A, V16, P896, DOI 10.1007/s00167-008-0566-2; Chien CS, 2012, J BIOMED MATER RES B, V100B, P948, DOI 10.1002/jbm.b.32657; Collins TJ, 2007, BIOTECHNIQUES, V43, P25; Foldager CB, 2012, INT ORTHOP, V36, P1507, DOI 10.1007/s00264-011-1479-0; GERLACH KL, 1993, CLIN MATER, V13, P21, DOI 10.1016/0267-6605(93)90085-L; Gotterbarm T, 2013, INT ORTHOP, V37, P1171, DOI 10.1007/s00264-013-1827-3; Inui Atsuyuki, 2011, Sports Med Arthrosc Rehabil Ther Technol, V3, P29, DOI 10.1186/1758-2555-3-29; Ivkovic A, 2010, GENE THER, V17, P779, DOI 10.1038/gt.2010.16; Larsen MW, 2005, AM J SPORT MED, V33, P68, DOI 10.1177/0363546504265927; Miljkovic ND, 2009, KNEE SURG SPORT TR A, V17, P1326, DOI 10.1007/s00167-009-0881-2; Park JK, 2009, ACTA BIOMATER, V5, P3394, DOI 10.1016/j.actbio.2009.05.019; Petersen W, 2008, ARCH ORTHOP TRAUM SU, V128, P505, DOI 10.1007/s00402-007-0348-1; Steadman J Richard, 2003, J Knee Surg, V16, P83	32	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0341-2695	1432-5195		INT ORTHOP	Int. Orthop.	NOV	2014	38	11					2413	2420		10.1007/s00264-013-2253-2		8	Orthopedics	Orthopedics	AS5ZQ	WOS:000344345300027		
J	Collins, K				Collins, Kristie			In the interval of the wave: Prince Edward Island women's nineteenth- and early twentieth-century life writing	ISLAND STUDIES JOURNAL			English	Book Review									[Collins, Kristie] Univ Tsukuba, Tsukuba, Ibaraki 305, Japan	Collins, K (reprint author), Univ Tsukuba, Tsukuba, Ibaraki 305, Japan.	kristiecollins@yahoo.com					McDonaldRissanen M, 2014, IN THE INTERVAL OF THE WAVE: PRINCE EDWARD ISLAND WOMEN'S NINETEENTH- AND EARLY TWENTIETH-CENTURY LIFE WRITING, P1	1	0	0	UNIV PRINCE EDWARD ISLAND, INST ISLAND STUDIES	CHARLOTTETOWN	550 UNIV AVE, CHARLOTTETOWN, PE C1A 4P3, CANADA	1715-2593			ISL STUD J	Isl. Stud. J.	NOV	2014	9	2					399	401				3	Geography; Social Sciences, Interdisciplinary	Geography; Social Sciences - Other Topics	AS0FZ	WOS:000343954800025		
J	Morita, K; Tamate, T; Kuroki, M; Nagasawa, T				Morita, Kentaro; Tamate, Tsuyoshi; Kuroki, Mari; Nagasawa, Toru			Temperature-dependent variation in alternative migratory tactics and its implications for fitness and population dynamics in a salmonid fish	JOURNAL OF ANIMAL ECOLOGY			English	Article						anadromous fish; climate change; maturation; phenotypic plasticity; portfolio effect	TROUT ONCORHYNCHUS-MYKISS; MASU SALMON; ATLANTIC SALMON; CLIMATE-CHANGE; LIFE-HISTORY; BODY-SIZE; PACIFIC SALMON; BROWN TROUT; LATITUDINAL VARIATION; MARINE SURVIVAL	Temperature-driven life-history modifications by adaptation occur in ectotherms, and therefore, life-history modifications by adaptation need to be taken into consideration when predicting population responses to the climate change. Partial migration is a common form of life-history diversity in which a population contains both migratory and resident behaviours. Salmonid fish exhibit a wide range of life-history diversity and, in particular, partial migration. We evaluated the effect of temperature-driven life-history modifications on population dynamics in partially migratory masu salmon (Oncorhynchus masou) by field observations and theoretical models. Field observations revealed that spatial patterns of alternative migratory tactics were associated with temperature gradients. The occurrence of resident males increased, whereas the proportion of migrant males and the proportion of delayed migrants including both sexes decreased with increasing temperature and, thereby, with improved early growth conditions. The expected fitness for each migratory tactic was computed in a life-history model with early growth conditions as a function. Individual fitness was maximized by adopting resident tactics under favourable early growth conditions, early migrant tactics under intermediate early growth conditions and delayed migrant tactics under unfavourable early growth conditions. The results suggest that individuals exhibited a status-dependent conditional strategy, that is, the adoption of alternative migratory tactics is influenced by the status of individuals to make the best of a situation. A simulation model suggests that increased residency by males to increased temperature leads to a substantial decrease in the number of migrants. Moreover, the decrease in the number of delayed (older) migrants with increasing temperature magnified fluctuations in abundance. Our findings indicate the importance of temperature-driven life-history modifications for predicting dynamics of natural populations under climate warming.	[Morita, Kentaro; Nagasawa, Toru] Fisheries Res Agcy, Hokkaido Natl Fisheries Res Inst, Toyohira Ku, Sapporo, Hokkaido, Japan; [Tamate, Tsuyoshi] Fisheries Res Agcy, Tohoku Natl Fisheries Res Inst, Shiogama, Japan; [Kuroki, Mari] Univ Tokyo, Grad Sch Agr & Life Sci, Bunkyo Ku, Tokyo, Japan	Morita, K (reprint author), Fisheries Res Agcy, Hokkaido Natl Fisheries Res Inst, Toyohira Ku, 2-2 Nakanoshima, Sapporo, Hokkaido, Japan.	moritak@affrc.go.jp	Morita, Kentaro/G-2578-2015	Morita, Kentaro/0000-0002-7803-2438	JSPS KAKENHI [22780187, 24570036, 25450293]	We thank Kazumasa Ohkuma and Hirokazu Urabe for helpful discussion; Masanori Oda, Genki Sahashi, Ryota Yokoyama and Shoichiro Yamamoto for their help with fieldwork; and Kaori Nakahata for help with fish measurement in the laboratory. This work was supported by JSPS KAKENHI Grant Numbers 22780187, 24570036 and 25450293. Finally, we are grateful to Yuuya Tachiki, Hitoshi Araki, Anders Gravbrot Finstad and Jason B. Dunham for their constructive comments on earlier versions of this article.	Gross MR, 1996, TRENDS ECOL EVOL, V11, P92, DOI 10.1016/0169-5347(96)81050-0; Jonsson B, 2013, J ANIM ECOL, V82, P201, DOI 10.1111/j.1365-2656.2012.02022.x; Watanabe M, 2008, CAN J ZOOL, V86, P1121, DOI 10.1139/Z08-093; Ohms HA, 2014, CAN J FISH AQUAT SCI, V71, P70, DOI 10.1139/cjfas-2013-0274; Chapman BB, 2011, OIKOS, V120, P1764, DOI 10.1111/j.1600-0706.2011.20131.x; Rollinson N, 2013, AM NAT, V182, P76, DOI 10.1086/670648; Morita K, 2009, ECOL RES, V24, P711, DOI 10.1007/s11284-008-0579-9; Hatase H, 2013, ECOLOGY, V94, P2583, DOI 10.1890/12-1588.1; JONSSON B, 1993, REV FISH BIOL FISHER, V3, P348, DOI 10.1007/BF00043384; Jonsson B, 2009, J FISH BIOL, V75, P2381, DOI 10.1111/j.1095-8649.2009.02380.x; Hutchings JA, 1999, J FISH BIOL, V55, P1020, DOI 10.1006/jfbi.1999.1106; METCALFE NB, 1988, J ANIM ECOL, V57, P463, DOI 10.2307/4918; Azumaya T, 2005, FISH OCEANOGR, V14, P81, DOI 10.1111/j.1365-2419.2004.00323.x; Schindler DE, 2005, ECOLOGY, V86, P198, DOI 10.1890/03-0408; CASWELL H, 1984, AQUACULTURE, V43, P123, DOI 10.1016/0044-8486(84)90016-4; Olsson IC, 2006, ECOL LETT, V9, P645, DOI 10.1111/j.1461-0248.2006.00909.x; Morita K, 2010, CAN J FISH AQUAT SCI, V67, P955, DOI 10.1139/F10-028; BRADFORD MJ, 1995, CAN J FISH AQUAT SCI, V52, P1327; Schindler DE, 2003, FRONT ECOL ENVIRON, V1, P31, DOI 10.2307/3867962; Schindler DE, 2010, NATURE, V465, P609, DOI 10.1038/nature09060; Dodson JJ, 2013, BIOL REV, V88, P602, DOI 10.1111/brv.12019; Morita K, 2010, OIKOS, V119, P1265, DOI 10.1111/j.1600-0706.2009.18125.x; HOLTBY LB, 1990, CAN J FISH AQUAT SCI, V47, P2181, DOI 10.1139/f90-243; Forseth T, 1999, J ANIM ECOL, V68, P783, DOI 10.1046/j.1365-2656.1999.00329.x; Crozier LG, 2008, EVOL APPL, V1, P252, DOI 10.1111/j.1752-4571.2008.00033.x; Reznick DN, 1997, SCIENCE, V275, P1934, DOI 10.1126/science.275.5308.1934; Greene CM, 2010, BIOL LETTERS, V6, P382, DOI 10.1098/rsbl.2009.0780; Anderson CNK, 2008, NATURE, V452, P835, DOI 10.1038/nature06851; Hoffmann AA, 2011, NATURE, V470, P479, DOI 10.1038/nature09670; Rouyer T, 2011, GLOBAL CHANGE BIOL, V17, P3046, DOI 10.1111/j.1365-2486.2011.02443.x; Aoyama T., 2010, SCI REPORTS HOKKAIDO, V64, P1; Avgar T., 2014, CANADIAN J IN PRESS; Beer WN, 2013, GLOBAL CHANGE BIOL, V19, P2547, DOI 10.1111/gcb.12242; Bryant MD, 2009, CLIMATIC CHANGE, V95, P169, DOI 10.1007/s10584-008-9530-x; Carlson SM, 2008, FUNCT ECOL, V22, P663, DOI 10.1111/j.1365-2435.2008.01416.x; Caswell H., 2001, MATRIX POPULATION MO; Crozier LG, 2008, GLOBAL CHANGE BIOL, V14, P236, DOI 10.1111/j.1365-2486.2007.01497.x; DensBoer P. J., 1968, ACTA BIOTHEOR, V18, P165; Finstad AG, 2012, GLOBAL CHANGE BIOL, V18, P2487, DOI 10.1111/j.1365-2486.2012.02717.x; Groot C., 1991, PACIFIC SALMON LIFE; Hedger RD, 2013, CAN J FISH AQUAT SCI, V70, P159, DOI 10.1139/cjfas-2012-0205; HUTCHINGS JA, 1987, CAN J ZOOL, V65, P766, DOI 10.1139/z87-120; IKUTA K, 1987, GEN COMP ENDOCR, V65, P99, DOI 10.1016/0016-6480(87)90228-0; Kawamura H., 1998, UO TO MIZU, V35, P201; Koseki M., 2000, BEHAV ECOL SOCIOBIOL, V48, P211; Kovach RP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053807; LUNDBERG P, 1988, TRENDS ECOL EVOL, V3, P172, DOI 10.1016/0169-5347(88)90035-3; Machidori S., 1984, INT N PAC FISH COMM, V43, P1; Mangel M, 2008, B MAR SCI, V83, P107; METCALFE NB, 1990, J ANIM ECOL, V59, P135, DOI 10.2307/5163; Middleton A. D., 2013, P ROYAL SOC LONDON B, V280; Miyakoshi Y., 2006, SCI REPORTS HOKKAIDO, V60, P1; Miyakoshi Y, 2011, FISHERIES SCI, V77, P939, DOI 10.1007/s12562-011-0397-9; Morita K, 2011, ICHTHYOL RES, V58, P134, DOI 10.1007/s10228-010-0201-3; Morita K, 2011, FISH OCEANOGR, V20, P258, DOI 10.1111/j.1365-2419.2011.00578.x; Morita K, 2009, J FISH BIOL, V74, P699, DOI 10.1111/j.1095-8649.2008.02150.x; Morita K, 2002, ECOL MODEL, V155, P85, DOI 10.1016/S0304-3800(02)00128-X; Munakata A, 2000, ZOOL SCI, V17, P863, DOI 10.2108/zsj.17.863; MYERS RA, 1984, CAN J FISH AQUAT SCI, V41, P1349; Ohkuma K., 1988, SCI REP HOKKAIDO SAL, V42, P37; Pavlov DS, 2009, J ICHTHYOL, V49, P390, DOI [10.1134/S0032945209050051, DOI 10.1134/S0032945209050051]; Quinn II. T., 1999, QUANTITATIVE FISH DY; Schmidt-Nielsen K., 1997, ANIMAL PHYSL; Shimoda K, 2003, NIPPON SUISAN GAKK, V69, P926; Sloat MR, 2013, CAN J FISH AQUAT SCI, V70, P64, DOI 10.1139/cjfas-2012-0228; Sloat MR, 2014, CAN J FISH AQUAT SCI, V71, P491, DOI 10.1139/cjfas-2013-0366; Soguri M., 1936, YOSHOKU KAISHI, V6, P35; Sugiwaka K., 1994, UO TO MIZU, V31, P75; Takami T., 1998, SCI REPORTS HOKKAIDO, V52, P79; Takeuchi K., 1998, UO TO MIZU, V35, P99; Todd C. D., 2008, GLOBAL CHANGE BIOL, V14, P1, DOI DOI 10.1111/J.1365-2486.2007.01522.X; TSIGER VV, 1994, CAN J FISH AQUAT SCI, V51, P197, DOI 10.1139/f94-022; Tsygir V. V, 1988, J ICHTHYOLOGY, V29, P38	73	3	3	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0021-8790	1365-2656		J ANIM ECOL	J. Anim. Ecol.	NOV	2014	83	6					1268	1278		10.1111/1365-2656.12240		11	Ecology; Zoology	Environmental Sciences & Ecology; Zoology	AS5XI	WOS:000344339500004		
J	Fukaya, K; Okuda, T; Nakaoka, M; Noda, T				Fukaya, Keiichi; Okuda, Takehiro; Nakaoka, Masahiro; Noda, Takashi			Effects of spatial structure of population size on the population dynamics of barnacles across their elevational range	JOURNAL OF ANIMAL ECOLOGY			English	Article						abundant-centre model; Bayesian inference; environmental gradients; intertidal rocky shore; population regulation; state-space models; Taylor's power law	ABUNDANT-CENTER HYPOTHESIS; TAYLORS POWER-LAW; TIME-SERIES; BUTTERFLY POPULATIONS; ANIMAL POPULATIONS; TEMPORAL STABILITY; DENSITY-DEPENDENCE; GEOGRAPHIC RANGE; SPECIES RANGE; VARIABILITY	Explanations for why population dynamics vary across the range of a species reflect two contrasting hypotheses: (i) temporal variability of populations is larger in the centre of the range compared to the margins because overcompensatory density dependence destabilizes population dynamics and (ii) population variability is larger near the margins, where populations are more susceptible to environmental fluctuations. In both of these hypotheses, positions within the range are assumed to affect population variability. In contrast, the fact that population variability is often related to mean population size implies that the spatial structure of the population size within the range of a species may also be a useful predictor of the spatial variation in temporal variability of population size over the range of the species. To explore how population temporal variability varies spatially and the underlying processes responsible for the spatial variation, we focused on the intertidal barnacle Chthamalus dalli and examined differences in its population dynamics along the tidal levels it inhabits. Changes in coverage of barnacle populations were monitored for 105years at 25 plots spanning the elevational range of this species. Data were analysed by fitting a population dynamics model to estimate the effects of density-dependent and density-independent processes on population growth. We also examined the temporal mean-variance relationship of population size with parameters estimated from the population dynamics model. We found that the relative variability of populations tended to increase from the centre of the elevational range towards the margins because of an increase in the magnitude of stochastic fluctuations of growth rates. Thus, our results supported hypothesis (2). We also found that spatial variations in temporal population variability were well characterized by Taylor's power law, the relative population variability being inversely related to the mean population size. Results suggest that understanding the population dynamics of a species over its range may be facilitated by taking the spatial structure of population size into account as well as by considering changes in population processes as a function of position within the range of the species.	[Fukaya, Keiichi] Inst Stat Math, Tachikawa, Tokyo 1908562, Japan; [Okuda, Takehiro] Fisheries Res Agcy, Natl Res Inst Far Seas Fisheries, Kanazawa Ku, Yokohama, Kanagawa 2368648, Japan; [Nakaoka, Masahiro] Hokkaido Univ, Field Sci Ctr Northern Biosphere, Akkeshi Marine Stn, Akkeshi, Hokkaido 0881113, Japan; [Noda, Takashi] Hokkaido Univ, Fac Environm Sci, Sapporo, Hokkaido 0600810, Japan	Fukaya, K (reprint author), Inst Stat Math, 10-3 Midoricho, Tachikawa, Tokyo 1908562, Japan.	kfukaya@ism.ac.jp			Ministry of Education, Science, Sports and Culture in Japan [20570012, 24570012, 14340242, 18201043, 21241055];  [23-5649]	We are grateful to S. Higashi, T. Saitoh and I. Koizumi for their helpful comments on an earlier version of this manuscript. This manuscript also benefited from comments and suggestions provided by two anonymous reviewers. For providing access to laboratory facilities, we are grateful to the staff and students of the Akkeshi Marine Stations of Hokkaido University. We also acknowledge the many researchers and students who helped with our fieldwork. This research was supported by Grants-in-Aid for Scientific Research by the Ministry of Education, Science, Sports and Culture in Japan (nos. 20570012, 24570012 to TN and nos. 14340242, 18201043, 21241055 to MN) and by a Grant in-Aid for a Research Fellow of the JSPS (no. 23-5649 to KF). The authors have no conflict of interest to declare.	TAYLOR LR, 1980, J ANIM ECOL, V49, P209, DOI 10.2307/4285; Gerst KL, 2011, J ECOL, V99, P591, DOI 10.1111/j.1365-2745.2010.01782.x; Martinez-Meyer E, 2013, BIOL LETTERS, V9, DOI 10.1098/rsbl.2012.0637; Noda T, 1998, MAR ECOL PROG SER, V169, P289, DOI 10.3354/meps169289; TAYLOR LR, 1961, NATURE, V189, P732, DOI 10.1038/189732a0; Rivadeneira MM, 2010, J BIOGEOGR, V37, P486, DOI 10.1111/j.1365-2699.2009.02224.x; Menge BA, 2000, ECOL MONOGR, V70, P265, DOI 10.1890/0012-9615(2000)070[0265:RVPPAD]2.0.CO;2; Clark JS, 2004, ECOLOGY, V85, P3140, DOI 10.1890/03-0520; Sexton JP, 2009, ANNU REV ECOL EVOL S, V40, P415, DOI 10.1146/annurev.ecolsys.110308.120317; Williams CK, 2003, ECOLOGY, V84, P2654, DOI 10.1890/03-0038; Angert AL, 2006, ECOLOGY, V87, P2014, DOI 10.1890/0012-9658(2006)87[2014:DOCAMP]2.0.CO;2; TAYLOR LR, 1982, J ANIM ECOL, V51, P879, DOI 10.2307/4012; Villellas J, 2013, ECOGRAPHY, V36, P136, DOI 10.1111/j.1600-0587.2012.07425.x; Engen S, 1998, BIOMETRICS, V54, P840, DOI 10.2307/2533838; Holt RD, 2009, P NATL ACAD SCI USA, V106, P19659, DOI 10.1073/pnas.0905137106; Freckleton RP, 2006, J ANIM ECOL, V75, P837, DOI 10.1111/j.1365-2656.2006.01121.x; MCARDLE BH, 1990, J ANIM ECOL, V59, P439, DOI 10.2307/4873; Kilpatrick AM, 2003, NATURE, V422, P65, DOI 10.1038/nature01471; Tuya F, 2008, MAR ECOL PROG SER, V372, P225, DOI 10.3354/meps07718; Gaston KJ, 2009, P R SOC B, V276, P1395, DOI 10.1098/rspb.2008.1480; Curnutt JL, 1996, OIKOS, V76, P131, DOI 10.2307/3545755; Sagarin RD, 2002, ECOL LETT, V5, P137, DOI 10.1046/j.1461-0248.2002.00297.x; Sagarin RD, 2002, J BIOGEOGR, V29, P985, DOI 10.1046/j.1365-2699.2002.00705.x; CONNELL JH, 1961, ECOLOGY, V42, P710, DOI 10.2307/1933500; Angert AL, 2009, P NATL ACAD SCI USA, V106, P19693, DOI 10.1073/pnas.0901652106; Guo QF, 2005, OIKOS, V108, P47, DOI 10.1111/j.0030-1299.2005.13149.x; Sagarin RD, 2006, TRENDS ECOL EVOL, V21, P524, DOI 10.1016/j.tree.2006.06.008; Barto K., 2013, MUMIN MULTIMODEL INF; Bates D, 2013, LME4 LINEAR MIXED EF; BROWN JH, 1984, AM NAT, V124, P255, DOI 10.1086/284267; Burnham K. P., 2002, MODEL SELECTION MULT; Chan BKK, 2006, MAR ECOL PROG SER, V328, P195, DOI 10.3354/meps328195; desValpine P., 2002, ECOL MONOGR, V72, P57; Fukaya K, 2010, J ANIM ECOL, V79, P1270, DOI 10.1111/j.1365-2656.2010.01727.x; Fukaya K, 2013, ECOSPHERE, V4, DOI 10.1890/ES12-00272.1; Fukaya K., 2014, DRYAD DIGITAL REPOSI, DOI [10.5061/dryad.4qs8c, DOI 10.5061/DRYAD.4QS8C]; GASTON K., 2003, STRUCTURE DYNAMICS G; HENGEVELD R, 1982, J BIOGEOGR, V9, P303, DOI 10.2307/2844717; Keil P, 2010, J THEOR BIOL, V265, P78, DOI 10.1016/j.jtbi.2010.04.014; Kendal Wayne S., 2004, Ecological Complexity, V1, P193, DOI 10.1016/j.ecocom.2004.05.001; Kluth C, 2005, OECOLOGIA, V145, P382, DOI 10.1007/s00442-005-0141-1; Maurer BA., 1994, GEOGRAPHICAL POPULAT; MCARDLE BH, 1995, OIKOS, V74, P165, DOI 10.2307/3545687; Mehlman DW, 1997, ECOL APPL, V7, P614; Mellin C, 2010, ECOLOGY, V91, P3138, DOI 10.1890/10-0267.1; Munroe DM, 2010, J EXP MAR BIOL ECOL, V392, P188, DOI 10.1016/j.jembe.2010.04.019; Munroe DM, 2009, J MAR BIOL ASSOC UK, V89, P345, DOI 10.1017/S0025315408003160; Munroe DM, 2010, MAR ECOL PROG SER, V412, P151, DOI 10.3354/meps08712; Nakaoka M, 2006, ECOL RES, V21, P425, DOI 10.1007/s11284-005-0138-6; Nantel P, 1999, J ECOL, V87, P748, DOI 10.1046/j.1365-2745.1999.00388.x; Oliver TH, 2012, GLOBAL CHANGE BIOL, V18, P1531, DOI 10.1111/j.1365-2486.2012.02659.x; PAINE RT, 1974, OECOLOGIA, V15, P93, DOI 10.1007/BF00345739; Raffaelli D., 1996, INTERTIDAL ECOLOGY; Royama T., 1992, ANAL POPULATION DYNA; Saether BE, 2008, J ANIM ECOL, V77, P869, DOI 10.1111/j.1365-2656.2008.01424.x; Stan Development Team, 2013, STAN C LIB PROB SAMP; THOMAS JA, 1994, ECOGRAPHY, V17, P215, DOI 10.1111/j.1600-0587.1994.tb00096.x; TITMUS G, 1983, OIKOS, V40, P64, DOI 10.2307/3544199; Turchin P., 2003, COMPLEX POPULATION D; Turchin Peter, 1995, P19, DOI 10.1016/B978-012159270-7/50003-8; WHITTAKE.JB, 1971, J ANIM ECOL, V40, P425, DOI 10.2307/3253	61	3	3	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0021-8790	1365-2656		J ANIM ECOL	J. Anim. Ecol.	NOV	2014	83	6					1334	1343		10.1111/1365-2656.12234		10	Ecology; Zoology	Environmental Sciences & Ecology; Zoology	AS5XI	WOS:000344339500010		
J	Yasuda, M; Ito, S; Kido, A; Hamano, K; Uchijima, Y; Uwatoko, N; Kusuyama, H; Watanabe, A; Miyamura, R; Miyata, K; Deguchi, T				Yasuda, Mitsuru; Ito, Shin; Kido, Akira; Hamano, Kiminari; Uchijima, Yutaka; Uwatoko, Noriyasu; Kusuyama, Hiroyuki; Watanabe, Akiko; Miyamura, Ryuzou; Miyata, Kazutoyo; Deguchi, Takashi			A single 2 g oral dose of extended-release azithromycin for treatment of gonococcal urethritis	JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY			English	Article						Neisseria gonorrhoeae; male urethritis; azithromycin-SR	RESISTANT NEISSERIA-GONORRHOEAE; UNCOMPLICATED GONORRHEA; SUSCEPTIBILITY; EMERGENCE; FAILURE; ADULTS; STRAIN; JAPAN; DRUGS; MEN	We treated gonococcal urethritis in men with a single 2 g dose of azithromycin extended-release formulation (azithromycin-SR) to determine its microbiological outcomes and tolerability. We enrolled 189 Japanese men with gonococcal urethritis between April 2009 and December 2013. The patients were given a single 2 g dose of azithromycin-SR. Microbiological efficacy was evaluated by the results of the post-treatment molecular testing of Neisseria gonorrhoeae. MIC testing was performed only for pretreatment isolates of N. gonorrhoeae collected from the patients. We evaluated 130 patients for microbiological outcomes. Of these patients, 122 (93.8%) were judged to be microbiologically cured on the basis of negative test results. All isolates for which the azithromycin MICs were a parts per thousand currency sign0.25 mg/L were eradicated, whereas 5 of 12 isolates for which the MICs were 1 mg/L persisted after the treatment. Forty-six adverse events occurred in 41 patients. However, all adverse events were classified as mild. The eradication rate of N. gonorrhoeae was 93.8% in men with gonococcal urethritis treated with a single 2 g dose of azithromycin-SR. The breakpoint MIC of a 2 g dose of azithromycin-SR for gonococcal urethritis associated with clinical treatment failures appeared to be 1 mg/L. With regard to side effects of higher doses of azithromycin, the 2 g dose of azithromycin-SR appeared to improve tolerability. However, the widespread use of a high-dose regimen of azithromycin might lead to the development of further resistance to azithromycin.	[Yasuda, Mitsuru] Gifu Univ Hosp, Dept Urol, Gifu, Japan; [Ito, Shin] iClinic, Sendai, Miyagi, Japan; [Kido, Akira; Hamano, Kiminari; Uchijima, Yutaka; Uwatoko, Noriyasu; Kusuyama, Hiroyuki; Watanabe, Akiko; Miyamura, Ryuzou; Miyata, Kazutoyo] Urol Infect Study Grp West Saitama, Saitama, Japan; [Deguchi, Takashi] Gifu Univ, Grad Sch Med, Dept Urol, Gifu, Japan	Yasuda, M (reprint author), Gifu Univ Hosp, Dept Urol, Gifu, Japan.	super7@gifu-u.ac.jp		Ito, Shin/0000-0001-9310-1852			Bignell C, 2010, SEX TRANSM INFECT, V86, P422, DOI 10.1136/sti.2010.044586; Tapsall JW, 1998, SEX TRANSM DIS, V25, P505, DOI 10.1097/00007435-199811000-00002; Kirkcaldy RD, 2013, SEX TRANSM INFECT, V89, P5, DOI 10.1136/sextrans-2013-051162; Workowski KA, 2008, ANN INTERN MED, V148, P606; Ehret JM, 1996, SEX TRANSM DIS, V23, P270, DOI 10.1097/00007435-199607000-00004; HANDSFIELD HH, 1992, CLIN INFECT DIS, V15, pS123; Ohnishi M, 2011, EMERG INFECT DIS, V17, P148, DOI 10.3201/eid1701.100397; Galarza PG, 2009, SEX TRANSM DIS, V36, P787, DOI 10.1097/OLQ.0b013e3181b61bb1; Wada K, 2012, J INFECT CHEMOTHER, V18, P729, DOI 10.1007/s10156-012-0410-y; MORAN JS, 1995, CLIN INFECT DIS, V20, pS47; Yokoi S, 2007, EMERG INFECT DIS, V13, P1275; Newman LM, 2007, CLIN INFECT DIS, V44, pS84, DOI 10.1086/511422; CDC, 1989, MMWR-MORBID MORTAL W, V38, P1; Center for Disease Control, 1993, MMWR-MORBID MORTAL W, V42, P1; Clinical and Laboratory Standards Institute, 2012, M100S22 CLSI; Deguchi T, 1997, SEX TRANSM DIS, V24, P247, DOI 10.1097/00007435-199705000-00002; Dillon JAR, 2001, SEX TRANSM DIS, V28, P521, DOI 10.1097/00007435-200109000-00008; Liu P, 2007, ANTIMICROB AGENTS CH, V51, P103, DOI 10.1128/AAC.00852-06; WAUGH MA, 1993, J ANTIMICROB CHEMOTH, V31, P193; Yasuda M, 2013, 28 INT C CHEM INF YO	20	3	3	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0305-7453	1460-2091		J ANTIMICROB CHEMOTH	J. Antimicrob. Chemother.	NOV	2014	69	11					3116	3118		10.1093/jac/dku221		3	Infectious Diseases; Microbiology; Pharmacology & Pharmacy	Infectious Diseases; Microbiology; Pharmacology & Pharmacy	AT0CU	WOS:000344605500038		
J	Yokoyama, H; Yamashita, T; Morioka, R; Ohmori, H				Yokoyama, Hiroshi; Yamashita, Takahiro; Morioka, Riki; Ohmori, Hideyuki			Extracellular Secretion of Noncatalytic Plant Cell Wall-Binding Proteins by the Cellulolytic Thermophile Caldicellulosiruptor bescii	JOURNAL OF BACTERIOLOGY			English	Article							FREE QUANTITATIVE PROTEOMICS; SP-NOV; ANAEROCELLUM-THERMOPHILUM; MICROCRYSTALLINE CELLULOSE; BIOMASS CONVERSION; DSM 6725; BACTERIUM; DOMAINS; ENZYME; DEGRADATION	Caldicellulosiruptor bescii efficiently degrades cellulose, xylan, and native grasses at high temperatures above 70 degrees C under anaerobic conditions. C. bescii extracellularly secretes multidomain glycoside hydrolases along with proteins of unknown function. In this study, we analyzed the C. bescii proteins that bind to the cell walls of timothy grass by using mass spectrometry, and we identified four noncatalytic plant cell wall-binding proteins (PWBPs) with high pI values (9.2 to 9.6). A search of a conserved domain database showed that these proteins possess a common domain related to solute-binding proteins. In addition, 12 genes encoding PWBP-like proteins were detected in the C. bescii genomic sequence. To analyze the binding properties of PWBPs, recombinant PWBP57 and PWBP65, expressed in Escherichia coli, were prepared. The PWBPs displayed a wide range of binding specificities: they bound to cellulose, lichenan, xylan, arabinoxylan, glucuronoxylan, mannan, glucomannan, pectin, oligosaccharides, and the cell walls of timothy grass. The proteins showed the highest binding affinity for the plant cell wall, with association constant (K-a) values of 5.2 x 10(6) to 44 x 10(6) M-1 among the insoluble polysaccharides tested, as measured using depletion binding isotherms. Affinity gel electrophoresis demonstrated that the proteins bound to the acidic polymer pectin most strongly among the soluble polysaccharides tested. Fluorescence microscopic analysis showed that the proteins bound preferentially to the cell wall in a section of grass leaf. Binding of noncatalytic PWBPs with high pI values might be necessary for efficient utilization of polysaccharides by C. bescii at high temperatures.	[Yokoyama, Hiroshi; Yamashita, Takahiro; Morioka, Riki] Natl Inst Livestock & Grassland Sci, Anim Waste Management & Environm Div, Tsukuba, Ibaraki, Japan; [Ohmori, Hideyuki] Natl Inst Livestock & Grassland Sci, Anim Physiol & Nutr Res Div, Tsukuba, Ibaraki, Japan	Yokoyama, H (reprint author), Natl Inst Livestock & Grassland Sci, Anim Waste Management & Environm Div, Tsukuba, Ibaraki, Japan.	hiroshiy@affrc.go.jp			JSPS KAKENHI [24580490]	This work was supported in part by JSPS KAKENHI grant 24580490.	Andrews G, 2010, ANAL BIOANAL CHEM, V398, P377, DOI DOI 10.1007/S00216-010-3955-6; Berntsson RPA, 2010, FEBS LETT, V584, P2606, DOI 10.1016/j.febslet.2010.04.043; Blumer-Schuette SE, 2008, CURR OPIN BIOTECH, V19, P210, DOI 10.1016/j.copbio.2008.04.007; Yokoyama H, 2013, ACTA CRYSTALLOGR F, V69, P438, DOI 10.1107/S174430911300554X; TEO VSJ, 1995, APPL MICROBIOL BIOT, V43, P291, DOI 10.1007/s002530050405; Ye LB, 2012, APPL ENVIRON MICROB, V78, P7048, DOI 10.1128/AEM.02009-12; DICKSON JS, 1989, APPL ENVIRON MICROB, V55, P832; Lochner A, 2011, APPL ENVIRON MICROB, V77, P4042, DOI 10.1128/AEM.02811-10; Lochner A, 2011, J PROTEOME RES, V10, P5302, DOI 10.1021/pr200536j; Yang SJ, 2010, INT J SYST EVOL MICR, V60, P2011, DOI 10.1099/ijs.0.017731-0; Jordan DB, 2012, BIOCHEM J, V442, P241, DOI 10.1042/BJ20111922; Saloheimo M, 2002, EUR J BIOCHEM, V269, P4202, DOI 10.1046/j.1432-1033.2002.03095.x; Lombard V, 2014, NUCLEIC ACIDS RES, V42, pD490, DOI 10.1093/nar/gkt1178; Brown S, 2013, ANNU REV MICROBIOL, V67, P313, DOI 10.1146/annurev-micro-092412-155620; Dam P, 2011, NUCLEIC ACIDS RES, V39, P3240, DOI 10.1093/nar/gkq1281; Scheller HV, 2010, ANNU REV PLANT BIOL, V61, P263, DOI 10.1146/annurev-arplant-042809-112315; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; Brunecky R, 2013, SCIENCE, V342, P1513, DOI 10.1126/science.1244273; MCQUEENMASON S, 1992, PLANT CELL, V4, P1425; Bolam DN, 1998, BIOCHEM J, V331, P775; Zverlov V, 1998, MICROBIOL-SGM, V144, P457; Kanafusa-Shinkai S, 2013, J BIOSCI BIOENG, V115, P64, DOI 10.1016/j.jbiosc.2012.07.019; Guillen D, 2010, APPL MICROBIOL BIOT, V85, P1241, DOI 10.1007/s00253-009-2331-y; Emanuelsson O, 2007, NAT PROTOC, V2, P953, DOI 10.1038/nprot.2007.131; SVETLICHNYI VA, 1990, MICROBIOLOGY+, V59, P598; Su XY, 2012, APPL ENVIRON MICROB, V78, P2230, DOI 10.1128/AEM.06814-11; Marchler-Bauer A, 2011, NUCLEIC ACIDS RES, V39, pD225, DOI 10.1093/nar/gkq1189; Kerff F, 2008, P NATL ACAD SCI USA, V105, P16876, DOI 10.1073/pnas.0809382105; Yang SJ, 2009, APPL ENVIRON MICROB, V75, P4762, DOI 10.1128/AEM.00236-09; Abbott DW, 2012, METHOD ENZYMOL, V510, P211, DOI 10.1016/B978-0-12-415931-0.00011-2; Blumer-Schuette SE, 2010, APPL ENVIRON MICROB, V76, P8084, DOI 10.1128/AEM.01400-10; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Creagh AL, 1996, P NATL ACAD SCI USA, V93, P12229, DOI 10.1073/pnas.93.22.12229; Fontes CMGA, 2010, ANNU REV BIOCHEM, V79, P655, DOI 10.1146/annurev-biochem-091208-085603; Gilbert HJ, 2010, PLANT PHYSIOL, V153, P444, DOI 10.1104/pp.110.156646; HETHENER P, 1992, SYST APPL MICROBIOL, V15, P52; Kleine J, 2006, EXTREMOPHILES, V10, P373, DOI 10.1007/s00792-006-0509-0; Lin H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075022; MADDEN RH, 1983, INT J SYST BACTERIOL, V33, P837; MURRAY WD, 1986, SYST APPL MICROBIOL, V8, P181; [Anonymous], 1988, METHODS ENZYMOL; Wuttge S, 2012, MOL MICROBIOL, V86, P908, DOI 10.1111/mmi.12025; Yi ZL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084172	43	2	2	AMER SOC MICROBIOLOGY	WASHINGTON	1752 N ST NW, WASHINGTON, DC 20036-2904 USA	0021-9193	1098-5530		J BACTERIOL	J. Bacteriol.	NOV	2014	196	21					3784	3792		10.1128/JB.01897-14		9	Microbiology	Microbiology	AR9XD	WOS:000343929200012		
J	Fujita, Y; Satomura, T; Tojo, S; Hirooka, K				Fujita, Yasutaro; Satomura, Takenori; Tojo, Shigeo; Hirooka, Kazutake			CcpA-Mediated Catabolite Activation of the Bacillus subtilis ilv-leu Operon and Its Negation by Either CodY- or TnrA-Mediated Negative Regulation	JOURNAL OF BACTERIOLOGY			English	Article							CHAIN AMINO-ACIDS; REQUIRES SEQUENCES UPSTREAM; GENE-EXPRESSION; TRANSCRIPTIONAL REGULATION; BINDING-SITES; STRINGENT RESPONSE; RNA-POLYMERASE; CARBON FLOW; GNT OPERON; IDENTIFICATION	The Bacillus subtilis ilv-leu operon functions in the biosynthesis of branched-chain amino acids. It undergoes catabolite activation involving a promoter-proximal cre which is mediated by the complex of CcpA and P-Ser-HPr. This activation of ilv-leu expression is negatively regulated through CodY binding to a high-affinity site in the promoter region under amino acid-rich growth conditions, and it is negatively regulated through TnrA binding to the TnrA box under nitrogen-limited growth conditions. The CcpA-mediated catabolite activation of ilv-leu required a helix face-dependent interaction of the complex of CcpA and P-Ser-HPr with RNA polymerase and needed a 19-nucleotide region upstream of cre for full activation. DNase I footprinting indicated that CodY binding to the high-affinity site competitively prevented the binding of the complex of CcpA and P-Ser-HPr to cre. This CodY binding not only negated catabolite activation but also likely inhibited transcription initiation from the ilv-leu promoter. The footprinting also indicated that TnrA and the complex of CcpA and P-Ser-HPr simultaneously bound to the TnrA box and the cre site, respectively, which are 112 nucleotides apart; TnrA binding to its box was likely to induce DNA bending. This implied that interaction of TnrA bound to its box with the complex of CcpA and P-Ser-HPr bound to cre might negate catabolite activation, but TnrA bound to its box did not inhibit transcription initiation from the ilv-leu promoter. Moreover, this negation of catabolite activation by TnrA required a 26-nucleotide region downstream of the TnrA box.	[Fujita, Yasutaro; Satomura, Takenori; Tojo, Shigeo; Hirooka, Kazutake] Fukuyama Univ, Dept Biotechnol, Fac Life Sci & Biotechnol, Fukuyama, Hiroshima, Japan	Fujita, Y (reprint author), Fukuyama Univ, Dept Biotechnol, Fac Life Sci & Biotechnol, Fukuyama, Hiroshima, Japan.	yfujita@bt.fubt.fukuyama-u.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology of Japan [S1001056]; JSPS KAKENHI [23380053]	This work was supported by a Grant-in-Aid for the Strategic Support Project of Research Infrastructure Formation for Private University (S1001056) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan. This work was also supported by JSPS KAKENHI grant number 23380053.	GRANDONI JA, 1992, J BACTERIOL, V174, P3212; Molle V, 2003, J BACTERIOL, V185, P1911, DOI 10.1128/JB.185.6.1911-1922.2003; Mader U, 2002, J BACTERIOL, V184, P4288, DOI 10.1128/JB.184.15.4288-4295.2002; Yoshida K, 2000, MICROBIOL-UK, V146, P573; Fujita M, 1998, GENE, V221, P185, DOI 10.1016/S0378-1119(98)00452-1; Belitsky BR, 2008, J BACTERIOL, V190, P1224, DOI 10.1128/JB.01780-07; Eymann C, 2002, J BACTERIOL, V184, P2500, DOI 10.1128/JB.184.9.2500-2520.2002; Brinsmade SR, 2010, J BACTERIOL, V192, P6357, DOI 10.1128/JB.00937-10; ANAGNOSTOPOULOS C, 1961, J BACTERIOL, V81, P741; Sierro N, 2008, NUCLEIC ACIDS RES, V36, pD93, DOI 10.1093/nar/gkm910; ATKINSON MR, 1990, J BACTERIOL, V172, P4758; Serror P, 1996, J BACTERIOL, V178, P5910; Tojo S, 2005, MOL MICROBIOL, V56, P1560, DOI 10.1111/j.1365-2958.2005.04635.x; Satomura T, 2005, J BACTERIOL, V187, P4813, DOI 10.1128/JB.187.4.4813-4821.2005; Kriel A, 2012, MOL CELL, V48, P231, DOI 10.1016/j.molcel.2012.08.009; Belitsky BR, 2013, P NATL ACAD SCI USA, V110, P7026, DOI 10.1073/pnas.1300428110; Shivers RP, 2006, MOL MICROBIOL, V62, P811, DOI 10.1111/j.1365-2958.2006.05410.x; Shivers RP, 2004, MOL MICROBIOL, V53, P599, DOI 10.1111/j.1365-2958.2004.04135.x; Fujita Y, 2009, BIOSCI BIOTECH BIOCH, V73, P245, DOI 10.1271/bbb.80479; Wunsche A, 2012, FEBS J, V279, P2201, DOI 10.1111/j.1742-4658.2012.08604.x; Moir-Blais TR, 2001, J BACTERIOL, V183, P2389, DOI 10.1128/JB.183.7.2389-2393.2001; de Mendoza D., 2002, BACILLUS SUBTILIS IT, P43; DEUTSCHER J, 1985, J BACTERIOL, V163, P1203; Fink Pamela S., 1993, P307; FUJITA Y, 1989, J BIOL CHEM, V264, P4201; Galinier A, 1998, P NATL ACAD SCI USA, V95, P1823, DOI 10.1073/pnas.95.4.1823; GOLDFARB DS, 1983, MOL GEN GENET, V191, P319, DOI 10.1007/BF00334833; Krasny L, 2008, MOL MICROBIOL, V69, P42, DOI 10.1111/j.1365-2958.2008.06256.x; Ludwig H, 2002, J BACTERIOL, V184, P5174, DOI 10.1128/JB.184.18.5174-5178.2002; MIWA Y, 1988, J BIOL CHEM, V263, P13252; MIWA Y, 1994, MICROBIOL-UK, V140, P2567; Miwa Y, 2001, J BACTERIOL, V183, P5877, DOI 10.1128/JB.183.20.5877-5884.2001; Presecan-Siedel E, 1999, J BACTERIOL, V181, P6889; Ratnayake-Lecamwasam M, 2001, GENE DEV, V15, P1093, DOI 10.1101/gad.874201; Sambrook J, 2001, MOL CLONING LAB MANU; Shivers RP, 2005, MOL MICROBIOL, V56, P1549, DOI 10.1111/j.1365-2958.2005.04634.x; Tojo S, 2008, J BACTERIOL, V190, P6134, DOI 10.1128/JB.00606-08; Tojo S, 2004, J BACTERIOL, V186, P7971, DOI 10.1128/JB.186.23.7971-7979.2004; Turinsky AJ, 1998, J BACTERIOL, V180, P5961; Wray LV, 2000, J MOL BIOL, V300, P29, DOI 10.1006/jmbi.2000.3846; Wray LV, 2001, CELL, V107, P427, DOI 10.1016/S0092-8674(01)00572-4; Wray LV, 2011, J BACTERIOL, V193, P4841, DOI 10.1128/JB.05258-11; Yoshida K, 2004, J BACTERIOL, V186, P5640, DOI 10.1128/JB.186.17.5640-5648.2004; Yoshida K, 2003, MOL MICROBIOL, V49, P157, DOI 10.1046/j.1365-2958.2003.03567.x	44	2	2	AMER SOC MICROBIOLOGY	WASHINGTON	1752 N ST NW, WASHINGTON, DC 20036-2904 USA	0021-9193	1098-5530		J BACTERIOL	J. Bacteriol.	NOV	2014	196	21					3793	3806		10.1128/JB.02055-14		14	Microbiology	Microbiology	AR9XD	WOS:000343929200013		
J	Akanuma, G; Kobayashi, A; Suzuki, S; Kawamura, F; Shiwa, Y; Watanabe, S; Yoshikawa, H; Hanai, R; Ishizuka, M				Akanuma, Genki; Kobayashi, Ako; Suzuki, Shota; Kawamura, Fujio; Shiwa, Yuh; Watanabe, Satoru; Yoshikawa, Hirofumi; Hanai, Ryo; Ishizuka, Morio			Defect in the Formation of 70S Ribosomes Caused by Lack of Ribosomal Protein L34 Can Be Suppressed by Magnesium	JOURNAL OF BACTERIOLOGY			English	Article							ESCHERICHIA-COLI RIBOSOMES; BACILLUS-SUBTILIS; TRANSFER-RNA; NUCLEOTIDE-SEQUENCE; CRYSTAL-STRUCTURE; SALMONELLA-ENTERICA; BACTERIAL RIBOSOME; MG2+ TRANSPORTER; ORIGIN REGION; 50-S SUBUNIT	To elucidate the biological functions of the ribosomal protein L34, which is encoded by the rpmH gene, the rpmH deletion mutant of Bacillus subtilis and two suppressor mutants were characterized. Although the Delta rpmH mutant exhibited a severe slow-growth phenotype, additional mutations in the yhdP or mgtE gene restored the growth rate of the Delta rpmH strain. Either the disruption of yhdP, which is thought to be involved in the efflux of Mg2+, or overexpression of mgtE, which plays a major role in the import of Mg2+, could suppress defects in both the formation of the 70S ribosome and growth caused by the absence of L34. Interestingly, the Mg2+ content was lower in the Delta rpmH cells than in the wild type, and the Mg2+ content in the Delta rpmH cells was restored by either the disruption of yhdP or overexpression of mgtE. In vitro experiments on subunit association demonstrated that 50S subunits that lacked L34 could form 70S ribosomes only at a high concentration of Mg2+. These results showed that L34 is required for efficient 70S ribosome formation and that L34 function can be restored partially by Mg2+. In addition, the Mg2+ content was consistently lower in mutants that contained significantly reduced amounts of the 70S ribosome, such as the Delta rplA (L1) and Delta rplW (L23) strains and mutant strains with a reduced number of copies of the rrn operon. Thus, the results indicated that the cellular Mg2+ content is influenced by the amount of 70S ribosomes.	[Akanuma, Genki; Kobayashi, Ako; Ishizuka, Morio] Chuo Univ, Fac Sci & Engn, Dept Appl Chem, Tokyo 112, Japan; [Suzuki, Shota; Kawamura, Fujio; Hanai, Ryo] Rikkyo Univ, Coll Sci, Dept Life Sci, Tokyo 171, Japan; [Suzuki, Shota; Kawamura, Fujio; Hanai, Ryo] Rikkyo Univ, Coll Sci, Res Ctr Life Sci, Tokyo 171, Japan; [Shiwa, Yuh; Yoshikawa, Hirofumi] Tokyo Univ Agr, Nodai Res Inst, Genome Res Ctr, Tokyo, Japan; [Watanabe, Satoru; Yoshikawa, Hirofumi] Tokyo Univ Agr, Dept Biosci, Tokyo, Japan	Akanuma, G (reprint author), Chuo Univ, Fac Sci & Engn, Dept Appl Chem, Tokyo 112, Japan.	akanuma@kc.chuo-u.ac.jp	Akanuma, Genki/J-2473-2014		Ministry of Education, Culture, Sports, Science, and Technology of Japan; MEXT-Supported Program for the Strategic Research Foundation at Private Universities [S0801025]	This work was supported in part by Grants-in-Aid for Scientific Research (C) (G.A.) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan and by the MEXT-Supported Program for the Strategic Research Foundation at Private Universities (S0801025) (http://www.jsps.go.jp/english/index.html).	Agrawal RK, 1999, INT J BIOCHEM CELL B, V31, P243, DOI 10.1016/S1357-2725(98)00149-6; Nanamiya H, 2004, MOL MICROBIOL, V52, P273, DOI 10.1111/j.1365-2958.2003.03972.x; Yano K, 2013, MICROBIOL-SGM, V159, P2225, DOI 10.1099/mic.0.067025-0; ALATOSSAVA T, 1985, J BACTERIOL, V162, P413; Akanuma G, 2012, J BACTERIOL, V194, P6282, DOI 10.1128/JB.01544-12; MONCANY MLJ, 1981, EXPERIENTIA, V37, P846, DOI 10.1007/BF01985672; TERAOKA H, 1978, FEBS LETT, V88, P223, DOI 10.1016/0014-5793(78)80179-3; Chen K, 2009, NAT METHODS, V6, P677, DOI [10.1038/nmeth.1363, 10.1038/NMETH.1363]; Schmeing TM, 2009, NATURE, V461, P1234, DOI 10.1038/nature08403; Nissen P, 2000, SCIENCE, V289, P920, DOI 10.1126/science.289.5481.920; Shoji S, 2011, J MOL BIOL, V413, P751, DOI 10.1016/j.jmb.2011.09.004; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Gao YG, 2009, SCIENCE, V326, P694, DOI 10.1126/science.1179709; Yusupov MM, 2001, SCIENCE, V292, P883, DOI 10.1126/science.1060089; Diedrich G, 2000, EMBO J, V19, P5241, DOI 10.1093/emboj/19.19.5241; Dann CE, 2007, CELL, V130, P878, DOI 10.1016/j.cell.2007.06.051; Fei J, 2008, MOL CELL, V30, P348, DOI 10.1016/j.molcel.2008.03.012; Ogle JM, 2001, SCIENCE, V292, P897, DOI 10.1126/science.1060612; Cowan JA, 2002, BIOMETALS, V15, P225, DOI 10.1023/A:1016022730880; Hartwig A, 2001, MUTAT RES-FUND MOL M, V475, P113, DOI 10.1016/S0027-5107(01)00074-4; ANAGNOSTOPOULOS C, 1961, J BACTERIOL, V81, P741; FUJITA MQ, 1990, GENE, V93, P73, DOI 10.1016/0378-1119(90)90138-H; Harms J, 2001, CELL, V107, P679, DOI 10.1016/S0092-8674(01)00546-3; GIBSON MM, 1991, MOL MICROBIOL, V5, P2753, DOI 10.1111/j.1365-2958.1991.tb01984.x; Hattori M, 2007, NATURE, V448, P1072, DOI 10.1038/nature06093; Kaczanowska M, 2007, MICROBIOL MOL BIOL R, V71, P477, DOI 10.1128/MMBR.00013-07; Klein DJ, 2004, RNA, V10, P1366, DOI 10.1261/rna.7390804; Hattori M, 2009, EMBO J, V28, P3602, DOI 10.1038/emboj.2009.288; Selmer M, 2006, SCIENCE, V313, P1935, DOI 10.1126/science.1131127; Liiv A, 2006, J BIOL CHEM, V281, P29850, DOI 10.1074/jbc.M603013200; Schmeing TM, 2009, SCIENCE, V326, P688, DOI 10.1126/science.1179700; PANAGIOTIDIS CA, 1995, INT J BIOCHEM CELL B, V27, P157, DOI 10.1016/1357-2725(94)00068-M; Konevega AL, 2004, RNA, V10, P90, DOI 10.1261/rna.5142404; Ishitani R, 2008, P NATL ACAD SCI USA, V105, P15393, DOI 10.1073/pnas.0802991105; Froschauer EM, 2004, FEMS MICROBIOL LETT, V237, P49, DOI 10.1016/j.femsle.2004.06.013; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Roberts E, 2008, P NATL ACAD SCI USA, V105, P13953, DOI 10.1073/pnas.0804861105; Ashikaga S, 2000, J BACTERIOL, V182, P2411, DOI 10.1128/JB.182.9.2411-2415.2000; Baba Tomoya, 2006, Mol Syst Biol, V2; Blaha G, 2002, BIOPHYS CHEM, V96, P153, DOI 10.1016/S0301-4622(02)00021-2; CALCUTT MJ, 1992, J BACTERIOL, V174, P3220; Drygin D, 2000, RNA, V6, P1714, DOI 10.1017/S1355838200001436; HANSEN FG, 1982, EMBO J, V1, P1043; HEROLD M, 1987, J BIOL CHEM, V262, P8826; Hirohawa G, 2002, J BIOL CHEM, V277, P35847, DOI 10.1074/jbc.M2069295200; Imamura D, 2004, J BACTERIOL, V186, P5450, DOI 10.1128/JB.186.16.5450-5459.2004; Joseph P, 2001, FEMS MICROBIOL LETT, V205, P91; KAZEMIE M, 1975, EUR J BIOCHEM, V58, P501, DOI 10.1111/j.1432-1033.1975.tb02398.x; Khaitovich P, 1999, P NATL ACAD SCI USA, V96, P85, DOI 10.1073/pnas.96.1.85; KIRILLOV SV, 1982, FEBS LETT, V148, P235, DOI 10.1016/0014-5793(82)80814-4; KURLAND CG, 1972, ANNU REV BIOCHEM, V41, P377, DOI 10.1146/annurev.bi.41.070172.002113; Liljas A, 2006, ACS CHEM BIOL, V1, P567, DOI 10.1021/cb600407u; MCCARTHY BJ, 1962, BIOCHIM BIOPHYS ACTA, V55, P880; MORIYA S, 1985, NUCLEIC ACIDS RES, V13, P2251, DOI 10.1093/nar/13.7.2251; Nanamiya H, 2010, MICROBIOL-SGM, V156, P2944, DOI 10.1099/mic.0.035295-0; Natori Y, 2007, MOL MICROBIOL, V63, P294, DOI 10.1111/j.1365-2958.2006.05513.x; NOMURA M, 1970, BACTERIOL REV, V34, P228; O'Connor K, 2009, P NATL ACAD SCI USA, V106, P17522, DOI 10.1073/pnas.0906160106; OLD IG, 1992, NUCLEIC ACIDS RES, V20, P6097; Petrov AS, 2012, J PHYS CHEM B, V116, P8113, DOI 10.1021/jp304723w; Sambrook J., 1989, MOL CLONING LAB MANU; SCHULZE H, 1982, EMBO J, V1, P609; Semenkov YP, 2000, NAT STRUCT BIOL, V7, P1027; SILVER S, 1971, J BIOL CHEM, V246, P569; Suzuki S, 2014, MICROBIOL-SGM, V160, P1040, DOI 10.1099/mic.0.076463-0; TISSIERES A, 1959, J MOL BIOL, V1, P221; Uhlein M, 1998, BIOCHEM J, V331, P423; WADA A, 1986, J BIOCHEM-TOKYO, V100, P1583; Wakeman CA, 2014, J BACTERIOL, V196, P1206, DOI 10.1128/JB.01238-13; Willumeit R, 2001, J MOL BIOL, V305, P167, DOI 10.1006/jmbi.2000.4289; Yamamoto T, 2010, J BIOL CHEM, V285, P5646, DOI 10.1074/jbc.M109.081836	72	4	4	AMER SOC MICROBIOLOGY	WASHINGTON	1752 N ST NW, WASHINGTON, DC 20036-2904 USA	0021-9193	1098-5530		J BACTERIOL	J. Bacteriol.	NOV	2014	196	22					3820	3830		10.1128/JB.01896-14		11	Microbiology	Microbiology	AR9XO	WOS:000343930600002		
J	Nohara, K; Orita, I; Nakamura, S; Imanaka, T; Fukui, T				Nohara, Kenta; Orita, Izumi; Nakamura, Satoshi; Imanaka, Tadayuki; Fukui, Toshiaki			Genetic Examination and Mass Balance Analysis of Pyruvate/Amino Acid Oxidation Pathways in the Hyperthermophilic Archaeon Thermococcus kodakarensis	JOURNAL OF BACTERIOLOGY			English	Article							2-KETOISOVALERATE FERREDOXIN OXIDOREDUCTASE; PYROCOCCUS-FURIOSUS; KODAKARAENSIS KOD1; PEPTIDE FERMENTATION; HYDROGEN-PRODUCTION; ESCHERICHIA-COLI; COA SYNTHETASES; FORMATE-LYASE; ENZYME; PURIFICATION	The present study investigated the simultaneous oxidation of pyruvate and amino acids during H-2-evolving growth of the hyperthermophilic archaeon Thermococcus kodakarensis. The comparison of mass balance between a cytosolic hydrogenase (HYH)deficient strain (the Delta hyhBGSL strain) and the parent strain indicated that NADPH generated via H-2 uptake by HYH was consumed by reductive amination of 2-oxoglutarate catalyzed by glutamate dehydrogenase. Further examinations were done to elucidate functions of three enzymes potentially involved in pyruvate oxidation: pyruvate formate-lyase (PFL), pyruvate: ferredoxin oxidoreductase (POR), and 2-oxoisovalerate: ferredoxin oxidoreductase (VOR) under the HYH-deficient background in T. kodakarensis. No significant change was observed by deletion of pflDA, suggesting that PFL had no critical role in pyruvate oxidation. The growth properties and mass balances of Delta porDAB and Delta vorDAB strains indicated that POR and VOR specifically functioned in oxidation of pyruvate and branched-chain amino acids, respectively, and the lack of POR or VOR was compensated for by promoting the oxidation of another substrate driven by the remaining oxidoreductase. The H-2 yields from the consumed pyruvate and amino acids were increased from 31% by the parent strain to 67% and 82% by the deletion of hyhBGSL and double deletion of hyhBGSL and vorDAB, respectively. Significant discrepancies in the mass balances were observed in excess formation of acetate and NH3, suggesting the presence of unknown metabolisms in T. kodakarensis grown in the rich medium containing pyruvate.	[Nohara, Kenta; Orita, Izumi; Nakamura, Satoshi; Fukui, Toshiaki] Tokyo Inst Technol, Grad Sch Biosci & Biotechnol, Dept Bioengn, Midori Ku, Yokohama, Kanagawa 227, Japan; [Imanaka, Tadayuki] Ritsumeikan Univ, Coll Life Sci, Dept Biotechnol, Shiga, Japan	Fukui, T (reprint author), Tokyo Inst Technol, Grad Sch Biosci & Biotechnol, Dept Bioengn, Midori Ku, Yokohama, Kanagawa 227, Japan.	tfukui@bio.titech.ac.jp	福居, 俊昭/K-5056-2012; Nakamura, Satoshi/D-2450-2015	Nakamura, Satoshi/0000-0001-5130-2488	Institute of Fermentations, Osaka, Japan	This work was supported by a research grant from the Institute of Fermentations, Osaka, Japan.	ANDREOTTI G, 1994, EUR J BIOCHEM, V220, P543, DOI 10.1111/j.1432-1033.1994.tb18654.x; Mai XH, 1996, J BACTERIOL, V178, P5897; Sapra R, 2003, P NATL ACAD SCI USA, V100, P7545, DOI 10.1073/pnas.1331436100; Ma K, 1997, P NATL ACAD SCI USA, V94, P9608, DOI 10.1073/pnas.94.18.9608; Silva PJ, 2000, EUR J BIOCHEM, V267, P6541, DOI 10.1046/j.1432-1327.2000.01745.x; Schut GJ, 2013, FEMS MICROBIOL REV, V37, P182, DOI 10.1111/j.1574-6976.2012.00346.x; Brasen C, 2014, MICROBIOL MOL BIOL R, V78, P89, DOI 10.1128/MMBR.00041-13; Leonhartsberger S, 2002, J MOL MICROB BIOTECH, V4, P269; Mai XH, 1996, J BACTERIOL, V178, P5890; Fukui T, 2005, GENOME RES, V15, P352, DOI 10.1101/gr.3003105; Sato T, 2005, APPL ENVIRON MICROB, V71, P3889, DOI 10.1128/AEM.71.7.3889-3899.2005; Amend JP, 2001, FEMS MICROBIOL REV, V25, P175, DOI 10.1016/S0168-6445(00)00062-0; Kobori H, 2010, J BACTERIOL, V192, P5192, DOI 10.1128/JB.00235-10; Kletzin A, 1996, J BACTERIOL, V178, P248; Sato T, 2003, J BACTERIOL, V185, P210, DOI 10.1128/JB.185.1.210-220.2003; Heider J, 1996, J BACTERIOL, V178, P780; Santangelo TJ, 2009, J BACTERIOL, V191, P7102, DOI 10.1128/JB.00982-09; Ward DE, 2000, J BACTERIOL, V182, P2559, DOI 10.1128/JB.182.9.2559-2566.2000; Santangelo TJ, 2011, MOL MICROBIOL, V81, P897, DOI 10.1111/j.1365-2958.2011.07734.x; Atomi Haruyuki, 2004, Archaea, V1, P263, DOI 10.1155/2004/204953; Awano T, 2014, J BACTERIOL, V196, P140, DOI 10.1128/JB.00877-13; Bagramyan K, 2003, BIOCHEMISTRY-MOSCOW+, V68, P1159, DOI 10.1023/B:BIRY.0000009129.18714.a4; Bashir Q, 2009, J BIOCHEM, V146, P95, DOI 10.1093/jb/mvp051; BLAMEY JM, 1993, BIOCHIM BIOPHYS ACTA, V1161, P19, DOI 10.1016/0167-4838(93)90190-3; Buis JM, 2005, ARCH BIOCHEM BIOPHYS, V433, P288, DOI 10.1016/j.abb.2004.09.028; Glasemacher J, 1997, EUR J BIOCHEM, V244, P561, DOI 10.1111/j.1432-1033.1997.00561.x; Huber R, 2001, METHOD ENZYMOL, V330, P11; Itoh T, 2003, J BIOSCI BIOENG, V96, P203, DOI 10.1016/S1389-1723(03)80183-4; Kanai T, 2011, J BACTERIOL, V193, P3109, DOI 10.1128/JB.01072-10; Kanai T, 2003, J BACTERIOL, V185, P1705, DOI 10.1128/JB.185.5.1705-1711.2003; Kanai T, 2005, J BIOTECHNOL, V116, P271, DOI 10.1016/j.jbiotec.2004.11.002; KENGEN SWM, 1994, ARCH MICROBIOL, V161, P168, DOI 10.1007/BF00276479; KNAPPE J, 1974, EUR J BIOCHEM, V50, P253, DOI 10.1111/j.1432-1033.1974.tb03894.x; KOOP DR, 1982, J BIOL CHEM, V257, P8472; MAI XH, 1994, J BIOL CHEM, V269, P16726; Matsui I, 2000, J BIOL CHEM, V275, P4871, DOI 10.1074/jbc.275.7.4871; Menon AL, 1998, BIOCHEMISTRY-US, V37, P12838, DOI 10.1021/bi980979p; Ozawa Y, 2005, J BIOCHEM, V137, P101, DOI 10.1093/jb/mvi012; Ozawa Y, 2012, J BIOSCI BIOENG, V114, P23, DOI 10.1016/j.jbiosc.2012.02.014; Pisa KY, 2007, FEBS J, V274, P3928, DOI 10.1111/j.1742-4658.2007.05925.x; Schut GJ, 2001, METHOD ENZYMOL, V331, P144; Schut GJ, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00163; Scott JW, 2014, ARCHAEA, DOI 10.1155/2014/176863; Shikata K, 2007, J BIOL CHEM, V282, P26963, DOI 10.1074/jbc.M702694200; Ward Donald E., 2002, Archaea, V1, P133, DOI 10.1155/2002/959031; Yokooji Y, 2013, J BACTERIOL, V195, P1940, DOI 10.1128/JB.01979-12	46	1	1	AMER SOC MICROBIOLOGY	WASHINGTON	1752 N ST NW, WASHINGTON, DC 20036-2904 USA	0021-9193	1098-5530		J BACTERIOL	J. Bacteriol.	NOV	2014	196	22					3831	3839		10.1128/JB.02021-14		9	Microbiology	Microbiology	AR9XO	WOS:000343930600003		
J	Hamada, M; Toyofuku, M; Miyano, T; Nomura, N				Hamada, Masakaze; Toyofuku, Masanori; Miyano, Tomoki; Nomura, Nobuhiko			cbb(3)-Type Cytochrome c Oxidases, Aerobic Respiratory Enzymes, Impact the Anaerobic Life of Pseudomonas aeruginosa PAO1	JOURNAL OF BACTERIOLOGY			English	Article							BIOFILM FORMATION; DENITRIFICATION; EXPRESSION; APOPTOSIS; GENETICS; NITRATE; OPERON; GROWTH; LEADS	For bacteria, many studies have focused on the role of respiratory enzymes in energy conservation; however, their effect on cell behavior is poorly understood. Pseudomonas aeruginosa can perform both aerobic respiration and denitrification. Previous studies demonstrated that cbb(3)-type cytochrome c oxidases that support aerobic respiration are more highly expressed in P. aeruginosa under anoxic conditions than are other aerobic respiratory enzymes. However, little is known about their role under such conditions. In this study, it was shown that cbb(3) oxidases of P. aeruginosa PAO1 alter anaerobic growth, the denitrification process, and cell morphology under anoxic conditions. Furthermore, biofilm formation was promoted by the cbb(3) oxidases under anoxic conditions. cbb(3) oxidases led to the accumulation of nitric oxide (NO), which is produced during denitrification. Cell elongation induced by NO accumulation was reported to be required for robust biofilm formation of P. aeruginosa PAO1 under anoxic conditions. Our data show that cbb(3) oxidases promote cell elongation by inducing NO accumulation during the denitrification process, which further leads to robust biofilms. Our findings show that cbb(3) oxidases, which have been well studied as aerobic respiratory enzymes, are also involved in denitrification and influence the lifestyle of P. aeruginosa PAO1 under anoxic conditions.	[Hamada, Masakaze; Toyofuku, Masanori; Miyano, Tomoki; Nomura, Nobuhiko] Univ Tsukuba, Grad Sch Life & Environm Sci, Ibaraki, Japan	Nomura, N (reprint author), Univ Tsukuba, Grad Sch Life & Environm Sci, Ibaraki, Japan.	nomura.nobuhiko.ge@u.tsukuba.ac.jp			Ministry of Education, Culture, Sports, Science and Technology in Japan (MEXT) [60292520]; MEXT [25701012]; Japan Science and Technology Agency; CREST; ALCA	This study was supported by a Grant-in-Aid for Scientific Research (60292520) to N.N. from the Ministry of Education, Culture, Sports, Science and Technology in Japan (MEXT). M.T. was supported by a Grant-in-Aid for Scientific Research (25701012) from MEXT. The Japan Science and Technology Agency, CREST, and ALCA also provided financial support for this study.	Alhede M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027943; Alvarez-Ortega C, 2007, MOL MICROBIOL, V65, P153, DOI 10.1111/j.1365-2958.2007.05772.x; Allesen-Holm M, 2006, MOL MICROBIOL, V59, P1114, DOI 10.1111/j.1365-2958.2005.05008.x; Huttemann M, 2012, BBA-BIOENERGETICS, V1817, P598, DOI 10.1016/j.bbabio.2011.07.001; Schreiber K, 2007, J BACTERIOL, V189, P4310, DOI 10.1128/JB.00240-07; Davey ME, 2000, MICROBIOL MOL BIOL R, V64, P847, DOI 10.1128/MMBR.64.4.847-867.2000; Comolli JC, 2004, MOL MICROBIOL, V51, P1193, DOI 10.1046/j.1365-2958.2003.03904.x; Justice SS, 2008, NAT REV MICROBIOL, V6, P162, DOI 10.1038/nrmicro1820; HOLLOWAY BW, 1979, MICROBIOL REV, V43, P73; Lee KM, 2012, INFECT IMMUN, V80, P1639, DOI 10.1128/IAI.06161-11; SIMON R, 1986, METHOD ENZYMOL, V118, P640; Toyofuku M, 2008, J BACTERIOL, V190, P7947, DOI 10.1128/JB.00968-08; Inaba T, 2013, MICROBIOL IMMUNOL, V57, P589, DOI 10.1111/1348-0421.12064; Brown GC, 2008, BBA-BIOENERGETICS, V1777, P877, DOI 10.1016/j.bbabio.2008.03.024; Yawata Y, 2008, APPL ENVIRON MICROB, V74, P5429, DOI 10.1128/AEM.00801-08; Barraud N, 2006, J BACTERIOL, V188, P7344, DOI 10.1128/JB.00779-06; Tashiro Y, 2008, J BACTERIOL, V190, P3969, DOI 10.1128/JB.02004-07; Yoon SS, 2002, DEV CELL, V3, P593, DOI 10.1016/S1534-5807(02)00295-2; Toyofuku M, 2007, J BACTERIOL, V189, P4969, DOI 10.1128/JB.00289-07; Yawata Y, 2010, J BIOSCI BIOENG, V110, P377, DOI 10.1016/j.jbiosc.2010.04.002; Arai H, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00103; Arai H, 1997, MOL MICROBIOL, V25, P1141, DOI 10.1046/j.1365-2958.1997.5431906.x; Fang H, 2013, BIOSCI BIOTECH BIOCH, V77, P1747, DOI 10.1271/bbb.130309; Farinha M A, 1990, FEMS Microbiol Lett, V58, P221; Jordan A, 1999, J BACTERIOL, V181, P3974; Kawakami T, 2010, ENVIRON MICROBIOL, V12, P1399, DOI 10.1111/j.1462-2920.2009.02109.x; Maseda H, 2004, ANTIMICROB AGENTS CH, V48, P1320, DOI 10.1128/AAC.48.4.1320-1328.2004; Merritt J. H., 2005, CURR PROTOC MICROBIO; NICHOLAS DJD, 1957, METHOD ENZYMOL, V3, P981; Petruschka L, 2001, MOL GENET GENOMICS, V266, P199, DOI 10.1007/s004380100539; Rosenbaum MA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030827; Su S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091813; Tavankar GR, 2003, J BIOL CHEM, V278, P4524, DOI 10.1074/jbc.M210355200; Toyofuku M, 2013, ENV MICROBIOL; Van Alst NE, 2009, INFECT IMMUN, V77, P4446, DOI 10.1128/IAI.00822-09; Yoon MY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016105	36	2	2	AMER SOC MICROBIOLOGY	WASHINGTON	1752 N ST NW, WASHINGTON, DC 20036-2904 USA	0021-9193	1098-5530		J BACTERIOL	J. Bacteriol.	NOV	2014	196	22					3881	3889		10.1128/JB.01978-14		9	Microbiology	Microbiology	AR9XO	WOS:000343930600008		
J	Nishida, H; Suzuki, H; Madokoro, H; Hayashi, M; Morimoto, C; Sakamoto, M; Yamada, T				Nishida, Hiroko; Suzuki, Hiroshi; Madokoro, Hiroko; Hayashi, Mutsumi; Morimoto, Chikao; Sakamoto, Michiie; Yamada, Taketo			Blockade of CD26 Signaling Inhibits Human Osteoclast Development	JOURNAL OF BONE AND MINERAL RESEARCH			English	Article						CD26; osteoclast; p38 MAPK; osteoclast precursor; bone resorption	ACTIVATED PROTEIN-KINASE; KAPPA-B LIGAND; ANTI-CD26 MONOCLONAL-ANTIBODY; COLONY-STIMULATING FACTOR; LARGE-CELL LYMPHOMA; RECEPTOR ACTIVATOR; P38 MAPK; EXTRACELLULAR-MATRIX; PEPTIDASE-IV; IN-VITRO	Bone remodeling is maintained by the delicate balance between osteoblasts (OBs) and osteoclasts (OCs). However, the role of CD26 in regulating bone remodeling has not yet been characterized. We herein show that CD26 is preferentially expressed on normal human OCs and is intensely expressed on activated human OCs in osteolytic bone alterations. Macrophage-colony stimulating factor (M-CSF) and soluble receptor activator of NF-B ligand (sRANKL) induced human OC differentiation, in association with CD26 expression on monocyte-macrophage lineage cells. CD26 expression was accompanied by increased phosphorylation of p38 mitogen-activated protein kinase (p38 MAPK), which is crucial for early human OC differentiation. The humanized anti-CD26 monoclonal antibody, huCD26mAb, impaired the formation and function of tartrate-resistant acid phosphatase (TRAP)/CD26 positive multi-nucleated (nuclei>3) OCs with maturation in the manner of dose-dependency. It was revealed that huCD26mAb inhibits early OC differentiation via the inactivation of MKK3/6, p38 MAPK and subsequent dephosphorylation of microphthalmia-associated transcription factor (mi/Mitf). These inhibitions occur immediately after RANKL binds to RANK on the human OC precursor cells and were demonstrated using the OC functional assays. huCD26mAb subsequently impaired OC maturation and bone resorption by suppressing the expression of TRAP and OC fusion proteins. In addition, p38 MAPK inhibitor also strongly inhibited OC formation and function. Our results suggest that the blockade of CD26 signaling impairs the development of human functional OCs by inhibiting p38 MAPK-mi/Mitf phosphorylation pathway and that targeting human OCs with huCD26mAb may have therapeutic potential for the treatment of osteolytic lesions following metastasis to alleviate bone destruction and reduce total skeletal-related events (SREs). (c) 2014 American Society for Bone and Mineral Research.	[Nishida, Hiroko; Suzuki, Hiroshi; Madokoro, Hiroko; Hayashi, Mutsumi; Sakamoto, Michiie; Yamada, Taketo] Keio Univ, Sch Med, Dept Pathol, Shinjuku Ku, Tokyo 1608582, Japan; [Morimoto, Chikao] Juntendo Univ, Grad Sch Med, Dept Therapy Dev & Innovat Immune Disorders & Can, Bunkyo Ku, Tokyo, Japan	Yamada, T (reprint author), Keio Univ, Sch Med, Dept Pathol, Shinjuku Ku, 35 Shinanomachi, Tokyo 1608582, Japan.	taketo@a5.keio.jp			Ministry of Education in Japan [25430157, 20590354, 1770124]; Program for Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation [07-17]; Ministry of Health, Labor and Welfare, Japan [H24-B10-003]	We would like to express thanks to Dr. N. Kiyokawa at the National Center for Child Health and Development, Tokyo, Japan, and Dr. K. Ohnuma at the Institute of Medical Science, the University of Tokyo, Tokyo, Japan for providing us with antibodies. We also thank Dr. K. Emoto at Keio University, School of Medicine, Tokyo, Japan, for his helpful advice regarding pathology. This work was supported by Grants-in-Aid for Scientific Research from the Ministry of Education in Japan (H.N. 25430157, T.Y. 20590354, M.S. 1770124), the Program for Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation (T.Y. and C.M. 07-17), and a Grant-in-Aid for Drug Design Biomarker Research (T.Y. and C.M., H24-B10-003) from the Ministry of Health, Labor and Welfare, Japan.	Amatya VJ, 2011, ONCOL REP, V26, P1369, DOI 10.3892/or.2011.1449; Yaccoby S, 2004, CANCER RES, V64, P2016, DOI 10.1158/0008-5472.CAN-03-1131; RAINGEAUD J, 1995, J BIOL CHEM, V270, P7420; Leung R, 2011, BLOOD, V117, P2044, DOI 10.1182/blood-2010-05-282574; Inamoto T, 2006, CLIN CANCER RES, V12, P3470, DOI 10.1158/1078-0432.CCR-06-0361; Rissanen JP, 2008, CALCIFIED TISSUE INT, V82, P108, DOI 10.1007/s00223-007-9091-4; Xiong JH, 2011, NAT MED, V17, P1235, DOI 10.1038/nm.2448; Li XT, 2002, ENDOCRINOLOGY, V143, P3105, DOI 10.1210/en.143.8.3105; Henry DH, 2011, J CLIN ONCOL, V29, P1125, DOI 10.1200/JCO.2010.31.3304; Aoe K, 2012, CLIN CANCER RES, V18, P1447, DOI 10.1158/1078-0432.CCR-11-1990; Giuliani N, 2004, EXP HEMATOL, V32, P685, DOI 10.1016/j.exphem.2004.03.015; Pang R, 2010, CELL STEM CELL, V6, P603, DOI 10.1016/j.stem.2010.04.001; Irie N, 2009, J BIOL CHEM, V284, P14637, DOI 10.1074/jbc.M807598200; Clynes RA, 2000, NAT MED, V6, P443; Song I, 2009, FEBS LETT, V583, P2435, DOI 10.1016/j.febslet.2009.06.047; Boyle WJ, 2003, NATURE, V423, P337, DOI 10.1038/nature01658; Fujita K, 2012, NAT MED, V18, P589, DOI 10.1038/nm.2659; Stopeck AT, 2010, J CLIN ONCOL, V28, P5132, DOI 10.1200/JCO.2010.29.7101; Dougall WC, 2012, CLIN CANCER RES, V18, P326, DOI 10.1158/1078-0432.CCR-10-2507; Castellano D, 2011, ONCOLOGIST, V16, P136, DOI [10.1634/theoncologist.2010-0154, 10.1634/theoncologist.20100154]; Matsumoto M, 2000, J BIOL CHEM, V275, P31155, DOI 10.1074/jbc.M001229200; Zwerina J, 2006, ARTHRITIS RHEUM, V54, P463, DOI 10.1002/art.21626; Sato T, 2005, CANCER RES, V65, P6950, DOI 10.1158/0008-5472.CAN-05-0647; Bohm C, 2009, J IMMUNOL, V183, P5938, DOI 10.4049/jimmunol.0901026; Matsuo K, 2008, ARCH BIOCHEM BIOPHYS, V473, P201, DOI 10.1016/j.abb.2008.03.027; Li XT, 2003, ENDOCRINOLOGY, V144, P4999, DOI 10.1210/en.2003-0166; Mansky KC, 2002, J BIOL CHEM, V277, P11077, DOI 10.1074/jbc.M111696200; Kim K, 2008, MOL ENDOCRINOL, V22, P176, DOI 10.1210/me.2007-0237; Cartron G, 2002, BLOOD, V99, P754, DOI 10.1182/blood.V99.3.754; Yamaguchi U, 2008, J CLIN ONCOL, V26, P4100, DOI 10.1200/JCO.2007.14.2331; Inamoto T, 2007, CLIN CANCER RES, V13, P4191, DOI 10.1158/1078-0432.CCR-07-0110; Fizazi K, 2011, LANCET, V377, P813, DOI 10.1016/S0140-6736(10)62344-6; Levaot N, 2011, J CLIN INVEST, V121, P3244, DOI 10.1172/JCI45843; Miyamoto T, 2000, BLOOD, V96, P4335; Udagawa N, 1999, BONE, V25, P517, DOI 10.1016/S8756-3282(99)00210-0; Ishida T, 2011, INT J HEMATOL, V94, P443, DOI 10.1007/s12185-011-0941-5; Ashley JW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025838; DANG NH, 1990, J IMMUNOL, V145, P3963; Dong RP, 1998, MOL IMMUNOL, V35, P13, DOI 10.1016/S0161-5890(98)00015-7; Eghabli FG, 2003, J CLIN INVEST, V111, P1221; Hirai K, 1999, PATHOL INT, V49, P264, DOI 10.1046/j.1440-1827.1999.00859.x; Kameoka J, 2006, LEUKEMIA LYMPHOMA, V47, P2181, DOI 10.1080/10428190600773396; Kobayashi S, 2004, BLOOD, V103, P1002, DOI 10.1182/blood-2003-08-2691; Miyazaki T, 2011, ANAL BIOCHEM, V410, P7, DOI 10.1016/j.ab.2010.11.014; Nakshima T, 2011, NAT MED, V17, P1231; Pennisi A, 2009, BRIT J HAEMATOL, V145, P775, DOI 10.1111/j.1365-2141.2009.07696.x; Voso MT, 2002, HAEMATOLOGICA, V87, P918; Yamochi T, 2005, CANCER RES, V65, P1973, DOI 10.1158/0008-5472.CAN-04-2611	48	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0884-0431	1523-4681		J BONE MINER RES	J. Bone Miner. Res.	NOV	2014	29	11					2439	2455		10.1002/jbmr.2277		17	Endocrinology & Metabolism	Endocrinology & Metabolism	AS4DF	WOS:000344222800013		
J	Osada, H; Nakajima, H; Meshii, K; Ohnaka, M				Osada, Hiroaki; Nakajima, Hiroyuki; Meshii, Katsuaki; Ohnaka, Motoaki			Right Atrial Volume Reduction for Severely Impaired Pulmonary Function	JOURNAL OF CARDIAC SURGERY			English	Article							GIANT RIGHT ATRIUM; PARTIAL LEFT VENTRICULECTOMY; STAGE HEART-DISEASE; ADULT	We report a patient with giant right atrium and severe pulmonary dysfunction who underwent successful surgical volume reduction with significant improvement of pulmonary function studies.	[Osada, Hiroaki; Nakajima, Hiroyuki; Meshii, Katsuaki; Ohnaka, Motoaki] Mitsubishi Kyoto Hosp, Dept Cardiovasc Surg, Kyoto 6158087, Japan	Osada, H (reprint author), Mitsubishi Kyoto Hosp, Dept Cardiovasc Surg, Nishikyo Ku, 1 Katsuragosho Machi, Kyoto 6158087, Japan.	osahiro@kuhp.kyoto-u.ac.jp					Batista RJV, 1997, ANN THORAC SURG, V64, P634, DOI 10.1016/S0003-4975(97)00779-0; Batista RJV, 1996, J CARDIAC SURG, V11, P96, DOI 10.1111/j.1540-8191.1996.tb00019.x; Apostotakis E, 2008, EUR J CARDIO-THORAC, V33, P182, DOI 10.1016/j.ejcts.2007.11.003; Ariyarajah V, 2008, ECHOCARDIOGR-J CARD, V25, P1121, DOI 10.1111/j.1540-8175.2008.00742.x; Gomes S, 2012, HEART LUNG CIRC, V21, P50, DOI 10.1016/j.hlc.2011.06.007; Hager S, 2006, CIRCULATION, V113, pE53, DOI 10.1161/CIRCULATIONAHA.105.502575; Marui A, 2008, J THORAC CARDIOV SUR, V135, P1297, DOI 10.1016/j.jtcvs.2008.02.026; MCKENNEY RN, 1987, CAN J SURG, V30, P264; Montes L, 2011, ANN THORAC SURG, V91, pE80, DOI 10.1016/j.athoracsur.2011.02.085; Sawazaki M, 2013, ANN THORAC SURG, V95, P1464, DOI 10.1016/j.athoracsur.2012.10.056; Sugiki H, 2006, ANN THORAC SURG, V81, P378, DOI 10.1016/j.athoracsur.2004.10.022; Yuasa S, 2003, ANN THORAC SURG, V75, P1985, DOI 10.1016/S0003-4975(02)04817-8	12	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0886-0440	1540-8191		J CARDIAC SURG	J. Card. Surg.	NOV	2014	29	6					787	789		10.1111/jocs.12397		3	Cardiac & Cardiovascular Systems; Surgery	Cardiovascular System & Cardiology; Surgery	AS6TQ	WOS:000344395500007		
J	Nishida, H; Tabata, M; Fukui, T; Takanashi, S				Nishida, Hidefumi; Tabata, Minoru; Fukui, Toshihiro; Takanashi, Shuichiro			Mycotic Coronary Artery Aneurysm and Mitral Valve Regurgitation Caused by Infectious Endocarditis	JOURNAL OF CARDIAC SURGERY			English	Editorial Material									[Nishida, Hidefumi; Tabata, Minoru; Fukui, Toshihiro; Takanashi, Shuichiro] Sakakibara Heart Inst, Dept Cardiovasc Surg, Fuchu, Tokyo 1830011, Japan	Nishida, H (reprint author), Sakakibara Heart Inst, Dept Cardiovasc Surg, 3-16-1 Asahi Cho, Fuchu, Tokyo 1830011, Japan.	da_nishi59@yahoo.co.jp						0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0886-0440	1540-8191		J CARDIAC SURG	J. Card. Surg.	NOV	2014	29	6					797	798		10.1111/jocs.12420		2	Cardiac & Cardiovascular Systems; Surgery	Cardiovascular System & Cardiology; Surgery	AS6TQ	WOS:000344395500011		
J	Aoyagi, S				Aoyagi, Shigeaki			Sutureless Repair of Ventricular Free Wall Rupture REPLY	JOURNAL OF CARDIAC SURGERY			English	Letter							SURGICAL-TREATMENT		St Marys Hosp, Dept Cardiovasc Surg, Ctr Cardiovasc, Kurume, Fukuoka 8308543, Japan	Aoyagi, S (reprint author), St Marys Hosp, Dept Cardiovasc Surg, Ctr Cardiovasc, 422 Tsubukuhon Machi, Kurume, Fukuoka 8308543, Japan.	shigeakiaoyagi@gmail.com					Sakaguchi G, 2008, ANN THORAC SURG, V85, P1344, DOI 10.1016/j.athoracsur.2007.12.073; Aoyagi S, 2014, J CARDIAC SURG, V29, P178, DOI 10.1111/jocs.12286; Mantovani V, 2002, EUR J CARDIO-THORAC, V22, P777, DOI 10.1016/S1010-7940(02)00485-2; Myers PO, 2014, J CARDIOVASC SURG, V29, P178	4	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0886-0440	1540-8191		J CARDIAC SURG	J. Card. Surg.	NOV	2014	29	6					805	805				1	Cardiac & Cardiovascular Systems; Surgery	Cardiovascular System & Cardiology; Surgery	AS6TQ	WOS:000344395500016		
J	Sekiguchi, Y; Takuwa, H; Kawaguchi, H; Kikuchi, T; Okada, E; Kanno, I; Ito, H; Tomita, Y; Itoh, Y; Suzuki, N; Sudo, R; Tanishita, K; Masamoto, K				Sekiguchi, Yuta; Takuwa, Hiroyuki; Kawaguchi, Hiroshi; Kikuchi, Takahiro; Okada, Eiji; Kanno, Iwao; Ito, Hiroshi; Tomita, Yutaka; Itoh, Yoshiaki; Suzuki, Norihiro; Sudo, Ryo; Tanishita, Kazuo; Masamoto, Kazuto			Pial arteries respond earlier than penetrating arterioles to neural activation in the somatosensory cortex in awake mice exposed to chronic hypoxia: an additional mechanism to proximal integration signaling?	JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM			English	Article						activity-induced vasodilation; cerebral blood flow regulation; laser scanning microscopy; microvascular plasticity; neurovascular coupling	LASER-DOPPLER FLOWMETRY; CEREBRAL-BLOOD-FLOW; IN-VIVO; MICROVASCULAR DILATION; BRAIN MICROCIRCULATION; STIMULATION; MOUSE; ISCHEMIA; DIAMETER; RAT	The pial and penetrating arteries have a crucial role in regulating cerebral blood flow (CBF) to meet neural demand in the cortex. Here, we examined the longitudinal effects of chronic hypoxia on the arterial diameter responses to single whisker stimulation in the awake mouse cortex, where activity-induced responses of CBF were gradually attenuated. The vasodilation responses to whisker stimulation under prehypoxia normal conditions were 8.1% and 12% relative to their baselines in the pial arteries and penetrating arterioles, respectively. After 3 weeks of hypoxia, however, these responses were significantly reduced to 5.5% and 4.1%, respectively. The CBF response, measured using laser-Doppler flowmetry (LDF), induced by the same whisker stimulation was also attenuated (14% to 2.6%). A close linear correlation was found for the responses between the penetrating arteriolar diameter and LDF, and their temporal dynamics. After 3 weeks of chronic hypoxia, the initiation of vasodilation in the penetrating arterioles was significantly extended, but the pial artery responses remained unchanged. These results show that vasodilation of the penetrating arterioles followed the pial artery responses, which are not explainable in terms of proximal integration signaling. The findings therefore indicate an additional mechanism for triggering pial artery dilation in the neurovascular coupling.	[Sekiguchi, Yuta; Sudo, Ryo; Tanishita, Kazuo] Keio Univ, Sch Integrated Design Engn, Yokohama, Kanagawa 223, Japan; [Sekiguchi, Yuta; Takuwa, Hiroyuki; Kawaguchi, Hiroshi; Kanno, Iwao; Ito, Hiroshi; Masamoto, Kazuto] Natl Inst Radiol Sci, Mol Imaging Ctr, Inage Ku, Chiba 260, Japan; [Kikuchi, Takahiro; Okada, Eiji] Keio Univ, Dept Elect & Elect Engn, Yokohama, Kanagawa 223, Japan; [Tomita, Yutaka; Itoh, Yoshiaki; Suzuki, Norihiro] Keio Univ, Sch Med, Dept Neurol, Shinjuku Ku, Tokyo, Japan; [Sudo, Ryo; Tanishita, Kazuo] Keio Univ, Dept Syst Design Engn, Yokohama, Kanagawa 223, Japan; [Masamoto, Kazuto] Univ Electrocommun, Brain Sci Inspired Life Support Res Ctr, Chofu, Tokyo 1828585, Japan	Masamoto, K (reprint author), Univ Electrocommun, Brain Sci Inspired Life Support Res Ctr, 1-5-1 Chofugaoka, Chofu, Tokyo 1828585, Japan.	masamoto@mce.uec.ac.jp	Suzuki, Norihiro/J-5125-2013		JSPS KAKENHI [25750400]; Ministry of Health, Labor and Welfare (MHLW), Japan [22700441, 24659578]	This study was partially supported through funding from JSPS KAKENHI (25750400) (to KM), the Grant-in-Aid for Young Scientists (B) (22700441) (HK), JSPS KEKENHI (24659578) (IK), and a grant from the Ministry of Health, Labor and Welfare (MHLW), Japan (IK).	Miekisiak G, 2008, J CEREBR BLOOD F MET, V28, P1656, DOI 10.1038/jcbfm.2008.57; DIRNAGL U, 1989, J CEREBR BLOOD F MET, V9, P589; Nishimura N, 2007, P NATL ACAD SCI USA, V104, P365, DOI 10.1073/pnas.0609551104; Itoh Y, 2012, J CEREBR BLOOD F MET, V32, P1167, DOI 10.1038/jcbfm.2012.5; Chuquet J, 2007, J NEUROSCI, V27, P4036, DOI 10.1523/JNEUROSCI.0721-07.2007; Yoshihara K, 2013, ADV EXP MED BIOL, V765, P357, DOI 10.1007/978-1-4614-4989-8_50; Tian PF, 2010, P NATL ACAD SCI USA, V107, P15246, DOI 10.1073/pnas.1006735107; Lecrux C, 2011, J NEUROSCI, V31, P9836, DOI 10.1523/JNEUROSCI.4943-10.2011; Hotta H, 2013, J CEREBR BLOOD F MET, V33, P1440, DOI 10.1038/jcbfm.2013.92; Tomita Y, 2005, J CEREBR BLOOD F MET, V25, P858, DOI 10.1038/sj.jcbfm.9600077; Masamoto K, 2012, NEUROSCIENCE, V212, P190, DOI 10.1016/j.neuroscience.2012.03.034; Horiuchi T, 2002, STROKE, V33, P2692, DOI 10.1161/01.STR.0000034791.52151.6B; Takuwa H, 2013, J CEREBR BLOOD F MET, V33, P774, DOI 10.1038/jcbfm.2013.16; Motoike T, 2000, GENESIS, V28, P75, DOI 10.1002/1526-968X(200010)28:2<75::AID-GENE50>3.0.CO;2-S; Hamel E, 2006, J APPL PHYSIOL, V100, P1059, DOI 10.1152/japplphysiol.00954.2005; Takuwa H, 2011, BRAIN RES, V1369, P103, DOI 10.1016/j.brainres.2010.11.007; Gordon GRJ, 2008, NATURE, V456, P745, DOI 10.1038/nature07525; Chavez JC, 2002, J NEUROSCI, V22, P8922; Sandor P, 1999, NEUROCHEM INT, V35, P237, DOI 10.1016/S0197-0186(99)00067-4; HARIK SI, 1995, J APPL PHYSIOL, V79, P136; Barrett MJP, 2012, NEUROIMAGE, V62, P482, DOI 10.1016/j.neuroimage.2012.05.005; Bauser-Heaton HD, 2007, AM J PHYSIOL-HEART C, V293, pH2193, DOI 10.1152/ajpheart.00190.2007; Ganjoo P, 1998, ANESTHESIOLOGY, V88, P429, DOI 10.1097/00000542-199802000-00022; Gotoh F, 1975, CEREBRAL CIRCULATION, P43; HABERL RL, 1989, AM J PHYSIOL, V256, pH1255; HABERL RL, 1989, AM J PHYSIOL, V256, pH1247; He JB, 2007, NEUROIMAGE, V34, P1391, DOI 10.1016/j.neuroimage.2006.11.017; IBAYASHI S, 1991, J CEREBR BLOOD F MET, V11, P678; Kawaguchi H, 2012, MICROVASC RES, V84, P178, DOI 10.1016/j.mvr.2012.05.001; ladecola C., 2004, NAT REV NEUROSCI, V5, P347, DOI DOI 10.1038/NRN1387; Mchedlishvili GI, 1986, ARTERIAL BEHAV BLOOD; MCHEDLIS.GI, 1967, NATURE, V213, P506, DOI 10.1038/213506a0; Ngai AC, 2002, AM J PHYSIOL-HEART C, V282, pH902; NGAI AC, 1995, J CEREBR BLOOD F MET, V15, P124; OBERG PA, 1984, ACTA MED SCAND, P17; Schaffer CB, 2006, PLOS BIOL, V4, P258, DOI 10.1371/journal.pbio.0040022; Sekiguchi Y, 2013, ADV EXP MED BIOL, V789, P419, DOI 10.1007/978-1-4614-7411-1_56; SKARPHEDINSSON JO, 1988, ACTA PHYSIOL SCAND, V134, P133, DOI 10.1111/j.1748-1716.1988.tb08469.x; Stewart PA, 1997, ACTA NEUROPATHOL, V93, P579; TUOR UI, 1984, AM J PHYSIOL, V247, pH40; UEMATSU D, 1987, J NEUROL SCI, V78, P303, DOI 10.1016/0022-510X(87)90044-X; Xu HL, 2008, AM J PHYSIOL-HEART C, V294, pH622, DOI 10.1152/ajpheart.00530.2007	42	1	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0271-678X	1559-7016		J CEREBR BLOOD F MET	J. Cereb. Blood Flow Metab.	NOV	2014	34	11					1761	1770		10.1038/jcbfm.2014.140		10	Endocrinology & Metabolism; Hematology; Neurosciences	Endocrinology & Metabolism; Hematology; Neurosciences & Neurology	AS7HZ	WOS:000344428800004		
J	Hamada, A; Murayama, Y; Takayabu, YN				Hamada, Atsushi; Murayama, Yuki; Takayabu, Yukari N.			Regional Characteristics of Extreme Rainfall Extracted from TRMM PR Measurements	JOURNAL OF CLIMATE			English	Article							PASSIVE MICROWAVE; DIURNAL-VARIATION; CONVECTIVE CELLS; SOUTH-AMERICA; PRECIPITATION EVENTS; PROFILING ALGORITHM; RADAR REFLECTIVITY; TROPICAL PACIFIC; VERTICAL PROFILE; FLASH-FLOOD	Characteristics and global distribution of regional extreme rainfall are presented using 12 yr of the Tropical Rainfall Measuring Mission (TRMM) Precipitation Radar (PR) measurements. By considering each rainfall event as a set of contiguous PR rainy pixels, characteristic values for each event are obtained. Regional extreme rainfall events are defined as those in which maximum near-surface rainfall rates are higher than the corresponding 99.9th percentile on a 2.5 degrees x 2.5 degrees horizontal-resolution grid. The geographical distribution of extreme rainfall rates shows clear regional differences. The size and volumetric rainfall of extreme events also show clear regional differences. Extreme rainfall rates show good correlations with the corresponding rain-top heights and event sizes over oceans but marginal or no correlation overland. The time of maximum occurrence of extreme rainfall events tends to be during 0000-1200 LT over oceans, whereas it has a distinct afternoon peak over land. There are also clear seasonal differences in which the occurrence over land is largely coincident with insolation. Regional extreme rainfall is classified by extreme rainfall rate (intensity) and the corresponding event size (extensity). Regions of "intense and extensive" extreme rainfall are found mainly over oceans near coastal areas and are likely associated with tropical cyclones and convective systems associated with the establishment of monsoons. Regions of "intense but less extensive" extreme rainfall are distributed widely over land and maritime continents, probably related to afternoon showers and mesoscale convective systems. Regions of "extensive but less intense" extreme rainfall are found almost exclusively over oceans, likely associated with well-organized mesoscale convective systems and extratropical cyclones.	[Hamada, Atsushi; Takayabu, Yukari N.] Univ Tokyo, Atmosphere & Ocean Res Inst, Kashiwa, Chiba 2778568, Japan; [Murayama, Yuki] Minist Econ Trade & Ind, Tokyo, Japan	Hamada, A (reprint author), Univ Tokyo, Atmosphere & Ocean Res Inst, 5-1-5 Kashiwanoha, Kashiwa, Chiba 2778568, Japan.	a-hamada@aori.u-tokyo.ac.jp			7th GPM/TRMM RA of the Japan Aerospace Exploration Agency (JAXA), Japan	The authors are grateful to Dr. Chie Yokoyama of the Atmosphere and Ocean Research Institute, University of Tokyo, for her support. The results presented in this paper are a part of a Master's thesis by the second author. This study is supported by the 7th GPM/TRMM RA of the Japan Aerospace Exploration Agency (JAXA), Japan. Most of the figures have been produced using the GFD-DENNOU Library and the Grid Analysis and Display System (GrADS).	ALEXANDER LV, 2006, 4 GEOPHYS RES, V111, DOI DOI 10.1029/2005JD006290; MADDOX RA, 1979, B AM METEOROL SOC, V60, P115, DOI 10.1175/1520-0477-60.2.115; Ushio T, 2009, J METEOROL SOC JPN, V87A, P137, DOI 10.2151/jmsj.87A.137; Iguchi T, 2000, J APPL METEOROL, V39, P2038, DOI 10.1175/1520-0450(2001)040<2038:RPAFTT>2.0.CO;2; Houze RA, 2012, REV GEOPHYS, V50, DOI 10.1029/2011RG000365; Cifelli R, 2007, MON WEATHER REV, V135, P1576, DOI 10.1175/MWR3340.1; RICHARDS F, 1981, MON WEATHER REV, V109, P1081, DOI 10.1175/1520-0493(1981)109<1081:OTRBSO>2.0.CO;2; Chen SS, 1997, Q J ROY METEOR SOC, V123, P357, DOI 10.1002/qj.49712353806; Barros AP, 2003, MON WEATHER REV, V131, P1408, DOI 10.1175/1520-0493(2003)131<1408:MTMITH>2.0.CO;2; BLACKMON ML, 1977, J ATMOS SCI, V34, P1040, DOI 10.1175/1520-0469(1977)034<1040:AOSOTN>2.0.CO;2; Catto JL, 2013, J GEOPHYS RES-ATMOS, V118, P10791, DOI 10.1002/jgrd.50852; Seiler C, 2013, J APPL METEOROL CLIM, V52, P130, DOI 10.1175/JAMC-D-12-0105.1; Shige S, 2013, J APPL METEOROL CLIM, V52, P242, DOI 10.1175/JAMC-D-12-074.1; Carvalho LMV, 2002, J CLIMATE, V15, P2377, DOI 10.1175/1520-0442(2002)015<2377:EPEISS>2.0.CO;2; Nair S, 2009, J METEOROL SOC JPN, V87, P927, DOI 10.2151/jmsj.87.927; Aonashi K, 2009, J METEOROL SOC JPN, V87A, P119, DOI 10.2151/jmsj.87A.119; Kirstetter PE, 2013, J HYDROMETEOROL, V14, P661, DOI 10.1175/JHM-D-12-030.1; Funatsu BM, 2009, MON WEATHER REV, V137, P3933, DOI 10.1175/2009MWR2922.1; ALBRIGHT MD, 1985, MON WEATHER REV, V113, P1663, DOI 10.1175/1520-0493(1985)113<1663:TDVODC>2.0.CO;2; Curtis S, 2007, J HYDROMETEOROL, V8, P678, DOI 10.1175/JHM601.1; Liu CT, 2011, J HYDROMETEOROL, V12, P394, DOI 10.1175/2010JHM1320.1; Carbone RE, 2002, J ATMOS SCI, V59, P2033, DOI 10.1175/1520-0469(2002)059<2033:IOPAWW>2.0.CO;2; Aguilar E, 2005, J GEOPHYS RES-ATMOS, V110, DOI 10.1029/2005JD006119; Knapp KR, 2010, B AM METEOROL SOC, V91, P363, DOI 10.1175/2009BAMS2755.1; Lin YL, 2001, WEATHER FORECAST, V16, P633, DOI 10.1175/1520-0434(2001)016<0633:SCIFHO>2.0.CO;2; Garreaud RD, 1997, MON WEATHER REV, V125, P3157, DOI 10.1175/1520-0493(1997)125<3157:TDMOCC>2.0.CO;2; Haylock MR, 2006, J CLIMATE, V19, P1490, DOI 10.1175/JCLI3695.1; Mohr KI, 1996, MON WEATHER REV, V124, P2417, DOI 10.1175/1520-0493(1996)124<2417:MCSDBT>2.0.CO;2; Iguchi T, 2009, J METEOROL SOC JPN, V87A, P1, DOI 10.2151/jmsj.87A.1; SZOKE EJ, 1986, J ATMOS SCI, V43, P182, DOI 10.1175/1520-0469(1986)043<0182:ARSOCC>2.0.CO;2; Nesbitt SW, 2003, J CLIMATE, V16, P1456, DOI 10.1175/1520-0442-16.10.1456; ZIPSER EJ, 1994, MON WEATHER REV, V122, P1751, DOI 10.1175/1520-0493(1994)122<1751:TVPORR>2.0.CO;2; Romatschke U, 2010, J CLIMATE, V23, P3761, DOI 10.1175/2010JCLI3465.1; Farr TG, 2007, REV GEOPHYS, V45, DOI 10.1029/2005RG000183; Rasmussen KL, 2012, B AM METEOROL SOC, V93, P1713, DOI 10.1175/BAMS-D-11-00236.1; Konrad CE, 2001, J HYDROMETEOROL, V2, P309, DOI 10.1175/1525-7541(2001)002<0309:TMEPEO>2.0.CO;2; Kubota T, 2007, IEEE T GEOSCI REMOTE, V45, P2259, DOI 10.1109/TGRS.2007.895337; Petersen WA, 1999, B AM METEOROL SOC, V80, P191, DOI 10.1175/1520-0477(1999)080<0191:MAROOT>2.0.CO;2; Short DA, 2010, J ATMOS OCEAN TECH, V27, P1247, DOI 10.1175/2010JTECHA1426.1; Taniguchi A, 2013, J HYDROMETEOROL, V14, P1859, DOI 10.1175/JHM-D-13-047.1; Ajayamohan RS, 2010, J CLIMATE, V23, P1004, DOI 10.1175/2009JCLI2918.1; Seto S, 2013, SOLA, V9, P98, DOI 10.2151/sola.2013-022; Sohn BJ, 2013, MON WEATHER REV, V141, P3873, DOI 10.1175/MWR-D-13-00075.1; Allen MR, 2002, NATURE, V419, P224, DOI 10.1038/nature01092; GRAY WM, 1977, MON WEATHER REV, V105, P1171, DOI 10.1175/1520-0493(1977)105<1171:DVODCC>2.0.CO;2; Zipser EJ, 2006, B AM METEOROL SOC, V87, P1057, DOI 10.1175/BAMS-87-8-1057; Cecil DJ, 2012, J CLIMATE, V25, P687, DOI 10.1175/JCLI-D-11-00130.1; Fu R, 1999, J CLIMATE, V12, P1306, DOI 10.1175/1520-0442(1999)012<1306:HDAALS>2.0.CO;2; Hamada A, 2014, J APPL METEOROL CLIM, V53, P1252, DOI 10.1175/JAMC-D-13-099.1; Hirose M, 2009, J METEOROL SOC JPN, V87A, P353, DOI 10.2151/jmsj.87A.353; Hirose M, 2012, J ATMOS OCEAN TECH, V29, P192, DOI 10.1175/JTECH-D-11-00067.1; Kelley OA, 2010, MON WEATHER REV, V138, P1651, DOI 10.1175/2009MWR3030.1; Lau KM, 2008, J GEOPHYS RES-ATMOS, V113, DOI 10.1029/2008JD009963; LEARY CA, 1979, J ATMOS SCI, V36, P437, DOI 10.1175/1520-0469(1979)036<0437:TSAEOC>2.0.CO;2; Marengo JA, 2001, J CLIMATE, V14, P833, DOI 10.1175/1520-0442(2001)014<0833:OAEOTR>2.0.CO;2; McCollum JR, 2000, J APPL METEOROL, V39, P666, DOI 10.1175/1520-0450-39.5.666; Monaghan AJ, 2010, J CLIMATE, V23, P5065, DOI 10.1175/2010JCLI3515.1; Sato T, 2013, MON WEATHER REV, V141, P2451, DOI 10.1175/MWR-D-12-00321.1; Smith JA, 1996, WATER RESOUR RES, V32, P3099, DOI 10.1029/96WR02107; SPENCER RW, 1985, J CLIM APPL METEOROL, V24, P860, DOI 10.1175/1520-0450(1985)024<0860:MTGDOI>2.0.CO;2; Takayabu YN, 2008, J METEOROL SOC JPN, V86A, P163	61	1	1	AMER METEOROLOGICAL SOC	BOSTON	45 BEACON ST, BOSTON, MA 02108-3693 USA	0894-8755	1520-0442		J CLIMATE	J. Clim.	NOV 1	2014	27	21					8151	8169		10.1175/JCLI-D-14-00107.1		19	Meteorology & Atmospheric Sciences	Meteorology & Atmospheric Sciences	AS2TE	WOS:000344131500012		
J	Yuen, M; Sandaradura, SA; Dowling, JJ; Kostyukova, AS; Moroz, N; Quinlan, KG; Lehtokari, VL; Ravenscroft, G; Todd, EJ; Ceyhan-Birsoy, O; Gokhin, DS; Maluenda, J; Lek, M; Nolent, F; Pappas, CT; Novak, SM; D'Amico, A; Malfatti, E; Thomas, BP; Gabriel, SB; Gupta, N; Daly, MJ; Ilkovski, B; Houweling, PJ; Davidson, AE; Swanson, LC; Brownstein, CA; Gupta, VA; Medne, L; Shannon, P; Martin, N; Bick, DP; Flisberg, A; Holmberg, E; Van den Bergh, P; Lapunzina, P; Waddell, LB; Sioboda, DD; Bertini, E; Chitayat, D; Telfer, WR; Laquerriere, A; Gregorio, CC; Ottenheijm, CAC; Bonnemann, CG; Pelin, K; Beggs, AH; Hayashi, YK; Romero, NB; Laing, NG; Nishino, I; Wallgren-Pettersson, C; Melki, J; Fowler, VM; MacArthur, DG; North, KN; Clarke, NF				Yuen, Michaele; Sandaradura, Sarah A.; Dowling, James J.; Kostyukova, Alla S.; Moroz, Natalia; Quinlan, Kate G.; Lehtokari, Vilma-Lotta; Ravenscroft, Gianina; Todd, Emily J.; Ceyhan-Birsoy, Ozge; Gokhin, David S.; Maluenda, Jerome; Lek, Monkol; Nolent, Flora; Pappas, Christopher T.; Novak, Stefanie M.; D'Amico, Adele; Malfatti, Edoardo; Thomas, Brett P.; Gabriel, Stacey B.; Gupta, Namrata; Daly, Mark J.; Ilkovski, Biljana; Houweling, Peter J.; Davidson, Ann E.; Swanson, Lindsay C.; Brownstein, Catherine A.; Gupta, Vandana A.; Medne, Livija; Shannon, Patrick; Martin, Nicole; Bick, David P.; Flisberg, Anders; Holmberg, Eva; Van den Bergh, Peter; Lapunzina, Pablo; Waddell, Leigh B.; Sioboda, Darcee D.; Bertini, Enrico; Chitayat, David; Telfer, William R.; Laquerriere, Annie; Gregorio, Carol C.; Ottenheijm, Coen A. C.; Boennemann, Carsten G.; Pelin, Katarina; Beggs, Alan H.; Hayashi, Yukiko K.; Romero, Norma B.; Laing, Nigel G.; Nishino, Ichizo; Wallgren-Pettersson, Carina; Melki, Judith; Fowler, Velia M.; MacArthur, Daniel G.; North, Kathryn N.; Clarke, Nigel F.			Leiomodin-3 dysfunction results in thin filament disorganization and nemaline myopathy	JOURNAL OF CLINICAL INVESTIGATION			English	Article							MUSCLE ALPHA-TROPOMYOSIN; SKELETAL-MUSCLE; POINTED-END; N-TERMINUS; ACTIN; TROPOMODULIN; MUTATIONS; LENGTH; POLYMERIZATION; DEFICIENCY	Nemaline myopathy (NM) is a genetic muscle disorder characterized by muscle dysfunction and electron-dense protein accumulations (nemaline bodies) in myofibers. Pathogenic mutations have been described in 9 genes to date, but the genetic basis remains unknown in many cases. Here, using an approach that combined whole-exome sequencing (WES) and Sanger sequencing, we identified homozygous or compound heterozygous variants in LMOD3 in 21 patients from 14 families with severe, usually lethal, NM. LMOD3 encodes leiomodin-3 (LMOD3), a 65-kDa protein expressed in skeletal and cardiac muscle. LMOD3 was expressed from early stages of muscle differentiation; localized to actin thin filaments, with enrichment near the pointed ends; and had strong actin filament-nucleating activity. Loss of LMOD3 in patient muscle resulted in shortening and disorganization of thin filaments. Knockdown of Imod3 in zebrafish replicated NM-associated functional and pathological phenotypes. Together, these findings indicate that mutations in the gene encoding LMOD3 underlie congenital myopathy and demonstrate that LMOD3 is essential for the organization of sarcomeric thin filaments in skeletal muscle.	[Yuen, Michaele; Sandaradura, Sarah A.; Quinlan, Kate G.; Ilkovski, Biljana; Houweling, Peter J.; Waddell, Leigh B.; North, Kathryn N.; Clarke, Nigel F.] Childrens Hosp Westmead, Inst Neurosci & Muscle Res, Sydney, NSW, Australia; [Yuen, Michaele; Sandaradura, Sarah A.; Quinlan, Kate G.; Houweling, Peter J.; Waddell, Leigh B.; Clarke, Nigel F.] Univ Sydney, Discipline Paediat & Child Hlth, Sydney, NSW 2006, Australia; [Dowling, James J.; Davidson, Ann E.; Telfer, William R.] Univ Michigan, Med Ctr, Dept Pediat, Ann Arbor, MI 48109 USA; [Dowling, James J.; Davidson, Ann E.; Telfer, William R.] Univ Michigan, Med Ctr, Dept Neurol, Ann Arbor, MI 48109 USA; [Dowling, James J.; Davidson, Ann E.] Hosp Sick Children, Div Neurol, Toronto, ON M5G 1X8, Canada; [Dowling, James J.; Davidson, Ann E.] Hosp Sick Children, Program Genet & Genome Biol, Toronto, ON M5G 1X8, Canada; [Kostyukova, Alla S.; Moroz, Natalia] Washington State Univ, Gene & Linda Voiland Sch Chem Engn & Bioengn, Pullman, WA 99164 USA; [Lehtokari, Vilma-Lotta; Wallgren-Pettersson, Carina] Univ Helsinki, Folkhalsan Inst Genet, Haartman Inst, Helsinki, Finland; [Lehtokari, Vilma-Lotta; Wallgren-Pettersson, Carina] Univ Helsinki, Haartman Inst, Dept Med Genet, Helsinki, Finland; [Ravenscroft, Gianina; Todd, Emily J.; Laing, Nigel G.] Univ Western Australia, Western Australia Inst Med Res, Nedlands, WA 6009, Australia; [Ravenscroft, Gianina; Todd, Emily J.; Laing, Nigel G.] Univ Western Australia, Med Res Ctr, Nedlands, WA 6009, Australia; [Ceyhan-Birsoy, Ozge; Swanson, Lindsay C.; Brownstein, Catherine A.; Gupta, Vandana A.; Beggs, Alan H.] Harvard Univ, Boston Childrens Hosp, Sch Med, Div Genet & Genom,Manton Ctr Orphan Dis Res, Boston, MA USA; [Gokhin, David S.; Fowler, Velia M.] Scripps Res Inst, Dept Cell & Mol Biol, La Jolla, CA 92037 USA; [Maluenda, Jerome; Nolent, Flora; Melki, Judith] INSERM, Unite Mixte Rech 788, F-94275 Le Kremlin Bicetre, France; [Maluenda, Jerome; Nolent, Flora; Melki, Judith] Univ Paris, Le Kremlin Bicetre, France; [Lek, Monkol; Thomas, Brett P.; Daly, Mark J.; MacArthur, Daniel G.] Massachusetts Gen Hosp, Analyt & Translat Genet Unit, Boston, MA 02114 USA; [Lek, Monkol; Thomas, Brett P.; Gabriel, Stacey B.; Gupta, Namrata; Daly, Mark J.; MacArthur, Daniel G.] Broad Inst Harvard & Massachusetts Inst Technol, Cambridge, MA USA; [Pappas, Christopher T.; Novak, Stefanie M.; Gregorio, Carol C.] Univ Arizona, Dept Cellular & Mol Med, Tucson, AZ USA; [D'Amico, Adele; Bertini, Enrico] Bambino Gesu Pediat Hosp, Lab Mol Med Neuromuscular & Neurodegenerat Dis, Rome, Italy; [Malfatti, Edoardo; Romero, Norma B.] Grp Hosp Univ La Pitie Salpetriere, Inst Myol, Neuromuscular Morphol Unit, Paris, France; [Houweling, Peter J.; North, Kathryn N.] Royal Childrens Hosp, Murdoch Childrens Res Inst, Parkville, Vic 3052, Australia; [Medne, Livija] Childrens Hosp Philadelphia, Div Human Genet & Neurol, Philadelphia, PA 19104 USA; [Shannon, Patrick] Mt Sinai Hosp, Dept Pathol & Lab Med, Toronto, ON M5G 1X5, Canada; [Martin, Nicole; Chitayat, David] Univ Toronto, Mt Sinai Hosp, Dept Obstet & Gynaecol, Prenatal Diag & Med Genet Program, Toronto, ON M5G 1X5, Canada; [Bick, David P.] Med Coll Wisconsin, Dept Pediat, Genet Sect, Milwaukee, WI 53226 USA; [Bick, David P.] Med Coll Wisconsin, Ctr Mol Genet, Milwaukee, WI 53226 USA; [Flisberg, Anders] Sahlgrens Univ Hosp, Dept Neonatol, Gothenburg, Sweden; [Holmberg, Eva] Sahlgrens Univ Hosp, Dept Clin Genet, Gothenburg, Sweden; [Van den Bergh, Peter] St Luc Univ Hosp, Neuromuscular Reference Ctr, Brussels, Belgium; [Lapunzina, Pablo] Hosp Univ La Paz, Inst Invest Sanitaria, Inst Genet Med & Mol, Madrid, Spain; [Lapunzina, Pablo] Univ Autonoma Madrid, Madrid, Spain; [Lapunzina, Pablo] Inst Salud Carlos III, Ctr Invest Biomed Red Enfermedades Raras, Madrid, Spain; [Sioboda, Darcee D.] Univ Michigan, Dept Biomed Engn, Ann Arbor, MI 48109 USA; [Chitayat, David] Univ Toronto, Hosp Sick Children, Dept Paediat, Div Clin & Med Genet, Toronto, ON M5G 1X8, Canada; [Laquerriere, Annie] Univ Rouen, Pathol Lab, Rouen, France; [Laquerriere, Annie] Univ Rouen, NeoVasc Reg INSERM Team ERI28, Rouen, France; [Ottenheijm, Coen A. C.] Vrije Univ Amsterdam, Med Ctr, Inst Cardiovasc Res, Dept Physiol, Amsterdam, Netherlands; [Boennemann, Carsten G.] NINDS, Neuromuscular & Neurogenet Disorders Childhood Se, NIH, Bethesda, MD 20892 USA; [Pelin, Katarina] Univ Helsinki, Dept Biosci, Helsinki, Finland; [Hayashi, Yukiko K.] Tokyo Med Univ, Dept Neurophysiol, Tokyo 1608402, Japan; [Hayashi, Yukiko K.; Nishino, Ichizo] Natl Ctr Neurol & Psychiat, Natl Inst Neurosci, Dept Neuromuscular Res, Tokyo, Japan; [Melki, Judith] Ctr Hosp Sud Francilien, Unite Genet Med, Corbel Essonnes, France; [North, Kathryn N.] Univ Melbourne, Dept Paediat, Melbourne, Vic 3010, Australia	North, KN (reprint author), Royal Childrens Hosp, Murdoch Childrens Res Inst, Flemington Rd, Parkville, Vic 3052, Australia.	kathryn.north@mcri.edu.au	North, Kathryn/K-6476-2012	North, Kathryn/0000-0003-0841-8009	National Health and Medical Research Council of Australia [1022707, 1031893, 1035828, 1035955, 0511981, 1002147, 1075451]; Association Francaise contre les Myopathies [15734, DAJ1891]; National Hospital Clinical Research Program [A0M10181]; National Institute of Child Health and Development of the NIH [R01 HD 075802]; Muscular Dystrophy Association (USA) [MDA201302]; AUism Charitable Foundation; National Institute on Aging [AG000114]; University of Sydney Australian Postgraduate Award; International Postgraduate Research Scholarship; University of Western Australia Postgraduate Award; Dubai-Harvard Foundation for Medical Research postdoctoral fellowship; Schlumberger Foundation Faculty; Italian Ministry of Health Ricerca finalizzata [GR-2010-2310981]; NIH [GM081688, K01 AR062601]; Muscular Dystrophy Association (USA); National Human Genome Research Institute of the NIH [U54 HG003067]	This work was funded by the National Health and Medical Research Council of Australia (1022707 and 1031893 to N.F. Clarke, K.N. North, and N.G. Laing; 1035828 to N.F. Clarke; 1035955 to G. Ravenscroft; 0511981 to K.G. Quinlan; 1002147 to N.G. Laing; and 1075451 to S.A. Sandaradura), the Association Francaise contre les Myopathies (15734 to G. Ravenscroft and N.G. Laing; DAJ1891 to J. Melki), the National Hospital Clinical Research Program (A0M10181 to J. Melki), the National Institute of Child Health and Development of the NIH (R01 HD 075802 to A.H. Beggs), the Muscular Dystrophy Association (USA) (MDA201302 to A.H. Beggs), the AUism Charitable Foundation (to A.H. Beggs), and the National Institute on Aging (AG000114 to D.D. Sloboda). M. Kreissl is supported by a University of Sydney Australian Postgraduate Award and an International Postgraduate Research Scholarship. E.J. Todd is supported by a University of Western Australia Postgraduate Award. O. Ceyhan-Birsoy is supported by a Dubai-Harvard Foundation for Medical Research postdoctoral fellowship and Schlumberger Foundation Faculty for the Future grant. A. D'Amico and E. Bertini are supported by the Italian Ministry of Health Ricerca finalizzata (GR-2010-2310981). A.S. Kostyukova is supported by NIH grant GM081688, and V.A. Gupta is supported by NIH grant K01 AR062601. D.S. Gokhin is supported by a Development Grant from the Muscular Dystrophy Association (USA). Exome sequencing was supported by grants from the National Human Genome Research Institute of the NIH (Medical Sequencing Program grant U54 HG003067 to the Broad Institute principal investigator, Lander) and by the Gene Partnership Project of Boston Children's Hospital. The authors would like to thank the study patients and their families, without whose participation this work would not have been possible. We thank F. Muntoni (Dubowitz Neuromuscular Centre, UCL Institute of Child Health and Great Ormond Street Hospital for Children), C. Lacroix, (Service de Neuropathologie, CHU Bicetre), V. Zupan-Simunek (Service de Neonatologie, Hopital Antoine Beclere), A. Kan and N. Graf (The Children's Hospital at Westmead), and F. Fattori (Bambino Gesu Children's Hospital) for contribution and/or analysis of patient samples; S. Brammah(Concord Hospital) for provision of EM control images; T. Peduto (The Children's Hospital at Westmead) for assistance with analysis of muscle MRI; D.M. Margulies (Boston Children's Hospital) for support of WES through The Gene Partnership; and T. Yu and P. Park (Boston Children's Hospital) for WES pipeline development. We thank S.V. Brooks (University of Michigan) for assistance with experimental work and R. Dominguez (University of Pennsylvania) for providing reagents.	Zdobnov EM, 2001, BIOINFORMATICS, V17, P847, DOI 10.1093/bioinformatics/17.9.847; Gokhin DS, 2010, J CELL BIOL, V189, P95, DOI 10.1083/jcb.201001125; Witt CC, 2006, EMBO J, V25, P3843, DOI 10.1038/sj.emboj.7601242; Gokhin DS, 2012, AM J PHYSIOL-CELL PH, V302, pC555, DOI 10.1152/ajpcell.00299.2011; Cooper ST, 2007, NEUROMUSCULAR DISORD, V17, P276, DOI 10.1016/j.nmd.2006.12.010; Conley CA, 2001, GENOMICS, V73, P127, DOI 10.1006/geno.2000.6501; Gupta VA, 2013, AM J HUM GENET, V93, P1108, DOI 10.1016/j.ajhg.2013.10.020; Majczenko K, 2012, AM J HUM GENET, V91, P365, DOI 10.1016/j.ajhg.2012.06.012; Chereau D, 2008, SCIENCE, V320, P239, DOI 10.1126/science.1155313; Ravenscroft G, 2013, AM J HUM GENET, V93, P6, DOI 10.1016/j.ajhg.2013.05.004; GRANZIER HLM, 1991, AM J PHYSIOL, V260, pC1060; Agrawal PB, 2004, ANN NEUROL, V56, P86, DOI 10.1002/ana.20157; Telfer WR, 2010, HUM MOL GENET, V19, P2433, DOI 10.1093/hmg/ddq126; Castillo A, 2009, BIOPHYS J, V96, P1856, DOI 10.1016/j.bpj.2008.10.053; Littlefield R, 2002, BIOPHYS J, V82, P2548; Lattanzi L, 1998, J CLIN INVEST, V101, P2119, DOI 10.1172/JCI1505; Telfer WR, 2012, DIS MODEL MECH, V5, P389, DOI 10.1242/dmm.008631; Garg A, 2014, J CLIN INVEST, V124, P3529, DOI 10.1172/JCI74994; Tsukada T, 2010, J CELL SCI, V123, P3136, DOI 10.1242/jcs.071837; Romero NB, 2013, CURR OPIN NEUROL, V26, P519, DOI 10.1097/WCO.0b013e328364d681; Menezes MP, 2014, NEUROMUSCULAR DISORD, V24, P666, DOI 10.1016/j.nmd.2014.04.010; Ottenheijm CAC, 2009, HUM MOL GENET, V18, P2359, DOI 10.1093/hmg/ddp168; Ryan MM, 2001, ANN NEUROL, V50, P312, DOI 10.1002/ana.1080; COOPER JA, 1983, J MUSCLE RES CELL M, V4, P253, DOI 10.1007/BF00712034; Cooper ST, 2003, NEUROLOGY, V61, P93; de Winter JM, 2013, J MED GENET, V50, P383, DOI 10.1136/jmedgenet-2012-101470; Greenfield NJ, 1998, BIOCHEMISTRY-US, V37, P7834, DOI 10.1021/bi973167m; Greenfield NJ, 2002, BIOPHYS J, V83, P2754; Kostyukova AS, 2004, J BIOL CHEM, V279, P5066, DOI 10.1074/jbc.M311186200; Kostyukova AS, 2007, J MOL BIOL, V372, P608, DOI 10.1016/j.jmb.2007.05.084; Kostyukova AS, 2007, ARCH BIOCHEM BIOPHYS, V465, P227, DOI 10.1016/j.abb.2007.05.012; KOUYAMA T, 1981, EUR J BIOCHEM, V114, P33; Nanda V, 2011, J BIOL CHEM, V287, P2459; North KN, 1997, J MED GENET, V34, P705, DOI 10.1136/jmg.34.9.705; Nowak KJ, 2007, ANN NEUROL, V61, P175, DOI 10.1002/ana.21035; Skwarek-Maruszewska A, 2010, MOL BIOL CELL, V21, P3352, DOI 10.1091/mbc.E10-02-0109; Sloboda DD, 2013, JOVE-J VIS EXP, DOI 10.3791/50539	37	13	13	AMER SOC CLINICAL INVESTIGATION INC	ANN ARBOR	35 RESEARCH DR, STE 300, ANN ARBOR, MI 48103 USA	0021-9738	1558-8238		J CLIN INVEST	J. Clin. Invest.	NOV	2014	124	11					4693	4708		10.1172/JCI75199		16	Medicine, Research & Experimental	Research & Experimental Medicine	AS3UK	WOS:000344203300008		
J	Klar, J; Hisatsune, C; Baig, SM; Tariq, M; Johansson, ACV; Rasool, M; Malik, NA; Ameur, A; Sugiura, K; Feuk, L; Mikoshiba, K; Dahl, N				Klar, Joakim; Hisatsune, Chihiro; Baig, Shahid M.; Tariq, Muhammad; Johansson, Anna C. V.; Rasool, Mahmood; Malik, Naveed Altaf; Ameur, Adam; Sugiura, Kotomi; Feuk, Lars; Mikoshiba, Katsuhiko; Dahl, Niklas			Abolished InsP(3)R2 function inhibits sweat secretion in both humans and mice	JOURNAL OF CLINICAL INVESTIGATION			English	Article							INOSITOL 1,4,5-TRISPHOSPHATE RECEPTOR; IP3 RECEPTOR; SIGNAL-TRANSDUCTION; GLAND-FUNCTION; TYPE-3; DISORDERS; BIOLOGY; TRISPHOSPHATE; LACKING; CELL	There are 3 major sweat-producing glands present in skin; eccrine, apocrine, and apoeccrine glands. Due to the high rate of secretion, eccrine sweating is a vital regulator of body temperature in response to thermal stress in humans; therefore, an inability to sweat (anhidrosis) results in heat intolerance that may cause impaired consciousness and death. Here, we have reported 5 members of a consanguineous family with generalized, isolated anhidrosis, but morphologically normal eccrine sweat glands. Whole-genome analysis identified the presence of a homozygous missense mutation in ITPR2, which encodes the type 2 inositol 1,4,5-trisphosphate receptor (InsP(3)R2), that was present in all affected family members. We determined that the mutation is localized within the pore forming region of InsP(3)R2 and abrogates Ca2+ release from the endoplasmic reticulum, which suggests that intracellular Ca2+ release by InsP(3)R2 in clear cells of the sweat glands is important for eccrine sweat production. Itpr2(-/-) mice exhibited a marked reduction in sweat secretion, and evaluation of sweat glands from Itpr2(-/-) animals revealed a decrease in Ca2+ response compared with controls. Together, our data indicate that loss of InsP(3)R2-mediated Ca2+ release causes isolated anhidrosis in humans and suggest that specific InsP(3)R inhibitors have the potential to reduce sweat production in hyperhidrosis.	[Klar, Joakim; Johansson, Anna C. V.; Ameur, Adam; Feuk, Lars; Dahl, Niklas] Uppsala Univ, Sci Life Lab, Dept Immunol Genet & Pathol, S-75108 Uppsala, Sweden; [Hisatsune, Chihiro; Sugiura, Kotomi; Mikoshiba, Katsuhiko] RIKEN, Brain Sci Inst, Dev Neurobiol Lab, Saitama, Japan; [Baig, Shahid M.; Tariq, Muhammad; Malik, Naveed Altaf] Natl Inst Biotechnol & Genet Engn, Human Mol Genet Lab, Faisalabad, Pakistan; [Rasool, Mahmood] King Abdulaziz Univ, Ctr Excellence Genom Med Res, Jeddah 21413, Saudi Arabia	Dahl, N (reprint author), Uppsala Univ, Sci Life Lab, Dept Immunol Genet & Pathol, BMC, Box 815, S-75108 Uppsala, Sweden.	mikosiba@brain.riken.jp; niklas.dahl@igp.uu.se	Rasool, Mahmood/H-9475-2012; Baig, Shahid Mahmood /I-7309-2015; 	Ameur, Adam/0000-0001-6085-6749	Swedish Research Council [K2013-66X-10829-20-3, 621-2009-4629]; Swedish Links, Asia [348-2008-6069]; Science for Life laboratory Uppsala University; Uppsala University Hospital; Moritani Scholarship Foundation; Swedish Society for Medical Research;  [20220007];  [24500451]	This work was supported in part by the Swedish Research Council (K2013-66X-10829-20-3 and 621-2009-4629) and Swedish Links, Asia (348-2008-6069); Science for Life laboratory Uppsala University and Uppsala University Hospital; Grants-in-Aid for Scientific Research (20220007, to K. Mikoshiba; 24500451, to C. Hisatsune); and The Moritani Scholarship Foundation (to C. Hisatsune). J. Klar is supported by the Swedish Society for Medical Research. We thank all family members who participated in this study. We also thank C. Yokoyama and A.V. Terashima for fruitful discussions; M.W. Sherwood, A. Miyamoto, E. Ebisui, and N. Ogawa for experimental advice and help; all staff of the Support Unit for Bio-Material Analysis RIKEN BSI Research Resources Center; and the Uppsala Genome Center for technical support.	Mikoshiba K, 2007, J NEUROCHEM, V102, P1426, DOI 10.1111/j.1471-4159.2007.04825.x; Sugawara H, 1997, EMBO J, V16, P3078, DOI 10.1093/emboj/16.11.3078; Matsumoto M, 1996, NATURE, V379, P168, DOI 10.1038/379168a0; Yule DI, 2010, CELL CALCIUM, V47, P469, DOI 10.1016/j.ceca.2010.04.005; SATO K, 1989, J AM ACAD DERMATOL, V20, P537, DOI 10.1016/S0190-9622(89)70063-3; BERRIDGE MJ, 1984, NATURE, V312, P315, DOI 10.1038/312315a0; Sato-Miyaoka M, 2012, J INVEST DERMATOL, V132, P2137, DOI 10.1038/jid.2012.141; Futatsugi A, 2005, SCIENCE, V309, P2232, DOI 10.1126/science.1114110; LATHROP GM, 1984, AM J HUM GENET, V36, P460; Hattori M, 2004, J BIOL CHEM, V279, P11967, DOI 10.1074/jbc.M311456200; Foskett JK, 2007, PHYSIOL REV, V87, P593, DOI 10.1152/physrev.00035.2006; Carr IM, 2006, HUM MUTAT, V27, P1041, DOI 10.1002/humu.20383; Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Miyakawa T, 1999, EMBO J, V18, P1303, DOI 10.1093/emboj/18.5.1303; Armah DB, 2009, CURR PEDIAT RES, V13, P13; DANN EJ, 1990, ISRAEL J MED SCI, V26, P451; FOLK GE, 1991, INT J BIOMETEOROL, V35, P180, DOI 10.1007/BF01049065; Hisatsune C, 2007, J BIOL CHEM, V282, P37225, DOI 10.1074/jbc.M705641200; Iwai M, 2005, J BIOL CHEM, V280, P10305, DOI 10.1074/jbc.M413824200; MAEDA N, 1988, J NEUROCHEM, V51, P1724, DOI 10.1111/j.1471-4159.1988.tb01151.x; MANGOS J, 1973, AM J PHYSIOL, V224, P1235; QUINTON PM, 1983, ANNU REV MED, V34, P429, DOI 10.1146/annurev.me.34.020183.002241; SATO K, 1989, J AM ACAD DERMATOL, V20, P713, DOI 10.1016/S0190-9622(89)70081-5; SATO K, 1981, AM J PHYSIOL, V240, pR44; Schug ZT, 2008, J BIOL CHEM, V283, P2939, DOI 10.1074/jbc.M706645200; Tafari AT, 1997, J NEUROSCI, V17, P4275; Uchida K, PLOS ONE; Wilke K., 2007, International Journal of Cosmetic Science, V29, P169, DOI 10.1111/j.1467-2494.2007.00387.x; Zancanaro C, 1999, J ANAT, V194, P433, DOI 10.1046/j.1469-7580.1999.19430433.x	29	3	3	AMER SOC CLINICAL INVESTIGATION INC	ANN ARBOR	35 RESEARCH DR, STE 300, ANN ARBOR, MI 48103 USA	0021-9738	1558-8238		J CLIN INVEST	J. Clin. Invest.	NOV	2014	124	11					4773	4780		10.1172/JCI70720		8	Medicine, Research & Experimental	Research & Experimental Medicine	AS3UK	WOS:000344203300014		
J	Theofilopoulos, S; Griffiths, WJ; Crick, PJ; Yang, SZ; Meljon, A; Ogundare, M; Kitambi, SS; Lockhart, A; Tuschl, K; Clayton, PT; Morris, AA; Martinez, A; Reddy, MA; Martinuzzi, A; Bassi, MT; Honda, A; Mizuochi, T; Kimura, A; Nittono, H; De Michele, G; Carbone, R; Criscuolo, C; Yau, JL; Seckl, JR; Schule, R; Schols, L; Sailer, AW; Kuhle, J; Fraidakis, MJ; Gustafsson, JA; Steffensen, KR; Bjorkhem, I; Ernfors, P; Sjovall, J; Arenas, E; Wang, YQ				Theofilopoulos, Spyridon; Griffiths, William J.; Crick, Peter J.; Yang, Shanzheng; Meljon, Anna; Ogundare, Michael; Kitambi, Satish Srinivas; Lockhart, Andrew; Tuschl, Karin; Clayton, Peter T.; Morris, Andrew A.; Martinez, Adelaide; Reddy, M. Ashwin; Martinuzzi, Andrea; Bassi, Maria T.; Honda, Akira; Mizuochi, Tatsuki; Kimura, Akihiko; Nittono, Hiroshi; De Michele, Giuseppe; Carbone, Rosa; Criscuolo, Chiara; Yau, Joyce L.; Seckl, Jonathan R.; Schuele, Rebecca; Schoels, Ludger; Sailer, Andreas W.; Kuhle, Jens; Fraidakis, Matthew J.; Gustafsson, Jan-Ake; Steffensen, Knut R.; Bjorkhem, Ingemar; Ernfors, Patrik; Sjovall, Jan; Arenas, Ernest; Wang, Yuqin			Cholestenoic acids regulate motor neuron survival via liver X receptors	JOURNAL OF CLINICAL INVESTIGATION			English	Article							CENTRAL-NERVOUS-SYSTEM; OXYSTEROL 7-ALPHA-HYDROXYLASE GENE; STEROL 27-HYDROXYLASE GENE; CEREBROTENDINOUS XANTHOMATOSIS; 7-ALPHA-HYDROXY-3-OXO-4-CHOLESTENOIC ACID; LXR-BETA; CEREBROSPINAL-FLUID; INBORN ERROR; BLOOD-BRAIN; BILE-ACIDS	Cholestenoic acids are formed as intermediates in metabolism of cholesterol to bile acids, and the biosynthetic enzymes that generate cholestenoic acids are expressed in the mammalian CNS. Here, we evaluated the cholestenoic acid profile of mammalian cerebrospinal fluid (CSF) and determined that specific cholestenoic acids activate the liver X receptors (LXRs), enhance islet-1 expression in zebrafish, and increase the number of oculomotor neurons in the developing mouse in vitro and in vivo. While 3 beta,7 alpha-dihydroxycholest-5-en-26-oic acid (3 beta,7 alpha-diHCA) promoted motor neuron survival in an LXR-dependent manner, 3 beta-hydroxy-7-oxocholest-5-en-26-oic acid (3 beta H,70-CA) promoted maturation of precursors into islet-1(+) cells. Unlike 3 beta,7 alpha-diHCA and 3 beta H,70-CA, 3 beta-hydroxycholest-5-en-26-oic acid (3 beta-HCA) caused motor neuron cell loss in mice. Mutations in CYP7B1 or CYP27A7, which encode enzymes involved in cholestenoic acid metabolism, result in different neurological diseases, hereditary spastic paresis type 5 (SPG5) and cerebrotendinous xanthomatosis (CTX), respectively. SPG5 is characterized by spastic paresis, and similar symptoms may occur in CTX. Analysis of CSF and plasma from patients with SPG5 revealed an excess of the toxic LXR ligand, 3 beta-HCA, while patients with CTX and SPG5 exhibited low levels of the survival-promoting LXR ligand 3 beta,7 alpha-diHCA. Moreover, 3 beta,7 alpha-diHCA prevented the loss of motor neurons induced by 3 beta-HCA in the developing mouse midbrain in vivo.Our results indicate that specific cholestenoic acids selectively work on motor neurons, via LXR, to regulate the balance between survival and death.	[Theofilopoulos, Spyridon; Yang, Shanzheng; Kitambi, Satish Srinivas; Ernfors, Patrik; Sjovall, Jan; Arenas, Ernest] Karolinska Inst, Dept Med Biochem & Biophys, Mol Neurobiol Lab, Stockholm, Sweden; [Griffiths, William J.; Crick, Peter J.; Meljon, Anna; Ogundare, Michael; Wang, Yuqin] Swansea Univ, Coll Med, Swansea SA2 8PP, W Glam, Wales; [Lockhart, Andrew] Addenbrookes Hosp, GlaxoSmithKline R&D China, Cambridge, England; [Tuschl, Karin; Clayton, Peter T.] UCL Inst Child Hlth, Clin & Mol Genet Unit, London, England; [Morris, Andrew A.] St Marys Hosp, Willink Biochem Genet Unit, Manchester M13 0JH, Lancs, England; [Martinez, Adelaide] Barts Hlth NHS Trust, London, England; [Reddy, M. Ashwin] Barts Hlth NHS Trust, Dept Ophthalmol, London, England; [Martinuzzi, Andrea] Sci Inst IRCCS Eugenio Medea, Conegliano Res Ctr, Conegliano, Italy; [Bassi, Maria T.] Sci Inst IRCCS Eugenio Medea, Mol Biol Lab, Lecce, Italy; [Honda, Akira] Tokyo Med Univ, Ibaraki Med Ctr, Ami, Ibaraki, Japan; [Mizuochi, Tatsuki; Kimura, Akihiko] Kurume Univ, Sch Med, Dept Pediat & Child Hlth, Kurume, Fukuoka 830, Japan; [Nittono, Hiroshi] Junshin Clin, Bile Acid Inst, Tokyo, Japan; [De Michele, Giuseppe; Carbone, Rosa; Criscuolo, Chiara] Univ Naples Federico II, Dept Neurosci & Reprod & Odontostomatol Sci, Naples, Italy; [Yau, Joyce L.; Seckl, Jonathan R.] Univ Edinburgh, Queens Med Res Inst, Endocrinol Unit, BHF Ctr Cardiovasc Sci, Edinburgh, Midlothian, Scotland; [Schuele, Rebecca; Schoels, Ludger] Univ Tubingen, Hertie Inst Clin Brain Res, Tubingen, Germany; [Schuele, Rebecca; Schoels, Ludger] Univ Tubingen, Ctr Neurol, Tubingen, Germany; [Schuele, Rebecca; Schoels, Ludger] German Ctr Neurodegenerat Dis DZNE, Tubingen, Germany; [Sailer, Andreas W.] Novartis Inst BioMed Res, Basel, Switzerland; [Kuhle, Jens] Univ Basel Hosp, CH-4031 Basel, Switzerland; [Fraidakis, Matthew J.] Univ Athens, Univ Hosp Attikon, Sch Med, Rare Neurol Dis Unit,Dept Neurol, Athens, Greece; [Gustafsson, Jan-Ake] Univ Houston, Ctr Nucl Receptors & Cell Signaling, Houston, TX USA; [Gustafsson, Jan-Ake] Ctr Biosci, Dept Biosci & Nutr, Stockholm, Sweden; [Steffensen, Knut R.; Bjorkhem, Ingemar] Karolinska Inst, Dept Lab Med, Div Clin Chem, Stockholm, Sweden; [Steffensen, Knut R.; Bjorkhem, Ingemar] Karolinska Univ Hosp Huddinge, Stockholm, Sweden	Griffiths, WJ (reprint author), Swansea Univ, Coll Med, Grove Bldg,Singleton Pk, Swansea SA2 8PP, W Glam, Wales.	w.j.griffiths@swansea.ac.uk; ernest.arenas@ki.se; y.wang@swansea.ac.uk	Theofilopoulos, Spyridon/B-2075-2015; 	Bjorkhem, Ingemar/0000-0001-6087-9190; wang, yuqin/0000-0002-3063-3066; griffiths, william/0000-0002-4129-6616	UK Research Councils BBSRC [BBC5157712, BBC5113561, BBI0017351, BBH0010181]; EPSRC; Swedish Research Council (DBRM program) [VR2011-3116, VR2011-3318]; European Union (DDPD program); Swedish Foundation for Strategic Research (DBRM and SRL program); Hjarnfonden and Karolinska Institutet (SFO Thematic Center in Stem cells and Regenerative Medicine); Swedish MRC; Onassis Foundation; Great Ormond Street Hospital Children's Charity; Italian Ministry of Health funds [RC2011-2012]; Robert A. Welch Foundation [E-0004]; Wellcome Trust [WT73429]; Carter Fellowship; EU [2012-305121]	Work in Swansea was supported by funding from the UK Research Councils BBSRC (BBC5157712, BBC5113561, BBI0017351 to W.J. Gtiffiths, BBH0010181 to Y. Wang, studentship to A. Meljon) and EPSRC (studentship to M. Ogundare). The EPSRC National Mass Spectrometry Service Centre is acknowledged for allowing access to the LTQ-Orbitrap XL mass spectrometer. Work in Karolinska Institutet was supported by funding from the Swedish Research Council (DBRM program; VR2011-3116 and VR2011-3318), the European Union (DDPD program), the Swedish Foundation for Strategic Research (DBRM and SRL program), and the Hjarnfonden and Karolinska Institutet (SFO Thematic Center in Stem cells and Regenerative Medicine). S. Theofilopoulos was supported by the Swedish MRC and the Onassis Foundation. P.T. Clayton is funded by Great Ormond Street Hospital Children's Charity. M.T. Bassi was supported by Italian Ministry of Health funds (grant no. RC2011-2012). Work in Houston was supported by the Robert A. Welch Foundation (grant no. E-0004, to J.-A. Gustafsson). Work in Edinburgh was supported by the Wellcome Trust (WT73429) and a Carter Fellowship to J.L. Yau from Alzheimer's Research UK. Work in Tubingen was supported by an EU grant to NEUROMICS (grant no. 2012-305121). Members of the European Network for Oxysterol Research are thanked for informative discussions.	Alberti S, 2001, J CLIN INVEST, V107, P565, DOI 10.1172/JCI9794; Andersson S, 2005, P NATL ACAD SCI USA, V102, P3857, DOI 10.1073/pnas.0500634102; Lutjohann D, 1996, P NATL ACAD SCI USA, V93, P9799, DOI 10.1073/pnas.93.18.9799; Liang XQ, 2011, MOL CELL NEUROSCI, V47, P215, DOI 10.1016/j.mcn.2011.04.007; Russell DW, 2003, ANNU REV BIOCHEM, V72, P137, DOI 10.1146/annurev.biochem.72.121801.161712; Leoni V, 2003, J LIPID RES, V44, P793, DOI 10.1194/jlr.M200434-JLR200; ERICSON J, 1992, SCIENCE, V256, P1555, DOI 10.1126/science.1350865; Shafaati M, 2011, J LIPID RES, V52, P1004, DOI 10.1194/jlr.M014548; Verrips A, 2000, BRAIN, V123, P908, DOI 10.1093/brain/123.5.908; Ogundare M, 2010, J BIOL CHEM, V285, P4666, DOI 10.1074/jbc.M109.086678; Schule R, 2010, J LIPID RES, V51, P819, DOI 10.1194/jlr.M002543; Dai DL, 2014, J INHERIT METAB DIS, V37, P851, DOI 10.1007/s10545-014-9695-6; Janowski BA, 1999, P NATL ACAD SCI USA, V96, P266, DOI 10.1073/pnas.96.1.266; Whitney KD, 2002, MOL ENDOCRINOL, V16, P1378, DOI 10.1210/me.16.6.1378; Fahy E, 2005, J LIPID RES, V46, P839, DOI 10.1194/jlr.E400004-JLR200; Heverin M, 2005, J LIPID RES, V46, P1047, DOI 10.1194/jlr.M500024-JLR200; Song MR, 2009, DEVELOPMENT, V136, P2923, DOI 10.1242/dev.037986; Sacchetti P, 2009, CELL STEM CELL, V5, P409, DOI 10.1016/j.stem.2009.08.019; Higashijima S, 2000, J NEUROSCI, V20, P206; Song C, 2000, ENDOCRINOLOGY, V141, P4180, DOI 10.1210/en.141.11.4180; Hutchinson SA, 2006, DEVELOPMENT, V133, P2137, DOI 10.1242/dev.02355; Uemura O, 2005, DEV BIOL, V278, P587, DOI 10.1016/j.ydbio.2004.11.031; Setchell KDR, 1998, J CLIN INVEST, V102, P1690, DOI 10.1172/JCI2962; Sugama S, 2001, J INHERIT METAB DIS, V24, P379, DOI 10.1023/A:1010564920930; Lehmann JM, 1997, J BIOL CHEM, V272, P3137; Rosen H, 1998, J BIOL CHEM, V273, P14805, DOI 10.1074/jbc.273.24.14805; Forman BM, 1997, P NATL ACAD SCI USA, V94, P10588, DOI 10.1073/pnas.94.20.10588; Kim HJ, 2008, P NATL ACAD SCI USA, V105, P2094, DOI 10.1073/pnas.0711599105; Lund EG, 2003, J BIOL CHEM, V278, P22980, DOI 10.1074/jbc.M303415200; Pfaff SL, 1996, CELL, V84, P309, DOI 10.1016/S0092-8674(00)80985-X; Dai YB, 2012, P NATL ACAD SCI USA, V109, P13112, DOI 10.1073/pnas.1210833109; Liao WL, 2011, J PROTEOME RES, V10, P241, DOI 10.1021/pr1008898; Heverin M, 2004, J LIPID RES, V45, P186, DOI 10.1194/jlr.M300320-JLR200; Archer A., 2012, OPEN J ENDOCR METAB, V2, P74; Arnoldi A, 2012, CLIN GENET, V81, P150, DOI 10.1111/j.1399-0004.2011.01624.x; AXELSON M, 1988, J LIPID RES, V29, P629; Bigini P, 2010, J NEUROPATH EXP NEUR, V69, P593, DOI 10.1097/NEN.0b013e3181df20e1; Bjorkhem I, 2010, BIOCHEM BIOPH RES CO, V396, P46, DOI 10.1016/j.bbrc.2010.02.140; Bjorkhem I, 2013, CURR OPIN LIPIDOL, V24, P283, DOI 10.1097/MOL.0b013e328362df13; Chiang JYL, 2000, J BIOL CHEM, V275, P10918, DOI 10.1074/jbc.275.15.10918; Chong CP, 2010, ANN S SOC STUD INB E; Criscuolo C, 2009, J NEUROL, V256, P1252, DOI 10.1007/s00415-009-5109-3; Diekstra FP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035333; Goizet C, 2009, BRAIN, V132, P1589, DOI 10.1093/brain/awp073; Griffiths WJ, 2011, BBA-MOL CELL BIOL L, V1811, P784, DOI 10.1016/j.bbalip.2011.05.012; Griffiths WJ, 2013, FREE RADICAL BIO MED, V59, P69, DOI 10.1016/j.freeradbiomed.2012.07.027; Higashijima S, 2008, DEV GROWTH DIFFER, V50, P407, DOI [10.1111/j.1440-169X.2008.01023.x, 10.1111/j.1440-169x.2008.01023.x]; KIMMEL CB, 1995, DEV DYNAM, V203, P253; Manganelli F, 2011, CLIN NEUROPHYSIOL, V122, P819, DOI 10.1016/j.clinph.2010.10.025; Meaney S, 2007, J LIPID RES, V48, P944, DOI 10.1194/jlr.M600529-JLR200; Meljon A, 2012, J LIPID RES, V53, P2469, DOI 10.1194/jlr.D028233; Mizuochi T, 2011, LIVER TRANSPLANT, V17, P1059, DOI 10.1002/lt.22331; MONDELLI M, 1992, ARCH NEUROL-CHICAGO, V49, P469; NAGATA K, 1992, BIOCHIM BIOPHYS ACTA, V1126, P229; Nishimaki-Mogami T, 2004, J LIPID RES, V45, P1538, DOI 10.1194/jlr.M400102; Rose K, 2001, J BIOL CHEM, V276, P23937, DOI 10.1074/jbc.M011564200; Steffensen KR, 2006, MOL CELL ENDOCRINOL, V256, P9, DOI 10.1016/j.mce.2006.03.044; Theofilopoulos S, 2013, NAT CHEM BIOL, V9, P126, DOI [10.1038/nchembio.1156, 10.1038/NCHEMBIO.1156]; Ueki I, 2008, J PEDIATR GASTR NUTR, V46, P465, DOI 10.1097/MPG.0b013e31815a9911; Verrips A, 1999, BRAIN, V122, P1589, DOI 10.1093/brain/122.8.1589; Wang L, 2002, P NATL ACAD SCI USA, V99, P13878, DOI 10.1073/pnas.172510899; Zhang J, 1997, BIOCHEM J, V322, P175	62	7	7	AMER SOC CLINICAL INVESTIGATION INC	ANN ARBOR	35 RESEARCH DR, STE 300, ANN ARBOR, MI 48103 USA	0021-9738	1558-8238		J CLIN INVEST	J. Clin. Invest.	NOV	2014	124	11					4829	4842		10.1172/JCI68506		14	Medicine, Research & Experimental	Research & Experimental Medicine	AS3UK	WOS:000344203300019		
J	Ogawa, F; Amano, H; Eshima, K; Ito, Y; Matsui, Y; Hosono, K; Kitasato, H; Iyoda, A; Iwabuchi, K; Kumagai, Y; Satoh, Y; Narumiya, S; Majima, M				Ogawa, Fumihiro; Amano, Hideki; Eshima, Koji; Ito, Yoshiya; Matsui, Yoshio; Hosono, Kanako; Kitasato, Hidero; Iyoda, Akira; Iwabuchi, Kazuya; Kumagai, Yuji; Satoh, Yukitoshi; Narumiya, Shuh; Majima, Masataka			Prostanoid induces premetastatic niche in regional lymph nodes	JOURNAL OF CLINICAL INVESTIGATION			English	Article							ENDOTHELIAL GROWTH-FACTOR; CELL LUNG-CANCER; TUMOR-ASSOCIATED ANGIOGENESIS; CHEMOKINE RECEPTOR CXCR4; REGULATORY T-CELLS; DENDRITIC CELLS; PROSTAGLANDIN E-2; IN-VIVO; INDOLEAMINE 2,3-DIOXYGENASE; METASTATIC NICHE	The lymphatic system is an important route for cancer dissemination, and lymph node metastasis (LNM) serves as a critical prognostic determinant in cancer patients. We investigated the contribution of COX-2-derived prostaglandin E-2 (PGE(2)) in the formation of a premetastatic niche and LNM. A murine model of Lewis lung carcinoma (LLC) cell metastasis revealed that COX-2 is expressed in DCs from the early stage in the lymph node subcapsular regions, and COX-2 inhibition markedly suppressed mediastinal LNM. Stromal cell-derived factor-1 (SDF-1) was elevated in DCs before LLC cell infiltration to the lymph nodes, and a COX-2 inhibitor, an SDF-1 antagonist, and a CXCR4 neutralizing antibody all reduced LNM. Moreover, LNM was reduced in mice lacking the PGE(2) receptor EP3, and stimulation of cultured DCs with an EP3 agonist increased SDF-1 production. Compared with WT CD11c(+) DCs, injection of EP3-deficient CD11c(+) DCs dramatically reduced accumulation of SDF-1(+)CD11c(+) DCs in regional LNs and LNM in LLC-injected mice. Accumulation of Tregs and lymph node lymphangiogenesis, which may influence the fate of metastasized tumor cells, was also COX-2/EP3-dependent. These results indicate that DCs induce a premetastatic niche during LNM via COX-2/EP3-dependent induction of SDF-1 and suggest that inhibition of this signaling axis may be an effective strategy to suppress premetastatic niche formation and LNM.	[Ogawa, Fumihiro; Amano, Hideki; Ito, Yoshiya; Matsui, Yoshio; Hosono, Kanako; Kumagai, Yuji; Majima, Masataka] Kitasato Univ, Sch Med, Dept Pharmacol, Sagamihara, Kanagawa 2520374, Japan; [Ogawa, Fumihiro; Kumagai, Yuji] Kitasato Univ, Sch Med, Dept Clin Res Ctr, Sagamihara, Kanagawa 2520374, Japan; [Eshima, Koji; Iwabuchi, Kazuya] Kitasato Univ, Sch Med, Dept Immunol, Sagamihara, Kanagawa 2520374, Japan; [Matsui, Yoshio; Satoh, Yukitoshi] Kitasato Univ, Sch Med, Dept Thorac Surg, Sagamihara, Kanagawa 2520374, Japan; [Kitasato, Hidero] Kitasato Univ, Sch Allied Hlth Sci, Dept Microbiol, Sagamihara, Kanagawa 2520374, Japan; [Iyoda, Akira] Toho Univ, Sch Med, Dept Thorac Surg, Tokyo, Japan; [Narumiya, Shuh] Kyoto Univ, Grad Sch Med, Dept Pharmacol, Kyoto, Japan	Majima, M (reprint author), Kitasato Univ, Sch Med, Dept Pharmacol, Minami Ku, Kitasato 1-15-1, Sagamihara, Kanagawa 2520374, Japan.	mmajima@med.kitasato-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology [23116102, 24659119, 26462132, 26293055]; Kitasato University Research Grant for Young Researchers; Takeda Science Foundation; Kitasato University Graduate School of Medical Sciences	We thank Mieko Hamano, Michiko Ogino, and Kyoko Yoshikawa for their technical assistance, Masato Saegusa and Miki Hashimura for their suggestions on pathological technique, and Makoto Murakami and Yoshitaka Taketomi (Tokyo Metropolitan Institute of Medical Science) for their suggestions on FACS experiments. This work was supported by grants from the Ministry of Education, Culture, Sports, Science and Technology, 23116102, 24659119, 26462132, and 26293055; Kitasato University Research Grant for Young Researchers; a grant from the Takeda Science Foundation; and a grant from Kitasato University Graduate School of Medical Sciences (Integrative Research Program 2013-2014).	Akhurst RJ, 2001, TRENDS CELL BIOL, V11, pS44, DOI 10.1016/S0962-8924(01)82259-5; Albrecht I, 2011, INT J DEV BIOL, V55, P483, DOI 10.1387/ijdb.103226ia; Amano H, 2002, JPN J PHARMACOL, V88, p179P; Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490; Teicher BA, 2010, CLIN CANCER RES, V16, P2927, DOI 10.1158/1078-0432.CCR-09-2329; Sharma S, 2005, CANCER RES, V65, P5211, DOI 10.1158/0008-5472.CAN-05-0141; Lutz MB, 2000, EUR J IMMUNOL, V30, P1048, DOI 10.1002/(SICI)1521-4141(200004)30:4<1048::AID-IMMU1048>3.0.CO;2-W; Kim M, 2010, CANCER RES, V70, P10411, DOI 10.1158/0008-5472.CAN-10-2591; Trinath J, 2013, BLOOD, V122, P1419, DOI 10.1182/blood-2012-11-468264; Kashiwagi S, 2011, LAB INVEST, V91, P1314, DOI 10.1038/labinvest.2011.84; Diamond MS, 2011, J EXP MED, V208, P1989, DOI 10.1084/jem.20101158; van Helden SFG, 2006, J IMMUNOL, V177, P1567; Legler DF, 2006, J IMMUNOL, V176, P966; Fuertes MB, 2011, J EXP MED, V208, P2005, DOI 10.1084/jem.20101159; Ogawa Y, 2009, BIOCHEM BIOPH RES CO, V382, P720, DOI 10.1016/j.bbrc.2009.03.094; Gualde N, 2004, IMMUNOL CELL BIOL, V82, P353, DOI 10.1111/j.1440-1711.2004.01251.x; Gobert M, 2009, CANCER RES, V69, P2000, DOI 10.1158/0008-5472.CAN-08-2360; Katoh H, 2010, AM J PATHOL, V176, P1469, DOI 10.2353/ajpath.2010.090607; Baratelli F, 2005, J IMMUNOL, V175, P1483; Bachelder RE, 2002, CANCER RES, V62, P7203; Majima M, 2000, BRIT J PHARMACOL, V130, P641, DOI 10.1038/sj.bjp.0703327; Singh P, 2012, BLOOD, V119, P1671, DOI 10.1182/blood-2011-03-342428; Amano H, 2009, CANCER SCI, V100, P2318, DOI 10.1111/j.1349-7006.2009.01322.x; Pepper MS, 2001, CLIN CANCER RES, V7, P462; Hosono K, 2011, ARTERIOSCL THROM VAS, V31, P1049, DOI 10.1161/ATVBAHA.110.222356; Greenhough A, 2009, CARCINOGENESIS, V30, P377, DOI 10.1093/carcin/bgp014; Wilson NS, 2005, ADV IMMUNOL, V86, P241, DOI 10.1016/S0065-2776(04)86007-3; Hiratsuka S, 2008, NAT CELL BIOL, V10, P1349, DOI 10.1038/ncb1794; Khuri FR, 2001, CLIN CANCER RES, V7, P861; Sun XQ, 2010, CANCER METAST REV, V29, P709, DOI 10.1007/s10555-010-9256-x; Scala S, 2005, CLIN CANCER RES, V11, P1835, DOI 10.1158/1078-0432.CCR-04-1887; Zeelenberg IS, 2003, CANCER RES, V63, P3833; Arya M, 2007, TUMOR BIOL, V28, P123, DOI 10.1159/000102979; Iwata C, 2007, CANCER RES, V67, P10181, DOI 10.1158/0008-5472.CAN-07-2366; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Ghiringhelli F, 2005, J EXP MED, V202, P919, DOI 10.1084/jem.20050463; Kalluri R, 2006, NAT REV CANCER, V6, P392, DOI 10.1038/nrc1877; Sallusto F, 1999, NATURE, V401, P708, DOI 10.1038/44385; Amano H, 2003, J EXP MED, V197, P221, DOI 10.1084/jem.20021408; Angeli V, 2006, IMMUNITY, V24, P203, DOI 10.1016/j.immuni.2006.01.003; Pan MR, 2008, J BIOL CHEM, V283, P11155, DOI 10.1074/jbc.M710038200; Kaplan RN, 2005, NATURE, V438, P820, DOI 10.1038/nature04186; Steinman RM, 2007, NATURE, V449, P419, DOI 10.1038/nature06175; Gentilini A, 2012, J HEPATOL, V57, P813, DOI 10.1016/j.jhep.2012.06.012; Pollard JW, 2004, NAT REV CANCER, V4, P71, DOI 10.1038/nrc1256; Hirakawa S, 2007, BLOOD, V109, P1010, DOI 10.1182/blood-2006-05-021758; Burger JA, 2006, BLOOD, V107, P1761, DOI 10.1182/blood-2005-08-3182; Forster R, 1999, CELL, V99, P23, DOI 10.1016/S0092-8674(00)80059-8; Belperio JA, 2004, CHEST, V125, p156S, DOI 10.1378/chest.125.5_suppl.156S; Braun D, 2005, BLOOD, V106, P2375, DOI 10.1182/blood-2005-03-0979; Burger M, 2003, ONCOGENE, V22, P8093, DOI 10.1038/sj.onc.1207097; Khayrullina T, 2008, J IMMUNOL, V181, P721; MACPHERSON GG, 1995, J IMMUNOL, V154, P1317; Mansfield AS, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-231; PAGET S, 1989, CANCER METAST REV, V8, P98; Peng L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058891; PUGH CW, 1983, J EXP MED, V157, P1758, DOI 10.1084/jem.157.6.1758; Singh S, 2004, LAB INVEST, V84, P1666, DOI 10.1038/labinvest.3700181; Sombroek CC, 2002, J IMMUNOL, V168, P4333; Uchida D, 2003, EXP CELL RES, V290, P289, DOI 10.1016/S0014-4827(03)00344-6; van Helden SFG, 2008, J CELL SCI, V121, P1096, DOI 10.1242/jcs.020289; von Bergwelt-Baildon MS, 2006, BLOOD, V108, P228, DOI 10.1182/blood-2005-08-3507; Wels J, 2008, GENE DEV, V22, P559, DOI 10.1101/gad.1636908; Yoshida S, 2003, LAB INVEST, V83, P1385, DOI 10.1097/01.LAB.0000090159.53224.B9	64	2	2	AMER SOC CLINICAL INVESTIGATION INC	ANN ARBOR	35 RESEARCH DR, STE 300, ANN ARBOR, MI 48103 USA	0021-9738	1558-8238		J CLIN INVEST	J. Clin. Invest.	NOV	2014	124	11					4882	4894		10.1172/JCI73530		13	Medicine, Research & Experimental	Research & Experimental Medicine	AS3UK	WOS:000344203300024		
J	Bhattacharya, M; Sundaram, A; Kudo, M; Farmer, J; Ganesan, P; Khalifeh-Soltani, A; Arjomandi, M; Atabai, K; Huang, XZ; Sheppard, D				Bhattacharya, Mallar; Sundaram, Aparna; Kudo, Makoto; Farmer, Jessica; Ganesan, Previn; Khalifeh-Soltani, Amin; Arjomandi, Mehrdad; Atabai, Kamran; Huang, Xiaozhu; Sheppard, Dean			IQGAP1-dependent scaffold suppresses RhoA and inhibits airway smooth muscle contraction	JOURNAL OF CLINICAL INVESTIGATION			English	Article							IQGAP1; MICE; ADHESION; RHOGAP; CDC42	The intracellular scaffold protein IQGAP1 supports protein complexes in conjunction with numerous binding partners involved in multiple cellular professes. Here, we determined that IQGAP1 modulates airway smooth muscle contractility. Compared with WT controls, at baseline as well as after immune sensitization and challenge, Iqgap1(-/-) mice had higher airway responsiveness. Tracheal rings from Iqgap1(-/-) mice generated greater agonist-induced contractile force, even after removal of the epithelium. RhoA, a regulator of airway smooth muscle contractility, was activated in airway smooth muscle lysates from Iqgap1(-/-) mice. Likewise, knockdown of IQGAP1 in primary human airway smooth muscle cells increased RhoA activity. Immunoprecipitation studies indicated that IQGAP1 binds to both RhoA and p190A-RhoGAP, a GTPase-activating protein that normally inhibits RhoA activation. Proximity ligation assays in primary airway human smooth muscle cells and mouse tracheal sections revealed colocalization of p190A-RhoGAP and RhoA; however, these proteins did not colocalize in IQGAP1 knockdown cells or in Iqgap1(-/-) trachea. Compared with healthy controls, human subjects with asthma had decreased IQGAP1 expression in airway biopsies. Together, these data demonstrate that IQGAP1 acts as a scaffold that colocalizes p190A-RhoGAP and RhoA, inactivating RhoA and suppressing airway smooth muscle contraction. Furthermore, our results suggest that IQGAP1 has the potential to modulate airway contraction severity in acute asthma.	[Bhattacharya, Mallar; Sundaram, Aparna; Farmer, Jessica; Ganesan, Previn; Khalifeh-Soltani, Amin; Arjomandi, Mehrdad; Atabai, Kamran; Huang, Xiaozhu; Sheppard, Dean] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; [Kudo, Makoto] Yokohama City Univ, Dept Internal Med & Clin Immunol, Yokohama, Kanagawa 232, Japan; [Arjomandi, Mehrdad] SF Vet Affairs Med Ctr, Pulm Res Grp, San Francisco, CA USA	Bhattacharya, M (reprint author), Univ Calif San Francisco, Dept Med, Box 2922, San Francisco, CA 94143 USA.	mallar.bhattacharya@ucsf.edu			American Lung Association [RG-224302-N]; NIH [HL102292, AI077439, HL112588, K23 HL083099]	This work was supported by American Lung Association grant RG-224302-N to M. Bhattacharya and by NIH grants HL102292 and AI077439 to D. Sheppard, HL112588 to A. Sundaram, and K23 HL083099 to M. Arjomandi.	Roskoski R, 2012, PHARMACOL RES, V66, P105, DOI 10.1016/j.phrs.2012.04.005; Mammoto A, 2007, J CELL SCI, V120, P456, DOI 10.1242/jcs.03353; Li SH, 2000, MOL CELL BIOL, V20, P697, DOI 10.1128/MCB.20.2.697-701.2000; Brown MD, 2006, TRENDS CELL BIOL, V16, P242, DOI 10.1016/j.tcb.2006.03.002; Arjomandi M, 2005, AM J RESP CRIT CARE, V172, P427, DOI 10.1164/rccm.200502-272OC; Kuroda S, 1998, SCIENCE, V281, P832, DOI 10.1126/science.281.5378.832; Roy M, 2005, MOL CELL BIOL, V25, P7940, DOI 10.1128/MCB.25.18.7940-7952.2005; Brouns MR, 2000, DEVELOPMENT, V127, P4891; Ren JG, 2007, P NATL ACAD SCI USA, V104, P10465, DOI 10.1073/pnas.0611308104; Brandt DT, 2007, EMBO REP, V8, P1019, DOI 10.1038/sj.embor.7401089; Casteel DE, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.377499; Chen C, 2006, MOL CELL BIOL, V26, P6950, DOI 10.1128/MCB.00646-06; Hart MJ, EMBO J; Ridley AJ, EMBO J; Roy M, J BIOL CHEM; Somlyo AP, 2003, PHYSL REV; Sugimoto K, 2012, J CLIN INVEST, V122, P748, DOI 10.1172/JCI58815; VANHOUTTE PM, 1989, J ALLERGY CLIN IMMUN, V83, P855, DOI 10.1016/0091-6749(89)90095-X; Vincent S, 1999, EUR J CELL BIOL, V78, P539	19	1	1	AMER SOC CLINICAL INVESTIGATION INC	ANN ARBOR	35 RESEARCH DR, STE 300, ANN ARBOR, MI 48103 USA	0021-9738	1558-8238		J CLIN INVEST	J. Clin. Invest.	NOV	2014	124	11					4895	4898		10.1172/JCI76658		4	Medicine, Research & Experimental	Research & Experimental Medicine	AS3UK	WOS:000344203300025		
J	Moriya, S; Hiramatsu, K; Kimura, E; Matsumoto, K; Kawakita, M				Moriya, Shun-suke; Hiramatsu, Kyoko; Kimura, Emi; Matsumoto, Kyoichi; Kawakita, Masao			Construction of an Immunochromatographic Determination System for N-1,N-12-diacetylspermine	JOURNAL OF CLINICAL LABORATORY ANALYSIS			English	Article						biological tumor markers; biomarkers; clinical chemical tests; clinical laboratory techniques; gold nanoparticles; neoplasms; urinalysis; urine	COLLOIDAL GOLD; HUMAN URINE; ASSAY; N-1,N-8-DIACETYLSPERMIDINE; MARKER	Background: N-1,N-12-diacetylspermine (DiAcSpm) is a recently identified tumor marker. Its concentration increases in the urine of cancer patients at early clinical stages. To utilize this characteristic feature and thus contribute to the early detection of cancer, we developed an immunochro-matographic determination system for DiAcSpm. Methods: We examined the factors that affect the performance and stability of our determination system, including antibody selection and the conditions for the formation of stably dispersed antibodycoated gold nanoparticles. We then tested the performance of the system by determining the DiAcSpm concentration in human urine samples. Results: We constructed an immunochromatographic strip using anti-DiAcSpm antibody-coated gold nanoparticles in the conjugate pad and an acetylspermine-protein conjugate (a DiAcSpm mimic) immobilized on the analyzing membrane. The use of the immunochromatographic strip and an immunochromatoreader allowed for the quantitative determination of DiAcSpm in the range of 20 to 700 nM. The analytical values obtained by this method were well correlated with those determined by a colloidal gold aggregation procedure using an automatic biochemical analyzer. The immunochromatographic strip was stable for at least 8 weeks at 50 degrees C. Conclusions: A competitive immunochromatographic device for DiAcSpm determination was developed in this study. This simple device will contribute to increasing the opportunities for early cancer detection and timely care. (C) 2014 Wiley Periodicals. Inc	[Moriya, Shun-suke; Hiramatsu, Kyoko; Kawakita, Masao] Tokyo Metropolitan Inst Med Sci, Translat Med Res Ctr, Tokyo 1568506, Japan; [Kimura, Emi; Matsumoto, Kyoichi] Mikuri Immunol Labs, Osaka, Japan	Kawakita, M (reprint author), Tokyo Metropolitan Inst Med Sci, Translat Med Res Ctr, Setagaya Ku, 2-1-6 Kami Kitazawa, Tokyo 1568506, Japan.	kawakita-ms@igakuken.or.jp			Japan Society for the Promotion of Science [21590639]	Grant sponsor: Japan Society for the Promotion of Science Grant-in-Aid for Scientific Research (C); Grant number: 21590639.	O'Farrell B, 2009, LATERAL FLOW IMMUNOASSAY, P1, DOI 10.1007/978-1-59745-240-3_1; Levy R, 2004, J AM CHEM SOC, V126, P10076, DOI 10.1021/ja0487269; Brooks T, 1997, LETT APPL MICROBIOL, V24, P203, DOI 10.1046/j.1472-765X.1997.00378.x; SUGIMOTO M, 1995, J CANCER RES CLIN, V121, P317, DOI 10.1007/BF01209602; Hiramatsu K, 1998, J BIOCHEM-TOKYO, V124, P231; Samejima K, 2010, ANAL BIOCHEM, V401, P22, DOI 10.1016/j.ab.2010.02.022; Chiao DJ, 2004, J CHROMATOGR B, V809, P37, DOI 10.1016/j.jchromb.2004.05.033; Kawakita M, 2006, J BIOCHEM, V139, P315, DOI 10.1093/jb.mvj068; Hiramatsu K, 2005, CLIN CANCER RES, V11, P2986, DOI 10.1158/1078-0432.CCR-04-2275; GEOGHEGAN WD, 1977, J HISTOCHEM CYTOCHEM, V25, P1187; HORISBERGER M, 1977, J HISTOCHEM CYTOCHEM, V25, P295; Paek SH, 2000, METHODS, V22, P53, DOI 10.1006/meth.2000.1036; Kawakita M, 2011, METHODS MOL BIOL, V720, P367, DOI 10.1007/978-1-61779-034-8_23; Hiramatsu K, 1997, J CANCER RES CLIN, V123, P539, DOI 10.1007/s004320050102; Chun P, 2009, LATERAL FLOW IMMUNOASSAY, P75, DOI 10.1007/978-1-59745-240-3_5; DWORETZKY SI, 1988, J CELL BIOL, V106, P575, DOI 10.1083/jcb.106.3.575; HIRAMATSU K, 1995, J BIOCHEM-TOKYO, V117, P107; Paek SH, 1999, ANAL LETT, V32, P335, DOI 10.1080/00032719908542824; Xiulan Sun, 2005, International Journal of Food Microbiology, V99, P185, DOI 10.1016/j.ijfoodmicro.2004.07.021; Zeng Q, 2009, AM J BIOMED SCI, V1, P70	20	1	1	JOHN WILEY & SONS INC	HOBOKEN	111 RIVER ST, HOBOKEN, NJ 07030 USA	0887-8013	1098-2825		J CLIN LAB ANAL	J. Clin. Lab. Anal.	NOV	2014	28	6					452	460		10.1002/jcla.21709		9	Medical Laboratory Technology	Medical Laboratory Technology	AS5ZP	WOS:000344345200006		
J	Albert, MJ; Al Obaid, K; Alfouzan, W; Sheikh, AR; Udo, E; Izumiya, H; Bulach, DM; Seemann, T				Albert, M. John; Al Obaid, Khaled; Alfouzan, Wadha; Sheikh, Abdul Rashid; Udo, Edet; Izumiya, Hidemasa; Bulach, Dieter M.; Seemann, Torsten			Isolation of Salmonella enterica Serovar Kentucky Strain ST 198 and Its H2S-Negative Variant from a Patient: Implications for Diagnosis	JOURNAL OF CLINICAL MICROBIOLOGY			English	Article							HYDROGEN-SULFIDE; RESISTANT; CIPROFLOXACIN; SEQUENCE; TYPHIMURIUM; BACTERIA; GENE	H2S-producing multiresistant Salmonella enterica serovar Kentucky strain sequence type (ST) 198 and its non-H2S-producing variant were isolated from a patient. Whole-genome comparison showed a base addition in the gene encoding molybdenum cofactor biosynthesis protein C, which could affect H2S production in the variant. Lack of H2S production has implications for diagnosis of salmonella.	[Albert, M. John; Alfouzan, Wadha; Udo, Edet] Kuwait Univ, Fac Med, Dept Microbiol, Jabriya, Kuwait; [Al Obaid, Khaled; Sheikh, Abdul Rashid] Al Amiri Hosp, Dept Microbiol, Sharq, Kuwait; [Izumiya, Hidemasa] Natl Inst Infect Dis, Tokyo, Japan; [Bulach, Dieter M.; Seemann, Torsten] Monash Univ, Victorian Bioinformat Consortium, Clayton, Vic, Australia	Albert, MJ (reprint author), Kuwait Univ, Fac Med, Dept Microbiol, Jabriya, Kuwait.	john@hsc.edu.kw		Seemann, Torsten/0000-0001-6046-610X; Alfouzan, Wadha/0000-0002-4501-5316			Levitt MD, 1999, J CLIN INVEST, V104, P1107, DOI 10.1172/JCI7712; Stoffels L, 2012, J BACTERIOL, V194, P475, DOI 10.1128/JB.06014-11; Hensel M, 1999, MOL MICROBIOL, V32, P275, DOI 10.1046/j.1365-2958.1999.01345.x; WUEBBENS MM, 1995, J BIOL CHEM, V270, P1082; Nusbaum C, 2009, NAT METHODS, V6, P67, DOI [10.1038/nmeth.1286, 10.1038/NMETH.1286]; Le Hello S, 2011, J INFECT DIS, V204, P675, DOI 10.1093/infdis/jir409; Sakano C, 2013, J CLIN MICROBIOL, V51, P328, DOI 10.1128/JCM.02225-12; Rohmer L, 2011, TRENDS MICROBIOL, V19, P341, DOI 10.1016/j.tim.2011.04.003; Mendel RR, 2013, J BIOL CHEM, V288, P13165, DOI 10.1074/jbc.R113.455311; BECK CF, 1982, J BACTERIOL, V150, P633; Clinical and Laboratory Standards Institute, 2008, M100S18 CLSINCCLS; Illumina, 2009, ILL PUBL; Jamal W, 2013, J MED MICROBIOL, V62, P1239, DOI 10.1099/jmm.0.059915-0; Le Hello S, 2013, LANCET INFECT DIS, V13, P672, DOI 10.1016/S1473-3099(13)70124-5; MALIGA P, 1988, MOL GEN GENET, V214, P456, DOI 10.1007/BF00330480; Mulvey MR, 2013, EMERG INFECT DIS, V19, P999, DOI 10.3201/eid1906.121351; Rickert-Hartman R, 2014, EMERG INFECT DIS, V20, P910, DOI 10.3201/eid2005.131575; SHINKAWA H, 1987, J GEN MICROBIOL, V133, P1289	18	1	1	AMER SOC MICROBIOLOGY	WASHINGTON	1752 N ST NW, WASHINGTON, DC 20036-2904 USA	0095-1137	1098-660X		J CLIN MICROBIOL	J. Clin. Microbiol.	NOV	2014	52	11					4090	4093		10.1128/JCM.01775-14		4	Microbiology	Microbiology	AS3EO	WOS:000344159500050		
J	Ochi, M; Ichikawa, N; Shiota, R; Hattori, Y; Harada, M; Hara, M; Uchida, H				Ochi, Mitsukazu; Ichikawa, Natsuko; Shiota, Ryou; Hattori, Yoshiki; Harada, Miyuki; Hara, Masanao; Uchida, Hiroshi			Surface properties of alicyclic epoxy coatings modified with reactive copolymer containing fluorinated side chains	JOURNAL OF COATINGS TECHNOLOGY AND RESEARCH			English	Article						Surface modification; Self-segregation; Refractive index; Alicyclic epoxy resin; Transparent coatings	MOLECULAR AGGREGATION STRUCTURE; THIN-FILMS; ISOCYANATES; TEMPERATURE; DYNAMICS; TENSION; SYSTEMS; BLOCK; ENDS	An alicyclic epoxy resin was modified with a copolymer having both a perfluoroalkyl side chain and a cyclohexenoxide-terminated side chain. The copolymer had a good solubility in the epoxy matrix during the reaction of the alicyclic epoxy groups on the terminal end of the side chains. Thus, the cured epoxy resin had a homogeneous phase structure and was a colorless material with excellent transparency. The fluorinated side chains were highly self-segregated in the air-side surface (thickness: less than 8 nm) to minimize the interfacial free energy between the air and cured epoxy resin. The surface of the epoxy coatings had a significantly low surface free energy (ca. 20 mJ/m(2)) and revealed both high hydro- and oleo-phobicities. In addition, the surface had a gradient in the refractive index due to the self-stratification of the C-F bond that has a low polarizability.	[Ochi, Mitsukazu; Ichikawa, Natsuko; Shiota, Ryou; Hattori, Yoshiki; Harada, Miyuki] Kansai Univ, Fac Chem Mat & Bioengn, Suita, Osaka 5648680, Japan; [Hara, Masanao; Uchida, Hiroshi] Showa Denko Co Ltd, Ichihara, Chiba 2900067, Japan	Ochi, M (reprint author), Kansai Univ, Fac Chem Mat & Bioengn, 3-3-35 Yamate Cho, Suita, Osaka 5648680, Japan.	mochi@kansai-u.ac.jp; n.ichikawa@elna.co.jp; k669007@kansai-u.ac.jp; ouzai_kansai-univ@excite.co.jp; mharada@kansai-u.ac.jp; hara.masanao.xhekm@showadenko.com; uchida.hiroshi.xhimt@showadenko.com					Schnurer AU, 1996, CHEM MATER, V8, P1475, DOI 10.1021/cm960049x; Tsibouklis J, 2000, MACROMOLECULES, V33, P8460, DOI 10.1021/ma0008185; Morita H, 2006, MACROMOLECULES, V39, P6233, DOI 10.1021/ma052632h; Matuszczak S, 2000, J FLUORINE CHEM, V102, P269, DOI 10.1016/S0022-1139(99)00288-2; van de Grampel RD, 2005, POLYMER, V46, P10531, DOI 10.1016/j.polymer.2005.08.024; Honda K, 2005, MACROMOLECULES, V38, P5699, DOI 10.1021/ma050394k; Morita M, 2009, KOBUNSHI RONBUNSHU, V66, P102; Sangermano M, 2003, J APPL POLYM SCI, V89, P1524, DOI 10.1002/app.12244; Wang JG, 1997, MACROMOLECULES, V30, P1906, DOI 10.1021/ma961412o; van Ravenstein L, 2004, MACROMOLECULES, V37, P408, DOI 10.1021/ma035296i; Honda K, 2007, KOBUNSHI RONBUNSHU, V64, P181, DOI 10.1295/koron.64.181; Jannasch P, 1998, MACROMOLECULES, V31, P1341, DOI 10.1021/ma971351+; KASEMURA T, 1993, J APPL POLYM SCI, V47, P2207, DOI 10.1002/app.1993.070471215; Maruno T, 1996, MACROMOLECULES, V29, P2006, DOI 10.1021/ma951348v; Ming W, 2003, PROG ORG COAT, V48, P316, DOI 10.1016/S0300-9440(03)00107-3; Ming WH, 2000, MACROMOLECULES, V33, P6886, DOI 10.1021/ma0005771; Montefusco F, 2004, POLYMER, V45, P4663, DOI 10.1016/j.polymer.2004.04.068; Takai H, 2003, SOSETSU EPOKISHI JUS, V1, P76; Tanaka K, 2003, POLYMER, V44, P4171, DOI 10.1016/S0032-3861(03)00391-4; Wang CZ, 2009, J APPL POLYM SCI, V114, P2528, DOI 10.1002/app.30803	20	2	2	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1547-0091	1935-3804		J COAT TECHNOL RES	J. Coat. Technol. Res.	NOV	2014	11	6					913	921		10.1007/s11998-014-9604-9		9	Chemistry, Applied; Materials Science, Coatings & Films	Chemistry; Materials Science	AS5YH	WOS:000344341900008		
J	Zhou, D; Li, Y; Zhang, YB; Zhang, C; Li, XF; Chen, ZL; Huang, JY; Li, X; Flores, G; Kamon, M				Zhou, Dan; Li, Yan; Zhang, Yinbo; Zhang, Chang; Li, Xiongfei; Chen, Zhiliang; Huang, Junyi; Li, Xia; Flores, Giancarlo; Kamon, Masashi			Column test-based optimization of the permeable reactive barrier (PRB) technique for remediating groundwater contaminated by landfill leachates	JOURNAL OF CONTAMINANT HYDROLOGY			English	Article						Permeable reactive barrier (PRB); Groundwater; Contamination; Remediation; Component ratio; Thickness; Longevity	LONG-TERM PERFORMANCE; ZERO-VALENT IRON; GRANULAR IRON; MINERALOGICAL CHARACTERISTICS; ORGANIC-COMPOUNDS; SOLUTE TRANSPORT; ACTIVATED CARBON; HEAVY-METALS; ADSORPTION; REMOVAL	We investigated the optimum composition of permeable reactive barrier (PRE) materials for remediating groundwater heavily contaminated by landfill leachate, in column tests using various mixtures of zero-valent iron (ZVI), zeolite (Zeo) and activated carbon (AC) with 0.01-0.25,3.0-5.0 and 0.7-1.0 mm grain sizes, respectively. The main contributors to the removal of organic/inorganic contaminants were ZVI and AC, and the optimum weight ratio of the three PRB materials for removing the contaminants and maintaining adequate hydraulic conductivity was found to be 5:1:4. Average reductions in chemical oxygen demand (COD) and contents of total nitrogen (TN), ammonium, Ni, Pb and 16 polycyclic aromatic hydrocarbons (PAHs) from test samples using this mixture were 55.8%, 70.8%, 89.2%, 70.7%, 92.7% and 94.2%, respectively. We also developed a systematic method for estimating the minimum required thickness and longevity of the PRB materials. A >= 309.6 cm layer with the optimum composition is needed for satisfactory longevity, defined here as meeting the Grade III criteria (the Chinese National Bureau of Standards: GB/T14848/93) for in situ treatment of the sampled groundwater for >= 10 years. (C) 2014 Elsevier B.V. All rights reserved.	[Zhou, Dan; Li, Yan; Huang, Junyi] Sun Yat Sen Univ, Sch Marine Sci, Guangdong Prov Key Lab Marine Resources & Coastal, Guangzhou 510275, Guangdong, Peoples R China; [Zhou, Dan; Li, Yan; Huang, Junyi] Sun Yat Sen Univ, Sch Marine Sci, Ministiy Educ, Key Lab Aquat Prod Safety, Guangzhou 510275, Guangdong, Peoples R China; [Zhang, Yinbo; Chen, Zhiliang] Minist Environm Protect, South China Inst Environm Sci, Guangzhou 510655, Guangdong, Peoples R China; [Zhang, Chang] Shandong Bonaray Anal Instrument Technol Co Ltd, Jining 272000, Peoples R China; [Li, Xiongfei] Guangdong Prov Environm Technol Ctr, Guangzhou 510308, Guangdong, Peoples R China; [Li, Xia] Nanhai Environm Technol Ctr Foshan City, Guicheng 528200, Foshan, Peoples R China; [Flores, Giancarlo] Kyoto Univ, Grad Sch Engn, Kyoto 6068501, Japan; [Kamon, Masashi] Natl Coll Technol, Takamatsu, Kagawa 7618058, Japan	Li, Y (reprint author), Sun Yat Sen Univ, Sch Marine Sci, Guangdong Prov Key Lab Marine Resources & Coastal, 135 Xingang RD W, Guangzhou 510275, Guangdong, Peoples R China.	eesly@mail.sysu.edu.cn			Chinese National Science Foundation [41072182, 21177162]; Guangdong Major Science and Technology Project [2012A030700008]; Guangzhou Science and Technology Project [2010Z1-E101]; Shandong Province: the industrialization and application research of hermetic high-flux intelligent electromagnetic digestion system	The authors gratefully acknowledge Dr. John Blackwell (Sees-editing Ltd.) for his editing of this paper. This work was supported by the Chinese National Science Foundation (grant nos. 41072182; 21177162), Guangdong Major Science and Technology Project (grant no. 2012A030700008), Guangzhou Science and Technology Project (grant no. 2010Z1-E101), and the industry support project by Shandong Province: the industrialization and application research of hermetic high-flux intelligent electromagnetic digestion system.	AFCEE (Air Force Center for Engineering and the Environment), 2008, TECHN PROT ENH AN BI; Ahmad F., 2007, REMEDIAT J, V18, P59, DOI 10.1002/rem.20151; Phillips DH, 2000, ENVIRON SCI TECHNOL, V34, P4169, DOI 10.1021/es001005z; Liang LY, 2000, ADV ENVIRON RES, V4, P273, DOI 10.1016/S1093-0191(00)00026-5; Peng XJ, 2003, CHEM PHYS LETT, V376, P154, DOI 10.1016/S0009-2614(03)00960-6; Higgins MR, 2009, ENVIRON SCI TECHNOL, V43, P9432, DOI 10.1021/es9015537; Moon HS, 2008, CHEMOSPHERE, V73, P723, DOI 10.1016/j.chemosphere.2008.06.065; Moraci N, 2010, J ENVIRON MANAGE, V91, P2336, DOI 10.1016/j.jenvman.2010.06.019; Carniato L, 2012, J CONTAM HYDROL, V142, P93, DOI 10.1016/j.jconhyd.2012.08.012; Nakagawa K, 2003, CARBON, V41, P823, DOI 10.1016/S0008-6223(02)00404-9; Liang LY, 2005, J CONTAM HYDROL, V78, P291, DOI 10.1016/j.jconhyd.2005.05.006; Scherer MM, 2000, CRIT REV MICROBIOL, V26, P221, DOI 10.1080/10408410091154237; [Anonymous], 2006, NATO SCI S SS IV EAR; Renou S, 2008, J HAZARD MATER, V150, P468, DOI 10.1016/j.jhazmat.2007.09.077; Jeen SW, 2008, J CONTAM HYDROL, V95, P76, DOI 10.1016/j.jconhyd.2007.07.012; Robertson WD, 2000, GROUND WATER, V38, P689, DOI 10.1111/j.1745-6584.2000.tb02704.x; Coombs DS, 1997, CAN MINERAL, V35, P1571; Dong J, 2009, J HAZARD MATER, V161, P224, DOI 10.1016/j.jhazmat.2008.03.086; Blowes DW, 2000, J CONTAM HYDROL, V45, P123, DOI 10.1016/S0169-7722(00)00122-4; Guerin TF, 2002, WATER RES, V36, P15, DOI 10.1016/S0043-1354(01)00233-0; McGovern T, 2002, WATER AIR SOIL POLL, V136, P11, DOI 10.1023/A:1015227530710; Peric J, 2004, WATER RES, V38, P1893, DOI 10.1016/j.watres.2003.12.035; Christensen TH, 2001, APPL GEOCHEM, V16, P659, DOI 10.1016/S0883-2927(00)00082-2; Furukawa Y, 2002, ENVIRON SCI TECHNOL, V36, P5469, DOI 10.1021/es025533h; Kao CM, 2000, WATER SCI TECHNOL, V42, P429; San I, 2001, J HAZARD MATER, V87, P259, DOI 10.1016/S0304-3894(01)00290-4; Mackenzie PD, 1999, J HAZARD MATER, V68, P1, DOI 10.1016/S0304-3894(99)00029-1; Zolla V, 2009, J ENVIRON QUAL, V38, P897, DOI 10.2134/jeq2007.0622; Wilkin RT, 2005, ENVIRON SCI TECHNOL, V39, P4599, DOI 10.1021/es050157x; McMahon PB, 1999, GROUND WATER, V37, P396, DOI 10.1111/j.1745-6584.1999.tb01117.x; Ruhl AS, 2012, CHEM ENG J, V213, P245, DOI 10.1016/j.cej.2012.10.007; Henderson AD, 2007, ENVIRON ENG SCI, V24, P401, DOI 10.1089/ees.2006.0071; Phillips DH, 2003, J ENVIRON QUAL, V32, P2033; Li L, 2006, J CONTAM HYDROL, V83, P89, DOI 10.1016/j.jconhyd.2005.11.004; Li L, 2010, J HAZARD MATER, V181, P170, DOI 10.1016/j.jhazmat.2010.04.113; Vogan JL, 1999, J HAZARD MATER, V68, P97, DOI 10.1016/S0304-3894(99)00033-3; Ranck JM, 2005, J ENVIRON ENG-ASCE, V131, P434, DOI 10.1061/(ASCE)0733-9372(2005)131:3(434); Wilkin RT, 2003, GROUND WATER, V41, P493, DOI 10.1111/j.1745-6584.2003.tb02383.x; Fallico C, 2010, BIOGEOSCIENCES, V7, P2545, DOI 10.5194/bg-7-2545-2010; Wantanaphong J, 2006, J CONTAM HYDROL, V86, P299, DOI 10.1016/j.jconhyd.2006.04.003; Yang J, 2010, J HAZARD MATER, V184, P782, DOI 10.1016/j.jhazmat.2010.08.109; Obiri-Nyarko F, 2014, CHEMOSPHERE, V111, P243, DOI 10.1016/j.chemosphere.2014.03.112; Pratt AR, 1997, ENVIRON SCI TECHNOL, V31, P2492, DOI 10.1021/es9607897; Strous M, 1998, APPL MICROBIOL BIOT, V50, P589; O'Hannesin SF, 1998, GROUND WATER, V36, P164, DOI 10.1111/j.1745-6584.1998.tb01077.x; Calabro PS, 2012, J HAZARD MATER, V207, P111, DOI 10.1016/j.jhazmat.2011.06.094; Cornelissen G, 2005, ENVIRON SCI TECHNOL, V39, P6881, DOI 10.1021/es050191b; Wilkin RT, 2009, J CONTAM HYDROL, V106, P1, DOI 10.1016/j.jconhyd.2008.12.002; ATSDR, 2005, TOX PROF POL HYDR; Blowes DW, 1998, IAHS-AISH P, P483; Bone B.D., 2012, 2012 TAIP INT C REM, P611; BOWMAN RS, 1995, ACS SYM SER, V594, P54; Cao F.L., 2011, NONWOOD FOR RES, V29, P1; CHRISTENSEN TH, 1994, CRIT REV ENV SCI TEC, V24, P119; Conca J., 2002, GROUNDWATER REMEDIAT, P221; [崔海炜 CUI Haiwei], 2011, [农业环境科学学报, Journal of Agro-Environment Science], V30, P1185; Di-Nardo A., 2010, P 20 EUR S COMP AID; Dong J., 2002, J GEOSCI RES NE ASIA, V5, P72; Dong J., 2003, ENV SCI, V24, P151; Eaton A. D., 2005, STANDARD METHODS EXA; Eljamal O, 2011, APPL MATH MODEL, V35, P5198, DOI 10.1016/j.apm.2011.04.040; Erto A, 2011, J ENVIRON MANAGE, V92, P23, DOI 10.1016/j.jenvman.2010.07.044; Eykholt GR, 1999, J HAZARD MATER, V68, P73, DOI 10.1016/S0304-3894(99)00032-1; FRTR Federal Remediation Technologies Roundtable, 2002, EV PERM REACT BARR P; Gandhi S, 2002, WATER RES, V36, P1973, DOI 10.1016/S0043-1354(01)00409-2; Gavaskar A., 2000, DESIGN GUIDANCE APPL; Gavaskar A.R., 1998, PERMEABLE BARRIERS G; Geranio L., 2007, REV ZERO VALENT IRON; Gillham R. W., 2010, SITU REMEDIATION CHL, P537, DOI 10.1007/978-1-4419-1401-9_16; Head K. H., 2008, MANUAL SOIL LAB TEST, V2; Henry B.M., 2008, SITU BIOREMEDIATION, P177; Henry B.M., 2003, P 7 INT IN SIT ON SI; ITRC, 2011, PERM REACT BARR TECH; ITRC Interstate Technology & Regulatory Council, 2005, PERM REACT BARR LESS; Jin O., 2009, J CONTAM HYDROL, V103, P145; Kacimov AR, 2011, J ENG MATH, V71, P319, DOI 10.1007/s10665-011-9457-5; Karnolpornwijit W., 2003, J CONTAM HYDROL, V66, P161; Katz LE., 2006, DEFC2602NT15461 NAT; Klammler H, 2008, J CONTAM HYDROL, V98, P1, DOI 10.1016/j.jconhyd.2008.01.005; Kober R., 2002, P GROUNDW QUAL 2001, P18; Kovalick J.W.W., 1995, CONT SOIL 95, P29; Li L, 2005, GROUND WATER, V43, P582, DOI 10.1111/j.1745-6584.2005.0042.x; Li ZH, 1999, ENVIRON SCI TECHNOL, V33, P4326, DOI 10.1021/es990334s; Lin MZ, 2010, CONFERENCE ON ENVIRONMENTAL POLLUTION AND PUBLIC HEALTH, VOL 1-2, P438; Liu X, 1997, CARBON, V35, P1387, DOI 10.1016/S0008-6223(97)00092-4; [罗育池 LUO Yuchi], 2007, [安徽农业科学, Journal of Anhui Agricultural Sciences], V35, P8656; Ma CW, 2008, ENVIRON GEOL, V55, P47, DOI 10.1007/s00254-007-0963-8; Morrison S, 2003, ENVIRON SCI TECHNOL, V37, P2302, DOI 10.1021/es0209565; Muegge J., 2008, 1219 OFF POLL PREV G; Mueller J., 2004, P BATT 4 INT C REM C, P8; Naftz D. L., 2002, HDB GROUNDWATER REME; [倪晋仁 Ni Jinren], 2004, [应用基础与工程科学学报, Journal of Basic Science and Engineering], V12, P148; Onay TT, 1998, WATER RES, V32, P1383, DOI 10.1016/S0043-1354(97)00392-8; Ott N., 2000, PERMEABLE REACTIVE B; Ozturk Z, 2012, CHEMOSPHERE, V89, P665, DOI 10.1016/j.chemosphere.2012.06.006; Panturu E., 2009, CHEM B POLITEHNICA, V54, P50; Park JB, 2002, J HAZARD MATER, V95, P65, DOI 10.1016/S0304-3894(02)00007-9; Powell R. M., 1998, EPA600R98125; Reynolds T., 1996, UNIT OPERATIONS PROC, V2nd; Rijnaarts HHM, 1997, BIOREMED SER, V4(4), P203; Roehl K.E., 2005, LONG TERM PERFORMANC; SABERI A, 2012, J ENERGY ENV, V3, P189; Sarr D., 2001, REMEDIATION, V11, P1; Schad H., 1998, 542R98003 EPA; Simon F. G., 2000, Land Contamination & Reclamation, V8, P103; Thiruverikatachari R, 2008, J IND ENG CHEM, V14, P145, DOI 10.1016/j.jiec.2007.10.001; Tratnyek P.G., 2003, CHEM DEGRADATION MET, P371; US. EPA, 1998, 542R98003 US EPA; US. EPA, 2002, FIELD APPL SIT REM T; Vidic R.D., 1996, TE9601 GROUD WAT REM; Vikesland PJ, 2003, J CONTAM HYDROL, V64, P3, DOI 10.1016/S0169-7722(02)00150-X; Wilkin R.T., 2003, EPA600R03045A NAT RI; Xenidis A., 2002, MINERAL WEALTH, V123, P35; [钟继洪 ZHONG Ji-hong], 2009, [水土保持学报, Journal of Soil and Water Conservation], V23, P244; Zhou Z.H., 2006, GUANGZHOU CHEM IND, V34, P56	115	4	5	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0169-7722	1873-6009		J CONTAM HYDROL	J. Contam. Hydrol.	NOV 1	2014	168						1	16		10.1016/j.jconhyd.2014.09.003		16	Environmental Sciences; Geosciences, Multidisciplinary; Water Resources	Environmental Sciences & Ecology; Geology; Water Resources	AS7KT	WOS:000344435800001		
J	Bando, K; Takahashi, H; Kinbara, M; Tanaka, Y; Kuroishi, T; Sasaki, K; Takano-Yamamoto, T; Sugawara, S; Endo, Y				Bando, K.; Takahashi, H.; Kinbara, M.; Tanaka, Y.; Kuroishi, T.; Sasaki, K.; Takano-Yamamoto, T.; Sugawara, S.; Endo, Y.			Resin Monomers Act as Adjuvants in Ni-induced Allergic Dermatitis in vivo	JOURNAL OF DENTAL RESEARCH			English	Article						methyl methacrylate; 2-hydroxyethyl methacrylate; dental material; macrophage; IL-1; allergy	METHYL-METHACRYLATE; HISTIDINE-DECARBOXYLASE; ORTHODONTIC APPLIANCES; NICKEL CONCENTRATION; MICE; IL-1; SENSITIZATION; ELICITATION; LIPOPOLYSACCHARIDE; DISEASES	Resin monomers (RMs) are inflammatory agents and are thought to cause allergic contact dermatitis (ACD). However, mouse models are lacking, possibly because of the weak antigenicities of RMs. We previously reported that inflammatory substances can promote the allergic dermatitis (AD) induced by intradermally injected nickel (Ni-AD) in mice. Here, we examined the effects of RMs on Ni-AD. To sensitize mice to Ni, a mixture containing non-toxic concentrations of NiCl2 and an RM [either methyl methacrylate (MMA) or 2-hydroxyethyl methacrylate (HEMA)] was injected intraperitoneally or into ear-pinnae intradermally. Ten days later, a mixture containing various concentrations of NiCl2 and/or an RM was intradermally injected into ear-pinnae, and ear-swelling was measured. In adoptive transfer experiments, spleen cells from sensitized mice were transferred intravenously into non-sensitized recipients, and 24 h later NiCl2 was challenged to ear-pinnae. Whether injected intraperitoneally or intradermally, RM plus NiCl2 mixtures were effective in sensitizing mice to Ni. AD-inducing Ni concentrations were greatly reduced in the presence of MMA or HEMA (at the sensitization step from 10 mM to 5 or 50 mu M, respectively, and at the elicitation step from 10 mu M to 10 or 100 nM, respectively). These effects of RMs were weaker in IL-1-knockout mice and in macrophage-depleted mice. Cell-transfer experiments in IL-1-knockout mice indicated that both the sensitization and elicitation steps depended on IL-1. Challenge with an RM alone did not induce allergic ear-swelling in mice given the same RM + NiCl2 10 days before the challenge. These results suggest that RMs act as adjuvants, not as antigens, to promote Ni-AD by reducing the AD-inducing concentration of Ni, and that IL-1 and macrophages are critically important for the adjuvant effects. We speculate that what were previously thought of as RM-ACD might include ACD caused by antigens other than RMs that have undergone promotion by the adjuvant effects of RMs.	[Bando, K.; Takahashi, H.; Kinbara, M.; Tanaka, Y.; Kuroishi, T.; Sugawara, S.; Endo, Y.] Tohoku Univ, Grad Sch Dent, Div Mol Regulat, Sendai, Miyagi 9808575, Japan; [Bando, K.; Kinbara, M.; Takano-Yamamoto, T.] Tohoku Univ, Grad Sch Dent, Div Orthodont & Dentofacial Orthoped, Sendai, Miyagi 9808575, Japan; [Takahashi, H.; Sasaki, K.] Tohoku Univ, Grad Sch Dent, Div Adv Prosthet Dent, Sendai, Miyagi 9808575, Japan	Bando, K (reprint author), Tohoku Univ, Grad Sch Dent, Div Mol Regulat, 4-1 Seiryo Machi, Sendai, Miyagi 9808575, Japan.	kananbando@dent.tohoku.ac.jp			JSPS KAKENHI Grant [24659835];  [2410432]	We are grateful to Dr. R. Timms for editing the manuscript. This work was supported by Grants-in-Aid for JSPS Fellows Grant Number 2410432 (to K.B.) and JSPS KAKENHI Grant Number 24659835 (to Y.E.). The authors declare no potential conflicts of interest with respect to the authorship and/or publication of this article.	Aalto-Korte K, 2007, CONTACT DERMATITIS, V57, P324, DOI 10.1111/j.1600-0536.2007.01237.x; Moharamzadeh K, 2007, DENT MATER, V23, P40, DOI 10.1016/j.dental.2005.11.039; Nambu Aya, 2010, Allergology International, V59, P125, DOI 10.2332/allergolint.10-RAI-0190; Deng X, 2012, INT IMMUNOPHARMACOL, V14, P658, DOI 10.1016/j.intimp.2012.10.001; Kimber I, 2003, FOOD CHEM TOXICOL, V41, P1799, DOI 10.1016/S0278-6915(03)00223-0; De Souza RM, 2008, ANGLE ORTHOD, V78, P345, DOI 10.2319/111806-466.1; Leggat PA, 2003, INT DENT J, V53, P126; Deng X, 2006, TOXICOL APPL PHARM, V213, P64, DOI 10.1016/j.taap.2005.09.005; Horai R, 1998, J EXP MED, V187, P1463, DOI 10.1084/jem.187.9.1463; Eliades T, 2003, EUR J ORTHODONT, V25, P103, DOI 10.1093/ejo/25.1.103; Liden C, 2008, CONTACT DERMATITIS, V59, P31, DOI 10.1111/j.1600-0536.2008.01363.x; Marichal T, 2011, NAT MED, V17, P996, DOI 10.1038/nm.2403; Paranjpe A, 2005, J DENT RES, V84, P172; VANROOIJEN N, 1994, J IMMUNOL METHODS, V174, P83; Sato N, 2007, CLIN EXP ALLERGY, V37, P743, DOI 10.1111/j.1365-2222.2007.02705.x; Dinarello CA, 2012, NAT REV DRUG DISCOV, V11, P633, DOI 10.1038/nrd3800; Petoumenou E, 2009, AM J ORTHOD DENTOFAC, V135, P59, DOI 10.1016/j.ajodo.2006.12.018; Pfeiffer P, 2004, J PROSTHET DENT, V92, P72, DOI 10.1016/j.prosdent.2004.04.003; Burton L, 2013, J ORTHOP RES, V31, P73, DOI 10.1002/jor.22190; Gabay C, 2010, NAT REV RHEUMATOL, V6, P232, DOI 10.1038/nrrheum.2010.4; Batista-Duharte A, 2011, TOXICOL LETT, V203, P97, DOI 10.1016/j.toxlet.2011.03.001; Rustemeyer T, 1996, CONTACT DERMATITIS, V34, P125, DOI 10.1111/j.1600-0536.1996.tb02144.x; Betts CJ, 2006, CONTACT DERMATITIS, V55, P140, DOI 10.1111/j.1600-0536.2006.00898.x; Bolling AK, 2013, TOXICOL LETT, V216, P130, DOI 10.1016/j.toxlet.2012.11.010; Contassot E, 2012, SWISS MED WKLY, V142, DOI 10.4414/smw.2012.13590; Fischer LA, 2005, CONTACT DERMATITIS, V52, P57, DOI 10.1111/j.0105-1873.2005.00523.x; Garner Lisa A, 2004, Dermatol Ther, V17, P321, DOI 10.1111/j.1396-0296.2004.04034.x; Goncalves TS, 2006, AM J ORTHOD DENTOFAC, V129, P431, DOI 10.1016/j.ajodo.2005.10.017; Grabbe S, 1996, J CLIN INVEST, V98, P1158, DOI 10.1172/JCI118899; Huang L, 2011, INT IMMUNOPHARMACOL, V11, P1916, DOI 10.1016/j.intimp.2011.07.025; Kinbara M, 2011, BRIT J DERMATOL, V164, P356, DOI 10.1111/j.1365-2133.2010.10016.x; MENNE T, 1994, SCI TOTAL ENVIRON, V148, P275, DOI 10.1016/0048-9697(94)90403-0; Rakich DR, 1999, J ENDODONT, V25, P114, DOI 10.1016/S0099-2399(99)80008-9; Rustemeyer T, 1998, TOXICOL APPL PHARM, V148, P83, DOI 10.1006/taap.1997.8304; Sandberg E, 2005, EUR J ORAL SCI, V113, P410, DOI 10.1111/j.1600-0722.2005.00234.x; Schmidt R, 2010, NAT IMMUNOL, V11, P814; Takahashi H, 2011, INT IMMUNOPHARMACOL, V11, P1534, DOI 10.1016/j.intimp.2011.05.010; Teik-Jin Goon A, 2007, CONTACT DERMATITIS, V57, P21; Yamaguchi K, 2006, BBA-MOL BASIS DIS, V1762, P269, DOI 10.1016/j.bbadis.2005.11.010	39	1	1	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0022-0345	1544-0591		J DENT RES	J. Dent. Res.	NOV	2014	93	11					1101	1107		10.1177/0022034514552674		7	Dentistry, Oral Surgery & Medicine	Dentistry, Oral Surgery & Medicine	AS0NU	WOS:000343975100009		
J	Nakajima, R; Ono, M; Hara, ES; Oida, Y; Shinkawa, S; Pham, HT; Akiyama, K; Sonoyama, W; Maekawa, K; Kuboki, T				Nakajima, R.; Ono, M.; Hara, E. S.; Oida, Y.; Shinkawa, S.; Pham, H. T.; Akiyama, K.; Sonoyama, W.; Maekawa, K.; Kuboki, T.			Mesenchymal Stem/Progenitor Cell Isolation from Tooth Extraction Sockets	JOURNAL OF DENTAL RESEARCH			English	Article						stem cells; granulation tissue; dental socket; bone marrow-derived stem cells; wound healing; dental tissue-derived mesenchymal stem cells	STEM-CELLS; MOUSE EMBRYOS; BONE-MARROW; RAT MODEL; REGENERATION; TISSUES	Bone marrow-derived mesenchymal stem/progenitor cells (BMSCs) are commonly used in regeneration therapy. The current primary source of BMSCs is the iliac crest; however, the procedure is associated with various burdens on the patient, including the risk of pain and infection. Hence, the possibility to collect BMSCs from other, more accessible, sources would be an attractive approach. It is well known that stem cells migrate from surrounding tissues and play important roles in wound healing. We thus hypothesized that stem/progenitor cells could be isolated from granulation tissue in the dental socket, and we subsequently collected granulation tissue from dog dental socket 3 d after tooth extraction. After enzyme digestion of the collected tissue, the cells forming colonies constituted the dental socket-derived stem/progenitor cells (dDSCs). Next, dDSCs were compared with dog BMSCs (dBMSCs) for phenotype characterization. A flow cytometric analysis showed that dDSCs were positive for CD44, CD90, and CD271 but negative for CD34 and CD45, similar to dBMSCs. dDSCs also exhibited osteogenic, adipogenic, and chondrogenic differentiation ability, similar to dBMSCs, with a higher capacity for colony formation, proliferation, and motility than dBMSCs. In addition, an in vivo ectopic bone formation assay showed that dDSCs and dBMSCs both induced hard tissue formation, although only dDSCs formed a fibrous tissue-like structure connected to the newly formed bone. Finally, we tested the ability of dDSCs to regenerate periodontal tissue in a one-wall defect model. The defects in the dDSC-transplanted group (-TCP/PGA/dDSCs) were regenerated with cementum-like and periodontal ligament-like tissues and alveolar bone, whereas only bony tissue was observed in the control group (-TCP/PGA). In conclusion, we identified and characterized a population of stem/progenitor cells in granulation tissue obtained from the dental socket that exhibited several characteristics similar to those of BMSCs. Dental sockets could therefore be a novel source for isolating stem/progenitor cells from bone.	[Nakajima, R.; Ono, M.; Hara, E. S.; Oida, Y.; Shinkawa, S.; Pham, H. T.; Akiyama, K.; Sonoyama, W.; Maekawa, K.; Kuboki, T.] Okayama Univ, Dept Oral Rehabil & Regenerat Med, Grad Sch Med Dent & Pharmaceut Sci, Okayama 7008530, Japan	Kuboki, T (reprint author), Okayama Univ, Dept Oral Rehabil & Regenerat Med, Grad Sch Med Dent & Pharmaceut Sci, Okayama 7008530, Japan.	kuboki@md.okayama-u.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology, Japan [22249064, 22390366]; Organ Technologies Inc.	This work was partially supported by a Grant-in-Aid for Scientific Research to T.K. (22249064) and K.M. (22390366) from the Ministry of Education, Culture, Sports, Science, and Technology, Japan. This work was also partially supported by Organ Technologies Inc. The authors declare no potential conflicts of interest with respect to the authorship and/or publication of this article.	Klein AM, 2011, DEVELOPMENT, V138, P3103, DOI 10.1242/dev.060103; Tang JM, 2006, EUR J CARDIO-THORAC, V30, P353, DOI 10.1016/j.ejcts.2006.02.070; MARTIN GR, 1981, P NATL ACAD SCI-BIOL, V78, P7634, DOI 10.1073/pnas.78.12.7634; Ng F, 2008, BLOOD, V112, P295, DOI 10.1182/blood-2007-07-103697; Kawamoto T, 2000, HISTOCHEM CELL BIOL, V113, P331; EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0; Sasaki M, 2008, J IMMUNOL, V180, P2581; Alge DL, 2010, J TISSUE ENG REGEN M, V4, P73, DOI 10.1002/term.220; Moviglia GA, 2006, CYTOTHERAPY, V8, P202, DOI 10.1080/14653240600736048; Tamaki Y, 2013, ODONTOLOGY, V101, P121, DOI 10.1007/s10266-012-0075-0; Schuldiner M, 2003, STEM CELLS, V21, P257, DOI 10.1634/stemcells.21-3-257; Karp JM, 2009, CELL STEM CELL, V4, P206, DOI 10.1016/j.stem.2009.02.001; FRIEDENSTEIN AJ, 1976, EXP HEMATOL, V4, P267; Iwata T, 2009, BIOMATERIALS, V30, P2716, DOI 10.1016/j.biomaterials.2009.01.032; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Hara ES, 2013, BIOCHIMIE, V95, P374, DOI 10.1016/j.biochi.2012.10.016; Ono M, 2011, J BONE MINER RES, V26, P193, DOI 10.1002/jbmr.205; Carvalho AS, 2013, EUR J HUM GENET, V21, P591, DOI 10.1038/ejhg.2012.232; Catacchio I., 2013, STEM CELLS INT, V2013; Hara ES, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083545; Mazzini L, 2006, NEUROL RES, V28, P523, DOI 10.1179/016164106X116791; Ono M, 2008, CELL TRANSPLANT, V17, P231, DOI 10.3727/000000008783907143; Sonoyama W, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000079; Ueda M, 2014, STEM CELL RES THER, V5, DOI 10.1186/scrt420	25	5	5	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0022-0345	1544-0591		J DENT RES	J. Dent. Res.	NOV	2014	93	11					1133	1140		10.1177/0022034514549377		8	Dentistry, Oral Surgery & Medicine	Dentistry, Oral Surgery & Medicine	AS0NU	WOS:000343975100013		
J	Takahashi, N; Matsuda, Y; Yamada, H; Tabeta, K; Nakajima, T; Murakami, S; Yamazaki, K				Takahashi, N.; Matsuda, Y.; Yamada, H.; Tabeta, K.; Nakajima, T.; Murakami, S.; Yamazaki, K.			Epithelial TRPV1 Signaling Accelerates Gingival Epithelial Cell Proliferation	JOURNAL OF DENTAL RESEARCH			English	Article						gingiva; epithelium; transient receptor potential cation channels; capsaicin; periodontal diseases; microarray analysis	GROWTH-FACTOR; CAPSAICIN; EXPRESSION; RECEPTOR; PERIODONTITIS; INFLAMMATION; ACTIVATION; APOPTOSIS; MIGRATION; CHANNEL	Transient receptor potential cation channel subfamily V member 1 (TRPV1), a member of the calcium-permeable thermosensitive transient receptor potential superfamily, is a sensor of thermal and chemical stimuli. TRPV1 is activated by noxious heat (> 43 degrees C), acidic conditions (pH < 6.6), capsaicin, and endovanilloids. This pain receptor was discovered on nociceptive fibers in the peripheral nervous system. TRPV1 was recently found to be expressed by non-neuronal cells, such as epithelial cells. The oral gingival epithelium is exposed to multiple noxious stimuli, including heat and acids derived from endogenous and exogenous substances; however, whether gingival epithelial cells (GECs) express TRPV1 is unknown. We show that both TRPV1 mRNA and protein are expressed by GECs. Capsaicin, a TRPV1 agonist, elevated intracellular Ca2+ levels in the gingival epithelial cell line, epi 4. Moreover, TRPV1 activation in epi 4 cells accelerated proliferation. These responses to capsaicin were inhibited by a specific TRPV1 antagonist, SB-366791. We also observed GEC proliferation in capsaicin-treated mice in vivo. No effects were observed on GEC apoptosis by epithelial TRPV1 signaling. To examine the molecular mechanisms underlying this proliferative effect, we performed complementary (c)DNA microarray analysis of capsaicin-stimulated epi 4 cells. Compared with control conditions, 227 genes were up-regulated and 232 genes were down-regulated following capsaicin stimulation. Several proliferation-related genes were validated by independent experiments. Among them, fibroblast growth factor-17 and neuregulin 2 were significantly up-regulated in capsaicin-treated epi 4 cells. Our results suggest that functional TRPV1 is expressed by GECs and contributes to the regulation of cell proliferation.	[Takahashi, N.; Matsuda, Y.; Yamada, H.; Yamazaki, K.] Niigata Univ, Grad Sch Med & Dent Sci, Div Oral Sci Hlth Promot, Lab Periodontol & Immunol, Niigata, Japan; [Takahashi, N.; Matsuda, Y.; Yamada, H.; Tabeta, K.] Niigata Univ, Fac Dent, Div Periodontol, Dept Oral Biol Sci, Niigata, Japan; [Nakajima, T.] Niigata Univ, Gen Dent & Clin Educ Unit, Med & Dent Hosp, Niigata, Japan; [Murakami, S.] Osaka Univ, Dept Periodontol, Grad Sch Dent, Osaka, Japan	Yamazaki, K (reprint author), Niigata Univ, Grad Sch Med & Dent Sci, Div Oral Sci Hlth Promot, Lab Periodontol & Immunol, Niigata, Japan.	kaz@dent.niigata-u.ac.jp			Japan Society for the Promotion of Science (JSPS)	We thank Dr. Ardem Patapoutian (Scripps Research Institute, La Jolla, CA, USA) for having kindly provided TRPV1 plasmid and Dr. Junichi Kitagawa (Niigata University, Division of Oral Physiology, Japan) for sharing of laboratory equipment. The authors acknowledge Dr. Petrus R de Jong (University of California San Diego, USA) for his helpful remarks. This study was supported by grants from the Japan Society for the Promotion of Science (JSPS) to N.T. The authors declare no potential conflicts of interest with respect to the authorship and/or publication of this article.	Sulniute R, 2011, AM J PATHOL, V179, P819, DOI 10.1016/j.ajpath.2011.05.003; Wang B, 2011, J DENT RES, V90, P163, DOI 10.1177/0022034510385459; Peier AM, 2002, SCIENCE, V296, P2046, DOI 10.1126/science.1073140; Falls DL, 2003, EXP CELL RES, V284, P14, DOI 10.1016/S0014-4827(02)00102-7; Pan Z, 2011, INVEST OPHTH VIS SCI, V52, P485, DOI 10.1167/iovs.10-5801; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Caterina MJ, 1997, NATURE, V389, P816; Dhaka A, 2006, ANNU REV NEUROSCI, V29, P135, DOI 10.1146/annurev.neuro.29.051605.112958; Birder LA, 2005, AM J PHYSIOL-RENAL, V289, pF489, DOI 10.1152/ajprenal.00467.2004; Brown KC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010243; Celenligil-Nazliel H, 2003, J PERIODONTOL, V74, P247, DOI 10.1902/jop.2003.74.2.247; Denda S, 2010, J DERMATOL SCI, V57, P108, DOI 10.1016/j.jdermsci.2009.11.007; Hajishengallis G, 2014, TRENDS IMMUNOL, V35, P3, DOI 10.1016/j.it.2013.09.001; Ip SW, 2012, ENVIRON TOXICOL, V27, P332, DOI 10.1002/tox.20646; Ji S, 2009, INFECT IMMUN, V77, P1044, DOI 10.1128/IAI.00449-08; Kang HJ, 2003, INT J CANCER, V103, P475, DOI 10.1002/ijc.10855; Lee IO, 2007, HELICOBACTER, V12, P510, DOI 10.1111/j.1523-5378.2007.00521.x; Lin Q, 2007, MOL PAIN, V3, DOI 10.1186/1744-8069-3-30; Liu NC, 2012, J AGR FOOD CHEM, V60, P2758, DOI 10.1021/jf204869w; Maheshwari G, 2001, J CELL BIOL, V155, P1123, DOI 10.1083/jcb.200109060; Malagarie-Cazenave S, 2009, FEBS LETT, V583, P141, DOI 10.1016/j.febslet.2008.11.038; Murakami S, 2002, J DENT RES, V81, P236; Ozturk A, 2011, J PERIODONTAL RES, V46, P475, DOI 10.1111/j.1600-0765.2011.01363.x; Polnaszek N, 2004, PROSTATE, V60, P18, DOI 10.1002/pros.20026; Takahashi N, 2011, EUR J ORAL SCI, V119, P339, DOI 10.1111/j.1600-0722.2011.00842.x; Takahashi N, 2010, J PERIODONTAL RES, V45, P512, DOI 10.1111/j.1600-0765.2009.01266.x; Takayama S, 2002, J PERIODONTOL, V73, P1467, DOI 10.1902/jop.2002.73.12.1467; Venier NA, 2012, J CANC THERAPEUT RES, V1, P1; Yang J, 2013, MOL IMMUNOL, V53, P161, DOI 10.1016/j.molimm.2012.06.015	29	0	0	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0022-0345	1544-0591		J DENT RES	J. Dent. Res.	NOV	2014	93	11					1141	1147		10.1177/0022034514552826		7	Dentistry, Oral Surgery & Medicine	Dentistry, Oral Surgery & Medicine	AS0NU	WOS:000343975100014		
J	Yoshimoto, T; Fujita, T; Ouhara, K; Kajiya, M; Imai, H; Shiba, H; Kurihara, H				Yoshimoto, T.; Fujita, T.; Ouhara, K.; Kajiya, M.; Imai, H.; Shiba, H.; Kurihara, H.			Smad2 is Involved in Aggregatibacter actinomycetemcomitans-induced Apoptosis	JOURNAL OF DENTAL RESEARCH			English	Article						epithelial cells; TGF- type I receptor; cleaved caspase-3; periodontitis; gingival epithelium; periodontopathic bacteria	GROWTH-FACTOR-BETA; GINGIVAL EPITHELIAL-CELLS; JUNCTIONAL INTERCELLULAR COMMUNICATION; ACTINOBACILLUS-ACTINOMYCETEMCOMITANS; IRSOGLADINE MALEATE; INFECTION; BIM; PERIODONTITIS; MACROPHAGES; INHIBITION	Apoptosis is thought to contribute to the progression of periodontitis. It has been suggested that the apoptosis of epithelial cells may contribute to the loss of epithelial barrier function. Smad2, a downstream signaling molecule of TGF- receptors (TGF-Rs), is critically involved in apoptosis in several cell types. However, the relationship between smad2 and bacteria-induced apoptosis has not yet been elucidated. It is possible that the regulation of apoptosis induced by periodontopathic bacteria may lead to novel preventive therapies for periodontitis. Therefore, in the present study, we investigated the involvement of smad2 phosphorylation in apoptosis of human gingival epithelial cells induced by Aggregatibacter actinomycetemcomitans (Aa). Aa apparently induced the phosphorylation of smad2 in primary human gingival epithelial cells (HGECs) or the human gingival epithelial cell line, OBA9 cells. In addition, Aa induced phosphorylation of the serine residue of the TGF- type I receptor (TGF-RI) in OBA9 cells. SB431542 (a TGF-RI inhibitor) and siRNA transfection for TGF-RI, which reduced both TGF-RI mRNA and protein levels, markedly attenuated the Aa-induced phosphorylation of smad2. Furthermore, the disruption of TGF-RI signaling cascade by SB431542 and siRNA transfection for TGF-RI abrogated the activation of cleaved caspase-3 expression and repressed apoptosis in OBA9 cells treated with Aa. Thus, Aa induced apoptosis in gingival epithelial cells by activating the TGF-RI-smad2-caspase-3 signaling pathway. The results of the present study may suggest that the periodontopathic bacteria, Aa, activates the TGF-R/smad2 signaling pathway in human gingival epithelial cells and induces apoptosis in epithelial cells, which may lead to new therapeutic strategies that modulate the initiation of periodontitis.	[Yoshimoto, T.; Fujita, T.; Ouhara, K.; Kajiya, M.; Imai, H.; Shiba, H.; Kurihara, H.] Hiroshima Univ, Div Appl Life Sci, Dept Periodontal Med, Inst Biomed & Hlth Sci, Hiroshima, Japan	Fujita, T (reprint author), Hiroshima Univ, Div Appl Life Sci, Dept Periodontal Med, Inst Biomed & Hlth Sci, Hiroshima, Japan.	tfuji@hiroshima-u.ac.jp			Japan Society for the Promotion of Science, Japan [24593123]	We thank Professor Shinya Murakami (Osaka University) for providing OBA9 cells. This study was supported by a Grant-in-Aid for Scientific Research (C) (No. 24593123) from the Japan Society for the Promotion of Science, Japan. The authors declare no potential conflicts of interest with respect to the authorship and/or publication of this article.	Abuhussein H, 2013, J PERIODONTOL, V85, P1086; Alaoui-El-Azher M, 2010, PLOS ONE, V5; Wildey GM, 2003, J BIOL CHEM, V278, P18069, DOI 10.1074/jbc.M211958200; Dileepan T, 2007, INFECT IMMUN, V75, P4851, DOI 10.1128/IAI.00314-07; Kachlany SC, 2010, J DENT RES, V89, P561, DOI 10.1177/0022034510363682; Shenker BJ, 2014, CELL MICROBIOL, V16, P1391, DOI 10.1111/cmi.12299; Kim Y, 2009, J CELL BIOL, V184, P309, DOI 10.1083/jcb.200806067; Li Y, 2011, PLACENTA, V32, P11, DOI 10.1016/j.placenta.2010.10.007; Ramjaun AR, 2007, ONCOGENE, V26, P970, DOI 10.1038/sj.onc.1209852; Wilson M, 1995, FEMS MICROBIOL REV, V17, P365; Rogers JE, 2007, J PERIODONTOL, V78, P550, DOI 10.1902/jop.2007.060321; Beswick EJ, 2011, INFECT IMMUN, V79, P2737, DOI 10.1128/IAI.01146-10; Kato S, 2000, J MED MICROBIOL, V49, P739; Kim KK, 2009, J CLIN INVEST, V119, P213, DOI 10.1172/JCI36940; Ohgushi M, 2005, MOL CELL BIOL, V25, P10017, DOI 10.1128/MCB.25.22.10017-10028.2005; Park SR, 2014, INFECT IMMUN, V82, P1914, DOI 10.1128/IAI.01226-13; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; Kusumoto Y, 2004, J PERIODONTOL, V75, P370, DOI 10.1902/jop.2004.75.3.370; Schreiner HC, 2003, P NATL ACAD SCI USA, V100, P7295, DOI 10.1073/pnas.1237223100; Dickinson BC, 2011, MOL ORAL MICROBIOL, V26, P210, DOI 10.1111/j.2041-1014.2011.00609.x; Blix IJS, 1999, EUR J ORAL SCI, V107, P14; Fujita T, 2010, BIOCHEM PHARMACOL, V79, P1496, DOI 10.1016/j.bcp.2010.01.017; Fujita T, 2012, ARCH ORAL BIOL, V57, P1567, DOI 10.1016/j.archoralbio.2012.08.011; Fujita T, 2006, CYTOKINE, V34, P271, DOI 10.1016/j.cyto.2006.06.002; Hoglund berg C, 2013, PLOS ONE, V8; Kang J, 2012, INFECT IMMUN, V80, P2247, DOI 10.1128/IAI.06371-11; Kato S, 2013, J MICROBIOL IMMUNOL, V46, P164, DOI 10.1016/j.jmii.2012.02.003; Lee JH, 2002, CURR EYE RES, V25, P147, DOI 10.1076/ceyr.25.3.147.13475; Mithani SK, 2004, J SURG RES, V117, P296, DOI 10.1016/S0022-4804(03)00335-4; Ouhara K, 2006, INFECT IMMUN, V74, P5211, DOI 10.1128/IAI.00056-06; Schroeder HE, 1997, PERIODONTOL 2000, V13, P91, DOI 10.1111/j.1600-0757.1997.tb00097.x; Tonetti MS, 1998, INFECT IMMUN, V66, P5190; Uchida Y, 2005, BIOCHEM BIOPH RES CO, V333, P502, DOI 10.1016/j.bbrc.2005.05.147; Yang JY, 2009, CANCER RES, V69, P2185, DOI 10.1158/0008-5472.CAN-08-3961	34	0	0	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0022-0345	1544-0591		J DENT RES	J. Dent. Res.	NOV	2014	93	11					1148	1154		10.1177/0022034514550041		7	Dentistry, Oral Surgery & Medicine	Dentistry, Oral Surgery & Medicine	AS0NU	WOS:000343975100015		
J	Sato, M; Amagai, M; Ohyama, M				Sato, Misato; Amagai, Masayuki; Ohyama, Manabu			Detailed clinicopathological characterization of progressive alopecia areata patients treated with i.v. corticosteroid pulse therapy toward optimization of inclusion criteria	JOURNAL OF DERMATOLOGY			English	Article						alopecia areata; dermoscopy; hair pull test; histopathology; i; v; corticosteroid pulse therapy	INVESTIGATIONAL ASSESSMENT GUIDELINES; METHYLPREDNISOLONE THERAPY; STEROID-THERAPY; SCALP; MANAGEMENT; SECTIONS	The management of progressive alopecia areata (AA) is often challenging. Recently, i.v. corticosteroid pulse therapy has been reported to be effective for acute and severe AA, however, inclusion criteria have not been sufficiently precise, leaving a chance that its efficacy could be further improved by optimizing therapeutic indications. In our attempts to delineate the factors that correlate with favorable outcomes, we minutely evaluated the clinicopathological findings and the prognoses of single-round steroid pulse-treated progressive AA cases with full sets of image and pathology records during the course. Almost complete hair regrowth has been achieved and maintained up to 2years in five out of seven AA patients with varying degrees of clinical severity. Interestingly, the worst clinical presentation observed during the course correlated with the size of the area where hairs with dystrophic roots were pulled rather than the extent of visible hair loss on the first visit. Dermoscopy detected disease spread but contributed little in assessing prognoses. Dense perifollicular cell infiltration was detected in all cases treated within 4weeks of onset and those treated later but with excellent response. Importantly, the cases with poor or incomplete hair regrowth were treated 6-8weeks of onset and showed moderate inflammatory change with high telogen conversion rate. These findings mandate global dermoscopy and hair pull test for judging the treatment indication and suggest that early administration of high-dose corticosteroid, ideally within 4weeks of onset, enable efficient suppression of active inflammation and maximize the effectiveness of the remedy.	[Sato, Misato; Amagai, Masayuki; Ohyama, Manabu] Keio Univ, Sch Med, Dept Dermatol, Tokyo 1608582, Japan	Ohyama, M (reprint author), Keio Univ, Sch Med, Dept Dermatol, Shinjuku Ku, 35 Shinanomachi, Tokyo 1608582, Japan.	manabuohy@z8.keio.jp	Amagai, Masayuki/K-5325-2013				Acikgoz G, 2014, J DERMATOL TREAT, V25, P164, DOI 10.3109/09546634.2013.768759; Alkhalifah A, 2010, CLIN DEV IMMUNOL, V62, P189; Whiting DA, 2003, ARCH DERMATOL, V139, P1555, DOI 10.1001/archderm.139.12.1555; Barahmani N, 2009, J AM ACAD DERMATOL, V61, P581, DOI 10.1016/j.jaad.2009.04.031; Shin BS, 2013, J DERMATOL SCI, V70, P141, DOI 10.1016/j.jdermsci.2013.01.006; Tosti A, 2005, BRIT J DERMATOL, V152, P1056, DOI 10.1111/J.1365-2133.2005.06469.x; WHITING DA, 1993, J AM ACAD DERMATOL, V28, P755; Im M, 2011, J DERMATOL, V38, P767, DOI 10.1111/j.1346-8138.2010.01135.x; Friedli A, 1998, J AM ACAD DERMATOL, V39, P597, DOI 10.1016/S0190-9622(98)70009-X; Ito T, 2013, CLIN DEV IMMUNOL, DOI 10.1155/2013/348546; Seiter S, 2001, DERMATOLOGY, V202, P230, DOI 10.1159/000051642; Nakajima T, 2007, DERMATOLOGY, V215, P320, DOI 10.1159/000107626; Olsen EA, 2004, J AM ACAD DERMATOL, V51, P440, DOI 10.1016/j.jaad.2003.09.032; Ohyama M, 2010, DERMATOL SIN, V28, P139, DOI 10.1016/S1027-8117(10)60032-8; Luggen P, 2008, J DTSCH DERMATOL GES, V6, P375, DOI 10.1111/j.1610-0387.2007.06608.x; Alkhalifah A, 2010, J AM ACAD DERMATOL, V62, P177, DOI 10.1016/j.jaad.2009.10.032; BURTON JL, 1975, ACTA DERM-VENEREOL, V55, P493; Staumont-Salle D, 2012, DERMATOLOGY, V225, P81, DOI 10.1159/000341523; Messenger AG, 2012, BRIT J DERMATOL, V166, P916, DOI 10.1111/j.1365-2133.2012.10955.x; Arase S, 2010, JPN J DERMATOL, V120, P1841; Assouly P, 2003, ANN DERMATOL VENER, V130, P326; Efentaki Pinelopi, 2009, Dermatoendocrinol, V1, P310, DOI 10.4161/derm.1.6.11236; Frishberg DP, 1996, J AM ACAD DERMATOL, V35, P220, DOI 10.1016/S0190-9622(96)90328-X; Inui S, 2007, J DERMATOL, V34, P635, DOI 10.1111/j.1346-8138.2007.00345.x; Kiesch N, 1997, DERMATOLOGY, V194, P395; Migita K, 1997, TRANSPLANTATION, V63, P583, DOI 10.1097/00007890-199702270-00017; Olsen E, 1999, J AM ACAD DERMATOL, V40, P242, DOI 10.1016/S0190-9622(99)70195-7; PERRIARDWOLFENSBERGER J, 1993, DERMATOLOGY, V187, P282; Sato-Kawamura M, 2002, DERMATOLOGY, V205, P367, DOI 10.1159/000066435; Tsai YM, 2002, J FORMOS MED ASSOC, V101, P223; Watanabe-Okada E, 2014, J DERMATOL, V41, P802, DOI 10.1111/1346-8138.12591	31	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0385-2407	1346-8138		J DERMATOL	J. Dermatol.	NOV	2014	41	11					957	963		10.1111/1346-8138.12637		7	Dermatology	Dermatology	AS5XN	WOS:000344340000002		
J	Kohno, K; Niihara, H; Hamano, T; Takeda, M; Yamasaki, M; Mizumoto, K; Nabika, T; Morita, E; Shiwaku, K				Kohno, Kunie; Niihara, Hiroyuki; Hamano, Tsuyoshi; Takeda, Miwako; Yamasaki, Masayuki; Mizumoto, Kazuo; Nabika, Toru; Morita, Eishin; Shiwaku, Kuninori			Standing posture at work and overweight exacerbate varicose veins: Shimane CoHRE Study	JOURNAL OF DERMATOLOGY			English	Article						body mass index; epidemiology; overweight; risk factors; varicose veins	CHRONIC VENOUS INSUFFICIENCY; RISK-FACTORS; FAMILY-HISTORY; EDINBURGH VEIN; PREVALENCE; WOMEN; POPULATION; DISEASE; EPIDEMIOLOGY; COMMUNITY	Varicose veins (VV) in legs are commonly observed in the general global population. However, the prevalence of and risk factors for VV in Japan are not clear. This study aimed at clarifying the risk factors for VV in traditional rural areas of Shimane prefecture. Subjects (113 men and 205 women aged 45years) were recruited from health examinations in those areas in 2012. VV were defined as a reflux of blood in the great and/or small saphenous vein and incompetent perforating veins detected by ultrasonography. Risk factors for VV were analyzed using logistic regression models that included various parameters. We also investigated the possible interaction between standing at work and overweight and calculated the synergistic index. VV were found in 20.1% of the subjects (12.4% of men and 24.4% of women). The previously known risk factors of prolonged upright standing posture during work, higher body mass index (BMI), female sex, and age were also significant factors for VV. There was a significant combined effect of overweight (BMI 25) and prolonged upright standing posture at work [adjusted odds ratio=3.42; 95% confidence interval (CI), 1.07-10.89], although the synergistic effect was not significant [synergistic index=1.3; 95% CI, 0.2-8.7]. The prevalence of VV in the traditional rural area of Shimane prefecture was comparable to that reported previously in European countries. Our results confirm that exposure to both prolonged standing at work and overweight exacerbate VV development. This finding is useful to develop strategies for VV prevention.	[Kohno, Kunie; Hamano, Tsuyoshi; Takeda, Miwako; Shiwaku, Kuninori] Org Promot Project Res, Ctr Community Based Hlth Res & Educ CoHRE, Izumo, Shimane, Japan; [Takeda, Miwako; Yamasaki, Masayuki; Shiwaku, Kuninori] Shimane Univ, Fac Med, Dept Environm & Prevent Med, Izumo, Shimane, Japan; [Mizumoto, Kazuo] Shimane Univ, Fac Med, Ohda Gen Med Educ Ctr, Dept Gen Med,Dept Surg, Izumo, Shimane, Japan; [Nabika, Toru] Shimane Univ, Fac Med, Dept Funct Pathol, Izumo, Shimane, Japan; [Kohno, Kunie; Niihara, Hiroyuki; Morita, Eishin] Shimane Univ Hosp, Dept Dermatol, Izumo, Shimane, Japan	Kohno, K (reprint author), 89-1 Enya Cho, Izumo, Shimane 6938501, Japan.	nine_kk@med.shimane-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology	Funding for this study was provided by the Ministry of Education, Culture, Sports, Science and Technology. The authors would like to thank Ai Fujii, Assistant of the Department of Dermatology, Shimane University Faculty of Medicine, for her assistance during the survey.	ABRAMSON JH, 1981, J EPIDEMIOL COMMUN H, V35, P213, DOI 10.1136/jech.35.3.213; Ahti TM, 2009, ANGIOLOGY, V60, P487, DOI 10.1177/0003319709335510; BRAND FN, 1988, AM J PREV MED, V4, P96; SISTO T, 1995, EUR J SURG, V161, P405; Fowkes FGR, 2001, ANGIOLOGY, V52, pS5; Lee AJ, 2003, J CLIN EPIDEMIOL, V56, P171, DOI 10.1016/S0895-4356(02)00518-8; Zoller B, 2012, BRIT J SURG, V99, P948, DOI 10.1002/bjs.8779; Campbell B, 2006, BRIT MED J, V333, P287, DOI 10.1136/bmj.333.7562.287; Hamano T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049122; MEKKY S, 1969, BRIT MED J, V2, P591; SCOTT TE, 1995, J VASC SURG, V22, P622, DOI 10.1016/S0741-5214(95)70050-1; Jawien A, 2003, ANGIOLOGY, V54, pS19; Tuchsen F, 2005, OCCUP ENVIRON MED, V62, P847, DOI 10.1136/oem.2005.020537; Evans CJ, 1999, J EPIDEMIOL COMMUN H, V53, P149; COON WW, 1973, CIRCULATION, V48, P839; HOSMER DW, 1992, EPIDEMIOLOGY, V3, P452, DOI 10.1097/00001648-199209000-00012; Eklof B, 2004, J VASC SURG, V40, P1248, DOI 10.1016/j.jvs.2004.09.027; HIRAI M, 1990, ANGIOLOGY, V41, P228, DOI 10.1177/000331979004100308; Willenberg T, 2010, J VASC SURG, V52, P664, DOI 10.1016/j.jvs.2010.04.023; Bahk JW, 2012, ERGONOMICS, V55, P133, DOI 10.1080/00140139.2011.582957; FRANKS PJ, 1992, EUR J SURG, V158, P143; London NJM, 2000, BRIT MED J, V320, P1391, DOI 10.1136/bmj.320.7246.1391; MAFFEI FHA, 1986, INT J EPIDEMIOL, V15, P210, DOI 10.1093/ije/15.2.210; Rothman K, 2008, MODERN EPIDEMIOLOGY; ROTHMAN KJ, 1976, AM J EPIDEMIOL, V103, P506; STVRTINOVA V, 1991, INT ANGIOL, V10, P2; Tuchsen F, 2000, SCAND J WORK ENV HEA, V26, P414	27	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0385-2407	1346-8138		J DERMATOL	J. Dermatol.	NOV	2014	41	11					964	968		10.1111/1346-8138.12643		5	Dermatology	Dermatology	AS5XN	WOS:000344340000003		
J	Shimizu, T; Takebayashi, T; Sato, Y; Niizeki, H; Aoyama, Y; Kitajima, Y; Iwatsuki, K; Hashimoto, T; Yamagami, J; Werth, VP; Amagai, M; Tanikawa, A				Shimizu, Tomoko; Takebayashi, Toru; Sato, Yuji; Niizeki, Hironori; Aoyama, Yumi; Kitajima, Yasuo; Iwatsuki, Keiji; Hashimoto, Takashi; Yamagami, Jun; Werth, Victoria P.; Amagai, Masayuki; Tanikawa, Akiko			Grading criteria for disease severity by pemphigus disease area index	JOURNAL OF DERMATOLOGY			English	Article						clinical trial; Japanese pemphigus disease severity score; outcome instrument; pemphigus; pemphigus disease area index; severity index	DISORDER INTENSITY SCORE	Pemphigus is a group of autoimmune blistering diseases that affect the skin and mucous membranes. A reliable and accurate disease severity tool to assess pemphigus severity is crucial for managing pemphigus and for clinical trials. The purpose of this study was to compare the pemphigus disease area index activity score (PDAI), the Japanese pemphigus disease severity score (JPDSS) and the physician's subjective impression, and also to find appropriate severity grading cut-offs for the PDAI. We also evaluated the correlation between PDAI activity score and the JPDSS. Thirty-seven pemphigus patients and 110 assessments were analyzed in this study. The optimal points of pemphigus disease severity score in PDAI were: mild (0-8), moderate (9-24) and severe (25). In mild or moderate cases, the JPDSS was well correlated with the PDAI, but in severe cases the JPDSS reached a plateau at a PDAI score of approximately 30. The PDAI evaluates disease severity more accurately than the JPDSS, particularly in severe cases. The PDAI is not only a useful tool to measure the extent of cutaneous lesions, but also an excellent scoring system for evaluating pemphigus disease severity.	[Shimizu, Tomoko; Yamagami, Jun; Amagai, Masayuki; Tanikawa, Akiko] Keio Univ, Sch Med, Dept Dermatol, Tokyo 1608582, Japan; [Takebayashi, Toru] Keio Univ, Sch Med, Dept Prevent Med & Publ Hlth, Tokyo 1608582, Japan; [Sato, Yuji] Keio Univ, Sch Med, Clin Res Ctr, Tokyo 1608582, Japan; [Niizeki, Hironori] Natl Ctr Child Hlth & Dev, Dept Dermatol, Tokyo, Japan; [Niizeki, Hironori] Nara Med Univ, Sch Med, Nara, Japan; [Aoyama, Yumi; Iwatsuki, Keiji] Okayama Univ Hosp, Okayama, Japan; [Kitajima, Yasuo] Kizawa Mem Hosp, Gifu, Japan; [Hashimoto, Takashi] Kurume Univ, Sch Med, Fukuoka, Japan; [Werth, Victoria P.] Philadelphia VA Med Ctr, Philadelphia, PA USA; [Werth, Victoria P.] Univ Penn, Philadelphia, PA 19104 USA	Tanikawa, A (reprint author), Keio Univ, Sch Med, Dept Dermatol, Shinjuku Ku, 35 Shinanomachi, Tokyo 1608582, Japan.	tanikawa@z3.keio.jp	Amagai, Masayuki/K-5325-2013; Takebayashi, Toru/K-7526-2013	Takebayashi, Toru/0000-0002-8268-8026	Ministry of Health, Labor and Welfare of Japan [H23-028]	This work was supported by the Research on Measures for Intractable Diseases Project: matching fund subsidy (H23-028) from the Ministry of Health, Labor and Welfare of Japan.	Amagai M, 2009, J AM ACAD DERMATOL, V60, P595, DOI 10.1016/j.jaad.2008.09.052; Murrell DE, 2008, J AM ACAD DERMATOL, V58, P1043, DOI 10.1016/j.jaad.2008.01.012; Ikeda S, 2003, ARCH DERMATOL RES, V295, pS12, DOI 10.1007/s00403-002-0367-2; Perkins NJ, 2005, BIOMETRICAL J, V47, P428, DOI 10.1002/bimj.200410133; Kwon EJ, 2008, J EUR ACAD DERMATOL, V22, P1070, DOI 10.1111/j.1468-3083.2008.02715.x; Pfutze M, 2007, EUR J DERMATOL, V17, P4; Rosenbach M, 2009, J INVEST DERMATOL, V129, P2404, DOI 10.1038/jid.2009.72; Daniel BS, 2012, CLIN DERMATOL, V30, P108, DOI 10.1016/j.clindermatol.2011.03.017; Ogawa H, 1994, DIAGNOSTIC CRITERIA, P183; Rahbar Z, 2014, JAMA DERMATOL, V150, P266, DOI 10.1001/jamadermatol.2013.8175	10	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0385-2407	1346-8138		J DERMATOL	J. Dermatol.	NOV	2014	41	11					969	973		10.1111/1346-8138.12649		5	Dermatology	Dermatology	AS5XN	WOS:000344340000004		
J	Hayashi, M; Umezawa, Y; Fukuchi, O; Ito, T; Saeki, H; Nakagawa, H				Hayashi, Mitsuha; Umezawa, Yoshinori; Fukuchi, Osamu; Ito, Toshihiro; Saeki, Hidehisa; Nakagawa, Hidemi			Efficacy and safety of ustekinumab treatment in elderly patients with psoriasis	JOURNAL OF DERMATOLOGY			English	Article						biologics; elderly patients; psoriasis; safety; ustekinumab	LATENT TUBERCULOSIS INFECTION; NECROSIS-FACTOR ANTAGONISTS; BIOLOGIC AGENTS; LONG-TERM; MODERATE; CYCLOSPORINE; REACTIVATION; ARTHRITIS; THERAPY; FOUNDATION	The ratio of the elderly among psoriasis patients has been increasing. However, satisfactory long-term management of psoriasis for the elderly is challenging because of the more frequent presence of comorbidities, and the higher risk of adverse events from systemic therapeutic agents than younger patients. The use of ustekinumab (UST) appears to be an appropriate systemic treatment because it is considered less likely to cause adverse events than other systemic treatments, as well as necessitating fewer hospital visits. Our retrospective study aimed to evaluate the efficacy and safety profile of UST in elderly patients with psoriasis. The study included 24 patients aged over 65years (range, 65-88years; mean, 73.1years) with moderate to severe plaque psoriasis with impaired quality of life. Efficacy and safety were assessed over a 1-year period using the Psoriasis Area and Severity Index (PASI) and the Dermatology Live Quality Index (DLQI). The efficacy was evaluated by the proportion of subjects who achieved 75% reduction in PASI score (PASI 75). PASI 75 responses were 56.5% at week 16, 59.1% at week 28, and 60.0% at week 52. None of the patients developed any serious infection during the 1-year treatment. The mean DLQI score at weeks 0, 16, 28, and 52 was 7.8 +/- 6.0, 2.5 +/- 3.4, 1.4 +/- 1.7, and 1.2 +/- 1.7, respectively. UST showed sufficient efficacy for elderly patients with psoriasis without any serious infection over the 1-year treatment. Our results suggest that UST is the preferable agent for the treatment of elderly patients with psoriasis.	[Hayashi, Mitsuha; Umezawa, Yoshinori; Fukuchi, Osamu; Ito, Toshihiro; Saeki, Hidehisa; Nakagawa, Hidemi] Jikei Univ, Sch Med, Dept Dermatol, Tokyo 1058461, Japan	Hayashi, M (reprint author), Jikei Univ, Sch Med, Dept Dermatol, Minato Ku, 3-25-8 Nishishimbashi, Tokyo 1058461, Japan.	mitsuha@jikei.ac.jp					Harris J, 2010, CLIN EXP IMMUNOL, V161, P1, DOI 10.1111/j.1365-2249.2010.04146.x; Falck P, 2008, TRANSPLANTATION, V86, P1379, DOI 10.1097/TP.0b013e31818aa4b6; Esposito M, 2012, DERMATOLOGY, V225, P312, DOI 10.1159/000345623; Clemmensen A, 2011, J EUR ACAD DERMATOL, V25, P1037, DOI 10.1111/j.1468-3083.2010.03914.x; BELL LM, 1991, ARCH DERMATOL, V127, P1184, DOI 10.1001/archderm.127.8.1184; Asahina A, 2010, J DERMATOL, V37, P299, DOI 10.1111/j.1346-8138.2009.00748.x; Igarashi A, 2012, J DERMATOL, V39, P242, DOI 10.1111/j.1346-8138.2011.01347.x; Sanchez-Moya AI, 2011, J EUR ACAD DERMATOL, V25, P730, DOI 10.1111/j.1468-3083.2010.03836.x; Doherty SD, 2008, J AM ACAD DERMATOL, V59, P209, DOI 10.1016/j.jaad.2008.03.023; O'Quinn DB, 2008, ADV IMMUNOL, V99, P115, DOI 10.1016/S0065-2776(08)00605-6; Grozdev IS, 2011, J AM ACAD DERMATOL, V65, P537, DOI 10.1016/j.jaad.2010.05.014; Carmona L, 2005, ARTHRITIS RHEUM, V52, P1766, DOI 10.1002/art.21043; Reich K, 2012, BRIT J DERMATOL, V166, P179, DOI 10.1111/j.1365-2133.2011.10583.x; Perlmutter A, 2009, BRIT J DERMATOL, V160, P8, DOI 10.1111/j.1365-2133.2008.08891.x; Tsai TF, 2012, BRIT J DERMATOL, V167, P1145, DOI 10.1111/j.1365-2133.2012.11142.x; Torii H, 2010, J DERMATOL SCI, V59, P40, DOI 10.1016/j.jdermsci.2010.04.014; Salas VR, 2012, J EUR ACAD DERMATOL, V26, P508, DOI 10.1111/j.1468-3083.2011.04325.x; Bissonnette R, 2009, J CUTAN MED SURG, V13, pS67, DOI 10.2310/7750.2009.00023; Coskey R J, 1986, Clin Dermatol, V4, P155, DOI 10.1016/0738-081X(86)90019-2; Flynn JL, 2001, ANNU REV IMMUNOL, V19, P93, DOI 10.1146/annurev.immunol.19.1.93; GERMANN T, 1995, INT ARCH ALLERGY IMM, V108, P103; Giannetti A, 1999, J EUR ACAD DERMATOL, V13, P91, DOI 10.1111/j.1468-3083.1999.tb00859.x; Gomez-Reino JJ, 2007, ARTHRIT RHEUM-ARTHR, V57, P756, DOI 10.1002/art.22768; Lebwohl M, 1998, J AM ACAD DERMATOL, V39, P464, DOI 10.1016/S0190-9622(98)70325-1; Ohtsuki M, 2003, J DERMATOL, V30, P290; Ranganath VK, 2007, RHEUM DIS CLIN N AM, V33, P197, DOI 10.1016/j.rdc.2006.12.011; Stamell EF, 2013, JAMA DERMATOL, V149, P1410, DOI 10.1001/jamadermatol.2013.5728; Tsai TF, 2014, BRIT J DERMATOL, V170, P478, DOI 10.1111/bjd.12613; Umezawa Yoshinori NH, 2012, GERIATR MED, V50, P831	29	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0385-2407	1346-8138		J DERMATOL	J. Dermatol.	NOV	2014	41	11					974	980		10.1111/1346-8138.12653		7	Dermatology	Dermatology	AS5XN	WOS:000344340000005		
J	Takahashi, H; Iinuma, S; Honma, M; Iizuka, H				Takahashi, Hidetoshi; Iinuma, Shin; Honma, Masaru; Iizuka, Hajime			Increased serum C-reactive protein level in Japanese patients of psoriasis with cardio- and cerebrovascular disease	JOURNAL OF DERMATOLOGY			English	Article						cardiovascular disease; cerebrovascular disease; high-sensitivity C-reactive protein; metabolic syndrome; psoriasis	CORONARY-ARTERY-DISEASE; CLINICAL-FEATURES; RISK; EVENTS; CELLS	Psoriasis is a chronic inflammatory skin disease, which may be associated with metabolic syndrome accompanied by cardio- and cerebrovascular diseases. We investigated the relation between serum C-reactive protein (CRP) and cardio- and cerebrovascular diseases in Japanese psoriasis vulgaris patients. Ninety-seven psoriasis vulgaris patients and 79 healthy controls were assessed for serum CRP levels by immunoturbidimetry. The data were analyzed in terms of Psoriasis Area and Severity Index (PASI) scores, and comorbidity of cardio- and cerebrovascular disease and metabolic syndrome. Serum CRP levels in psoriasis vulgaris patients were significantly higher than those of healthy controls. There was no significant difference between male and female CRP levels in either psoriasis or healthy controls. No correlation was detected between PASI scores and serum CRP levels, either. Psoriasis with cardio- and cerebrovascular disease showed significantly higher CRP levels compared with those without the diseases. Furthermore, psoriasis with metabolic syndrome showed significantly higher serum CRP levels than those without the metabolic syndrome. In conclusion, serum CRP level is increased in psoriasis, and may be a useful marker for the prediction of the future risk of cardio- and cerebrovascular disease.	[Takahashi, Hidetoshi; Iinuma, Shin; Honma, Masaru; Iizuka, Hajime] Asahikawa Med Univ, Dept Dermatol, Asahikawa, Hokkaido 0788510, Japan	Takahashi, H (reprint author), Asahikawa Med Univ, Dept Dermatol, 2-1-1-1 Midorigaokahigashi, Asahikawa, Hokkaido 0788510, Japan.	ht@asahikawa-med.ac.jp					ALEXANDER RW, 1994, NEW ENGL J MED, V331, P468, DOI 10.1056/NEJM199408183310709; Kaptoge S, 2012, NEW ENGL J MED, V367, P1310, DOI 10.1056/NEJMoa1107477; Ridker PM, 1998, CIRCULATION, V98, P731; Takahashi H, 2012, J DERMATOL, V39, P212, DOI 10.1111/j.1346-8138.2011.01408.x; CERMAK J, 1993, BLOOD, V82, P513; [Anonymous], 2002, CIRCULATION, V106, P3143; Taniguchi H, 2005, ATHEROSCLEROSIS, V178, P173, DOI 10.1016/j.atherosclerosis.2004.08.012; HENSELER T, 1995, J AM ACAD DERMATOL, V32, P982, DOI 10.1016/0190-9622(95)91336-X; Wakkee M, 2007, ATHEROSCLEROSIS, V190, P1, DOI 10.1016/j.atherosclerosis.2006.07.011; Langley RGB, 2005, ANN RHEUM DIS, V64, P18, DOI 10.1136/ard.2004.033217; Mallbris L, 2004, EUR J EPIDEMIOL, V19, P225; Neimann AL, 2006, J AM ACAD DERMATOL, V55, P829, DOI 10.1016/j.jaad.2006.08.040; Calabro P, 2009, SEMIN IMMUNOPATHOL, V31, P79, DOI 10.1007/s00281-009-0149-4; Gelfand JM, 2006, JAMA-J AM MED ASSOC, V296, P1735, DOI 10.1001/jama.296.14.1735; Myers WA, 2006, CLIN DERMATOL, V24, P438, DOI 10.1016/j.clindermatol.2006.07.006; Montero I, 2006, J AM COLL CARDIOL, V47, P1369, DOI 10.1016/j.jacc.2005.10.070; Coimbra S, 2010, J EUR ACAD DERMATOL, V24, P789, DOI 10.1111/j.1468-3083.2009.03527.x; Lizzo G, 2007, J AM COLL CARDIOL, V49, P185; Mallbris Lotus, 2006, Curr Rheumatol Rep, V8, P355, DOI 10.1007/s11926-006-0065-8; MCDONALD CJ, 1978, BRIT J DERMATOL, V99, P469, DOI 10.1111/j.1365-2133.1978.tb02012.x; Nabata A, 2008, ATHEROSCLEROSIS, V196, P129, DOI 10.1016/j.atherosclerosis.2007.03.003; Nakamura Haruo, 2002, Nihon Rinsho, V60, P916; Ridker PM, 1997, NEW ENGL J MED, V336, P937; Takahashi H, 2009, J DERMATOL, V36, P632, DOI 10.1111/j.1346-8138.2009.00721.x	24	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0385-2407	1346-8138		J DERMATOL	J. Dermatol.	NOV	2014	41	11					981	985		10.1111/1346-8138.12632		5	Dermatology	Dermatology	AS5XN	WOS:000344340000006		
J	Motegi, S; Toki, S; Yamada, K; Uchiyama, A; Ishikawa, O				Motegi, Sei-ichiro; Toki, Sayaka; Yamada, Kazuya; Uchiyama, Akihiko; Ishikawa, Osamu			Elevated plasma homocysteine level is possibly associated with skin sclerosis in a series of Japanese patients with systemic sclerosis	JOURNAL OF DERMATOLOGY			English	Article						carotid intima-media thickness; digital ulcers; homocysteine; skin sclerosis; systemic sclerosis	CAROTID-ARTERY STENOSIS; RAYNAUDS-PHENOMENON; VASCULAR-DISEASE; RISK-FACTORS; B-VITAMINS; ATHEROSCLEROSIS; HYPERHOMOCYSTEINEMIA; SCLERODERMA; PREVALENCE; SEVERITY	Homocysteine is a sulfhydryl-containing amino acid that is derived from dietary methionine, and there has been increasing evidence that elevated plasma homocysteine levels are associated with increased risk of cardiovascular diseases, including carotid, coronary and peripheral arterial disease (PAD). The association of plasma homocysteine levels with peripheral vascular involvements, such as Raynaud phenomenon (RP), digital ulcers (DU) in systemic sclerosis (SSc) patients has not been well studied. The objective of this study was to examine plasma homocysteine levels and their clinical associations in patients with SSc. Plasma homocysteine levels in 151 Japanese patients with SSc and 20 healthy controls were examined. No significant differences were observed in plasma homocysteine levels between SSc patients and healthy individuals. Demographic and clinical features of the SSc patients revealed that severe skin sclerosis, anti-topoisomerase I antibody positivity, complications of DU, acro-osteolysis (AO) and interstitial lung disease (ILD) were significantly more prevalent among the patients with elevated plasma homocysteine levels. The plasma homocysteine levels were positively correlated with modified Rodnan total skin score. The plasma homocysteine levels in the SSc patients with DU, AO and ILD were significantly higher than those in the SSc without DU, AO and ILD, respectively. Plasma homocysteine levels did not correlate with either the mean or max intima-media thickness (IMT) or plaque score, suggesting that plasma homocysteine levels might not be associated with carotid artery atherosclerosis in SSc patients. The measurement of plasma homocysteine levels in SSc patients might be useful for the risk stratifications of severe skin sclerosis, DU and AO.	[Motegi, Sei-ichiro; Toki, Sayaka; Yamada, Kazuya; Uchiyama, Akihiko; Ishikawa, Osamu] Gunma Univ, Grad Sch Med, Dept Dermatol, Maebashi, Gumma 3718511, Japan	Motegi, S (reprint author), Gunma Univ, Grad Sch Med, Dept Dermatol, 3-39-22 Showa Machi, Maebashi, Gumma 3718511, Japan.	smotegi@gunma-u.ac.jp					Lonn E, 2006, NEW ENGL J MED, V354, P1567; LEROY EC, 1988, J RHEUMATOL, V15, P202; STAMLER JS, 1993, J CLIN INVEST, V91, P308, DOI 10.1172/JCI116187; Johnstone EM, 2012, RHEUMATOLOGY, V51, P2234, DOI 10.1093/rheumatology/kes214; Verhoef P, 1997, ARTERIOSCL THROM VAS, V17, P989; Matte C, 2009, INT J DEV NEUROSCI, V27, P337, DOI 10.1016/j.ijdevneu.2009.03.005; Hofmann MA, 2001, J CLIN INVEST, V107, P675, DOI 10.1172/JCI10588; Matucci-Cerinic M, 2013, ARTHRITIS RHEUM-US, V65, P1953, DOI 10.1002/art.37988; Devi S, 2006, CARDIOVASC PATHOL, V15, P75, DOI 10.1016/j.carpath.2005.11.001; HANDA N, 1990, STROKE, V21, P1567; Khandanpour N, 2009, EUR J VASC ENDOVASC, V38, P316, DOI 10.1016/j.ejvs.2009.05.007; Raaf L, 2011, MOL CELL BIOCHEM, V347, P63, DOI 10.1007/s11010-010-0612-5; vandenBerg M, 1996, ARTERIOSCL THROM VAS, V16, P165; ARAKI A, 1987, J CHROMATOGR-BIOMED, V422, P43, DOI 10.1016/0378-4347(87)80438-3; Araki Y, 2012, ATHEROSCLEROSIS, V223, P473, DOI 10.1016/j.atherosclerosis.2012.05.019; Caramaschi P, 2003, J RHEUMATOL, V30, P298; Caramaschi P, 2007, CLIN RHEUMATOL, V26, P902, DOI 10.1007/s10067-006-0425-9; Joseph J, 2008, J HEART LUNG TRANSPL, V27, P1237, DOI 10.1016/j.healun.2008.07.024; Lazzerini PE, 2010, AUTOIMMUN REV, V9, P181, DOI 10.1016/j.autrev.2009.08.004; Levy Y, 1999, J RHEUMATOL, V26, P2383; Marasini B, 2000, J RHEUMATOL, V27, P2621; Motegi S, 2014, J DERMATOL, V41, P604, DOI 10.1111/1346-8138.12532; Preliminary criteria for the classification of systemic sclerosis (scleroderma). Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee, 1980, ARTHRITIS RHEUM, V23, P581; SELHUB J, 1995, NEW ENGL J MED, V332, P286, DOI 10.1056/NEJM199502023320502; Szamosi S, 2009, CLIN REV ALLERG IMMU, V36, P145, DOI 10.1007/s12016-008-8105-y; Wierzbicki Anthony S, 2007, Diab Vasc Dis Res, V4, P143; Zou CG, 2009, J MOL MED-JMM, V87, P75, DOI 10.1007/s00109-008-0407-2	27	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0385-2407	1346-8138		J DERMATOL	J. Dermatol.	NOV	2014	41	11					986	991		10.1111/1346-8138.12642		6	Dermatology	Dermatology	AS5XN	WOS:000344340000007		
J	Nakamura, Y; Teramoto, Y; Tanaka, R; Nakamura, Y; Maruyama, H; Fujisawa, Y; Sato, S; Fujimoto, M; Yamamoto, A				Nakamura, Yasuhiro; Teramoto, Yukiko; Tanaka, Ryota; Nakamura, Yoshiyuki; Maruyama, Hiroshi; Fujisawa, Yasuhiro; Sato, Sayuri; Fujimoto, Manabu; Yamamoto, Akifumi			Surgical management of umbilical basal cell carcinoma: Published work review and the optimal depth of surgical excision	JOURNAL OF DERMATOLOGY			English	Article						basal cell carcinoma; invasion depth; margin assessment; surgery; umbilicus	TUMORS	Basal cell carcinoma (BCC) is a common malignant skin tumor. However, BCC that arise at the umbilicus is rare. We present three cases of umbilical BCC. Each BCC was excised at a different depth level, and all deep surgical margins were negative. All patients had no evidence of local recurrence or metastasis during the follow-up periods (12, 24, and 52months). Reviewing the reported cases of umbilical BCC, the BCC cells did not seem to invade into the umbilical scar in most cases, and the deepest invasion levels of tumor cells were up to the middle layer of the subcutaneous tissue. However, the dermatological surgeons have to consider the possibility of surgical excision down to and including the umbilical attachment to the peritoneum, and intraoperative margin assessment should be necessary to avoid the risk of excessive or incomplete excision.	[Nakamura, Yasuhiro; Teramoto, Yukiko; Sato, Sayuri; Yamamoto, Akifumi] Saitama Med Univ, Int Med Ctr, Dept Skin Oncol Dermatol, Hidaka, Saitama 3501298, Japan; [Tanaka, Ryota; Nakamura, Yoshiyuki; Maruyama, Hiroshi; Fujisawa, Yasuhiro; Fujimoto, Manabu] Univ Tsukuba, Fac Med, Dept Dermatol, Tsukuba, Ibaraki, Japan	Nakamura, Y (reprint author), Saitama Med Univ, Int Med Ctr, Dept Skin Oncol Dermatol, 1397-1 Yamane, Hidaka, Saitama 3501298, Japan.	ynakamur@saitama-med.ac.jp			National Cancer Center Research and Development Fund [26-A-4]	This work was partly supported by National Cancer Center Research and Development Fund (26-A-4).	Betti R, 1997, INT J DERMATOL, V36, P503, DOI 10.1046/j.1365-4362.1997.00139.x; Bastiaens MT, 1998, J INVEST DERMATOL, V110, P880, DOI 10.1046/j.1523-1747.1998.00217.x; Chuang GS, 2009, DERMATOL SURG, V35, P1290, DOI 10.1111/j.1524-4725.2009.01228.x; Durrani AJ, 2005, PLAST RECONSTR SURG, V116, P348, DOI 10.1097/01.PRS.0000173546.88835.CB; Etter L, 2003, CUTIS, V71, P123; Lin TC, 2011, AM J DERMATOPATH, V33, P750, DOI 10.1097/DAD.0b013e31820978cf; Meine Jon G, 2003, Dermatol Surg, V29, P405, DOI 10.1046/j.1524-4725.2003.29094.x; Ramirez Paloma, 2011, Dermatol Online J, V17, P16; Schneider HJ, 1998, EUR J SURG ONCOL, V24, P155, DOI 10.1016/S0748-7983(98)91797-8; STECK WD, 1965, CANCER, V18, P907, DOI 10.1002/1097-0142(196507)18:7<907::AID-CNCR2820180721>3.0.CO;2-U; Walker SL, 2001, CLIN EXP DERMATOL, V26, P458, DOI 10.1046/j.1365-2230.2001.00857-4.x	11	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0385-2407	1346-8138		J DERMATOL	J. Dermatol.	NOV	2014	41	11					992	995		10.1111/1346-8138.12640		4	Dermatology	Dermatology	AS5XN	WOS:000344340000008		
J	Kubo, Y; Aoi, J; Johno, T; Makino, T; Sakai, K; Masuguchi, S; Fukushima, S; Jinnin, M; Inoue, Y; Ihn, H				Kubo, Yosuke; Aoi, Jun; Johno, Takamitsu; Makino, Takamitsu; Sakai, Keisuke; Masuguchi, Shinichi; Fukushima, Satoshi; Jinnin, Masatoshi; Inoue, Yuji; Ihn, Hironobu			A case of anaplastic large cell lymphoma of skeletal muscle	JOURNAL OF DERMATOLOGY			English	Article						ALK; CD30; extranodal involvement; non-Hodgkin lymphoma; T cell lymphoma	FEATURES	Anaplastic large cell lymphoma (ALCL) is a high grade non-Hodgkin lymphoma (NHL) that is comprised of the malignant proliferation of large lymphoid cells, which express CD30. Primary ALCL of the skeletal muscle is extremely uncommon. A 51-year-old Japanese female presented at our hospital with a 2-month history of severe pain and swelling of the right leg. A gallium-67 SPECT/CT scan showed a large mass involving the skeletal muscles from the gluteus to femoris. A biopsy of the mass demonstrated diffuse infiltration of medium and large neoplastic cells with round or lobulated hyperchromatic pleomorphic nuclei. A subset of Reed-Sternberg-like cells was also identified. Immunohistochemically, the neoplastic cells were strongly positive for CD4 and CD30, but negative for CD3, CD8, anaplastic lymphoma kinase (ALK), CD20, CD79, CD21 and CD23. Based on the histological examination, this patient was diagnosed to have ALK-negative ALCL of the skeletal muscle. Further studies are needed to clarify the biological behavior of primary skeletal muscle ALCL.	[Kubo, Yosuke; Aoi, Jun; Johno, Takamitsu; Makino, Takamitsu; Sakai, Keisuke; Masuguchi, Shinichi; Fukushima, Satoshi; Jinnin, Masatoshi; Inoue, Yuji; Ihn, Hironobu] Kumamoto Univ, Fac Life Sci, Dept Dermatol & Plast Surg, Kumamoto 8608556, Japan; [Aoi, Jun] Kumamoto Univ, Fac Life Sci, Dept Community Med, Kumamoto 8608556, Japan	Aoi, J (reprint author), Kumamoto Univ, Dept Dermatol & Plast Surg, 1-1-1 Honjo, Kumamoto 8608556, Japan.	junjunaoi@gmail.com					Chim CS, 2002, AM J MED, V112, P79, DOI 10.1016/S0002-9343(01)00916-0; SANDLUND JT, 1994, BLOOD, V84, P2467; Savage KJ, 2008, BLOOD, V111, P5496, DOI 10.1182/blood-2008-01-134270; Campo E, 2011, BLOOD, V117, P5019, DOI 10.1182/blood-2011-01-293050; Stein H, 2000, BLOOD, V96, P3681; Kadin ME, 2014, J AM ACAD DERMATOL, V70, P374, DOI 10.1016/j.jaad.2013.09.007; Chim CS, 1999, LEUKEMIA LYMPHOMA, V33, P601; Emori Makoto, 2014, J Med Case Rep, V8, P9, DOI 10.1186/1752-1947-8-9; Gaiser T, 2012, DIAGN PATHOL, V7, DOI 10.1186/1746-1596-7-38; Ishii E, 2000, CANCER GENET CYTOGEN, V122, P116, DOI 10.1016/S0165-4608(00)00285-5; Liao WP, 2005, ANN HEMATOL, V84, P764, DOI 10.1007/s00277-005-1063-z; Masaoka Satoru, 2002, J Orthop Sci, V7, P688, DOI 10.1007/s007760200122; SHIOTA M, 1995, BLOOD, V86, P1954; STANSFELD AG, 1988, LANCET, V1, P292	14	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0385-2407	1346-8138		J DERMATOL	J. Dermatol.	NOV	2014	41	11					999	1002		10.1111/1346-8138.12641		4	Dermatology	Dermatology	AS5XN	WOS:000344340000010		
J	Uchida, S; Oiso, N; Koga, H; Ishii, N; Okahashi, K; Matsuda, H; Hashimoto, T; Kawada, A				Uchida, Shusuke; Oiso, Naoki; Koga, Hiroshi; Ishii, Norito; Okahashi, Kazunori; Matsuda, Hiromasa; Hashimoto, Takashi; Kawada, Akira			Refractory bullous pemphigoid leaving numerous milia during recovery	JOURNAL OF DERMATOLOGY			English	Article						BP180-NC16a domain; bullous pemphigoid; epidermolysis bullosa acquisita; linear immunoglobulin A bullous dermatosis-1; milium; mucous membrane pemphigoid	DISEASES; BP180	Recovery with milia may occur in bullous pemphigoid (BP), mucous membrane pemphigoid (MMP) and epidermolysis bullosa acquisita (EBA). Scarring commonly occurs in MMP and EBA. Here, we report a 62-year-old man patient with BP, who was left with numerous milia during recovery. The patient had immunoglobulin (Ig)G autoantibodies to the recombinant protein of the BP180-NC16a domain and the soluble 120-kDa ectodomain of BP180 (linear IgA bullous dermatosis [LAD]-1). There are cases of BP with IgG autoantibodies to LAD-1 and/or the recombinant protein of BP180 C-terminal domain. Extensive milia formation during recovery may be associated with immunological predisposition and/or improper interaction between hemidesmosomes and the extracellular matrix components.	[Uchida, Shusuke; Oiso, Naoki; Okahashi, Kazunori; Matsuda, Hiromasa; Kawada, Akira] Kinki Univ, Fac Med, Dept Dermatol, Osaka 5898511, Japan; [Koga, Hiroshi; Ishii, Norito; Hashimoto, Takashi] Kurume Univ, Sch Med, Dept Dermatol, Kurume, Fukuoka 830, Japan; [Koga, Hiroshi; Ishii, Norito; Hashimoto, Takashi] Kurume Univ, Inst Cutaneous Cell Biol, Kurume, Fukuoka 830, Japan	Uchida, S (reprint author), Kinki Univ, Fac Med, Dept Dermatol, 377-2 Ohno Higashi, Osaka 5898511, Japan.	uchishu@med.kindai.ac.jp					Fairley JA, 2013, J AM ACAD DERMATOL, V68, P395, DOI 10.1016/j.jaad.2012.09.012; Tsuruta D, 2011, J DERMATOL SCI, V62, P1, DOI 10.1016/j.jdermsci.2011.01.005; Mulyowa GK, 2006, J AM ACAD DERMATOL, V54, pS43, DOI 10.1016/j.jaad.2005.03.054; Gupta R, 2012, CLIN DERMATOL, V30, P60, DOI 10.1016/j.clindermatol.2011.03.011; Banfield CC, 1998, BRIT J DERMATOL, V138, P1085; Goto-Ohguchi Y, 2009, DERMATOLOGY, V218, P265, DOI 10.1159/000182268; Nishie W, 2014, J DERMATOL SCI, V73, P179, DOI 10.1016/j.jdermsci.2013.12.001; PROST C, 1987, J INVEST DERMATOL, V89, P567, DOI 10.1111/1523-1747.ep12461226; Tsuruta D, 2013, ACTA DERMATOVENER CR, V21, P35; VENNING VA, 1991, BRIT J DERMATOL, V125, P561, DOI 10.1111/j.1365-2133.1991.tb14794.x	10	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0385-2407	1346-8138		J DERMATOL	J. Dermatol.	NOV	2014	41	11					1003	1005		10.1111/1346-8138.12650		3	Dermatology	Dermatology	AS5XN	WOS:000344340000011		
J	Iijima, S; Okazaki, Y; Watanabe, S; Maruyama, Y				Iijima, Shigeruko; Okazaki, Yukiko; Watanabe, Shinya; Maruyama, Yoko			Case of acrodermatitis continua of Hallopeau following psoriasis with atypical clinical presentation	JOURNAL OF DERMATOLOGY			English	Article						acrodermatitis continua of Hallopeau; cyclosporin; nail biopsy; pustular psoriasis; vitamin D3 ointment	PUSTULAR PSORIASIS; CYCLOSPORINE	We present a 63-year-old Japanese woman who had clinically unique symmetrical skin rashes on her lower face, inframammary area, back and extremities, with some pustules on the cheeks. Skin biopsy specimens showed typical findings of psoriasis, and Psoriasis Area and Severity Index score was 5.9. After the skin lesions were treated successfully with vitamin D3 ointment, pustules developed on the tips of the fingers and toes, with paronychial and subungual involvement. The pathology of the nail matrix was consistent with pustular psoriasis, and the patient was diagnosed with acrodermatitis continua of Hallopeau (ACH) following psoriasis with an unusual clinical presentation. ACH was well controlled with a low dose of cyclosporin. Our patient is a rare case chronologically affected by two diseases in the same category. We confirmed that ACH is a variant of pustular psoriasis, and believe that the patient could provide another clue to determining the entity of ACH.	[Iijima, Shigeruko; Okazaki, Yukiko; Watanabe, Shinya; Maruyama, Yoko] Mito Saiseikai Gen Hosp, Dept Dermatol, Ibaraki, Japan	Iijima, S (reprint author), Hanamizuki Clin, 1-6-22 Chuo, Ushiku, Ibaraki 3001234, Japan.	imacintosh@poppy.ocn.ne.jp					BAKER H, 1968, BRIT J DERMATOL, V80, P771, DOI 10.1111/j.1365-2133.1968.tb11947.x; GUPTA AK, 1990, ARCH DERMATOL, V126, P339, DOI 10.1001/archderm.126.3.339; Bugatti L, 1997, CHRON DERMATOL, V7, P379; HARLAND CC, 1992, CLIN EXP DERMATOL, V17, P376, DOI 10.1111/j.1365-2230.1992.tb00239.x; Jo SJ, 2006, J DERMATOL, V33, P787, DOI 10.1111/j.1346-8138.2006.00180.x; KORSTANJE MJ, 1989, DERMATOLOGICA, V179, P90; Lavaroni G, 1994, J DERMATOL TREAT, V5, P209, DOI 10.3109/09546639409080569; Mrowietz U, 2012, FITZPATRICKS DERMATO, P256; PETER RU, 1990, J AM ACAD DERMATOL, V23, P515, DOI 10.1016/S0190-9622(08)81109-7; PIRACCINI BM, 1994, ACTA DERM-VENEREOL, V74, P65; Ranugha Poovanur Ss, 2013, Indian J Dermatol, V58, P161, DOI 10.4103/0019-5154.108096; Sehgal VN, 2011, INT J DERMATOL, V50, P1195, DOI 10.1111/j.1365-4632.2011.04993.x; ZACHARIAE H, 1987, DERMATOLOGICA, V175, P29	13	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0385-2407	1346-8138		J DERMATOL	J. Dermatol.	NOV	2014	41	11					1006	1008		10.1111/1346-8138.12639		3	Dermatology	Dermatology	AS5XN	WOS:000344340000012		
J	Kadono, T; Tomita, M; Tamaki, Z; Sato, S; Asano, Y				Kadono, Takafumi; Tomita, Manabu; Tamaki, Zenshiro; Sato, Shinichi; Asano, Yoshihide			Serum levels of anti-Fc gamma receptor IIB/C antibodies are increased in patients with systemic sclerosis	JOURNAL OF DERMATOLOGY			English	Article						anti-Fc receptor IIB; C antibodies; calcinosis; diffuse pigmentation; nail-fold bleeding; systemic sclerosis	COLLAGEN-INDUCED ARTHRITIS; RIIB-DEFICIENT MICE; AUTOIMMUNE-DISEASE; SCLERODERMA; AUTOANTIBODIES; PATHOGENESIS	Systemic sclerosis (SSc) is a systemic autoimmune disorder that results in fibrosis of the skin and multiple internal organs. Although the precise mechanism is unknown, it appears to result from the overproduction of extracellular matrix proteins and aberrant immune activations. Receptors for the Fc region of immunoglobulin (Ig)G (FcR) are members of the Ig superfamily that modulate both activation and inhibition of immune responses. FcRIIB is the sole inhibitory member, which has an intrinsic cytoplasmic immunoreceptor tyrosine-based inhibitory motif. The present study was undertaken to investigate the circulating concentrations of anti-FcRIIB/C antibodies (Ab) in patients with SSc. Serum levels of anti-FcRIIB/C Ab were significantly increased in patients with SSc compared to those in controls and in patients with localized scleroderma. Serum levels of anti-FcRIIB/C Ab in patients with limited cutaneous SSc were similar to those in patients with diffuse cutaneous SSc. Among SSc patients, serum levels of anti-FcRIIB/C Ab were increased in those with nail-fold bleeding and decreased in those with diffuse pigmentation and calcinosis. These findings support the notion that increased serum anti-FcRIIB/C Ab levels are involved in aberrant immune responses in SSc.	[Kadono, Takafumi; Tomita, Manabu; Tamaki, Zenshiro; Sato, Shinichi; Asano, Yoshihide] Univ Tokyo, Grad Sch Med, Dept Dermatol, Tokyo 1138655, Japan	Asano, Y (reprint author), Univ Tokyo, Grad Sch Med, Dept Dermatol, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan.	tkadono-tky@umin.ac.jp; yasano-tky@umin.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan	We thank Tamami Kaga for technical assistance. This work was supported by a grant from the Ministry of Education, Culture, Sports, Science and Technology of Japan.	LEROY EC, 1988, J RHEUMATOL, V15, P202; Nakamura A, 2003, J AUTOIMMUN, V20, P227, DOI 10.1016/S0896-8411(03)00034-9; Nimmerjahn F, 2008, NAT REV IMMUNOL, V8, P34, DOI 10.1038/nri2206; Bolland S, 2000, IMMUNITY, V13, P277, DOI 10.1016/S1074-7613(00)00027-3; Asano Y, 2010, J DERMATOL, V37, P54, DOI 10.1111/j.1346-8138.2009.00758.x; Sundgren NC, 2011, CIRC RES, V109, P1132, DOI 10.1161/CIRCRESAHA.111.254573; Steen VD, 2000, ARTHRITIS RHEUM, V43, P2437, DOI 10.1002/1529-0131(200011)43:11<2437::AID-ANR10>3.0.CO;2-U; Ravetch JV, 2000, SCIENCE, V290, P84, DOI 10.1126/science.290.5489.84; Mackay M, 2006, J EXP MED, V203, P2157, DOI 10.1084/jem.20051503; BOROS P, 1994, J IMMUNOL, V152, P302; DAVIS K, 1995, J AM ACAD DERMATOL, V33, P612, DOI 10.1016/0190-9622(95)91280-0; LEROY EC, 1992, ANN RHEUM DIS, V51, P286, DOI 10.1136/ard.51.2.286; Magnusson SE, 2008, CLIN IMMUNOL, V127, P225, DOI 10.1016/j.clim.2008.02.002; Okano Y, 1996, RHEUM DIS CLIN N AM, V22, P709, DOI 10.1016/S0889-857X(05)70297-0	14	0	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0385-2407	1346-8138		J DERMATOL	J. Dermatol.	NOV	2014	41	11					1009	1012		10.1111/1346-8138.12651		4	Dermatology	Dermatology	AS5XN	WOS:000344340000013		
J	Otaguchi, R; Kawakami, T; Matsuoka, M; Kimura, S; Soma, Y; Matsuda, M; Hamada, T; Hashimoto, T				Otaguchi, Risako; Kawakami, Tamihiro; Matsuoka, Maya; Kimura, Satoko; Soma, Yoshinao; Matsuda, Mitsuhiro; Hamada, Takahiro; Hashimoto, Takashi			A sporadic elder case of erythrokeratodermia variabilis with a single base-pair transversion in GJB3 gene successfully treated with systemic vitamin A derivative	JOURNAL OF DERMATOLOGY			English	Letter							MUTATION		[Otaguchi, Risako; Kawakami, Tamihiro; Matsuoka, Maya; Kimura, Satoko; Soma, Yoshinao] St Marianna Univ, Sch Med, Dept Dermatol, Kawasaki, Kanagawa 2168511, Japan; [Kawakami, Tamihiro; Matsuda, Mitsuhiro; Hamada, Takahiro; Hashimoto, Takashi] Kurume Univ, Sch Med, Dept Dermatol, Kurume, Fukuoka 830, Japan; [Kawakami, Tamihiro; Matsuda, Mitsuhiro; Hamada, Takahiro; Hashimoto, Takashi] Kurume Univ, Inst Cutaneous Cell Biol, Kurume, Fukuoka 830, Japan	Kawakami, T (reprint author), St Marianna Univ, Sch Med, Dept Dermatol, Miyamae Ku, 2-16-1 Sugao, Kawasaki, Kanagawa 2168511, Japan.	tami@marianna-u.ac.jp					Morley SM, 2005, BRIT J DERMATOL, V152, P1143, DOI 10.1111/j.1365-2133.2005.06610.x; Richard G, 1998, NAT GENET, V20, P366, DOI 10.1038/3840; Richard G, 2003, J INVEST DERMATOL, V120, P601, DOI 10.1046/j.1523-1747.2003.12080.x; Ikeya S, 2013, J DERMATOL, V40, P402, DOI 10.1111/1346-8138.12101; Macari F, 2000, AM J HUM GENET, V67, P1296	5	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0385-2407	1346-8138		J DERMATOL	J. Dermatol.	NOV	2014	41	11					1016	1018		10.1111/1346-8138.12628		3	Dermatology	Dermatology	AS5XN	WOS:000344340000016		
J	Kitazawa, T; Kawakami, T; Matsuoka, M; Kimura, S; Soma, Y; Nakano, H				Kitazawa, Tomoko; Kawakami, Tamihiro; Matsuoka, Maya; Kimura, Satoko; Soma, Yoshinao; Nakano, Hajime			Splicing mutation in the COL7A1 gene mRNA exon 71 in a female patient with pretibial epidermolysis bullosa	JOURNAL OF DERMATOLOGY			English	Letter									[Kitazawa, Tomoko; Kawakami, Tamihiro; Matsuoka, Maya; Kimura, Satoko; Soma, Yoshinao] St Marianna Univ, Sch Med, Dept Dermatol, Kawasaki, Kanagawa 2168511, Japan; [Nakano, Hajime] Hirosaki Univ, Grad Sch Med, Dept Dermatol, Hirosaki, Aomori, Japan	Kawakami, T (reprint author), St Marianna Univ, Sch Med, Dept Dermatol, Miyamae Ku, 2-16 1 Sugao, Kawasaki, Kanagawa 2168511, Japan.	tami@marianna-u.ac.jp					Kern JS, 2009, BRIT J DERMATOL, V161, P1089, DOI 10.1111/j.1365-2133.2009.09333.x; Koga H, 2011, J DERMATOL, V38, P489, DOI 10.1111/j.1346-8138.2010.01008.x; LEE JYY, 1993, J AM ACAD DERMATOL, V29, P974; Liu YH, 2013, GENE, V524, P377, DOI 10.1016/j.gene.2013.03.143; Saito M, 1999, CLIN EXP DERMATOL, V34, pe934	5	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0385-2407	1346-8138		J DERMATOL	J. Dermatol.	NOV	2014	41	11					1018	1019		10.1111/1346-8138.12648		2	Dermatology	Dermatology	AS5XN	WOS:000344340000017		
J	Hida, T; Okura, M; Tanaka, T; Yamashita, T				Hida, Tokimasa; Okura, Masae; Tanaka, Toju; Yamashita, Toshiharu			A case of oculocutaneous albinism type 4: aberrant expression of SLC45A2 transcript with exon skipping	JOURNAL OF DERMATOLOGY			English	Letter							OCA4; GENE		[Hida, Tokimasa; Okura, Masae; Yamashita, Toshiharu] Sapporo Med Univ, Sch Med, Dept Dermatol, Sapporo, Hokkaido 0608543, Japan; [Tanaka, Toju] Natl Hosp Org, Hokkaido Med Ctr, Dept Pediat & Clin Res, Sapporo, Hokkaido, Japan	Hida, T (reprint author), Sapporo Med Univ, Sch Med, Dept Dermatol, Chuo Ku, South 1,West 16, Sapporo, Hokkaido 0608543, Japan.	hidat@sapmed.ac.jp					Inagaki K, 2004, AM J HUM GENET, V74, P466, DOI 10.1086/382195; Martinez-Garcia M, 2013, J DERMATOL, V40, P319, DOI 10.1111/1346-8138.12170; Inagaki K, 2005, PIGM CELL RES, V18, P385, DOI 10.1111/j.1600-0749.2005.00261.x; Newton JM, 2001, AM J HUM GENET, V69, P981, DOI 10.1086/324340; OETTING WS, 1991, J INVEST DERMATOL, V97, P15, DOI 10.1111/1523-1747.ep12477808	5	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0385-2407	1346-8138		J DERMATOL	J. Dermatol.	NOV	2014	41	11					1019	1021		10.1111/1346-8138.12652		3	Dermatology	Dermatology	AS5XN	WOS:000344340000018		
J	Kobayashi, E; Koyama, T; Kobayashi, K; Setsu, N; Kawashima, M; Kawai, A				Kobayashi, Eisuke; Koyama, Taro; Kobayashi, Kazuhiro; Setsu, Nokitaka; Kawashima, Makoto; Kawai, Akira			Reversible hair depigmentation in a Japanese female treated with pazopanib	JOURNAL OF DERMATOLOGY			English	Letter									[Kobayashi, Eisuke; Setsu, Nokitaka; Kawai, Akira] Tokyo Womens Med Univ, Div Musculoskeletal Oncol, Natl Canc Ctr Hosp, Tokyo 1040045, Japan; [Koyama, Taro; Kobayashi, Kazuhiro; Kawashima, Makoto] Tokyo Womens Med Univ, NPO Future Med Lab, Tokyo 1040045, Japan; [Koyama, Taro; Kobayashi, Kazuhiro] Tokyo Womens Med Univ, Mens Hlth Clin, Tokyo 1040045, Japan; [Kawashima, Makoto] Tokyo Womens Med Univ, Dept Dermatol, Tokyo 1040045, Japan	Kobayashi, E (reprint author), Natl Canc Ctr, Div Musculoskeletal Oncol, Chuo Ku, 5-1-1 Tsukiji, Tokyo 1040045, Japan.	ekobayas@ncc.go.jp					van der Graaf WTA, 2012, LANCET, V379, P1879, DOI 10.1016/S0140-6736(12)60651-5; Brazzelli V, 2012, ACTA DERM-VENEREOL, V92, P218, DOI 10.2340/00015555-1289; Brzezniak C, 2014, NEW ENGL J MED, V370, pE27, DOI 10.1056/NEJMicm1309906; Tobin D. J., 2008, International Journal of Cosmetic Science, V30, P233, DOI 10.1111/j.1468-2494.2008.00456.x; Yun SK, 2014, J DERMATOL, V41, P107, DOI 10.1111/1346-8138.12342	5	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0385-2407	1346-8138		J DERMATOL	J. Dermatol.	NOV	2014	41	11					1021	1022		10.1111/1346-8138.12654		2	Dermatology	Dermatology	AS5XN	WOS:000344340000019		
J	Fujita, H; Oda, K; Sato, M; Wada, H; Aihara, M				Fujita, Hiroyuki; Oda, Kayoko; Sato, Maki; Wada, Hidefumi; Aihara, Michiko			Pazopanib-induced leg ulcer in a patient with malignant fibrous histiocytoma	JOURNAL OF DERMATOLOGY			English	Letter									[Fujita, Hiroyuki; Oda, Kayoko; Sato, Maki; Wada, Hidefumi; Aihara, Michiko] Yokohama City Univ, Grad Sch Med, Dept Environm Immunodermatol, Yokohama, Kanagawa 2360004, Japan	Fujita, H (reprint author), Yokohama City Univ, Grad Sch Med, Dept Environm Immunodermatol, Kanazawa Ku, 3-9 Fukuura, Yokohama, Kanagawa 2360004, Japan.	fuji_fuji_fuji_0101@yahoo.co.jp					van der Graaf WTA, 2012, LANCET, V379, P1879, DOI 10.1016/S0140-6736(12)60651-5; Kumar R, 2007, MOL CANCER THER, V6, P2012, DOI 10.1158/1535-7163.MCT-07-0193; Friedlander M, 2010, GYNECOL ONCOL, V119, P32, DOI 10.1016/j.ygyno.2010.05.033; Xu CF, 2011, J CLIN ONCOL, V29, P2557, DOI 10.1200/JCO.2010.32.9110; Versleijen-Jonkers YMH, 2014, CRIT REV ONCOL HEMAT, V91, P172, DOI 10.1016/j.critrevonc.2014.02.001	5	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0385-2407	1346-8138		J DERMATOL	J. Dermatol.	NOV	2014	41	11					1022	1023		10.1111/1346-8138.12647		2	Dermatology	Dermatology	AS5XN	WOS:000344340000020		
J	Hayashi, M; Tanemura, A; Matsuda, K; Hosokawa, K; Izumi, M; Ohara, K; Mihm, MC; Katayama, I				Hayashi, Misa; Tanemura, Atsushi; Matsuda, Ken; Hosokawa, Ko; Izumi, Miki; Ohara, Kuniaki; Mihm, Martin C.; Katayama, Ichiro			Pigmented epithelioid melanocytoma with lymph node metastasis in a patient with uncontrolled atopic dermatitis	JOURNAL OF DERMATOLOGY			English	Letter							BLUE NEVUS; MELANOMA		[Hayashi, Misa; Tanemura, Atsushi; Katayama, Ichiro] Osaka Univ, Grad Sch Med, Dept Dermatol Integrated Med, Suita, Osaka 5650871, Japan; [Matsuda, Ken; Hosokawa, Ko] Osaka Univ, Grad Sch Med, Dept Plast Surg, Suita, Osaka 5650871, Japan; [Izumi, Miki] Tokyo Med Univ, Dept Med Educ, Tokyo 1608402, Japan; [Ohara, Kuniaki] Toranomon Gen Hosp, Dept Dermatol, Tokyo, Japan; [Mihm, Martin C.] Massachusetts Gen Hosp, Div Dermatopathol, Boston, MA 02114 USA; [Mihm, Martin C.] Harvard Univ, Sch Med, Boston, MA USA	Tanemura, A (reprint author), Osaka Univ, Grad Sch Med, Dept Dermatol Integrated Med, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan.	tanemura@derma.med.osaka-u.ac.jp					Zembowicz A, 2004, AM J SURG PATHOL, V28, P31, DOI 10.1097/00000478-200401000-00002; Cheng PS, 2012, DERMATOL SIN, V30, P57, DOI 10.1016/j.dsi.2011.09.011; Zembowicz A, 2007, AM J SURG PATHOL, V31, P1764; Ito K, 2008, J CUTAN PATHOL, V36, P439; Misago N, 2008, EUR J DERMATOL, V18, P586, DOI 10.1684/ejd.2008.0493	5	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0385-2407	1346-8138		J DERMATOL	J. Dermatol.	NOV	2014	41	11					1023	1025		10.1111/1346-8138.12631		3	Dermatology	Dermatology	AS5XN	WOS:000344340000021		
J	Aoi, J; Nagamoto, E; Masuguchi, S; Fukushima, S; Jinnin, M; Ihn, H				Aoi, Jun; Nagamoto, Eiko; Masuguchi, Shinichi; Fukushima, Satoshi; Jinnin, Masatoshi; Ihn, Hironobu			A simple and effective reconstructive technique for repairing defects of the upper lip using a hatchet flap	JOURNAL OF DERMATOLOGY			English	Letter							Y ADVANCEMENT FLAP		[Aoi, Jun; Nagamoto, Eiko; Masuguchi, Shinichi; Fukushima, Satoshi; Jinnin, Masatoshi; Ihn, Hironobu] Kumamoto Univ, Fac Life Sci, Dept Dermatol & Plast Surg, Kumamoto 8608556, Japan; [Aoi, Jun] Kumamoto Univ, Fac Life Sci, Dept Community Med, Kumamoto 8608556, Japan	Aoi, J (reprint author), Kumamoto Univ, Dept Dermatol & Plast Surg, 1-1-1 Honjo, Kumamoto 8608556, Japan.	junjunaoi@gmail.com					Griffin GR, 2012, ARCH FACIAL PLAST S, V14, P193, DOI 10.1001/archfacial.2012.35; Urushidate S, 2011, J PLAST SURG HAND SU, V45, P66, DOI 10.3109/2000656X.2011.569193; Chiu ES, 2012, PLAST RECONSTR SURG, V130, P561, DOI 10.1097/PRS.0b013e31825dc0b6; Kuwahara M, 2012, J PLAST SURG HAND SU, V46, P80, DOI 10.3109/2000656X.2012.669193; Raphael P, 2013, PLAST RECONSTR SURG, V132, P543, DOI 10.1097/PRS.0b013e31829accb6	5	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0385-2407	1346-8138		J DERMATOL	J. Dermatol.	NOV	2014	41	11					1025	1026		10.1111/1346-8138.12645		2	Dermatology	Dermatology	AS5XN	WOS:000344340000022		
J	Aoi, J; Masuguchi, S; Fukushima, S; Jinnin, M; Ihn, H				Aoi, Jun; Masuguchi, Shinichi; Fukushima, Satoshi; Jinnin, Masatoshi; Ihn, Hironobu			Aesthetic reconstruction of defects in the lateral side wall of the nose using a local V-Y flap	JOURNAL OF DERMATOLOGY			English	Letter							NASAL RECONSTRUCTION; SUBUNITS		[Aoi, Jun; Masuguchi, Shinichi; Fukushima, Satoshi; Jinnin, Masatoshi; Ihn, Hironobu] Kumamoto Univ, Dept Dermatol & Plast Surg, Kumamoto 8608556, Japan; [Aoi, Jun] Kumamoto Univ, Fac Life Sci, Kumamoto 8608556, Japan	Aoi, J (reprint author), Kumamoto Univ, Dept Dermatol & Plast Surg, 1-1-1 Honjo, Kumamoto 8608556, Japan.	junjunaoi@gmail.com					Rohrich RJ, 2004, PLAST RECONSTR SURG, V114, P1405, DOI 10.1097/01.PRS.0000138596.57393.05; BURGET GC, 1985, PLAST RECONSTR SURG, V76, P239, DOI 10.1097/00006534-198508000-00010; Yotsuyanagi T, 2000, PLAST RECONSTR SURG, V106, P36, DOI 10.1097/00006534-200007000-00006	3	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0385-2407	1346-8138		J DERMATOL	J. Dermatol.	NOV	2014	41	11					1026	1028		10.1111/1346-8138.12660		3	Dermatology	Dermatology	AS5XN	WOS:000344340000023		
J	Suzuki, M; Hosoda, S; Yamada, T; Komine, M; Murata, S; Yokokura, H; Ohtsuki, M				Suzuki, Masayuki; Hosoda, Satomi; Yamada, Tomoko; Komine, Mayumi; Murata, Satoru; Yokokura, Hideto; Ohtsuki, Mamitaro			case of dermatitis herpetiformis with blister formation between laminin-332 and type 7 collagen	JOURNAL OF DERMATOLOGY			English	Letter							LAMINA-LUCIDA; ZONE		[Suzuki, Masayuki; Hosoda, Satomi; Yamada, Tomoko; Komine, Mayumi; Murata, Satoru; Ohtsuki, Mamitaro] Jichi Med Univ, Dept Dermatol, Shimotsuke, Tochigi 3290498, Japan; [Yokokura, Hideto] Saiseikai Utsunomiya Hosp, Dept Dermatol, Utsunomiya, Tochigi, Japan	Komine, M (reprint author), Jichi Med Univ, Dept Dermatol, 3311-1 Yakushiji, Shimotsuke, Tochigi 3290498, Japan.	mkomine12@jichi.ac.jp					Hosoda S, 2013, J DERMATOL, V40, P211, DOI 10.1111/1346-8138.12034; KLEIN GF, 1983, BRIT J DERMATOL, V109, P499, DOI 10.1111/j.1365-2133.1983.tb07671.x; Shibahara M, 2002, DERMATOLOGY, V204, P37, DOI 10.1159/000051808; SMITH JB, 1992, J AM ACAD DERMATOL, V27, P209, DOI 10.1016/0190-9622(92)70172-C	4	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0385-2407	1346-8138		J DERMATOL	J. Dermatol.	NOV	2014	41	11					1030	1031		10.1111/1346-8138.12630		2	Dermatology	Dermatology	AS5XN	WOS:000344340000025		
J	Ansai, S; Hashizume, S; Kawana, S; Tateishi, C; Koga, H; Hashimoto, T				Ansai, Shin-ichi; Hashizume, Shiho; Kawana, Seiji; Tateishi, Chiharu; Koga, Hiroshi; Hashimoto, Takashi			Case of anti-laminin gamma-1 pemphigoid with antibody against C-terminal domain of BP180 in a patient with psoriasis vulgaris	JOURNAL OF DERMATOLOGY			English	Letter									[Ansai, Shin-ichi; Hashizume, Shiho] Musashi Kosugi Hosp, Nippon Med Sch, Div Dermatol, Kawasaki, Kanagawa 2118533, Japan; [Kawana, Seiji] Nippon Med Sch, Dept Dermatol, Tokyo 113, Japan; [Tateishi, Chiharu] Osaka City Univ, Sch Med, Dept Dermatol, Osaka 545, Japan; [Koga, Hiroshi; Hashimoto, Takashi] Kurume Univ, Sch Med, Dept Dermatol, Kurume, Fukuoka 830, Japan; [Koga, Hiroshi; Hashimoto, Takashi] Kurume Univ, Inst Cutaneous Cell Biol, Kurume, Fukuoka 830, Japan	Ansai, S (reprint author), Musashi Kosugi Hosp, Nippon Med Sch, Div Dermatol, Nakahara Ku, 1-396 Kosugi Cho, Kawasaki, Kanagawa 2118533, Japan.	shin8113@nms.ac.jp					Dainichi T, 2009, P NATL ACAD SCI USA, V106, P2800, DOI 10.1073/pnas.0809230106; Chan LS, 1998, J INVEST DERMATOL, V110, P103, DOI 10.1046/j.1523-1747.1998.00107.x; Chen KR, 1996, BRIT J DERMATOL, V134, P340; DisZenzo G, 2011, J INVEST DERMATOL, V131, P2271; Zillikens Detlef, 1996, Journal of Investigative Dermatology, V106, P1333, DOI 10.1111/1523-1747.ep12349283	5	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0385-2407	1346-8138		J DERMATOL	J. Dermatol.	NOV	2014	41	11					1031	1033		10.1111/1346-8138.12625		3	Dermatology	Dermatology	AS5XN	WOS:000344340000026		
J	Saito, K; Ito, A; Ishikawa, K; Shimada, H; Takeo, N; Hatano, Y; Sugiura, K; Akiyama, M; Inomata, M; Kitano, S; Fujiwara, S				Saito, Kanami; Ito, Akiko; Ishikawa, Kazushi; Shimada, Hiromitsu; Takeo, Naoko; Hatano, Yutaka; Sugiura, Kazumitsu; Akiyama, Masashi; Inomata, Masafumi; Kitano, Seigo; Fujiwara, Sakuhei			Pustular psoriasis occurring after total colectomy for ulcerative colitis and relieved by administration of infliximab	JOURNAL OF DERMATOLOGY			English	Letter							VULGARIS		[Saito, Kanami; Ito, Akiko; Ishikawa, Kazushi; Shimada, Hiromitsu; Takeo, Naoko; Hatano, Yutaka; Fujiwara, Sakuhei] Oita Univ, Fac Med, Dept Dermatol, Oita 8795593, Japan; [Inomata, Masafumi; Kitano, Seigo] Oita Univ, Fac Med, Dept Surg Gastroenterol, Oita 8795593, Japan; [Sugiura, Kazumitsu; Akiyama, Masashi] Nagoya Univ, Grad Sch Med, Dept Dermatol, Nagoya, Aichi 4648601, Japan	Fujiwara, S (reprint author), Oita Univ, Fac Med, Dept Dermatol, 1-1 Idaigaoka,Hasama Machi, Oita 8795593, Japan.	fujiwara@oita-u.ac.jp	Sugiura, Kazumitsu /M-8913-2014	Sugiura, Kazumitsu /0000-0002-5207-4592			Capon F, 2007, HUM GENET, V122, P201, DOI 10.1007/s00439-007-0397-0; Sugiura K, 2014, J INVEST DERMATOL, V134, P1755, DOI 10.1038/jid.2014.46; Sugiura K, 2013, J INVEST DERMATOL, V133, P2514, DOI 10.1038/jid.2013.230; Shimizu A, 2013, J CLIN EXP DERMATOL, V4, DOI [10.4172/2155-9554.1000192, DOI 10.4172/2155-9554.1000192]; Vazquez J, 2003, J EUR ACAD DERMATOL, V17, P77, DOI 10.1046/j.1468-3083.2003.00581.x	5	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0385-2407	1346-8138		J DERMATOL	J. Dermatol.	NOV	2014	41	11					1033	1034		10.1111/1346-8138.12629		2	Dermatology	Dermatology	AS5XN	WOS:000344340000027		
J	Kato, M; Oiso, N; Nozaki, Y; Inoue, A; Hosono, Y; Funauchi, M; Mimori, T; Matsumura, I; Kawada, A				Kato, Maiko; Oiso, Naoki; Nozaki, Yuji; Inoue, Asuka; Hosono, Yuji; Funauchi, Masanori; Mimori, Tsuneyo; Matsumura, Itaru; Kawada, Akira			Antitumor necrosis factor alpha inhibitor-induced dermatomyositis and interstitial lung disease with anti-PL12 autoantibody: Signs of antisynthetase syndrome	JOURNAL OF DERMATOLOGY			English	Letter									[Kato, Maiko; Oiso, Naoki; Kawada, Akira] Kinki Univ, Fac Med, Dept Dermatol, Osaka 5898511, Japan; [Nozaki, Yuji; Inoue, Asuka; Funauchi, Masanori; Matsumura, Itaru] Kinki Univ, Fac Med, Dept Hematol & Rheumatol, Osaka 5898511, Japan; [Hosono, Yuji; Mimori, Tsuneyo] Kyoto Univ, Grad Sch Med, Dept Rheumatol & Clin Immunol, Kyoto, Japan	Kato, M (reprint author), Kinki Univ, Fac Med, Dept Dermatol, 377-2 Ohno Higashi, Osaka 5898511, Japan.	mkato@med.kindai.ac.jp					Ishikawa Y, 2010, CLIN RHEUMATOL, V29, P563, DOI 10.1007/s10067-009-1370-1; Chatterjee S, 2013, CLEV CLIN J MED, V80, P655, DOI 10.3949/ccjm.80a.12171; Kalluri M, 2009, CHEST, V135, P1550, DOI 10.1378/chest.08-2233; Brunasso AMG, 2014, SCI WORLD J, DOI 10.1155/2014/179180; Ishikawa Y, 2011, CLIN RHEUMATOL, V30, P429, DOI 10.1007/s10067-010-1666-1	5	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0385-2407	1346-8138		J DERMATOL	J. Dermatol.	NOV	2014	41	11					1034	1036		10.1111/1346-8138.12626		3	Dermatology	Dermatology	AS5XN	WOS:000344340000028		
J	Ohtsuka, M; Yamamoto, T; Yago, K				Ohtsuka, Mikio; Yamamoto, Toshiyuki; Yago, Keiko			Blepharochalasis showing prominent infiltration of neutrophils in dermal vessels	JOURNAL OF DERMATOLOGY			English	Letter							MATRIX METALLOPROTEINASES		[Ohtsuka, Mikio; Yamamoto, Toshiyuki] Fukushima Med Univ, Sch Med, Dept Dermatol, Fukushima 9601295, Japan; [Yago, Keiko] Northern Fukushima Med Ctr, Dept Ophthalmol, Fukushima, Japan	Ohtsuka, M (reprint author), Fukushima Med Univ, Sch Med, Dept Dermatol, 1 Hikarigaoka, Fukushima 9601295, Japan.	motsuka@fmu.ac.jp					REED WB, 1971, ARCH DERMATOL, V103, P661, DOI 10.1001/archderm.103.6.661; Grassegger A, 1996, BRIT J DERMATOL, V135, P791; Kaneoya K, 2005, J DERMATOL, V32, P26; Karaconji T, 2012, OPHTHAL PLAST RECONS, V28, pE76, DOI 10.1097/IOP.0b013e31822ddf6e; Motegi S, 2014, J DERMATOL, V41, P536, DOI 10.1111/1346-8138.12503	5	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0385-2407	1346-8138		J DERMATOL	J. Dermatol.	NOV	2014	41	11					1036	1037		10.1111/1346-8138.12634		2	Dermatology	Dermatology	AS5XN	WOS:000344340000029		
J	Nojiri, T; Kurano, M; Tokuhara, Y; Ohkubo, S; Hara, M; Ikeda, H; Tsukamoto, K; Yatomi, Y				Nojiri, Takahiro; Kurano, Makoto; Tokuhara, Yasunori; Ohkubo, Shigeo; Hara, Masumi; Ikeda, Hitoshi; Tsukamoto, Kazuhisa; Yatomi, Yutaka			Modulation of sphingosine-1-phosphate and apolipoprotein M levels in the plasma, liver and kidneys in streptozotocin-induced diabetic mice	JOURNAL OF DIABETES INVESTIGATION			English	Article						Apolipoprotein M; Sphingosine-1-phosphate; Streptozotocin-induced diabetes mice	EXPRESSION IN-VIVO; SPHINGOSINE 1-PHOSPHATE; APOM; SUSCEPTIBILITY; POLYMORPHISMS; MECHANISMS; SECRETION; DISEASES; RECEPTOR; INSULIN	Aims/IntroductionSphingosine-1-phosphate (S1P), a multifunctional bioactive lipid mediator, is involved in various diseases. Apolipoprotein M (ApoM) carries S1P on high-density lipoprotein and modulates S1P metabolism to increase the total S1P mass in the body. Both S1P and ApoM are involved in diabetes. Materials and MethodsThe present study examined the modulation of S1P and ApoM levels in the plasma, liver and kidneys in streptozotocin-induced diabetes (STZ) mice, and the effects of insulin on the S1P and ApoM levels in the plasma and liver in STZ mice and normal mice. We also examined the effects of insulin and glucose on the ApoM levels in HepG2 cells. ResultsIn STZ mice, both the plasma S1P and ApoM levels were higher than those in control mice. The hepatic S1P and ApoM contents were also elevated. The hepatic S1P and ApoM contents were reduced by insulin treatment, whereas high-dose insulin decreased the plasma S1P and ApoM levels. In mice without streptozotocin treatment, the administration of insulin decreased the plasma S1P and ApoM levels, and the hepatic content of ApoM, whereas the hepatic level of S1P was not altered. Treatment with insulin and incubation under a low glucose level decreased the ApoM levels in HepG2 cells. Regarding the kidney, the renal levels of S1P and ApoM were increased in STZ mice, and insulin treatment partially restored this increment. ConclusionsIn STZ mice, the levels of S1P and ApoM in the plasma, liver, and kidneys were increased. Insulin treatment somehow reversed this modulation in STZ mice.	[Nojiri, Takahiro; Tokuhara, Yasunori; Ohkubo, Shigeo; Ikeda, Hitoshi; Yatomi, Yutaka] Tokyo Univ Hosp, Dept Clin Lab, Tokyo 113, Japan; [Kurano, Makoto; Ikeda, Hitoshi; Yatomi, Yutaka] Univ Tokyo, Grad Sch Med, Dept Clin Lab Med, Tokyo, Japan; [Tokuhara, Yasunori] Osaka Univ, Grad Sch Med, Div Hlth Sci, Neurobiol Grp, Osaka, Japan; [Hara, Masumi] Teikyo Univ Sch Med, Mizonokuchi Hosp, Dept Med 4, Kawasaki, Kanagawa, Japan; [Tsukamoto, Kazuhisa] Fukushima Med Univ, Dept Metab Diabet & Nephrol, Aizu Med Ctr, Fukushima, Japan	Yatomi, Y (reprint author), Tokyo Univ Hosp, Dept Clin Lab, Tokyo 113, Japan.	yatoyuta-tky@umin.ac.jp			JSPS KAKENHI [22249017, 25253040, 25860740]	This work was supported by JSPS KAKENHI Grant Number 22249017 and 25253040 (YY), and Grant Number 25860740 (MK). No conflicts of interest, financial or otherwise, are declared by the authors.	Christoffersen C, 2011, P NATL ACAD SCI USA, V108, P9613, DOI 10.1073/pnas.1103187108; Zhang X, 2008, BIOCHEM BIOPH RES CO, V371, P114, DOI 10.1016/j.bbrc.2008.04.017; Koch A, 2013, CELL PHYSIOL BIOCHEM, V31, P745, DOI 10.1159/000350093; Fox TE, 2011, J LIPID RES, V52, P509, DOI 10.1194/jlr.M010595; Stanford JC, 2012, J BIOL CHEM, V287, P13457, DOI 10.1074/jbc.M111.268185; Feingold KR, 2008, ATHEROSCLEROSIS, V199, P19, DOI 10.1016/j.atherosclerosis.2007.10.007; Yatomi Y, 2008, BBA-GEN SUBJECTS, V1780, P606, DOI 10.1016/j.bbagen.2007.10.006; Zhang XY, 2003, ACTA HISTOCHEM, V105, P67, DOI 10.1078/0065-1281-00687; Maceyka M, 2012, TRENDS CELL BIOL, V22, P50, DOI 10.1016/j.tcb.2011.09.003; Cnop M, 2005, DIABETES, V54, pS97, DOI 10.2337/diabetes.54.suppl_2.S97; Kurano M, 2013, ATHEROSCLEROSIS, V229, P102, DOI 10.1016/j.atherosclerosis.2013.04.024; Xu N, 1999, J BIOL CHEM, V274, P31286, DOI 10.1074/jbc.274.44.31286; Faber K, 2006, MOL ENDOCRINOL, V20, P212, DOI 10.1210/me.2005-0209; Yatomi Y, 2006, CURR PHARM DESIGN, V12, P575, DOI 10.2174/138161206775474404; Faber K, 2004, J LIPID RES, V45, P1272, DOI 10.1194/jlr.M300451-JLR200; Jessup Claire F., 2011, Endocrine Metabolic & Immune Disorders-Drug Targets, V11, P262; Johnson JD, 2010, ADV EXP MED BIOL, V654, P447, DOI 10.1007/978-90-481-3271-3_19; Lan TA, 2010, BIOMED CHROMATOGR, V24, P1075, DOI 10.1002/bmc.1407; Marchetti Piero, 2012, Adv Exp Med Biol, V771, P288; Niu NF, 2007, DIABETES-METAB RES, V23, P21, DOI 10.1002/dmrr.641; Qi Y, 2013, FASEB J, V10, P4294; Wu XP, 2009, CLIN BIOCHEM, V42, P17, DOI 10.1016/j.clinbiochem.2008.10.008; Xu N, 2006, BIOCHEM BIOPH RES CO, V342, P1174, DOI 10.1016/j.bbrc.2006.02.022; Zhang XY, 2007, BBA-MOL CELL BIOL L, V1771, P879, DOI 10.1016/j.bbalip.2007.04.020; Zhou JW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017324	25	5	5	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	2040-1116	2040-1124		J DIABETES INVEST	J. Diabetes Investig.	NOV	2014	5	6					639	648		10.1111/jdi.12232		10	Endocrinology & Metabolism	Endocrinology & Metabolism	AS6EZ	WOS:000344358600005		
J	Aoyama-Sasabe, S; Xin, X; Taniguchi, A; Nakai, Y; Mitsui, R; Tsuji, H; Yabe, D; Yasuda, K; Kurose, T; Inagaki, N; Seino, Y; Fukushima, M				Aoyama-Sasabe, Sae; Xin, Xin; Taniguchi, Ataru; Nakai, Yoshikatsu; Mitsui, Rie; Tsuji, Hideaki; Yabe, Daisuke; Yasuda, Koichiro; Kurose, Takeshi; Inagaki, Nobuya; Seino, Yutaka; Fukushima, Mitsuo			Relationship and factors responsible for regulating fasting and post-challenge plasma glucose levels in the early stage development of type 2 diabetes mellitus	JOURNAL OF DIABETES INVESTIGATION			English	Article						Fasting plasma glucose; Post-challenge plasma glucose; Type2 diabetes	INSULIN SENSITIVITY; CARDIOVASCULAR-DISEASE; DIAGNOSTIC-CRITERIA; JAPANESE SUBJECTS; RISK-FACTOR; TOLERANCE; SECRETION; HYPERGLYCEMIA; RESISTANCE; MORTALITY	Aims/IntroductionElevation of 2-h plasma glucose (2-h PG) levels keeps step with fasting plasma glucose (FPG) levels elevation, but some individuals show dominant elevation of 2-h PG and others FPG. We analyzed dependent and independent relationships between 2-h PG and FPG, and investigated the factors regulating 2-h PG and FPG. Materials and MethodsIn 1,657 Japanese participants who underwent a 75-g oral glucose tolerance test at the initial examination for a medical check-up, we carried out simple linear regression analysis between 2-h PG and FPG levels on the three patterns of independent variables. We divided the participants into two subgroups: the 2-h PG-side group and the FPG-side from the regression line, and examined the relationships between 2-h PG-FPG and factors responsible for elevation of plasma glucose levels. ResultsThere was a significant positive correlation between 2-h PG and FPG levels. The regression line of both 2-h PG and FPG as independent variables was in accordance with the regression line of 2-h PG as an independent variable and FPG as a dependent variable. In 2-h PG-side group, age was the independent factor affecting 2-h PG in addition to insulinogenic index and insulin sensitivity index (ISI composite). In the FPG-side group, triglyceride was the independent factor affecting FPG in addition to insulinogenic index and ISI composite. ConclusionsTwo-hour PG was an independent predictor of FPG. In addition to the importance of decreased insulin secretion and insulin sensitivity, age was the strong factor to elevate 2-h PG levels in the 2-h PG-side group and triglyceride was the strong factor to elevate FPG levels in the FPG-side group in the early stage of development of type2 diabetes.	[Aoyama-Sasabe, Sae; Fukushima, Mitsuo] Okayama Prefectural Univ, Fac Hlth & Welf Sci, Dept Nutr Sci, Div Clin Nutr & Internal Med, Okayama, Japan; [Xin, Xin] Okayama Prefectural Univ, Dept Syst Engn, Fac Comp Sci & Syst Engn, Okayama, Japan; [Tsuji, Hideaki] Okayama Prefectural Univ, Fac Hlth & Welf Sci, Dept Nutr Sci, Okayama, Japan; [Taniguchi, Ataru] Kyoto Univ, Div Diabet & Endocrinol, Kyoto Prevent Med Ctr, Kyoto, Japan; [Nakai, Yoshikatsu] Kyoto Univ, Kyoto Inst Hlth Sci, Kyoto, Japan; [Inagaki, Nobuya] Kyoto Univ, Grad Sch Med, Dept Diabet & Clin Nutr, Kyoto, Japan; [Mitsui, Rie] St Lukes Int Hosp, Ctr Prevent Med, Tokyo, Japan; [Yabe, Daisuke; Kurose, Takeshi; Seino, Yutaka] Kansai Elect Power Hosp, Div Diabet Clin Nutr & Endocrinol, Osaka, Japan; [Yasuda, Koichiro] Saiseikai Noe Hosp, Dept Diabet & Endocrinol, Osaka, Japan	Fukushima, M (reprint author), Okayama Prefectural Univ, Fac Hlth & Welf Sci, Dept Nutr Sci, Div Clin Nutr & Internal Med, Okayama, Japan.	fukushima7788@yahoo.co.jp	Yabe, Daisuke/J-6682-2014	Yabe, Daisuke/0000-0002-5334-7687	Japan Diabetes Society; Japan Association for Diabetes Education and Care; Manpei Suzuki Diabetes Foundation; Ministry of Education, Culture, Sports, Science and Technology, Japan	This research was supported by a Research Grant from the Japan Diabetes Society, Japan Association for Diabetes Education and Care, Manpei Suzuki Diabetes Foundation and Supporting Organization of Clinical Research on Life Style Related Disease, Leading Project of Biosimulation, Kobe Translational Research Cluster, and the Knowledge Cluster Initiative from the Ministry of Education, Culture, Sports, Science and Technology, Japan. The authors do not have any financial support or relationships that pose a conflict of interest. We thank Kobe Industrial Health Association, Kyoto Industrial Health Association, Fukuoka Institute of Occupational Health, Morinomiyako Occupational Health Association, Niigata Association of Occupational Health and Hokkaido Industrial Health Association for their help in the study.	Seino Y, 2010, J DIABETES INVEST, V1, P212, DOI 10.1111/j.2040-1124.2010.00074.x; Stancakova A, 2009, DIABETES, V58, P1212, DOI 10.2337/db08-1607; Festa A, 2004, DIABETES, V53, P1549, DOI 10.2337/diabetes.53.6.1549; Szoke E, 2008, DIABETES CARE, V31, P539, DOI 10.2337/dc07-1443; Meyer C, 2006, DIABETES CARE, V29, P1909, DOI 10.2337/dc06-0438; Mitsui R, 2006, METABOLISM, V55, P53, DOI 10.1016/j.metabol.2005.07.006; Fukushima M, 2004, METABOLISM, V53, P831, DOI 10.1016/j.metabol.2004.02.012; Nathan DM, 2007, DIABETES CARE, V30, P753, DOI 10.2337/dc07-9920; Tominaga M, 1999, DIABETES CARE, V22, P920, DOI 10.2337/diacare.22.6.920; Weyer C, 1999, DIABETES, V48, P2197, DOI 10.2337/diabetes.48.11.2197; Matsuda M, 1999, DIABETES CARE, V22, P1462, DOI 10.2337/diacare.22.9.1462; Nakagami T, 2004, DIABETOLOGIA, V47, P385, DOI 10.1007/s00125-004-1334-6; Taniguchi A, 2001, METABOLISM, V50, P477, DOI 10.1053/meta.2001.21028; Bando Y, 2001, DIABETES CARE, V24, P1156, DOI 10.2337/diacare.24.7.1156; Carnevale SG, 2003, DIABETES CARE, V26, P1333; Tuomilehto J, 2003, DIABETES CARE, V26, P61; Fukushima M, 2004, DIABETES RES CLIN S, V66S, P37; Hanefeld M, 2003, DIABETES CARE, V26, P868, DOI 10.2337/diacare.26.3.868; HARRIS M, 1979, DIABETES, V28, P1039; Ning F, 2010, DIABETES CARE, V33, P2211, DOI 10.2337/dc09-2328; Nishi Y, 2005, DIABETES RES CLIN PR, V70, P46, DOI 10.1016/j.diabres.2005.02.015; Oka R, 2012, ENDOCR J, V59, P55; Qian L, 2009, DIABETES-METAB RES, V25, P144, DOI 10.1002/dmrr.922; Qiao Q, 2005, DIABETIC MED, V22, P1476, DOI 10.1111/j.1464-5491.2005.01655.x; Rhee SY, 2010, DIABETES RES CLIN PR, V89, P250, DOI 10.1016/j.diabres.2010.05.002; SEINO Y, 1975, HORM METAB RES, V7, P107; Suzuki H, 2003, DIABETES CARE, V26, P1211, DOI 10.2337/diacare.26.4.1211; Taniguchi A, 2000, DIABETES CARE, V23, P1766, DOI 10.2337/diacare.23.12.1766; Taniguchi A, 2000, METABOLISM, V49, P1001, DOI 10.1053/meta.2000.7735; Teramoto T, 2012, CARDIOVASC DIABETOL, V11, DOI 10.1186/1475-2840-11-29; Tuomilehto J, 2003, DIABETES CARE, V26, P1770; Borch-Johnsen K, 2001, ARCH INTERN MED, V161, P397; Yokota K, 2012, J DIABETES INVEST, V3, P371, DOI 10.1111/j.2040-1124.2012.00212.x	33	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	2040-1116	2040-1124		J DIABETES INVEST	J. Diabetes Investig.	NOV	2014	5	6					663	670		10.1111/jdi.12239		8	Endocrinology & Metabolism	Endocrinology & Metabolism	AS6EZ	WOS:000344358600008		
J	Horinouchi, S; Deguchi, T; Arimura, K; Arimura, A; Dochi, Y; Uto, T; Nakamura, T; Arimura, Y; Nishio, Y; Takashima, H				Horinouchi, Shuji; Deguchi, Takahisa; Arimura, Kimiyoshi; Arimura, Aiko; Dochi, Yukari; Uto, Tadashi; Nakamura, Tomonori; Arimura, Yumiko; Nishio, Yoshihiko; Takashima, Hiroshi			Median neuropathy at the wrist as an early manifestation of diabetic neuropathy	JOURNAL OF DIABETES INVESTIGATION			English	Article						Carpal tunnel syndrome; Diabetic neuropathy; Median neuropathy	CARPAL-TUNNEL-SYNDROME; ENTRAPMENT NEUROPATHIES; NERVE-CONDUCTION; POLYNEUROPATHY; DIAGNOSIS	Aims/IntroductionTo elucidate the clinical significance of median neuropathy at the wrist (MN) in patients with diabetes. Materials and MethodsIn total, 340 patients with diabetes who were hospitalized for glycemic control were enrolled in the present study. The diagnoses of MN and diabetic polyneuropathy (DPN) were based on electrophysiological criteria. A total of 187 patients were divided into four subgroups: patients without MN or DPN; patients with MN without DPN; patients with MN and DPN; and patients with DPN without MN. Intergroup comparisons of clinical characteristics and results of nerve conduction studies were carried out. ResultsA total of 71 patients had neither MN nor DPN; 25 had MN, but no DPN; 55 had MN and DPN; and 36 had DPN, but no MN. In comparison with the MN and DPN group, the MN without DPN group included more patients in the early phase of diabetes (diagnosed within the past 5years) and fewer patients with diabetic microangiopathy. Comparative median nerve conduction studies showed significantly lower motor and sensory nerve conduction velocities, longer F-wave latencies, and smaller sensory nerve action potentials in patients with MN and DPN than in those without DPN. ConclusionsMN in patients with diabetes could be attributed to an impairment in axonal function at common entrapment sites, and could be used to identify an early manifestation of diabetic neuropathy.	[Horinouchi, Shuji] Kagoshima City Hosp, Dept Internal Med, Kagoshima, Japan; [Horinouchi, Shuji; Deguchi, Takahisa; Arimura, Aiko; Dochi, Yukari; Uto, Tadashi; Nishio, Yoshihiko] Kagoshima Univ Grad Sch Med & Dent Sci, Dept Diabet & Endocrine Med, Kagoshima, Japan; [Horinouchi, Shuji; Deguchi, Takahisa; Nakamura, Tomonori; Arimura, Yumiko; Takashima, Hiroshi] Kagoshima Univ Grad Sch Med & Dent Sci, Dept Neurol & Geriatr, Kagoshima, Japan; [Arimura, Kimiyoshi] Ookatsu Neurol & Rehabil Hosp, Kagoshima, Japan	Deguchi, T (reprint author), Kagoshima Univ Grad Sch Med & Dent Sci, Dept Diabet & Endocrine Med, Kagoshima, Japan.	degdeg@m3.kufm.kagoshima-u.ac.jp					Albers JW, 1996, MUSCLE NERVE, V19, P140, DOI 10.1002/(SICI)1097-4598(199602)19:2<140::AID-MUS3>3.0.CO;2-E; England JD, 2005, NEUROLOGY, V64, P199; Tracy JA, 2008, PHYS MED REHABIL CLI, V19, P1, DOI 10.1016/j.pmr.2007.10.010; Becker J, 2002, CLIN NEUROPHYSIOL, V113, P1429, DOI 10.1016/S1388-2457(02)00201-8; Thomas PK, 1997, DIABETES, V46, pS54; Perkins BA, 2002, DIABETES CARE, V25, P565, DOI 10.2337/diacare.25.3.565; BRISMAR T, 1987, ANN NEUROL, V21, P504, DOI 10.1002/ana.410210515; Imada M, 2007, CLIN NEUROPHYSIOL, V118, P1405, DOI 10.1016/j.clinph.2007.03.003; Dyck PJ, 1996, J NEUROPATH EXP NEUR, V55, P1181, DOI 10.1097/00005072-199612000-00001; Gulliford MC, 2006, DIABETES CARE, V29, P1929, DOI 10.2337/dc06-0939; UPTON ARM, 1973, LANCET, V2, P359; GREENE DA, 1987, NEW ENGL J MED, V316, P599; DAWSON DM, 1993, NEW ENGL J MED, V329, P2013, DOI 10.1056/NEJM199312303292707; Dyck PJ, 1999, DIABETIC NEUROPATHY; Gazioglu S, 2011, CLIN NEUROPHYSIOL, V122, P1463, DOI 10.1016/j.clinph.2010.11.021; Kikkawa Y, 2005, CLIN NEUROPHYSIOL, V116, P270, DOI 10.1016/j.clinph.2004.08.011; Kuwabara S, 2003, CLIN NEUROPHYSIOL, V114, P169, DOI 10.1016/S1388-2457(02)00381-4; Misawa S, 2006, NEUROLOGY, V66, P1545, DOI 10.1212/01.wnl.0000216260.39452.bf; Monge L, 1995, DIABETIC MED, V12, P1097; Sima AAF, 1996, SEMIN NEUROL, V16, P129, DOI 10.1055/s-2008-1040968; Vinik A, 2004, DIABETES CARE, V27, P1783, DOI 10.2337/diacare.27.7.1783	21	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	2040-1116	2040-1124		J DIABETES INVEST	J. Diabetes Investig.	NOV	2014	5	6					709	713		10.1111/jdi.12211		5	Endocrinology & Metabolism	Endocrinology & Metabolism	AS6EZ	WOS:000344358600014		
J	Yamada, H; Yoshida, M; Takayuki, F; Kakei, M; Ishikawa, SE				Yamada, Hodaka; Yoshida, Masashi; Takayuki, Fujiwara; Kakei, Masafumi; Ishikawa, San-e			Case of fulminant type 1 diabetes with coronary microcirculatory dysfunction	JOURNAL OF DIABETES INVESTIGATION			English	Letter							OXIDATIVE STRESS; SHORT-TERM; HYPERGLYCEMIA		[Yamada, Hodaka; Yoshida, Masashi; Kakei, Masafumi; Ishikawa, San-e] Jichi Med Univ Saitama Med Ctr, Div Endocrinol & Metab, Saitama, Japan; [Takayuki, Fujiwara] Jichi Med Univ Saitama Med Ctr, Div Cardiol, Saitama, Japan	Ishikawa, SE (reprint author), Jichi Med Univ Saitama Med Ctr, Div Endocrinol & Metab, Saitama, Japan.	saneiskw@jichi.ac.jp					Esposito K, 2002, CIRCULATION, V106, P2067, DOI 10.1161/01.CIR.0000034509.14906.AE; Gresele P, 2003, J AM COLL CARDIOL, V41, P1013, DOI 10.1016/S0735-1097(02)02972-8; Ceriello A, 2002, CIRCULATION, V106, P1211, DOI 10.1161/01.CIR.0000027569.76671.A8; COHEN A, 1981, ANGIOLOGY, V32, P361, DOI 10.1177/000331978103200510	4	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	2040-1116	2040-1124		J DIABETES INVEST	J. Diabetes Investig.	NOV	2014	5	6					748	749		10.1111/jdi.12233		2	Endocrinology & Metabolism	Endocrinology & Metabolism	AS6EZ	WOS:000344358600020		
J	Morisaki, S; Hayashi, S; Fujita, Y; Higashi, S				Morisaki, Seiji; Hayashi, Shohei; Fujita, Yuji; Higashi, Seiichiro			Improvement in Characteristic Variability of TFTs Using Grain Growth Control by Micro Thermal Plasma Jet Irradiation on a-Si Strips	JOURNAL OF DISPLAY TECHNOLOGY			English	Article						CMOS integrated circuits; thin-film transistors (TFTs)	THIN-FILM TRANSISTORS; INDUCED LATERAL CRYSTALLIZATION; ORIENTATION CONTROL; SILICON; LOCATION; FABRICATION; BOUNDARY	Grain growth from molten silicon during microthermal-plasma-jet (mu-TPJ) irradiation has been controlled by applying amorphous-silicon (a-Si) strips. The grain boundaries (GBs) in strip pattern with the width of 1 mu m are significantly reduced compared with the case without strip pattern. In strip pattern, random GBs were almost excluded and most of the strips consist of Sigma 3 coincidence site lattices (CSLs) GBs or in some cases single grains. TFTs with strip pattern showed threshold voltage (V-th), field effect mobility (mu(FE)) and sub-threshold swing value (S) of 1.8 +/- 0.10 V, 303 +/- 24 cm(2)/V.s and 240 +/- 17 mV/dec, respectively. In the case of P-type TFTs, they were 1.8 +/- 0.22 V, 98 +/- 7 cm(2)/V.s, 285 +/- 17 mV/dec, respectively. TFTs fabricated with the proposed pattern showed high performance and the variability reduced to 1/3 compared with the case without strip pattern. These characteristics and small variation with proposed patterns enabled us to operate CMOS circuits. The 8-bits shift register fabricated with proposed pattern was operated at a supply voltage of 5 V clock frequency of 4 MHz.	[Morisaki, Seiji; Hayashi, Shohei; Fujita, Yuji; Higashi, Seiichiro] Hiroshima Univ, Grad Sch Adv Sci Matter, Hiroshima 7398530, Japan	Morisaki, S (reprint author), Hiroshima Univ, Grad Sch Adv Sci Matter, Hiroshima 7398530, Japan.	semicon@hi-roshima-u.ac.jp; hayashishohei@hiroshima-u.ac.jp; y_fujita@towajapan.co.jp; sehiga@hiroshima-u.ac.jp			Research Institute for Nanodevice and Bio Systems (RNBS) Hiroshima University, Japan; Japan Society for the Promotion of Science (JSPS)	This work was supported in part by Research Institute for Nanodevice and Bio Systems (RNBS) Hiroshima University, Japan, and in part by Funding Program for Next Generation World-Leading Researchers (NEXT Program) from the Japan Society for the Promotion of Science (JSPS).	Akiyama K, 2009, JPN J APPL PHYS, V48, DOI 10.1143/JJAP.48.03B014; LUCOVSKY G, 1987, J VAC SCI TECHNOL A, V5, P2231, DOI 10.1116/1.574963; Watakabe H, 2002, IEEE T ELECTRON DEV, V49, P2217, DOI 10.1109/TED.2002.805234; Hara A, 2002, JPN J APPL PHYS 2, V41, pL311, DOI 10.1143/JJAP.41.L311; Fujita Y, 2012, JPN J APPL PHYS, V51, DOI 10.1143/JJAP.51.02BH05; Hara A, 2004, JPN J APPL PHYS 1, V43, P1269, DOI 10.1143/JJAP.43.1269; Hayashi S, 2012, APPL PHYS LETT, V101, DOI 10.1063/1.4764522; Hayashi S, 2010, APPL PHYS EXPRESS, V3, DOI 10.1143/APEX.3.061401; He M, 2007, THIN SOLID FILMS, V515, P2872, DOI 10.1016/j.tsf.2006.08.019; Higashi N, 2006, JPN J APPL PHYS 1, V45, P4347, DOI 10.1143/JJAP.45.4347; Higashi S, 2001, JPN J APPL PHYS 1, V40, P480, DOI 10.1143/JJAP.40.480; Higashi S, 2011, JPN J APPL PHYS, V50, DOI 10.1143/JJAP.50.03CB10; Higashi S, 2010, JPN J APPL PHYS, V49, DOI 10.1143/JJAP.49.03CA08; Hsieh H. H., 2008, APPL PHYS LETT, V92; Ishihara R, 2005, THIN SOLID FILMS, V487, P97, DOI 10.1016/j.tsf.2005.01.044; Kitahara K, 2002, JPN J APPL PHYS 1, V41, P5055, DOI 10.1143/JJAP.41.5055; Lim KM, 2008, DISPLAYS, V29, P497, DOI 10.1016/j.displa.2008.04.005; Matsumoto K, 2011, JPN J APPL PHYS, V50, DOI 10.1143/JJAP.50.04DA07; Matsumoto K, 2010, JPN J APPL PHYS, V49, DOI 10.1143/JJAP.49.04DA02; Nishii J, 2003, JPN J APPL PHYS 2, V42, pL347, DOI 10.1143/JJAP.42.L347; Nomura K, 2004, NATURE, V432, P488, DOI 10.1038/nature03090; SAMESHIMA T, 1986, IEEE ELECTR DEVICE L, V7, P276, DOI 10.1109/EDL.1986.26372; SAMESHIMA T, 1987, JPN J APPL PHYS 2, V26, pL1678; Tao C, 2008, JPN J APPL PHYS, V47, P1880, DOI 10.1143/JJAP.47.1880; Taya J, 2013, SOLID STATE ELECTRON, V79, P14, DOI 10.1016/j.sse.2012.07.011; Toyotaka K, 2011, JPN J APPL PHYS, V50, DOI 10.1143/JJAP.50.03CC09; Usami N, 2006, JPN J APPL PHYS 1, V45, P1734, DOI 10.1143/JJAP.45.1734; Wang HY, 2009, ACTA MATER, V57, P3268, DOI 10.1016/j.actamat.2009.03.033; Watakabe H, 2005, JPN J APPL PHYS 1, V44, P8367, DOI 10.1143/JJAP.44.8367; Yorimoto T, 2008, JPN J APPL PHYS, V47, P6949, DOI 10.1143/JJAP.47.6949	30	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	1551-319X	1558-9323		J DISP TECHNOL	J. Disp. Technol.	NOV	2014	10	11					950	955		10.1109/JDT.2014.2326993		6	Engineering, Electrical & Electronic; Optics; Physics, Applied	Engineering; Optics; Physics	AS8EY	WOS:000344484000001		
J	Furuyama, S; Tahara, K; Iwasaki, T; Matsutani, A; Hatano, M				Furuyama, Satoko; Tahara, Kosuke; Iwasaki, Takayuki; Matsutani, Akihiro; Hatano, Mutsuko			Fluorinated Graphene FETs Controlled by Ionic Liquid Gate	JOURNAL OF DISPLAY TECHNOLOGY			English	Article						Fluorination; graphene; ionic liquid (IL)	TRANSPORT	Fluorinated graphene field effect transistors (FETs) with an ionic liquid (IL) top-gate are demonstrated. Fluorinated graphene functionalized with different fluorine concentrations were prepared. Highly fluorinated graphene FETs controlled by ionic liquid gating (ILG) exhibited higher on/off ratios than pristine (non-fluorinated) graphene FET, while conventional back gating (BG) configuration resulted in lower on/off ratios. ILG can induce high charge density in fluorinated graphene with localized states because of extremely high electric field effect of an electric double layer between IL and fluorinated graphene. Thus, a higher on/off ratio was obtained by the combination of graphene fluorination and ILG.	[Furuyama, Satoko; Tahara, Kosuke; Iwasaki, Takayuki; Hatano, Mutsuko] Tokyo Inst Technol, Dept Phys Elect, Meguro Ku, Tokyo 1528550, Japan; [Matsutani, Akihiro] Tokyo Inst Technol, Semicond & MEMS Proc Ctr, Tech Dept, Midori Ku, Yokohama, Kanagawa 2268503, Japan	Furuyama, S (reprint author), Tokyo Inst Technol, Dept Phys Elect, Meguro Ku, Tokyo 1528550, Japan.	.hatano.m.ab@m.titech.ac.jp			MEXT/JSPS KAKENHI [24656202, 24760252]; MEXT Nanotechnology platform [12025014, F-12-IT-0015, F-12-IT-0026]	This work was supported in part by MEXT/JSPS KAKENHI under Grant 24656202 and Grant 24760252, and in part by MEXT Nanotechnology platform 12025014 under F-12-IT-0015 and F-12-IT-0026. (Corresponding author: Mutsuko Hatano.)	Elias DC, 2009, SCIENCE, V323, P610, DOI 10.1126/science.1167130; Lin YM, 2010, SCIENCE, V327, P662, DOI 10.1126/science.1184289; Novoselov KS, 2004, SCIENCE, V306, P666, DOI 10.1126/science.1102896; Chen JH, 2008, NAT PHYS, V4, P377, DOI 10.1038/nphys935; Shon NH, 1998, J PHYS SOC JPN, V67, P2421, DOI 10.1143/JPSJ.67.2421; Nair RR, 2010, SMALL, V6, P2877, DOI 10.1002/smll.201001555; Ye JT, 2011, P NATL ACAD SCI USA, V108, P13002, DOI 10.1073/pnas.1018388108; Withers F, 2010, PHYS REV B, V82, DOI 10.1103/PhysRevB.82.073403; Zhu YW, 2010, ADV MATER, V22, P3906, DOI 10.1002/adma.201001068; Cancado LG, 2011, NANO LETT, V11, P3190, DOI 10.1021/nl201432g; Jeong J, 2013, SCIENCE, V339, P1402, DOI 10.1126/science.1230512; Ueno K, 2011, NAT NANOTECHNOL, V6, P408, DOI [10.1038/nnano.2011.78, 10.1038/NNANO.2011.78]; Hong X, 2011, PHYS REV B, V83, DOI 10.1103/PhysRevB.83.085410; Leenaerts O, 2010, PHYS REV B, V82, DOI 10.1103/PhysRevB.82.195436; Matsutani A, 2012, JPN J APPL PHYS, V51, DOI 10.1143/JJAP.51.087001; Sahin H, 2011, PHYS REV B, V83, DOI 10.1103/PhysRevB.83.115432; Shklovskii B I, 1984, ELECT PROPERTIES DOP; Tahara K., 2012, APPL PHYS LETT, V101; Tahara K., 2013, APPL PHYS LETT, V103; Yamashiro Y., 2012, J VAC SCI TECHNOL, V30	20	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	1551-319X	1558-9323		J DISP TECHNOL	J. Disp. Technol.	NOV	2014	10	11					962	965		10.1109/JDT.2014.2332636		4	Engineering, Electrical & Electronic; Optics; Physics, Applied	Engineering; Optics; Physics	AS8EY	WOS:000344484000003		
J	Domen, K; Miyase, T; Abe, K; Hosono, H; Kamiya, T				Domen, Kay; Miyase, Takaya; Abe, Katsumi; Hosono, Hideo; Kamiya, Toshio			Positive-Bias Stress Test on Amorphous In-Ga-Zn-O Thin Film Transistor: Annealing-Temperature Dependence	JOURNAL OF DISPLAY TECHNOLOGY			English	Article						Amorphous In-Ga-Zn-O (a-IGZO); degradation; dry annealing; stress test; thermal desorption spectroscopy (TDS); thin-film transistor (TFT); wet annealing		We performed constant positive gate bias stress tests on sputter-deposited amorphous In-Ga-Zn-O (a-IGZO) thin-film transistors (TFTs) fabricated with various annealing conditions. We found that the time evolution of threshold voltage shift (Delta V-th) during the stress test exhibits two different behaviors; a power function type and a logarithmic function type. Combining with thermal desorption spectroscopy (TDS), we found that the Delta V-th type changes fromthe log-function type to the power-function type as H desorption increases. The power-function type is attributed to a H-diffusion limited process. As for the log-function type, the magnitude of Delta V-th has correlation with the hysteresis width in a first transfer curve and the desorption amount of H2O and O-2 species between 200 degrees C-300 degrees C. Hence, it is considered that the traps causing the log-function type Delta V-th are meta-stable states related to O- and/or OH-related weak bonds.	[Domen, Kay; Miyase, Takaya; Abe, Katsumi; Hosono, Hideo; Kamiya, Toshio] Tokyo Inst Technol, Mat & Struct Lab, Midori Ku, Yokohama, Kanagawa 2268503, Japan; [Hosono, Hideo] Tokyo Inst Technol, Frontier Res Ctr, Midori Ku, Yokohama, Kanagawa 2268503, Japan	Domen, K (reprint author), Tokyo Inst Technol, Mat & Struct Lab, Midori Ku, Yokohama, Kanagawa 2268503, Japan.	GDG02125@nifty.com; t-miyase@lucid.msl.titech.ac.jp; k_abe@lucid.msl.titech.ac.jp; hosono@msl.titech.ac.jp; kamiya.t.aa@m.titech.ac.jp	Hosono, Hideo/J-3489-2013; Kamiya, Toshio/E-8615-2014	Hosono, Hideo/0000-0001-9260-6728; Kamiya, Toshio/0000-0002-8358-240X	Funding Program for Next Generation-World-Leading Researchers under NEXT Program [GR035]; Japan Society for the Promotion of Science [21360319]	This work was supported by Funding Program for Next Generation-World-Leading Researchers under NEXT Program, Project GR035, and by Grant-in-Aid for Scientific Research (B) under Project 21360319 through Japan Society for the Promotion of Science. Date of publication August 27, 2014; date of current version October 21, 2014.	Abtew TA, 2006, PHYS REV B, V74, DOI 10.1103/PhysRevB.74.085201; Alam MA, 2005, MICROELECTRON RELIAB, V45, P71, DOI 10.1016/j.microrel.2004.03.019; Ide K., 2011, APPL PHYS LETT, V99; Kamiya T., 2010, SCI TECHNOL ADV MAT, V11; Lee J.-M., 2008, APPL PHYS LETT, V93; Nomura K, 2004, NATURE, V432, P488, DOI 10.1038/nature03090; Nomura K, 2010, THIN SOLID FILMS, V518, P3012, DOI 10.1016/j.tsf.2009.09.193; Nomura K., 2009, APPL PHYS LETT, V95; Nomura K., 2008, APPL PHYS LETT, V93; Saito N., 2010, P 17 INT DISPL WORKS, V1855; Suresh A., 2008, APPL PHYS LETT, V92	11	2	2	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	1551-319X	1558-9323		J DISP TECHNOL	J. Disp. Technol.	NOV	2014	10	11					975	978		10.1109/JDT.2014.2350518		4	Engineering, Electrical & Electronic; Optics; Physics, Applied	Engineering; Optics; Physics	AS8EY	WOS:000344484000006		
J	Hanyu, Y; Abe, K; Domen, K; Nomura, K; Hiramatsu, H; Kumomi, H; Hosono, H; Kamiya, T				Hanyu, Yuichiro; Abe, Katsumi; Domen, Kay; Nomura, Kenji; Hiramatsu, Hidenori; Kumomi, Hideya; Hosono, Hideo; Kamiya, Toshio			Effects of High-Temperature Annealing on Operation Characteristics of a-In-Ga-Zn-O TFTs	JOURNAL OF DISPLAY TECHNOLOGY			English	Article						Amorphous materials; defect; hydrogen passivation; thin-film transistors (TFTs)	THIN-FILM TRANSISTORS; CAPACITANCE-VOLTAGE CHARACTERISTICS; POLYCRYSTALLINE SILICON; STATE DENSITY; SEMICONDUCTORS; CRYSTALLINE; MODEL	We report operation characteristics of amorphous In-Ga-Zn-O (a-IGZO) thin-film transistors (TFTs) annealed in dry O-2 at temperatures up to 700 degrees C. The largest TFT mobilities were obtained by annealing at 200 degrees C-300 degrees C and the smallest subthreshold voltage swing (S) was obtained at 200 degrees C, while those annealed at higher T exhibited poorer mobilities and S values. The TFTs annealed at >= 600 degrees C were crystallized and exhibited further poorer characteristics probably due to grain boundary issues; while, the deterioration by the 400 degrees C-500 degrees C annealing is attributed to depletion of hydrogen and consequent de-passivation effects. Device simulations and photoresponse spectroscopy extracted systematic variation of trap densities in the a-IGZO layer.	[Hanyu, Yuichiro; Abe, Katsumi; Domen, Kay; Hiramatsu, Hidenori; Hosono, Hideo; Kamiya, Toshio] Tokyo Inst Technol, Mat & Struct Lab, Yokohama, Kanagawa 2268503, Japan; [Nomura, Kenji] Tokyo Inst Technol, Frontier Res Ctr, Yokohama, Kanagawa 2268503, Japan; [Kumomi, Hideya] Tokyo Inst Technol, Mat Res Ctr Element Strategy, Yokohama, Kanagawa 2268503, Japan	Hanyu, Y (reprint author), Tokyo Inst Technol, Mat & Struct Lab, Yokohama, Kanagawa 2268503, Japan.	y-hanyu@lucid.msl.titech.ac.jp; k_abe@lucid.msl.titech.ac.jp; kdomen@lucid.msl.titech.ac.jp; nomura@lucid.msl.titech.ac.jp; h-hirama@lucid.msl.titech.ac.jp; ku-momi@lucid.msl.titech.ac.jp; hosono@msl.titech.ac.jp; tkamiya@msl.titech.ac.jp	Hiramatsu, Hidenori/E-8882-2014; Hosono, Hideo/J-3489-2013; Kamiya, Toshio/E-8615-2014	Hiramatsu, Hidenori/0000-0002-5664-5831; Hosono, Hideo/0000-0001-9260-6728; Kamiya, Toshio/0000-0002-8358-240X	Funding Program for Next Generation World-Leading Researchers (NEXT Program) [GR035]; Japan Society for the Promotion of Science [21360319]	This work was supported by Funding Program for Next Generation World-Leading Researchers (NEXT Program, Project #GR035) and Grant-in-Aid for Scientific Research (B) (Project #21360319) through Japan Society for the Promotion of Science.	Ide K, 2012, THIN SOLID FILMS, V520, P3787, DOI 10.1016/j.tsf.2011.10.062; Park JH, 2009, IEEE ELECTR DEVICE L, V30, P1069, DOI 10.1109/LED.2009.2028042; Kikuchi Y, 2010, THIN SOLID FILMS, V518, P3017, DOI 10.1016/j.tsf.2009.10.132; SUZUKI T, 1982, JPN J APPL PHYS 2, V21, pL159, DOI 10.1143/JJAP.21.L159; FORTUNATO G, 1986, APPL PHYS LETT, V49, P1025, DOI 10.1063/1.97460; SETO JYW, 1975, J APPL PHYS, V46, P5247, DOI 10.1063/1.321593; Kamiya T, 2009, J DISP TECHNOL, V5, P462, DOI 10.1109/JDT.2009.2022064; Abe K, 2014, THIN SOLID FILMS, V559, P40, DOI 10.1016/j.tsf.2013.11.066; Chen C, 2009, IEEE T ELECTRON DEV, V56, P1177, DOI 10.1109/TED.2009.2019157; Abe K, 2012, THIN SOLID FILMS, V520, P3791, DOI 10.1016/j.tsf.2011.10.060; Ito M, 2005, IDW/AD '05: PROCEEDINGS OF THE 12TH INTERNATIONAL DISPLAY WORKSHOPS IN CONJUNCTION WITH ASIA DISPLAY 2005, VOLS 1 AND 2, P845; Fung TC, 2009, J APPL PHYS, V106, DOI 10.1063/1.3234400; Takechi K, 2009, JPN J APPL PHYS, V48, DOI 10.1143/JJAP.48.078001; Nomura K, 2003, SCIENCE, V300, P1269, DOI 10.1126/science.1083212; Takechi K, 2009, JPN J APPL PHYS, V48, DOI 10.1143/JJAP.48.011301; Godo H, 2009, 2009 SID INTERNATIONAL SYMPOSIUM DIGEST OF TECHNICAL PAPERS, VOL XL, BOOKS I - III, P1110; Hosono H., 2012, HDB VISUAL DISPLAY T, P730; Hsieh H.-H., 2008, APPL PHYS LETT, V92; Ide K., 2012, J APPL PHYS, V111; Jeon K., 2008, APPL PHYS LETT, V93; Kamiya T., 2012, HDB ZINC OXIDE RELAT; Kimura M., 2008, APPL PHYS LETT, V92; Kwon J. Y., 2007, DIG IMID 2007, P141; Lee HN, 2006, IDW '06: PROCEEDINGS OF THE 13TH INTERNATIONAL DISPLAY WORKSHOPS, VOLS 1-3, P663; Nomura K, 2004, NATURE, V432, P488, DOI 10.1038/nature03090; Nomura K., 2011, J APPL PHYS, V109; Nomura K., 2008, APPL PHYS LETT, V93; Nomura K., 2011, J APPL PHYS, V109; Nomura K., 2008, APPL PHYS LETT, V92; Park JH, 2008, IEEE ELECTR DEVICE L, V29, P1292, DOI 10.1109/LED.2008.2006415; Park JH, 2010, J ELECTROCHEM SOC, V157, pH272, DOI 10.1149/1.3273203; Sung M.-C., 2007, P IMID S, P133	32	2	2	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	1551-319X	1558-9323		J DISP TECHNOL	J. Disp. Technol.	NOV	2014	10	11					979	983		10.1109/JDT.2014.2352860		5	Engineering, Electrical & Electronic; Optics; Physics, Applied	Engineering; Optics; Physics	AS8EY	WOS:000344484000007		
J	Nishimura, T				Nishimura, Takeshi			Sequential procurement auctions with risk-averse suppliers	JOURNAL OF ECONOMICS			English	Article						Sequential auctions; Bundling; Risk sharing; Procurement; Public-private partnerships	PUBLIC-PRIVATE PARTNERSHIPS; CONTRACTS	We compare two procurement mechanisms, bundling and unbundling, in a two-stage auction model with risk-averse suppliers. The mechanisms differ in that the two tasks of investment and production are procured through a single auction or two sequential auctions. Suppliers' production costs are affected by two risk factors, aggregate risk and idiosyncratic risk, as well as by the cost-reducing investment. We show that the bundling mechanism is optimal for a buyer and socially desirable if the aggregate risk is below certain thresholds. The result may not hold true for idiosyncratic risk.	Hitotsubashi Univ, Kunitachi, Tokyo 186, Japan	Nishimura, T (reprint author), Hitotsubashi Univ, Naka 2-1, Kunitachi, Tokyo 186, Japan.	yoshihirotake@hotmail.co.jp					Hart O, 2003, ECON J, V113, pC69, DOI 10.1111/1468-0297.00119; HOLT CA, 1980, J POLIT ECON, V88, P433; Martimort D, 2008, INT J IND ORGAN, V26, P393, DOI 10.1016/j.ijindorg.2006.10.004; HANOCH G, 1969, REV ECON STUD, V36, P335, DOI 10.2307/2296431; Auriol E, 1992, J ECON MANAGE STRAT, V1, P507, DOI 10.1111/j.1430-9134.1992.00507.x; ENR, 2012, TOP 100 DES BUILD FI; Gibson GEJ, 2007, ALTERNATIVE PROJECT; Grimm V, 2007, J ECON, V90, P1, DOI 10.1007/s00712-006-0225-3; Hoppe EI, 2013, J ECON BEHAV ORGAN, V89, P145, DOI 10.1016/j.jebo.2011.05.001; Iossa E., 2007, CONTRACT DESIGN PUBL; Kay M, 2009, THESIS MIT CAMBRIDGE; LI S., 2011, BUNDLING DECISIONS P; Organization for Economic Cooperation and Development (OECD), 2008, PUBL PRIV PARTN PURS; Yescombe E. R, 2007, PUBLIC PRIVATE PARTN	14	0	0	SPRINGER WIEN	WIEN	SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA	0931-8658	1617-7134		J ECON	J. Econ.	NOV	2014	113	3					229	252		10.1007/s00712-013-0381-1		24	Economics	Business & Economics	AS3IW	WOS:000344171700002		
J	Inoue, T; Iwamoto, T; Setsune, Y				Inoue, Takehiro; Iwamoto, Takuya; Setsune, Yoko			LATERAL ABDOMINAL WALL HEMATOMA DUE TO BLUNT INTERCOSTAL ARTERIAL INJURY IN A PATIENT WITH SERIOUS COMORBIDITIES	JOURNAL OF EMERGENCY MEDICINE			English	Article							MANAGEMENT; DIAGNOSIS		[Inoue, Takehiro] Mimihara Gen Hosp, Dept Cardiovasc Surg, Sakai, Osaka 5908505, Japan; [Iwamoto, Takuya] Mimihara Gen Hosp, Dept Intervent Radiol, Sakai, Osaka 5908505, Japan; [Setsune, Yoko] Mimihara Gen Hosp, Dept Emergency Med, Sakai, Osaka 5908505, Japan	Inoue, T (reprint author), Mimihara Gen Hosp, Dept Cardiovasc Surg, 4-465 Sakaiku Kyowacho, Sakai, Osaka 5908505, Japan.						ZAINEA GG, 1988, AM SURGEON, V54, P630; Chemelli AP, 2009, J VASC SURG, V49, P1505, DOI 10.1016/j.jvs.2009.02.001; DUCATMAN BS, 1983, JAMA-J AM MED ASSOC, V249, P924, DOI 10.1001/jama.249.7.924; Dutta Sumanta, 2009, Cases J, V2, P9358, DOI 10.1186/1757-1626-2-9358; Konerding MA, 1997, PLAST RECONSTR SURG, V99, P705, DOI 10.1097/00006534-199703000-00016; Lefere P, 1999, EUR RADIOL, V9, P1553, DOI 10.1007/s003300050883	6	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0736-4679	1090-1280		J EMERG MED	J. Emerg. Med.	NOV	2014	47	5					E125	E127		10.1016/j.jemermed.2014.06.043		3	Emergency Medicine	Emergency Medicine	AS4IZ	WOS:000344239500004		
J	Sasaki, A; Yamaji, N; Ma, JF				Sasaki, Akimasa; Yamaji, Naoki; Ma, Jian Feng			Overexpression of OsHMA3 enhances Cd tolerance and expression of Zn transporter genes in rice	JOURNAL OF EXPERIMENTAL BOTANY			English	Article						OsHMA3; Cd; overexpression; Oryza sativa; Zn transporter; tolerance	CADMIUM; ZINC; TRANSLOCATION; IDENTIFICATION; ARABIDOPSIS; P-1B-ATPASE; SHOOTS; ATHMA3; JAPAN	As a member of the heavy metal ATPase (HMA) family, OsHMA3 is a tonoplast-localized transporter for Cd in the roots of rice (Oryza sativa). Overexpression of OsHMA3 selectively reduces Cd accumulation in the grain. Further characterization in the present study revealed that overexpression of OsHMA3 also enhances the tolerance to toxic Cd. The growth of both the roots and shoots was similar in the absence of Cd between an OsHMA3-overexpressed line and vector control, but the Cd-inhibited growth was significantly alleviated in the OsHMA3-overexpressed line. The over-expressed line showed higher Cd concentration in the roots, but lower Cd concentration in the shoots compared with the wild-type rice and vector control line, indicating that overexpression of OsHMA3 enhanced vacuolar sequestration of Cd in the roots. The Zn concentration in the roots of the OsHMA3-overexpressed line was constantly higher than that of vector control, but the Zn concentration in the shoots was similar between the overexpressed line and vector control. Five transporter genes belonging to the ZIP family were constitutively up-regulated in the OsHMA3-overexpressed line. These results suggest that shoot Zn level was maintained by up-regulating these genes involved in the Zn uptake/translocation. Taken together, overexpression of OsHMA3 is an efficient way to reduce Cd accumulation in the grain and to enhance Cd tolerance in rice.	[Sasaki, Akimasa; Yamaji, Naoki; Ma, Jian Feng] Okayama Univ, Inst Plant Sci & Resources, Kurashiki, Okayama, Japan	Ma, JF (reprint author), Okayama Univ, Inst Plant Sci & Resources, Chuo 2-20-1, Kurashiki, Okayama, Japan.	maj@rib.okayama-u.ac.jp	YAMAJI, Naoki/B-2524-2011	YAMAJI, Naoki/0000-0002-7499-3004	JSPS KAKENHI [24248014]; MEXT KAKENHI [22119002]	The research was supported by JSPS KAKENHI Grant Number 24248014 and MEXT KAKENHI Grant Number 22119002 to JFM.	Ueno D, 2011, J EXP BOT, V62, P2265, DOI 10.1093/jxb/erq383; Ishikawa S, 2012, P NATL ACAD SCI USA, V109, P19166, DOI 10.1073/pnas.1211132109; Uraguchi S, 2011, P NATL ACAD SCI USA, V108, P20959, DOI 10.1073/pnas.1116531109; Miyadate H, 2011, NEW PHYTOL, V189, P190, DOI 10.1111/j.1469-8137.2010.03459.x; Verbruggen N, 2009, CURR OPIN PLANT BIOL, V12, P364, DOI 10.1016/j.pbi.2009.05.001; Kramer U, 2007, FEBS LETT, V581, P2263, DOI 10.1016/j.febslet.2007.04.010; Lee S, 2010, PLANT MOL BIOL, V73, P507, DOI 10.1007/s11103-010-9637-0; Morel M, 2009, PLANT PHYSIOL, V149, P894, DOI 10.1104/pp.108.130294; Satoh-Nagasawa N, 2012, PLANT CELL PHYSIOL, V53, P213, DOI 10.1093/pcp/pcr166; Ueno D, 2009, PLANT CELL PHYSIOL, V50, P2223, DOI 10.1093/pcp/pcp160; Sasaki A, 2012, PLANT CELL, V24, P2155, DOI 10.1105/tpc.112.096925; Takahashi R, 2012, PLANT CELL ENVIRON, V35, P1948, DOI 10.1111/j.1365-3040.2012.02527.x; Bashir K, 2012, PLANT SOIL, V361, P189, DOI 10.1007/s11104-012-1240-5; Ishimaru Y, 2005, J EXP BOT, V56, P3207, DOI 10.1093/jxb/eri317; Becher M, 2004, PLANT J, V37, P251, DOI 10.1046/j.1365-313X.2003.01959.x; Yamaji N, 2013, PLANT PHYSIOL, V162, P927, DOI 10.1104/pp.113.216564; Ueno D, 2010, P NATL ACAD SCI USA, V107, P16500, DOI 10.1073/pnas.1005396107; Gravot A, 2004, FEBS LETT, V561, P22, DOI 10.1016/S0014-5793(04)00072-9; Clemens S, 2013, TRENDS PLANT SCI, V18, P92, DOI 10.1016/j.tplants.2012.08.003; Lee S, 2010, MOL CELLS, V29, P551, DOI 10.1007/s10059-010-0069-0; Ishimaru Y, 2006, PLANT J, V45, P335, DOI 10.1111/j.1365-313X.2005.02624.x; Shimbo S, 2001, SCI TOTAL ENVIRON, V281, P165, DOI 10.1016/S0048-9697(01)00844-0; Zheng LQ, 2012, PLANT CELL, V24, P3767, DOI 10.1105/tpc.112.103820; HORIGUCHI H, 1994, ARCH TOXICOL, V68, P632, DOI 10.1007/BF03208342; Olsen LI, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00030	25	4	5	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0022-0957	1460-2431		J EXP BOT	J. Exp. Bot.	NOV	2014	65	20					6013	6021		10.1093/jxb/eru340		9	Plant Sciences	Plant Sciences	AT0YB	WOS:000344658800024		
J	Kawabata, Y; Nishihara, GN; Yamaguchi, T; Takebe, T; Teruya, K; Sato, T; Soyano, K				Kawabata, Y.; Nishihara, G. N.; Yamaguchi, T.; Takebe, T.; Teruya, K.; Sato, T.; Soyano, K.			The effect of spine postures on the hydrodynamic drag in Epinephelus ongus larvae	JOURNAL OF FISH BIOLOGY			English	Article						computational fluid dynamics analysis; drag coefficient; elongated spine; morphology; Serranidae	CORAL-REEF FISH; WHITE-STREAKED GROUPER; POPULATION CONNECTIVITY; ACTIVITY PATTERNS; DISPERSAL; BEHAVIOR; SERRANIDAE; SETTLEMENT; ONTOGENY; TROUT	Laboratory behavioural observation and computational fluid dynamics (CFD) analysis were conducted to examine whether the movement of the elongated dorsal and pelvic spines changed the hydrodynamic drag in white-streaked grouper Epinephelus ongus larvae. The behavioural observation in the tank revealed that the larvae extended the dorsal and pelvic spines during passive transport and retracted during swimming; the angles of the dorsal and pelvic spines in relation to the anteroposterior axis were larger during the passive transport (mean +/- s.d. = 2884 +/- 1427 and 2035 +/- 1505 degrees) than those during the swimming (mean +/- s.d. = 259 +/- 555 and 032 +/- 649 degrees). The CFD analysis indicated that the relative hydrodynamic drag acting on the larvae was approximately 125 times higher when the spines were extended (passive transport) than when the spines were retracted (swimming), suggesting that the E. ongus larvae have an ability to adjust their hydrodynamic drag depending on the behavioural context.	[Kawabata, Y.; Nishihara, G. N.; Yamaguchi, T.; Soyano, K.] Nagasaki Univ, Inst East China Sea Res, Nagasaki 8512213, Japan; [Yamaguchi, T.; Takebe, T.; Teruya, K.; Sato, T.] Fisheries Res Agcy, Res Ctr Subtrop Fisheries, Seikai Natl Fisheries Res Inst, Okinawa 9070451, Japan	Kawabata, Y (reprint author), Nagasaki Univ, Inst East China Sea Res, Nagasaki 8512213, Japan.	yuuki-k@nagasaki-u.ac.jp		Nishihara, Gregory/0000-0003-2543-1301	Japan Society for the Promotion of Science [23380113]	We acknowledge A. Nanami at the Research Center for Subtropical Fisheries, Seikai National Fisheries Research Institute, Fisheries Research Agency, for his help in collecting wild white-streaked grouper for broodstock. We thank T. Takagi at the Faculty of Agriculture, Kinki University, R. Kawabe and S. Furukawa at the Institute for East China Sea Research, Nagasaki University, for their advice on the preliminary experiment. We are also grateful to E. Forsgren and two anonymous reviewers for their valuable comments. This research was supported by a Grant-in-Aid for Scientific Research (B) to K. S. (grant number 23380113) from the Japan Society for the Promotion of Science.	Leis JM, 2007, MAR ECOL PROG SER, V347, P185, DOI 10.3354/meps06977; Fisher R, 2005, MAR ECOL PROG SER, V285, P223, DOI 10.3354/meps285223; Hirata Y, 2009, NIPPON SUISAN GAKK, V75, P652; TAKAHASHI K, 1984, DEEP-SEA RES, V31, P1477, DOI 10.1016/0198-0149(84)90083-9; Zeller DC, 1997, MAR ECOL PROG SER, V154, P65, DOI 10.3354/meps154065; Leis JM, 2009, MAR ECOL PROG SER, V379, P163, DOI 10.3354/meps07904; Claisse JT, 2011, ENVIRON BIOL FISH, V91, P185, DOI 10.1007/s10641-011-9771-9; Gerlach G, 2007, P NATL ACAD SCI USA, V104, P858, DOI 10.1073/pnas.0606777104; Putman NF, 2012, J EXP BIOL, V215, P1863, DOI 10.1242/jeb.067587; Meyer CG, 2010, MAR BIOL, V157, P1499, DOI 10.1007/s00227-010-1424-6; Lecchini D, 2005, OECOLOGIA, V143, P326, DOI 10.1007/s00442-004-1805-y; Hamner WM, 2012, FISH FISH SER, V35, P159, DOI 10.1007/978-94-007-1980-4_6; Simpson SD, 2005, SCIENCE, V308, P221, DOI 10.1126/science.1107406; Jones GP, 2005, CURR BIOL, V15, P1314, DOI 10.1016/j.cub.2005.06.061; Planes S, 2009, P NATL ACAD SCI USA, V106, P5693, DOI 10.1073/pnas.0808007106; Przybilla A, 2010, J EXP BIOL, V213, P2976, DOI 10.1242/jeb.041632; Paris CB, 2007, MAR ECOL PROG SER, V347, P285, DOI 10.3354/meps06985; Sponaugle S, 2012, MAR ECOL PROG SER, V453, P201, DOI 10.3354/meps09641; Nanami A, 2013, MAR BIOL, V160, P1511, DOI 10.1007/s00227-013-2205-9; Almany GR, 2007, SCIENCE, V316, P742, DOI 10.1126/science.1140597; Leis JM, 2006, ADV MAR BIOL, V51, P57, DOI 10.1016/S0065-2881(06)51002-8; Sale PF, 2005, TRENDS ECOL EVOL, V20, P74, DOI 10.1016/j.tree.2004.11.007; Colin P. L., 1996, BIOL FISHERIES CULTU, P399; Craig MT, 2007, ICHTHYOL RES, V54, P81, DOI 10.1007/s10228-006-0377-8; Grafen A, 2002, MODERN STAT LIFE SCI; JONES FRH, 1952, J EXP BIOL, V29, P94; Kawabata Y, 2007, FISHERIES SCI, V73, P1147, DOI 10.1111/j.1444-2906.2007.01446.x; Kawabe K, 2009, FISHERIES SCI, V75, P1239, DOI 10.1007/s12562-009-0128-7; Kusaka A, 2001, ICHTHYOL RES, V48, P355, DOI 10.1007/s10228-001-8158-x; Leis Jeffrey L., 2002, P171, DOI 10.1016/B978-012615185-5/50011-6; Leis JM, 1999, MAR BIOL, V134, P51, DOI 10.1007/s002270050524; Leis J.M., 1991, P183; McHenry MJ, 2006, J MORPHOL, V267, P1099, DOI 10.1002/jmor.10462; MORGAN SG, 1989, ECOLOGY, V70, P464, DOI 10.2307/1937551; Nanami A, 2014, MAR BIOL, V161, P669, DOI 10.1007/s00227-013-2369-3; Nanami A, 2013, ICHTHYOL RES, V60, P380, DOI 10.1007/s10228-013-0354-y; Ohta I, 2009, ANN REP OKINAWA PREF, V70, P28; Popinet S, 2003, J COMPUT PHYS, V190, P572, DOI 10.1016/S0021-9991(03)00298-5; Russo T, 2009, J MORPHOL, V270, P83, DOI 10.1002/jmor.10674; Simpson SD, 2013, ECOL COMPLEX, V16, P68, DOI 10.1016/j.ecocom.2013.08.001; Soyano K., 2008, AQUACULTURE GROUPER, P1; Takebe T., 2011, Journal of Fisheries Technology, V3, P107	42	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0022-1112	1095-8649		J FISH BIOL	J. Fish Biol.	NOV	2014	85	5					1757	1765		10.1111/jfb.12502		9	Fisheries; Marine & Freshwater Biology	Fisheries; Marine & Freshwater Biology	AS0MF	WOS:000343970400031		
J	Kanatani, T; Nagura, I; Kurosaka, M; Kokubu, T; Sumi, M				Kanatani, Takako; Nagura, Issei; Kurosaka, Masahiro; Kokubu, Takeshi; Sumi, Masatoshi			Electrophysiological Assessment of Carpal Tunnel Syndrome in Elderly Patients: One-Year Follow-Up Study	JOURNAL OF HAND SURGERY-AMERICAN VOLUME			English	Article						Elderly carpal tunnel syndrome; carpal tunnel release; electrophysiological assessment	NERVE-CONDUCTION; ADVANCED DISEASE; RELEASE; SURGERY; OLDER; ATROPHY	Purpose To objectively assess elderly patients with carpal tunnel syndrome to characterize their preoperative severity and prognosis after carpal tunnel release using a electrophysiological severity scale. Methods Electrophysiologic assessment was performed preoperatively and 1 year post-operatively following carpal tunnel release in 112 hands in patients over 70 years of age prospectively by the use of the following electrophysiological severity scale: stage 1, normal distal motor latency (DML) and normal sensory conduction velocity (SCV); stage 2, DML >= 4.5 milliseconds and normal SCV; stage 3, DML >= 4.5 milliseconds and SCV < 40.0 m/s; stage 4, DML >= 4.5 milliseconds and non-measurable SCV; stage 5; non-measurable DML and non-measurable SCV. Additionally, the outcomes of clinical symptoms of pain, nocturnal symptoms, numbness, loss of 2-point discrimination in the median nerve territory, and thenar atrophy were assessed. Results The mean age of patients was 77 years at the time of the operation. Preoperatively, the most common severity was stage 5 (70 of 112 hands, 63%), and clustering stage 4 and 5 together as severe resulted in 103 hands (92%). One year postoperatively, 97 hands (87%) demonstrated at least one stage improvement, and the numbers of mild (stage 1 or 2) increased from 3 (3%) to 45 hands (40%). Parallel with the electrophysiological improvement, pain and nocturnal symptoms resolved in 17 of 17 hands and 11 of 11 hands, respectively, in whom they were present preoperatively. Numbness, loss of 2-point discrimination, and thenar atrophy demonstrated the improvement in 96 of 112 (86%) hands, in 58 of 112 (52%) hands, and in 80 of 96 (83%) hands: Conclusions We observed electrophysiologic improvement in 86% of elderly patients following carpal tunnel release. Electrophysiologic outcomes correlated with improvement in clinical variables. Copyright (C) 2014 by the American Society for Surgery of the Hand. All rights reserved.	Kobe Rosai Hosp, Dept Orthopaed Surg, Kobe, Hyogo 6510053, Japan; Kobe Univ, Sch Med, Dept Orthopaed Surg, Kobe, Hyogo 650, Japan	Kanatani, T (reprint author), Kobe Rosai Hosp, Dept Orthopaed, Chuo Ku, 4-1-23 Kagoike Dori, Kobe, Hyogo 6510053, Japan.	takakokatie@kobeh.rofuku.go.jp					Bland JDP, 2000, MUSCLE NERVE, V23, P1280, DOI 10.1002/1097-4598(200008)23:8<1280::AID-MUS20>3.0.CO;2-Y; Bland JDP, 2003, J NEUROL NEUROSUR PS, V74, P1674, DOI 10.1136/jnnp.74.12.1674; Padua L, 1996, ACTA NEUROL SCAND, V94, P343; Lee D, 1999, RADIOL CLIN N AM, V37, P859, DOI 10.1016/S0033-8389(05)70132-9; Aulisa L, 1998, J HAND SURG-AM, V23A, P687, DOI 10.1016/S0363-5023(98)80056-7; Bickel KD, 2010, J HAND SURG-AM, V35A, P147, DOI 10.1016/j.jhsa.2009.11.003; Bland JDP, 2001, MUSCLE NERVE, V24, P935, DOI 10.1002/mus.1091; Choi SJ, 1998, PLAST RECONSTR SURG, V102, P2374, DOI 10.1097/00006534-199812000-00016; Concannon MJ, 1997, PLAST RECONSTR SURG, V100, P1452, DOI 10.1097/00006534-199711000-00011; Fajardo M, 2012, J HAND SURG-AM, V37A, P1599, DOI 10.1016/j.jhsa.2012.04.035; GELBERMAN RH, 1987, J BONE JOINT SURG AM, V69A, P896; Kanatani T, 2013, J CLIN NEUROPHYSIOL, V30, P95, DOI 10.1097/WNP.0b013e31827ed839; Leit ME, 2004, J HAND SURG-AM, V29A, P379, DOI 10.1016/j.jhsa.2004.02.003; Longstaff L, 2001, J HAND SURG-BRIT EUR, V26, P475, DOI 10.1054/jhsb.2001.0616; Mondelli M, 2001, CLIN NEUROPHYSIOL, V112, P1237, DOI 10.1016/S1388-2457(01)00555-7; Nagaoka M, 2004, ARTHROSCOPY, V20, P848, DOI 10.1016/j.arthro.2004.06.033; Norlan III WB, 1992, J HAND SURG-AM, V17, P1020; Reale F, 2003, NEUROSURGERY, V53, P343, DOI 10.1227/01.NEU.0000073421.92105.62; SEROR P, 1991, Annales de Chirurgie de la Main et du Membre Superieur, V10, P217, DOI 10.1016/S0753-9053(05)80286-8; Tomaino MM, 2001, J HAND SURG-BRIT EUR, V26, P481, DOI 10.1054/jhsb.2001.0614; Townshend DN, 2005, J HAND SURG-AM, V30, P501; Tuncali D, 2006, PLAST RECONSTR SURG, V117, P1916, DOI 10.1097/01.prs.0000209932.12235.b8; Verdu E, 2000, J PERIPHER NERV SYST, V5, P191, DOI 10.1046/j.1529-8027.2000.00026.x; Weber RA, 2005, J HAND SURG-AM, V30A, P75, DOI 10.1016/j.jhsa.2004.08.005	24	0	0	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0363-5023	1531-6564		J HAND SURG-AM	J. Hand Surg.-Am. Vol.	NOV	2014	39	11					2188	2191		10.1016/j.jhsa.2014.08.011		4	Orthopedics; Surgery	Orthopedics; Surgery	AS5KU	WOS:000344310700007		
J	Sugiyama, Y; Naito, K; Igeta, Y; Obata, H; Kaneko, K; Obayashi, O				Sugiyama, Yoichi; Naito, Kiyohito; Igeta, Yuka; Obata, Hiroyuki; Kaneko, Kazuo; Obayashi, Osamu			Treatment Strategy for Distal Radius Fractures With Ipsilateral Arteriovenous Shunts	JOURNAL OF HAND SURGERY-AMERICAN VOLUME			English	Article						Arteriovenous fistula; distal radius fracture; hemodialysis patients; Henry approach	ELECTIVE EPINEPHRINE USE; PLATE FIXATION; HIP FRACTURE; FISTULA; FAILURE; DISEASE; RISK	Purpose To describe our management of 3 patients with chronic renal failure who sustained distal radius fractures in limbs containing dialysis shunts. Methods The 3 patients were 48-61 years old, and 2 of them were men. Because the injured limbs contained arteriovenous shunts, tourniquets were not used. Volar locking plate fixation was applied via the Henry approach. The patients' grip strength; visual analog scale scores; Quick Disabilities of the Arm, Shoulder, and Hand (QuickDASH) scores; modified Mayo scores; and their range of wrist joint motion were assessed during the final follow-up examination. In addition, complications and the presence/absence of dysfunction of the forearm shunt were also investigated. Results The mean duration of the postoperative follow-up period was 9 months (range, 7-10 mo), and the subjects' mean wrist motion values were 75 degrees, 79 degrees, 78 degrees, and 87 degrees during flexion, extension, pronation, and supination, respectively. Grip strength on the affected side as a percentage of that seen on the healthy side ranged from 71% to 90%. The patients' visual analog scale; QuickDASH; and modified Mayo scores were all excellent, and bone union was achieved in all 3 cases. No shunt dysfunction or skin soft tissue complications were noted. Conclusions Volar locking plate fixation via the Henry approach might be useful for treating distal radius fractures in cases in which an arteriovenous shunt is present in the same limb. Shunt dysfunction and hemorrhaging are of concern during open surgery, but these were not issues in our patients. Copyright (C) 2014 by the American Society for Surgery of the Hand. All rights reserved.	[Naito, Kiyohito] Juntendo Univ, Shizuoka Hosp, Dept Orthopaed Surg, Shizuoka 4102295, Japan; Juntendo Univ, Sch Med, Dept Orthopaed, Shizuoka 4102295, Japan	Naito, K (reprint author), Juntendo Univ, Shizuoka Hosp, Dept Orthopaed Surg, 1129 Nagaoka, Shizuoka 4102295, Japan.	knaito@juntendo.ac.jp					Thomson CJ, 2007, PLAST RECONSTR SURG, V119, P260, DOI 10.1097/01.prs.0000237039.71227.11; Chung KC, 2006, J BONE JOINT SURG AM, V88A, P2687, DOI 10.2106/JBJS.E.01298; AHEARN DJ, 1972, ANN INTERN MED, V77, P201; Ensrud KE, 2007, ARCH INTERN MED, V167, P133, DOI 10.1001/archinte.167.2.133; Lalonde D, 2005, J HAND SURG-AM, V30A, P1061, DOI 10.1016/j.jhsa.2005.05.006; Wolowczyk L, 2000, EUR J VASC ENDOVASC, V19, P70, DOI 10.1053/ejvs.1999.0969; Alem AM, 2000, KIDNEY INT, V58, P396, DOI 10.1046/j.1523-1755.2000.00178.x; Arora R, 2007, J ORTHOP TRAUMA, V21, P316, DOI 10.1097/BOT.0b013e318059b993; Nickolas TL, 2006, J AM SOC NEPHROL, V17, P3223, DOI 10.1681/ASN.2005111184; Freeland AE, 2005, HAND CLIN, V21, P329, DOI 10.1016/j.hcl.2005.03.002; PIRAINO B, 1988, CLIN NEPHROL, V30, P57; Trombetti A, 2013, OSTEOPOROSIS INT, V24, P1721, DOI 10.1007/s00198-012-2133-4; Arora R, 2008, J ORTHOP TRAUMA, V22, pS116, DOI 10.1097/BOT.0b013e318162ab0b; Boyd AS, 2009, AM FAM PHYSICIAN, V79, P16; Brescia MJ, 1999, J AM SOC NEPHROL, V10, P193; Downing ND, 2008, J BONE JOINT SURG BR, V90B, P1271, DOI 10.1302/0301-620X.90B10.21293; Fuji M, 2011, BIOL PHARM BULL, V34, P1890; Hagert Elisabet, 2012, J Wrist Surg, V1, P55, DOI 10.1055/s-0032-1312045; Ishiguro S, 2007, J HAND SURG-AM, V32A, P821, DOI 10.1016/j.jhsa.2007.03.008; Kapandji A., 1987, ANN CHIR MAIN, V6, P58; Kodama N, 2014, J ORTHOP SCI, V19, P292, DOI 10.1007/s00776-013-0514-y; McCann PA, 2010, INJURY, V41, P1012, DOI 10.1016/j.injury.2010.02.031; NAITO M, 1987, J HAND SURG-BRIT EUR, V12B, P366, DOI 10.1016/0266-7681(87)90191-4; Orbay J, 2005, HAND CLIN, V21, P347, DOI 10.1016/j.hcl.2005.02.003; Payandeh JB, 2010, HAND CLIN, V26, P55, DOI 10.1016/j.hcl.2009.08.008; Strohm PC, 2004, J BONE JOINT SURG AM, V86A, P2621; Tosun Bilgehan, 2010, Musculoskelet Surg, V94, P71, DOI 10.1007/s12306-010-0080-9; Wolfe SW, 2011, GREENS OPERATIVE HAN, P12; Zupan IP, 2011, THER APHER DIAL, V15, P34, DOI 10.1111/j.1744-9987.2010.00853.x	29	0	0	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0363-5023	1531-6564		J HAND SURG-AM	J. Hand Surg.-Am. Vol.	NOV	2014	39	11					2265	2268		10.1016/j.jhsa.2014.08.013		4	Orthopedics; Surgery	Orthopedics; Surgery	AS5KU	WOS:000344310700020		
J	Kodama, N; Doi, K; Hattori, Y				Kodama, Narihito; Doi, Kazuteru; Hattori, Yasunori			Force Recovery Assessment of Functioning Free Muscle Transfers Using Ultrasonography	JOURNAL OF HAND SURGERY-AMERICAN VOLUME			English	Article						Functioning free muscle transfer; ultrasonography; cross-sectional area	BRACHIAL-PLEXUS; ULTRASOUND; CONTRACTION; COMPARTMENT; THICKNESS; STRENGTH	Purpose To evaluate the usefulness of ultrasonography for measurement of functioning free muscle transfer strength and estimate the capacity and potential of ultrasonography measurement. Methods Twenty-five patients underwent functioning free muscle transfer for brachial plexus injury. The cross-sectional areas (CSAs) of the transferred muscle and the contralateral gracilis (control) were measured using ultrasonography. First, the reliability and reproducibility of the ultrasonography measurements of the muscle CSA was investigated. Next, force recovery was evaluated by calculating the contraction ratio (CR), which was defined as the value equal to the CSA of the transferred muscle under maximum isometric contraction divided by the CSA value in a complete rest position. The CR of the contralateral gracilis was calculated in the same manner. The CR of the transferred muscle and the control were compared statistically. We also analyzed the correlation between the CR of the transferred muscle and other measurements of muscle strength. The follow-up duration was 24 to 87 months after surgery. Results The reliability and reproducibility of the ultrasonography measurements was determined statistically. The CR of the transferred muscle (1.30 +/- 0.12) was significantly greater than that of the contralateral gracilis (1.22 +/- 0.13). Furthermore, the CR of the transferred muscle showed significant correlations with both manual muscle testing and elbow arc of motion. Conclusions Ultrasonography measurement of transferred muscle can easily indicate the recovery process of rehabilitation in a quantitative and dynamic manner. This study demonstrated that ultrasonography has the capacity to evaluate force recovery objectively. Copyright (C) 2014 by the American Society for Surgery of the Hand. All rights reserved.	[Kodama, Narihito; Doi, Kazuteru; Hattori, Yasunori] Ogori Daidi Gen Hosp, Dept Orthopaed Surg, Yamaguchi 7540002, Japan	Kodama, N (reprint author), Ogori Daidi Gen Hosp, Dept Orthopaed Surg, 862-3 Shimogo Ogori, Yamaguchi 7540002, Japan.	koda62@belle.shiga-med.ac.jp					Jacobs J, 2013, MUSCLE NERVE, V47, P856, DOI 10.1002/mus.23690; Scanlon TC, 2014, MUSCLE NERVE, V49, P584, DOI 10.1002/mus.23969; Hodges PW, 2003, MUSCLE NERVE, V27, P682, DOI 10.1002/mus.10375; Salmi A, 1995, MICROSURG, V16, P601, DOI 10.1002/micr.1920160905; Strasser EM, 2013, AGE, V35, P2377, DOI 10.1007/s11357-013-9517-z; BRAHIM F, 1986, AM J SPORT MED, V14, P300, DOI 10.1177/036354658601400410; Dodakundi C, 2013, J BONE JOINT SURG AM, V95A, P1505, DOI 10.2106/JBJS.K.01279; Doi Kazuteru, 2011, J Bone Joint Surg Am, V93, pe105, DOI 10.2106/JBJS.J.01846; Doi K, 2000, J BONE JOINT SURG AM, V82A, P652; Fukunaga T, 1992, J Orthop Res, V10, P928; GERSHUNI DH, 1982, CLIN ORTHOP RELAT R, P185; Hattori Y, 2001, J HAND SURG-AM, V26A, P645, DOI 10.1053/jhsu.2001.26202; Hattori Y, 2006, J RECONSTR MICROSURG, V22, P423, DOI 10.1055/s-2006-947696; KUNO SY, 1995, EUR J APPL PHYSIOL O, V70, P45, DOI 10.1007/BF00601807; Mickle KJ, 2013, J FOOT ANKLE RES, V6, DOI 10.1186/1757-1146-6-12; Oishi Scott N, 2010, Tech Hand Up Extrem Surg, V14, P104, DOI 10.1097/BTH.0b013e3181d4459d; RUTHERFORD OM, 1992, EUR J APPL PHYSIOL O, V65, P433, DOI 10.1007/BF00243510; Salmi A, 1996, PLAST RECONSTR SURG, V97, P1443, DOI 10.1097/00006534-199606000-00021; Young A, 1980, RHEUMATOL REHAB, V14, P141	19	0	0	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0363-5023	1531-6564		J HAND SURG-AM	J. Hand Surg.-Am. Vol.	NOV	2014	39	11					2269	2276		10.1016/j.jhsa.2014.06.120		8	Orthopedics; Surgery	Orthopedics; Surgery	AS5KU	WOS:000344310700021		
J	Takagi, T; Mochida, J; Takayama, S				Takagi, Takehiko; Mochida, Joji; Takayama, Shinichiro			Gentle Manual Reduction for Traumatic Bowing/Plastic Deformation of the Ulna With Radial Head Dislocation	JOURNAL OF HAND SURGERY-AMERICAN VOLUME			English	Letter							PLASTIC-DEFORMATION; FOREARM		[Takagi, Takehiko; Mochida, Joji] Tokai Univ, Sch Med, Dept Orthopaed Surg, Isehara, Kanagawa 25911, Japan; [Takagi, Takehiko; Takayama, Shinichiro] Natl Ctr Child Hlth & Dev, Dept Orthopaed Surg, Setagaya Ku, Tokyo, Japan	Takagi, T (reprint author), Tokai Univ, Sch Med, Dept Orthopaed Surg, Isehara, Kanagawa 25911, Japan.						BORDEN S, 1974, J BONE JOINT SURG AM, VA 56, P611; Curry JD, 1975, J BONE JOINT SURG AM, V57, P810; MABREY JD, 1989, J PEDIATR ORTHOPED, V9, P310; RYDHOLM U, 1979, CLIN ORTHOP RELAT R, P121; SANDERS WE, 1984, CLIN ORTHOP RELAT R, P58	5	0	0	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0363-5023	1531-6564		J HAND SURG-AM	J. Hand Surg.-Am. Vol.	NOV	2014	39	11					2346	2348		10.1016/j.jhsa.2014.08.023		3	Orthopedics; Surgery	Orthopedics; Surgery	AS5KU	WOS:000344310700040		
J	Tsuyuguchi, T; Miyakawa, K; Sugiyama, H; Sakai, Y; Nishikawa, T; Sakamoto, D; Nakamura, M; Yasui, S; Mikata, R; Yokosuka, O				Tsuyuguchi, Toshio; Miyakawa, Kaoru; Sugiyama, Harutoshi; Sakai, Yuji; Nishikawa, Takao; Sakamoto, Dai; Nakamura, Masato; Yasui, Shin; Mikata, Rintaro; Yokosuka, Osamu			Ten-year long-term results after non-surgical management of hepatolithiasis, including cases with choledochoenterostomy	JOURNAL OF HEPATO-BILIARY-PANCREATIC SCIENCES			English	Article						Cholangiocarcinoma; Endoscopic treatment; Hepatolithiasis	TRANSHEPATIC CHOLANGIOSCOPIC LITHOTOMY; RECURRENT PYOGENIC CHOLANGITIS; BILIARY-ENTERIC DRAINAGE; BENIGN DISEASE; SINGLE-CENTER; FOLLOW-UP; CHOLANGIOCARCINOMA; EXPERIENCE; EXCISION	BackgroundLong-term follow-up of non-surgical procedures for the management of hepatolithiasis has been reported, but risk factors for mortality have not been properly evaluated. MethodsWe conducted a retrospective study of the case records of 121 patients with hepatolithiasis who underwent endoscopic retrograde cholangiopancreatography (ERCP), peroral cholangioscopy (POCS), percutaneous transhepatic cholangioscopy (PTCS), or conservative treatment at the Department of Gastroenterology of Chiba University Hospital between January 1980 and July 2011. The primary outcome measure was mortality, defined as death due to hepatolithiasis (concomitant liver failure with cholangitis and cholangiocarcinoma). ResultsComplete clearance of intrahepatic stones was achieved in 22 (57.8%) of 38 patients by POCS, in 12 (66.7%) of 18 patients by ERCP, and in 10 (52.6%) of 18 patients by PTCS. The remaining 46 patients were treated conservatively. The mean follow-up period was 11.4 7.1 years (range, 0.6-32.8). There were 14 hepatolithiasis-related deaths (11 with cholangiocarcinoma and three from liver failure with cholangitis) during the follow-up periods. Multivariate Cox proportional hazards analysis revealed liver atrophy (P = 0.015; HR = 3.98; 95% CI, 1.30-12.20) and congenital biliary dilatation after biliary-enteric anastomosis (P = 0.036; HR = 4.57; 95% CI, 1.11-18.87) as significant risk factors for mortality. ConclusionsAnalysis of the 10-year long-term results after non-surgical management of hepatolithiasis identified liver atrophy and congenital biliary dilatation as risk factors for mortality. Patients with hepatic lobe atrophy should undergo a hepatectomy, if operable.	[Tsuyuguchi, Toshio; Miyakawa, Kaoru; Sugiyama, Harutoshi; Sakai, Yuji; Nishikawa, Takao; Sakamoto, Dai; Nakamura, Masato; Yasui, Shin; Mikata, Rintaro; Yokosuka, Osamu] Chiba Univ, Grad Sch Med, Dept Gastroenterol & Nephrol, Chuo Ku, Chiba 2608670, Japan	Tsuyuguchi, T (reprint author), Chiba Univ, Grad Sch Med, Dept Gastroenterol & Nephrol, Chuo Ku, 1-8-1 Inohana, Chiba 2608670, Japan.	tsuyuguchi@faculty.chiba-u.jp			Ministry of Health, Labor, and Welfare of Japan	This study was in part supported by a grant from the Ministry of Health, Labor, and Welfare of Japan. The authors would like to thank Enago (http://www.enago.jp) for the English language review.	Tocchi A, 2001, ANN SURG, V234, P210, DOI 10.1097/00000658-200108000-00011; Cheon YK, 2009, SURGERY, V146, P843, DOI 10.1016/j.surg.2009.04.009; Chen CH, 2005, SURG ENDOSC, V19, P505, DOI 10.1007/s00464-004-8125-5; Tsui WMS, 2011, SEMIN LIVER DIS, V31, P33, DOI 10.1055/s-0031-1272833; Huang MH, 2003, AM J GASTROENTEROL, V98, P2655, DOI 10.1016/j.amjgastroenterol.2003.09.040; Okugawa T, 2002, GASTROINTEST ENDOSC, V56, P366, DOI 10.1067/mge.2002.126830; Ono S, 2010, J PEDIATR SURG, V45, P376, DOI 10.1016/j.jpedsurg.2009.10.078; Tabrizian P, 2012, J AM COLL SURGEONS, V215, P622, DOI 10.1016/j.jamcollsurg.2012.07.005; Bettschart V, 2002, GUT, V51, P128, DOI 10.1136/gut.51.1.128; Chen ZY, 2008, TRANSPL P, V40, P3517, DOI 10.1016/j.transproceed.2008.07.142; Kobayashi S, 1999, SURGERY, V126, P939, DOI 10.1016/S0039-6060(99)70036-X; Kusano T, 2001, J CLIN GASTROENTEROL, V33, P114, DOI 10.1097/00004836-200108000-00004; Lee KF, 2009, HPB, V11, P75, DOI 10.1111/j.1477-2574.2008.00018.x; Suzuki Y, 2012, HEPATOL RES, V42, P166, DOI 10.1111/j.1872-034X.2011.00908.x; Yamashita S, 2012, BIOSCI TRENDS, V6, P98, DOI 10.5582/bst.2012.v6.2.98	15	2	3	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1868-6974	1868-6982		J HEPATO-BIL-PAN SCI	J. Hepato-Biliary-Pancreat. Sci.	NOV	2014	21	11					795	800		10.1002/jhbp.134		6	Gastroenterology & Hepatology; Surgery	Gastroenterology & Hepatology; Surgery	AS4OW	WOS:000344256700002		
J	Ogawa, T; Horaguchi, J; Fujita, N; Noda, Y; Kobayashi, G; Ito, K; Koshita, S; Kanno, Y; Masu, K; Sugita, R				Ogawa, Takahisa; Horaguchi, Jun; Fujita, Naotaka; Noda, Yutaka; Kobayashi, Go; Ito, Kei; Koshita, Shinsuke; Kanno, Yoshihide; Masu, Kaori; Sugita, Reiji			Diffusion-weighted magnetic resonance imaging for evaluating the histological degree of malignancy in patients with intraductal papillary mucinous neoplasm	JOURNAL OF HEPATO-BILIARY-PANCREATIC SCIENCES			English	Article						Diffusion-weighted magnetic resonance imaging; Intraductal papillary mucinous neoplasm; Pancreatic cystic lesion	INTERNATIONAL CONSENSUS GUIDELINES; FOLLOW-UP; PANCREAS; LESIONS; MANAGEMENT; COEFFICIENT; CARCINOMA; GRADE; TUMOR; MRI	BackgroundThe aim of this study was to evaluate the usefulness of high b-value diffusion-weighted magnetic resonance imaging (DWI) for evaluating the histological degree of malignancy in patients with intraductal papillary mucinous neoplasm (IPMN). MethodsA total of 35 patients (mean age 68 10 years, 23 males) who had undergone DWI before surgery were included in this study. Of these 35 patients, 13 had IPMN with low- or intermediate-grade dysplasia, eight had IPMN with high-grade dysplasia, and 14 had IPMN with an associated invasive carcinoma. We evaluated the positive signal rate on DWI and the apparent diffusion coefficient (ADC) value of each pathology. ResultsThe positive signal rate on DWI of IPMN with low- or intermediate-grade dysplasia, of IPMN with high-grade dysplasia, and of IPMN with an associated invasive carcinoma were 0% (0/13), 38% (3/8), and 93% (13/14), respectively. The sensitivity, specificity, and accuracy for malignancy (IPMN with high-grade dysplasia or IPMN with an associated invasive carcinoma) using DWI were 73%, 100%, and 83%, respectively. The mean ADC value of malignancy was significantly lower than that of benignity (P = 0.002). ConclusionsDiffusion-weighted magnetic resonance imaging, easily applicable in addition to conventional MRI, is considered an efficient modality for evaluating the histological degree of malignancy in patients with IPMN.	[Ogawa, Takahisa; Horaguchi, Jun; Fujita, Naotaka; Noda, Yutaka; Kobayashi, Go; Ito, Kei; Koshita, Shinsuke; Kanno, Yoshihide; Masu, Kaori] Sendai City Med Ctr, Dept Gastroenterol, Miyagino Ku, Sendai, Miyagi 9830824, Japan; [Sugita, Reiji] Sendai City Med Ctr, Dept Radiol, Sendai, Miyagi 9830824, Japan	Ogawa, T (reprint author), Sendai City Med Ctr, Dept Gastroenterol, Miyagino Ku, 5-22-1 Tsurugaya, Sendai, Miyagi 9830824, Japan.	t-ogawa@openhp.or.jp					Sugiyama M, 2003, BRIT J SURG, V90, P1244, DOI 10.1002/bjs.4265; Muraoka N, 2008, J MAGN RESON IMAGING, V27, P1302, DOI 10.1002/jmri.21340; LEBIHAN D, 1986, RADIOLOGY, V161, P401; Kang KM, 2013, J MAGN RESON IMAGING, V38, P555, DOI 10.1002/jmri.24022; Tanaka M, 2006, PANCREATOLOGY, V6, P17, DOI 10.1159/000090023; Koh DM, 2007, AM J ROENTGENOL, V188, P1622, DOI 10.2214/AJR.06.1403; Wang Y, 2011, J MAGN RESON IMAGING, V33, P136, DOI 10.1002/jmri.22414; Ichikawa T, 2007, AM J ROENTGENOL, V188, P409, DOI 10.2214/AJR.05.1918; Tang RS, 2008, CLIN GASTROENTEROL H, V6, P815, DOI 10.1016/j.cgh.2008.04.005; Maguchi H, 2011, PANCREAS, V40, P364, DOI 10.1097/MPA.0b013e31820a5975; Pelaez-Luna M, 2007, AM J GASTROENTEROL, V102, P1759, DOI 10.1111/j.1572-0241.2007.01224.x; Uehara H, 2008, GUT, V57, P1561, DOI 10.1136/gut.2007.145631; Muhi A, 2009, J MAGN RESON IMAGING, V30, P1005, DOI 10.1002/jmri.21931; Kobayashi G, 2005, J GASTROENTEROL, V40, P744, DOI 10.1007/s00535-005-1619-7; Tanaka M, 2012, PANCREATOLOGY, V12, P183, DOI 10.1016/j.pan.2012.04.004; Fatima Z, 2011, CLIN RADIOL, V66, P108, DOI 10.1016/j.crad.2010.10.004; Uto T, 2009, RADIOLOGY, V252, P247, DOI 10.1148/radiol.2521081195; Kobayashi G, 2008, J MED ULTRASON, V35, P85, DOI 10.1007/s10396-008-0188-9; Ogawa T, 2012, J GASTROENTEROL, V47, P1352, DOI 10.1007/s00535-012-0604-1; Ohashi K, 1982, PROG DIG ENDOSC, V20, P348; Padhani Anwar R, 2009, Neoplasia, V11, P102; Sandrasegaran K, 2011, CLIN RADIOL, V66, P808, DOI 10.1016/j.crad.2011.01.016; Wang Y, 2011, RADIOGRAPHICS, V31, pE13, DOI 10.1148/rg.313105174	23	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1868-6974	1868-6982		J HEPATO-BIL-PAN SCI	J. Hepato-Biliary-Pancreat. Sci.	NOV	2014	21	11					801	808		10.1002/jhbp.135		8	Gastroenterology & Hepatology; Surgery	Gastroenterology & Hepatology; Surgery	AS4OW	WOS:000344256700003		
J	Kubo, S; Kinoshita, M; Takemura, S; Tanaka, S; Shinkawa, H; Nishioka, T; Hamano, G; Ito, T; Abue, M; Aoki, M; Nakagawa, K; Unno, M; Hijioka, S; Fujiyoshi, T; Shimizu, Y; Mizuguchi, T; Shirabe, K; Nishie, A; Oda, Y; Takenaka, K; Kobarai, T; Hisano, T; Saiura, A; Numao, H; Toda, M; Kuwae, Y; Nakanuma, Y; Endo, G				Kubo, Shoji; Kinoshita, Masahiko; Takemura, Shigekazu; Tanaka, Shogo; Shinkawa, Hiroji; Nishioka, Takayoshi; Hamano, Genya; Ito, Tokuji; Abue, Makoto; Aoki, Masaru; Nakagawa, Kei; Unno, Michiaki; Hijioka, Susumu; Fujiyoshi, Toshihisa; Shimizu, Yasuhiro; Mizuguchi, Toru; Shirabe, Ken; Nishie, Akihiro; Oda, Yoshinao; Takenaka, Kenji; Kobarai, Tomonari; Hisano, Terumasa; Saiura, Akio; Numao, Hiroshi; Toda, Mayura; Kuwae, Yuko; Nakanuma, Yasuni; Endo, Ginji			Characteristics of printing company workers newly diagnosed with occupational cholangiocarcinoma	JOURNAL OF HEPATO-BILIARY-PANCREATIC SCIENCES			English	Article						gamma-glutamyl transpeptidase; Biliary intraepithelial neoplasia; Intraductal papillary neoplasm of the bile duct; Occupational cholangiocarcinoma; Organic solvent	BILIARY INTRAEPITHELIAL NEOPLASIA; INTRAHEPATIC CHOLANGIOCARCINOGENESIS; HEPATOLITHIASIS; EPIDEMIOLOGY	BackgroundCholangiocarcinoma has been reported in workers exposed to chlorinated organic solvents and has consequently been classified as an occupational disease (occupational cholangiocarcinoma) by the Japanese Ministry of Health, Labour and Welfare. This study aimed to identify the characteristics of nine workers newly diagnosed with occupational cholangiocarcinoma. MethodsThis study was a retrospective study conducted in 13 hospitals and three universities. Clinicopathological findings of nine occupational cholangiocarcinoma patients from seven printing companies in Japan were investigated and compared with 17 cholangiocarcinoma patients clustered in a single printing company in Osaka. ResultsPatient age at diagnosis was 31-57 years. Patients were exposed to 1,2-dichloropropane and/or dichloromethane. Serum -glutamyl transpeptidase activity was elevated in all patients. Regional dilatation of the intrahepatic bile ducts without tumor-induced obstruction was observed in two patients. Four patients developed intrahepatic cholangiocarcinoma and five developed hilar cholangiocarcinoma. Biliary intraepithelial neoplasia and/or intraductal papillary neoplasm of the bile duct was observed in four patients with available operative or autopsy specimens. ConclusionsMost of these patients with occupational cholangiocarcinoma exhibited typical findings, including high serum -glutamyl transpeptidase activity, regional dilatation of the bile ducts, and precancerous lesions, similar to findings previously reported in 17 occupational cholangiocarcinoma patients in Osaka.	[Kubo, Shoji; Kinoshita, Masahiko; Takemura, Shigekazu; Tanaka, Shogo; Shinkawa, Hiroji; Nishioka, Takayoshi; Hamano, Genya; Ito, Tokuji] Osaka City Univ, Dept Hepatobiliary Pancreat Surg, Abeno Ku, Osaka 5458585, Japan; [Abue, Makoto] Miyagi Canc Ctr, Dept Gastroenterol, Natori, Miyagi 9811293, Japan; [Aoki, Masaru] Nippon Univ, Dept Digest Surg, Sch Med, Tokyo, Japan; [Nakagawa, Kei; Unno, Michiaki] Tohoku Univ, Grad Sch Med, Dept Surg, Div Hepatobiliary Pancreat Surg, Sendai, Miyagi 980, Japan; [Hijioka, Susumu; Fujiyoshi, Toshihisa] Aichi Canc Ctr Hosp, Dept Gastroenterol, Nagoya, Aichi 464, Japan; [Shimizu, Yasuhiro] Aichi Canc Ctr Hosp, Dept Surg, Nagoya, Aichi 464, Japan; [Mizuguchi, Toru] Sapporo Med Univ, Sch Med, Dept Surg 1, Sapporo, Hokkaido, Japan; [Shirabe, Ken] Kyushu Univ, Dept Surg & Sci, Grad Sch Med Sci, Fukuoka 812, Japan; [Nishie, Akihiro] Kyushu Univ, Dept Clin Radiol, Grad Sch Med Sci, Fukuoka 812, Japan; [Oda, Yoshinao] Kyushu Univ, Grad Sch Med Sci, Dept Anat Pathol, Fukuoka 812, Japan; [Takenaka, Kenji] Fukuoka City Hosp, Dept Surg, Fukuoka, Japan; [Kobarai, Tomonari] HaraSanshin Hosp, Dept Surg, Fukuoka, Japan; [Hisano, Terumasa] Natl Hosp Org Kyushu Canc Ctr, Dept Hepatobiliary Pancreatol, Fukuoka, Japan; [Saiura, Akio] Japanese Fdn Canc Res, Canc Inst Hosp, Dept Surg, Tokyo, Japan; [Numao, Hiroshi] Aomori Prefectural Cent Hosp, Dept Gastroenterol, Aomori, Japan; [Toda, Mayura] Kansai Rosai Hosp, Dept Gastroenterol & Hepatol, Amagasaki, Hyogo, Japan; [Kuwae, Yuko] Osaka City Univ, Grad Sch Med, Dept Diagnost Pathol, Osaka 558, Japan; [Nakanuma, Yasuni] Kanazawa Univ, Grad Sch Med, Dept Human Pathol, Kanazawa, Ishikawa, Japan; [Endo, Ginji] Osaka City Univ, Grad Sch Med, Dept Prevent Med & Environm Hlth, Osaka 558, Japan	Kubo, S (reprint author), Osaka City Univ, Dept Hepatobiliary Pancreat Surg, Abeno Ku, 1-4-3 Asahimachi, Osaka 5458585, Japan.	m7696493@msic.med.osaka-cu.ac.jp	Unno, Michiaki/A-8633-2010	Unno, Michiaki/0000-0002-2145-6416	Health and Labour Sciences Research Grants for Research on Occupational Safety and Health "The epidemiological and cause-investigated study of cholangiocarcinoma in workers of a printing company"	This study was supported in part by the Health and Labour Sciences Research Grants for Research on Occupational Safety and Health "The epidemiological and cause-investigated study of cholangiocarcinoma in workers of a printing company." We thank Drs K. Kimura and H. Uchiyama for their assistance with data collection.	Abue M, CASE INTRAH IN PRESS; PARKIN DM, 1993, CANCER EPIDEM BIOMAR, V2, P537; Yamamoto S, 2004, CANCER SCI, V95, P592, DOI 10.1111/j.1349-7006.2004.tb02492.x; Nakanuma Y, 1997, MICROSC RES TECHNIQ, V38, P552, DOI 10.1002/(SICI)1097-0029(19970915)38:6<552::AID-JEMT2>3.0.CO;2-H; Kubo S, 2014, J HEPATO-BIL-PAN SCI, V21, P479, DOI 10.1002/jhbp.86; Zen Y, 2007, MODERN PATHOL, V20, P701, DOI 10.1038/modpathol.3800788; KUBO S, 1995, WORLD J SURG, V19, P637; Zen Y, 2006, J HEPATOL, V44, P350, DOI 10.1016/j.jhep.2005.09.025; Itatsu K, 2007, LIVER INT, V27, P1174, DOI 10.1111/j.1478-3231.2007.01577.x; Shaib Y, 2004, SEMIN LIVER DIS, V24, P115, DOI 10.1055/s-2004-828889; Kumagai S, 2013, OCCUP ENVIRON MED, V70, P508, DOI 10.1136/oemed-2012-101246; Khan SA, 2005, LANCET, V366, P1303, DOI 10.1016/S0140-6736(05)67530-7; Bosman FT, 2010, WHO CLASSIFICATION T, P195; IARC (International Agency for Research on Cancer), 2012, LIST CLASS CANC SIT, V1 to 105; Kubo S, 2014, J OCCUP HLTH; Ministry of Health, 2013, OCC BIL TRACT CANC C; Tomimaru Y, 2014, HEPATOL RES, DOI [10.1111/hepr.12363, DOI 10.1111/HEPR.12363]	17	2	2	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1868-6974	1868-6982		J HEPATO-BIL-PAN SCI	J. Hepato-Biliary-Pancreat. Sci.	NOV	2014	21	11					809	817		10.1002/jhbp.137		9	Gastroenterology & Hepatology; Surgery	Gastroenterology & Hepatology; Surgery	AS4OW	WOS:000344256700004		
J	Inokawa, Y; Sugimoto, H; Kanda, M; Yamada, S; Fujii, T; Nomoto, S; Takeda, S; Suzuki, N; Matsushita, T; Kodera, Y				Inokawa, Yoshikuni; Sugimoto, Hiroyuki; Kanda, Mitsuro; Yamada, Suguru; Fujii, Tsutomu; Nomoto, Shuji; Takeda, Shin; Suzuki, Nobuaki; Matsushita, Tadashi; Kodera, Yasuhiro			Hepatectomy for hepatocellular carcinoma in patients with hemophilia	JOURNAL OF HEPATO-BILIARY-PANCREATIC SCIENCES			English	Article						Hemophilia; Hepatocellular carcinoma; Resection	HEPATITIS-C; FACTOR-VIII; LIVER-DISEASE; MANAGEMENT; INHIBITOR; SURGERY; CANCER; COHORT; HIV	BackgroundHepatitis C virus infection due to contamination in large-pool clotting factor concentrate is a major co-morbidity in adult patients with hemophilia. Although the development of hepatocellular carcinoma following infection with hepatitis virus is a crucial health problem, there are few reports of hemophilia patients undergoing liver resection for hepatocellular carcinoma. MethodsSix patients with hemophilia underwent liver resection for hepatocellular carcinoma in our department from January 2003 to December 2012. We compared these hemophilic patients (H group, n = 6) to control patients without hemophilia (C group, n = 191) who underwent liver resection in the same period. ResultsAll six patients in the H group were hepatitis C virus positive. Administration of coagulation factors was performed perioperatively, and no differences in the operative time and estimated blood loss were observed between the groups. No postoperative complications occurred in the H group, but five patients suffered from recurrence after surgery and subsequently underwent radiofrequency ablation or transcatheter arterial chemoembolization. The median recurrence-free survival time was 17.9 months and 25.3 months in H and C group, respectively, with no significant difference between the two groups. ConclusionsAdequate replacement of coagulation factors enables hepatic resection for hepatocellular carcinoma patients with hemophilia.	[Inokawa, Yoshikuni; Sugimoto, Hiroyuki; Kanda, Mitsuro; Yamada, Suguru; Fujii, Tsutomu; Nomoto, Shuji; Kodera, Yasuhiro] Nagoya Univ, Grad Sch Med, Showa Ku, Nagoya, Aichi 4668550, Japan; [Takeda, Shin] Nagoya Med Ctr, Dept Surg, Nagoya, Aichi, Japan; [Suzuki, Nobuaki] Nagoya Univ Hosp, Dept Clin Lab Med, Nagoya, Aichi, Japan; [Matsushita, Tadashi] Nagoya Univ Hosp, Dept Transfus Med, Nagoya, Aichi, Japan	Inokawa, Y (reprint author), Nagoya Univ, Grad Sch Med, Showa Ku, 65 Tsurumai Cho, Nagoya, Aichi 4668550, Japan.	yinokawa@med.nagoya-u.ac.jp					Dindo D, 2004, ANN SURG, V240, P205, DOI 10.1097/01.sla.0000133083.54934.ae; Seeff LB, 2009, LIVER INT, V29, P89, DOI 10.1111/j.1478-3231.2008.01927.x; Strasberg SM, 2005, J HEPATO-BILIARY-PAN, V12, P351, DOI 10.1007/s00534-005-0999-7; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Hay CRM, 2006, BRIT J HAEMATOL, V133, P591, DOI 10.1111/j.1365-2141.2006.06087.x; Srivastava A, 2013, HAEMOPHILIA, V19, pE1, DOI 10.1111/j.1365-2516.2012.02909.x; Forner A, 2012, LANCET, V379, P1245, DOI 10.1016/S0140-6736(11)61347-0; Iorio A, 2010, J THROMB HAEMOST, V8, P1256, DOI 10.1111/j.1538-7836.2010.03823.x; Livraghi T, 1999, RADIOLOGY, V210, P655; Goedert JJ, 2002, BLOOD, V100, P1584; Bruix J, 2011, HEPATOLOGY, V53, P1020, DOI 10.1002/hep.24199; Darby SC, 1997, LANCET, V350, P1425, DOI 10.1016/S0140-6736(97)05413-5; Batorova A, 2000, BRIT J HAEMATOL, V110, P715, DOI 10.1046/j.1365-2141.2000.02226.x; Jones AE, 2009, HAEMOPHILIA, V15, P1332, DOI 10.1111/j.1365-2516.2009.02070.x; Meijer K, 2012, HAEMOPHILIA, V18, P17, DOI 10.1111/j.1365-2516.2011.02575.x; Narushima Y, 2004, J HEPATO-BILIARY-PAN, V11, P207, DOI 10.1007/s00534-003-0876-1; Santagostino E, 2003, BLOOD, V102, P78, DOI 10.1182/blood-2002-10-3310; SHEN SC, 1994, HEPATO-GASTROENTEROL, V41, P283; Uchino K, 2013, J CLIN VIROL, V57, P173, DOI 10.1016/j.jcv.2013.01.012; van de Putte DEF, 2014, J HEPATOL, V60, P39	20	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1868-6974	1868-6982		J HEPATO-BIL-PAN SCI	J. Hepato-Biliary-Pancreat. Sci.	NOV	2014	21	11					824	828		10.1002/jhbp.142		5	Gastroenterology & Hepatology; Surgery	Gastroenterology & Hepatology; Surgery	AS4OW	WOS:000344256700006		
J	Hirota, M; Mayumi, T; Shimosegawa, T				Hirota, Morihisa; Mayumi, Toshihiko; Shimosegawa, Tooru			Acute pancreatitis bundles: 10 clinical regulations for the early management of patients with severe acute pancreatitis in Japan	JOURNAL OF HEPATO-BILIARY-PANCREATIC SCIENCES			English	Article						Acute pancreatitis; Bundle; Fluid therapy; Initial therapy; Severe acute pancreatitis		Acute pancreatitis (AP) is an inflammatory disease of diverse severity. Early management is indispensable to cure patients with AP, especially those who show symptoms of severe AP (SAP) [1-3]. The mortality from sepsis, which is another fatal disease, has been improved by the establishment and implementation of guidelines for the early management with sepsis change bundles for the initial resuscitation (6 h) and management (24 h) [4]. Pancreatitis bundles, which consist of 10 statements extracted from the Japanese guidelines for AP, specify the management and treatment within the first 48 h after the onset of SAP. They were established in 2010 for the purpose of improving the mortality of SAP patients (Table 1) [5]. We conducted a nationwide survey of patients who developed AP in 2011 in Japan. The survey consisted of two sequential surveys [6]. The first survey was carried out by mailing a questionnaire to 4,175 randomly chosen departments in Japan. The response rate of the first survey was 45.8%. Finally, clinical data of 2,694 patients with AP were collected by the second survey. The rate of implementation of each statement in the pancreatitis bundles was investigated by the second survey. Additionally, we studied the effect of following or not following the pancreatitis bundles on the mortality of patients with SAP. SAP was defined by the Japanese severity scoring system in this study [6].	[Hirota, Morihisa; Shimosegawa, Tooru] Tohoku Univ, Div Gastroenterol, Grad Sch Med, Aoba Ku, Sendai, Miyagi 9808574, Japan; [Mayumi, Toshihiko] Univ Occupat & Environm Hlth, Emergency & Intens Care Unit, Kitakyushu, Fukuoka 807, Japan	Shimosegawa, T (reprint author), Tohoku Univ, Div Gastroenterol, Grad Sch Med, Aoba Ku, 1-1 Seiryo Cho, Sendai, Miyagi 9808574, Japan.	tshimosegawa@int3.med.tohoku.ac.jp					Tenner S, 2013, AM J GASTROENTEROL, V108, P1400, DOI 10.1038/ajg.2013.218; Hirota M, 2010, J HEPATO-BIL-PAN SCI, V17, P45, DOI 10.1007/s00534-009-0210-7; Dallinger RP, 2005, CRIT CARE, V9, P653; Fisher JM, 2012, AM J GASTROENTEROL, V107, P1146, DOI 10.1038/ajg.2012.91; Hamada S, 2014, PANCREAS, V43, P1244, DOI 10.1097/MPA.0000000000000200; Mayumi T, 2010, J HEPATO-BIL-PAN SCI, V17, P87, DOI 10.1007/s00534-009-0219-y	6	2	2	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1868-6974	1868-6982		J HEPATO-BIL-PAN SCI	J. Hepato-Biliary-Pancreat. Sci.	NOV	2014	21	11					829	830		10.1002/jhbp.163		2	Gastroenterology & Hepatology; Surgery	Gastroenterology & Hepatology; Surgery	AS4OW	WOS:000344256700007		
J	Ueno, A; Masugi, Y; Yamazaki, K; Komuta, M; Effendi, K; Tanami, Y; Tsujikawa, H; Tanimoto, A; Okuda, S; Itano, O; Kitagawa, Y; Kuribayashi, S; Sakamoto, M				Ueno, Akihisa; Masugi, Yohei; Yamazaki, Ken; Komuta, Mina; Effendi, Kathryn; Tanami, Yutaka; Tsujikawa, Hanako; Tanimoto, Akihiro; Okuda, Shigeo; Itano, Osamu; Kitagawa, Yuko; Kuribayashi, Sachio; Sakamoto, Michiie			OATP1B3 expression is strongly associated with Wnt/beta-catenin signalling and represents the transporter of gadoxetic acid in hepatocellular carcinoma	JOURNAL OF HEPATOLOGY			English	Article						beta-Catenin; Gadoxetic acid; Hepatocellular carcinoma; MRI; OATP1B3; Wnt	PROTEIN-COUPLED RECEPTOR; MR IMAGING-CORRELATION; GENE-EXPRESSION; MUTATIONS; LIVER; CLASSIFICATION; CHOLESTASIS; PREDICTION; INTENSITY; PROMOTER	Background & Aims: In the current era of emerging molecular targeted drugs, it is necessary to identify before treatment the specific subclass to which a tumour belongs. Gadoxetic acid is a liver-specific contrast agent that is preferentially taken up by hepatocytes. Therefore, gadoxetic acid-enhanced magnetic resonance imaging (EOB-MRI) should provide precise molecular information about hepatocellular carcinomas (HCCs). The aim of this study was to investigate the transporters of gadoxetic acid in HCC comprehensively and to analyse the molecular regulatory mechanism of such transporters. Methods: Expression levels of transporters, transcriptional factors and Wnt target genes in clinical samples were examined by quantitative real-time reverse transcription polymerase chain reaction and immunohistochemistry. Lid I treatment of the HCC cell line KYN-2 was conducted in vitro to assess the effects of Wnt signalling activity. Results: Comprehensive analyses of transporter mRNAs and protein expressions revealed that the organic anion transporting polypeptide 1B3 (OATP1B3) had the strongest correlation with tumour enhancement in hepatobiliary-phase images of EOB-MRI. Association analysis with OATP1B3 expression revealed significant correlation with the expression of Wnt/beta-catenin target genes. Further, LiCl treatment induced OATP1B3 mRNA expression in KYN-2 cells, indicating a strong association between OATP1B3 expression and Wnt/beta-catenin signalling. The sensitivity and specificity to predict Wnt/beta-catenin-activated HCC using tumour enhancement in EOB-MRI were 78.9% and 81.7%, respectively. Conclusions: OATP1B3 was confirmed as the most important transporter mediating HCC enhancement in EOB-MRI. OATP1B3 expression showed a strong association with the expression of Wnt/beta-catenin target genes, therefore, OATP1B3-upregulated HCC likely represents a specific subclass of Wnt/beta-catenin-activated HCC. (C) 2014 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.	[Ueno, Akihisa; Masugi, Yohei; Yamazaki, Ken; Komuta, Mina; Effendi, Kathryn; Tsujikawa, Hanako; Sakamoto, Michiie] Keio Univ, Sch Med, Dept Pathol, Tokyo 1608582, Japan; [Ueno, Akihisa; Tanami, Yutaka; Tanimoto, Akihiro; Okuda, Shigeo; Kuribayashi, Sachio] Keio Univ, Sch Med, Dept Diagnost Radiol, Tokyo 1608582, Japan; [Komuta, Mina] Univ Hosp Leuven, Dept Translat Cell & Tissue Res, Leuven, Belgium; [Itano, Osamu; Kitagawa, Yuko] Keio Univ, Sch Med, Dept Surg, Tokyo 1608582, Japan	Sakamoto, M (reprint author), Keio Univ, Sch Med, Dept Pathol, Shinjuku Ku, 35 Shinanomachi, Tokyo 1608582, Japan.	msakamot@z5.keio.jp	Sakamoto, Michiie/N-2917-2015				Kitao A, 2011, EUR RADIOL, V21, P2056, DOI 10.1007/s00330-011-2165-8; Joishi D, 2013, MAGN RESON MED SCI, V12, P281, DOI 10.2463/mrms.2012-0097; Tsuboyama T, 2010, RADIOLOGY, V255, P824, DOI 10.1148/radiol.10091557; Bedossa P, 1996, HEPATOLOGY, V24, P289, DOI 10.1002/hep.510240201; Hailfinger S, 2006, HEPATOLOGY, V43, P407, DOI 10.1002/hep.21082; Durnez A, 2006, HISTOPATHOLOGY, V49, P138, DOI 10.1111/j.1365-2559.2006.02468.x; Zucman-Rossi J, 2007, ONCOGENE, V26, P774, DOI 10.1038/sj.onc.1209824; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; de La Coste A, 1998, P NATL ACAD SCI USA, V95, P8847; Lee JS, 2004, HEPATOLOGY, V40, P667, DOI 10.1002/hep.20375; Farazi PA, 2006, NAT REV CANCER, V6, P674, DOI 10.1038/nrc1934; Kitao A, 2012, RADIOLOGY, V265, P780, DOI 10.1148/radiol.12120226; Villanueva A, 2010, CLIN CANCER RES, V16, P4688, DOI 10.1158/1078-0432.CCR-09-1811; Cadoret A, 2002, ONCOGENE, V21, P8293, DOI 10.1038/sj.onc.1206118; Vasuri F, 2011, VIRCHOWS ARCH, V459, P141, DOI 10.1007/s00428-011-1099-5; Llovet JM, 2008, NEW ENGL J MED, V359, P378, DOI 10.1056/NEJMoa0708857; Audard V, 2007, J PATHOL, V212, P345, DOI 10.1002/path.2169; Llovet JM, 2003, LANCET, V362, P1907, DOI 10.1016/S0140-6736(03)14964-1; Roessler S, 2010, CANCER RES, V70, P10202, DOI 10.1158/0008-5472.CAN-10-2607; Boyault S, 2007, HEPATOLOGY, V45, P42, DOI 10.1002/hep.21467; Jho EH, 2002, MOL CELL BIOL, V22, P1172, DOI 10.1128/MCB.22.4.1172-1183.2002; Jung D, 2002, GASTROENTEROLOGY, V122, P1954, DOI 10.1053/gast.2002.33583; Narita M, 2009, J GASTROENTEROL, V44, P793, DOI 10.1007/s00535-009-0056-4; Yamamoto Y, 2003, HEPATOLOGY, V37, P528, DOI 10.1053/jhep.2003.50029; Fukuma M, 2013, EXP CELL RES, V319, P113, DOI 10.1016/j.yexcr.2012.10.011; Vavricka SR, 2004, J HEPATOL, V40, P212, DOI 10.1016/j.jhep.2003.10.008; Thompson MD, 2007, HEPATOLOGY, V45, P1298, DOI 10.1002/hep.21651; Lee JS, 2006, NAT MED, V12, P410, DOI 10.1038/nm1377; Chiang DY, 2008, CANCER RES, V68, P6779, DOI 10.1158/0008-5472.CAN-08-0742; Jung D, 2001, J BIOL CHEM, V276, P37206, DOI 10.1074/jbc.M103988200; Sekine S, 2011, CANCER SCI, V102, P1742, DOI 10.1111/j.1349-7006.2011.01990.x; Miyoshi Y, 1998, CANCER RES, V58, P2524; Hoshida Y, 2008, NEW ENGL J MED, V359, P1995, DOI 10.1056/NEJMoa0804525; Kitao A, 2010, RADIOLOGY, V256, P817, DOI 10.1148/radiol.10092214; Burke ZD, 2009, GASTROENTEROLOGY, V136, pe2311; Liver Cancer Study Group of Japan, 2010, GEN RUL CLIN PATH ST; World Medical Association, 2001, B WORLD HEALTH ORGAN, V79, P373; Zucman-Rossi Jessica, 2010, Dig Liver Dis, V42 Suppl 3, pS235, DOI 10.1016/S1590-8658(10)60511-7	38	1	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0168-8278	1600-0641		J HEPATOL	J. Hepatol.	NOV	2014	61	5					1080	1087		10.1016/j.jhep.2014.06.008		8	Gastroenterology & Hepatology	Gastroenterology & Hepatology	AR8QO	WOS:000343839900016		
J	Kawada, T				Kawada, Tomoyuki			Advantage of bariatric surgery for patients with type 2 diabetes mellitus	JOURNAL OF HEPATOLOGY			English	Letter							INTENSIVE MEDICAL THERAPY; TRIAL		Nippon Med Sch, Dept Hyg & Publ Hlth, Bunkyo Ku, Tokyo 1138602, Japan	Kawada, T (reprint author), Nippon Med Sch, Dept Hyg & Publ Hlth, Bunkyo Ku, 1-1-5 Sendagi, Tokyo 1138602, Japan.	kawada@nms.ac.jp					Schauer PR, 2014, NEW ENGL J MED, V370, P2002, DOI 10.1056/NEJMoa1401329; Parikh M, 2013, J AM COLL SURGEONS, V217, P527, DOI 10.1016/j.jamcollsurg.2013.04.023; Schauer PR, 2012, NEW ENGL J MED, V366, P1567, DOI 10.1056/NEJMoa1200225; Courcoulas AP, 2014, JAMA SURG, V149, P707, DOI 10.1001/jamasurg.2014.467; Kashyap SR, 2013, DIABETES CARE, V36, P2175, DOI 10.2337/dc12-1596; Maggard-Gibbons M, 2013, JAMA-J AM MED ASSOC, V309, P2250, DOI 10.1001/jama.2013.4851; Immonen H, 2014, J HEPATOL, V60, P377, DOI 10.1016/j.jhep.2013.09.012; Mingrone G, 2012, NEW ENGL J MED, V366, P1577, DOI 10.1056/NEJMoa1200111	8	1	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0168-8278	1600-0641		J HEPATOL	J. Hepatol.	NOV	2014	61	5					1188	1188				1	Gastroenterology & Hepatology	Gastroenterology & Hepatology	AR8QO	WOS:000343839900032		
J	Kurita, K; Hikida, T; Toda, M				Kurita, Kazuki; Hikida, Tsutomu; Toda, Mamoru			An Investigation for Population Maintenance Mechanism in a Miniature Garden: Genetic Connectivity or Independence of Small Islet Populations of the Ryukyu Five-Lined Skink	JOURNAL OF HEREDITY			English	Article						genetic structure; islands; microsatellite; mitochondrial DNA; Plestiodon marginatus	BAYESIAN PHYLOGENETIC INFERENCE; ISLAND POPULATIONS; WALL LIZARD; MICROSATELLITE LOCI; PODARCIS-LILFORDI; ENDEMIC LIZARD; PLESTIODON; DISTANCE; DIVERSITY; SCINCIDAE	The Ryukyu five-lined skink (Plestiodon marginatus) is an island lizard that is even found in tiny islets with less than half a hectare of habitat area. We hypothesized that the island populations are maintained under frequent gene flow among the islands or independent of each other. To test our hypotheses, we investigated genetic structure of 21 populations from 11 land-bridge islands that were connected during the latest glacial age, and 4 isolated islands. Analyses using mitochondrial cytochrome b gene sequence (n = 67) and 10 microsatellite loci (n = 235) revealed moderate to high levels of genetic differentiation, existence of many private alleles/haplotypes in most islands, little contemporary migration, a positive correlation between genetic variability and island area, and a negative correlation between relatedness and island area. These evidences suggest a strong effect of independent genetic drift as opposed to gene flow, favoring the isolation hypothesis even in tiny islet populations. Isolation-by-distance effect was demonstrated and it became more prominent when the 4 isolated islands were excluded, suggesting that the pattern is a remnant of the land-bridge age. In a few island populations, however, the possibility of occasional overwater dispersals was partially supported and therefore could not be ruled out.	[Kurita, Kazuki; Hikida, Tsutomu] Kyoto Univ, Grad Sch Sci, Dept Zool, Kyoto 6068502, Japan; [Toda, Mamoru] Univ Ryukyus, Trop Biosphere Res Ctr, Nishihara, Okinawa 9030213, Japan	Kurita, K (reprint author), Kyoto Univ, Grad Sch Sci, Dept Zool, Kyoto 6068502, Japan.	kurita@zoo.zool.kyoto-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan [A06]; Grants for Excellent Graduate Schools program of MEXT, Japan; Japan Society for the Promotion of Science (JSPS KAKENHI) [22570094]	Grant-in-Aid for the Global COE Program "Formation of a Strategic Base for Biodiversity and Evolutionary Research: From Genome To Ecosystem" (A06) from the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan; the Grants for Excellent Graduate Schools program of MEXT, Japan; the Grant from the Japan Society for the Promotion of Science (JSPS KAKENHI grant number 22570094 to M.T.).	QUELLER DC, 1989, EVOLUTION, V43, P258, DOI 10.2307/2409206; Huelsenbeck JP, 2004, SYST BIOL, V53, P904, DOI 10.1080/1063515049522629; RICE WR, 1989, EVOLUTION, V43, P223, DOI 10.2307/2409177; MANTEL N, 1967, CANCER RES, V27, P209; Tanabe AS, 2011, MOL ECOL RESOUR, V11, P914, DOI 10.1111/j.1755-0998.2011.03021.x; Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x; [Anonymous], 2006, MOL ECOL NOTES, DOI DOI 10.1111/J.1471-8286.2005.01155.X; NEI M, 1974, GENETICS, V76, P379; Leache AD, 2002, SYSTEMATIC BIOL, V51, P44, DOI 10.1080/106351502753475871; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Hutchison DW, 1999, EVOLUTION, V53, P1898, DOI 10.2307/2640449; SMOUSE PE, 1986, SYST ZOOL, V35, P627, DOI 10.2307/2413122; Pritchard JK, 2000, GENETICS, V155, P945; Hurston H, 2009, MOL PHYLOGENET EVOL, V52, P395, DOI 10.1016/j.ympev.2009.03.028; SLATKIN M, 1985, EVOLUTION, V39, P53, DOI 10.2307/2408516; Wilson GA, 2003, GENETICS, V163, P1177; Frankham R, 1997, HEREDITY, V78, P311, DOI 10.1038/hdy.1997.46; Goudet J, 1995, J HERED, V86, P485; Tzika AC, 2008, MOL ECOL, V17, P4943, DOI 10.1111/j.1365-294X.2008.03967.x; Szpiech ZA, 2008, BIOINFORMATICS, V24, P2498, DOI 10.1093/bioinformatics/btn478; Brandley MC, 2012, ZOOL J LINN SOC-LOND, V165, P163, DOI 10.1111/j.1096-3642.2011.00801.x; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; GUO SW, 1992, BIOMETRICS, V48, P361, DOI 10.2307/2532296; Meirmans PG, 2012, MOL ECOL, V21, P2839, DOI 10.1111/j.1365-294X.2012.05578.x; Jordan MA, 2008, MOL ECOL, V17, P1224, DOI 10.1111/j.1365-294X.2007.03658.x; Baker CS, 2013, J HERED, V104, P1, DOI 10.1093/jhered/ess137; Goslee SC, 2007, J STAT SOFTW, V22, P1; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Altekar G, 2004, BIOINFORMATICS, V20, P407, DOI 10.1093/bioinformatics/btg427; Garza JC, 2001, MOL ECOL, V10, P305, DOI 10.1046/j.1365-294x.2001.01190.x; HILLIS DM, 1993, SYST BIOL, V42, P182, DOI 10.2307/2992540; Schuelke M, 2000, NAT BIOTECHNOL, V18, P233, DOI 10.1038/72708; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Alberto F, 2009, J HERED, V100, P394, DOI 10.1093/jhered/esn110; BRISCOE D. A., 2002, INTRO CONSERVATION G; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.2307/2408678; HASEGAWA M, 1994, COPEIA, P732; HIKIDA T, 1981, Zoological Magazine (Tokyo), V90, P85; Honda M, 2008, PAC SCI, V62, P351, DOI 10.2984/1534-6188(2008)62[351:MPOTEF]2.0.CO;2; Howes BJ, 2004, MOL ECOL NOTES, V4, P237, DOI 10.1111/j.1471.8286.2004.00628.x; Japan Association for Quaternary Research, 1987, QUAT MAPS JAP; Jobb G, 2004, BMC EVOL BIOL, V4, DOI 10.1186/1471-2148-4-18; Kurita K, 2010, AKAMATA, V21, P39; Kurita K, 2013, CONSERV GENET RESOUR, V5, P355, DOI 10.1007/s12686-012-9802-7; Kurita K, 2014, ZOOL SCI, V31, P187, DOI 10.2108/zs130179; Lomolino M. V., 2006, BIOGEOGRAPHY; Malone CL, 2003, CONSERV GENET, V4, P1, DOI 10.1023/A:1021885323539; Okamoto T, 2006, ZOOL SCI, V23, P419, DOI 10.2108/zsj.23.419; Okinawa Prefectural Museum, 1995, AN NANS ISL; Perez-Mellado V, 2008, AMPHIBIA-REPTILIA, V29, P49, DOI 10.1163/156853808783431587; Perry G, 1998, GLOBAL ECOL BIOGEOGR, V7, P353, DOI 10.1046/j.1466-822x.1998.00307.x; R Core Team, 2012, R LANG ENV STAT COMP; Rambaut A, 2007, TRACER V1 5; Rannala B, 2007, BAYESASS EDITION 3 0; Rodriguez V, 2013, MOL ECOL, V22, P4829, DOI 10.1111/mec.12443; Runemark A, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-269; Runemark A, 2012, MOL ECOL, V21, P117, DOI 10.1111/j.1365-294X.2011.05377.x; SUGIURA N, 1978, COMMUN STAT A-THEOR, V7, P13, DOI 10.1080/03610927808827599; Terrasa B, 2009, DIVERS DISTRIB, V15, P207, DOI 10.1111/j.1472-4642.2008.00520.x; Toyama M., 1979, REPTILES AMPHIBIANS, P44; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.2307/2408641	62	0	0	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0022-1503	1465-7333		J HERED	J. Hered.	NOV-DEC	2014	105	6					773	783		10.1093/jhered/esu055		11	Genetics & Heredity	Genetics & Heredity	AS6UG	WOS:000344397000005		
J	Yu, CI; Becker, C; Metang, P; Marches, F; Wang, YY; Toshiyuki, H; Banchereau, J; Merad, M; Palucka, AK				Yu, Chun I.; Becker, Christian; Metang, Patrick; Marches, Florentina; Wang, Yuanyuan; Toshiyuki, Hori; Banchereau, Jacques; Merad, Miriam; Palucka, A. Karolina			Human CD141(+) Dendritic Cells Induce CD4(+) T Cells To Produce Type 2 Cytokines	JOURNAL OF IMMUNOLOGY			English	Article							HOUSE-DUST MITE; OX40 LIGAND; ASPERGILLUS-FUMIGATUS; IN-VIVO; RESPONSES; IMMUNITY; SUBSETS; BLOOD; DIFFERENTIATION; CD8-ALPHA(+)	Dendritic cells (DCs) play the central role in the priming of naive T cells and the differentiation of unique effector T cells. In this study, using lung tissues and blood from both humans and humanized mice, we analyzed the response of human CD1c(+) and CD141(+) DC subsets to live-attenuated influenza virus. Specifically, we analyzed the type of CD4(+) T cell immunity elicited by live-attenuated influenza virus-exposed DCs. Both DC subsets induce proliferation of allogeneic naive CD4(+) T cells with the capacity to secrete IFN-gamma. However, CD141(+) DCs are uniquely able to induce the differentiation of IL-4- and IL-13-producing CD4(+) T cells. CD141(+) DCs induce IL-4- and IL-13-secreting CD4(+) T cells through OX40 ligand. Thus, CD141(+) DCs demonstrate remarkable plasticity in guiding adaptive immune responses.	[Yu, Chun I.; Metang, Patrick; Marches, Florentina; Wang, Yuanyuan; Palucka, A. Karolina] Baylor Inst Immunol Res, Dallas, TX 75204 USA; [Becker, Christian] Mt Sinai Sch Med, Dept Med, Div Pulm Crit Care & Sleep Med, New York, NY 10029 USA; [Becker, Christian; Merad, Miriam] Mt Sinai Sch Med, Inst Immunol, New York, NY 10029 USA; [Wang, Yuanyuan] Baylor Univ, Inst Biomed Studies, Waco, TX 76798 USA; [Toshiyuki, Hori] Ritsumeikan Univ, Coll Life Sci, Kusatsu, Shiga 5258577, Japan; [Banchereau, Jacques] Jackson Lab Genom Med, Farmington, CT 06030 USA; [Merad, Miriam] Mt Sinai Sch Med, Dept Oncol Sci, New York, NY 10029 USA	Palucka, AK (reprint author), Jackson Lab Genom Med, 10 Discovery Dr, Farmington, CT 06032 USA.	Karolina.Palucka@jax.org			National Institutes of Health [5T32CA078207-12, U19AI057234, U19AI089987, U01AI095611]; Lucille A. Fennessy Pulmonary Research Fund; Vivian Richenthal Institute for Pulmonary and Critical Care Research	This work was supported by grants from the National Institutes of Health (5T32CA078207-12 to C.B., U19AI057234 to K.P. and J.B., U19AI089987 to K.P., and U01AI095611 to K.P. and M.M.). C.B. was supported by a research fellowship grant from the Lucille A. Fennessy Pulmonary Research Fund and the Vivian Richenthal Institute for Pulmonary and Critical Care Research.	Gao Y, 2013, IMMUNITY, V39, P722, DOI 10.1016/j.immuni.2013.08.028; Kool M, 2011, IMMUNITY, V34, P527, DOI 10.1016/j.immuni.2011.03.015; Ito T, 2005, J EXP MED, V202, P1213, DOI 10.1084/jem.20051135; Cella M, 1996, J EXP MED, V184, P747, DOI 10.1084/jem.184.2.747; Bachem A, 2010, J EXP MED, V207, P1273, DOI 10.1084/jem.20100348; Mittag D, 2011, J IMMUNOL, V186, P6207, DOI 10.4049/jimmunol.1002632; Iezzi G, 2009, P NATL ACAD SCI USA, V106, P876, DOI 10.1073/pnas.0810769106; Caux C, 1996, J EXP MED, V184, P695, DOI 10.1084/jem.184.2.695; Dzionek A, 2001, J EXP MED, V194, P1823, DOI 10.1084/jem.194.12.1823; Merad M, 2013, ANNU REV IMMUNOL, V31, P563, DOI 10.1146/annurev-immunol-020711-074950; Nizzoli G, 2013, BLOOD, V122, P932, DOI 10.1182/blood-2013-04-495424; Tarbell KV, 2007, J EXP MED, V204, P191, DOI 10.1084/jem.20061631; Lauterbach H, 2010, J EXP MED, V207, P2703, DOI 10.1084/jem.20092720; Dzionek A, 2000, J IMMUNOL, V165, P6037; Yerkovich ST, 2009, J ALLERGY CLIN IMMUN, V123, P209, DOI 10.1016/j.jaci.2008.09.009; Kreindler JL, 2010, J CLIN INVEST, V120, P3242, DOI 10.1172/JCI42388; Yu CI, 2013, IMMUNITY, V38, P818, DOI 10.1016/j.immuni.2013.03.004; Willart MAM, 2012, J EXP MED, V209, P1505, DOI 10.1084/jem.20112691; Jongbloed SL, 2010, J EXP MED, V207, P1247, DOI 10.1084/jem.20092140; Hammad H, 2009, NAT MED, V15, P410, DOI 10.1038/nm.1946; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Coffman RL, 2010, IMMUNITY, V33, P492, DOI 10.1016/j.immuni.2010.10.002; Crozat K, 2010, J EXP MED, V207, P1283, DOI 10.1084/jem.20100223; Lambrecht BN, 2012, ANNU REV IMMUNOL, V30, P243, DOI 10.1146/annurev-immunol-020711-075021; Segura E, 2012, J EXP MED, V209, P653, DOI 10.1084/jem.20111457; Yu CI, 2008, BLOOD, V112, P3671, DOI 10.1182/blood-2008-05-157016; Ohshima Y, 1997, J IMMUNOL, V159, P3838; Godefroy E, 2011, CANCER CELL, V19, P333, DOI 10.1016/j.ccr.2011.01.037; Tanaka H, 2000, J EXP MED, V192, P405, DOI 10.1084/jem.192.3.405; Hemont C, 2013, J LEUKOCYTE BIOL, V93, P599, DOI 10.1189/jlb.0912452; Boonstra A, 2003, J EXP MED, V197, P101, DOI 10.1084/jem.20021908; Steinman RM, 2003, ANNU REV IMMUNOL, V21, P685, DOI 10.1146/annurev.immunol.21.120601.141040; Soumelis V, 2002, NAT IMMUNOL, V3, P673, DOI 10.1038/ni805; Nguyen NLH, 2013, INFECT IMMUN, V81, P1510, DOI 10.1128/IAI.01345-12; Haniffa M, 2012, IMMUNITY, V37, P60, DOI 10.1016/j.immuni.2012.04.012; Liu YJ, 2007, ANNU REV IMMUNOL, V25, P193, DOI 10.1146/annurev.immunol.25.022106.141718; MacDonald KPA, 2002, BLOOD, V100, P4512, DOI 10.1182/blood-2001-11-0097; Tan AM, 2010, J IMMUNOL, V184, P3535, DOI 10.4049/jimmunol.0900340; Ying S, 2005, J IMMUNOL, V174, P8183; Kumamoto Y, 2013, IMMUNITY, V39, P733, DOI 10.1016/j.immuni.2013.08.029; Maldonado-Lopez R, 1999, J EXP MED, V189, P587, DOI 10.1084/jem.189.3.587; Brocker T, 1999, EUR J IMMUNOL, V29, P1610, DOI 10.1002/(SICI)1521-4141(199905)29:05<1610::AID-IMMU1610>3.0.CO;2-8; Meixlsperger S, 2013, BLOOD, V121, P5034, DOI 10.1182/blood-2012-12-473413; Poulin LF, 2010, J EXP MED, V207, P1261, DOI 10.1084/jem.20092618; Byun M, 2013, J EXP MED, V210, P1743, DOI 10.1084/jem.20130592; Brimnes MK, 2003, J EXP MED, V198, P133, DOI 10.1084/jem.20030266; CAUX C, 1994, J EXP MED, V180, P1263, DOI 10.1084/jem.180.4.1263; Grewal IS, 1996, IMMUNOL TODAY, V17, P410, DOI 10.1016/0167-5699(96)10030-X; Hayashi Y, 2013, RESP RES, V14, DOI 10.1186/1465-9921-14-29; HOSKEN NA, 1995, J EXP MED, V182, P1579, DOI 10.1084/jem.182.5.1579; Krause P, 2009, BLOOD, V113, P2451, DOI 10.1182/blood-2008-05-157123; Maxwell JR, 2006, J IMMUNOL, V177, P234; Pulendran B, 1998, J EXP MED, V188, P2075, DOI 10.1084/jem.188.11.2075; Raymond M, 2009, J ALLERGY CLIN IMMUN, V124, P1333, DOI 10.1016/j.jaci.2009.07.021; Schlitzer A, 2013, IMMUNITY, V38, P970, DOI 10.1016/j.immuni.2013.04.011; Wang YH, 2006, IMMUNITY, V24, P827, DOI 10.1016/j.immuni.2006.03.019; Williams JW, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3990	57	6	6	AMER ASSOC IMMUNOLOGISTS	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0022-1767	1550-6606		J IMMUNOL	J. Immunol.	NOV 1	2014	193	9					4335	4343		10.4049/jimmunol.1401159		9	Immunology	Immunology	AS1ZS	WOS:000344079500009		
J	Mouri, Y; Nishijima, H; Kawano, H; Hirota, F; Sakaguchi, N; Morimoto, J; Matsumoto, M				Mouri, Yasuhiro; Nishijima, Hitoshi; Kawano, Hiroshi; Hirota, Fumiko; Sakaguchi, Nobuo; Morimoto, Junko; Matsumoto, Mitsuru			NF-kappa B-Inducing Kinase in Thymic Stroma Establishes Central Tolerance by Orchestrating Cross-Talk with Not Only Thymocytes but Also Dendritic Cells	JOURNAL OF IMMUNOLOGY			English	Article							REGULATORY T-CELLS; ALYMPHOPLASIA ALY/ALY MICE; SELF-TOLERANCE; EPITHELIAL-CELLS; IMMUNE-RESPONSES; TRANSGENIC MICE; DEFICIENT MICE; ALY MICE; DIFFERENTIATION; EXPRESSION	Essential roles of NF-kappa B-inducing kinase (NIK) for the development of medullary thymic epithelial cells (mTECs) and regulatory T cells have been highlighted by studies using a strain of mouse bearing a natural mutation of the NIK gene (aly mice). However, the exact mechanisms underlying the defect in thymic cross-talk leading to the breakdown of self-tolerance in aly mice remain elusive. In this study, we demonstrated that production of regulatory T cells and the final maturation process of positively selected conventional alpha beta T cells are impaired in aly mice, partly because of a lack of mature mTECs. Of note, numbers of thymic dendritic cells and their expression of costimulatory molecules were also affected in aly mice in a thymic stroma-dependent manner. The results suggest a pivotal role of NIK in the thymic stroma in establishing self-tolerance by orchestrating cross-talk between mTECs and dendritic cells as well as thymocytes. In addition, we showed that negative selection was impaired in aly mice as a result of the stromal defect, which accounts for the development of organ-specific autoimmunity through a lack of normal NIK.	[Mouri, Yasuhiro; Nishijima, Hitoshi; Kawano, Hiroshi; Hirota, Fumiko; Morimoto, Junko; Matsumoto, Mitsuru] Univ Tokushima, Inst Enzyme Res, Div Mol Immunol, Tokushima 7708503, Japan; [Sakaguchi, Nobuo] Kumamoto Univ, Grad Sch Life Sci, Dept Immunol, Kumamoto 8608556, Japan	Matsumoto, M (reprint author), Univ Tokushima, Inst Enzyme Res, Div Mol Immunol, 3-18-15 Kuramoto, Tokushima 7708503, Japan.	mitsuru@ier.tokushima-u.ac.jp			Japan Society for the Promotion of Science; Ministry of Education, Culture, Sports, Science and Technology of Japan; Japan Science Technology Agency	This work was supported in part by Grants-in-Aid for Scientific Research from the Japan Society for the Promotion of Science and the Ministry of Education, Culture, Sports, Science and Technology of Japan and by a Core Research for Evolutionary Science and Technology grant from the Japan Science Technology Agency (to M.M.).	Aschenbrenner K, 2007, NAT IMMUNOL, V8, P351, DOI 10.1038/ni1444; Coquet JM, 2013, J EXP MED, V210, P715, DOI 10.1084/jem.20112061; Hofmann J, 2011, J EXP MED, V208, P1917, DOI 10.1084/jem.20110128; VANEWIJK W, 1994, IMMUNOL TODAY, V15, P214, DOI 10.1016/0167-5699(94)90246-1; Hogquist KA, 2005, NAT REV IMMUNOL, V5, P772, DOI 10.1038/nri1707; KISIELOW P, 1988, NATURE, V333, P742, DOI 10.1038/333742a0; MIYAWAKI S, 1994, EUR J IMMUNOL, V24, P429, DOI 10.1002/eji.1830240224; Barnden MJ, 1998, IMMUNOL CELL BIOL, V76, P34, DOI 10.1046/j.1440-1711.1998.00709.x; Yano M, 2008, J EXP MED, V205, P2827, DOI 10.1084/jem.20080046; McCaughtry TM, 2008, J EXP MED, V205, P2575, DOI 10.1084/jem.20080866; Sun SC, 2012, IMMUNOL REV, V246, P125, DOI 10.1111/j.1600-065X.2011.01088.x; Dejardin E, 2002, IMMUNITY, V17, P525, DOI 10.1016/S1074-7613(02)00423-5; Shinkura R, 1999, NAT GENET, V22, P74, DOI 10.1038/8780; Tamura C, 2006, AUTOIMMUNITY, V39, P445, DOI 10.1080/08916930600833390; Cowan JE, 2013, J EXP MED, V210, P675, DOI 10.1084/jem.20122070; Murray SE, 2011, J CLIN INVEST, V121, P4775, DOI 10.1172/JCI44943; Anderson G, 2007, NAT REV IMMUNOL, V7, P954, DOI 10.1038/nri2187; Boehm T, 2003, J EXP MED, V198, P757, DOI 10.1084/jem.20030794; Nishikawa Y, 2010, J EXP MED, V207, P963, DOI 10.1084/jem.20092144; Niki S, 2006, J CLIN INVEST, V116, P1292, DOI 10.1172/JCI26971; Malinin NL, 1997, NATURE, V385, P540, DOI 10.1038/385540a0; Mouri Y, 2011, J IMMUNOL, V186, P5047, DOI 10.4049/jimmunol.1003533; Gallegos AM, 2004, J EXP MED, V200, P1039, DOI 10.1084/jem.20041457; Kajiura F, 2004, J IMMUNOL, V172, P2067; Anderson MS, 2005, IMMUNITY, V23, P227, DOI 10.1016/j.immuni.2005.07.005; Ishimaru N, 2006, NAT IMMUNOL, V7, P763, DOI 10.1038/ni1351; Kyewski B, 2006, ANNU REV IMMUNOL, V24, P571, DOI 10.1146/annurev.immunol.23.021704.115601; Yamada T, 2000, J IMMUNOL, V165, P804; Jin W, 2009, BLOOD, V113, P6603, DOI 10.1182/blood-2008-12-192914; Dresch C, 2012, TRENDS IMMUNOL, V33, P381, DOI 10.1016/j.it.2012.04.009; Ramakrishnan P, 2004, IMMUNITY, V21, P477, DOI 10.1016/j.immuni.2004.08.009; Kuroda N, 2005, J IMMUNOL, V174, P1862; Zachariah MA, 2010, SCIENCE, V328, P1129, DOI 10.1126/science.1188222; Proietto AI, 2009, IMMUNOL CELL BIOL, V87, P39, DOI 10.1038/icb.2008.86; Kurts C, 1996, J EXP MED, V184, P923, DOI 10.1084/jem.184.3.923; Cuss SM, 2012, J IMMUNOL, V189, P1717, DOI 10.4049/jimmunol.1200588; Hsieh CS, 2005, CURR TOP MICROBIOL, V293, P25, DOI 10.1007/3-540-27702-1_2; Kuwata N, 1999, J IMMUNOL, V163, P6355; Macpherson AJ, 2003, IMMUNOGENETICS, V54, P693, DOI 10.1007/s00251-002-0517-x; Matsumoto M, 2002, J IMMUNOL, V169, P1151; Matsumoto M, 2007, ARCH IMMUNOL THER EX, V55, P27, DOI 10.1007/s00005-007-0007-9; Matsumoto M, 1999, J IMMUNOL, V163, P1584; McCaughtry TM, 2007, J EXP MED, V204, P2513, DOI 10.1084/jem.20070601; Proietto AI, 2008, IMMUNOL CELL BIOL, V86, P700, DOI 10.1038/icb.2008.63; Sakaguchi S, 2004, ANNU REV IMMUNOL, V22, P531, DOI 10.1146/annurev.immunol.21.120601.141122; Sanchez-Valdepenas C, 2006, J IMMUNOL, V176, P4666	46	5	5	AMER ASSOC IMMUNOLOGISTS	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0022-1767	1550-6606		J IMMUNOL	J. Immunol.	NOV 1	2014	193	9					4356	4367		10.4049/jimmunol.1400389		12	Immunology	Immunology	AS1ZS	WOS:000344079500011		
J	Soni, C; Wong, EB; Domeier, PP; Khan, TN; Satoh, T; Akira, S; Rahman, ZSM				Soni, Chetna; Wong, Eric B.; Domeier, Phillip P.; Khan, Tahsin N.; Satoh, Takashi; Akira, Shizuo; Rahman, Ziaur S. M.			B Cell-Intrinsic TLR7 Signaling Is Essential for the Development of Spontaneous Germinal Centers	JOURNAL OF IMMUNOLOGY			English	Article							SYSTEMIC-LUPUS-ERYTHEMATOSUS; HELPER T-CELLS; PRIMARY IMMUNE-RESPONSE; TOLL-LIKE RECEPTORS; LYN-DEFICIENT MICE; MURINE LUPUS; AUTOANTIBODY PRODUCTION; NUCLEIC ACID; ANTIBODY-PRODUCTION; DENDRITIC CELLS	Spontaneous germinal center (Spt-GC) B cells and follicular helper T cells generate high-affinity autoantibodies that are involved in the development of systemic lupus erythematosus. TLRs play a pivotal role in systemic lupus erythematosus pathogenesis. Although previous studies focused on the B cell-intrinsic role of TLR-MyD88 signaling on immune activation, autoantibody repertoire, and systemic inflammation, the mechanisms by which TLRs control the formation of Spt-GCs remain unclear. Using nonautoimmune C57BL/6 (B6) mice deficient in MyD88, TLR2, TLR3, TLR4, TLR7, or TLR9, we identified B cell-intrinsic TLR7 signaling as a prerequisite to Spt-GC formation without the confounding effects of autoimmune susceptibility genes and the overexpression of TLRs. TLR7 deficiency also rendered autoimmune B6.Sle1b mice unable to form Spt-GCs, leading to markedly decreased autoantibodies. Conversely, B6.yaa and B6.Sle1b.yaa mice expressing an extra copy of TLR7 and B6.Sle1b mice treated with a TLR7 agonist had increased Spt-GCs and follicular helper T cells. Further, TLR7/MyD88 deficiency led to compromised B cell proliferation and survival after B cell stimulation both in vitro and in vivo. In contrast, TLR9 inhibited Spt-GC development. Our findings demonstrate an absolute requirement for TLR7 and a negative regulatory function for TLR9 in Spt-GC formation under nonautoimmune and autoimmune conditions. Our data suggest that, under nonautoimmune conditions, Spt-GCs initiated by TLR7 produce protective Abs. However, in the presence of autoimmune susceptibility genes, TLR7-dependent Spt-GCs produce pathogenic autoantibodies. Thus, a single copy of TLR7 in B cells is the minimal requirement for breaking the GC-tolerance checkpoint.	[Soni, Chetna; Wong, Eric B.; Domeier, Phillip P.; Khan, Tahsin N.; Rahman, Ziaur S. M.] Penn State Univ, Coll Med, Dept Microbiol & Immunol, Hershey, PA 17033 USA; [Satoh, Takashi] Oregon Hlth & Sci Univ, Dept Mol Microbiol & Immunol, Portland, OR 97239 USA; [Satoh, Takashi; Akira, Shizuo] Osaka Univ, Microbial Dis Res Inst, Dept Host Def, Osaka 5650871, Japan	Rahman, ZSM (reprint author), Penn State Univ, Coll Med, Dept Microbiol & Immunol, H107,500 Univ Dr, Hershey, PA 17033 USA.	zrahman@hmc.psu.edu	Akira, Shizuo/C-3134-2009; 	Domeier, Phillip/0000-0002-9937-8251	National Institutes of Health [AI091670]	This work was supported by National Institutes of Health Grant AI091670 (to Z.S.M.R.).	Allman D, 2001, J IMMUNOL, V167, P6834; Koh YT, 2013, J IMMUNOL, V190, P4982, DOI 10.4049/jimmunol.1202986; Rahman ZSM, 2007, J IMMUNOL, V178, P897; Meffre E, 2008, CURR OPIN IMMUNOL, V20, P632, DOI 10.1016/j.coi.2008.09.001; Clingan JM, 2013, J IMMUNOL, V191, P810, DOI 10.4049/jimmunol.1300244; Wong EB, 2012, J IMMUNOL, V189, P5667, DOI 10.4049/jimmunol.1201661; Silver KL, 2007, EUR J IMMUNOL, V37, P2734, DOI 10.1002/eji.200737293; Kawai T, 2005, ARTHRITIS RES THER, V7, P12, DOI 10.1186/ar1469; Hua ZL, 2014, J IMMUNOL, V192, P875, DOI 10.4049/jimmunol.1300683; Morel L, 2001, P NATL ACAD SCI USA, V98, P1787, DOI 10.1073/pnas.031336098; Yu P, 2006, INT IMMUNOL, V18, P1211, DOI 10.1093/intimm/dxl067; Zotos D, 2012, TRENDS IMMUNOL, V33, P281, DOI 10.1016/j.it.2012.04.003; Santiago-Raber ML, 2010, J AUTOIMMUN, V34, P339, DOI 10.1016/j.jaut.2009.11.001; Vinuesa CG, 2005, NATURE, V435, P452, DOI 10.1038/nature03555; Desnues B, 2014, P NATL ACAD SCI USA, V111, P1497, DOI 10.1073/pnas.1314121111; Fairhurst AM, 2008, EUR J IMMUNOL, V38, P1971, DOI 10.1002/eji.200838138; Christensen SR, 2006, IMMUNITY, V25, P417, DOI 10.1016/j.immuni.2006.07.013; Celhar T, 2012, IMMUNOL RES, V53, P58, DOI 10.1007/s12026-012-8270-1; Lee SK, 2012, IMMUNITY, V37, P880, DOI 10.1016/j.immuni.2012.10.010; Wu XB, 2006, ARTHRITIS RHEUM, V54, P336, DOI 10.1002/art.21553; Jackson SW, 2014, J IMMUNOL, V192, P4525, DOI 10.4049/jimmunol.1400098; Walsh ER, 2012, P NATL ACAD SCI USA, V109, P16276, DOI 10.1073/pnas.1209372109; Inamine A, 2005, INT IMMUNOL, V17, P581, DOI 10.1093/intimm/dxh241; Takahashi Y, 1998, J EXP MED, V187, P885, DOI 10.1084/jem.187.6.885; Umiker BR, 2014, EUR J IMMUNOL, V44, P1503, DOI 10.1002/eji.201344283; Hemmi H, 2000, NATURE, V408, P740; Groom JR, 2007, J EXP MED, V204, P1959, DOI 10.1084/jem.20062567; Pisitkun P, 2006, SCIENCE, V312, P1669, DOI 10.1126/science.1124978; HARDY RR, 1991, J EXP MED, V173, P1213, DOI 10.1084/jem.173.5.1213; Genestier L, 2007, J IMMUNOL, V178, P7779; Rookhuizen DC, 2014, P NATL ACAD SCI USA, V111, pE3224, DOI 10.1073/pnas.1323985111; Matzinger P, 2002, SCIENCE, V296, P301, DOI 10.1126/science.1071059; Christensen SR, 2005, J EXP MED, V202, P321, DOI 10.1084/jem.20050338; Ehlers M, 2006, J EXP MED, V203, P553, DOI 10.1084/jem.20052438; Wandstrat AE, 2004, IMMUNITY, V21, P769, DOI 10.1016/j.immuni.2004.10.009; Kono DH, 2009, P NATL ACAD SCI USA, V106, P12061, DOI 10.1073/pnas.0905441106; Mohan C, 1998, J CLIN INVEST, V101, P1362; BEREK C, 1991, CELL, V67, P1121, DOI 10.1016/0092-8674(91)90289-B; Rubtsov AV, 2008, J IMMUNOL, V180, P3882; William J, 2002, SCIENCE, V297, P2066, DOI 10.1126/science.1073924; Meyer-Bahlburg A, 2008, AUTOIMMUN REV, V7, P313, DOI 10.1016/j.autrev.2007.11.027; Yu P, 2012, IMMUNITY, V37, P867, DOI 10.1016/j.immuni.2012.07.018; Hemmi H, 2002, NAT IMMUNOL, V3, P196, DOI 10.1038/ni758; Nickerson KM, 2010, J IMMUNOL, V184, P1840, DOI 10.4049/jimmunol.0902592; Blink EJ, 2005, J EXP MED, V201, P545, DOI 10.1084/jem.20042060; Giltiay NV, 2013, J EXP MED, V210, P2773, DOI 10.1084/jem.20122798; Sun XZ, 2013, J IMMUNOL, V190, P2536, DOI 10.4049/jimmunol.1202689; Linterman MA, 2009, J EXP MED, V206, P561, DOI 10.1084/jem.20081886; Cappione A, 2005, J CLIN INVEST, V115, P3205, DOI 10.1172/JCI24179; Simpson N, 2010, ARTHRITIS RHEUM-US, V62, P234, DOI 10.1002/art.25032; Hwang SH, 2012, J IMMUNOL, V189, P5786, DOI 10.4049/jimmunol.1202195; JACOB J, 1991, NATURE, V354, P389, DOI 10.1038/354389a0; Li XY, 2010, CYTOKINE, V49, P1, DOI 10.1016/j.cyto.2009.08.010; Lartigue A, 2006, J IMMUNOL, V177, P1349; MACLENNAN ICM, 1994, ANNU REV IMMUNOL, V12, P117, DOI 10.1146/annurev.immunol.12.1.117; Lamagna C, 2014, J IMMUNOL, V192, P919, DOI 10.4049/jimmunol.1301979; Luzina IG, 2001, J LEUKOCYTE BIOL, V70, P578; Shlomchik MJ, 2012, IMMUNOL REV, V247, P5, DOI 10.1111/j.1600-065X.2012.01125.x; Herlands RA, 2008, IMMUNITY, V29, P249, DOI 10.1016/j.immuni.2008.06.009; Avalos AM, 2010, AUTOIMMUNITY, V43, P76, DOI 10.3109/08916930903374618; BENNER R, 1981, CLIN EXP IMMUNOL, V46, P1; Browne EP, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002293; Cline AM, 2004, AUTOIMMUNITY, V37, P85, DOI 10.1080/0891693042000196219; Croker BP, 2003, GENES IMMUN, V4, P575, DOI 10.1038/sj.gene.6364028; DeFranco AL, 2012, IMMUNOL REV, V247, P64, DOI 10.1111/j.1600-065X.2012.01115.x; Hou B, 2008, IMMUNITY, V29, P272, DOI 10.1016/j.immuni.2008.05.016; Hou BD, 2011, IMMUNITY, V34, P375, DOI 10.1016/j.immuni.2011.01.011; Neeli I, 2007, MOL IMMUNOL, V44, P1914, DOI 10.1016/j.molimm.2006.09.027; Pan ZJ, 2010, ANN RHEUM DIS, V69, P1195, DOI 10.1136/ard.2009.108282; Pawar RD, 2006, J AM SOC NEPHROL, V17, P141, DOI 10.1681/ASN.2005070714; Pone EJ, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1769	71	12	12	AMER ASSOC IMMUNOLOGISTS	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0022-1767	1550-6606		J IMMUNOL	J. Immunol.	NOV 1	2014	193	9					4400	4414		10.4049/jimmunol.1401720		15	Immunology	Immunology	AS1ZS	WOS:000344079500015		
J	Ujiie, H; Sasaoka, T; Izumi, K; Nishie, W; Shinkuma, S; Natsuga, K; Nakamura, H; Shibaki, A; Shimizu, H				Ujiie, Hideyuki; Sasaoka, Tetsumasa; Izumi, Kentaro; Nishie, Wataru; Shinkuma, Satoru; Natsuga, Ken; Nakamura, Hideki; Shibaki, Akihiko; Shimizu, Hiroshi			Bullous Pemphigoid Autoantibodies Directly Induce Blister Formation without Complement Activation	JOURNAL OF IMMUNOLOGY			English	Article							DERMAL-EPIDERMAL SEPARATION; NONCOLLAGENOUS 16A DOMAIN; XVII COLLAGEN; MONOCLONAL-ANTIBODY; HERPES-GESTATIONIS; SKIN DISEASES; IGG AUTOANTIBODIES; BP180 ECTODOMAIN; MOUSE COMPLEMENT; LAMINA-LUCIDA	Complement activation and subsequent recruitment of inflammatory cells at the dermal/epidermal junction are thought to be essential for blister formation in bullous pemphigoid (BP), an autoimmune blistering disease induced by autoantibodies against type XVII collagen (COL17); however, this theory does not fully explain the pathological features of BP. Recently, the involvement of complement-independent pathways has been proposed. To directly address the question of the necessity of the complement activation in blister formation, we generated C3-deficient COL17-humanized mice. First, we show that passive transfer of autoantibodies from BP patients induced blister formation in neonatal C3-deficient COL17-humanized mice without complement activation. By using newly generated human and murine mAbs against the pathogenic noncollagenous 16A domain of COL17 with high (human IgG1, murine IgG2), low (murine IgG1), or no (human IgG4) complement activation abilities, we demonstrate that the deposition of Abs, and not complements, is relevant to the induction of blister formation in neonatal and adult mice. Notably, passive transfer of BP autoantibodies reduced the amount of COL17 in lesional mice skin, as observed in cultured normal human keratinocytes treated with the same Abs. Moreover, the COL17 depletion was associated with a ubiquitin/proteasome pathway. In conclusion, the COL17 depletion induced by BP autoantibodies, and not complement activation, is essential for the blister formation under our experimental system.	[Ujiie, Hideyuki; Sasaoka, Tetsumasa; Izumi, Kentaro; Nishie, Wataru; Shinkuma, Satoru; Natsuga, Ken; Nakamura, Hideki; Shibaki, Akihiko; Shimizu, Hiroshi] Hokkaido Univ, Grad Sch Med, Dept Dermatol, Sapporo, Hokkaido 0608638, Japan; [Sasaoka, Tetsumasa] Nihon Pharmaceut Co Ltd, Div Res & Dev, Res Lab 3G, Osaka 5980061, Japan	Ujiie, H (reprint author), Hokkaido Univ, Grad Sch Med, Dept Dermatol, Kita Ku, N15 W7, Sapporo, Hokkaido 0608638, Japan.	h-ujiie@med.hokudai.ac.jp		Natsuga, Ken/0000-0003-3865-6366	Japan Society for the Promotion of Science [21249063, 23591635, 23791242]; Program for Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation [06-42]; Ministry of Health, Labor, and Welfare of Japan [H23-028]	This work was supported by Japan Society for the Promotion of Science Grants-in-Aid for Scientific Research 21249063 (to H.S.), 23591635 (to A.S.), and 23791242 (to H.U.), Program for Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation Grant 06-42 (to H.S.), and "Research on Measures for Intractable Diseases" Project/Matching Fund Subsidy H23-028 from the Ministry of Health, Labor, and Welfare of Japan.	Zhao ML, 2006, J IMMUNOL, V177, P3398; LIU Z, 1995, J CLIN INVEST, V95, P1539, DOI 10.1172/JCI117826; Woof JM, 2004, NAT REV IMMUNOL, V4, P89, DOI 10.1038/nri1266; Li QA, 2010, J IMMUNOL, V185, P7746, DOI 10.4049/jimmunol.1000667; Goldberg AL, 2003, NATURE, V426, P895, DOI 10.1038/nature02263; Martin RM, 1998, J IMMUNOL METHODS, V212, P187, DOI 10.1016/S0022-1759(98)00015-5; Liu Z, 1997, J CLIN INVEST, V100, P1256, DOI 10.1172/JCI119639; Chen RY, 2001, J CLIN INVEST, V108, P1151; NEUBERGER MS, 1981, EUR J IMMUNOL, V11, P1012, DOI 10.1002/eji.1830111212; Natsuga K, 2012, J IMMUNOL, V188, P5792, DOI [10.4049/jimmunol.1003402, 10.4049/jimmunol.1103402]; da Silveira SA, 2002, J EXP MED, V195, P665, DOI 10.1084/jem.20012024; GIUDICE GJ, 1993, J IMMUNOL, V151, P5742; Messingham KN, 2011, J IMMUNOL, V187, P553, DOI 10.4049/jimmunol.1001753; Zillikens D, 1997, J INVEST DERMATOL, V109, P573, DOI 10.1111/1523-1747.ep12337492; Iwata H, 2013, EXP DERMATOL, V22, P381, DOI 10.1111/exd.12146; GIUDICE GJ, 1992, J INVEST DERMATOL, V99, P243, DOI 10.1111/1523-1747.ep12616580; Iwata H, 2009, J INVEST DERMATOL, V129, P919, DOI 10.1038/jid.2008.305; Wang G, 2010, AM J PATHOL, V176, P914, DOI 10.2353/ajpath.2010.090744; Sitaru C, 2007, ARCH DERMATOL RES, V299, P1, DOI 10.1007/s00403-007-0734-0; TAO MH, 1993, J EXP MED, V178, P661, DOI 10.1084/jem.178.2.661; Koster J, 2003, J CELL SCI, V116, P387, DOI 10.1242/jcs.00241; Bedane C, 1997, J INVEST DERMATOL, V108, P901, DOI 10.1111/1523-1747.ep12292701; BIRD P, 1986, J INVEST DERMATOL, V86, P21, DOI 10.1111/1523-1747.ep12283737; DIAZ LA, 1990, J CLIN INVEST, V86, P1088, DOI 10.1172/JCI114812; Franzke CW, 2004, J BIOL CHEM, V279, P24521, DOI 10.1074/jbc.M308835200; Higo-Moriguchi K, 2004, J VIROL, V78, P3325, DOI 10.1128/JVI.78.7.3325-3332.2004; Hiroyasu S, 2013, AM J PATHOL, V182, P828, DOI 10.1016/j.ajpath.2012.11.029; Hofmann SC, 2009, J INVEST DERMATOL, V129, P1730, DOI 10.1038/jid.2008.424; Hopkinson SB, 1998, J INVEST DERMATOL, V111, P1015, DOI 10.1046/j.1523-1747.1998.00452.x; JORDON RE, 1975, J INVEST DERMATOL, V65, P162, DOI 10.1111/1523-1747.ep12598113; Kitajima Yasuo, 1994, Journal of Dermatology (Tokyo), V21, P838; Kitajima Y, 1998, BRIT J DERMATOL, V138, P71; KLAUS GGB, 1979, IMMUNOLOGY, V38, P687; Kuhara M, 2009, CELL STRUCT FUNCT, V34, P23; Kuzuhara T, 2008, BIOL PHARM BULL, V31, P816, DOI 10.1248/bpb.31.816; Liu Z, 2000, CELL, V102, P647, DOI 10.1016/S0092-8674(00)00087-8; Ma XZ, 2010, J VIROL, V84, P12419, DOI 10.1128/JVI.01219-10; Mazot P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033581; MCGRATH JA, 1995, NAT GENET, V11, P83, DOI 10.1038/ng0995-83; Mihai S, 2007, J CELL MOL MED, V11, P1117, DOI 10.1111/j.1582-4934.2007.00081.x; Nelson KC, 2006, J CLIN INVEST, V116, P2892, DOI 10.1172/JCI17891; Nishie W, 2011, AM J PATHOL, V179, P829, DOI 10.1016/j.ajpath.2011.04.019; Nishie W, 2009, J IMMUNOL, V183, P4088, DOI 10.4049/jimmunol.0800389; Nishie W, 2007, NAT MED, V13, P378, DOI 10.1038/nm1496; Olasz EB, 2007, J INVEST DERMATOL, V127, P2807, DOI 10.1038/sj.jid.5700970; Phaeton R, 2010, CANCER-AM CANCER SOC, V116, P1067, DOI 10.1002/cncr.24794; PROVOST TT, 1973, J CLIN INVEST, V52, P1779, DOI 10.1172/JCI107359; Schmidt E, 2000, J INVEST DERMATOL, V115, P842, DOI 10.1046/j.1523-1747.2000.00141.x; Sesarman A, 2012, IMMUNOL LETT, V143, P92, DOI 10.1016/j.imlet.2012.01.006; Shimizu H, 1998, EXP DERMATOL, V7, P303, DOI 10.1111/j.1600-0625.1998.tb00329.x; Sitaru C, 2002, J INVEST DERMATOL, V118, P664, DOI 10.1046/j.1523-1747.2002.01720.x; Ujiie H, 2012, CLIN IMMUNOL, V142, P167, DOI 10.1016/j.clim.2011.10.002; Ujiie H, 2010, J IMMUNOL, V184, P2166, DOI 10.4049/jimmunol.0903101	53	3	3	AMER ASSOC IMMUNOLOGISTS	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0022-1767	1550-6606		J IMMUNOL	J. Immunol.	NOV 1	2014	193	9					4415	4428		10.4049/jimmunol.1400095		14	Immunology	Immunology	AS1ZS	WOS:000344079500016		
J	Oda, M; Yamamoto, H; Shibutani, M; Nakano, M; Yabiku, K; Tarui, T; Kameyama, N; Shirakawa, D; Obayashi, S; Watanabe, N; Nakase, H; Suenaga, M; Matsunaga, Y; Nagahama, M; Takahashi, H; Imagawa, H; Kurosawa, M; Terao, Y; Nishizawa, M; Sakurai, J				Oda, Masataka; Yamamoto, Hirofumi; Shibutani, Masahiro; Nakano, Mayo; Yabiku, Kenta; Tarui, Takafumi; Kameyama, Naoya; Shirakawa, Daiki; Obayashi, Sumiyo; Watanabe, Naoyuki; Nakase, Hiroshi; Suenaga, Midori; Matsunaga, Yoichi; Nagahama, Masahiro; Takahashi, Hironobu; Imagawa, Hiroshi; Kurosawa, Mie; Terao, Yutaka; Nishizawa, Mugio; Sakurai, Jun			Vizantin Inhibits Endotoxin-Mediated Immune Responses via the TLR 4/MD-2 Complex	JOURNAL OF IMMUNOLOGY			English	Article							BACILLUS-CALMETTE-GUERIN; TOLL-LIKE RECEPTOR-4; MYCOBACTERIUM-TUBERCULOSIS; ANTAGONIST ERITORAN; CORD FACTOR; CELL-WALL; ADJUVANT ACTIVITIES; CYTOKINE PRODUCTION; SEVERE SEPSIS; IN-VIVO	Vizantin has immunostimulating properties and anticancer activity. In this study, we investigated the molecular mechanism of immune activation by vizantin. THP-1 cells treated with small interfering RNA for TLR-4 abolished vizantin-induced macrophage activation processes such as chemokine release. In addition, compared with wild-type mice, the release of MIP-1 beta induced by vizantin in vivo was significantly decreased in TLR-4 knockout mice, but not in TLR-2 knockout mice. Vizantin induced the release of IL-8 when HEK293T cells were transiently cotransfected with TLR-4 and MD-2, but not when they were transfected with TLR-4 or MD-2 alone or with TLR-2 or TLR-2/MD-2. A dipyrromethene boron difluoride-conjugated vizantin colocalized with TLR-4/MD-2, but not with TLR-4 or MD-2 alone. A pull-down assay with vizantin-coated magnetic beads showed that vizantin bound to TLR-4/MD-2 in extracts from HEK293T cells expressing both TLR-4 and MD-2. Furthermore, vizantin blocked the LPS-induced release of TNF-alpha and IL-1 beta and inhibited death in mice. We also performed in silico docking simulation analysis of vizantin and MD-2 based on the structure of MD-2 complexed with the LPS antagonist E5564; the results suggested that vizantin could bind to the active pocket of MD-2. Our observations show that vizantin specifically binds to the TLR-4/MD-2 complex and that the vizantin receptor is identical to the LPS receptor. We conclude that vizantin could be an effective adjuvant and a therapeutic agent in the treatment of infectious diseases and the endotoxin shock caused by LPS.	[Oda, Masataka; Shibutani, Masahiro; Yabiku, Kenta; Tarui, Takafumi; Kameyama, Naoya; Shirakawa, Daiki; Obayashi, Sumiyo; Watanabe, Naoyuki; Nakase, Hiroshi; Nagahama, Masahiro; Sakurai, Jun] Tokushima Bunri Univ, Fac Pharmaceut Sci, Dept Microbiol, Tokushima 7708514, Japan; [Oda, Masataka; Kurosawa, Mie; Terao, Yutaka] Niigata Univ, Grad Sch Med & Dent Sci, Div Microbiol & Infect Dis, Chuo Ku, Niigata 9518514, Japan; [Yamamoto, Hirofumi; Nakano, Mayo; Nakase, Hiroshi; Nishizawa, Mugio] Tokushima Bunri Univ, Fac Pharmaceut Sci, Dept Chem & Funct Mol, Tokushima 7708514, Japan; [Suenaga, Midori; Matsunaga, Yoichi] Tokushima Bunri Univ, Fac Pharmaceut Sci, Dept Med Pharmacol, Tokushima 7708514, Japan; [Takahashi, Hironobu] Tokushima Bunri Univ, Fac Pharmaceut Sci, Inst Pharmacognosy, Tokushima 7708514, Japan	Sakurai, J (reprint author), Tokushima Bunri Univ, Fac Pharmaceut Sci, Yamashiro Cho, Tokushima 7708514, Japan.	sakurai@ph.bunri-u.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology of the Japanese Government [S0891078]	This work was supported by a grant-in-aid (Senryaku-project S0891078) from the Ministry of Education, Culture, Sports, Science, and Technology of the Japanese Government.	Ii M, 2006, MOL PHARMACOL, V69, P1288, DOI 10.1124/mol.105.019695; Godowski PJ, 2005, NAT IMMUNOL, V6, P544, DOI 10.1038/ni0605-544; Fort MM, 2005, J IMMUNOL, V174, P6416; Fleischer JG, 2012, INNATE IMMUN-LONDON, V18, P171, DOI 10.1177/1753425910394395; Sandhu A, 2010, NANOTECHNOLOGY, V21, DOI 10.1088/0957-4484/21/44/442001; Czeslick E, 2006, INFLAMM RES, V55, P511, DOI 10.1007/s00011-006-6057-3; Shirey KA, 2013, NATURE, V497, P498, DOI 10.1038/nature12118; Kawai T, 2007, SEMIN IMMUNOL, V19, P24, DOI 10.1016/j.smim.2006.12.004; Rossignol DP, 2002, J ENDOTOXIN RES, V8, P483, DOI 10.1179/096805102125001127; Opal SM, 2013, JAMA-J AM MED ASSOC, V309, P1154, DOI 10.1001/jama.2013.2194; Okamoto M, 2004, CANCER RES, V64, P5461, DOI 10.1158/0008-5472.CAN-03-4005; Kobayashi M, 2006, J IMMUNOL, V176, P6211; Mai CW, 2013, ONCOTARGETS THER, V6, P1573, DOI 10.2147/OTT.S50838; Jiang ZF, 2005, NAT IMMUNOL, V6, P565, DOI 10.1038/ni1207; Artner D, 2013, ACS CHEM BIOL, V8, P2423, DOI 10.1021/cb4003199; Tapping RI, 2000, J IMMUNOL, V165, P5780; Shimazu R, 1999, J EXP MED, V189, P1777, DOI 10.1084/jem.189.11.1777; Nagai Y, 2002, NAT IMMUNOL, V3, P667, DOI 10.1038/ni809; Liang QL, 2011, J BIOL CHEM, V286, P26470, DOI 10.1074/jbc.M111.227934; Qureshi ST, 1999, J EXP MED, V189, P615, DOI 10.1084/jem.189.4.615; Poltorak A, 1998, BLOOD CELL MOL DIS, V24, P340, DOI 10.1006/bcmd.1998.0201; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Lemaitre B, 1996, CELL, V86, P973, DOI 10.1016/S0092-8674(00)80172-5; Hoshino K, 1999, J IMMUNOL, V162, P3749; WRIGHT SD, 1990, SCIENCE, V249, P1431, DOI 10.1126/science.1698311; Didierlaurent AM, 2009, J IMMUNOL, V183, P6186, DOI 10.4049/jimmunol.0901474; Visintin A, 2005, J IMMUNOL, V175, P6465; Yamamoto H, 2013, CHEM PHARM BULL, V61, P452; Kim HM, 2007, CELL, V130, P906, DOI 10.1016/j.cell.2007.08.002; Schromm AB, 2001, J EXP MED, V194, P79, DOI 10.1084/jem.194.1.79; Barochia A, 2011, EXPERT OPIN DRUG MET, V7, P479, DOI 10.1517/17425255.2011.558190; Angus DC, 2001, CRIT CARE MED, V29, P1303, DOI 10.1097/00003246-200107000-00002; Akira S, 2001, NAT IMMUNOL, V2, P675, DOI 10.1038/90609; Ohto U, 2007, SCIENCE, V316, P1632, DOI 10.1126/science.1139111; Daubeuf B, 2007, J IMMUNOL, V179, P6107; AZUMA I, 1974, GANN, V65, P493; Azuma I, 2001, INT IMMUNOPHARMACOL, V1, P1249, DOI 10.1016/S1567-5769(01)00055-8; BEKIERKU.A, 1971, SCIENCE, V174, P1240, DOI 10.1126/science.174.4015.1240; BEKIERKU.A, 1968, J BACTERIOL, V96, P958; BLOCH H, 1950, J EXP MED, V92, P507, DOI 10.1084/jem.92.6.507; Bowdish DME, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000474; CHRIST WJ, 1995, SCIENCE, V268, P80, DOI 10.1126/science.7701344; Lin YS, 2011, J BIOL CHEM, V286, P43782, DOI 10.1074/jbc.M111.285171; NATSUHARA Y, 1990, CANCER IMMUNOL IMMUN, V31, P99, DOI 10.1007/BF01742373; NOLL H, 1956, BIOCHIM BIOPHYS ACTA, V20, P299, DOI 10.1016/0006-3002(56)90289-X; NUMATA F, 1985, CHEM PHARM BULL, V33, P4544; OHTSURO Y, 1991, IMMUNOLOGY, V74, P497; Okamoto Masato, 2003, Journal of Medical Investigation, V50, P9; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Rangel-Frausto MS, 2005, ARCH MED RES, V36, P672, DOI 10.1016/j.arcmed.2005.06.006; RIBI E, 1982, IMMUNOLOGY, V46, P297; SAKURAI T, 1989, VACCINE, V7, P269, DOI 10.1016/0264-410X(89)90242-9; SASAKI H, 1990, CANCER RES, V50, P4032; SASAKI H, 1993, NAT IMMUN, V12, P104; TANIYAMA T, 1975, JPN J MICROBIOL, V19, P255; TENU JP, 1980, EUR J IMMUNOL, V10, P647, DOI 10.1002/eji.1830100813; Uehori J, 2003, INFECT IMMUN, V71, P4238, DOI 10.1128/IAI.71.8.4238-4249.2003; Yamamoto H, 2013, J MED CHEM, V56, P381, DOI 10.1021/jm3016443; YAMAMURA Y, 1976, ANN NY ACAD SCI, V277, P209, DOI 10.1111/j.1749-6632.1976.tb41699.x	59	1	1	AMER ASSOC IMMUNOLOGISTS	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0022-1767	1550-6606		J IMMUNOL	J. Immunol.	NOV 1	2014	193	9					4507	4514		10.4049/jimmunol.1401796		8	Immunology	Immunology	AS1ZS	WOS:000344079500025		
J	Wang, HS; Yan, M; Sun, JF; Jain, S; Yoshimi, R; Abolfath, SM; Ozato, K; Coleman, WG; Ng, AP; Metcalf, D; DiRago, L; Nutt, SL; Morse, HC				Wang, Hongsheng; Yan, Ming; Sun, Jiafang; Jain, Shweta; Yoshimi, Ryusuke; Abolfath, Sanaz Momben; Ozato, Keiko; Coleman, William G., Jr.; Ng, Ashley P.; Metcalf, Donald; DiRago, Ladina; Nutt, Stephen L.; Morse, Herbert C., III			A reporter mouse reveals lineage-specific and heterogeneous expression of IRF8 during lymphoid and myeloid cell differentiation (vol 193, pg 1766, 2014)	JOURNAL OF IMMUNOLOGY			English	Correction									[Wang, Hongsheng; Sun, Jiafang; Jain, Shweta; Abolfath, Sanaz Momben; Morse, Herbert C., III] Natl Inst Allergy & Infect Dis, Virol & Cellular Immunol Sect, Immunogenet Lab, NIH, Rockville, MD 20852 USA; [Yan, Ming; Coleman, William G., Jr.] Natl Inst Minor Hlth & Hlth Dispar, Div Intramural Res, NIH, Bethesda, MD 20892 USA; [Yan, Ming; Coleman, William G., Jr.] Natl Inst Diabet & Digest & Kidney Dis, Lab Biochem & Genet, NIH, Bethesda, MD 20892 USA; [Yoshimi, Ryusuke] Yokohama City Univ, Grad Sch Med, Dept Internal Med & Clin Immunol, Yokohama, Kanagawa 2360004, Japan; [Ozato, Keiko] NICHHD, Program Genom Differentiat, NIH, Bethesda, MD 20892 USA; [Ng, Ashley P.; Metcalf, Donald; DiRago, Ladina; Nutt, Stephen L.] Walter & Eliza Hall Inst Med Res, Parkville, Vic 3052, Australia; [Ng, Ashley P.; Metcalf, Donald; Nutt, Stephen L.] Univ Melbourne, Dept Med Biol, Parkville, Vic 3010, Australia	Wang, HS (reprint author), Natl Inst Allergy & Infect Dis, Virol & Cellular Immunol Sect, Immunogenet Lab, NIH, Rockville, MD 20852 USA.						Wang HS, 2014, J IMMUNOL, V193, P1766, DOI 10.4049/jimmunol.1301939	1	0	0	AMER ASSOC IMMUNOLOGISTS	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0022-1767	1550-6606		J IMMUNOL	J. Immunol.	NOV 1	2014	193	9					4749	4749		10.4049/jimmunol.1490036		1	Immunology	Immunology	AS1ZS	WOS:000344079500050		
J	Nakajima, Y; Meijer, J; Dobritzsch, D; Ito, T; Meinsma, R; Abeling, NGGM; Roelofsen, J; Zoetekouw, L; Watanabe, Y; Tashiro, K; Lee, T; Takeshima, Y; Mitsubuchi, H; Yoneyama, A; Ohta, K; Eto, K; Saito, K; Kuhara, T; van Kuilenburg, ABP				Nakajima, Yoko; Meijer, Judith; Dobritzsch, Doreen; Ito, Tetsuya; Meinsma, Rutger; Abeling, Nico G. G. M.; Roelofsen, Jeroen; Zoetekouw, Lida; Watanabe, Yoriko; Tashiro, Kyoko; Lee, Tomoko; Takeshima, Yasuhiro; Mitsubuchi, Hiroshi; Yoneyama, Akira; Ohta, Kazuhide; Eto, Kaoru; Saito, Kayoko; Kuhara, Tomiko; van Kuilenburg, Andre B. P.			Clinical, biochemical and molecular analysis of 13 Japanese patients with beta-ureidopropionase deficiency demonstrates high prevalence of the c.977G < A (p.R326Q) mutation (vol 37, pg 801, 2014)	JOURNAL OF INHERITED METABOLIC DISEASE			English	Correction									[Nakajima, Yoko; Meijer, Judith; Meinsma, Rutger; Abeling, Nico G. G. M.; Roelofsen, Jeroen; Zoetekouw, Lida; van Kuilenburg, Andre B. P.] Univ Amsterdam, Acad Med Ctr, Dept Clin Chem, Lab Genet Metab, NL-1105 AZ Amsterdam, Netherlands; [Nakajima, Yoko; Ito, Tetsuya] Nagoya City Univ, Grad Sch Med Sci, Dept Pediat & Neonatol, Nagoya, Aichi 4678601, Japan; [Dobritzsch, Doreen] Uppsala Univ, BMC, Dept Chem, S-75123 Uppsala, Sweden; [Watanabe, Yoriko] Kurume Univ, Sch Med, Dept Pediat & Child Hlth, Kurume, Fukuoka 8300011, Japan; [Watanabe, Yoriko; Tashiro, Kyoko] Kurume Univ, Sch Med, Res Inst Med Mass Spectrometry, Kurume, Fukuoka 8300011, Japan; [Lee, Tomoko; Takeshima, Yasuhiro] Kobe Univ, Grad Sch Med, Dept Pediat, Kobe, Hyogo 6500017, Japan; [Mitsubuchi, Hiroshi] Kumamoto Univ Hosp, Dept Neonatol, Kumamoto 8608556, Japan; [Yoneyama, Akira] Natl Rehabil Ctr Disabled Children, Tokyo 1730037, Japan; [Ohta, Kazuhide] Natl Hosp Org Kanazawa, Med Ctr, Dept Pediat, Kanazawa, Ishikawa 9208650, Japan; [Eto, Kaoru] Tokyo Womens Med Univ, Dept Pediat, Tokyo 1628111, Japan; [Saito, Kayoko] Tokyo Womens Med Univ, Inst Med Genet, Tokyo 1620054, Japan; [Kuhara, Tomiko] Japan Clin Metabol Inst, Kahoku, Ishikawa 9291174, Japan	Nakajima, Y (reprint author), Nagoya City Univ, Grad Sch Med Sci, Dept Pediat & Neonatol, Nagoya, Aichi 4678601, Japan.	ncu.metabolism@gmail.com					Nakajima Y, 2014, J INHERIT METAB DIS, V37, P801, DOI 10.1007/s10545-014-9682-y	1	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0141-8955	1573-2665		J INHERIT METAB DIS	J. Inherit. Metab. Dis.	NOV	2014	37	6					1023	1023		10.1007/s10545-014-9754-z		1	Endocrinology & Metabolism; Genetics & Heredity	Endocrinology & Metabolism; Genetics & Heredity	AS5SN	WOS:000344330000017		
J	Kosugi, Y; Bandow, S				Kosugi, Yuta; Bandow, Shunji			Structure and Electronic States of Zinc-Doped Iron Oxide Nanotubes Prepared by a Surfactant-Assisted Sol-Gel Method	JOURNAL OF INORGANIC AND ORGANOMETALLIC POLYMERS AND MATERIALS			English	Article						Iron oxide; Zinc doped iron oxide; Nanotube; Sol-Gel; Band gap	PHOTOCATALYTIC ACTIVITY; TEMPLATE SYNTHESIS; TIO2 NANOTUBE; ZNFE2O4; ZNO; NANOSTRUCTURES; NANOPARTICLES; ARRAYS; CARBON; IN2O3	We report the doping of iron oxide nanotubes with zinc, and the characterization of the resulting zinc ferrite nanotubes. Gels were prepared by polycondensing iron nitrate nonahydrate and zinc nitrate hexahydrate on the surface of a self-assembled non-ionic surfactant in 1-propanol at 45 A degrees C. Evaporation of the solvent within the gels at 120 A degrees C led to the formation of tubular structures, as evidenced by transmission electron microscopy. The nanotubes had internal and external diameters of similar to 2-6 and 4-10 nm, respectively, and were similar to 50 nm long. X-ray diffraction and X-ray photoelectron spectroscopy indicated that the nanotubes possessed a spinel structure, and had a composition of Zn (x) Fe3-x O-4, with x ranging from 0 to 0.66. Direct band gaps were evaluated from optical absorption spectra, using the Tauc plot method. The band gaps ranged from 2.4 (x = 0) to 2.0 eV (x = 0.27), thus narrowing upon doping with Zn. This was tentatively attributed to a widening of the band width, and the formation of sub-levels at octahedral B sites of the spinel structure.	[Kosugi, Yuta] Meijo Univ, Dept Mat Sci & Engn, Tenpa Ku, Nagoya, Aichi 4688502, Japan; [Bandow, Shunji] Meijo Univ, Dept Appl Chem, Tenpa Ku, Nagoya, Aichi 4688502, Japan	Bandow, S (reprint author), Meijo Univ, Dept Appl Chem, Tenpa Ku, 1-501 Shiogamaguchi, Nagoya, Aichi 4688502, Japan.	bandow@meijo-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology (MEXT) [25390021]; promotion of advanced research project, Nano Carbon Research Center, Meijo University, Nagoya, Japan	The authors acknowledge financial support from the Grants-in-Aid for Scientific Research (C) no. 25390021 of the Ministry of Education, Culture, Sports, Science and Technology (MEXT). This study was also supported by the promotion of advanced research project, Nano Carbon Research Center, Meijo University, Nagoya, Japan.	Janaky C, 2012, J PHYS CHEM C, V116, P19145, DOI 10.1021/jp305181h; Chandiran AK, 2014, NANO LETT, V14, P1190, DOI 10.1021/nl4039955; IIJIMA S, 1991, NATURE, V354, P56, DOI 10.1038/354056a0; Juarez BH, 2005, ADV MATER, V17, P2761, DOI 10.1002/adma.200500569; Cimitan S, 2009, J COLLOID INTERF SCI, V329, P73, DOI 10.1016/j.jcis.2008.09.060; Li XY, 2011, CHEMOSPHERE, V82, P581, DOI 10.1016/j.chemosphere.2010.09.068; Cai B, 2013, ENERG ENVIRON SCI, V6, P1480, DOI 10.1039/c3ee40343b; Hsu CY, 2012, ACS NANO, V6, P6687, DOI 10.1021/nn3011625; Lee N, 2012, CHEM SOC REV, V41, P2575, DOI 10.1039/c1cs15248c; Lakshmi BB, 1997, CHEM MATER, V9, P857, DOI 10.1021/cm9605577; Lin H, 2006, APPL CATAL B-ENVIRON, V68, P1, DOI 10.1016/j.apcatb.2006.07.018; JEYADEVAN B, 1994, J APPL PHYS, V76, P6325, DOI 10.1063/1.358255; Lakshmi BB, 1997, CHEM MATER, V9, P2544, DOI 10.1021/cm970268y; McFarland EW, 2013, CHEM REV, V113, P4391, DOI 10.1021/cr300418s; Jung JH, 2002, CHEM MATER, V14, P1445, DOI 10.1021/cm011625e; Kislov N, 2008, MATER SCI ENG B-ADV, V153, P70, DOI 10.1016/j.mseb.2008.10.032; Jia CJ, 2005, ANGEW CHEM INT EDIT, V44, P4328, DOI 10.1002/anie.200463038; TAUC J, 1966, PHYS STATUS SOLIDI, V15, P627, DOI 10.1002/pssb.19660150224; Ehrhardt H, 2003, SCRIPTA MATER, V48, P1141, DOI [10.1016/S1359-6462(02)00598-5, 10.1016/S135906462(02)00598-5]; Bandow S., 2014, MATER RES SOC S P, V1659, DOI [10.1557/opl.2014.133, DOI 10.1557/0PL.2014.133]; Boxall C, 1996, J CHEM SOC FARADAY T, V92, P791, DOI 10.1039/ft9969200791; Cheng B, 2001, J MATER CHEM, V11, P2901, DOI 10.1039/b108167e; Torres CER, 2014, PHYS REV B, V89, DOI 10.1103/PhysRevB.89.104411; Jolivet JP, 2004, CHEM COMMUN, P481, DOI 10.1039/b304532n; Kato R, 2013, J INORG ORGANOMET P, V23, P167, DOI 10.1007/s10904-012-9725-5; Kumar S.S., 2013, INT NANO LETT, V3, P30, DOI DOI 10.1186/2228-5326-3-30; Lai C.W., 2014, INT J PHOTOENERGY, V2014, P15; Li YB, 2003, ADV MATER, V15, P581, DOI 10.1002/adma.200304539; Liu H, 2012, J NANOMATER, DOI 10.1155/2012/235879; Liu XY, 2013, J MATER CHEM C, V1, P329, DOI 10.1039/c2tc00072e; Marand Z. R., 2012, P 4 INT C NAN ICNS4, P211; Nunome T, 2013, J CERAM SOC JPN, V121, P26, DOI 10.2109/jcersj2.121.26; Shen XP, 2004, CHEM LETT, V33, P1128, DOI 10.1246/cl.2004.1128; Sutka A, 2014, PHYS SCRIPTA, V89, DOI 10.1088/0031-8949/89/04/044011; Tokudome H, 2004, CHEM LETT, V33, P1108, DOI 10.1246/cl.2004.1108; Valenzuela MA, 2002, J PHOTOCH PHOTOBIO A, V148, P177, DOI 10.1016/S1010-6030(02)00040-0; Wagner C. D., 1979, HDB XRAY PHOTOELECTR; Wongsaprom K, 2014, APPL PHYS A-MATER, V114, P373, DOI 10.1007/s00339-013-8197-y; Zelis PM, 2013, J PHYS D APPL PHYS, V46, DOI 10.1088/0022-3727/46/12/125006; Zhou Q, 2013, SENSORS-BASEL, V13, P6171, DOI 10.3390/s130506171	40	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	1574-1443	1574-1451		J INORG ORGANOMET P	J. Inorg. Organomet. Polym. Mater.	NOV	2014	24	6					933	939		10.1007/s10904-014-0072-6		7	Polymer Science	Polymer Science	AS2FB	WOS:000344094000003		
J	Yanai, H; Taniguchi, T				Yanai, H.; Taniguchi, T.			Nucleic acid sensing and beyond: virtues and vices of high-mobility group box 1	JOURNAL OF INTERNAL MEDICINE			English	Review						autophagy; high-mobility group box 1; infection; inflammation; nucleic acids; sepsis	PATTERN-RECOGNITION RECEPTORS; INNATE IMMUNE-RESPONSE; MITOCHONDRIAL QUALITY-CONTROL; SYSTEMIC-LUPUS-ERYTHEMATOSUS; CYTOSOLIC DNA SENSOR; TOLL-LIKE RECEPTORS; CYCLIC GMP-AMP; ACUTE-PANCREATITIS; INTRACELLULAR DNA; DENDRITIC CELLS	High-mobility group box 1 (HMGB1) was first described as an architectural chromatin-binding protein. Today, a wealth of evidence indicates that this protein is very versatile and serves an amazing assortment of roles in the nucleus, cytoplasm and extracellular milieu. As a result, HMGB1 is fast becoming recognized as a key regulator of protective and pathological immune responses. Whilst acknowledging the many functions of HMGB1 and its family members, we focus this review on their role as broad effectors of immune responses mediated by nucleic acids. In addition, we touch upon the recent progress in determining the in vivo role of HMGB1 as revealed by the study of mice conditionally null for the Hmgb1 gene.	[Yanai, H.; Taniguchi, T.] Univ Tokyo, Max Planck Univ Tokyo Ctr Integrat Inflammol, Dept Mol Immunol, Inst Ind Sci, Tokyo 1538505, Japan; [Yanai, H.; Taniguchi, T.] Japan Sci & Technol Agcy, Core Res Evolut Sci & Technol, Tokyo, Japan	Taniguchi, T (reprint author), Univ Tokyo, Max Planck Univ Tokyo Ctr Integrat Inflammol, Dept Mol Immunol, Inst Ind Sci,Meguro Ku, Komaba 4-6-1, Tokyo 1538505, Japan.	tada@m.u-tokyo.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan; Core Research for Evolutional Science and Technology (CREST) of the Japan Science and Technology Agency (JST); BONAC Corporation; Kyowa Hakko Kirin Co., Ltd.	This work was supported in part by a Grant-in-Aid for Scientific Research on Innovative Areas from the Ministry of Education, Culture, Sports, Science and Technology of Japan, and by Core Research for Evolutional Science and Technology (CREST) of the Japan Science and Technology Agency (JST). The Department of Molecular Immunology is supported by BONAC Corporation and Kyowa Hakko Kirin Co., Ltd.	Harris HE, 2012, NAT REV RHEUMATOL, V8, P195, DOI 10.1038/nrrheum.2011.222; Li JH, 2003, MOL MED, V9, P37; Pandol SJ, 2007, GASTROENTEROLOGY, V132, P1127, DOI 10.1053/j.gastro.2007.01.055; Hu XY, 2008, IMMUNOL REV, V226, P41, DOI 10.1111/j.1600-065X.2008.00707.x; Yanai H, 2013, P NATL ACAD SCI USA, V110, P20699, DOI 10.1073/pnas.1320808110; Calogero S, 1999, NAT GENET, V22, P276, DOI 10.1038/10338; Moisy D, 2012, J VIROL, V86, P9122, DOI 10.1128/JVI.00789-12; Sun LJ, 2013, SCIENCE, V339, P786, DOI 10.1126/science.1232458; Parvatiyar K, 2012, NAT IMMUNOL, V13, P1155, DOI 10.1038/ni.2460; Burdette DL, 2011, NATURE, V478, P515, DOI 10.1038/nature10429; Tang DL, 2011, CELL METAB, V13, P701, DOI 10.1016/j.cmet.2011.04.008; Kang R, 2010, AUTOPHAGY, V6, P1209, DOI 10.1083/jcb.200911078; Wang HC, 1999, SCIENCE, V285, P248, DOI 10.1126/science.285.5425.248; Cooke MS, 2003, FASEB J, V17, P1195, DOI 10.1096/fj.02-0752rev; Camargo FD, 2003, NAT MED, V9, P1520, DOI 10.1038/nm963; Matsumoto Y, 2012, CELL HOST MICROBE, V11, P492, DOI 10.1016/j.chom.2012.04.009; Shi CS, 2012, NAT IMMUNOL, V13, P255, DOI 10.1038/ni.2215; Chiba S, 2012, NAT IMMUNOL, V13, P832, DOI 10.1038/ni.2376; Stetson DB, 2008, CELL, V134, P587, DOI 10.1016/j.cell.2008.06.032; Nakano H, 2001, J EXP MED, V194, P1171, DOI 10.1084/jem.194.8.1171; Tamura T, 2008, ANNU REV IMMUNOL, V26, P535, DOI 10.1146/annurev.immunol.26.021607.090400; Kawane K, 2006, NATURE, V443, P998, DOI 10.1038/nature05245; Urbonaviciute V, 2008, J EXP MED, V205, P3007, DOI 10.1084/jem.20081165; Gardella S, 2002, EMBO REP, V3, P995, DOI 10.1093/embo-reports/kvf198; Yanai H, 2009, NATURE, V462, P99, DOI 10.1038/nature08512; Takaoka A, 2007, NATURE, V448, P501, DOI 10.1038/nature06013; Kuma A, 2004, NATURE, V432, P1032, DOI 10.1038/nature03029; Yanai H, 2011, P NATL ACAD SCI USA, V108, P11542, DOI 10.1073/pnas.1108535108; Napirei M, 2000, NAT GENET, V25, P177; Hreggvidsdottir HS, 2012, MOL MED, V18, P224, DOI 10.2119/molmed.2011.00327; Taniguchi T, 2001, NAT REV MOL CELL BIO, V2, P378, DOI 10.1038/35073080; Martinon F, 2009, ANNU REV IMMUNOL, V27, P229, DOI [10.1146/annurev.immunol.021908.132715, 10.1146/annurev.immunol.021908.132532]; Pisitkun P, 2006, SCIENCE, V312, P1669, DOI 10.1126/science.1124978; Lee MN, 2013, NAT IMMUNOL, V14, P179, DOI 10.1038/ni.2509; Scaffidi P, 2002, NATURE, V418, P191, DOI 10.1038/nature00858; Yoneyama M, 2009, IMMUNOL REV, V227, P54, DOI 10.1111/j.1600-065X.2008.00727.x; Honda K, 2006, NAT REV IMMUNOL, V6, P644, DOI 10.1038/nri1900; Huang H, 2014, HEPATOLOGY, V59, P1984, DOI 10.1002/hep.26976; Tsung A, 2007, J EXP MED, V204, P2913, DOI 10.1084/jem.20070247; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Sims GP, 2010, ANNU REV IMMUNOL, V28, P367, DOI 10.1146/annurev.immunol.021908.132603; Xu Y, 2007, IMMUNITY, V27, P135, DOI 10.1016/j.immuni.2007.05.022; Woodward JJ, 2010, SCIENCE, V328, P1703, DOI 10.1126/science.1189801; Rouleau M, 2010, NAT REV CANCER, V10, P293, DOI 10.1038/nrc2812; Lu B, 2014, P NATL ACAD SCI USA, V111, P3068, DOI 10.1073/pnas.1316925111; Ellerman JE, 2007, CLIN CANCER RES, V13, P2836, DOI 10.1158/1078-0432.CCR-06-1953; Yasuda T, 2006, PANCREAS, V33, P359, DOI 10.1097/01.mpa.0000236741.15477.8b; Ivanov S, 2007, BLOOD, V110, P1970, DOI 10.1182/blood-2006-09-044776; READ CM, 1993, NUCLEIC ACIDS RES, V21, P3427, DOI 10.1093/nar/21.15.3427; Antoine DJ, 2014, MOL MED, V20, P135, DOI 10.2119/molmed.2014.00022; Kawasaki T, 2011, IMMUNOL REV, V243, P61, DOI 10.1111/j.1600-065X.2011.01048.x; Bianchi ME, 2009, J LEUKOCYTE BIOL, V86, P573, DOI 10.1189/jlb.1008585; Barbalat R, 2011, ANNU REV IMMUNOL, V29, P185, DOI 10.1146/annurev-immunol-031210-101340; TOVEY MG, 1987, P NATL ACAD SCI USA, V84, P5038, DOI 10.1073/pnas.84.14.5038; Unterholzner L, 2010, NAT IMMUNOL, V11, P997, DOI 10.1038/ni.1932; Ishii KJ, 2006, NAT IMMUNOL, V7, P40, DOI 10.1038/ni1282; Martinon F, 2002, MOL CELL, V10, P417, DOI 10.1016/S1097-2765(02)00599-3; Andersson U, 2011, ANNU REV IMMUNOL, V29, P139, DOI 10.1146/annurev-immunol-030409-101323; Tang DL, 2010, J CELL BIOL, V190, P881, DOI 10.1083/jcb.200911078; Schiraldi M, 2012, J EXP MED, V209, P551, DOI 10.1084/jem.20111739; Yanai H, 2012, TRENDS IMMUNOL, V33, P633, DOI 10.1016/j.it.2012.10.005; Tang DL, 2012, MOL MED, V18, P1360, DOI 10.2119/molmed.2012.00314; Nakahira K, 2011, NAT IMMUNOL, V12, P222, DOI 10.1038/ni.1980; Medzhitov R, 2007, NATURE, V449, P819, DOI 10.1038/nature06246; Yan N, 2010, NAT IMMUNOL, V11, P1005, DOI 10.1038/ni.1941; Yang H, 2004, P NATL ACAD SCI USA, V101, P296, DOI 10.1073/pnas.2434651100; Baccala R, 2009, NAT REV RHEUMATOL, V5, P448, DOI 10.1038/nrrheum.2009.136; Kocsis AK, 2009, PANCREATOLOGY, V9, P383, DOI 10.1159/000181172; Zhang ZQ, 2011, NAT IMMUNOL, V12, P959, DOI 10.1038/ni.2091; Stetson DB, 2006, IMMUNITY, V24, P93, DOI 10.1016/j.immuni.2005.12.003; Honda K, 2006, IMMUNITY, V25, P349, DOI 10.1016/j.immuni.2006.08.009; Tsung A, 2005, J EXP MED, V201, P1135, DOI 10.1084/jem.20042614; Ishikawa H, 2009, NATURE, V461, P788, DOI 10.1038/nature08476; Thomas JO, 2001, TRENDS BIOCHEM SCI, V26, P167, DOI 10.1016/S0968-0004(01)01801-1; MERENMIES J, 1991, J BIOL CHEM, V266, P16722; Wu JX, 2013, SCIENCE, V339, P826, DOI 10.1126/science.1229963; Saitoh T, 2008, NATURE, V456, P264, DOI 10.1038/nature07383; Schroder K, 2009, CURR BIOL, V19, pR262, DOI 10.1016/j.cub.2009.02.011; Dumitriu IE, 2007, J LEUKOCYTE BIOL, V81, P84, DOI 10.1189/jlb.0306171; Huebener P, 2014, CELL METAB, V19, P539, DOI 10.1016/j.cmet.2014.01.014; Kang R, 2014, GASTROENTEROLOGY, V146, P1097, DOI 10.1053/j.gastro.2013.12.015; Lenert P, 2010, CLIN EXP IMMUNOL, V161, P208, DOI 10.1111/j.1365-2249.2010.04176.x; Li GQ, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00068; Ogawa M, 2011, MICROBIOL IMMUNOL, V55, P459, DOI 10.1111/j.1348-0421.2011.00343.x; Park HJ, 2012, J CLIN IMMUNOL, V32, P1148, DOI 10.1007/s10875-012-9815-8; Prinz M, 2006, J CLIN INVEST, V116, P456, DOI 10.1172/JCI26078; Schriewer JM, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.113.000159; Segal BM, 2000, J IMMUNOL, V164, P5683	88	3	3	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0954-6820	1365-2796		J INTERN MED	J. Intern. Med.	NOV	2014	276	5					444	453		10.1111/joim.12285		10	Medicine, General & Internal	General & Internal Medicine	AS5SP	WOS:000344330200004		
J	Takasaki, Y				Takasaki, Yoshito			HOW IS DISASTER AID ALLOCATED WITHIN POOR COMMUNITIES? RISK SHARING AND SOCIAL HIERARCHY	JOURNAL OF INTERNATIONAL DEVELOPMENT			English	Article						disaster aid; targeting; informal risk sharing; social hierarchy; Fiji	SUSTAINABLE DEVELOPMENT; SAFETY NETS; PARTICIPATION; VILLAGE; PROGRAM; FIJI	How disaster aid is allocated within poor communities is little understood. Using original post-disaster survey data in rural Fiji that capture household-level traditional kin status, cyclone damage and aid allocations over post-disaster phases, this paper demonstrates that allocations are driven by informal risk-sharing institutions and social hierarchies. On one hand, in response to a disaster with moderate severity, private risk sharing can strongly make up limited aid, making targeting aid on damage appear weak as a result. On the other hand, local elites can dominate not only aid allocation for given damage but also the targeting on damage. Copyright (c) 2014 John Wiley & Sons, Ltd.	Univ Tsukuba, Fac Humanities & Social Sci, Tsukuba, Ibaraki, Japan	Takasaki, Y (reprint author), Univ Tsukuba, Fac Humanities & Social Sci, Tsukuba, Ibaraki, Japan.	takasaki@sk.tsukuba.ac.jp					Amins S, 2008, DATA NATURAL DISASTE; Bardhan P, 2006, J DEV ECON, V79, P303, DOI 10.1016/j.jdeveco.2006.01.004; Davidson CH, 2007, HABITAT INT, V31, P100, DOI 10.1016/j.habitatint.2006.08.003; Platteau JP, 2002, J DEV STUD, V39, P104, DOI 10.1080/00220380412331322771; Meheux K, 2010, DISASTERS, V34, P1102, DOI 10.1111/j.1467-7717.2010.01185.x; TURNER JW, 1992, ETHNOLOGY, V31, P291, DOI 10.2307/3773421; Morduch J, 1999, WORLD BANK RES OBSER, V14, P187; BERTRAM G, 1986, WORLD DEV, V14, P809, DOI 10.1016/0305-750X(86)90033-1; Steinberg F, 2007, HABITAT INT, V31, P150, DOI 10.1016/j.habitatint.2006.11.002; Jayne TS, 2002, J DEV ECON, V68, P247, DOI 10.1016/S0304-3878(02)00013-5; Dercon S, 2002, WORLD BANK RES OBSER, V17, P141, DOI 10.1093/wbro/17.2.141; Conning J, 2002, WORLD DEV, V30, P375, DOI 10.1016/S0305-750X(01)00119-X; Galasso E, 2005, J PUBLIC ECON, V89, P705, DOI 10.1016/j.jpubeco.2003.01.002; Takasaki Y, 2011, ECON DEV CULT CHANGE, V59, P387, DOI 10.1086/657126; Takasaki Y, 2011, J DEV STUD, V47, P1281, DOI 10.1080/00220388.2010.509786; BERKE PR, 1993, DISASTERS, V17, P93, DOI 10.1111/j.1467-7717.1993.tb01137.x; Choguill MBG, 1996, HABITAT INT, V20, P431, DOI 10.1016/0197-3975(96)00020-3; Chen LC, 2006, NAT HAZARDS, V37, P209, DOI 10.1007/s11069-005-4669-5; Mansuri G, 2004, WORLD BANK RES OBSER, V19, P1, DOI 10.1093/wbro/lkh012; Campbells JR, 1984, DEALING DISASTER HUR; Dercons S, 2005, INSURANCE POVERTY; des Ville de Goyets C, 2008, DATA NATURAL DISASTE; Miletis D, 1999, DISASTER DESIGN REAS; Morduchs J, 2005, INSURANCE POVERTY; Ravuvus A, 1983, VAKA I TAUKEI FIJIAN; World Bank, 2002, REACH POOR REN STRAT	26	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0954-1748	1099-1328		J INT DEV	J. Int. Dev.	NOV	2014	26	8			SI		1097	1114		10.1002/jid.2985		18	Planning & Development	Public Administration	AT2BQ	WOS:000344736300001		
J	Hongo, F; Kawauchi, A; Itoh, Y; Fujii, H; Naitoh, Y; Nakamura, T; Naya, Y; Kamoi, K; Okihara, K; Miki, T				Hongo, Fumiya; Kawauchi, Akihiro; Itoh, Yoshizo; Fujii, Hidetaka; Naitoh, Yasuyuki; Nakamura, Terukazu; Naya, Yoshio; Kamoi, Kazumi; Okihara, Koji; Miki, Tsuneharu			Experience of Laparoscopic Partial Nephrectomy Using a Kidney Grasper in Selective Cases	JOURNAL OF LAPAROENDOSCOPIC & ADVANCED SURGICAL TECHNIQUES			English	Article							NEPHRON-SPARING SURGERY; RENAL-CELL CARCINOMA; INITIAL-EXPERIENCE; PARENCHYMA; TUMORS; GUIDELINES	Objective: To evaluate the feasibility of regional cramp in laparoscopic partial nephrectomy, we performed partial nephrectomy using a kidney grasper that enabled the application of ischemia to a limited region of the kidney. Materials and Methods: The subjects were 5 renal cell carcinoma patients. The mean tumor diameter was 15 mm. There were 2 male and 3 female patients. A transperitoneal approach was used in all cases. Following the standard procedure of laparoscopic partial resection, the hilum of the kidney was confirmed and treated to prepare for rapidly applying clamping with forceps. Tumor resection and suture were then performed under partial warm ischemia using a kidney grasper. Results: Surgery could be completed in 4 patients using this method. In the remaining patient, control of bleeding was considered difficult during tumor resection after applying partial ischemia, and so the procedure was switched to renal artery clamping using bulldog forceps. In the 4 patients in whom a kidney grasper was used, the mean partial warm ischemia time was 23.6 minutes (range, 23-25 minutes), and the mean blood loss was 110 mL (range, 20-260 mL). Conclusions: This procedure may be a useful option in ischemia for partial nephrectomy.	[Hongo, Fumiya; Fujii, Hidetaka; Naitoh, Yasuyuki; Nakamura, Terukazu; Naya, Yoshio; Kamoi, Kazumi; Okihara, Koji; Miki, Tsuneharu] Kyoto Prefectural Univ Med, Dept Urol, Kyoto 6028566, Japan; [Kawauchi, Akihiro] Shiga Univ Med Sci, Dept Urol, Otsu, Shiga, Japan; [Itoh, Yoshizo] Kyoto Second Red Cross Hosp, Dept Urol, Kyoto, Japan	Hongo, F (reprint author), Kyoto Prefectural Univ Med, Dept Urol, Kamigyo Ku, 465 Kajii Cho, Kyoto 6028566, Japan.	fhongo@koto.kpu-m.ac.jp					Viprakasit DP, 2011, J ENDOUROL, V25, P1487, DOI 10.1089/end.2010.0667; Motzer RJ, 2009, J NATL COMPR CANC NE, V7, P618; Hung AJ, 2013, J UROLOGY, V189, P36, DOI 10.1016/j.juro.2012.09.042; Gill IS, 2012, J UROLOGY, V187, P807, DOI 10.1016/j.juro.2011.10.146; Ljungberg B, 2010, EUR UROL, V58, P398, DOI 10.1016/j.eururo.2010.06.032; Bensalah K, 2008, BJU INT, V101, P467, DOI 10.1111/j.1464-410X.2007.07276.x; Ogan K, 2003, J ENDOUROL, V17, P295, DOI 10.1089/089277903322145468; Denardi F, 2005, BJU INT, V96, P1036, DOI 10.1111/j.1464-410X.2005.05805.x; Fujioka T, 2009, INT J UROL, V16, P339, DOI 10.1111/j.1442-2042.2008.02242.x; GILL IS, 1995, J UROLOGY, V154, P1113, DOI 10.1016/S0022-5347(01)66991-X; Harmon WJ, 2000, UROLOGY, V56, P754, DOI 10.1016/S0090-4295(00)00766-4; Janetschek G, 2007, EUR UROL, V52, P1303, DOI 10.1016/j.eururo.2007.05.006; Moinzadeh A, 2005, J UROLOGY, V174, P317, DOI 10.1097/01.ju.0000161587.95033.c9; Nozaki T, 2012, J LAPAROENDOSC ADV S, V22, P168, DOI 10.1089/lap.2011.0245; Simon J, 2009, BJU INT, V103, P805, DOI 10.1111/j.1464-410X.2008.08112.x; Sundaram CP, 2003, UROLOGY, V61, P906, DOI 10.1016/S0090-4295(02)02550-5; Tatsugami K, 2012, BJU INT, V110, pE357, DOI [10.1111/j.1464-410X.2012.011027.x, 10.1111/j.1464-410X.2012.11027.x]; Terai A, 2004, EUR UROL, V45, P744, DOI 10.1016/j.eururo.2004.02.007; Toren Paul, 2010, Can Urol Assoc J, V4, pE133; Verhoest G, 2007, EUR UROL, V52, P1340, DOI 10.1016/j.eururo.2007.04.072; Viprakasit DP, 2010, UROLOGY, V76, P750, DOI 10.1016/j.urology.2010.03.051; Zeltser IS, 2008, BJU INT, V101, P36, DOI 10.1111/j.1464-410X.2007.07176.x	22	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	1092-6429	1557-9034		J LAPAROENDOSC ADV S	J. Laparoendosc. Adv. Surg. Tech.	NOV 1	2014	24	11					795	798		10.1089/lap.2014.0212		4	Surgery	Surgery	AS6QN	WOS:000344387700009		
J	Haspelmath, M; Calude, A; Spagnol, M; Narrog, H; Bamyaci, E				Haspelmath, Martin; Calude, Andreea; Spagnol, Michael; Narrog, Heiko; Bamyaci, Elif			Coding causal-noncausal verb alternations: A form-frequency correspondence explanation	JOURNAL OF LINGUISTICS			English	Article							MARKEDNESS; MORPHOLOGY; GRAMMAR	We propose, and provide corpus-based support for, a usage-based explanation for cross-linguistic trends in the coding of causal-noncausal verb pairs, such as raise/rise, break (tr.)/break (intr.). While English mostly uses the same verb form both for the causal and the noncausal sense (labile coding), most languages have extra coding for the causal verb (causative coding) and/or for the noncausal verb (anticausative coding). Causative and anticausative coding is not randomly distributed (Haspelmath 1993): Some verb meanings, such as freeze', dry' and melt', tend to be coded as causatives, while others, such as break', open' and split', tend to be coded as anticausatives. We propose an explanation of these coding tendencies on the basis of the form-frequency correspondence principle, which is a general efficiency principle that is responsible for many grammatical asymmetries, ultimately grounded in predictability of frequently expressed meanings. In corpus data from seven languages, we find that verb pairs for which the noncausal member is more frequent tend to be coded as anticausatives, while verb pairs for which the causal member is more frequent tend to be coded as causatives. Our approach implies that linguists should not rely on form-meaning parallelism when trying to explain cross-linguistic or language-particular patterns in this domain.	[Haspelmath, Martin] Max Planck Inst Evolutionary Anthropol, D-04103 Leipzig, Germany; [Calude, Andreea] Univ Waikato, Hamilton, New Zealand; [Spagnol, Michael] Univ Malta, Msida, Malta; [Narrog, Heiko] Tohoku Univ, Sendai, Miyagi 980, Japan; [Bamyaci, Elif] Univ Wurzburg, Wurzburg, Germany	Haspelmath, M (reprint author), Max Planck Inst Evolutionary Anthropol, Deutsch Pl 6, D-04103 Leipzig, Germany.	haspelmt@eva.mpg.de					Alexiadou Artemis, 2010, SYNTAX LEXICAL SEMAN, P177; Haspelmath M, 2010, LANGUAGE, V86, P663; Haspelmath M, 2008, COGN LINGUIST, V19, P1, DOI 10.1515/COG.2008.001; Haspelmath M, 2006, J LINGUIST, V42, P25, DOI 10.1017/S0022226705003683; Bybee J, 2006, LANGUAGE, V82, P711, DOI 10.1353/lan.2006.0186; Koontz-Garboden A, 2009, NAT LANG LINGUIST TH, V27, P77, DOI 10.1007/s11049-008-9058-9; HAIMAN J, 1983, LANGUAGE, V59, P781, DOI 10.2307/413373; BORER H, 1991, LINGUIST REV, V8, P119, DOI 10.1515/tlir.1991.8.2-4.119; Clark Eve V., 1978, UNIVERSALS HUMAN LAN, P225; Comrie Bernard, 1985, LANGUAGE TYPOLOGY SY, V3, P309; Comrie Bernard, 1993, CAUSATIVES TRANSITIV, V23, P87, DOI DOI 10.1075/SLCS.23.05HAS; Croft William, 1990, MEANINGS PROTOTYPES, P48; Croft William H., 2003, TYPOLOGY UNIVERSALS; Cysouw Michael, 2008, LINGUISTISCHE ARBEIT, V86, P379; Dixon Robert M. W., 2000, CHANGING VALENCY CAS, P1, DOI [10.1017/CBO9780511627750.002, DOI 10.1017/CBO9780511627750.002]; Doron Edit, 2003, NAT LANG SEMANT, V11, P1, DOI 10.1023/A:1023021423453; Frascarelli Mara, 2006, PHASES INTERPRETATIO, V91, P187, DOI 10.1515/9783110197723.4.187; GIVON T, 1991, STUD LANG, V15, P335, DOI 10.1075/sl.15.2.05giv; Greenberg Joseph, 1966, LANGUAGE UNIVERSALS; Guerssel Mohamed, 1985, CHICAGO LINGUISTIC S, V21, P48; Hakkani-Tur Dilek Zeynep., 2000, THESIS BILKENT U ANK; Haspelmath M, 2011, FOLIA LINGUIST, V45, P31, DOI 10.1515/FLIN.2011.002; Haspelmath M, 2004, STUD LANG, V28, P554, DOI 10.1075/sl.28.3.06has; Haspelmath Martin, 1987, ARBEITSPAPIERE I SPR; Haspelmath Martin, 2008, LANGUAGE UNIVERSALS, P185; Hawkins J. A., 2004, EFFICIENCY COMPLEXIT; Heidinger Steffen, 2010, FRENCH ANTICAUSATIVE; Heidinger Steffen., J LINGUISTI IN PRESS; Heidinger Steffen, 2012, ROMANISTISCHES JB, V62, P31; Lehmann Christian., 2007, LEVEN MET WOORDEN OP, P409; Letuchiy Alexander, 2010, TRANSITIVITY, P237; Levin Beth, 1995, UNACCUSATIVITY SYNTA; Marantz Alec, 1984, NATURE GRAMMATICAL R; Melcuk Igor A., 1967, IZVESTIJA AKAD NAUK, V26, P352; Mihalcea Rada F., 2002, 6 C COMP NAT LANG LE, P105; Narrog Heiko, 2007, TADOSEI TSUGENGOTEKI, p,; Narrog Heiko, 2014, MOTIVATING CODING DI; Nedjalkov Vladimir P., 1973, TRENDS SOVIET THEORE, P1; Nedjalkov Vladimir P., 1969, TIPOLOGIJA KAUZATIVN, P20; Nichols Johanna, 2004, LINGUISTIC TYPOLOGY, V8, P149, DOI 10.1515/lity.2004.005; PAYNE THOMAS, 1997, DESCRIBING MORPHOSYN; Pinon Christopher, 2001, SALT, VXI, P346; Pylkkanen Lina, 2008, INTRO ARGUMENTS; R Development Core Team, 2004, R LANG ENV STAT COMP; Rosch E. H., 1978, COGNITION CATEGORIZA, P189; Samardzic Tanja, 2012, LINGUISTIC ISSUES LA, V7, P1; Schafer Florian, 2008, SYNTAX ANTICAUSATIVE; Schafer Florian, 2009, LANGUAGE LINGUISTICS, V3, P641; Siewierska Anna, 1984, PASSIVE COMP LINGUIS; Spagnol M., 2011, THESIS U KONSTANZ; Wright Saundra K., 2001, THESIS NW U; Zipf G. K., 1935, PSYCHOBIOLOGY LANGUA	52	4	4	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	0022-2267	1469-7742		J LINGUIST	J. Linguist.	NOV	2014	50	3					587	625		10.1017/S0022226714000255		39	Linguistics; Language & Linguistics	Linguistics	AS1OG	WOS:000344049500003		
J	Haspelmath, M; Calude, A; Spagnol, M; Narrog, H; Bamyaci, E				Haspelmath, Martin; Calude, Andreea; Spagnol, Michael; Narrog, Heiko; Bamyaci, Elif			Coding causal-noncausal verb alternations: A form-frequency correspondence explanation (vol 50, pg 587, 2014)	JOURNAL OF LINGUISTICS			English	Correction									[Haspelmath, Martin] Max Planck Inst Evolutionary Anthropol, Leipzig, Germany; [Calude, Andreea] Univ Waikato, Hamilton, New Zealand; [Spagnol, Michael] Univ Malta, Msida, Malta; [Narrog, Heiko] Tohoku Univ, Sendai, Miyagi 980, Japan; [Bamyaci, Elif] Univ Wurzburg, Wurzburg, Germany	Haspelmath, M (reprint author), Max Planck Inst Evolutionary Anthropol, Leipzig, Germany.						Haspelmath M, 2014, J LINGUIST, V50, P587, DOI 10.1017/S0022226714000255; Martin Haspelmath, 2014, J LINGUIST, V50, P587	2	0	0	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	0022-2267	1469-7742		J LINGUIST	J. Linguist.	NOV	2014	50	3					779	779		10.1017/S0022226714000449		1	Linguistics; Language & Linguistics	Linguistics	AS1OG	WOS:000344049500017		
J	Kawamura, M; Ruskin, DN; Geiger, JD; Boison, D; Masino, SA				Kawamura, Masahito, Jr.; Ruskin, David N.; Geiger, Jonathan D.; Boison, Detlev; Masino, Susan A.			Ketogenic diet sensitizes glucose control of hippocampal excitability	JOURNAL OF LIPID RESEARCH			English	Article						adenosine A 1 receptors; bicuculline; 8-cyclopentyl-1,3-dipropylxanthine; epilepsy; K-ATP channel; ketones; metabolism; pannexin; purine; seizure	ADENOSINE A(1) RECEPTORS; CENTRAL-NERVOUS-SYSTEM; K-ATP CHANNELS; ELECTROCONVULSIVE THRESHOLD; SYNAPTIC-TRANSMISSION; CHILDHOOD EPILEPSY; RAT HIPPOCAMPUS; IN-VITRO; BRAIN; SEIZURES	A high-fat low-carbohydrate ketogenic diet (KD) is an effective treatment for refractory epilepsy, yet myriad metabolic effects in vivo have not been reconciled clearly with neuronal effects. A KD limits blood glucose and produces ketone bodies from beta-oxidation of lipids. Studies have explored changes in ketone bodies and/or glucose in the effects of the KD, and glucose is increasingly implicated in neurological conditions. To examine the interaction between altered glucose and the neural effects of a KD, we fed rats and mice a KD and restricted glucose in vitro while examining the seizure-prone CA3 region of acute hippocampal slices. Slices from KD-fed animals were sensitive to small physiological changes in glucose, and showed reduced excitability and seizure propensity. Similar to clinical observations, reduced excitability depended on maintaining reduced glucose. Enhanced glucose sensitivity and reduced excitability were absent in slices obtained from KD-fed mice lacking adenosine A(1) receptors (A(1)Rs); in slices from normal animals effects of the KD could be reversed with blockers of pannexin-1 channels, A(1)Rs, or K-ATP channels. Overall, these studies reveal that a KD sensitizes glucose-based regulation of excitability via purinergic mechanisms in the hippocampus and thus link key metabolic and direct neural effects of the KD.	[Kawamura, Masahito, Jr.] Jikei Univ, Sch Med, Dept Pharmacol, Minato Ku, Tokyo 1058461, Japan; [Ruskin, David N.; Masino, Susan A.] Trinity Coll, Dept Psychol, Hartford, CT 06106 USA; [Ruskin, David N.; Masino, Susan A.] Trinity Coll, Neurosci Program, Hartford, CT 06106 USA; [Geiger, Jonathan D.] Univ N Dakota, Sch Med & Hlth Sci, Dept Basic Biomed Sci, Grand Forks, ND 58203 USA; [Boison, Detlev] Legacy Res Inst, Robert Stone Dow Neurobiol Labs, Portland, OR 97232 USA	Masino, SA (reprint author), Trinity Coll, Dept Psychol, Hartford, CT 06106 USA.	Susan.Masino@trincoll.edu			National Institutes of Health [NS065957, NS066392, GM103329, AG043338, NS061844]; National Science Foundation [IOS-0843585]; JSPS KAKENHI [23790303]; Naito Foundation; Takeda Science Foundation	This work was supported by National Institutes of Health Grants NS065957 (to S.A.M., J.D.G., and D.B.), NS066392 (to S.A.M.), GM103329 and AG043338 (to J.D.G.), and NS061844 (to D.B.); National Science Foundation Grant IOS-0843585 (to S.A.M); JSPS KAKENHI Grant 23790303 (to M.K.); Naito Foundation (to M.K.); and Takeda Science Foundation (to M.K.).	HUTTENLOCHER PR, 1976, PEDIATR RES, V10, P536, DOI 10.1203/00006450-197605000-00006; Dahlin M, 2007, EPILEPSY RES, V73, P199, DOI 10.1016/j.eplepsyres.2006.10.005; Schwartz MW, 2005, SCIENCE, V307, P375, DOI 10.1126/science.1104344; Juge N, 2010, NEURON, V68, P99, DOI 10.1016/j.neuron.2010.09.002; Ma WY, 2007, J NEUROSCI, V27, P3618, DOI 10.1523/JNEUROSCI.0132-07.2007; DEVIVO DC, 1978, ANN NEUROL, V3, P331, DOI 10.1002/ana.410030410; Masino SA, 2002, J PHARMACOL EXP THER, V303, P356, DOI 10.1124/jpet.102.036731; UHLEMANN ER, 1972, J PHARMACOL EXP THER, V180, P231; Clarke K, 2012, REGUL TOXICOL PHARM, V63, P401, DOI 10.1016/j.yrtph.2012.04.008; Neal EG, 2008, LANCET NEUROL, V7, P500, DOI 10.1016/S1474-4422(08)70092-9; Kawamura M, 2004, J NEUROSCI, V24, P10835, DOI 10.1523/JNEUROSCI.3028-04.2004; Dunwiddie TV, 1997, J NEUROSCI, V17, P7673; Groesbeck DK, 2006, DEV MED CHILD NEUROL, V48, P978, DOI 10.1017/S0012162206002143; Freeman JM, 1998, PEDIATRICS, V102, P1358, DOI 10.1542/peds.102.6.1358; Tanner GR, 2011, J NEUROSCI, V31, P8689, DOI 10.1523/JNEUROSCI.5951-10.2011; Cherbuin N, 2012, NEUROLOGY, V79, P1019, DOI 10.1212/WNL.0b013e31826846de; Aviles-Olmos I, 2013, BRAIN, V136, P374, DOI 10.1093/brain/aws009; Masino SA, 2009, CURR NEUROPHARMACOL, V7, P257, DOI 10.2174/157015909789152164; Hu YB, 1997, J NEUROCHEM, V68, P1745; Dunwiddie TV, 2001, ANNU REV NEUROSCI, V24, P31, DOI 10.1146/annurev.neuro.24.1.31; Kim B, 2009, ENDOCRINOLOGY, V150, P5294, DOI 10.1210/en.2009-0695; Musa-Veloso K, 2002, AM J CLIN NUTR, V76, P65; THOMPSON SM, 1992, J PHYSIOL-LONDON, V451, P347; Romanov RA, 2007, EMBO J, V26, P657, DOI 10.1038/sj.emboj.7601526; Johansson B, 2001, P NATL ACAD SCI USA, V98, P9407, DOI 10.1073/pnas.161292398; Masino SA, 2011, J CLIN INVEST, V121, P2679, DOI 10.1172/JCI57813; APPLETON DB, 1974, EPILEPSIA, V15, P211, DOI 10.1111/j.1528-1157.1974.tb04943.x; Boison D, 2011, EXPERT OPIN DRUG DIS, V6, P713, DOI 10.1517/17460441.2011.575777; Bough KJ, 1999, DEV NEUROSCI-BASEL, V21, P400, DOI 10.1159/000017390; D'Agostino DP, 2013, AM J PHYSIOL-REG I, V304, pR829, DOI 10.1152/ajpregu.00506.2012; Dell CA, 2001, LIPIDS, V36, P373, DOI 10.1007/s11745-001-0730-8; FOWLER JC, 1993, NEUROSCI LETT, V157, P83, DOI 10.1016/0304-3940(93)90648-5; Greene AE, 2001, EPILEPSIA, V42, P1371, DOI 10.1046/j.1528-1157.2001.17601.x; Hassan AM, 1999, PEDIATR NEUROL, V21, P548, DOI 10.1016/S0887-8994(99)00045-4; Kawamura Jr M., 2013, ADENOSINE KEY LINK M, P71; Kawamura M, 2010, J NEUROSCI, V30, P3886, DOI 10.1523/JNEUROSCI.0055-10.2010; Kim DY, 2010, J NEUROCHEM, V114, P130, DOI 10.1111/j.1471-4159.2010.06728.x; Kossoff EH, 2003, NEUROLOGY, V61, P1789; Mantis JG, 2004, NUTR METAB, V1, P11, DOI 10.1186/1743-7075-1-11; Masino S. A., 2010, OPEN NEUROSCI J, V4, P58; Masino SA, 2008, TRENDS NEUROSCI, V31, P273, DOI 10.1016/j.tins.2008.02.009; NAKAZAWA M, 1983, BRAIN DEV-JPN, V5, P375; Ruskin DN, 2013, J PAIN, V14, P467, DOI 10.1016/j.jpain.2012.12.015; Samala R, 2011, NEUROCHEM INT, V58, P5, DOI 10.1016/j.neuint.2010.10.011; Samoilova M, 2010, J NEUROCHEM, V113, P826, DOI 10.1111/j.1471-4159.2010.06645.x; Seymour KJ, 1999, MAGN RESON MATER PHY, V8, P33; Shram NF, 1997, NEUROREPORT, V8, P1109, DOI 10.1097/00001756-199703240-00009; Stafstrom CE, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00059; Thibert RL, 2012, EPILEPSIA, V53, P1498, DOI 10.1111/j.1528-1167.2012.03537.x; Tian GF, 2000, J NEUROPHYSIOL, V83, P1830; Wilder R. M., 1921, MAYO CLIN B, V2, P308; Wilder RM., 1921, MAYO CLINIC B, V2, P307; Yau PL, 2012, PEDIATRICS, V130, pE856, DOI 10.1542/peds.2012-0324	53	2	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0022-2275	1539-7262		J LIPID RES	J. Lipid Res.	NOV	2014	55	11					2254	2260		10.1194/jlr.M046755		7	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	AS6EB	WOS:000344356300006		
J	Reading, BJ; Hiramatsu, N; Schilling, J; Molloy, KT; Glassbrook, N; Mizuta, H; Luo, WS; Baltzegar, DA; Williams, VN; Todo, T; Hara, A; Sullivan, CV				Reading, Benjamin J.; Hiramatsu, Naoshi; Schilling, Justin; Molloy, Katelyn T.; Glassbrook, Norm; Mizuta, Hiroko; Luo, Wenshu; Baltzegar, David A.; Williams, Valerie N.; Todo, Takashi; Hara, Akihiko; Sullivan, Craig V.			Lrp13 is a novel vertebrate lipoprotein receptor that binds vitellogenins in teleost fishes	JOURNAL OF LIPID RESEARCH			English	Article						affinity purification; egg; endocytosis; oocyte; oogenesis; ovary; vitellogenesis; very low density lipoprotein receptor; yolk; low density lipoprotein receptor-related protein 13	PERCH MORONE-AMERICANA; TROUT ONCORHYNCHUS-CLARKI; CHICKEN OOCYTE GROWTH; WHITE PERCH; STRIPED BASS; MOLECULAR CHARACTERIZATION; RAINBOW-TROUT; MESSENGER-RNA; YOLK PROTEINS; LDL-RECEPTOR	Transcripts encoding a novel member of the lipoprotein receptor superfamily, termed LDL receptor-related protein (Lrp)13, were sequenced from striped bass (Morone saxatilis) and white perch (Morone americana) ovaries. Receptor proteins were purified from perch ovary membranes by protein-affinity chromatography employing an immobilized mixture of vitellogenins Aa and Ab. RT-PCR revealed lrp13 to be predominantly expressed in striped bass ovary, and in situ hybridization detected lrp13 transcripts in the ooplasm of early secondary growth oocytes. Quantitative RT-PCR confirmed peak lrp13 expression in the ovary during early secondary growth. Quantitative mass spectrometry revealed peak Lrp13 protein levels in striped bass ovary during late-vitellogenesis, and immunohistochemistry localized Lrp13 to the oolemma and zona radiata of vitellogenic oocytes. Previously unreported orthologs of lrp13 were identified in genome sequences of fishes, chicken (Gallus gallus), mouse (Mus musculus), and dog (Canis lupus familiaris). Zebrafish (Danio rerio) and Nile tilapia (Oreochromis niloticus) lrp13 loci are discrete and share genomic synteny. The Lrp13 appears to function as a vitellogenin receptor and may be an important mediator of yolk formation in fishes and other oviparous vertebrates.jlr The presence of lrp13 orthologs in mammals suggests that this lipoprotein receptor is widely distributed among vertebrates, where it may generally play a role in lipoprotein metabolism.	[Reading, Benjamin J.; Schilling, Justin; Molloy, Katelyn T.; Williams, Valerie N.] N Carolina State Univ, Dept Appl Ecol, Raleigh, NC 27695 USA; [Baltzegar, David A.; Sullivan, Craig V.] N Carolina State Univ, Dept Biol Sci, Raleigh, NC 27695 USA; [Glassbrook, Norm] N Carolina State Univ, Genom Sci Lab, Raleigh, NC 27695 USA; [Hiramatsu, Naoshi; Mizuta, Hiroko; Luo, Wenshu; Todo, Takashi; Hara, Akihiko] Hokkaido Univ, Grad Sch Fisheries Sci, Hakodate, Hokkaido, Japan; [Sullivan, Craig V.] Carolina AquaGyn, Raleigh, NC USA	Reading, BJ (reprint author), N Carolina State Univ, Dept Appl Ecol, Raleigh, NC 27695 USA.	bjreadin@ncsu.edu			North Carolina Sea Grant [R/AF-49, R/MG-0609, R/12-SSS-3]; North Carolina Agricultural Foundation, Inc.	This research was supported by grant awards to C.V.S and B.J.R. from North Carolina Sea Grant (R/AF-49, R/MG-0609, and R/12-SSS-3) and from the North Carolina Agricultural Foundation, Inc.	Prat F, 1998, BIOL REPROD, V58, P1146, DOI 10.1095/biolreprod58.5.1146; Gould CM, 2010, NUCLEIC ACIDS RES, V38, pD167, DOI 10.1093/nar/gkp1016; Hiramatsu N, 2002, BIOL REPROD, V67, P655, DOI 10.1095/biolreprod67.2.655; Hiramatsu N, 2002, FISH PHYSIOL BIOCHEM, V26, P355, DOI 10.1023/B:FISH.0000009266.58556.9a; [Anonymous], 2011, GUIDE CARE USE LAB A; Tao YX, 1996, BIOL REPROD, V55, P646, DOI 10.1095/biolreprod55.3.646; Mizuta H, 2013, COMP BIOCHEM PHYS B, V166, P81, DOI 10.1016/j.cbpb.2013.07.005; HERZ J, 1988, EMBO J, V7, P4119; SHEN XY, 1993, CELL TISSUE RES, V272, P459, DOI 10.1007/BF00318552; TAKAHASHI S, 1992, P NATL ACAD SCI USA, V89, P9252, DOI 10.1073/pnas.89.19.9252; Flicek P, 2012, NUCLEIC ACIDS RES, V40, pD84, DOI 10.1093/nar/gkr991; BUJO H, 1994, EMBO J, V13, P5165; Jacobsen L, 1996, J BIOL CHEM, V271, P31379; Ingham RJ, 2005, MOL CELL BIOL, V25, P7092, DOI 10.1128/MCB.25.16.7092-7106.2005; Matsubara T, 1999, DEV BIOL, V213, P18, DOI 10.1006/dbio.1999.9365; Davail B, 1998, J LIPID RES, V39, P1929; BROWN SA, 1986, BIOCHEM BIOPH RES CO, V139, P333, DOI 10.1016/S0006-291X(86)80118-8; Williams VN, 2014, J EXP ZOOL PART A, V321, P301, DOI 10.1002/jez.1859; YAMAMOTO T, 1984, CELL, V39, P27, DOI 10.1016/0092-8674(84)90188-0; Hey PJ, 1998, GENE, V216, P103, DOI 10.1016/S0378-1119(98)00311-4; Reading BJ, 2011, BIOL REPROD, V84, P392, DOI 10.1095/biolreprod.110.087981; JACKSON LF, 1995, T AM FISH SOC, V124, P563, DOI 10.1577/1548-8659(1995)124<0563:ROWPTA>2.3.CO;2; Yaffe MB, 2001, CURR OPIN CELL BIOL, V13, P131, DOI 10.1016/S0955-0674(00)00189-7; Reading BJ, 2009, MAR BIOTECHNOL, V11, P169, DOI 10.1007/s10126-008-9133-6; Luo WS, 2013, COMP BIOCHEM PHYS A, V166, P263, DOI 10.1016/j.cbpa.2013.06.026; SAITO A, 1994, P NATL ACAD SCI USA, V91, P9725, DOI 10.1073/pnas.91.21.9725; Bradford Y, 2011, NUCLEIC ACIDS RES, V39, pD822, DOI 10.1093/nar/gkq1077; Picha ME, 2008, J ENDOCRINOL, V199, P81, DOI 10.1677/JOE-07-0649; Hiramatsu N, 2013, FISH PHYSIOL BIOCHEM, V39, P29, DOI 10.1007/s10695-012-9612-6; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Sudol M, 2001, FEBS LETT, V490, P190, DOI 10.1016/S0014-5793(01)02122-6; Tipsmark CK, 2008, AM J PHYSIOL-REG I, V294, pR1004, DOI 10.1152/ajpregu.00112.2007; Babin PJ, 2008, GENE, V413, P76, DOI 10.1016/j.gene.2008.02.001; Letunic I, 2012, NUCLEIC ACIDS RES, V40, pD302, DOI 10.1093/nar/gkr931; Picha ME, 2006, GEN COMP ENDOCR, V147, P196, DOI 10.1016/j.ygcen.2005.12.020; BUJO H, 1995, J BIOL CHEM, V270, P23546; Bonifacino JS, 2003, ANNU REV BIOCHEM, V72, P395, DOI 10.1146/annurev.biochem.72.121801.161800; Kim DH, 1996, J BIOL CHEM, V271, P8373; Nakayama M, 1998, GENOMICS, V51, P27, DOI 10.1006/geno.1998.5341; Li AK, 2003, J BIOL CHEM, V278, P2799, DOI 10.1074/jbc.M205067200; Brown SD, 1998, BIOCHEM BIOPH RES CO, V248, P879, DOI 10.1006/bbrc.1998.9061; Finn RN, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-2; Finn RN, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000169; Heppell SA, 1999, T AM FISH SOC, V128, P532, DOI 10.1577/1548-8659(1999)128<0532:ELIAEO>2.0.CO;2; Hiramatsu N, 2004, BIOL REPROD, V70, P1720, DOI 10.1095/biolreprod.103.023655; Hong L, 2009, COMP BIOCHEM PHYS C, V149, P9, DOI 10.1016/j.cbpc.2008.05.017; Ilsley JL, 2002, CELL SIGNAL, V14, P183, DOI 10.1016/S0898-6568(01)00236-4; Ishii H, 1998, GENOMICS, V51, P132, DOI 10.1006/geno.1998.5339; Okabayashi K, 1996, BIOCHEM BIOPH RES CO, V224, P406, DOI 10.1006/bbrc.1996.1040; Perazzolo LM, 1999, BIOL REPROD, V60, P1057, DOI 10.1095/biolreprod60.5.1057; Qing J, 1999, ONCOGENE, V18, P335, DOI 10.1038/sj.onc.1202290; Reading BJ, 2013, J PROTEOME RES, V12, P1691, DOI 10.1021/pr3010293; Reading Benjamin J., 2012, BMC Research Notes, V5, P111, DOI 10.1186/1756-0500-5-111; ROEHRKASTEN A, 1989, ARCH INSECT BIOCHEM, V10, P141, DOI 10.1002/arch.940100205; STIFANI S, 1991, J BIOL CHEM, V266, P19079; Sugiyama T, 2000, BIOCHEMISTRY-US, V39, P15817, DOI 10.1021/bi001583s; VANDRIEL IR, 1987, J BIOL CHEM, V262, P16127; Williams VN, 2014, FISH PHYSIOL BIOCHEM, V40, P395, DOI 10.1007/s10695-013-9852-0	58	5	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0022-2275	1539-7262		J LIPID RES	J. Lipid Res.	NOV	2014	55	11					2287	2295		10.1194/jlr.M050286		9	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	AS6EB	WOS:000344356300009		
J	Omura, R; Nagao, K; Kobayashi, N; Ueda, K; Saito, H				Omura, Risa; Nagao, Kohjiro; Kobayashi, Norihiro; Ueda, Kazumitsu; Saito, Hiroyuki			Direct detection of ABCA1-dependent HDL formation based on lipidation-induced hydrophobicity change in apoA-I	JOURNAL OF LIPID RESEARCH			English	Article						cholesterol efflux; POLARIC; hydrophobicity-sensitive fluorescence probe; ATP binding cassette transporter A1; high density lipoprotein; apolipoprotein A-I	APOLIPOPROTEIN-A-I; HIGH-DENSITY-LIPOPROTEIN; CASSETTE TRANSPORTER 1; CHOLESTEROL EFFLUX; PLASMA-MEMBRANE; TANGIER-DISEASE; CYCLOSPORINE-A; PRE-BETA; ABCA1; BINDING	ABCA1 mediates the efflux of cholesterol and phospholipids into apoA-I to form HDL, which is important in the prevention of atherosclerosis. To develop a novel method for the evaluation of HDL formation, we prepared an apoA-I-POLARIC by labeling the specific residue of an apoA-I variant with a hydrophobicity-sensitive fluorescence probe that detects the environmental change around apoA-I during HDL formation. apoA-I-POLARIC possesses the intact ABCA1-dependent HDL formation activity and shows 4.0-fold higher fluorescence intensity in HDL particles than in the lipid-free state. Incubation of apoA-I-POLARIC with ABCA1-expressing cells, but not ABCA1-non-expressing cells, caused a 1.7-fold increase in fluorescence intensity. Gel filtration analysis demonstrated that the increase in fluorescence intensity of apoA-I-POLARIC represents the amount of apoA-I incorporated into the discoidal HDL particles rather than the amount of secreted cholesterol. THP-1 macrophage-mediated HDL formation and inhibition of HDL formation by cyclosporine A could also be measured using apoA-I-POLARIC. Furthermore, HDL formation-independent lipid release induced by microparticle formation or cell death was not detected by apoA-I-POLARIC. These results demonstrate that HDL formation by ABCA1-expressing cells can be specifically detected by sensing hydrophobicity change in apoA-I, thus providing a novel method for assessing HDL formation and screening of the HDL formation modulator.	[Omura, Risa; Nagao, Kohjiro; Saito, Hiroyuki] Univ Tokushima, Inst Hlth Biosci, Tokushima 7708505, Japan; [Omura, Risa; Nagao, Kohjiro; Saito, Hiroyuki] Univ Tokushima, Grad Sch Pharmaceut Sci, Tokushima 7708505, Japan; [Kobayashi, Norihiro] Kobe Pharmaceut Univ, Kobe, Hyogo 6588558, Japan; [Ueda, Kazumitsu] Kyoto Univ, Grad Sch Agr, Lab Cellular Biochem, Div Appl Life Sci, Kyoto 6068502, Japan; [Ueda, Kazumitsu] Kyoto Univ, Inst Integrated Cell Mat Sci iCeMS, Kyoto 6068502, Japan	Nagao, K (reprint author), Kyoto Univ, Grad Sch Engn, Dept Synthet Chem & Biol Chem, Kyoto 6158510, Japan.	nagao@sbchem.kyoto-u.ac.jp			Japan Society for the Promotion of Science (JSPS) [25293006, 25670014, 25850070, 25221203]	This work was supported by grants-in-aid for scientific research 25293006 and 25670014 (H.S.), 25850070 (K.N.), and 25221203 (K.N., K.U.) from Japan Society for the Promotion of Science (JSPS).	Abe-Dohmae S, 2000, BIOCHEMISTRY-US, V39, P11092, DOI 10.1021/bi0008175; Laffitte BA, 2001, P NATL ACAD SCI USA, V98, P507, DOI 10.1073/pnas.021488798; Lund-Katz S, 2013, J BIOL CHEM, V288, P23150, DOI 10.1074/jbc.M113.495523; Khera AV, 2011, NEW ENGL J MED, V364, P127, DOI 10.1056/NEJMoa1001689; Chetty PS, 2009, P NATL ACAD SCI USA, V106, P19005, DOI 10.1073/pnas.0909708106; Gillotte KL, 1999, J BIOL CHEM, V274, P2021, DOI 10.1074/jbc.274.4.2021; Munehira Y, 2004, J BIOL CHEM, V279, P15091, DOI 10.1074/jbc.M313436200; Duong PT, 2006, J LIPID RES, V47, P832, DOI 10.1194/jlr.M500531-JLR200; Hamon Y, 2000, NAT CELL BIOL, V2, P399; Brooks-Wilson A, 1999, NAT GENET, V22, P336; Vaughan AM, 2003, J LIPID RES, V44, P1373, DOI 10.1194/jlr.M300078-JLR200; Phillips MC, 2013, J LIPID RES, V54, P2034, DOI 10.1194/jlr.R034025; Mulya A, 2007, ARTERIOSCL THROM VAS, V27, P1828, DOI 10.1161/ATVBA.107.142455; Rosenson RS, 2012, CIRCULATION, V125, P1905, DOI 10.1161/CIRCULATIONAHA.111.066589; Saito H, 2003, J BIOL CHEM, V278, P23227, DOI 10.1074/jbc.M303365200; Yokoyama S, 2006, ARTERIOSCL THROM VAS, V26, P20, DOI 10.1161/01.ATV.0000195789.39418.e8; Bodzioch M, 1999, NAT GENET, V22, P347; DAVIDSON WS, 1995, J BIOL CHEM, V270, P5882; Liu LJ, 2003, J BIOL CHEM, V278, P42976, DOI 10.1074/jbc.M308420200; Linsel-Nitschke P, 2005, J LIPID RES, V46, P86, DOI 10.1194/jlr.M400247-JLR200; Nandi S, 2009, J LIPID RES, V50, P456, DOI 10.1194/jlr.M800345-JLR200; Wang N, 2000, J BIOL CHEM, V275, P33053, DOI 10.1074/jbc.M005438200; Oram JF, 2000, J BIOL CHEM, V275, P34508, DOI 10.1074/jbc.M006738200; Vedhachalam C, 2007, J BIOL CHEM, V282, P25123, DOI 10.1074/jbc.M704590200; Rust S, 1999, NAT GENET, V22, P352, DOI 10.1038/11921; Wang N, 2001, J BIOL CHEM, V276, P23742, DOI 10.1074/jbc.M102348200; Jayaraman S, 2011, J BIOL CHEM, V286, P35610, DOI 10.1074/jbc.M111.262485; Nagao K, 2011, FEBS J, V278, P3190, DOI 10.1111/j.1742-4658.2011.08170.x; Amundson DM, 1999, J BIOCHEM BIOPH METH, V38, P43, DOI 10.1016/S0165-022X(98)00036-0; Davidson WS, 2007, J BIOL CHEM, V282, P22249, DOI 10.1074/jbc.R700014200; Kono M, 2008, BIOCHEMISTRY-US, V47, P11340, DOI 10.1021/bi801503r; Le Goff W, 2004, ARTERIOSCL THROM VAS, V24, P2155, DOI 10.1161/01.ATV.0000144811.94581.52; Massey JB, 2008, BBA-MOL CELL BIOL L, V1781, P245, DOI 10.1016/j.bbalip.2008.03.003; MATZ CE, 1982, J BIOL CHEM, V257, P4535; Nagao K, 2014, BBA-MOL CELL BIOL L, V1841, P80, DOI 10.1016/j.bbalip.2013.10.005; Nagao K, 2012, BBA-MOL CELL BIOL L, V1821, P530, DOI 10.1016/j.bbalip.2011.06.024; Nagao K, 2012, J LIPID RES, V53, P126, DOI 10.1194/jlr.M019976; Nagao K, 2010, FEBS LETT, V584, P2717, DOI 10.1016/j.febslet.2010.04.036; Nagao K, 2013, BBA-MOL CELL BIOL L, V1831, P398, DOI 10.1016/j.bbalip.2012.11.002; Sankaranarayanan S, 2011, J LIPID RES, V52, P2332, DOI 10.1194/jlr.D018051; SEGREST JP, 1992, J LIPID RES, V33, P141; Sparks DL, 1999, BIOCHEMISTRY-US, V38, P1727, DOI 10.1021/bi981945k; SPARKS DL, 1992, J BIOL CHEM, V267, P25839; Wang SH, 2013, ARTERIOSCL THROM VAS, V33, P1197, DOI 10.1161/ATVBAHA.112.301195	44	2	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0022-2275	1539-7262		J LIPID RES	J. Lipid Res.	NOV	2014	55	11					2423	2431		10.1194/jlr.D049445		9	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	AS6EB	WOS:000344356300022		
J	Kakihara, D; Nishie, A; Harada, N; Shirabe, K; Tajima, T; Asayama, Y; Ishigami, K; Nakayama, T; Takayama, Y; Okamoto, D; Fujita, N; Kishimoto, J; Honda, H				Kakihara, Daisuke; Nishie, Akihiro; Harada, Noboru; Shirabe, Ken; Tajima, Tsuyoshi; Asayama, Yoshiki; Ishigami, Kousei; Nakayama, Tomohiro; Takayama, Yukihisa; Okamoto, Daisuke; Fujita, Nobuhiro; Kishimoto, Junji; Honda, Hiroshi			Performance of Gadoxetic Acid-Enhanced MRI for Detecting Hepatocellular Carcinoma in Recipients of Living-Related-Liver-Transplantation: Comparison With Dynamic Multidetector Row Computed Tomography and Angiography-Assisted Computed Tomography	JOURNAL OF MAGNETIC RESONANCE IMAGING			English	Article						MDCT; gadoxetic acid; MRI; angiography-assisted CT; hepatocellular carcinoma; living-related-liver-transplantation	GD-EOB-DTPA; SUPERPARAMAGNETIC IRON-OXIDE; CT HEPATIC ARTERIOGRAPHY; HELICAL CT; ARTERIAL PORTOGRAPHY; PHASE IMAGES; CIRRHOSIS; DISEASE; NODULES; MDCT	Purpose: To clarify the diagnostic performance of gadoxetic acid-enhanced MRI for the detection of hepatocellular carcinoma (HCC) in recipients of living related-liver transplantation (LRLT). Materials and Methods: This retrospective study group consisted of 15 patients with 61 HCCs who each underwent multidetector row computed tomography (MDCT), gadoxetic acid-enhanced MRI, and angiography-assisted computed tomography (CT) before LRLT. The three modalities were compared for their ability to detect HCC. Two blinded readers independently reviewed the images obtained by each modality for the presence of HCC on a segment-by-segment basis using a 5-point confidence scale. The diagnostic performance of the modalities was evaluated in a receiver operating characteristic (ROC) analysis. The area under the ROC curve (Az), sensitivity, specificity, and accuracy were compared for the three modalities. Results: No significant difference in Az, sensitivity, specificity, or accuracy was obtained among gadoxetic acid-enhanced MRI, MDCT, and angiography-assisted CT for both readers. For reader 1, the sensitivity (55.6%) and the accuracy (84.7%) of angiography-assisted CT were significantly higher than those of MDCT (33.3% and 78.0%) (P < 0.05). Conclusion: Gadoxetic acid-enhanced MRI has a relatively high diagnostic ability to detect HCC even in recipients of LRLT, equivalent to the abilities of MDCT and angiography-assisted CT.	[Kakihara, Daisuke; Nishie, Akihiro; Tajima, Tsuyoshi; Asayama, Yoshiki; Ishigami, Kousei; Nakayama, Tomohiro; Okamoto, Daisuke; Honda, Hiroshi] Kyushu Univ, Grad Sch Med Sci, Dept Clin Radiol, Higashi Ku, Fukuoka 8128582, Japan; [Harada, Noboru; Shirabe, Ken] Kyushu Univ, Grad Sch Med Sci, Dept Surg & Sci, Higashi Ku, Fukuoka 8128582, Japan; [Takayama, Yukihisa] Kyushu Univ, Grad Sch Med Sci, Dept Mol Imaging & Diag, Higashi Ku, Fukuoka 8128582, Japan; [Fujita, Nobuhiro] Kyushu Univ, Grad Sch Med Sci, Dept Anat Pathol, Higashi Ku, Fukuoka 8128582, Japan; [Kishimoto, Junji] Kyushu Univ, Grad Sch Med Sci, Ctr Clin & Translat Res, Higashi Ku, Fukuoka 8128582, Japan	Nishie, A (reprint author), Kyushu Univ, Grad Sch Med Sci, Dept Clin Radiol, Higashi Ku, 3-1-1 Maidashi, Fukuoka 8128582, Japan.	anishie@radiol.med.kyushu-u.ac.jp					Hyodo T, 2013, RADIOLOGY, V266, P480, DOI 10.1148/radiol.12112677; Baek CK, 2012, CLIN RADIOL, V67, P148, DOI 10.1016/j.crad.2011.08.011; Nishie A, 2012, EUR J RADIOL, V81, P1100, DOI 10.1016/j.ejrad.2011.02.053; Kim YK, 2010, CLIN RADIOL, V65, P358, DOI 10.1016/j.crad.2009.11.012; Tajima T, 2010, J COMPUT ASSIST TOMO, V34, P362, DOI 10.1097/RCT.0b013e3181cd3304; Haradome H, 2010, J MAGN RESON IMAGING, V32, P334, DOI 10.1002/jmri.22241; Chan EY, 2008, LIVER TRANSPLANT, V14, P956, DOI 10.1002/lt.21449; Kim SH, 2009, AM J ROENTGENOL, V192, P1675, DOI 10.2214/AJR.08.1262; Van Beers BE, 2001, AM J ROENTGENOL, V176, P667; Motosugi U, 2009, J MAGN RESON IMAGING, V30, P1042, DOI 10.1002/jmri.21956; Kim AY, 2012, ACTA RADIOL, V53, P830, DOI 10.1258/ar.2012.120099; Motosugi U, 2011, J MAGN RESON IMAGING, V34, P88, DOI 10.1002/jmri.22630; Kim YK, 2004, J MAGN RESON IMAGING, V20, P826, DOI 10.1002/jmri.20188; Laghi A, 2003, RADIOLOGY, V226, P543, DOI 10.1148/radiol.2262012043; Inoue T, 2012, J GASTROENTEROL, V47, P1036, DOI 10.1007/s00535-012-0571-6; Nishie A, 2012, J MAGN RESON IMAGING, V36, P664, DOI 10.1002/jmri.23691; Nakamura Y, 2013, J MAGN RESON IMAGING, V37, P684, DOI 10.1002/jmri.23855; OLIVER JH, 1995, AM J ROENTGENOL, V164, P333; Iannaccone R, 2005, RADIOLOGY, V234, P460, DOI 10.1148/radiol.2342031202; Kim YK, 2009, J COMPUT ASSIST TOMO, V33, P844, DOI 10.1097/RCT.0b013e3181a7e3c7; Akai H, 2011, EUR J RADIOL, V80, P310, DOI 10.1016/j.ejrad.2010.07.026; Murakami T, 2001, RADIOLOGY, V218, P763; Couinaud C., 1957, FOIE ETUDES ANATOMIQ; Hirakawa M, 2011, JPN J RADIOL, V29, P129, DOI 10.1007/s11604-010-0528-8; Kanematsu M, 1997, AM J ROENTGENOL, V169, P1507; Kanwal F, 2012, GASTROENTEROLOGY, V143, P70, DOI 10.1053/j.gastro.2012.03.038; Kwak Hyo-Sung, 2004, Eur Radiol, V14, P447, DOI 10.1007/s00330-003-2070-x; Makita O, 2000, ACTA RADIOL, V41, P464, DOI 10.1080/028418500127345695; Mazzaferro V, 1996, NEW ENGL J MED, V334, P693, DOI 10.1056/NEJM199603143341104; Nishie A, 2010, J MAGN RESON IMAGING, V31, P373, DOI 10.1002/jmri.22059; Nishie A, 2008, AM J ROENTGENOL, V190, P81, DOI 10.2214/AJR.07.2810; Ooka Y, 2012, MAGN RESON IMAGING, V30, P854; Taura K, 2007, SURGERY, V142, P685, DOI 10.1016/j.surg.2007.05.009; Tsurusaki M, 2007, CLIN RADIOL, V62, P1189, DOI 10.1016/j.crad.2007.05.005; Yukisawa S, 2007, EUR J RADIOL, V61, P279, DOI 10.1016/j.ejrad.2006.09.011; Zavaglia C, 2005, AM J GASTROENTEROL, V100, P2708, DOI 10.1111/j.1572-0241.2005.00289.x	36	3	3	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1053-1807	1522-2586		J MAGN RESON IMAGING	J. Magn. Reson. Imaging	NOV	2014	40	5					1112	1120		10.1002/jmri.24454		9	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	AS0ZR	WOS:000344005800012		
J	Kuhn, JP; Holmes, JH; Brau, ACS; Iwadate, Y; Hernando, D; Reeder, SB				Kuehn, Jens-P.; Holmes, James H.; Brau, Anja C. S.; Iwadate, Yuji; Hernando, Diego; Reeder, Scott B.			Navigator Flip Angle Optimization for Free-Breathing T1-Weighted Hepatobiliary Phase Imaging With Gadoxetic Acid	JOURNAL OF MAGNETIC RESONANCE IMAGING			English	Article						navigator respirator gating; flip angle; navigator profile; liver imaging; gadoxetic acid	FOCAL LIVER-LESIONS; GD-EOB-DTPA; GADOBENATE DIMEGLUMINE; ECHO SEQUENCE; ENHANCED MRI; CONTRAST; BILIARY; TESLA; TRIAL	Purpose: To characterize and optimize the navigator-flip angle (FA), and the influence of imaging-FA on optimizing liver/lung contrast of the navigator profile, while avoiding visible navigator saturation artifacts, for hepatobiliary phase gadoxetic acid-enhanced MRI. Materials and Methods: Ten volunteers; six men, four women; ages 37.1 +/- 11.0 years underwent navigator-gated three-dimensional (3D) -spoiled-gradient-echo sequences in randomized combinations of imaging-FA (10 degrees/30 degrees) and navigator-FA (10-90 degrees) before contrast and 20 min after injection of gadoxetic acid at 3 Tesla. The signal intensities of the liver and lung were measured from navigator profiles. Furthermore, the intensity of saturation artifacts for each navigator FA was quantified using measurements of relative contrast at the artifact location. Results: For the postcontrast images, the optimal navigator FA was 90 degrees. However, saturation artifacts were highly dependent on the imaging-FA and the presence of gadolinium contrast. A smaller imaging-FA of 10 degrees led to greater saturation artifacts for both pre- and postcontrast, and saturation artifacts worsen with increasing navigator-FA. Using a higher imaging-FA of 30 degrees, saturation artifacts are ignorable over the entire range of navigator-FA. Conclusion: For navigator-gated gadoxetic acid-enhanced hepatobiliary imaging, navigator-FA of 90 degrees and imaging-FA of 30 degrees provide an optimal balance with maximum navigator liver/lung contrast while avoiding visible imaging saturation artifacts.	[Kuehn, Jens-P.; Hernando, Diego] Ernst Moritz Arndt Univ Greifswald, Dept Radiol & Neuroradiol, D-17475 Greifswald, Germany; [Kuehn, Jens-P.; Hernando, Diego] Univ Wisconsin, Dept Radiol, Madison, WI 53706 USA; [Holmes, James H.] Global Appl Sci Lab GE Healthcare, Madison, WI USA; [Brau, Anja C. S.] MR Applicat & Workflow GE Healthcare, Munich, Germany; [Iwadate, Yuji; Reeder, Scott B.] Global Appl Sci Lab GE Healthcare, Hino, Tokyo, Japan; [Reeder, Scott B.] Univ Wisconsin, Dept Med Phys Biomed Engn & Med, Madison, WI USA	Kuhn, JP (reprint author), Ernst Moritz Arndt Univ Greifswald, Dept Radiol & Neuroradiol, Ferdinand Sauerbruch Str NK, D-17475 Greifswald, Germany.	kuehn@uni-greifswald.de			NIH [RC1 EB010384, R01 DK083380, R01 DK088925]; German Federal Ministry of Education and Research [FKZ 03IS2061A]; Ministry of Cultural Affairs of the Federal State of Mecklenburg-West Pomerania [UG 09 033]	Contract grant sponsor: NIH; Contract grant number: RC1 EB010384; Contract grant number: R01 DK083380; Contract grant number: R01 DK088925; Contract grant sponsor: The German Federal Ministry of Education and Research; Contract grant number: FKZ 03IS2061A; Contract grant sponsor: The Ministry of Cultural Affairs of the Federal State of Mecklenburg-West Pomerania; Contract grant number: UG 09 033.	Wang Y, 1996, RADIOLOGY, V198, P55; Frydrychowicz A, 2012, J MAGN RESON IMAGING, V36, P632, DOI 10.1002/jmri.23683; Nagle SK, 2012, J MAGN RESON IMAGING, V36, P890, DOI 10.1002/jmri.23713; Brau ACS, 2008, MAGN RESON MED, V59, P382, DOI 10.1002/mrm.21481; Huppertz A, 2004, RADIOLOGY, V230, P266, DOI 10.1148/radiol.2301020269; Motosugi U, 2011, INVEST RADIOL, V46, P141, DOI 10.1097/RLI.0b013e3181f9c487; Young PM, 2010, AM J ROENTGENOL, V195, P687, DOI 10.2214/AJR.09.3892; Nassif A, 2012, RADIOLOGY, V264, P741, DOI 10.1148/radiol.12112061; Ichikawa T, 2010, INVEST RADIOL, V45, P133, DOI 10.1097/RLI.0b013e3181caea5b; Lee MS, 2011, J MAGN RESON IMAGING, V33, P149, DOI 10.1002/jmri.22429; Kuhn JP, 2009, AM J ROENTGENOL, V193, P1318, DOI 10.2214/AJR.09.2412; Halavaara J, 2006, J COMPUT ASSIST TOMO, V30, P345, DOI 10.1097/00004728-200605000-00001; Brismar TB, 2009, ACTA RADIOL, V50, P709, DOI 10.1080/02841850903055603; Kim S, 2013, AM J ROENTGENOL, V200, P90, DOI 10.2214/AJR.12.8722; Vasanawala SS, 2010, PEDIATR RADIOL, V40, P340, DOI 10.1007/s00247-009-1502-4; Nishie A, 2012, J MAGN RESON IMAGING, V36, P664, DOI 10.1002/jmri.23691; Frydrychowicz A, 2011, J MAGN RESON IMAGING, V34, P585, DOI 10.1002/jmri.22713; Raman SS, 2010, J COMPUT ASSIST TOMO, V34, P163, DOI 10.1097/RCT.0b013e3181c89d87; Bashir MR, 2012, J MAGN RESON IMAGING, V35, P611, DOI 10.1002/jmri.22850; FISCHER SE, 1993, MAGNET RESON MED, V30, P191, DOI 10.1002/mrm.1910300207; CARLSON JW, 1990, MAGNET RESON MED, V15, P438, DOI 10.1002/mrm.1910150309; Dobritz M, 2002, ROFO-FORTSCHR RONTG, V174, P738, DOI 10.1055/s-2002-32223; Du YPP, 2004, J CARDIOV MAGN RESON, V6, P483, DOI 10.1081/JCMR-120030567; Kim MJ, 2001, ABDOM IMAGING, V26, P269, DOI 10.1007/s002610000177; Klessen C, 2005, J MAGN RESON IMAGING, V21, P576, DOI 10.1002/jmri.20293; LOW RN, 1993, AM J ROENTGENOL, V160, P501; Pauly John, 2011, J Magn Reson, V213, P544, DOI 10.1016/j.jmr.2011.09.023; REEDER SB, 1994, MAGNET RESON MED, V31, P521, DOI 10.1002/mrm.1910310508; Stemmer A, 2010, P 18 ANN M ISMRM STO	29	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1053-1807	1522-2586		J MAGN RESON IMAGING	J. Magn. Reson. Imaging	NOV	2014	40	5					1129	1136		10.1002/jmri.24480		8	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	AS0ZR	WOS:000344005800014		
J	Teraguchi, M; Yamada, H; Yoshida, M; Nakayama, Y; Kondo, T; Ito, H; Terada, M; Kaneoke, Y				Teraguchi, Masatoshi; Yamada, Hiroshi; Yoshida, Munehito; Nakayama, Yoshiaki; Kondo, Tomoyoshi; Ito, Hidefumi; Terada, Masaki; Kaneoke, Yoshiki			Contrast Enrichment of Spinal Cord MR Imaging Using a Ratio of T1-Weighted and T2-Weighted Signals	JOURNAL OF MAGNETIC RESONANCE IMAGING			English	Article						contrast; magnetic resonance imaging; ratio; spinal cord; T1 weighted image; T2 weighted image	CERVICAL SPONDYLOTIC MYELOPATHY; MYELIN WATER; MULTIPLE-SCLEROSIS; AGE; INTENSITY; SEQUENCES; LESIONS; IMAGES; ECHO	Purpose: We aimed to assess if the T1-weighted (T1w)/T2-weighted (T2w) signal ratio could be used to improve image contrast in MR spinal cord imaging. Materials and Methods: T1w and T2w cervical spinal cord MR images were acquired from 23 normal subjects using 3 Tesla (T) MR scanner. In addition, a multiple sclerosis patient, and a cervical spondylotic myelopathy patient were evaluated. White matter (WM) and gray matter (GM) signal intensities were measured for each image (T1w, T2w, and T1w/T2w) for seven cervical segments in each subject to calculate the contrast. Age-related changes in signal intensity were assessed at each location (lateral column, anterior column, dorsal column, and GM) for each image. Additionally, the imaging results of two subjects with spinal diseases and the controls were numerically compared. Results: The contrast between the WM and GM in the T1w/T2w ratio image was approximately twice as much as that in the T1w and T2w images (mean +/- SD = 1.8 +/- 0.4). The signal intensity ratio was related to age. For both clinical patients, the signal intensities were significantly lower in the lesion areas in the ratio images. Conclusion: The T1w/T2w ratio images demonstrated increased image contrast compared with T1w and T2w images alone and, reduced inter-individual signal intensity differences.	[Teraguchi, Masatoshi; Yamada, Hiroshi; Yoshida, Munehito] Wakayama Med Univ, Grad Sch, Dept Orthoped, Wakayama 6418509, Japan; [Nakayama, Yoshiaki; Kondo, Tomoyoshi; Ito, Hidefumi] Wakayama Med Univ, Grad Sch, Dept Neurol, Wakayama 6418509, Japan; [Terada, Masaki] Wakayama Minami Radiol Clin, Wakayama, Japan; [Kaneoke, Yoshiki] Wakayama Med Univ, Grad Sch, Dept Syst Neurophysiol, Wakayama 6418509, Japan	Teraguchi, M (reprint author), Wakayama Med Univ, Grad Sch, Dept Orthoped, 811-1 Kimiidera, Wakayama 6418509, Japan.	m-tera@wakayama-med.ac.jp			Wakayama Medical Award for Young Researchers	Contract grant sponsor: 2013 Wakayama Medical Award for Young Researchers.	Glasser MF, 2011, J NEUROSCI, V31, P11597, DOI 10.1523/JNEUROSCI.2180-11.2011; Kozlowski P, 2008, MAGN RESON MED, V59, P796, DOI 10.1002/mrm.21527; Meindl T, 2009, EUR RADIOL, V19, P713, DOI 10.1007/s00330-008-1175-7; van Walderveen MAA, 1998, NEUROLOGY, V50, P1282; Pruessmann KP, 1999, MAGNET RESON MED, V42, P952, DOI 10.1002/(SICI)1522-2594(199911)42:5<952::AID-MRM16>3.0.CO;2-S; OHSHIO I, 1993, SPINE, V18, P1140, DOI 10.1097/00007632-199307000-00005; Mastronardi L, 2007, J NEUROSURG-SPINE, V7, P615, DOI 10.3171/SPI-07/12/615; Cohen-Adad J, 2011, NEUROIMAGE, V55, P1024, DOI 10.1016/j.neuroimage.2010.11.089; Poloni G, 2011, NEUROLOGIST, V17, P185, DOI 10.1097/NRL.0b013e31821a2643; TERAO S, 1994, ACTA NEUROPATHOL, V88, P137; Kolind SH, 2011, MAGN RESON MED, V65, P551, DOI 10.1002/mrm.22634; Ross JS, 1999, AM J NEURORADIOL, V20, P361; Mamata H, 2005, J MAGN RESON IMAGING, V22, P38, DOI 10.1002/jmri.20357; Zhang YZ, 2010, SPINE, V35, pE396, DOI 10.1097/BRS.0b013e3181c6dbc4; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; Biton IE, 2006, MAGN RESON IMAGING, V24, P161, DOI 10.1016/j.mri.2005.10.029; Do-Dai Daniel D, 2010, Curr Probl Diagn Radiol, V39, P160, DOI 10.1067/j.cpradiol.2009.05.004; Green C, 2012, ADV ORTHOP, V2012; KANEOKE Y, 1987, MAGN RESON IMAGING, V5, P415, DOI 10.1016/0730-725X(87)90375-4; MacMillan EL, 2011, NEUROIMAGE, V54, P1083, DOI 10.1016/j.neuroimage.2010.08.076; Maier SE, 2007, NEUROTHERAPEUTICS, V4, P453, DOI 10.1016/j.nurt.2007.05.003; Minty EP, 2009, MAGN RESON MED, V61, P883, DOI 10.1002/mrm.21936	22	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1053-1807	1522-2586		J MAGN RESON IMAGING	J. Magn. Reson. Imaging	NOV	2014	40	5					1199	1207		10.1002/jmri.24456		9	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	AS0ZR	WOS:000344005800022		
J	Katsura, M; Suzuki, Y; Hata, J; Hori, M; Sasaki, H; Akai, H; Mori, H; Kunimatsu, A; Masutani, Y; Aoki, S; Ohtomo, K				Katsura, Masaki; Suzuki, Yuichi; Hata, Junichi; Hori, Masaaki; Sasaki, Hiroki; Akai, Hiroyuki; Mori, Harushi; Kunimatsu, Akira; Masutani, Yoshitaka; Aoki, Shigeki; Ohtomo, Kuni			Non-Gaussian Diffusion-Weighted Imaging for Assessing Diurnal Changes in Intervertebral Disc Microstructure	JOURNAL OF MAGNETIC RESONANCE IMAGING			English	Article						non-Gaussian diffusion-weighted imaging; q-space imaging; intervertebral disc; diurnal changes	MULTIPLE-SCLEROSIS; WATER DIFFUSION; HUMAN BRAIN; IN-VIVO; KURTOSIS; MRI; NMR; COMPARTMENTATION; VALUES; SPINE	Purpose: To investigate the use of non-Gaussian diffusion-weighted imaging (q-space imaging [QSI]) to estimate diurnal changes in intervertebral disc (IVD) microstructure. Materials and Methods: IVDs of 15 male subjects (mean age, 27.3 years; mean body mass index, 22.50 kg/m(2)) were investigated once in the morning, less than 30 min after rising, and a second time in the evening after at least 10 h of normal physical activity, using 3 Tesla (T) MR imaging. T2 mapping and QSI data values (apparent diffusion coefficient [ADC], root mean square displacement [RMSD], and apparent kurtosis coefficient [AKC]) were calculated and compared between the morning and evening imaging sessions. Results: The T2, ADC, and RMSD values showed a significant decrease in the evening (175.8 +/- 49.5 ms, 1.56 +/- 0.32 10(-3) mm(2)/s and 40.0 +/- 3.0 mu m, respectively; P < 0.05 for all values; paired t-test), when compared with the morning values (226.5 +/- 83.8 ms, 1.69 +/- 0.29 10(-3) mm(2)/s and 45.2 +/- 2.9 mm, respectively). The AKC value showed a significant increase in the evening (0.67 +/- 0.08), when compared with the morning value (0.58 +/- 0.04; P < 0.05). Conclusion: The RMSD and AKC values obtained from QSI analysis may be biomarkers for IVD diurnal microstructural changes.	[Katsura, Masaki; Sasaki, Hiroki; Akai, Hiroyuki; Mori, Harushi; Kunimatsu, Akira; Masutani, Yoshitaka; Ohtomo, Kuni] Univ Tokyo, Grad Sch Med, Dept Radiol, Tokyo 1138655, Japan; [Suzuki, Yuichi; Hata, Junichi] Tokyo Univ Hosp, Dept Radiol Technol, Tokyo 113, Japan; [Hori, Masaaki; Aoki, Shigeki] Juntendo Univ, Sch Med, Dept Radiol, Tokyo 113, Japan	Katsura, M (reprint author), Univ Tokyo, Grad Sch Med, Dept Radiol, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan.	mkatsura-tky@umin.ac.jp					Karakida O, 2003, CLIN RADIOL, V58, P389, DOI 10.1016/S0009-9260(02)00583-4; Assaf Y, 2002, MAGNET RESON MED, V47, P115, DOI 10.1002/mrm.10040; MARCHAND F, 1990, SPINE, V15, P402, DOI 10.1097/00007632-199005000-00011; Hori M, 2012, EUR RADIOL, V22, P1797, DOI 10.1007/s00330-012-2410-9; Niu G, 2011, AM J NEURORADIOL, V32, P1617, DOI 10.3174/ajnr.A2556; Zhang ZP, 2012, MAGN RESON IMAGING, V30, P181, DOI 10.1016/j.mri.2011.09.021; Clark CA, 2000, MAGNET RESON MED, V44, P852, DOI 10.1002/1522-2594(200012)44:6<852::AID-MRM5>3.0.CO;2-A; Stelzeneder D, 2012, EUR J RADIOL, V81, P324, DOI 10.1016/j.ejrad.2010.12.093; Pfirrmann CWA, 2001, SPINE, V26, P1873, DOI 10.1097/00007632-200109010-00011; Raab P, 2010, RADIOLOGY, V254, P876, DOI 10.1148/radiol.09090819; Jensen JH, 2005, MAGNET RESON MED, V53, P1432, DOI 10.1002/mrm.20508; Wu EX, 2010, NMR BIOMED, V23, P836, DOI 10.1002/nbm.1506; Farrell JAD, 2008, MAGN RESON MED, V59, P1079, DOI 10.1002/mrm.21563; KARGER J, 1985, ADV COLLOID INTERFAC, V23, P129, DOI 10.1016/0001-8686(85)80018-X; Hori M, 2011, ACAD RADIOL, V18, P837, DOI 10.1016/j.acra.2011.02.005; CALLAGHAN PT, 1991, NATURE, V351, P467, DOI 10.1038/351467a0; Jensen JH, 2011, NMR BIOMED, V24, P452, DOI 10.1002/nbm.1610; Roberts N, 1998, CLIN ANAT, V11, P1; Hori M, 2012, MAGN RESON MED SCI, V11, P221; Ludescher B, 2008, J MAGN RESON IMAGING, V28, P252, DOI 10.1002/jmri.21390; CORY DG, 1990, MAGNET RESON MED, V14, P435, DOI 10.1002/mrm.1910140303; De Puky P, 1935, ACTA ORTHOP SCAND, V6, P338, DOI 10.3109/17453673508991358; EKLUND JAE, 1984, SPINE, V9, P189, DOI 10.1097/00007632-198403000-00009; KRAG MH, 1990, SPINE, V15, P202, DOI 10.1097/00007632-199003000-00008; Mwale F, 2008, EUR SPINE J, V17, pS432, DOI 10.1007/s00586-008-0744-4; REILLY T, 1984, Chronobiology International, V1, P121, DOI 10.3109/07420528409059129	26	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1053-1807	1522-2586		J MAGN RESON IMAGING	J. Magn. Reson. Imaging	NOV	2014	40	5					1208	1214		10.1002/jmri.24459		7	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	AS0ZR	WOS:000344005800023		
J	Naito, K				Naito, Kimiyoshi			Tensile Properties and Fracture Behavior of Different Carbon Nanotube-Grafted Polyacrylonitrile-Based Carbon Fibers	JOURNAL OF MATERIALS ENGINEERING AND PERFORMANCE			English	Article						failure analysis; mechanical; nanomaterials; static	CHEMICAL-VAPOR-DEPOSITION; WEIBULL STATISTICS; STRENGTH; COMPOSITES; GROWTH; MODULUS; SURFACE; SPUN	The tensile properties and fracture behavior of different carbon nanotube (CNT)-grafted polyacrylonitrile-based (T1000GB) single carbon fibers were investigated. Grafting of CNTs was achieved via chemical vapor deposition (CVD). When Fe(C5H5)(2) (also applied via CVD) was used as the catalyst, the tensile strength and Weibull modulus of the carbon fibers were improved, possibly due to the growth of dense CNT networks on the carbon fibers, which may have led to a reduction in the number of strength-limiting defects. Separately, at lower concentrations of an Fe(NO3)(3)center dot 9H(2)O catalyst in ethanol, which was applied via dipping, the tensile strength of CNT-grafted fibers was nearly identical to that of the as-received fibers, although the Weibull modulus was higher. For higher concentrations of the Fe(NO3)(3)center dot 9H(2)O catalyst, however, the tensile strength and the Weibull modulus were lower than those for the as-received material. Although the density of the CNT network increased with the concentration of the Fe(NO3)(3)center dot 9H(2)O catalyst in the ethanol solution, heating of the ethanolic Fe(NO3)(3)center dot 9H(2)O catalyst solution generated nitric acid (HNO3) due to decomposition, which damaged the fiber surfaces, resulting in an increase in the number of flaws and consequently a reduction in the tensile strength. Therefore, the tensile strength and Weibull modulus of CNT-grafted carbon fibers vary due to the combination of these effects and as a function of the catalyst concentration.	Natl Inst Mat Sci, Composite Mat Grp, Hybrid Mat Unit, Tsukuba, Ibaraki 3050047, Japan	Naito, K (reprint author), Natl Inst Mat Sci, Composite Mat Grp, Hybrid Mat Unit, 1-2-1 Sengen, Tsukuba, Ibaraki 3050047, Japan.	naito.kimiyoshi@nims.go.jp			JSPS (Japan Society for the Promotion of Science) KAKENHI [26420715]; JST (Japan Science and Technology Agency) through Advanced Low Carbon Technology Research and Development Program (ALCA)	This work was supported by JSPS (Japan Society for the Promotion of Science) KAKENHI 26420715 and JST (Japan Science and Technology Agency) through Advanced Low Carbon Technology Research and Development Program (ALCA).	Angoni K, 1998, J MATER SCI, V33, P3693, DOI 10.1023/A:1004628017725; [Anonymous], 2013, ASTM ANN BOOK STAND, V5.04; [Anonymous], 2009, ASTM ANN BOOK STAND; Li DC, 2000, CHEM PHYS LETT, V316, P349, DOI 10.1016/S0009-2614(99)01334-2; Zhao JO, 2008, CARBON, V46, P380, DOI 10.1016/j.carbon.2007.11.021; Yan H, 2002, CARBON, V40, P2693, DOI 10.1016/S0008-6223(02)00175-6; Kulkarni R, 2006, J COMPOS MATER, V40, P733, DOI 10.1177/0021998305055545; HUANG Y, 1995, CARBON, V33, P97, DOI 10.1016/0008-6223(94)00109-D; KUMAR S, 1993, J MATER SCI, V28, P423, DOI 10.1007/BF00357820; Qian H, 2008, CHEM MATER, V20, P1862, DOI 10.1021/cm702782j; Zhu S, 2003, DIAM RELAT MATER, V12, P1825, DOI 10.1016/S0925-9635(03)00205-X; Zhang XF, 2007, SMALL, V3, P244, DOI 10.1002/smll.200600368; Steiner SA, 2013, ACS APPL MATER INTER, V5, P4892, DOI 10.1021/am4006385; Thostenson ET, 2002, J APPL PHYS, V91, P6034, DOI 10.1063/1.1466880; Bekyarova E, 2007, LANGMUIR, V23, P3970, DOI 10.1021/la062743p; Curtin WA, 2000, J COMPOS MATER, V34, P1301, DOI 10.1106/0GU5-LMTA-9R99-2W8K; Naito K, 2008, CARBON, V46, P189, DOI 10.1016/j.carbon.2007.11.001; Bandow S, 1998, PHYS REV LETT, V80, P3779, DOI 10.1103/PhysRevLett.80.3779; Tzeng SS, 2006, CARBON, V44, P859, DOI 10.1016/j.carbon.2005.10.033; Danzer R, 2006, J EUR CERAM SOC, V26, P3043, DOI 10.1016/j.jeurceramsoc.2005.08.021; Tran CD, 2009, CARBON, V47, P2662, DOI 10.1016/j.carbon.2009.05.020; Sung MG, 2002, CARBON, V40, P2013, DOI 10.1016/S0008-6223(02)00059-3; Chand S, 2000, J MATER SCI, V35, P1303, DOI 10.1023/A:1004780301489; Demczyk BG, 2002, MAT SCI ENG A-STRUCT, V334, P173, DOI 10.1016/S0921-5093(01)01807-X; Fitzer E., 1988, FIBRE REINFORCEMENTS, P73; Lu CS, 2002, J AM CERAM SOC, V85, P1640; Matthews M.J., 1999, PHYS REV B, V59, P6585; Morgan PE, 2005, CARBON FIBERS THEIR, P185; Naito K., 2008, APPL PHYS LETT, V92; Naito K, 2012, J MATER SCI, V47, P8044, DOI 10.1007/s10853-012-6694-6; Naito K, 2009, J AM CERAM SOC, V92, P186, DOI 10.1111/j.1551-2916.2008.02868.x; Naito K, 2012, J MATER SCI, V47, P632, DOI 10.1007/s10853-011-5832-x; Ouyang Y, 2008, PHYSICA E, V40, P2386, DOI 10.1016/j.physe.2007.11.008; PADGETT WJ, 1995, J COMPOS MATER, V29, P1873; Pesin LA, 2002, J MATER SCI, V37, P1, DOI 10.1023/A:1013100920130; VEZIE DL, 1990, J MATER SCI LETT, V9, P883, DOI 10.1007/BF00722159; WATSON AS, 1985, J MATER SCI, V20, P3260, DOI 10.1007/BF00545193; WEIBULL W, 1951, J APPL MECH-T ASME, V18, P293; YUDASAKA M, 1994, APPL PHYS LETT, V64, P842, DOI 10.1063/1.110998	39	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1059-9495	1544-1024		J MATER ENG PERFORM	J. Mater. Eng. Perform.	NOV	2014	23	11					3916	3925		10.1007/s11665-014-1207-1		10	Materials Science, Multidisciplinary	Materials Science	AS5TA	WOS:000344331200012		
J	Morisada, Y; Imaizumi, T; Fujii, H; Matsushita, M; Ikeda, R				Morisada, Yoshiaki; Imaizumi, Takuya; Fujii, Hidetoshi; Matsushita, Muneo; Ikeda, Rinsei			Three-Dimensional Visualization of Material Flow During Friction Stir Welding of Steel and Aluminum	JOURNAL OF MATERIALS ENGINEERING AND PERFORMANCE			English	Article						aluminum; friction stir welding; material flow; steel; x-ray radiography	TOOL STEEL; ALLOY; MICROSTRUCTURES; JOINTS; MODEL	Material flow is a key phenomenon to obtain sound joints by friction stir welding (FSW), and it is highly dependent of the welded material. It is well known that the optimal FSW condition depends on the welded material. However, the material flow during FSW has not been totally clarified in spite of many researches. Especially, the material flow of steel during FSW is still unclear. It seems difficult to understand the material flow by the traditional method such as the tracer method or observation of the microstructure in the stir zone. Therefore, in this study, the material flow of steel was three dimensionally visualized by x-ray radiography using two pairs of x-ray transmission real-time imaging systems, and was then compared with the material flow of aluminum. The result revealed the effect of the welded material on the material flow during FSW.	[Morisada, Yoshiaki; Imaizumi, Takuya; Fujii, Hidetoshi] Osaka Univ Joining & Welding Res Inst, Osaka, Japan; [Matsushita, Muneo; Ikeda, Rinsei] JFE Steel Corp, Chiba, Japan	Morisada, Y (reprint author), Osaka Univ Joining & Welding Res Inst, Osaka, Japan.	morisada@jwri.osaka-u.ac.jp			Japan Science and Technology Agency (JST); Global COE Programs; Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan; ISIJ Research Promotion Grant	The authors wish to acknowledge the financial support of a Collaborative Research Based on Industrial Demand "Heterogeneous Structure Control: Towards Innovative Development of Metallic Structural Materials" by Japan Science and Technology Agency (JST), the Global COE Programs and Grant-in-Aid from the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan, and ISIJ Research Promotion Grant.	Dawes CJ, 1996, WELD J, V75, P41; Ueji R, 2006, MAT SCI ENG A-STRUCT, V423, P324, DOI 10.1016/j.msea.2006.02.038; Li Y, 1999, MAT SCI ENG A-STRUCT, V271, P213, DOI 10.1016/S0921-5093(99)00204-X; Park SHC, 2003, SCRIPTA MATER, V49, P161, DOI 10.1016/S1359-6462(03)00210-0; Pashazadeh H, 2014, MATER DESIGN, V55, P619, DOI 10.1016/j.matdes.2013.09.028; Liu HJ, 2003, J MATER PROCESS TECH, V142, P692, DOI 10.1016/S0924-0136(03)00806-9; Fujii H, 2006, MAT SCI ENG A-STRUCT, V429, P50, DOI 10.1016/j.msea.2006.04.118; Buffa G, 2006, MAT SCI ENG A-STRUCT, V419, P381, DOI 10.1016/j.msea.2005.09.041; Reynolds AP, 2003, SCRIPTA MATER, V48, P1289, DOI 10.1016/S1359-6462(03)00024-1; Park SHC, 2003, SCRIPTA MATER, V49, P1175, DOI 10.1016/j.scriptamat.2003.08.022; Morisada Y, 2011, SCRIPTA MATER, V65, P1085, DOI 10.1016/j.scriptamat.2011.09.021; Heidarzadeh A, 2012, MATER DESIGN, V37, P166, DOI 10.1016/j.matdes.2011.12.022; Cam G, 2014, J MATER ENG PERFORM, V23, P1936, DOI 10.1007/s11665-014-0968-x; Morisada Y, 2007, COMPOS PART A-APPL S, V38, P2097, DOI 10.1016/j.compositesa.2007.07.004; Su P, 2007, METALL MATER TRANS A, V38A, P584, DOI 10.1007/s11661-006-9067-4; Liu G, 1997, SCRIPTA MATER, V37, P355, DOI 10.1016/S1359-6462(97)00093-6; Cam G, 2011, INT MATER REV, V56, P1, DOI 10.1179/095066010X12777205875750; Chen GQ, 2014, J MATER ENG PERFORM, V23, P1321, DOI 10.1007/s11665-014-0886-y; Colligan K., 1999, WELD J, P229; Guerra M., 2003, MATER CHARACT, V49, P95; Knipstrom KE, 1997, WELD J, V76, P55; Konkol P, 2003, J SHIP PROD, V19, P159; Liechty BC, 2007, J MATER PROCESS TECH, V184, P240, DOI 10.1016/j.jmatprotec.2006.10.049; Lienert TJ, 2003, WELD J, V82, p1S; Morisada Y., 2014, J JPN WELD SOC, V32, P31; Morisada Y, 2009, MAT SCI ENG A-STRUCT, V505, P157, DOI 10.1016/j.msea.2008.11.006; Morisada Y, 2009, SURF COAT TECH, V204, P386, DOI 10.1016/j.surfcoat.2009.07.043; Shimoda Y., 2011, J JPN WELD SOC, V29, P114; Thomas W, 1999, OPT PHOTONICS NEWS, V10, P4; Thomas W.M., 1991, Int. patent Appl. No, Patent No. [PCT/GB92/02203, 9202203]	30	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1059-9495	1544-1024		J MATER ENG PERFORM	J. Mater. Eng. Perform.	NOV	2014	23	11					4143	4147		10.1007/s11665-014-1202-6		5	Materials Science, Multidisciplinary	Materials Science	AS5TA	WOS:000344331200036		
J	Uemura, K; Kanamori, A; Aoto, K; Yamazaki, M; Sakane, M				Uemura, Kenta; Kanamori, Akihiro; Aoto, Katsuya; Yamazaki, Masashi; Sakane, Masataka			Novel unidirectional porous hydroxyapatite used as a bone substitute for open wedge high tibial osteotomy	JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE			English	Article							MEDIAL COMPARTMENT; FOLLOW-UP; OSTEOARTHRITIS; KNEE	Purpose: The purpose of this study was to clinically and radiologically evaluate the availability, osteoconductivity, and resorption of a novel unidirectional porous hydroxyapatite (UDPHAp) used as an artificial substitute for open wedge high tibial osteotomy (OWHTO). Our hypothesis was that UDPHAp is a safe and useful bone substitute for OWHTO. Materials and methods: Seven patients (2 men and 5 women aged 34-72years) who underwent OWHTO and were followed up for more than 12months were retrospectively studied. After the osteotomy, the gap created was filled with UDPHAp(REGENOSA (R) Kuraray Co.Ltd). Radiography and computed tomography(CT) were performed, and gap healing was assessed postoperatively. The Japanese Orthopaedic Association (JOA) knee score was determined pre- and post-operatively for clinical evaluation. Results: Neither gross displacement nor collapse of the UDPHAp block graft was observed within 12 months after surgery. Both radiographs and CT showed attenuation of lucency and increasing sclerosis over time. JOA score improved from 71.2 (65-80) to 95.8 (85-100). Conclusions: Short term results for OWHTO using UDPHAp was satisfactory. Clinical improvement of JOA scores were seen, besides osteogenesis was progressing in and around the artificial bone grafts.	[Uemura, Kenta; Aoto, Katsuya] Univ Tsukuba, Grad Sch Comprehens Human Sci, Dept Orthopaed Surg, Tsukuba, Ibaraki 3058575, Japan; [Kanamori, Akihiro; Yamazaki, Masashi; Sakane, Masataka] Univ Tsukuba, Fac Med, Dept Orthopaed Surg, Tsukuba, Ibaraki 3058575, Japan	Uemura, K (reprint author), Univ Tsukuba, Grad Sch Comprehens Human Sci, Dept Orthopaed Surg, 1-1-1 Tennodai, Tsukuba, Ibaraki 3058575, Japan.	sakane-m@tsukuba-seikei.jp			Kuraray Co., Ltd., Okayama, Japan	Funding was partially provided by Kuraray Co., Ltd., Okayama, Japan.	Takeuchi R, 2010, KNEE, V17, P217, DOI 10.1016/j.knee.2009.09.002; COVENTRY MB, 1993, J BONE JOINT SURG AM, V75A, P196; Koshino T, 2003, J BONE JOINT SURG AM, V85A, P78; Agneskirchner JD, 2006, KNEE SURG SPORT TR A, V14, P291, DOI 10.1007/s00167-005-0690-1; Miller BS, 2009, ARTHROSCOPY, V25, P639, DOI 10.1016/j.arthro.2008.12.020; Chang CB, 2010, OSTEOARTHR CARTILAGE, V18, P530, DOI 10.1016/j.joca.2009.12.004; Aryee S, 2008, BIOMATERIALS, V29, P3497, DOI 10.1016/j.biomaterials.2008.05.027; HERNIGOU P, 1987, J BONE JOINT SURG AM, V69A, P332; Takeuchi R, 2009, ARTHROSCOPY, V25, P46, DOI 10.1016/j.arthro.2008.08.015; Hernigou P, 2001, KNEE, V8, P103, DOI 10.1016/S0968-0160(00)00061-2; Koshino T, 2001, BIOMATERIALS, V22, P1579, DOI 10.1016/S0142-9612(00)00318-5; Marti CB, 2000, KNEE SURG SPORT TR A, V8, P83, DOI 10.1007/s001670050191; Murakoshi Takuma, 2012, Journal of the Japan Society for Composite Materials, V38; Myoui A, 2011, JPN J ARTIF ORGANS, V40, P76; Pape D, 2007, OPER TECH ORTHOP, V17, P2, DOI 10.1053/j.oto.2006.09.007; Spahn Gunter, 2002, J Orthop Sci, V7, P683, DOI 10.1007/s007760200121; Tanaka T, 2014, KNEE SURG SPORT TR A, DOI [10.1007/s00167-014-2870-3., DOI 10.1007/S00167-014-2870-3]; Tanaka T, 2008, J BIOMED MATER RES B, V86B, P453, DOI 10.1002/jbm.b.31041; van Hemert WLW, 2004, KNEE, V11, P451, DOI 10.1016/j.knee.2004.08.004; Watanabe Arata, 2010, [Biomaterials Research, 생체재료학회지], V14, P6	20	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0957-4530	1573-4838		J MATER SCI-MATER M	J. Mater. Sci.-Mater. Med.	NOV	2014	25	11					2541	2547		10.1007/s10856-014-5266-5		7	Engineering, Biomedical; Materials Science, Biomaterials	Engineering; Materials Science	AR9WN	WOS:000343927300008		
J	Mohan, N; Nair, PD; Tabata, Y				Mohan, Neethu; Nair, Prabha D.; Tabata, Yasuhiko			A 3D biodegradable protein based matrix for cartilage tissue engineering and stem cell differentiation to cartilage (vol 20, pg 49, 2009)	JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE			English	Correction									[Mohan, Neethu; Nair, Prabha D.] Sree Chitra Tirunal Inst Med Sci & Technol, Biomed Technol Wing, Lab Polymer Anal, Trivandrum 695012, Kerala, India; [Tabata, Yasuhiko] Kyoto Univ, Inst Frontier Med Sci, Dept Biomat, Kyoto, Japan	Nair, PD (reprint author), Sree Chitra Tirunal Inst Med Sci & Technol, Biomed Technol Wing, Lab Polymer Anal, Trivandrum 695012, Kerala, India.	biochemneethu@gmail.com; pdnair49@gmail.com; yasuhiko@frontier.kyoto-u.ac.jp					Mohan N, 2009, J MATER SCI-MATER M, V20, P49, DOI 10.1007/s10856-008-3481-7	1	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0957-4530	1573-4838		J MATER SCI-MATER M	J. Mater. Sci.-Mater. Med.	NOV	2014	25	11					2603	2603		10.1007/s10856-008-3535-x		1	Engineering, Biomedical; Materials Science, Biomaterials	Engineering; Materials Science	AR9WN	WOS:000343927300015		
J	Morioka, I; Matsumoto, M; Miwa, A; Yokota, T; Matsuo, K; Koda, T; Nagasaka, M; Shibata, A; Fujita, K; Yamane, M; Yamada, H; Enomoto, M; Chikahira, M; Iijima, K				Morioka, Ichiro; Matsumoto, Masaaki; Miwa, Akihiro; Yokota, Tomoyuki; Matsuo, Kiyomi; Koda, Tsubasa; Nagasaka, Miwako; Shibata, Akio; Fujita, Kaori; Yamane, Masayuki; Yamada, Hideto; Enomoto, Miki; Chikahira, Masatsugu; Iijima, Kazumoto			Dried umbilical cord is a potential material for retrospective diagnosis of intrauterine enterovirus infection	JOURNAL OF MATERNAL-FETAL & NEONATAL MEDICINE			English	Article						Coxsackievirus; echovirus; persistent pulmonary hypertension of the newborn; sepsis; transmission route	SEQUENCE	Objective: To determine whether dried umbilical cords (UCs) are useful for retrospective diagnosis of intrauterine enterovirus (EV) infection. Methods: Dried UCs in two patients with neonatal EV sepsis and 10 neonates without infectious signs were enrolled. Viral RNA was extracted from their dried UCs, and nested reverse transcription polymerase chain reaction (RT-PCR) was performed. Results: Infection routes estimated by the clinical course were intrauterine infection in Case 1 and post-natal horizontal infection in Case 2. EV-RNA was detected from dried UC in Case 1, but not in Case 2 and 10 neonates. Conclusions: This report showed the potential use of dried UCs for retrospective diagnosis of intrauterine EV infection.	[Morioka, Ichiro; Matsumoto, Masaaki; Miwa, Akihiro; Yokota, Tomoyuki; Matsuo, Kiyomi; Koda, Tsubasa; Nagasaka, Miwako; Shibata, Akio; Iijima, Kazumoto] Kobe Univ Hosp, Dept Pediat, Kobe, Hyogo 6500017, Japan; [Fujita, Kaori; Yamane, Masayuki] Saiseikai Hyogo Gen Hosp, Dept Pediat, Kobe, Hyogo, Japan; [Yamada, Hideto; Enomoto, Miki] Kobe Univ Hosp, Dept Obstet & Gynecol, Kobe, Hyogo 6500017, Japan; [Chikahira, Masatsugu] Hyogo Prefectural Inst Publ Hlth & Consumer Sci, Infect Dis Res Div, Kobe, Hyogo, Japan	Morioka, I (reprint author), Kobe Univ Hosp, Dept Paediat, Chuo Ku, 7-5-2 Kusunoki Cho, Kobe, Hyogo 6500017, Japan.	ichim@med.kobe-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan; Ministry of Health, Labour and Welfare of Japan [H23-Jisedai-Ippan-001, H25-Jisedai-Shitei-003]	This work was supported in part by Grants-in-Aid from the Ministry of Education, Culture, Sports, Science and Technology of Japan (I.M.) and the Ministry of Health, Labour and Welfare of Japan (H23-Jisedai-Ippan-001 and H25-Jisedai-Shitei-003).	Abzug Mark J, 2004, Paediatr Drugs, V6, P1, DOI 10.2165/00148581-200406010-00001; Ishiko H, 2002, J INFECT DIS, V185, P744, DOI 10.1086/339298; JENISTA JA, 1984, J PEDIATR-US, V104, P685, DOI 10.1016/S0022-3476(84)80944-0; ABZUG MJ, 1993, PEDIATR INFECT DIS J, V12, P820, DOI 10.1097/00006454-199310000-00005; Koyano S, 2004, PEDIATR INFECT DIS J, V23, P481, DOI 10.1097/00006454-200405000-00028; MAHL MC, 1975, CAN J MICROBIOL, V21, P819; Miyata I, 2013, J CLIN VIROL, V56, P274, DOI 10.1016/j.jcv.2012.11.008; Modlin JF, 2010, PRINCIPLES PRACTICE, P2337; Saijets S, 2003, J MED VIROL, V70, P430, DOI 10.1002/jmv.10413; Takami T, 2000, J HOSP INFECT, V45, P283, DOI 10.1053/jhin.2000.0788; Willems A, 2006, AM J PERINAT, V23, P59, DOI 10.1055/s-2005-918890	11	0	0	INFORMA HEALTHCARE	LONDON	TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND	1476-7058	1476-4954		J MATERN-FETAL NEO M	J. Matern.-Fetal Neonatal Med.	NOV	2014	27	17					1820	1822		10.3109/14767058.2013.879701		3	Obstetrics & Gynecology	Obstetrics & Gynecology	AS2AE	WOS:000344080600020		
J	Lee, WH; Wu, HM; Lee, CG; Sung, DI; Song, HJ; Matsui, T; Kim, HB; Kim, SG				Lee, Woo Hyung; Wu, Hong Min; Lee, Chan Gyu; Sung, Dae Il; Song, Hye Jung; Matsui, Toshiro; Kim, Han Bok; Kim, Sang Geon			Specific Oligopeptides in Fermented Soybean Extract Inhibit NF-kappa B-Dependent iNOS and Cytokine Induction by Toll-Like Receptor Ligands	JOURNAL OF MEDICINAL FOOD			English	Article						inflammation; chungkookjang; food supplement	NITRIC-OXIDE SYNTHASE; ETHANOL EXTRACT; SEPTIC SHOCK; DOUBLE-BLIND; SOY PROTEIN; EXPRESSION; ACTIVATION; CHUNGKOOKJANG; INFLAMMATION; CELLS	The ethanol extract of fermented soybean from Glycine max (chungkookjang, CHU) has been claimed to have chemopreventive and cytoprotective effects. In the present study, we examined the inhibitory effect of CHU on inducible nitric oxide synthase (iNOS) and cytokine induction by toll-like receptor (TLR) ligands treatment and attempted to identify the responsible active components. Nitric oxide (NO) content and iNOS levels in the media or RAW264.7 cells were measured using the Griess reagent and real-time polymerase chain reaction assays. CHU treatment inhibited NO production and iNOS induction elicited by lipopolysaccharide (LPS, TLR4L) in a concentration-dependent manner. Tumor necrosis factor-alpha and interleukin-6 productions were also diminished. Peptidoglycans (TLR2/6L) and CpG-oligodeoxynucleotides (TLR9L) from CHU inhibited iNOS induction, but not poly I:C (TLR3L) or loxoribine (TLF7L). The anti-inflammatory effect resulted from the inhibition of nuclear factor-kappa B (NF-kappa B) through the inhibition of inhibitory-kappa B degradation. Of the representative components in CHU, specific oligopeptides (AFPG and GVAWWMY) had the ability to inhibit iNOS induction by LPS, whereas others failed to do so. Daidzein, an isoflavone used for comparative purposes, was active at a relatively higher concentration. In an animal model, oral administration of CHU to rats significantly diminished carrageenan-induced paw edema and iNOS induction. Our results demonstrate that CHU has anti-inflammatory effects against TLR ligands by inhibiting NF-kappa B activation, which may result from specific oligopeptide components in CHU. Since CHU is orally effective, dietary applications of CHU and/or the identified oligopeptides may be of use in the prevention of inflammatory diseases.	[Lee, Woo Hyung; Wu, Hong Min; Lee, Chan Gyu; Kim, Sang Geon] Seoul Natl Univ, Pharmaceut Sci Res Inst, Coll Pharm, Seoul 151742, South Korea; [Sung, Dae Il; Song, Hye Jung; Kim, Han Bok] Hoseo Univ, Res Inst Basic Sci, Dept Biotechnol, Asan, South Korea; [Matsui, Toshiro] Kyushu Univ, Grad Sch, Dept Biosci & Biotechnol, Fukuoka 812, Japan	Kim, SG (reprint author), Seoul Natl Univ, Pharmaceut Sci Res Inst, Coll Pharm, Seoul 151742, South Korea.	hbkim@hoseo.edu; sgk@snu.ac.kr			National Research Foundation of Korea (NRF) - Korea government (MSIP) [2007-0056817]; World Class University project [R32-2012-000-10098-0]; National Research Foundation of Korea [2010-0021179]	This work was supported by the National Research Foundation of Korea (NRF) grant funded by the Korea government (MSIP) (No. 2007-0056817), and, in part, by the World Class University project (R32-2012-000-10098-0) and a grant from National Research Foundation of Korea (2010-0021179).	Hamalainen M, 2007, MEDIAT INFLAMM, DOI 10.1155/2007/45673; Lu Y, 2012, INT IMMUNOPHARMACOL, V12, P175, DOI 10.1016/j.intimp.2011.11.008; Kawai T, 2007, TRENDS MOL MED, V13, P460, DOI 10.1016/j.molmed.2007.09.002; Hayden MS, 2004, GENE DEV, V18, P2195, DOI 10.1101/gad.1228704; Neuman MG, 2008, DIGEST DIS SCI, V53, P1468, DOI 10.1007/s10620-007-0047-3; Zambrowicz A, 2013, AMINO ACIDS, V44, P315, DOI 10.1007/s00726-012-1379-7; Arbibe L, 2000, NAT IMMUNOL, V1, P533, DOI 10.1038/82797; Takahashi Y, 2008, J NUTR BIOCHEM, V19, P682, DOI 10.1016/j.jnutbio.2007.09.003; Beutler B, 2004, NATURE, V430, P257, DOI 10.1038/nature02761; Kataoka T, 2012, INFLAMMATION, V35, P713, DOI 10.1007/s10753-011-9364-y; Yoshikawa M, 2000, BIOFACTORS, V12, P143; BEUTLER B, 1989, ANNU REV IMMUNOL, V7, P625, DOI 10.1146/annurev.iy.07.040189.003205; Schoenemeyer A, 2005, J BIOL CHEM, V280, P17005, DOI 10.1074/jbc.M412584200; Gasparini C, 2012, CURR PHARM DESIGN, V18, P5735; Beutler B, 2000, CURR OPIN IMMUNOL, V12, P20, DOI 10.1016/S0952-7915(99)00046-1; Kleinert H, 2003, BIOL CHEM, V384, P1343, DOI 10.1515/BC.2003.152; Lee CG, 2012, GASTROENTEROLOGY, V142, P1206, DOI 10.1053/j.gastro.2012.01.007; Doyle SE, 2002, IMMUNITY, V17, P251, DOI 10.1016/S1074-7613(02)00390-4; Honda K, 2004, P NATL ACAD SCI USA, V101, P15416, DOI 10.1079/pnas.1016933101; Kwak CS, 2007, NUTR RES, V27, P719, DOI 10.1016/j.nutres.2007.09.004; Jin MS, 2008, IMMUNITY, V29, P182, DOI 10.1016/j.immuni.2008.07.007; Bogdan C, 2001, NAT IMMUNOL, V2, P907, DOI 10.1038/ni1001-907; Lim EJ, 2007, EXP MOL MED, V39, P239; CORRIVEAU CC, 1993, INFECT AGENT DIS, V2, P35; Wong BW, 2012, CAN J CARDIOL, V28, P631, DOI 10.1016/j.cjca.2012.06.023; Bonizzi G, 2004, TRENDS IMMUNOL, V25, P280, DOI 10.1016/j.it.2004.03.008; Chai C, 2012, J CHROMATOGR B, V880, P42, DOI 10.1016/j.jchromb.2011.11.013; Kim NY, 2008, FOOD CHEM TOXICOL, V46, P1184, DOI 10.1016/j.fct.2007.12.003; Ghosh S, 2002, CELL, V109, pS81, DOI 10.1016/S0092-8674(02)00703-1; Lee AK, 2003, BRIT J PHARMACOL, V139, P11, DOI 10.1038/sj.bjp.0705231; Back HI, 2011, J MED FOOD, V14, P532, DOI 10.1089/jmf.2010.1199; Barnes S, 1997, BREAST CANCER RES TR, V46, P169, DOI 10.1023/A:1005956326155; Bektic Jasmin, 2005, Clin Prostate Cancer, V4, P124, DOI 10.3816/CGC.2005.n.021; Cho IJ, 2005, FREE RADICAL BIO MED, V39, P1523, DOI 10.1016/j.freeradbiomed.2005.07.017; Choi YH, 2008, J MED FOOD, V11, P539, DOI 10.1089/jmf.2007.0125; Cronin JG, 2012, BIOL REPROD, V86, DOI 10.1095/biolreprod.111.092718; Demonty I, 2002, J NUTR BIOCHEM, V13, P671, DOI 10.1016/S0955-2863(02)00214-0; Do H, 2010, J NUTR BIOCHEM, V21, P671, DOI 10.1016/j.jnutbio.2009.03.013; Hwang JS, 2011, NUTR CANCER, V63, P645, DOI 10.1080/01635581.2011.551987; Inoguchi S, 2012, INT J FOOD SCI NUTR, V63, P402, DOI 10.3109/09637486.2011.630992; Kim DJ, 2008, J MED FOOD, V11, P215, DOI 10.1089/jmf.2007.560; Kim HB, 2007, J MICROBIOL, V45, P256; Kwon DY, 2011, BMC COMPLEM ALTERN M, V11, DOI 10.1186/1472-6882-11-125; LLOYD SS, 1993, FREE RADICAL BIO MED, V14, P233, DOI 10.1016/0891-5849(93)90020-U; Matsumoto M, 2004, MICROBIOL IMMUNOL, V48, P147	45	2	2	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	1096-620X	1557-7600		J MED FOOD	J. Med. Food	NOV 1	2014	17	11					1239	1246		10.1089/jmf.2013.3070		8	Chemistry, Medicinal; Food Science & Technology; Nutrition & Dietetics	Pharmacology & Pharmacy; Food Science & Technology; Nutrition & Dietetics	AS8CB	WOS:000344476800012		
J	Sakai, H; Ikeda, Y; Honda, T; Tanaka, Y; Shiraishi, K; Inui, M				Sakai, Hiroki; Ikeda, Yasuhiro; Honda, Takeshi; Tanaka, Yoshie; Shiraishi, Kozo; Inui, Makoto			A cell-penetrating phospholamban-specific RNA aptamer enhances Ca2+ transients and contractile function in cardiomyocytes	JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY			English	Article						Aptamer; Calcium signaling; Cardiac sarcoplasmic reticulum; Cardiomyocyte; Cell-penetrating peptide; Phospholamban	CARDIAC SARCOPLASMIC-RETICULUM; ADVANCED HEART-FAILURE; IN-VITRO; EXPONENTIAL ENRICHMENT; DILATED CARDIOMYOPATHY; VENTRICULAR MYOCYTES; CALCIUM-TRANSPORT; GENE-TRANSFER; PHOSPHORYLATION; DYSFUNCTION	The sarco(endo)plasmic reticulum Ca2+-ATPase 2a (SERCA2a)-phospholamban (PLN) system of sarcoplasmic reticulum plays a pivotal role in regulation of intracellular Ca2+ cycling in ventricular cardiomyocytes. Given that Ca2+ cycling is impaired in heart failure, proteins that contribute to this process are potential targets for the treatment of this condition. We have now isolated PLN-specific aptamers with a phosphorothioatemodified backbone from a library of RNA molecules containing a randomized 40-nucleotide sequence by application of the systematic evolution of ligands by exponential enrichment (SELEX) protocol with a fusion protein containing the cytoplasmic region of human PLN. One of these aptamers was shortened to a 30-nucleotide oligomer (RNA-Apt30) without loss of function. RNA-Apt30 showed a high affinity for the cytoplasmic region of PLN (K-d = 11 nM), but it did not bind to the phosphorylated form of PLN or to a phosphomimetic mutant. It also increased SERCA2a activity in isolated cardiac SR vesicles with an EC50 of 18 nM by relieving PLN-mediated inhibition. Conjugation of RNA-Apt30 to a cell-penetrating peptide allowed its delivery into adult rat cardiomyocytes, in which it enhanced both Ca2+ transients and contractile function. These effects of the aptamer were also apparent in the presence of the beta-adrenergic receptor antagonist propranolol. This cell-penetrating PLN aptamer may thus provide a basis for the development of new therapeutic agents for heart failure without the need for gene transfer or a change in endogenous protein expression. (c) 2014 Elsevier Ltd. All rights reserved.	[Sakai, Hiroki; Honda, Takeshi; Tanaka, Yoshie; Inui, Makoto] Yamaguchi Univ, Dept Pharmacol, Grad Sch Med, Ube, Yamaguchi 7558505, Japan; [Ikeda, Yasuhiro; Shiraishi, Kozo] Yamaguchi Univ, Div Cardiol, Grad Sch Med, Dept Med & Clin Sci, Ube, Yamaguchi 7558505, Japan	Inui, M (reprint author), Yamaguchi Univ, Dept Pharmacol, Grad Sch Med, 1-1-1 Minami Kogushi, Ube, Yamaguchi 7558505, Japan.	minui@yamaguchi-u.ac.jp			Japan Society for the Promotion of Science [22390050, 25293062, 25870470]; Yamaguchi University; Yamada Research Foundation	This work was supported in part by Grants-in-Aid for Scientific Research (B) (22390050 and 25293062 to M.I.) and a Grant-in-Aid for Young Scientists (B) (25870470 to H.S.) from the Japan Society for the Promotion of Science, by a research promotion grant from Yamaguchi University (to M.I.), and by a grant from Yamada Research Foundation (to M.I.).	Ni X, 2011, CURR MED CHEM, V18, P4206; Suckau L, 2009, CIRCULATION, V119, P1241, DOI 10.1161/CIRCULATIONAHA.108.783852; LUO WS, 1994, CIRC RES, V75, P401; Kaye DM, 2007, J AM COLL CARDIOL, V50, P253, DOI 10.1016/j.jacc.2007.03.047; ELLINGTON AD, 1990, NATURE, V346, P818, DOI 10.1038/346818a0; Eckstein F, 2000, ANTISENSE NUCLEIC A, V10, P117, DOI 10.1089/oli.1.2000.10.117; Kranias EG, 2012, CIRC RES, V110, P1646, DOI 10.1161/CIRCRESAHA.111.259754; Iwanaga Y, 2004, J CLIN INVEST, V113, P727, DOI 10.1172/JCI200418716; Haghighi K, 2003, J CLIN INVEST, V111, P869, DOI 10.1172/JCI200317892; Kajstura J, 1997, J MOL CELL CARDIOL, V29, P859, DOI 10.1006/jmcc.1996.0333; Lee JF, 2006, CURR OPIN CHEM BIOL, V10, P282, DOI 10.1016/j.cbpa.2006.03.015; MacLennan DH, 2003, NAT REV MOL CELL BIO, V4, P566, DOI 10.1038/nrm1151; Zhang T, 2010, CIRC RES, V106, P354, DOI 10.1161/CIRCRESAHA.109.207423; Jessup M, 2011, CIRCULATION, V124, P304, DOI 10.1161/CIRCULATIONAHA.111.022889; FLEISCHER S, 1989, ANNU REV BIOPHYS BIO, V18, P333, DOI 10.1146/annurev.biophys.18.1.333; Ho A, 2001, CANCER RES, V61, P474; Heitz F, 2009, BRIT J PHARMACOL, V157, P195, DOI 10.1111/j.1476-5381.2009.00057.x; TUERK C, 1990, SCIENCE, V249, P505, DOI 10.1126/science.2200121; Song QJ, 2003, J CLIN INVEST, V111, P859, DOI 10.1172/JCI200316738; LETSINGER RL, 1989, P NATL ACAD SCI USA, V86, P6553, DOI 10.1073/pnas.86.17.6553; Asp ML, 2013, BBA-MOL CELL RES, V1833, P895, DOI 10.1016/j.bbamcr.2012.09.007; Bish LT, 2011, HUM GENE THER, V22, P969, DOI 10.1089/hum.2011.035; Di Carlo MN, 2014, J MOL CELL CARDIOL, V74, P274, DOI 10.1016/j.yjmcc.2014.06.004; Dieterle T, 2005, CARDIOVASC RES, V67, P678, DOI 10.1016/j.cardiores.2005.04.029; Eckhouse SR, 2013, BIOCHEM PHARMACOL, V85, P1, DOI 10.1016/j.bcp.2012.08.018; Hoshijima M, 2002, NAT MED, V8, P864, DOI 10.1038/nm739; INUI M, 1986, J BIOL CHEM, V261, P1794; JAMES P, 1989, NATURE, V342, P90, DOI 10.1038/342090a0; Kang J, 2007, FEBS LETT, V581, P2497, DOI 10.1016/j.febslet.2007.04.072; Li J, 2013, BIOMED ENVIRON SCI, V26, P577, DOI 10.3967/0895-3988.2013.07.009; Metcalfe EE, 2005, BIOCHEMISTRY-US, V44, P4386, DOI 10.1021/bi04751e; MILLIGAN JF, 1989, BIOCHEMISTRY-US, V28, P2849, DOI 10.1021/bi00433a016; Minamisawa S, 1999, CELL, V99, P313, DOI 10.1016/S0092-8674(00)81662-1; Miyazaki Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035875; SASAKI T, 1992, J BIOL CHEM, V267, P1674; SHAM JSK, 1991, AM J PHYSIOL, V261, pH1344; Shintani-Ishida K, 2012, J MOL CELL CARDIOL, V53, P233, DOI 10.1016/j.yjmcc.2012.05.012; TADA M, 1982, ANNU REV PHYSIOL, V44, P401, DOI 10.1146/annurev.ph.44.030182.002153; TADA M, 1983, J MOL CELL CARDIOL, V15, P565, DOI 10.1016/0022-2828(83)90267-5; TADA M, 1983, J MOL CELL CARDIOL, V15, P335, DOI 10.1016/0022-2828(83)91345-7; Tanaka Y, 2009, J PHARMACOL EXP THER, V329, P57, DOI 10.1124/jpet.108.149526; Thiel Kristina W, 2010, Ther Deliv, V1, P849, DOI 10.4155/tde.10.61; Xu AG, 2001, J BIOL CHEM, V276, P2555, DOI 10.1074/jbc.M008982200; Zhang HS, 2012, MOL THER, V20, P1508, DOI 10.1038/mt.2012.80	44	2	2	ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD	LONDON	24-28 OVAL RD, LONDON NW1 7DX, ENGLAND	0022-2828	1095-8584		J MOL CELL CARDIOL	J. Mol. Cell. Cardiol.	NOV	2014	76						177	185		10.1016/j.yjmc.2014.09.006		9	Cardiac & Cardiovascular Systems; Cell Biology	Cardiovascular System & Cardiology; Cell Biology	AS3UF	WOS:000344202800022		
J	Lee, EJ; Lee, JH; Jin, L; Jin, OS; Shin, YC; Oh, SJ; Lee, J; Hyon, SH; Han, DW				Lee, Eun Ji; Lee, Jong Ho; Jin, Linhua; Jin, Oh Seong; Shin, Yong Cheol; Oh, Sang Jin; Lee, Jaebeom; Hyon, Suong-Hyu; Han, Dong-Wook			Hyaluronic Acid/Poly(lactic-co-glycolic acid) Core/Shell Fiber Meshes Loaded with Epigallocatechin-3-O-Gallate as Skin Tissue Engineering Scaffolds	JOURNAL OF NANOSCIENCE AND NANOTECHNOLOGY			English	Article						Hyaluronic Acid; PLGA; EGCG; Core/Shell Fiber Mesh; Skin Tissue Engineering	ELECTROSPUN NANOFIBROUS SCAFFOLDS; CONTROLLED-RELEASE; CELL-ADHESION; REGENERATION; GROWTH; PLGA	In this study, hyaluronic acid (HA)/poly(lactic-co-glycolic acid, PLGA) core/shell fiber meshes loaded with epigallocatechin-3-O-gallate (EGCG) (HA/PLGA-E) for application to tissue engineering scaffolds for skin regeneration were prepared via coaxial electrospinning. Physicochemical properties of HA/PLGA-E core/shell fiber meshes were characterized by SEM, Raman spectroscopy, contact angle, EGCG release profiling and in vitro degradation. Biomechanical properties of HA/PLGA-E meshes were also investigated by a tensile strength test. SEM images showed that HA/PLGA-E fiber meshes had a three-dimensional interconnected pore structure with an average fiber diameter of about 1270 nm. Raman spectra revealed that EGCG was uniformly dispersed in the PLGA shell of meshes. HA/PLGA-E meshes showed sustained EGCG release patterns by controlled diffusion and PLGA degradation over 4 weeks. EGCG loading did not adversely affect the tensile strength and elastic modulus of HA/PLGA meshes, while increased their hydrophilicity and surface energy. Attachment of human dermal fibroblasts on HA/PLGA-E meshes was appreciably increased and their proliferation was steadily retained during the culture period. These results suggest that HA/PLGA-E core/shell fiber meshes can be potentially used as scaffolds supporting skin regeneration.	[Lee, Eun Ji; Lee, Jong Ho; Jin, Linhua; Jin, Oh Seong; Shin, Yong Cheol; Oh, Sang Jin; Lee, Jaebeom; Han, Dong-Wook] Pusan Natl Univ, Dept Cognomechatron Engn, Pusan 609735, South Korea; [Hyon, Suong-Hyu] Kyoto Inst Technol, Ctr Fiber & Text Sci, Kyoto 6068585, Japan	Han, DW (reprint author), Pusan Natl Univ, Dept Cognomechatron Engn, Pusan 609735, South Korea.			Han, Dong-Wook/0000-0001-8314-1981	National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology [2012R1A2A2A02010181]	This study was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (2012R1A2A2A02010181).	Makadia HK, 2011, POLYMERS-BASEL, V3, P1377, DOI 10.3390/polym3031377; Kim H, 2008, WOUND REPAIR REGEN, V16, P714, DOI 10.1111/j.1524-475X.2008.00422.x; Voigt J, 2012, WOUND REPAIR REGEN, V20, P317, DOI 10.1111/j.1524-475X.2012.00777.x; Byun EH, 2010, J IMMUNOL, V185, P33, DOI 10.4049/jimmunol.0903742; Chong EJ, 2007, ACTA BIOMATER, V3, P321, DOI 10.1016/j.actbio.2007.01.002; Kim K, 2003, BIOMATERIALS, V24, P4977, DOI 10.1016/S0142-9612(03)00407-1; Um IC, 2004, BIOMACROMOLECULES, V5, P1428, DOI 10.1021/bm034539b; Siddiqui IA, 2010, NUTR CANCER, V62, P883, DOI 10.1080/01635581.2010.509537; Arima Y, 2007, BIOMATERIALS, V28, P3074, DOI 10.1016/j.biomaterials.2007.03.013; Zahedi P, 2010, POLYM ADVAN TECHNOL, V21, P77, DOI 10.1002/pat.1625; Jiang HL, 2005, J CONTROL RELEASE, V108, P237, DOI 10.1016/j.jconrel.2005.08.006; Saraf A, 2009, TISSUE ENG PART C-ME, V15, P333, DOI 10.1089/ten.tec.2008.0422; Hallab NJ, 2001, TISSUE ENG, V7, P55, DOI 10.1089/107632700300003297; Liu WY, 2012, ADV HEALTHC MATER, V1, P10, DOI 10.1002/adhm.201100021; Su Y, 2009, J MATER SCI-MATER M, V20, P2285, DOI 10.1007/s10856-009-3805-2; Yang Y, 2011, BIOMATERIALS, V32, P4243, DOI 10.1016/j.biomaterials.2011.02.042; Vey E, 2011, POLYM DEGRAD STABIL, V96, P1882, DOI 10.1016/j.polymdegradstab.2011.07.011; Wu LL, 2010, J BIOMED MATER RES A, V92A, P563, DOI 10.1002/jbm.a.32393; Kim K, 2004, J CONTROL RELEASE, V98, P47, DOI 10.1016/j.jconrel.2004.04.009; Kim HL, 2012, TISSUE ENG PT A, V18, P2315, DOI [10.1089/ten.TEA.2011.0686, 10.1089/ten.tea.2011.0686]; Singh BN, 2011, BIOCHEM PHARMACOL, V82, P1807, DOI 10.1016/j.bcp.2011.07.093; Chakraborty S, 2009, ADV DRUG DELIVER REV, V61, P1043, DOI 10.1016/j.addr.2009.07.013; Ji Y, 2006, BIOMATERIALS, V27, P3782, DOI 10.1016/j.biomaterials.2006.02.037; Burdick JA, 2011, ADV MATER, V23, pH41, DOI 10.1002/adma.201003963; Kim BS, 1998, TRENDS BIOTECHNOL, V16, P224, DOI 10.1016/S0167-7799(98)01191-3; Xie JW, 2010, ACS NANO, V4, P5027, DOI 10.1021/nn101554u; Calheiros R, 2008, J RAMAN SPECTROSC, V39, P95, DOI 10.1002/jrs.1822; Gluck JM, 2011, J BIOMED MATER RES B, V99B, P180, DOI 10.1002/jbm.b.31885; Han DW, 2011, ACTA PHARMACOL SIN, V32, P637, DOI 10.1038/aps.2011.17; Leung V., 2011, J FIBER BIOENG INFOR, V4, P1; Rim NG, 2013, BIOMED MATER, V8, DOI 10.1088/1748-6041/8/1/014102; Yun S. H., 2012, J TISSUE ENG REGEN M, V9, P33; Zgheib C., 2014, ADV WOUND CARE, V3, P344	33	3	3	AMER SCIENTIFIC PUBLISHERS	VALENCIA	26650 THE OLD RD, STE 208, VALENCIA, CA 91381-0751 USA	1533-4880	1533-4899		J NANOSCI NANOTECHNO	J. Nanosci. Nanotechnol.	NOV	2014	14	11					8458	8463		10.1166/jnn.2014.9922		6	Chemistry, Multidisciplinary; Nanoscience & Nanotechnology; Materials Science, Multidisciplinary; Physics, Applied; Physics, Condensed Matter	Chemistry; Science & Technology - Other Topics; Materials Science; Physics	AS2RE	WOS:000344126500062		
J	Park, CY; Yang, YH; Kim, SW; Lee, SM; Kim, HT; Jang, BK; Lim, DS; Oh, YS				Park, Chan-Young; Yang, Young-Hwan; Kim, Seong-Won; Lee, Sung-Min; Kim, Hyung-Tae; Jang, Byung-Koog; Lim, Dae-Soon; Oh, Yoon-Suk			Effect of La2O3 Addition on Interface Chemistry Between 4YSZ Top Layer and Ni Based Alloy Bond Coat in Thermal Barrier Coating by EB PVD	JOURNAL OF NANOSCIENCE AND NANOTECHNOLOGY			English	Article						La2O3; YSZ; EB PVD; Thermal Barrier Coating (TBC); Interdiffusion; NiCrAlY	TURBINE APPLICATIONS; CYCLIC OXIDATION; CONDUCTIVITY; SYSTEMS; MORPHOLOGY; EXPANSION; BEHAVIOR; TBCS	The effect of a 5 mol% La2O3 addition on the forming behavior and compositional variation at interface between a 4 mol% Yttria (Y2O3) stabilized ZrO2 (4YSZ) top coat and bond coat (NiCrAlY) as a thermal barrier coating (TBC) has been investigated. Top coats were deposited by electron\ beam physical vapor deposition (EB PVD) onto a super alloy (Ni-Cr-Co-Al) substrate without pre-oxidation of the bond coat. Top coats are found to consist of dense columnar grains with a thin interdiffusion layer between metallic bond coats. In the as-received 4YSZ coating, a thin interdiffusion zone at the interface between the top and bond coats was found to consist of a Ni-Zr intermetallic compound with a reduced quantity of Y, Al or O elements. On the other hand, in the case of an interdiffusion area of 5 mol% La2O3-added 4YSZ coating, it was found that the complicated composition and structure with La-added YSZ and Ni-Al rich compounds separately. The thermal conductivity of 5 mor/o La2O3-added 4YSZ coating (similar to 1.6 W/m.k at 1100 degrees C) was lower than a 4YSZ coating (similar to 3.2 W/m.k at 1100 degrees C) alone.	[Park, Chan-Young; Yang, Young-Hwan; Kim, Seong-Won; Lee, Sung-Min; Kim, Hyung-Tae; Oh, Yoon-Suk] Korea Inst Ceram Engn & Technol, Sindun Myeon 467843, Icheon, South Korea; [Jang, Byung-Koog] Natl Inst Mat Sci, High Temp Mat Unit, Tsukuba, Ibaraki 3050047, Japan; [Park, Chan-Young; Yang, Young-Hwan; Lim, Dae-Soon] Korea Univ, Dept Mat Sci & Engn, Seoul 136713, South Korea	Oh, YS (reprint author), Korea Inst Ceram Engn & Technol, 30 Gyeongchung Rd, Sindun Myeon 467843, Icheon, South Korea.				Fundamental R&D Program for Strategic Core Technology of Materials - Ministry of Trade,Industry and Energy; Basic and Strategic R&D Program - Korea Institute of Ceramic Engineering and Technology, Republic of Korea	This research was supported by a grant from the Fundamental R&D Program for Strategic Core Technology of Materials funded by the Ministry of Trade,Industry and Energy and by a grant from the Basic and Strategic R&D Program funded by the Korea Institute of Ceramic Engineering and Technology, Republic of Korea.	Absi J, 2005, J EUR CERAM SOC, V25, P367, DOI 10.1016/j.jeurceramsoc.2004.02.005; Shillington EAG, 1999, ACTA MATER, V47, P1297, DOI 10.1016/S1359-6454(98)00407-8; Wellman RG, 2005, WEAR, V258, P349, DOI 10.1016/j.wear.2004.04.011; Schulz U, 2001, SURF COAT TECH, V146, P117, DOI 10.1016/S0257-8972(01)01481-5; Chaudhury ZA, 1997, MAT SCI ENG A-STRUCT, V231, P34, DOI 10.1016/S0921-5093(97)00093-2; RANGASWAMY S, 1980, THIN SOLID FILMS, V73, P43, DOI 10.1016/0040-6090(80)90327-2; Saruhan B, 2004, SURF COAT TECH, V182, P175, DOI 10.1016/j.surfcoat.2003.08.068; Tolpygo VK, 2000, MATER HIGH TEMP, V17, P59; Winter MR, 2007, J AM CERAM SOC, V90, P533, DOI 10.1111/j.1551-2916.2006.01410.x; Wolfe DE, 2005, SURF COAT TECH, V190, P132, DOI 10.1016/j.surfcoat.2004.04.071; Tolpygo VK, 2004, SURF COAT TECH, V188, P62, DOI 10.1016/j.surfcoat.2004.08.001; Zhao HB, 2006, ACTA MATER, V54, P5195, DOI 10.1016/j.actamat.2006.06.028; Lehmann H, 2003, J AM CERAM SOC, V86, P1338; Cao XQ, 2004, J EUR CERAM SOC, V24, P1, DOI 10.1016/S0955-2219(03)00129-8; Tolpygo V, 2003, SURF COAT TECH, V163, P81, DOI 10.1016/S0257-8972(02)00595-9; ECKERT J, 1991, J MATER RES, V6, P1874, DOI 10.1557/JMR.1991.1874; Jang BK, 2011, J CERAM SOC JPN, V119, P929, DOI 10.2109/jcersj2.119.929; Lia M. H., 2004, SURF COAT TECH, V176, P209; Lipkin DM, 1997, APPL PHYS LETT, V70, P2550, DOI 10.1063/1.118917; Markocsan N, 2007, J THERM SPRAY TECHN, V16, P498, DOI 10.1007/s11666-007-9068-x; Meier S. M., 1992, J ENG GAS TURB POWER, V114, P259; Peters M, 2001, ADV ENG MATER, V3, P193, DOI 10.1002/1527-2648(200104)3:4<193::AID-ADEM193>3.0.CO;2-U; Schilbe JE, 2000, SURF COAT TECH, V133, P35, DOI 10.1016/S0257-8972(00)00870-7; Schulz U, 2008, SURF COAT TECH, V203, P449, DOI 10.1016/j.surfcoat.2008.08.056; SOHN YH, 1994, J MATER ENG PERFORM, V3, P55, DOI 10.1007/BF02654499; Trunova O., 2008, SURF COAT TECH, V202, P5027; WORTMAN DJ, 1989, MAT SCI ENG A-STRUCT, V121, P433	27	0	0	AMER SCIENTIFIC PUBLISHERS	VALENCIA	26650 THE OLD RD, STE 208, VALENCIA, CA 91381-0751 USA	1533-4880	1533-4899		J NANOSCI NANOTECHNO	J. Nanosci. Nanotechnol.	NOV	2014	14	11					8659	8664		10.1166/jnn.2014.10000		6	Chemistry, Multidisciplinary; Nanoscience & Nanotechnology; Materials Science, Multidisciplinary; Physics, Applied; Physics, Condensed Matter	Chemistry; Science & Technology - Other Topics; Materials Science; Physics	AS2RE	WOS:000344126500096		
J	Park, T; You, J; Oikawa, H; Kim, E				Park, Teahoon; You, Jungmok; Oikawa, Hidetoshi; Kim, Eunkyoung			Synthesis of Photolabile Fluorescent Polymeric Micelles	JOURNAL OF NANOSCIENCE AND NANOTECHNOLOGY			English	Article						Fluorescent Polymer; Amphiphilic Block Copolymer; Self-Assembly; Core-Shell Nanoparticle; Photolabile Nanocarrier	TRANSFER RADICAL POLYMERIZATION; CONJUGATED POLYELECTROLYTE; COPOLYMERS BEARING; VESICLES; DESIGN	A new amphiphilic block copolymers were synthesized with the atom transfer radical polymerization (ATRP) method. Then, the micelle structures were fabricated with a self-assembly method for application in nanocarriers and sensing. The fluorescent intensity was increased by a factor of 4 in the micelle solution due to more stacked pyrene moieties. The core-shell structure of the micelle was confirmed by HR-TEM images. The pyrene moieties were positioned in the core of the micelle, and the surface consisted of hydrophilic PMMA blocks. The ester bond of the polymer backbone was breakable by irradiation with UV light. Therefore, the micelle structure was deformed after UV irradiation, and the excimer peak was drastically reduced as the monomer peak appeared. The deformation of micelle structures was clearly confirmed by FE-SEM and NMR analysis. These photolabile polymeric micelles may be widely useful for photo-stimulative nanocarriers as well as for the design of new functional micelles with many other chromophores.	[Park, Teahoon; You, Jungmok; Kim, Eunkyoung] Yonsei Univ, Dept Chem & Biomol Engn, Act Polymer Ctr Pattern Integrat, Seoul 120749, South Korea; [Oikawa, Hidetoshi] Tohoku Univ, Inst Multidisciplinary Res Adv Mat, Aoba Ku, Sendai, Miyagi 9808577, Japan	Kim, E (reprint author), Yonsei Univ, Dept Chem & Biomol Engn, Act Polymer Ctr Pattern Integrat, 50 Yonsei Ro, Seoul 120749, South Korea.		Kim, Eunkyoung/G-8420-2012		National Research Foundation (NRF) grant - Korean government (MEST) through the Active Polymer Center for Pattern Integration [R11-2007-050-00000-0]	We acknowledge the financial support of the National Research Foundation (NRF) grant funded by the Korean government (MEST) through the Active Polymer Center for Pattern Integration (R11-2007-050-00000-0).	Schumers JM, 2012, J POLYM SCI POL CHEM, V50, P599, DOI 10.1002/pola.25069; Jiang JQ, 2005, J AM CHEM SOC, V127, P8290, DOI 10.1021/ja0521019; Tsarevsky NV, 2007, CHEM REV, V107, P2270, DOI 10.1021/cr050947p; Haag R, 2004, ANGEW CHEM INT EDIT, V43, P278, DOI 10.1002/anie.200301694; Bellomo EG, 2004, NAT MATER, V3, P244, DOI 10.1038/nmat1093; You J, 2014, ACS APPL MATER INTER, V6, P3305, DOI 10.1021/am500269t; Jiang JQ, 2006, MACROMOLECULES, V39, P4633, DOI 10.1021/ma060142z; Matyjaszewski K, 2009, NAT CHEM, V1, P276, DOI [10.1038/nchem.257, 10.1038/NCHEM.257]; Deepak VD, 2009, J PHYS CHEM B, V113, P11887, DOI 10.1021/jp901398e; Pintauer T, 2005, COORDIN CHEM REV, V249, P1155, DOI 10.1016/j.ccr.2004.11.010; You J, 2010, CHEM MATER, V22, P4426, DOI 10.1021/cm1011026; Ji XF, 2012, MACROMOLECULES, V45, P6457, DOI 10.1021/ma301162s; Napoli A, 2004, NAT MATER, V3, P183, DOI 10.1038/nmat1081; Wu YH, 2013, LANGMUIR, V29, P3711, DOI 10.1021/la400145f; Schumers JM, 2010, POLYM CHEM-UK, V1, P161, DOI 10.1039/b9py00218a; Kim H, 2013, MACROMOL RES, V21, P815, DOI 10.1007/s13233-013-1093-7; Oeda Y, 1996, CHEM PHYS, V213, P421, DOI 10.1016/S0301-0104(96)00261-3; Peng T, 2013, MACROMOL RES, V21, P400, DOI 10.1007/s13233-013-1046-1; Xu W, 2012, ACS NANO, V7, P598; You J, 2012, ADV FUNCT MATER, V22, P1417, DOI 10.1002/adfm.201102309	20	0	0	AMER SCIENTIFIC PUBLISHERS	VALENCIA	26650 THE OLD RD, STE 208, VALENCIA, CA 91381-0751 USA	1533-4880	1533-4899		J NANOSCI NANOTECHNO	J. Nanosci. Nanotechnol.	NOV	2014	14	11					8678	8682		10.1166/jnn.2014.10011		5	Chemistry, Multidisciplinary; Nanoscience & Nanotechnology; Materials Science, Multidisciplinary; Physics, Applied; Physics, Condensed Matter	Chemistry; Science & Technology - Other Topics; Materials Science; Physics	AS2RE	WOS:000344126500099		
J	Suzuki, H; Ono, K; Sawada, M				Suzuki, Hiromi; Ono, Kenji; Sawada, Makoto			Protective effect of INI-0602, a gap junction inhibitor, on dopaminergic neurodegeneration of mice with unilateral 6-hydroxydopamine injection	JOURNAL OF NEURAL TRANSMISSION			English	Article						Microglia; INI-0602; Gap junction inhibitor; 6-Hydroxydopamine; Parkinson's disease; Dopaminergic protection	CENTRAL-NERVOUS-SYSTEM; NECROSIS-FACTOR-ALPHA; PARKINSONS-DISEASE; ACTIVATED MICROGLIA; SYNAPTIC PLASTICITY; GLUTAMATE RELEASE; NEUROTOXICITY; BRAIN; RECEPTORS; CYTOKINES	INI-0602, a novel gap junction hemichannel inhibitor, was administered to hemi-Parkinsonism mice generated by striatal 6-hydroxydopamine injection. INI-0602 prevented the toxic activation of microglia, such as the increased number of the activated form, enlargement of cell bodies and induction of proinflammatory cytokines, such as IL-1 beta and TNF alpha, in the ipsilateral striatum. On the other hand, INI-0602 induced the expression of neurotrophic factors, such as brain-derived neurotrophic factor and NT-4/5, in the 6-hydroxydopamine-treated striatum. INI-0602 treatment blocked not only dopaminergic loss in both the striatum and substantia nigra, but also apomorphine-induced rotational behavior.	[Suzuki, Hiromi; Ono, Kenji; Sawada, Makoto] Nagoya Univ, Environm Med Res Inst, Div Stress Adaptat & Protect, Dept Brain Funct, Nagoya, Aichi 4648601, Japan	Ono, K (reprint author), Nagoya Univ, Environm Med Res Inst, Div Stress Adaptat & Protect, Dept Brain Funct, Nagoya, Aichi 4648601, Japan.	k_ono@riem.nagoya-u.ac.jp					AKIYAMA H, 1989, BRAIN RES, V489, P247, DOI 10.1016/0006-8993(89)90857-3; Nagatsu T, 2006, CELL MOL NEUROBIOL, V26, P781, DOI 10.1007/s10571-006-9061-9; Ransohoff RM, 2009, ANNU REV IMMUNOL, V27, P119, DOI 10.1146/annurev.immunol.021908.132528; Takeuchi H, 2008, EXP NEUROL, V214, P144, DOI 10.1016/j.expneurol.2008.08.001; Takeuchi H, 2005, J BIOL CHEM, V280, P10444, DOI 10.1074/jbc.M413863200; Block ML, 2007, BIOCHEM SOC T, V35, P1127; Kreutzberg GW, 1996, TRENDS NEUROSCI, V19, P312, DOI 10.1016/0166-2236(96)10049-7; Zou JY, 2005, BRAIN RES, V1034, P11, DOI 10.1016/j.brainres.2004.11.014; Hunot S, 1996, NEUROSCIENCE, V72, P355, DOI 10.1016/0306-4522(95)00578-1; CHAO CC, 1992, J IMMUNOL, V149, P2736; Calabresi P, 2007, PARKINSONISM RELAT D, V13, pS259, DOI 10.1016/S1353-8020(08)70013-0; Chase TN, 2000, TRENDS NEUROSCI, V23, pS86, DOI 10.1016/S1471-1931(00)00018-5; Barger SW, 2001, J NEUROCHEM, V76, P846, DOI 10.1046/j.1471-4159.2001.00075.x; Shen WX, 2008, SCIENCE, V321, P848, DOI 10.1126/science.1160575; Takeuchi H, 2006, J BIOL CHEM, V281, P21362, DOI 10.1074/jbc.M600504200; Floden AM, 2005, J NEUROSCI, V25, P2566, DOI 10.1523/JNEUROSCI.4998-04.2005; Juszczak GR, 2009, PROG NEURO-PSYCHOPH, V33, P181, DOI 10.1016/j.pnpbp.2008.12.014; Laird DW, 2010, TRENDS CELL BIOL, V20, P92, DOI 10.1016/j.tcb.2009.11.001; Cassarino DS, 1997, BBA-MOL BASIS DIS, V1362, P77, DOI 10.1016/S0925-4439(97)00070-7; Johnson KA, 2009, CNS NEUROL DISORD-DR, V8, P475; Nagatsu T, 2000, J NEURAL TRANSM-SUPP, P143; Nelson PT, 2002, ANN MED, V34, P491, DOI 10.1080/078538902321117698; SAWADA M, 1995, INT J DEV NEUROSCI, V13, P253, DOI 10.1016/0736-5748(94)00076-F; Suzuki H, 2001, NEUROSCI LETT, V312, P95, DOI 10.1016/S0304-3940(01)02198-X; Takeuchi H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021108; Vilhardt F, 2002, J BIOL CHEM, V277, P42136, DOI 10.1074/jbc.M200862200	26	1	1	SPRINGER WIEN	WIEN	SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA	0300-9564	1435-1463		J NEURAL TRANSM	J. Neural Transm.	NOV	2014	121	11					1349	1355		10.1007/s00702-014-1209-z		7	Clinical Neurology; Neurosciences	Neurosciences & Neurology	AS6DA	WOS:000344353700004		
J	Nishioka, K; Tanaka, R; Shimura, H; Hirano, K; Hatano, T; Miyakawa, K; Arai, H; Hattori, N; Urabe, T				Nishioka, Kenya; Tanaka, Ryota; Shimura, Hideki; Hirano, Kazuoki; Hatano, Taku; Miyakawa, Koichi; Arai, Heii; Hattori, Nobutaka; Urabe, Takao			Quantitative evaluation of electroconvulsive therapy for Parkinson's disease with refractory psychiatric symptoms	JOURNAL OF NEURAL TRANSMISSION			English	Article						Catatonia; Depression; ECT; NPI score; Parkinson's disease	MOVEMENT-DISORDERS; RATING-SCALES; DEMENTIA; RECOMMENDATIONS; DEPRESSION; INVENTORY; MORTALITY; ACCURACY; CRITIQUE	Patients with advanced-stage Parkinson's disease (PD) occasionally experience refractory depression or catatonic stupor. Electroconvulsive therapy (ECT) has been reported as a successful procedure for both severe psychosis and motor symptoms in patients with PD. Four patients with PD who were receiving ECT were quantitatively evaluated using the Unified PD Rating scale part III, Hoehn and Yahr scale, Barthel index, Neuropsychiatric Inventory, mini-mental state examination, Revised Hasegawa's Dementia scale, Beck's Depression Inventory, and Hamilton Rating Scale for Depression-17. We adopted the "half-age" method, which is an age-based stimulus-dosing method. The patients showed improvement in symptoms of psychosis and motor symptoms without any adverse effects. The interval of improvement after ECT varied among patients. Of note, a decrease in psychiatric symptoms successfully alleviated the burden of caregivers. ECT may be useful to treat parkinsonism with refractory psychosis, major depression, or catatonic stupor, within the limitations of the patients enrolled.	[Nishioka, Kenya; Tanaka, Ryota; Hirano, Kazuoki; Hatano, Taku; Hattori, Nobutaka] Juntendo Univ, Sch Med, Dept Neurol, Bunkyo Ku, Tokyo 1138421, Japan; [Shimura, Hideki; Urabe, Takao] Juntendo Univ, Urayasu Hosp, Dept Neurol, Chiba 2790021, Japan; [Miyakawa, Koichi] Juntendo Univ, Urayasu Hosp, Dept Psychiat, Chiba 2790021, Japan; [Arai, Heii] Juntendo Univ, Sch Med, Dept Psychiat, Bunkyo Ku, Tokyo 1138421, Japan	Nishioka, K (reprint author), Juntendo Univ, Sch Med, Dept Neurol, Bunkyo Ku, 2-1-1 Hongo, Tokyo 1138421, Japan.	kenya.nishioka@gmail.com					Aarsland D, 1997, CONVULSIVE THER, V13, P274; Madsen TM, 2000, BIOL PSYCHIAT, V47, P1043, DOI 10.1016/S0006-3223(00)00228-6; Pintor LP, 2012, J ECT, V28, P87, DOI 10.1097/YCT.0b013e31823c98c0; HUGHES AJ, 1992, J NEUROL NEUROSUR PS, V55, P181, DOI 10.1136/jnnp.55.3.181; HOEHN MM, 1967, NEUROLOGY, V17, P427; Leentjens AFG, 2008, MOVEMENT DISORD, V23, P2004, DOI 10.1002/mds.22229; Aarsland D, 2007, J NEUROL NEUROSUR PS, V78, P36, DOI 10.1136/jnnp.2005.083113; Ueda S, 2010, J ECT, V26, P111, DOI 10.1097/YCT.0b013e3181c18a3d; Leentjens AFG, 2008, MOVEMENT DISORD, V23, P2015, DOI 10.1002/mds.22233; Aarsland D, 2012, NAT REV NEUROL, V8, P35, DOI 10.1038/nrneurol.2011.189; Raveendranathan D, 2012, EUR ARCH PSY CLIN N, V262, P425, DOI 10.1007/s00406-011-0285-4; Kim KW, 2005, DEMENT GERIATR COGN, V19, P324, DOI 10.1159/000084558; Fregni F, 2005, J NEUROL NEUROSUR PS, V76, P1614, DOI 10.1136/jnnp.2005.069849; CUMMINGS JL, 1994, NEUROLOGY, V44, P2308; Kennedy R, 2003, J NEUROPSYCH CLIN N, V15, P407, DOI 10.1176/appi.neuropsych.15.4.407; Moellentine C, 1998, J NEUROPSYCH CLIN N, V10, P187; BECK AT, 1961, ARCH GEN PSYCHIAT, V4, P561; Goetz CG, 2008, MOVEMENT DISORD, V23, P2129, DOI 10.1002/mds.22340; Tomlinson CL, 2010, MOVEMENT DISORD, V25, P2649, DOI 10.1002/mds.23429; Usui C, 2011, PROG NEURO-PSYCHOPH, V35, P1704, DOI 10.1016/j.pnpbp.2011.05.003; Collin C, 1988, Int Disabil Stud, V10, P61; FABER R, 1991, MOVEMENT DISORD, V6, P293, DOI 10.1002/mds.870060405; GOETZ CG, 1995, NEUROLOGY, V45, P669; Kamigaichi R, 2009, EUR J NEUROL, V16, pE6, DOI 10.1111/j.1468-1331.2008.02357.x; Pridmore S, 1996, J NEUROL NEUROSUR PS, V60, P693, DOI 10.1136/jnnp.60.6.693; RAMOSBRIEVA JA, 1988, J PSYCHIAT RES, V22, P21, DOI 10.1016/0022-3956(88)90024-6; Suzuki K, 2006, MOVEMENT DISORD, V21, P123, DOI 10.1002/mds.20749; Swartz CM, 2006, J ECT, V22, P54, DOI 10.1097/00124509-200603000-00012	28	2	2	SPRINGER WIEN	WIEN	SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA	0300-9564	1435-1463		J NEURAL TRANSM	J. Neural Transm.	NOV	2014	121	11					1405	1410		10.1007/s00702-014-1212-4		6	Clinical Neurology; Neurosciences	Neurosciences & Neurology	AS6DA	WOS:000344353700010		
J	Suzuki, A; Nobusawa, S; Natsume, A; Suzuki, H; Kim, YH; Yokoo, H; Nagaishi, M; Ikota, H; Nakazawa, T; Wakabayashi, T; Ohgaki, H; Nakazato, Y				Suzuki, Aya; Nobusawa, Sumihito; Natsume, Atsushi; Suzuki, Hiromichi; Kim, Young-Ho; Yokoo, Hideaki; Nagaishi, Masaya; Ikota, Hayato; Nakazawa, Takuro; Wakabayashi, Toshihiko; Ohgaki, Hiroko; Nakazato, Yoichi			Olig2 labeling index is correlated with histological and molecular classifications in low-grade diffuse gliomas	JOURNAL OF NEURO-ONCOLOGY			English	Article						Olig2; Low-grade diffuse glioma; Diffuse astrocytoma; Oligoastrocytoma; Oligodendroglioma	BRAIN-TUMORS; NEURAL PROGENITORS; FREQUENT ATRX; MUTATIONS; DIFFERENTIATION; IDH1; OLIGODENDROGLIOMAS; OLIGODENDROCYTES; EXPRESSION; CONTRIBUTE	Diagnosis of low-grade diffuse gliomas based on morphology is highly subjective and, therefore, is often difficult, with significant intra- and interobserver variability. Here, we investigated WHO grade II diffuse astrocytomas, oligoastrocytomas and oligodendrogliomas for immunohistochemical expression of Olig2, measuring its labeling index (LI), and evaluated the significance of Olig2 LI in the histological and molecular classifications. The means of Olig2 LI in glioma cells were 43.7 % in diffuse astrocytomas, 59.3 % in oligoastrocytomas and 76.1 % in oligodendrogliomas. There was a statistically significant difference between all pairs of histological types. The mean of Olig2 LI of gliomas with 1p/19q loss +/- A IDH1/2 mutation, the majority of them being oligodendrogliomas, was significantly higher than the means of those with TP53 mutation +/- A IDH1/2 mutation and IDH1/2 mutation only, the majority of which were diffuse astrocytomas (70.1 vs. 47.2 and 46.5 %, respectively). When categorized according to the classification of Jiao et al., Olig2 LI of I-CF gliomas (cases with IDH and one or more of CIC, FUBP1 or combined 1p/19q loss; mean 71.0 %) was significantly higher than that of I-A gliomas (cases with IDH and ATRX alterations; mean 45.3 %). These molecular classifications were reported to correlate well with clinical outcome. However, borderlines of Olig2 LI were broad and could not clearly distinguish genotypes in the molecular classifications. In conclusion, Olig2 LI cannot be taken as a complete surrogate marker for molecular genotype, but could possibly provide some ancillary information when molecular assay is not availabe.	[Suzuki, Aya; Nobusawa, Sumihito; Yokoo, Hideaki; Nagaishi, Masaya; Ikota, Hayato; Nakazawa, Takuro; Nakazato, Yoichi] Gunma Univ, Grad Sch Med, Dept Human Pathol, Maebashi, Gumma 3718511, Japan; [Natsume, Atsushi; Suzuki, Hiromichi; Wakabayashi, Toshihiko] Nagoya Univ, Sch Med, Dept Neurosurg, Nagoya, Aichi 466, Japan; [Kim, Young-Ho; Ohgaki, Hiroko] Int Agcy Res Canc, F-69372 Lyon, France; [Kim, Young-Ho] Natl Canc Ctr, Div Canc Epidemiol & Prevent, Translat Epidemiol Res Branch, Goyang, South Korea; [Nagaishi, Masaya] Dokkyo Univ, Sch Med, Koshigaya Hosp, Dept Neurosurg, Koshigaya, Japan; [Nakazawa, Takuro] Hidaka Hosp, Dept Pathol, Takasaki, Gumma, Japan	Nobusawa, S (reprint author), Gunma Univ, Grad Sch Med, Dept Human Pathol, 3-39-22 Showa Machi, Maebashi, Gumma 3718511, Japan.	nobusawa0319@gunma-u.ac.jp					Aguirre-Cruz L, 2004, J NEURO-ONCOL, V67, P265, DOI 10.1023/B:NEON.0000024190.56750.81; Jiao YC, 2012, ONCOTARGET, V3, P709; Takebayashi H, 2002, CURR BIOL, V12, P1157, DOI 10.1016/S0960-9822(02)00926-0; Zhou Q, 2001, NEURON, V31, P791, DOI 10.1016/S0896-6273(01)00414-7; Hartmann C, 2009, ACTA NEUROPATHOL, V118, P469, DOI 10.1007/s00401-009-0561-9; Bettegowda C, 2011, SCIENCE, V333, P1453, DOI 10.1126/science.1210557; Copray S, 2006, STEM CELLS, V24, P1001, DOI 10.1634/stemcells.2005-0239; Mehta S, 2011, CANCER CELL, V19, P359, DOI 10.1016/j.ccr.2011.01.035; Yokoo H, 2004, AM J PATHOL, V164, P1717, DOI 10.1016/S0002-9440(10)63730-3; Kannan K, 2012, ONCOTARGET, V3, P1194; Capper D, 2010, BRAIN PATHOL, V20, P245, DOI 10.1111/j.1750-3639.2009.00352.x; Yip S, 2012, J PATHOL, V226, P7, DOI 10.1002/path.2995; Zhang JH, 2013, NAT GENET, V45, P602, DOI 10.1038/ng.2611; Kim YH, 2010, AM J PATHOL, V177, P2708, DOI 10.2353/ajpath.2010.100680; Yoshida K, 2011, NATURE, V478, P64, DOI 10.1038/nature10496; Liu XY, 2012, ACTA NEUROPATHOL, V124, P615, DOI 10.1007/s00401-012-1031-3; Watanabe T, 2002, ACTA NEUROPATHOL, V103, P267, DOI 10.1007/s004010100464; Sahm F, 2012, ACTA NEUROPATHOL, V123, P853, DOI 10.1007/s00401-012-0993-5; Heaphy CM, 2011, SCIENCE, V333, P425, DOI 10.1126/science.1207313; Ligon KL, 2004, J NEUROPATH EXP NEUR, V63, P499; Lu QR, 2001, P NATL ACAD SCI USA, V98, P10851, DOI 10.1073/pnas.181340798; Louis DN, 2007, WHO CLASSIFICATION T; Mokhtari K, 2005, NEUROPATH APPL NEURO, V31, P62, DOI 10.1111/j.1365-2990.2004.00612.x; Schwartzentruber J, 2012, NATURE, V482, P226, DOI 10.1038/nature10833; Sun Y, 2011, NEURON, V69, P906, DOI 10.1016/j.neuron.2011.02.005; Tanaka G, 2004, INT CONGR SER, V1259, P15, DOI 10.1016/S0531-5131(03)01668-6	26	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0167-594X	1573-7373		J NEURO-ONCOL	J. Neuro-Oncol.	NOV	2014	120	2					283	291		10.1007/s11060-014-1568-1		9	Oncology; Clinical Neurology	Oncology; Neurosciences & Neurology	AS3JD	WOS:000344172600007		
J	Onodera, S; Aoyama, H; Tha, KK; Hashimoto, N; Toyomaki, A; Terae, S; Shirato, H				Onodera, Shunsuke; Aoyama, Hidefumi; Tha, Khin Khin; Hashimoto, Naoki; Toyomaki, Atsuhito; Terae, Satoshi; Shirato, Hiroki			The value of 4-month neurocognitive function as an endpoint in brain metastases trials	JOURNAL OF NEURO-ONCOLOGY			English	Article						Neurocognitive function; Whole-brain radiation therapy; Stereotactic radiosurgery; Brain; Metastasis	PHASE-III TRIAL; RADIATION-THERAPY; NEUROPSYCHOLOGICAL STATUS; REPEATABLE BATTERY; STEREOTACTIC RADIOSURGERY; MOTEXAFIN GADOLINIUM; SURGICAL RESECTION; CLINICAL-TRIALS; RANO GROUP; RADIOTHERAPY	To investigate whether the neurocognitive function at 4 months could be a relevant primary endpoint in clinical trials dealing with brain metastases, we created a Japanese neurocognitive battery and examined the changes in patients' neurocognitive function for 1 year after their brain radiotherapy. In this prospective pilot study, we enrolled 27 patients (20 patients who received whole-brain radiation therapy [WBRT] and seven who received stereotactic irradiation [STI] alone) between March 2009 and December 2010. The follow-up neurocognitive data at 4, 8 and 12 months were available in 22 (17 WBRT, 5 STI), 19 patients (14 WBRT, 5 STI) and 13 patients (9 WBRT, 4 STI), respectively. Among the patients who received WBRT, significant deterioration in delayed memory compared to the baseline (p = 0.04) was observed at 4 months, and at 8 months, significant improvements were observed in immediate memory compared to the baseline (p = 0.008) and 4-months scores (p = 0.005). At 12 months, however, the immediate memory scores had returned to the baseline. Similar trends were observed in other functions (delayed memory, attention and executive functions). In these patients, the correlations between 4-months scores of neurocognitive functions and 12-months scores were significant in immediate memory (gamma = 0.68, p = 0.004), delayed memory (gamma = 0.738, p = 0.023) and attention (gamma = 0.817, p = 0.007). Among the patients who received STI, no significant changes were observed in any functions. These results suggest that 4-months changes in neurocognitive functions were transient but could also be a premonitory index for predicting the neurocognitive function 1 year or later after brain radiation therapy.	[Onodera, Shunsuke; Tha, Khin Khin; Terae, Satoshi; Shirato, Hiroki] Hokkaido Univ, Grad Sch Med, Dept Radiat Med, Sapporo, Hokkaido, Japan; [Aoyama, Hidefumi] Niigata Univ, Grad Sch Med & Dent Sci, Dept Radiol, Chuo Ku, Niigata 9518510, Japan; [Hashimoto, Naoki; Toyomaki, Atsuhito] Hokkaido Univ, Grad Sch Med, Dept Psychiat, Sapporo, Hokkaido, Japan	Aoyama, H (reprint author), Niigata Univ, Grad Sch Med & Dent Sci, Dept Radiol, Chuo Ku, 1-757 Asahimachi Dori, Niigata 9518510, Japan.	h-aoyama@med.niigata-u.ac.jp	Shirato, Hiroki/A-7068-2010; Tha, Khin/A-4762-2012	Tha, Khin/0000-0002-9072-4509			Abe Mitsuyo, 2004, No To Shinkei, V56, P567; Tsao M, 2012, CANCER-AM CANCER SOC, V118, P2486, DOI 10.1002/cncr.26515; Murray KJ, 2000, INT J RADIAT ONCOL, V48, P59, DOI 10.1016/S0360-3016(00)00600-3; Li J, 2007, J CLIN ONCOL, V25, P1260, DOI 10.1200/JCO.2006.09.2536; Meyers CA, 2004, J CLIN ONCOL, V22, P157, DOI 10.1200/JCO.2004.05.128; Akiyama K, 2001, NEUROL MED-CHIR, V41, P590, DOI 10.2176/nmc.41.590; Chang EL, 2009, LANCET ONCOL, V10, P1037, DOI 10.1016/S1470-2045(09)70263-3; Soffietti R, 2013, J CLIN ONCOL, V31, P65, DOI 10.1200/JCO.2011.41.0639; Hirota C, 2010, GERIATR GERONTOL INT, V10, P40, DOI 10.1111/j.1447-0594.2009.00557.x; Sun A, 2011, J CLIN ONCOL, V29, P279, DOI 10.1200/JCO.2010.29.6053; Randolph C, 1998, J CLIN EXP NEUROPSYC, V20, P310, DOI 10.1076/jcen.20.3.310.823; Aoyama H, 2007, INT J RADIAT ONCOL, V68, P1388, DOI 10.1016/j.ijrobp.2007.03.048; Kocher M, 2011, J CLIN ONCOL, V29, P134, DOI 10.1200/JCO.2010.30.1655; Welzel G, 2008, INT J RADIAT ONCOL, V72, P1311, DOI 10.1016/j.ijrobp.2008.03.009; Aoyama H, 2006, JAMA-J AM MED ASSOC, V295, P2483, DOI 10.1001/jama.295.21.2483; Hashimoto R, 2006, PSYCHIAT CLIN NEUROS, V60, P422, DOI 10.1111/j.1440-1819.2006.01526.x; Mehta MP, 2003, J CLIN ONCOL, V21, P2529, DOI 10.1200/JCO.2003.12.122; Gold JM, 1999, AM J PSYCHIAT, V156, P1944; Chapman CH, 2012, INT J RADIAT ONCOL, V82, P2033, DOI 10.1016/j.ijrobp.2011.01.068; Gontkovsky ST, 2002, CLIN NEUROPSYCHOL, V16, P258, DOI 10.1076/clin.16.3.258.13844; Lin NU, 2013, LANCET ONCOL, V14, pE407, DOI 10.1016/S1470-2045(13)70308-5; Lin NU, 2013, LANCET ONCOL, V14, pE396, DOI 10.1016/S1470-2045(13)70311-5; Matsui M, 2010, J LIB ARTS SCI, V38, P87; Matsui M, 2010, TOYAMA MED J, V21, P31; Matui M, 2009, J LIB ARTS SCI, V37, P31; McDuff SGR, 2013, J NEUROL NEUROSUR PS, V84, P1384, DOI 10.1136/jnnp-2013-305166; Strauss E, 2006, COMPENDIUM NEUROPSYC; Wilde MC, 2006, CLIN NEUROPSYCHOL, V20, P702, DOI 10.1080/13854040500246901; Yamashima Tetsumori, 2002, No To Shinkei, V54, P463	29	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0167-594X	1573-7373		J NEURO-ONCOL	J. Neuro-Oncol.	NOV	2014	120	2					311	319		10.1007/s11060-014-1550-y		9	Oncology; Clinical Neurology	Oncology; Neurosciences & Neurology	AS3JD	WOS:000344172600010		
J	Yamamoto, N; Tanida, M; Kasahara, R; Sobue, K; Suzuki, K				Yamamoto, Naoki; Tanida, Mamoru; Kasahara, Rika; Sobue, Kazuya; Suzuki, Kenji			Leptin inhibits amyloid beta-protein fibrillogenesis by decreasing GM1 gangliosides on the neuronal cell surface through PI3K/Akt/mTOR pathway	JOURNAL OF NEUROCHEMISTRY			English	Article						Alzheimer's disease; amyloid beta protein; GM1 ganglioside; leptin	A-BETA; ALZHEIMERS-DISEASE; PRECURSOR PROTEIN; FIBRIL FORMATION; RECEPTOR; BRAIN; MEMBRANES; KINASE; ACTIVATION; TERMINALS	Leptin is a centrally acting hormone that controls metabolic pathways. Recent epidemiological studies suggest that plasma leptin is protective against Alzheimer's disease. However, the mechanism that underlies this effect remains uncertain. To investigate whether leptin inhibits the assembly of amyloid -protein (A) on the cell surface of neurons, we treated primary neurons with leptin. Leptin treatment decreased the GM1 ganglioside (GM1) levels in the detergent-resistant membrane microdomains (DRMs) of neurons. The increase in GM1 expression induced by leptin was inhibited after pre-treatment with inhibitors of phosphatidylinositol 3-kinase (LY294002), Akt (triciribine) and the mammalian target of rapamycin (i.e. rapamycin), but not by an inhibitor of extracellular signal-regulated kinase (PD98059). In addition, pre-treatment with these reagents blocked the induction of GM1 in DRMs by leptin. Furthermore, A assembly on the cell surface of neurons was inhibited greatly after treatment with leptin. This reduction was markedly inhibited after pre-treatment with LY294002, triciribine, and rapamycin. These results suggest that leptin significantly inhibits A assembly by decreasing GM1 expression in DRMs of the neuronal surface through the phosphatidylinositol 3-kinase/Akt/mammalian target of rapamycin pathway.	[Yamamoto, Naoki] Hokuriku Univ, Fac Pharmaceut Sci, Kanazawa, Ishikawa 9201181, Japan; [Yamamoto, Naoki; Kasahara, Rika] Ritsumeikan Univ, Dept Pharm, Coll Pharmaceut Sci, Lab Neurochem, Kusatsu, Shiga, Japan; [Tanida, Mamoru] Ritsumeikan Univ, Coll Life Sci, Dept Biomed Sci, Appl Physiol Lab, Kusatsu, Shiga, Japan; [Tanida, Mamoru] Kanazawa Med Univ, Dept Physiol 2, Uchinada, Ishikawa 92002, Japan; [Sobue, Kazuya] Nagoya City Univ, Grad Sch Med Sci, Dept Anesthesiol & Med Crisis Management, Nagoya, Aichi, Japan; [Suzuki, Kenji] Ritsumeikan Univ, Coll Pharmaceut Sci, Dept Pharm, Lab Mol Med Sci, Kusatsu, Shiga, Japan	Yamamoto, N (reprint author), Hokuriku Univ, Fac Pharmaceut Sci, Kanazawa, Ishikawa 9201181, Japan.	na-yamam@hokuriku-u.ac.jp			KAKENHI, Takeda Science Foundation [25870906]; Ritsumeikan Global Innovation Research Organization (R-GIRO), Ritsumeikan University; The Specific Research Fund of Hokuriku University, Japan	This work was supported by a KAKENHI, Grant-in-Aid for Young Scientists B (25870906) from the Takeda Science Foundation and grants from Ritsumeikan Global Innovation Research Organization (R-GIRO), Ritsumeikan University and The Specific Research Fund of Hokuriku University, Japan.	VLAHOS CJ, 1994, J BIOL CHEM, V269, P5241; Power DA, 2001, DEMENT GERIATR COGN, V12, P167, DOI 10.1159/000051252; Gursel DB, 2011, NEURO-ONCOLOGY, V13, P610, DOI 10.1093/neuonc/nor035; Fruhbeck G, 2006, BIOCHEM J, V393, P7, DOI 10.1042/BJ20051578; Cohen B, 1996, SCIENCE, V274, P1185, DOI 10.1126/science.274.5290.1185; Kojro E, 2006, FASEB J, V20, P512, DOI 10.1096/fj.05-4812fje; Yamamoto N, 2001, MOL BRAIN RES, V90, P26, DOI 10.1016/S0169-328X(01)00064-X; Morris DL, 2009, AM J PHYSIOL-ENDOC M, V297, pE1247, DOI 10.1152/ajpendo.00274.2009; Wen Y, 2008, NEURON, V57, P680, DOI 10.1016/j.neuron.2008.02.024; Yamamoto N, 2007, BBA-BIOMEMBRANES, V1768, P1128, DOI 10.1016/j.bbamem.2007.01.009; Lieb W, 2009, JAMA-J AM MED ASSOC, V302, P2565, DOI 10.1001/jama.2009.1836; Cota D, 2006, SCIENCE, V312, P927, DOI 10.1126/science.1124147; Gylys KH, 2007, NEUROBIOL AGING, V28, P8, DOI 10.1016/j.neurobiolaging.2005.10.018; Yamamoto N, 2012, J NEUROCHEM, V121, P619, DOI 10.1111/j.1471-4159.2012.07668.x; Meydan N, 1996, NATURE, V379, P645, DOI 10.1038/379645a0; Petanceska SS, 1999, J NEUROCHEM, V73, P2316, DOI 10.1046/j.1471-4159.1999.0732316.x; Fewlass DC, 2004, FASEB J, V18, P1870, DOI 10.1096/fj.04-2572com; KUO CJ, 1992, NATURE, V358, P70, DOI 10.1038/358070a0; Kellerer M, 1997, DIABETOLOGIA, V40, P1358, DOI 10.1007/s001250050832; Morrison CD, 2009, BBA-MOL BASIS DIS, V1792, P401, DOI 10.1016/j.bbadis.2008.12.004; Hay N, 2004, GENE DEV, V18, P1926, DOI 10.1101/gad.1212704; ALESSI DR, 1995, J BIOL CHEM, V270, P27489; Vecchione C, 2002, DIABETES, V51, P168; YANAGISAWA K, 1995, NAT MED, V1, P1062, DOI 10.1038/nm1095-1062; Naiki H, 1999, METHOD ENZYMOL, V309, P305; Li XL, 2002, NEUROSCIENCE, V113, P607, DOI 10.1016/S0306-4522(02)00162-8; Banks AS, 2000, J BIOL CHEM, V275, P14563, DOI 10.1074/jbc.275.19.14563; Moloney AM, 2010, NEUROBIOL AGING, V31, P224, DOI 10.1016/j.neurobiolaging.2008.04.002; Banks WA, 2004, PEPTIDES, V25, P331, DOI 10.1016/j.peptides.2004.02.014; Solano DC, 2000, FASEB J, V14, P1015; Molander-Melin M, 2005, J NEUROCHEM, V92, P171, DOI 10.1111/j.1471-4159.2004.02849.x; Yamamoto N, 2004, FEBS LETT, V569, P135, DOI 10.1016/j.febslet.2004.05.037; TERRY RD, 1981, ANN NEUROL, V10, P184, DOI 10.1002/ana.410100209; Marwarha Gurdeep, 2012, Am J Neurodegener Dis, V1, P245; Marwarha G, 2010, J ALZHEIMERS DIS, V19, P1007, DOI 10.3233/JAD-2010-1298; BUGIANI O, 1990, NEUROSCI LETT, V119, P56, DOI 10.1016/0304-3940(90)90754-W; Greco SJ, 2010, J ALZHEIMERS DIS, V19, P1155, DOI 10.3233/JAD-2010-1308; Kim Su-Kyoung, 2006, FASEB J, V20, P157; Kirken RA, 1999, J LEUKOCYTE BIOL, V65, P891; PROBST A, 1991, ACTA NEUROPATHOL, V83, P21; Shineman DW, 2009, BIOCHEMISTRY-US, V48, P3787, DOI 10.1021/bi802070j; Tamagno E, 2009, NEUROBIOL AGING, V30, P1563, DOI 10.1016/j.neurobiolaging.2007.12.015; Yamamoto N, 2010, J NEUROCHEM, V113, P628, DOI 10.1111/j.1471-4159.2010.06620.x; Yamamoto N, 2013, ANESTHESIOLOGY, V118, P1408, DOI 10.1097/ALN.0b013e31828afc16; Yamamoto N, 2008, BBA-BIOMEMBRANES, V1778, P2717, DOI 10.1016/j.bbamem.2008.07.028; Yanagisawa K., 2011, INT J ALZHEIMERS DIS, V2011, DOI 10.4061/2011/286536; Yuyama K, 2006, FEBS LETT, V580, P6972, DOI 10.1016/j.febslet.2006.11.072	47	4	4	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0022-3042	1471-4159		J NEUROCHEM	J. Neurochem.	NOV	2014	131	3					323	332		10.1111/jnc.12828		10	Biochemistry & Molecular Biology; Neurosciences	Biochemistry & Molecular Biology; Neurosciences & Neurology	AS4CX	WOS:000344222000007		
J	Hamaguchi, A; Fujima, N; Yoshida, D; Hamaguchi, N; Kodera, S				Hamaguchi, Akiyoshi; Fujima, Noriyuki; Yoshida, Daisuke; Hamaguchi, Naoko; Kodera, Shuichi			Improvement of the Diagnostic Accuracy of MRA with Subtraction Technique in Cerebral Vasospasm	JOURNAL OF NEUROIMAGING			English	Article						Subtraction technique; cerebral vasospasm; subarachnoid hemorrhage; MRA	MAGNETIC-RESONANCE ANGIOGRAPHY; SUBARACHNOID HEMORRHAGE; CT ANGIOGRAPHY; TOMOGRAPHY; ANEURYSMS	PURPOSE Vasospasm has been considered the most severe acute complication after subarachnoid hemorrhage (SAH). MRA is not considered ideal for detecting cerebral vasospasm because of background including the hemorrhage. The aim of this study is to evaluate the efficacy of Subtraction MRA (SMRA) by comparing it to that of conventional MRA (CMRA) for diagnosis of cerebral vasospasm. METHODS Arteries were assigned to one of three categories based on the degree of MRA diagnostic quality of vasospasm (quality score): 0, bad ... 2, good. Furthermore each artery was assigned to one of four categories based on the degree of vasospasm severity (SV score): 0, no vasospasm ... 3, severe. The value of the difference between DSA-SV score and MRA-SV score was defined as the DIF score. CMRA and SMRA were compared for each arterial region with regard to quality score and DIF score. RESULTS The average CMRA and SMRA quality score were 1.46 and 1.79; the difference was statistically significant. The average CMRA and SMRA DIF score were 1.08 and.60; the difference was statistically significant. CONCLUSIONS Diagnosis of cerebral vasospasm is more accurate by SMRA than by CMRA. The advantages are its noninvasive nature and its ability to detect cerebral vasospasm.	[Hamaguchi, Akiyoshi; Hamaguchi, Naoko; Kodera, Shuichi] Sapporo Azabu Neurosurg Hosp, Dept Radiol, Higashi Ku, Sapporo, Hokkaido, Japan; [Fujima, Noriyuki; Yoshida, Daisuke] Hokkaido Univ, Grad Sch Med, Dept Radiol, Kita Ku, Sapporo, Hokkaido, Japan	Hamaguchi, A (reprint author), Sapporo Azabu Neurosurg Hosp, Dept Radiol, Higashi Ku, 1-40 N22 E1, Sapporo, Hokkaido, Japan.	hammer@zc5.so-net.ne.jp					Rosenwasser RH, 1999, NEUROSURGERY, V44, P975, DOI 10.1097/00006123-199905000-00022; Bash S, 2005, AM J NEURORADIOL, V26, P1012; Binaghi S, 2007, AM J NEURORADIOL, V28, P750; WEIR B, 1978, J NEUROSURG, V48, P173, DOI 10.3171/jns.1978.48.2.0173; Chan JHM, 2003, AM J ROENTGENOL, V181, P242; Janjua Nazli, 2003, Curr Opin Crit Care, V9, P113, DOI 10.1097/00075198-200304000-00006; Kessel NF, 1992, J NEUROSURG, V77, P848; Pryor JC, 1996, NEUROIMAG CLIN N AM, V6, P751; RUGGIERI PM, 1992, CARDIOVASC INTER RAD, V15, P71; SAITO I, 1979, J NEUROSURG, V51, P466, DOI 10.3171/jns.1979.51.4.0466; Song JK, 1997, NEUROIMAG CLIN N AM, V7, P819; Tamatani S, 1997, NEUROSURGERY, V40, P748, DOI 10.1097/00006123-199704000-00017; vanLoon JJL, 1997, NEUROSURGERY, V41, P851, DOI 10.1097/00006123-199710000-00016; WILCOCK DJ, 1995, CLIN RADIOL, V50, P526, DOI 10.1016/S0009-9260(05)83186-1; WILLIAMS DS, 1992, P NATL ACAD SCI USA, V89, P212, DOI 10.1073/pnas.89.1.212; Yoon DY, 2006, AM J NEURORADIOL, V27, P370; Zouaoui A, 1997, NEUROSURGERY, V41, P125, DOI 10.1097/00006123-199707000-00026	17	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1051-2284	1552-6569		J NEUROIMAGING	J. Neuroimaging	NOV-DEC	2014	24	6					548	553		10.1111/jon.12147		6	Clinical Neurology; Neuroimaging; Radiology, Nuclear Medicine & Medical Imaging	Neurosciences & Neurology; Radiology, Nuclear Medicine & Medical Imaging	AS6DJ	WOS:000344354600003		
J	Tatewaki, Y; Higano, S; Taki, Y; Thyreau, B; Murata, T; Mugikura, S; Ito, D; Takase, K; Takahashi, S				Tatewaki, Yasuko; Higano, Shuichi; Taki, Yasuyuki; Thyreau, Benjamin; Murata, Takaki; Mugikura, Shunji; Ito, Daisuke; Takase, Kei; Takahashi, Shoki			Regional Reliability of Quantitative Signal Targeting with Alternating Radiofrequency (STAR) Labeling of Arterial Regions (QUASAR)	JOURNAL OF NEUROIMAGING			English	Article						ASL; QUASAR; regional cerebral blood flow; regional reliability	CEREBRAL-BLOOD-FLOW; HUMAN BRAIN; PERFUSION; MRI; PET; REPRODUCIBILITY; QUANTIFICATION	BACKGROUND AND PURPOSE Quantitative signal targeting with alternating radiofrequency labeling of arterial regions (QUASAR) is a recent spin labeling technique that could improve the reliability of brain perfusion measurements. Although it is considered reliable for measuring gray matter as a whole, it has never been evaluated regionally. Here we assessed this regional reliability. METHODS Using a 3-Tesla Philips Achieva whole-body system, we scanned four times 10 healthy volunteers, in two sessions 2 weeks apart, to obtain QUASAR images. We computed perfusion images and ran a voxel-based analysis within all brain structures. We also calculated mean regional cerebral blood flow (rCBF) within regions of interest configured for each arterial territory distribution. RESULTS The mean CBF over whole gray matter was 37.74 with intraclass correlation coefficient (ICC) of.70. In white matter, it was 13.94 with an ICC of.30. Voxel-wise ICC and coefficient-of-variation maps showed relatively lower reliability in watershed areas and white matter especially in deeper white matter. The absolute mean rCBF values were consistent with the ones reported from PET, as was the relatively low variability in different feeding arteries. CONCLUSIONS Thus, QUASAR reliability for regional perfusion is high within gray matter, but uncertain within white matter.	[Higano, Shuichi; Murata, Takaki; Mugikura, Shunji; Takase, Kei; Takahashi, Shoki] Tohoku Univ, Grad Sch Med, Dept Diagnost Radiol, Sendai, Miyagi 9808575, Japan; [Thyreau, Benjamin] Tohoku Univ, Div Dev Cognit Neurosci, Inst Dev Aging & Canc, Sendai, Miyagi 9808575, Japan; Tohoku Univ, Tohoku Med Megabank Org, Dept Community Med Megabank, Sendai, Miyagi 9808575, Japan; Tohoku Univ, Inst Dev Aging & Canc, Depatment Nucl Med & Radiol, Sendai, Miyagi 9808575, Japan; [Ito, Daisuke] Tohoku Univ Hosp, Div Radiol, Sendai, Miyagi, Japan	Tatewaki, Y (reprint author), Tohoku Univ, Grad Sch Med, Dept Diagnost Radiol, Aoba Ku, 1-1 Seiryo Cho, Sendai, Miyagi 9808575, Japan.	ysktate@rad.med.tohoku.ac.jp					DETRE JA, 1992, MAGNET RESON MED, V23, P37, DOI 10.1002/mrm.1910230106; Tatu L, 1998, NEUROLOGY, V50, P1699; Bokkers RPH, 2010, J CEREBR BLOOD F MET, V30, P222, DOI 10.1038/jcbfm.2009.204; Donahue MJ, 2006, NMR BIOMED, V19, P1043, DOI 10.1002/nbm.1075; LEENDERS KL, 1990, BRAIN, V113, P27, DOI 10.1093/brain/113.1.27; SHROUT PE, 1979, PSYCHOL BULL, V86, P420, DOI 10.1037//0033-2909.86.2.420; Bremmer JP, 2011, MOL IMAGING BIOL, V13, P759, DOI 10.1007/s11307-010-0382-1; Gevers S, 2011, J CEREBR BLOOD F MET, V31, P1706, DOI 10.1038/jcbfm.2011.10; Wang JJ, 2002, MAGNET RESON MED, V48, P242, DOI 10.1002/mrm.10211; Ashburner J, 2005, NEUROIMAGE, V26, P839, DOI 10.1016/j.neuroimage.2005.02.018; BRANTZAWADZKI M, 1992, RADIOLOGY, V182, P769; Kudo K, 2003, AM J NEURORADIOL, V24, P419; Petersen ET, 2006, MAGN RESON MED, V55, P219, DOI 10.1002/mrm.20784; Petersen ET, 2010, NEUROIMAGE, V49, P104, DOI 10.1016/j.neuroimage.2009.07.068; Wong EC, 1998, MAGNET RESON MED, V39, P702, DOI 10.1002/mrm.1910390506; Jahng GH, 2005, RADIOLOGY, V234, P909, DOI 10.1148/radiol.2343031499; van Gelderen P, 2008, MAGN RESON MED, V59, P788, DOI 10.1002/mrm.21515; Wang JJ, 2005, RADIOLOGY, V235, P218, DOI 10.1148/radiol.2351031663; van Osch MJP, 2009, MAGN RESON MED, V62, P165, DOI 10.1002/mrm.22002; Gunther M, 2001, MAGNET RESON MED, V46, P974; McGraw KO, 1996, PSYCHOL METHODS, V1, P30, DOI 10.1037/1082-989X.1.4.390; Ye FQ, 2000, MAGNET RESON MED, V44, P450, DOI 10.1002/1522-2594(200009)44:3<450::AID-MRM16>3.0.CO;2-0; Friston KJ, 1995, HUMAN BRAIN MAPPING, V2, P189, DOI DOI 10.1002/HBM.460020402; Grossman EJ, 2009, J MAGN RESON IMAGING, V29, P1425, DOI 10.1002/jmri.21794; Knutsson L, 2008, MAGN RESON IMAGING, V26, P554, DOI 10.1016/j.mri.2007.10.006; Petersen ET, P 15 ANN M ISMRM 200, P376; Young S, 2006, P SPIE	27	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1051-2284	1552-6569		J NEUROIMAGING	J. Neuroimaging	NOV-DEC	2014	24	6					554	561		10.1111/jon.12076		8	Clinical Neurology; Neuroimaging; Radiology, Nuclear Medicine & Medical Imaging	Neurosciences & Neurology; Radiology, Nuclear Medicine & Medical Imaging	AS6DJ	WOS:000344354600004		
J	Yamashita, K; Taniwaki, Y; Utsunomiya, H; Taniwaki, T				Yamashita, Ken-ichiro; Taniwaki, Yoshihide; Utsunomiya, Hidetsuna; Taniwaki, Takayuki			Cerebral Blood Flow Reduction Associated with Orientation for Time in Amnesic Mild Cognitive Impairment and Alzheimer Disease Patients	JOURNAL OF NEUROIMAGING			English	Article						Alzheimer disease; mild cognitive impairment; orientation for time; single photon emission computed tomography (SPECT); posterior cingulate cortex	MINI-MENTAL STATE; CORTICAL AFFERENTS; CINGULATE CORTEX; SPECT; DISORIENTATION; DIAGNOSIS; MONKEY; PLACE; BRAIN	BACKGROUND AND PURPOSE Impairment of orientation for time (OT) is a characteristic symptom of Alzheimer disease (AD). However, the brain regions underlying OT remain to be elucidated. Using single photon emission computed tomography (SPECT), we examined the brain regions exhibiting hypoperfusion that were associated with OT. METHODS We compared regional cerebral blood flow (rCBF) differences between AD and amnesic mild cognitive impairment (aMCI) or normal subjects using 3-dimensional stereotactic surface projection (3D-SSP) analysis. AD patients were divided into OT good and poor groups according to their mean OT scores, and rCBF then compared between the groups to elucidate OT-specific brain areas. RESULTS 3D-SSP analysis showed reduced rCBF in the left superior parietal lobule (SPL) and bilateral inferior parietal lobule (IPL) in AD patients. In the poor OT group, 3D-SSP analysis revealed hypoperfusion in the bilateral SPL, IPL, posterior cingulated cortex (PCC), and precuneus. Among these areas, region of interest analysis revealed a significant higher number of hypoperfused pixels in the left PCC in the OT poor AD group. CONCLUSIONS Our SPECT study suggested that hypoperfusion in the left SPL and bilateral IPL was AD specific, and reduced rCBF in the left PCC was specifically associated with OT.	[Yamashita, Ken-ichiro; Taniwaki, Takayuki] Kurume Univ, Sch Med, Dept Med, Div Respirol Neurol & Rheumatol, Kurume, Fukuoka 8300011, Japan; [Taniwaki, Yoshihide] Fukuoka Sanno Hosp, Dept Neurol, Fukuoka, Japan; [Utsunomiya, Hidetsuna] Fukuoka Sanno Hosp, Dept Radiol, Fukuoka, Japan	Yamashita, K (reprint author), Kurume Univ, Sch Med, Dept Med, Div Respirol Neurol & Rheumatol, 67 Asahimachi, Kurume, Fukuoka 8300011, Japan.	yamashita_kenichirou@med.kurume-u.ac.jp			Japan Society for the Promotion of Science (JSPS), Japan	This work was supported in part by a Grant-in-Aid for Scientific Research (C) to KY from the Japan Society for the Promotion of Science (JSPS), Japan.	OKeefe J, 1996, NATURE, V381, P425, DOI 10.1038/381425a0; Hirono N, 1998, J NEUROL NEUROSUR PS, V64, P552, DOI 10.1136/jnnp.64.4.552; VOGT BA, 1979, SCIENCE, V204, P205, DOI 10.1126/science.107587; Mizumura S, 2003, ANN NUCL MED, V17, P289, DOI 10.1007/BF02988523; Nishimura T, 2007, ANN NUCL MED, V21, P15; Ganguli M, 2004, NEUROLOGY, V63, P115; Morgan LK, 2011, J NEUROSCI, V31, P1238, DOI 10.1523/JNEUROSCI.4667-10.2011; VanHoesen GW, 1997, J NEUROPSYCH CLIN N, V9, P331; Engler H, 2006, BRAIN, V129, P2856, DOI 10.1093/brain/awl178; Petersen RC, 1999, ARCH NEUROL-CHICAGO, V56, P303, DOI 10.1001/archneur.56.3.303; MINOSHIMA S, 1995, J NUCL MED, V36, P1238; Schmahmann JD, 2003, STROKE, V34, P2264, DOI 10.1161/01.STR.0000087786.38997.9E; VOGT BA, 1987, J COMP NEUROL, V262, P271, DOI 10.1002/cne.902620208; MACLEAN PD, 1949, PSYCHOSOM MED, V11, P338; Kumral E, 2007, J NEUROL NEUROSUR PS, V78, P880, DOI 10.1136/jnnp.2006.113654; Hirao K, 2005, NEUROIMAGE, V28, P1014, DOI 10.1016/j.neuroimage.2005.06.066; Ashford J., 1989, J GERONTOL B-PSYCHOL, V44, P139, DOI 10.1093/geronj/44.5; BONTE FJ, 1986, J COMPUT ASSIST TOMO, V10, P579, DOI 10.1097/00004728-198607000-00005; Carcaillon L, 2009, DEMENT GERIATR COGN, V27, P429, DOI 10.1159/000214632; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; GALASKO D, 1990, ARCH NEUROL-CHICAGO, V47, P49; Giannakopoulos P, 2000, ACTA NEUROPATHOL, V100, P189; Guerrero-Berroa E, 2009, INT J GERIATR PSYCH, V24, P1429, DOI 10.1002/gps.2282; HEBERT LE, 1995, JAMA-J AM MED ASSOC, V273, P1354, DOI 10.1001/jama.273.17.1354; MCKHANN G, 1984, NEUROLOGY, V34, P939; NEARY D, 1987, J NEUROL NEUROSUR PS, V50, P1101, DOI 10.1136/jnnp.50.9.1101; Nitrini R, 2000, ACTA NEUROL SCAND, V101, P172, DOI 10.1034/j.1600-0404.2000.101003172.x; OBRIEN JT, 1992, J NEUROL NEUROSUR PS, V55, P1182, DOI 10.1136/jnnp.55.12.1182; Small BJ, 1997, J GERONTOL MED SCI, V52, P299; SPINNLER H, 1988, J NEUROL, V235, P258, DOI 10.1007/BF00314172; TERI L, 1989, J AM GERIATR SOC, V37, P109	31	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1051-2284	1552-6569		J NEUROIMAGING	J. Neuroimaging	NOV-DEC	2014	24	6					590	594		10.1111/jon.12096		5	Clinical Neurology; Neuroimaging; Radiology, Nuclear Medicine & Medical Imaging	Neurosciences & Neurology; Radiology, Nuclear Medicine & Medical Imaging	AS6DJ	WOS:000344354600009		
J	Suzuki, K; Igarashi, H; Huber, VJ; Kitaura, H; Kwee, IL; Nakada, T				Suzuki, Kiyotaka; Igarashi, Hironaka; Huber, Vincent J.; Kitaura, Hiroki; Kwee, Ingrid L.; Nakada, Tsutomu			Ligand-Based Molecular MRI: O-17 JJVCPE Amyloid Imaging in Transgenic Mice	JOURNAL OF NEUROIMAGING			English	Article						JJ vicinal coupling; amyloid; PiB; Pittsburg compound B; O-17	PITTSBURGH COMPOUND-B; ALZHEIMERS-DISEASE; GLUCOSE-METABOLISM; BRAIN; RAT	BACKGROUND Development of molecular MR imaging (MRI) similar to PET imaging using contrast agents such as gadolinium as probe have been inherently hampered by incompatibility between potential probe (charged molecules) and membrane permeability. Nevertheless, considering the inherent spatial resolution limit for PET of 700 mu, the superior microscopic resolution of MRI of 4 mu presents a strong incentive for research into ligand-based molecular MRI. METHODS O-17 exhibits JJ vicinal coupling with a covalently bound proton in a hydroxyl group. This O-17 coupled proton can be ionized in water solution and interexchange with other water protons. This property can be utilized as "probe" in T2-weighted imaging and developed into ligand-based molecular MRI. We examined beta-amyloid distribution in human APP overexpressed transgenic mice in vivo following injection of O-17 labeled Pittsburg compound B (O-17-PiB). RESULTS JJVCPE imaging successfully imaged O-17-PiB, unequivocally establishing that O-17 JJVCPE imaging can be developed into PET-like molecular MRI in clinical medicine. CONCLUSIONS The study represents the first successful ligand-based molecular MRI in vivo. This is also the first in vivo amyloid imaging using MRI. High-resolution molecular MRI with high specificity under clinical settings, such as in vivo microscopic imaging of senile plaque, is a foreseeable aim.	[Suzuki, Kiyotaka; Igarashi, Hironaka; Huber, Vincent J.; Kitaura, Hiroki; Nakada, Tsutomu] Niigata Univ, Ctr Integrated Human Brain Sci, Brain Res Inst, Niigata 95021, Japan; [Kwee, Ingrid L.; Nakada, Tsutomu] Univ Calif Davis, Dept Neurol, Davis, CA 95616 USA	Nakada, T (reprint author), Niigata Univ, Ctr Integrated Human Brain Sci, Brain Res Inst, Niigata 95021, Japan.	tnakada@bri.niigata-u.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology (Japan); University of Niigata	The work was supported by grants from the Ministry of Education, Culture, Sports, Science, and Technology (Japan) and University of Niigata.	Maudsley AA, 2006, NMR BIOMED, V19, P492, DOI 10.1002/nbm.1025; Oakley H, 2006, J NEUROSCI, V26, P10129, DOI 10.1523/JNEUROSCI.1202-06.2006; Klunk WE, 2004, ANN NEUROL, V55, P306, DOI 10.1002/ana.20009; LUYTEN PR, 1990, RADIOLOGY, V176, P791; Mathis CA, 2003, J MED CHEM, V46, P2740, DOI 10.1021/jm030026b; IDO T, 1978, J LABELLED COMPD RAD, V14, P175, DOI 10.1002/jlcr.2580140204; Castleman KR, 1996, DIGITAL IMAGE PROCES, P462; Johnson KA, 2006, CURR NEUROL NEUROSCI, V6, P496, DOI 10.1007/s11910-006-0052-5; NAKADA T, 1988, RADIOLOGY, V168, P823; NAKADA T, 1988, MAGNET RESON MED, V6, P307, DOI 10.1002/mrm.1910060309; NAKADA T, 1988, MAGN RESON IMAGING, V6, P633, DOI 10.1016/0730-725X(88)90085-9; NAKADA T, 1987, MAGN RESON IMAGING, V5, P259, DOI 10.1016/0730-725X(87)90002-6; Nakada T, GRANT IN AID SCI RES; Snellman A, 2012, EUR J NUCL MED MOL I, V11, P1784; Zhu XH, 2005, NMR BIOMED, V18, P83, DOI 10.1002/nbm.930	15	2	2	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1051-2284	1552-6569		J NEUROIMAGING	J. Neuroimaging	NOV-DEC	2014	24	6					595	598		10.1111/jon.12091		4	Clinical Neurology; Neuroimaging; Radiology, Nuclear Medicine & Medical Imaging	Neurosciences & Neurology; Radiology, Nuclear Medicine & Medical Imaging	AS6DJ	WOS:000344354600010		
J	Asai, H; Okamoto, T; Tsuchida, E; Nohara, F; Nagaya, K; Azuma, H				Asai, Hiroko; Okamoto, Toshio; Tsuchida, Etsushi; Nohara, Fumikatsu; Nagaya, Ken; Azuma, Hiroshi			Thrombosed Dural Sinus Malformation in a Fetus: A Case Report	JOURNAL OF NEUROIMAGING			English	Article						Thrombosed dural sinus malformation; outcome; fetus	PRENATAL-DIAGNOSIS; SPONTANEOUS RESOLUTION; TORCULAR HEROPHILI; INFANT; MRI	BACKGROUND AND PURPOSE A thrombosed dural sinus malformation (DSM) is a rare condition, the clinical features of which have not yet been completely characterized. Here, we describe the clinical course of a patient with a thrombosed DSM and discuss the outcomes in live birth cases from a review of the literature. CASE DESCRIPTION An ultrasonography examination of a 32- year- old woman at 25 weeks' gestation indicated a fetal posterior fossa mass. The size of the intracranial mass remained constant during the second trimester and was observed to decrease from 33 weeks of gestation. A postnatal diagnosis of thrombosis in the dural sinus was established by magnetic resonance imaging and venography. No brain damage or hydrocephalus was noted. Although the circumference of the infant's head was enlarged at birth, her neurological outcome was normal at 1 year of age. CONCLUSIONS Although normal cranial circumference is reportedly an essential factor for a favorable prognosis, the patient in this report with a cranial circumference at + 2.0 SD (35.6 cm) had a favorable prognosis. Further studies focused on improving clinical diagnostic accuracy in this rare entity will facilitate appropriate counseling.	[Asai, Hiroko; Okamoto, Toshio; Tsuchida, Etsushi; Nohara, Fumikatsu; Nagaya, Ken; Azuma, Hiroshi] Asahikawa Med Univ, Dept Pediat, Asahikawa, Hokkaido, Japan	Asai, H (reprint author), Asahikawa Med Univ, Dept Pediat, 2-1-1-1 Midorigaoka Higashi, Asahikawa, Hokkaido, Japan.	h-asai5p@asahikawa-med.ac.jp					Byrd SE, 2012, PEDIATR RADIOL, V42, P536, DOI 10.1007/s00247-011-2287-9; Clode N, 2005, INT J GYNECOL OBSTET, V91, P172, DOI 10.1016/j.ijgo.2005.07.016; de Haan TR, 2008, EUR J PAEDIATR NEURO, V12, P41, DOI 10.1016/j.ejpn.2007.04.003; Delmas HL, 2008, ULTRASOUND OBST GYN, V32, P188, DOI 10.1002/uog.5348; Emamian SA, 2002, PEDIATR RADIOL, V32, P593, DOI 10.1007/s00247-002-0710-y; Gicquel JM, 2000, PRENATAL DIAG, V20, P824; Jenny B, 2010, J NEUROSURG-PEDIATR, V5, P523, DOI 10.3171/2009.12.PEDS0862; Jung E, 2006, ULTRASOUND OBST GYN, V27, P562, DOI 10.1002/uog.2764; Legendre G, 2009, PRENATAL DIAG, V29, P808, DOI 10.1002/pd.2277; Merzoug V, 2008, EUR RADIOL, V18, P692, DOI 10.1007/s00330-007-0783-y; Pandey V, 2012, J PERINATOL, V32, P728, DOI 10.1038/jp.2011.161; Rossi A, 2006, PRENATAL DIAG, V26, P11, DOI 10.1002/pd.1347; Simsek Y, 2012, ULTRASOUND OBST GYN, V40, P614, DOI 10.1002/uog.12265; Van Keirsbilck J, 2007, PRENATAL DIAG, V27, P1056, DOI 10.1002/pd.1816; Visentin A, 2001, ULTRASOUND OBST GYN, V17, P322, DOI 10.1046/j.1469-0705.2001.00372.x	15	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1051-2284	1552-6569		J NEUROIMAGING	J. Neuroimaging	NOV-DEC	2014	24	6					603	606		10.1111/jon.12099		4	Clinical Neurology; Neuroimaging; Radiology, Nuclear Medicine & Medical Imaging	Neurosciences & Neurology; Radiology, Nuclear Medicine & Medical Imaging	AS6DJ	WOS:000344354600012		
J	Sadamasa, N; Koyanagi, M; Fukuda, H; Chin, M; Handa, A; Yamagata, S				Sadamasa, Nobutake; Koyanagi, Masaomi; Fukuda, Hitoshi; Chin, Masaki; Handa, Akira; Yamagata, Sen			Is aneurysm repair justified for the patients aged 80 or older after aneurysmal subarachnoid hemorrhage?	JOURNAL OF NEUROINTERVENTIONAL SURGERY			English	Article							ELDERLY-PATIENTS	Background With the advancement of an aging society in the world, an increasing number of elderly patients have been hospitalized due to aneurysmal subarachnoid hemorrhage (aSAH). There is no study that compares the elderly cases of aSAH who receive the definitive treatment with those who treated conservatively. The aim of this study was to investigate the feasibility of the definitive surgery for the acute subarachnoid cases aged 80 or older. Methods We reviewed 500 consecutive cases with acute aSAH with surgical indication for aneurysm repair. Inoperable cases such as dead-on-arrival and the cases with both pupils dilated were excluded. We compared the cases aged 80 or older that received clipping or coil embolization with the controls that the family selected conservative treatment. Results 69 cases were included in this study (ranged 80-98, male: female=9: 60). 56 cases (81.2%) had an aneurysm in the anterior circulation. 23 cases received clipping, 20 cases coil embolization and 26 cases treated conservatively. The cases with aneurysm repair showed significantly better clinical outcome than the controls, while World Federation of Neurological Surgeons (WFNS) grade on admission and premorbid modified Rankin Scale showed no difference between them. Conclusions Better prognosis was obtained when ruptured aneurysm was repaired in the elderly than it was treated conservatively. From the results of this study, we should not hesitate to offer the definitive surgery for the elderly with aSAH.	[Sadamasa, Nobutake; Koyanagi, Masaomi; Fukuda, Hitoshi; Chin, Masaki; Handa, Akira; Yamagata, Sen] Kurashiki Cent Hosp, Dept Neurosurg, Kurashiki, Okayama 7108602, Japan	Sadamasa, N (reprint author), Kurashiki Cent Hosp, Dept Neurosurg, 1-1-1 Miwa, Kurashiki, Okayama 7108602, Japan.	ns11267@kchnet.or.jp					Scholler K, 2013, J NEUROL, V260, P1052, DOI 10.1007/s00415-012-6758-1; Johansson M, 2001, STROKE, V32, P2845, DOI 10.1161/hs1201.099416; Cai YL, 2005, NEUROSURGERY, V57, P1096, DOI 10.1227/01.NEU.0000185583.25420.DF; Dorhout Mees SM, 2012, STROKE, V43, P2126; Horiuchi T, 2011, NEUROL RES, V33, P853, DOI 10.1179/1743132811Y.0000000013; Proust F, 2010, J NEUROSURG, V112, P1200, DOI 10.3171/2009.10.JNS08754; Statistics bureau, 2005 POP CENS SEX AG, V2	7	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1759-8478	1759-8486		J NEUROINTERV SURG	J. NeuroInterventional Surg.	NOV	2014	6	9					664	666		10.1136/neurintsurg-2013-010951		3	Neuroimaging; Surgery	Neurosciences & Neurology; Surgery	AS2HJ	WOS:000344100200010		
J	Mori, R; Joki, T; Nonaka, Y; Ikeuchi, S; Abe, T				Mori, Ryosuke; Joki, Tatsuhiro; Nonaka, Yuichiro; Ikeuchi, Satoshi; Abe, Toshiaki			Parallel Insertion Endoscopic Technique for Precise Catheter Placement in Cystic Craniopharyngiomas	JOURNAL OF NEUROLOGICAL SURGERY PART A-CENTRAL EUROPEAN NEUROSURGERY			English	Article						craniopharyngioma; neuroendoscope; neuronavigation; Ommaya reservoir	MANAGEMENT; SURGERY	BackgroundTotal removal of craniopharyngioma is the most acceptable therapeutic modality; however, there are cases in which radical excision is not possible. To reduce the cystic component volume, an Ommaya reservoir catheter can be placed endoscopically. However, there are certain complications and risks with this type of maneuver, such as misplacement of the catheter, which may result in leakage of cyst contents or installed fluids such as bleomycin. Thus, accurate placement of intracystic catheter is extremely important. Patients and MethodsThe authors placed Ommaya reservoir catheters running over the outer surface of a transparent endoscopic sheath in three cases. ResultsThis neuroendoscopic procedure permits easier manipulation of the catheter and precise placement of the catheter tip. This technique was useful for placement of Ommaya reservoir catheters. ConclusionsThis new technique of catheter placement with neuroendoscopy is more accurate, safer, and less invasive.	[Mori, Ryosuke; Joki, Tatsuhiro; Nonaka, Yuichiro; Ikeuchi, Satoshi; Abe, Toshiaki] Jikei Univ, Sch Med, Dept Neurosurg, Tokyo, Japan	Mori, R (reprint author), Jikei Univ, Sch Med, Dept Neurosurg, Minato Ku, 3-25-8 Nishishinbashi, Tokyo, Japan.	ryotam@jikei.ac.jp					Nakahara Y, 2004, NEUROL MED-CHIR, V44, P408, DOI 10.2176/nmc.44.408; Joki T, 2002, CHILD NERV SYST, V18, P629, DOI 10.1007/s00381-002-0638-4; Delitala A, 2004, CHILD NERV SYST, V20, P858, DOI 10.1007/s00381-004-0943-1; Zanon N, 2008, SURG NEUROL, V70, P66, DOI 10.1016/j.surneu.2007.05.048; Barajas MA, 2002, J NEUROSURG, V97, P607; Di X, 2007, MINIM INVAS NEUROSUR, V50, P227, DOI 10.1055/s-2007-985861; Nakahara Y, 2004, NEUROL MED CHIR TOKY, V44, P414; Nakamizo A, 2001, MINIM INVAS NEUROSUR, V44, P85, DOI 10.1055/s-2001-16003; Nonaka Y, 2006, CHILD NERV SYST, V22, P18, DOI 10.1007/s00381-005-1175-8; Savas A, 2000, NEUROSURGERY, V46, P213; Savas A, 2000, NEUROSURGERY, V46, P216; Zanon N, 2008, SURG NEUROL, V70, P69	12	2	2	THIEME MEDICAL PUBL INC	NEW YORK	333 SEVENTH AVE, NEW YORK, NY 10001 USA	2193-6315	2193-6323		J NEUROL SURG PART A	J. Neurol. Surg. Part A	NOV	2014	75	6					442	446		10.1055/s-0033-1349341		5	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	AS6KO	WOS:000344372800005		
J	Oshima, Y; Takeshita, K; Inanami, H; Takano, Y; Koga, H; Iwahori, T; Baba, S; Tanaka, S				Oshima, Yasushi; Takeshita, Katsushi; Inanami, Hirohiko; Takano, Yuichi; Koga, Hisashi; Iwahori, Tomoyuki; Baba, Satoshi; Tanaka, Sakae			Cervical Microendoscopic Interlaminar Decompression through a Midline Approach in Patients with Cervical Myelopathy: A Technical Note	JOURNAL OF NEUROLOGICAL SURGERY PART A-CENTRAL EUROPEAN NEUROSURGERY			English	Article						cervical myelopathy; microendoscopic decompression; midline approach	DOOR LAMINOPLASTY; LAMINOFORAMINOTOMY; STENOSIS	IntroductionMicroendoscopic techniques through a unilateral paramedian approach or muscle-preserving techniques using a microscope have been reported as minimally invasive spinal decompression procedures for the cervical spine. In this study, we developed a novel technique, cervical microendoscopic interlaminar decompression (CMID) through a midline approach, for treating cervical compression myelopathy. MethodsA total of 29 consecutive patients with single- or two-level cervical compression myelopathy were reviewed. For the single-level cases (e.g., C5-C6), a midline skin incision, approximate to 2 cm in length, was made at the spinal level to be decompressed (C5-C6) under fluoroscopic guidance. The nuchal ligament was longitudinally cut, and tips of the spinous processes (C5 and C6) were exposed. A 16-mm tubular retractor was inserted between the tips of the C5 and C6 spinous processes. A dome-like laminectomy of C5, partial laminectomy of the upper part of C6, and flavectomy were performed. For the two-level cases (e.g., C4-C5 and C5-C6), the decompression procedure was completed by splitting the spinous process (C5). Pre- and postoperative neurologic status was evaluated using the Japanese Orthopedic Association (JOA) score. Neck and arm pain was also evaluated using a numerical rating scale (NRS). ResultsOverall, 10 patients underwent single-level decompression, and 19 patients underwent two-level decompression. The average age was 67 years (range: 40-83 years), and the mean follow-up period was 11 months (range: 4-14 months). The average pre- and postoperative JOA scores were 10.2 and 13.5, with a mean recovery rate of 49%. The mean preoperative and postoperative NRS scores were 3.5 and 1.5 for neck pain and 4.6 and 2.9 for arm pain, respectively. One patient showed transient mild weakness of the leg that recovered neurologically within a few weeks. No other postoperative complications were observed. ConclusionThis procedure revealed good short-term surgical results. This technique has advantages including (1) a symmetrical orientation of the surgical field, (2) an intermuscular incision that minimizes blood loss and muscle trauma, and (3) the ability to safely complete the decompression procedure without retracting the cervical spinal cord compared with the unilateral approach. Although long-term surgical results are required, this technique is not only safe but also minimally invasive as a treatment for cervical compression myelopathy.	[Oshima, Yasushi; Takeshita, Katsushi; Baba, Satoshi; Tanaka, Sakae] Univ Tokyo, Dept Orthopaed Surg, Tokyo 1130033, Japan; [Oshima, Yasushi; Inanami, Hirohiko; Takano, Yuichi; Koga, Hisashi; Iwahori, Tomoyuki; Tanaka, Sakae] Iwai Orthopaed Med Hosp, Dept Orthopaed Surg, Tokyo, Japan	Oshima, Y (reprint author), Univ Tokyo, Dept Orthopaed Surg, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.	yoo-tky@umin.ac.jp					Minamide A, 2010, EUR SPINE J, V19, P487, DOI 10.1007/s00586-009-1233-0; Khoo LT, 2002, NEUROSURGERY, V51, pS146, DOI 10.1227/01.NEU.0000031220.75770.29; Hosono N, 1996, SPINE, V21, P1969, DOI 10.1097/00007632-199609010-00005; Ikuta K, 2005, J NEUROSURG-SPINE, V2, P624, DOI 10.3171/spi.2005.2.5.0624; Adamson TE, 2001, J NEUROSURG, V95, P51, DOI 10.3171/spi.2001.95.1.0051; Chiba K, 2006, SPINE, V31, P2998, DOI 10.1097/01.brs.0000250307.78987.6b; Fessler RG, 2002, NEUROSURGERY, V51, pS37, DOI 10.1227/01.NEU.0000030928.34393.63; Coric D, 2008, NEUROSURG FOCUS, V25, DOI 10.3171/FOC/2008/25/8/E2; Dahdaleh NS, 2013, NEUROSURG FOCUS, V35, DOI 10.3171/2013.3.FOCUS135; Foley K T, 1999, Neurosurg Focus, V7, pe5; McAllister Beck D, 2012, Surg Neurol Int, V3, pS225, DOI 10.4103/2152-7806.98581; Perez-Cruet MJ, 2002, NEUROSURGERY, V51, pS129, DOI 10.1227/01.NEU.0000031004.69814.2D; Seichi A, 2001, SPINE, V26, P479, DOI 10.1097/00007632-200103010-00010; Shiraishi T, 2002, J NEUROSURG, V96, P122, DOI 10.3171/spi.2002.96.1.0122; Shiraishi Tateru, 2002, Spine J, V2, P108, DOI 10.1016/S1529-9430(01)00118-8; Shiraishi T, 2012, SPINE, V37, pE286; Wiggins Gregory C, 2007, Neurosurgery, V60, pS71; Yabuki S, 2005, J NEUROSURG-SPINE, V2, P170, DOI 10.3171/spi.2005.2.2.0170; Yabuki S, 2010, J SPINE RES, V1, P50	19	0	0	THIEME MEDICAL PUBL INC	NEW YORK	333 SEVENTH AVE, NEW YORK, NY 10001 USA	2193-6315	2193-6323		J NEUROL SURG PART A	J. Neurol. Surg. Part A	NOV	2014	75	6					474	478		10.1055/s-0034-1373663		5	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	AS6KO	WOS:000344372800010		
J	Kato, S; Hozumi, T; Yamakawa, K; Goto, T; Kondo, T				Kato, So; Hozumi, Takahiro; Yamakawa, Kiyofumi; Goto, Takahiro; Kondo, Taiji			Antibiotic-Impregnated Cement Embedding Technique for Spinal Instrumentation Infections	JOURNAL OF NEUROLOGICAL SURGERY PART A-CENTRAL EUROPEAN NEUROSURGERY			English	Article						spinal instrument; infection; antibiotic impregnated cement; embedding	VACUUM-ASSISTED CLOSURE; DEEP WOUND INFECTIONS; LOADED BONE-CEMENT; POSTOPERATIVE INFECTIONS; MANAGEMENT; IRRIGATION; SURGERY; THERAPY; FUSION	Background and Study AimsWhen surgical site infection occurs in patients with an instrumented spine, the management of infection is challenging because a biofilm is formed around the metallic surface of the implant. Although a wide variety of methods to salvage implants has been developed, previously reported methods reduce the patients' quality of life and are frequently time consuming and costly. Patients and MethodsWe performed a cement embedding technique in 13 consecutive patients with infection after spinal instrumentation. After meticulous open debridement, the metallic implants were embedded using polymethylmethacrylate (PMMA) mixed with antibiotics. Antibiotics were selected in each case according to the pathogens and their sensitivity. The wound was primarily closed. We did not restrict the patients' activity postoperatively. The implants were not removed unless it was necessary for further procedures. ResultsNine patients, including those infected by methicillin-resistant Staphylococcus aureus (MRSA), were cured by debridement and PMMA embedding followed by systemic antibiotic treatment. No complications were reported. ConclusionsThe antibiotic-impregnated PMMA embedding technique is an effective method for the treatment of spinal instrumentation infections. It is easy to perform and is also effective for MRSA infection.	[Kato, So; Hozumi, Takahiro; Yamakawa, Kiyofumi; Goto, Takahiro; Kondo, Taiji] Tokyo Metropolitan Komagome Hosp, Dept Orthopaed Surg & Musculoskeletal Oncol, Tokyo, Japan	Kato, S (reprint author), Univ Tokyo, Grad Sch Med, Dept Orthopaed Surg Sensory & Motor Syst Med, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan.	skatou-tky@umin.org					Donlan RM, 2001, CLIN INFECT DIS, V33, P1387, DOI 10.1086/322972; Chikawa T, 2011, BRIT J NEUROSURG, V25, P621, DOI 10.3109/02688697.2010.546902; Hanssen AD, 2004, CLIN ORTHOP RELAT R, P79, DOI 10.1097/01.blo.0000143806.72379.7d; Ahmed R, 2012, J SPINAL DISORD TECH, V25, P299, DOI 10.1097/BSD.0b013e31821fbf72; Weinstein MA, 2000, J SPINAL DISORD, V13, P422, DOI 10.1097/00002517-200010000-00009; Labler L, 2006, EUR SPINE J, V15, P1388, DOI 10.1007/s00586-006-0164-2; GRISTINA AG, 1985, J BONE JOINT SURG AM, V67A, P264; Pitto RP, 2004, INT ORTHOP, V28, P129, DOI 10.1007/s00264-004-0545-2; Glassman SD, 1996, SPINE, V21, P2163, DOI 10.1097/00007632-199609150-00021; Levi ADO, 1997, J NEUROSURG, V86, P975, DOI 10.3171/jns.1997.86.6.0975; Ploumis A, 2008, J SPINAL DISORD TECH, V21, P320, DOI 10.1097/BSD.0b013e318141f99d; Mehbod AA, 2005, J SPINAL DISORD TECH, V18, P14, DOI 10.1097/01.bsd.0000133493.32503.d3; Aydinli U, 1999, Acta Orthop Belg, V65, P182; Hedequist D, 2009, SPINE, V34, P60; Ido K, 1996, Eur Spine J, V5, P345, DOI 10.1007/BF00304351; Jones GA, 2007, J NEUROSURG-SPINE, V6, P407, DOI 10.3171/spi.2007.6.5.407; Richards BS, 2001, SPINE, V26, P1990; Seligson D, 1992, J Orthop Trauma, V6, P401, DOI 10.1097/00005131-199212000-00001; Sheehan E, 2004, J ORTHOP RES, V22, P39; Smith J, 2011, ROTHMAN SIMEONE SPIN, P1789; Vender JR, 2005, J NEUROSURG-SPINE, V3, P276, DOI 10.3171/spi.2005.3.4.0276; Vicario C, 2007, ACTA ORTHOP BELG, V73, P102	22	0	0	THIEME MEDICAL PUBL INC	NEW YORK	333 SEVENTH AVE, NEW YORK, NY 10001 USA	2193-6315	2193-6323		J NEUROL SURG PART A	J. Neurol. Surg. Part A	NOV	2014	75	6					479	484		10.1055/s-0034-1371519		6	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	AS6KO	WOS:000344372800011		
J	Kokubun, N; Nagashima, T; Okamura, M; Hirata, K; Yuki, N				Kokubun, Norito; Nagashima, Takahide; Okamura, Madoka; Hirata, Koich; Yuki, Nobuhiro			Timing is crucial for electrodiagnosis of Guillain-Barre syndrome	JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY			English	Letter							CONDUCTION		[Kokubun, Norito; Nagashima, Takahide; Okamura, Madoka; Hirata, Koich] Dokkyo Med Univ, Dept Neurol, Shimotsuga, Tochigi 3220293, Japan; [Yuki, Nobuhiro] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Med, Singapore 117595, Singapore; [Yuki, Nobuhiro] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Physiol, Singapore 117595, Singapore	Kokubun, N (reprint author), Dokkyo Med Univ, Dept Neurol, Kitakobayashi 880, Shimotsuga, Tochigi 3220293, Japan.	kokubun@dokkyomed.ac.jp					HO TW, 1995, BRAIN, V118, P597, DOI 10.1093/brain/118.3.597; Uncini A, 2012, CLIN NEUROPHYSIOL, V123, P1487, DOI 10.1016/j.clinph.2012.01.025; Kuwabara S, 1998, ANN NEUROL, V44, P202, DOI 10.1002/ana.410440210; Shahrizaila N, 2013, CLIN NEUROPHYSIOL, V124, P1456, DOI 10.1016/j.clinph.2012.12.047; Rajabally YA, 2015, J NEUROL NEUROSUR PS, V86, P115, DOI 10.1136/jnnp-2014-307815	5	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0022-3050	1468-330X		J NEUROL NEUROSUR PS	J. Neurol. Neurosurg. Psychiatry	NOV	2014	85	11								10.1136/jnnp-2014-308999		2	Clinical Neurology; Psychiatry; Surgery	Neurosciences & Neurology; Psychiatry; Surgery	AS2ER	WOS:000344093100024		
J	Fujihara, K				Fujihara, K.			BENEFIT 8-year results provide further support for the long-term value of early treatment of multiple sclerosis	JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY			English	Editorial Material									Tohoku Univ, Dept Multiple Sclerosis Therapeut, Grad Sch Med, Aoba Ku, Sendai, Miyagi 9808574, Japan	Fujihara, K (reprint author), Tohoku Univ, Dept Multiple Sclerosis Therapeut, Grad Sch Med, Aoba Ku, 1-1 Seiryomachi, Sendai, Miyagi 9808574, Japan.	fujikazu@med.tohoku.ac.jp					Kuhlmann T, 2002, BRAIN, V125, P2202, DOI 10.1093/brain/awf235; Noyes K, 2011, NEUROLOGY, V77, P355, DOI 10.1212/WNL.0b013e3182270402; Brex PA, 2002, NEW ENGL J MED, V346, P158, DOI 10.1056/NEJMoa011341; Edan G, 2014, J NEUROL NEUROSUR PS, V85, P1183, DOI 10.1136/jnnp-2013-306222	4	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0022-3050	1468-330X		J NEUROL NEUROSUR PS	J. Neurol. Neurosurg. Psychiatry	NOV	2014	85	11					1179	1179		10.1136/jnnp-2013-306720		1	Clinical Neurology; Psychiatry; Surgery	Neurosciences & Neurology; Psychiatry; Surgery	AS2ER	WOS:000344093100001		
J	Mori, M; Kuwabara, S				Mori, Masahiro; Kuwabara, Satoshi			Are more sphingosine 1-phosphate receptor agonists a better therapeutic option against multiple sclerosis?	JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY			English	Editorial Material							ORAL FINGOLIMOD		[Mori, Masahiro; Kuwabara, Satoshi] Chiba Univ, Dept Neurol, Grad Sch Med, Chiba 2608670, Japan	Mori, M (reprint author), Chiba Univ, Dept Neurol, Grad Sch Med, Chuo Ku, 1-8-1 Inohana, Chiba 2608670, Japan.	morim@faculty.chiba-u.jp					Selmaj K, 2013, LANCET NEUROL, V12, P756, DOI 10.1016/S1474-4422(13)70102-9; Kappos L, 2010, NEW ENGL J MED, V362, P387, DOI 10.1056/NEJMoa0909494; Murakami A, 2010, MOL PHARMACOL, V77, P704, DOI 10.1124/mol.109.061481; Cohen JA, 2010, NEW ENGL J MED, V362, P402, DOI 10.1056/NEJMoa0907839; Bigaud M, 2013, BIOCH BIOPH IN PRESS; Olsson T, 2014, J NEUROL NEUROSUR PS, V85, P1198, DOI 10.1136/jnnp-2013-307282; Zipp F, EFFICACY SAFETY S1P	7	1	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0022-3050	1468-330X		J NEUROL NEUROSUR PS	J. Neurol. Neurosurg. Psychiatry	NOV	2014	85	11					1180	1180		10.1136/jnnp-2013-307538		1	Clinical Neurology; Psychiatry; Surgery	Neurosciences & Neurology; Psychiatry; Surgery	AS2ER	WOS:000344093100002		
J	Arii, Y; Sawada, Y; Kawamura, K; Miyake, S; Taichi, Y; Izumi, Y; Kuroda, Y; Inui, T; Kaji, R; Mitsui, T				Arii, Yoshiharu; Sawada, Yuki; Kawamura, Kazuyuki; Miyake, Sayaka; Taichi, Yasuo; Izumi, Yuishin; Kuroda, Yukiko; Inui, Toshio; Kaji, Ryuji; Mitsui, Takao			Immediate effect of spinal magnetic stimulation on camptocormia in Parkinson's disease	JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY			English	Article							CORD STIMULATION; PATHOGENESIS; MOTOR; PAIN; DEFORMITIES; LOCOMOTION; DIAGNOSIS; PATIENT	Objectives Spinal cord stimulation is a potential therapeutic option for the treatment of Parkinson's disease (PD)-associated symptoms. Repetitive trans-spinal magnetic stimulation (rTSMS) is a non-invasive and safe alternative for stimulation of spinal pathways that has not been studied for therapeutic efficacy in PD. We assessed the benefits of rTSMS on camptocormia, an often treatment-resistant postural abnormality observed in PD patients. Methods We compared rTSMS to sham stimulation in PD patients with camptocormia in a single-centre, randomised, single-blind, crossover, placebo-controlled study. PD patients with camptocormia were administered a single trial of rTSMS (a train of 40 stimuli) or sham treatment followed 1 week later by the alternate treatment. Primary outcome measure was thoracolumbar spine flexion angle in the standing position immediately after the trial. Results Of 320 PD patients examined, 37 had concomitant camptocormia and were randomly assigned to either the rTSMS first group (n=19) or sham first group (n=18). Flexion angle in the standing position decreased by a mean of 10.9 degrees (95% CI -8.1 to 13.65) after rTSMS but remained unchanged after sham stimulation (mean, -0.1 degrees; 95% CI -0.95 to 0.71). The flexion angle while sitting (secondary outcome) decreased by 8.1 degrees (95% CI 5.89 to 10.25) after rTSMS, whereas sham treatment had no significant effect (mean, -0.8 degrees; 95% CI -1.62 to 0.05). Conclusions We found an immediate beneficial effect of rTSMS on camptocormia in PD patients. Although the effect was transient, this successful trial justifies further studies to test if repeated rTSMS treatments can induce longer term improvements in camptocormia associated with PD.	[Arii, Yoshiharu; Kawamura, Kazuyuki; Inui, Toshio; Mitsui, Takao] Natl Hosp Org, Dept Neurol, Tokushima Natl Hosp, Tokushima 7760031, Japan; [Sawada, Yuki; Taichi, Yasuo] Natl Hosp Org, Dept Rehabil, Tokushima Natl Hosp, Tokushima 7760031, Japan; [Miyake, Sayaka; Kuroda, Yukiko; Mitsui, Takao] Natl Hosp Org, Dept Clin Res, Tokushima Natl Hosp, Tokushima 7760031, Japan; [Izumi, Yuishin; Kaji, Ryuji] Univ Tokushima, Dept Clin Neurosci, Inst Hlth Biosci, Grad Sch, Tokushima 770, Japan	Mitsui, T (reprint author), Natl Hosp Org, Dept Clin Res, Tokushima Natl Hosp, 1354 Shikiji, Tokushima 7760031, Japan.	tmitsui@tokushima-nh.hosp.go.jp			Japan Society for the Promotion of Society (JSPS) KAKENHI Grant [23500639, 24500636]	This study was supported by Japan Society for the Promotion of Society (JSPS) KAKENHI Grant Numbers, 23500639 and 24500636.	ABE K, 2010, PARKINSONS DIS, P1, DOI DOI 10.4061/2010/267640; Lepoutre AC, 2006, J NEUROL NEUROSUR PS, V77, P1229, DOI 10.1136/jnnp.2005.083998; HOEHN MM, 1967, NEUROLOGY, V17, P427; Azher SN, 2005, NEUROLOGY, V65, P355, DOI 10.1212/01.wnl.0000171857.09079.9f; Bloch F, 2006, J NEUROL NEUROSUR PS, V77, P1223, DOI 10.1136/jnnp.2006.087908; Leydeker M, 2013, ELECTROMAGN BIOL MED, V32, P155, DOI 10.3109/15368378.2013.776353; Finsterer J, 2010, EUR NEUROL, V64, P1, DOI 10.1159/000314897; Fuentes R, 2009, SCIENCE, V323, P1578, DOI 10.1126/science.1164901; Savitt JM, 2006, J CLIN INVEST, V116, P1744, DOI 10.1172/JCI29178; Tiple D, 2009, J NEUROL NEUROSUR PS, V80, P145, DOI 10.1136/jnnp.2008.150011; Shirota Y, 2013, NEUROLOGY, V80, P1400, DOI 10.1212/WNL.0b013e31828c2f66; Fenelon G, 2012, PARKINSONISM RELAT D, V18, P213, DOI 10.1016/j.parkreldis.2011.07.015; Doherty KM, 2011, LANCET NEUROL, V10, P538, DOI 10.1016/S1474-4422(11)70067-9; Ashour R, 2006, MOVEMENT DISORD, V21, P1856, DOI 10.1002/mds.21058; Fuentes R, 2010, EUR J NEUROSCI, V32, P1100, DOI 10.1111/j.1460-9568.2010.07417.x; Agari T, 2012, NEUROL MED-CHIR, V52, P470; Krause P, 2004, SPINAL CORD, V42, P67, DOI 10.1038/sj.sc.3101564; Hassan S, 2013, J CLIN NEUROSCI, V20, P1155, DOI 10.1016/j.jocn.2012.08.018; Ponfick M, 2011, NEURODEGENER DIS, V8, P283, DOI 10.1159/000324372; Litvan I, 2003, MOVEMENT DISORD, V18, P467, DOI 10.1002/mds.10459; Lo YL, 2011, PAIN MED, V12, P1041, DOI 10.1111/j.1526-4637.2011.01143.x; Djaldetti R, 1999, MOVEMENT DISORD, V14, P443, DOI 10.1002/1531-8257(199905)14:3<443::AID-MDS1009>3.0.CO;2-G; MELZACK R, 1965, SCIENCE, V150, P971, DOI 10.1126/science.150.3699.971; Furusawa Y, 2012, MOVEMENT DISORD, V27, P802, DOI 10.1002/mds.24930; Seki M, 2011, MOVEMENT DISORD, V26, P2567, DOI 10.1002/mds.23955; Yoritaka A, 2013, PARKINSONISM RELAT D, V19, P725, DOI 10.1016/j.parkreldis.2013.04.001; Fahn S, 1987, RECENT DEV PARKINSON, V2, P153; GIBB WRG, 1988, J NEUROL NEUROSUR PS, V51, P745, DOI 10.1136/jnnp.51.6.745; Stojanovic Milan P, 2002, Pain Physician, V5, P156; Thevathasan W, 2010, NEUROLOGY, V74, P1325, DOI 10.1212/WNL.0b013e3181d9ed58	30	5	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0022-3050	1468-330X		J NEUROL NEUROSUR PS	J. Neurol. Neurosurg. Psychiatry	NOV	2014	85	11					1221	1226				6	Clinical Neurology; Psychiatry; Surgery	Neurosciences & Neurology; Psychiatry; Surgery	AS2ER	WOS:000344093100010		
J	Arima, H; Anderson, C; Omae, T; Woodward, M; MacMahon, S; Mancia, G; Bousser, MG; Tzourio, C; Harrap, S; Liu, LS; Neal, B; Chalmers, J				Arima, Hisatomi; Anderson, Craig; Omae, Teruo; Woodward, Mark; MacMahon, Stephen; Mancia, Giuseppe; Bousser, Marie-Germaine; Tzourio, Christophe; Harrap, Stephen; Liu, Lisheng; Neal, Bruce; Chalmers, John		PROGRESS Collaborative Grp	Degree of blood pressure reduction and recurrent stroke: the PROGRESS trial	JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY			English	Article							RANDOMIZED-TRIAL; PREVENTION	Objective There is ongoing controversy regarding a 'J-curve' phenomenon such that low and high blood pressure (BP) levels are associated with increased risks of recurrent stroke. We aimed to determine whether large treatment-related BP reductions are associated with increased risks of recurrent stroke. Design Data are from the PROGRESS trial, where 6105 patients with cerebrovascular disease were randomly assigned to either active treatment (perindopril +/- indapamide) or placebo(s). There were no BP criteria for entry. BP was measured at every visit, and participant groups defined by reduction in systolic BP (SBP) from baseline were used for the analyses. Outcome was recurrent stroke. Results During a mean follow-up of 3.9 years, 727 recurrent strokes were observed. There were clear associations between the magnitude of SBP reduction and the risk of recurrent stroke. After adjustment for cardiovascular risk factors and randomised treatment, annual incidence was 2.08%, 2.10%, 2.31% and 2.96% for participant groups defined by SBP reductions of >= 20, 10-19, 0-9 and <0 mm Hg, respectively (p=0.0006 for trend). Conclusions The present analysis provided no evidence of an increase in recurrent stroke associated with larger reductions in SBP produced by treatment among patients with cerebrovascular disease.	[Arima, Hisatomi; Anderson, Craig; Woodward, Mark; MacMahon, Stephen; Neal, Bruce; Chalmers, John] Univ Sydney, George Inst Global Hlth, Sydney, NSW 2006, Australia; [Omae, Teruo] Natl Cerebral & Cardiovasc Ctr, Suita, Osaka, Japan; [MacMahon, Stephen] Univ Oxford, George Ctr Healthcare Innovat, Oxford, England; [Mancia, Giuseppe] Univ Milano Bicocca, Osped San Gerardo, Milan, Italy; [Bousser, Marie-Germaine] Hop Lariboisiere, Dept Neurol, F-75475 Paris, France; [Tzourio, Christophe] INSERM, U897, Bordeaux, France; [Tzourio, Christophe] Univ Bordeaux, Bordeaux, France; [Harrap, Stephen] Univ Melbourne, Dept Physiol, Melbourne, Vic, Australia; [Liu, Lisheng] Chinese Acad Med Sci, Natl Ctr Cardiovasc Dis, Cardiovasc Inst, Beijing 100730, Peoples R China; [Liu, Lisheng] Chinese Acad Med Sci, Fuwai Hosp, Beijing 100730, Peoples R China	Chalmers, J (reprint author), George Inst Global Hlth, POB M201,Missenden Rd, Sydney, NSW 2050, Australia.	chalmers@georgeinstitute.org.au	Woodward, Mark/D-8492-2015; 	Harrap, Stephen/0000-0003-2907-6714	Servier; National Health and Medical Research Council of Australia; Health Research Council of New Zealand [HRC98/149]	This work was supported by Servier, National Health and Medical Research Council of Australia (special grant) and Health Research Council of New Zealand (HRC98/149).	Staessen JA, 2001, LANCET, V358, P1305, DOI 10.1016/S0140-6736(01)06411-X; Arima H, 2006, J HYPERTENS, V24, P1201, DOI 10.1097/01.hjh.0000226212.34055.86; Ovbiagele B, 2011, JAMA-J AM MED ASSOC, V306, P2137, DOI 10.1001/jama.2011.1650; Benavente OR, 2013, LANCET, V382, P507, DOI 10.1016/S0140-6736(13)60852-1; Arima H, 2011, J CLIN HYPERTENS, V13, P693, DOI 10.1111/j.1751-7176.2011.00530.x; MacMahon S, 2001, LANCET, V358, P1033	6	2	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0022-3050	1468-330X		J NEUROL NEUROSUR PS	J. Neurol. Neurosurg. Psychiatry	NOV	2014	85	11					1284	1285		10.1136/jnnp-2014-307856		2	Clinical Neurology; Psychiatry; Surgery	Neurosciences & Neurology; Psychiatry; Surgery	AS2ER	WOS:000344093100020		
J	Tajima, Y; Satoh, C; Yaguchi, H; Mito, Y				Tajima, Yasutaka; Satoh, Chika; Yaguchi, Hiroaki; Mito, Yasunori			Pure motor monoparesis of the leg after carbon monoxide intoxication	JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY			English	Editorial Material							STROKE		[Tajima, Yasutaka; Satoh, Chika; Yaguchi, Hiroaki; Mito, Yasunori] Sapporo City Gen Hosp, Dept Neurol, Brain Sci Ctr, Sapporo, Hokkaido 0608604, Japan	Tajima, Y (reprint author), Sapporo City Gen Hosp, Dept Neurol, Brain Sci Ctr, N11 W13 Chu O Ku, Sapporo, Hokkaido 0608604, Japan.	yasutaka.tajima@doc.city.sapporo.jp					Penfield W, 1937, BRAIN, V60, P389, DOI 10.1093/brain/60.4.389; Choi S, 2001, J KOREAN MED SCI, V16, P253; Hon KLE, 2006, J CHILD NEUROL, V21, P737, DOI 10.2310/7010.2006.00172; Paciaroni M, 2005, J NEUROL NEUROSUR PS, V76, P805, DOI 10.1136/jnnp.2004.047779; Roland NA, 2004, GREENFIELDS NEUROPAT, P275; SCHNEIDER R, 1994, BRAIN, V117, P347, DOI 10.1093/brain/117.2.347	6	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0022-3050	1468-330X		J NEUROL NEUROSUR PS	J. Neurol. Neurosurg. Psychiatry	NOV	2014	85	11					1286	1287		10.1136/jnnp-2013-306757		2	Clinical Neurology; Psychiatry; Surgery	Neurosciences & Neurology; Psychiatry; Surgery	AS2ER	WOS:000344093100021		
J	Perron, A; Turchi, PEA; Landa, A; Soderlind, P; Ravat, B; Oudot, B; Delaunay, F; Kurata, M				Perron, A.; Turchi, P. E. A.; Landa, A.; Soederlind, P.; Ravat, B.; Oudot, B.; Delaunay, F.; Kurata, M.			Thermodynamic re-assessment of the Pu-U system and its application to the ternary Pu-U-Ga system	JOURNAL OF NUCLEAR MATERIALS			English	Article							PHASE-TRANSFORMATIONS; PLUTONIUM-URANIUM; MATERIALS SCIENCE; ACTINIDE ALLOYS; THERMO-CALC; ZR SYSTEM; EQUILIBRIA; DIAGRAM; CHALLENGES	Phase diagram and thermodynamic properties of the Plutonium-Uranium (Pu-U) system have been successfully re-assessed using the CALPHAD method with input from ab initio electronic-structure calculations for the bcc phase (gamma-U, is an element of-Pu). Results and methodology are discussed and compared with previous assessments. In addition, the already assessed Pu-Ga (Gallium) and U-Ga data are combined to build the Pu-U-Ga thermodynamic database. The predictions made using this database indicate that a small amount of U impacts the (delta-Pu) Pu-Ga phase stability by precipitating the complicated eta and zeta phases that exist in the Pu-U system. Finally, the present investigation provides guidelines for further experimental studies. Published by Elsevier B.V.	[Perron, A.; Turchi, P. E. A.; Landa, A.; Soederlind, P.] Lawrence Livermore Natl Lab, Livermore, CA 94550 USA; [Ravat, B.; Oudot, B.; Delaunay, F.] CEA Ctr Valduc, F-21120 Is Sur Tille, France; [Kurata, M.] JAEA, Nucl Sci & Engn Directorate, Tokai, Ibaraki 3191195, Japan	Perron, A (reprint author), Lawrence Livermore Natl Lab, Livermore, CA 94550 USA.	perron1@llni.gov		Perron, Aurelien/0000-0002-5280-003X	U.S Department of Energy by Lawrence Livermore National Laboratory [DE-AC52-07NA27344]; Laboratory Directed Research and Development Program [12-SI-008]; CEA-Centre de Valduc (France); Post-doctoral program at LLNL; DOE-NNSA; CEA-DAM	This work was performed under the auspices of the U.S Department of Energy by Lawrence Livermore National Laboratory under contract DE-AC52-07NA27344. Work at LLNL was funded by the Laboratory Directed Research and Development Program under project tracking code 12-SI-008. This work was done as part of the international agreement on cooperation between DOE-NNSA and CEA-DAM in fundamental science supporting stockpile stewardship. A.P. gratefully acknowledges the financial support from the CEA-Centre de Valduc (France), the Post-doctoral program at LLNL, and M. Fluss for a thorough reading of the manuscript.	Hecker SS, 2004, PROG MATER SCI, V49, P429, DOI 10.1016/S0079-6425(03)00032-X; Wang J, 2008, J NUCL MATER, V380, P105, DOI 10.1016/j.jnucmat.2008.07.009; REDLICH O, 1948, IND ENG CHEM, V40, P345, DOI 10.1021/ie50458a036; MUGGIANU YM, 1975, J CHIM PHYS PCB, V72, P83; [Anonymous], 1967, MLM1445; Andersson JO, 2002, CALPHAD, V26, P273, DOI 10.1016/S0364-5916(02)00037-8; Schwartz AJ, 2009, PROG MATER SCI, V54, P909, DOI 10.1016/j.pmatsci.2009.03.003; BUSCHOW KHJ, 1973, J LESS-COMMON MET, V31, P165, DOI 10.1016/0022-5088(73)90140-9; SUNDMAN B, 1985, CALPHAD, V9, P153, DOI 10.1016/0364-5916(85)90021-5; DAYAN D, 1985, J NUCL MATER, V135, P40, DOI 10.1016/0022-3115(85)90435-0; DINSDALE AT, 1991, CALPHAD, V15, P317, DOI 10.1016/0364-5916(91)90030-N; Salhov S, 2007, J ALLOY COMPD, V444, P257, DOI 10.1016/j.jallcom.2006.11.118; Zinkle SJ, 2013, ACTA MATER, V61, P735, DOI 10.1016/j.actamat.2012.11.004; Kurata M, 2010, IOP CONF SER-MAT SCI, V9, DOI 10.1088/1757-899X/9/1/012022; Bajaj S, 2011, J NUCL MATER, V419, P177, DOI 10.1016/j.jnucmat.2011.08.050; CALAIS D, 1967, PLUTONIUM 1965, P358; Chebotarev N., 1975, PLUTONIUM 1975 OTHER; ELLINGER FH, 1959, J NUCL MATER, V1, P233, DOI 10.1016/0022-3115(59)90019-4; Havela L, 2011, J NUCL MATER, V414, P458, DOI 10.1016/j.jnucmat.2011.05.033; Kattner UR, 1997, JOM-J MIN MET MAT S, V49, P14, DOI 10.1007/s11837-997-0024-5; Kaufman L., 1970, COMPUTER CALCULATION; Kurata M., 1997, 1997 FALL M JAP AT E; Kurata M, 1999, CALPHAD, V23, P305, DOI 10.1016/S0364-5916(00)00004-3; Kutty TRG, 2012, J NUCL MATER, V429, P341, DOI 10.1016/j.jnucmat.2012.06.025; Landa A, 2009, J ALLOY COMPD, V478, P103, DOI 10.1016/j.jallcom.2008.12.052; Landa A, 2009, J NUCL MATER, V385, P68, DOI 10.1016/j.jnucmat.2008.09.029; Landa A, 2011, J NUCL MATER, V408, P61, DOI 10.1016/j.jnucmat.2010.10.066; Landa A, 2009, J NUCL MATER, V393, P141, DOI 10.1016/j.jnucmat.2009.05.014; Lawson AC, 1996, ACTA CRYSTALLOGR B, V52, P32, DOI 10.1107/S0108768195006811; LEIBOWITZ L, 1988, J NUCL MATER, V154, P145, DOI 10.1016/0022-3115(88)90128-6; LEIBOWITZ L, 1991, J NUCL MATER, V184, P59, DOI 10.1016/0022-3115(91)90533-D; Lukas H., 2007, COMPUTATIONAL THERMO; Makarov ES., 1956, KRISTALLOGRAFIYA, V1, P644; NAKAJIMA K, COMMUNICATION, P84215; OKAMOTO Y, 1994, J ALLOY COMPD, V213, P372, DOI 10.1016/0925-8388(94)90935-0; Perron A, 2013, ACTA MATER, V61, P7109, DOI 10.1016/j.actamat.2013.07.060; Peterson D.E., 1989, B ALLOY PHASE DIAGRA, V10, P160, DOI 10.1007/BF02881431; PETRI MC, 1994, J NUCL MATER, V211, P1, DOI 10.1016/0022-3115(94)90275-5; Ravat B, 2013, J ALLOY COMPD, V580, P298, DOI 10.1016/j.jallcom.2013.04.142; ROSEN S, 1963, J NUCL MATER, V9, P128, DOI 10.1016/0022-3115(63)90128-4; Saunders N., 1998, PERGAMON MAT SERIES; Schwartz AJ, 2007, J ALLOY COMPD, V444, P4, DOI 10.1016/j.jallcom.2006.11.108; Turchi P.E.A., 2004, UCRLTR206658 LAWR LI; Turchi PEA, 2007, J ALLOY COMPD, V444, P28, DOI 10.1016/j.jallcom.2006.10.046; Turchi PEA, 2014, JOM-US, V66, P375, DOI 10.1007/s11837-014-0882-6; Turchi P.E.A., 2012, LLNLTR553775; Turchi PEA, 2011, J NUCL MATER, V418, P165, DOI 10.1016/j.jnucmat.2011.06.034; Turchi P.E.A., 2012, LLNLTR603054	48	2	2	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0022-3115	1873-4820		J NUCL MATER	J. Nucl. Mater.	NOV	2014	454	1-3					81	95		10.1016/j.jnucmat.2014.07.051		15	Materials Science, Multidisciplinary; Nuclear Science & Technology; Mining & Mineral Processing	Materials Science; Nuclear Science & Technology; Mining & Mineral Processing	AS7IA	WOS:000344428900012		
J	Alimov, VK; Hatano, Y; Sugiyama, K; Balden, M; Oyaidzu, M; Akamaru, S; Tada, K; Kurishita, H; Hayashi, T; Matsuyama, M				Alimov, V. Kh.; Hatano, Y.; Sugiyama, K.; Balden, M.; Oyaidzu, M.; Akamaru, S.; Tada, K.; Kurishita, H.; Hayashi, T.; Matsuyama, M.			Surface morphology and deuterium retention in tungsten and tungsten-rhenium alloy exposed to low-energy, high flux D plasma	JOURNAL OF NUCLEAR MATERIALS			English	Article							TO-DUCTILE TRANSITION; HYDROGEN; TRANSMUTATION; TEMPERATURE; DEPENDENCE; ARMOR	Surface topography and deuterium retention in polycrystalline hot-rolled W and W-5%Re have been examined after exposure to a low-energy (76 eV), high flux (around 10(22) D/m(2) s) deuterium plasma to an ion fluence of 10(26) D/m(2) at various temperatures. The methods used were confocal laser scanning microscopy and the D(He-3, p)He-4 nuclear reaction at He-3 energies varied from 0.69 to 4.0 MeV. During exposure to the D plasma at temperatures in the range from 348 to 673 K, small blisters of size in the range from about 1 to about 15 mu m, depending on the exposure temperature, are formed on the W and W-5%Re surfaces. In the W-5%Re, the deuterium retention demonstrates its maximum at exposure temperature of 463 K, while in the W this maximum is shifted to 523 K. A difference in the temperature dependence of the D retention for the W and W-5%Re is explained, as a rough approximation, by temperature dependences of the ductility of these materials. (C) 2014 Elsevier B.V. All rights reserved.	[Alimov, V. Kh.; Hatano, Y.; Akamaru, S.; Matsuyama, M.] Toyama Univ, Hydrogen Isotope Res Ctr, Toyama 9308555, Japan; [Sugiyama, K.; Balden, M.] Max Planck Inst Plasma Phys, D-85748 Garching, Germany; [Oyaidzu, M.; Hayashi, T.] Japan Atom Energy Agcy, Int Fus Energy Res Ctr, Fus Res & Dev Directorate, Aomori 0393212, Japan; [Tada, K.] Tohoku Univ, Grad Sch Engn, Dept Quantum Sci & Energy Engn, Sendai, Miyagi 9808579, Japan; [Kurishita, H.] Tohoku Univ, Inst Mat Res, Int Res Ctr Nucl Mat Sci, Oarai, Ibaraki 3111313, Japan	Alimov, VK (reprint author), Toyama Univ, Hydrogen Isotope Res Ctr, Toyama 9308555, Japan.	vkahome@mail.ru			NIFS [NIFS13KUMR013]; Japan Atomic Energy Agency, Broader Approach Activities [25K286]	The authors would like to thank G. Matern (IPP Garching, Germany) for preparation and metallographic images of the W and W-5%Re samples, and J. Dorner and M. Fusseder (IPP Garching, Germany) for technical assistance with the <SUP>3</SUP>He beam analyses. This work was partly supported by the NIFS Collaboration Research Program (NIFS13KUMR013) and the Japan Atomic Energy Agency as a part of Broader Approach Activities (#25K286).	Skinner CH, 2008, FUSION SCI TECHNOL, V54, P891; Zehetbauer MJ, 2006, MATER SCI FORUM, V503-504, P57; CONDON JB, 1993, J NUCL MATER, V207, P1, DOI 10.1016/0022-3115(93)90244-S; Gilbert MR, 2011, NUCL FUSION, V51, DOI 10.1088/0029-5515/51/4/043005; MUTOH Y, 1995, J MATER SCI, V30, P770, DOI 10.1007/BF00356341; Alimov VK, 2012, J NUCL MATER, V420, P519, DOI 10.1016/j.jnucmat.2011.11.003; Cottrell GA, 2004, J NUCL MATER, V334, P166, DOI 10.1016/j.jnucmat.2004.07.001; Balden M, 2011, J NUCL MATER, V414, P69, DOI 10.1016/j.jnucmat.2011.04.031; Cottrell GA, 2006, FUSION SCI TECHNOL, V50, P89; Gao HP, 2001, J MATER SCI LETT, V20, P885, DOI 10.1023/A:1010915012522; Lindig S, 2009, PHYS SCRIPTA, VT138, DOI 10.1088/0031-8949/2009/T138/014040; Mayer M, 2008, NUCL INSTRUM METH B, V266, P1852, DOI 10.1016/j.nimb.2007.11.071; Giannattasio A, 2010, PHILOS MAG, V90, P3947, DOI 10.1080/14786435.2010.502145; Giannattasio A, 2007, PHILOS MAG, V87, P2589, DOI 10.1080/14786430701253197; Benamati G, 2000, J NUCL MATER, V283, P1033, DOI 10.1016/S0022-3115(00)00202-6; FRANZEN P, 1992, NUCL INSTRUM METH B, V67, P536, DOI 10.1016/0168-583X(92)95868-R; Golubeva AV, 2007, J NUCL MATER, V363, P893, DOI 10.1016/j.jnucmat.2007.01.110; Gumbsch P, 1998, SCIENCE, V282, P1293, DOI 10.1126/science.282.5392.1293; Haasz AA, 1999, J NUCL MATER, V266, P520, DOI 10.1016/S0022-3115(98)00586-8; Kolasinski RD, 2013, J NUCL MATER, V438, pS1019, DOI 10.1016/j.jnucmat.2013.01.222; Kolasinski RD, 2011, J NUCL MATER, V415, pS676, DOI 10.1016/j.jnucmat.2010.10.077; Luo GN, 2004, REV SCI INSTRUM, V75, P4374, DOI 10.1063/1.1807006; Makarov P, 2002, INT J REFRACT MET H, V20, P277, DOI 10.1016/S0263-4368(02)00030-6; Alimov VK, 2005, NUCL INSTRUM METH B, V234, P169, DOI 10.1016/j.nimb.2005.01.009; Mayer M., 1997, 9113 IPP MAX PLANCK; Noda T, 1998, J NUCL MATER, V258, P934, DOI 10.1016/S0022-3115(98)00088-9; Raffo P.L., 1968, D4567 NASA; Tyburska-Puschel B, 2013, NUCL FUSION, V53, DOI 10.1088/0029-5515/53/12/123021; Ueda Y., 2005, Journal of Nuclear Materials, V337-339, DOI 10.1016/j.jnucmat.2004.10.077; Wurster S, 2013, J NUCL MATER, V442, pS181, DOI 10.1016/j.jnucmat.2013.02.074	30	1	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0022-3115	1873-4820		J NUCL MATER	J. Nucl. Mater.	NOV	2014	454	1-3					136	141		10.1016/j.jnucmat.2014.07.064		6	Materials Science, Multidisciplinary; Nuclear Science & Technology; Mining & Mineral Processing	Materials Science; Nuclear Science & Technology; Mining & Mineral Processing	AS7IA	WOS:000344428900019		
J	Nagai, T; Uehara, A; Fujii, T; Sato, N; Kofuji, H; Myochin, M; Yamana, H				Nagai, Takayuki; Uehara, Akihiro; Fujii, Toshiyuki; Sato, Nobuaki; Kofuji, Hirohide; Myochin, Munetaka; Yamana, Hajimu			Redox equilibrium of the UO22+/UO2+ couple in Li2MoO4-Na2MoO4 eutectic melt at 550 degrees C	JOURNAL OF NUCLEAR MATERIALS			English	Article							MOLYBDATE MELTS; MOLYBDENUM OXIDES; URANYL MOLYBDATE; URANIUM-OXIDES; RECRYSTALLIZATION; GLASSES; ELECTROLYSIS; ABSORPTION; IONS; FUEL	The redox equilibrium of UO22+/UO2+ couple was measured in Li2MoO4-Na2MoO4 eutectic melt at 550 degrees C by cyclic voltammetry and absorption spectrophotometry. The standard redox potential of UO22+/UO2+ couple was approximately evaluated by cyclic voltammetry. Further, the absorption spectrum and equilibrium potential were measured, repeatedly adding Lie source material into the melt containing UO2+. From the correlation between the equilibrium potential of the melt and the concentration ratio [UO22+]/[UO2+] spectrophotometrically evaluated, the standard redox potential of UO22+/UO2+ couple was determined to be -0.847 +/- 0.010 V vs. O-2/O2-. (C) 2014 Elsevier B.V. All rights reserved.	[Nagai, Takayuki; Kofuji, Hirohide; Myochin, Munetaka] Japan Atom Energy Agcy, Nucl Fuel Cycle Engn Lab, Naka, Ibaraki 3191194, Japan; [Uehara, Akihiro; Fujii, Toshiyuki; Yamana, Hajimu] Kyoto Univ, Inst Res Reactor, Sen Nan, Osaka 5900494, Japan; [Sato, Nobuaki] Tohoku Univ, Inst Multidisciplinary Res Adv Mat, Aoba Ku, Sendai, Miyagi 9808577, Japan	Nagai, T (reprint author), Japan Atom Energy Agcy, Nucl Fuel Cycle Engn Lab, 4-33 Muramatsu, Naka, Ibaraki 3191194, Japan.	nagai.takayuki00@jaea.go.jp					Abo-Naf SM, 2012, J NON-CRYST SOLIDS, V358, P406, DOI 10.1016/j.jnoncrysol.2011.10.013; ADAMS MD, 1963, J PHYS CHEM-US, V67, P1939, DOI 10.1021/j100803a518; Afonichkin VK, 2013, RUSS J APPL CHEM+, V86, P133, DOI 10.1134/S1070427213020018; Afonichkin VK, 2006, RUSS J ELECTROCHEM+, V42, P626, DOI 10.1134/S102319350606005X; Rao PS, 2012, J NON-CRYST SOLIDS, V358, P3372, DOI 10.1016/j.jnoncrysol.2012.08.017; Dieterle M, 2002, PHYS CHEM CHEM PHYS, V4, P822, DOI 10.1039/b107046k; Pointurier F, 2010, SPECTROCHIM ACTA B, V65, P797, DOI 10.1016/j.sab.2010.06.008; Nagai T, 2013, J NUCL MATER, V433, P397, DOI 10.1016/j.jnucmat.2012.10.010; CARRELL MA, 1964, J NUCL MATER, V13, P142, DOI 10.1016/0022-3115(64)90036-4; Gossink R. G., 1971, Journal of Non-Crystalline Solids, V5, DOI 10.1016/0022-3093(71)90033-0; Hamdy YM, 2013, PHYSICA B, V429, P57, DOI 10.1016/j.physb.2013.08.009; Hoermann F., 1929, Z ANORG ALLG CHEM, V177, P145, DOI 10.1002/zaac.19291770117; Laurinavichyute VK, 2012, J SOLID STATE ELECTR, V16, P3515, DOI 10.1007/s10008-012-1870-9; Mizuguchi Koji, 2007, Transactions of the Atomic Energy Society of Japan, V6; Nagai T., 2011, P RADIOCHIM ACTA, V1, P151; Nagai T, 2013, J NUCL MATER, V439, P1, DOI 10.1016/j.jnucmat.2013.03.078; Nagai T, 2004, J NUCL SCI TECHNOL, V41, P690, DOI 10.3327/jnst.41.690; Radha KC, 2008, APPL MAGN RESON, V35, P1, DOI 10.1007/s00723-008-0139-z; Saraiva GD, 2008, J RAMAN SPECTROSC, V39, P937, DOI 10.1002/jrs.1942; SMOLENSKII VV, 1995, RADIOCHEMISTRY+, V37, P308; SMOLENSKII VV, 1994, RUSS J ELECTROCHEM+, V30, P707; Ustinov OA, 1997, ATOM ENERGY+, V82, P99, DOI 10.1007/BF02413458; Ustinov OA, 2007, ATOM ENERGY+, V102, P361, DOI 10.1007/s10512-007-0056-5; Ustinov OA, 2006, ATOM ENERGY+, V101, P771, DOI 10.1007/s10512-006-0167-4	24	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0022-3115	1873-4820		J NUCL MATER	J. Nucl. Mater.	NOV	2014	454	1-3					159	163		10.1016/j.jnucmat.2014.07.070		5	Materials Science, Multidisciplinary; Nuclear Science & Technology; Mining & Mineral Processing	Materials Science; Nuclear Science & Technology; Mining & Mineral Processing	AS7IA	WOS:000344428900022		
J	Suetsugu, Y				Suetsugu, Yasushi			Synthesis of lead vanadate iodoapatite utilizing dry mechanochemical process	JOURNAL OF NUCLEAR MATERIALS			English	Article							IODINE-BEARING APATITE; IMMOBILIZATION; PB-5(VO4)(3)I; VANADINITE; COMPOUND; SYSTEM	For consolidation and subsequent deep geological repository of radioactive I-129, a novel synthesis method of iodine-bearing lead vanadate apatite Pb-10(VO4)(6)I-2 was developed. In order to reduce the reaction temperature, a dry mechanochemical process was applied and iodoapatite was successfully synthesized without heating. Calcining the as-synthesized low crystalline specimen at 300 degrees C gave a single-phase with high crystallinity. The obtained powder was consolidated by hot-press sintering at 400 degrees C under uniaxial pressure of 90 MPa and submitted to leach tests by immersion into pure water at room temperature. The normalized leach rate of iodine on the first day was about 2.6 x 10(-1) g m(-2) d(-1). After 56 days of immersion, the iodine leach rate was reduced to less than 1/30 of the initial rate in newly changed water. lodoapatite specimens in which part of VO43- was substituted with PO43-, Pb-10(VO4)(4.8)(PO4)(1.2)I-2, were also synthesized by the same method. (C) 2014 Elsevier B.V. All rights reserved.	Natl Inst Mat Sci, Biomat Unit, Tsukuba, Ibaraki 3050044, Japan	Suetsugu, Y (reprint author), Natl Inst Mat Sci, Biomat Unit, 1-1 Namiki, Tsukuba, Ibaraki 3050044, Japan.	SUETSUGU.Yasushi@nims.go.jp					ENGEL G, 1972, J SOLID STATE CHEM, V5, P28, DOI 10.1016/0022-4596(72)90004-7; MERKER L, 1959, Z ANORG ALLG CHEM, V300, P41, DOI 10.1002/zaac.19593000104; Guy C, 2002, CR PHYS, V3, P827, DOI 10.1016/S1631-0705(02)01377-4; Redfern SAT, 2012, MINERAL MAG, V76, P997, DOI 10.1180/minmag.2012.076.4.15; Eon JG, 2006, PHYS CHEM CHEM PHYS, V8, P1845, DOI 10.1039/b515762e; Audubert F, 1997, SOLID STATE IONICS, V95, P113, DOI 10.1016/S0167-2738(96)00570-X; Stennett MC, 2011, J NUCL MATER, V414, P352, DOI 10.1016/j.jnucmat.2011.04.041; Le Gallet S, 2010, J NUCL MATER, V400, P251, DOI 10.1016/j.jnucmat.2010.03.011; Uno M, 2001, J NUCL MATER, V294, P119, DOI 10.1016/S0022-3115(01)00462-7; [Anonymous], 1983, MCC1P PAC NW LAB; Liao CJ, 1999, BIOMATERIALS, V20, P1807, DOI 10.1016/S0142-9612(99)00076-9; Audubert F., 2000, INT C SCI RES BACK E; Audubert F, 1999, ACTA CRYSTALLOGR C, V55, P271, DOI 10.1107/S0108270198005034; BISHOP HE, 1968, J PHYS D APPL PHYS, V1, P673, DOI 10.1088/0022-3727/1/6/301; Clark G.L., 1941, J AM CHEM SOC, V63, P1302, DOI 10.1021/ja01850a045; Clark GL, 1942, J AM CHEM SOC, V64, P1637, DOI 10.1021/ja01259a046; Kikuchi M., 1996, MINERAL J, V18, P79, DOI 10.2465/minerj.18.79; Maddrell ER, 2004, MATER RES SOC SYMP P, V807, P261; Nakayama S, 2007, J EUR CERAM SOC, V27, P4413, DOI [10.1016/j.jeurceramsoc.2007.02.210, 10.1016/j.jeurceramsoc.2006.02.210]; Philibert J., 1962, 3RD P INT S XRAY OPT, P379; ROLLS W, 1984, MATER SCI ENG, V65, pL5, DOI 10.1016/0025-5416(84)90095-8; Shimohira T., 1967, J CERAM ASS JAPAN, V75, P352; Springer G., 1967, FORTSCHR MINERAL, V45, P103; van Klooster HS, 1935, J AM CHEM SOC, V57, P670; Zhang M, 2007, MAT SCI ENG B-SOLID, V137, P149, DOI 10.1016/j.mseb.2006.11.003	25	1	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0022-3115	1873-4820		J NUCL MATER	J. Nucl. Mater.	NOV	2014	454	1-3					223	229		10.1016/j.jnucmat.2014.07.073		7	Materials Science, Multidisciplinary; Nuclear Science & Technology; Mining & Mineral Processing	Materials Science; Nuclear Science & Technology; Mining & Mineral Processing	AS7IA	WOS:000344428900032		
J	Sugawara, T; Katsuki, J; Shiono, T; Yoshida, S; Matsuoka, J; Minami, K; Ochi, E				Sugawara, Toru; Katsuki, Junki; Shiono, Takashi; Yoshida, Satoshi; Matsuoka, Jun; Minami, Kazuhiro; Ochi, Eiji			High-temperature heat capacity and density of simulated high-level waste glass	JOURNAL OF NUCLEAR MATERIALS			English	Article							INDEPENDENT THERMAL EXPANSIVITIES; SODIUM-SILICATE LIQUIDS; ALUMINOSILICATE MELTS; HIGH-RESOLUTION; THERMODYNAMIC PROPERTIES; CONFIGURATIONAL ENTROPY; COORDINATION CHEMISTRY; RAMAN-SPECTROSCOPY; NMR; MODEL	The heat capacities of two simulated high-level waste borosilicate glasses and glass melts have been determined from differential scanning calorimetry and drop-calorimetry measurements between 345 K and 1673 K. The densities of the glass melts have been measured by double-bob Archimedean method between 1273 K and 1573 K. The volume expansivity between glass transition temperature and 1573 K has been determined by combining the measured densities and density of supercooled melts below 1273 K reported previously. Both of the heat capacity and the volume expansivity of the simulated high-level waste glass melts are characterized by a large increase at the glass transition temperature and the rapid decrease with increasing temperature. The configurational contributions to the heat capacity and the volume expansivity at the glass transition temperature are 35% and 88%, respectively. The significant change of the heat capacity is probably attributed to temperature dependence of chemical mixing of boron, aluminum and silicon in the tetrahedral sites, while the change of the volume expansivity is caused by temperature-induced coordination change of boron. (C) 2014 Elsevier B.V. All rights reserved.	[Sugawara, Toru] Akita Univ, Ctr Engn Sci, Akita 0108502, Japan; [Katsuki, Junki; Shiono, Takashi; Yoshida, Satoshi; Matsuoka, Jun] Univ Shiga Prefecture, Dept Mat Sci, Hikone, Shiga 5228533, Japan; [Minami, Kazuhiro; Ochi, Eiji] Japan Nucl Fuel Ltd, Reproc Business Div, Dept Res & Dev, Rokkasho, Aomori 0393212, Japan	Sugawara, T (reprint author), Akita Univ, Ctr Engn Sci, Tegata Gakuenmachi 1-1, Akita 0108502, Japan.	toru@gipc.akita-u.ac.jp			Japan Nuclear Fuel Limited; Ministry of Economy, Trade and Industry, Japan	This work was a part of the research supported by Japan Nuclear Fuel Limited with Grant-in-Aid by the Ministry of Economy, Trade and Industry, Japan.	KIRBY RK, 1991, INT J THERMOPHYS, V12, P679, DOI 10.1007/BF00534223; Sugawara T, 2013, PHYS CHEM GLASSES-B, V54, P270; RICHET P, 1982, GEOCHIM COSMOCHIM AC, V46, P2639, DOI 10.1016/0016-7037(82)90383-0; Lee SK, 1999, AM MINERAL, V84, P937; Lange RA, 1997, CONTRIB MINERAL PETR, V130, P1, DOI 10.1007/s004100050345; Du LS, 2003, J PHYS CHEM B, V107, P10063, DOI 10.1021/jp0340481; RICHET P, 1990, PHYS CHEM MINER, V17, P385; Stebbins JF, 1996, J AM CERAM SOC, V79, P2247, DOI 10.1111/j.1151-2916.1996.tb08969.x; FURUKAWA GT, 1956, J RES NAT BUR STAND, V57, P67, DOI 10.6028/jres.057.008; Kiczenski TJ, 2005, J NON-CRYST SOLIDS, V351, P3571, DOI [10.1016/j.jnoncrysol.2005.09.026, 10.1016/j.noncrysol.2005.09.026]; Richet P, 1997, J NON-CRYST SOLIDS, V211, P271, DOI 10.1016/S0022-3093(96)00646-1; Dubinsky EV, 2006, AM MINERAL, V91, P753, DOI 10.2138/am.2006.2039; Toplis MJ, 1997, AM MINERAL, V82, P979; RICHET P, 1985, GEOCHIM COSMOCHIM AC, V49, P471, DOI 10.1016/0016-7037(85)90039-0; Lange RA, 1996, GEOCHIM COSMOCHIM AC, V60, P4989, DOI 10.1016/S0016-7037(96)00301-8; BOCKRIS JO, 1956, T FARADAY SOC, V52, P299, DOI 10.1039/tf9565200299; RICHET P, 1991, J GEOPHYS RES-SOLID, V96, P445, DOI 10.1029/90JB02172; Toplis MJ, 2000, CONTRIB MINERAL PETR, V139, P672, DOI 10.1007/s004100000171; STEBBINS JF, 1987, NATURE, V330, P465, DOI 10.1038/330465a0; Stebbins JF, 2008, CHEM GEOL, V256, P80, DOI 10.1016/j.chemgeo.2008.03.011; RICHET P, 1986, REV GEOPHYS, V24, P1, DOI 10.1029/RG024i001p00001; Farges F, 1996, GEOCHIM COSMOCHIM AC, V60, P3039, DOI 10.1016/0016-7037(96)00145-7; Stebbins JF, 2008, GEOCHIM COSMOCHIM AC, V72, P910, DOI 10.1016/j.gca.2007.11.018; Greaves GN, 2007, ADV PHYS, V56, P1, DOI 10.1080/00018730601147426; MCMILLAN PF, 1994, GEOCHIM COSMOCHIM AC, V58, P3653, DOI 10.1016/0016-7037(94)90156-2; MAEKAWA H, 1991, J NON-CRYST SOLIDS, V127, P53, DOI 10.1016/0022-3093(91)90400-Z; MYSEN BO, 1982, REV GEOPHYS, V20, P353, DOI 10.1029/RG020i003p00353; RICHET P, 1987, CHEM GEOL, V62, P111, DOI 10.1016/0009-2541(87)90062-3; STEBBINS JF, 1991, NATURE, V351, P638, DOI 10.1038/351638a0; Wu JS, 2010, J NON-CRYST SOLIDS, V356, P2097, DOI 10.1016/j.jnoncrysol.2010.08.015; Barth N., 2012, J ENG MATER-T ASME, V134, P1; Bouhifd MA, 1999, GEOCHIM COSMOCHIM AC, V63, P2429; Bruckner R., 1970, Journal of Non-Crystalline Solids, V5, DOI 10.1016/0022-3093(70)90190-0; Farges F, 1996, GEOCHIM COSMOCHIM AC, V60, P3055, DOI 10.1016/0016-7037(96)00146-9; Gan H, 1996, GEOCHIM COSMOCHIM AC, V60, P4123; Ghiorso MS, 2004, AM J SCI, V304, P679, DOI 10.2475/ajs.304.8-9.679; GINNINGS DC, 1947, J RES NAT BUR STAND, V38, P583; Gottsmann J, 2000, CONTRIB MINERAL PETR, V139, P127, DOI 10.1007/PL00007666; GREAVES GN, 1991, PHILOS MAG A, V64, P1059; Heidtkamp G., 1936, GLASTECH BER, V14, P89; IGARASHI H, 1991, GLASS TECHNOL, V32, P206; Islam MM, 2010, PHYS CHEM GLASSES-B, V51, P137; Japan Atomic Energy Agency, 2007, REP INN VIABL NUCL E, P37; Kawamura Takumi, 2008, Transactions of the Atomic Energy Society of Japan, V7; Knacke O., 1991, THERMOCHEMICAL PROPE; KNOCHE R, 1994, CHEM GEOL, V116, P1, DOI 10.1016/0009-2541(94)90154-6; KNOCHE R, 1992, GEOCHIM COSMOCHIM AC, V56, P689, DOI 10.1016/0016-7037(92)90090-6; LANGE RA, 1987, GEOCHIM COSMOCHIM AC, V51, P2931, DOI 10.1016/0016-7037(87)90368-1; LARKIN MJ, 1986, NUCL ENERG-J BR NUCL, V25, P343; Linard Y, 2008, J NON-CRYST SOLIDS, V354, P4917, DOI 10.1016/j.jnoncrysol.2008.07.013; Linard Y., 2000, CEAR5928; Linard Y., 2002, J JAPANESE SOC CAL, V29, P122; Liu Q, 2001, GEOCHIM COSMOCHIM AC, V65, P2379, DOI 10.1016/S0016-7037(01)00565-8; Lutze W., 1988, RADIOACTIVE WASTE FO; Mysen B.O., 2005, SILICATE GLASSES MEL; NAPOLITA.A, 1965, J AM CERAM SOC, V48, P613, DOI 10.1111/j.1151-2916.1965.tb14690.x; Ojovan M. I., 2005, INTRO NUCL WASTE IMM; Potuzak M, 2006, GEOCHIM COSMOCHIM AC, V70, P3059, DOI 10.1016/j.gca.2006.03.013; RICHET P, 1984, EARTH PLANET SC LETT, V67, P415, DOI 10.1016/0012-821X(84)90179-1; RICHET P, 1991, EUR J MINERAL, V3, P475; RICHET P, 1992, ADV PHYS GEOCHEM, V11, P132; RICHET P, 1984, J AM CERAM SOC, V67, pC6; RIEBLING EF, 1967, J AM CERAM SOC, V50, P46, DOI 10.1111/j.1151-2916.1967.tb14970.x; Sasek L., 1972, SB VYS SK CHEM TEC L, VL2, P217; SAVITSKY E, 1978, PHYS METALLURGY PLAT; SEIFERT FA, 1981, GEOCHIM COSMOCHIM AC, V45, P1879, DOI 10.1016/0016-7037(81)90017-X; Sugawara T, 2013, J CERAM SOC JPN, V121, P972, DOI 10.2109/jcersj2.121.972; Tangeman JA, 1998, PHYS CHEM MINER, V26, P83, DOI 10.1007/s002690050164; Vernaz E, 2012, COMPREHENSIVE NUCLEAR MATERIALS, VOL 5: MATERIAL PERFORMANCE AND CORROSION/WASTE MATERIALS, P451; Yano T, 2003, J NON-CRYST SOLIDS, V321, P157, DOI 10.1016/S0022-3093(03)00160-1	70	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0022-3115	1873-4820		J NUCL MATER	J. Nucl. Mater.	NOV	2014	454	1-3					298	307		10.1016/j.jnucmat.2014.07.055		10	Materials Science, Multidisciplinary; Nuclear Science & Technology; Mining & Mineral Processing	Materials Science; Nuclear Science & Technology; Mining & Mineral Processing	AS7IA	WOS:000344428900041		
J	Inoue, K; Gibbs, SL; Liu, FB; Lee, JH; Xie, Y; Ashitate, Y; Fujii, H; Frangioni, JV; Choi, HS				Inoue, Kazumasa; Gibbs, Summer L.; Liu, Fangbing; Lee, Jeong Heon; Xie, Yang; Ashitate, Yoshitomo; Fujii, Hirofumi; Frangioni, John V.; Choi, Hak Soo			Microscopic Validation of Macroscopic In Vivo Images Enabled by Same-Slide Optical and Nuclear Fusion	JOURNAL OF NUCLEAR MEDICINE			English	Article						molecular and cellular basis of signal; multimodality imaging; fiducial marker; autoradiography; NIR fluorescence; HE staining	NEAR-INFRARED FLUOROPHORES; PROSTATE-CANCER; PHOSPHOR; AUTORADIOGRAPHY; SYSTEM; SPECT; PET	It is currently difficult to determine the molecular and cellular basis for radioscintigraphic signals obtained during macroscopic in vivo imaging. The field is in need of technology that helps bridge the macroscopic and microscopic regimes. To solve this problem, we developed a fiducial marker (FM) simultaneously compatible with 2-color near-infrared (NIR) fluorescence (700 and 800 nm), autoradiography, and conventional hematoxylin eosin (HE) histology. Methods: The FM was constructed from an optimized concentration of commercially available human serum albumin, 700- and 800-nm NIR fluorophores, Tc-99m-pertechnetate, dimethyl sulfoxide, and glutaraldehyde. Lymphangioleiomyomatosis cells coexpressing the sodium iodide symporter and green fluorescent protein were labeled with 700-nm fluorophore and Tc-99m-pertechnatate and then administered intratracheally into CD-1 mice. After in vivo SPECT imaging and ex vivo SPECT and NIR fluorescence imaging of the lungs, 30-mu m frozen sections were prepared and processed for 800-nm NIR fluorophore costaining, autoradiography, and HE staining on the same slide using the FMs to coregister all datasets. Results: Optimized FMs, composed of 100 mu M unlabeled human serum albumin, 1 mu M NIR fluorescent human serum albumin, 15% dimethyl sulfoxide, and 3% glutaraldehyde in phosphate-buffered saline (pH 7.4), were prepared within 15 min, displayed homogeneity and stability, and were visible by all imaging modalities, including HE staining. Using these FMs, tissue displaying high signal by SPECT could be dissected and analyzed on the same slide and at the microscopic level for 700-nm NIR fluorescence, 800-nm NIR fluorescence, autoradiography, and HE histopathologic staining. Conclusion: When multimodal FMs are combined with a new technique for simultaneous same-slide NIR fluorescence imaging, autoradiography, and HE staining, macroscopic in vivo images can now be studied unambiguously at the microscopic level.	[Inoue, Kazumasa; Gibbs, Summer L.; Liu, Fangbing; Lee, Jeong Heon; Xie, Yang; Ashitate, Yoshitomo; Frangioni, John V.; Choi, Hak Soo] Beth Israel Deaconess Med Ctr, Dept Med, Div Hematol Oncol, Boston, MA 02215 USA; [Inoue, Kazumasa; Gibbs, Summer L.; Liu, Fangbing; Lee, Jeong Heon; Xie, Yang; Ashitate, Yoshitomo; Frangioni, John V.; Choi, Hak Soo] Harvard Univ, Sch Med, Boston, MA USA; [Inoue, Kazumasa] Tokyo Metropolitan Univ, Dept Radiol Sci, Tokyo 158, Japan; [Fujii, Hirofumi] Natl Canc Ctr Hosp East, Funct Imaging Div, Res Ctr Innovat Oncol, Chiba, Japan; [Frangioni, John V.] Beth Israel Deaconess Med Ctr, Dept Radiol, Boston, MA 02215 USA; [Frangioni, John V.] Curadel LLC, Worcester, MA USA	Choi, HS (reprint author), Beth Israel Deaconess Med Ctr, Room SL-436A,330 Brookline Ave, Boston, MA 02215 USA.	hchoi@bidmc.harvard.edu	Choi, Hak Soo/C-9954-2011		National Institutes of Health (NCI) [R01-CA-134493]; National Institutes of Health (NIBIB) [R01-EB-010022, R01-EB-011523]; Tuberous Sclerosis Alliance	The costs of publication of this article were defrayed in part by the payment of page charges. Therefore, and solely to indicate this fact, this article is hereby marked "advertisement" in accordance with 18 USC section 1734. Dr. Frangioni is currently CEO of Curadel, LLC, a for-profit company that has licensed FLARE technology from Beth Israel Deaconess Medical Center. This study was supported by grants from the National Institutes of Health (NCI grant R01-CA-134493, NIBIB grant R01-EB-010022, and NIBIB grant R01-EB-011523) and by a grant from the Tuberous Sclerosis Alliance. The views expressed are solely those of the authors and do not necessarily reflect those of the National Institutes of Health. No other potential conflict of interest relevant to this article was reported.	Ankle Madhuri R, 2011, J Oral Maxillofac Pathol, V15, P161, DOI 10.4103/0973-029X.84482; De Saint-Hubert M, 2009, METHODS, V48, P178, DOI 10.1016/j.ymeth.2009.03.022; Muller C, 2008, J NUCL MED, V49, P310, DOI 10.2967/jnumed.107.045856; Bengel FM, 2005, EUR J NUCL MED MOL I, V32, pS404, DOI 10.1007/s00259-005-1898-5; Abasolo I, 2009, EUR J NUCL MED MOL I, V36, P1156, DOI 10.1007/s00259-009-1083-3; Hyun H, 2012, CONTRAST MEDIA MOL I, V7, P516, DOI 10.1002/cmmi.1484; Oka S, 2007, J NUCL MED, V48, P46; Tanaka E, 2006, ANN SURG ONCOL, V13, P1671, DOI 10.1245/s10434-006-9194-6; Seo JH, 2010, J NUCL MED, V51, P1637, DOI 10.2967/jnumed.110.077891; Choi HS, 2011, ANGEW CHEM INT EDIT, V50, P6258, DOI 10.1002/anie.201102459; Troyan SL, 2009, ANN SURG ONCOL, V16, P2943, DOI 10.1245/s10434-009-0594-2; Zhang R, 2011, J NUCL MED, V52, P958, DOI 10.2967/jnumed.110.083220; Buckle T, 2010, NANOTECHNOLOGY, V21, DOI 10.1088/0957-4484/21/35/355101; Axente M, 2011, J NUCL MED, V52, P1621, DOI 10.2967/jnumed.111.091595; Chen LY, 2009, IEEE T NUCL SCI, V56, P2628, DOI 10.1109/TNS.2009.2023519; Chen LY, 2008, J NUCL MED, V49, P1141, DOI 10.2967/jnumed.107.040568; Humm JL, 2003, MED PHYS, V30, P2303, DOI 10.1118/1.1600738; Knol RJJ, 2008, J NEUROSCI METH, V168, P341, DOI 10.1016/j.jneumeth.2007.10.028; Liu F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038589; Miller BW, 2008, NUCL INSTRUM METH A, V591, P272, DOI 10.1016/j.nima.2008.03.072; Patil V, 2012, EUR J NUCL MED MOL I, V39, P824, DOI 10.1007/s00259-011-2050-3; Valencia JC, 2006, AM J RESP CELL MOL, V35, P40, DOI 10.1165/rcmb.2005-03870C; Wuest M, 2011, NUCL MED BIOL, V38, P461, DOI 10.1016/j.nucmedbio.2010.11.004	23	0	0	SOC NUCLEAR MEDICINE INC	RESTON	1850 SAMUEL MORSE DR, RESTON, VA 20190-5316 USA	0161-5505	1535-5667		J NUCL MED	J. Nucl. Med.	NOV	2014	55	11					1899	1904		10.2967/jnumed.114.141606		6	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	AS3XT	WOS:000344209200023		
J	Kinoshita, S; Noda, K; Tagawa, Y; Inafuku, S; Dong, YK; Fukuhara, J; Dong, ZY; Ando, R; Kanda, A; Ishida, S				Kinoshita, Satoshi; Noda, Kousuke; Tagawa, Yoshiaki; Inafuku, Saori; Dong, Yoko; Fukuhara, Junichi; Dong, Zhenyu; Ando, Ryo; Kanda, Atsuhiro; Ishida, Susumu			Genistein attenuates choroidal neovascularization	JOURNAL OF NUTRITIONAL BIOCHEMISTRY			English	Article						Genistein; Flavonoid; Choroidal neovascularization; Age-related macular Degeneration; Matrix metalloproteinase-9	AGE-RELATED MACULOPATHY; ENDOTHELIAL GROWTH-FACTOR; BLUE-MOUNTAINS-EYE; MACULAR DEGENERATION; MATRIX METALLOPROTEINASES; JAPANESE POPULATION; VASCULAR INFLAMMATION; RISK-FACTORS; CEREBROVASCULAR ACCIDENTS; CLINICAL-TRIAL	Genistein is a dietary-derived flavonoid abundantly present in soybeans and known to possess various biological effects including anti-inflammation and anti-angiogenic activity. To investigate the effects of genistein on intraocular neovascularization, we used an animal model of laser-induced choroidal neovascularization (CNV). Male C57BL/6J mice were treated in accordance with the ARVO Statement for the Use of Animals in Ophthalmic and Vision Research. CNV was induced by laser photocoagulation. The animals were fed a mixture diet containing 0.5% genistein or a control diet ad libitum for 7 days before laser photocoagulation and the treatment was continued until the end of the study. Seven days after laser injury, the size of CNV lesions was quantified. Retinal pigment epithelium (RPE)-choroid complex was also harvested 1 or 3 days after laser injury and the level of monocyte chemoattractant protein (MCP)-1, intercellular adhesion molecule (ICAM)-1, and matrix metalloproteinase (MMP)-9 were measured by enzyme-linked immunosorbent assay. Expression levels of Ets-1 and F4/80 were examined by real-time PCR. A significant decrease in CNV size was observed in animals treated with genistein (15441.9+/-1511.8 mu m(2)) compared to control mice (21074.0+/-1940.7 mu m(2), P<.05). Genistein significantly reduced the protein level of MCP-1, ICAM-1, and MMP-9 in the RPE-choroid complex (P<.05). In addition, genistein suppressed the expression levels of Ets-1 and F4/80 (P<.05). The current data indicate the anti-angiogenic property of genistein during CNV formation. (C) 2014 Elsevier Inc. All rights reserved.	[Kinoshita, Satoshi; Noda, Kousuke; Tagawa, Yoshiaki; Inafuku, Saori; Dong, Yoko; Fukuhara, Junichi; Dong, Zhenyu; Ando, Ryo; Kanda, Atsuhiro; Ishida, Susumu] Hokkaido Univ, Grad Sch Med, Dept Ophthalmol, Lab Ocular Cell Biol & Visual Sci, Sapporo, Hokkaido 0608638, Japan	Noda, K (reprint author), Hokkaido Univ, Grad Sch Med, Dept Ophthalmol, Kita Ku, North 15,West 7, Sapporo, Hokkaido 0608638, Japan.	nodako@med.hokudai.ac.jp			Japanese Ministry of Agriculture, Forestry and Fisheries [24390392]	This study was supported by the Japanese Ministry of Agriculture, Forestry and Fisheries (Grant-in-Aid for Scientific Research [No. 24390392]). The authors wish to thank Ikuyo Hirose, Shiho Yoshida and Erdal Tan Ishizuka for their skillful technical assistance in this project.	Chew EY, 2013, JAMA-J AM MED ASSOC, V309, P2005, DOI 10.1001/jama.2013.4997; Kassoff A, 2001, ARCH OPHTHALMOL-CHIC, V119, P1417; Verdrengh M, 2003, INFLAMM RES, V52, P341, DOI 10.1007/s00011-003-1182-8; Zhang HP, 2013, ARCH MED RES, V44, P13, DOI 10.1016/j.arcmed.2012.12.001; Kwak N, 2000, INVEST OPHTH VIS SCI, V41, P3158; Hong T, 2013, OPHTHALMOLOGY, V120, P2091, DOI 10.1016/j.ophtha.2013.03.032; Singh AV, 2006, CANCER RES, V66, P1851, DOI 10.1158/0008-5472.CAN-05-1332; Pepper MS, 2001, ARTERIOSCL THROM VAS, V21, P1104, DOI 10.1161/hq0701.093685; Lambert V, 2002, AM J PATHOL, V161, P1247, DOI 10.1016/S0002-9440(10)64401-X; Zhan YM, 2005, J CLIN INVEST, V115, P2508, DOI 10.1172/JCI24403; Kawasaki R, 2008, OPHTHALMOLOGY, V115, P1376, DOI 10.1016/j.ophtha.2007.11.015; Oda N, 1999, J CELL PHYSIOL, V178, P121, DOI 10.1002/(SICI)1097-4652(199902)178:2<121::AID-JCP1>3.0.CO;2-F; Van der Reis MI, 2011, RETINA-J RET VIT DIS, V31, P1449, DOI 10.1097/IAE.0b013e3182278ab4; Vu TH, 2000, GENE DEV, V14, P2123, DOI 10.1101/gad.815400; Oshima Y, 2001, BRIT J OPHTHALMOL, V85, P1153, DOI 10.1136/bjo.85.10.1153; LEUNG DW, 1989, SCIENCE, V246, P1306, DOI 10.1126/science.2479986; Babu PVA, 2012, J NUTR, V142, P724, DOI 10.3945/jn.111.152322; FERRARA N, 1989, BIOCHEM BIOPH RES CO, V161, P851, DOI 10.1016/0006-291X(89)92678-8; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Sakurai E, 2003, INVEST OPHTH VIS SCI, V44, P2743, DOI 10.1167/iovs.02-1246; SENGER DR, 1983, SCIENCE, V219, P983, DOI 10.1126/science.6823562; Hiraoka N, 1998, CELL, V95, P365, DOI 10.1016/S0092-8674(00)81768-7; Watanabe D, 2004, AM J PATHOL, V164, P1827, DOI 10.1016/S0002-9440(10)63741-8; Yasuda M, 2009, OPHTHALMOLOGY, V116, P2135, DOI 10.1016/j.ophtha.2009.04.017; MITCHELL P, 1995, OPHTHALMOLOGY, V102, P1450; Heier JS, 2012, OPHTHALMOLOGY, V119, P2537, DOI 10.1016/j.ophtha.2012.09.006; Aoki T, 2010, GENE THER, V17, P1117, DOI 10.1038/gt.2010.60; Rosenfeld PJ, 2006, NEW ENGL J MED, V355, P1419, DOI 10.1056/NEJMoa054481; Bressler NM, 2012, RETINA-J RET VIT DIS, V32, P1821, DOI 10.1097/IAE.0b013e31825db6ba; Oettgen P, 2006, CIRC RES, V99, P1159, DOI 10.1161/01.RES.0000251056.85990.db; de Launoit Y, 1998, ONCOGENE, V16, P2065, DOI 10.1038/sj.onc.1201726; Rofagha S, 2013, OPHTHALMOLOGY, V120, P2292, DOI 10.1016/j.ophtha.2013.03.046; Brown DM, 2006, NEW ENGL J MED, V355, P1432, DOI 10.1056/NEJMoa062655; Rundhaug JE, 2005, J CELL MOL MED, V9, P267, DOI 10.1111/j.1582-4934.2005.tb00355.x; Gragoudas ES, 2004, NEW ENGL J MED, V351, P2805, DOI 10.1056/NEJMoa042760; Tsutsumi C, 2003, J LEUKOCYTE BIOL, V74, P25, DOI 10.1189/jlb.0902436; SOMMER A, 1991, NEW ENGL J MED, V325, P1412, DOI 10.1056/NEJM199111143252004; Zhang YJ, 2012, INFLAMMATION, V35, P377, DOI 10.1007/s10753-011-9365-x; VanNewkirk MR, 2000, OPHTHALMOLOGY, V107, P1593, DOI 10.1016/S0161-6420(00)00175-5; Kiriakidis S, 2005, BRIT J NUTR, V93, P317, DOI 10.1079/BJN20041330; Hanahan D, 1996, CELL, V86, P353, DOI 10.1016/S0092-8674(00)80108-7; Cho HY, 2011, NUTR RES PRACT, V5, P381, DOI 10.4162/nrp.2011.5.5.381; Gu Y, 2005, WORLD J GASTROENTERO, V11, P6512; Hoffmann S, 2006, RETINA-J RET VIT DIS, V26, P454, DOI 10.1097/00006982-200604000-00012; Lambert V, 2003, FASEB J, V17, P2290, DOI 10.1096/fj.03-0113fje; Lois N, 2013, RETINA-J RET VIT DIS, V33, P13, DOI 10.1097/IAE.0b013e3182657fff; Majji AB, 1999, INVEST OPHTH VIS SCI, V40, P1477; Miyazaki M, 2003, BRIT J OPHTHALMOL, V87, P469, DOI 10.1136/bjo.87.4.469; Miyazaki M, 2005, INVEST OPHTH VIS SCI, V46, P1907, DOI 10.1167/iovs.04-0923; Moorthy S, 2009, OPHTHALMOLOGY, V116, P1834, DOI 10.1016/j.ophtha.2009.04.008; Schmack I, 2009, MOL VIS, V15, P146; Yockell-Lelievre J, 2009, BIOCHEM CELL BIOL, V87, P905, DOI [10.1139/o09-055, 10.1139/O09-055]	52	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0955-2863	1873-4847		J NUTR BIOCHEM	J. Nutr. Biochem.	NOV	2014	25	11					1177	1182		10.1016/j.jnutbio.2014.06.004		6	Biochemistry & Molecular Biology; Nutrition & Dietetics	Biochemistry & Molecular Biology; Nutrition & Dietetics	AS3WI	WOS:000344205600009		
J	Nagai, N; Kubota, S; Tsubota, K; Ozawa, Y				Nagai, Norihiro; Kubota, Shunsuke; Tsubota, Kazuo; Ozawa, Yoko			Resveratrol prevents the development of choroidal neovascularization by modulating AMP-activated protein kinase in macrophages and other cell types	JOURNAL OF NUTRITIONAL BIOCHEMISTRY			English	Article						Retina; AMPK; Inflammation; Macrophage; Neovascularization; Resveratrol	ENDOTHELIAL GROWTH-FACTOR; EMERGING DRUG TARGET; MACULAR DEGENERATION; CLINICAL-TRIAL; EYE DISEASE; INHIBITION; ANGIOGENESIS; MICE; INFLAMMATION; RANIBIZUMAB	The development of choroidal neovascularization (CNV) is a critical step in the pathogenesis of age-related macular degeneration (AMD), a vision-threatening disease. In this study, we used a mouse model of AMD to study the protective effects of resveratrol (RSV) supplementation against CNV as well as the underlying molecular mechanisms. Mice were orally pretreated with RSV daily for 5 days. On the fifth day, the mice underwent laser photocoagulation to induce CNV. One week after laser treatment, CNV volume was significantly lower in the RSV-treated mice compared with vehicle-treated animals. In addition, RSV treatment significantly inhibited macrophage infiltration into the retinal pigment epithelium (RPE)-choroid and suppressed the expression of inflammatory and angiogenic molecules, including vascular endothelial growth factor, monocyte chemotactic protein-1 and intercellular adhesion molecule-1. Importantly, RSV prevented the CNV-induced decrease in activated AMP-activated protein kinase and increase in activated nuclear factor-kappa B in the RPE-choroid complex. The regulatory effects of RSV on these molecules were confirmed in RPE, microvascular endothelial and macrophage cell lines. Inhibition of macrophage infiltration by RSV was confirmed by in vitro scratch and migration assays. RSV suppressed CNV development, reducing the levels of multiple cytokines secreted from several cell types and inhibiting macrophage migration. The direct effects of RSV on each cell type were confirmed in vitro. Although further studies are needed, RSV could potentially be applied in the clinic to prevent CNV development in AMD. (C) 2014 The Authors. Published by Elsevier Inc.	[Nagai, Norihiro; Kubota, Shunsuke; Ozawa, Yoko] Keio Univ, Sch Med, Lab Retinal Cell Biol, Tokyo 1608582, Japan; [Nagai, Norihiro; Kubota, Shunsuke; Tsubota, Kazuo; Ozawa, Yoko] Keio Univ, Sch Med, Dept Ophthalmol, Tokyo 1608582, Japan	Ozawa, Y (reprint author), Keio Univ, Sch Med, Dept Ophthalmol, Lab Retinal Cell Biol,Shinjuku Ku, 35 Shinanomachi, Tokyo 1608582, Japan.	ozawa@a5.keio.jp					Giri S, 2004, J NEUROSCI, V24, P479, DOI 10.1523/JNEUROSCI.4288-03.2004; Lavalette S, 2011, AM J PATHOL, V178, P2416, DOI 10.1016/j.ajpath.2011.01.013; Imler TJ, 2009, INT IMMUNOPHARMACOL, V9, P134, DOI 10.1016/j.intimp.2008.10.015; Lin MT, 2003, MOL PHARMACOL, V64, P1029, DOI 10.1124/mol.64.5.1029; Hung LM, 2004, FREE RADICAL BIO MED, V36, P774, DOI 10.1016/j.freeradbiomed.2003.12.016; Radisavljevic Z, 2000, J BIOL CHEM, V275, P20770, DOI 10.1074/jbc.M002448200; Nishijima K, 2007, AM J PATHOL, V171, P53, DOI 10.2353/ajpath.2007.061237; KILLINGSWORTH MC, 1990, EYE, V4, P613; Zhao X, 2008, AM J PHYSIOL-LUNG C, V295, pL497, DOI 10.1152/ajplung.90210.2008; Grisanti S, 2008, PROG RETIN EYE RES, V27, P372, DOI 10.1016/j.preteyeres.2008.05.002; Izumi-Nagai K, 2007, ARTERIOSCL THROM VAS, V27, P2555, DOI 10.1161/ATVBAHA.107.151431; Nowak JZ, 2006, PHARMACOL REP, V58, P353; [Anonymous], 2013, JAMA, V309, P2005; Zhao H, 2013, INVEST OPHTH VIS SCI, V54, P5321, DOI 10.1167/iovs.13-12122; Nagai N, 2006, ARTERIOSCL THROM VAS, V26, P2252, DOI 10.1161/01.ATV.0000240050.15321.fe; Salminen A, 2011, J MOL MED, V89, P667, DOI 10.1007/s00109-011-0748-0; Hirano Y, 2010, INVEST OPHTH VIS SCI, V51, P508, DOI 10.1167/iovs.09-3457; Izumi-Nagai K, 2007, AM J PATHOL, V170, P2149, DOI 10.2353/ajpath.2007.061018; Kubota S, 2011, INVEST OPHTH VIS SCI, V52, P9142, DOI 10.1167/iovs.11-8041; Sakurai E, 2003, INVEST OPHTH VIS SCI, V44, P2743, DOI 10.1167/iovs.02-1246; Pilon G, 2004, J BIOL CHEM, V279, P20767, DOI 10.1074/jbc.M401390200; Dasgupta B, 2007, P NATL ACAD SCI USA, V104, P7217, DOI 10.1073/pnas.0610068104; Heier JS, 2012, OPHTHALMOLOGY, V119, P2537, DOI 10.1016/j.ophtha.2012.09.006; Satofuka S, 2008, AM J PATHOL, V173, P1911, DOI 10.2353/ajpath.2008.080457; Kanamori H, 2013, AM J PATHOL, V182, P701, DOI 10.1016/j.ajpath.2012.11.009; Rosenfeld PJ, 2006, NEW ENGL J MED, V355, P1419, DOI 10.1056/NEJMoa054481; Bai AP, 2010, J PHARMACOL EXP THER, V333, P717, DOI 10.1124/jpet.109.164954; Jang MS, 1997, SCIENCE, V275, P218, DOI 10.1126/science.275.5297.218; Sheu SJ, 2013, INVEST OPHTH VIS SCI, V54, P6426, DOI 10.1167/iovs.13-12024; Suzuki M, 2012, J CELL SCI, V125, P2407, DOI 10.1242/jcs.097683; Srivastava RAK, 2012, J LIPID RES, V53, P2490, DOI 10.1194/jlr.R025882; Sakurai E, 2003, INVEST OPHTH VIS SCI, V44, P3578, DOI 10.1167/iovs.03-0097; Baur JA, 2006, NATURE, V444, P337, DOI 10.1038/nature05354; Brown DM, 2006, NEW ENGL J MED, V355, P1432, DOI 10.1056/NEJMoa062655; Kim D, 2007, EMBO J, V26, P3169, DOI 10.1038/sj.emboj.7601758; Norata GD, 2007, ATHEROSCLEROSIS, V191, P265, DOI 10.1016/j.atherosclerosis.2006.05.047; Izumi-Nagai K, 2008, INVEST OPHTH VIS SCI, V49, P1679, DOI 10.1167/iovs.07-1426; Lin JN, 2010, J AGR FOOD CHEM, V58, P1584, DOI 10.1021/jf9035782; Tsutsumi C, 2003, J LEUKOCYTE BIOL, V74, P25, DOI 10.1189/jlb.0902436; Frampton JE, 2013, DRUG AGING, V30, P331, DOI 10.1007/s40266-013-0077-9; Saint-Geniez M, 2009, P NATL ACAD SCI USA, V106, P18751, DOI 10.1073/pnas.0905010106; Khan AA, 2010, AM J PATHOL, V177, P481, DOI 10.2353/ajpath.2010.090836; Zhang BB, 2009, CELL METAB, V9, P407, DOI 10.1016/j.cmet.2009.03.012; Nagai N, 2007, INVEST OPHTH VIS SCI, V48, P2321, DOI 10.1167/iovs.06-1296; Kubota S, 2010, AM J PATHOL, V177, P1725, DOI [10.2353/ajpath.2010.100098, 10.2355/ajpath.2010.100098]; [Anonymous], 2001, ARCH OPHTHALMOL, V119, P1439; Ferguson TA, 2008, SEMIN IMMUNOPATHOL, V30, P111, DOI 10.1007/s00281-008-0113-8; Ungvari Z, 2007, AM J PHYSIOL-HEART C, V292, pH2417, DOI 10.1152/ajpheart.01258.2006; Apte RS, 2006, PLOS MED, V3, P1371, DOI 10.1371/journal.pmed.0030310; Bressler Neil M, 2004, JAMA, V291, P1900, DOI 10.1001/jama.291.15.1900; Caputo M, 2011, CURR DRUG TARGETS, V12, P234, DOI 10.2174/138945011794182791; Dolinsky VW, 1832, BIOCHIM BIOPHYS ACTA, V2013, P1723; Mochimaru H, 2007, INVEST OPHTH VIS SCI, V48, P4795, DOI 10.1167/iovs.07-0425; Ochoa O, 2007, AM J PHYSIOL-REG I, V293, pR651, DOI 10.1152/ajpregu.00069.2007; Suzuki M, 2014, BR J OPHTHA IN PRESS; Suzuki M, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-176; VANDERSCHAFT TL, 1993, BRIT J OPHTHALMOL, V77, P657, DOI 10.1136/bjo.77.10.657; Yamada K, 2007, INVEST OPHTH VIS SCI, V48, P1839, DOI 10.1167/iovs.06-1085; Zong Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044107	59	6	7	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0955-2863	1873-4847		J NUTR BIOCHEM	J. Nutr. Biochem.	NOV	2014	25	11					1218	1225		10.1016/j.jnutbio.2014.05.015		8	Biochemistry & Molecular Biology; Nutrition & Dietetics	Biochemistry & Molecular Biology; Nutrition & Dietetics	AS3WI	WOS:000344205600013		
J	Matsubara, S; Takahashi, Y; Yoshiba, T; Usui, R; Koike, Y				Matsubara, S.; Takahashi, Y.; Yoshiba, T.; Usui, R.; Koike, Y.			Reduced fetal movements at 27 weeks: An alarm for maternal-fetal listeriosis?	JOURNAL OF OBSTETRICS AND GYNAECOLOGY			English	Editorial Material									[Matsubara, S.; Takahashi, Y.; Yoshiba, T.; Usui, R.] Jichi Med Univ, Dept Obstet & Gynecol, Shimotsuke, Tochigi 3290498, Japan; [Koike, Y.] Jichi Med Univ, Shimotsuke, Tochigi 3290498, Japan	Matsubara, S (reprint author), Jichi Med Univ, Dept Obstet & Gynecol, 3311-1 Yakushiji, Shimotsuke, Tochigi 3290498, Japan.	matsushi@jichi.ac.jp					Winje BA, 2011, BJOG-INT J OBSTET GY, V118, P1229, DOI 10.1111/j.1471-0528.2011.02993.x; Daly N, 2011, EUR J OBSTET GYN R B, V159, P57, DOI 10.1016/j.ejogrb.2011.07.002; Matsubara S, 2013, ACTA OBSTET GYN SCAN, V92, P1426, DOI 10.1111/aogs.12200; Tveit JVH, 2009, BMC PREGNANCY CHILDB, V9, DOI 10.1186/1471-2393-9-32	4	0	0	INFORMA HEALTHCARE	NEW YORK	52 VANDERBILT AVE, NEW YORK, NY 10017 USA	0144-3615			J OBSTET GYNAECOL	J. Obstet. Gynaecol.	NOV	2014	34	8					740	+		10.3109/01443615.2014.925859		2	Obstetrics & Gynecology	Obstetrics & Gynecology	AS5WM	WOS:000344337400021		
J	Sato, S; Nishida, M; Nasu, K; Narahara, H; Norose, K; Aosai, F				Sato, Shimpei; Nishida, Masakazu; Nasu, Kaei; Narahara, Hisashi; Norose, Kazumi; Aosai, Fumie			Congenital toxoplasmosis from a mother with type 2 diabetes mellitus: A case report	JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH			English	Article						magnetic resonance imaging; obesity; pregnancy; second trimester; visceral adiposity	FETAL TRANSMISSION; PREGNANT-WOMEN; GONDII; INFECTION; MULTICENTER; JAPAN	A 33-year-old woman with type 2 diabetes mellitus (DM) was suspected of being primarily infected with Toxoplasma gondii at 12 weeks of gestation (GW). Although acetylspiramycin was started at 17 GW, the T.gondiiDNA gene was detected in the amniotic fluid at 18 GW. Chemotherapy was changed to pyrimethamine plus sulfadiazine from 20 GW, but was changed back to acetylspiramycin after 2 weeks because of vomiting. Acetylspiramycin was continued until her delivery. DM was controlled well during the pregnancy. An asymptomatic male baby was born by cesarean section at 37 GW, and was treated with acetylspiramycin for 4 weeks because the polymerase chain reaction results of umbilical cord blood were positive. He has developed normally until the present, that is, 6 months of age. Herein, we describe a case report in which symptomatic congenital toxoplasmosis was avoided in a pregnant woman with an immunosuppressive risk due to prompt chemotherapy.	[Sato, Shimpei; Nishida, Masakazu] Nakatsu Municipal Hosp, Dept Obstet & Gynecol, Nakatsu, Oita 8718511, Japan; [Nasu, Kaei; Narahara, Hisashi] Oita Univ, Fac Med, Dept Obstet & Gynecol, Oita 87011, Japan; [Nasu, Kaei] Oita Univ, Dept Community Med, Dept Obstet & Gynecol, Oita 87011, Japan; [Norose, Kazumi; Aosai, Fumie] Chiba Univ, Grad Sch Med, Dept Infect & Host Def, Chiba, Japan	Sato, S (reprint author), Nakatsu Municipal Hosp, Dept Obstet & Gynecol, 173 Shimoikenaga, Nakatsu, Oita 8718511, Japan.	m01038ss@jichi.ac.jp					Jones JL, 2007, AM J TROP MED HYG, V77, P405; Foulon W, 1999, AM J OBSTET GYNECOL, V180, P410, DOI 10.1016/S0002-9378(99)70224-3; Minakami H, 2011, J OBSTET GYNAECOL RE, V37, P1174, DOI 10.1111/j.1447-0756.2011.01653.x; Sakikawa M, 2012, CLIN VACCINE IMMUNOL, V19, P365, DOI 10.1128/CVI.05486-11; Cook AJC, 2000, BRIT MED J, V321, P142, DOI 10.1136/bmj.321.7254.142; Tenter AM, 2000, INT J PARASITOL, V30, P1217, DOI 10.1016/S0020-7519(00)00124-7; Gokce C, 2008, NATL MED J INDIA, V21, P51; Guerina N. G., 1994, PEDIATR ANN, V23, P147; GUERINA NG, 1994, PEDIATR ANN, V23, P138; Inoue A, 1982, Jpn J Antibiot, V35, P1998; Remington JS, 2011, INFECT DIS FETUS NEW, P918, DOI 10.1016/B978-1-4160-6400-8.00031-6; Shiono Y, 2007, PARASITOL INT, V56, P141, DOI 10.1016/j.parint.2007.01.008; Wallon M, 2010, OBSTET GYNECOL, V115, P727, DOI 10.1097/AOG.0b013e3181d57b09	13	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1341-8076	1447-0756		J OBSTET GYNAECOL RE	J. Obstet. Gynaecol. Res.	NOV	2014	40	11					2158	2161		10.1111/jog.12477		4	Obstetrics & Gynecology	Obstetrics & Gynecology	AS6BZ	WOS:000344351100005		
J	Matsuura, K; Suto, C; Inoue, Y; Sasaki, S; Odawara, S; Gotou, T				Matsuura, Kazuki; Suto, Chikako; Inoue, Yoshitsugu; Sasaki, Shin-ichi; Odawara, Shoko; Gotou, Takahiro			Safety of Intracameral Injection of Moxifloxacin Using Total Replacement Technique (Bag and Chamber Flushing)	JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS			English	Article							CATARACT-SURGERY; POSTOPERATIVE ENDOPHTHALMITIS; OPHTHALMIC SOLUTION; INTRAOCULAR-LENS; FLUOROQUINOLONES; PROPHYLAXIS; 0.5-PERCENT; CELLS	Purpose: To assess the safety of intracameral injection of moxifloxacin (MFLX) using the total replacement technique [bag and chamber (BC) flushing]. Methods: The anterior chamber including the area behind the intraocular lens was irrigated and replaced using BC flushing. In Group A, 36 patients received balanced salt solution irrigation in the right eye and intracameral MFLX (150 mu g/mL: 33-fold dilution of 0.5% eye drops) in the left eye. In Group B, 33 patients received intracameral MFLX in the right (500 mu g/mL: 10-fold dilution) and left eyes (150 mu g/mL: 33-fold dilution). Visual acuity, intraocular pressure, corneal endothelial cell density, corneal thickness, and foveal thickness were recorded before and up to 3 months after surgery. Results: In either group, there were no statistically significant differences between the right and left eyes with respect to visual acuity, intraocular pressure, corneal endothelial cell count, and foveal thickness before and at 3 months after surgery. There was no difference in corneal thickness before and at 3 months after surgery. In patients who received 500 mu g/mL MFLX during surgery, central corneal thickness at 1 week after surgery was significantly reduced. Conclusions: In the present study, there was no adverse effect associated with intracameral injection of 150-500 mu g/mL MFLX. Moreover, our results supported the safety of BC flushing. Thus, BC flushing, which can irrigate the inside of the capsular bag and attain stable antibiotic concentrations, appears to be a favorable technique for intracameral injection of MFLX.	[Matsuura, Kazuki] Nojima Hosp, Dept Ophthalmol, Kurayoshi City, Japan; [Suto, Chikako] Tokyo Womens Med Univ, Dept Ophthalmol, Tokyo, Japan; [Suto, Chikako; Odawara, Shoko] Saiseikai Kurihashi Hosp, Dept Ophthalmol, Kuki, Saitama 3491105, Japan; [Inoue, Yoshitsugu; Sasaki, Shin-ichi] Tottori Univ, Fac Med, Div Ophthalmol & Visual Sci, Yonago, Tottori 683, Japan; [Gotou, Takahiro] Tottori Univ, Grad Sch Med Sci, Inst Regenerat Med & Biofunct, Div Integrat Biosci, Yonago, Tottori, Japan	Suto, C (reprint author), Saiseikai Kurihashi Hosp, Dept Ophthalmol, 714-6 Koemon, Kuki, Saitama 3491105, Japan.	chikakos@pastel.ocn.ne.jp					Koktekir BE, 2012, J OCUL PHARMACOL TH, V28, P278, DOI 10.1089/jop.2011.0132; Friling E, 2013, J CATARACT REFR SURG, V39, P15, DOI 10.1016/j.jcrs.2012.10.037; Miller D, 2006, ARCH OPHTHALMOL-CHIC, V124, P479, DOI 10.1001/archopht.124.4.479; Dalhoff A, 2005, INFECTION, V33, P55, DOI 10.1007/s15010-005-8209-8; Duggirala Aparna, 2007, Indian Journal of Ophthalmology, V55, P15; Lane SS, 2008, J CATARACT REFR SURG, V34, P1451, DOI 10.1016/j.jcrs.2008.05.034; Gao H, 2006, INVEST OPHTH VIS SCI, V47, P1606, DOI 10.1167/iovs.05-0702; Matsuura K, 2013, GRAEF ARCH CLIN EXP, V251, P81, DOI 10.1007/s00417-012-2098-1; Shalit I, 2006, J ANTIMICROB CHEMOTH, V57, P230, DOI 10.1093/jac/dki.441; Matsuura K, 2013, J CATARACT REFR SURG, V39, P1702, DOI 10.1016/j.jcrs.2013.05.036; Espiritu CRG, 2007, J CATARACT REFR SURG, V33, P63, DOI 10.1016/j.jcrs.2006.09.019; Kim SY, 2008, CLIN EXP OPHTHALMOL, V36, P367, DOI 10.1111/j.1442-9071.2008.01771.x; Arshinoff SA, 2011, J CATARACT REFR SURG, V37, P2105, DOI 10.1016/j.jcrs.2011.06.036; Arbisser LB, 2008, J CATARACT REFR SURG, V34, P1114, DOI 10.1016/j.jcrs.2008.03.017; Bennett MD, 2008, RETINA-J RET VIT DIS, V28, P976, DOI 10.1097/IAE.0b013e3181733733; Barry P, 2007, J CATARACT REFR SURG, V33, P978, DOI 10.1016/j.jcrs.2007.02.032; Hariprasad SM, 2005, ARCH OPHTHALMOL-CHIC, V123, P39, DOI 10.1001/archopht.123.1.39; Kernt M, 2009, CORNEA, V28, P553, DOI 10.1097/ICO.0b013e318191447b; Kowalski RP, 2005, AM J OPHTHALMOL, V140, P497, DOI 10.1016/j.ajo.2005.04.015; Matsuura Kazuki, 2013, Clin Ophthalmol, V7, P1397, DOI 10.2147/OPTH.S47629; Matsuura K, 2013, GRAEF ARCH CLIN EXP, V251, P1955, DOI 10.1007/s00417-013-2294-7; Metzler K, 2004, INT J ANTIMICROB AG, V24, P161, DOI 10.1016/j.ijantimicag.2004.02.021; O'Brien TP, 2007, J CATARACT REFR SURG, V33, P1790, DOI 10.1016/j.jcrs.2007.06.026; Suzuki T, 2008, J CATARACT REFR SURG, V34, P1776, DOI 10.1016/j.jcrs.2008.06.033; Suzuki T, 2005, J CATARACT REFR SURG, V31, P2019, DOI 10.1016/j.jcrs.2005.02.032	25	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	1080-7683	1557-7732		J OCUL PHARMACOL TH	J. Ocular Pharmacol. Ther.	NOV 1	2014	30	9					771	776		10.1089/jop.2014.0029		6	Ophthalmology; Pharmacology & Pharmacy	Ophthalmology; Pharmacology & Pharmacy	AS6PZ	WOS:000344386300010		
J	Essa, AAM; Yamazaki, M; Maruyama, S; Abe, T; Babkair, H; Cheng, J; Saku, T				Essa, Ahmed A. M.; Yamazaki, Manabu; Maruyama, Satoshi; Abe, Tatsuya; Babkair, Hamzah; Cheng, Jun; Saku, Takashi			Keratin pearl degradation in oral squamous cell carcinoma: reciprocal roles of neutrophils and macrophages	JOURNAL OF ORAL PATHOLOGY & MEDICINE			English	Article						keratin 17; keratin pearl degradation; macrophages; neutrophils; oral squamous cell carcinoma	TUMOR-ASSOCIATED MACROPHAGES; IN-SITU; INFLAMMATION; ACTIVATION; EXPRESSION; ELASTASE; PROTEIN; MARKER; GROWTH; CANCER	BackgroundWe have reported that neutrophilic infiltration was associated with round-shaped dyskeratosis foci, a kind of keratin pearl, of oral carcinoma in situ and that those inflammatory cells are recruited from intra-epithelially entrapped blood vessels. Based on these lines of evidence, we have formulated a hypothesis that keratin pearls are terminally degraded by neutrophils. To confirm this hypothesis, we investigated immunohistochemically stepwise degradation of keratin pearls in oral squamous cell carcinoma (SCC) to clarify any other type scavenger cells in addition to neutrophils are involved in this particular degradation process. MethodsNeutrophils (neutrophil elastase) and macrophage subpopulations (CD68, CD163 and CD204) were immunohistochemically localized in 30 cases of oral SCC with typical round-shaped keratin pearls. SCC cells were revealed by immunohistochemistry for keratin (K) 17, and blood vessels were demonstrated by CD31. ResultsKeratin pearl degradation process was divided into four steps: (i) intact stage: no macrophage infiltration but minimal neutrophils were found in keratin pearls; (ii) neutrophil recruit stage: no macrophage infiltration but focal neutrophilic infiltration within the pearls; (iii) neutrophil predominant stage: dense neutrophil infiltration with minimal macrophages and segregated keratinized cancer cells strongly positive for K17; and (iv) macrophage predominant stage: dense infiltration of CD68-, CD163 (mononuclear)- and CD204 (multinucleated)-positive macrophages engulfing detached keratinized SCC cells. ConclusionKeratin pearl degradation in oral SCC is strictly regulated by two types of scavenger cells: neutrophils, which perform initial tasks, and macrophages, which reciprocally take over from neutrophils the role to finalize the degradation processes.	[Essa, Ahmed A. M.; Yamazaki, Manabu; Abe, Tatsuya; Babkair, Hamzah; Cheng, Jun; Saku, Takashi] Niigata Univ, Grad Sch Med & Dent Sci, Dept Tissue Regenerat & Reconstruct, Div Oral Pathol, Niigata 9518514, Japan; [Essa, Ahmed A. M.] Tanta Univ, Fac Dent, Dept Oral Pathol, Tanta, Egypt; [Maruyama, Satoshi; Abe, Tatsuya; Saku, Takashi] Niigata Univ Hosp, Dept Surg Pathol, Oral Pathol Sect, Niigata, Japan	Saku, T (reprint author), Niigata Univ, Grad Sch Med & Dent Sci, Dept Tissue Regenerat & Reconstruct, Div Oral Pathol,Chuo Ku, 2-5274 Gakkocho Dori, Niigata 9518514, Japan.	tsaku@dent.niigata-u.ac.jp			Japan Society for the Promotion of Science [19406030, 20406029, 20791372]	This work was supported by Grants-in-Aid for Scientific Research from the Japan Society for the Promotion of Science (19406030, 20406029, and 20791372).	Al-Eryani K, 2013, J CELL PHYSIOL, V228, P1977, DOI 10.1002/jcp.24364; Kawamura K, 2009, PATHOL INT, V59, P300, DOI 10.1111/j.1440-1827.2009.02369.x; Lau SK, 2004, AM J CLIN PATHOL, V122, P794, DOI 10.1309/QHD6YFN81KQXUUH6; Mantovani A, 2011, NAT REV IMMUNOL, V11, P519, DOI 10.1038/nri3024; Kumar V, 2010, INT IMMUNOPHARMACOL, V10, P1325, DOI 10.1016/j.intimp.2010.08.012; Laoui D, 2011, INT J DEV BIOL, V55, P861, DOI 10.1387/ijdb.113371dl; Cuartero MI, 2013, STROKE, V44, P3498, DOI 10.1161/STROKEAHA.113.002470; Brinkmann V, 2004, SCIENCE, V303, P1532, DOI 10.1126/science.1092385; Serhan CN, 2005, NAT IMMUNOL, V6, P1191, DOI 10.1038/ni1276; Borregaard N, 2010, IMMUNITY, V33, P657, DOI 10.1016/j.immuni.2010.11.011; Caulin C, 2000, J CELL BIOL, V149, P17, DOI 10.1083/jcb.149.1.17; Silva MT, 2011, J LEUKOCYTE BIOL, V89, P675, DOI 10.1189/jlb.0910536; Schweizer J, 2006, J CELL BIOL, V174, P169, DOI 10.1083/jcb.200603161; Brinkmann V, 2007, NAT REV MICROBIOL, V5, P577, DOI 10.1038/nrmicro1710; Gordon S, 2003, NAT REV IMMUNOL, V3, P23, DOI 10.1038/nri978; Moll R, 2008, HISTOCHEM CELL BIOL, V129, P705, DOI 10.1007/s00418-008-0435-6; Qian BZ, 2010, CELL, V141, P39, DOI 10.1016/j.cell.2010.03.014; Tsuneki M, 2013, VIRCHOWS ARCH, V462, P297, DOI 10.1007/s00428-012-1359-z; Galdiero MR, 2013, IMMUNOBIOLOGY, V218, P1402, DOI 10.1016/j.imbio.2013.06.003; Houghton AM, 2010, NAT MED, V16, P219, DOI 10.1038/nm.2084; Piccard H, 2012, CRIT REV ONCOL HEMAT, V82, P296, DOI 10.1016/j.critrevonc.2011.06.004; Korkmaz B, 2010, PHARMACOL REV, V62, P726, DOI 10.1124/pr.110.002733; Elliott MR, 2010, J CELL BIOL, V189, P1059, DOI 10.1083/jcb.201004096; Oshima RG, 2007, EXP CELL RES, V313, P1981, DOI 10.1016/j.yexcr.2007.04.007; Kim S, 2006, NATURE, V441, P362, DOI 10.1038/nature04659; Bank U, 2001, J LEUKOCYTE BIOL, V69, P197; Funayama A, 2012, VIRCHOWS ARCH, V460, P473, DOI 10.1007/s00428-012-1224-0; Ida-Yonemochi H, 2012, MODERN PATHOL, V25, P784, DOI 10.1038/modpathol.2011.218; Kobayashi T, 2010, PATHOL INT, V60, P156, DOI 10.1111/j.1440-1827.2009.02499.x; Mikami T, 2011, ORAL ONCOL, V47, P497, DOI 10.1016/j.oraloncology.2011.03.015; Takeya M, 1999, ACTA HISTOCHEM CYTOC, V32, P47; Tripathi Prachi B, 2009, Trop Gastroenterol, V30, P219	32	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0904-2512	1600-0714		J ORAL PATHOL MED	J. Oral Pathol. Med.	NOV	2014	43	10					778	784		10.1111/jop.12197		7	Dentistry, Oral Surgery & Medicine; Pathology	Dentistry, Oral Surgery & Medicine; Pathology	AS9DI	WOS:000344543000009		
J	Ono, M; Komiya, K; Oka, H; Kadota, J				Ono, Mariko; Komiya, Kosaku; Oka, Hiroaki; Kadota, Jun-ichi			Prognosis of Pneumothorax in Elderly Patients Treated with Thoracic Drainage	JOURNAL OF PALLIATIVE MEDICINE			English	Letter									[Ono, Mariko] Tenshindo Hetsugi Hosp, Dept Nursing, Oita, Japan; [Komiya, Kosaku; Oka, Hiroaki] Tenshindo Hetsugi Hosp, Clin Res Ctr Resp Med, Oita, Japan; [Komiya, Kosaku; Oka, Hiroaki; Kadota, Jun-ichi] Oita Univ, Fac Med, Oita 87011, Japan	Komiya, K (reprint author), Oita Univ, Fac Med, 1-1 Idaigaoka, Hasama, Oita 8795593, Japan.	komiyakh1@oita-u.ac.jp					MacDuff A, 2010, THORAX, V65, P18, DOI 10.1136/thx.2010.136986; Kagohashi Katsunori, 2013, Tuberk Toraks, V61, P342; KIRCHER LT, 1954, JAMA-J AM MED ASSOC, V155, P24	3	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	1096-6218	1557-7740		J PALLIAT MED	J. Palliat. Med.	NOV 1	2014	17	11					1197	1198		10.1089/jpm.2014.0298		2	Health Care Sciences & Services	Health Care Sciences & Services	AS9XX	WOS:000344592800003		
J	Odagiri, T; Morita, T; Yamauchi, T; Imai, K; Tei, Y; Inoue, S				Odagiri, Takuya; Morita, Tatsuya; Yamauchi, Toshihiro; Imai, Kengo; Tei, You; Inoue, Satoshi			Convenient Measurement of Systolic Pressure: The Reliability and Validity of Manual Radial Pulse Pressure Measurement	JOURNAL OF PALLIATIVE MEDICINE			English	Article							GOOD DEATH; CANCER; STIFFNESS	Background: It is important to assess a patient's medical condition noninvasively, particularly in hospice care settings. Objective: The aim of this study was to investigate the reliability of manually measuring the radial pulse pressure and its validity for predicting the systolic blood pressure. Design: An observational study consisting of two phases: a reliability study and a validity study. Setting/Subjects: Patients admitted to a palliative care unit. Measurements: To assess the interrater reliability, the radial pulse pressure was prospectively measured independently by a physician and nurse using a three-level assessment (impalpable, weak, and normal) in 43 patients admitted to a palliative care unit. To assess the validity, we analyzed a total of 156 patients, consisting of the prospectively collected patients and 113 patients retrospectively recruited. Radial pulse and systolic blood pressures were recorded on admission. We calculated the sensitivity and specificity of the radial pulse pressure to predict a systolic blood pressure of 90 mm Hg or more. Results: The kappa coefficient of the physician and nurse was 0.788. The sensitivity and specificity to predict a systolic blood pressure of 90 mm Hg or more using the cutoff point of a normal versus weak/impalpable radial pulse pressure were 84% (95% confidence intervals, 77-89) and 82% (52-96), respectively. Conclusions: Manually measuring the radial pulse pressure is reliable and can be used to indicate a systolic blood pressure of 90 mm Hg or more.	[Odagiri, Takuya; Morita, Tatsuya; Yamauchi, Toshihiro; Imai, Kengo; Tei, You; Inoue, Satoshi] Seirei Mikatahara Gen Hosp, Seirei Hosp, Hamamatsu, Shizuoka 4338558, Japan; [Morita, Tatsuya] Seirei Mikatahara Gen Hosp, Palliat Care Team, Dept Palliat & Support Care, Hamamatsu, Shizuoka 4338558, Japan	Odagiri, T (reprint author), Seirei Mikatahara Gen Hosp, Seirei Hosp, Kita Ku, 3453 Mikatahara Cho, Hamamatsu, Shizuoka 4338558, Japan.	oddytaku@sis.seirei.or.jp					Laurent S, 2006, EUR HEART J, V27, P2588, DOI 10.1093/eurheartj/ehl254; Hwang IC, 2013, SUPPORT CARE CANCER, V21, P835, DOI 10.1007/s00520-012-1587-4; Deakin CD, 2000, BRIT MED J, V321, P673, DOI 10.1136/bmj.321.7262.673; Tuma R, 2000, ARCH NEUROL-CHICAGO, V57, P1727, DOI 10.1001/archneur.57.12.1727; Cavalcante JL, 2011, J AM COLL CARDIOL, V57, P1511, DOI 10.1016/j.jacc.2010.12.017; McColgan P, 2012, QJM-INT J MED, V105, P1171, DOI 10.1093/qjmed/hcs140; Miyashita M, 2007, ANN ONCOL, V18, P1090, DOI 10.1093/annonc/mom068; Asmar RG, 1997, J HYPERTENS, V15, pS99; Bickley LS, 1999, BATES GUIDE PHYS EXA; Conn Robert D, 2012, Mo Med, V109, P150; Constant J, 1999, BEDSIDE CARDIOLOGY; Kao YH, 2009, J FORMOS MED ASSOC, V108, P231, DOI 10.1016/S0929-6646(09)60057-7; Lewin J, 2008, EMERG MED J, V25, P325, DOI 10.1136/emj.2007.055244; Mangione S, 2008, PHYS DIAGNOSIS SECRE; McGee S. R., 2007, EVIDENCE BASED PHYS; McManus John, 2005, Prehosp Emerg Care, V9, P423, DOI 10.1080/10903120500255891; Morita T, 1998, Am J Hosp Palliat Care, V15, P217, DOI 10.1177/104990919801500407; Sasser Scott M, 2012, MMWR Recomm Rep, V61, P1; Shirado A, 2012, J PAIN SYMPTOM MANAG, V45, P848; Steinhauser KE, 2000, ANN INTERN MED, V132, P825; Camm AJ, 1996, CIRCULATION, V93, P1043	21	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	1096-6218	1557-7740		J PALLIAT MED	J. Palliat. Med.	NOV 1	2014	17	11					1226	1230		10.1089/jpm.2013.0665		5	Health Care Sciences & Services	Health Care Sciences & Services	AS9XX	WOS:000344592800009		
J	Kajiwara, R; Yokosuka, T; Sasaki, K; Takeuchi, M; Kikuchi, M; Kato, H; Yokota, S				Kajiwara, Ryosuke; Yokosuka, Tomoko; Sasaki, Koji; Takeuchi, Masanobu; Kikuchi, Masako; Kato, Hiromi; Yokota, Shumpei			Kaposiform Hemangioendothelioma Infiltrates the Gut Wall: A Rare Case Report	JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY			English	Letter									[Kajiwara, Ryosuke; Yokosuka, Tomoko; Sasaki, Koji; Takeuchi, Masanobu; Kikuchi, Masako; Kato, Hiromi; Yokota, Shumpei] Yokohama City Univ Med, Dept Pediat, Yokohama, Kanagawa, Japan	Kajiwara, R (reprint author), Yokohama City Univ Med, Dept Pediat, Yokohama, Kanagawa, Japan.						Brasanac D, 2003, PATHOL INT, V53, P627, DOI 10.1046/j.1440-1827.2003.01518.x; Fernandez Y, 2009, EUR J INTERN MED, V20, P106, DOI 10.1016/j.ejim.2008.06.008; JONES EW, 1989, J AM ACAD DERMATOL, V20, P214, DOI 10.1016/S0190-9622(89)70025-6; Pietroletti R, 2002, Tech Coloproctol, V6, P117, DOI 10.1007/s101510200025	4	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	1077-4114	1536-3678		J PEDIAT HEMATOL ONC	J. Pediatr. Hematol. Oncol.	NOV	2014	36	8					657	658				3	Oncology; Hematology; Pediatrics	Oncology; Hematology; Pediatrics	AS4DX	WOS:000344224500034		
J	Ueki, H; Maeda, N; Sekimizu, M; Yamashita, Y; Moritani, S; Horibe, K				Ueki, Hideaki; Maeda, Naoko; Sekimizu, Masahiro; Yamashita, Yuka; Moritani, Suzuko; Horibe, Keizo			A Case of NUT Midline Carcinoma With Complete Response to Gemcitabine Following Cisplatin and Docetaxel	JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY			English	Article						NUT midline carcinoma; docetaxel; gemcitabine; vinorelbine		Background: NUT midline carcinoma (NMC) is recognized as a very rare tumor that most often occurs around the midline and shows NUT rearrangement. This tumor affects children and younger adults, progresses rapidly, and shows an extremely poor prognosis, even with intensive chemotherapy. Very few reports have described effective treatment for this tumor. Methods: A 12-year-old girl with NMC was treated using cisplatin (CDDP), docetaxel, gemcitabine, pemetrexed, and vinorelbine. Results: Imaging showed partial response with CDDP and docetaxel, and complete response with gemcitabine. After reexacerbation of the tumor, although partial response was achieved with vinorelbine, the patient died 89 weeks after onset because of reexacerbation. Conclusions: NMC is a very rare disease with poor prognosis. This study is the first to report response of NMC to gemcitabine and vinorelbine. The findings suggest that combination chemotherapies including CDDP, docetaxel, gemcitabine, and vinorelbine may be a choice in the treatment for NMC.	[Ueki, Hideaki; Maeda, Naoko; Sekimizu, Masahiro; Horibe, Keizo] Natl Hosp Org Nagoya Med Ctr, Dept Pediat, Nagoya, Aichi, Japan; [Moritani, Suzuko] Natl Hosp Org Nagoya Med Ctr, Dept Pathol, Nagoya, Aichi, Japan; [Yamashita, Yuka; Horibe, Keizo] Natl Hosp Org Nagoya Med Ctr, Clin Res Ctr, Nagoya, Aichi, Japan; [Ueki, Hideaki] Japanese Red Cross Narita Hosp, Dept Pediat, Chiba 2868523, Japan	Ueki, H (reprint author), Japanese Red Cross Narita Hosp, Dept Pediat, Iida Cho 90-1, Chiba 2868523, Japan.	uekih0209@gmail.com					French CA, 2010, J CLIN PATHOL, V63, P492, DOI 10.1136/jcp.2007.052902; French CA, 2012, ANNU REV PATHOL-MECH, V7, P247, DOI 10.1146/annurev-pathol-011811-132438; Schiller JH, 2002, NEW ENGL J MED, V346, P92, DOI 10.1056/NEJMoa011954; KUBONISHI I, 1991, CANCER RES, V51, P3327; Filippakopoulos P, 2010, NATURE, V468, P1067, DOI 10.1038/nature09504; den Bakker MA, 2009, AM J SURG PATHOL, V33, P1253, DOI 10.1097/PAS.0b013e3181abe120; French CA, 2004, J CLIN ONCOL, V22, P4135, DOI 10.1200/JCO.2004.02.107; Haack H, 2009, AM J SURG PATHOL, V33, P984, DOI 10.1097/PAS.0b013e318198d666; French CA, 2010, CANCER GENET CYTOGEN, V203, P16, DOI 10.1016/j.cancergencyto.2010.06.007; Bauer DE, 2011, CLIN CANCER RES, V71, P5773; Engleson J, 2006, BMC CANCER, V6, P1; Mertens F, 2006, PEDIAT BLOOD CANC, V10, P1015; Schwartz BE, 2012, CANCER RES, V18, P5773	13	1	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	1077-4114	1536-3678		J PEDIAT HEMATOL ONC	J. Pediatr. Hematol. Oncol.	NOV	2014	36	8					E476	E480				5	Oncology; Hematology; Pediatrics	Oncology; Hematology; Pediatrics	AS4DX	WOS:000344224500001		
J	Takeuchi, S; Tsume, Y; Amidon, GE; Amidon, GL				Takeuchi, Susumu; Tsume, Yasuhiro; Amidon, Gregory E.; Amidon, Gordon L.			Evaluation of a Three Compartment In Vitro Gastrointestinal Simulator Dissolution Apparatus to Predict In Vivo Dissolution	JOURNAL OF PHARMACEUTICAL SCIENCES			English	Article						dissolution; ASD; GIS; gastric emptying; GastroPlus; in vitro; in vivo correlations (IVIVC); Gastrointestinal transit; In vitro models; Transit time; Dissolution rate	STOMACH-DUODENUM MODEL; RELATIVE BIOAVAILABILITY; ORAL ABSORPTION; SMALL-INTESTINE; DRUGS; MEDIA; PH; PHARMACOKINETICS; CLASSIFICATION; PRECIPITATION	In vitro dissolution tests are performed for new formulations to evaluate in vivo performance, which is affected by the change of gastrointestinal (GI) physiology, in the GI tract. Thus, those environmental changes should be introduced to an in vitro dissolution test. Many studies have successfully shown the improvement of in vitro-in vivo correlations (IVIVC) by introducing those physiological changes into dissolution tests. The gastrointestinal simulator (GIS), a multicompartment in vitro dissolution apparatus, was developed to evaluate in vivo drug dissolution. A gastric-emptying rate along with transit rate are key factors to evaluate in vivo drug dissolution and, hence, drug absorption. Dissolution tests with the GIS were performed with Biopharmaceutical Classification System class I drugs at five different gastric-emptying rates in the fasted state. Computational models were used to determine in vivo gastric-emptying time for propranolol and metoprolol based on the GIS dissolution results. Those were compared with published clinical data to determine the gastric half-emptying time. In conclusion, the GIS is a practical tool to assess dissolution properties and can improve IVIVC. (c) 2014 Wiley Periodicals, Inc. and the American Pharmacists Association J Pharm Sci 103:3416-3422, 2014	[Takeuchi, Susumu; Tsume, Yasuhiro; Amidon, Gregory E.; Amidon, Gordon L.] Univ Michigan, Coll Pharm, Ann Arbor, MI 48109 USA; [Takeuchi, Susumu] Sawai Pharmaceut Co Ltd, Pharmacokinet Grp, Osaka 5320003, Japan	Amidon, GL (reprint author), Univ Michigan, Coll Pharm, 428 Church St, Ann Arbor, MI 48109 USA.	glamidon@med.umich.edu					Carino SR, 2010, J PHARM SCI-US, V99, P3923, DOI 10.1002/jps.22236; Sheng JJ, 2009, MOL PHARMACEUT, V6, P29, DOI 10.1021/mp800148u; Brouwers J, 2009, J PHARM SCI-US, V98, P2549, DOI 10.1002/jps.21650; Fallingborg J, 1999, DAN MED BULL, V46, P183; McFarland JW, 2001, J CHEM INF COMP SCI, V41, P1355, DOI 10.1021/ci0102822; Psachoulias D, 2011, PHARM RES-DORDR, V28, P3145, DOI 10.1007/s11095-011-0506-6; Pade V, 1997, PHARMACEUT RES, V14, P1210, DOI 10.1023/A:1012111008617; Carino SR, 2006, J PHARM SCI-US, V95, P116, DOI 10.1002/jps.20495; Tsume Y, 2012, BIOPHARM DRUG DISPOS, V33, P366, DOI 10.1002/bdd.1800; MOONEY KG, 1981, J PHARM SCI, V70, P22, DOI 10.1002/jps.2600700104; ROUTLEDGE PA, 1979, CLIN PHARMACOKINET, V4, P73, DOI 10.2165/00003088-197904020-00001; Kostewicz ES, 2004, J PHARM PHARMACOL, V56, P43, DOI 10.1211/0022357022511; Kasim NA, 2004, MOL PHARMACEUT, V1, P85, DOI 10.1021/mp034006h; Mudie DM, 2012, BIOPHARM DRUG DISPOS, V33, P378, DOI 10.1002/bdd.1803; Hsieh YL, 2012, PHARM RES-DORDR, V29, P2738, DOI 10.1007/s11095-012-0759-8; Mudie DM, 2010, MOL PHARMACEUT, V7, P1388, DOI 10.1021/mp100149j; AMIDON GL, 1995, PHARMACEUT RES, V12, P413, DOI 10.1023/A:1016212804288; Jantratid E, 2008, PHARM RES-DORDR, V25, P1663, DOI 10.1007/s11095-008-9569-4; CHADHURI TK, 1975, AM J DIG DIS, V20, P1063; Eddington N D, 1998, Pharm Dev Technol, V3, P535, DOI 10.3109/10837459809028636; Galia E, 1998, PHARMACEUT RES, V15, P698, DOI 10.1023/A:1011910801212; KIM JS, 2006, MOL PHARM, V3, P686; Kim MS, 2013, INT J PHARMACEUT, V445, P108, DOI 10.1016/j.ijpharm.2013.01.067; PRESSMAN JH, 1987, DIGEST DIS SCI, V32, P689, DOI 10.1007/BF01296133; Rekhi G S, 1997, Pharm Dev Technol, V2, P11, DOI 10.3109/10837459709022605; SHAND DG, 1972, PHARMACOLOGY, V7, P159, DOI 10.1159/000136285; Steingoetter A, 2006, SCAND J GASTROENTERO, V41, P1155, DOI 10.1080/00365520600610451; Taguchi M, 2004, BIOL PHARM BULL, V27, P1642, DOI 10.1248/bpb.27.1642; TAKAGI T, 2006, MOL PHARMACEUT, V3, P631; Vertzoni M, 2004, J PHARM PHARMACOL, V56, P453, DOI 10.1211/0022357022935; Yamashita S, 2013, PHARM RES-DORDR, V30, P951, DOI 10.1007/s11095-012-0931-1	31	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0022-3549	1520-6017		J PHARM SCI-US	J. Pharm. Sci.	NOV	2014	103	11					3416	3422		10.1002/jps.24112		7	Chemistry, Medicinal; Chemistry, Multidisciplinary; Pharmacology & Pharmacy	Pharmacology & Pharmacy; Chemistry	AS2ZO	WOS:000344145200007		
J	Ozaki, S; Nakagawa, Y; Shirai, O; Kano, K				Ozaki, Shunsuke; Nakagawa, Yoshiaki; Shirai, Osamu; Kano, Kenji			Substituent Effect on the Thermodynamic Solubility of Structural Analogs: Relative Contribution of Crystal Packing and Hydration	JOURNAL OF PHARMACEUTICAL SCIENCES			English	Article						solubility; crystal packing; calorimetry; hydration; log P; thermodynamics; drug design	QUANTITATIVE STRUCTURE-ACTIVITY; PARTITION-COEFFICIENTS; AQUEOUS SOLUBILITY; ORAL ABSORPTION; BENZOYLPHENYLUREA LARVICIDES; AMORPHOUS PHARMACEUTICALS; ORGANIC LIQUIDS; DRUG DISCOVERY; SOLUBLE DRUGS; DISSOLUTION	Thermodynamic analysis of the solubility of benzoylphenylurea (BPU) derivatives was conducted to investigate the relative importance of crystal packing and hydration for improving solubility with minor structural modification. The contribution of crystal packing to solubility was evaluated from the change in Gibbs energy on the transition from the crystalline to liquid state. Hydration Gibbs energy was estimated using a linear free-energy relationship between octanol-water partition coefficients and gas-water partition coefficients. The established solubility model satisfactorily explained the relative thermodynamic solubility of the model compounds and revealed that crystal packing and hydration equally controlled solubility of the structural analogs. All hydrophobic substituents were undesirable for solubility in terms of hydration, as expected. On the other hand, some of these hydrophobic substituents destabilized crystal packing and improved the solubility of the BPU derivatives when their impact on crystal packing exceeded their negative influence on hydration. The replacement of a single substituent could cause more than a 10-fold enhancement in thermodynamic solubility; this degree of improvement was comparable to that generally achieved by amorphous formulations. Detailed analysis of thermodynamic solubility will allow us to better understand the true substituent effect and design drug-like candidates efficiently. (c) 2014 Wiley Periodicals, Inc. and the American Pharmacists Association J Pharm Sci 103:3524-3531, 2014	[Ozaki, Shunsuke] Eisai & Co Ltd, Eisai Prod Creat Syst, Analyt Dev Res, Kamisu, Ibaraki 3140255, Japan; [Ozaki, Shunsuke; Nakagawa, Yoshiaki; Shirai, Osamu; Kano, Kenji] Kyoto Univ, Grad Sch Agr, Div Appl Life Sci, Sakyo Ku, Kyoto 6068502, Japan	Ozaki, S (reprint author), Eisai & Co Ltd, Eisai Prod Creat Syst, Analyt Dev Res, Kamisu, Ibaraki 3140255, Japan.	s3-ozaki@hhc.eisai.co.jp					Campeta AM, 2010, J PHARM SCI-US, V99, P3874, DOI 10.1002/jps.22230; Vistoli G, 2008, DRUG DISCOV TODAY, V13, P285, DOI 10.1016/j.drudis.2007.11.007; Brouwers J, 2009, J PHARM SCI-US, V98, P2549, DOI 10.1002/jps.21650; HANSCH C, 1968, J ORG CHEM, V33, P347, DOI 10.1021/jo01265a071; Takano R, 2006, PHARM RES, V23, P1144, DOI 10.1007/s11095-006-0162-4; Murdande SB, 2010, PHARM RES-DORDR, V27, P2704, DOI 10.1007/s11095-010-0269-5; Jain N, 2001, J PHARM SCI, V90, P234, DOI 10.1002/1520-6017(200102)90:2<234::AID-JPS14>3.0.CO;2-V; Ritchie TJ, 2009, DRUG DISCOV TODAY, V14, P1011, DOI 10.1016/j.drudis.2009.07.014; Fujita Y, 2010, BIOORGAN MED CHEM, V18, P1194, DOI 10.1016/j.bmc.2009.12.036; Goss KU, 2001, ENVIRON SCI TECHNOL, V35, P1, DOI 10.1021/es000996d; Kushida I, 2002, J PHARM SCI, V91, P258, DOI 10.1002/jps.10020; Ishikawa M, 2011, J MED CHEM, V54, P1539, DOI 10.1021/jm101356p; BRAZIER DW, 1969, CAN J CHEMISTRY, V47, P893, DOI 10.1139/v69-147; Fray MJ, 2001, J MED CHEM, V44, P1951, DOI 10.1021/jm001124p; Eddleston MD, 2014, J PHARM SCI-US, V103, P2859, DOI 10.1002/jps.23865; Wenglowsky S, 2012, BIOORG MED CHEM LETT, V22, P912, DOI 10.1016/j.bmcl.2011.12.030; Stepan AF, 2013, J MED CHEM, V56, P6985, DOI 10.1021/jm4008642; Solinas A, 2012, J MED CHEM, V55, P1559, DOI 10.1021/jm2013369; Sugano K, 2007, DRUG METAB PHARMACOK, V22, P225, DOI 10.2133/dmpk.22.225; Ozaki S, 2012, J PHARM SCI-US, V101, P214, DOI 10.1002/jps.22760; YALKOWSKY SH, 1980, J PHARM SCI, V69, P912, DOI 10.1002/jps.2600690814; Pudipeddi M, 2005, J PHARM SCI-US, V94, P929, DOI 10.1002/jps.20302; Hill AP, 2010, DRUG DISCOV TODAY, V15, P648, DOI 10.1016/j.drudis.2010.05.016; Schultheiss N, 2009, CRYST GROWTH DES, V9, P2950, DOI 10.1021/cg900129f; Kawakami K, 2009, J PHARM SCI-US, V98, P2875, DOI 10.1002/jps.21816; Perlovich GL, 2014, MOL PHARMACEUT, V11, P1, DOI 10.1021/mp400460r; DEARDEN JC, 1985, ENVIRON HEALTH PERSP, V61, P203, DOI 10.2307/3430073; FUJITA T, 1977, J MED CHEM, V20, P1071, DOI 10.1021/jm00218a017; Hansch C, 1995, EXPLORING QSAR HYDRO; Klabunde T, 2005, J MED CHEM, V48, P6187; Kushida I., 2011, J PHARM PHARMACOL, V64, P366; Lamanna C, 2008, J MED CHEM, V51, P2891, DOI 10.1021/jm701407x; Marsella AM, 2000, PEST MANAG SCI, V56, P789, DOI 10.1002/1526-4998(200009)56:9<789::AID-PS209>3.0.CO;2-L; NAKAGAWA Y, 1989, PESTIC BIOCHEM PHYS, V33, P144, DOI 10.1016/0048-3575(89)90005-9; NAKAO K, 2009, J COMPUT AIDED MOL D, V23, P309; Ozaki S, 2012, J PHARM SCI-US, V101, P4220, DOI 10.1002/jps.23306; Scott JS, 2012, J MED CHEM, V55, P5361, DOI 10.1021/jm300310c; SOTOMATSU T, 1987, PESTIC BIOCHEM PHYS, V27, P156, DOI 10.1016/0048-3575(87)90042-3; Tarsa PB, 1991, EUR J PHARM SCI, V41, P21; Yamagami C, 2000, J PHARM SCI, V89, P1505, DOI 10.1002/1520-6017(200012)89:12<1505::AID-JPS1>3.0.CO;2-0; Yang LH, 2006, BIOORG MED CHEM LETT, V16, P3735, DOI 10.1016/j.bmcl.2006.04.045	41	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0022-3549	1520-6017		J PHARM SCI-US	J. Pharm. Sci.	NOV	2014	103	11					3524	3531		10.1002/jps.24139		8	Chemistry, Medicinal; Chemistry, Multidisciplinary; Pharmacology & Pharmacy	Pharmacology & Pharmacy; Chemistry	AS2ZO	WOS:000344145200018		
J	Onuki, Y; Hasegawa, N; Kida, C; Obata, Y; Takayama, K				Onuki, Yoshinori; Hasegawa, Naoki; Kida, Chihiro; Obata, Yasuko; Takayama, Kozo			Study of the Contribution of the State of Water to the Gel Properties of a Photocrosslinked Polyacrylic Acid Hydrogel using Magnetic Resonance Imaging	JOURNAL OF PHARMACEUTICAL SCIENCES			English	Article						Bayesian network; multivariate analysis; hydrogels; imaging methods; relaxation time; MRI; hydration; state of water; diffusion coefficient	LATENT STRUCTURE-ANALYSIS; PROTON NMR RELAXATION; FIELD GRADIENT NMR; BAYESIAN NETWORKS; SELF-DIFFUSION; FORMULATION OPTIMIZATION; STYRENATED GELATIN; CONTROLLED-RELEASE; PROTEIN SOLUTIONS; DRUG-DELIVERY	Photocrosslinked polyacrylic acid (PAA-HEMA) hydrogels are a promising candidate for use in dermatological patch adhesives. To gain further knowledge about the properties of this gel, we investigated the T-1 relaxation time and the diffusion coefficient (D) of water in the hydrogels using magnetic resonance (MR) imaging. Hydrogels with different formulations and process factors were prepared and tested. The observed data were analyzed by ANOVA, which clarified the mode of action of the formulation and process factors based on these MR parameters. Various gel properties (i.e., gel fraction, swelling capacity, gel strength, and water-retention ability) were also measured, followed by a Bayesian network (BN) analysis. The BN allowed us to summarize well the relationships between the formulation and process factors, MR parameters, and gel properties. T-1 was associated with the swelling and water-retention properties of the hydrogel, whereas D was associated with gel formation and gel strength. Furthermore, this study clarified that T-1 and D mostly represented the hydration and water-compartmentalization effects of the hydrogel, respectively. In conclusion, the state of water seems to play an important role in the properties of the PAA-HEMA hydrogel. (c) 2014 Wiley Periodicals, Inc. and the American Pharmacists Association J Pharm Sci 103:3532-3541, 2014	[Onuki, Yoshinori; Hasegawa, Naoki; Kida, Chihiro; Obata, Yasuko; Takayama, Kozo] Hoshi Univ, Dept Pharmaceut, Shinagawa Ku, Tokyo 1428501, Japan	Onuki, Y (reprint author), Hoshi Univ, Dept Pharmaceut, Shinagawa Ku, Tokyo 1428501, Japan.	onuki@hoshi.ac.jp			OTC Self-Medication Promotion Foundation; Ministry of Education, Culture, Sports, Science, and Technology of Japan	This work was supported by the OTC Self-Medication Promotion Foundation and a Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science, and Technology of Japan. We thank Ms Ayaka Shirai, Ms Asami Fujiya, and Ms Mai Nonaka at Hoshi University for their technical assistance.	Lu SX, 1999, J CONTROL RELEASE, V57, P291, DOI 10.1016/S0168-3659(98)00125-4; Bryant SJ, 2001, BIOMATERIALS, V22, P619, DOI 10.1016/S0142-9612(00)00225-8; WANG JH, 1954, J AM CHEM SOC, V76, P4755, DOI 10.1021/ja01648a001; Cruise GM, 1999, CELL TRANSPLANT, V8, P293; MITCHELL DG, 1987, AM J ROENTGENOL, V149, P831; Venkatraman S, 1998, BIOMATERIALS, V19, P1119, DOI 10.1016/S0142-9612(98)00020-9; HILLS BP, 1991, MACROMOLECULES, V24, P2944, DOI 10.1021/ma00010a047; Park H, 2009, BIOMACROMOLECULES, V10, P541, DOI 10.1021/bm801197m; Van Tomme SR, 2008, INT J PHARM, V355, P1, DOI 10.1016/j.ijpharm.2008.01.057; Kingsley PB, 1999, CONCEPT MAGNETIC RES, V11, P243, DOI 10.1002/(SICI)1099-0534(1999)11:4<243::AID-CMR5>3.0.CO;2-C; COOPER GF, 1992, MACH LEARN, V9, P309, DOI 10.1007/BF00994110; Hoshikawa A, 2006, TISSUE ENG, V12, P2333, DOI 10.1089/ten.2006.12.2333; Separovic F, 1998, PHARMACEUT RES, V15, P1816, DOI 10.1023/A:1011993620177; Burdick JA, 2002, BIOMATERIALS, V23, P4315, DOI 10.1016/S0142-9612(02)00176-X; Fleysher L, 2007, MAGN RESON MED, V57, P380, DOI 10.1002/mrm.21144; Yilmaz A, 2008, MAGN RESON IMAGING, V26, P254, DOI 10.1016/j.mri.2007.05.008; Jansen R, 2003, SCIENCE, V302, P449, DOI 10.1126/science.1087361; CLEVELAND GG, 1976, BIOPHYS J, V16, P1043; Kikuchi S, 2011, J PHARM SCI-US, V100, P964, DOI 10.1002/jps.22340; Nishikawa M, 2011, CHEM PHARM BULL, V59, P332, DOI 10.1248/cpb.59.332; Miyata T, 1996, MACROMOL CHEM PHYSIC, V197, P1135, DOI 10.1002/macp.1996.021970330; Elisseeff J, 2000, J BIOMED MATER RES, V51, P164, DOI 10.1002/(SICI)1097-4636(200008)51:2<164::AID-JBM4>3.0.CO;2-W; Tai HY, 2009, BIOMACROMOLECULES, V10, P2895, DOI 10.1021/bm900712j; HILLWEST JL, 1994, OBSTET GYNECOL, V83, P59; Ishihara M, 2002, BIOMATERIALS, V23, P833, DOI 10.1016/S0142-9612(01)00189-2; Anseth KS, 2002, J CONTROL RELEASE, V78, P199, DOI 10.1016/S0168-3659(01)00500-4; ATKINS TW, 1995, J BIOMED MATER RES, V29, P291, DOI 10.1002/jbm.820290303; Bai RL, 2014, J APPL POLYM SCI, V131, DOI 10.1002/app.40001; Baumgartner S, 2002, AAPS PHARMSCITECH, V3; Burdick JA, 2001, BIOMATERIALS, V22, P1779, DOI 10.1016/S0142-9612(00)00347-1; Burgardt VDD, 2012, J FOOD NUTR RES, V51, P207; Chen J, 2010, J APPL POLYM SCI, V117, P1631, DOI 10.1002/app.32066; Cilurzo F, 2012, EXPERT OPIN DRUG DEL, V9, P33, DOI 10.1517/17425247.2012.637107; Ghi PY, 2002, BIOMACROMOLECULES, V3, P554, DOI 10.1021/bm010169k; GIRARD C, 1977, J CHEM PHYS, V67, P1555, DOI 10.1063/1.434985; Hashemi R. H., 2010, MRI BASICS; Hayashi Y, 2011, DRUG DEV IND PHARM, V37, P1290, DOI 10.3109/03639045.2011.569935; Hayashi Y, 2012, CHEM PHARM BULL, V60, P1419; Ishihara M, 2003, J BIOMED MATER RES A, V64A, P551, DOI 10.1002/jbm.a.10427; Kikuchi S, 2012, CHEM PHARM BULL, V60, P536; KIM SW, 1992, PHARMACEUT RES, V9, P283, DOI 10.1023/A:1015887213431; Kim SJ, 2004, J APPL POLYM SCI, V92, P1467, DOI 10.1002/app.13717; Kowalczuk J, 2011, CARBOHYD POLYM, V83, P166, DOI 10.1016/j.carbpol.2010.07.037; Kristl J, 1992, STP PHARMA SCI, V2, P265; Laszlo K, 2010, LANGMUIR, V26, P4415, DOI 10.1021/la903468h; Li R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082104; Lue SJ, 2009, POLYMER, V50, P654, DOI 10.1016/j.polymer.2008.11.026; Lyman MD, 1996, BIOMATERIALS, V17, P359, DOI 10.1016/0142-9612(96)85574-8; Manabe T, 2004, BIOMATERIALS, V25, P5867, DOI 10.1016/j.biomaterials.2004.01.036; McConville P, 2000, POLYMER, V41, P9081, DOI 10.1016/S0032-3861(00)00295-0; Nagura M, 1996, POLYMER, V37, P5649, DOI 10.1016/S0032-3861(96)00417-X; Nishikawa M, 2008, AAPS PHARMSCITECH, V9, P1038, DOI 10.1208/s12249-008-9141-x; Okino H, 2002, J BIOMED MATER RES, V59, P233, DOI 10.1002/jbm.1237; Onuki Y, 2008, INT J PHARM, V349, P47, DOI 10.1016/j.ijpham.2007.07.021; Onuki Y, 2005, J CONTROL RELEASE, V108, P331, DOI 10.1016/j.jconrel.2005.08.022; PESCHIER LJC, 1993, BIOMATERIALS, V14, P945, DOI 10.1016/0142-9612(93)90137-Q; ROORDA WE, 1990, BIOMATERIALS, V11, P17, DOI 10.1016/0142-9612(90)90046-S; Tranoudis Ioannis, 2004, Cont Lens Anterior Eye, V27, P193, DOI 10.1016/j.clae.2004.08.003; Tsuda Y, 2013, J TISSUE ENG REGEN M, V7, P720, DOI 10.1002/term.1462; Wilson WI, 2005, J PHARM SCI-US, V94, P2764, DOI 10.1002/jps.20358; WISNIEWSKI S, 1980, J MEMBRANE SCI, V6, P299, DOI 10.1016/S0376-7388(00)82171-7; Xue Y, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-458	62	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0022-3549	1520-6017		J PHARM SCI-US	J. Pharm. Sci.	NOV	2014	103	11					3532	3541		10.1002/jps.24140		10	Chemistry, Medicinal; Chemistry, Multidisciplinary; Pharmacology & Pharmacy	Pharmacology & Pharmacy; Chemistry	AS2ZO	WOS:000344145200019		
J	Yuminoki, K; Seko, F; Horii, S; Takeuchi, H; Teramoto, K; Nakada, Y; Hashimoto, N				Yuminoki, Kayo; Seko, Fuko; Horii, Shota; Takeuchi, Haruka; Teramoto, Katsuya; Nakada, Yuichiro; Hashimoto, Naofumi			Preparation and Evaluation of High Dispersion Stable Nanocrystal Formulation of Poorly Water-Soluble Compounds by Using Povacoat	JOURNAL OF PHARMACEUTICAL SCIENCES			English	Article						nanoparticles; milling; nanotechnology; poorly water-soluble drugs; polymers; freeze-drying: oral absorption	IMPROVED ORAL BIOAVAILABILITY; SOLID DISPERSION; DRUG NANOCRYSTALS; NANOPARTICLES; DISSOLUTION; DELIVERY; STABILIZATION; NANOSUSPENSIONS; MICROPARTICLES; PERMEABILITY	In this study, we reported the application of Povacoat (R), a hydrophilic polyvinylalcohol copolymer, as a dispersion stabilizer of nanoparticles of poorly water-soluble compounds. In addition, the influence of aggregation of the nanoparticles on their solubility and oral absorption was studied. Griseofulvin (GF) was used as a model compound with poor water solubility and was milled to nanoparticles by wet bead milling. The dispersion stability of GF milled with Povacoat (R) or the generally used polymers (polyvinylalcohol, hydroxypropylcellulose SSL, and polyvinylpyrrolidone K30) was compared. Milled GF suspended in Povacoat (R) aqueous solution with D-mannitol, added to improve the disintegration rate of freeze-dried GF, exhibited high dispersion stability without aggregation (D90 = ca. 0.220 m), whereas milled GF suspended in aqueous solutions of the other polymers aggregated (D90 > 5 m). Milled GF with Povacoat (R) showed improved aqueous solubility and bioavailability compared with the other polymers. The aggregation of nanoparticles had significant impact on the solubility and bioavailability of GF. Povacoat (R) also prevented the aggregation of the various milled poorly water-soluble compounds (hydrochlorothiazide and tolbutamide, etc.) more effectively than the other polymers. These results showed that Povacoat (R) could have wide applicability to the development of nanoformulations of poorly water-soluble compounds. (c) 2014 Wiley Periodicals, Inc. and the American Pharmacists Association J Pharm Sci 103:3772-3781, 2014	[Yuminoki, Kayo; Seko, Fuko; Horii, Shota; Takeuchi, Haruka; Teramoto, Katsuya; Hashimoto, Naofumi] Setsunan Univ, Fac Pharmaceut Sci, Hirakata, Osaka 5730101, Japan; [Nakada, Yuichiro] Santen Pharmaceut Co Ltd, Qual Compliance Div, Qual Management Grp, Kita Ku, Osaka 5308552, Japan	Yuminoki, K (reprint author), Setsunan Univ, Fac Pharmaceut Sci, Hirakata, Osaka 5730101, Japan.	yuminoki@pharm.setsunan.ac.jp					Horter D, 2001, ADV DRUG DELIVER REV, V46, P75, DOI 10.1016/S0169-409X(00)00130-7; Kipp JE, 2004, INT J PHARM, V284, P109, DOI 10.1016/j.ijpharm.2004.07.019; Ohshima H, 2009, INT J PHARMACEUT, V377, P180, DOI 10.1016/j.ijpharm.2009.05.004; Lipinski CA, 2001, ADV DRUG DELIVER REV, V46, P3, DOI 10.1016/S0169-409X(00)00129-0; Lee J, 2006, J CONTROL RELEASE, V111, P185, DOI 10.1016/j.jconrel.2005.12.003; Van Eerdenbrugh B, 2009, J PHARM SCI-US, V98, P2091, DOI 10.1002/jps.21563; Jinno J, 2006, J CONTROL RELEASE, V111, P56, DOI 10.1016/j.jconrel.2005.11.013; Merisko-Liversidge E, 2011, ADV DRUG DELIVER REV, V63, P427, DOI 10.1016/j.addr.2010.12.007; Choi JY, 2005, CURR APPL PHYS, V5, P472, DOI 10.1016/j.cap.2005.01.012; Bhakay A, 2013, POWDER TECHNOL, V236, P221, DOI 10.1016/j.powtec.2011.12.066; Aumelas A, 2007, COLLOID SURFACE B, V59, P74, DOI 10.1016/j.colsurfb.2007.04.021; Kesisoglou F, 2012, AAPS J, V14, P677, DOI 10.1208/s12248-012-9383-0; Cui ZR, 2003, DRUG DEV IND PHARM, V29, P689, DOI 10.1081/DDC-120021318; Bhakay A, 2014, INT J PHARMACEUT, V461, P367, DOI 10.1016/j.ijpharm.2013.11.059; Lee J, 2005, EUR J PHARM SCI, V24, P441, DOI 10.1016/j.ejps.2004.12.010; Onoue S, 2011, J PHARM SCI-US, V100, P3793, DOI 10.1002/jps.22585; Badawi AA, 2011, AAPS PHARMSCITECH, V12, P811, DOI 10.1208/s12249-011-9651-9; Rabinow BE, 2004, NAT REV DRUG DISCOV, V3, P785, DOI 10.1038/nrd1494; Takatsuka T, 2009, CHEM PHARM BULL, V57, P1061; Bilgili E, 2012, INT J PHARMACEUT, V439, P193, DOI 10.1016/j.ijpharm.2012.09.040; Sugimoto S, 2012, CHEM PHARM BULL, V60, P325; Dressman JB, 1998, PHARMACEUT RES, V15, P11, DOI 10.1023/A:1011984216775; Onoue S, 2010, J PHARM SCI-US, V99, P1871, DOI 10.1002/jps.21964; Van Eerdenbrugh B, 2008, INT J PHARMACEUT, V364, P64, DOI 10.1016/j.ijpharm.2008.07.023; D'Addio SM, 2011, ADV DRUG DELIVER REV, V63, P417, DOI 10.1016/j.addr.2011.04.005; Konan YN, 2002, INT J PHARM, V233, P239, DOI 10.1016/S0378-5173(01)00944-9; Lipinski CA, 2000, J PHARMACOL TOXICOL, V44, P235, DOI 10.1016/S1056-8719(00)00107-6; Sievens-Figueroa L, 2012, INT J PHARMACEUT, V423, P496, DOI 10.1016/j.ijpharm.2011.12.001; Bhakay A, 2013, DRUG DEV IND PHARM; Filippos K, 2007, ADV DRUG DELIV REV, V59, P631; Guo W, 2012, ANAL SCI, V28, P693; Ikeda Y, 2012, J DRUG DELIV SCI TEC, V22, P131; Jakob B, 2011, J PHARM SCI, V100, P1985; Kamiya S, 2009, DRUG DEV IND PHARM, V35, P1022, DOI 10.1080/03639040802698786; Lipinski CA, 2002, AM PHARM REV, V5, P82; Monteiro A, 2013, DRUG DEV IND PHARM, V39, P266, DOI 10.3109/03639045.2012.676048; Onoue S, 2013, INT J PHARMACEUT, V452, P220, DOI 10.1016/j.ijpharm.2013.05.022; Sameti M, 2003, INT J PHARM, V266, P51, DOI 10.1016/S0378-5173(03)00380-6; Sigfridsson K, 2013, DRUG DEV IND PHARM, V39, P1832, DOI 10.3109/03639045.2012.738684; Uramatsu S, 2010, J JAPAN SOC PHARM MA, V19, P60; Wassim A, 2006, ADV DRUG DELIVERY RE, V58, P1688; Xu M, 2014, DRUG DEV IND PHARM, V40, P126, DOI 10.3109/03639045.2012.752497; Yuminoki K, 2012, PHARMAZIE, V67, P681, DOI 10.1691/ph.2012.1834; Zhang LJ, 2008, EUR J PHARM BIOPHARM, V69, P750, DOI 10.1016/j.ejpb.2007.12.003	44	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0022-3549	1520-6017		J PHARM SCI-US	J. Pharm. Sci.	NOV	2014	103	11					3772	3781		10.1002/jps.24147		10	Chemistry, Medicinal; Chemistry, Multidisciplinary; Pharmacology & Pharmacy	Pharmacology & Pharmacy; Chemistry	AS2ZO	WOS:000344145200045		
J	Manabe, Y; Takagi, M; Nakamura-Yamada, M; Goto-Inoue, N; Taoka, M; Isobe, T; Fujii, NL				Manabe, Yasuko; Takagi, Mayumi; Nakamura-Yamada, Mio; Goto-Inoue, Naoko; Taoka, Masato; Isobe, Toshiaki; Fujii, Nobuharu L.			Redox proteins are constitutively secreted by skeletal muscle	JOURNAL OF PHYSIOLOGICAL SCIENCES			English	Article						Thioredoxin; Myokines; Skeletal muscle; Secretion	EXTRACELLULAR-MATRIX PROTEIN; INSULIN-RESISTANCE; OXIDATIVE STRESS; T-CELLS; THIOREDOXIN; EXERCISE; INTERLEUKIN-6; NEUTROPHILS; ANTIOXIDANT; MODULATION	Myokines are skeletal muscle-derived hormones. In this study, using a C2C12 myotube contraction system, we sought to determine whether the skeletal muscle secreted thioredoxin (TRX) and related redox proteins. Redox proteins such as TRXs, peroxiredoxins, and glutaredoxins were detected in the C2C12 myotube culture medium in the absence of any stimulation. The amounts of TRXs, peroxiredoxins, and glutaredoxins secreted by the C2C12 myotubes were not affected by the contraction, unless the myotubes were injured. Because TRX-1 was known to be a secreted protein that lacks a signal peptide, we examined whether this protein was secreted via exosome vesicles. The results indicated that TRX-1 was not secreted via exosome vesicles. We concluded that TRX-1 and related redox proteins are myokines that are constitutively secreted by the skeletal muscle cells. Although the mechanism of TRX-1 secretion remains unclear, our findings suggest that the skeletal muscle is an endocrine organ and the redox proteins that are constitutively secreted from the skeletal muscle may exert antioxidant and systemic health-promoting effects.	[Manabe, Yasuko; Takagi, Mayumi; Nakamura-Yamada, Mio; Goto-Inoue, Naoko; Fujii, Nobuharu L.] Tokyo Metropolitan Univ, Grad Sch Human Hlth Sci, Dept Hlth Promot Sci, Hachioji, Tokyo 1920397, Japan; [Taoka, Masato; Isobe, Toshiaki] Tokyo Metropolitan Univ, Grad Sch Sci, Dept Chem, Hachioji, Tokyo 1920397, Japan	Fujii, NL (reprint author), Tokyo Metropolitan Univ, Grad Sch Human Hlth Sci, Dept Hlth Promot Sci, 1-1 Minami Osawa, Hachioji, Tokyo 1920397, Japan.	fujiin@tmu.ac.jp			Funding Program for World-Leading Innovative R&D on Science and Technology by the Council for Science and Technology Policy [LS102];  [24700700]	This work was supported by Grant-in-Aid for Young Scientists B 24700700 (to YM) and the Funding Program for World-Leading Innovative R&D on Science and Technology by the Council for Science and Technology Policy LS102 (to NLF).	Nakanishi H, 2003, MOL NEUROBIOL, V27, P163, DOI 10.1385/MN:27:2:163; Lagathu C, 2003, BIOCHEM BIOPH RES CO, V311, P372, DOI 10.1016/j.bbrc.2003.10.013; Senn JJ, 2002, DIABETES, V51, P3391, DOI 10.2337/diabetes.51.12.3391; Radak Z, 2003, LIFE SCI, V72, P1627, DOI 10.1016/S0024-3205(02)02476-1; Carey AL, 2006, DIABETES, V55, P2688, DOI 10.2337/db05-1404; Nedachi T, 2008, AM J PHYSIOL-ENDOC M, V295, pE1191, DOI 10.1152/ajpendo.90280.2008; RUBARTELLI A, 1992, J BIOL CHEM, V267, P24161; Powers SK, 2008, PHYSIOL REV, V88, P1243, DOI 10.1152/physrev.00031.2007; Nieto-Vazquez I, 2008, DIABETES, V57, P3211, DOI 10.2337/db07-1062; Takahashi M, 2013, EUR J APPL PHYSIOL, V113, P1117, DOI 10.1007/s00421-012-2531-5; Schwertassek U, 2007, EMBO J, V26, P3086, DOI 10.1038/sj.emboj.7601746; Mohamed MM, 2006, NAT REV CANCER, V6, P764, DOI 10.1038/nrc1949; NAKAMURA H, 1994, IMMUNOL LETT, V42, P75, DOI 10.1016/0165-2478(94)90038-8; Nickel W, 2009, NAT REV MOL CELL BIO, V10, P148, DOI 10.1038/nrm2617; Pedersen BK, 2012, NAT REV ENDOCRINOL, V8, P457, DOI 10.1038/nrendo.2012.49; Gomes EC, 2012, OXID MED CELL LONGEV, DOI 10.1155/2012/756132; Kleemann R, 1998, J MOL BIOL, V280, P85, DOI 10.1006/jmbi.1998.1864; Bertini R, 1999, J EXP MED, V189, P1783, DOI 10.1084/jem.189.11.1783; Piccioli P, 2013, SEMIN IMMUNOL, V25, P425, DOI 10.1016/j.smim.2013.10.007; Tiaden AN, 2012, STEM CELLS, V30, P2271, DOI 10.1002/stem.1190; Pedersen BK, 2007, J APPL PHYSIOL, V103, P1093, DOI 10.1152/japplphysiol.00080.2007; Gomez-Cabrera MC, 2008, FREE RADICAL BIO MED, V44, P126, DOI 10.1016/j.freeradbiomed.2007.02.001; Hawke TJ, 2001, J APPL PHYSIOL, V91, P534; Bostrom P, 2012, NATURE, V481, P463, DOI 10.1038/nature10777; Billiet L, 2005, J BIOL CHEM, V280, P40310, DOI 10.1074/jbc.M503644200; Clarke MSF, 1996, FASEB J, V10, P502; Dekigai H, 2001, FREE RADICAL RES, V35, P23, DOI 10.1080/10715760100300561; ERICSON ML, 1992, LYMPHOKINE CYTOK RES, V11, P201; Guescini M, 2010, EXP CELL RES, V316, P1977; Lu Y, 2007, FREE RADIC BIOL MED, V43, P1061; Makino Y, 1996, J CLIN INVEST, V98, P2469, DOI 10.1172/JCI119065; Manabe Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052592; Manabe Y, 2013, J PHYS FIT SPORTS ME, V1, P51; Miyatake S, 2014, BIOCHEM BIOPH RES CO, V444, P496, DOI 10.1016/j.bbrc.2014.01.089; POWIS G, 1994, ONCOL RES, V6, P539; RUBARTELLI A, 1995, CANCER RES, V55, P675; SALMINEN A, 1983, EXP MOL PATHOL, V38, P380, DOI 10.1016/0014-4800(83)90077-1; Schagger H, 2006, NAT PROTOC, V1, P16, DOI 10.1038/nprot.2006.4; Sugimoto M, 2002, MOL IMMUNOL, V38, P793, DOI 10.1016/S0161-5890(01)00116-X; Sumida S, 2004, GEN PHYSIOL BIOPHYS, V23, P241; Weigert C, 2005, AM J PHYSIOL-ENDOC M, V289, pE251, DOI 10.1152/ajpendo.00448.2004; Xie LF, 2010, CARDIOVASC RES, V87, P628, DOI 10.1093/cvr/cvq138	42	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1880-6546	1880-6562		J PHYSIOL SCI	J. Physiol. Sci.	NOV	2014	64	6					401	409		10.1007/s12576-014-0334-7		9	Physiology	Physiology	AS8ZA	WOS:000344532200002		
J	Okamoto, K; Ishikawa, T; Abe, R; Ishikawa, D; Kobayashi, C; Mizunuma, M; Norimoto, H; Matsuki, N; Ikegaya, Y				Okamoto, Kazuki; Ishikawa, Tomoe; Abe, Reimi; Ishikawa, Daisuke; Kobayashi, Chiaki; Mizunuma, Mika; Norimoto, Hiroaki; Matsuki, Norio; Ikegaya, Yuji			Ex vivo cultured neuronal networks emit in vivo-like spontaneous activity	JOURNAL OF PHYSIOLOGICAL SCIENCES			English	Article						Spontaneous activity; Slice culture; Machine learning algorism; Soft confidence-weighted learning	NEOCORTICAL PYRAMIDAL NEURONS; SLICE CULTURES; VISUAL-CORTEX; ORGANOTYPIC CULTURES; HIPPOCAMPAL-NEURONS; SYNAPTIC ACTIVITY; DYNAMICS; RAT; CONNECTIONS; CELLS	Spontaneous neuronal activity is present in virtually all brain regions, but neither its function nor spatiotemporal patterns are fully understood. Ex vivo organotypic slice cultures may offer an opportunity to investigate some aspects of spontaneous activity, because they self-restore their networks that collapsed during slicing procedures. In hippocampal networks, we compared the levels and patterns of in vivo spontaneous activity to those in acute and cultured slices. We found that the firing rates and excitatory synaptic activity in the in vivo hippocampus are more similar to those in slice cultures compared to acute slices. The soft confidence-weighted algorithm, a machine learning technique without human bias, also revealed that hippocampal slice cultures resemble the in vivo hippocampus in terms of the overall tendency of the parameters of spontaneous activity.	[Okamoto, Kazuki; Ishikawa, Tomoe; Abe, Reimi; Ishikawa, Daisuke; Kobayashi, Chiaki; Mizunuma, Mika; Norimoto, Hiroaki; Matsuki, Norio] Univ Tokyo, Grad Sch Pharmaceut Sci, Chem Pharmacol Lab, Bunkyo Ku, Tokyo 1130033, Japan; [Ikegaya, Yuji] Ctr Informat & Neural Networks, Suita, Osaka 5650871, Japan	Ikegaya, Y (reprint author), Univ Tokyo, Grad Sch Pharmaceut Sci, Chem Pharmacol Lab, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.	ikegaya@mol.f.u-tokyo.ac.jp			Kakenhi [22115003, 26250003, 25119004]	We are grateful to Dr. Hiroshi Ban (CiNET) for his technical support for soft confidence weighted. This work was supported by Kakenhi (22115003; 26250003; 25119004).	Takahashi N, 2010, P NATL ACAD SCI USA, V107, P10244, DOI 10.1073/pnas.0914594107; Arieli A, 1996, SCIENCE, V273, P1868, DOI 10.1126/science.273.5283.1868; Zhang LI, 2001, NAT NEUROSCI, V4, P1207, DOI 10.1038/nn753; Ikegaya Y, 2004, SCIENCE, V304, P559, DOI 10.1126/science.1093173; Langston RF, 2010, SCIENCE, V328, P1576, DOI 10.1126/science.1188210; Gasparini S, 2006, J NEUROSCI, V26, P2088, DOI 10.1523/JNEUROSCI.4428-05.2006; Mizunuma M, 2014, NAT NEUROSCI, V17, P503, DOI 10.1038/nn.3674; KANDEL ER, 1961, J NEUROPHYSIOL, V24, P243; DEBANNE D, 1995, J NEUROPHYSIOL, V73, P1282; PAVLIDES C, 1989, J NEUROSCI, V9, P2907; Mao BQ, 2001, NEURON, V32, P883, DOI 10.1016/S0896-6273(01)00518-9; Shu YS, 2003, J NEUROSCI, V23, P10388; Takahashi N, 2012, SCIENCE, V335, P353, DOI 10.1126/science.1210362; Ikegaya Y, 2005, NEUROSCI RES, V52, P132, DOI 10.1016/j.neures.2005.02.004; Gahwiler BH, 1997, TRENDS NEUROSCI, V20, P471, DOI 10.1016/S0166-2236(97)01122-3; Koyama R, 2007, J PHARMACOL SCI, V104, P191, DOI 10.1254/jphs.SC0070119; Rochefort NL, 2009, P NATL ACAD SCI USA, V106, P15049, DOI 10.1073/pnas.0907660106; De Simoni A, 2003, J PHYSIOL-LONDON, V550, P135, DOI 10.1113/jphysiol.2003.039099; Stepanyants A, 2009, P NATL ACAD SCI USA, V106, P3555, DOI 10.1073/pnas.0810390106; Golshani P, 2009, J NEUROSCI, V29, P10890, DOI 10.1523/JNEUROSCI.2012-09.2009; Kenet T, 2003, NATURE, V425, P954, DOI 10.1038/nature02078; Sanchez-Vives MV, 2000, NAT NEUROSCI, V3, P1027; Stuart G, 1997, J PHYSIOL-LONDON, V505, P617, DOI 10.1111/j.1469-7793.1997.617ba.x; Fiser J, 2004, NATURE, V431, P573, DOI 10.1038/nature02907; Beggs JM, 2003, J NEUROSCI, V23, P11167; Ishikawa D, 2014, J NEUROSCI, V34, P5044, DOI 10.1523/JNEUROSCI.5298-13.2014; Pare D, 1998, J NEUROPHYSIOL, V79, P1450; Petersen CCH, 2003, P NATL ACAD SCI USA, V100, P13638, DOI 10.1073/pnas.2235811100; MULLER D, 1993, DEV BRAIN RES, V71, P93, DOI 10.1016/0165-3806(93)90109-N; Softky W R, 1995, Curr Opin Neurobiol, V5, P239, DOI 10.1016/0959-4388(95)80032-8; Buzsáki G, 1983, Brain Res, V287, P139; GEISLER WS, 1991, J NEUROPHYSIOL, V66, P334; GULYAS AI, 1993, EUR J NEUROSCI, V5, P1729, DOI 10.1111/j.1460-9568.1993.tb00240.x; Ikegaya Y, 2012, CEREB CORTEX; Ikegaya Y, 1999, J NEUROSCI, V19, P802; Namiki S, 2013, J NEUROSCI, V33, P987, DOI 10.1523/JNEUROSCI.2522-12.2013; Penn AA, 1999, PEDIATR RES, V45, P447, DOI 10.1203/00006450-199904010-00001; Raichle ME, 2006, SCIENCE, V314, P1249, DOI 10.1126/science.1134405; Ranck J B Jr, 1973, Exp Neurol, V41, P461; REDMAN SJ, 1968, J NEUROPHYSIOL, V31, P499; Sasaki T, 2008, J NEUROPHYSIOL, V100, P1668, DOI 10.1152/jn.00084.2008; Sasaki T, 2007, J NEUROSCI, V27, P517, DOI 10.1523/JNEUROSCI.4514-06.2007; STOPPINI L, 1991, J NEUROSCI METH, V37, P173, DOI 10.1016/0165-0270(91)90128-M; Takahashi N, 2007, NEUROSCI RES, V58, P219, DOI 10.1016/j.neures.2007.03.001; Traynelis SF, 1998, J NEUROSCI METH, V86, P25, DOI 10.1016/S0165-0270(98)00140-X; Wang J, 2012, INT C MACH LEARN P, V1206, P4612; YAMAMOTO N, 1989, SCIENCE, V245, P192, DOI 10.1126/science.2749258	47	2	2	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1880-6546	1880-6562		J PHYSIOL SCI	J. Physiol. Sci.	NOV	2014	64	6					421	431		10.1007/s12576-014-0337-4		11	Physiology	Physiology	AS8ZA	WOS:000344532200004		
J	Sun, HX; Niisato, N; Inui, T; Marunaka, Y				Sun, Hongxin; Niisato, Naomi; Inui, Toshio; Marunaka, Yoshinori			Insulin is involved in transcriptional regulation of NKCC and the CFTR Cl- channel through PI3K activation and ERK inactivation in renal epithelial cells	JOURNAL OF PHYSIOLOGICAL SCIENCES			English	Article						Insulin; NKCC; CFTR; Cl-; secretion	GASTRIC-CANCER CELLS; INDUCED NEURITE OUTGROWTH; PROTEIN-TYROSINE KINASE; NA+/K+/2CL(-) COTRANSPORTER; NA+-TRANSPORT; ANION SECRETION; A6 CELLS; MUSCLE-CELLS; K+-ATPASE; LINE A6	It is is well known that insulin stimulates glucose transport and epithelial Na+ channel (ENaC)-mediated Na+ reabsorption; however, the action of insulin on Cl- secretion is not fully understood. In this study, we investigated the action of insulin on Na+-K+-2Cl(-) cotransporter (NKCC)-mediated Cl- secretion in epithelial A6 cells. Interestingly, insulin treatment remarkably enhanced the forskolin-stimulated Cl- secretion associated with an increase in apical Cl- conductance by upregulating mRNA expression of both CFTR and NKCC, although insulin treatment alone had no effect on the basal Cl- secretion or apical Cl- conductance without forskolin application. We next elucidated a role of phosphoinositide 3-kinase (PI3K) in the insulin-induced enhancement of the Cl- secretion, since insulin actually activated PI3K, resulting in activation of Akt, a downstream molecule of PI3K. LY294002 (a PI3K inhibitor) reduced the Cl- secretion by suppressing mRNA expression of NKCC, whereas insulin still had a stimulatory action on mRNA expression of CFTR even in the presence of LY294002. On the other hand, we found that a MEK inhibitor (PD98059) further enhanced the insulin-stimulated CFTR mRNA expression and the Cl- secretion in forskolin-stimulated A6 cells and that insulin induced slight, transient activation of ERK followed by significant inactivation of ERK. These observations suggest that: (1) insulin respectively upregulates mRNA expression of NKCC and CFTR through activation of PI3K and inactivation of ERK; (2) insulin signals on mRNA expression of NKCC and CFTR are not enough to stimulate transepithelial Cl- secretion, but enhance the stimulatory action of cAMP on transepithelial Cl- secretion.	[Sun, Hongxin; Niisato, Naomi; Inui, Toshio; Marunaka, Yoshinori] Kyoto Prefectural Univ Med, Grad Sch Med Sci, Dept Mol Cell Physiol, Kyoto 6028566, Japan; [Niisato, Naomi; Marunaka, Yoshinori] St Agnes Univ, Japan Inst Food Educ & Hlth, Kyoto 6028013, Japan; [Inui, Toshio; Marunaka, Yoshinori] Kyoto Prefectural Univ Med, Grad Sch Med Sci, Dept Bioion, Kyoto 6028566, Japan; [Inui, Toshio] Saisei Mirai Clin, Moriguchi, Osaka 5700012, Japan	Niisato, N (reprint author), Kyoto Prefectural Univ Med, Grad Sch Med Sci, Dept Mol Cell Physiol, Kyoto 6028566, Japan.	naomi@koto.kpu-m.ac.jp; marunaka@koto.kpu-m.ac.jp			Japan Society of the Promotion of Science [24590283, 25670111]; Salt Science [1235]; Cell Research Conference	This work was supported by Grants-in-Aid from the Japan Society of the Promotion of Science (24590283 to NN, 25670111 to YM), Salt Science (1235 to YM and NN) and Cell Research Conference to YM.	Asano J, 2009, AM J RESP CELL MOL, V41, P688, DOI 10.1165/rcmb.2008-0338OC; Okada Y, 2009, J PHYSIOL-LONDON, V587, P2141, DOI 10.1113/jphysiol.2008.165076; Tse WKF, 2007, J EXP BIOL, V210, P2113, DOI 10.1242/jeb.004101; Bulley S, 2014, PFLUG ARCH EUR J PHY, V466, P861, DOI 10.1007/s00424-013-1357-2; Bachmann O, 2011, ACTA PHYSIOL, V201, P33, DOI 10.1111/j.1748-1716.2010.02153.x; Hong JH, 2014, PFLUG ARCH EUR J PHY, V466, P1487, DOI 10.1007/s00424-013-1390-1; Banga A, 2014, AM J PHYSIOL-LUNG C, V306, pL937, DOI 10.1152/ajplung.00190.2013; Mizuno H, 2014, J PHYSIOL SCI, V64, P305, DOI 10.1007/s12576-014-0319-6; Nakajima K, 2011, CELL PHYSIOL BIOCHEM, V28, P147, DOI 10.1159/000331723; Butterworth MB, 2009, AM J PHYSIOL-RENAL, V296, pF10, DOI 10.1152/ajprenal.90248.2008; Silvis MR, 2009, MOL BIOL CELL, V20, P2337, DOI 10.1091/mbc.E08-01-0084; Hiraoka K, 2010, CELL PHYSIOL BIOCHEM, V25, P379, DOI 10.1159/000303042; Ohsawa R, 2010, J CELL PHYSIOL, V223, P764, DOI 10.1002/jcp.22088; Akita T, 2014, NEUROSCIENCE, V275, P211, DOI 10.1016/j.neuroscience.2014.06.015; Lee RJ, 2014, CELL CALCIUM, V55, P325, DOI 10.1016/j.ceca.2014.02.001; Hayata H, 2014, BIOCHEM BIOPH RES CO, V445, P170, DOI 10.1016/j.bbrc.2014.01.162; Aoi W, 2013, BIOCHEM BIOPH RES CO, V432, P650, DOI 10.1016/j.bbrc.2013.02.029; Miyazaki H, 2008, BIOCHEM BIOPH RES CO, V366, P506, DOI 10.1016/j.bbrc.2007.11.144; Fujii T, 2013, FEBS LETT, V587, P3898, DOI 10.1016/j.febslet.2013.10.030; Niisato N, 1999, BIOCHEM BIOPH RES CO, V254, P368, DOI 10.1006/bbrc.1998.9952; Nakajima K, 2007, BIOCHEM BIOPH RES CO, V359, P604, DOI 10.1016/j.bbrc.2007.05.133; de los Heros P, 2014, BIOCHEM J, V458, P559, DOI 10.1042/BJ20131478; Marunaka Y, 2014, RESP PHYSIOL NEUROBI, V196, P39, DOI 10.1016/j.resp.2014.02.013; Takahashi Y, 2014, BIOL OPEN, V3, P12, DOI 10.1242/bio.20136205; Okada S, 2003, J IMMUNOL, V171, P2556; BLAZERYOST BL, 1988, AM J PHYSIOL, V255, pC413; BLAZERYOST BL, 1989, AM J PHYSIOL, V257, pC612; BLAZERYOST BL, 1992, BIOCHEM INT, V28, P143; Chen B, 2007, J MEMBRANE BIOL, V215, P1, DOI 10.1007/s00232-007-9000-9; Diakov A, 2010, CELL PHYSIOL BIOCHEM, V26, P913, DOI 10.1159/000324000; Diener M, 1997, COMP BIOCHEM PHYS A, V118, P375, DOI 10.1016/S0300-9629(96)00322-2; Fujii T, 2012, J PHYSIOL SCI, V62, P53, DOI 10.1007/s12576-011-0176-5; Guo SD, 2014, J ENDOCRINOL, V220, pT1, DOI 10.1530/JOE-13-0327; Handler J S, 1981, Ann N Y Acad Sci, V372, P442, DOI 10.1111/j.1749-6632.1981.tb15493.x; HANDLER JS, 1981, AM J PHYSIOL, V240, pC103; Ikehara O, 2014, J PHYSIOL SCI, V64, P119, DOI 10.1007/s12576-013-0302-7; Ikehara O, 2012, J PHYSIOL SCI, V62, P211, DOI 10.1007/s12576-012-0198-7; Kamynina E, 2002, AM J PHYSIOL-RENAL, V283, pF377, DOI 10.1152/ajprenal.00143.2002; Kim D, 2014, AM J PHYSIOL-CELL PH, V307, pC208, DOI 10.1152/ajpcell.00083.2014; Kitagawa M, 2013, ARCH BIOCHEM BIOPHYS, V539, P92, DOI 10.1016/j.abb.2013.06.014; Longo N, 1996, BBA-BIOMEMBRANES, V1281, P38, DOI 10.1016/0005-2736(96)00004-1; Maki M, 2007, BIOCHEM BIOPH RES CO, V361, P1038, DOI 10.1016/j.bbrc.2007.07.131; Markadieu N, 2005, AM J PHYSIOL-RENAL, V288, pF1201, DOI 10.1152/ajprenal..00383.2004; MARUNAKA Y, 1990, J GEN PHYSIOL, V95, P773, DOI 10.1085/jgp.95.5.773; Marunaka Y, 2014, J PHARM SCI IN PRESS; Niisato N, 1999, J PHYSIOL-LONDON, V518, P417, DOI 10.1111/j.1469-7793.1999.0417p.x; Marunaka Y, 1998, J MEMBRANE BIOL, V161, P235, DOI 10.1007/s002329900330; MARUNAKA Y, 1992, AM J PHYSIOL, V263, pF392; Marunaka Y, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/978196; Marunaka Y, 1999, J MEMBRANE BIOL, V168, P91, DOI 10.1007/s002329900500; Mohebbi N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055286; Nakajima K, 2012, BIOCHEM BIOPH RES CO, V425, P225, DOI 10.1016/j.bbrc.2012.07.072; Niisato N, 2000, J MEMBRANE BIOL, V175, P63, DOI 10.1007/s002320001055; Niisato N, 2004, AM J PHYSIOL-RENAL, V287, pF932, DOI 10.1152/ajprenal.00131.2004; Niisato N, 2012, AM J PHYSIOL-RENAL, V303, pF240, DOI 10.1152/ajprenal.00198.2011; O'Mahony F, 2008, AM J PHYSIOL-CELL PH, V294, pC1362, DOI 10.1152/ajpcell.00256.2007; PANET R, 1991, J CELL BIOL, V114, P337, DOI 10.1083/jcb.114.2.337; PERKINS FM, 1981, AM J PHYSIOL, V241, pC154; Ponce-Coria J, 2014, J BIOL CHEM, V289, P17680, DOI 10.1074/jbc.M113.540518; SARGEANT RJ, 1995, AM J PHYSIOL-CELL PH, V269, pC217; Sasamoto K, 2012, J PHYSIOL SCI, V62, pS136; Schobel N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048005; Shiozaki A, 2006, J PHYSIOL SCI, V56, P401, DOI 10.2170/physiolsci.RP10806; Sun H, 2014, BIOMED RES INT, V2014; Sun HX, 2013, J PHYSIOL SCI, V63, pS197; Ueda-Nishimura T, 2005, BIOCHEM BIOPH RES CO, V332, P1042, DOI 10.1016/j.bbrc.2005.05.046; Zhao HY, 2004, J PHYSIOL-LONDON, V560, P123, DOI 10.1113/jphysiol.2004.066423	67	1	1	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1880-6546	1880-6562		J PHYSIOL SCI	J. Physiol. Sci.	NOV	2014	64	6					433	443		10.1007/s12576-014-0338-3		11	Physiology	Physiology	AS8ZA	WOS:000344532200005		
J	Kawai, M; Hama, N; Ito, S; Hirota, A				Kawai, Minako; Hama, Noriyuki; Ito, Shin-ichi; Hirota, Akihiko			Improvement of the optical imaging technique for intact rat brain using a plano-concave lens	JOURNAL OF PHYSIOLOGICAL SCIENCES			English	Article						Plano-concave lens; Optical recording; Noise reduction; Central nervous system	VOLTAGE-SENSITIVE DYES; CENTRAL NERVOUS-SYSTEM; NEURAL ACTIVITY; FUNCTIONAL-ORGANIZATION; NEURONAL-ACTIVITY; RECORDING SYSTEM; CORTEX	Use of a plano-concave lens improved the quality of optical signals from the rat cerebral cortex by improving the focus. When detecting neural activity from a curved surface of an in vivo brain by optical techniques, it is not possible to adjust the focus equally over the entire detecting area in the two-dimensional plane, since the active window of the optical detector is usually flat, while the intact brain surface is spherical. It has been known that the size of the optical signal is reduced as the distance of the real image to the active window of the detector increases; therefore, the level of the signal-to-noise ratio obtained from the unfocused area often becomes insufficient for quantitative physiological analyses. By placing a plano-concave lens on the cerebral cortex, we succeeded in obtaining a two-dimensional image that has no unfocused area over an entire image recorded by the detector.	[Kawai, Minako; Hama, Noriyuki; Ito, Shin-ichi; Hirota, Akihiko] Shimane Univ, Sch Med, Dept Neural & Muscular Physiol, Izumo, Shimane 6938501, Japan	Hirota, A (reprint author), Shimane Univ, Sch Med, Dept Neural & Muscular Physiol, 89-1 En Ya, Izumo, Shimane 6938501, Japan.	hirophy2@med.shimane-u.ac.jp			KAKENHI [20390385, 21650095, 24700397]; Japan Society for the Promotion of Science	We are most grateful to Dr. Kohtaro Kamino for his constant encouragement and many comments throughout the course of our work and for critically reading the manuscript. This work was partly supported by KAKENHI Grant Numbers 20390385, 21650095 and 24700397, and from the Japan Society for the Promotion of Science.	SALZBERG BM, 1977, J NEUROPHYSIOL, V40, P1281; ORBACH HS, 1983, J NEUROSCI, V3, P2251; KAMINO K, 1991, PHYSIOL REV, V71, P53; Grinvald A, 2004, NAT REV NEUROSCI, V5, P874, DOI 10.1038/nrn1536; GRINVALD A, 1988, PHYSIOL REV, V68, P1285; MOMOSESATO Y, 1995, J MEMBRANE BIOL, V144, P167; Lustig BR, 2013, J NEUROPHYSIOL, V109, P2382, DOI 10.1152/jn.00430.2012; HIROTA A, 1995, J NEUROSCI METH, V56, P187, DOI 10.1016/0165-0270(94)00123-X; COHEN LB, 1978, REV PHYSIOL BIOCH P, V83, P35; Bere Z, 2013, NEUROSCIENCE, V260, P217; Cohen L B, 1986, Soc Gen Physiol Ser, V40, P71; Hama N, 2010, J NEUROSCI METH, V194, P73, DOI 10.1016/j.jneumeth.2010.09.012; Hama N, 2012, J PHYSIOL SCI, V62, pS179; Hama N, 2014, J PHYSIOL SCI, V64, pS232; Hama N, 2013, J PHYSIOL SCI, V63, pS141; Hirota A, 2006, J PHYSIOL SCI, V56, P263, DOI 10.2170/physiolsci.TN003006; KAMINO K, 1990, JPN J PHYSIOL, V40, P443, DOI 10.2170/jjphysiol.40.443	17	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1880-6546	1880-6562		J PHYSIOL SCI	J. Physiol. Sci.	NOV	2014	64	6					445	449		10.1007/s12576-014-0336-5		5	Physiology	Physiology	AS8ZA	WOS:000344532200006		
J	Lau, M; Manna, S; Herdrich, G; Schonherr, T; Komurasaki, K				Lau, Matthias; Manna, Sebastian; Herdrich, Georg; Schoenherr, Tony; Komurasaki, Kimiya			Investigation of the Plasma Current Density of a Pulsed Plasma Thruster	JOURNAL OF PROPULSION AND POWER			English	Article								The pulsed plasma thruster of the magnetoplasmadynamic type represents a promising and cheap solution to today's propulsion challenges in space. The work presented in this paper covers new information on the electromagnetic conditions during thrust generation by revealing the temporal and spatial distributions of the current density vectors between the thruster electrodes. This is achieved by building and calibrating miniaturized induction probes. The local magnetic field components of all three spatial directions are combined to derive the current density vector. Quantitative determination of the temporal behavior of vectors at 27 points evenly distributed in three planes delivers a comprehensive picture of the position and development of the current in a pulsed plasma thruster. Maximum current densities of 80 kA/m(2) and magnetic flux densities of up to 0.82 T have been observed close to the surface of the solid Teflon (R) propellant. It is concluded that no distinct movement of a current sheet was observed. The current density data are discussed and compared to high-speed camera photographs.	[Lau, Matthias; Manna, Sebastian; Herdrich, Georg] Univ Stuttgart, D-70569 Baden Wurttemberg, Germany; [Schoenherr, Tony] Univ Tokyo, Dept Aeronaut & Astronaut, Bunkyo Ku, Tokyo 1138656, Japan; [Komurasaki, Kimiya] Univ Tokyo, Chiba 2778561, Japan	Lau, M (reprint author), Univ Stuttgart, Pfaffenwaldring 29, D-70569 Baden Wurttemberg, Germany.		Schonherr, Tony/E-8777-2010	Schonherr, Tony/0000-0003-1545-3822	DLR, German Aerospace Center; German Federal Ministry of Economics and Technology [50-RS-1002]	The authors gratefully acknowledge funding by the DLR, German Aerospace Center and the German Federal Ministry of Economics and Technology under contract number 50-RS-1002. M. Lau would like to thank Anuscheh Nawaz for her inspiration and professional work at the Institute of Space Systems that made all this possible, as well as Nico Karrer from ETH Zurich for his technical support on laboratory measurement equipment and electromagnetic compatibility.	Burton RL, 1998, J PROPUL POWER, V14, P716, DOI 10.2514/2.5334; Brill Y., 1982, 19821956 AIAA; DECKER G, 1972, J PHYS E SCI INSTRUM, V5, P481, DOI 10.1088/0022-3735/5/5/034; Jahn R. G., 1968, MCGRAW HILL SERIES M, P263; Lau M., 2011, 32 INT EL PROP C EL; Lau M., 2013, 49 JOINT PROP C; Markusic T. E., 2002, THESIS PRINCETON U P; Nawaz A., 2009, THESIS U STUTTGART S; Nawaz A, 2008, AIAA J, V46, P2881, DOI 10.2514/1.37161; Neudorfer J., 2011, 32 INT EL PROP C EL; Palumbo D. J., 1979, 19792097 AIAA; Schonherr T, 2013, PHYS PLASMAS, V20, DOI 10.1063/1.4794198; Schonherr T, 2013, J PROPUL POWER, V29, P1478, DOI 10.2514/1.B34789; Schonherr T., 2009, 31 INT EL PROP C EL	14	1	1	AMER INST AERONAUTICS  ASTRONAUTICS	RESTON	1801 ALEXANDER BELL DRIVE, STE 500, RESTON, VA 22091-4344 USA	0748-4658	1533-3876		J PROPUL POWER	J. Propul. Power	NOV-DEC	2014	30	6					1459	1470		10.2514/1.B35131		12	Engineering, Aerospace	Engineering	AS2ZM	WOS:000344145000003		
J	Tsuruta, H; Wang, B; Wang, ZY; Yokota, S; Sasoh, A				Tsuruta, Hisashi; Wang, Bin; Wang, Zhogyuan; Yokota, Shigeru; Sasoh, Akihiro			Repetitive Pulse Performance of One-Micrometer Laser-Ablation Propulsion onto Aluminum	JOURNAL OF PROPULSION AND POWER			English	Article							IMPULSE; VACUUM; SINGLE	The impulse characteristics of an aluminum ablator against repetitive Nd:YLF laser pulses with a 1047 nm wavelength and 5 to 15 ns pulsewidth were investigated. The laser was operated in burst mode varying the pulse repetition frequency, single-pulse energy, and number of pulses in a burst. The burst was repeated until the impulse reached saturation. A torsion pendulum was used to measure the total impulse generated in a single burst with an accuracy higher than 2%, even with a 1 s burst period. The impulse increased, and then it gradually reached saturation as the total laser energy increased. In the operation range examined, the saturation value of the impulse increased with increasing single-pulse fluence.	[Tsuruta, Hisashi; Wang, Bin; Wang, Zhogyuan; Yokota, Shigeru; Sasoh, Akihiro] Nagoya Univ, Dept Aerosp Engn, Chikusa Ku, Nagoya, Aichi 4648603, Japan	Tsuruta, H (reprint author), Nagoya Univ, Dept Aerosp Engn, Chikusa Ku, Furo Cho, Nagoya, Aichi 4648603, Japan.	tsuruta@fuji.nuae.nagoya-u.ac.jp			Nagoya University Global Center of Excellence Program for Education and Research of Micro-Nano Mechatronics; Leadership Development Program for Space Exploration and Research; Japan Society for Promotion of Science [22226014]	This work was supported by the Nagoya University Global Center of Excellence Program for Education and Research of Micro-Nano Mechatronics, and it was also supported by the Leadership Development Program for Space Exploration and Research. Additionally, this research was supported by the Japan Society for Promotion of Science as Grant-in-Aid for Scientific Research (S), no. 22226014. The authors wish to thank John E. Sinko for his careful proofreading, and the Technical Division at Nagoya University, especially Akira Saito, for their technical support.	PHIPPS CR, 1988, J APPL PHYS, V64, P1083, DOI 10.1063/1.341867; Phipps C, 2002, AIAA J, V40, P310, DOI 10.2514/2.1647; Colao F, 2002, SPECTROCHIM ACTA B, V57, P1167, DOI 10.1016/S0584-8547(02)00058-7; Phipps CR, 1996, LASER PART BEAMS, V14, P1; Caridi F, 2006, CZECH J PHYS, V56, pB449, DOI 10.1007/s10582-006-0237-9; D'Souza B. C., 2007, THESIS U SO CALIFORN; Kawamoto S, 2006, ACTA ASTRONAUT, V59, P139, DOI 10.1016/j.actaastro.2006.02.035; LINDLEY RA, 1994, J APPL PHYS, V76, P5457, DOI 10.1063/1.357204; Pakhomov AV, 2002, AIAA J, V40, P2305, DOI 10.2514/2.1567; Phipps C., 2007, LASER ABLATION ITS A, P407; Phipps C., 2005, INT EL PROP C EL ROC; Phipps C, 2010, J PROPUL POWER, V26, P609, DOI 10.2514/1.43733; Phipps C, 2006, APPL SURF SCI, V252, P4838, DOI 10.1016/j.apsusc.2005.07.079; Phipps CR, 2006, AIP CONF PROC, V830, P224; Suzuki K, 2008, J PROPUL POWER, V24, P834, DOI 10.2514/1.32477; Uchida S., 2005, J PLASMA FUSION RES, V81, P186	16	0	1	AMER INST AERONAUTICS  ASTRONAUTICS	RESTON	1801 ALEXANDER BELL DRIVE, STE 500, RESTON, VA 22091-4344 USA	0748-4658	1533-3876		J PROPUL POWER	J. Propul. Power	NOV-DEC	2014	30	6					1485	1489		10.2514/1.B35288		5	Engineering, Aerospace	Engineering	AS2ZM	WOS:000344145000006		
J	Iga, Y; Yoshida, Y				Iga, Yuka; Yoshida, Yoshiki			Influence of Pipe Length on Cavitation Surge Frequency in a Cascade	JOURNAL OF PROPULSION AND POWER			English	Article							NUMERICAL-ANALYSIS; CENTRIFUGAL PUMP; INSTABILITIES; INDUCER	Cavitation surge is a system instability that occurs in pumping machineries in which the unsteady characteristics depend on system components such as the pipe length. On the other hand, under typical boundary conditions of numerical simulations of internal flow, it is supposed that a uniform flow extends infinitely upstream and downstream from the boundaries. Therefore, a numerical simulation of the influence of the pipe length of fluid machinery cannot be realized just by changing the position of a boundary of the computational region. In the present study, a boundary condition that takes into account the pipe length was used to numerically simulate unsteady cavitation in a three-blade cyclic cascade. The resulting cavitation surge frequency became lower when the upstream pipe length becomes longer, which is consistent with previous findings. Also, the resulting cavitation surge frequency showed good agreement with empirical frequencies of the actual cavitation surge of pumps, although the empirical frequency is a rough prediction because it covers various system components. Additionally, the theoretical frequencies were predicted by estimating quasi-steady and local cavitation compliances from the present results. The theoretical frequency takes into account the upstream pipe length. As a result, local cavitation compliance was relatively effective for prediction of the theoretical cavitation surge frequency.	[Iga, Yuka] Tohoku Univ, Inst Fluid Sci, Aoba Ku, Sendai, Miyagi 9808577, Japan; [Yoshida, Yoshiki] Japan Aerosp Explorat Agcy, Kakuda Space Ctr, Kakuda, Miyagi 9811525, Japan	Iga, Y (reprint author), Tohoku Univ, Inst Fluid Sci, Aoba Ku, Katahira 2-1-1, Sendai, Miyagi 9808577, Japan.						Acosta A. J., 1958, P 2 S NAV HYDR, P533; Furukawa A, 2002, JSME INT J B-FLUID T, V45, P672, DOI 10.1299/jsmeb.45.672; Tsujimoto Y, 1997, J FLUID ENG-T ASME, V119, P775, DOI 10.1115/1.2819497; Tsujimoto Y, 2001, J PROPUL POWER, V17, P636, DOI 10.2514/2.5790; Brennen CE, 2013, J FLUID ENG-T ASME, V135, DOI 10.1115/1.4023663; Brennen C. E., 1994, HYDRODYNAMICS PUMPS, P193; Brennen C.E., 1975, 1975WAFE16 ASME, P1; Friedrichs J, 2002, J FLUID ENG-T ASME, V124, P356, DOI 10.1115/1.1457451; Iga Y, 2011, T JPN SOC AERONAUT S, V54, P137, DOI 10.2322/tjsass.54.137; Iga Y, 2004, J FLUID ENG-T ASME, V126, P419, DOI 10.1115/1.1760539; Iga Y, 2011, J PROPUL POWER, V27, P675, DOI 10.2514/1.49454; Iga Y, 2003, J FLUID ENG-T ASME, V125, P643, DOI 10.1115/1.1596239; Iga Y, 2011, J FLUID ENG-T ASME, V133, DOI 10.1115/1.4003663; Iga Y., 2009, J ENV ENG, V4, P524, DOI [10.1299/jee.4.524, DOI 10.1299/JEE.4.524]; Kamijo K., 1977, ASME WINT ANN M ATL; Morino Y., 1986, P 15 INT S SPAC TECH, V1, P333; Sedlar Milan, 2012, International Journal of Fluid Machinery and Systems, V5, DOI 10.5293/IJFMS.2012.5.1.018; Shimagaki M., 2006, 20065071 AIAA, P1; Sloteman D. P., 1984, P 1 INT PUMP S TEX A, P9; Watanabe S., 1998, P 3 INT S CAV, V1, P347; YAMAMOTO K, 1991, JSME INT J II-FLUID, V34, P9; Yee H. C., 1987, TM89464 NASA; Yonezawa Koichi, 2012, International Journal of Fluid Machinery and Systems, V5, DOI 10.5293/IJFMS.2012.5.3.126	23	0	0	AMER INST AERONAUTICS  ASTRONAUTICS	RESTON	1801 ALEXANDER BELL DRIVE, STE 500, RESTON, VA 22091-4344 USA	0748-4658	1533-3876		J PROPUL POWER	J. Propul. Power	NOV-DEC	2014	30	6					1520	1527		10.2514/1.B35229		8	Engineering, Aerospace	Engineering	AS2ZM	WOS:000344145000010		
J	Kitagawa, S; Buno, H; Sakabe, K; Nakagawa, H; Ohtani, H				Kitagawa, Shinya; Buno, Hiroki; Sakabe, Koichi; Nakagawa, Hiroyuki; Ohtani, Hajime			Analyte zone sharpening in pressurized capillary electrochromatography based on electrophoretic migration under a heterogeneous field	JOURNAL OF SEPARATION SCIENCE			English	Article						Conductivity; Field-amplified stacking; Gradient elution; Perchloric acid; Potential gradient	ONLINE SAMPLE PRECONCENTRATION; MICELLAR ELECTROKINETIC CHROMATOGRAPHY; LIQUID-CHROMATOGRAPHY; ELECTRIC-FIELD; GRADIENT; SEPARATION; STACKING; FLOW; ISOTACHOPHORESIS; EFFICIENCY	Significant peak width reductions, or peak height enhancements, of angiotensins were observed when a high voltage was applied to hydrophilic interaction pressurized capillary electrochromatography using gradient elution with mobile phases containing perchloric acid. The investigation using a contactless conductivity detector revealed that perchloric acid was adsorbed on the surface of the stationary phase, when the acetonitrile content in the mobile phase was high, and released from the stationary phase by increasing the water content during a gradient procedure. The released perchloric acid formed a highly concentrated zone moving from the column inlet to the outlet. The electrochromatographic behavior of the analytes, primarily electrophoretic migration, was changed in this zone. As a consequence of the significant variation in migration velocity of the analytes, the sample band width was reduced similar fashion to on-capillary concentration in capillary electrophoresis. Using this result, the reduction of band width and enhancement in separation efficiency was demonstrated in reversed-phase pressurized electrochromatography, in which the conductivity of the mobile phase was significantly altered using a step gradient. The resolution between benzoic acid and 1-naphthalene sulfonic acid was successfully improved from 2.7 to 4.3 by using the band width reduction method based on field-amplified stacking.	[Kitagawa, Shinya; Buno, Hiroki; Sakabe, Koichi; Nakagawa, Hiroyuki; Ohtani, Hajime] Nagoya Inst Technol, Dept Mat Sci & Engn, Grad Sch Engn, Showa Ku, Nagoya, Aichi 4668555, Japan	Kitagawa, S (reprint author), Nagoya Inst Technol, Dept Mat Sci & Engn, Grad Sch Engn, Showa Ku, Nagoya, Aichi 4668555, Japan.	kitagawa.shinya@nitech.ac.jp					Kasicka V, 2012, ELECTROPHORESIS, V33, P48, DOI 10.1002/elps.201100419; Slampova A, 2013, ELECTROPHORESIS, V34, P3, DOI 10.1002/elps.201200346; Timerbaev AR, 2006, ELECTROPHORESIS, V27, P323, DOI 10.1002/elps.200500320; Kitagawa F, 2014, J CHROMATOGR A, V1335, P43, DOI 10.1016/j.chroma.2013.10.066; Fekete S, 2012, J CHROMATOGR A, V1228, P57, DOI 10.1016/j.chroma.2011.09.050; Svec F, 2012, J CHROMATOGR A, V1228, P250, DOI 10.1016/j.chroma.2011.07.019; Breadmore MC, 2013, ELECTROPHORESIS, V34, P29, DOI 10.1002/elps.201200396; Righetti PG, 2013, PROTEOMICS, V13, P325, DOI 10.1002/pmic.201200378; Kasicka V, 2014, ELECTROPHORESIS, V35, P69, DOI 10.1002/elps.201300331; Cabrera K, 2004, J SEP SCI, V27, P843, DOI 10.1002/jssc.200401827; Phung SC, 2013, ELECTROPHORESIS, V34, P1657, DOI 10.1002/elps.201200479; BURGI DS, 1991, ANAL CHEM, V63, P2042, DOI 10.1021/ac00018a028; Kitagawa S, 2008, BUNSEKI KAGAKU, V57, P937; Ross D, 2002, ANAL CHEM, V74, P2556, DOI 10.1021/ac025528w; Quirino JP, 1998, SCIENCE, V282, P465, DOI 10.1126/science.282.5388.465; Sakai T, 2008, ANAL SCI, V24, P735, DOI 10.2116/analsci.24.735; Nakashima R, 2004, J CHROMATOGR A, V1044, P305, DOI 10.1016/j.chroma.2004.03.081; Nguyen DTT, 2006, J SEP SCI, V29, P1836, DOI 10.1002/jssc.200600189; Silvertand LHH, 2008, J CHROMATOGR A, V1204, P157, DOI 10.1016/j.chroma.2008.05.057; Kazarian AA, 2011, J SEP SCI, V34, P2800, DOI 10.1002/jssc.201100414; Balss KM, 2004, J AM CHEM SOC, V126, P1936, DOI 10.1021/ja0385641; Greenlee RD, 1998, BIOTECHNOL PROGR, V14, P300, DOI 10.1021/bp970113v; Hoebel SJ, 2006, ANAL CHEM, V78, P7186, DOI 10.1021/ac060934r; HORI A, 1993, ANAL CHEM, V65, P2882, DOI 10.1021/ac00068a027; Hung SH, 2013, J SEP SCI, V36, P3635, DOI 10.1002/jssc.201300649; Kamour R., 2013, INT J PHARM PHARM SC, V5, P961; Kim SM, 2006, ANAL CHEM, V78, P8028, DOI 10.1021/ac061194p; Kitagawa S, 2011, ELECTROPHORESIS, V32, P1480, DOI 10.1002/elps.201000673; Koegler WS, 1996, J CHROMATOGR A, V726, P229, DOI 10.1016/0021-9673(95)01069-6; Sueyoshi K, 2008, ANAL CHEM, V80, P1255, DOI 10.1021/ac702049r; Svec F., 2004, J CHROMATOGR A, P1044; Tsuda T., 1995, ELECT FIELD APPL CHR; Wang CW, 2014, ELECTROPHORESIS, V35, P1251, DOI 10.1002/elps.201300446; Wei SY, 2012, ELECTROPHORESIS, V33, P1571, DOI 10.1002/elps.201100716	34	2	2	WILEY-V C H VERLAG GMBH	WEINHEIM	BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY	1615-9306	1615-9314		J SEP SCI	J. Sep. Sci.	NOV	2014	37	21					3181	3187		10.1002/jssc.201400668		7	Chemistry, Analytical	Chemistry	AS4ML	WOS:000344250300022		
J	Mutair, S; Ikegami, Y				Mutair, Sami; Ikegami, Yasuyuki			Design Optimization of Shore-Based Low Temperature Thermal Desalination System Utilizing the Ocean Thermal Energy	JOURNAL OF SOLAR ENERGY ENGINEERING-TRANSACTIONS OF THE ASME			English	Article						desalination; ocean thermal energy; ocean thermal energy conversion (OTEC); specific energy; specific heat transfer area		A model for calculation and optimization of seawater desalination process is presented. In this process, temperature difference between the upper and the lower strata of the ocean is utilized in producing fresh water, by evaporating the warm surface seawater at a reduced pressure and then condensing the generated steam by using the colder seawater drawn from the depth of the ocean to produce distilled water. In order to make the optimization process realistic, the developed model takes into consideration the characteristics of the proposed location such as temperature and density variation with depth, seabed topography, and subsequently the actual lengths of the cold and the warm seawater intake pipes. This article gives details of the process and investigates on the influence of various parameters on its economics. As electricity is the sole source of energy used, the objective function was taken as the specific energy, i.e., the amount of electrical energy required for producing a unit mass of distilled water. Results indicate that distilled water can be produced at a value as low as 5.5 kWh per ton, which makes the process competitive with most of the existing desalination technologies.	[Mutair, Sami; Ikegami, Yasuyuki] Saga Univ, Inst Ocean Energy, Saga 8408502, Japan	Mutair, S (reprint author), Saga Univ, Inst Ocean Energy, 1 Honjo Machi, Saga 8408502, Japan.	samymutair@hotmail.com; ikegami@ioes.saga-u.ac.jp					Vega LA, 2002, MAR TECHNOL SOC J, V36, P25; Bharathan D., 1988, ERITP2523108 NAT REN; Gleick P.H., 2002, DIRTY WATER ESTIMATE; Ikegami Y., 2005, P 15 INT OFFSH POL E; Lisa H., 2009, COMMUNICATION; Mutair S, 2009, INT J HEAT MASS TRAN, V52, P5643, DOI 10.1016/j.ijheatmasstransfer.2009.05.009; Mutair S, 2010, DESALINATION, V251, P103, DOI 10.1016/j.desal.2009.09.136; STOUGHTO.RW, 1967, J CHEM ENG DATA, V12, P101, DOI 10.1021/je60032a032; Taborek J., 1988, PROCESS HEAT EXCHANG; WHO, 2000, GLOB WAT SUPPL SAN A	10	1	1	ASME	NEW YORK	TWO PARK AVE, NEW YORK, NY 10016-5990 USA	0199-6231	1528-8986		J SOL ENERG-T ASME	J. Sol. Energy Eng. Trans.-ASME	NOV	2014	136	4							041005	10.1115/1.4027575		8	Energy & Fuels; Engineering, Mechanical	Energy & Fuels; Engineering	AS6AE	WOS:000344346600005		
J	Kawaguchi, T; Fukuda, K; Tokuda, K; Shimada, K; Ichitsubo, T; Oishi, M; Mizuki, J; Matsubara, E				Kawaguchi, T.; Fukuda, K.; Tokuda, K.; Shimada, K.; Ichitsubo, T.; Oishi, M.; Mizuki, J.; Matsubara, E.			Revisit to diffraction anomalous fine structure	JOURNAL OF SYNCHROTRON RADIATION			English	Article						diffraction anomalous fine structure; powder diffraction; site specification; logarithmic dispersion relation; non-iterative method	RESONANT POWDER DIFFRACTION; KRAMERS-KRONIG ANALYSIS; X-RAY; STRUCTURE SPECTROSCOPY; SCATTERING; DAFS; SUPERLATTICE; REFLECTION; MAGNETITE; CRYSTALS	The diffraction anomalous fine structure (DAFS) method that is a spectroscopic analysis combined with resonant X-ray diffraction enables the determination of the valence state and local structure of a selected element at a specific crystalline site and/or phase. This method has been improved by using a polycrystalline sample, channel-cut monochromator optics with an undulator synchrotron radiation source, an area detector and direct determination of resonant terms with a logarithmic dispersion relation. This study makes the DAFS method more convenient and saves a large amount of measurement time in comparison with the conventional DAFS method with a single crystal. The improved DAFS method has been applied to some model samples, Ni foil and Fe3O4 powder, to demonstrate the validity of the measurement and the analysis of the present DAFS method.	[Kawaguchi, T.; Tokuda, K.; Shimada, K.; Ichitsubo, T.; Matsubara, E.] Kyoto Univ, Dept Mat Sci & Engn, Kyoto 6068501, Japan; [Fukuda, K.] Kyoto Univ, Off Soc Acad Collaborat Innovat, Kyoto 6110011, Japan; [Oishi, M.] Kyoto Univ, Grad Sch Engn, Kyoto 6068501, Japan; [Mizuki, J.] Kwansei Gakuin Univ, Sch Sci & Technol, Nishinomiya, Hyogo 6691337, Japan	Kawaguchi, T (reprint author), Kyoto Univ, Dept Mat Sci & Engn, Kyoto 6068501, Japan.	kawaguchi.tomoya.55a@st.kyoto-u.ac.jp	Ichitsubo, Tetsu/F-3201-2010		New Energy and Industrial Technology Development Organization (NEDO) under the Research & Development Initiative for Scientific Innovation of New Generation Batteries (RISING); JSPS [25-2242]	This work was partly supported by the New Energy and Industrial Technology Development Organization (NEDO) under the Research & Development Initiative for Scientific Innovation of New Generation Batteries (RISING) and JSPS Grant-in-Aid for JSPS Fellows numbers 25-2242.	CLINTON WL, 1993, PHYS REV B, V48, P1, DOI 10.1103/PhysRevB.48.1; Favre-Nicolin V, 2012, EUR PHYS J-SPEC TOP, V208, P189, DOI 10.1140/epjst/e2012-01619-x; STRAGIER H, 1992, PHYS REV LETT, V69, P3064, DOI 10.1103/PhysRevLett.69.3064; TORAYA H, 1990, J APPL CRYSTALLOGR, V23, P485, DOI 10.1107/S002188989000704X; Palancher H, 2012, EUR PHYS J-SPEC TOP, V208, P275, DOI 10.1140/epjst/e2012-01624-1; Renevier H, 2003, J SYNCHROTRON RADIAT, V10, P435, DOI 10.1107/S0909049503021332; Cross JO, 1998, PHYS REV B, V58, P11215, DOI 10.1103/PhysRevB.58.11215; Izumi F, 2007, SOL ST PHEN, V130, P15; BURGE RE, 1976, P ROY SOC LOND A MAT, V350, P191, DOI 10.1098/rspa.1976.0103; Proietti MG, 1999, PHYS REV B, V59, P5479, DOI 10.1103/PhysRevB.59.5479; FAHRENFORT J, 1961, SPECTROCHIM ACTA, V17, P698, DOI 10.1016/0371-1951(61)80136-7; Frenkel AI, 1999, J SYNCHROTRON RADIAT, V6, P332, DOI 10.1107/S0909049598013636; Hahn T, 2006, INT TABLES CRYSTALLO, VA; Joly Y., 2008, PHYS REV B, V78, P1; Kobayashi K, 1998, J SYNCHROTRON RADIAT, V5, P972, DOI 10.1107/S0909049597016646; Lee Y.-R., 2006, PHYS REV LETT, V97, P1; Lorimier J, 2003, J APPL CRYSTALLOGR, V36, P301, DOI 10.1107/S002188980300150X; Meyer DC, 1998, J SYNCHROTRON RADIAT, V5, P1275, DOI 10.1107/S0909049598004026; Meyer DC, 1999, PHYS REV B, V59, P15253, DOI 10.1103/PhysRevB.59.15253; PICKERING IJ, 1993, J AM CHEM SOC, V115, P6302, DOI 10.1021/ja00067a052; Renevier H, 1997, PHYS REV LETT, V78, P2775, DOI 10.1103/PhysRevLett.78.2775; ROESSLER DM, 1966, BRIT J APPL PHYS, V17, P1313, DOI 10.1088/0508-3443/17/10/309; ROESSLER DM, 1965, BRIT J APPL PHYS, V16, P1119, DOI 10.1088/0508-3443/16/8/310; SASAKI S, 1995, REV SCI INSTRUM, V66, P1573, DOI 10.1063/1.1145911; Sasaki S., 1989, 8814 KEK, P1; Sorensen L. B., 1994, RESONANT ANOMALOUS X, P389; Tanida H, 2014, J SYNCHROTRON RADIAT, V21, P268, DOI 10.1107/S1600577513025733; Tweet D. J., 1992, JPN J APPL PHYS, V32, P203; VACINOVA J, 1995, J SYNCHROTRON RADIAT, V2, P236, DOI 10.1107/S0909049595007886; Warren B. E., 1990, XRAY DIFFRACTION; Zschornak M, 2014, CRYST RES TECHNOL, V49, P43, DOI 10.1002/crat.201300430	31	2	2	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0909-0495	1600-5775		J SYNCHROTRON RADIAT	J. Synchrot. Radiat.	NOV	2014	21		6				1247	1251		10.1107/S1600577514015148		5	Instruments & Instrumentation; Optics; Physics, Applied	Instruments & Instrumentation; Optics; Physics	AS6JR	WOS:000344370400005		
J	Fujii, T; Fukuyama, N; Tanaka, C; Ikeya, Y; Shinozaki, Y; Kawai, T; Atsumi, T; Shiraishi, T; Sato, E; Kuroda, R; Toyokawa, H; Yamada, K; Ikari, Y; Mori, H				Fujii, Toshiharu; Fukuyama, Naoto; Tanaka, Chiharu; Ikeya, Yoshimori; Shinozaki, Yoshiro; Kawai, Toshiaki; Atsumi, Takuji; Shiraishi, Takashi; Sato, Eiichi; Kuroda, Ryunosuke; Toyokawa, Hiroyuki; Yamada, Kawakatsu; Ikari, Yuji; Mori, Hidezo			Visualization of microvessels by angiography using inverse-Compton scattering X-rays in animal models	JOURNAL OF SYNCHROTRON RADIATION			English	Article						inverse-Compton scattering X-rays; spatial resolution; microangiography	SYNCHROTRON-RADIATION MICROANGIOGRAPHY; HINDLIMB ISCHEMIA; CS2TE PHOTOCATHODE; IMAGING PLATE; RAT MODEL; IN-SITU; RF GUN; ARTERIES	The fundamental performance of microangiography has been evaluated using the S-band linac-based inverse-Compton scattering X-ray (iCSX) method to determine how many photons would be required to apply iCSX to human microangiography. ICSX is characterized by its quasi-monochromatic nature and small focus size which are fundamental requirements for microangiography. However, the current iCSX source does not have sufficient flux for microangiography in clinical settings. It was determined whether S-band compact linac-based iCSX can visualize small vessels of excised animal organs, and the amount of X-ray photons required for real time microangiography in clinical settings was estimated. The iCSX coupled with a high-gain avalanche rushing amorphous photoconductor camera could visualize a resolution chart with only a single iCSX pulse of similar to 3 ps duration; the resolution was estimated to be similar to 500 mu m. The iCSX coupled with an X-ray cooled charge-coupled device image sensor camera visualized seventh-order vascular branches (80 mu m in diameter) of a rabbit ear by accumulating the images for 5 and 30 min, corresponding to irradiation of 3000 and 18000 iCSX pulses, respectively. The S-band linac-based iCSX visualized microvessels by accumulating the images. An iCSX source with a photon number of 3.6 x 10(3)-5.4 x 10(4) times greater than that used in this study may enable visualizing microvessels of human fingertips even in clinical settings.	[Fujii, Toshiharu; Fukuyama, Naoto; Tanaka, Chiharu; Ikeya, Yoshimori; Shinozaki, Yoshiro; Mori, Hidezo] Tokai Univ, Sch Med, Div Physiol, Isehara, Kanagawa 25911, Japan; [Fujii, Toshiharu; Ikari, Yuji] Tokai Univ, Sch Med, Div Cardiol, Isehara, Kanagawa 25911, Japan; [Kawai, Toshiaki; Atsumi, Takuji] Hamamatsu Photon Co Ltd, Tokyo, Japan; [Shiraishi, Takashi] NHK Engn Serv Co Ltd, Tokyo, Japan; [Sato, Eiichi] Iwate Med Univ, Dept Phys, Morioka, Iwate, Japan; [Kuroda, Ryunosuke; Toyokawa, Hiroyuki; Yamada, Kawakatsu] Natl Inst Adv Ind Sci & Technol, Tsukuba, Ibaraki, Japan	Mori, H (reprint author), Tokai Univ, Sch Med, Div Physiol, Isehara, Kanagawa 25911, Japan.	coronary@is.icc.u-tokai.ac.jp	Kuroda, Ryunosuke/D-2722-2014	Kuroda, Ryunosuke/0000-0002-8970-3321			LUDMER PL, 1986, NEW ENGL J MED, V315, P1046, DOI 10.1056/NEJM198610233151702; Mori H, 1996, RADIOLOGY, V201, P173; AMEMIYA Y, 1988, NATURE, V336, P89, DOI 10.1038/336089a0; SONODA M, 1983, RADIOLOGY, V148, P833; Fukuda M, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.164801; Kasahara H, 2003, J AM COLL CARDIOL, V41, P1056, DOI 10.1016/S0935-1097(02)03007-3; Kim JY, 2011, APPL RADIAT ISOTOPES, V69, P1241, DOI 10.1016/j.apradiso.2011.03.048; Kuroda R, 2008, NUCL INSTRUM METH A, V593, P91, DOI 10.1016/j.nima.2008.04.066; MORI H, 1994, CIRCULATION, V89, P863; Mori H, 1999, AM J PHYSIOL-HEART C, V276, pH429; MORI N, 1988, ULTRAMICROSCOPY, V25, P195, DOI 10.1016/0304-3991(88)90014-9; Takeshita S, 1997, CIRCULATION, V95, P805; Takeshita S, 1998, CIRCULATION, V98, P1261; Tanioka K, 2009, NUCL INSTRUM METH A, V608, pS15, DOI 10.1016/j.nima.2009.05.066; Terunuma N, 2010, NUCL INSTRUM METH A, V613, P1, DOI 10.1016/j.nima.2009.10.151; Umetani K., 2011, C P IEEE ENG MED BIO, V2011, P7791; Umetani K, 2009, NUCL INSTRUM METH A, V609, P38, DOI 10.1016/j.nima.2009.07.058; Umetani K., 2007, C P IEEE ENG MED BIO, V2007, P3926, DOI DOI 10.1109/IEMBS.2007.4353192; Yamashita T, 2002, CIRCULATION, V105, pE3, DOI 10.1161/hc0202.100423; Yoshiaki I., 2006, KITASATO MED J, V36, P15	20	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0909-0495	1600-5775		J SYNCHROTRON RADIAT	J. Synchrot. Radiat.	NOV	2014	21		6				1327	1332		10.1107/S1600577514017500		6	Instruments & Instrumentation; Optics; Physics, Applied	Instruments & Instrumentation; Optics; Physics	AS6JR	WOS:000344370400016		
J	Hoshino, M; Uesugi, K; Tsukube, T; Yagi, N				Hoshino, Masato; Uesugi, Kentaro; Tsukube, Takuro; Yagi, Naoto			Quantitative and dynamic measurements of biological fresh samples with X-ray phase contrast tomography	JOURNAL OF SYNCHROTRON RADIATION			English	Article						X-ray phase contrast tomography; quantitative imaging; three-dimensional densitometry; dynamic imaging	MICRO COMPUTED-TOMOGRAPHY; SYNCHROTRON-RADIATION; GRATING INTERFEROMETER; TALBOT INTERFEROMETRY; STRAIN FIELDS; RESOLUTION; SPECIMENS	X-ray phase contrast tomography using a Talbot grating interferometer was applied to biological fresh samples which were not fixed by any fixatives. To achieve a high-throughput measurement for the fresh samples the X-ray phase contrast tomography measurement procedure was improved. The three-dimensional structure of a fresh mouse fetus was clearly depicted as a mass density map using X-ray phase contrast tomography. The mouse fetus measured in the fresh state was then fixed by formalin and measured in the fixed state. The influence of the formalin fixation on soft tissue was quantitatively evaluated by comparing the fresh and fixed samples. X-ray phase contrast tomography was also applied to the dynamic measurement of a biological fresh sample. Morphological changes of a ring-shaped fresh pig aorta were measured tomographically under different degrees of stretching.	[Hoshino, Masato; Uesugi, Kentaro; Yagi, Naoto] Japan Synchrotron Radiat Res Inst, Res & Utilizat Div, Sayo, Hyogo 6795198, Japan; [Tsukube, Takuro] Japanese Red Cross Kobe Hosp, Chuo Ku, Kobe, Hyogo 6510073, Japan	Hoshino, M (reprint author), Japan Synchrotron Radiat Res Inst, Res & Utilizat Div, 1-1-1 Kouto, Sayo, Hyogo 6795198, Japan.	hoshino@spring8.or.jp					Wilkins SW, 1996, NATURE, V384, P335, DOI 10.1038/384335a0; Pfeiffer F, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.108105; Zanette I, 2011, APPL PHYS LETT, V98, DOI 10.1063/1.3559849; Chapman D, 1997, PHYS MED BIOL, V42, P2015, DOI 10.1088/0031-9155/42/11/001; SCHMAHL G, 1995, REV SCI INSTRUM, V66, P1282, DOI 10.1063/1.1145955; Momose A, 2006, JPN J APPL PHYS 1, V45, P5254, DOI 10.1143/JJAP.45.5254; Pfeiffer F, 2007, PHYS MED BIOL, V52, P6923, DOI 10.1088/0031-9155/52/23/010; BONSE U, 1965, APPL PHYS LETT, V6, P155, DOI 10.1063/1.1754212; Bech M, 2009, PHYS MED BIOL, V54, P2747, DOI 10.1088/0031-9155/54/9/010; Momose A, 2003, JPN J APPL PHYS 2, V42, pL866, DOI [10.1143/JJAP.42.L866, 10.1143/JJAP.L866]; Snigirev A, 1995, REV SCI INSTRUM, V66, P5486, DOI 10.1063/1.1146073; Bormann T, 2014, ACTA BIOMATER, V10, P1024, DOI 10.1016/j.actbio.2013.11.007; Momose A, 2011, OPT EXPRESS, V19, P8423, DOI 10.1364/OE.19.008423; Weitkamp T, 2005, OPT EXPRESS, V13, P6296, DOI 10.1364/OPEX.13.006296; DAVIS TJ, 1995, NATURE, V373, P595, DOI 10.1038/373595a0; MOMOSE A, 1995, MED PHYS, V22, P375, DOI 10.1118/1.597472; McDonald SA, 2009, J SYNCHROTRON RADIAT, V16, P562, DOI 10.1107/S0909049509017920; Zanette I, 2012, P NATL ACAD SCI USA, V109, P10199, DOI 10.1073/pnas.1117861109; Germann M, 2008, J NEUROSCI METH, V170, P149, DOI 10.1016/j.jneumeth.2008.01.011; Goto S, 2001, NUCL INSTRUM METH A, V467, P682, DOI 10.1016/S0168-9002(01)00445-4; Hoshino M, 2012, AIP CONF PROC, V1466, P255, DOI 10.1063/1.4742301; Hoshino M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025140; Hoshino M, 2010, AIP CONF PROC, V1266, P57, DOI 10.1063/1.3478199; Hoshino M, 2012, BIOL OPEN, V1, P269, DOI 10.1242/bio.2012430; Hoshino M, 2013, J INSTRUM, V8, DOI 10.1088/1748-0221/8/07/P07018; Mokso R, 2011, AIP CONF PROC, V1365, P38, DOI 10.1063/1.3625299; MOMOSE A, 1995, REV SCI INSTRUM, V66, P1434, DOI 10.1063/1.1145931; Olbinado MP, 2013, APPL PHYS EXPRESS, V6, DOI 10.7567/APEX.6.096601; Pfeiffer F, 2009, J PHYS CONF SER, V186, DOI 10.1088/1742-6596/186/1/012046; Schulz G, 2011, J NEUROSCI METH, V202, P17, DOI 10.1016/j.jneumeth.2011.08.031; Schulz G, 2010, J R SOC INTERFACE, V7, P1665, DOI 10.1098/rsif.2010.0281; Schulz G, 2010, PROC SPIE, V7804, DOI 10.1117/12.859273; Uesugi K, 2011, AIP CONF PROC, V1365, P309, DOI 10.1063/1.3625366; Uesugi K, 2012, PROC SPIE, V8506, DOI 10.1117/12.929575; Uesugi K, 2006, J SYNCHROTRON RADIAT, V13, P403, DOI 10.1107/S0909049506023466; Uesugi K, 2011, J SYNCHROTRON RADIAT, V18, P217, DOI 10.1107/S0909049510044523; Xi Y, 2012, J SYNCHROTRON RADIAT, V19, P821, DOI 10.1107/S0909049512029354; Xiao XH, 2012, PROC SPIE, V8506, DOI 10.1117/12.936331	38	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0909-0495	1600-5775		J SYNCHROTRON RADIAT	J. Synchrot. Radiat.	NOV	2014	21		6				1347	1357		10.1107/S1600577514018128		11	Instruments & Instrumentation; Optics; Physics, Applied	Instruments & Instrumentation; Optics; Physics	AS6JR	WOS:000344370400018		
J	Sekiguchi, Y; Yamamoto, M; Oroguchi, T; Takayama, Y; Suzuki, S; Nakasako, M				Sekiguchi, Yuki; Yamamoto, Masaki; Oroguchi, Tomotaka; Takayama, Yuki; Suzuki, Shigeyuki; Nakasako, Masayoshi			IDATEN and G-SITENNO: GUI-assisted software for coherent X-ray diffraction imaging experiments and data analyses at SACLA	JOURNAL OF SYNCHROTRON RADIATION			English	Article						coherent X-ray diffraction imaging; X-ray free-electron laser; structural analysis of non-crystalline particles	FREE-ELECTRON LASER; PHASE RETRIEVAL; CRYSTALLOGRAPHY; PULSES; ALLOW; CELLS	Using our custom-made diffraction apparatus KOTOBUKI-1 and two multiport CCD detectors, cryogenic coherent X-ray diffraction imaging experiments have been undertaken at the SPring-8 Angstrom Compact free electron LAser (SACLA) facility. To efficiently perform experiments and data processing, two software suites with user-friendly graphical user interfaces have been developed. The first is a program suite named IDATEN, which was developed to easily conduct four procedures during experiments: aligning KOTOBUKI-1, loading a flash-cooled sample into the cryogenic goniometer stage inside the vacuum chamber of KOTOBUKI-1, adjusting the sample position with respect to the X-ray beam using a pair of telescopes, and collecting diffraction data by raster scanning the sample with X-ray pulses. Named G-SITENNO, the other suite is an automated version of the original SITENNO suite, which was designed for processing diffraction data. These user-friendly software suites are now indispensable for collecting a large number of diffraction patterns and for processing the diffraction patterns immediately after collecting data within a limited beam time.	[Sekiguchi, Yuki; Oroguchi, Tomotaka; Takayama, Yuki; Suzuki, Shigeyuki; Nakasako, Masayoshi] Keio Univ, Fac Sci & Technol, Dept Phys, Kohoku Ku, Yokohama, Kanagawa 2238522, Japan; [Sekiguchi, Yuki; Yamamoto, Masaki; Oroguchi, Tomotaka; Takayama, Yuki; Nakasako, Masayoshi] RIKEN SPring 8 Ctr, Sayo, Hyogo 6795148, Japan	Yamamoto, M (reprint author), RIKEN SPring 8 Ctr, 1-1-1 Kohto, Sayo, Hyogo 6795148, Japan.	yamamoto@riken.jp; nakasako@phys.keio.ac.jp	Yamamoto, Masaki/B-7844-2015	Yamamoto, Masaki/0000-0002-1311-1768	XFEL key technology; JSPS [24654140]; TO [26800227, 24113723, 26104535]; MEXT [23120525, 25120725]; SACLA [2012A8005, 2012B8037, 2013A8043, 2013B8049, 2014A8033]; CXDI experiments at SPring-8 [20090097, 20100035, 20110006]	The authors are grateful to Drs Takashi Kameshima, Yasumasa Joti and Kensuke Tono of SACLA for their kind help during the XFEL-CXDI experiments and data analyses. The implementation of the two GUI suites was supported by the grant for XFEL key technology and the X-ray Free Electron Laser Priority Strategy Program from the MEXT to MN and MY. Sample preparation and software development were also supported by grants from the JSPS to MN (No. 24654140) and TO (No. 26800227) and from the MEXT to MN (Nos. 23120525 and 25120725) and TO (No. 24113723 and 26104535). For software development, we used diffraction data collected in cryogenic XFEL-CXDI experiments performed at SACLA (proposal Nos. 2012A8005, 2012B8037, 2013A8043, 2013B8049 and 2014A8033) and cryogenic synchrotron-CXDI experiments at SPring-8 (proposal Nos. 20090097, 20100035 and 20110006).	Nakasako M, 2013, REV SCI INSTRUM, V84, DOI 10.1063/1.4822123; Chapman HN, 2006, NAT PHYS, V2, P839, DOI 10.1038/nphys461; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Kameshima T, 2014, REV SCI INSTRUM, V85, DOI 10.1063/1.4867668; Miao JW, 1999, NATURE, V400, P342, DOI 10.1038/22498; Nishino Y, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.018101; Takahashi Y, 2013, NANO LETT, V13, P6028, DOI 10.1021/nl403247x; Kuo CH, 2007, ADV FUNCT MATER, V17, P3773, DOI 10.1002/adfm.200700356; Ishikawa T, 2012, NAT PHOTONICS, V6, P540, DOI 10.1038/nphoton.2012.141; FIENUP JR, 1982, APPL OPTICS, V21, P2758, DOI 10.1364/AO.21.002758; Jiang HD, 2010, P NATL ACAD SCI USA, V107, P11234, DOI 10.1073/pnas.1000156107; Rodriguez JA, 2013, J APPL CRYSTALLOGR, V46, P312, DOI 10.1107/S0021889813002471; Seibert MM, 2011, NATURE, V470, P78, DOI 10.1038/nature09748; Howells MR, 2009, J ELECTRON SPECTROSC, V170, P4, DOI 10.1016/j.elspec.2008.10.008; Miao J, 2003, PHYS REV B, V67, DOI 10.1103/PhysRevB.67.174104; Miao JW, 2008, ANNU REV PHYS CHEM, V59, P387, DOI 10.1146/annurev.physchem.59.032607.093642; Kodama W, 2011, PHYS REV E, V84, DOI 10.1103/PhysRevE.84.021902; Luke DR, 2005, INVERSE PROBL, V21, P37, DOI 10.1088/0266-5611/21/1/004; Martin AV, 2012, OPT EXPRESS, V20, P16650, DOI 10.1364/OE.20.016650; Nakagawa A., 2013, ACTA CRYSTALLOGR A, V69, ps28; Oroguchi T, 2013, PHYS REV E, V87, DOI 10.1103/PhysRevE.87.022712; Sekiguchi Y, 2014, J SYNCHROTRON RADIAT, V21, P600, DOI 10.1107/S1600577514003439; Takayama Y, 2012, REV SCI INSTRUM, V83, DOI 10.1063/1.4718359; Tono K, 2013, J PHYS CONF SER, V425, DOI 10.1088/1742-6596/425/7/072006; Williams T., 2014, GNUPLOT 4 6 INTERACT; Xu R, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5061; Yumoto H, 2013, NAT PHOTONICS, V7, P43, DOI [10.1038/nphoton.2012.306, 10.1038/NPHOTON.2012.306]	27	3	3	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0909-0495	1600-5775		J SYNCHROTRON RADIAT	J. Synchrot. Radiat.	NOV	2014	21		6				1378	1383		10.1107/S1600577514017111		6	Instruments & Instrumentation; Optics; Physics, Applied	Instruments & Instrumentation; Optics; Physics	AS6JR	WOS:000344370400023		
J	Ikeda-Naito, E; Hondoh, H; Ueno, S; Sato, K				Ikeda-Naito, Eriko; Hondoh, Hironori; Ueno, Satoru; Sato, Kiyotaka			Mixing Phase Behavior of 1,3-Dipalmitoyl-2-Oleoyl-sn-Glycerol (POP) and 1,2-Dipalmitoyl-3-Oleoyl-rac-Glycerol (PPO) in n-Dodecane Solution	JOURNAL OF THE AMERICAN OIL CHEMISTS SOCIETY			English	Article						Triacylglycerols; Polymorphism; Binary mixture; Molecular compound; X-ray diffraction; Lipid crystallization	X-RAY-DIFFRACTION; BINARY-MIXTURES; PALM OIL; CRYSTALLIZATION KINETICS; SOS; POLYMORPHISM; TRIACYLGLYCEROLS; 1,3-DISTEAROYL-2-OLEOYL-SN-GLYCEROL; SYSTEMS	We examined the mixing phase behavior of 1,3-dipalmitoyl-2-oleoyl-sn-glycerol (POP) and 1,2-dipalmitoyl-3-oleoyl-rac-glycerol (PPO) in organic solutions containing n-dodecane (C-12) as a solvent to confirm whether the molecular compound (MC) crystals of POP/PPO are formed as metastable and most stable forms in the dilute solution by using DSC and synchrotron radiation X-ray diffraction. The POP/PPO mixtures were prepared at different concentration ratios of POP and PPO with a 10 % increment in two solutions having weight concentration ratios of (POP+PPO):C-12 of 50:50 (50 % solution) and 20:80 (20 % solution). We found that MC crystals formed at a ratio of POP/PPO = 50/50 having the melting point of 23.1 and 20.6 degrees C in 50 and 20 % solution systems in stable states of incubated samples, respectively. The metastable (beta') and stable (beta) forms of MC of POP/PPO = 50/50 having a double-chain-length structure were confirmed in kinetic behavior and thermodynamically stable states attained after long time incubation, in contrast to the triple-chain-length structure of stable forms of POP (beta) and PPO (beta'). In addition, we observed the formation of MC crystals of POP/PPO in diluted solutions having n-dodecane concentrations up to 98 % and conclude that molecular interactions between POP and PPO molecules to form MC crystals are not altered by solvent molecules in diluted solutions.	[Ikeda-Naito, Eriko; Hondoh, Hironori; Ueno, Satoru; Sato, Kiyotaka] Hiroshima Univ, Grad Sch Biosphere Sci, Lab Food Biophys, Higash Hiroshima 7398528, Japan	Ikeda-Naito, E (reprint author), Mitsubishi Kagaku Foods Co, Aoba Ku, Yokohama, Kanagawa 2278502, Japan.	2616725@cc.m-kagaku.co.jp			Ministry of Education, Culture, Sports, Science, and Technology [20540397]; Photon Factory Program Advisory committee [2008G623, 2010G656]	This work is partially supported by the following project: the Ministry of Education, Culture, Sports, Science, and Technology (Grant-in-Aid 20540397). The SR-XRD experiments were conducted with the approval of the Photon Factory Program Advisory committee (proposal no. 2008G623 and No. 2010G656). The authors acknowledge the help of Prof. M. Nomura, the station manager at the Photon Factory, KEK Institute, Tsukuba, Japan. The authors also appreciate Mr. Y. Shinohara, the University of Tokyo, for great support with the SR-XRD measurements.	Zhang X, 2013, MOLECULES, V18, P1036, DOI 10.3390/molecules18011036; Kellens M, 2007, EUR J LIPID SCI TECH, V109, P336, DOI 10.1002/ejlt.200600309; Bayes-Garcia L, 2011, CRYSTENGCOMM, V13, P6694, DOI 10.1039/c1ce05667k; Zhang L, 2009, J THERM ANAL CALORIM, V98, P105, DOI 10.1007/s10973-009-0451-3; Sato K, 2014, FATS IN FOOD TECHNOLOGY, 2ND EDITION, P1; SATO K, 1989, J AM OIL CHEM SOC, V66, P664, DOI 10.1007/BF02669949; Kallio H, 2001, J AGR FOOD CHEM, V49, P3363, DOI 10.1021/jf010015w; AMEMIYA Y, 1995, REV SCI INSTRUM, V66, P2290, DOI 10.1063/1.1145667; Boodhoo MV, 2009, CHEM PHYS LIPIDS, V160, P11, DOI 10.1016/j.chemphyslip.2009.02.008; Boodhoo MV, 2008, CHEM PHYS LIPIDS, V154, P7, DOI 10.1016/j.chemphyslip.2008.04.001; Boodhoo MV, 2009, CHEM PHYS LIPIDS, V157, P21, DOI 10.1016/j.chemphyslip.2008.08.002; Bouzidi L, 2010, CHEM PHYS LIPIDS, V163, P607, DOI 10.1016/j.chemphyslip.2010.05.002; Floter E, 2012, STRUCTURE FUNCTION A, P107; Gibon V., 2012, Palm oil: production, processing, characterization, and uses, P329; Ikeda E, 2010, J PHYS CHEM B, V114, P10961, DOI 10.1021/jp101821c; KELLENS M, 1991, CHEM PHYS LIPIDS, V58, P145, DOI 10.1016/0009-3084(91)90120-Z; KOYANO T, 1992, J PHYS CHEM-US, V96, P10514, DOI 10.1021/j100204a072; Larsson K., 2006, LIPIDS STRUCTURE PHY; LUTTON ES, 1951, J AM CHEM SOC, V73, P5595, DOI 10.1021/ja01156a028; Marangoni A. G., 2013, STRUCTURE PROPERTIES, V2nd; Minato A, 1997, CHEM PHYS LIPIDS, V88, P63, DOI 10.1016/S0009-3084(97)00045-5; Minato A, 1997, J AM OIL CHEM SOC, V74, P1213, DOI 10.1007/s11746-997-0047-7; Minato A, 1997, J PHYS CHEM B, V101, P3498, DOI 10.1021/jp962956v; Minato A, 1996, J AM OIL CHEM SOC, V73, P1567, DOI 10.1007/BF02523526; Mizobe H, 2013, J AM OIL CHEM SOC, V90, P1809, DOI 10.1007/s11746-013-2339-4; Rousset P, 1998, J AM OIL CHEM SOC, V75, P857, DOI 10.1007/s11746-998-0237-y; Sasaki M, 2012, COCOA BUTTER RELATED, P151; Sato K., 2001, CRYSTALLIZATION PROC, P177; Sato K, 2005, BAILEYS IND OIL FAT, P77; Smith K. W., 2001, CRYSTALLIZATION PROC, P357; Smith KW, 2013, EUR J LIPID SCI TECH, V115, P838, DOI 10.1002/ejlt.201300035; Takeuchi M, 2003, CRYST GROWTH DES, V3, P369, DOI 10.1021/cg025594r; Takeuchi M, 2002, FOOD RES INT, V35, P919, DOI 10.1016/S0963-9969(02)00154-0; Takeuchi M, 2002, J AM OIL CHEM SOC, V79, P627, DOI 10.1007/s11746-002-0535-1; TIMMS RE, 1984, PROG LIPID RES, V23, P1, DOI 10.1016/0163-7827(84)90004-3; Timms RE, 2003, CONFECTIONERY FAT HD; Zhang L, 2007, J AM OIL CHEM SOC, V84, P219, DOI 10.1007/s11746-006-1034-0	37	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0003-021X	1558-9331		J AM OIL CHEM SOC	J. Am. Oil Chem. Soc.	NOV	2014	91	11					1837	1848		10.1007/s11746-014-2534-y		12	Chemistry, Applied; Food Science & Technology	Chemistry; Food Science & Technology	AS3GG	WOS:000344164900002		
J	Kobayashi, T; Ogino, A; Miyake, Y; Mori, H; Hosoda, A; Fujita, M; Tsuno, T; Adachi, S				Kobayashi, Takashi; Ogino, Akane; Miyake, Yasuhito; Mori, Hajime; Hosoda, Asao; Fujita, Muneki; Tsuno, Takuo; Adachi, Shuji			Lipase-Catalyzed Esterification of Triterpene Alcohols and Phytosterols with Oleic Acid	JOURNAL OF THE AMERICAN OIL CHEMISTS SOCIETY			English	Article						Esterification; Lipase; Oleic acid; Phytosterol; Triterpene alcohol	RICE BRAN; FERULIC ACID; CYCLOARTENOL; PURIFICATION; SITOSTEROL; SEPARATION; STEROLS; SKIN; OIL	Oleic acid esters of phytosterols (PSs) and triterpene alcohols (TAs), derived from rice bran, were synthesized using lipases under mild conditions. Some lipases, especially from Candida rugosa, type VII, showed very high substrate specificity towards both PSs and TAs, when a mixture of PS and TA (PS/TA mixture) was used as the substrate source. The maximum yield of PS esters was ca. 80 % in each case; however, the maximum yield of TA esters was much lower when the reaction was continued for 7 days. Due to the difficulty in purifying the esters obtained when the PS/TA mixture was used as source of substrate, free PSs and TAs were separated from the PS/TA mixture by silica-gel and reverse-phase chromatography prior to esterification. The pure PSs or TAs were esterified with oleic acid to obtain the corresponding esters with high purity. Differential scanning calorimetric analysis of the resulting esters revealed that their melting points ranged from 7.0 to 42 degrees C. These values were at least 100 degrees C lower than those of the free PSs and TAs.	[Kobayashi, Takashi; Ogino, Akane; Adachi, Shuji] Kyoto Univ, Grad Sch Agr, Div Food Sci & Biotechnol, Sakyo Ku, Kyoto 6068502, Japan; [Miyake, Yasuhito; Mori, Hajime; Hosoda, Asao] Ind Technol Ctr Wakayama Prefecture, Wakayama 6496261, Japan; [Fujita, Muneki; Tsuno, Takuo] Tsuno Food Ind Co Ltd, Katsuragi, Wakayama 6497194, Japan	Adachi, S (reprint author), Kyoto Univ, Grad Sch Agr, Div Food Sci & Biotechnol, Sakyo Ku, Kyoto 6068502, Japan.	adachi@kais.kyoto-u.ac.jp			Project Support R&D of the Innovative Industry Technology, Wakayama Prefecture, Japan	This study was financially supported by Project Support R&D of the Innovative Industry Technology, Wakayama Prefecture, Japan.	POLLAK OJ, 1953, CIRCULATION, V7, P702; CHANG RC, 1994, BIOTECHNOL APPL BIOC, V19, P93; Kikuzaki H, 2002, J AGR FOOD CHEM, V50, P2161, DOI 10.1021/jf011348w; Xu ZM, 1999, J AGR FOOD CHEM, V47, P2724, DOI 10.1021/jf981175j; GRAF E, 1992, FREE RADICAL BIO MED, V13, P435, DOI 10.1016/0891-5849(92)90184-I; Puglia C, 2008, J COSMET SCI, V59, P217; Akihisa T, 2000, J AGR FOOD CHEM, V48, P2313, DOI 10.1021/jf000135o; BENTLEY HR, 1953, J CHEM SOC, P3673, DOI 10.1039/jr9530003673; FERNHOLZ ERHARD, 1941, JOUR AMER CHEM SOC, V63, P1155, DOI 10.1021/ja01849a079; Folmer BM, 2003, ADV COLLOID INTERFAC, V103, P99, DOI 10.1016/S0001-8686(01)00100-2; Hircher HW, 1973, LIPIDS, V8, P453, DOI 10.1007/BF02531763; HOPPE U, 1981, J DISPER SCI TECHNOL, V2, P433, DOI 10.1080/01932698108943922; KIRCHER HW, 1973, LIPIDS, V8, P97, DOI 10.1007/BF02531803; Li JG, 2000, J FOOD LIPIDS, V7, P11, DOI 10.1111/j.1745-4522.2000.tb00156.x; NISHIOKA I, 1965, CHEM PHARM BULL, V13, P379; PETERSON DW, 1951, P SOC EXP BIOL MED, V78, P143; STARRATT AN, 1966, PHYTOCHEMISTRY, V5, P1341, DOI 10.1016/S0031-9422(00)86134-8; Yasukawa K, 1998, BIOL PHARM BULL, V21, P1072	18	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0003-021X	1558-9331		J AM OIL CHEM SOC	J. Am. Oil Chem. Soc.	NOV	2014	91	11					1885	1890		10.1007/s11746-014-2531-1		6	Chemistry, Applied; Food Science & Technology	Chemistry; Food Science & Technology	AS3GG	WOS:000344164900007		
J	Maezawa, Y; Onay, T; Scott, RP; Keir, LS; Dimke, H; Li, CJ; Eremina, V; Maezawa, Y; Jeansson, M; Shan, JD; Binnie, M; Lewin, M; Ghosh, A; Miner, JH; Vainio, SJ; Quaggin, SE				Maezawa, Yoshiro; Onay, Tuncer; Scott, Rizaldy P.; Keir, Lindsay S.; Dimke, Henrik; Li, Chengjin; Eremina, Vera; Maezawa, Yuko; Jeansson, Marie; Shan, Jingdong; Binnie, Matthew; Lewin, Moshe; Ghosh, Asish; Miner, Jeffrey H.; Vainio, Seppo J.; Quaggin, Susan E.			Loss of the Podocyte-Expressed Transcription Factor Tcf21/Pod1 Results in Podocyte Differentiation Defects and FSGS	JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY			English	Article							DIABETIC-NEPHROPATHY; KIDNEY DEVELOPMENT; GENES; MICE; ORGANOGENESIS; CAPSULIN; PROTEIN; POD1	Podocytes are terminally differentiated cells with an elaborate cytoskeleton and are critical components of the glomerular barrier. We identified a bHLH transcription factor, Tcf21, that is highly expressed in developing and mature podocytes. Because conventional Tcf21 knockout mice die in the perinatal period with major cardiopulmonary defects, we generated a conditional Tcf21 knockout mouse to explore the role of this transcription factor in podocytes in vivo. Tcf21 was deleted from podocytes and podocyte progenitors using podocin-cre (podTcf21) and wnt4-cre (wnt4creTcf21) driver strains, respectively. Loss of Tcf21 from capillary-loop stage podocytes (podTcf21) results in simplified glomeruli with a decreased number of endothelial and mesangial cells. By 5 weeks of age, 40% of podTcf21 mice develop massive proteinuria and lesions similar to FSGS. Notably, the remaining 60% of mice do not develop proteinuria even when aged to 8 months. By contrast, earlier deletion of Tcf21 from podocyte precursors (wnt4creTcf21) results in a profound developmental arrest of podocyte differentiation and renal failure in 100% of mice during the perinatal period. Taken together, our results demonstrate a critical role for Tcf21 in the differentiation and maintenance of podocytes. Identification of direct targets of this transcription factor may provide new therapeutic avenues for proteinuric renal disease, including FSGS.	[Maezawa, Yoshiro; Onay, Tuncer; Scott, Rizaldy P.; Dimke, Henrik; Li, Chengjin; Eremina, Vera; Jeansson, Marie; Quaggin, Susan E.] Mt Sinai Hosp, Lunenfeld Tanenbaum Res Inst, Toronto, ON M5G 1X5, Canada; [Maezawa, Yoshiro] Chiba Univ Hosp, Dept Diabet Metab & Endocrinol, Chiba, Japan; [Onay, Tuncer; Li, Chengjin; Ghosh, Asish; Quaggin, Susan E.] Northwestern Univ, Feinberg Cardiovasc Res Inst, Chicago, IL 60611 USA; [Onay, Tuncer; Li, Chengjin; Ghosh, Asish; Quaggin, Susan E.] Northwestern Univ, Div Nephrol & Hypertens, Chicago, IL 60611 USA; [Keir, Lindsay S.] Univ Bristol, Acad Renal Unit, Bristol, Avon, England; [Maezawa, Yuko] Hosp Sick Children, Res Inst, Neurosci & Mental Hlth Program, Toronto, ON M5G 1X8, Canada; [Jeansson, Marie] Uppsala Univ, Dept Immunol Genet & Pathol, Uppsala, Sweden; [Shan, Jingdong; Vainio, Seppo J.] Univ Oulu, Bioctr & Infotech Oulu, Fac Biochemisty & Mol Med, Lab Dev Biol,Oulu Ctr Cell Matrix Res, SF-90100 Oulu, Finland; [Binnie, Matthew] Univ Toronto, St Michaels Hosp, Div Respirol, Toronto, ON, Canada; [Lewin, Moshe] RAMBAM Hlth Care Campus, Dept Nephrol, Haifa, Israel; [Miner, Jeffrey H.] Washington Univ, Sch Med, Dept Internal Med, Renal Div, St Louis, MO 63110 USA	Quaggin, SE (reprint author), Lurie Med Res Bldg,303 E Super, Chicago, IL 60611 USA.	quaggin@northwestern.edu	Dimke, Henrik/G-7970-2011	Dimke, Henrik/0000-0002-9170-2168	Canadian Institutes of Health Research [62931]; Terry Fox grant	We are grateful to Ken Harpal and Douglas Holmyard for histology and EM analysis. We thank Chao Lu and staff for help with microarray analysis and Dr. Paul Thorner, Mazdak Bagherie, and Antoine Reginensi for helpful discussions. This work is supported by Canadian Institutes of Health Research grant 62931 and a Terry Fox grant.	Cui SY, 2004, DEVELOPMENT, V131, P4095, DOI 10.1242/dev.01266; Takemoto M, 2006, EMBO J, V25, P1160, DOI 10.1038/sj.emboj.7601014; Lu JR, 2000, P NATL ACAD SCI USA, V97, P9525, DOI 10.1073/pnas.97.17.9525; Kobayashi A, 2008, CELL STEM CELL, V3, P169, DOI 10.1016/j.stem.2008.05.020; Eremina V, 2008, NEW ENGL J MED, V358, P1129, DOI 10.1056/NEJMoa0707330; KREIDBERG JA, 1993, CELL, V74, P679, DOI 10.1016/0092-8674(93)90515-R; Makino H, 2006, DIABETES, V55, P2747, DOI 10.2337/db05-1683; Sadl VS, 2002, DEV BIOL, V249, P16, DOI 10.1006/dbio.2002.0751; Humphreys BD, 2010, AM J PATHOL, V176, P85, DOI 10.2353/ajpath.2010.090517; Novak A, 2000, GENESIS, V28, P147, DOI 10.1002/1526-968X(200011/12)28:3/4<147::AID-GENE90>3.3.CO;2-7; SPITZER A, 1974, J CLIN INVEST, V53, P279, DOI 10.1172/JCI107548; Eremina V, 2003, J CLIN INVEST, V111, P707, DOI 10.1172/JCI200317423; HUSDAN H, 1968, CLIN CHEM, V14, P222; Breyer MD, 2005, J AM SOC NEPHROL, V16, P27, DOI 10.1681/ASN.2004080648; Woroniecka KI, 2011, DIABETES, V60, P2354, DOI 10.2337/db10-1181; Greka A, 2012, ANNU REV PHYSIOL, V74, P299, DOI 10.1146/annurev-physiol-020911-153238; Liu PT, 2003, GENOME RES, V13, P476, DOI 10.1101/gr.749203; Miner JH, 1999, KIDNEY INT, V56, P2016, DOI 10.1046/j.1523-1755.1999.00785.x; RUBIN MI, 1949, J CLIN INVEST, V28, P1144, DOI 10.1172/JCI102149; Takemoto M, 2002, AM J PATHOL, V161, P799, DOI 10.1016/S0002-9440(10)64239-3; DEAN RFA, 1947, J PHYSIOL-LONDON, V106, P431; Quaggin SE, 1999, DEVELOPMENT, V126, P5771; Lu JR, 2002, SCIENCE, V298, P2378, DOI 10.1126/science.1078273; Maezawa Y, 2012, SELDIN GIEBISCHS KID, P721; Maezawa Y, 2011, BRENNER RECTORS KIDN; Miner JH, 2002, J CLIN INVEST, V109, P1065, DOI 10.1172/JCi200213954; Piscione TD, 2004, GENE EXPR PATTERNS, V4, P707, DOI 10.1016/j.modgep.2004.04.007; Shan JD, 2010, DIFFERENTIATION, V79, P57, DOI 10.1016/j.diff.2009.08.006	28	2	2	AMER SOC NEPHROLOGY	WASHINGTON	1725 I ST, NW STE 510, WASHINGTON, DC 20006 USA	1046-6673	1533-3450		J AM SOC NEPHROL	J. Am. Soc. Nephrol.	NOV	2014	25	11					2459	2470		10.1681/ASN.2013121307		12	Urology & Nephrology	Urology & Nephrology	AS1KO	WOS:000344040300011		
J	Lanaspa, MA; Ishimoto, T; Cicerchi, C; Tamura, Y; Roncal-Jimenez, CA; Chen, W; Tanabe, K; Andres-Hernando, A; Orlicky, DJ; Finol, E; Inaba, S; Li, NX; Rivard, CJ; Kosugi, T; Sanchez-Lozada, LG; Petrash, JM; Sautin, YY; Ejaz, AA; Kitagawa, W; Garcia, GE; Bonthron, DT; Asipu, A; Diggle, CP; Rodriguez-Iturbe, B; Nakagawa, T; Johnson, RJ				Lanaspa, Miguel A.; Ishimoto, Takuji; Cicerchi, Christina; Tamura, Yoshifuru; Roncal-Jimenez, Carlos A.; Chen, Wei; Tanabe, Katsuyuki; Andres-Hernando, Ana; Orlicky, David J.; Finol, Esteban; Inaba, Shinichiro; Li, Nanxing; Rivard, Christopher J.; Kosugi, Tomoki; Sanchez-Lozada, Laura G.; Petrash, J. Mark; Sautin, Yuri Y.; Ejaz, A. Ahsan; Kitagawa, Wataru; Garcia, Gabriela E.; Bonthron, David T.; Asipu, Aruna; Diggle, Christine P.; Rodriguez-Iturbe, Bernardo; Nakagawa, Takahiko; Johnson, Richard J.			Endogenous Fructose Production and Fructokinase Activation Mediate Renal Injury in Diabetic Nephropathy	JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY			English	Article							INDUCED METABOLIC SYNDROME; PROXIMAL TUBULAR CELLS; URIC-ACID; GLOMERULAR HYPERTENSION; ALDOSE REDUCTASE; OXIDATIVE STRESS; KAPPA-B; TUBULOINTERSTITIAL INJURY; KIDNEY-DISEASE; DB/DB MICE	Diabetes is associated with activation of the polyol pathway, in which glucose is converted to sorbitol by aldose reductase. Previous studies focused on the role of sorbitol in mediating diabetic complications. However, in the proximal tubule, sorbitol can be converted to fructose, which is then metabolized largely by fructokinase, also known as ketohexokinase, leading to ATP depletion, proinflammatory cytokine expression, and oxidative stress. We and others recently identified a potential deleterious role of dietary fructose in the generation of tubulointerstitial injury and the acceleration of CKD. In this study, we investigated the potential role of endogenous fructose production, as opposed to dietary fructose, and its metabolism through fructokinase in the development of diabetic nephropathy. Wild-type mice with streptozotocin-induced diabetes developed proteinuria, reduced GFR, and renal glomerular and proximal tubular injury. Increased renal expression of aldose reductase; elevated levels of renal sorbitol, fructose, and uric acid; and low levels of ATP confirmed activation of the fructokinase pathway. Furthermore, renal expression of inflammatory cytokines with macrophage infiltration was prominent. In contrast, diabetic fructokinase-deficient mice demonstrated significantly less proteinuria, renal dysfunction, renal injury, and inflammation. These studies identify fructokinase as a novel mediator of diabetic nephropathy and document a novel role for endogenous fructose production, or fructoneogenesis, in driving renal disease.	[Lanaspa, Miguel A.; Ishimoto, Takuji; Cicerchi, Christina; Tamura, Yoshifuru; Roncal-Jimenez, Carlos A.; Chen, Wei; Tanabe, Katsuyuki; Andres-Hernando, Ana; Orlicky, David J.; Finol, Esteban; Inaba, Shinichiro; Li, Nanxing; Rivard, Christopher J.; Sanchez-Lozada, Laura G.; Petrash, J. Mark; Kitagawa, Wataru; Garcia, Gabriela E.; Nakagawa, Takahiko; Johnson, Richard J.] Univ Colorado, Dept Med, Div Renal Dis & Hypertens, Denver, CO USA; [Finol, Esteban; Rodriguez-Iturbe, Bernardo] Venezuelan Sci Res Inst, Maracaibo, Venezuela; [Finol, Esteban; Rodriguez-Iturbe, Bernardo] Univ Hosp Zulia, Maracaibo, Venezuela; [Kosugi, Tomoki] Nagoya Univ, Grad Sch Med, Dept Nephrol, Nagoya, Aichi 4648601, Japan; [Sanchez-Lozada, Laura G.] INC Ignacio Chavez, Lab Renal Physiopathol, Mexico City, DF, Mexico; [Sanchez-Lozada, Laura G.] INC Ignacio Chavez, Dept Nephrol, Mexico City, DF, Mexico; [Sautin, Yuri Y.] Univ Florida, Div Nephrol & Hypertens, Gainesville, FL USA; [Ejaz, A. Ahsan] Univ Florida, Div Nephrol Hypertens & Transplantat, Gainesville, FL USA; [Bonthron, David T.; Asipu, Aruna; Diggle, Christine P.] Univ Leeds, Leeds Inst Biomed & Clin Sci, Leeds, W Yorkshire, England; [Nakagawa, Takahiko] Kyoto Univ, Grad Sch Med, TMK Project, Kyoto, Japan	Lanaspa, MA (reprint author), 12700 East 19th Ave,C-281, Aurora, CO 80045 USA.	Miguel.lanaspagarcia@ucdenver.edu		Finol, Esteban/0000-0002-9830-439X	National Institutes of Health, Diabetes UK (UK) [HL-68607, RC4-DK090859-01, 1K01-DK095930-01, RO1-DK082509]; University of Colorado;  [RD04/0002833]	This work was supported by grants HL-68607 and RC4-DK090859-01 (to R.J.J.), grant 1K01-DK095930-01 (to M.A.L.), and grant RO1-DK082509 (to G.G.) from the National Institutes of Health, Diabetes UK (UK), grant RD04/0002833, and startup funds from the University of Colorado.	Wang S, 2008, NEPHROL DIAL TRANSPL, V23, P2167, DOI 10.1093/ndt/gfn115; Magri CJ, 2009, EUR J INTERN MED, V20, P551, DOI 10.1016/j.ejim.2008.12.012; Sanchez-Lozada LG, 2008, NEPHROL DIAL TRANSPL, V23, P1179, DOI 10.1093/ndt/gfm783; Zhao HJ, 2006, J AM SOC NEPHROL, V17, P2664, DOI 10.1681/ASN.2006070798; Thomas MC, 2005, ADV CHRONIC KIDNEY D, V12, P177, DOI 10.1053/j.ackd.2005.01.008; Lanaspa MA, 2012, J BIOL CHEM, V287, P40732, DOI 10.1074/jbc.M112.399899; Ishimoto T, 2012, P NATL ACAD SCI USA, V109, P4320, DOI 10.1073/pnas.1119908109; Gilbert RE, 1999, KIDNEY INT, V56, P1627, DOI 10.1046/j.1523-1755.1999.00721.x; Wang XXX, 2010, DIABETES, V59, P2916, DOI 10.2337/db10-0019; Ishimoto T, 2013, HEPATOLOGY, V58, P1632, DOI 10.1002/hep.26594; Suryanarayana P, 2004, MOL VIS, V10, P148; HAYMAN S, 1965, J BIOL CHEM, V240, P877; Sanchez-Lozada LG, 2005, KIDNEY INT, V67, P237, DOI 10.1111/j.1523-1755.2005.00074.x; Kosugi T, 2009, AM J PHYSIOL-RENAL, V297, pF481, DOI 10.1152/ajprenal.00092.2009; Yu MA, 2010, J HYPERTENS, V28, P1234, DOI 10.1097/HJH.0b013e328337da1d; Nakagawa T, 2007, J AM SOC NEPHROL, V18, P539, DOI 10.1681/ASN.2006050459; Brenner BM, 2001, NEW ENGL J MED, V345, P861, DOI 10.1056/NEJMoa011161; Corry DB, 2008, J HYPERTENS, V26, P269, DOI 10.1097/HJH.0b013e3282f240bf; Sanchez-Lozada LG, 2012, NEPHRON EXP NEPHROL, V121, pE71, DOI 10.1159/000345509; Hudkins KL, 2010, J AM SOC NEPHROL, V21, P1533, DOI 10.1681/ASN.2009121290; Koya D, 2000, FASEB J, V14, P439; Kanamori H, 2007, BIOCHEM BIOPH RES CO, V360, P772, DOI 10.1016/j.bbrc.2007.06.148; Tanabe K, 2012, AM J PHYSIOL-RENAL, V302, pF1151, DOI 10.1152/ajprenal.00596.2011; Nakayama T, 2010, AM J PHYSIOL-RENAL, V298, pF712, DOI 10.1152/ajprenal.00433.2009; Kanellis J, 2003, HYPERTENSION, V41, P1287, DOI 10.1161/01.HYP.0000072820.07472.3B; Ohga S, 2007, AM J PHYSIOL-RENAL, V292, pF1141, DOI 10.1152/ajprenal.00288.2005; Breyer MD, 2005, J AM SOC NEPHROL, V16, P27, DOI 10.1681/ASN.2004080648; Diggle CP, 2009, J HISTOCHEM CYTOCHEM, V57, P763, DOI 10.1369/jhc.2009.953190; Cirillo P, 2009, J AM SOC NEPHROL, V20, P545, DOI 10.1681/ASN.2008060576; Grgic I, 2012, KIDNEY INT, V82, P172, DOI 10.1038/ki.2012.20; Kanetsuna Y, 2007, AM J PATHOL, V170, P1473, DOI 10.2353/ajpath.2007.060481; Sanchez-Lozada LG, 2007, AM J PHYSIOL-RENAL, V292, pF423, DOI 10.1152/ajprenal.00124.2006; Bonventre JV, 2012, SEMIN NEPHROL, V32, P452, DOI 10.1016/j.semnephrol.2012.07.008; Prabhakar S, 2007, J AM SOC NEPHROL, V18, P2945, DOI 10.1681/ASN.2006080895; Huang SP, 2010, J OPHTHALMOL, DOI 10.1155/2010/521204; Glushakova O, 2008, J AM SOC NEPHROL, V19, P1712, DOI 10.1681/ASN.2007121304; Bren-Mattison Y, 2008, MOL PHARMACOL, V73, P709, DOI 10.1124/mol.107.042002; BURCH HB, 1980, J BIOL CHEM, V255, P8239; Gersch MS, 2007, AM J PHYSIOL-RENAL, V293, pF1256, DOI 10.1152/ajprenal.00181.2007; Ho ECM, 2006, DIABETES, V55, P1946, DOI 10.2337/db05-1497; Lanaspa MA, 2010, J BIOL CHEM, V285, P31694, DOI 10.1074/jbc.M109.093690; Lanaspa MA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047948; Lee FTH, 2004, J AM SOC NEPHROL, V15, P2139, DOI 10.1097/01.ASN.0000135055.61833.A8; Phillips AO, 2002, HISTOL HISTOPATHOL, V17, P247; Van Putten V, 2001, J BIOL CHEM, V276, P1226, DOI 10.1074/jbc.M003581200; Wang H, 2010, AM J PHYSIOL-RENAL, V299, pF1374, DOI 10.1152/ajprenal.00403.2010	46	5	5	AMER SOC NEPHROLOGY	WASHINGTON	1725 I ST, NW STE 510, WASHINGTON, DC 20006 USA	1046-6673	1533-3450		J AM SOC NEPHROL	J. Am. Soc. Nephrol.	NOV	2014	25	11					2526	2538		10.1681/ASN.2013080901		13	Urology & Nephrology	Urology & Nephrology	AS1KO	WOS:000344040300016		
J	Morito, N; Yoh, K; Ojima, M; Okamura, M; Nakamura, M; Hamada, M; Shimohata, H; Moriguchi, T; Yamagata, K; Takahashi, S				Morito, Naoki; Yoh, Keigyou; Ojima, Masami; Okamura, Midori; Nakamura, Megumi; Hamada, Michito; Shimohata, Homare; Moriguchi, Takashi; Yamagata, Kunihiro; Takahashi, Satoru			Overexpression of Mafb in Podocytes Protects against Diabetic Nephropathy	JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY			English	Article							CHRONIC KIDNEY-DISEASE; MESSENGER-RNA LEVELS; HUMAN NEPHRIN GENE; OXIDATIVE STRESS; F4/80 EXPRESSION; NOTCH PATHWAY; IN-VIVO; C-MAF; MICE; RATS	We previously showed that the transcription factor Mafb is essential for podocyte differentiation and foot process formation. Podocytes are susceptible to injury in diabetes, and this injury leads to progression of diabetic nephropathy. In this study, we generated transgenic mice that overexpress Mafb in podocytes using the nephrin promoter/enhancer. To examine a potential pathogenetic role for Mafb in diabetic nephropathy, Mafb transgenic mice were treated with either streptozotocin or saline solution. Diabetic nephropathy was assessed by renal histology and biochemical analyses of urine and serum. Podocyte-specific overexpression of Mafb had no effect on body weight or blood glucose levels in either diabetic or control mice. Notably, albuminuria and changes in BUN levels and renal histology observed in diabetic wild-type animals were ameliorated in diabetic Mafb transgenic mice. Moreover, hyperglycemia-induced downregulation of Nephrin was mitigated in diabetic Mafb transgenic mice, and reporter assay results suggested that Mafb regulates Nephrin directly. Mafb transgenic glomeruli also overexpressed glutathione peroxidase, an antioxidative stress enzyme, and levels of the oxidative stress marker 8-hydroxydeoxy-guanosine decreased in the urine of diabetic Mafb transgenic mice. Finally, Notch2 expression increased in diabetic glomeruli, and this effect was enhanced in diabetic Mafb transgenic glomeruli. These data indicate Mafb has a protective role in diabetic nephropathy through regulation of slit diaphragm proteins, antioxidative enzymes, and Notch pathways in podocytes and suggest that Mafb could be a therapeutic target.	[Morito, Naoki; Yoh, Keigyou; Yamagata, Kunihiro] Univ Tsukuba, Fac Med, Dept Nephrol, Tsukuba, Ibaraki 3058575, Japan; [Ojima, Masami; Okamura, Midori; Nakamura, Megumi; Hamada, Michito; Takahashi, Satoru] Univ Tsukuba, Fac Med, Dept Anat & Embryol, Tsukuba, Ibaraki 3058575, Japan; [Takahashi, Satoru] Univ Tsukuba, Int Inst Integrat Sleep Med WPI IIIS, Tsukuba, Ibaraki 3058575, Japan; [Takahashi, Satoru] Univ Tsukuba, TARA, Life Sci Ctr, Tsukuba, Ibaraki 3058575, Japan; [Shimohata, Homare] Tokyo Med Univ, Ibaraki Med Ctr, Dept Nephrol, Inashiki, Ibaraki, Japan; [Moriguchi, Takashi] Tohoku Univ, Grad Sch Med, Dept Med Biochem, Sendai, Miyagi 980, Japan	Morito, N (reprint author), Univ Tsukuba, Fac Med, Dept Nephrol, 1-1-1 Tennodai, Tsukuba, Ibaraki 3058575, Japan.	morito@md.tsukuba.ac.jp			Japan Society for the Promotion of Science KAKENHI [24591223]	This work was supported by The Japan Society for the Promotion of Science KAKENHI Grant-in-Aid for Scientific Research 24591223.	Ahn SH, 2010, DIABETES, V59, P1865, DOI 10.2337/db10-0077; Forbes JM, 2008, DIABETES, V57, P1446, DOI 10.2337/db08-0057; Pagtalunan ME, 1997, J CLIN INVEST, V99, P342, DOI 10.1172/JCI119163; Zankl A, 2012, AM J HUM GENET, V90, P494, DOI 10.1016/j.ajhg.2012.01.003; Doublier S, 2003, DIABETES, V52, P1023, DOI 10.2337/diabetes.52.4.1023; Bonnet F, 2002, CLIN EXP HYPERTENS, V24, P371, DOI 10.1081/CEH-120004798; Nadarajah R, 2012, KIDNEY INT, V82, P292, DOI 10.1038/ki.2012.83; Jefferson JA, 2008, KIDNEY INT, V74, P22, DOI 10.1038/ki.2008.128; Niranjan T, 2008, NAT MED, V14, P290, DOI 10.1038/nm1731; Moriguchi T, 2006, MOL CELL BIOL, V26, P5715, DOI 10.1128/MCB.00001-06; Susztak K, 2006, DIABETES, V55, P225, DOI 10.2337/diabetes.55.01.06.db05-0894; Sunde RA, 2009, BIOSCIENCE REP, V29, P329, DOI 10.1042/BSR20080146; Moeller MJ, 2002, J AM SOC NEPHROL, V13, DOI 10.1097/01.ASN.0000015614.68893.0B; Isermann B, 2007, NAT MED, V13, P1349, DOI 10.1038/nm1667; Waters AM, 2012, J AM SOC NEPHROL, V23, P27, DOI 10.1681/ASN.2011010027; Calderon-Salinas JV, 2011, MOL CELL BIOCHEM, V357, P171, DOI 10.1007/s11010-011-0887-1; Guo G, 2004, J AM SOC NEPHROL, V15, P2851, DOI 10.1097/01.ASN.0000143474.91362.C4; Deb DK, 2011, J BIOL CHEM, V286, P32011, DOI 10.1074/jbc.M111.269118; Pavenstadt H, 2003, PHYSIOL REV, V83, P253, DOI 10.1152/physrev.00020.2002; Obrosova IG, 2003, FREE RADICAL BIO MED, V34, P186, DOI 10.1016/S0891-5849(02)01195-4; Meyer TW, 1999, DIABETOLOGIA, V42, P1341, DOI 10.1007/s001250051447; van Stralen E, 2009, EXP HEMATOL, V37, P78, DOI 10.1016/j.exphem.2008.08.006; Murea M, 2010, KIDNEY INT, V78, P514, DOI 10.1038/ki.2010.172; Takemoto M, 2002, AM J PATHOL, V161, P799, DOI 10.1016/S0002-9440(10)64239-3; Chu D, 2011, ANN ONCOL, V22, P2440, DOI 10.1093/annonc/mdq776; Schiwek D, 2004, KIDNEY INT, V66, P91, DOI 10.1111/j.1523-1755.2004.00711.x; Quack I, 2011, J BIOL CHEM, V286, P12959, DOI 10.1074/jbc.M110.204024; Barnes KM, 2009, J NUTR, V139, P199, DOI 10.3945/jn.108.098624; Brunskill EW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024640; Chen HC, 2001, J LAB CLIN MED, V137, P279, DOI 10.1067/mlc.2001.113231; Connor A, 2007, AM J KIDNEY DIS, V50, P649, DOI 10.1053/j.ajkd.2007.06.014; de Haan JB, 2005, AM J PHYSIOL-RENAL, V289, pF544, DOI 10.1152/ajprenal.00088.2005; Fan QL, 2003, KIDNEY INT, V64, P1978, DOI 10.1046/j.1523-1755.2003.00312.x; Fredersdorf S, 2007, N-S ARCH PHARMACOL, V375, P95, DOI 10.1007/s00210-007-0147-9; Granqvist A, 2010, AM J PHYSIOL-RENAL, V299, pF898, DOI 10.1152/ajprenal.00124.2010; Gui DK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039824; Kajihara M, 2003, BIOCHEM BIOPH RES CO, V312, P831, DOI 10.1016/j.bbrc.2003.10.196; KATAOKA K, 1994, MOL CELL BIOL, V14, P7581; KATAOKA K, 1994, MOL CELL BIOL, V14, P700; Machiya J, 2007, AM J RESP CELL MOL, V36, P418, DOI 10.1165/rcmb.2006-0248OC; Menne J, 2006, KIDNEY INT, V70, P1456, DOI 10.1038/sj.ki.5001830; Nakamura M, 2009, GENE, V445, P66, DOI 10.1016/j.gene.2009.06.003; Nyfeler Y, 2005, EMBO J, V24, P3504, DOI 10.1038/sj.emboj.7600816; Park SJ, 2009, YONSEI MED J, V50, P273, DOI 10.3349/ymj.2009.50.2.273; Piwkowska A, 2011, J CELL BIOCHEM, V112, P1661, DOI 10.1002/jcb.23088; Ren XJ, 2009, NEPHROLOGY, V14, P311, DOI 10.1111/j.1440-1797.2008.01059.x; Sharma S, 2011, CURR OPIN NEPHROL HY, V20, P56, DOI 10.1097/MNH.0b013e3283414c88; Shirota S, 2006, BIOCHEM BIOPH RES CO, V348, P501, DOI 10.1016/j.bbrc.2006.07.111; Wong MA, 2000, AM J PHYSIOL-RENAL, V279, pF1027; Zhang W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063472	50	1	1	AMER SOC NEPHROLOGY	WASHINGTON	1725 I ST, NW STE 510, WASHINGTON, DC 20006 USA	1046-6673	1533-3450		J AM SOC NEPHROL	J. Am. Soc. Nephrol.	NOV	2014	25	11					2546	2557		10.1681/ASN.2013090993		12	Urology & Nephrology	Urology & Nephrology	AS1KO	WOS:000344040300018		
J	Kanda, S; Tanigawa, S; Ohmori, T; Taguchi, A; Kudo, K; Suzuki, Y; Sato, Y; Hino, S; Sander, M; Perantoni, AO; Sugano, S; Nakao, M; Nishinakamura, R				Kanda, Shoichiro; Tanigawa, Shunsuke; Ohmori, Tomoko; Taguchi, Atsuhiro; Kudo, Kuniko; Suzuki, Yutaka; Sato, Yuki; Hino, Shinjiro; Sander, Maike; Perantoni, Alan O.; Sugano, Sumio; Nakao, Mitsuyoshi; Nishinakamura, Ryuichi			Sall1 Maintains Nephron Progenitors and Nascent Nephrons by Acting as Both an Activator and a Repressor	JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY			English	Article							TOWNES-BROCKS-SYNDROME; EMBRYONIC STEM-CELLS; KIDNEY DEVELOPMENT; CAUSATIVE GENE; MAMMALIAN KIDNEY; OKIHIRO-SYNDROME; CRE RECOMBINASE; MURINE HOMOLOG; MOUSE KIDNEY; POPULATION	The balanced self-renewal and differentiation of nephron progenitors are critical for kidney development and controlled, in part, by the transcription factor Six2, which antagonizes canonical Wnt signaling-mediated differentiation. A nuclear factor, Sall1 is expressed in Six2-positive progenitors as well as differentiating nascent nephrons, and it is essential for kidney formation. However, the molecular functions and targets of Sal 11, especially the functions and targets in the nephron progenitors, remain unknown. Here, we report that Sall1 deletion in Six2-positive nephron progenitors results in severe progenitor depletion and apoptosis of the differentiating nephrons in mice. Analysis of mice with an inducible Sall1 deletion revealed that Sall1 activates genes expressed in progenitors while repressing genes expressed in differentiating nephrons. Sall1 and Six2 co-occupied many progenitor-related gene loci, and Sall1 bound to Six2 biochemically. In contrast, Sal did not bind to the Wnt4 locus suppressed by Six2. Sall1-mediated repression was also independent of its binding to DNA. Thus, Sal 11 maintains nephron progenitors and their derivatives by a unique mechanism, which partly overlaps but is distinct from that of Six2: Sall1 activates progenitor-related genes in Six2-positive nephron progenitors and represses gene expression in Six2-negative differentiating nascent nephrons.	[Kanda, Shoichiro; Tanigawa, Shunsuke; Ohmori, Tomoko; Taguchi, Atsuhiro; Kudo, Kuniko; Nishinakamura, Ryuichi] Kumamoto Univ, Inst Mol Embryol & Genet, Dept Kidney Dev, Kumamoto 8600811, Japan; [Hino, Shinjiro; Nakao, Mitsuyoshi] Kumamoto Univ, Inst Mol Embryol & Genet, Dept Med Cell Biol, Kumamoto 8600811, Japan; [Sato, Yuki] Kumamoto Univ, Prior Org Innovat & Excellence, Kumamoto 8600811, Japan; [Suzuki, Yutaka; Sugano, Sumio] Univ Tokyo, Dept Med Genome Sci, Tokyo, Japan; [Sander, Maike] Univ Calif San Diego, Dept Pediat, La Jolla, CA 92093 USA; [Sander, Maike] Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; [Perantoni, Alan O.] NCI, Canc & Dev Biol Lab, NIH, Frederick, MD 21701 USA; [Nakao, Mitsuyoshi; Nishinakamura, Ryuichi] Japan Sci & Technol Agcy, CREST, Saitama, Japan	Nishinakamura, R (reprint author), Kumamoto Univ, Inst Mol Embryol & Genet, Dept Kidney Dev, 2-2-1 Honjo, Kumamoto 8600811, Japan.	ryuichi@kumamoto-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology, Japan [23390228, 25111725, 221S0002]; National Institutes of Health [R01-DK68471]	This study was supported by KAKENHI Grants 23390228, 25111725, and 221S0002 from Ministry of Education, Culture, Sports, Science and Technology, Japan. Research in the laboratory of M.S. was supported by National Institutes of Health Grant R01-DK68471.	Boyle S, 2008, DEV BIOL, V313, P234, DOI 10.1016/j.ydbio.2007.10.014; Kohlhase J, 1998, NAT GENET, V18, P81, DOI 10.1038/ng0198-81; KUHNLEIN RP, 1994, EMBO J, V13, P168; Kobayashi A, 2008, CELL STEM CELL, V3, P169, DOI 10.1016/j.stem.2008.05.020; Denner DR, 2013, DEV BIOL, V375, P105, DOI 10.1016/j.ydbio.2012.11.018; Fujimura S, 2010, J AM SOC NEPHROL, V21, P803, DOI 10.1681/ASN.2009040353; Schaffer AE, 2010, DEV CELL, V18, P1022, DOI 10.1016/j.devcel.2010.05.015; Karner CM, 2011, DEVELOPMENT, V138, P1247, DOI 10.1242/dev.057646; Sakaki-Yumoto M, 2006, DEVELOPMENT, V133, P3005, DOI 10.1242/dev.02457; Kohlhase J, 2002, HUM MOL GENET, V11, P2979, DOI 10.1093/hmg/11.23.2979; Osafune K, 2006, DEVELOPMENT, V133, P151, DOI 10.1242/dev.02174; Lauberth SM, 2006, J BIOL CHEM, V281, P23922, DOI 10.1074/jbc.M513461200; Lim CY, 2008, CELL STEM CELL, V3, P543, DOI 10.1016/j.stem.2008.08.004; Mugford JW, 2008, DEV BIOL, V324, P88, DOI 10.1016/j.ydbio.2008.09.010; Self M, 2006, EMBO J, V25, P5214, DOI 10.1038/sj.emboj.7601381; Mugford JW, 2009, DEV BIOL, V333, P312, DOI 10.1016/j.ydbio.2009.06.043; Kim JW, 2008, CELL, V132, P1049, DOI 10.1016/j.cell.2008.02.039; Grieshammer U, 2004, DEV CELL, V6, P709, DOI 10.1016/S1534-5807(04)00108-X; Yuri S, 2009, STEM CELLS, V27, P796, DOI 10.1002/stem.14; Tanaka S, 2012, BLOOD, V120, P1107, DOI 10.1182/blood-2011-11-394932; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; Inoue S, 2010, GENESIS, V48, P207, DOI 10.1002/dvg.20603; Nishinakamura R, 2001, DEVELOPMENT, V128, P3105; James RG, 2006, DEVELOPMENT, V133, P2995, DOI 10.1242/dev.02442; Sander M, 2000, GENE DEV, V14, P2134, DOI 10.1101/gad.820400; Sakai K, 1997, BIOCHEM BIOPH RES CO, V237, P318, DOI 10.1006/bbrc.1997.7111; Sander M, 2000, DEVELOPMENT, V127, P5533; Barak H, 2012, DEV CELL, V22, P1191, DOI 10.1016/j.devcel.2012.04.018; Park JS, 2012, DEV CELL, V23, P637, DOI 10.1016/j.devcel.2012.07.008; Brown AC, 2011, DEVELOPMENT, V138, P5099, DOI 10.1242/dev.065995; Nishinakamura R, 2008, KIDNEY INT, V73, P913, DOI 10.1038/sj.ki.5002784; Sato A, 2004, BIOCHEM BIOPH RES CO, V319, P103, DOI 10.1016/j.bbrc.2004.04.156; Tanigawa S, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.448; Yamashita K, 2007, GENES CELLS, V12, P171, DOI 10.1111/j.1365-2443.2007.01042.x	34	6	6	AMER SOC NEPHROLOGY	WASHINGTON	1725 I ST, NW STE 510, WASHINGTON, DC 20006 USA	1046-6673	1533-3450		J AM SOC NEPHROL	J. Am. Soc. Nephrol.	NOV	2014	25	11					2584	2595		10.1681/ASN.2013080896		12	Urology & Nephrology	Urology & Nephrology	AS1KO	WOS:000344040300021		
J	Kawatani, Y; Lee, JN; Hamilton, K				Kawatani, Yoshio; Lee, Jae N.; Hamilton, Kevin			Interannual Variations of Stratospheric Water Vapor in MLS Observations and Climate Model Simulations	JOURNAL OF THE ATMOSPHERIC SCIENCES			English	Article							QUASI-BIENNIAL OSCILLATION; GENERAL-CIRCULATION; CMIP5; TROPOSPHERE; ATMOSPHERE	By analyzing the almost-decade-long record of water vapor measurements from the Microwave Limb Sounder (MLS) instrument on the NASA Aura satellite and by detailed diagnostic analysis of the results from state-of-the art climate model simulations, this study confirmed the conceptual picture of the interannual variation in equatorial stratospheric water vapor discussed in earlier papers (e.g., Geller et al.). The interannual anomalies in water vapor are strongly related to the dynamical quasi-biennial oscillation (QBO), and this study presents the first QBO composite of the time height structure of the equatorial water vapor anomalies. The anomalies display upward propagation below about 10 hPa in a manner analogous to the annual "tape recorder" effect, but at higher levels they show clear downward propagation. This study examined these variations in the Model for Interdisciplinary Research on Climate (MIROC)-AGCM and in four models in phase 5 of the Coupled Model Intercomparison Project (CMIP5) that simulate realistic QBOs. Diagnostic budget analysis of the MIROC-AGCM data and comparisons among the CMIP5 model results demonstrate (i) the importance of temperature anomalies at the tropopause induced by the QBO for lower-stratospheric water vapor variations and (ii) that upper-stratospheric water vapor anomalies are largely driven by advection of the mean vertical gradient of water content by the QBO interannual fluctuations in the vertical wind.	[Kawatani, Yoshio] Japan Agcy Marine Earth Sci & Technol, Yokohama, Kanagawa 2360001, Japan; [Lee, Jae N.] Univ Maryland Baltimore Cty, Joint Ctr Earth Syst Technol, Baltimore, MD 21228 USA; [Hamilton, Kevin] Univ Hawaii Manoa, Int Pacific Res Ctr, Honolulu, HI 96822 USA	Kawatani, Y (reprint author), Japan Agcy Marine Earth Sci & Technol, Kanazawa Ku, 3173-25 Showamachi, Yokohama, Kanagawa 2360001, Japan.	yoskawatani@jamstec.go.jp			Environment Research and Technology Development Fund of the Ministry of the Environment, Japan [2A-1201]; Japan Society for the Promotion of Science [26287117]; Japan Agency for Marine-Earth Science and Technology (JAMSTEC); NOAA [NA11NMF4320128]; NASA Living With a Star Targeted Research and Technology Program [NNH10ZDA001N-LWSTRT]; MEXT	The authors thank Drs. A. Noda, S. Watanabe, and N. Eguchi for their valuable suggestions on this study. We also express our gratitude to Prof. M. A. Geller and an anonymous reviewer for constructive comments on the original manuscript. This work was supported by the Environment Research and Technology Development Fund (2A-1201) of the Ministry of the Environment, Japan; and by Grant-in-Aid for Scientific Research B (26287117) from the Japan Society for the Promotion of Science. This research was also supported by the Japan Agency for Marine-Earth Science and Technology (JAMSTEC) through its sponsorship of research at the International Pacific Research Center and by NOAA through Grant NA11NMF4320128. This research was also supported by the NASA Living With a Star Targeted Research and Technology Program (NNH10ZDA001N-LWSTRT). The MIROC model simulation was conducted using the JAMSTEC Earth Simulator. The GFD Dennou Library and GrADS were used to draw the figures. We acknowledge the World Climate Research Programme's Working Group on Coupled Modelling, which is responsible for CMIP, and we thank the climate modeling groups for making available their model output. For CMIP the U.S. Department of Energy's Program for Climate Model Diagnosis and Intercomparison provides coordinating support and led development of software infrastructure in partnership with the Global Organization for Earth System Science Portals. We also acknowledge the Data Integration and Analysis System (DIAS) Fund for National Key Technology from MEXT.	Andrews DG, 1987, INT GEOPHYS SERIES, V40; Roeckner E, 2006, J CLIMATE, V19, P3771, DOI 10.1175/JCLI3824.1; Collins WJ, 2011, GEOSCI MODEL DEV, V4, P1051, DOI 10.5194/gmd-4-1051-2011; Watanabe S, 2011, GEOSCI MODEL DEV, V4, P845, DOI 10.5194/gmd-4-845-2011; Livesey NJ, 2006, IEEE T GEOSCI REMOTE, V44, P1144, DOI 10.1109/TGRS.2006.872327; Lambert A, 2007, J GEOPHYS RES-ATMOS, V112, DOI 10.1029/2007JD008724; Schmidt H, 2013, J ADV MODEL EARTH SY, V5, P98, DOI 10.1002/jame.20014; Mote PW, 1998, J GEOPHYS RES-ATMOS, V103, P8651, DOI 10.1029/98JD00203; Martin GM, 2011, GEOSCI MODEL DEV, V4, P723, DOI 10.5194/gmd-4-723-2011; PLUMB RA, 1982, Q J ROY METEOR SOC, V108, P335, DOI 10.1002/qj.49710845604; Read WG, 2007, J GEOPHYS RES-ATMOS, V112, DOI 10.1029/2007JD008752; MCFARLANE NA, 1987, J ATMOS SCI, V44, P1775, DOI 10.1175/1520-0469(1987)044<1775:TEOOEG>2.0.CO;2; Jones CD, 2011, GEOSCI MODEL DEV, V4, P543, DOI 10.5194/gmd-4-543-2011; Fujiwara M, 2010, J GEOPHYS RES-ATMOS, V115, DOI 10.1029/2010JD014179; Kawatani Y, 2013, NATURE, V497, P478, DOI 10.1038/nature12140; Waters JW, 2006, IEEE T GEOSCI REMOTE, V44, P1075, DOI 10.1109/TGRS.2006.873771; Solomon S, 2010, SCIENCE, V327, P1219, DOI 10.1126/science.1182488; Taylor KE, 2012, B AM METEOROL SOC, V93, P485, DOI 10.1175/BAMS-D-11-00094.1; Baldwin MP, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2004GL022328; Brasseur G., 1984, AERONOMY MIDDLE ATMO; *ECMWF, IFS DOC CY40R1 4; Geller MA, 2002, J ATMOS SCI, V59, P1076, DOI 10.1175/1520-0469(2002)059<1076:SOTIVO>2.0.CO;2; Giorgetta MA, 1999, J GEOPHYS RES-ATMOS, V104, P6003, DOI 10.1029/1998JD200112; Hamilton K., 1981, ATMOS OCEAN, V19, P236, DOI DOI 10.1080/07055900.1981.9649111; Holton JR, 2001, GEOPHYS RES LETT, V28, P2799, DOI 10.1029/2001GL013148; Kawatani Y, 2011, J ATMOS SCI, V68, P265, DOI 10.1175/2010JAS3623.1; KUNZE M, 2014, QUASI BIENNIAL OSCIL; Mote PW, 1996, J GEOPHYS RES-ATMOS, V101, P3989, DOI 10.1029/95JD03422; Niwano M, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2003JD003871; Randel WJ, 1998, J ATMOS SCI, V55, P163, DOI 10.1175/1520-0469(1998)055<0163:SCAQVI>2.0.CO;2; REID CG, 1985, J GEOPHYS RES, V90, P5629, DOI DOI 10.1029/JD090ID03P05629; ROSENLOF KH, 1995, J GEOPHYS RES-ATMOS, V100, P5173, DOI 10.1029/94JD03122; RUSSELL JM, 1993, J GEOPHYS RES-ATMOS, V98, P10777, DOI 10.1029/93JD00799; Zhou XL, 2001, J CLIMATE, V14, P1823, DOI 10.1175/1520-0442(2001)014<1823:TCPTCD>2.0.CO;2	34	1	1	AMER METEOROLOGICAL SOC	BOSTON	45 BEACON ST, BOSTON, MA 02108-3693 USA	0022-4928	1520-0469		J ATMOS SCI	J. Atmos. Sci.	NOV	2014	71	11					4072	4085		10.1175/JAS-D-14-0164.1		14	Meteorology & Atmospheric Sciences	Meteorology & Atmospheric Sciences	AS4BS	WOS:000344219100008		
J	Takahashi, T				Takahashi, Tsuneya			Influence of Liquid Water Content and Temperature on the Form and Growth of Branched Planar Snow Crystals in a Cloud	JOURNAL OF THE ATMOSPHERIC SCIENCES			English	Article							ICE CRYSTALS; VAPOR-DEPOSITION; RATES; HABIT	How liquid water content (LWC) and temperature affect the growth of branched planar snow crystals is poorly understood. To address this issue, a vertical supercooled cloud tunnel was used to grow 167 individual snow crystals for 10 min under nearly constant conditions. The LWC varied within 0.07-0.76 g m(-3) and average temperature varied from -12.4 degrees to -16.3 degrees C, with the latter varying by at most 0.2 degrees C per run. The crystal habits are divided mainly by temperature, warm to cold, into nine regions: sector above -12.5 degrees C; then broad branch to -13.0 degrees C; and then stellar, dendrite, and fern to -14.5 degrees C. Then the pattern reverses, with dendrite to -14.8 degrees C, stellar to -15.7 degrees C, broad branch to -16.1 degrees C, and finally sector. From -13.3 degrees to -13.8 degrees C, stellar changes to dendrite with LWC increase as well as with temperature decrease. From -13.8 degrees to -14.5 degrees C, dendrites coexist with ferns below an LWC of 0.25 g m-3, but only ferns exist at higher LWC. At other temperatures, a higher LWC does not produce greater side-branch development. Nevertheless, an increase of LWC produces heavier crystals (particularly crystals larger than 1 mm across), despite the crystal diameters being independent of LWC. Stellars at -14.9 degrees C have the maximum mass and diameter, whereas ferns at about -14.3 degrees C have the maximum basal-plane area and minimum fall speed. The apparent crystal density varies with temperature, with two local minima for stellars near -13.3 degrees and -15.3 degrees C and a local maximum for ferns near -14.2 degrees C.	Hokkaido Univ, Sapporo, Hokkaido 0028502, Japan	Takahashi, T (reprint author), Hokkaido Univ, Sapporo, Hokkaido 0028502, Japan.	takahashi.tsuneya@s.hokkyodai.ac.jp					CHEN JP, 1994, J ATMOS SCI, V51, P1206, DOI 10.1175/1520-0469(1994)051<1206:TTBFTP>2.0.CO;2; Kikuchi K, 2013, ATMOS RES, V132, P460, DOI 10.1016/j.atmosres.2013.06.006; Byers H. R., 1965, ELEMENTS CLOUD PHYS; FUKUTA N, 1969, J ATMOS SCI, V26, P522, DOI 10.1175/1520-0469(1969)026<0522:ESOTGO>2.0.CO;2; HALLETT J, 1958, PROC R SOC LON SER-A, V247, P440, DOI 10.1098/rspa.1958.0199; Hobbs P. V., 1972, 7 U WASH DEP ATM SCI, V7; KELLER VW, 1982, J CRYST GROWTH, V60, P91, DOI 10.1016/0022-0248(82)90176-2; KURODA T, 1984, J METEOROL SOC JPN, V62, P552; MARSHALL JS, 1954, J METEOROL, V11, P104, DOI 10.1175/1520-0469(1954)011<0104:ATOSCH>2.0.CO;2; MCDONALD JE, 1963, Z ANGEW MATH PHYS, V14, P610, DOI 10.1007/BF01601268; MICHAELI G, 1976, NATURE, V259, P110, DOI 10.1038/259110a0; Nakaya U., 1954, SNOW CRYSTALS NATURA; Nelson J, 2005, CRYST GROWTH DES, V5, P1509, DOI 10.1021/cg049685v; PODZIMEK J, 1966, STUD GEOPHYS GEOD, V10, P235, DOI 10.1007/BF02585763; RYAN BF, 1974, J ATMOS SCI, V31, P2136, DOI 10.1175/1520-0469(1974)031<2136:TDAGRO>2.0.CO;2; SONG NH, 1994, J ATMOS SCI, V51, P91, DOI 10.1175/1520-0469(1994)051<0091:EIOIIS>2.0.CO;2; TAKAHASHI T, 1988, J METEOROL SOC JPN, V66, P841	17	1	1	AMER METEOROLOGICAL SOC	BOSTON	45 BEACON ST, BOSTON, MA 02108-3693 USA	0022-4928	1520-0469		J ATMOS SCI	J. Atmos. Sci.	NOV	2014	71	11					4127	4142		10.1175/JAS-D-14-0043.1		16	Meteorology & Atmospheric Sciences	Meteorology & Atmospheric Sciences	AS4BS	WOS:000344219100011		
J	Kobayashi, K; Sakka, Y				Kobayashi, Kiyoshi; Sakka, Yoshio			Research progress in nondoped lanthanoid silicate oxyapatites as new oxygen-ion conductors	JOURNAL OF THE CERAMIC SOCIETY OF JAPAN			English	Review						Rare-earth silicate; Oxyapatite; Oxygen-ion conductivity; Crystal structure	RARE-EARTH-SILICATES; APATITE-TYPE STRUCTURE; FLOATING-ZONE METHOD; OXIDE FUEL-CELLS; POWDER NEUTRON-DIFFRACTION; CRYSTAL-STRUCTURE REFINEMENT; X-RAY-DIFFRACTION; SOL-GEL SYNTHESIS; SINGLE-CRYSTALS; ELECTRICAL-PROPERTIES	The discovery of oxygen-ion conductivity and changes in the crystal-structure model of nondoped lanthanum silicate oxyapatites are reviewed from the researches which led to the discovery to current work. The oxygen-ion conductivity of lanthanoid silicate oxyapatites was discovered by Nakayama et al., during development of new oxide lithium-ion conductors. Although samples with compositions of LiRESiO4 (RE = La, Nd, Sm, Gd, Dy) were initially reported to be single phases with the same crystal structure, the accurate crystal structure of LiRESiO4 was not clarified until later. The crystal structure determined from X-ray diffraction patterns of LiLnSiO(4) was revised as oxyapatite by another group. The chemical composition of the crystal phases in LiRESiO4 was also revised to RE10Si6O25 and/or RE9.33Si6O24. The discovery of oxygen-ion conductivity in these materials was confirmed when researchers noted that samples of RE10Si6O25, specifically, the samples without lithium, are electrically conducting. Furthermore, very high oxygen-ion conductivity in the direction parallel to c-axis was discovered after single crystals of RE9.33(SiO4)(6)O-2 (RE = Nd, Pr, and Sm) were successfully grown. The crystal structure and defect models were also altered after the discovery of oxygen-ion conductivity. Although numerous reports related to the electrical conductivity of La9.33+x(SiO4)(6)O2+3x/2 ceramics have appeared in the literature, clear dependences of the total conductivity on the cation nonstoichiometry (x) as well as the sintering temperature are still unclear because of large discrepancies in the reported data. Furthermore, the composition region, where the lanthanum silicate oxyapatite single phase is formed, is also still unclear because of the inconsistencies in the reported results. (c) 2014 The Ceramic Society of Japan. All rights reserved.	[Kobayashi, Kiyoshi; Sakka, Yoshio] Natl Inst Mat Sci, Mat Proc Unit, Tsukuba, Ibaraki 3050047, Japan	Kobayashi, K (reprint author), Natl Inst Mat Sci, Mat Proc Unit, 1-2-1 Sengen, Tsukuba, Ibaraki 3050047, Japan.	kiyoshi@nims.go.jp					An T, 2011, J CRYST GROWTH, V333, P70, DOI 10.1016/j.jcrysgro.2011.08.010; Anderson O.L., 1954, J AM CERAM SOC, V37, P573, DOI 10.1111/j.1151-2916.1954.tb13991.x; NAKAYAMA S, 1995, J MATER CHEM, V5, P1801, DOI 10.1039/jm9950501801; Fukuda K, 2013, CHEM MATER, V25, P2154, DOI 10.1021/cm400892p; Shen YQ, 2010, J SOLID STATE CHEM, V183, P3093, DOI 10.1016/j.jssc.2010.10.025; Fukuda K, 2012, CHEM MATER, V24, P2611, DOI 10.1021/cm301484q; Chesnaud A, 2008, SOLID STATE IONICS, V179, P1929, DOI 10.1016/j.ssi.2008.04.035; Nakayama S, 1999, J EUR CERAM SOC, V19, P507, DOI 10.1016/S0955-2219(98)00215-5; Momma K, 2011, J APPL CRYSTALLOGR, V44, P1272, DOI 10.1107/S0021889811038970; Sansom JEH, 2006, J MATER CHEM, V16, P1410, DOI 10.1039/b600122j; Shen YQ, 2010, J AM CERAM SOC, V93, P1176, DOI 10.1111/j.1551-2916.2009.03563.x; Tolchard JR, 2008, J PHYS CHEM SOLIDS, V69, P2433, DOI 10.1016/j.jpcs.2008.04.033; Tao SW, 2000, IONICS, V6, P389, DOI 10.1007/BF02374158; Leon-Reina L, 2005, J MATER CHEM, V15, P2489, DOI 10.1039/b503374h; Masubuchi Y, 2006, J ALLOY COMPD, V408, P641, DOI 10.1016/j.jallcom.2004.12.097; Fukuda K, 2012, SOLID STATE IONICS, V217, P40, DOI 10.1016/j.ssi.2012.04.018; Kobayashi K, 2008, SOLID STATE IONICS, V179, P2209, DOI 10.1016/j.ssi.2008.07.023; Nakayama S, 1998, J EUR CERAM SOC, V18, P1413, DOI 10.1016/S0955-2219(98)00032-6; Liu W, 2013, J POWER SOURCES, V235, P62, DOI 10.1016/j.jpowsour.2013.01.194; Tao SW, 2001, MATER RES BULL, V36, P1245, DOI 10.1016/S0025-5408(01)00625-0; Leon-Reina L, 2004, J MATER CHEM, V14, P1142, DOI 10.1039/b315257j; White TJ, 2003, ACTA CRYSTALLOGR B, V59, P1, DOI 10.1107/S0108768102019894; Ferdov S, 2006, CHEM MATER, V18, P5958, DOI 10.1021/cm0617384; BLASSE G, 1967, J INORG NUCL CHEM, V29, P2231, DOI 10.1016/0022-1902(67)80277-X; Yoshioka H, 2004, CHEM LETT, V33, P392, DOI 10.1246/cl.2004.392; Kobayashi K, 2014, J CERAM SOC JPN, V122, P649, DOI 10.2109/jcersj2.122.649; Tolchard JR, 2003, J MATER CHEM, V13, P1956, DOI 10.1039/b302748c; Shi QL, 2012, J WUHAN UNIV TECHNOL, V27, P841, DOI 10.1007/s11595-012-0559-3; Chesnaud A, 2007, CHEM COMMUN, P1550, DOI 10.1039/b615524c; Ali R, 2008, CHEM MATER, V20, P5203, DOI 10.1021/cm7035234; Fukuda K, 2011, CHEM MATER, V23, P5474, DOI 10.1021/cm2029905; Yoshioka H, 2006, J ALLOY COMPD, V408, P649, DOI 10.1016/j.jallcom.2004.12.180; Rodriguez-Reyna E, 2006, J SOLID STATE CHEM, V179, P522, DOI 10.1016/j.jssc.2005.11.008; Guillot S, 2009, J SOLID STATE CHEM, V182, P3358, DOI 10.1016/j.jssc.2009.09.031; PILLARS WW, 1973, AM MINERAL, V58, P681; An T, 2013, CHEM MATER, V25, P1109, DOI 10.1021/cm4000685; Izumi F, 2007, SOL ST PHEN, V130, P15; NOE DC, 1993, Z KRISTALLOGR, V206, P233, DOI 10.1524/zkri.1993.206.Part-2.233; Yoshioka H, 2007, J AM CERAM SOC, V90, P3099, DOI 10.1111/j.1551-2916.2007.01862.x; Leon-Reina L, 2006, SOLID STATE IONICS, V177, P1307, DOI 10.1016/j.ssi.2006.05.034; Fukuda K, 2012, CHEM MATER, V24, P4623, DOI 10.1021/cm3034643; Sansom JEH, 2004, SOLID STATE IONICS, V167, P17, DOI 10.1016/j.ssi.2003.12.014; Higuchi M, 2004, SOLID STATE IONICS, V174, P73, DOI 10.1016/j.ssi.2004.05.028; Kobayashi K, 2009, ECS TRANSACTIONS, V25, P1785, DOI 10.1149/1.3205719; Nakayama S, 2014, CERAM INT, V40, P1221, DOI 10.1016/j.ceramint.2013.05.136; Arikawa H, 2000, SOLID STATE IONICS, V136, P31, DOI 10.1016/S0167-2738(00)00386-6; Zhang FX, 2013, PHYS CHEM MINER, V40, P817, DOI 10.1007/s00269-013-0616-2; Porras-Vazquez JM, 2009, J AM CERAM SOC, V92, P1062, DOI 10.1111/j.1551-2916.2009.03032.x; Nakayama S, 2013, J EUR CERAM SOC, V33, P207, DOI 10.1016/j.jeurceramsoc.2012.09.013; Yang TR, 2014, J EUR CERAM SOC, V34, P1563, DOI 10.1016/j.jeurceramsoc.2013.12.007; Kharlamova T, 2010, EUR J INORG CHEM, P589, DOI 10.1002/ejic.200900867; Panteix PJ, 2008, CERAM INT, V34, P1579, DOI 10.1016/j.ceramint.2007.05.004; Nakayama S, 2000, J MATER SCI LETT, V19, P91, DOI 10.1023/A:1006674708833; Ali R, 2009, J SOLID STATE CHEM, V182, P2846, DOI 10.1016/j.jssc.2009.07.053; Sansom JEH, 2001, SOLID STATE IONICS, V139, P205, DOI 10.1016/S0167-2738(00)00835-3; Yoshioka H, 2005, SOLID STATE IONICS, V176, P2395, DOI 10.1016/j.ssi.2005.06.026; FELSCHE J, 1972, J SOLID STATE CHEM, V5, P266, DOI 10.1016/0022-4596(72)90039-4; Baikie T, 2010, ACTA CRYSTALLOGR B, V66, P1, DOI 10.1107/S0108768109053981; Beaudet-Savignat S, 2007, J MATER CHEM, V17, P2078, DOI 10.1039/b615104c; Bechade E, 2008, J EUR CERAM SOC, V28, P2717, DOI 10.1016/j.jeurceramsoc.2008.03.045; BLASSE G, 1967, J INORG NUCL CHEM, V29, P1541, DOI 10.1016/0022-1902(67)80260-4; Bondar I. A., 1982, Ceramics International, V8, DOI 10.1016/0272-8842(82)90022-0; Briois P, 2011, J ELECTROCHEM SOC, V158, pB1479, DOI 10.1149/2.026112jes; Chefi S, 2008, J POWER SOURCES, V177, P464, DOI 10.1016/j.jpowsour.2007.11.091; Cohen E. R., 2007, QUANTITIES UNITS SYM; DELAFUENTE GF, 1989, SOLID STATE IONICS, V32-3, P494, DOI 10.1016/0167-2738(89)90261-0; Felsche J., 1973, STRUCT BOND, P99; FELSCHE J, 1969, NATURWISSENSCHAFTEN, V56, P325; Fleet ME, 2005, J SOLID STATE CHEM, V178, P3275, DOI 10.1016/j.jssc.2005.08.007; Gao W, 2013, J THERM SPRAY TECHN, V22, P1103, DOI 10.1007/s11666-013-9950-7; Gao W, 2011, J THERM SPRAY TECHN, V20, P888, DOI 10.1007/s11666-011-9625-1; Get'man EI, 2013, RUSS J INORG CHEM+, V58, P265, DOI 10.1134/S0036023613030078; Gibbs W., 1993, SCI PAPERS JW GIBBS, V1, P55; Gorshkov MY, 2007, RUSS J ELECTROCHEM+, V43, P721, DOI 10.1134/S102319350706016X; Gorshkov MY, 2006, RUSS J ELECTROCHEM+, V42, P737, DOI 10.1134/S102319350607007X; Guillot S, 2011, SOLID STATE IONICS, V185, P18, DOI 10.1016/j.ssi.2010.12.005; Hartenbach I, 2005, Z KRISTALLOGR, V220, P206, DOI 10.1524/zkri.220.2.206.59113; Higuchi M, 2000, J CRYST GROWTH, V216, P317, DOI 10.1016/S0022-0248(00)00421-8; Higuchi M, 1999, J CRYST GROWTH, V207, P298, DOI 10.1016/S0022-0248(99)00374-7; Higuchi M, 2000, J CRYST GROWTH, V218, P282, DOI 10.1016/S0022-0248(00)00577-7; Higuchi Y, 2010, CERAM INT, V36, P955, DOI 10.1016/j.ceramint.2009.10.022; HOPKINS RH, 1971, J ELECTROCHEM SOC, V118, P637, DOI 10.1149/1.2408128; Hsu CH, 2012, J ELECTROCHEM SOC, V159, pJ193, DOI 10.1149/2.077205jes; Huang ZX, 2010, PHYS STATUS SOLIDI A, V207, P2247, DOI 10.1002/pssa.200925605; HUGHES JM, 1992, NEUES JB MINER MONAT, P311; Islam MS, 2003, CHEM COMMUN, P1486, DOI 10.1039/b301179h; Iwata T, 2007, SOLID STATE IONICS, V178, P1523, DOI 10.1016/j.ssi.2007.09.006; Iwata T, 2008, J AM CERAM SOC, V91, P3714, DOI 10.1111/j.1551-2916.2008.02731.x; Izumi F., 2000, MATER SCI FORUM, V321-324, P198; Izumi F., 2002, RECENT RES DEV PHYS, V3, P669; Jo SH, 2009, J MATER RES, V24, P237, DOI 10.1557/JMR.2009.0018; Kinoshita T, 2010, SOLID STATE IONICS, V181, P1024, DOI 10.1016/j.ssi.2010.06.001; Kobayashi K, 2012, SCI TECHNOL ADV MAT, V13, DOI 10.1088/1468-6996/13/4/045006; Kobayashi K, 2012, SOLID STATE IONICS, V225, P443, DOI 10.1016/j.ssi.2012.02.008; Kudo T., 1990, SOLID STATE IONICS; Kuo YL, 2012, CERAM INT, V38, P3955, DOI 10.1016/j.ceramint.2012.01.049; Lambert S, 2006, J SOLID STATE CHEM, V179, P2602, DOI 10.1016/j.jssc.2006.04.056; Larson A.C., 1994, LAUR86748 LOS AL NAT; Leon-Reina L, 2007, DALTON T, P2058, DOI 10.1039/b616211h; Leu LC, 2011, J AM CERAM SOC, V94, P2625, DOI 10.1111/j.1551-2916.2011.04388.x; Li BY, 2011, J ALLOY COMPD, V509, P3172, DOI 10.1016/j.jallcom.2010.10.215; Manu KM, 2013, J AM CERAM SOC, V96, P1504, DOI 10.1111/jace.12215; Masubuchi Y, 2004, SOLID STATE IONICS, V166, P213, DOI 10.1016/j.ssi.2003.09.019; Matsushita Y, 2009, NUCL INSTRUM METH A, V600, P319, DOI 10.1016/j.nima.2008.11.081; Mineshige A, 2010, J ELECTROCHEM SOC, V157, pB1465, DOI 10.1149/1.3464803; Mineshige A, 2008, SOLID STATE IONICS, V179, P1009, DOI 10.1016/j.ssi.2008.02.037; Misture ST, 2004, J MATER RES, V19, P2330, DOI [10.1557/JMR.2004.0294, 10.1557/jmr.2004.0294]; Mizusaki J, 1996, J AM CERAM SOC, V79, P109, DOI 10.1111/j.1151-2916.1996.tb07887.x; MONTORSI M, 1982, J LESS-COMMON MET, V84, P25, DOI 10.1016/0022-5088(82)90124-2; Nakayama S., 1992, Journal of the Ceramic Society of Japan, V100; Nakayama S, 2002, NIPPON KAGAKU KAISHI, P243, DOI 10.1246/nikkashi.2002.243; NAKAYAMA S, 1995, CHEM LETT, P431, DOI 10.1246/cl.1995.431; NAKAYAMA S, 1995, ELECTROCHIM ACTA, V40, P2541, DOI 10.1016/0013-4686(94)00210-R; Nakayama S, 2001, J MATER SCI LETT, V20, P913, DOI 10.1023/A:1010928800227; NAKAYAMA S, 1993, J MATER CHEM, V3, P1251, DOI 10.1039/jm9930301251; Nojiri Y, 2010, J POWER SOURCES, V195, P4059, DOI 10.1016/j.jpowsour.2010.01.050; Okudera H, 2004, Z KRISTALLOGR, V219, P27, DOI 10.1524/zkri.219.1.27.25399; Okudera H, 2005, SOLID STATE IONICS, V176, P1473, DOI 10.1016/j.ssi.2005.02.014; Okudera H, 2004, J SOLID STATE CHEM, V177, P4451, DOI 10.1016/j.jssc.2004.09.024; Orera A, 2008, DALTON T, P5296, DOI 10.1039/b809062a; PETERSE WJA, 1966, ACTA CRYSTALLOGR, V20, P147, DOI 10.1107/S0365110X66000318; Pushcharovskii D. I., 1978, SOV PHYS DOKL, V242, p[835, 694]; Redhammer G.R., 2003, ACTA CRYSTALLOGR C, VC59, pi120; Sadykov VA, 2011, RUSS J ELECTROCHEM+, V47, P427, DOI 10.1134/S1023193511040136; Sakakura T, 2010, ACTA CRYSTALLOGR E, V66, pI68, DOI 10.1107/S1600536810033349; Sansom JEH, 2003, SOL ST PHEN, V90-91, P189; Sansom JEH, 2004, SOLID STATE IONICS, V167, P23, DOI 10.1016/j.ssi.2003.12.015; SATO M, 1994, CHEM LETT, P1425, DOI 10.1246/cl.1994.1425; Sato M, 1996, SOLID STATE IONICS, V83, P249, DOI 10.1016/0167-2738(95)00240-5; SIDOROV PM, 1977, J STRUCT CHEM+, V18, P319, DOI 10.1007/BF00753986; Slater PR, 2003, SOL ST PHEN, V90-91, P195; Takeda N, 2007, J CERAM SOC JPN, V115, P643, DOI 10.2109/jcersj2.115.643; Toropov N., 1961, T INT CER C 7 INT CE, P435; Toropov N. A., 1961, B ACAD SCI USSR CH, V10, P497, DOI 10.1007/BF00909108; Toropov N. A., 1971, INORG MATER, V7, p[1220, 1082]; Toropov N. A., 1961, B ACAD SCI USSR CH, V10, P1278, DOI 10.1007/BF00910095; Toropov N. A., 1961, B ACAD SCI USSR CH, V10, P682, DOI 10.1007/BF00905927; Toropov N. A., 1961, B ACAD SCI USSR CH, V10, p[1365, 1271], DOI 10.1007/BF00910094; Toropov N.A., 1961, B ACAD SCI USSR CH, V10, P502, DOI 10.1007/BF00909109; Uvarov V, 2010, J SOLID STATE CHEM, V183, P1484, DOI 10.1016/j.jssc.2010.04.028; Vincent A, 2007, J EUR CERAM SOC, V27, P1187, DOI 10.1016/j.jeurceramsoc.2006.05.090; Wang C, 2006, J SOLID STATE CHEM, V179, P2245, DOI 10.1016/j.jssc.2006.03.047; Werner F, 2005, MATER LETT, V59, P3660, DOI 10.1016/j.matlet.2005.06.039; Yao HC, 2010, SOLID STATE IONICS, V181, P41, DOI 10.1016/j.ssi.2009.12.004; Yin GC, 2014, J ALLOY COMPD, V586, P279, DOI 10.1016/j.jallcom.2013.09.216; Yoshioka H, 2008, SOLID STATE IONICS, V179, P2165, DOI 10.1016/j.ssi.2008.07.022; Yu J, 2010, INORG MATER+, V46, P1212, DOI 10.1134/S0020168510110105; Zhang H, 2007, J MATER SCI TECHNOL, V23, P629	148	3	3	CERAMIC SOC JAPAN-NIPPON SERAMIKKUSU KYOKAI	TOKYO	22-17, HYAKUNIN-CHO 2-CHOME, SHINJUKU-KU, TOKYO, 169-0073, JAPAN	1882-0743	1348-6535		J CERAM SOC JPN	J. Ceram. Soc. Jpn.	NOV	2014	122	1431					921	939		10.2109/jcersj2.122.921		19	Materials Science, Ceramics	Materials Science	AS7XJ	WOS:000344464900001		
J	Katagiri, N; Adachi, N; Ota, T				Katagiri, Naruhito; Adachi, Nobuyasu; Ota, Toshitaka			Addition of BaTiO3 and carbon nanoparticles to silica aerogel and its dielectric properties	JOURNAL OF THE CERAMIC SOCIETY OF JAPAN			English	Article						Dielectric properties; BaTiO3; Carbon; Silica aerogel; Nanocomposite; Sol-gel; Supercritical drying	PERCOLATION-THRESHOLD; COMPOSITES; INSULATOR; CERAMICS; BEHAVIOR	A tetramethylorthosilicate(TMOS)/ethanol solution was gelled together with BaTiO3 nanoparticles or carbon nanoparticles. The wet gel was dried in supercritical carbon dioxide, resulting in aerogel nanocomposites with compositions in the range of BaTiO3/SiO2 = 1/100 to 20/100 and C/SiO2 = 20/100 to 80/100. The bulk density of the aerogel obtained was in the range of 0.1 to 0.2 g/cm(3), the porosity was about 95%, and the specific surface area was in the range of 400 to 700m(2)/g. These values represent the characteristics of the aerogel. The relative permittivity and dielectric loss were respectively approximately 2 and 5 x 10(-3) for the BaTiO3-silica aerogel nanocomposite, and in the range of 5 to 10 and 0.012 to 0.4 for the carbon-silica aerogel nanocomposite. (c) 2014 The Ceramic Society of Japan. All rights reserved.	[Katagiri, Naruhito; Adachi, Nobuyasu; Ota, Toshitaka] Nagoya Inst Technol, Adv Ceram Res Ctr, Tajimi, Gifu 5070071, Japan; [Katagiri, Naruhito] Rinnai Corp, Technol Dev Ctr, Oguchi, Aichi 4800133, Japan	Katagiri, N (reprint author), Nagoya Inst Technol, Adv Ceram Res Ctr, 10-6-29 Asahigaoka, Tajimi, Gifu 5070071, Japan.	NaruhitoKatagiri@rinnai.co.jp					Ajiri M., 2010, NANOTECHNOLOGY SUPER, P189; Ryan JV, 2000, NATURE, V406, P169; Chung UC, 2009, APPL PHYS LETT, V94, DOI 10.1063/1.3076125; Pecharroman C, 2000, ADV MATER, V12, P294, DOI 10.1002/(SICI)1521-4095(200002)12:4<294::AID-ADMA294>3.0.CO;2-D; Si M, 2013, J MATER CHEM A, V1, P13490, DOI 10.1039/c3ta12925j; Chung UC, 2010, J AM CERAM SOC, V93, P865, DOI 10.1111/j.1551-2916.2009.03474.x; WURST JC, 1972, J AM CERAM SOC, V55, P109, DOI 10.1111/j.1151-2916.1972.tb11224.x; Sui G, 2008, ACTA MATER, V56, P2381, DOI 10.1016/j.actamat.2008.01.034; Khattari Z, 2012, PHYSICA B, V407, P759, DOI 10.1016/j.physb.2011.12.019; Qi L, 2005, ADV MATER, V17, P1777, DOI 10.1002/adma.200401816; Hu T, 2007, J EUR CERAM SOC, V27, P3997, DOI 10.1016/j.jeurceramsoc.2007.02.082; Hossain ME, 2014, ACTA MECH, V225, P1197, DOI 10.1007/s00707-013-1067-z; Li YJ, 2006, APPL PHYS LETT, V89, DOI 10.1063/1.2337157; Pecharroman C, 2001, ADV MATER, V13, P1541, DOI 10.1002/1521-4095(200110)13:20<1541::AID-ADMA1541>3.0.CO;2-X; Brunauer S, 1938, J AM CHEM SOC, V60, P309, DOI 10.1021/ja01269a023; BARRETT EP, 1951, J AM CHEM SOC, V73, P373, DOI 10.1021/ja01145a126; BRUESCH P, 1993, APPL PHYS A-MATER, V57, P329, DOI 10.1007/BF00332286; Chen RZ, 2002, MATER LETT, V54, P314, DOI 10.1016/S0167-577X(01)00584-5; GESSER HD, 1989, CHEM REV, V89, P765, DOI 10.1021/cr00094a003; Hadik N., ACTIVE PASSIVE ELECT, V2009; Hubert T, 2005, MATER SCI-POLAND, V23, P61; Izumi H., 2002, DENSHI SERAMIKKUSU, P27; Jasem S.H., 2012, J BASRAH RES SCI, V38, P60; Jiang Z., 2013, APPL PETROCHEM RES, V3, P91; Katagiri N., 2014, CHEMXPRESS, V4, P221; Katagiri N, 2014, J CERAM SOC JPN, V122, P29, DOI 10.2109/jcersj2.122.29; Kawakami N., 2002, KOBE STEEL WORKS ENG, V52, P39; Kingery W. D., 1976, INTRO CERAMICS, P953; Kingery W.D., 1976, INTRO CERAMICS, P947; Liu CL, 1995, J POROUS MAT, V1, P75, DOI 10.1007/BF00486526; Liu JX, 2014, J SOL-GEL SCI TECHN, V69, P93, DOI 10.1007/s10971-013-3190-7; Macutkevic J, 2009, APPL PHYS LETT, V95, DOI 10.1063/1.3224187; Nuzhnyy D., 2011, Journal of Advanced Dielectrics, V1, DOI 10.1142/S2010135X11000367; Nuzhnyy D., 2010, PROCESSING APPL CERA, V4, P215; Tajiri K., 1993, HYOMEN KAGAKU, V14, P546; Xu JW, 2006, IEEE T ADV PACKAGING, V29, P295, DOI 10.1109/TADVP.2006.874701	36	0	0	CERAMIC SOC JAPAN-NIPPON SERAMIKKUSU KYOKAI	TOKYO	22-17, HYAKUNIN-CHO 2-CHOME, SHINJUKU-KU, TOKYO, 169-0073, JAPAN	1882-0743	1348-6535		J CERAM SOC JPN	J. Ceram. Soc. Jpn.	NOV	2014	122	1431					944	950		10.2109/jcersj2.122.944		7	Materials Science, Ceramics	Materials Science	AS7XJ	WOS:000344464900003		
J	Rami-Porta, R; Bolejack, V; Giroux, DJ; Chansky, K; Crowley, J; Asamura, H; Goldstraw, P				Rami-Porta, Ramon; Bolejack, Vanessa; Giroux, Dorothy J.; Chansky, Kari; Crowley, John; Asamura, Hisao; Goldstraw, Peter		Int Assoc Study Lung Canc Staging; Advisory Board Members	The IASLC Lung Cancer Staging Project: The New Database to Inform the Eighth Edition of the TNM Classification of Lung Cancer	JOURNAL OF THORACIC ONCOLOGY			English	Article						Lung cancer; Lung cancer databases; Lung cancer staging; Nonsmall cell lung cancer; Small cell lung cancer; TNM classification	FORTHCOMING 7TH EDITION; INTERNATIONAL-ASSOCIATION; MALIGNANT-TUMORS; PROGNOSTIC-FACTORS; SMALL-CE; PROPOSALS; REVISION; DESCRIPTORS; GROUPINGS	The analyses of the retrospective database of the International Association for the Study of Lung Cancer (IASLC), consisting of more than 81,000 evaluable patients diagnosed with lung cancer between 1990 and 2000, formed the basis of recommendations to the Union for International Cancer Control and the American Joint Committee on Cancer for the revision of the sixth edition of the tumor, node, and metastasis (TNM) classification of lung cancer. However, despite the large number of patients, not all descriptors could be validated. This prompted a new collection of retrospective and prospective data to overcome the limitations of the original retrospective database. The new IASLC database has information on 94,708 new patients diagnosed of lung cancer between 1999 and 2010. They originated from 35 sources in 16 countries, and 4,667 were submitted via the online electronic data capture system. Europe contributed 46,560 patients, Asia: 41,705, North America: 4,660, Australia: 1,593, and South America: 190. After exclusions, 77,156 (70,967 with nonsmall cell lung cancer and 6,189 with small cell lung cancer) remained for analysis. This database will be analyzed according to established objectives for the T, the N, and the M components to inform the eighth edition of the TNM classification of lung cancer due to be published in 2016. The IASLC hopes for the continuing contribution of our partners around the world to improve the classification of anatomical extent of disease, but also to create prognostic groups in a parallel project of the IASLC Staging and Prognostic Factors Committee.	[Rami-Porta, Ramon] Univ Barcelona, Hosp Univ Mutua Terrassa, Dept Thorac Surg, Barcelona, Spain; [Rami-Porta, Ramon] CIBERES Lung Canc Grp, Barcelona, Spain; [Bolejack, Vanessa; Giroux, Dorothy J.; Chansky, Kari; Crowley, John] Canc Res & Biostat, Seattle, WA USA; [Asamura, Hisao] Natl Canc Ctr, Dept Thorac Surg, Tokyo, Japan; [Goldstraw, Peter] Royal Brompton Hosp, Dept Thorac Surg, London SW3 6LY, England; [Goldstraw, Peter] Univ London Imperial Coll Sci Technol & Med, London, England	Rami-Porta, R (reprint author), Hosp Univ Mutua Terrassa, Dept Thorac Surg, Plaza Dr Robert 5, Barcelona 08221, Spain.	rramip@yahoo.es	Nowak, Anna/B-2487-2013; Galateau Salle, Francoise/J-1530-2015; Fong, Kwun/G-6369-2010; 	Nowak, Anna/0000-0002-9317-9526; Galateau Salle, Francoise/0000-0003-3642-0165; Gullon, Jose Antonio/0000-0002-3007-0873; Rami-Porta, Ramon/0000-0003-3366-7664			Goldstraw P, 2007, J THORAC ONCOL, V2, P706, DOI 10.1097/JTO.0b013e31812f3c1a; Groome PA, 2007, J THORAC ONCOL, V2, P694, DOI 10.1097/JTO.0b013e31812d05d5; Vallieres E, 2009, J THORAC ONCOL, V4, P1049, DOI 10.1097/JTO.0b013e3181b27799; Rusch VW, 2007, J THORAC ONCOL, V2, P603, DOI 10.1097/JTO.0b013e31807ec803; Rami-Porta R, 2007, J THORAC ONCOL, V2, P593; Postmus PE, 2007, J THORAC ONCOL, V2, P686, DOI 10.1097/JTO.0b013e31811f4703; Rusch VW, 2009, J THORAC ONCOL, V4, P568, DOI 10.1097/JTO.0b013e3181a0d82e; Goldstraw P, 2006, J THORAC ONCOL, V1, P281, DOI 10.1097/01243894-200605000-00002; Travis WD, 2008, J THORAC ONCOL, V3, P1213, DOI 10.1097/JTO.0b013e31818b06e3; Shepherd FA, 2007, J THORAC ONCOL, V2, P1067, DOI 10.1097/JTO.0b013e31815bdc0d; Giroux DJ, 2009, J THORAC ONCOL, V4, P679, DOI 10.1097/JTO.0b013e3181a52370; Travis WD, 2008, J THORAC ONCOL, V3, P1384, DOI 10.1097/JTO.0b013e31818e0d9f; Sculier JP, 2008, J THORAC ONCOL, V3, P457, DOI 10.1097/JTO.0b013e31816de2b8; Chansky K, 2009, J THORAC ONCOL, V4, P792, DOI 10.1097/JTO.0b013e3181a7716e; Edge SB, 2010, CANC STAGING MANUAL, P253; Goldstraw P, 2009, STAGING MANUAL THORA; Goldstraw P, 2009, STAGING HDB THORACIC; Goldstraw P, 1997, LUNG CANCER-J IASLC, V18, P107, DOI 10.1016/S0169-5002(97)00051-2; Rami-Porta R, 2010, EUR RESPIR J, V36, P237, DOI 10.1183/09031936.00016210; Rami-Porta R, 2013, J THORAC ONCOL, V8, pS47; Sobin LH, 2009, TNM CLASSIFICATION M, P138	21	10	11	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	1556-0864	1556-1380		J THORAC ONCOL	J. Thorac. Oncol.	NOV	2014	9	11					1618	1624		10.1097/JTO.0000000000000334		7	Oncology; Respiratory System	Oncology; Respiratory System	AS6IT	WOS:000344368100009		
J	Blackhall, F; Kim, DW; Besse, B; Nokihara, H; Han, JY; Wilner, KD; Reisman, A; Iyer, S; Hirsh, V; Shaw, AT				Blackhall, Fiona; Kim, Dong-Wan; Besse, Benjamin; Nokihara, Hiroshi; Han, Ji-Youn; Wilner, Keith D.; Reisman, Arlene; Iyer, Shrividya; Hirsh, Vera; Shaw, Alice T.			Patient-Reported Outcomes and Quality of Life in PROFILE 1007: A Randomized Trial of Crizotinib Compared with Chemotherapy in Previously Treated Patients with ALK-Positive Advanced Non-Small-Cell Lung Cancer	JOURNAL OF THORACIC ONCOLOGY			English	Article						Patient-reported outcomes; Quality of life; Crizotinib; Non-small-cell lung cancer	CLINICAL-TRIALS; PHASE-III; SYMPTOM; ERLOTINIB; ADENOCARCINOMA; GEFITINIB; DISTRESS; AFATINIB; FATIGUE; QLQ-C30	Introduction: The main objective of the current post hoc analysis was to compare patient-reported outcomes between crizotinib (N = 172) and chemotherapy subgroups (pemetrexed [N = 99] and docetaxel [N = 72]) in previously treated patients with advanced ALK-positive non-small-cell lung cancer, in PROFILE 1007 study (Pfizer; NCT0093283). Methods: Patient-reported outcomes were assessed at baseline, day 1 of each cycle, and end of treatment. General health status was measured using the EuroQol-5D visual analog scale and health utility index scores were assessed using the EuroQol-5D descriptive system. Functioning, lung cancer symptoms, and global quality of life (QOL) were assessed using European Organisation for Research and Treatment of Cancer QLQ-C30 and the QLQ-LC13 lung cancer module. Repeated measures mixed-effects analyses compared overall scores and change from baseline scores, controlling for baseline scores. Results: The overall mean EQ-5D health utility index scores (95% CI) on treatment were significantly greater (p < 0.05) for crizotinib (0.82 [0.79-0.85]) than for chemotherapy (0.73 [0.70-0.77]; 0.74 [0.70-0.79] for pemetrexed and 0.66 [0.58-0.74] for docetaxel). A significantly greater improvement from baseline was observed with crizotinib versus pemetrexed and versus docetaxel treatment groups for general health status, physical functioning, global QOL, dyspnea, fatigue, and pain. Improvement rates for fatigue, cough, pain, dyspnea, and global QOL were significantly greater on crizotinib compared with pemetrexed and docetaxel, respectively. Worsening rates for diarrhea and constipation were higher with crizotinib. Conclusion: The benefits of crizotinib in improving symptoms and QOL are demonstrated regardless of whether the comparator is pemetrexed or docetaxel.	[Blackhall, Fiona] Univ Manchester, Inst Canc Sci, Dept Med Oncol, Manchester, Lancs, England; [Blackhall, Fiona] Christie Hosp NHS Fdn Trust, Manchester M20 4BX, Lancs, England; [Kim, Dong-Wan] Seoul Natl Univ Hosp, Dept Internal Med, Seoul 110744, South Korea; [Besse, Benjamin] Inst Gustave Roussy, Dept Thorac Oncol, Villejuif, France; [Nokihara, Hiroshi] Natl Canc Ctr, Tokyo, Japan; [Han, Ji-Youn] Natl Canc Ctr, Ctr Lung Canc, Div Translat & Clin Res, Goyang, South Korea; [Wilner, Keith D.] Pfizer Oncol, Clin Dev, La Jolla, CA USA; [Reisman, Arlene] Pfizer Global Innovat Pharma Business, Biostat, New York, NY USA; [Iyer, Shrividya] Pfizer Oncol, Global Outcomes & Evidence, New York, NY USA; [Hirsh, Vera] McGill Univ, Ctr Hlth, Dept Oncol, Montreal, PQ, Canada; [Shaw, Alice T.] Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA	Blackhall, F (reprint author), Christie Hosp NHS Fdn Trust, Dept Med Oncol, Wilmslow Rd, Manchester M20 4BX, Lancs, England.	Fiona.Blackhall@chris-tie.nhs.ukx	Blackhall, Fiona/N-2186-2015	Blackhall, Fiona/0000-0001-8716-3395	Pfizer, Inc.	Editorial support was provided by Roger Wild at ACUMED (Tytherington, UK) with funding from Pfizer, Inc. Programming support was provided by Pfizer, Inc.	AARONSON NK, 1993, J NATL CANCER I, V85, P365, DOI 10.1093/jnci/85.5.365; BERGMAN B, 1994, EUR J CANCER, V30A, P635, DOI 10.1016/0959-8049(94)90535-5; Bezjak A, 2006, J CLIN ONCOL, V24, P3831, DOI 10.1200/JCO.2006.05.8073; Osoba D, 1998, J CLIN ONCOL, V16, P139; HOCHBERG Y, 1988, BIOMETRIKA, V75, P800, DOI 10.1093/biomet/75.4.800; Di Maio M, 2012, J THORAC ONCOL, V7, P1830, DOI 10.1097/JTO.0b013e318275b327; Yennurajalingam S, 2013, J CLIN ONCOL, V31, P3076, DOI 10.1200/JCO.2012.44.4661; Hirsh V, 2013, J THORAC ONCOL, V8, P229, DOI 10.1097/JTO.0b013e3182773fce; Fallowfield LJ, 2012, NAT REV CLIN ONCOL, V9, P41, DOI 10.1038/nrclinonc.2011.156; Silvestri G, 1998, BRIT MED J, V317, P771; Iyer S, 2013, LUNG CANCER, V81, P288, DOI 10.1016/j.lungcan.2013.03.008; Mok TS, 2009, NEW ENGL J MED, V361, P947, DOI 10.1056/NEJMoa0810699; Hanna N, 2004, J CLIN ONCOL, V22, P1589, DOI 10.1200/JCO.2004.08.163; HOPWOOD P, 1995, BRIT J CANCER, V71, P633, DOI 10.1038/bjc.1995.124; Molassiotis A, 2011, LUNG CANCER, V71, P94, DOI 10.1016/j.lungcan.2010.04.002; Shaw AT, 2013, NEW ENGL J MED, V368, P2385, DOI 10.1056/NEJMoa1214886; Bergethon K, 2012, J CLIN ONCOL, V30, P863, DOI 10.1200/JCO.2011.35.6345; Ou SHI, 2011, J THORAC ONCOL, V6, P942, DOI 10.1097/JTO.0b013e31821528d3; Broberger E, 2006, NURS RES, V55, P274, DOI 10.1097/00006199-200607000-00008; BROOKMEYER R, 1982, BIOMETRICS, V38, P29, DOI 10.2307/2530286; Chernecky C, 2004, ONCOL NURS FORUM, V31, P1095, DOI 10.1188/04.ONF.1095-1101; Fitzmaurice G, 2004, APPL LONGITUDINAL AN; Plunkett Tim A, 2003, Clin Lung Cancer, V5, P28, DOI 10.3816/CLC.2003.n.018; Scott NW, 2008, EORTC QLQ C30 REFERE; The EuroQol Group EQ-5D-3L, 2011, EQ5D3L; Tishelman C, 2005, CANCER, V104, P2013, DOI 10.1002/cncr.21398; Yang JCH, 2013, J CLIN ONCOL, V31, P3342, DOI 10.1200/JCO.2012.46.1764	27	3	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	1556-0864	1556-1380		J THORAC ONCOL	J. Thorac. Oncol.	NOV	2014	9	11					1625	1633		10.1097/JTO.0000000000000318		9	Oncology; Respiratory System	Oncology; Respiratory System	AS6IT	WOS:000344368100010		
J	Kodama, T; Motoi, N; Ninomiya, H; Sakamoto, H; Kitada, K; Tsukaguchi, T; Satoh, Y; Nomura, K; Nagano, H; Ishii, N; Terui, Y; Hatake, K; Ishikawa, Y				Kodama, Tatsushi; Motoi, Noriko; Ninomiya, Hironori; Sakamoto, Hiroshi; Kitada, Kunio; Tsukaguchi, Toshiyuki; Satoh, Yasuko; Nomura, Kimie; Nagano, Hiroko; Ishii, Nobuya; Terui, Yasuhito; Hatake, Kiyohiko; Ishikawa, Yuichi			A Novel Mechanism of EML4-ALK Rearrangement Mediated by Chromothripsis in a Patient-Derived Cell Line	JOURNAL OF THORACIC ONCOLOGY			English	Article						ALK; Lung cancer; Chromosomal rearrangement; Chromothripsis; ALK inhibitor	LUNG-CANCER; FUSION GENE; ALK; RET; IDENTIFICATION; NEUROBLASTOMA; CRIZOTINIB; INHIBITOR; MUTATIONS; CH5424802	Introduction:EML4-ALK is a driver oncogene in non-small-cell lung cancer (NSCLC) and has been developed into a promising molecular target for antitumor agents. Although EML4-ALK is reported to be formed by inversion of chromosome 2, other mechanisms of this gene fusion remain unknown. This study aimed to examine the mechanism of EML4-ALK rearrangement using a novel cell line with the EML4-ALK fusion gene. Methods: An EML4-ALK-positive cell line, termed JFCR-LC649, was established from pleomorphic carcinoma, a rare subtype of NSCLC. We investigated the chromosomal aberrations using fluorescence in situ hybridization and comparative genomic hybridization (CGH). Alectinib/CH5424802, a selective ALK inhibitor, was evaluated in the antitumor activity against JFCR-LC649 in vitro and in vivo xenograft model. Results: We established an EML4-ALK-positive cell line, termed JFCR-LC649, derived from a patient with NSCLC and revealed that the JFCR-LC649 cells harbor variant 3 of the EML4-ALK fusion with twofold copy number gain. Interestingly, comparative genomic hybridization and metaphase-fluorescence in situ hybridization analysis showed that in addition to two normal chromosome 2, JFCR-LC649 cells contained two aberrant chromosome 2 that were fragmented and scattered. These observations provided the first evidence that EML4-ALK fusion in JFCR-LC649 cells was formed in chromosome 2 by a distinct mechanism of genomic rearrangement, termed chromothripsis. Furthermore, a selective ALK inhibitor alectinib/CH5424802 suppressed tumor growth of the JFCR-LC649 cells through inhibition of phospho-ALK in vitro and in vivo in a xenograft model. Conclusion: Our results suggested that chromothripsis may be a mechanism of oncogenic rearrangement of EML4-ALK. In addition, alectinib was effective against EML4-ALK-positive tumors with ALK copy number gain mediated by chromothripsis.	[Kodama, Tatsushi; Sakamoto, Hiroshi; Kitada, Kunio; Tsukaguchi, Toshiyuki; Satoh, Yasuko; Ishii, Nobuya] Chugai Pharmaceut Co Ltd, Div Res, Kamakura, Kanagawa 2478530, Japan; [Motoi, Noriko; Ninomiya, Hironori; Nomura, Kimie; Nagano, Hiroko; Ishikawa, Yuichi] Japanese Fdn Canc Res, Inst Canc, Dept Pathol, Tokyo 170, Japan; [Terui, Yasuhito; Hatake, Kiyohiko] Japanese Fdn Canc Res, Ctr Canc Chemotherapy, Div Clin Chemotherapy, Tokyo 170, Japan; [Motoi, Noriko; Ninomiya, Hironori; Ishikawa, Yuichi] Canc Inst Hosp, Dept Pathol, Tokyo, Japan	Sakamoto, H (reprint author), Chugai Pharmaceut Co Ltd, Div Res, 200 Kajiwara, Kamakura, Kanagawa 2478530, Japan.	sakamotohrs@chugai-pharm.co.jp			Ministry of Education, Culture, Sports, Science and Technology, Japan; Japan Society for the Promotion of Science; Ministry of Health, Labour and Welfare; Princess Takamatsu Cancer Research Fund; Smoking Research Foundation	Parts of this study were supported financially by Grants-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology, Japan, grants from the Japan Society for the Promotion of Science, the Ministry of Health, Labour and Welfare, and the Princess Takamatsu Cancer Research Fund, and Smoking Research Foundation.	Magrangeas F, 2011, BLOOD, V118, P675, DOI 10.1182/blood-2011-03-344069; Soda M, 2007, NATURE, V448, P561, DOI 10.1038/nature05945; Camidge DR, 2012, LANCET ONCOL, V13, P1011, DOI 10.1016/S1470-2045(12)70344-3; Bishop JA, 2010, HUM PATHOL, V41, P20, DOI 10.1016/j.humpath.2009.06.014; Gainor JF, 2013, CLIN CANCER RES, V19, P4273, DOI 10.1158/1078-0432.CCR-13-0318; Seto T, 2013, LANCET ONCOL, V14, P590, DOI 10.1016/S1470-2045(13)70142-6; Stephens PJ, 2011, CELL, V144, P27, DOI 10.1016/j.cell.2010.11.055; Drilon A, 2013, CANCER DISCOV, V3, P630, DOI 10.1158/2159-8290.CD-13-0035; Kantarjian H, 2002, NEW ENGL J MED, V346, P645, DOI 10.1056/NEJMoa011573; Wu CX, 2012, GENE CHROMOSOME CANC, V51, P1144, DOI 10.1002/gcc.21999; Northcott PA, 2012, NATURE, V488, P49, DOI 10.1038/nature11327; Rossi G, 2003, AM J SURG PATHOL, V27, P311, DOI 10.1097/00000478-200303000-00004; Cazes A, 2013, CANCER RES, V73, P195, DOI 10.1158/0008-5472.CAN-12-1242; Lipson D, 2012, NAT MED, V18, P382, DOI 10.1038/nm.2673; Sakamoto H, 2011, CANCER CELL, V19, P679, DOI 10.1016/j.ccr.2011.04.004; Katayama R, 2011, P NATL ACAD SCI USA, V108, P7535, DOI 10.1073/pnas.1019559108; Kohno T, 2012, NAT MED, V18, P375, DOI 10.1038/nm.2644; Molenaar JJ, 2012, NATURE, V483, P589, DOI 10.1038/nature10910; Koivunen JP, 2008, CLIN CANCER RES, V14, P4275, DOI 10.1158/1078-0432.CCR-08-0168; Rausch T, 2012, CELL, V148, P59, DOI 10.1016/j.cell.2011.12.013; Takeuchi K, 2012, NAT MED, V18, P378, DOI 10.1038/nm.2658; Bishop JA, 2012, MODERN PATHOL, V25, P405, DOI 10.1038/modpathol.2011.173; Boland JM, 2009, HUM PATHOL, V40, P1152, DOI 10.1016/j.humpath.2009.01.012; Devarajan E, 2012, INT J CANCER, V131, P1023, DOI 10.1002/ijc.26493; Johansson Leif, 2004, Ann Diagn Pathol, V8, P259, DOI 10.1016/j.anndiagpath.2004.07.001; Katayama R, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003316; Kitada K, 2012, CYTOGENET GENOME RES, V136, P30, DOI 10.1159/000334349; Kitada K, 2011, GENE CHROMOSOME CANC, V50, P217, DOI 10.1002/gcc.20847; Kloosterman WP, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-10-r103; Kuromitsu S, 2011, CANC RES S, V71; Kwak EL, 2010, NEW ENGL J MED, V363, P1693, DOI 10.1056/NEJMoa1006448; Ou SHI, 2013, J CLIN ONCOL S, V31; Sequist LV, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002003; Tanizaki J, 2012, BRIT J CANCER, V106, P763, DOI 10.1038/bjc.2011.586	34	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	1556-0864	1556-1380		J THORAC ONCOL	J. Thorac. Oncol.	NOV	2014	9	11					1638	1646		10.1097/JTO.0000000000000311		9	Oncology; Respiratory System	Oncology; Respiratory System	AS6IT	WOS:000344368100012		
J	Iwamoto, S; Tanimoto, K; Nishio, Y; Putra, AC; Fuchita, H; Ohe, M; Sutani, A; Kuraki, T; Hiyama, K; Murakami, I; Eguchi, H; Isobe, T				Iwamoto, Shinichi; Tanimoto, Keiji; Nishio, Yumi; Putra, Andika Chandra; Fuchita, Hiroshi; Ohe, Miki; Sutani, Akihisa; Kuraki, Takashige; Hiyama, Keiko; Murakami, Isao; Eguchi, Hidetaka; Isobe, Takeshi			Association of EPAS1 Gene rs4953354 Polymorphism with Susceptibility to Lung Adenocarcinoma in Female Japanese Non-Smokers	JOURNAL OF THORACIC ONCOLOGY			English	Article						Lung adenocarcinoma; EPAS1; HIF-2; SNP	CANCER; EXPRESSION	Introduction: Hypoxia-inducible factor-2 (also called endothelial periodic acid-Schiff domain protein 1 [EPAS1]) seems to play an important role in some carcinogenesis, though there is no information on the relationship between single nucleotide polymorphism of EPAS1 and lung cancer development. The aim of this study was to explore a possible association of the EPAS1 gene rs4953354 polymorphism with susceptibility to lung cancer. Methods: A case-control study of 346 patients with non-small-cell lung carcinoma (adenocarcinoma = 249, squamous cell carcinoma = 97) and 247 healthy control subjects was carried out. A/G polymorphism within an intron 2 of the EPAS1 (rs4953354) was determined by direct sequencing. Results: A frequency of lung adenocarcinoma patients with a minor allele G (A/G or G/G genotype) at the rs4953354 was much higher than that of controls (odds ratio, 1.800; 95% confidence interval, 1.161-2.791; p = 0.008). This association was more evident when analyzed using female never-smokers (odds ratio, 3.31; 95% confidence interval, 1.21-9.01; p = 0.017). Mutations in epidermal growth factor receptor tended to be frequent in patients with G allele at the rs4953354, compared with those with other genotypes. Conclusion: The EPAS1 rs4953354 may be a potentially susceptible marker for development of lung adenocarcinoma, especially in female never-smokers.	[Iwamoto, Shinichi; Nishio, Yumi; Fuchita, Hiroshi; Ohe, Miki; Sutani, Akihisa; Kuraki, Takashige; Isobe, Takeshi] Shimane Univ, Div Med Oncol & Resp Med, Dept Internal Med, Fac Med, Izumo, Shimane 6938501, Japan; [Tanimoto, Keiji; Putra, Andika Chandra] Hiroshima Univ, Dept Radiat Med, Res Inst Radiat Biol & Med, Hiroshima 7348553, Japan; [Hiyama, Keiko] Hiroshima Univ, Nat Sci Ctr Basic Res & Dev, Hiroshima 7348553, Japan; [Murakami, Isao] Higashihiroshima Med Ctr, Dept Resp Med, Hiroshima, Japan; [Eguchi, Hidetaka] Saitama Med Univ, Div Translat Res, Res Ctr Genom Med, Saitama, Japan	Isobe, T (reprint author), Shimane Univ, Div Med Oncol & Resp Med, Dept Internal Med, Fac Med, 89-1 Enya Cho, Izumo, Shimane 6938501, Japan.	ktanimo@hiroshima-u.ac.jp; isobeti@med.shimane-u.ac.jp					Gordan JD, 2007, CURR OPIN GENET DEV, V17, P71, DOI 10.1016/j.gde.2006.12.006; Peng XH, 2006, J BIOL CHEM, V281, P25903, DOI 10.1074/jbc.M603414200; Putra AC, 2011, RESPIROLOGY, V16, P796, DOI 10.1111/j.1440-1843.2011.01972.x; Ema M, 1997, P NATL ACAD SCI USA, V94, P4273, DOI 10.1073/pnas.94.9.4273; Tian H, 1997, GENE DEV, V11, P72, DOI 10.1101/gad.11.1.72; Ciampa J, 2011, CANCER RES, V71, P3287, DOI 10.1158/0008-5472.CAN-10-2646; Jemal A, 2008, CA-CANCER J CLIN, V58, P71, DOI 10.3322/CA.2007.0010; Purdue MP, 2011, NAT GENET, V43, P60, DOI 10.1038/ng.723; Sun S, 2007, NAT REV CANCER, V7, P778, DOI 10.1038/nrc2190; Hanaoka M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050566; R Development Core Team, 2010, R LANG ENV STAT COMP; Wu XH, 2011, CHIN MED J, V124, P11	12	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	1556-0864	1556-1380		J THORAC ONCOL	J. Thorac. Oncol.	NOV	2014	9	11					1709	1713		10.1097/JTO.0000000000000309		5	Oncology; Respiratory System	Oncology; Respiratory System	AS6IT	WOS:000344368100022		
J	Hussain, A; Bessho, K; Takahashi, K; Tabata, Y				Hussain, Ahmed; Bessho, Kazuhisa; Takahashi, Katsu; Tabata, Yasuhiko			Magnesium calcium phosphate/beta-tricalcium phosphate incorporation into gelatin scaffold: an in vitro comparative study	JOURNAL OF TISSUE ENGINEERING AND REGENERATIVE MEDICINE			English	Article						gelatin scaffolds; MSCs; MCP; TCP; in vitro; osteogenic differentiation	MESENCHYMAL STEM-CELLS; BONE; DIFFERENTIATION; PROLIFERATION; OSTEOBLASTS; ADHESION; IMPLANTS	Gelatin scaffolds incorporating or not 50wt% of magnesium calcium phosphate (MCP) or -tricalcium phosphate (TCP) were prepared and the in vitro osteogenic differentiation of rat bone marrow mesenchymal stem cells (MSCs) in the scaffolds was investigated. The pore sizes of the scaffolds were in the range 123.8 +/- 47.2-153 +/- 60.72 mu m in diameter, while the porosity was 33.3 +/- 2-44.9 +/- 3.4%. The compression modulus of the sponges was about 2.04-2.24mPa. There was no significant difference among groups regarding the physical and mechanical properties. When seeded into the sponges by an agitation method, the MSCs were distributed throughout the scaffold. Higher MSC proliferation was observed for scaffolds incorporating minerals. Following the incubation of MSCs in scaffolds incorporating MCP, the alkaline phosphatase activity was significantly higher at weeks 2, 3 and 4 in comparison with other scaffolds; however, the osteocalcin levels of MSCs did not show significant differences among groups. These findings indicate that MSCs seeded in scaffolds incorporating MCP showed significantly superior biological results in terms of proliferation and osteogenic differentiation in comparison with other scaffold types. Copyright (c) 2012 John Wiley & Sons, Ltd.	[Hussain, Ahmed; Bessho, Kazuhisa; Takahashi, Katsu] Kyoto Univ, Grad Sch Med, Dept Oral & Maxillofacial Surg, Kyoto 6068507, Japan; [Tabata, Yasuhiko] Kyoto Univ, Inst Frontier Med Sci, Field Tissue Engn, Dept Biomat, Kyoto 6068507, Japan	Hussain, A (reprint author), Kyoto Univ, Grad Sch Med, Dept Oral & Maxillofacial Surg, Sakyo Ku, 54 Kawahara Cho, Kyoto 6068507, Japan.	frontierscientist@gmail.com					Vandrovcova M, 2011, PHYSIOL RES, V60, P403; Stock UA, 2001, ANNU REV MED, V52, P443, DOI 10.1146/annurev.med.52.1.443; Takahashi Y, 2005, BIOMATERIALS, V26, P3587, DOI 10.1016/j.biomaterials.2004.09.046; Kobayashi D, 1996, J BIOCHEM, V119, P475; Sader MS, 2009, J MATER SCI-MATER M, V20, P521, DOI 10.1007/s10856-008-3610-3; Feyerabend F, 2006, TISSUE ENG, V12, P3545, DOI 10.1089/ten.2006.12.3545; LENNON DP, 1995, EXP CELL RES, V219, P211, DOI 10.1006/excr.1995.1221; Takahashi Y, 2003, TISSUE ENG, V9, P931, DOI 10.1089/107632703322495574; Marchi J, 2007, MATER RES BULL, V42, P1040, DOI 10.1016/j.materresbull.2006.09.015; GRIGORIADIS AE, 1988, J CELL BIOL, V106, P2139, DOI 10.1083/jcb.106.6.2139; Aubin JE, 2002, PRINCIPLES BONE BIOL, P59, DOI 10.1016/B978-012098652-1.50106-2; Bessho K, 2000, BRIT J ORAL MAX SURG, V38, P645, DOI 10.1054/bjom.2000.0533; Dietrich E, 2009, J BIOMED MATER RES A, V88A, P1087, DOI 10.1002/jbm.a.31901; Jias J, 2010, J R SOC INTERFACE, V7, P1171; Kims BS, 1999, EXP CELL RES, V251, P318; Lennon DP, 2000, DEV DYNAM, V219, P50, DOI 10.1002/1097-0177(2000)9999:9999<::AID-DVDY1037>3.0.CO;2-7; Lius XH, 2004, ANN BIOMED ENG, V32, P477; Logeart-Avramoglou D, 2005, J CELL MOL MED, V9, P72, DOI 10.1111/j.1582-4934.2005.tb00338.x; Lus J, 2011, J MATER SCI-MATER M, V22, P607; Qis GC, 2008, APPL SURF SCI, V255, P304; Raos J, 1992, ANAL BIOCHEM, V207, P186; Revell PA, 2004, KEY ENG MAT, V254-2, P447; Sodeks J, 2000, BONE ENG, P31; Straigers MP, 2006, BIOMATERIALS, V27, P1728; Suns HL, 2006, BIOMATERIALS, V27, P5651	25	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1932-6254	1932-7005		J TISSUE ENG REGEN M	J. Tissue Eng. Regen. Med.	NOV	2014	8	11					919	924		10.1002/term.1596		6	Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell Biology; Engineering, Biomedical	Cell Biology; Biotechnology & Applied Microbiology; Engineering	AS5UU	WOS:000344335700008		
J	Uraguchi, K; Ueno, M; Iijima, H; Saitoh, T				Uraguchi, Kohji; Ueno, Mayumi; Iijima, Hayato; Saitoh, Takashi			Demographic Analyses of a Fox Population Suffering From Sarcoptic Mange	JOURNAL OF WILDLIFE MANAGEMENT			English	Article						cohort analysis; mortality; Sarcoptes scabiei; state space model; Vulpes vulpes	VULPES-VULPES POPULATION; STATE-SPACE MODELS; RED FOX; ECHINOCOCCUS-MULTILOCULARIS; DENSITY-DEPENDENCE; RURAL BRITAIN; HARVEST DATA; DYNAMICS; SURVIVAL; MORTALITY	We reconstructed a red fox population through a cohort analysis based on age-specific numbers of culled individuals between 1987 and 2008, a timeframe that covers the pre-mange and mange periods, and analyzed the impact of sarcoptic mange on the fox population in Nemuro, Japan. In the process of the reconstruction, we estimated annual mortality (caused by natural factors and culling) and birth rates by referring to the annual change in an index of population abundance and the recovery of tagged individuals. The estimated total population size decreased greatly from 303.2 to 70.8 between 1996 and 2000 in the study area (136.5km(2)); the first mange-infected individual was found in 1997. The natural mortality estimate (0.613) in 1998 was high, and it was also high in 1997 and 1999 (0.504 and 0.507, respectively), whereas mortality caused by culling did not show any particular change in these years. The birth rate (number of cubs per adult) was high in 1998 and 1999 despite the mange prevalence. Although the infection rate (number of infected individuals per inspected fox) decreased after the peak in 1999, foxes were found infected with mange in every study year between 1997 and 2013, except for 2002. Natural mortality was higher during the mange period (1997-2008) than during the pre-mange period (1987-1996), whereas we did not detect a significant difference in birth rates between the periods. A generalized linear model analysis showed significant effects of adult density and birth rate on natural mortality together with the effects of mange. We interpreted higher natural mortality in years with higher birth rates as simply a result of the population in those years including more cubs with higher mortality. The positive effect of adult density during the pre-mange period on natural mortality can be explained by competition for territory, whereas high adult density may also have contributed to the spread of mange for the mange period, causing higher mortality. This study shows that the use of cohort analysis can be extended to estimating demographic parameters by referring to external data. (c) 2014 The Wildlife Society.	[Uraguchi, Kohji] Hokkaido Inst Publ Hlth, Sapporo, Hokkaido 0600819, Japan; [Ueno, Mayumi] Hokkaido Res Org, Inst Environm Sci, Eastern Hokkaido Wildlife Res Stn, Kushiro 0850835, Japan; [Iijima, Hayato] Yamanashi Forest Res Inst, Fujikawa, Yamanashi 4000502, Japan; [Saitoh, Takashi] Hokkaido Univ, Field Sci Ctr, Sapporo, Hokkaido 0600811, Japan	Uraguchi, K (reprint author), Hokkaido Inst Publ Hlth, N19,W12, Sapporo, Hokkaido 0600819, Japan.	tsaitoh@fsc.hokudai.ac.jp	Saitoh, Takashi/D-6021-2012; 	Saitoh, Takashi/0000-0003-4085-5014; Iijima, Hayato/0000-0003-1064-9420	Ministry of Health, Labor and Welfare, Japan [H21-Shinko-Ippan-004]	We thank members of the Hokkaido Hunting Public Service Corporation for helping us in collecting samples. We also thank K. Takahashi for helping us in identifying mite species and C. Terada for advising us about the statistical analyses. This study was supported in part by a grant-in-aid from the Ministry of Health, Labor and Welfare, Japan (H21-Shinko-Ippan-004) to K.U.	MAY RM, 1978, J ANIM ECOL, V47, P249, DOI 10.2307/3934; ANDERSON RM, 1978, J ANIM ECOL, V47, P219, DOI 10.2307/3933; Davidson RK, 2008, VET PARASITOL, V156, P277, DOI 10.1016/j.vetpar.2008.05.019; Oishi T, 2011, J HERED, V102, P38, DOI 10.1093/jhered/esq091; Calder C, 2003, ECOLOGY, V84, P1395, DOI 10.1890/0012-9658(2003)084[1395:IMSOSI]2.0.CO;2; Saunders G, 2002, MAMMALIA, V66, P247, DOI 10.1515/mamm.2002.66.2.247; Forchhammer MC, 2000, P ROY SOC B-BIOL SCI, V267, P779, DOI 10.1098/rspb.2000.1071; Gelman A, 2006, BAYESIAN ANAL, V1, P515; Iijima H, 2013, J WILDLIFE MANAGE, V77, P1038, DOI 10.1002/jwmg.556; Heydon MJ, 2000, J ZOOL, V251, P253, DOI 10.1111/j.1469-7998.2000.tb00608.x; Hudson PJ, 1998, SCIENCE, V282, P2256, DOI 10.1126/science.282.5397.2256; HARRIS S, 1981, J APPL ECOL, V18, P455, DOI 10.2307/2402406; Tompkins DM, 2011, J ANIM ECOL, V80, P19, DOI 10.1111/j.1365-2656.2010.01742.x; Pence DB, 2002, REV SCI TECH OIE, V21, P385; Webbon CC, 2004, J APPL ECOL, V41, P768, DOI 10.1111/j.0021-8901.2004.00930.x; Clark JS, 2004, ECOLOGY, V85, P3140, DOI 10.1890/03-0520; Raoul F, 2003, INT J PARASITOL, V33, P945, DOI 10.1016/S0020-7519(03)00127-9; Brooks SP, 1998, J COMPUT GRAPH STAT, V7, P434, DOI 10.2307/1390675; Yamamura K, 2008, POPUL ECOL, V50, P131, DOI 10.1007/s10144-007-0069-x; Heydon MJ, 2000, J ZOOL, V251, P265, DOI 10.1017/S0952836900006117; HARRIS S, 1987, J APPL ECOL, V24, P75, DOI 10.2307/2403788; Smedshaug CA, 1999, WILDLIFE BIOL, V5, P157; Devenish-Nelson ES, 2013, OIKOS, V122, P705, DOI 10.1111/j.1600-0706.2012.20706.x; HARRIS S, 1986, J ANIM ECOL, V55, P575, DOI 10.2307/4740; Buckland ST, 2004, ECOL MODEL, V171, P157, DOI 10.1016/j.ecolmodel.2003.08.002; Elton CS, 1924, BR J EXP BIOL, V2, P119; Saitoh T, 1998, RES POPUL ECOL, V40, P97, DOI 10.1007/BF02765225; Baker PJ, 2000, ANIM BEHAV, V59, P127, DOI 10.1006/anbe.1999.1285; Barton KA, 2007, GLOBAL ECOL BIOGEOGR, V16, P281, DOI 10.1111/j.1466-8238.2007.00299.x; Chronert JM, 2007, J WILDLIFE MANAGE, V71, P1987, DOI 10.2193/2006-225; Colchero F, 2009, J ANIM ECOL, V78, P666, DOI 10.1111/j.1365-2656.2009.01528.x; DANELL K, 1987, OECOLOGIA, V73, P533, DOI 10.1007/BF00379412; Dobson A. P., 1995, ECOLOGY INFECT DIS N, P52; Englund J., 1980, Biogeographica, V18, P107; Fox J, 2011, R COMPANION APPL REG; Fryxell J, 2001, WILDLIFE BIOL, V7, P151; Fryxell JM, 1999, ECOLOGY, V80, P1311, DOI 10.1890/0012-9658(1999)080[1311:DDPDAP]2.0.CO;2; Gosselink TE, 2007, J WILDLIFE MANAGE, V71, P1862, DOI 10.2193/2006-020; Gove NE, 2002, J WILDLIFE MANAGE, V66, P310, DOI 10.2307/3803163; Holmala K, 2006, MAMMAL REV, V36, P17, DOI 10.1111/j.1365-2907.2006.00078.x; HUDSON P.J., 2002, ECOLOGY WILDLIFE DIS; Iossa G, 2008, J MAMMAL, V89, P1481, DOI 10.1644/07-MAMM-A-405.1; Krebs C.J., 2009, ECOLOGY; Lindstrom E. R., 1991, GLOBAL TRENDS WILDLI, V1, P591; LINDSTROM ER, 1994, ECOLOGY, V75, P1042, DOI 10.2307/1939428; McKelvey KS, 2011, POPUL ECOL, V53, P263, DOI 10.1007/s10144-010-0242-5; Morner T., 1992, Revue Scientifique et Technique Office International des Epizooties, V11, P1115; Newman TJ, 2002, CAN J ZOOL, V80, P154, DOI 10.1139/Z01-216; Pope J. G., 1972, RES B INT COMM NW AT, V9, P65; R Development Core Team, 2013, R LANG ENV STAT COMP; Royama T., 1992, ANAL POPULATION DYNA; Ruette S, 2011, EUR J WILDLIFE RES, V57, P555, DOI 10.1007/s10344-010-0465-y; Servanty S, 2010, ECOLOGY, V91, P1916, DOI 10.1890/09-1931.1; Skalski JR, 2007, J WILDLIFE MANAGE, V71, P1309, DOI 10.2193/2005-707; Soulsbury CD, 2007, MAMMAL REV, V37, P278, DOI 10.1111/j.1365-2907.2007.00101.x; Stubbe M., 1980, Biogeographica, V18, P71; TULLAR BF, 1981, NEW YORK FISH GAME J, V28, P138; Ueno M, 2009, MAMM STUDY, V34, P65, DOI 10.3106/041.034.0202; Uraguchi Kohji, 1998, Mammal Study, V23, P31, DOI 10.3106/mammalstudy.23.31; YONEDA M, 1982, J WILDLIFE MANAGE, V46, P781, DOI 10.2307/3808575	60	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0022-541X	1937-2817		J WILDLIFE MANAGE	J. Wildl. Manage.	NOV	2014	78	8					1356	1371		10.1002/jwmg.794		16	Ecology; Zoology	Environmental Sciences & Ecology; Zoology	AS6OP	WOS:000344382900005		
J	Kusumoto, B; Kubota, Y				Kusumoto, Buntarou; Kubota, Yasuhiro			Phylogenetic Patterns Predicting Variations in Bark-Stripping by Sika Deer	JOURNAL OF WILDLIFE MANAGEMENT			English	Article						anti-herbivore defense; bark-stripping; Cervus nippon; evolutionary lability; Japan; K-statistic; palatability; phylogenetic signal; sika deer	COMMUNITY STRUCTURE; CERVUS-ELAPHUS; FOREST; TREE; RELATEDNESS; SIMILARITY; VEGETATION; DIVERSITY; EVOLUTION; NITROGEN	Phylogenetic signal of species traits is a potentially powerful tool in the conservation of biodiversity and wildlife management. To develop a predictor for evaluating deer foraging risk in forest ecosystems, we examined the phylogenetic patterns in susceptibility to bark-stripping by Cervus nippon across the Japanese archipelago. We tested the variance of phylogenetically independent contrasts among bark-stripped ratios of 180 tree species, and found a significant phylogenetic signal, i.e., phylogenetically closely related species had similar bark-stripped ratios. To assess evolutionary processes generating clade-specific patterns of bark-stripped ratios, we evaluated the strength of phylogenetic signal by using the K-statistics. The K-statistics were <1, demonstrating that bark-stripped ratio was not tightly conserved in particular clades, i.e., woody plant traits related to palatability or anti-herbivore defense may be labile among families or genera. Based on phylogenetic relationships and bark-stripped ratios among species, we examined the vulnerability to deer foraging at the tree species assemblage level. We estimated the bark-stripped ratios for all Japanese woody plants (928 species) by phylogenetic imputation, and mapped the geographic pattern of the vulnerability at the 10x10-km grid cell level. Compared with taxonomic-based assessment focusing on 180 tree species with the records of bark-stripping, the phylogenetic-based vulnerability map showed spatially heterogeneous patterns. Our results demonstrate that the phylogenetic pattern in the interspecific variation of bark-stripped ratios serves as an indicator for better understanding the vulnerability of forests to deer foraging, and has 2 implications for the management of the deer population. First, phylogenetic constraint of selective foraging could be a driver that causes aggregated degradation of forest ecosystems containing palatable plant lineages for deer. Second, evolutionary lability of palatability or anti-herbivore defense across various tree families may be an important factor for the geographic spread of foraging damage in forests harboring taxonomically different species. (c) 2014 The Wildlife Society.	[Kusumoto, Buntarou; Kubota, Yasuhiro] Univ Ryukyus, Fac Sci, Nishihara, Okinawa 90301, Japan	Kusumoto, B (reprint author), Univ Ryukyus, Fac Sci, 1 Senbaru, Nishihara, Okinawa 90301, Japan.	kusumoto.buntarou@gmail.com			Japan Society for the Promotion of Science [21310025, 22405006, 22657008]	We thank Dr. T. Aakala for his valuable suggestions for improving our manuscript. Financial support was provided by the Japan Society for the Promotion of Science (nos. 21310025, 22405006 and 22657008).	Stromayer KAK, 1997, WILDLIFE SOC B, V25, P227; Takatsuki S, 2009, BIOL CONSERV, V142, P1922, DOI 10.1016/j.biocon.2009.02.011; Kembel SW, 2010, BIOINFORMATICS, V26, P1463, DOI 10.1093/bioinformatics/btq166; Verdu M, 2012, P ROY SOC B-BIOL SCI, V279, P1761, DOI 10.1098/rspb.2011.2268; Webb CO, 2005, MOL ECOL NOTES, V5, P181, DOI 10.1111/j.1471-8286.2004.00829.x; Cote SD, 2004, ANNU REV ECOL EVOL S, V35, P113, DOI 10.1146/annurev.ecolsys.35.021103.105725; Iijima H, 2013, J WILDLIFE MANAGE, V77, P1038, DOI 10.1002/jwmg.556; Losos JB, 2008, ECOL LETT, V11, P995, DOI 10.1111/j.1461-0248.2008.01229.x; Webb CO, 2008, BIOINFORMATICS, V24, P2098, DOI 10.1093/bioinformatics/btn358; GILL RMA, 1992, FORESTRY, V65, P145, DOI 10.1093/forestry/65.2.145; Wikstrom N, 2001, P ROY SOC B-BIOL SCI, V268, P2211, DOI 10.1098/rspb.2001.1782; Pearse IS, 2009, P NATL ACAD SCI USA, V106, P18097, DOI 10.1073/pnas.0904867106; Kerkhoff AJ, 2006, AM NAT, V168, pE103, DOI 10.1086/507879; Blomberg SP, 2003, EVOLUTION, V57, P717, DOI 10.1111/j.0014-3820.2003.tb00285.x; Chave J, 2006, ECOL APPL, V16, P2356, DOI 10.1890/1051-0761(2006)016[2356:RAPVOW]2.0.CO;2; Lloyd KM, 2010, NEW ZEAL J ECOL, V34, P219; Boulanger V, 2009, FOREST ECOL MANAG, V258, P1397, DOI 10.1016/j.foreco.2009.06.055; Ando M, 2003, FOREST ECOL MANAG, V177, P323, DOI 10.1016/S0378-1127(02)00336-5; Bronstom G., 2011, GLMMML GEN LINEAR MO; Bruggeman J, 2009, NUCLEIC ACIDS RES, V37, pW179, DOI 10.1093/nar/gkp370; Forsyth DM, 2005, FUNCT ECOL, V19, P495, DOI 10.1111/j.1365-2435.2005.00991.x; Guenard G, 2011, ECOL APPL, V21, P3178, DOI 10.1890/10-2242.1; Kojima Y., 2006, Journal of the Japanese Forest Society, V88, P337, DOI 10.4005/jjfs.88.337; Kubota Y, 2014, J BIOGEOGR, V41, P1267, DOI 10.1111/jbi.12290; Kursar TA, 2003, BIOCHEM SYST ECOL, V31, P929, DOI 10.1016/S0305-1978(03)00087-5; Novriyanti E., 2010, Eurasian Journal of Forest Research, V13-2, P77; R Development Core Team, 2012, R LANG ENV STAT COMP; Rossell CR, 2005, FOREST ECOL MANAG, V210, P415, DOI 10.1016/j.foreco.2005.02.035; Seagle SW, 2003, OIKOS, V103, P230, DOI 10.1034/j.1600-0706.2003.12287.x; Swenson N. G., 2013, ECOGRAPHY, V37, P105; Tanentzap AJ, 2011, ECOLOGY, V92, P994, DOI 10.1890/10-0861.1; Verheyden H, 2006, MAMMAL REV, V36, P217, DOI 10.1111/j.1365-2907.2006.00085.x; Yessoufou K, 2013, J ECOL, V101, P614, DOI 10.1111/1365-2745.12059; Yonekura K., 2003, BG PLANTS JAPANESE S	34	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0022-541X	1937-2817		J WILDLIFE MANAGE	J. Wildl. Manage.	NOV	2014	78	8					1492	1498		10.1002/jwmg.782		7	Ecology; Zoology	Environmental Sciences & Ecology; Zoology	AS6OP	WOS:000344382900018		
J	Takagi, H; Sugimura, Y; Suzuki, H; Iwama, S; Izumida, H; Fujisawa, H; Ogawa, K; Nakashima, K; Ochiai, H; Takeuchi, S; Kiyota, A; Suga, H; Goto, M; Banno, R; Arima, H; Oiso, Y				Takagi, Hiroshi; Sugimura, Yoshihisa; Suzuki, Haruyuki; Iwama, Shintaro; Izumida, Hisakazu; Fujisawa, Haruki; Ogawa, Koichiro; Nakashima, Kotaro; Ochiai, Hiroshi; Takeuchi, Seiji; Kiyota, Atsushi; Suga, Hidetaka; Goto, Motomitsu; Banno, Ryoichi; Arima, Hiroshi; Oiso, Yutaka			Minocycline prevents osmotic demyelination associated with aquaresis	KIDNEY INTERNATIONAL			English	Article						hyponatremia; ODS; SIADH; vasopressin	CENTRAL PONTINE MYELINOLYSIS; VASOPRESSIN V-2-RECEPTOR ANTAGONIST; CHRONIC HYPONATREMIA; RAPID CORRECTION; ORAL TOLVAPTAN; RATS; OVERCORRECTION; ACTIVATION; MICROGLIA; EFFICACY	Overly rapid correction of chronic hyponatremia can cause osmotic demyelination syndrome (ODS). Minocycline protects ODS associated with overly rapid correction of chronic hyponatremia with hypertonic saline infusion in rats. In clinical practice, inadvertent rapid correction frequently occurs due to water diuresis, when vasopressin action suddenly ceases. In addition, vasopressin receptor antagonists have been applied to treat hyponatremia. Here the susceptibility to and pathology of ODS were evaluated using rat models developed to represent rapid correction of chronic hyponatremia in the clinical setting. The protective effect of minocycline against ODS was assessed. Chronic hyponatremia was rapidly corrected by 1 (T1) or 10 mg/kg (T10) of tolvaptan, removal of desmopressin infusion pumps (RP), or administration of hypertonic saline. The severity of neurological impairment in the T1 group was significantly milder than in other groups and brain hemorrhage was found only in the T10 and desmopressin infusion removal groups. Minocycline inhibited demyelination in the T1 group. Further, immunohistochemistry showed loss of aquaporin-4 (AQP4) in astrocytes before demyelination developed. Interestingly, serum AQP4 levels were associated with neurological impairments. Thus, minocycline can prevent ODS caused by overly rapid correction of hyponatremia due to water diuresis associated with vasopressin action suppression. Increased serum AQP4 levels may be a predictive marker for ODS.	[Takagi, Hiroshi; Sugimura, Yoshihisa; Suzuki, Haruyuki; Iwama, Shintaro; Izumida, Hisakazu; Fujisawa, Haruki; Ogawa, Koichiro; Nakashima, Kotaro; Ochiai, Hiroshi; Takeuchi, Seiji; Kiyota, Atsushi; Suga, Hidetaka; Goto, Motomitsu; Banno, Ryoichi; Arima, Hiroshi; Oiso, Yutaka] Nagoya Univ, Grad Sch Med, Dept Endocrinol & Diabet, Nagoya, Aichi 4668550, Japan	Sugimura, Y (reprint author), Nagoya Univ, Grad Sch Med, Dept Endocrinol & Diabet, Showa Ku, 65 Tsurumai Cho, Nagoya, Aichi 4668550, Japan.	sugiyosi@med.nagoya-u.ac.jp	SUGA, HIDETAKA/I-7452-2014		Japanese Society for the Promotion of Science [24591360]; Ministry of Health, Labor and Welfare, Japan	This work was supported in part by a Grant-in-Aid for Scientific Research from Japanese Society for the Promotion of Science 24591360 (to YS) and by Grants-in-Aid for Scientific Research (Research on Hypothalamo-hypophyseal Disorders) from the Ministry of Health, Labor and Welfare, Japan.	Verbalis JG, 2011, EUR J ENDOCRINOL, V164, P725, DOI 10.1530/EJE-10-1078; Suzuki H, 2010, J AM SOC NEPHROL, V21, P2090, DOI 10.1681/ASN.2010040438; Papadopoulos MC, 2013, NAT REV NEUROSCI, V14, P265, DOI 10.1038/nrn3468; Iwama S, 2011, GLIA, V59, P452, DOI 10.1002/glia.21114; LIEN YHH, 1991, J CLIN INVEST, V88, P303, DOI 10.1172/JCI115292; Sterns RH, 2009, KIDNEY INT, V76, P587, DOI 10.1038/ki.2009.251; STERNS RH, 1986, NEW ENGL J MED, V314, P1535, DOI 10.1056/NEJM198606123142402; ROJIANI AM, 1987, J NEUROPATH EXP NEUR, V46, P495, DOI 10.1097/00005072-198707000-00008; Berl T, 2010, J AM SOC NEPHROL, V21, P705, DOI 10.1681/ASN.2009080857; Gross PA, 2011, KIDNEY INT, V80, P594, DOI 10.1038/ki.2011.78; Yamamura Y, 1998, J PHARMACOL EXP THER, V287, P860; Moe SE, 2008, GENOMICS, V91, P367, DOI 10.1016/j.ygeno.2007.12.003; Gheorghiade M, 2007, JAMA-J AM MED ASSOC, V297, P1332, DOI 10.1001/jama.297.12.1332; Adrogue HJ, 2000, NEW ENGL J MED, V342, P1581, DOI 10.1056/NEJM200005253422107; Wake H, 2013, TRENDS NEUROSCI, V36, P209, DOI 10.1016/j.tins.2012.11.007; Gankam-Kengne F, 2010, J AM SOC NEPHROL, V21, P2099, DOI 10.1681/ASN.2010050467; VERBALIS JG, 1991, KIDNEY INT, V39, P1274, DOI 10.1038/ki.1991.161; Silver SM, 2006, J NEUROPATH EXP NEUR, V65, P37, DOI 10.1097/01.jnen.0000195938.02292.39; SOUPART A, 1994, KIDNEY INT, V45, P193, DOI 10.1038/ki.1994.23; Soupart A, 2012, CLIN J AM SOC NEPHRO, V7, P742, DOI 10.2215/CJN.06990711; Schrier RW, 2006, NEW ENGL J MED, V355, P2099, DOI 10.1056/NEJMoa065181; STERNS RH, 1994, J AM SOC NEPHROL, V4, P1522; Miyazaki T, 2005, ENDOCRINOLOGY, V146, P3037, DOI 10.1210/en.2004-1590; Sugimura Y, 2005, EXP NEUROL, V192, P178, DOI 10.1016/j.expneurol.2004.10.018; ANDERSON RJ, 1985, ANN INTERN MED, V102, P164; Kengne FG, 2009, KIDNEY INT, V76, P614, DOI 10.1038/ki.2009.254; Baker EA, 2000, EXP NEUROL, V165, P221, DOI 10.1006/exnr.2000.7474; Blocher J, 2011, NEUROSCI LETT, V504, P23, DOI 10.1016/j.neulet.2011.08.049; Frydenlund Didrik S, 2006, Proc Natl Acad Sci U S A, V103, P13532, DOI 10.1073/pnas.0605796103; Kengne FG, 2011, J AM SOC NEPHROL, V22, P1834, DOI 10.1681/ASN.2010111127; GIANNETTI AV, 1993, CLIN NEUROPATHOL, V12, P156; Ginès Pere, 2007, J Hepatol, V46, P1150, DOI 10.1016/j.jhep.2007.03.007; Imoto S, 2010, J MATERN-FETAL NEO M, V23, P742, DOI [10.1080/14767050903265097, 10.3109/14767050903265097]; Kamel KS, 2010, J AM SOC NEPHROL, V21, P2015, DOI 10.1681/ASN.2010101062; Kamel KS, 2012, NEPHROL DIAL TRANSPL, V27, P872, DOI 10.1093/ndt/gfr790; KLEINSCHMIDTDEMASTERS BK, 1981, SCIENCE, V211, P1068, DOI 10.1126/science.7466381; Reagan-Shaw S, 2008, FASEB J, V22, P659, DOI 10.1096/fj.07-9574LSF; Ruiz-Sandoval J, 2013, ACTA NEUROL BELG, V113, P19, DOI 10.1007/s13760-012-0110-5; SOUPART A, 1992, KIDNEY INT, V41, P1662, DOI 10.1038/ki.1992.239; Verbalis Joseph G, 2013, Am J Med, V126, pS1, DOI 10.1016/j.amjmed.2013.07.006	40	4	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0085-2538	1523-1755		KIDNEY INT	Kidney Int.	NOV	2014	86	5					954	964		10.1038/ki.2014.119		11	Urology & Nephrology	Urology & Nephrology	AS7OW	WOS:000344446000015		
J	Kawakami, T; Mimura, I; Shoji, K; Tanaka, T; Nangaku, M				Kawakami, Takahisa; Mimura, Imari; Shoji, Kumi; Tanaka, Tetsuhiro; Nangaku, Masaomi			Hypoxia and fibrosis in chronic kidney disease: crossing at pericytes	KIDNEY INTERNATIONAL SUPPLEMENTS			English	Review						angiogenesis; chronic kidney disease; fibrosis; hypoxia; pericytes	INDUCIBLE FACTOR; RENAL-DISEASE; PROMOTES FIBROGENESIS; LIVER FIBROSIS; ANGIOGENESIS; FIBROBLASTS; INJURY; RAREFACTION; METABOLISM; MECHANISMS	Chronic kidney disease (CKD) is placing an increasing burden on patients and societies because no decisive therapy has been established. Tubulointerstitial lesions accompanied by fibrosis, inflammatory cells, and capillary rarefaction not only characterize, but also aggravate renal dysfunction in CKD. In this setting, renal cells, particularly tubular cells, suffer from hypoxia caused by the imbalance of blood perfusion and oxygen demand despite their adaptive responses represented by upregulation of hypoxia-inducible factors (HIFs). Fibrosis is a pathological state characterized by excess extracellular matrix (ECM) deposition, which is also a hallmark and causative factor of many chronic diseases including CKD. Recent studies have suggested that the dominant origin of ECM-producing myofibroblasts (MFs) may be pericytes, which are indispensable cells for maintaining proper capillary functions, as they wrap capillaries and stabilize them through a fine-tuned interplay with endothelial cells. During fibrosis, pericytes are activated and detach from capillaries before conversion into MFs, which compromises capillaries and worsens hypoxia. We also discuss how hypoxia and HIFs affect fibrogenesis. Given that hypoxia is caused by insufficient angiogenesis and that fibrosis results from pericyte loss, restoration of pericytes should be an intriguing target for overcoming both hypoxia and fibrosis. We propose the deactivation of MFs to recover lost pericytes as a promising therapy for CKD.	[Kawakami, Takahisa; Mimura, Imari; Shoji, Kumi; Tanaka, Tetsuhiro; Nangaku, Masaomi] Univ Tokyo, Div Nephrol & Endocrinol, Bunkyo Ku, Tokyo 1138655, Japan	Nangaku, M (reprint author), Univ Tokyo, Div Nephrol & Endocrinol, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan.	mnangaku-tky@umin.ac.jp			Japan Society for the Promotion of Science [24390213]; Ministry of Health, Labour and Welfare of Japan; Major State Basic Research Development Program of China [2012CB517700]; Guangdong Medical Association	Supported in part by Grants-in-Aid for Scientific Research (B) (24390213 to MN) from the Japan Society for the Promotion of Science and a Grant-in-Aid for Progressive Renal Disease Research, Research on Intractable Disease, from the Ministry of Health, Labour and Welfare of Japan. This article is published in a supplement partially supported by the Major State Basic Research Development Program of China (no. 2012CB517700) and the Guangdong Medical Association.	Kobayashi H, 2012, J IMMUNOL, V188, P5106, DOI 10.4049/jimmunol.1103377; Friedman SL, 2013, J HEPATOL, V58, P1, DOI 10.1016/j.jhep.2012.10.014; Lin SL, 2009, J IMMUNOL, V183, P6733, DOI 10.4049/jimmunol.0901473; Carmeliet P, 2011, NATURE, V473, P298, DOI 10.1038/nature10144; Asada N, 2011, J CLIN INVEST, V121, P3981, DOI 10.1172/JCI57301; Humphreys BD, 2010, AM J PATHOL, V176, P85, DOI 10.2353/ajpath.2010.090517; Kida Y, 2013, J AM SOC NEPHROL, V24, P559, DOI 10.1681/ASN.2012080871; Higgins DF, 2007, J CLIN INVEST, V117, P3810, DOI 10.1172/JCI30487; Mimura I, 2012, MOL CELL BIOL, V32, P3018, DOI 10.1128/MCB.06643-11; RISDON RA, 1968, LANCET, V2, P363; Mimura I, 2010, NAT REV NEPHROL, V6, P667, DOI 10.1038/nrneph.2010.124; Matsumoto K, 2001, SCIENCE, V294, P559, DOI 10.1126/science.1063889; Copple BL, 2012, J PHARMACOL EXP THER, V341, P307, DOI 10.1124/jpet.111.189340; LeBleu VS, 2013, NAT MED, V19, P1047, DOI 10.1038/nm.3218; Borges FT, 2013, J AM SOC NEPHROL, V24, P385, DOI 10.1681/ASN.2012101031; Epstein FH, 1997, KIDNEY INT, V51, P381, DOI 10.1038/ki.1997.50; Tanaka T, 2005, LAB INVEST, V85, P1292, DOI 10.1038/labinvest.3700328; Safran M, 2006, P NATL ACAD SCI USA, V103, P105, DOI 10.1073/pnas.0509459103; Inoue T, 2011, J AM SOC NEPHROL, V22, P1429, DOI 10.1681/ASN.2010111143; Lin SL, 2011, AM J PATHOL, V178, P911, DOI 10.1016/j.ajpath.2010.10.012; Corpechot C, 2002, HEPATOLOGY, V35, P1010, DOI 10.1053/jhep.2002.32524; Ellis EL, 2012, J HEPATOL, V56, P1171, DOI 10.1016/j.jhep.2011.09.024; Norman JT, 2000, KIDNEY INT, V58, P2351, DOI 10.1046/j.1523-1755.2000.00419.x; Armulik A, 2011, DEV CELL, V21, P193, DOI 10.1016/j.devcel.2011.07.001; Nangaku M, 2006, J AM SOC NEPHROL, V17, P17, DOI 10.1681/ASN.2005070757; Kawakami T, 2013, J IMMUNOL, V191, P3358, DOI 10.4049/jimmunol.1300342; Semenza GL, 2011, NEW ENGL J MED, V365, P537, DOI 10.1056/NEJMra1011165; Tanaka T, 2004, AM J PATHOL, V165, P1979, DOI 10.1016/S0002-9440(10)63249-X; Tanaka T, 2013, NAT REV NEPHROL, V9, P211, DOI 10.1038/nrneph.2013.35; Theilig F, 2011, AM J PATHOL, V179, P2177, DOI 10.1016/j.ajpath.2011.07.012; Willam C, 2002, P NATL ACAD SCI USA, V99, P10423, DOI 10.1073/pnas.162119399; Wu SR, 2008, MOL THER, V16, P1227, DOI 10.1038/mt.2008.90	32	3	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	2157-1724	2157-1716		KIDNEY INT SUPPL	Kidney Int. Suppl.	NOV	2014	4	1					107	112		10.1038/kisup.2014.20		6	Urology & Nephrology	Urology & Nephrology	AS7OT	WOS:000344445800020		
J	Harato, K; Nagura, T; Matsumoto, H; Otani, T; Toyama, Y; Suda, Y				Harato, Kengo; Nagura, Takeo; Matsumoto, Hideo; Otani, Toshiro; Toyama, Yoshiaki; Suda, Yasunori			Asymmetry of the knee extension deficit in standing affects weight-bearing distribution in patients with bilateral end-stage knee osteoarthritis	KNEE SURGERY SPORTS TRAUMATOLOGY ARTHROSCOPY			English	Article						End-stage knee osteoarthritis; Weight-bearing distribution; Gait analysis; Standing; Extension deficit	ADDUCTION MOMENT; QUADRICEPS STRENGTH; FLEXION CONTRACTURE; DISEASE SEVERITY; GAIT ANALYSIS; JOINT LOADS; PAIN RELIEF; WALKING; OUTCOMES; DIFFERS	The aim of this study was to evaluate weight-bearing distribution in patients with bilateral end-stage knee osteoarthritis (OA) and to clarify the gait parameters affecting the weight-bearing distribution during both standing and walking using gait analysis. Twenty-five patients (averaged 71 years) with symptomatic bilateral end-stage medial knee OA participated in this study. They performed relaxed standing, placing one foot on a force plate and thereafter, level walking. First, knee resultant force was calculated on bilateral knees during standing. The knees in each patient were divided into Higher and Lower force side for the definition of dominant side limb. Second, gait parameters in each subject were compared between both sides. Each patient had large weight-bearing asymmetry, though passive range of motion, subjective pain level, femorotibial angle and radiographic disease severities were not significantly different between both sides. In standing, knees on Higher force side were significantly extended (11.2 +/- A 6.5A degrees) than on Lower force side (14.4 +/- A 7.3A degrees, P = 0.0086). Similarly, knees on Higher force side were also significantly extended at heel strike during gait. Besides, peak values of extension moment, knee adduction moment, knee adduction moment impulse and vertical force during gait were significantly greater on Higher force side. Ability to extend the knee in standing was considered to be an essential factor to decide loading condition. It is clinically important to examine the ability to extend the knee in standing when considering loading asymmetry during gait in patients with bilateral knee OA. III.	[Harato, Kengo; Nagura, Takeo; Matsumoto, Hideo; Otani, Toshiro; Toyama, Yoshiaki; Suda, Yasunori] Keio Univ, Dept Orthoped Surg, Shinjuku Ku, Tokyo 1608582, Japan; [Harato, Kengo] Kawasaki Municipal Kawasaki Hosp, Dept Orthoped Surg, Kawasaki Ku, Kawasaki, Kanagawa 2100013, Japan	Harato, K (reprint author), Kawasaki Municipal Kawasaki Hosp, Dept Orthoped Surg, Kawasaki Ku, 12-1 Shinkawadouri, Kawasaki, Kanagawa 2100013, Japan.	kharatoh@yahoo.co.jp					Kaufman KR, 2001, J BIOMECH, V34, P907, DOI 10.1016/S0021-9290(01)00036-7; Shrader MW, 2004, CLIN ORTHOP RELAT R, P188, DOI 10.1097/01.blo.0000119248.70353.a5; INSALL JN, 1989, CLIN ORTHOP RELAT R, P13; Kean CO, 2012, CLIN BIOMECH, V27, P520, DOI 10.1016/j.clinbiomech.2011.12.007; Teichtahl AJ, 2006, J RHEUMATOL, V33, P1845; Henriksen M, 2006, KNEE, V13, P445, DOI 10.1016/j.knee.2006.08.005; Sharma L, 1998, ARTHRITIS RHEUM, V41, P1233, DOI 10.1002/1529-0131(199807)41:7<1233::AID-ART14>3.0.CO;2-L; Thorp LE, 2007, ARTHRIT RHEUM-ARTHR, V57, P1254, DOI 10.1002/art.22991; Liikavainio T, 2010, KNEE, V17, P69, DOI 10.1016/j.knee.2009.05.003; Thorlund JB, 2012, KNEE SURG SPORT TR A, V20, P1110, DOI 10.1007/s00167-011-1719-2; Anker LC, 2008, GAIT POSTURE, V27, P471, DOI 10.1016/j.gaitpost.2007.06.002; Thorp LE, 2006, ARTHRITIS RHEUM, V54, P3842, DOI 10.1002/art.22247; DAVIS MA, 1991, J RHEUMATOL, V18, P591; Hurwitz DE, 2000, J ORTHOPAED RES, V18, P572, DOI 10.1002/jor.1100180409; Hinman RS, 2002, RHEUMATOLOGY, V41, P1388, DOI 10.1093/rheumatology/41.12.1388; Gunther KP, 1998, ANN RHEUM DIS, V57, P717, DOI 10.1136/ard.57.12.717; BELLAMY N, 1988, J RHEUMATOL, V15, P1833; Creaby MW, 2012, ARCH PHYS MED REHAB, V93, P822, DOI 10.1016/j.apmr.2011.11.029; MCHORNEY CA, 1993, MED CARE, V31, P247, DOI 10.1097/00005650-199303000-00006; Nagura T, 2002, J ORTHOPAED RES, V20, P881, DOI 10.1016/S0736-0266(01)00178-4; Lim BW, 2009, ARTHRIT RHEUM-ARTHR, V61, P451, DOI 10.1002/art.24278; ANDRIACCHI TP, 1982, J BONE JOINT SURG AM, V64, P1328; SCHNITZER TJ, 1993, ARTHRITIS RHEUM, V36, P1207, DOI 10.1002/art.1780360905; Harato K, 2008, GAIT POSTURE, V28, P687, DOI 10.1016/j.gaitpost.2008.05.008; Hurwitz DE, 2002, J ORTHOPAED RES, V20, P101, DOI 10.1016/S0736-0266(01)00081-X; Baliunas AJ, 2002, OSTEOARTHR CARTILAGE, V10, P573, DOI 10.1053/joca.2002.0797; Yoshida Y, 2008, CLIN BIOMECH, V23, P320, DOI 10.1016/j.clinbiomech.2007.10.008; Messier SP, 2005, ARCH PHYS MED REHAB, V86, P703, DOI 10.1016/j.apmr.2004.05.015; Baert IAC, 2013, CLIN BIOMECH, V28, P40, DOI 10.1016/j.clinbiomech.2012.10.007; BLIN O, 1990, ANN RHEUM DIS, V49, P990, DOI 10.1136/ard.49.12.990; Harato K, 2010, J ARTHROPLASTY, V25, P225, DOI 10.1016/j.arth.2009.02.003; Harato K, 2008, KNEE, V15, P467, DOI 10.1016/j.knee.2008.07.003; Henriksen M, 2012, KNEE, V19, P392, DOI 10.1016/j.knee.2011.07.003; Kellgren LH, 1957, ANN RHEUM DIS, V16, P494; POTTER PJ, 1990, AM J PHYS MED REHAB, V69, P144, DOI 10.1097/00002060-199006000-00009	35	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0942-2056	1433-7347		KNEE SURG SPORT TR A	Knee Surg. Sports Traumatol. Arthrosc.	NOV	2014	22	11					2608	2613		10.1007/s00167-013-2442-y		6	Orthopedics; Sport Sciences; Surgery	Orthopedics; Sport Sciences; Surgery	AS3GE	WOS:000344164600005		
J	Seki, K; Sakka, A; Tokushige, A; Imagama, T; Mutou, M; Taguchi, T				Seki, Kazushige; Sakka, Akihito; Tokushige, Atsunori; Imagama, Takashi; Mutou, Masanori; Taguchi, Toshihiko			Treatment for Staphylococcus aureus infection following open wedge high tibial osteotomy using antibiotic-impregnated calcium phosphate cement	KNEE SURGERY SPORTS TRAUMATOLOGY ARTHROSCOPY			English	Article						OWHTO; Infection; Antibiotic-impregnated calcium phosphate cement; Staphylococcus aureus	KNEE; OSTEOARTHRITIS; COMPLICATIONS; VANCOMYCIN; ELUTION; PLATE	This report describes a case of Staphylococcus aureus infection following open wedge high tibial osteotomy, which was successfully treated with by implant removal and replacement with antibiotic-impregnated calcium phosphate cement along with external fixation. The infection occurred 7 months after primary surgery and was treated by implant removal, debridement, external fixation, and application of vancomycin impregnated calcium phosphate cement to fill the defect. Subsequently, the infection resolved completely, and the osteotomy healed with no correction loss. Compared with conventional bone cement, calcium phosphate cement might be an optimal material for certain cases of infection after open wedge high tibial osteotomy because of its higher antibiotic retention, biocompatibility, osteoconductivity, and compatibility with heatlabile antibiotics. Level of evidence V.	[Seki, Kazushige; Sakka, Akihito; Tokushige, Atsunori; Imagama, Takashi; Mutou, Masanori; Taguchi, Toshihiko] Yamaguchi Univ, Sch Med, Dept Orthopaed Surg, Ube, Yamaguchi 7558505, Japan	Seki, K (reprint author), Yamaguchi Univ, Sch Med, Dept Orthopaed Surg, 1-1-1 Minamikogushi, Ube, Yamaguchi 7558505, Japan.	sk0105@yamaguchi-u.ac.jp					Sasaki T, 2005, J ARTHROPLASTY, V20, P1055, DOI 10.1016/j.arth.2005.03.035; Chae DJ, 2011, KNEE, V18, P278, DOI 10.1016/j.knee.2010.05.009; Lazarettos J, 2004, CLIN ORTHOP RELAT R, P253, DOI 10.1097/01.blo.0000127422.06956.35; Song EK, 2010, J BONE JOINT SURG BR, V92B, P1245, DOI 10.1302/0301-620X.92B9.23660; KOSHINO T, 1982, J BONE JOINT SURG AM, V64, P47; IVARSSON I, 1990, J BONE JOINT SURG BR, V72, P238; Staubli AE, 2003, INJURY, V34, P55, DOI 10.1016/j.injury.2003.09.025; Dewilde TR, 2013, KNEE SURG SPORT TR A, V21, P249, DOI 10.1007/s00167-012-2156-6; Hidaka Noriaki, 2002, J Orthop Sci, V7, P182, DOI 10.1007/s007760200031; JENNY K, 1985, ORTHOPADE, V14, P161; Magyar G, 1999, J BONE JOINT SURG BR, V81B, P444, DOI 10.1302/0301-620X.81B3.8925; Reischl N, 2009, ARCH ORTHOP TRAUM SU, V129, P1483, DOI 10.1007/s00402-008-0773-9; Spahn Gunter, 2004, Arch Orthop Trauma Surg, V124, P649, DOI 10.1007/s00402-003-0588-7; Takahashi T, 2000, ARCH ORTHOP TRAUM SU, V120, P32; Urabe K, 2009, J ORTHOP SCI, V14, P784, DOI 10.1007/s00776-009-1397-9; Valkering Kars P, 2009, J Knee Surg, V22, P218; Viskontas DG, 2006, CAN J SURG, V49, P245	17	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0942-2056	1433-7347		KNEE SURG SPORT TR A	Knee Surg. Sports Traumatol. Arthrosc.	NOV	2014	22	11					2614	2617		10.1007/s00167-013-2460-9		4	Orthopedics; Sport Sciences; Surgery	Orthopedics; Sport Sciences; Surgery	AS3GE	WOS:000344164600006		
J	Sugimura, N; Ikeuchi, M; Izumi, M; Aso, K; Ushida, T; Tani, T				Sugimura, Natsuki; Ikeuchi, Masahiko; Izumi, Masashi; Aso, Koji; Ushida, Takahiro; Tani, Toshikazu			The dorsal pedis artery as a new distal landmark for extramedullary tibial alignment in total knee arthroplasty	KNEE SURGERY SPORTS TRAUMATOLOGY ARTHROSCOPY			English	Article						Total knee arthroplasty; Alignment; Distal landmark; Dorsal pedis artery; Ultrasonography	PULSE; PALPATION; ANKLE; VARIABILITY; ANATOMY; FOOT	It is better to use multiple anatomical landmarks to reduce errors in component alignment in total knee arthroplasty. Therefore, it is worthwhile to find a new landmark that can be used as an addition to conventional ones. Herein, we assessed the dorsal pedis artery as a new distal landmark for extramedullary tibial alignment. Fifty-two ankles in patients undergoing total knee arthroplasty and 10 ankles in normal controls were included. Color Doppler ultrasonography was used to locate the dorsal pedis artery at the level of the ankle joint. Conventional landmarks, including the tibialis anterior tendon, the extensor hallucis longus tendon, the extensor digitorum longus tendon, and the malleolar centre, were also located on ultrasound images. The distances between the ankle centre and each landmark were measured and compared. The dorsal pedis artery was absent in 2 patients and impalpable but visible with ultrasonography in other 2 patients. The dorsal pedis artery was located anatomically closest to the ankle centre in patients (0.4 +/- A 3.4 mm lateral). Statistical analysis showed that the dorsal pedis artery, the extensor hallucis longus tendon, and the malleolar centre were located significantly closer to the ankle centre comparing with the extensor digitorum longus tendon and the tibialis anterior tendon in both patients and controls (p < 0.001). As long as the dorsal pedis artery exists, it can be used as an addition to the conventional landmarks in total knee arthroplasty. Using this new landmark will help reduce errors in coronal plane alignment of tibial component. II.	[Sugimura, Natsuki; Ikeuchi, Masahiko; Izumi, Masashi; Aso, Koji; Tani, Toshikazu] Kochi Univ, Dept Orthopaed Surg, Kochi Med Sch, Nanko Ku, Kochi 7838505, Japan; [Ushida, Takahiro] Aichi Med Sch, Ctr Multidisciplinary Pain, Nagakutecho, Aichi 4801195, Japan	Ikeuchi, M (reprint author), Kochi Univ, Dept Orthopaed Surg, Kochi Med Sch, Nanko Ku, Oko Cho, Kochi 7838505, Japan.	ikeuchim@kochi-u.ac.jp					Akagi M, 2012, KNEE, V19, P836, DOI 10.1016/j.knee.2012.03.006; Schneider M, 2007, J ARTHROPLASTY, V22, P219, DOI 10.1016/j.arth.2006.04.023; Mowlavi A, 2002, POSTGRAD MED J, V78, P746, DOI 10.1136/pmj.78.926.746; Sun TZ, 2009, J ARTHROPLASTY, V24, P427, DOI 10.1016/j.arth.2007.11.021; Lundin M, 1999, WORLD J SURG, V23, P252; Fukagawa S, 2011, J ORTHOP RES, V29, P919, DOI 10.1002/jor.21335; Dennis D A, 1993, J Arthroplasty, V8, P43, DOI 10.1016/S0883-5403(06)80106-3; Hovinga KR, 2009, J ORTHOP RES, V27, P1191, DOI 10.1002/jor.20858; Robinson M, 2006, CLIN ORTHOP RELAT R, P57, DOI 10.1097/01.blo.0000197081.72341.4b; Catani F, 2012, KNEE SURG SPORT TR A, V20, P546, DOI 10.1007/s00167-011-1602-1; Siston Robert A, 2005, Clin Orthop Relat Res, V439, P129, DOI 10.1097/01.blo.0000170873.88306.56; CHAVATZA.D, 1974, ANAT REC, V178, P289, DOI 10.1002/ar.1091780211; Imagama S, 2011, SPINE, V36, P1204, DOI 10.1097/BRS.0b013e3181ebd86f; ISON JW, 1968, J AMER MED ASSOC, V206, P2745; LUDBROOK J, 1962, BMJ-BRIT MED J, P1724; MEADE TW, 1968, BRIT HEART J, V30, P661; Rajadhyaksha Amar D, 2009, Am J Orthop (Belle Mead NJ), V38, pE68; Tsukeoka T, 2012, KNEE; Vazquez T, 2006, ARTHROSCOPY, V22, P287, DOI 10.1016/j.arthro.2005.10.021; YAMADA T, 1993, AM J SURG, V166, P130, DOI 10.1016/S0002-9610(05)81043-8; YOSHIOKA Y, 1989, J ORTHOPAED RES, V7, P132, DOI 10.1002/jor.1100070118	21	2	4	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0942-2056	1433-7347		KNEE SURG SPORT TR A	Knee Surg. Sports Traumatol. Arthrosc.	NOV	2014	22	11					2618	2622		10.1007/s00167-013-2461-8		5	Orthopedics; Sport Sciences; Surgery	Orthopedics; Sport Sciences; Surgery	AS3GE	WOS:000344164600007		
J	Nishikawa, K; Okazaki, K; Matsuda, S; Tashiro, Y; Kawahara, S; Nakahara, H; Okamoto, S; Shimoto, T; Higaki, H; Iwamoto, Y				Nishikawa, Kazutaka; Okazaki, Ken; Matsuda, Shuichi; Tashiro, Yasutaka; Kawahara, Shinya; Nakahara, Hiroyuki; Okamoto, Shigetoshi; Shimoto, Takeshi; Higaki, Hidehiko; Iwamoto, Yukihide			Improved design decreases wear in total knee arthroplasty with varus malalignment	KNEE SURGERY SPORTS TRAUMATOLOGY ARTHROSCOPY			English	Article						Total knee arthroplasty (TKA); Design; Alignment; Wear; Contact stress	MECHANICAL AXIS ALIGNMENT; FINITE-ELEMENT-ANALYSIS; POLYETHYLENE WEAR; SURVIVAL; REPLACEMENTS; COMPONENT; STRESSES; FAILURE	Controversy still exists whether coronal malalignment would influence the long-term survival of total knee arthroplasty (TKA). The hypothesis was that an improved design of the articular surface of modern TKA would prevent the increase in contact stresses and thus decrease the wear even when the implant was placed in a varus position. Two different designs of TKA were compared biomechanically and clinically. The patients whose prosthesis was initially placed in a varus alignment by the postoperative long-leg radiographs were selected. Seventeen knees using the NexGen LPS and 16 knees using the MG I were examined. Changes in postoperative alignment and the thickness of the polyethylene insert in a follow-up period of approximately 7 years were evaluated. Additionally, an in vitro biomechanical testing was conducted to measure the contact stresses and the contact area at the tibiofemoral joint of the NexGen LPS and the MG I components mounted on a servohydraulic testing device. Although the long-leg alignment did not change in NexGen LPS, the varus alignment significantly progressed in MG I. The thickness of polyethylene insert in MG I decreased a significantly greater amount compared with that in NexGen LPS. Biomechanical test showed that the NexGen LPS had a larger contact area and lower mean and peak contact stresses than the MG I significantly. These results suggest that comprehensive factors of modern prosthesis including improved implant designs could improve the durability of polyethylene insert and decrease implant failures due to component malalignment.	[Nishikawa, Kazutaka; Okazaki, Ken; Matsuda, Shuichi; Tashiro, Yasutaka; Kawahara, Shinya; Nakahara, Hiroyuki; Okamoto, Shigetoshi; Iwamoto, Yukihide] Kyushu Univ, Grad Sch Med Sci, Dept Orthopaed Surg, Higashi Ku, Fukuoka 8128582, Japan; [Shimoto, Takeshi; Higaki, Hidehiko] Kyushu Sangyo Univ, Fac Engn, Dept Biorobot, Higashi Ku, Fukuoka 8138503, Japan	Okazaki, K (reprint author), Kyushu Univ, Grad Sch Med Sci, Dept Orthopaed Surg, Higashi Ku, 3-1-1 Maidashi, Fukuoka 8128582, Japan.	okazaki@med.kyushu-u.ac.jp		Okazaki, Ken/0000-0003-1274-8406			Bonner TJ, 2011, J BONE JOINT SURG BR, V93B, P1217, DOI 10.1302/0301-620X.93B9.26573; Perillo-Marcone A, 2000, J ARTHROPLASTY, V15, P1020, DOI 10.1054/arth.2000.17941; D'Lima DD, 2001, CLIN ORTHOP RELAT R, P124; Liau JJ, 2002, CLIN BIOMECH, V17, P140, DOI 10.1016/S0268-0033(01)00109-7; Chauhan SK, 2004, J BONE JOINT SURG BR, V86B, P818, DOI 10.1302/0301-620X.86B6.15456; Matziolis G, 2010, ARCH ORTHOP TRAUM SU, V130, P1487, DOI 10.1007/s00402-010-1064-9; Longstaff LM, 2009, J ARTHROPLASTY, V24, P570, DOI 10.1016/j.arth.2008.03.002; Ezzet KA, 2012, J ARTHROPLASTY, V27, P116, DOI 10.1016/j.arth.2011.06.002; Matsuda S, 1999, ORTHOPEDICS, V22, P303; Matsuda S, 1999, J ARTHROPLASTY, V14, P566, DOI 10.1016/S0883-5403(99)90078-5; Taylor M, 1997, J BONE JOINT SURG BR, V79B, P181, DOI 10.1302/0301-620X.79B2.7461; Parratte S, 2010, J BONE JOINT SURG AM, V92A, P2143, DOI 10.2106/JBJS.I.01398; Pang HN, 2011, KNEE SURG SPORT TR A, V19, P1496, DOI 10.1007/s00167-011-1483-3; Fang DM, 2009, J ARTHROPLASTY, V24, P39, DOI 10.1016/j.arth.2009.04.034; Berend ME, 2004, CLIN ORTHOP RELAT R, P26, DOI 10.1097/01.blo.0000148578.22729.0e; Bugbee WD, 1998, CLIN ORTHOP RELAT R, P158; itter MA, 2011, J BONE JOINT SURG AM, V93, P1588; Kuster MS, 2002, ORTHOPEDICS, V25, pS235; Lombardi AV, 2011, ORTHOPEDICS, V34, pE504, DOI 10.3928/01477447-20110714-40; Pijls BG, 2012, INT ORTHOP, V36, P1175, DOI 10.1007/s00264-011-1412-6; RITTER MA, 1994, CLIN ORTHOP RELAT R, P153	21	2	2	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0942-2056	1433-7347		KNEE SURG SPORT TR A	Knee Surg. Sports Traumatol. Arthrosc.	NOV	2014	22	11					2635	2640		10.1007/s00167-013-2506-z		6	Orthopedics; Sport Sciences; Surgery	Orthopedics; Sport Sciences; Surgery	AS3GE	WOS:000344164600010		
J	Yanagisawa, S; Sato, N; Ohsawa, T; Saito, K; Shimizu, M; Takagishi, K				Yanagisawa, Shinya; Sato, Naoki; Ohsawa, Takashi; Saito, Kenichi; Shimizu, Masaki; Takagishi, Kenji			Influence of the anterior-posterior femoral translation on the range of motion in cruciate-retaining total knee arthroplasty	KNEE SURGERY SPORTS TRAUMATOLOGY ARTHROSCOPY			English	Article						Cruciate-retaining total knee arthroplasty; Anterior-posterior femoral translation; Navigation; Post-operative range of motion	NAVIGATION; LIGAMENT; REPLACEMENT; KINEMATICS; ACCURACY; BEARING; FLEXION; SYSTEM; GAP; TKA	The purpose of this study is to evaluate the post-operative range of motion (ROM) of the knee related to the anterior-posterior femoral translation on the tibia observed during surgery in cruciate-retaining total knee arthroplasty (TKA) using a navigation system. Our hypothesis is that the intraoperative anterior-posterior femoral translation is correlated with the post-operative ROM in patients undergoing cruciate-retaining TKA. The subjects were 20 patients involving 23 joints. The passive maximum ROM was measured before and 1 year after surgery. In addition, we evaluated the intraoperative anterior-posterior femoral translation that was measured after inserting a tensor device from 10A degrees to 120A degrees of knee flexion. The starting point of the anterior-posterior femoral translation was defined as when the femur started to move posteriorly. The anterior-posterior femoral translation 120 was set as the amount of femoral movement from 10A degrees to 120A degrees. The subjects were divided into those with an increased or maintained ROM (group A) and those with a decreased ROM (group B). There were no significant differences between the two groups in terms of the age or pre-operative ROM. The starting point of the anterior-posterior femoral translation was significantly earlier in group B (58.0 +/- A 5.7A degrees for group A, 48.7 +/- A 3.2A degrees for group B) (P < 0.05). Regarding the anterior-posterior femoral translation 120, Group B showed a larger amount of femoral movement posteriorly than group A (13.0 +/- A 6.5 mm for group A, 19.0 +/- A 6.2 mm for group B) (P < 0.05). The present study shows that intraoperative anterior-posterior femoral translation has a significant correlation with the post-operative ROM in patients undergoing cruciate-retaining TKA. If the starting point of the anterior-posterior femoral translation is early and the anterior-posterior femoral translation 120 is large, there is likely to be a decrease in the post-operative ROM. III.	[Yanagisawa, Shinya; Ohsawa, Takashi; Saito, Kenichi; Takagishi, Kenji] Gunma Univ, Grad Sch Med, Dept Orthopaed Surg, Maebashi, Gunma 3718511, Japan; [Sato, Naoki] Isesaki City Hosp, Dept Orthopaed Surg, Gunma, Japan; [Shimizu, Masaki] Keiyu Orthopaed Hosp, Gunma, Japan	Yanagisawa, S (reprint author), Gunma Univ, Grad Sch Med, Dept Orthopaed Surg, 3-39-15 Showa Machi, Maebashi, Gunma 3718511, Japan.	yanashin87@yahoo.co.jp					EWALD FC, 1989, CLIN ORTHOP RELAT R, P9; Matsumoto T, 2009, J BONE JOINT SURG BR, V91B, P475, DOI 10.1302/0301-620X.91B4.21862; Siston RA, 2006, J ORTHOP RES, V24, P1607, DOI 10.1002/jor.20163; Lutzner J, 2008, J BONE JOINT SURG BR, V90B, P1039, DOI 10.1302/0301-620X.90B8.20553; Griffin FM, 2000, J ARTHROPLASTY, V15, P970, DOI 10.1054/arth.2000.6503; Martelli S, 2007, COMPUT BIOL MED, V37, P872, DOI 10.1016/j.compbiomed.2006.09.004; Mihalko WM, 2008, J ARTHROPLASTY, V23, P57, DOI 10.1016/j.arth.2006.12.048; Arima J, 1998, CLIN ORTHOP RELAT R, P194; Massin P, 2012, KNEE SURG SPORT TR A, V20, P1714, DOI 10.1007/s00167-011-1740-5; Rosenberger RE, 2008, KNEE SURG SPORT TR A, V16, P249, DOI 10.1007/s00167-007-0420-y; Christen B, 2007, J BONE JOINT SURG BR, V89B, P1046, DOI 10.1302/0301-620X.89B8; Wyss T, 2008, ARCH ORTHOP TRAUM SU, V128, P129, DOI 10.1007/s00402-007-0541-2; Ritter MA, 2003, J BONE JOINT SURG AM, V85A, P1278; Casino D, 2009, KNEE SURG SPORT TR A, V17, P369, DOI 10.1007/s00167-008-0699-3; Seon JK, 2011, INT ORTHOP, V35, P515, DOI 10.1007/s00264-010-1029-1; Asano H, 2004, J ARTHROPLASTY, V19, P632; Bathis H, 2004, INT ORTHOP, V28, P87, DOI 10.1007/s00264-003-0533-y; Conditt MA, 2004, J ARTHROPLASTY, V19, P107, DOI 10.1016/j.arth.2004.06.006; Cromie MJ, 2008, J ORTHOP RES, V26, P1494, DOI 10.1002/jor.20664; Horiuchi H, 2012, J ARTHROPLASTY, V27, P1196, DOI 10.1016/j.arth.2012.01.017; Iwaki H, 2001, CONTROVERSIES TOTAL, P106; Martin A, 2007, CLIN ORTHOP RELAT R, P178, DOI 10.1097/BLO.0b013e31804ea45f; Nakagawa S, 2004, J BONE JOINT SURG BR, V86B, P450, DOI 10.1302/0301-620X.86B3.14330; Nozaki H, 2002, CLIN ORTHOP RELAT R, P308, DOI 10.1097/01.blo.0000030061.92399.b1; Picard F, 2007, CLIN ORTHOP RELAT R, P50, DOI 10.1097/BLO.0b013e3181468734; Stiehl JB, 2009, INT ORTHOP, V33, P679, DOI 10.1007/s00264-008-0562-7	26	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0942-2056	1433-7347		KNEE SURG SPORT TR A	Knee Surg. Sports Traumatol. Arthrosc.	NOV	2014	22	11					2709	2714		10.1007/s00167-013-2579-8		6	Orthopedics; Sport Sciences; Surgery	Orthopedics; Sport Sciences; Surgery	AS3GE	WOS:000344164600020		
J	Onodera, J; Kondo, E; Omizu, N; Ueda, D; Yagi, T; Yasuda, K				Onodera, Jun; Kondo, Eiji; Omizu, Nobuyuki; Ueda, Daisuke; Yagi, Tomonori; Yasuda, Kazunori			Beta-tricalcium phosphate shows superior absorption rate and osteoconductivity compared to hydroxyapatite in open-wedge high tibial osteotomy	KNEE SURGERY SPORTS TRAUMATOLOGY ARTHROSCOPY			English	Article						Open-wedge high tibial osteotomy; Beta-tricalcium phosphate; Hydroxyapatite; Wedge-shaped spacer; Knee osteoarthritis	BONE-GRAFT SUBSTITUTES; FOLLOW-UP; KNEE; REGENERATION; GRANULES; MICROSTRUCTURE; OSTEOARTHRITIS; BIORESORPTION; IMPLANTATION; PARTICLES	The purpose of this study was to clinically and radiologically compare the utility, osteoconductivity, and absorbability of hydroxyapatite (HAp) and beta-tricalcium phosphate (TCP) spacers in medial open-wedge high tibial osteotomy (HTO). Thirty-eight patients underwent medial open-wedge HTO with a locking plate. In the first 19 knees, a HAp spacer was implanted in the opening space (HAp group). In the remaining 19 knees, a TCP spacer was implanted in the same manner (TCP group). All patients underwent clinical and radiological examinations before surgery and at 18 months after surgery. Concerning the background factors, there were no statistical differences between the two groups. Post-operatively, the knee score significantly improved in each group. Concerning the post-operative knee alignment and clinical outcome, there was no statistical difference in each parameter between the two groups. Regarding the osteoconductivity, the modified van Hemert's score of the TCP group was significantly higher (p = 0.0009) than that of the HAp group in the most medial osteotomy zone. The absorption rate was significantly greater in the TCP group than in the HAp group (p = 0.00039). The present study demonstrated that a TCP spacer was significantly superior to a HAp spacer concerning osteoconductivity and absorbability at 18 months after medial open-wedge HTO. Retrospective comparative study, Level III.	[Onodera, Jun; Kondo, Eiji; Yasuda, Kazunori] Hokkaido Univ, Grad Sch Med, Dept Sports Med & Joint Surg, Kita Ku, Sapporo, Hokkaido 0608638, Japan; [Omizu, Nobuyuki; Ueda, Daisuke; Yagi, Tomonori] Yamanote Dori Yagi Hosp, Dept Orthopaed Surg, Sapporo, Hokkaido, Japan	Kondo, E (reprint author), Hokkaido Univ, Grad Sch Med, Dept Sports Med & Joint Surg, Kita Ku, Kita 15 Nishi 7, Sapporo, Hokkaido 0608638, Japan.	eijik@med.hokudai.ac.jp	Yasuda, Kazunori/C-9998-2009; Kondo, Eiji/G-2004-2012		Ministry of Education, Science and Culture, Japan [24592218]	This research was supported in part by the grants-in-aid for scientific research (24592218) from the Ministry of Education, Science and Culture, Japan.	Amendola A, 2005, ORTHOP CLIN N AM, V36, P497, DOI 10.1016/j.ocl.2005.05.009; Okuda T, 2007, BIOMATERIALS, V28, P2612, DOI 10.1016/j.biomaterials.2007.01.040; Yuan HP, 2010, P NATL ACAD SCI USA, V107, P13614, DOI 10.1073/pnas.1003600107; Wenisch S, 2003, J BIOMED MATER RES A, V67A, P713, DOI 10.1002/jbm.a.10091; Dorozhkin SV, 2010, BIOMATERIALS, V31, P1465, DOI 10.1016/j.biomaterials.2009.11.050; [Anonymous], 2000, CLIN ORTHOPAEDICS, DOI 10.1097/00003086-200002000-00003; Finkemeier CG, 2002, J BONE JOINT SURG AM, V84A, P454; Velard F, 2013, ACTA BIOMATER, V9, P4956, DOI 10.1016/j.actbio.2012.09.035; KELLGREN JH, 1957, ANN RHEUM DIS, V16, P494, DOI 10.1136/ard.16.4.494; Bonnin MP, 2013, KNEE SURG SPORT TR A, V21, P64, DOI 10.1007/s00167-011-1461-9; Amis AA, 2013, KNEE SURG SPORT TR A, V21, P197, DOI 10.1007/s00167-012-2122-3; Walsh WR, 2008, BIOMATERIALS, V29, P266, DOI 10.1016/j.biomaterials.2007.09.035; Koshino T, 2003, J BONE JOINT SURG AM, V85A, P78; Floerkemeier S, 2013, KNEE SURG SPORT TR A, V21, P170, DOI 10.1007/s00167-012-2087-2; Brosset T, 2011, ORTHOP TRAUMATOL-SUR, V97, P705, DOI 10.1016/j.otsr.2011.06.011; Chazono M, 2004, J BIOMED MATER RES A, V70A, P542, DOI 10.1002/jbm.a.30094; Smith JO, 2013, KNEE SURG SPORT TR A, V21, P3, DOI 10.1007/s00167-012-2206-0; Lu JX, 1998, J BIOMED MATER RES, V42, P357, DOI 10.1002/(SICI)1097-4636(19981205)42:3<357::AID-JBM3>3.0.CO;2-I; Kohn L, 2013, KNEE SURG SPORT TR A, V21, P146, DOI 10.1007/s00167-012-2016-4; Hwang JW, 2012, J BIOMED MATER RES B, V100B, P2044, DOI 10.1002/jbm.b.32768; INSALL J, 1971, RADIOLOGY, V101, P101; MOORE TM, 1974, J BONE JOINT SURG AM, VA 56, P155; Chatterjea A, 2014, J BIOMED MATER RES A, V102, P1399, DOI 10.1002/jbm.a.34815; Pape D, 2013, KNEE SURG SPORT TR A, V21, P82, DOI 10.1007/s00167-011-1693-8; Ogose A, 2005, J BIOMED MATER RES B, V72B, P94, DOI 10.1002/jbm.b.30136; Ozalay M, 2009, ARCH ORTHOP TRAUM SU, V129, P747, DOI 10.1007/s00402-008-0781-9; ALTERMATT S, 1992, EUR J PEDIATR SURG, V2, P180, DOI 10.1055/s-2008-1063435; Lobenhoffer P, 2003, KNEE SURG SPORT TR A, V11, P132, DOI 10.1007/s00167-002-0334-7; Gouin F, 2010, ORTHOP TRAUMATOL-SUR, V96, P637, DOI 10.1016/j.otsr.2010.03.022; McNamara I, 2013, KNEE SURG SPORT TR A, V21, P23, DOI 10.1007/s00167-012-2218-9; Juhasz JA, 2008, J MATER SCI-MATER M, V19, P1823, DOI 10.1007/s10856-007-3344-7; Hannink G, 2011, INJURY, V42, pS22, DOI 10.1016/j.injury.2011.06.008; Takeuchi R, 2009, ARTHROSCOPY, V25, P46, DOI 10.1016/j.arthro.2008.08.015; Staubli AE, 2003, INJURY, V34, P55, DOI 10.1016/j.injury.2003.09.025; Aoki Y, 2006, J BONE JOINT SURG BR, V88B, P1336, DOI 10.1302/0301-620X.88B10.17532; Billstrom GH, 2013, INJURY, V44, pS28, DOI 10.1016/S0020-1383(13)70007-X; Chazono M, 2008, J ORTHOP SCI, V13, P550, DOI 10.1007/s00776-008-1271-1; Fujita R, 2003, J ORAL MAXIL SURG, V61, P1045, DOI 10.1016/S0278-2391(03)00317-3; Hench LL, 1982, BIOMATERIALS INTERFA, P126; KLEIN CPAT, 1990, BIOMATERIALS, V11, P509, DOI 10.1016/0142-9612(90)90067-Z; Tanaka Takaaki, 2006, Jikeikai Medical Journal, V53, P45; Valkering Kars P, 2009, J Knee Surg, V22, P218; van Hemert WLW, 2004, KNEE, V11, P451, DOI 10.1016/j.knee.2004.08.004; Yamasaki N, 2009, J BIOMED MATER RES B, V91B, P788, DOI 10.1002/jbm.b.31457; YASUDA K, 1992, CLIN ORTHOP RELAT R, P186	45	2	2	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0942-2056	1433-7347		KNEE SURG SPORT TR A	Knee Surg. Sports Traumatol. Arthrosc.	NOV	2014	22	11					2763	2770		10.1007/s00167-013-2681-y		8	Orthopedics; Sport Sciences; Surgery	Orthopedics; Sport Sciences; Surgery	AS3GE	WOS:000344164600028		
J	Koga, H; Muneta, T; Yagishita, K; Watanabe, T; Mochizuki, T; Horie, M; Nakamura, T; Sekiya, I				Koga, Hideyuki; Muneta, Takeshi; Yagishita, Kazuyoshi; Watanabe, Toshifumi; Mochizuki, Tomoyuki; Horie, Masafumi; Nakamura, Tomomasa; Sekiya, Ichiro			Effect of femoral tunnel position on graft tension curves and knee stability in anatomic double-bundle anterior cruciate ligament reconstruction	KNEE SURGERY SPORTS TRAUMATOLOGY ARTHROSCOPY			English	Article						Double-bundle; Anterior cruciate ligament (ACL) reconstruction; Graft tension; Tunnel position	SINGLE-BUNDLE; HAMSTRING TENDONS; POSTEROLATERAL BUNDLES; ACL RECONSTRUCTION; FIXATION ANGLES; ATTACHMENTS; INSERTIONS; ROTATION; FORCES; LOADS	To evaluate the effect of the femoral tunnel position of the anteromedial bundle (AMB) and the posterolateral bundle (PLB) on the graft tension curves and knee stability in anatomic double-bundle anterior cruciate ligament (ACL) reconstruction. Forty-five patients who underwent anatomic double-bundle ACL reconstruction were included. AMB and PLB were provisionally fixed to a graft tensioning system in the following settings during surgery: (1) AMB at 20A degrees and PLB at 0A degrees (A20P0), (2) AMB at 20A degrees and PLB at 20A degrees (A20P20), and (3) AMB at 20A degrees and PLB at 45A degrees (A20P45). Bundle tension was recorded during knee flexion-extension. A pivot shift test was also evaluated. Femoral tunnel positions of the AMB and PLB were then assessed by three-dimensional computed tomography, and the correlation between femoral tunnel position and tension change pattern or residual pivot shift was evaluated. The depth of the PLB tunnel position was correlated with the extent of tension reduction in the PLB between 0A degrees and 30A degrees irrespective of graft fixation settings, while neither the AMB tunnel position nor the height of the PLB tunnel position affected the tension change pattern. Ten cases showed grade 1 pivot shift only in the A20P0 setting. The PLB tunnel position in the pivot shift-positive cases was significantly deeper than that in the pivot shift-negative cases (27.5 +/- A 6.2 and 34.1 +/- A 5.5 %, respectively, P = 0.002). In anatomic double-bundle reconstruction, deeper PLB tunnel position was correlated with the larger tension reduction in the PLB between 0A degrees and 30A degrees. Fixation of the AMB at 20A degrees and the PLB at 0A degrees resulted in residual pivot shift phenomenon in 10/45 cases, and the PLB tunnel position in the pivot shift-positive cases was significantly deeper than that in the pivot shift-negative cases. In anatomic double-bundle reconstruction, the placement of PLB femoral tunnel must not be too deep, as it might lead to significant tension reduction in the PLB near extension and thus insufficient tension in the PLB, resulting in residual pivot shift phenomenon. IV.	[Koga, Hideyuki; Muneta, Takeshi; Yagishita, Kazuyoshi; Watanabe, Toshifumi; Mochizuki, Tomoyuki; Horie, Masafumi; Nakamura, Tomomasa; Sekiya, Ichiro] Tokyo Med & Dent Univ Hosp Med, Dept Orthopaed Surg, Bunkyo Ku, Tokyo 1138519, Japan	Koga, H (reprint author), Tokyo Med & Dent Univ Hosp Med, Dept Orthopaed Surg, Bunkyo Ku, 1-5-45 Yushima, Tokyo 1138519, Japan.	koga-z@rg7.so-net.ne.jp					Aglietti P, 2007, CLIN ORTHOP RELAT R, P108, DOI 10.1097/BLO.0b013e31802baaf4; Ferretti M, 2007, ARTHROSCOPY, V23, P1218, DOI 10.1016/j.arthro.2007.09.008; Harner CD, 1999, ARTHROSCOPY, V15, P741, DOI 10.1016/S0749-8063(99)70006-X; Meredick RB, 2008, AM J SPORT MED, V36, P1414, DOI 10.1177/0363546508317964; Yasuda K, 2008, ARTHROSCOPY, V24, P276, DOI 10.1016/j.arthro.2007.08.031; Tsuda E, 2002, ARTHROSCOPY, V18, P960, DOI 10.1053/jars.2002.36112; Xu Y, 2014, KNEE SURG SPORT TR A, V22, P308, DOI 10.1007/s00167-013-2398-y; Woo SLY, 2002, J BONE JOINT SURG AM, V84A, P907; Zavras TD, 2001, KNEE SURG SPORT TR A, V9, P28, DOI 10.1007/s001670000170; Mochizuki T, 2006, ARTHROSCOPY, V22, P356, DOI 10.1016/j.arthro.2005.09.020; Hara K, 2009, AM J SPORT MED, V37, P2386, DOI 10.1177/0363546509340404; Asagumo H, 2007, ARTHROSCOPY, V23, P602, DOI 10.1016/j.arthro.2007.01.009; Koga H, 2012, AM J SPORT MED, V40, P615, DOI 10.1177/0363546511426696; Yasuda K, 2011, AM J SPORT MED, V39, P1789, DOI 10.1177/0363546511402659; Koga H, 2013, ARTHROSCOPY, V29, P529, DOI 10.1016/j.arthro.2012.10.018; Wu CF, 2009, J ORTHOP RES, V27, P879, DOI 10.1002/jor.20822; Muneta T, 2007, ARTHROSCOPY, V23, P618, DOI 10.1016/j.arthro.2007.04.010; Jarvela T, 2007, KNEE SURG SPORT TR A, V15, P500, DOI 10.1007/s00167-006-0254-z; NAKAJIMA H, 1979, ARCH ORTHOP TRAUM SU, V95, P233, DOI 10.1007/BF00389691; Sasaki N, 2012, ARTHROSCOPY, V28, P1135, DOI 10.1016/j.arthro.2011.12.021; Kondo E, 2008, AM J SPORT MED, V36, P1675, DOI 10.1177/0363546508317123; Yagi M, 2002, AM J SPORT MED, V30, P660; Murray PJ, 2010, ARTHROSCOPY, V26, P202, DOI 10.1016/j.arthro.2009.07.014; Hutchinson MR, 2003, ARTHROSCOPY, V19, P931, DOI 10.1016/S0749-8063(03)00809-0; Conner CS, 2008, ARTHROSCOPY, V24, P1323, DOI 10.1016/j.arthro.2008.07.006; Kerner S, 2007, J CLIN PERIODONTOL, V34, P969, DOI 10.1111/j.1600-051X.2007.01137.x; Mochizuki T, 2014, KNEE SURG SPORT TR A, V22, P336, DOI 10.1007/s00167-013-2404-4; Bach JM, 1997, J BIOMECH, V30, P281, DOI 10.1016/S0021-9290(96)00132-7; Takahashi M, 2006, AM J SPORT MED, V34, P787, DOI 10.1177/0363546505282625; Shino K, 2010, KNEE SURG SPORT TR A, V18, P1164, DOI 10.1007/s00167-009-0979-6; HEFZY MS, 1989, AM J SPORT MED, V17, P208, DOI 10.1177/036354658901700210; Yagi M, 2007, CLIN ORTHOP RELAT R, P100, DOI 10.1097/BLO.0b013e31802ba45c; AMIS AA, 1991, J BONE JOINT SURG BR, V73, P260; Adachi N, 2004, J BONE JOINT SURG BR, V86B, P515, DOI 10.1302/0301-620X.86B4.14856; MARKOLF KL, 1990, J BONE JOINT SURG AM, V72A, P557; Gabriel MT, 2004, J ORTHOPAED RES, V22, P85, DOI 10.1016/S0736-0266(03)00133-5; Zantop T, 2007, AM J SPORT MED, V35, P223, DOI 10.1177/0363546506294571; Inoue M, 2010, KNEE SURG SPORT TR A, V18, P1176, DOI 10.1007/s00167-009-0989-4; Colombet P, 2006, ARTHROSCOPY, V22, P984, DOI 10.1016/j.arthro.2006.04.102; Bernard M, 1997, Am J Knee Surg, V10, P14; GIRGIS FG, 1975, CLIN ORTHOP RELAT R, P216; Hefti F, 1993, Knee Surg Sports Traumatol Arthrosc, V1, P226; Iwahashi T, 2010, ARTHROSCOPY, V26, pS13, DOI 10.1016/j.arthro.2010.01.023; Kobayashi M, 2006, ARTHROSCOPY, V22, P1093, DOI 10.1016/j.arthro.2006.05.017; Sonnery-Cottet B, 2007, ARTHROSCOPY, V23, pe1121	45	5	5	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0942-2056	1433-7347		KNEE SURG SPORT TR A	Knee Surg. Sports Traumatol. Arthrosc.	NOV	2014	22	11					2811	2820		10.1007/s00167-013-2693-7		10	Orthopedics; Sport Sciences; Surgery	Orthopedics; Sport Sciences; Surgery	AS3GE	WOS:000344164600035		
J	Onoda, Y; Hagiwara, Y; Ando, A; Watanabe, T; Chimoto, E; Suda, H; Yabe, Y; Saijo, Y; Itoi, E				Onoda, Yoshito; Hagiwara, Yoshihiro; Ando, Akira; Watanabe, Takashi; Chimoto, Eiichi; Suda, Hideaki; Yabe, Yutaka; Saijo, Yoshifumi; Itoi, Eiji			Joint haemorrhage partly accelerated immobilization-induced synovial adhesions and capsular shortening in rats	KNEE SURGERY SPORTS TRAUMATOLOGY ARTHROSCOPY			English	Article						Immobilization; Joint haemorrhage; Joint contracture; Synovial membrane; Adhesion	CRUCIATE LIGAMENT RECONSTRUCTION; COLLAGEN TYPE-III; KNEE MODEL; FROZEN SHOULDER; HEMOPHILIC ARTHROPATHY; POSTTRAUMATIC JOINT; GROWTH-FACTOR; RABBIT MODEL; EXPRESSION; CONTRACTURE	To elucidate the effects of intra-articular haemorrhage on the joint capsule of immobilized knees in rats. The unilateral knee joints were immobilized using a plastic plate and screws. Sham operated rats had only screws inserted. A single injection of fresh autologous blood was given postoperatively into the knee joints of the immobilized blood injection (Im-B) and the Sham blood injection (Sm-B) groups. Normal saline was administered for the immobilized-saline injection (Im-S) group. Sagittal sections were prepared from the medial midcondylar region of the knee and assessed with histological, histomorphometric, and immunohistochemical methods. The range of motion (ROM) was measured, and the mechanical property of the capsule was assessed by scanning acoustic microscope. Absorption of the injected blood was delayed and made severe adhesions in the Im-B group. The length of the synovial membrane in the Im-B group was significantly shorter than that of the other groups. The ROM was significantly restricted in the Im-B group compared with the other groups. The elasticity of the posterior capsule in the Im-B group was significantly lower than that in the Sm-B group. Iron deposition was observed in the Im-B and Sm-B groups. Strong immunoreactivities of CD68, TGF-beta 1, and alpha-SMA were observed in the adhesion area of the Im-B group. Joint immobilization with blood injection caused severe capsular adhesion and limited range of motion. Immunostaining related to fibrosis increased with joint haemorrhage. Intra-articular haemorrhage with joint immobilization might be an accelerated risk factor for joint contracture. It is likely that leaving a haematoma inside an immobilized joint should be avoided.	[Onoda, Yoshito; Hagiwara, Yoshihiro; Ando, Akira; Chimoto, Eiichi; Suda, Hideaki; Yabe, Yutaka; Itoi, Eiji] Tohoku Univ, Sch Med, Dept Orthopaed Surg, Aoba Ku, Sendai, Miyagi 9808574, Japan; [Watanabe, Takashi] Tohoku Univ, Grad Sch Med, Div Epidemiol, Dept Publ Hlth & Forens Med,Aoba Ku, Sendai, Miyagi 9808574, Japan; [Saijo, Yoshifumi] Tohoku Univ, Dept Biomed Imaging, Grad Sch Biomed Engn, Aoba Ku, Sendai, Miyagi 9808575, Japan	Hagiwara, Y (reprint author), Tohoku Univ, Sch Med, Dept Orthopaed Surg, Aoba Ku, 1-1 Seiryo Machi, Sendai, Miyagi 9808574, Japan.	hagi@med.tohoku.ac.jp					AKESON WH, 1987, CLIN ORTHOP RELAT R, P28; Ando A, 2008, TOHOKU J EXP MED, V215, P321, DOI 10.1620/tjem.215.321; Ando A, 2009, TOHOKU J EXP MED, V217, P271; Valentino LA, 2010, J THROMB HAEMOST, V8, P1895, DOI 10.1111/j.1538-7836.2010.03962.x; Lindenhovius ALC, 2007, J HAND SURG-AM, V32A, P1605, DOI 10.1016/j.jhsa.2007.09.015; Kruse LM, 2012, J BONE JOINT SURG AM, V94A, P1737, DOI 10.2106/JBJS.K.01246; Heiland GR, 2010, ANN RHEUM DIS, V69, P1214, DOI 10.1136/ard.2009.120204; DAMOISEAUX JGMC, 1994, IMMUNOLOGY, V83, P140; Robins SP, 2003, J INVEST DERMATOL, V121, P267, DOI 10.1046/j.1523-1747.2003.12373.x; Lucas T, 2010, J IMMUNOL, V184, P3964, DOI 10.4049/jimmunol.0903356; BUNKER TD, 1995, J BONE JOINT SURG BR, V77, P677; Hildebrand KA, 2004, J ORTHOPAED RES, V22, P313, DOI 10.1016/j.orthres.2003.08.012; Bunker TD, 2000, J BONE JOINT SURG BR, V82B, P768, DOI 10.1302/0301-620X.82B5.9888; Rodeo SA, 1997, J ORTHOPAED RES, V15, P427, DOI 10.1002/jor.1100150316; Wynn TA, 2010, SEMIN LIVER DIS, V30, P245, DOI 10.1055/s-0030-1255354; Roosendaal G, 1999, ARTHRITIS RHEUM, V42, P1033, DOI 10.1002/1529-0131(199905)42:5<1033::AID-ANR24>3.0.CO;2-#; Leask A, 2004, FASEB J, V18, P816, DOI 10.1096/fj.03-1273rev; Matsumoto F, 2002, ACTA ORTHOP SCAND, V73, P335, DOI 10.1080/000164702320155365; Solimeno L, 2010, HAEMOPHILIA, V16, P115, DOI 10.1111/j.1365-2516.2010.02308.x; van Grinsven S, 2010, KNEE SURG SPORT TR A, V18, P1128, DOI 10.1007/s00167-009-1027-2; Bochaton-Piallat ML, 2000, INVEST OPHTH VIS SCI, V41, P2336; Serini G, 1999, EXP CELL RES, V250, P273, DOI 10.1006/excr.1999.4543; Wen FQ, 2002, BLOOD, V100, P912, DOI 10.1182/blood-2002-02-0390; BORNSTEIN P, 1980, ANNU REV BIOCHEM, V49, P957, DOI 10.1146/annurev.bi.49.070180.004521; Hagiwara Y, 2012, OSTEOARTHR CARTILAGE, V20, P241, DOI 10.1016/j.joca.2011.12.008; Okazaki R, 2001, J BONE MINER METAB, V19, P228, DOI 10.1007/s007740170025; Brancato SK, 2011, AM J PATHOL, V178, P19, DOI 10.1016/j.ajpath.2010.08.003; Ando A, 2010, TOHOKU J EXP MED, V221, P161, DOI 10.1620/tjem.221.161; Jansen NWD, 2009, OSTEOARTHR CARTILAGE, V17, P433, DOI 10.1016/j.joca.2008.09.001; TOMASEK J, 1995, J HAND SURG-AM, V20A, P450, DOI 10.1016/S0363-5023(05)80105-4; Tomasek JJ, 2002, NAT REV MOL CELL BIO, V3, P349, DOI 10.1038/nrm809; Lee S, 2010, CONNECT TISSUE RES, V51, P467, DOI 10.3109/03008201003686941; Chimoto E, 2007, UPSALA J MED SCI, V112, P347; DABBAGH AJ, 1993, ANN RHEUM DIS, V52, P67, DOI 10.1136/ard.52.1.67; Hagiwara Y, 2008, UPSALA J MED SCI, V113, P221; Hagiwara Y, 2010, J ORTHOP RES, V28, P315, DOI 10.1002/jor.20997; Hagiwara Y, 2006, UPSALA J MED SCI, V111, P303; Hildebrand KA, 2006, J ORTHOP RES, V24, P1036, DOI 10.1002/jor.20128; Hildebrand KA, 2007, CLIN ORTHOP RELAT R, P85, DOI 10.1097/BLO.0b013e3180312c01; Horisberger M, 2011, CLIN BIOMECH, V26, P790, DOI 10.1016/j.clinbiomech.2011.02.013; KLEFTOGIANNIS F, 1994, J ORTHOPAED RES, V12, P365, DOI 10.1002/jor.1100120309; Levy O, 2008, J SHOULDER ELB SURG, V17, P410, DOI 10.1016/j.jse.2007.11.014; LUNDBERG BJ, 1970, CLIN ORTHOP RELAT R, P279; NISHIYA K, 1994, J RHEUMATOL, V21, P1802; Parker M J, 2007, COCHRANE DB SYST REV, V3; RodriguezMerchan EC, 1997, CLIN ORTHOP RELAT R, P6; SAFRAN MR, 1994, CLIN ORTHOP RELAT R, P280; SCHOLLMEIER G, 1996, CLIN ORHTOP RES, V323, P310, DOI 10.1097/00003086-199602000-00044; Thompson RW, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000023; Trudel G, 2000, J RHEUMATOL, V27, P351; Wallman Paul, 2002, Emerg Med J, V19, P50, DOI 10.1136/emj.19.1.50-a	51	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0942-2056	1433-7347		KNEE SURG SPORT TR A	Knee Surg. Sports Traumatol. Arthrosc.	NOV	2014	22	11					2874	2883		10.1007/s00167-013-2659-9		10	Orthopedics; Sport Sciences; Surgery	Orthopedics; Sport Sciences; Surgery	AS3GE	WOS:000344164600043		
J	Ikeda, D; Suzuki, E				Ikeda, Daisuke; Suzuki, Einoshin			Finding peculiar compositions of two frequent strings with background texts	KNOWLEDGE AND INFORMATION SYSTEMS			English	Article						Algorithms; Exceptional pattern mining; Text mining; Bioinformatics; Genetic maps; Suffix trees	DISCOVERY; WORDS; CONSTRUCTION; GENES; SETS	We consider mining unusual patterns from a set T of target texts. A typical method outputs unusual patterns if their observed frequencies are far from their expectation estimated under an assumed probabilistic model. However, it is difficult for the method to deal with the zero frequency and thus it suffers from data sparseness. We employ another set B of background texts to define a composition x y to be peculiar if both x and y are more frequent in B than in T and conversely xy is more frequent in T. xy is unusual because x and y are infrequent in T while xy is unexpectedly frequent compared to xy in B. To find frequent subpatterns and infrequent patterns simultaneously, we develop a fast algorithm using the suffix tree and show that it scales almost linearly under practical settings of parameters. Experiments using DNA sequences show that found peculiar compositions basically appear in rRNA while patterns found by an existing method seem not to relate to specific biological functions. We also show that discovered patterns have similar lengths at which the distribution of frequencies of fixed length substrings begins to skew. This fact explains why our method can find long peculiar compositions.	[Ikeda, Daisuke; Suzuki, Einoshin] Kyushu Univ, Dept Informat, Fukuoka 8190395, Japan	Ikeda, D (reprint author), Kyushu Univ, Dept Informat, Fukuoka 8190395, Japan.	daisuke@inf.kyushu-u.ac.jp			KAKENHI [21300053, 25280085, 19700150, 21650031, 24300059]; Strategic International Cooperative Program - Japan Science and Technology Agency (JST)	This research was partially supported by the KAKENHI Grant No. 21300053, 25280085, 19700150, 21650031, and 24300059, and the Strategic International Cooperative Program funded by Japan Science and Technology Agency (JST). This paper is a major value-added version of a conference paper that appeared in [16]. In addition to genetic maps of peculiar compositions, which first appeared in [15], those of patterns found by other criteria are added in this paper.	Agrawal R., 1993, P 1993 ACM SIGMOD IN, V22, P207, DOI DOI 10.1145/170035.170072; Sarawagi S, 1998, LECT NOTES COMPUT SC, V1377, P168; Ji X, 2007, KNOWL INF SYST, V11, P259, DOI 10.1007/s10115-006-0038-2; Andrade MA, 1998, BIOINFORMATICS, V14, P600, DOI 10.1093/bioinformatics/14.7.600; Apostolico A, 2000, J COMPUT BIOL, V7, P71, DOI 10.1089/10665270050081397; Beissbarth T, 2004, BIOINFORMATICS, V20, P1464, DOI 10.1093/bioinformatics/bth088; Gomez JC, 2012, KNOWL INF SYST, V31, P23, DOI 10.1007/s10115-011-0403-7; UKKONEN E, 1995, ALGORITHMICA, V14, P249, DOI 10.1007/BF01206331; Apostolico A, 2008, MATH COMPUT SCI, V1, P639, DOI 10.1007/s11786-007-0032-4; Arimura H, 1998, LECT NOTES COMPUT SC, V1533, P39; Berry M., 2003, SURVEY TEXT MINING C; Chan P. K., 1998, KDD, V1998, P164; Fayyad U. M., 1996, ADV KNOWLEDGE DISCOV; Gusfield D., 1997, ALGORITHMS STRINGS T; Horng Jorng-Tzong, 2002, In Silico Biology, V2, P263; Huang HD, 2003, J INF SCI ENG, V19, P923; Ikeda Daisuke, 2013, Proceedings of the 4th International Conference on Bioinformatics Models, Methods and Algorithms. BIOINFORMATICS 2013; Ikeda D, 1999, LECT NOTES ARTIF INT, V1721, P139; Ikeda D, 2009, LECT NOTES ARTIF INT, V5781, P596; Jagadish H. V., 1999, Proceedings of the Eighteenth ACM SIGMOD-SIGACT-SIGART Symposium on Principles of Database Systems, DOI 10.1145/303976.304001; Keogh E., 2006, KNOWL INF SYST, V11, P1, DOI DOI 10.1007/S10115-006-0034-6; Knorr EM, 1999, 25 INT C VER LARG DA, P211; Leung MY, 1996, J COMPUT BIOL, V3, P345, DOI 10.1089/cmb.1996.3.345; Marschall T, 2009, BIOINFORMATICS, V25, pI356, DOI 10.1093/bioinformatics/btp188; MCCREIGHT EM, 1976, J ACM, V23, P262, DOI 10.1145/321941.321946; Padmanabhan B, 2000, 6 ACM SIGKDD INT C K, P54; Parida L., 2007, PATTERN DISCOVERY BI; Pham DS, 2013, KNOWL INF SYST, V35, P33, DOI 10.1007/s10115-012-0509-6; Schbath S, 1997, J COMPUT BIOL, V4, P189, DOI 10.1089/cmb.1997.4.189; Suzuki E, 1996, 2 INT C KNOWL DISC D, P275; Suzuki E, 2002, INT J PATTERN RECOGN, V16, P1065, DOI 10.1142/S0218001402002155; Suzuki E, 2000, LECT NOTES ARTIF INT, V1805, P208; Suzuki E, 1997, 3 INT C KNOWL DISC D, P259; Uemura T, 2008, LECT NOTES COMPUT SC, V5255, P319, DOI 10.1007/978-3-540-88411-8_30; Wang J. Y., 2003, P 9 ACM SIGKDD INT C, P236; Yan X, 2003, P 4 SIAM INT C DAT M	36	0	0	SPRINGER LONDON LTD	LONDON	236 GRAYS INN RD, 6TH FLOOR, LONDON WC1X 8HL, ENGLAND	0219-1377	0219-3116		KNOWL INF SYST	Knowl. Inf. Syst.	NOV	2014	41	2			SI		499	530		10.1007/s10115-013-0688-9		32	Computer Science, Artificial Intelligence; Computer Science, Information Systems	Computer Science	AS0XO	WOS:000344000200012		
J	Xu, Y; Bernard, A; Perry, N; Xu, J; Sugimoto, S				Xu, Yang; Bernard, Alain; Perry, Nicolas; Xu, Jing; Sugimoto, Shigeo			Knowledge evaluation in product lifecycle design and support	KNOWLEDGE-BASED SYSTEMS			English	Article						Knowledge management; Knowledge value; Product design; Life cycle management; Evaluation	MANAGEMENT; SYSTEM; RATIONALE; SELECTION	Enterprises are focusing more and more on knowledge issues for global product development. This paper describes knowledge evolution processes in product development activities and proposes a knowledge evaluation method in product lifecycle design. The paper also theoretically analyzes the evaluation model and illustrates how knowledge values can be assessed by case study. The case study shows how knowledge values calculated by the model can provide suggestions about which knowledge to choose and what to do next. The knowledge evaluation model serves as a useful tool for managing knowledge in product lifecycle design and support. (C) 2014 Elsevier B.V. All rights reserved.	[Xu, Yang] Peking Univ, Dept Informat Management, Beijing 100871, Peoples R China; [Bernard, Alain] Ecole Cent Nantes, IRCCyN, F-44321 Nantes, France; [Perry, Nicolas] Arts & Metiers ParisTech, I2M, UMR 5295, F-33400 Talence, France; [Xu, Jing] Yangzhou Univ, Coll Mech Engn, Yangzhou, Peoples R China; [Sugimoto, Shigeo] Univ Tsukuba, Res Ctr Knowledge Commun, Ibaraki 3058550, Japan	Xu, Y (reprint author), Peking Univ, Dept Informat Management, Beijing 100871, Peoples R China.	yang.xu@pku.edu.cn		Nicolas, PERRY/0000-0003-3215-4867	National Social Science Foundation of China [13CTQ022]; National Natural Science Foundation of China [51205344]	This work is partly supported by the National Social Science Foundation of China (No. 13CTQ022) and the National Natural Science Foundation of China (No. 51205344). We would like to appreciate Prof. Robert B. Allen from Research Center for Knowledge Communities (RCKC) of University of Tsukuba, for his helpful suggestions and support.	Akasaka F, 2012, COMPUT IND, V63, P309, DOI 10.1016/j.compind.2012.02.009; Al-Ashaab A, 2012, KNOWL-BASED SYST, V26, P48, DOI 10.1016/j.knosys.2011.06.019; Hung HF, 2008, EXPERT SYST APPL, V35, P338, DOI 10.1016/j.eswa.2007.07.030; Maropoulos PG, 2010, CIRP ANN-MANUF TECHN, V59, P740, DOI 10.1016/j.cirp.2010.05.005; Bracewell R, 2009, COMPUT AIDED DESIGN, V41, P173, DOI 10.1016/j.cad.2008.10.005; Tang A, 2007, J SYST SOFTWARE, V80, P918, DOI 10.1016/j.jss.2006.08.040; Karacapilidis N, 2006, COMPUT IND, V57, P178, DOI 10.1016/j.compind.2005.07.001; Nieto MJ, 2007, TECHNOVATION, V27, P367, DOI 10.1016/j.technovation.2006.10.001; Chen Y, 2012, COMPUT AIDED DESIGN, V44, P146, DOI 10.1016/j.cad.2011.02.016; Chen YJ, 2010, COMPUT IND, V61, P659, DOI 10.1016/j.compind.2010.03.013; Tomiyama T, 2007, CIRP ANN-MANUF TECHN, V56, P185, DOI 10.1016/j.cirp.2007.05.044; Chen CH, 2008, EXPERT SYST APPL, V34, P2555, DOI 10.1016/j.eswa.2007.04.019; Chandrasegaran SK, 2013, COMPUT AIDED DESIGN, V45, P204, DOI 10.1016/j.cad.2012.08.006; Xu Y, 2011, KNOWL-BASED SYST, V24, P166, DOI 10.1016/j.knosys.2010.08.001; Argyris C., 1978, ORG LEARNING THEORY; Bernard A, 2009, CIRP ANN-MANUF TECHN, V58, P119, DOI 10.1016/j.cirp.2009.03.013; Chan JWK, 2008, INT J PROD RES, V46, P2889, DOI 10.1080/00207540601043124; Chang HC, 2011, KNOWL-BASED SYST, V24, P652, DOI 10.1016/j.knosys.2011.02.003; De Vries R.W., 2011, P ENG, V9, P379; Del Prete A, 2010, ADV ENG SOFTW, V41, P427, DOI 10.1016/j.advengsoft.2009.03.007; Gunendran AG, 2010, INT J PROD RES, V48, P5885, DOI 10.1080/00207540903104210; He W, 2006, INT J PROD RES, V44, P1757, DOI 10.1080/00207540500445453; Heliades GP, 2000, KNOWL-BASED SYST, V13, P215, DOI 10.1016/S0950-7051(00)00072-1; Karande P, 2013, MATER DESIGN, V45, P349, DOI 10.1016/j.matdes.2012.08.067; Lee MR, 2012, KNOWL-BASED SYST, V28, P47, DOI 10.1016/j.knosys.2011.11.016; Maddulapalli AK, 2007, EUR J OPER RES, V180, P1245, DOI 10.1016/j.ejor.2006.03.055; Nonaka I., 1995, KNOWLEDGE CREATING C; Perry N., 2011, P 18 CIRP INT C LIF, P681; Tichkiewitch S, 2008, METHODS TOOLS EFFECT; Ueda K, 2005, CIRP ANN-MANUF TECHN, V54, P407, DOI 10.1016/S0007-8506(07)60133-4; Von Krogh G., 2000, ENABLING KNOWLEDGE C; Xu Y, 2010, EXPERT SYST, V27, P374, DOI 10.1111/j.1468-0394.2010.00554.x	32	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0950-7051	1872-7409		KNOWL-BASED SYST	Knowledge-Based Syst.	NOV	2014	70				SI		256	267		10.1016/j.knosys.2014.07.003		12	Computer Science, Artificial Intelligence	Computer Science	AS3XS	WOS:000344209100025		
J	Han, D; Kaito, K; Kobayashi, K				Han, Daeseok; Kaito, Kiyoyuki; Kobayashi, Kiyoshi			Application of Bayesian Estimation Method with Markov Hazard Model to Improve Deterioration Forecasts for Infrastructure Asset Management	KSCE JOURNAL OF CIVIL ENGINEERING			English	Article						asset management; pavement deterioration forecasting; Bayesian estimation method; Markov chain; Monte Carlo simulation; Bayesian Markov hazard model; Korean national highways		The heart of asset management systems for road infrastructure is the deterioration forecasting model. It provides the most fundamental information for better asset management. So far, there are many practices to build a reliable forecasting model using inspection data in conjunction with statistical theories. In many applications, however, an inadequate stock of inspection data or difficulty in applying sophisticated statistical methods have often been serious obstacles. As a solution, this paper suggests applying the Bayesian estimation method with a multi-state exponential hazard Markov chain model for simple and reliable deterioration forecasting for infrastructure. The main contents of this paper are an introduction of the model's framework combining Markov chain, hazard theory, and Bayesian estimation method, and a demonstration of its practical application with an empirical study. The empirical study was conducted with time-series inspection data of pavement from the Korean National Highways. The estimation results from the suggested method would be useful for improving the current pavement maintenance strategy for Korean National Highways. However, the most important message of this paper is that the framework of the Bayesian Markov hazard model could be the best model to use for other civil infrastructure that has gradual changes in condition. The great advantages from the Bayesian estimation method may facilitate development of customized asset management systems.	[Han, Daeseok] Korea Inst Civil & Bldg Technol, Highway Pavement Res Div, Goyang 411712, South Korea; [Kaito, Kiyoyuki] Osaka Univ, Dept Civil Engn, Suita, Osaka 21, Japan; [Kobayashi, Kiyoshi] Kyoto Univ, Dept Urban Management, Kyoto 6158540, Japan	Han, D (reprint author), Korea Inst Civil & Bldg Technol, Highway Pavement Res Div, Goyang 411712, South Korea.	hands@kict.re.kr; kaito@ga.eng.osaka-u.ac.jp; kobayashi.kiyoshi.6n@kyoto-u.ac.jp					HASTINGS WK, 1970, BIOMETRIKA, V57, P97, DOI 10.2307/2334940; NEWEY WK, 1987, ECONOMETRICA, V55, P703, DOI 10.2307/1913610; Chib S, 1995, J AM STAT ASSOC, V90, P1313, DOI 10.2307/2291521; Kobayashi K, 2012, TRANSPORT RES B-METH, V46, P544, DOI 10.1016/j.trb.2011.11.008; Kobayashi K, 2010, KSCE J CIV ENG, V14, P343, DOI 10.1007/s12205-010-0343-x; Gelman A., 1992, COMPUT SCI STAT, V24, P433, DOI 10.1.1.63.7666; Geweke J, 1992, BAYESIAN STATISTICS, V4, P169, DOI DOI 10.1371/J0URNAL.P0NE.0059328; Han D., 2011, THESIS KYOTO U JAPAN; Han D., 2007, J KOREAN SOC CIVIL E, V27, P727; Ibrahim J., 2001, SPRINGER SERIES STAT; Jido M, 2008, J INFRASTRUCT SYST, V14, P150, DOI 10.1061/(ASCE)1076-0342(2008)14:2(150); Kaito K., 2005, JSCE J EARTHQUAKE EN, P83, DOI [10.2208/jscej.2005.801_83, DOI 10.2208/JSCEJ.2005.801_83]; Kaito K., 2007, JSCE J CIVIL ENG, V63, P336, DOI [10.2208/jsceja.63.336, DOI 10.2208/JSCEJA.63.336]; Kobayashi K, 2010, J INFRASTRUCT SYST, V16, P282, DOI 10.1061/(ASCE)IS.1943-555X.0000033; Kobayashi K., 2007, NEW HORIZONS REGIONA; Koop G., 2007, BAYESIAN ECONOMETRIC; Lancaster T., 1990, ECONOMETRIC ANAL TRA; METROPOLIS N, 1953, J CHEM PHYS, V21, P1087, DOI 10.1063/1.1699114; Nam L.T., 2009, THESIS KYOTO U JAPAN; Permanent International Association of Road Congress (PIARC), 2000, HIGHW DEV MAN SER, V1-7; Sugisaki T., 2006, JSCE J STRUCTURAL EN, P781; Train KE, 2009, DISCRETE CHOICE METHODS WITH SIMULATION, 2ND EDITION, P1, DOI 10.1017/CBO9780511805271; Tsuda Y., 2006, JSCE J CONSTRUCTION, V62, P473, DOI [10.2208/jscejf.62.473., DOI 10.2208/JSCEJF.62.473]; Tsuda Y., 2006, J STRUCTURAL ENG EAR, V23, p241s, DOI DOI 10.1007/S12205-010-0343-X; Walubita L. F., 2012, TECHNICAL REPORT; Walubita L. F., 2010, FHWATX10048223 TEX D	26	0	0	KOREAN SOCIETY OF CIVIL ENGINEERS-KSCE	SEOUL	50-7 OGUM-DONG, SONGPA-KU, SEOUL, 138-857, SOUTH KOREA	1226-7988	1976-3808		KSCE J CIV ENG	KSCE J. Civ. Eng.	NOV	2014	18	7					2107	2119		10.1007/s12205-012-0070-6		13	Engineering, Civil	Engineering	AR9TU	WOS:000343921100022		
J	Moriyama, K; Kukita, A; Li, YJ; Uehara, N; Zhang, JQ; Takahashi, I; Kukita, T				Moriyama, Kanako; Kukita, Akiko; Li, Yin-Ji; Uehara, Norihisa; Zhang, Jing-Qi; Takahashi, Ichiro; Kukita, Toshio			Regulation of osteoclastogenesis through Tim-3:possible involvement of the Tim-3/galectin-9 system in the modulation of inflammatory bone destruction	LABORATORY INVESTIGATION			English	Article							RHEUMATOID-ARTHRITIS; TUMOR-IMMUNITY; STROMAL CELLS; TH17 CELLS; T-CELLS; GALECTIN-9; TIM-3; INDUCTION; RANKL; DIFFERENTIATION	Galectins are a unique family of lectins bearing one or two carbohydrate recognition domains (CRDs) that have the ability to bind molecules with beta-galactoside-containing carbohydrates. It has been shown that galectins regulate not only cell growth and differentiation but also immune responses, as well as inflammation. Galectin-9, a tandem repeat type of galectin, was originally identified as a chemotactic factor for eosinophils, and is also involved in the regulatory process of inflammation. Here, we examined the involvement of galectin-9 and its receptor, T-cell innnnunoglobulin- and mucin-domain-containing molecule 3 (Tim-3), in the control of osteoclastogenesis and inflammatory bone destruction. Expression of Tim-3 was detected in osteoclasts and its mononuclear precursors in vivo and in vitro. Galectin-9 markedly inhibited osteoclastogenesis as evaluated in osteoclast precursor cell line RAW-D cells and primary bone marrow cells of mice and rats. The inhibitory effects of galectin-9 on osteoclastogenesis was negated by the addition of beta-lactose, an antagonist for galectin binding, suggesting that the inhibitory effect of galectin-9 was mediated through CRD. When galectin-9 was injected into rats with adjuvant-induced arthritis, marked suppression of bone destruction was observed. Inflammatory bone destruction could be efficiently ameliorated by controlling the Tim-3/galectin-9 system in rheumatoid arthritis.	[Moriyama, Kanako; Li, Yin-Ji; Uehara, Norihisa; Zhang, Jing-Qi; Kukita, Toshio] Kyushu Univ, Grad Sch Dent Sci, Fac Dent Sci, Dept Mol Cell Biol & Oral Anat, Fukuoka 8128582, Japan; [Moriyama, Kanako; Takahashi, Ichiro] Kyushu Univ, Grad Sch Dent Sci, Dept Orthodont, Fukuoka 8128582, Japan; [Kukita, Akiko] Saga Univ, Dept Microbiol, Fac Med, Saga 840, Japan	Kukita, T (reprint author), Kyushu Univ, Grad Sch Dent Sci, Fac Dent Sci, Dept Mol Cell Biol & Oral Anat, 3-1-1 Maidashi, Fukuoka 8128582, Japan.	kukitat@dent.kyushu-u.ac.jp			Japan Society for Promotion of Science (JSPS) [21390492, 21659424, 23659860, 25670780, 26670803]	We thank Dr Yasuyoshi Osaki, Dr Takayoshi Yamaza, Dr Tomoko Kitsuki and Dr Mizuho Kido of Kyushu University, Faculty of Dental Science for helpful suggestions. This work is funded in part by a Grant-in-Aid for Scientific Research (B) and (Challenging Exploratory Research) of Japan Society for Promotion of Science (JSPS) (project nos. 21390492, 21659424, 23659860, 25670780, and 26670803).	Bottini N, 2013, NAT REV RHEUMATOL, V9, P24, DOI 10.1038/nrrheum.2012.190; Seki M, 2008, CLIN IMMUNOL, V127, P78, DOI 10.1016/j.clim.2008.01.006; Tang DL, 2012, NAT IMMUNOL, V13, P808, DOI 10.1038/ni.2396; Nakae S, 2007, J LEUKOCYTE BIOL, V81, P1258, DOI 10.1186/jlb.1006610; Seki M, 2007, ARTHRITIS RHEUM-US, V56, P3968, DOI 10.1002/art.23076; Sakai H, 2002, ANN RHEUM DIS, V61, P103, DOI 10.1136/ard.61.2.103; Wada J, 1997, J BIOL CHEM, V272, P6078; Gaffen SL, 2008, J DENT RES, V87, P817; Lee J, 2011, MOL CELL BIOL, V31, P3963, DOI 10.1128/MCB.05297-11; Chiba S, 2012, NAT IMMUNOL, V13, P832, DOI 10.1038/ni.2376; Rangachari M, 2013, J AUTOIMMUN, V45, P31, DOI 10.1016/j.jaut.2013.06.008; Monney L, 2002, NATURE, V415, P536, DOI 10.1038/415536a; Sakuishi K, 2011, TRENDS IMMUNOL, V32, P345, DOI 10.1016/j.it.2011.05.003; Bettelli E, 2008, NATURE, V453, P1051, DOI 10.1038/nature07036; Hastings WD, 2009, EUR J IMMUNOL, V39, P2492, DOI 10.1002/eji.200939274; Vasta GR, 2009, NAT REV MICROBIOL, V7, P424, DOI 10.1038/nrmicro2146; Kanai Y, 2012, ACTA DERM-VENEREOL, V92, P367, DOI 10.2340/00015555-1285; Ariel A, 2013, J PATHOL, V229, P250, DOI 10.1002/path.4108; Kashio Y, 2003, J IMMUNOL, V170, P3631; Kukita A, 2011, ARTHRITIS RHEUM-US, V63, P2744, DOI 10.1002/art.30455; McMorrow JP, 2011, BIOCHEM SOC T, V39, P688, DOI 10.1042/BST0390688; Kukita T, 2004, J EXP MED, V200, P941, DOI 10.1084/jem.20040518; Jayaraman P, 2010, J EXP MED, V207, P2343, DOI 10.1084/jem.20100687; Watanabe T, 2004, J ENDOCRINOL, V180, P193, DOI 10.1677/joe.0.1800193; Goh FG, 2012, RHEUMATOLOGY, V51, P7, DOI 10.1093/rheumatology/ker257; Arikawa T, 2009, CLIN IMMUNOL, V133, P382, DOI 10.1016/j.clim.2009.09.004; Grigorian A, 2009, IMMUNOL REV, V230, P232, DOI 10.1111/j.1600-065X.2009.00796.x; KUKITA A, 1993, BONE MINER, V23, P113, DOI 10.1016/S0169-6009(08)80048-7; KUKITA A, 1993, BIOCHEM BIOPH RES CO, V196, P1383, DOI 10.1006/bbrc.1993.2406; Li YJ, 2012, LAB INVEST, V92, P1777, DOI 10.1038/labinvest.2012.134; Li YJ, 2009, LAB INVEST, V89, P26, DOI 10.1038/labinvest.2008.111; Matsumoto R, 1998, J BIOL CHEM, V273, P16976, DOI 10.1074/jbc.273.27.16976; Nobumoto A, 2009, CLIN IMMUNOL, V130, P322, DOI 10.1016/j.clim.2008.09.014; Tsuboi Y, 2007, CLIN IMMUNOL, V124, P221, DOI 10.1016/j.clim.2007.04.015	34	1	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0023-6837	1530-0307		LAB INVEST	Lab. Invest.	NOV	2014	94	11					1200	1211		10.1038/labinvest.2014.107		12	Medicine, Research & Experimental; Pathology	Research & Experimental Medicine; Pathology	AS2UJ	WOS:000344134500002		
J	Abe-Suzuki, S; Kurata, M; Abe, S; Onishi, I; Kirimura, S; Nashimoto, M; Murayama, T; Hidaka, M; Kitagawa, M				Abe-Suzuki, Shiho; Kurata, Morito; Abe, Shinya; Onishi, Iichiroh; Kirimura, Susumu; Nashimoto, Manami; Murayama, Toshihiko; Hidaka, Michihiro; Kitagawa, Masanobu			CXCL12(+) stromal cells as bone marrow niche for CD34(+) hematopoietic cells and their association with disease progression in myelodysplastic syndromes	LABORATORY INVESTIGATION			English	Article							ACUTE MYELOID-LEUKEMIA; STEM-CELLS; PROGENITOR CELLS; SDF-1; APOPTOSIS; AML; ANGIOGENESIS; RECRUITMENT; MAINTENANCE; MECHANISMS	The bone marrow microenvironment, known as 'hematopoietic stem cell niche,' is essential for the survival and maintenance of hematopoietic stem cells. Myelodysplastic syndromes (MDS) are a group of clonal hematopoietic stem cell diseases, which eventually result in leukemic transformation (acute myelogenous leukemia with nnyelodysplasia-related changes, AML-MRC). However, the precise components and functions of the MDS niche remain unclear. Recently, CXCL12-abundant reticular cells were shown to act as a hennatopoietic stem cell niche in the murine bone marrow. Using immunohistochemistry, we show here that CXCL12(+) cells were located in the cellular marrow or perivascular area, and were in contact with CD34(+) hematopoietic cells in control and MDS/AML-MRC bone marrow. MDS bone marrow exhibited higher CXCL12(+) cell density than control or AML, not otherwise specified (AML-NOS) bone marrow. Moreover, AML-MRC bone marrow also exhibited higher CXCL12(+) cell density than control bone marrow. CXCL12(+) cell density correlated positively with bone marrow blast ratio in MDS cases. CXCL12 mRNA level was also higher in MDS bone marrow than in control or AML-NOS bone marrow. In vitro coculture analysis revealed that overexpression of CXCL12 in stromal cells upregulated BCL-2 expression of leukemia cell lines. Triple immunostaining revealed that the CD34(+) hematopoietic cells of MDS bone marrow in contact with CXCL12(+) cells were BCL-2-positive and TUNEL-negative. In the bone marrow of MDS cases, CXCL12-high group showed significantly higher Bc1-2(+)/CD34 cell ratio and lower apoptotic cell ratio than CXCL12-low group. Moreover, CXCL12-high refractory cytopenia with multilineage dysplasia (RCMD) cases had a greater tendency to progress to refractory anemia with excess blasts (RAEBs) or AML-MRC than CXCL12-low RCMD cases. These results suggest that CXCL12 cells constitute the niche for CD34(+) hematopoietic cells, and may be associated with the survival/antiapoptosis of CD34(+) hennatopoietic cells and disease progression in MDS. Thus, CXCL12(+) cells may represent a novel MDS therapeutic target.	[Abe-Suzuki, Shiho; Kurata, Morito; Abe, Shinya; Onishi, Iichiroh; Kirimura, Susumu; Nashimoto, Manami; Kitagawa, Masanobu] Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Dept Comprehens Pathol, Tokyo 1138519, Japan; [Murayama, Toshihiko] Natl Hosp Org, Kumamoto Med Ctr, Dept Pathol, Kumamoto, Japan; [Hidaka, Michihiro] Natl Hosp Org, Kumamoto Med Ctr, Dept Internal Med, Kumamoto, Japan	Abe-Suzuki, S (reprint author), Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Dept Comprehens Pathol, Bunkyo Ku, 1-5-45 Yushima, Tokyo 1138519, Japan.	ssuzpth2@tmd.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology of Japan [21590432]	We thank Ms Miori Inoue and Ms Sachiko Ishibashi for their technical assistance. This work was supported in part by a grant-in-aid (No. 21590432) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan.	Abe S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040129; Suzuki S, 2012, EXP MOL PATHOL, V92, P160, DOI 10.1016/j.yexmp.2011.11.003; Jin DK, 2006, NAT MED, V12, P557, DOI 10.1038/nm1400; Omatsu Y, 2010, IMMUNITY, V33, P387, DOI 10.1016/j.immuni.2010.08.017; Mendez-Ferrer S, 2010, NATURE, V466, P829, DOI 10.1038/nature09262; Parker JE, 2000, BLOOD, V96, P3932; De Falco E, 2004, BLOOD, V104, P3472, DOI 10.1182/blood-2003-12-4423; Zhang YZ, 2012, LEUKEMIA RES, V36, P281, DOI 10.1016/j.leukres.2011.06.017; Zhou B, 2012, BRIT J HAEMATOL, V157, P299, DOI 10.1111/j.1365-2141.2012.09050.x; Yamazaki S, 2011, CELL, V147, P1146, DOI 10.1016/j.cell.2011.09.053; Colmone A, 2008, SCIENCE, V322, P1861, DOI 10.1126/science.1164390; Flores-Figueroa E, 2012, LAB INVEST, V92, P1330, DOI 10.1038/labinvest.2012.93; Bonnet D, 1997, NAT MED, V3, P730, DOI 10.1038/nm0797-730; Zhang B, 2012, CANCER CELL, V21, P577, DOI 10.1016/j.ccr.2012.02.018; Wilson A, 2006, NAT REV IMMUNOL, V6, P93, DOI 10.1038/nri1779; Lataillade JJ, 2002, BLOOD, V99, P1117, DOI 10.1182/blood.V99.4.1117; LAPIDOT T, 1994, NATURE, V367, P645, DOI 10.1038/367645a0; Sugiyama T, 2006, IMMUNITY, V25, P977, DOI 10.1016/j.immuni.2006.10.016; Zeng ZH, 2009, BLOOD, V113, P6215, DOI 10.1182/blood-2008-05-158311; Konopleva M, 2002, LEUKEMIA, V16, P1713, DOI 10.1038/sj.leu.2402608; Walter DH, 2005, CIRC RES, V97, P1142, DOI 10.1161/01.RES.0000193596.94936.2c; Aiuti A, 1997, J EXP MED, V185, P111, DOI 10.1084/jem.185.1.111; Saito Y, 2010, NAT BIOTECHNOL, V28, P275, DOI 10.1038/nbt.1607; Morrison SJ, 2008, CELL, V132, P598, DOI 10.1016/j.cell.2008.01.038; Broxmeyer HE, 2003, J IMMUNOL, V170, P421; Dick JE, 2005, INT J HEMATOL, V82, P389, DOI 10.1532/IJH97.05144; Jordan CT, 2006, NEW ENGL J MED, V355, P1253, DOI 10.1056/NEJMra061808; Keith T, 2007, BRIT J HAEMATOL, V137, P206, DOI 10.1111/j.1365-2141.2007.06539.x; Matsuda M, 2004, LEUKEMIA, V18, P1038, DOI 10.1038/sj.leu.2403301; Nagasawa T, 2011, TRENDS IMMUNOL, V32, P315, DOI 10.1016/j.it.2011.03.009; Sawada K, 1999, LEUKEMIA RES, V23, P1, DOI 10.1016/S0145-2126(98)00128-3; Szotkowski T, 2010, NEOPLASMA, V57, P170, DOI 10.4149/neo_2010_02_170	32	1	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0023-6837	1530-0307		LAB INVEST	Lab. Invest.	NOV	2014	94	11					1212	1223		10.1038/labinvest.2014.110		12	Medicine, Research & Experimental; Pathology	Research & Experimental Medicine; Pathology	AS2UJ	WOS:000344134500003		
J	Tanaka, K; Fujita, T; Umezawa, H; Namiki, K; Yoshioka, K; Hagihara, M; Sudo, T; Kimura, S; Tatsumi, K; Kasuya, Y				Tanaka, Kensuke; Fujita, Tetsuo; Umezawa, Hiroki; Namiki, Kana; Yoshioka, Kento; Hagihara, Masahiko; Sudo, Tatsuhiko; Kimura, Sadao; Tatsumi, Koichiro; Kasuya, Yoshitoshi			Therapeutic effect of lung mixed culture-derived epithelial cells on lung fibrosis	LABORATORY INVESTIGATION			English	Article							MESENCHYMAL STEM-CELLS; PULMONARY-FIBROSIS; IN-VITRO; ALVEOLAR; INJURY; DIFFERENTIATION; MIGRATION; TRANSPLANTATION; INFLAMMATION; MAINTENANCE	Cell-based therapy is recognized as one of potential therapeutic options for lung fibrosis. However, preparing stem/progenitor cells is complicated and not always efficient. Here, we show easily prepared cell populations having therapeutic capacity for lung inflammatory disease that are named as 'lung mixed culture-derived epithelial cells' (LMDECs). LMDECs expressed surfactant protein (SP)-C and gave rise to type I alveolar epithelial cells (AECs) in vitro and in vivo that partly satisfied type II AEC-like characteristics. An intratracheal delivery of not HEK 293 cells but LMDECs to the lung ameliorated bleomycin (BLM)-induced lung injury. A comprehensive analysis of bronchoalveolar fluid by western blot array revealed that LMDEC engraftment could improve the microenvironment in the BLM-instilled lung in association with stromal cell-derived factor-1 (SDF-1)/CXC chemokine receptor 4 signaling axis. SDF-1 enhanced both migration activity and differentiating efficiency of LMDECs. Further classification of LMDECs by flow cytometric study showed that a major population of LMDECs (LMDECMaj, 84% of total LMDECs) was simultaneously SP-C+, CD44(+), CD45(+), and hematopoietic cell lineage(+) and that LMDECs included bronchioalveolar stem cells (BASCs) showing SP-C+ Clara cell secretory protein(+) stem cell antigen (Sca)1(+) as a small population (1.8% of total LMDECs). CD44(+)-sorted LMDECMaj and Sca1(+)-sorted LMDECs equally ameliorated fibrosis induced by BLM like LMDECs did. However, infiltrated neutrophils were observed in Sca1(+)-sorted LMDEC-treated alveoli that was not typical in LMDECMaj- or LMDEC-treated alveoli. These findings suggest that the protective effect of LMDECs against BLM-induced lung injury depends greatly on that of LMDECMaj. Furthermore, the cells expressing both alveolar epithelial and hematopoietic cell lineage markers (SP-C+ CD45(+)) that have characteristics corresponding to LMDECMaj were observed in the alveoli of lung and increased approximately threefold in response to BLM instillation. Taken together, LMDECs newly classified in the present study are easily culture expanded and have a potential role in future regenerative cell therapy for pulmonary fibrosis.	[Tanaka, Kensuke; Fujita, Tetsuo; Umezawa, Hiroki; Namiki, Kana; Yoshioka, Kento; Kimura, Sadao; Kasuya, Yoshitoshi] Chiba Univ, Grad Sch Med, Dept Biochem & Mol Pharmacol, Chiba 2608670, Japan; [Tanaka, Kensuke; Fujita, Tetsuo; Umezawa, Hiroki; Tatsumi, Koichiro] Chiba Univ, Grad Sch Med, Dept Respirol, Chiba 2608670, Japan; [Hagihara, Masahiko] Ube Ind, Corp Res & Dev, Ube, Yamaguchi, Japan; [Sudo, Tatsuhiko] RIKEN, Adv Sci Inst, Chem Biol Core Facil, Wako, Saitama, Japan; [Sudo, Tatsuhiko] RIKEN, Adv Sci Inst, Antibiot Lab, Wako, Saitama, Japan	Kasuya, Y (reprint author), Chiba Univ, Grad Sch Med, Dept Biochem & Mol Pharmacol, Chuo Ku, 1-8-1 Inohana, Chiba 2608670, Japan.	kasuya@faculty.chiba-u.jp			Japan Society for the Promotion of Science [24390137, 25670256]; Takeda Science Foundation for Visionary Research	The human SPC/SV40 vector was kindly provided by Dr Jeffrey A Whitsett (Children's Hospital Medical Center, Division of Pulmonary Biology, Cincinnati, OH, USA). This work was supported in part by Grants-in-Aid for Scientific Research ((B), 24390137 to YK) and for Challenging Exploratory Research (25670256 to YK) from the Japan Society for the Promotion of Science, and by the Takeda Science Foundation for Visionary Research (to YK). We thank Dr Wendy Gray for editing our manuscript.	Rock JR, 2011, P NATL ACAD SCI USA, V108, pE1475, DOI 10.1073/pnas.1117988108; Serrano-Mollar A, 2007, AM J RESP CRIT CARE, V176, P1261, DOI 10.1164/rccm.200610-1491OC; Marsh LM, 2009, AM J PHYSIOL-LUNG C, V296, pL442, DOI 10.1152/ajplung.00525.2007; Kim CFB, 2005, CELL, V121, P823, DOI 10.1016/j.cell.2005.03.032; Fehrenbach H, 1999, EUR RESPIR J, V14, P534, DOI 10.1034/j.1399-3003.1999.14c10.x; Busillo JM, 2010, J BIOL CHEM, V285, P7805, DOI 10.1074/jbc.M109.091173; Mei SHJ, 2010, AM J RESP CRIT CARE, V182, P1047, DOI 10.1164/rccm.201001-0010OC; Kim YC, 2009, P NATL ACAD SCI USA, V106, P8278, DOI 10.1073/pnas.0903390106; McQualter JL, 2010, P NATL ACAD SCI USA, V107, P1414, DOI 10.1073/pnas.0909207107; Verma S, 2007, NEW ENGL J MED, V356, P1370, DOI 10.1056/NEJMcibr070490; Liu AR, 2013, J CELL PHYSIOL, V228, P1270, DOI 10.1002/jcp.24282; Wang DC, 2010, MOL THER, V18, P625, DOI 10.1038/mt.2009.317; Miura M, 2006, STEM CELLS, V24, P1095, DOI 10.1634/stemcells.2005-0403; Barkauskas CE, 2013, J CLIN INVEST, V123, P3025, DOI 10.1172/JCI68782; Epperly MW, 2003, AM J RESP CELL MOL, V29, P213, DOI 10.1165/rcmb.2002-0069OC; Ortiz LA, 2003, P NATL ACAD SCI USA, V100, P8407, DOI 10.1073/pnas.1432929100; Ventura JJ, 2007, NAT GENET, V39, P750, DOI 10.1038/ng2037; Rawlins EL, 2009, CELL STEM CELL, V4, P525, DOI 10.1016/j.stem.2009.04.002; Xu JG, 2007, AM J RESP CELL MOL, V37, P291, DOI 10.1165/rcmb.2006-01870C; Reddy R, 2004, AM J PHYSIOL-LUNG C, V286, pL658, DOI 10.1152/ajplung.00159.2003; Gomperts BN, 2006, J IMMUNOL, V176, P1916; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1172482; Ortiz LA, 2007, P NATL ACAD SCI USA, V104, P11002, DOI 10.1073/pnas.0704421104; Ghosh MC, 2012, AM J PHYSIOL-LUNG C, V302, pL846, DOI [10.​1152/​ajplung.​00321.​2011, 10.1152/ajplung.00321.2011]; Zacharek SJ, 2011, CELL STEM CELL, V9, P272, DOI 10.1016/j.stem.2011.07.007; Aguilar S, 2007, STEM CELLS, V25, P1586, DOI 10.1634/stemcells.2006.0762; Kajstura J, 2011, NEW ENGL J MED, V364, P1795, DOI 10.1056/NEJMoa1101324; Curley GF, 2012, THORAX, V67, P496, DOI 10.1136/thoraxjnl-2011-201059; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Fujino N, 2011, LAB INVEST, V91, P363, DOI 10.1038/labinvest.2010.187; Kim SY, 2012, AM J PHYSIOL-LUNG C, V302, pL891, DOI 10.1152/ajplung.00288.2011; Rice WR, 2002, AM J PHYSIOL-LUNG C, V283, pL256, DOI 10.1152/ajplung.00302.2001; Teder P, 2002, SCIENCE, V296, P155, DOI 10.1126/science.1069659; ASHCROFT T, 1988, J CLIN PATHOL, V41, P467, DOI 10.1136/jcp.41.4.467; Banerjee ER, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033165; DeMaio L, 2009, AM J PHYSIOL-LUNG C, V296, pL1051, DOI 10.1152/ajplung.00021.2009; Germano D, 2009, AM J RESP CRIT CARE, V179, P939, DOI 10.1164/rccm.200809-1390OC; Makino Hideki, 2013, J Med Invest, V60, P127; McNulty Katrina, 2012, Proc Am Thorac Soc, V9, P164, DOI 10.1513/pats.201201-010AW; Oeztuerk-Winder F, 2012, EMBO J, V31, P3431, DOI 10.1038/emboj.2012.192	40	2	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0023-6837	1530-0307		LAB INVEST	Lab. Invest.	NOV	2014	94	11					1247	1259		10.1038/labinvest.2014.109		13	Medicine, Research & Experimental; Pathology	Research & Experimental Medicine; Pathology	AS2UJ	WOS:000344134500006		
J	Yamazaki, M; Maruyama, S; Abe, T; Essa, A; Babkair, H; Cheng, J; Saku, T				Yamazaki, Manabu; Maruyama, Satoshi; Abe, Tatsuya; Essa, Ahmed; Babkair, Hamzah; Cheng, Jun; Saku, Takashi			MFG-E8 expression for progression of oral squamous cell carcinoma and for self-clearance of apoptotic cells	LABORATORY INVESTIGATION			English	Article							FACTOR-VIII; GLOBULE; CANNIBALISM; MELANOMA; PROTEIN; PHAGOCYTOSIS; CLONING; EPITHELIUM; FACTOR-8; REVEALS	Milk fat globule-epidermal growth factor (EGF)-factor VIII (MFG-E8) is a secreted glycoprotein that promotes clearance of apoptotic cells by bridging phosphatidylserine on apoptotic cells and integrin alpha beta 3/5 on phagocytes. High expression of MFG-E8 has been reported in various types of cancer in humans. Apoptotic figures are frequently found in the surgical samples of oral squamous cell carcinoma (SCC) and carcinoma in situ, and we have often observed apoptotic carcinoma cells engulfed by macrophages or even by neighboring carcinoma cells. Thus we hypothesized that MFG-E8 might promote engulfment of apoptotic carcinoma cells by living carcinoma cells and that MFG-E8 expressed by carcinoma cells could contribute to tumor progression. The aim of this study was to elucidate the biological role of MFG-E8 in oral SCC. Fifty-three surgical specimens of oral SCC were used for immunohistochemistry for MFG-E8, and the expression profiles were correlated with clinicopathological properties. Also, we examined the MFG-E8 expression patterns and functions using three human oral SCC cell lines. Most of the cases had MFG-E8-positive SCC cells, and the expression of MFG-E8 was correlated with such clinicopathological features as tumor size, pathological stage, locoregional recurrence, scattering invasion pattern, and SCC cell figures engulfing apoptotic SCC cells. The MFG-E8 staining was enhanced in apoptotic SCC cells, some of which were apparently engulfed by the neighboring SCC cells. ZK-1 cells showed high MFG-E8 expression, and its localization was found in the cytoplasm and the cell surface. Transient MFG-E8 knockdown by siRNA in ZK-1 decreased cell proliferation and invasiveness and increased cell death. Thus we have demonstrated that MFG-E8 promotes tumor progression in oral SCC and that it might be involved in the clearance of apoptotic SCC cells by living SCC cells.	[Yamazaki, Manabu; Abe, Tatsuya; Essa, Ahmed; Babkair, Hamzah; Cheng, Jun; Saku, Takashi] Niigata Univ, Grad Sch Med & Dent Sci, Dept Tissue Regenerat & Reconstruct, Div Oral Pathol, Niigata, Japan; [Maruyama, Satoshi; Abe, Tatsuya; Saku, Takashi] Niigata Univ Hosp, Oral Pathol Sect, Dept Surg Pathol, Niigata, Japan	Saku, T (reprint author), Niigata Univ, Grad Sch Med & Dent Sci, Dept Tissue Regenerat & Reconstruct, Div Oral Pathol, Niigata, Japan.	tsaku@dent.niigata-u.ac.jp			Japan Society for Promotion of Science (JSPS)	This study was supported by Grants-in-Aid for Scientific Research from the Japan Society for Promotion of Science (JSPS) (to MY, SM, TA, JC, and TS).	Al-Eryani K, 2013, J CELL PHYSIOL, V228, P1977, DOI 10.1002/jcp.24364; Kojima SI, 1998, ACTA CYTOL, V42, P1365; Roukos V, 2007, J BIOL CHEM, V282, P9346, DOI 10.1074/jbc.M611643200; Yang CW, 2011, CANCER RES, V71, P937, DOI 10.1158/0008-5472.CAN-10-1471; Lugini L, 2006, CANCER RES, V66, P3629, DOI 10.1158/0008-5472.CAN-05-3204; McGarry TJ, 1998, CELL, V93, P1043, DOI 10.1016/S0092-8674(00)81209-X; Jinushi M, 2009, J EXP MED, V206, P1317, DOI 10.1084/jem.20082614; Lugini L, 2003, LAB INVEST, V83, P1555, DOI 10.1097/01.LAB.0000098425.03006.42; STUBBS JD, 1990, P NATL ACAD SCI USA, V87, P8417, DOI 10.1073/pnas.87.21.8417; Carrascosa C, 2012, ONCOGENE, V31, P1521, DOI 10.1038/onc.2011.356; Hanayama R, 2002, NATURE, V417, P182, DOI 10.1038/417182a; Miyasaka K, 2004, EUR J IMMUNOL, V34, P1414, DOI 10.1002/eji.2004249301; Fais S, 2007, CANCER LETT, V258, P155, DOI 10.1016/j.canlet.2007.09.014; Couto JR, 1996, DNA CELL BIOL, V15, P281, DOI 10.1089/dna.1996.15.281; Silvestre JS, 2005, NAT MED, V11, P499, DOI 10.1038/nm1233; Raymond AS, 2009, J CELL SCI, V122, P849, DOI 10.1242/jcs.041731; Hanayama R, 2004, SCIENCE, V304, P1147, DOI 10.1126/science.1094359; Bu HF, 2007, J CLIN INVEST, V117, P3673, DOI 10.1172/JCI31841; Caruso RA, 2002, ULTRASTRUCT PATHOL, V26, P315, DOI 10.1080/01913120290104593; Jinushi M, 2007, J CLIN INVEST, V117, P1902, DOI 10.1172/JCI30966; CERIANI RL, 1982, P NATL ACAD SCI-BIOL, V79, P5420, DOI 10.1073/pnas.79.17.5420; D'mello V, 2009, J BIOL CHEM, V284, P17030, DOI 10.1074/jbc.M109.010066; Ensslin M, 1998, BIOL REPROD, V58, P1057, DOI 10.1095/biolreprod58.4.1057; Ensslin MA, 2007, P NATL ACAD SCI USA, V104, P2715, DOI 10.1073/pnas.0610296104; Ensslin Michael A, 2007, Soc Reprod Fertil Suppl, V63, P367; Fens MHAM, 2008, BLOOD, V111, P4542, DOI 10.1182/blood-2007-06-094763; Hanayama R, 2005, P NATL ACAD SCI USA, V102, P16886, DOI 10.1073/pnas.0508599102; Jinushi M, 2008, CANCER RES, V68, P8889, DOI 10.1158/0008-5472.CAN-08-2147; LAROCCA D, 1991, CANCER RES, V51, P4994; Monteacudo C, 1997, HISTOPATHOLOGY, V31, P367, DOI 10.1046/j.1365-2559.1997.2670867.x; Oba J, 2011, BRIT J DERMATOL, V165, P506, DOI 10.1111/j.1365-2133.2011.10409.x; OSAMURA RY, 1980, AM J PATHOL, V99, P105; Simamura E, 2001, TISSUE CELL, V33, P161; Sugano G, 2011, ONCOGENE, V30, P642, DOI 10.1038/onc.2010.446; Tibaldi L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072708; Wang M, 2012, AGING CELL, V11, P500; Watanabe T, 2005, CELL TISSUE RES, V321, P185, DOI 10.1007/s00441-005-1148-y	37	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0023-6837	1530-0307		LAB INVEST	Lab. Invest.	NOV	2014	94	11					1260	1272		10.1038/labinvest.2014.108		13	Medicine, Research & Experimental; Pathology	Research & Experimental Medicine; Pathology	AS2UJ	WOS:000344134500007		
J	Murono, S; Tsuji, A; Endo, K; Kondo, S; Wakisaka, N; Yoshizaki, T				Murono, Shigeyuki; Tsuji, Akira; Endo, Kazuhira; Kondo, Satoru; Wakisaka, Naohiro; Yoshizaki, Tomokazu			Evaluation of Modified Killian's Method: A Technique to Expose the Hypopharyngeal Space	LARYNGOSCOPE			English	Article						hypopharyngeal space; flexible laryngeal endoscopy; Valsalva maneuver; head torsion; Killian position	SQUAMOUS-CELL CARCINOMA; TRUMPET MANEUVER; LARYNX; RESECTION; CANCER; HEAD	Objectives/HypothesisThe objective of this study was to evaluate the Modified Killian's method, a recently proposed endoscopic technique to observe a wider area of the hypopharngeal space than is possible with the conventional method. Study DesignProspective case series. MethodsFifty-seven patients underwent transnasal flexible endoscopy in a sequence of eight different procedures with or without head torsion, the Valsalva maneuver, and a position similar to bowing named the modified Killian position. The visibility of subsites of the hypopharynx and esophageal inlet was evaluated based on a 5-point scale. ResultsThe Modified Killian's method, a combination of all three procedures of head torsion, the Valsalva maneuver, and the modified Killian position, demonstrated a highly significant score for hypopharyngeal visibility. Previous treatment with radiotherapy or chemoradiotherapy did not significantly affect the visibility of the hypopharynx. ConclusionThe newly proposed Modified Killian's method provides an effective view of the entire circumference of the hypopharyngeal space even in patients receiving radiotherapy. This useful procedure can be performed easily and should be a part of flexible laryngoscopy for outpatients. Level of Evidence4. Laryngoscope, 124:2526-2530, 2014	[Murono, Shigeyuki; Tsuji, Akira; Endo, Kazuhira; Kondo, Satoru; Wakisaka, Naohiro; Yoshizaki, Tomokazu] Kanazawa Univ, Dept Otolaryngol Head & Neck Surg, Kanazawa, Ishikawa 9208640, Japan	Murono, S (reprint author), Kanazawa Univ, Dept Otolaryngol Head & Neck Surg, 13-1 Takarama Chi, Kanazawa, Ishikawa 9208640, Japan.	murono@med.kanazawa-u.ac.jp					Hanaoka N, 2013, HEAD NECK-J SCI SPEC, V35, P1248, DOI 10.1002/hed.23106; Watanabe A, 2008, OTOLARYNG HEAD NECK, V138, P446, DOI 10.1016/j.otohns.2007.12.034; Colquhoun-Flannery W, 2000, J LARYNGOL OTOL, V114, P283; Freeman SRM, 2007, CLIN OTOLARYNGOL, V32, P488; HILLEL AD, 1989, HEAD NECK-J SCI SPEC, V11, P231, DOI 10.1002/hed.2880110307; Joo YH, 2012, ORAL ONCOL, V48, P168, DOI 10.1016/j.oraloncology.2011.08.018; Muto M, 2004, CANCER, V101, P1375, DOI 10.1002/cncr.20482; Ni XG, 2013, J LARYNGOL OTOL, V127, P882, DOI 10.1017/S0022215113001709; Okami K, 2013, HEAD NECK-J SCI SPEC, V35, P1162, DOI 10.1002/hed.23094; PURSER S, 1995, HEAD NECK-J SCI SPEC, V17, P389, DOI 10.1002/hed.2880170505; Sakai A, 2010, LARYNGOSCOPE, V120, P1779, DOI 10.1002/lary.21030; Sakai A, 2014, AURIS NASUS LARYNX, V41, P207, DOI 10.1016/j.anl.2013.10.012; Seiffert A, 1925, HDB HALS NASEN OHREN, V1, P762; SPRAGGS PDR, 1995, J LARYNGOL OTOL, V109, P863; Tsunoda A, 2007, J LARYNGOL OTOL, V121, P489, DOI 10.1017/S0022215106005251; Williams RS, 2004, CLIN OTOLARYNGOL, V29, P175, DOI 10.1111/j.0307-7772.2004.00784.x	16	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0023-852X	1531-4995		LARYNGOSCOPE	Laryngoscope	NOV	2014	124	11					2526	2530		10.1002/lary.24760		5	Medicine, Research & Experimental; Otorhinolaryngology	Research & Experimental Medicine; Otorhinolaryngology	AS6OH	WOS:000344382100025		
J	Sato, K; Kurita, T; Chitose, S; Umeno, H; Nakashima, T				Sato, Kiminori; Kurita, Takashi; Chitose, Shun-ichi; Umeno, Hirohito; Nakashima, Tadashi			Cytoskeleton of Newborn Vocal Fold Stellate Cells	LARYNGOSCOPE			English	Article						Vocal fold stellate cell; cytoskeleton; macula flava; human newborn vocal fold	MACULA FLAVA; FUNCTIONAL HISTOLOGY; SYSTEM; MUCOSA	Objectives/HypothesisVocal fold stellate cells (VFSCs) in the human maculae flavae located at both ends of the vocal fold mucosa are inferred to be involved in the metabolism of extracellular matrices of the vocal fold mucosa. Tension caused by phonation (vocal fold vibration) likely regulates the behavior of the VFSCs in the human maculae flava. Tensile and compressive strains have direct effects on cell morphology and structure, including changes in cytoskeletal structure and organization. Cytoskeletons play a role as mechanoreceptors for the cells. The microstructure of the intermediate filaments and the expression of their characteristic proteins were investigated regarding the human newborn VFSCs. Study DesignHistopathologic analysis of the human newborn vocal fold. MethodsThree newborn vocal fold mucosae were investigated by immunohistochemistry and electron microscopy. ResultsThe intermediate filaments in the cytoplasm of the newborn VFSCs were few in number. However, their characteristic proteins (vimentin, desmin, GFAP [Glial fibrillary acidic protein], cytokeratin) had already expressed. ConclusionThe function and fate of VFSCs are regulated by various microenvironmental factors. Not only chemical factors but also mechanical factors could also modulate VFSC behaviors. The cytoskeletal structure of the newborn VFSCs is under development. And the newborn VFSCs have not acquired mechanical regulation. Level of EvidenceN/A. Laryngoscope, 124:2551-2554, 2014	[Sato, Kiminori; Kurita, Takashi; Chitose, Shun-ichi; Umeno, Hirohito; Nakashima, Tadashi] Kurume Univ, Sch Med, Dept Otolaryngol Head & Neck Surg, Kurume, Fukuoka 8300011, Japan	Sato, K (reprint author), Kurume Univ, Sch Med, Dept Otolaryngol Head & Neck Surg, 67 Asahi Machi, Kurume, Fukuoka 8300011, Japan.	kimisato@oct-net.ne.jp			Japanese Ministry of Education, Culture, Sports, Science and Technology [24592612]	This investigation was supported by a Grant-in-Aid for Scientific Research (No. 24592612) from the Japanese Ministry of Education, Culture, Sports, Science and Technology.	Zhao LN, 2007, J MOL HISTOL, V38, P53, DOI 10.1007/s10735-007-9078-5; Becker W, 2006, WORLD CELL, P446; Hirano M., 1983, VOCAL FOLD PHYSL CON, P22; Hirano M, 1975, OTOLOGIA FUKUOKA  S1, V21, P239; Hirano MS, 1993, HISTOLOGICAL COLOR A; Kurpinski K, 2010, CELLULAR MECHANOTRAN, P403; Mofrad M, 2010, DIVERSE PERSPECTIVES; Sato K, 2003, ACTA OTO-LARYNGOL, V123, P106, DOI 10.1080/0036554021000028077; Sato K, 2008, ACTA OTO-LARYNGOL, V128, P694, DOI 10.1080/00016480701675643; Sato K, 2001, ANN OTO RHINOL LARYN, V110, P319; Sato K, 2012, ANN OTO RHINOL LARYN, V121, P51; Sato K, 2010, FOLIA PHONIATR LOGO, V62, P178, DOI 10.1159/000314261; Sato K, 2012, J VOICE, V26, P37, DOI 10.1016/j.jvoice.2010.10.006; Sato K, 2004, ANN OTO RHINOL LARYN, V113, P108; SATO K, 1995, ANN OTO RHINOL LARYN, V104, P556; Sato K, 2001, ANN OTO RHINOL LARYN, V110, P417; Sato K, 2010, FOLIA PHONIATR LOGO, V62, P263, DOI 10.1159/000316962; Sato K, 2005, ANN OTO RHINOL LARYN, V114, P517; Sato K, 2012, ANN OTO RHINOL LARYN, V121, P798; Sato K, 2009, ANN OTO RHINOL LARYN, V118, P773; Titze IR, 2004, J ACOUST SOC AM, V115, P2264, DOI 10.1121/1.698832	21	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0023-852X	1531-4995		LARYNGOSCOPE	Laryngoscope	NOV	2014	124	11					2551	2554		10.1002/lary.24776		4	Medicine, Research & Experimental; Otorhinolaryngology	Research & Experimental Medicine; Otorhinolaryngology	AS6OH	WOS:000344382100029		
J	Yamauchi, D; Yamazaki, M; Ohta, J; Kadowaki, S; Nomura, K; Hidaka, H; Oshima, T; Kawase, T; Katori, Y				Yamauchi, Daisuke; Yamazaki, Muneharu; Ohta, Jun; Kadowaki, Seiichi; Nomura, Kazuhiro; Hidaka, Hiroshi; Oshima, Takeshi; Kawase, Tetsuaki; Katori, Yukio			Closure Technique for Labyrinthine Fistula by "Underwater" Endoscopic Ear Surgery	LARYNGOSCOPE			English	Article						Labyrinthine fistula; cholesteatoma; endoscopic ear surgery; underwater	CHOLESTEATOMA; MANAGEMENT		[Yamauchi, Daisuke; Nomura, Kazuhiro; Hidaka, Hiroshi; Oshima, Takeshi; Kawase, Tetsuaki; Katori, Yukio] Tohoku Univ, Grad Sch Med, Dept Otolaryngol Head & Neck Surg, Sendai, Miyagi 9808575, Japan; [Yamazaki, Muneharu; Ohta, Jun; Kadowaki, Seiichi] Osaki Citizen Hosp, Dept Otolaryngol, Osaki, Miyagi, Japan	Yamauchi, D (reprint author), Tohoku Univ, Grad Sch Med, Dept Otolaryngol Head & Neck Surg, Aoba Ku, 1-1 Seiryo Machi, Sendai, Miyagi 9808575, Japan.	dyama@orl.med.tohoku.ac.jp					Binmoeller KF, 2012, GASTROINTEST ENDOSC, V75, P1086, DOI 10.1016/j.gie.2011.12.022; Copeland BJ, 2003, AM J OTOLARYNG, V24, P51, DOI 10.1053/ajot.2003.10; BERGSTROM R, 1986, Arthroscopy, V2, P41, DOI 10.1016/S0749-8063(86)80009-3; Hiraumi H, 2013, EUR ARCH OTO-RHINO-L, V270, P477, DOI 10.1007/s00405-012-2004-9; Hosoi H, 1998, J LARYNGOL OTOL, V112, P31; Ikeda R, 2011, OTOLARYNG HEAD NECK, V145, P801, DOI 10.1177/0194599811409516; Ikeda R, 2011, ACTA OTO-LARYNGOL, V131, P572, DOI 10.3109/00016489.2010.539262; Ikeda R, 2012, ANN OTO RHINOL LARYN, V121, P162; Kakehata S, 2014, OTOL NEUROTOL, V35, P101, DOI 10.1097/MAO.0b013e3182a446bc; Larcher Piero, 2005, Arch Ital Urol Androl, V77, P141; RITTER FN, 1970, LARYNGOSCOPE, V80, P1025, DOI 10.1288/00005537-197007000-00001; SANNA M, 1988, AM J OTOL, V9, P470	12	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0023-852X	1531-4995		LARYNGOSCOPE	Laryngoscope	NOV	2014	124	11					2616	2618		10.1002/lary.24785		3	Medicine, Research & Experimental; Otorhinolaryngology	Research & Experimental Medicine; Otorhinolaryngology	AS6OH	WOS:000344382100042		
J	Imaizumi, M; Thibeault, SL; Leydon, C				Imaizumi, Mitsuyoshi; Thibeault, Susan L.; Leydon, Ciara			Classification for Animal Vocal Fold Surgery: Resection Margins Impact Histological Outcomes of Vocal Fold Injury	LARYNGOSCOPE			English	Article						Surgical classification; vocal fold injury; wound healing; animal model	EUROPEAN-LARYNGOLOGICAL-SOCIETY; HEPATOCYTE GROWTH-FACTOR; EXTRACELLULAR-MATRIX; GENE-EXPRESSION; SCAR FORMATION; RABBIT MODEL; CANINE MODEL; RAT; PROPOSAL; COMMITTEE	Objectives/HypothesisExtent of vocal fold injury impacts the nature and timing of wound healing and voice outcomes. However, depth and extent of the lesion created to study wound healing in animal models vary across studies, likely contributing to different outcomes. Our goal was to create a surgery classification system to enable comparison of postoperative outcomes across animal vocal fold wound-healing studies. Study DesignProspective, controlled animal study. MethodsRats underwent one of three types of unilateral vocal fold surgeries classified by depth and length of resection. The surgeries were: for subepithelial injury, resection of epithelium and superficial layer of the lamina propria at the midmembranous portion of the vocal fold; for transmucosal injury, resection of epithelium and lamina propria; and for transmuscular injury, resection of epithelium, lamina propria, and superficial portion of the vocalis muscle. Wound healing was evaluated histologically at various time points up to 35 days postinjury. ResultsComplete healing occurred by 14 days postsurgery for subepithelial injury, and by day 35 for transmucosal injury. Injury remained present at day 35 for transmuscular injury. ConclusionsTiming and completeness of healing varied by extent and depth of resection. Scarless healing occurred rapidly following subepithelial injury, whereas scarring was observed at 5 weeks after transmuscular injury. The proposed classification system may facilitate comparison of surgical outcomes across vocal fold wound-healing studies. Levels of EvidenceN/A. Laryngoscope, 124:E437-E444, 2014	[Imaizumi, Mitsuyoshi] Fukushima Med Univ, Dept Otolaryngol, Sch Med, Fukushima, Japan; [Thibeault, Susan L.; Leydon, Ciara] Univ Wisconsin, Div Otolaryngol Head & Neck Surg, Dept Surg, Madison, WI 53705 USA	Leydon, C (reprint author), Univ Wisconsin, 5105 WIMR,1111 Highland Ave, Madison, WI 53705 USA.	leydon@surgery.wisc.edu			NIH-NIDCD [R03 DC011355, R01 DC04336, R01 DC012773]; Fukushima Medical University	Work was completed at the University of Wisconsin-Madison, Madison, Wisconsin, U.S.A. Funding was received from NIH-NIDCD (R03 DC011355, R01 DC04336, R01 DC012773) and Fukushima Medical University. The authors have no other funding, financial relationships, or conflicts of interest to disclose.	Li NYK, 2010, ANN OTO RHINOL LARYN, V119, P412; Hahn MS, 2006, ANN OTO RHINOL LARYN, V115, P156; Rousseau B, 2003, LARYNGOSCOPE, V113, P620, DOI 10.1097/00005537-200304000-00007; Johnson BQ, 2010, LARYNGOSCOPE, V120, P537, DOI 10.1002/lary.20782; Hahn MS, 2006, ANN OTO RHINOL LARYN, V115, P225; Ling CY, 2010, WOUND REPAIR REGEN, V18, P89, DOI 10.1111/j.1524-475X.2009.00550.x; Welham NV, 2008, ANN OTO RHINOL LARYN, V117, P145; Rousseau B, 2004, J VOICE, V18, P116, DOI 10.1016/j.jvoice.2003.06.001; Lim XH, 2006, ANN OTO RHINOL LARYN, V115, P921; Hirano S, 2009, J VOICE, V23, P399, DOI 10.1016/j.jvoice.2007.12.002; Remacle M, 2007, EUR ARCH OTO-RHINO-L, V264, P499, DOI 10.1007/s00405-007-0279-z; Allen J, 2010, CURR OPIN OTOLARYNGO, V18, P475, DOI 10.1097/MOO.0b013e32833fecd1; Thibeault SL, 2002, J VOICE, V16, P96, DOI 10.1016/S0892-1997(02)00078-4; Welham NV, 2009, J SPEECH LANG HEAR R, V52, P1008, DOI 10.1044/1092-4388(2009/08-0049); Bless DM, 2010, CURR OPIN OTOLARYNGO, V18, P481, DOI 10.1097/MOO.0b013e3283407d87; Cho SH, 2000, ANN OTO RHINOL LARYN, V109, P658; Friedrich G, 2007, EUR ARCH OTO-RHINO-L, V264, P1191, DOI 10.1007/s00405-007-0333-x; Garrett CG, 2000, LARYNGOSCOPE, V110, P814, DOI 10.1097/00005537-200005000-00011; Hirano S, 2003, LARYNGOSCOPE, V113, P966, DOI 10.1097/00005537-200306000-00010; Krausert CR, 2013, OTOLARYNG HEAD NECK, V148, P89, DOI 10.1177/0194599812464336; Kurita S, 1983, VOCAL FOLD PHYSL CON, P3; Li NYK, 2012, LARYNGOSCOPE, V122, P364, DOI 10.1002/lary.22435; Ling CY, 2011, CELLS TISSUES ORGANS, V193, P158, DOI 10.1159/000318605; Moore J, 2012, J VOICE, V26, P269, DOI 10.1016/j.jvoice.2011.05.003; Ohno T, 2008, ANN OTO RHINOL LARYN, V117, P696; Ohno T, 2009, LARYNGOSCOPE, V119, P806, DOI 10.1002/lary.20174; Remacle M, 2000, EUR ARCH OTO-RHINO-L, V257, P227, DOI 10.1007/s004050050228; Rousseau B, 2004, ANN OTO RHINOL LARYN, V113, P767; Rousseau B, 2006, J VOICE, V20, P443, DOI 10.1016/j.jvoice.2005.06.002; Suzuki T, 2002, ANN OTO RHINOL LARYN, V111, P684; Tateya I, 2006, ANN OTO RHINOL LARYN, V115, P135; Tateya T, 2006, ANN OTO RHINOL LARYN, V115, P285; Tateya T, 2005, ANN OTO RHINOL LARYN, V114, P183; Thibeault SL, 2011, J VOICE, V25, P249, DOI 10.1016/j.jvoice.2009.10.003; Yamashita M, 2010, CELLS TISSUES ORGANS, V192, P262, DOI 10.1159/000315476; Yamashita M, 2009, ANN OTO RHINOL LARYN, V118, P131	36	2	2	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0023-852X	1531-4995		LARYNGOSCOPE	Laryngoscope	NOV	2014	124	11					E437	E444		10.1002/lary.24799		8	Medicine, Research & Experimental; Otorhinolaryngology	Research & Experimental Medicine; Otorhinolaryngology	AS6OH	WOS:000344382100003		
J	Murakami, N; Mori, T; Yoshimoto, S; Ito, Y; Kobayashi, K; Ken, H; Kitaguchi, M; Sekii, S; Takahashi, K; Yoshio, K; Inaba, K; Morota, M; Sumi, M; Itami, J				Murakami, Naoya; Mori, Taisuke; Yoshimoto, Seiichi; Ito, Yoshinori; Kobayashi, Kazuma; Ken, Harada; Kitaguchi, Mayuka; Sekii, Shuhei; Takahashi, Kana; Yoshio, Kotaro; Inaba, Koji; Morota, Madoka; Sumi, Minako; Itami, Jun			Expression of EpCAM and Prognosis in Early-Stage Glottic Cancer Treated by Radiotherapy	LARYNGOSCOPE			English	Article						Head and neck squamous cell carcinoma; EpCAM; BerEP4; early-stage glottic cancer; radiation therapy	SQUAMOUS-CELL CARCINOMA; GROWTH-FACTOR RECEPTOR; ADHESION-MOLECULE; NECK-CARCINOMA; HUMAN-PAPILLOMAVIRUS; P53 MUTATIONS; HEAD; CHEMOTHERAPY; SURVIVAL; THERAPY	Objectives/HypothesisTreatment of head and neck squamous cell carcinoma (HNSCC) often requires radiotherapy, but relapse can occur. There is, therefore, an urgent need for the identification of a predictive novel biomarker for radiosensitivity. The epithelial cell adhesion molecule (EpCAM) has been shown to promote the transformation of malignant tumors, and EpCAM may have prognostic significance, but it is not known if EpCAM determines prognosis, especially with respect to radiotherapy. Therefore, we determined the incidence of the expression of EpCAM in HNSCC and analyzed the prognostic value in patients with early-stage glottic cancer treated with radiotherapy. Study DesignRetrospective analysis. MethodsAll patients with HNSCCs examined in our hospital between January 2012 and February 2013 were analyzed prospectively for the expression of EpCAM. T1-2N0 glottic cancer patients who were primarily treated by radiation therapy between 1995 and 2008 were retrospectively investigated. Patients with or without local recurrence after radical radiation therapy were extracted. The relationship between local recurrence and histopathologic EpCAM expression was compared within these two groups. ResultsOne hundred eighteen patients with HNSCCs from the nasopharynx, oropharynx, hypopharynx, larynx, oral cavity, paranasal cavity, unknown primary, and other sites were analyzed. Positive expression of EpCAM was noted in the oropharynx, hypopharynx, and larynx (72%, 90%, and 58%, respectively). Seventeen and 22 patients with or without local recurrence were extracted, respectively. There was no difference between two groups, with the exception of EpCAM expression. ConclusionsThe expression of EpCAM in HNSCC was investigated. Patients with strong EpCAM expression were associated with local recurrence after primary radiation therapy. Level of EvidenceNA Laryngoscope, 124:E431-E436, 2014	[Murakami, Naoya; Ito, Yoshinori; Kobayashi, Kazuma; Ken, Harada; Kitaguchi, Mayuka; Sekii, Shuhei; Takahashi, Kana; Yoshio, Kotaro; Inaba, Koji; Morota, Madoka; Sumi, Minako; Itami, Jun] Natl Canc Ctr, Dept Radiat Oncol, Tokyo 1040045, Japan; [Mori, Taisuke] Natl Canc Ctr, Dept Clin Lab & Pathol, Tokyo 1040045, Japan; [Yoshimoto, Seiichi] Natl Canc Ctr, Dept Head & Neck Surg, Tokyo 1040045, Japan	Murakami, N (reprint author), Natl Canc Ctr, Dept Radiat Oncol, Chuo Ku, 5-1-1 Tsukiji, Tokyo 1040045, Japan.	namuraka@ncc.go.jp; tamori@ncc.go.jp			Cancer Research Development Fund [23A-13]; National Cancer Center	This study was partially supported by the Cancer Research Development Fund 23A-13. The funding body was the National Cancer Center.	Schache AG, 2011, CLIN CANCER RES, V17, P6262, DOI 10.1158/1078-0432.CCR-11-0388; DASSONVILLE O, 1993, J CLIN ONCOL, V11, P1873; Couture C, 2002, CANCER-AM CANCER SOC, V94, P713, DOI 10.1002/cncr.10232; Franchin G, 2003, CANCER-AM CANCER SOC, V98, P765, DOI 10.1002/cncr.11575; Lassen P, 2013, RADIOTHER ONCOL, V108, P489, DOI 10.1016/j.radonc.2013.08.036; Le QTX, 1997, INT J RADIAT ONCOL, V39, P115, DOI 10.1016/S0360-3016(97)00284-8; Patriarca C, 2012, CANCER TREAT REV, V38, P68, DOI 10.1016/j.ctrv.2011.04.002; Lassen P, 2010, RADIOTHER ONCOL, V95, P371, DOI 10.1016/j.radonc.2010.04.022; Cooper JS, 2004, NEW ENGL J MED, V350, P1937, DOI 10.1056/NEJMoa032646; Okegawa T, 2004, ACTA BIOCHIM POL, V51, P445; Lindel K, 2001, CANCER-AM CANCER SOC, V92, P805, DOI 10.1002/1097-0142(20010815)92:4<805::AID-CNCR1386>3.0.CO;2-9; Bellone S, 2009, INT J GYNECOL CANCER, V19, P860, DOI 10.1111/IGC.0b013e3181a8331f; NYLANDER K, 1995, BRIT J CANCER, V71, P826, DOI 10.1038/bjc.1995.159; Trzpis M, 2007, AM J PATHOL, V171, P386, DOI 10.2353/ajpath.2007.070152; Adelstein DJ, 2003, J CLIN ONCOL, V21, P92, DOI 10.1200/JCO.2003.01.008; Muller PAJ, 2013, NAT CELL BIOL, V15, P2, DOI 10.1038/ncb2641; Ang KK, 2002, CANCER RES, V62, P7350; Stoecklein NH, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-165; Barnes L, 2005, WHO CLASSIFICATION T; DIAZARIAS AA, 1993, DIAGN CYTOPATHOL, V9, P516, DOI 10.1002/dc.2840090509; Forastiere AA, 2003, NEW ENGL J MED, V349, P2091, DOI 10.1056/NEJMoa031317; Okunieff P, 2004, J CLIN ONCOL, V22, P2207, DOI 10.1200/JCO.2004.09.101; Imadome K, 2010, CANCER BIOL THER, V10, P1019, DOI 10.4161/cbt.10.10.13249; Romeu C, 2013, HISTOPATHOLOGY, V62, P654; Saadatmand S, 2013, BRIT J SURG, V100, P252, DOI 10.1002/bjs.8980; Sobin LH, 2009, UICC TNM CLASSIFICAT	26	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0023-852X	1531-4995		LARYNGOSCOPE	Laryngoscope	NOV	2014	124	11					E431	E436		10.1002/lary.24839		6	Medicine, Research & Experimental; Otorhinolaryngology	Research & Experimental Medicine; Otorhinolaryngology	AS6OH	WOS:000344382100002		
J	Ganeev, RA; Suzuki, M; Yoneya, S; Kuroda, H				Ganeev, R. A.; Suzuki, M.; Yoneya, S.; Kuroda, H.			Quasi-phase-matching induced enhancement of the groups of high-order harmonics generating in various multi-jet plasmas produced using perforated targets and modulated heating pulses	LASER PHYSICS			English	Article						high-order harmonic generation; laser plasma; quasi-phase-matching	COUNTERPROPAGATING LIGHT; LASER-PULSES; TRAINS; FIBERS; GASES	Quasi-phase-matching (QPM) of the harmonics of ultrashort pulses in the perforated aluminum, indium, and chromium plasma plumes produced by different techniques is analyzed. We extend our recent studies (2014 J. Phys. B: At. Mol. Opt. Phys. 47 105401) to other plasma ablations and show the advantages of modulated plasma profiles for the harmonic generation. We demonstrate the 20 x growth of QPM-enhanced harmonics in the plasma produced on the perforated aluminum surface. The calculations of plasma concentrations at different delays and distances from ablating targets are presented. We show the tuning of maximally enhanced harmonics using variable excitation of metallic targets at the conditions of QPM, as well as demonstrate the use of a two-color pump of the four-jet indium plasma for enhancement of the harmonics, which were not present in the spectra obtained from the extended indium plasma.	[Ganeev, R. A.; Suzuki, M.; Yoneya, S.; Kuroda, H.] Saitama Med Univ, Ophthalmol & Adv Laser Med Ctr, Saitama 3500495, Japan	Ganeev, RA (reprint author), Saitama Med Univ, Ophthalmol & Adv Laser Med Ctr, Saitama 3500495, Japan.	rashid_ganeev@mail.ru			JSPS KAKENHI [24760048]	This work was supported by JSPS KAKENHI (grant 24760048). We thank P V Redkin for the calculation of plasma concentration. We also thank J P Marangos and C Hutchison for providing the perforated aluminum target.	Andreev AV, 2013, EUR PHYS J D, V67, DOI 10.1140/epjd/e2012-30527-0; SHKOLNIKOV PL, 1994, PHYS REV A, V50, pR4461; Willner A, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.175002; Zepf M, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.143901; Castro A, 2006, PHYS STATUS SOLIDI B, V243, P2465, DOI 10.1002/pssb.200642067; Kan C, 1997, PHYS REV LETT, V79, P2971, DOI 10.1103/PhysRevLett.79.2971; Ganeev RA, 2014, JETP LETT+, V99, P368, DOI 10.1134/S0021364014070078; Zhang XH, 2007, NAT PHYS, V3, P270, DOI 10.1038/nphys541; Zheng L, 2007, OPT EXPRESS, V15, P17985, DOI 10.1364/OE.15.017985; Seres J, 2007, NAT PHYS, V3, P878, DOI 10.1038/nphys775; Bahabad A, 2010, NAT PHOTONICS, V4, P570, DOI 10.1038/NPHOTON.2010.122; Sheinfux AH, 2011, APPL PHYS LETT, V98, DOI 10.1063/1.3578407; Ganeev RA, 2012, J PHYS B-AT MOL OPT, V45, DOI 10.1088/0953-4075/45/16/165402; Paul A, 2003, NATURE, V421, P51, DOI 10.1038/nature01222; Liu LZ, 2012, PHYS REV A, V85, DOI 10.1103/PhysRevA.85.053823; Stadler J, 1997, INT J MOD PHYS C, V8, P1131, DOI 10.1142/S0129183197000990; Ganeev RA, 2014, PHYS REV A, V89, DOI 10.1103/PhysRevA.89.033821; Ganeev RA, 2014, J PHYS B-AT MOL OPT, V47, DOI 10.1088/0953-4075/47/10/105401; Ganeev RA, 2014, J NONLINEAR OPT PHYS, V23, DOI 10.1142/S0218863514500131; Tosa V, 2008, NEW J PHYS, V10, DOI 10.1088/1367-2630/10/2/025016; Geissler M, 2000, PHYS REV A, V62, part. no., DOI 10.1103/PhysRevA.62.033817; Auguste T, 2007, PHYS REV A, V76, DOI 10.1103/PhysRevA.76.011802; Bahabad A, 2008, OPT LETT, V33, P1936, DOI 10.1364/OL.33.001936; Ganeev RA, 2007, J PHYS B-AT MOL OPT, V40, pR213, DOI 10.1088/0953-4075/40/22/R01; Kortsalioudakis N, 2005, APPL PHYS B-LASERS O, V80, P211, DOI 10.1007/s00340-004-1683-3; Liu LZ, 2013, PHYS REV A, V87, DOI 10.1103/PhysRevA.87.023810; Lytle AL, 2008, OPT EXPRESS, V16, P6544, DOI 10.1364/OE.16.006544; O'Keeffe K, 2014, OPT EXPRESS, V22, P7722, DOI 10.1364/OE.22.007722; O'Keeffe K, 2012, OPT EXPRESS, V20, P6236, DOI 10.1364/OE.20.006236; Pfeifer T, 2007, J OPT SOC AM B, V24, P1025, DOI 10.1364/JOSAB.24.001025; Pirri A, 2008, PHYS REV A, V78, DOI 10.1103/PhysRevA.78.011801; Ren H, 2008, OPT EXPRESS, V16, P17052, DOI 10.1364/OE.16.017052; Robinson T, 2010, J OPT SOC AM B, V27, P763, DOI 10.1364/JOSAB.27.000763; Wang XW, 2012, PHYS REV A, V86, DOI 10.1103/PhysRevA.86.021802	34	1	1	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	1054-660X	1555-6611		LASER PHYS	Laser Phys.	NOV	2014	24	11							115405	10.1088/1054-660X/24/11/115405		7	Optics; Physics, Applied	Optics; Physics	AT2YE	WOS:000344799600019		
J	Kobayashi, Y; Hatta, Y; Sugitani, M; Hojo, A; Nakagawa, M; Kusuda, M; Uchino, Y; Takahashi, H; Kiso, S; Hirabayashi, Y; Yagi, M; Kodaira, H; Kurita, D; Miura, K; Iriyama, N; Kobayashi, S; Kura, Y; Horikoshi, A; Sawada, U; Takeuchi, J; Takei, M				Kobayashi, Yujin; Hatta, Yoshihiro; Sugitani, Masahiko; Hojo, Atsuko; Nakagawa, Masaru; Kusuda, Machiko; Uchino, Yoshihito; Takahashi, Hiromichi; Kiso, Satomi; Hirabayashi, Yukio; Yagi, Mai; Kodaira, Hitomi; Kurita, Daisuke; Miura, Katsuhiro; Iriyama, Noriyoshi; Kobayashi, Sumiko; Kura, Yoshimasa; Horikoshi, Akira; Sawada, Umihiko; Takeuchi, Jin; Takei, Masami			Safety and efficacy of high-dose cyclophosphamide, etoposide and ranimustine regimen followed by autologous peripheral blood stem cell transplant for patients with diffuse large B-cell lymphoma	LEUKEMIA & LYMPHOMA			English	Article						Diffuse large B-cell lymphoma; follicular lymphoma; autologous peripheral blood stem cell transplant; CEM regimen; high-dose chemotherapy; conditioning	NON-HODGKINS-LYMPHOMA; BONE-MARROW-TRANSPLANTATION; MYELODYSPLASTIC SYNDROME; MALIGNANT-LYMPHOMA; CHEMOTHERAPY; LEUKEMIA; THERAPY; BEAM; TOXICITY; COMPLICATIONS	We retrospectively evaluated the safety and efficacy of high-dose chemotherapy consisting of cyclophosphamide, etoposide and ranimustine (CEM) with autologous peripheral blood stem cell transplant (PBSCT) in 55 adult patients with relapsed or high-risk de novo diffuse large B-cell lymphoma (DLBCL) or DLBCL associated with follicular lymphoma. This included 36 patients in the upfront setting in their first complete remission. The median follow-up of 42 patients surviving at the time of the analysis was 52 months (range 1-159). Relapse or disease progression after PBSCT was a frequent cause of death, but no therapy-related mortality associated with PBSCT was observed. The 5-year overall survival and progression-free survival were 70.6% (95% confidence interval [CI], 54.0-82.1) and 57.0% (95% CI, 39.5-71.2), respectively. Chronic renal impairment, therapy-related myelodysplastic syndrome and prostate cancer were the major late complications. The CEM regimen is a tolerable, effective conditioning regimen for autologous PBSCT for DLBCL, with no therapy-related mortality observed.	[Kobayashi, Yujin; Hatta, Yoshihiro; Hojo, Atsuko; Nakagawa, Masaru; Kusuda, Machiko; Uchino, Yoshihito; Takahashi, Hiromichi; Kiso, Satomi; Hirabayashi, Yukio; Yagi, Mai; Kodaira, Hitomi; Kurita, Daisuke; Miura, Katsuhiro; Iriyama, Noriyoshi; Kobayashi, Sumiko; Horikoshi, Akira; Takeuchi, Jin; Takei, Masami] Nihon Univ, Sch Med, Dept Hematol & Rheumatol, Tokyo 1738610, Japan; [Sugitani, Masahiko] Nihon Univ, Sch Med, Dept Pathol, Tokyo 1738610, Japan; [Kura, Yoshimasa; Sawada, Umihiko] Kasukabe Municipal Hosp, Dept Hematol & Oncol, Saitama, Japan	Kobayashi, Y (reprint author), Nihon Univ, Sch Med, Dept Hematol & Rheumatol, Itabashi Ku, 30-1 Oyaguchi Kamicho, Tokyo 1738610, Japan.	eumagene@gmail.com		Miura, Katsuhiro/0000-0002-1538-3804			Metayer C, 2003, BLOOD, V101, P2015, DOI 10.1182/blood-2002-04-1261; Cheson BD, 2007, J CLIN ONCOL, V25, P579, DOI 10.1200/JCO.2006.09.2403; Olivieri A, 2005, ANN ONCOL, V16, P1941, DOI 10.1093/annonc/mdi399; Kameoka Y, 2012, INT J HEMATOL, V96, P624, DOI 10.1007/s12185-012-1186-7; Puig N, 2006, LEUKEMIA LYMPHOMA, V47, P1488, DOI 10.1080/10428190500527769; [Anonymous], 1993, N ENGL J MED, V329, P987; Majhail NS, 2012, BIOL BLOOD MARROW TR, V18, P348, DOI 10.1016/j.bbmt.2011.12.519; Friedberg JW, 2011, HEMATOL-AM SOC HEMAT, P498, DOI 10.1182/asheducation-2011.1.498; Caballero MD, 1997, BONE MARROW TRANSPL, V20, P451, DOI 10.1038/sj.bmt.1700913; Shivakumar R, 2008, ANN ONCOL, V19, P1634, DOI 10.1093/annonc/mdn182; Stiff PJ, 2013, NEW ENGL J MED, V369, P1681, DOI 10.1056/NEJMoa1301077; Gisselbrecht C, 2010, J CLIN ONCOL, V28, P4184, DOI 10.1200/JCO.2010.28.1618; Oliansky DM, 2011, BIOL BLOOD MARROW TR, V17, P20, DOI 10.1016/j.bbmt.2010.07.008; Frisk P, 2002, BONE MARROW TRANSPL, V29, P129, DOI 10.1038/sj.bmt.1703312; Gunnellini M, 2012, ADV HEMATOL, V2012; Herget-Rosenthal S, 2000, NEPHRON, V84, P136, DOI 10.1159/000045561; Howe R, 2003, BONE MARROW TRANSPL, V32, P317, DOI 10.1038/sj.bmt.1704124; Kanda Y, 2013, BONE MARROW TRANSPL, V48, P452, DOI 10.1038/bmt.2012.244; Kato J, 2011, BONE MARROW TRANSPL, V46, P923, DOI 10.1038/bmt.2010.243; Kurita D, 2011, BLOOD, V118, P706; Lane AA, 2012, LEUKEMIA LYMPHOMA, V53, P1130, DOI 10.3109/10428194.2011.645208; Martin A, 2004, BONE MARROW TRANSPL, V34, P675, DOI 10.1038/sj.bmt.1704595; Miura K, 2011, INT J HEMATOL, V94, P90, DOI 10.1007/s12185-011-0884-x; Robertson MJ, 2005, LEUKEMIA LYMPHOMA, V46, P1477, DOI 10.1080/10428190500158466; SEIDEN MV, 1992, BONE MARROW TRANSPL, V10, P57; Stewart DA, 2006, BLOOD, V107, P4623, DOI 10.1182/blood-2005-12-4898; TAKAUE Y, 1991, CANCER, V67, P1830, DOI 10.1002/1097-0142(19910401)67:7<1830::AID-CNCR2820670703>3.0.CO;2-E; Wilczynski SW, 1998, AM J RESP CRIT CARE, V157, P565	28	1	1	INFORMA HEALTHCARE	LONDON	TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND	1042-8194	1029-2403		LEUKEMIA LYMPHOMA	Leuk. Lymphoma	NOV	2014	55	11					2514	2519		10.3109/10428194.2014.889827		6	Oncology; Hematology	Oncology; Hematology	AS5XD	WOS:000344339000017		
J	Yamazaki, S; Nakamura, F; Yoshimi, A; Ichikawa, M; Nannya, Y; Kurokawa, M				Yamazaki, Sho; Nakamura, Fumihiko; Yoshimi, Akihide; Ichikawa, Motoshi; Nannya, Yasuhito; Kurokawa, Mineo			Safety of high-dose micafungin for patients with hematological diseases	LEUKEMIA & LYMPHOMA			English	Article						Micafungin; high dose; safety; adverse events; hepatotoxicity	LIPOSOMAL AMPHOTERICIN-B; MYCOSES STUDY-GROUP; EUROPEAN-ORGANIZATION; FUNGAL-INFECTIONS; ECHINOCANDIN; EFFICACY; FK463; NEUTROPENIA; CASPOFUNGIN; THERAPY	This study was conducted as a retrospective, observational, exploratory cohort study with the aim of elucidating the safety profile of micafungin at doses exceeding 150 mg daily. We identified adult patients with hematological diseases who had received micafungin therapy for >= 7 consecutive days. Twenty-six patients administered micafungin at 300 mg daily (high-dose group) were compared with 58 patients administered micafungin at 150 mg daily (standard-dose group). The most frequent adverse events (AEs) were hepatotoxicity, hypertension and diarrhea. AEs were recorded in 42 (72%) and 19 (73%) patients in the standard-dose and high-dose groups, respectively (p = 1.00). Hepatobiliary AEs were noted in 28 (48%) and 15 (58%) patients, respectively (p = 0.48). Serious AEs and resultant treatment discontinuation were infrequent. Our results suggest that micafungin was safe and well tolerated at 300 mg daily.	[Yamazaki, Sho; Nakamura, Fumihiko; Yoshimi, Akihide; Ichikawa, Motoshi; Nannya, Yasuhito; Kurokawa, Mineo] Univ Tokyo, Grad Sch Med, Dept Hematol & Oncol, Tokyo, Japan; [Yoshimi, Akihide; Kurokawa, Mineo] Tokyo Univ Hosp, Dept Cell Therapy & Transplantat Med, Tokyo 113, Japan	Kurokawa, M (reprint author), 7-3-1 Hongo,Bunkyo Ku, Tokyo 1138655, Japan.	kurokawa-tky@umin.ac.jp					Chandrasekar PH, 2006, CLIN INFECT DIS, V42, P1171, DOI 10.1086/501020; Sirohi B, 2006, BONE MARROW TRANSPL, V38, P47, DOI 10.1038/sj.bmt.1705398; Goto N, 2010, AM J HEMATOL, V85, P872, DOI 10.1002/ajh.21858; Lehrnbecher T, 2010, PEDIATR BLOOD CANCER, V55, P229, DOI 10.1002/pbc.22449; Tamura K, 2009, LEUKEMIA LYMPHOMA, V50, P92, DOI 10.1080/10428190802635500; Kohno S, 2004, SCAND J INFECT DIS, V36, P372, DOI 10.1080/00365540410020406; Walsh TJ, 2008, CLIN INFECT DIS, V46, P327, DOI 10.1086/525258; Denning DW, 2003, LANCET, V362, P1142, DOI 10.1016/S0140-6736(03)14472-8; Walsh TJ, 2004, NEW ENGL J MED, V351, P1391, DOI 10.1056/NEJMoa040446; Hanadate T, 2011, J INFECT CHEMOTHER, V17, P622, DOI 10.1007/s10156-011-0219-0; Yamaguchi M, 2011, ANN HEMATOL, V90, P1209, DOI 10.1007/s00277-011-1277-1; Segal BH, 2008, CLIN INFECT DIS, V47, P674, DOI 10.1086/590566; Kuse ER, 2007, LANCET, V369, P1519, DOI 10.1016/S0140-6736(07)60605-9; Pappas PG, 2007, CLIN INFECT DIS, V45, P883, DOI 10.1086/520980; De Pauw B, 2008, CLIN INFECT DIS, V46, P1813, DOI 10.1086/588660; Ikawa K, 2009, J ANTIMICROB CHEMOTH, V64, P840, DOI 10.1093/jac/dkp298; Ostrosky-Zeichner L, 2003, ANTIMICROB AGENTS CH, V47, P3149, DOI 10.1128/AAC.47.10.3149-3154.2003; Tomishima M, 1999, J ANTIBIOT, V52, P674; Yoshida M, 2012, ANN HEMATOL, V91, P449, DOI 10.1007/s00277-011-1316-y	19	4	5	INFORMA HEALTHCARE	LONDON	TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND	1042-8194	1029-2403		LEUKEMIA LYMPHOMA	Leuk. Lymphoma	NOV	2014	55	11					2572	2576		10.3109/10428194.2014.885514		5	Oncology; Hematology	Oncology; Hematology	AS5XD	WOS:000344339000025		
J	Nakajima, S; Fujiwara, T; Ohguchi, H; Onishi, Y; Kamata, M; Okitsu, Y; Fukuhara, N; Ishizawa, K; Harigae, H				Nakajima, Shinji; Fujiwara, Tohru; Ohguchi, Hiroto; Onishi, Yasushi; Kamata, Mayumi; Okitsu, Yoko; Fukuhara, Noriko; Ishizawa, Kenichi; Harigae, Hideo			Induction of thymic stromal lymphopoietin in mesenchymal stem cells by interaction with myeloma cells	LEUKEMIA & LYMPHOMA			English	Article						Multiple myeloma; microenvironment; TSLP	ALLERGIC AIRWAY INFLAMMATION; BONE-MARROW MICROENVIRONMENT; TUMOR-ASSOCIATED MACROPHAGES; ENDOTHELIAL GROWTH-FACTOR; HUMAN MULTIPLE-MYELOMA; T-CELLS; THERAPEUTIC APPLICATIONS; DENDRITIC CELLS; FACTOR-BETA; B-CELLS	Recently, the bone marrow (BM) microenvironment has been reported to support the survival of multiple myeloma (MM) cells. In this study, we examined changes in gene expression profile in human mesenchymal stem cells (MSCs) by co-culture with MM cells. cDNA array analysis indicated that co-culture induced multiple factors which have positive effects on the survival of MM cells, such as interleukin-6 (IL-6) and insulin-like growth factor-1. Other than these factors, thymic stromal lymphopoietin (TSLP), which is a cytokine involved in the progression of pancreatic and breast cancer through induction of T helper 2 cell responses, was up-regulated in MSCs. TSLP exhibited no effect on proliferation or drug resistance of MM cells, but TSLP secreted from MSCs by co-culture expanded IL-13 + CD4 + T cells through stimulation of dendritic cells. These results suggested that MM cells positively act to induce various molecules in MSCs, leading to the formation of a more advantageous BM microenvironment for their survival.	[Nakajima, Shinji; Fujiwara, Tohru; Ohguchi, Hiroto; Onishi, Yasushi; Kamata, Mayumi; Okitsu, Yoko; Fukuhara, Noriko; Ishizawa, Kenichi; Harigae, Hideo] Tohoku Univ, Grad Sch Med, Dept Hematol & Rheumatol, Sendai, Miyagi 9808574, Japan; [Fujiwara, Tohru; Ishizawa, Kenichi; Harigae, Hideo] Tohoku Univ, Grad Sch Med, Sendai, Miyagi 9808574, Japan	Harigae, H (reprint author), Tohoku Univ, Grad Sch Med, Dept Hematol & Rheumatol, Aoba Ku, 1-1 Seiryo Machi, Sendai, Miyagi 9808574, Japan.	harigae@med.tohoku.ac.jp					Podar K, 2009, LEUKEMIA, V23, P10, DOI 10.1038/leu.2008.259; Zheng YH, 2009, BLOOD, V114, P3625, DOI 10.1182/blood-2009-05-220285; Suyani E, 2013, ANN HEMATOL, V92, P669, DOI 10.1007/s00277-012-1652-6; Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205; Hideshima T, 2007, NAT REV CANCER, V7, P585, DOI 10.1038/nrc2189; Mantovani A, 2010, CURR OPIN IMMUNOL, V22, P231, DOI 10.1016/j.coi.2010.01.009; Ito T, 2005, J EXP MED, V202, P1213, DOI 10.1084/jem.20051135; KLEIN B, 1995, BLOOD, V85, P863; Yoo J, 2005, J EXP MED, V202, P541, DOI 10.1084/jem.20041503; Roodman GD, 2009, LEUKEMIA, V23, P435, DOI 10.1038/leu.2008.336; Gupta D, 2001, LEUKEMIA, V15, P1950; Dankbar B, 2000, BLOOD, V95, P2630; Pedroza-Gonzalez A, 2011, J EXP MED, V208, P479, DOI 10.1084/jem.20102131; Chauhan D, 1997, BLOOD, V89, P227; Hideshima T, 2001, ONCOGENE, V20, P4519, DOI 10.1038/sj.onc.1204623; Kyle RA, 2008, BLOOD, V111, P2962, DOI 10.1182/blood-2007-10-078022; Martinon F, 2009, ANNU REV IMMUNOL, V27, P229, DOI [10.1146/annurev.immunol.021908.132715, 10.1146/annurev.immunol.021908.132532]; Watanabe N, 2004, NAT IMMUNOL, V5, P426, DOI 10.1038/ni1048; Urashima M, 1996, BLOOD, V87, P1928; Zhou BH, 2005, NAT IMMUNOL, V6, P1047, DOI 10.1038/ni1247; Berzofsky JA, 2008, CANCER IMMUNOL IMMUN, V57, P1679, DOI 10.1007/s00262-008-0495-4; Ogata A, 1997, J IMMUNOL, V159, P2212; Mantovani A, 2002, TRENDS IMMUNOL, V23, P549, DOI 10.1016/S1471-4906(02)02302-5; DeNardo DG, 2009, CANCER CELL, V16, P91, DOI 10.1016/j.ccr.2009.06.018; LICHTENSTEIN A, 1995, CELL IMMUNOL, V162, P248, DOI 10.1006/cimm.1995.1076; FRIEND SL, 1994, EXP HEMATOL, V22, P321; De Monte L, 2011, J EXP MED, V208, P469, DOI 10.1084/jem.20101876; Mitsiades CS, 2004, CANCER CELL, V5, P221, DOI 10.1016/S1535-6108(04)00050-9; Grivennikov SI, 2010, CELL, V140, P883, DOI 10.1016/j.cell.2010.01.025; YI Q, 1995, BLOOD, V86, P3043; Olkhanud PB, 2011, J IMMUNOL, V186, P5656, DOI 10.4049/jimmunol.1100463; Cook G, 1999, J LEUKOCYTE BIOL, V66, P981; Haabeth OAW, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1239; Hong SY, 2008, CANCER RES, V68, P8456, DOI 10.1158/0008-5472.CAN-08-2213; Jang S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056433; Park JM, 2008, CANCER IMMUNOL IMMUN, V57, P907, DOI 10.1007/s00262-007-0414-0; Park JM, 2005, INT J CANCER, V114, P80, DOI 10.1002/ijc.20669; Ribatti D, 2006, ONCOGENE, V25, P4257, DOI 10.1038/sj.onc.1209456; Sharma A, 2010, LEUKEMIA LYMPHOMA, V51, P920, DOI 10.3109/10428191003699563; Wang YH, 2006, IMMUNITY, V24, P827, DOI 10.1016/j.immuni.2006.03.019; Zhang YL, 2012, EUR J IMMUNOL, V42, P1735, DOI 10.1002/eji.201142123	41	1	2	INFORMA HEALTHCARE	LONDON	TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND	1042-8194	1029-2403		LEUKEMIA LYMPHOMA	Leuk. Lymphoma	NOV	2014	55	11					2605	2613		10.3109/10428194.2014.881478		9	Oncology; Hematology	Oncology; Hematology	AS5XD	WOS:000344339000030		
J	Kon, Y; Ohmura, Y				Kon, Yoshiaki; Ohmura, Yoshihito			Regeneration of Pseudocyphellaria aurata transplanted on a tree in Japan	LICHENOLOGIST			English	Article							JUVENILE DEVELOPMENT; LICHENS; CONSERVATION; SURVIVAL; SOREDIA; FOREST		[Kon, Yoshiaki] Tokyo Metropolitan Hitotsubashi High Sch, Chiyoda Ku, Tokyo 1010031, Japan; [Ohmura, Yoshihito] Natl Museum Nat & Sci, Dept Bot, Tsukuba, Ibaraki 3050005, Japan	Ohmura, Y (reprint author), Natl Museum Nat & Sci, Dept Bot, Amakubo 4-1-1, Tsukuba, Ibaraki 3050005, Japan.	ohmura-y@kahaku.go.jp					Zoller S, 2000, PLANT BIOLOGY, V2, P496, DOI 10.1055/s-2000-5954; Hilmo O, 2011, LICHENOLOGIST, V43, P241, DOI 10.1017/S0024282910000794; SCHEIDEGGER C, 1995, LICHENOLOGIST, V27, P361, DOI 10.1017/S0024282995000478; GALLOWAY DJ, 1990, LICHENOLOGIST, V22, P103, DOI 10.1017/S0024282990000081; Gustafsson L, 2013, FOREST ECOL MANAG, V291, P436, DOI 10.1016/j.foreco.2012.12.005; Hilmo O., 1999, INT C LICH CONS BIOL, P15; Hilmo O, 2002, PLANT BIOLOGY, V4, P273, DOI 10.1055/s-2002-25734; Honegger R, 1996, NEW PHYTOL, V133, P573, DOI 10.1111/j.1469-8137.1996.tb01926.x; Kon Y., 2008, JAPANESE J BIOL ED, V48, P221; Kon Yoshiaki, 2005, Bulletin of the National Science Museum Series B (Botany), V31, P127; Kon Yoshiaki, 2010, Bulletin of the National Museum of Nature and Science Series B-Botany, V36, P65; Liden M, 2004, BIOL CONSERV, V118, P431, DOI 10.1016/j.biocon.2003.09.026; Ohmura Yoshihito, 2009, Bulletin of the National Museum of Nature and Science Series B-Botany, V35, P91; Ott S, 2004, LICHENOLOGIST, V36, P413, DOI 10.1017/S0024282904014380; Saitama Prefecture, 2011, SAIT RED DAT BOOK 20; Scheidegger C., 1998, LOBARION LICHENS IND, P33; Scheidegger C., 1995, CONSERVATION BIOL LI, P41; SCHUSTER G, 1985, LICHENOLOGIST, V17, P247, DOI 10.1017/S0024282985000317; The Committee of the Red Data Book Chiba, 2009, IMP SPEC PROT CHIB P	19	0	0	CAMBRIDGE UNIV PRESS	CAMBRIDGE	EDINBURGH BLDG, SHAFTESBURY RD, CB2 8RU CAMBRIDGE, ENGLAND	0024-2829	1096-1135		LICHENOLOGIST	Lichenologist	NOV	2014	46	6					833	836		10.1017/S0024282914000450		4	Plant Sciences; Mycology	Plant Sciences; Mycology	AS5MO	WOS:000344315100010		
J	Omura, K; Ohsaki, A; Zhou, BA; Kushida, M; Mitsuma, T; Kobayashi, A; Hagey, LR; Hofmann, AF; Iida, T				Omura, Kaoru; Ohsaki, Ayumi; Zhou, Biao; Kushida, Manaka; Mitsuma, Takashi; Kobayashi, Akiko; Hagey, Lee R.; Hofmann, Alan F.; Iida, Takashi			Improved Chemical Synthesis, X-Ray Crystallographic Analysis, and NMR Characterization of (22R)-/(22S)-Hydroxy Epimers of Bile Acids	LIPIDS			English	Article						(22R)-Hydroxy-bile acids; (22S)-Hydroxy-bile acids; Oxidative decarboxylation; Reformatosky reaction; X-ray crystallography; NMR	CEREBROTENDINOUS XANTHOMATOSIS; TURTLE BILE; FISH BILE; ALCOHOLS; SALTS; STEROIDS; PATIENT; C-23	We report an improved synthesis of the (22R)- and (22S)-epimers of 3 alpha,7 alpha,12 alpha,22-tetrahydroxy-5 beta-cholan-24-oic acid and 3 alpha,7 alpha,22-trihydroxy-5 beta-cholan-24-oic acid from cholic acid (CA) and chenodeoxycholic acid (CDCA), respectively. The principal reactions involved were as follows: (1) oxidative decarboxylation of the bile acid peracetates with lead tetraacetate, and (2) subsequent Reformatsky reaction of the 23,24-dinor-22-aldehydes with ethyl bromoacetate in the presence of activated Zn as a catalyst with the reaction temperature maintained precisely at 75 A degrees C. The absolute configuration of the chiral center at C-22 of each epimer was established by single-crystal X-ray diffraction data using its ethyl ester-peracetate derivative. The H-1- and C-13-NMR spectra that permit the (22R)- and (22S)-epimers to be distinguished are reported as well as the specific H-1 shift effects induced by C5D5N. Bile acids having hydroxyl groups at C-22 are present in a variety of animal biles, previously have been difficult to identify, and are known to have distinctive physicochemical and biological properties.	[Omura, Kaoru; Ohsaki, Ayumi; Zhou, Biao; Kushida, Manaka; Mitsuma, Takashi; Kobayashi, Akiko; Iida, Takashi] Nihon Univ, Coll Humanities & Sci, Dept Chem, Setagaya Ku, Tokyo 1568550, Japan; [Kushida, Manaka] Waseda Univ, Grad Sch Adv Sci & Engn, Dept Appl Chem, Shinjuku Ku, Tokyo 1698555, Japan; [Hagey, Lee R.; Hofmann, Alan F.] Univ Calif San Diego, Dept Med, San Diego, CA 92093 USA	Iida, T (reprint author), Nihon Univ, Coll Humanities & Sci, Dept Chem, Setagaya Ku, Tokyo 1568550, Japan.	takaiida@chs.nihon-u.ac.jp			Ministry of Education, Culture, Sports, Sciences, and Technology of Japan [21550091]; Supported Program for the Strategic Research Foundation at Private Universities [S0901022]	This work was supported in part by a Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Sciences, and Technology of Japan (to T. I., 21550091) for 2012-2014 and the Supported Program for the Strategic Research Foundation at Private Universities subsidized MEXT 2009 (S0901022) for 2009-2013.	ANDERSON IG, 1980, ZOOL J LINN SOC-LOND, V68, P41, DOI 10.1111/j.1096-3642.1980.tb01917.x; Hofmann AF, 2010, J LIPID RES, V51, P226, DOI 10.1194/jlr.R000042; HOSHITA T, 1967, J BIOCHEM-TOKYO, V61, P136; Kuipers F, 2014, NAT REV ENDOCRINOL, V10, P488, DOI 10.1038/nrendo.2014.60; BELOEIL JC, 1980, STEROIDS, V35, P281, DOI 10.1016/0039-128X(80)90041-0; BROOKS CJW, 1973, J CHEM SOC CHEM COMM, P194, DOI 10.1039/c39730000194; CARLSON GL, 1977, STEROIDS, V30, P787, DOI 10.1016/S0039-128X(77)80024-X; FUJIMOTO Y, 1985, J CHEM SOC PERK T 1, P2701, DOI 10.1039/p19850002701; HASLEWOOD GAD, 1978, BIOCHEM J, V171, P409; IIDA T, 1977, CHEM PHYS LIPIDS, V20, P157, DOI 10.1016/0009-3084(77)90088-3; ISHIDA H, 1991, CHEM PHARM BULL, V39, P3153; Kakiyama G, 2004, J LIPID RES, V45, P567, DOI 10.1194/jlr.D300027-JLR200; Ketuly KA, 2009, ACTA CRYSTALLOGR E, V65, pO1026, DOI 10.1107/S160053680901188X; KIHIRA K, 1982, CHEM PHARM BULL, V30, P3040; KIHIRA K, 1981, J LIPID RES, V22, P1181; KOOPMAN BJ, 1987, BIOCHIM BIOPHYS ACTA, V917, P238, DOI 10.1016/0005-2760(87)90128-7; Kuramoto T, 2000, CHEM PHARM BULL, V48, P53; PELLICCIARI R, 1985, J CHEM SOC PERK T 1, P493, DOI 10.1039/p19850000493; RODA A, 1990, J LIPID RES, V31, P289; Sharma U, 2008, MED CHEM RES, V17, P326, DOI 10.1007/s00044-007-9068-x; UNE M, 1989, J LIPID RES, V30, P541; Une Mizuho, 1994, Hiroshima Journal of Medical Sciences, V43, P37; VAIDYA AS, 1968, TETRAHEDRON LETT, P5173	23	1	1	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	0024-4201	1558-9307		LIPIDS	Lipids	NOV	2014	49	11					1169	1180		10.1007/s11745-014-3955-y		12	Biochemistry & Molecular Biology; Nutrition & Dietetics	Biochemistry & Molecular Biology; Nutrition & Dietetics	AS3BU	WOS:000344151800010		
J	Hamaguchi, Y; Kaido, T; Okumura, S; Fujimoto, Y; Ogawa, K; Mori, A; Hammad, A; Tamai, Y; Inagaki, N; Uemoto, S				Hamaguchi, Yuhei; Kaido, Toshimi; Okumura, Shinya; Fujimoto, Yasuhiro; Ogawa, Kohei; Mori, Akira; Hammad, Ahmed; Tamai, Yumiko; Inagaki, Nobuya; Uemoto, Shinji			Impact of Quality as Well as Quantity of Skeletal Muscle on Outcomes After Liver Transplantation	LIVER TRANSPLANTATION			English	Article							CHAIN AMINO-ACIDS; HEPATOCELLULAR-CARCINOMA; COMPUTED-TOMOGRAPHY; AMMONIA METABOLISM; ADIPOSE-TISSUE; OLDER PERSONS; SARCOPENIA; CIRRHOSIS; MASS; RESECTION	Intramuscular fat accumulation has come to be associated with loss of muscle strength and function, one of the components of sarcopenia. However, the impact of preoperative quality of skeletal muscle on outcomes after living donor liver transplantation (LDLT) is unclear. The present study evaluated the intramuscular adipose tissue content (IMAC) and psoas muscle mass index (PMI) in 200 adult patients undergoing LDLT at our institution between January 2008 and October 2013. Correlations of IMAC with other factors, overall survival rates in patients classified according to IMAC or PMI, and risk factors for poor survival after LDLT were analyzed. IMAC was significantly correlated with age (r=0.229, P=0.03) and PMI (r=-0.236, P=0.02) in males and with age (r=0.349, P<0.001) and branched-chain amino acid (BCAA)-to-tyrosine ratio (r=-0.250, P=0.01) in females. The overall survival rates in patients with high IMAC or low PMI were significantly lower than those for patients with normal IMAC or PMI (P<0.001, P<0.001, respectively). Multivariate analysis showed that high IMAC [odds ratio (OR)=3.898, 95% confidence interval (CI)=2.025-7.757, P<0.001] and low PMI (OR=3.635, 95% CI=1.896-7.174, P<0.001) were independent risk factors for death after LDLT. In conclusion, high IMAC and low PMI were closely involved with posttransplant mortality. Preoperative quality and quantity of skeletal muscle could be incorporated into new selection criteria for LDLT. Perioperative nutritional therapy and rehabilitation could be important for good outcomes after LDLT. Liver Transpl 20:1413-1419, 2014. (c) 2014 AASLD.	[Hamaguchi, Yuhei; Kaido, Toshimi; Okumura, Shinya; Fujimoto, Yasuhiro; Ogawa, Kohei; Mori, Akira; Hammad, Ahmed; Uemoto, Shinji] Kyoto Univ, Grad Sch Med, Dept Surg, Div Hepatobiliary Pancreat & Transplant Surg, Kyoto 6068507, Japan; [Tamai, Yumiko; Inagaki, Nobuya] Kyoto Univ, Grad Sch Med, Dept Metab & Clin Nutr, Kyoto 6068507, Japan; [Inagaki, Nobuya] Kyoto Univ, Grad Sch Med, Dept Diabet Endocrinol & Nutr, Kyoto 6068507, Japan	Kaido, T (reprint author), Kyoto Univ, Grad Sch Med, Dept Surg, Div Hepatobiliary Pancreat & Transplant Surg,Saky, 54 Kawahara Cho, Kyoto 6068507, Japan.	kaido@kuhp.kyoto-u.ac.jp					Peng P, 2012, J GASTROINTEST SURG, V16, P1478, DOI 10.1007/s11605-012-1923-5; Peng PD, 2011, HPB, V13, P439, DOI 10.1111/j.1477-2574.2011.00301.x; Montano-Loza AJ, 2012, CLIN GASTROENTEROL H, V10, P166, DOI 10.1016/j.cgh.2011.08.028; Englesbe MJ, 2010, J AM COLL SURGEONS, V211, P271, DOI 10.1016/j.jamcollsurg.2010.03.039; Schaap LA, 2009, J GERONTOL A-BIOL, V64, P1183, DOI 10.1093/gerona/glp097; Janssen I, 2002, J AM GERIATR SOC, V50, P889, DOI 10.1046/j.1532-5415.2002.50216.x; Morioka D, 2007, ANN SURG, V245, P315, DOI 10.1097/01.sla.0000236600.24667.a4; Kaido T, 2013, AM J TRANSPLANT, V13, P1549, DOI 10.1111/ajt.12221; Harimoto N, 2013, BRIT J SURG, V100, P1523, DOI 10.1002/bjs.9258; Cruz-Jentoft AJ, 2010, AGE AGEING, V39, P412, DOI 10.1093/ageing/afq034; Holecek M, 2013, NUTRITION, V29, P1186, DOI 10.1016/j.nut.2013.01.022; Tilg H, 2006, NAT REV IMMUNOL, V6, P772, DOI 10.1038/nri1937; Marcus RL, 2010, J NUTR HEALTH AGING, V14, P362, DOI 10.1007/s12603-010-0081-2; Chien MY, 2008, J AM GERIATR SOC, V56, P1710, DOI 10.1111/j.1532-5415.2008.01854.x; Inomata Y, 2000, TRANSPLANTATION, V69, P258, DOI 10.1097/00007890-200001270-00011; Kitajima Y, 2013, J GASTROEN HEPATOL, V28, P1507, DOI 10.1111/jgh.12227; Visser M, 2002, J AM GERIATR SOC, V50, P897, DOI 10.1046/j.1532-5415.2002.50217.x; Dam G, 2011, AM J PHYSIOL-GASTR L, V301, pG269, DOI 10.1152/ajpgi.00062.2011; Ito T, 2003, TRANSPLANTATION, V76, P158, DOI 10.1097/01.TP.0000072372.42396.47; Goodpaster BH, 2000, J APPL PHYSIOL, V89, P104; Delmonico MJ, 2009, AM J CLIN NUTR, V90, P1579, DOI 10.3945/ajcn.2009.28047; Durand F, 2014, J HEPATOL, V60, P1151, DOI 10.1016/j.jhep.2014.02.026; Lutz CT, 2012, AGING-US, V4, P535; Dam G, 2013, METAB BRAIN DIS, V28, P217, DOI 10.1007/s11011-013-9377-3; Hardin BJ, 2008, J APPL PHYSIOL, V104, P694, DOI 10.1152/japplphysiol.00898.2007; Kitajima Y, 2010, J GASTROENTEROL, V45, P218, DOI 10.1007/s00535-009-0147-2; Meza-Junco J, 2013, J CLIN GASTROENTEROL, V47, P861, DOI 10.1097/MCG.0b013e318293a825; vansVledder MG, 2012, BRIT J SURG, V99, P550	28	7	7	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1527-6465	1527-6473		LIVER TRANSPLANT	Liver Transplant.	NOV	2014	20	11					1413	1419		10.1002/lt.23970		7	Gastroenterology & Hepatology; Surgery; Transplantation	Gastroenterology & Hepatology; Surgery; Transplantation	AS6OJ	WOS:000344382300016		
J	Terao, C; Yamada, R; Mimori, T; Yamamoto, K; Sumida, T				Terao, C.; Yamada, R.; Mimori, T.; Yamamoto, K.; Sumida, T.			A nationwide study of SLE in Japanese identified subgroups of patients with clear signs patterns and associations between signs and age or sex	LUPUS			English	Article						Systemic lupus erythematosus; anti-dsDNA antibodies; anticardiolipin; antibodies; hematologic changes; renal lupus; musculoskeletal	SYSTEMIC-LUPUS-ERYTHEMATOSUS; CLINICAL-FEATURES; DISEASE EXPRESSION; OCCASIONAL SERIES; INCEPTION COHORT; OF-RHEUMATOLOGY; FOLLOW-UP; POPULATION; PREVALENCE; ONSET	We performed a nationwide study to determine the distributions of the signs and clinical markers of systemic lupus erythematosus (SLE) and identify any patterns in their distributions to allow patient subclassification. We obtained 256,999 patient-year records describing the disease status of SLE patients from 2003 to 2010. Of these, 14,779 involved patients diagnosed within the last year, and 242,220 involved patients being followed up. Along with basic descriptive statistics, we analyzed the effects of sex, age and disease duration on the frequencies of signs in the first year and follow-up years. The patients and major signs were clustered using the Ward method. The female patients were younger at onset. Renal involvement and discoid eczema were more frequent in males, whereas arthritis, photosensitivity and cytopenia were less. Autoantibody production and malar rash were positively associated with young age, and serositis and arthritis were negatively associated. Photosensitivity was positively associated with a long disease duration, and autoantibody production, serositis and cytopenia were negatively associated. The SLE patients were clustered into subgroups, as were the major signs. We identified differences in SLE clinical features according to sex, age and disease duration. Subgroups of SLE patients and the major signs of SLE exist.	[Terao, C.; Yamada, R.] Kyoto Univ, Grad Sch Med, Ctr Genom Med, Shogoin Kawahara, Kyoto 6068507, Japan; [Terao, C.; Mimori, T.] Kyoto Univ, Grad Sch Med, Dept Rheumatol & Clin Immunol, Shogoin Kawahara, Kyoto 6068507, Japan; [Yamamoto, K.] Univ Tokyo, Grad Sch Med, Dept Allergy & Rheumatol, Tokyo, Japan; [Sumida, T.] Univ Tsukuba, Fac Med, Dept Internal Med, Ibaraki, Japan	Yamada, R (reprint author), Kyoto Univ, Grad Sch Med, Ctr Genom Med, Shogoin Kawahara, Kyoto 6068507, Japan.	ryamada@genome.med.kyoto-u.ac.jp			Ministry of Health, Labor, and Welfare of Japan	This work was supported by grants-in-aid from the Ministry of Health, Labor, and Welfare of Japan.	AMOR B, 1983, REV RHUM, V50, P733; Chiu YM, 2010, LUPUS, V19, P1250, DOI 10.1177/0961203310373780; Chiu CC, 2012, INTERNAL MED, V51, P17, DOI 10.2169/internalmedicine.51.6154; FONT J, 1992, ANN RHEUM DIS, V51, P1050, DOI 10.1136/ard.51.9.1050; Pons-Estel BA, 2004, MEDICINE, V83, P1, DOI 10.1097/01.md.0000104742.42401.c2; Hochberg MC, 1997, ARTHRITIS RHEUM, V40, P1725, DOI 10.1002/art.1780400928; Hiraki LT, 2012, ARTHRITIS RHEUM-US, V64, P2669, DOI 10.1002/art.34472; Somers EC, 2007, ARTHRIT RHEUM-ARTHR, V57, P612, DOI 10.1002/art.22683; Petri M, 2012, ARTHRITIS RHEUM-US, V64, P2677, DOI 10.1002/art.34473; Jacobsen S, 1998, CLIN RHEUMATOL, V17, P468, DOI 10.1007/BF01451282; Ward MM, 2004, J WOMENS HEALTH, V13, P713, DOI 10.1089/jwh.2004.13.713; Garcia MA, 2005, LUPUS, V14, P938, DOI 10.1191/0961203305lu2245oa; Lalani S, 2010, J RHEUMATOL, V37, P38, DOI 10.3899/jrheum.080957; Lu LJ, 2010, LUPUS, V19, P119, DOI 10.1177/0961203309350755; Mok CC, 2008, J RHEUMATOL, V35, P1978; Ohta A, 2013, MOD RHEUMATOL, V23, P759, DOI 10.1007/s10165-012-0733-7; Feng JB, 2010, RHEUMATOL INT, V30, P1017, DOI 10.1007/s00296-009-1087-0; Stefanidou S, 2011, LUPUS, V20, P1090, DOI 10.1177/0961203311403640; WARD MM, 1989, ARTHRITIS RHEUM, V32, P1226, DOI 10.1002/anr.1780321007; Voulgari PV, 2002, LUPUS, V11, P722, DOI 10.1191/0961203302lu253oa; Tan TC, 2012, J RHEUMATOL, V39, P759, DOI 10.3899/jrheum.111061; Bengtsson C, 2012, LUPUS, V21, P452, DOI 10.1177/0961203311425524; Pons-Estel GJ, 2010, SEMIN ARTHRITIS RHEU, V39, P257, DOI 10.1016/j.semarthrit.2008.10.007; Jakes RW, 2012, ARTHRIT CARE RES, V64, P159, DOI 10.1002/acr.20683; BALLOU SP, 1982, ARTHRITIS RHEUM, V25, P55, DOI 10.1002/art.1780250109; CERVERA R, 1993, MEDICINE, V72, P113; CHAHADE WH, 1995, LUPUS, V4, P100, DOI 10.1177/096120339500400204; GUDMUNDSSON S, 1990, J RHEUMATOL, V17, P1162; HELVE T, 1985, SCAND J RHEUMATOL, V14, P43; Lahita R G, 1999, Curr Opin Rheumatol, V11, P352, DOI 10.1097/00002281-199909000-00005; Levy DM, 2013, ARTHRIT CARE RES, V65, P152, DOI 10.1002/acr.21779; Malaviya AN, 1997, LUPUS, V6, P690, DOI 10.1177/096120339700600903; Murray SG, 2012, ARTHRIT CARE RES, V64, P1328, DOI 10.1002/acr.21691; Soto ME, 2004, CLIN EXP RHEUMATOL, V22, P713; Tsokos GC, 2011, NEW ENGL J MED, V365, P2110, DOI 10.1056/NEJMra1100359; Wang F, 1997, LUPUS, V6, P248, DOI 10.1177/096120339700600306	36	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	0961-2033	1477-0962		LUPUS	Lupus	NOV	2014	23	13					1435	1442		10.1177/0961203314547790		8	Rheumatology	Rheumatology	AS1TR	WOS:000344064900014		
J	Lin, BW; Tamaki, T; Zhao, FD; Raytchev, B; Kaneda, K; Ichii, K				Lin, Baowei; Tamaki, Toru; Zhao, Fangda; Raytchev, Bisser; Kaneda, Kazufumi; Ichii, Koji			Scale alignment of 3D point clouds with different scales	MACHINE VISION AND APPLICATIONS			English	Article						Scale; ICP; 3D point cloud; Spin images; Registration	OBJECT RECOGNITION; SCENES	In this paper, we propose two methods for estimating the scales of point clouds to align them. The first method estimates the scale of each point cloud separately: each point cloud has its own scale that is something like the size of a scene. We call it a keyscale, which is a representative scale and is defined for a given 3D point cloud as the minimum of the cumulative contribution rates of PCA of descriptors over different scales. Our second method directly estimates the ratio of scales (scale ratio) of two point clouds. Instead of finding the minimum, this approach registers the two sets of curves of the cumulative contribution rate of PCA by assuming that those differ only in scale. Experimental results with simulated and real scene point clouds demonstrate that the scale alignment of 3D point clouds can be effectively accomplished by our scale ratio estimation.	[Lin, Baowei] Dalian Neusoft Univ Informat, Dept Elect Engn, Dalian, Peoples R China; [Lin, Baowei; Tamaki, Toru; Zhao, Fangda; Raytchev, Bisser; Kaneda, Kazufumi; Ichii, Koji] Hiroshima Univ, Dept Informat Engn, Grad Sch Engn, Hiroshima, Japan	Lin, BW (reprint author), Dalian Neusoft Univ Informat, Dept Elect Engn, Dalian, Peoples R China.	linbaowei@neusoft.edu.cn; tamaki@hiroshima-u.ac.jp	Ichii, Koji/D-6376-2011; Tamaki, Toru/D-7091-2011; Kaneda, Kazufumi/J-5562-2015	Tamaki, Toru/0000-0001-9712-7777; Kaneda, Kazufumi/0000-0002-5231-1826	JSPS KAKENHI [23700211]	This work was supported in part by JSPS KAKENHI Grant Number 23700211.	Akagunduz E., 2007, CVPR, P1; Belongie S, 2002, IEEE T PATTERN ANAL, V24, P509, DOI 10.1109/34.993558; Salvi J, 2007, IMAGE VISION COMPUT, V25, P578, DOI 10.1016/j.imavis.2006.05.012; Cheung W, 2009, IEEE T IMAGE PROCESS, V18, P2012, DOI 10.1109/TIP.2009.2024578; Tam GKL, 2013, IEEE T VIS COMPUT GR, V19, P1199, DOI 10.1109/TVCG.2012.310; Zaharescu A, 2009, PROC CVPR IEEE, P373; Baatz G, 2012, INT J COMPUT VISION, V96, P315, DOI 10.1007/s11263-011-0458-7; Snavely N, 2008, INT J COMPUT VISION, V80, P189, DOI 10.1007/s11263-007-0107-3; Castellani U, 2008, COMPUT GRAPH FORUM, V27, P643, DOI 10.1111/j.1467-8659.2008.01162.x; Mian AS, 2008, INT J COMPUT VISION, V79, P1, DOI 10.1007/s11263-007-0085-5; Johnson AE, 1998, IMAGE VISION COMPUT, V16, P635, DOI 10.1016/S0262-8856(98)00074-2; Johnson AE, 1999, IEEE T PATTERN ANAL, V21, P433, DOI 10.1109/34.765655; HURLEY JR, 1962, BEHAV SCI, V7, P258; Besl P. J., 1991, PAMI, V14, P239; Conde C., 2005, CVPR 05, P115; Du S., 2007, IEEE INT C IM PROC, V5, P193; Dyden L. L., 1998, STAT SHAPE ANAL; Furukawa Y., 2007, CVPR, P1362; Haker M., 2008, CVPRW; Izadi S., 2011, P 24 ANN ACM S US IN, P559; Kaick O. V., 2011, P COMP GRAPH FOR, P1681; Lin B., 2013, ICIP; Lin B., 2013, IEEJ T ELECTRO INF S, V133, P84; Makadia A., 2006, CVPR 06, P1297; Scovanner P., 2007, ACM MULTIMEDIA, P357; Steder B., 2010, WORKSH DEF SOLV REAL; Tamaki T., 2010, ICPR, P3480; Unnikrishnan R., 2008, P WORKSH SEARCH 3D, VS3D, P1; Wu C., 2008, CVPR; Zinsser T., P INT C PATT REC IM, P116	30	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0932-8092	1432-1769		MACH VISION APPL	Mach. Vis. Appl.	NOV	2014	25	8					1989	2002		10.1007/s00138-014-0633-2		14	Computer Science, Artificial Intelligence; Computer Science, Cybernetics; Engineering, Electrical & Electronic	Computer Science; Engineering	AS1XK	WOS:000344073100005		
J	Kobayashi, K; Kanmuri, S; Hayashi, Y; Masutani, K; Kimura, Y				Kobayashi, Koji; Kanmuri, Shuhei; Hayashi, Yuichiro; Masutani, Kazunari; Kimura, Yoshiharu			Preparation of Chain-Extended Poly(hexamethylene carbonate)s and their Block Copolymerization with Poly-L-lactide to Synthesize Partly Biobased Thermoplastic Elastomers	MACROMOLECULAR MATERIALS AND ENGINEERING			English	Article						chain extension; block copolymers; poly(hexamethylene carbonate); polylactide; thermoplastic elastomers	TRIBLOCK COPOLYMERS; POLYLACTIDE; POLYCARBONATES; DEGRADATION	An oligomer of poly(hexamethylene carbonate) (PHMC) that is synthesized by ester-exchanging polycondensation of ethylene carbonate and 1,6-hexanediol is chain-extended by using diphenyl carbonate as chain extender. The resultant PHMC, dihydroxyl-terminated, is then subjected to tin-catalyzed ring-opening polymerization of L-lactide to prepare ABA tri-block copolymers consisting of poly-L-lactide (PLLA: A) and PHMC (B), which retain significantly high molecular weights even at increased contents of PHMC. Polymer films of these block copolymers exhibit high elongation, reaching 700% at a high PHMC content. It is therefore suggested that the present block copolymer system can be a novel thermoplastic elastomer, which is partly bio-based.<inline-graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="">mame201400098-gra-0001</inline-graphic	[Kobayashi, Koji] TOYOBO Co Ltd, Res Ctr Katata, Otsu, Shiga 5200292, Japan; [Kanmuri, Shuhei; Hayashi, Yuichiro; Masutani, Kazunari; Kimura, Yoshiharu] Kyoto Inst Technol, Dept Biobased Mat Sci, Sakyo Ku, Kyoto 6068585, Japan	Kimura, Y (reprint author), Kyoto Inst Technol, Dept Biobased Mat Sci, Sakyo Ku, Kyoto 6068585, Japan.	ykimura@kit.ac.jp					Wanamaker CL, 2007, BIOMACROMOLECULES, V8, P3634, DOI 10.1021/bm700699g; Frick EM, 2003, BIOMACROMOLECULES, V4, P216, DOI 10.1021/bm025628b; Yamamoto Y, 2009, MACROMOL BIOSCI, V9, P968, DOI 10.1002/mabi.200900039; Drumright RE, 2000, ADV MATER, V12, P1841, DOI 10.1002/1521-4095(200012)12:23<1841::AID-ADMA1841>3.0.CO;2-E; Clements JH, 2003, IND ENG CHEM RES, V42, P663, DOI 10.1021/ie020678i; Martello MT, 2011, MACROMOLECULES, V44, P8537, DOI 10.1021/ma201063t; Zhu WX, 2011, POLYM INT, V60, P1060, DOI 10.1002/pi.3043; Bates F. S., 1996, BLOCK COPOLYMER THER, P335; Dubois P., 1995, J MACROMOL SCI REV M, V35, P379; Frick EM, 2000, MACROMOL RAPID COMM, V21, P1317, DOI 10.1002/1521-3927(20001201)21:18<1317::AID-MARC1317>3.3.CO;2-2; Fukuoka S, 2014, CHEM ENG NEWS, V92, P4; Hartmann M. H., 1998, BIOPOLYMERS RENEWABL; Holden G., 1993, THERMOPLASTIC ELASTO; Hu YQ, 2004, POLYM DEGRAD STABIL, V85, P705, DOI 10.1016/j.polymdegradstab.2003.12.010; Kennedy J. P, 1992, DESIGNED POLYM CARBO; KIM JH, 2002, MACROMOL RES, V10, P54; Kim JH, 2000, POLYM J, V32, P1056, DOI 10.1295/polymj.32.1056; Kim JH, 2002, POLYM J, V34, P203, DOI 10.1295/polymj.34.203; Nishihara R, 2010, CATAL SURV ASIA, V14, P140, DOI 10.1007/s10563-010-9095-3; Tsuji H., 2002, POLYLACTIDES BIOPOLY; Wanamaker CL, 2009, BIOMACROMOLECULES, V10, P443, DOI 10.1021/bm801292v; Zhang S, 1996, J POLYM SCI POL CHEM, V34, P2737, DOI 10.1002/(SICI)1099-0518(19960930)34:13<2737::AID-POLA18>3.0.CO;2-D; Zhang Z, 2004, MACROMOL CHEM PHYSIC, V205, P867, DOI 10.1002/macp.200300184	23	2	2	WILEY-V C H VERLAG GMBH	WEINHEIM	BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY	1438-7492	1439-2054		MACROMOL MATER ENG	Macromol. Mater. Eng.	NOV	2014	299	11					1384	1394		10.1002/mame.201400098		11	Materials Science, Multidisciplinary; Polymer Science	Materials Science; Polymer Science	AS6ND	WOS:000344379200011		
J	Salim, M; Minamikawa, H; Sugimura, A; Hashim, R				Salim, Malinda; Minamikawa, Hiroyuki; Sugimura, Akihiko; Hashim, Rauzah			Amphiphilic designer nano-carriers for controlled release: from drug delivery to diagnostics	MEDCHEMCOMM			English	Review							LIQUID-CRYSTALLINE PHASES; ALKYL GLYCOSIDE VESICLES; SYNTHETIC GLYCOLIPID/WATER SYSTEMS; NONIONIC SURFACTANT VESICLES; MEDIATED GENE-TRANSFER; SPAN 80 VESICLES; IN-VIVO; POLY(ETHYLENE GLYCOL); CATIONIC LIPOSOMES; CANCER-THERAPY	Vesicles formed by self-assembly of lipids and surfactants are increasingly recognised as carriers for drug delivery applications in disease targeting and many other biomedical-related areas, demonstrable by the growing number of significant publications. This manuscript reviews important facets of lipid-based vesicles as drug carriers and their surface modifications to achieve controlled release and selective cell targeting. We cover both the more commonly used ionic phospholipid vesicle carriers and the rapidly growing field of non-ionic vesicles/niosomes using self-assembly of uncharged amphiphilic molecules, which could be formed by using sugar surfactants or glycolipids, sorbitan esters, and polyoxyethylene alkyl ethers. Due to their lower cost, biodegradability, low-toxicity, low-immunogenicity and specific sugar-cell recognition, much attention would be devoted to glycolipid bio-surfactants as potential carriers for targeted delivery. Specifically, our review points to the design consideration of lipid and surfactant nano-carriers based on critical packing parameter, membrane curvature, and the effects of hydrophobic chain structures. We have also dedicated a section of this review to summarise some novel applications of various lipid liquid crystal phases in drug delivery, and how in turn these are related to chemical structures of the lipid entities. The final section of this review outlines the application of lipid vesicles as delivery agents for diagnostic imaging.	[Salim, Malinda; Hashim, Rauzah] Univ Malaya, Dept Chem, Kuala Lumpur 50603, Malaysia; [Sugimura, Akihiko; Hashim, Rauzah] Osaka Sangyo Univ, Sch Informat Syst Engn, Daito, Osaka 5748530, Japan; [Minamikawa, Hiroyuki] Natl Inst Adv Ind Sci & Technol, Nanosyst Res Inst, Morphofunct Nanosyst Grp, Tsukuba, Ibaraki, Japan; [Sugimura, Akihiko] Osaka Sangyo Univ, Inst Ind Res, Osaka, Japan	Hashim, R (reprint author), Univ Malaya, Dept Chem, Kuala Lumpur 50603, Malaysia.	rauzah@um.edu.my	Hashim, Rauzah/B-9566-2010	Hashim, Rauzah/0000-0002-4074-9783	University of Malaya; Ministry of Higher Education High Impact Research Grant [UM.C/625/1/HIR/MOHE/05]; Japan Society for the Promotion of Science (JSPS) [B-24360127]	We thank the University of Malaya and the Ministry of Higher Education High Impact Research Grant UM.C/625/1/HIR/MOHE/05 grant for financial support. This work was also supported by a Grant-in Aid for Scientific Research (B-24360127) of the Japan Society for the Promotion of Science (JSPS).	Abraham T, 2004, COLLOID SURFACE B, V35, P107, DOI 10.1016/j.colsurfb.2004.02.015; Al-Achi A., 2013, INTEGRATED PHARMACEU; Alinaghi A., 2013, J LIPOSOME RES, P1; LEWIS RNAH, 1989, BIOCHEMISTRY-US, V28, P541, DOI 10.1021/bi00428a020; Lopes LB, 2006, PHARM RES, V23, P1332, DOI 10.1007/s11095-006-0143-7; Weinberg BD, 2008, J PHARM SCI-US, V97, P1681, DOI 10.1002/jps.21038; Hato M, 1999, ADV COLLOID INTERFAC, V80, P233, DOI 10.1016/S0001-8686(98)00085-2; Di Marzio L, 2011, COLLOID SURFACE B, V82, P18, DOI 10.1016/j.colsurfb.2010.08.004; Ntziachristos V, 2005, NAT BIOTECHNOL, V23, P313, DOI 10.1038/nbt1074; Gambhir SS, 2002, NAT REV CANCER, V2, P683, DOI 10.1038/nrc882; Kibria G, 2013, BIOMATERIALS, V34, P5617, DOI 10.1016/j.biomaterials.2013.03.094; Sharma A, 1997, INT J PHARM, V154, P123, DOI 10.1016/S0378-5173(97)00135-X; SUURKUUSK J, 1976, BIOCHEMISTRY-US, V15, P1393, DOI 10.1021/bi00652a007; Hashim R, 2012, LIQ CRYST, V39, P1, DOI 10.1080/02678292.2011.614017; Hashida M, 2005, CHEM PHARM BULL, V53, P871, DOI 10.1248/cpb.53.871; Li SH, 2012, BIOCONJUGATE CHEM, V23, P1322, DOI 10.1021/bc300175d; Hayashi K, 2011, COLLOID SURFACE B, V87, P28, DOI 10.1016/j.colsurfb.2011.04.029; Henriksen-Lacey M, 2011, J CONTROL RELEASE, V154, P131, DOI 10.1016/j.jconrel.2011.05.019; You J, 2013, BIOMATERIALS, V34, P4510, DOI 10.1016/j.biomaterials.2013.02.069; Nobs L, 2004, J PHARM SCI-US, V93, P1980, DOI 10.1002/jps.20098; Manconi M, 2002, INT J PHARM, V234, P237, DOI 10.1016/S0378-5173(01)00971-1; Brooks SA, 2001, ACTA HISTOCHEM, V103, P37, DOI 10.1078/0065-1281-00576; Spicer PT, 2005, CURR OPIN COLLOID IN, V10, P274, DOI 10.1016/j.cocis.2005.09.004; Noble CO, 2004, EXPERT OPIN THER TAR, V8, P335, DOI 10.1517/14728222.8.4.335; Peer D, 2007, NAT NANOTECHNOL, V2, P751, DOI 10.1038/nnano.2007.387; Raffy S, 1999, BIOPHYS J, V76, P2072; BANGHAM AD, 1972, ANNU REV BIOCHEM, V41, P753, DOI 10.1146/annurev.bi.41.070172.003541; Lowman AM, 1999, J PHARM SCI, V88, P933, DOI 10.1021/js980337n; Hao YM, 2002, INT J PHARM, V244, P73, DOI 10.1016/S0378-5173(02)00301-0; Seddon JM, 1997, BBA-BIOMEMBRANES, V1327, P131, DOI 10.1016/S0005-2736(97)00047-3; Omokawa Y, 2010, INT J PHARMACEUT, V389, P157, DOI 10.1016/j.ijpharm.2010.01.033; Blessing T, 2001, BIOCONJUGATE CHEM, V12, P529, DOI 10.1021/bc0001488; Maruyama K, 2011, ADV DRUG DELIVER REV, V63, P161, DOI 10.1016/j.addr.2010.09.003; HINZ HJ, 1991, BIOCHEMISTRY-US, V30, P5125, DOI 10.1021/bi00235a003; Nguan HS, 2010, LIQ CRYST, V37, P1205, DOI 10.1080/02678292.2010.492245; Laginha K, 2005, BBA-BIOMEMBRANES, V1711, P25, DOI 10.1016/j.bbamem.2005.02.007; Lestini BJ, 2002, J CONTROL RELEASE, V78, P235, DOI 10.1016/S0168-3659(01)00505-3; Boyd BJ, 2006, INT J PHARM, V309, P218, DOI 10.1016/j.ijpharm.2005.11.033; Mannock DA, 2007, CHEM PHYS LIPIDS, V148, P26, DOI 10.1016/j.chemphyslip.2007.04.004; Uster PS, 1996, FEBS LETT, V386, P243, DOI 10.1016/0014-5793(96)00452-8; Semple SC, 1998, ADV DRUG DELIVER REV, V32, P3, DOI 10.1016/S0169-409X(97)00128-2; Rizwan SB, 2010, EXPERT OPIN DRUG DEL, V7, P1133, DOI 10.1517/17425247.2010.515584; WU MS, 1981, BIOCHIM BIOPHYS ACTA, V674, P19, DOI 10.1016/0304-4165(81)90342-1; Nagayasu A, 1999, ADV DRUG DELIVER REV, V40, P75, DOI 10.1016/S0169-409X(99)00041-1; Kawakami S, 2000, GENE THER, V7, P292, DOI 10.1038/sj.gt.3301089; Rao JH, 2007, CURR OPIN BIOTECH, V18, P17, DOI 10.1016/j.copbio.2007.01.003; Goldberg M, 2003, NAT REV DRUG DISCOV, V2, P289, DOI 10.1038/nrd1067; CHAPMAN D, 1975, Q REV BIOPHYS, V8, P185; Ahmad N, 2012, LANGMUIR, V28, P2395, DOI 10.1021/la203736b; Petersen AL, 2012, ADV DRUG DELIVER REV, V64, P1417, DOI 10.1016/j.addr.2012.09.003; Lai J, 2009, AAPS PHARMSCITECH, V10, P960, DOI 10.1208/s12249-009-9292-4; Hill K, 1999, FETT-LIPID, V101, P25; Saul JM, 2006, J CONTROL RELEASE, V114, P277, DOI 10.1016/j.jconrel.2006.05.028; HOPE MJ, 1986, CHEM PHYS LIPIDS, V40, P89, DOI 10.1016/0009-3084(86)90065-4; SEDDON JM, 1993, PHILOS T ROY SOC A, V344, P377, DOI 10.1098/rsta.1993.0096; Moghimi SM, 2001, PHARMACOL REV, V53, P283; Vill V, 2002, CURR OPIN COLLOID IN, V7, P395, DOI 10.1016/S1359-0294(02)00091-2; Veronese FM, 2001, BIOMATERIALS, V22, P405, DOI 10.1016/S0142-9612(00)00193-9; Yu JN, 2010, ACTA PHARMACOL SIN, V31, P759, DOI 10.1038/aps.2010.55; Misran O, 2013, J PHYS CHEM B, V117, P7335, DOI 10.1021/jp401787b; Krasnici S, 2003, INT J CANCER, V105, P561, DOI 10.1002/ijc.11108; Iannello A, 2005, CANCER METAST REV, V24, P487, DOI 10.1007/s10555-005-6192-2; Hoare TR, 2008, POLYMER, V49, P1993, DOI 10.1016/j.polymer.2008.01.027; Uchegbu IF, 1998, INT J PHARM, V172, P33, DOI 10.1016/S0378-5173(98)00169-0; Muller-Goymann CC, 2004, EUR J PHARM BIOPHARM, V58, P343, DOI 10.1016/j.ejpb.2004.03.028; Kobayashi T, 2007, INT J PHARM, V329, P94, DOI 10.1016/j.ijpharm.2006.08.039; Ishida T, 2002, BIOSCIENCE REP, V22, P197, DOI 10.1023/A:1020134521778; Garg G, 2007, BIOL PHARM BULL, V30, P350, DOI 10.1248/bpb.30.350; Moghimi SM, 2003, PROG LIPID RES, V42, P463, DOI 10.1016/S0163-7827(03)00033-X; Surace C, 2009, MOL PHARMACEUT, V6, P1062, DOI 10.1021/mp800215d; Veldman RJ, 2005, J PHARMACOL EXP THER, V315, P704, DOI 10.1124/jpet.105.087486; GREGORIADIS G, 1993, DRUGS, V45, P15, DOI 10.2165/00003495-199345010-00003; Kisel MA, 2001, INT J PHARM, V216, P105, DOI 10.1016/S0378-5173(01)00579-8; KIWADA H, 1985, CHEM PHARM BULL, V33, P753; Cevc G, 1996, CRIT REV THER DRUG, V13, P257; Heyes J, 2006, J CONTROL RELEASE, V112, P280, DOI 10.1016/j.jconrel.2006.02.012; Manosroi A, 2003, COLLOID SURFACE B, V30, P129, DOI 10.1016/S0927-7765(03)00080-8; Kawakami S, 2000, BBA-GEN SUBJECTS, V1524, P258, DOI 10.1016/S0304-4165(00)00163-X; Yezhelyev MV, 2006, LANCET ONCOL, V7, P657, DOI 10.1016/S1470-2045(06)70793-8; Smith TJ, 2005, ANN ONCOL, V16, P825, DOI 10.1093/annonc/mdi156; VANOSS CJ, 1995, COLLOID SURFACE B, V5, P91, DOI 10.1016/0927-7765(95)01217-7; BANGA AK, 1988, INT J PHARM, V48, P15, DOI 10.1016/0378-5173(88)90246-3; Hirai M, 2007, BIOCHEM BIOPH RES CO, V353, P553, DOI 10.1016/j.bbrc.2006.12.060; Imura T, 2006, CHEM-EUR J, V12, P2434, DOI 10.1002/chem.200501199; Hong JS, 2010, LANGMUIR, V26, P11581, DOI 10.1021/la100879p; Bagwe RP, 2001, CRIT REV THER DRUG, V18, P77; Aripin NFK, 2013, J MICROENCAPSUL, V30, P265, DOI 10.3109/02652048.2012.720723; Goldberg M, 2007, J BIOMAT SCI-POLYM E, V18, P241, DOI 10.1163/156856207779996931; Wang Y, 2013, J COLLOID INTERF SCI, V406, P247, DOI 10.1016/j.jcis.2013.05.081; Shigeta Y, 2004, BIOL PHARM BULL, V27, P591, DOI 10.1248/bpb.27.591; Kibria G, 2011, J CONTROL RELEASE, V153, P141, DOI 10.1016/j.jconrel.2011.03.012; Kato K, 2008, LANGMUIR, V24, P10762, DOI 10.1021/la801581f; GREF R, 1995, ADV DRUG DELIVER REV, V16, P215, DOI 10.1016/0169-409X(95)00026-4; Muzzalupo R, 2013, INT J PHARMACEUT, V458, P224, DOI 10.1016/j.ijpharm.2013.09.011; Kwon TK, 2010, INT J PHARMACEUT, V392, P268, DOI 10.1016/j.ijpharm.2010.03.049; Araseki M, 2002, BIOSCI BIOTECH BIOCH, V66, P2573; Balzer D., 2000, NONIONIC SURFACTANTS; Benson Heather A. E., 2005, Current Drug Delivery, V2, P23, DOI 10.2174/1567201052772915; BONTE F, 1986, CHEM PHYS LIPIDS, V40, P359, DOI 10.1016/0009-3084(86)90079-4; BROCKERH.H, 1974, LIPIDS, V9, P645, DOI 10.1007/BF02532169; Campbell N. A., 2005, BIOLOGY; Chan A., 2013, NOTES TO BIOCHEMICAL, P343; DAICHO Y, 1992, BIOCHIM BIOPHYS ACTA, V1107, P61, DOI 10.1016/0005-2736(92)90329-K; DEKRUIJFF B, 1976, BIOCHIM BIOPHYS ACTA, V436, P729, DOI 10.1016/0005-2736(76)90402-8; Dian LH, 2013, INT J NANOMED, V8, P845, DOI 10.2147/IJN.S40547; Faivre V, 2010, EXPERT OPIN DRUG DEL, V7, P1031, DOI 10.1517/17425247.2010.511172; Fiandaca M. S., 2013, THE TEXTBOOK OF NANO; Franz TJ, 1992, TREATISE CONTROLLED, P341; HANSEN CB, 1995, BBA-BIOMEMBRANES, V1239, P133, DOI 10.1016/0005-2736(95)00138-S; Harashima H, 1995, J DRUG TARGET, V3, P253, DOI 10.3109/10611869509015954; Harris J. M., 1992, POLY ETHYLENE GLYCOL; Hato M, 2001, CURR OPIN COLLOID IN, V6, P268, DOI 10.1016/S1359-0294(01)00096-6; Hendradi E, 2003, BIOL PHARM BULL, V26, P1739, DOI 10.1248/bpb.26.1739; Hermanson G. T., 1996, BIOCONJUGATE TECHNIQ, P783; Hill K., 2008, ALKYL POLYGLYCOSIDES; Hosmer JM, 2011, J PHARM SCI-US, V100, P1444, DOI 10.1002/jps.22370; Hyde S., 2001, HDB APPL SURFACE COL, P299; Innis R. B., 2011, NEUROBIOLOGY OF MENT, P193; Israelachvili JN, 2011, INTERMOLECULAR AND SURFACE FORCES, 3RD EDITION, P1; JONES MN, 1994, ADV DRUG DELIVER REV, V13, P215, DOI 10.1016/0169-409X(94)90013-2; JOUSMA H, 1988, COLLOID POLYM SCI, V266, P640, DOI 10.1007/BF01411505; Karukstis KK, 2012, J PHYS CHEM B, V116, P3816, DOI 10.1021/jp208097c; Kato K, 2006, J DISPER SCI TECHNOL, V27, P1217, DOI 10.1080/01932690600859903; Kawakami S, 1998, BIOCHEM BIOPH RES CO, V252, P78, DOI 10.1006/bbrc.1998.9602; KIWADA H, 1988, CHEM PHARM BULL, V36, P1841; KIWADA H, 1985, CHEM PHARM BULL, V33, P2475; Krause W., 2002, CONTRAST AGENTS II O, V2, P181; Lam SK, 2013, EXPERT REV VACCINES, V12, P995, DOI 10.1586/14760584.2013.824712; Laouini A., 2012, J COLLOID SCI BIOTEC, V1, P147; LAWRENCE MJ, 1994, CHEM SOC REV, V23, P417, DOI 10.1039/cs9942300417; Lazzeroni M, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3233; Li C, 2002, LANGMUIR, V18, P575, DOI 10.1021/la101949e; Lim WH, 2004, COLLOID SURFACE A, V250, P449, DOI 10.1016/j.colsurfa.2004.06.042; Luzzati V, 1968, BIOL MEMBR, P71; Mannock DA, 2004, CURR OPIN COLLOID IN, V8, P426, DOI 10.1016/j.cocis.2004.01.009; MARGALIT R, 1991, J CONTROL RELEASE, V17, P285, DOI 10.1016/0168-3659(91)90147-6; Martin-Moe S., 2010, FORMULATION AND PROC; Marty C., 2005, ADOPTIVE IMMUNOTHERA, P389; Maruyama K, 1999, ADV DRUG DELIVER REV, V40, P89, DOI 10.1016/S0169-409X(99)00042-3; Minamikawa H, 1997, LANGMUIR, V13, P2564, DOI 10.1021/la961037t; Muzykantov V. R., 2002, BIOMEDICAL ASPECTS O; New R. R., 1990, LIPOSOMES A PRACTICA; OMOTOSHO JA, 1989, J MICROENCAPSUL, V6, P183, DOI 10.3109/02652048909098019; Nie SF, 2011, INT J NANOMED, V6, P151, DOI 10.2147/IJN.S15057; Park SN, 2013, BIOCHEM BIOPH RES CO, V435, P361, DOI 10.1016/j.bbrc.2013.04.093; Patel J. P., 2010, ACAD RADIOL, V17, P1199; Rosen MJ, 2012, SURFACTANTS AND INTERFACIAL PHENOMENA, 4TH EDITION, P1, DOI 10.1002/9781118228920; Ruiz C. C., 2010, SUGAR BASED SURFACTA; Sadzuka Y, 2002, INT J PHARM, V238, P171, DOI 10.1016/S0378-5173(02)00075-3; Salim M, 2007, LAB CHIP, V7, P523, DOI 10.1039/b615328c; BRANDLEY BK, 1986, J LEUKOCYTE BIOL, V40, P97; Seddon JM, 1995, HDB BIOL PHYS A&B, V1, P97; SEKIGUCHI A, 1995, COLLOID SURFACE B, V4, P287, DOI 10.1016/0927-7765(94)01180-D; Semple Sean C., 1996, Journal of Liposome Research, V6, P33, DOI 10.3109/08982109609037201; Sezgin Z, 2007, INT J PHARM, V332, P161, DOI 10.1016/j.ijpharm.2006.09.030; Shelton D. K., 2012, FUNDAMENTALS OF DIAG; Simoes S, 1999, CURR OPIN MOL THER, V1, P147; SMALL DM, 1984, J LIPID RES, V25, P1490; Spicer P, 2005, CHEM ENG RES DES, V83, P1283, DOI 10.1205/cherd.05087; Swarnakar NK, 2007, PHARM RES, V24, P2223, DOI 10.1007/s11095-007-9409-y; Tadros T.F., 2013, EMULSION FORMATION A, P1; Takakura Y, 1996, PHARMACEUT RES, V13, P820, DOI 10.1023/A:1016084508097; TAKEOKA S, 1992, J COLLOID INTERF SCI, V152, P351, DOI 10.1016/0021-9797(92)90037-M; Tavano L, 2010, COLLOID SURFACE B, V75, P319, DOI 10.1016/j.colsurfb.2009.09.003; Tiberg F., 2005, BUSINESS BRIEFING PH, P62; Tiwari A., 2013, NANOMATERIALS IN DRU; Torchilin V., 2010, DRUG DELIV, P3, DOI DOI 10.1007/978-3-642-00477-3_1; Uchegbu L., 2003, SYNTHETIC URFACTANT; Ullrich M., 2012, J COLLOID INTERF SCI, V394, P380; Ulrich AS, 2002, BIOSCIENCE REP, V22, P129, DOI 10.1023/A:1020178304031; vanHal DA, 1996, J COLLOID INTERF SCI, V178, P263, DOI 10.1006/jcis.1996.0114; Vernooij EAAM, 2002, LANGMUIR, V18, P3466, DOI 10.1021/la011589y; Webb MS, 1998, BBA-BIOMEMBRANES, V1372, P272, DOI 10.1016/S0005-2736(98)00077-7; ZALIPSKY S, 1995, BIOCONJUGATE CHEM, V6, P150, DOI 10.1021/bc00032a002; Zhu JM, 2007, BIOCONJUGATE CHEM, V18, P1366, DOI 10.1021/bc700212b	175	6	6	ROYAL SOC CHEMISTRY	CAMBRIDGE	THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS, ENGLAND	2040-2503	2040-2511		MEDCHEMCOMM	MedChemComm	NOV	2014	5	11					1602	1618		10.1039/c4md00085d		17	Biochemistry & Molecular Biology; Chemistry, Medicinal	Biochemistry & Molecular Biology; Pharmacology & Pharmacy	AS5OU	WOS:000344320700001		
J	Dell'Orto, S; Masciocchi, D; Villa, S; Meneghetti, F; Celentano, G; Barlocco, D; Colombo, D; Legnani, L; Toma, L; Jeon, YJ; Kwon, BM; Asai, A; Gelain, A				Dell'Orto, Silvia; Masciocchi, Daniela; Villa, Stefania; Meneghetti, Fiorella; Celentano, Giuseppe; Barlocco, Daniela; Colombo, Diego; Legnani, Laura; Toma, Lucio; Jeon, Yoon Jung; Kwon, Byoung-Mog; Asai, Akira; Gelain, Arianna			Modeling, synthesis and NMR characterization of novel chimera compounds targeting STAT3	MEDCHEMCOMM			English	Article							DENSITY-FUNCTIONAL THEORY; ABSOLUTE-CONFIGURATION; INHIBITORS; MOLECULES; SYSTEM	Signal Transducer and Activator of Transcription 3 (STAT3) is a cytoplasmic factor that mediates intracellular signaling commonly generated at cell surface receptors and transmits it to the nucleus. In previous research studies we synthesized several molecules inhibiting STAT3 and among them oxadiazole MD77 and pyridazinone I showed an interesting activity. For the first one, a direct inhibition mechanism was determined, while I interfered within the STAT3 pathway at a different level. In order to discover novel compounds possibly endowed with an improved activity, we decided to merge their scaffolds on the basis of their calculated conformational properties. Therefore we designed and synthesized the chimera diastereomers 3-oxo-N-(4-(trifluoromethyl)phenyl)-2,3,4,4a,5,6-hexahydrobenzo[h]cinnoline-6-carboxamide (1, 2) and 3-oxo-N-(4-(trifluoromethyl)phenyl)-2,3,5,6-tetrahydrobenzo[h] cinnoline-6-carboxamide (3) as racemate and their enantiomeric separation was performed. Modeling studies and theoretical prediction of [a] D values were carried out beside NMR studies which allowed us to assign 1 and 2 relative configurations.	[Dell'Orto, Silvia; Masciocchi, Daniela; Villa, Stefania; Meneghetti, Fiorella; Celentano, Giuseppe; Barlocco, Daniela; Gelain, Arianna] Univ Milan, Dipartimento Sci Farmaceut, I-20133 Milan, Italy; [Colombo, Diego; Legnani, Laura] Univ Milan, Dipartimento Biotecnol Med & Med Traslaz, I-20133 Milan, Italy; [Legnani, Laura; Toma, Lucio] Univ Pavia, Dipartimento Chim, I-27100 Pavia, Italy; [Jeon, Yoon Jung; Kwon, Byoung-Mog] Korea Univ Sci & Technol, Korea Res Inst Biosci & Biotechnol, Lab Chem Biol & Genom, Taejon 305333, South Korea; [Jeon, Yoon Jung; Kwon, Byoung-Mog] Korea Univ Sci & Technol, Dept Biomol Sci, Taejon 305333, South Korea; [Asai, Akira] Univ Shizuoka, Grad Sch Pharmaceut Sci, Ctr Drug Discovery, Suruga Ku, Shizuoka 4228526, Japan	Legnani, L (reprint author), Univ Milan, Dipartimento Biotecnol Med & Med Traslaz, Via Saldini 50, I-20133 Milan, Italy.	arianna.gelain@unimi.it		MENEGHETTI, FIORELLA/0000-0002-6511-7360; Gelain, Arianna/0000-0001-9104-732X; Villa, Stefania/0000-0002-0636-7589; Toma, Lucio/0000-0001-8916-7445	Universities of Milan and Pavia; CINECA; PRIN; Bio&Medical Technology Development Program [2012M3A9C404877]	The authors acknowledge the Universities of Milan and Pavia, and CINECA for the allocation of computer time. This study was supported by funds from PRIN 2010-2011. B.M.K won was supported by the Bio & Medical Technology Development Program (2012M3A9C404877).	Darnell JE, 1997, SCIENCE, V277, P1630, DOI 10.1126/science.277.5332.1630; Helgaker T, 2000, J CHEM PHYS, V113, P9402, DOI 10.1063/1.1321296; Stephens PJ, 2002, ORG LETT, V4, P4595, DOI 10.1021/ol0201714; Shin DS, 2009, CANCER RES, V69, P193, DOI 10.1158/0008-5472.CAN-08-2575; Mennucci B, 2002, J PHYS CHEM A, V106, P6102, DOI 10.1021/jp020124t; WOLINSKI K, 1990, J AM CHEM SOC, V112, P8251, DOI 10.1021/ja00179a005; Zappala M, 2006, J MED CHEM, V49, P575, DOI 10.1021/jm050552y; DITCHFIE.R, 1974, MOL PHYS, V27, P789, DOI 10.1080/00268977400100711; Frisch M. J., 2009, GAUSSIAN 09 REVISION; Giorgio E, 2005, J ORG CHEM, V70, P6557, DOI 10.1021/jo048023+; Masciocchi D, 2012, MEDCHEMCOMM, V3, P592, DOI 10.1039/c2md20018j; Masciocchi D., 2011, FUTURE MED CHEM, V3, P367; Masciocchi D, 2013, MEDCHEMCOMM, V4, P1181, DOI 10.1039/c3md00095h; Petrovic AG, 2005, ORG BIOMOL CHEM, V3, P1977, DOI 10.1039/b501220a; Sherf BA, 1996, PROMEGA NOTES, V57, P2; TOMA L, 1990, J MED CHEM, V33, P1591, DOI 10.1021/jm00168a010; Uehara Y, 2009, BIOCHEM BIOPH RES CO, V380, P627, DOI 10.1016/j.bbrc.2009.01.137	17	0	0	ROYAL SOC CHEMISTRY	CAMBRIDGE	THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS, ENGLAND	2040-2503	2040-2511		MEDCHEMCOMM	MedChemComm	NOV	2014	5	11					1651	1657		10.1039/c4md00177j		7	Biochemistry & Molecular Biology; Chemistry, Medicinal	Biochemistry & Molecular Biology; Pharmacology & Pharmacy	AS5OU	WOS:000344320700005		
J	Kato, T; Funamoto, K; Hayase, T; Sone, S; Kadowaki, H; Shimazaki, T; Jibiki, T; Miyama, K; Liu, L				Kato, Takaumi; Funamoto, Kenichi; Hayase, Toshiyuki; Sone, Shusaku; Kadowaki, Hiroko; Shimazaki, Tadashi; Jibiki, Takao; Miyama, Koji; Liu, Lei			Development and feasibility study of a two-dimensional ultrasonic-measurement-integrated blood flow analysis system for hemodynamics in carotid arteries	MEDICAL & BIOLOGICAL ENGINEERING & COMPUTING			English	Article						Hemodynamics; Ultrasound color Doppler imaging; Computational fluid dynamics; Measurement-integrated simulation; Carotid artery	SHEAR-STRESS; IN-VIVO; SIMULATION; COMMON; BIFURCATION; PROFILES; MODELS; AORTA	Prevention and early detection of atherosclerosis are critical for protection against subsequent circulatory disease. In this study, an automated two-dimensional ultrasonic-measurement-integrated (2D-UMI) blood flow analysis system for clinical diagnosis was developed, and the feasibility of the system for hemodynamic analysis in a carotid artery was revealed. The system automatically generated a 2D computational domain based on ultrasound color Doppler imaging and performed a UMI simulation of blood flow field to visualize hemodynamics in the domain. In the UMI simulation, compensation of errors was applied by adding feedback signals proportional to the differences between Doppler velocities by measurement and computation while automatically estimating the cross-sectional average inflow velocity. The necessity of adjustment of the feedback gain was examined by analyzing blood flow in five carotid arteries: three healthy, one sclerosed, and one stenosed. The same feedback gain was generally applicable for the 2D-UMI simulation in all carotid arteries, depending on target variables. Thus, the present system was shown to be versatile in the sense that the parameter is patient independent. Moreover, the possibility of a new diagnostic method based on the hemodynamic information obtained by the 2D-UMI simulation, such as a waveform of the cross-sectional average inflow velocity and wall shear stress distributions, was suggested.	[Kato, Takaumi; Sone, Shusaku] Tohoku Univ, Grad Sch Biomed Engn, Sendai, Miyagi 9808579, Japan; [Funamoto, Kenichi; Hayase, Toshiyuki] Tohoku Univ, Inst Fluid Sci, Aoba Ku, Sendai, Miyagi 9808577, Japan; [Kadowaki, Hiroko] Tohoku Univ, Grad Sch Engn, Sendai, Miyagi 9808579, Japan; [Shimazaki, Tadashi; Jibiki, Takao; Miyama, Koji; Liu, Lei] GE Healthcare Japan, Hino, Tokyo 1918503, Japan	Funamoto, K (reprint author), Tohoku Univ, Inst Fluid Sci, Aoba Ku, 2-1-1 Katahira, Sendai, Miyagi 9808577, Japan.	funamoto@reynolds.ifs.tohoku.ac.jp			 [24360064]	Part of this study was supported by Grant-in-Aid for Scientific Research (B) (24360064). All computations were performed using the supercomputer system at the Advanced Fluid Information (AFI) Research Center, Institute of Fluid Science, Tohoku University.	Moyle KR, 2006, J BIOMECH ENG-T ASME, V128, P371, DOI 10.1115/1.2187035; Manbachi A, 2011, PHYSIOL MEAS, V32, P1885, DOI 10.1088/0967-3334/32/12/001; Funamoto K, 2005, ANN BIOMED ENG, V33, P415, DOI 10.1007/s10439-005-2495-2; Lee SW, 2009, J BIOMECH ENG-T ASME, V131, DOI 10.1115/1.3127252; Hoi Y, 2010, J BIOMECH ENG-T ASME, V132, DOI 10.1115/1.4001265; Tortoli P, 2003, ULTRASOUND MED BIOL, V29, P407, DOI 10.1016/S0301-5629(02)00705-6; Filipovic N, 2013, MED BIOL ENG COMPUT, V51, P607, DOI 10.1007/s11517-012-1031-4; Gelfand BD, 2006, J MAGN RESON IMAGING, V24, P1386, DOI 10.1002/jmri.20765; Ford MD, 2008, PHYSIOL MEAS, V29, P1335, DOI 10.1088/0967-3334/29/11/008; Kamenskiy AV, 2011, J VASC SURG, V54, P1011, DOI 10.1016/j.jvs.2011.03.254; Reneman RS, 2008, MED BIOL ENG COMPUT, V46, P499, DOI 10.1007/s11517-008-0330-2; Wake AK, 2009, J BIOMECH ENG-T ASME, V131, DOI 10.1115/1.3005157; HAYASE T, 1992, J COMPUT PHYS, V98, P108, DOI 10.1016/0021-9991(92)90177-Z; Steinman DA, 2002, ANN BIOMED ENG, V30, P483, DOI 10.1114/1.1467679; Funamoto K, 2013, INT J NUMER METH BIO, V29, P726, DOI 10.1002/cnm.2522; Funamoto K, 2006, JSME INT J C-MECH SY, V49, P144, DOI 10.1299/jsmec.49.144; Funamoto K, 2008, ANN BIOMED ENG, V36, P1383, DOI 10.1007/s10439-008-9519-7; Funamoto K, 2009, ANN BIOMED ENG, V37, P34, DOI 10.1007/s10439-008-9600-2; Funamoto K, 2011, IEEE T BIO-MED ENG, V58, P653, DOI 10.1109/TBME.2010.2095418; Morbiducci U, 2010, ANN BIOMED ENG, V38, P3688, DOI 10.1007/s10439-010-0102-7; Patankar S. V., 1980, NUMERICAL HEAT TRANS; Poepping TL, 2010, ULTRASOUND MED BIOL, V36, P1125, DOI 10.1016/j.ultrasmedbio.2010.02.005; Press WH, 1986, NUMERICAL RECIPES, V1st, P274; Santhiyakumari N, 2011, MED BIOL ENG COMPUT, V49, P1299, DOI 10.1007/s11517-011-0800-9; Schneider G. E., 1981, NUMER HEAT TRANSFER, V4, P1; The Joint Committee of The Japan Academy of Neurosonology and The Japan Society of Embolus Detection and Treatment on Guideline for Neurosonology, 2006, NEUROSONOLOGY, V19, P49	26	2	3	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	0140-0118	1741-0444		MED BIOL ENG COMPUT	Med. Biol. Eng. Comput.	NOV	2014	52	11					933	943		10.1007/s11517-014-1193-3		11	Computer Science, Interdisciplinary Applications; Engineering, Biomedical; Mathematical & Computational Biology; Medical Informatics	Computer Science; Engineering; Mathematical & Computational Biology; Medical Informatics	AS1XT	WOS:000344074300003		
J	Takagi, S; Murase, N; Kime, R; Niwayama, M; Osada, T; Katsumura, T				Takagi, Shun; Murase, Norio; Kime, Ryotaro; Niwayama, Masatsugu; Osada, Takuya; Katsumura, Toshihito			Skeletal Muscle Deoxygenation Abnormalities in Early Post-Myocardial Infarction	MEDICINE AND SCIENCE IN SPORTS AND EXERCISE			English	Article						NEAR INFRARED SPECTROSCOPY; OXYGEN TRANSPORT; CYCLING EXERCISE; HEART DISEASE; MICROCIRCULATION	NEAR-INFRARED SPECTROSCOPY; CHRONIC HEART-FAILURE; PERIPHERAL ARTERIAL-DISEASE; VENOUS OXYGEN-SATURATION; SUPINE BICYCLE EXERCISE; MYOCARDIAL-INFARCTION; GAS-EXCHANGE; METABOLIC ABNORMALITIES; OXIDATIVE-METABOLISM; ANAEROBIC THRESHOLD	Purpose: Reduced peak aerobic capacity in chronic heart failure can be partly explained by impaired peripheral factors. However, skeletal muscle deoxygenation responses during exercise and their relation to peak aerobic capacity have not been fully established in early post-myocardial infarction (MI) patients. Methods: Patients early post-MI (age, 61 +/- 9 yr; n = 16; 21 +/- 8 d after the first MI) and age-, height-, and weight-matched control participants (age, 61 +/- 9 yr; n = 18) performed a ramp cycling exercise until exhaustion. Near-infrared spectroscopy at the belly of the vastus lateralis muscle in the left leg was recorded continuously for measurement of skeletal muscle deoxygenation responses during exercise. Results: Peak oxygen uptake (18.4 +/- 3.5 vs 28.2 +/- 10.7 mL.kg(-1).min(-1), P < 0.01) was significantly lower in MI. Change in muscle oxygen saturation from rest to peak exercise (Delta SmO2) was significantly greater in MI than that in controls (2.5% +/- 5.6% vs -7.4% +/- 3.4%, P < 0.01). Relative change in deoxygenated hemoglobin/myoglobin concentration from rest to peak exercise (Delta deoxy-Hb/Mb) was significantly lower in MI than that in controls (0.1 +/- 3.6 vs 8.7 +/- 6.4 mu M, P < 0.01). In contrast, change in total hemoglobin/myoglobin, which is an indicator of blood volume, was not significantly different between groups. Peak oxygen uptake was negatively correlated with Delta SmO2 (r = -0.53, P < 0.05) and positively associated with Delta deoxy-Hb/Mb at peak exercise (r = 0.65, P < 0.01) in MI. Conclusions: Skeletal muscle deoxygenation abnormalities were observed during dynamic cycling exercise in early post-MI patients. These abnormalities were related to impaired peak aerobic capacity in early post-MI patients.	[Takagi, Shun; Murase, Norio; Kime, Ryotaro; Osada, Takuya; Katsumura, Toshihito] Tokyo Med Univ, Dept Sports Med Hlth Promot, Tokyo 1608402, Japan; [Niwayama, Masatsugu] Shizuoka Univ, Fac Engn, Dept Elect & Elect Engn, Shizuoka, Japan	Takagi, S (reprint author), Tokyo Med Univ, Dept Sports Med Hlth Promot, Shinjuku Ku, 6-1-1 Shinjuku, Tokyo 1608402, Japan.	stakagi@tokyo-med.ac.jp			Japan Society for the Promotion of Science [12J06298, 24500799]	This work was supported in part by grant-in-aid for scientific research from the Japan Society for the Promotion of Science (12J06298 to S. T. and 24500799 to R. K.).	Adamopoulos S, 1999, J MOL CELL CARDIOL, V31, P1913, DOI 10.1006/jmcc.1999.1024; Hammond RL, 2001, J APPL PHYSIOL, V90, P55; Poole DC, 2012, AM J PHYSIOL-HEART C, V302, pH1050, DOI 10.1152/ajpheart.00943.2011; Rossiter HB, 2011, COMPR PHYSIOL, V1, P203, DOI 10.1002/cphy.c090010; SULLIVAN MJ, 1989, CIRCULATION, V80, P769; BEAVER WL, 1986, J APPL PHYSIOL, V60, P2020; Lanfranconi F, 2006, MED SCI SPORT EXER, V38, P1374, DOI 10.1249/01.mss.0000228943.62776.69; Day JR, 2003, J APPL PHYSIOL, V95, P1901, DOI 10.1152/japplphysiol.00024.2003; DREXLER H, 1992, CIRCULATION, V85, P1751; WILSON JR, 1989, CIRCULATION, V80, P1668; DREXLER H, 1986, BASIC RES CARDIOL, V81, P350, DOI 10.1007/BF01907456; Bauer TA, 2007, EUR J APPL PHYSIOL, V100, P143, DOI 10.1007/s00421-007-0412-0; GORDON NF, 1991, MED SCI SPORT EXER, V23, P668; Tew GA, 2010, EUR J APPL PHYSIOL, V110, P1083, DOI 10.1007/s00421-010-1596-2; Mezzani A, 2013, INT J CARDIOL, V167, P2189, DOI 10.1016/j.ijcard.2012.05.124; Belardinelli R, 1995, G Ital Cardiol, V25, P715; Boone J, 2008, RESP PHYSIOL NEUROBI, V161, P291, DOI 10.1016/j.resp.2008.03.008; Ding H, 2001, BRIT J SPORT MED, V35, P441, DOI 10.1136/bjsm.35.6.441; DREXLER H, 1986, J AM COLL CARDIOL, V8, P134; Esaki K, 2005, EUR J APPL PHYSIOL, V95, P361, DOI 10.1007/s00421-005-008-5; Grassi B, 2007, MUSCLE NERVE, V35, P510, DOI 10.1002/mus.20708; Hamaoka T, 2007, J BIOMED OPT, V12, DOI 10.1117/1.2805437; Komiyama T, 2001, CLIN SCI, V101, P715, DOI 10.1042/CS20010233; Marchionni N, 2000, J AM GERIATR SOC, V48, P146; Mettaure B, 2001, J AM COLL CARDIOL, V38, P947, DOI 10.1016/S0735-1097(01)01460-7; Meyer K, 1998, MED SCI SPORT EXER, V30, P643, DOI 10.1097/00005768-199805000-00001; Mohler ER, 2006, DIABETES CARE, V29, P1856, DOI 10.2337/dc06-0182; NAKANISHI N, 1993, CHEST, V104, P419, DOI 10.1378/chest.104.2.419; Niwayama M, 2012, J JAPANESE COLL ANGI, V52, P211; Poole DC, 2008, EUR J APPL PHYSIOL, V103, P117, DOI 10.1007/s00421-007-0668-4; POWERS SK, 1988, EUR J APPL PHYSIOL O, V58, P298, DOI 10.1007/BF00417266; Spencer CT, 2011, AM J PHYSIOL-HEART C, V301, pH2122, DOI 10.1152/ajpheart.00479.2010; Stallknecht B, 2001, J PHYSIOL-LONDON, V536, P283, DOI 10.1111/j.1469-7793.2001.00283.x; Sumimoto T, 1996, AM J CARDIOL, V78, P841, DOI 10.1016/S0002-9149(96)00421-3; SUMIMOTO T, 1993, CHEST, V103, P514, DOI 10.1378/chest.103.2.514; Takagi S, 2013, ADV EXP MED BIOL, V765, P273, DOI 10.1007/978-1-4614-4989-8_38; TAKAISHI T, 1992, EUR J APPL PHYSIOL O, V65, P335, DOI 10.1007/BF00868137; THOMPSON CH, 1994, CLIN SCI, V87, P403; THOMPSON CH, 1995, CARDIOVASC RES, V29, P344, DOI 10.1016/S0008-6363(96)88591-9; WASSERMA.K, 1973, J APPL PHYSIOL, V35, P236	40	2	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0195-9131	1530-0315		MED SCI SPORT EXER	Med. Sci. Sports Exerc.	NOV	2014	46	11					2062	2069		10.1249/MSS.0000000000000334		8	Sport Sciences	Sport Sciences	AS3AU	WOS:000344148600004		
J	Miyamoto, N; Kawakami, Y				Miyamoto, Naokazu; Kawakami, Yasuo			Effect of Pressure Intensity of Compression Short-Tight on Fatigue of Thigh Muscles	MEDICINE AND SCIENCE IN SPORTS AND EXERCISE			English	Article						MAGNETIC RESONANCE IMAGING; TRANSVERSE RELAXATION TIME; TREADMILL RUNNING; HAMSTRING; HIP ADDUCTORS; MALE ADULTS	MAGNETIC-RESONANCE; SKELETAL-MUSCLE; EXERCISE; GARMENTS; PERFORMANCE; ACTIVATION; STOCKINGS; RECOVERY; PH	Purpose: Existing studies have failed to provide evidence of a positive effect on exercise performance by wearing compression short tights covering only both thighs. This could be due to an inadequate pressure intensity that otherwise has a significant effect if applied on the crucial point in the thigh. This study aimed to examine the effect of pressure intensity of elastic compression short-tights on the metabolic state of thigh muscles during submaximal running. Methods: Two groups of 11 male subjects performed treadmill running at 12 km.h(-1) in three conditions in each of experiment 1 (short-tights with a compression intensity at the thigh of 8 mm Hg (LOW) and 15 mm Hg (MID) and noncompression shorts as control (CON1)) and experiment 2 (short-tights with 20 mm Hg (MID-HIGH) and 25 mm Hg (HIGH) and CON2). Before and immediately after the running exercises, T2-weighted magnetic resonance images of the right thigh were obtained without testing garments. From the images, skeletal muscle proton transverse relaxation time (T2) of each muscle in the thigh was calculated. Results: T2 was significantly increased after the treadmill running in all conditions in the hamstring and adductor muscles. In experiment 1, after the running, T2 elevation was significantly smaller in MID than that in CON1 for the biceps femoris, semimembranosus, adductor longus, and adductor magnus muscles. In experiment 2, after the running, T2 elevation was significantly lower in MID-HIGH than that in CON2 and HIGH for the biceps femoris, semimembranosus, and adductor longus. Conclusions: The findings suggest that wearing compression short tights with a pressure intensity of 15-20 mm Hg at the thigh can reduce development of fatigue of exercising muscles during submaximal running exercise in healthy adult males.	[Miyamoto, Naokazu] Natl Inst Fitness & Sports Kanoya, Kanoya, Kagoshima 8912393, Japan; [Kawakami, Yasuo] Waseda Univ, Fac Sport Sci, Tokorozawa, Saitama, Japan	Miyamoto, N (reprint author), Natl Inst Fitness & Sports Kanoya, 1 Shiromizu, Kanoya, Kagoshima 8912393, Japan.	miyamoto@nifs-k.jp					Agu Obi, 2004, Vascular, V12, P69; Akima H, 1999, MED SCI SPORT EXER, V31, P588, DOI 10.1097/00005768-199904000-00016; Doan BK, 2003, J SPORT SCI, V21, P601, DOI 10.1080/0264041031000101971; Kraemer WJ, 2010, J STRENGTH COND RES, V24, P804, DOI 10.1519/JSC.0b013e3181d33025; Ibegbuna V, 2003, J VASC SURG, V37, P420, DOI 10.1067/mva.2003.104; [Anonymous], 1996, J STRENGTH COND RES; Westerblad H, 1997, J PHYSIOL-LONDON, V500, P193; Bringard A, 2006, INT J SPORTS MED, V27, P373, DOI 10.1055/s-2005-865718; Vandenborne K, 2000, EUR J APPL PHYSIOL, V82, P76, DOI 10.1007/s004210050654; Wakahara T, 2013, MED SCI SPORT EXER, V45, P2158, DOI 10.1249/MSS.0b013e3182995349; Wakahara T, 2012, EUR J APPL PHYSIOL, V112, P1569, DOI 10.1007/s00421-011-2121-y; MacRae BA, 2011, SPORTS MED, V41, P815, DOI 10.2165/11591420-000000000-00000; Scanlan AT, 2008, INTJ SPORT PHYSIOL, V3, P424; ADAMS GR, 1992, J APPL PHYSIOL, V73, P1578; Bernhardt T, 2005, J STRENGTH COND RES, V19, P292; BERRY MJ, 1987, AM J PHYS MED REHAB, V66, P121; Bringard A, 2006, J SPORT MED PHYS FIT, V46, P548; CHENG HA, 1995, J APPL PHYSIOL, V79, P1370; DAWSON MJ, 1978, NATURE, V274, P861; FLECKENSTEIN JL, 1991, J APPL PHYSIOL, V71, P961; Goh SS, 2011, EUR J APPL PHYSIOL, V111, P819, DOI 10.1007/s00421-010-1705-2; Kinugasa R, 2005, J APPL PHYSIOL, V99, P1149, DOI 10.1152/japplphysiol.01160.2004; Kraemer WJ, 1998, SPORTS MED TRAIN REH, V8, P163; Kraemer WJ, 1998, J STRENGTH COND RES, V12, P211; Maton B, 2006, EUR J APPL PHYSIOL, V97, P432, DOI 10.1007/s00421-006-0187-8; Matsumoto N, 2013, J TRAIN SCI EXERC SP, V25, P55; Miyamoto N, 2011, J ELECTROMYOGR KINES, V21, P249, DOI 10.1016/j.jelekin.2010.08.006; Rassier DE, 2002, J APPL PHYSIOL, V92, P1293, DOI 10.1152/japplphysiol.00912.2001; YUE G, 1994, J APPL PHYSIOL, V77, P84	29	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0195-9131	1530-0315		MED SCI SPORT EXER	Med. Sci. Sports Exerc.	NOV	2014	46	11					2168	2174		10.1249/MSS.0000000000000330		7	Sport Sciences	Sport Sciences	AS3AU	WOS:000344148600017		
J	Aizawa, T; Tanaka, HL; Satoh, M				Aizawa, Takuro; Tanaka, H. L.; Satoh, Masaki			Rapid development of arctic cyclone in June 2008 simulated by the cloud resolving global model NICAM	METEOROLOGY AND ATMOSPHERIC PHYSICS			English	Article							CLIMATOLOGY; REANALYSIS	In this study, we conducted a numerical simulation of a rapid development of an arctic cyclone (AC) that appeared in June 2008 using a cloud resolving global model, Nonhydrostatic ICosahedral Atmospheric Model (NICAM). We investigated the three dimensional structure and intensification mechanism of the simulated AC that developed to the minimum sea level pressure of 971 hPa in the model. According to the result, the AC indicates a barotropic structure with a warm core in the lower stratosphere and a cold core in the troposphere. The development of the AC is accompanied by an intense mesoscale cyclone (MC) showing baroclinic structure with a marked local arctic front. The upper level warm core of the AC is formed by an adiabatic heating associated with the downdraft in the lower stratosphere. The rapid development of the AC is caused by the combination of the intensification of the upper level warm core and the merging with the baroclinically growing MC in the lower level. The merging of the AC and MC and the vertical vortex coupling with the upper air polar vortex are the most important mechanisms for the rapid development of the arctic cyclone.	[Aizawa, Takuro] Univ Tsukuba, Grad Sch Life & Environm Sci, Tsukuba, Ibaraki 3050877, Japan; [Tanaka, H. L.] Univ Tsukuba, Ctr Computat Sci, Tsukuba, Ibaraki 3050877, Japan; [Satoh, Masaki] Univ Tokyo, Atmosphere & Ocean Res Inst, Kashiwa, Chiba 2778564, Japan	Aizawa, T (reprint author), Univ Tsukuba, Grad Sch Life & Environm Sci, 1-1-1 Tennoudai, Tsukuba, Ibaraki 3050877, Japan.	s1230210@u.tsukuba.ac.jp	Satoh, Masaki/G-3325-2015	Satoh, Masaki/0000-0003-3580-8897	GRENE Arctic Climate Change Research Project	This study was partly supported by the GRENE Arctic Climate Change Research Project. Our colleague Mr. Akio Yamagami and Mr. Shinji Takahashi provided this study with thankful information. This research was conducted as a part of the joint works of the general circulation laboratory at the Center for Computational Sciences of the University of Tsukuba.	Adachi S, 2007, SOLA, V3, P113, DOI 10.2151/sola.2007-029; Nakanishi M, 2004, BOUND-LAY METEOROL, V112, P1, DOI 10.1023/B:BOUN.0000020164.04146.98; Stroeve JC, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2004GL021810; Grabowski WW, 1998, J ATMOS SCI, V55, P3283, DOI 10.1175/1520-0469(1998)055<3283:TCRMOL>2.0.CO;2; Simmonds I, 2008, J CLIMATE, V21, P5777, DOI 10.1175/2008JCLI2366.1; [Anonymous], 2007, GEOPHYS RES LETT, DOI DOI 10.1029/2007GL029703; Satoh M, 2008, J COMPUT PHYS, V227, P3486, DOI 10.1016/j.jcp.2007.02.006; Serreze MC, 2001, J CLIMATE, V14, P1550, DOI 10.1175/1520-0442(2001)014<1550:TAFZAS>2.0.CO;2; Zhang XD, 2004, J CLIMATE, V17, P2300, DOI 10.1175/1520-0442(2004)017<2300:CAIVOA>2.0.CO;2; Cavalieri DJ, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2003GL018031; Inoue J, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL047696; LeDrew E. F., 1989, GeoJournal, V18, DOI 10.1007/BF00722390; LeDrew E. F., 1984, ATMOS OCEAN, V22, P309; LeDrew EF, 1987, J CLIM APPL METEOROL, V8, P125; Serreze M. C., 2007, J CLIMATOL, V21, P1048; Simmonds I, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL039810; Takahashi S, 2009, THESIS U TUSKUBA JAP; Tanaka HL, 2012, POLAR SCI, V6, P55, DOI 10.1016/j.polar.2012.03.001	18	1	1	SPRINGER WIEN	WIEN	SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA	0177-7971	1436-5065		METEOROL ATMOS PHYS	Meteorol. Atmos. Phys.	NOV	2014	126	3-4					105	117		10.1007/s00703-013-0272-6		13	Meteorology & Atmospheric Sciences	Meteorology & Atmospheric Sciences	AS5TN	WOS:000344332500001		
J	Lee, K; Kobayashi, N; Watanabe, M; Sugita-Konishi, Y; Tsubone, H; Kumagai, S; Hara-Kudo, Y				Lee, Ken-ichi; Kobayashi, Naoki; Watanabe, Maiko; Sugita-Konishi, Yoshiko; Tsubone, Hirokazu; Kumagai, Susumu; Hara-Kudo, Yukiko			Spread and change in stress resistance of Shiga toxin-producing Escherichia coli O157 on fungal colonies	MICROBIAL BIOTECHNOLOGY			English	Article							BIOFILM FORMATION; SURFACE HYDROPHOBICITY; DEGRADING BACTERIA; MYCORRHIZAL FUNGUS; SOIL; SALMONELLA; SURVIVAL; GROWTH; FOOD; MECHANISMS	To elucidate the effect of fungal hyphae on the behaviour of Shiga toxin-producing Escherichia coli (STEC) O157, the spread and change in stress resistance of the bacterium were evaluated after coculture with 11 species of food-related fungi including fermentation starters. Spread distances of STEC O157 varied depending on the co-cultured fungal species, and the motile bacterial strain spread for longer distances than the non-motile strain. The population of STEC O157 increased when co-cultured on colonies of nine fungal species but decreased on colonies of Emericella nidulans and Aspergillus ochraceus. Confocal scanning microscopy visualization of green fluorescent protein-tagged STEC O157 on fungal hyphae revealed that the bacterium colonized in the water film that existed on and between hyphae. To investigate the physiological changes in STEC O157 caused by co-culturing with fungi, the bacterium was harvested after 7 days of co-culturing and tested for acid resistance. After co-culture with eight fungal species, STEC O157 showed greater acid resistance compared to those cultured without fungi. Our results indicate that fungal hyphae can spread the contamination of STEC O157 and can also enhance the stress resistance of the bacteria.	[Lee, Ken-ichi; Sugita-Konishi, Yoshiko; Tsubone, Hirokazu; Kumagai, Susumu; Hara-Kudo, Yukiko] Univ Tokyo, Grad Sch Agr & Life Sci, Bunkyo Ku, Tokyo 1138657, Japan; [Kobayashi, Naoki; Watanabe, Maiko; Sugita-Konishi, Yoshiko; Hara-Kudo, Yukiko] Natl Inst Hlth Sci, Div Microbiol, Setagaya Ku, Tokyo 1588501, Japan	Hara-Kudo, Y (reprint author), Univ Tokyo, Grad Sch Agr & Life Sci, Bunkyo Ku, 1-1-1 Yayoi, Tokyo 1138657, Japan.	ykudo@nihs.go.jp			Research Fellowships of the Japan Society for the Promotion of Science for Young Scientists	This study was partially supported by the Research Fellowships of the Japan Society for the Promotion of Science for Young Scientists.	Irlinger F, 2009, CURR OPIN BIOTECH, V20, P142, DOI 10.1016/j.copbio.2009.02.016; Leveau JHJ, 2008, NEW PHYTOL, V177, P859, DOI 10.1111/j.1469-8137.2007.02325.x; Franz E, 2008, CRIT REV MICROBIOL, V34, P143, DOI 10.1080/10408410802357432 ; Shanks RMQ, 2007, J BACTERIOL, V189, P7262, DOI 10.1128/JB.00859-07; Zhang XS, 2007, J BACTERIOL, V189, P3051, DOI 10.1128/JB.01832-06; SU CY, 1995, ANN INTERN MED, V123, P698; Frey-Klett P, 2011, MICROBIOL MOL BIOL R, V75, P583, DOI 10.1128/MMBR.00020-11; Rashid MH, 2000, P NATL ACAD SCI USA, V97, P4885, DOI 10.1073/pnas.060030097; Warmink JA, 2009, ENVIRON MICROBIOL, V11, P300, DOI 10.1111/j.1462-2920.2008.01767.x; Kubota H, 2009, FOOD MICROBIOL, V26, P592, DOI 10.1016/j.fm.2009.04.001; Nazir R, 2010, FEMS MICROBIOL ECOL, V71, P169, DOI 10.1111/j.1574-6941.2009.00807.x; Warmink JA, 2011, SOIL BIOL BIOCHEM, V43, P760, DOI 10.1016/j.soilbio.2010.12.009; Dykes GA, 2003, INT J FOOD MICROBIOL, V89, P1, DOI 10.1016/S0168-1605(03)00123-5; Baylis CL, 2009, INT J DAIRY TECHNOL, V62, P293, DOI 10.1111/j.1471-0307.2009.00504.x; Warmink JA, 2008, ISME J, V2, P887, DOI 10.1038/ismej.2008.41; Coburn B, 2007, CLIN MICROBIOL REV, V20, P535, DOI 10.1128/CMR.00013-07; Wargo MJ, 2006, CURR OPIN MICROBIOL, V9, P359, DOI 10.1016/j.mib.2006.06.001; Warmink JA, 2009, APPL ENVIRON MICROB, V75, P2820, DOI 10.1128/AEM.02110-08; Kohlmeier S, 2005, ENVIRON SCI TECHNOL, V39, P4640, DOI 10.1021/es047979z; VOGEL HJ, 1956, J BIOL CHEM, V218, P97; Bianciotto V, 1996, PROTOPLASMA, V193, P123, DOI 10.1007/BF01276640; Lin JS, 1996, APPL ENVIRON MICROB, V62, P3094; Barkley W. Emmett, 1994, P715; Bevilacqua A, 2008, J FOOD PROTECT, V71, P1366; Chau HW, 2010, LETT APPL MICROBIOL, V50, P295, DOI 10.1111/j.1472-765X.2009.02791.x; Cibelli F, 2008, J FOOD PROTECT, V71, P2129; Cuny C, 2007, APPL ENVIRON MICROB, V73, P885, DOI 10.1128/AEM.01874-06; Erickson MC, 2007, J FOOD PROTECT, V70, P2426; Furuno S, 2010, ENVIRON MICROBIOL, V12, P1391, DOI 10.1111/j.1462-2920.2009.02022.x; Gawande PV, 2002, APPL ENVIRON MICROB, V68, P86, DOI 10.1128/AEM.68.1.86-92.2002; Gurtler JB, 2013, APPL ENVIRON MICROB, V79, P1813, DOI 10.1128/AEM.02855-12; Gyles CL, 2007, J ANIM SCI, V85, pE45, DOI 10.2527/jas.2006-508; LEBEN C, 1984, PHYTOPATHOLOGY, V74, P983, DOI 10.1094/Phyto-74-983; Lee K, 2012, APPL ENVIRON MICROB, V78, P3361, DOI 10.1128/AEM.06646-11; Lee K, 2012, J FOOD SCI, V77, pM102, DOI 10.1111/j.1750-3841.2011.02533.x; Moreira CG, 2006, J BACTERIOL, V188, P3952, DOI 10.1128/JB.00177-06; National Institute of Infectious Diseases, 2011, INFECT AGENTS SURVEI, V32, P125; RAHARDJO YSP, 2007, MYCOLOGY S, V25, P241; Sambrook J, 2001, MOLECULAR CLONING A; Seneviratne G, 2008, WORLD J MICROB BIOT, V24, P739, DOI 10.1007/s11274-007-9539-8; Shaw RK, 2008, APPL ENVIRON MICROB, V74, P2908, DOI 10.1128/AEM.02704-07; Sun YP, 1999, MYCORRHIZA, V9, P137, DOI 10.1007/s005720050298; Wick LY, 2007, ENVIRON SCI TECHNOL, V41, P500, DOI 10.1021/es061407s; WONG PTW, 1976, SOIL BIOL BIOCHEM, V8, P219, DOI 10.1016/0038-0717(76)90007-9	44	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1751-7907	1751-7915		MICROB BIOTECHNOL	Microb. Biotechnol.	NOV	2014	7	6			SI		621	629		10.1111/1751-7915.12071		9	Biotechnology & Applied Microbiology; Microbiology	Biotechnology & Applied Microbiology; Microbiology	AS6TB	WOS:000344394000012		
J	Yabutani, T; Waterhouse, GIN; Sun-Waterhouse, D; Metson, JB; Iinuma, A; Thuy, LTX; Yamada, Y; Takayanagi, T; Motonaka, J				Yabutani, Tomoki; Waterhouse, Geoffrey I. N.; Sun-Waterhouse, Dongxiao; Metson, James B.; Iinuma, Akiko; Le Thi Xuan Thuy; Yamada, Yohei; Takayanagi, Toshio; Motonaka, Junko			Facile synthesis of platinum nanoparticle-containing porous carbons, and their application to amperometric glucose biosensing	MICROCHIMICA ACTA			English	Article						Agarose; Electrocatalysis; Glucose biosensing; Platinum nanoparticle; Porous carbon; Polyol synthesis	PASTE ELECTRODE; FUEL-CELLS; GEL; DEHYDROGENATION; CYCLOHEXANE; FABRICATION; COMPOSITES; CATALYSTS; NETWORKS; FIBERS	This study describes the facile synthesis of platinum nanoparticle-containing porous carbons (Pt/C) by carbonization of freeze-dried agarose gels containing potassium tetrachloroplatinate under a nitrogen atmosphere at 800 A degrees C. By adjusting the ratio between agarose and platinate in the freeze-dried gels, the Pt content in the final Pt/C products could be systematically varied from 0-10 wt.%. Transmission electron microscopy, inductively coupled plasma atomic emission spectrometry, X-ray photoelectron spectroscopy, Raman spectroscopy, and nitrogen physisorption measurements revealed that the Pt/C materials obtained by this method possess high surface areas (350-500 m(2) g(-1)), narrow Pt nanoparticle size distributions (6 +/- 3 nm) and nanocrystalline graphite -like carbon character. By immobilization of glucose oxidase on the surface of a 4 wt.% Pt/C electrocatalyst prepared by this route, a very sensitive amperometric glucose biosensor was obtained (response time < 2 min, sensitivity 1.9 mA M-1; and a linear response with glucose concentration up to 10 mM). The simplicity and versatility of the described synthetic method suggests its application to the preparation of carbon supported noble metal catalysts including palladium/C and gold/C.	[Yabutani, Tomoki; Iinuma, Akiko; Le Thi Xuan Thuy; Yamada, Yohei; Takayanagi, Toshio; Motonaka, Junko] Univ Tokushima, Inst Sci & Technol, Dept Life Syst, Tokushima 7708506, Japan; [Waterhouse, Geoffrey I. N.; Sun-Waterhouse, Dongxiao; Metson, James B.] Univ Auckland, Sch Chem Sci, Auckland 1142, New Zealand; [Le Thi Xuan Thuy] Danang Univ Technol, Fac Environm, Danang City, Vietnam	Yabutani, T (reprint author), Univ Tokushima, Inst Sci & Technol, Dept Life Syst, 2-1 Minamijosanjima, Tokushima 7708506, Japan.	yabutani@chem.tokushima-u.ac.jp; g.waterhouse@auckland.ac.nz		Waterhouse, Geoffrey/0000-0002-3296-3093	University of Tokushima; (KAKENHI) from Japan Society for the Promotion of Science (JSPS) [25870473]; Australian Institute for Nuclear Science and Engineering [ALNGRA10131]; MacDiarmid Institute for Advanced Materials and Nanotechnology; JSPS [S-13179]	T.Y. acknowledges support in part by the international education and research exchange program from The University of Tokushima and Grant-in-Aid for Challenging Exploratory Research (KAKENHI No. 25870473), from Japan Society for the Promotion of Science (JSPS). GINW acknowledges funding support from the Australian Institute for Nuclear Science and Engineering (ALNGRA10131), the MacDiarmid Institute for Advanced Materials and Nanotechnology, and from JSPS for the Invitation Fellowship for Research in Japan (S-13179)	You CP, 2009, MICROCHIM ACTA, V167, P109, DOI 10.1007/s00604-009-0228-1; You CP, 2009, TALANTA, V78, P705, DOI 10.1016/j.talanta.2008.12.032; Nakagawa K, 2012, APPL CATAL A-GEN, V419, P13, DOI 10.1016/j.apcata.2011.12.020; Tani Y, 2008, ANAL CHIM ACTA, V619, P215, DOI 10.1016/j.aca.2008.04.063; Fujiwara N, 2007, J POWER SOURCES, V164, P457, DOI 10.1016/j.jpowsour.2006.10.08; Su FB, 2010, ENERG FUEL, V24, P3727, DOI 10.1021/ef901275q; Bonet F, 1999, NANOSTRUCT MATER, V11, P1277, DOI 10.1016/S0965-9773(99)00419-5; Vines F, 2010, CHEM-EUR J, V16, P6530, DOI 10.1002/chem.201000296; Wang XD, 2011, CHEMCATCHEM, V3, P1763, DOI 10.1002/cctc.201100213; Chand S, 2000, J MATER SCI, V35, P1303, DOI 10.1023/A:1004780301489; Male KB, 2007, ANALYST, V132, P1254, DOI 10.1039/b712478c; Silvert PY, 1997, J MATER CHEM, V7, P293, DOI 10.1039/a605347e; Colin-Orozco E, 2012, INT J ELECTROCHEM SC, V7, P6097; Dembowski J., 1993, Surface Science Spectra, V2, DOI 10.1116/1.1247716; Faoucher E, 2009, CHEM COMMUN, P6661, DOI 10.1039/b915787e; He JH, 2004, CHEM COMMUN, P410, DOI 10.1039/b314407k; Huang FZ, 2006, CHEM MATER, V18, P5835, DOI 10.1021/cm060833; International Diabetes Federation, 2011, 2011 GUID MAN POSTME; Jianzhi Z, 2009, J MATER CHEM, V19, P4108, DOI [10.1039/b821216n, DOI 10.1039/B821216N]; Ming L, 2006, BIOTECHNOL LETT, V28, P1341, DOI 10.1007/s10529-006-9099-2; Muthuswamy E, 2007, J NANOPART RES, V9, P561, DOI 10.1007/s11051-006-9071-z; Nakagawa K, 2009, CHEM LETT, V38, P480, DOI 10.1246/cl.2009.480; Sugawara K, 2009, ANAL SCI, V25, P1365; Wang XD, 2007, CHEM COMMUN, P3060, DOI 10.1039/b704825d; Yamada Y, 2013, ANAL SCI, V29, P79	25	1	1	SPRINGER WIEN	WIEN	SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA	0026-3672	1436-5073		MICROCHIM ACTA	Microchim. Acta	NOV	2014	181	15-16					1871	1878		10.1007/s00604-014-1270-1		8	Chemistry, Analytical	Chemistry	AS0XZ	WOS:000344001200013		
J	Inoue, N; Ooya, T; Takeuchi, T				Inoue, Naoko; Ooya, Tooru; Takeuchi, Toshifumi			Hydrophilic molecularly imprinted polymers for bisphenol A prepared in aqueous solution (vol 180, pg 1387, 2013)	MICROCHIMICA ACTA			English	Correction									[Inoue, Naoko; Ooya, Tooru; Takeuchi, Toshifumi] Kobe Univ, Grad Sch Engn, Nada Ku, Kobe, Hyogo 6578501, Japan; [Inoue, Naoko] Kobe Univ, Ctr Collaborat Res & Technol Dev, Nada Ku, Kobe, Hyogo 6578501, Japan	Takeuchi, T (reprint author), Kobe Univ, Grad Sch Engn, Nada Ku, 1-1 Rokkodai Cho, Kobe, Hyogo 6578501, Japan.	takeuchi@gold.kobe-u.ac.jp	Takeuchi, Toshifumi/E-6379-2014; Ooya, Tooru/C-5573-2012	Takeuchi, Toshifumi/0000-0002-5641-2333; 			Inoue N, 2013, MICROCHIM ACTA, V180, P1387, DOI 10.1007/s00604-013-0996-5	1	0	0	SPRINGER WIEN	WIEN	SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA	0026-3672	1436-5073		MICROCHIM ACTA	Microchim. Acta	NOV	2014	181	15-16					2009	2009		10.1007/s00604-014-1337-z		1	Chemistry, Analytical	Chemistry	AS0XZ	WOS:000344001200028		
J	Cheong, Y; Nam, SW; Choi, S; Jang, H; Park, HK				Cheong, Youjin; Nam, Seong-Won; Choi, Samjin; Jang, Hoyoung; Park, Hun-Kuk			Analysis of cerebral blood flow by pneumatic-valves-controlled microfluidic device: risk assessment of infarction correlated with morphometric variation of cerebral vascular system	MICROFLUIDICS AND NANOFLUIDICS			English	Article						Microfluidics; Cerebrovascular circulation; Circle of Willis; Infarction; Cerebral ischemia	CAROTID-ARTERY OCCLUSION; COLLATERAL CIRCULATION; COMMUNICATING ARTERY; WILLIS; CIRCLE; ANGIOGRAPHY; POSTERIOR; STENOSIS; MODEL; HEMODYNAMICS	Although cerebral blood flow is the crucial factor for cerebral infarction and the circle of Willis (CoW) is considered the primary control structure for cerebral hemodynamics, risk of cerebral infarction caused by the morphological variation in the CoW has never been studied due to lack of proper tools. Here, the alteration of cerebral blood flow in CoW variation was quantitatively assessed by a new analysis method using a microfluidic device that was controlled by pneumatic valves. Using this device, the occlusion of diverse major arteries was realized by closing the channel with pneumatic valves. The morphological variations of the CoW and their hemodynamics were designed and analyzed after occlusion of the major arteries. While the differences in hemodynamics of CoW variants were not statistically significant compared with a complete CoW without occlusion or with occlusion of the efferent arteries, the occlusion of afferent arteries such as common carotid artery and vertebral artery severely affected the flow rate (28.4-48.8 %) and related arterial pressure of efferent arteries (48.6 +/- A 6.7-36.0 +/- A 1.4 mmHg) in CoW variants where the posterior communicating artery and the P1 segment are absent, which is associated with cerebral ischemic infarction. The novel analysis system using microfluidics provides a robust and accurate method, in which the hemodynamics of individual morphological variation and stenosis, and occlusion of vessels can be analyzed. Thus, this method is particularly suitable for personalized analysis of hemodynamics and may find new applications in biomedical researches.	[Cheong, Youjin; Nam, Seong-Won; Choi, Samjin; Park, Hun-Kuk] Kyung Hee Univ, Healthcare Ind Res Inst, Dept Biomed Engn, Coll Med, Seoul 130701, South Korea; [Jang, Hoyoung] Yamaguchi Univ, Dept Mech Engn, Ube, Yamaguchi 7558611, Japan	Park, HK (reprint author), Kyung Hee Univ, Healthcare Ind Res Inst, Dept Biomed Engn, Coll Med, 1 Hoegi Dong, Seoul 130701, South Korea.	sigmoidus@khu.ac.kr; snam@khu.ac.kr			Korean Health Technology R&D Project, Ministry of Health and Welfare, Republic of Korea [A110216]; Kyung Hee University [KHU-20100851]	This study was supported by a grant from the Korean Health Technology R&D Project, Ministry of Health and Welfare, Republic of Korea (A110216) and a grant from Kyung Hee University in 2010 (KHU-20100851).	Steiner LA, 2006, BRIT J ANAESTH, V97, P26, DOI 10.1093/bja/ael110; Zhao M, 2007, AM J NEURORADIOL, V28, P1470, DOI 10.3174/ajnr.A0582; Kenis PJA, 1999, SCIENCE, V285, P83, DOI 10.1126/science.285.5424.83; Hoksbergen AWJ, 2000, STROKE, V31, P1656; COKELET GR, 1993, MICROVASC RES, V46, P394, DOI 10.1006/mvre.1993.1062; Alastruey J, 2007, J BIOMECH, V40, P1794, DOI 10.1016/j.jbiomech.2006.07.008; Duffy DC, 1998, ANAL CHEM, V70, P4974, DOI 10.1021/ac980656z; Squires TM, 2005, REV MOD PHYS, V77, P977, DOI 10.1103/RevModPhys.77.977; Hirsch S, 2012, J CEREBR BLOOD F MET, V32, P952, DOI 10.1038/jcbfm.2012.39; Chiu JJ, 2011, PHYSIOL REV, V91, P327, DOI 10.1152/physrev.00047.2009; Moore S, 2006, J BIOMECH, V39, P1454, DOI 10.1016/j.biomech.2005.04.005; Henderson RD, 2000, STROKE, V31, P128; Huh D, 2010, SCIENCE, V328, P1662, DOI 10.1126/science.1188302; Hassan T, 2004, AM J NEURORADIOL, V25, P1356; Liebeskind DS, 2003, STROKE, V34, P2279, DOI 10.1161/01.STR.0000086465.41263.06; Quinn DJ, 2011, ANN BIOMED ENG, V39, P1041, DOI 10.1007/s10439-010-0232-y; Chung EML, 2010, STROKE, V41, P647, DOI 10.1161/STROKEAHA.109.574400; CASSOT F, 1995, CIRCULATION, V92, P3122; TIMSIT SG, 1992, STROKE, V23, P486; Shevkoplyas SS, 2003, MICROVASC RES, V65, P132, DOI 10.1016/S0026-2862(02)00034-1; Fischer PF, 2007, COMPUT METHOD APPL M, V196, P3049, DOI 10.1016/j.cma.2006.10.015; ALPERS BJ, 1959, ARCH NEURO PSYCHIATR, V81, P409; Chung S, 2010, ANN BIOMED ENG, V38, P1164, DOI 10.1007/s10439-010-9899-3; SCHOMER DF, 1994, NEW ENGL J MED, V330, P1565, DOI 10.1056/NEJM199406023302204; Hendrikse J, 2001, STROKE, V32, P2768, DOI 10.1161/hs1201.099892; Devault K, 2008, MULTISCALE MODEL SIM, V7, P888, DOI 10.1137/07070231X; Papantchev V, 2007, EUR J CARDIO-THORAC, V31, P982, DOI 10.1016/j.ejcts.2007.03.020; van Raamt AF, 2006, CEREBROVASC DIS, V22, P217, DOI 10.1159/000094007; BATTACHA.SK, 1967, BRAIN, V90, P747, DOI 10.1093/brain/90.4.747; Braeuninger Stefan, 2009, Exp Transl Stroke Med, V1, P8, DOI 10.1186/2040-7378-1-8; Bugnicourt JM, 2009, HEADACHE, V49, P879, DOI 10.1111/j.1526-4610.2009.01389.x; Choi S, 2010, PHYSIOL MEAS, V31, P439, DOI 10.1088/0967-3334/31/3/011; Choi SJ, 2006, SENSOR ACTUAT A-PHYS, V128, P317, DOI 10.1016/j.sna.2006.02.012; Cucchiara B, 2008, MED HYPOTHESES, V70, P860, DOI 10.1016/j.mehy.2007.05.057; EDELMAN RR, 1990, STROKE, V21, P56; Eftekhar B, 2006, BMC NEUROL, V6, DOI 10.1186/1471-2377-6-22; Ku DN, 1997, ANNU REV FLUID MECH, V29, P399, DOI 10.1146/annurev.fluid.29.1.399; Long Q, 2008, J BIOMECH, V41, P2735, DOI 10.1016/j.jbiomech.2008.06.006; Marcinkowska-Gapinska A, 2007, MED BIOL ENG COMPUT, V45, P837, DOI 10.1007/s11517-007-0236-4; Nam SW, 2007, LAB CHIP, V7, P638, DOI 10.1039/b617357h; Nam SW, 2009, PROTIST, V160, P331, DOI 10.1016/j.protis.2008.10.005; Osborn AG, 1999, DIAGNOSTIC CEREBRAL; Rutgers DR, 2000, STROKE, V31, P1913; Tanaka H, 2006, AM J NEURORADIOL, V27, P1770; Tao WD, 2012, STROKE, V43, P2060, DOI 10.1161/STROKEAHA.112.652420; Wetzel SG, 2005, AM J NEURORADIOL, V26, P1425	46	0	0	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1613-4982	1613-4990		MICROFLUID NANOFLUID	Microfluid. Nanofluid.	NOV	2014	17	5					843	853		10.1007/s10404-014-1366-2		11	Nanoscience & Nanotechnology; Instruments & Instrumentation; Physics, Fluids & Plasmas	Science & Technology - Other Topics; Instruments & Instrumentation; Physics	AS5TR	WOS:000344332900005		
J	Ushida, A; Hasegawa, T; Narumi, T				Ushida, Akiomi; Hasegawa, Tomiichi; Narumi, Takatsune			Anomalous phenomena in pressure drops of water flows through micro-orifices	MICROFLUIDICS AND NANOFLUIDICS			English	Article						Micro-orifice; Water flow; Pressure drop; Jet thrust; Elastic stress	DILUTE POLYMER-SOLUTIONS; TRAPEZOIDAL SILICON MICROCHANNELS; LIQUID FLOW; JET THRUST; STRESS; FRICTION; LAMINAR; APERTURES; TUBES	Pressure drops were measured for high-velocity water flows through micro-orifices of various diameters. The observed pressure drop values agreed well with the values predicted by the Navier-Stokes equation for 400 and 100 mu m diameter orifices, but were lower than the predicted values for orifices less than 50 mu m in diameter. In particular, the measured pressure drop value was almost two orders of magnitude lower than the predicted value for the 10 and 5 mu m diameter orifices. Several factors that may cause a reduction in pressure drop were considered, including orifice shape and deformation of the orifice foil, but none proved to be significant enough to cause such a large reduction. Elastic stress in orifice flow appeared to be the most plausible cause of the pressure drop reduction. The elastic stress, which was estimated by the jet thrust method, was found to be dependent on the mean velocity passing through the micro-orifices, which strongly supported the elasticity of water flows.	[Ushida, Akiomi; Hasegawa, Tomiichi; Narumi, Takatsune] Niigata Univ, Fac Engn, Dept Mech & Prod Engn, Nishi Ku, Niigata 9502181, Japan	Ushida, A (reprint author), Niigata Univ, Fac Engn, Dept Mech & Prod Engn, Nishi Ku, 8050-2 Ikarashi, Niigata 9502181, Japan.	akiomiushida@nagoya-u.jp			Grant for Promotion of Niigata University Research Projects	We wish to thank Mr. Ryuichi Kayaba, Mr. Masanao Takahashi, Mr. Hiroteru Haruyama, Mr. Takehiro Hoshina, Mr. Shouta Kudou, Mr. Masato Kawami, and Mr. Hiroshige Uchiyama for assistance in the experiments. We also thank the CFIL members of Niigata University for helpful comments and suggestions. A part of this study was financially supported by Grant for Promotion of Niigata University Research Projects.	Ushida A, 2010, J NON-NEWTON FLUID, V165, P1516, DOI 10.1016/j.jnnfm.2010.07.015; HASEGAWA T, 1991, J NON-NEWTON FLUID, V38, P159, DOI 10.1016/0377-0257(91)83004-N; Peng XF, 1996, INT J HEAT MASS TRAN, V39, P2599, DOI 10.1016/0017-9310(95)00327-4; WILDING P, 1994, CLIN CHEM, V40, P43; Kohl MJ, 2005, INT J HEAT MASS TRAN, V48, P1518, DOI 10.1016/j.ijheatmasstransfer.2004.10.030; Xu B, 2000, INT COMMUN HEAT MASS, V27, P1165, DOI 10.1016/S0735-1933(00)00203-7; Mala GM, 1999, INT J HEAT FLUID FL, V20, P142; DAGAN Z, 1982, J FLUID MECH, V115, P505, DOI 10.1017/S0022112082000883; YOUNG DF, 1973, J BIOMECH, V6, P395, DOI 10.1016/0021-9290(73)90099-7; Qu WL, 2000, INT J HEAT MASS TRAN, V43, P353; Hasegawa T, 2009, PHYS FLUIDS, V21, DOI 10.1063/1.3129592; PENG XF, 1994, EXP HEAT TRANSFER, V7, P249; ASTARITA G, 1968, IND ENG CHEM FUND, V7, P27, DOI 10.1021/i160025a005; Bakhtiyarov SI, 2000, J ELASTOM PLAST, V32, P73, DOI 10.1106/J81H-NE1M-U37X-CJVL; BOGER DV, 1980, J NON-NEWTON FLUID, V6, P163, DOI 10.1016/0377-0257(80)80001-2; Bond WN, 1922, P PHYS SOC LOND, V34, P0139; DERDOURI A, 1988, CAN J CHEM ENG, V66, P709; HAPPEL J., 1965, LOW REYNOLDS NUMBER; Hasegawa T, 1997, PHYS FLUIDS, V9, P1, DOI 10.1063/1.869170; HASEGAWA T, 1984, J NON-NEWTON FLUID, V15, P257, DOI 10.1016/0377-0257(84)80014-2; Hasegawa T, 2003, J SOC RHEOL JPN, V31, P243; HASEGAWA T, 1979, B JSME, V22, P54; Hsiai TK, 2002, J FLUID ENG-T ASME, V124, P1053, DOI 10.1115/1.1514209; Jeong JT, 2005, PHYS FLUIDS, V17, DOI 10.1063/1.1921867; Johansen FC, 1930, P R SOC LOND A-CONTA, V126, P231, DOI 10.1098/rspa.1930.0004; Kusmanto F, 2004, PHYS FLUIDS, V16, P4129, DOI 10.1063/1.1800051; LODGE AS, 1989, J RHEOL, V33, P821; McCarthy M. J., 1974, Chemical Engineering Journal, V7, DOI 10.1016/0300-9467(74)80021-3; Mishra C, 2005, J MICROELECTROMECH S, V14, P1000, DOI 10.1109/JMEMS.2005.851825; Oliver D. R., 1969, Rheologica Acta, V8, DOI 10.1007/BF01984655; Pfahler J, 1989, SENSOR ACTUAT A-PHYS, V22, P431, DOI 10.1016/0924-4247(89)80008-1; Pfund D, 2000, AICHE J, V46, P1496, DOI 10.1002/aic.690460803; ROSCOE R, 1949, PHILOS MAG, V40, P338; SAMPSON R.A., 1891, PHILOS T R SOC A, V182, P449, DOI DOI 10.1098/RSTA.1891.0012; Sharp KV, 2004, EXP FLUIDS, V36, P741, DOI 10.1007/s00348-003-0753-3; SPARROW EM, 1964, PHYS FLUIDS, V7, P338, DOI 10.1063/1.1711204; Sylvester ND, 1985, J RHEOL, V29, P1027, DOI 10.1122/1.549834; TOMITA Y, 1980, J NON-NEWTON FLUID, V7, P237, DOI 10.1016/0377-0257(80)85008-7; Ushida A, 2012, J FLUID ENG-T ASME, V134, DOI 10.1115/1.4007014; VLEGGAAR J, 1972, J PHYS E SCI INSTRUM, V5, P1200, DOI 10.1088/0022-3735/5/12/020; Wu HY, 2003, INT J HEAT MASS TRAN, V46, P2519, DOI 10.1016/S0017-9310(03)00106-6	41	2	2	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1613-4982	1613-4990		MICROFLUID NANOFLUID	Microfluid. Nanofluid.	NOV	2014	17	5					863	870		10.1007/s10404-014-1362-6		8	Nanoscience & Nanotechnology; Instruments & Instrumentation; Physics, Fluids & Plasmas	Science & Technology - Other Topics; Instruments & Instrumentation; Physics	AS5TR	WOS:000344332900007		
J	Heuser, JE				Heuser, John E.			Some personal and historical notes on the utility of "deep-etch" electron microscopy for making cell structure/function correlations	MOLECULAR BIOLOGY OF THE CELL			English	Article							TRANSMITTER RELEASE; MEMBRANE; ORGANIZATION	This brief essay talks up the advantages of metal replicas for electron microscopy and explains why they are still the best way to image frozen cells in the electron microscope. Then it explains our approach to freezing, namely the Van Harreveld trick of "slamming" living cells onto a supercold block of metal sprayed with liquid helium at -269 degrees C, and further talks up this slamming over the alternative of high-pressure freezing, which is much trickier but enjoys greater favor at the moment. This leads me to bemoan the fact that there are not more young investigators today who want to get their hands on electron microscopes and use our approach to get the most "true to life" views of cells out of them with a minimum of hassle. Finally, it ends with a few perspectives on my own career and concludes that, personally, I'm permanently stuck with the view of the "founding fathers" that cell ultrastructure will ultimately display and explain all of cell function, or as Palade said in his Nobel lecture, electron micrographs are "irresistible and half transparent. their meaning buried under only a few years of work," and "reasonable working hypotheses are already suggested by the ultrastructural organization itself."	[Heuser, John E.] Kyoto Univ, WPI Inst, Kyoto 6068501, Japan; [Heuser, John E.] Washington Univ, Sch Med, Dept Cell Biol & Physiol, St Louis, MO 63110 USA	Heuser, JE (reprint author), Kyoto Univ, WPI Inst, Kyoto 6068501, Japan.	jheuser@icems.kyoto-u.ac.jp			American Society for Cell Biology	John E. Heuser is corecipient of the 2014 E. B. Wilson Medal from the American Society for Cell Biology.	Hanson PI, 1997, CELL, V90, P523, DOI 10.1016/S0092-8674(00)80512-7; GOODENOUGH U, 1984, J MOL BIOL, V180, P1083, DOI 10.1016/0022-2836(84)90272-9; HEUSER JE, 1980, J CELL BIOL, V86, P212, DOI 10.1083/jcb.86.1.212; HEUSER JE, 1973, J CELL BIOL, V57, P315, DOI 10.1083/jcb.57.2.315; HEUSER JE, 1979, J CELL BIOL, V81, P275, DOI 10.1083/jcb.81.2.275; Heuser JE, 2011, J ELECTRON MICROSC, V60, pS3, DOI 10.1093/jmicro/dfr044; HEUSER JE, 1983, J MOL BIOL, V169, P155, DOI 10.1016/S0022-2836(83)80179-X; HEUSER JE, 1979, J CELL BIOL, V82, P150, DOI 10.1083/jcb.82.1.150; Heuser J, 2000, TRAFFIC, V1, P545, DOI 10.1034/j.1600-0854.2000.010704.x	9	1	1	AMER SOC CELL BIOLOGY	BETHESDA	8120 WOODMONT AVE, STE 750, BETHESDA, MD 20814-2755 USA	1059-1524	1939-4586		MOL BIOL CELL	Mol. Biol. Cell	NOV 1	2014	25	21					3273	3276		10.1091/mbc.E14-05-1016		4	Cell Biology	Cell Biology	AS4HY	WOS:000344236100009		
J	Takahashi, M; Hohjoh, H				Takahashi, Masaki; Hohjoh, Hirohiko			A novel measurement of allele discrimination for assessment of allele-specific silencing by RNA interference	MOLECULAR BIOLOGY REPORTS			English	Article						RNA interference; Small interfering RNA; Allele-specific silencing; Allele discrimination; Novel formula	ALZHEIMERS-DISEASE GENES; ARGONAUTE2; SIRNAS	Allele-specific silencing by RNA interference (ASP-RNAi) is an atypical RNAi that is capable of discriminating target alleles from non-target alleles, and may be therapeutically useful for specific inhibition of disease-causing alleles without affecting their corresponding normal alleles. However, it is difficult to design and select small interfering RNA (siRNAs) that confer ASP-RNAi. A major problem is that there are few appropriate measures in determining optimal allele-specific siRNAs. Here we show two novel formulas for calculating a new measure of allele-discrimination, named "ASP-score''. The formulas and ASP-score allow for an unbiased determination of optimal siRNAs, and may contribute to characterizing such allele-specific siRNAs.	[Takahashi, Masaki; Hohjoh, Hirohiko] Natl Ctr Neurol & Psychiat, Natl Inst Neurosci, Dept Mol Pharmacol, Kodaira, Tokyo 1878502, Japan	Hohjoh, H (reprint author), Natl Ctr Neurol & Psychiat, Natl Inst Neurosci, Dept Mol Pharmacol, 4-1-1 Ogawahigashi, Kodaira, Tokyo 1878502, Japan.	hohjohh@ncnp.go.jp			Ministry of Health, Labour and Welfare of Japan; Japan Society for the Promotion of Science	This work was supported by research grants from the Ministry of Health, Labour and Welfare of Japan, and also by Grants-in-Aid for Scientific Research and Yong Scientists from Japan Society for the Promotion of Science.	Pfister EL, 2009, CURR BIOL, V19, P774, DOI 10.1016/j.cub.2009.03.030; Sah DWY, 2011, J CLIN INVEST, V121, P500, DOI 10.1172/JCI45130; Dykxhoorn DM, 2003, NAT REV MOL CELL BIO, V4, P457, DOI 10.1038/nrm1129; Miller VM, 2004, NUCLEIC ACIDS RES, V32, P661, DOI 10.1093/nar/gkh208; Miller VM, 2003, P NATL ACAD SCI USA, V100, P7195, DOI 10.1073/pnas.1231012100; Rodriguez-Lebron E, 2009, MOL THER, V17, P1563, DOI 10.1038/mt.2009.123; Seyhan AA, 2011, HUM GENET, V130, P583, DOI 10.1007/s00439-011-0995-8; Feng XR, 2006, GENE, V371, P68, DOI 10.1016/j.gene.2005.11.006; Liu JD, 2004, SCIENCE, V305, P1437, DOI 10.1126/science.1102513; Rodriguez-Lebron E, 2006, GENE THER, V13, P576, DOI 10.1038/sj.gt.3302702; Meister G, 2004, MOL CELL, V15, P185, DOI 10.1016/j.molcel.2004.07.007; Meister G, 2004, NATURE, V431, P343, DOI 10.1038/nature02873; Hohjoh Hirohiko, 2013, Pharmaceuticals (Basel), V6, P522, DOI 10.3390/ph6040522; Hohjoh H, 2010, METHODS MOL BIOL, V623, P67, DOI 10.1007/978-1-60761-588-0_4; Huang H, 2009, NUCLEIC ACIDS RES, V37, P7560, DOI 10.1093/nar/gkp835; Ohnishi Yusuke, 2006, J RNAi Gene Silencing, V2, P154; Ohnishi Y, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002248; Schwarz DS, 2006, PLOS GENET, V2, P1307, DOI 10.1371/journal.pgen.0020140; Sierant M, 2011, J ALZHEIMERS DIS INT; Takahashi M, 2010, P NATL ACAD SCI USA, V107, P21731, DOI 10.1073/pnas.1012153107; Takahashi M, 2011, GENE THER, V19, P781; Sibley CR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026194	22	1	1	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0301-4851	1573-4978		MOL BIOL REP	Mol. Biol. Rep.	NOV	2014	41	11					7115	7120		10.1007/s11033-014-3586-7		6	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	AS2HS	WOS:000344101300009		
J	Kawajiri, M; Yoshida, K; Fujimoto, S; Mokodongan, DF; Ravinet, M; Kirkpatrick, M; Yamahira, K; Kitano, J				Kawajiri, Maiko; Yoshida, Kohta; Fujimoto, Shingo; Mokodongan, Daniel Frikli; Ravinet, Mark; Kirkpatrick, Mark; Yamahira, Kazunori; Kitano, Jun			Ontogenetic stage-specific quantitative trait loci contribute to divergence in developmental trajectories of sexually dimorphic fins between medaka populations	MOLECULAR ECOLOGY			English	Article						growth; orthogonal polynomial; secondary sex characteristics; sexual antagonism; steroid	FUNCTION-VALUED TRAITS; GENETIC ARCHITECTURE; ORYZIAS-LATIPES; ANAL FIN; DROSOPHILA-MELANOGASTER; DEPENDENT DEVELOPMENT; TARGETED MUTAGENESIS; NATURAL-POPULATIONS; SILENE-LATIFOLIA; SIZE DIMORPHISM	Sexual dimorphism can evolve when males and females differ in phenotypic optima. Genetic constraints can, however, limit the evolution of sexual dimorphism. One possible constraint is derived from alleles expressed in both sexes. Because males and females share most of their genome, shared alleles with different fitness effects between sexes are faced with intralocus sexual conflict. Another potential constraint is derived from genetic correlations between developmental stages. Sexually dimorphic traits are often favoured at adult stages, but selected against as juvenile, so developmental decoupling of traits between ontogenetic stages may be necessary for the evolution of sexual dimorphism in adults. Resolving intralocus conflicts between sexes and ages is therefore a key to the evolution of age-specific expression of sexual dimorphism. We investigated the genetic architecture of divergence in the ontogeny of sexual dimorphism between two populations of the Japanese medaka (Oryzias latipes) that differ in the magnitude of dimorphism in anal and dorsal fin length. Quantitative trait loci (QTL) mapping revealed that few QTL had consistent effects throughout ontogenetic stages and the majority of QTL change the sizes and directions of effects on fin growth rates during ontogeny. We also found that most QTL were sex-specific, suggesting that intralocus sexual conflict is almost resolved. Our results indicate that sex- and age-specific QTL enable the populations to achieve optimal developmental trajectories of sexually dimorphic traits in response to complex natural and sexual selection.	[Kawajiri, Maiko; Yoshida, Kohta; Ravinet, Mark; Kitano, Jun] Natl Inst Genet, Ecol Genet Lab, Mishima, Shizuoka 4118540, Japan; [Fujimoto, Shingo; Mokodongan, Daniel Frikli; Yamahira, Kazunori] Univ Ryukyus, Trop Biosphere Res Ctr, Nishihara, Okinawa 9030213, Japan; [Fujimoto, Shingo; Mokodongan, Daniel Frikli; Yamahira, Kazunori] Univ Ryukyus, Grad Sch Engn & Sci, Nishihara, Okinawa 9030213, Japan; [Kirkpatrick, Mark] Univ Texas Austin, Dept Integrat Biol, Austin, TX 78712 USA	Kitano, J (reprint author), Natl Inst Genet, Ecol Genet Lab, Yata 1111, Mishima, Shizuoka 4118540, Japan.	jkitano@lab.nig.ac.jp			MEXT [23113007, 23113001, 24370039]; JST PRESTO; Collaborative Research of Tropical Biosphere Research Center, University of the Ryukyus; NIG Cooperative Research Program [2013-A35]; JSPS	JK was supported by the MEXT Grant-in-Aid for Scientific Research on Innovative Areas 'Gene Correlative System' (23113007 and 23113001), the MEXT Grant-in-Aid for Scientific Research (B) (24370039), JST PRESTO, and the Collaborative Research of Tropical Biosphere Research Center, University of the Ryukyus, KY by NIG Cooperative Research Program (2013-A35) and MKa, MR and SF by JSPS postdoctoral fellowships. We thank Dr. Jon Slate and four anonymous reviewers for constructive comments on the manuscript.	Andersson M., 1994, SEXUAL SELECTION; Rice WR, 2001, J EVOLUTION BIOL, V14, P685, DOI 10.1046/j.1420-9101.2001.00319.x; McLean CY, 2011, NATURE, V471, P216, DOI 10.1038/nature09774; Mackay TFC, 2001, ANNU REV GENET, V35, P303, DOI 10.1146/annurev.genet.35.102401.090633; Johnston SE, 2011, MOL ECOL, V20, P2555, DOI 10.1111/j.1365-294X.2011.05076.x; KIRKPATRICK M, 1989, J MATH BIOL, V27, P429, DOI 10.1007/BF00290638; Lauder GV, 2002, INTEGR COMP BIOL, V42, P1009, DOI 10.1093/icb/42.5.1009; Slate J, 2005, MOL ECOL, V14, P363, DOI 10.1111/j.1365-294X.2004.02378.x; Bonduriansky Russell, 2009, Trends Ecol Evol, V24, P280, DOI 10.1016/j.tree.2008.12.005; Ansai S, 2013, GENETICS, V193, P739, DOI 10.1534/genetics.112.147645; Chippindale AK, 2001, P NATL ACAD SCI USA, V98, P1671, DOI 10.1073/pnas.041378098; Podisi BK, 2011, REPRODUCTION, V141, P381, DOI 10.1530/REP-10-0276; Cox RM, 2009, AM NAT, V173, P176, DOI 10.1086/595841; Mank JE, 2009, AM NAT, V173, P141, DOI 10.1086/595754; Badyaev AV, 2002, TRENDS ECOL EVOL, V17, P369, DOI 10.1016/S0169-5347(02)02569-7; Abe G, 2007, DEV BIOL, V304, P355, DOI 10.1016/j.ydbio.2006.12.040; Johnston SE, 2013, NATURE, V502, P93, DOI 10.1038/nature12489; Kopp A, 2003, GENETICS, V163, P771; Poissant J, 2012, HEREDITY, V108, P256, DOI 10.1038/hdy.2011.69; Wright D, 2008, EVOLUTION, V62, P86, DOI 10.1111/j.1558-5646.2007.00281.x; Chenoweth SF, 2010, ANNU REV ECOL EVOL S, V41, P81, DOI 10.1146/annurev-ecolsys-102209-144657; Nuzhdin SV, 1997, P NATL ACAD SCI USA, V94, P9734, DOI 10.1073/pnas.94.18.9734; Topp CN, 2013, P NATL ACAD SCI USA, V110, pE1695, DOI 10.1073/pnas.1304354110; MEYER A, 1994, NATURE, V368, P539, DOI 10.1038/368539a0; Williams TM, 2009, NAT REV GENET, V10, P797, DOI 10.1038/nrg2687; Kasahara M, 2007, NATURE, V447, P714, DOI 10.1038/nature05846; Turner CL, 1941, J MORPHOL, V69, P161, DOI 10.1002/jmor.1050690107; Iovine MK, 2007, NAT CHEM BIOL, V3, P613, DOI 10.1038/nchembio.2007.36; Stinchcombe JR, 2012, TRENDS ECOL EVOL, V27, P637, DOI 10.1016/j.tree.2012.07.002; RICE WR, 1984, EVOLUTION, V38, P735, DOI 10.2307/2408385; Delph LF, 2010, EVOLUTION, V64, P2873, DOI 10.1111/j.1558-5646.2010.01048.x; Williams TM, 2008, CELL, V134, P610, DOI 10.1016/j.cell.2008.06.052; Falcon S, 2007, BIOINFORMATICS, V23, P257, DOI 10.1093/bioinformatics/btl567; Langerhans RB, 2005, P NATL ACAD SCI USA, V102, P7618, DOI 10.1073/pnas.0500935102; Chadwell BA, 2012, J EXP BIOL, V215, P2869, DOI 10.1242/jeb.068585; Xiong H, 2011, GENETICS, V189, P305, DOI 10.1534/genetics.111.129221; Cox RM, 2009, J EVOLUTION BIOL, V22, P1586, DOI 10.1111/j.1420-9101.2009.01772.x; Kitano J, 2009, NATURE, V461, P1079, DOI 10.1038/nature08441; MEYER A, 1993, P ROY SOC B-BIOL SCI, V254, P153, DOI 10.1098/rspb.1993.0140; KIRKPATRICK M, 1992, EVOLUTION, V46, P954, DOI 10.2307/2409749; Offen N, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-98; LANDE R, 1982, ECOLOGY, V63, P607, DOI 10.2307/1936778; Ansai S, 2014, BIOL OPEN, V3, P362, DOI 10.1242/bio.20148177; Arnqvist G, 2005, SEXUAL CONFLICT; Badyaev AV, 2004, PHENOTYPIC INTEGRATION: STUDYING THE ECOLOGY AND EVOLUTION OF COMPLEX PHENOTYPES, P50; Badyaev AV, 2007, J EVOLUTION BIOL, V20, P1277, DOI 10.1111/j.1420-9101.2007.01354.x; Broman KW, 2009, STAT BIOL HEALTH, P1, DOI 10.1007/978-0-387-92125-9_1; Broman KW, 2006, GENETICS, V174, P2151, DOI 10.1534/genetics.106.061176; Bull J. J., 1983, EVOLUTION SEX DETERM; Conte GL, 2012, P ROY SOC B-BIOL SCI, V279, P5039, DOI 10.1098/rspb.2012.2146; Darwin C., 1871, DESCENT MAN SELECTIO; EGAMI N., 1961, JOUR FAC SCI TOKYO UNIV SECT IV ZOOL, V9, P263; Fox CW, 2006, EVOLUTIONARY GENETIC; Fujimoto S, 2014, ZOOLOGICAL IN PRESS; HOLDEN MJ, 1971, NATURE, V232, P135, DOI 10.1038/232135b0; IRIKI SHIGEMORI, 1932, PROC IMP ACAD [TOKYO], V8, P262; Iwamatsu T, 2006, INTEGRATED BOOK BIOL; Kawajiri M, 2009, BIOL J LINN SOC, V97, P571; Kawajiri M, 2011, ENVIRON BIOL FISH, V92, P285, DOI 10.1007/s10641-011-9839-6; Kijimoto T, 2013, WIRES DEV BIOL, V2, P405, DOI 10.1002/wdev.81; Kinoshita M., 2009, MEDAKA BIOL MANAGEME; Kitano J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029253; Koseki Y, 2000, FISHERIES SCI, V66, P633, DOI 10.1046/j.1444-2906.2000.00103.x; Lynch M, 1998, GENETICS ANAL QUANTI; Norris DO, 2011, HORMONES REPROD VERT; Ogino Y, 2004, FEBS LETT, V575, P119, DOI 10.1016/j.febslet.2004.08.046; Ogino Y, 2013, ENDOCRINOLOGY, V155, P449; Poissant J, 2009, J EVOLUTION BIOL, V22, P2558, DOI 10.1111/j.1420-9101.2009.01862.x; Qvarnstrom A., 2008, HEREDITY, V102, P4, DOI DOI 10.1038/HDY.2008.93; Rhen T, 2000, EVOLUTION, V54, P37, DOI 10.1111/j.0014-3820.2000.tb00005.x; Roff D. A., 2002, LIFE HIST EVOLUTION; Salzburger W, 2005, BMC EVOL BIOL, V5, DOI 10.1186/1471-2148-5-17; Scotti I, 2006, EVOLUTION, V60, P1793; Seki M, 2004, ENVIRON TOXICOL CHEM, V23, P774, DOI 10.1897/03-26; Spigler RB, 2011, EVOLUTION, V65, P1114, DOI 10.1111/j.1558-5646.2010.01189.x; Stearns S. C., 1992, EVOLUTION LIFE HIST; Taniguchi Y, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-12-r116; Van Ooijen JW, 2001, JOINMAP 3 0 SOFTWARE; Yang RQ, 2006, GENETICS, V173, P2339, DOI 10.1534/genetics.105.054775; Yoshida K, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004223; Zhao W, 2004, PHYSIOL GENOMICS, V19, P218, DOI 10.1152/physiolgenomics.00129.2004	81	1	2	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0962-1083	1365-294X		MOL ECOL	Mol. Ecol.	NOV	2014	23	21					5258	5275		10.1111/mec.12933		18	Biochemistry & Molecular Biology; Ecology; Evolutionary Biology	Biochemistry & Molecular Biology; Environmental Sciences & Ecology; Evolutionary Biology	AS6LB	WOS:000344374000011		
J	Leung, KP; Qu, YH; Qiao, DF; Xie, WB; Li, DR; Xu, JT; Wang, HJ; Yue, X				Leung, Ka-Pui; Qu, Yi-Hong; Qiao, Dong-Fang; Xie, Wei-Bing; Li, Dong-Ri; Xu, Jing-Tao; Wang, Hui-Jun; Yue, Xia			Critical role of insulin-like growth factor binding protein-5 in methamphetamine-induced apoptosis in cardiomyocytes	MOLECULAR MEDICINE REPORTS			English	Article						methamphetamine; insulin-like growth factor binding protein-5; small interfering RNA; cardiotoxicity; apoptosis	ACUTE MYOCARDIAL-INFARCTION; CASPASE-ACTIVATED DNASE; CRYSTAL METHAMPHETAMINE; NEURONAL APOPTOSIS; HEART-FAILURE; CELL-DEATH; RAT-BRAIN; CARDIOMYOPATHY; IGFBP-5; NEUROTOXICITY	Methamphetamine (MA). is a highly abused amphetamine-like psychostimulant. At present, the mechanisms underlying MA-induced cardiotoxicity are poorly understood. The cardiotoxic effects have yet not been clearly elucidated with respect to the apoptotic pathway. Insulin-like growth factor binding protein-5 (IGFBP5) is important for cell growth control and the induction of apoptosis. The aim of the present study was to analyze whether IGFBP5 is involved in MA-induced apoptosis as a novel target. MA-induced apoptosis was observed in neonatal rat ventricular myocytes (NRVMs) in a concentration-dependent manner using a terminal deoxyribonucleotide transferase-mediated dUTP nick end-labeling assay. Using reverse transcription polymerase chain reaction and western blotting, MA was demonstrated to induce concentration-dependent increases in the expression of IGFBP5. Silencing IGFBP5 with small interfering RNA significantly reduced apoptosis and suppressed the expression of caspase-3 in NRVMs following treatment with MA. To the best of our knowledge, the present study provided the first evidence suggesting that IGFBP5 is a potential therapeutic target in MA-induced apoptosis in vitro, providing a foundation for future in vivo studies.	[Leung, Ka-Pui; Qu, Yi-Hong; Qiao, Dong-Fang; Xie, Wei-Bing; Li, Dong-Ri; Xu, Jing-Tao; Wang, Hui-Jun; Yue, Xia] Southern Med Univ, Dept Forens Med, Guangzhou 510515, Guangdong, Peoples R China; [Li, Dong-Ri] Osaka City Univ, Dept Legal Med, Sch Med, Abeno Ku, Osaka 5458585, Japan	Wang, HJ (reprint author), Southern Med Univ, Dept Forens Med, 1838 Guangzhou Northern Ave, Guangzhou 510515, Guangdong, Peoples R China.	hjwang711@163.com; yiluyangguang@163.com			National Natural Science Foundation of China [81102301, 81172907]	This study was supported by the National Natural Science Foundation of China (grant nos. 81102301 and 81172907).	Wolf BB, 1999, J BIOL CHEM, V274, P30651, DOI 10.1074/jbc.274.43.30651; Scott JC, 2007, NEUROPSYCHOL REV, V17, P275, DOI 10.1007/s11065-007-9031-0; Nickerson T, 1998, ENDOCRINOLOGY, V139, P807, DOI 10.1210/en.139.2.807; McManus MT, 2002, NAT REV GENET, V3, P737, DOI 10.1038/nrg908; Carvalho M, 2012, ARCH TOXICOL, V86, P1167, DOI 10.1007/s00204-012-0815-5; Tonner E, 2002, DEVELOPMENT, V129, P4547; Su Y, 2011, ONCOGENE, V30, P3907, DOI 10.1038/onc.2011.97; Narula J, 2000, CURR OPIN CARDIOL, V15, P183, DOI 10.1097/00001573-200005000-00011; Li XF, 2008, NEUROCHEM INT, V52, P256, DOI 10.1016/j.neuint.2007.06.014; Enari M, 1998, NATURE, V391, P43; Fischer F, 2004, CLIN ENDOCRINOL, V61, P595, DOI 10.1111/j.1365-2265.2004.02136.x; Li Y, 2012, TOXICOL LETT, V215, P1, DOI 10.1016/j.toxlet.2012.09.019; SMITH HJ, 1976, AM HEART J, V91, P792, DOI 10.1016/S0002-8703(76)80545-5; Waksman J, 2001, MAYO CLIN PROC, V76, P323; Hung MJ, 2003, INT J CLIN PRACT, V57, P62; Butt AJ, 2005, ENDOCRINOLOGY, V146, P3113, DOI 10.1210/en.2004-1408; Kaye S, 2007, ADDICTION, V102, P1204, DOI 10.1111/j.1360-0443.2007.01874.x; Kim KS, 2007, MOL BIOL CELL, V18, P4543, DOI 10.1091/mbc.E07-03-0280; Shrem MT, 2008, J HEALTH PSYCHOL, V13, P669, DOI 10.1177/1359105307082461; Iwasa M, 1996, INT J LEGAL MED, V109, P23, DOI 10.1007/BF01369597; Cadet JL, 2003, FASEB J, V17, P1775, DOI 10.1096/fj.03-0073rev; Jayanthi S, 2004, FASEB J, V18, P238, DOI 10.1096/fj.03-0295com; Cobb LJ, 2004, J CELL SCI, V117, P1737, DOI 10.1242/jcs.01028; Darke S, 2008, DRUG ALCOHOL REV, V27, P253, DOI 10.1080/09595230801923702; BEILHARZ EJ, 1993, MOL BRAIN RES, V18, P209, DOI 10.1016/0169-328X(93)90191-Q; Deng XL, 2001, MOL BRAIN RES, V93, P64, DOI 10.1016/S0169-328X(01)00184-X; Thornberry NA, 1998, SCIENCE, V281, P1312, DOI 10.1126/science.281.5381.1312; Lee DH, 2013, KOREAN J PHYSIOL PHA, V17, P157, DOI 10.4196/kjpp.2013.17.2.157; Brennan Kathleen, 2004, Cardiol Rev, V12, P282, DOI 10.1097/01.crd.0000132372.38506.45; Costa G M, 2001, Ital Heart J, V2, P478; Crean AM, 2004, BRIT J CLIN PHARMACO, V58, P558, DOI 10.1111/j.1365-2125.2004.02176.x; Davidson C, 2001, BRAIN RES REV, V36, P1; Godard MP, 2012, CLIN INTERV AGING, V7, P489, DOI 10.2147/CIA.S37879; HONG R, 1991, JAMA-J AM MED ASSOC, V265, P1152, DOI 10.1001/jama.265.9.1152; KALANT H, 1975, CAN MED ASSOC J, V112, P299; Narula J, 1996, NEW ENGL J MED, V335, P1182, DOI 10.1056/NEJM199610173351603; Olivetti G, 1997, NEW ENGL J MED, V336, P1131, DOI 10.1056/NEJM199704173361603; Sokolović Aleksandar, 2010, Fibrogenesis Tissue Repair, V3, P3, DOI 10.1186/1755-1536-3-3; Sztajnkrycer Matthew D, 2002, Pediatr Emerg Care, V18, pE11, DOI 10.1097/00006565-200208000-00004; Takemura G, 2004, PHARMACOL THERAPEUT, V104, P1, DOI 10.1016/j.pharmthera.2004.07.005; Tanno B, 2006, BIOCHEM BIOPH RES CO, V351, P547, DOI 10.1016/j.bbrc.2006.10.062; Watts DJ, 2006, AM J EMERG MED, V24, P132, DOI 10.1016/j.ajem.2005.08.005; Wijetunga M, 2003, J TOXICOL-CLIN TOXIC, V41, P981, DOI 10.1081/CLT-120026521	43	2	3	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1791-2997	1791-3004		MOL MED REP	Mol. Med. Rep.	NOV	2014	10	5					2306	2312		10.3892/mmr.2014.2572		7	Oncology; Medicine, Research & Experimental	Oncology; Research & Experimental Medicine	AS7GB	WOS:000344424000012		
J	Ohta, K; Ishida, Y; Fukui, A; Mizuta, K; Nishi, H; Takechi, M; Kamata, N				Ohta, Kouji; Ishida, Yoko; Fukui, Akiko; Mizuta, Kuniko; Nishi, Hiromi; Takechi, Masaaki; Kamata, Nobuyuki			Toll-like receptor (TLR) expression and TLR-mediated interleukin-8 production by human submandibular gland epithelial cells	MOLECULAR MEDICINE REPORTS			English	Article						submandibular gland epithelial cells; Toll-like receptor; interleukin-8; tumor necrosis factor-alpha	MESSENGER-RNA EXPRESSION; POLYINOSINIC-POLYCYTIDYLIC ACID; SJOGRENS-SYNDROME; INFLAMMATORY CYTOKINES; ACTIVATION; LIPOPOLYSACCHARIDE; PROFILES; PATHWAY; GENES; MOUSE	Toll-like receptor (TLR) family members are pattern recognition receptors that are essential in the activation of innate and adaptive immune responses. Submandibular gland epithelial cells (SMGCs) may recognize microbial components through TLRs and be involved in the development of inflammatory reactions in the submandibular glands. Therefore, the functional expression of TLRs in SMGCs was investigated in the present study. The mRNA expression of TLRs in SMGC and whole submandibular tissues was determined by RT-PCR. Subsequently, the effects of various TLR agonists and tumor necrosis factor alpha (TNF-alpha) on IL-8 production were examined using an ELISA. SMGCs, as well as whole submandibular tissues, expressed TLR1-10 mRNA. Furthermore, interleukin (IL)-8 production in SMGCs was increased by Pam3CSK4 (TLR1/2 agonist), poly I:C (TLR3 agonist), E. coli lipopolysaccharide (LPS; TLR4 agonist), flagellin (TLR5 agonist) and macrophage-activating lipopeptide (MALP)-2 (TLR2/6 agonist) treatments in a dose-dependent manner, whereas administration of either imiquimod (TLR7 agonist) or CpG-oligodeoxynucletide (TLR9 agonist) exerted no evident effect. Pam3CSK4, poly I:C, LPS, flagellin and MALP-2 also enhanced TNF-alpha-induced IL-8 production in SMGCs. These findings suggest that innate immune responses against microbial components result in the delielopment of TNF-alpha-mediated autoimmune inflammatory disease in the submandibular glands.	[Ohta, Kouji; Ishida, Yoko; Fukui, Akiko; Mizuta, Kuniko; Nishi, Hiromi; Takechi, Masaaki; Kamata, Nobuyuki] Hiroshima Univ, Grad Sch Biomed & Hlth Sci, Dept Oral & Maxillofacial Surg, Hiroshima 7348553, Japan	Ohta, K (reprint author), Hiroshima Univ, Grad Sch Biomed & Hlth Sci, Dept Oral & Maxillofacial Surg, 1-2-3 Kasumi, Hiroshima 7348553, Japan.	otkouji@hiroshima-u.ac.jp			Japan Society for Young Scientists (B) from the Ministry of Education, Culture, Sports, Science and Technology of Japan [21109871]	This study was supported by a Grant-in-Aid of scientific research from the Japan Society for Young Scientists (B) from the Ministry of Education, Culture, Sports, Science and Technology of Japan (grant no. 21109871).	Ittah M, 2009, EUR J IMMUNOL, V39, P1271, DOI 10.1002/eji.200839086; Anders HJ, 2004, FASEB J, V18, P534, DOI 10.1096/fj.03-0646fje; Zarember KA, 2002, J IMMUNOL, V168, P554; Takeda K, 2003, ANNU REV IMMUNOL, V21, P335, DOI 10.1146/annurev.immunol.21.120601.141126; Szlavik V, 2008, TISSUE ENG PT A, V14, P1915, DOI 10.1089/ten.tea.2007.0208; Kawai T, 2001, J IMMUNOL, V167, P5887; Deshmukh US, 2009, J ORAL PATHOL MED, V38, P42, DOI 10.1111/j.1600-0714.2008.00700.x; Matsumura R, 2000, CLIN EXP RHEUMATOL, V18, P311; Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Park JH, 2011, J ORAL PATHOL MED, V40, P187, DOI 10.1111/j.1600-0714.2010.00929.x; Nishimura M, 2005, BIOL PHARM BULL, V28, P886, DOI 10.1248/bpb.28.886; Dimitriou ID, 2002, EUR J ORAL SCI, V110, P21, DOI 10.1034/j.1600-0722.2002.00152.x; FOX RI, 1994, J IMMUNOL, V152, P5532; Pflugfelder SC, 1999, CURR EYE RES, V19, P201, DOI 10.1076/ceyr.19.3.201.5309; Spachidou MP, 2007, CLIN EXP IMMUNOL, V147, P497, DOI 10.1111/j.1365-2249.2006.03311.x; Hertz CJ, 2003, J IMMUNOL, V171, P6820; Hajnicka V, 2001, PARASITE IMMUNOL, V23, P483, DOI 10.1046/j.1365-3024.2001.00403.x; Birchler T, 2001, EUR J IMMUNOL, V31, P3131, DOI 10.1002/1521-4141(200111)31:11<3131::AID-IMMU3131>3.0.CO;2-G; Roescher N, 2009, ORAL DIS, V15, P519, DOI 10.1111/j.1601-0825.2009.01582.x; Midwood KS, 2009, CURR DRUG TARGETS, V10, P1139; Kumar H, 2009, BIOCHEM BIOPH RES CO, V388, P621, DOI 10.1016/j.bbrc.2009.08.062; Bocker U, 2003, INT J COLORECTAL DIS, V18, P25, DOI 10.1007/s00384-002-0415-6; Cuello C, 1998, BRIT J RHEUMATOL, V37, P779; Han DC, 2003, ORAL MICROBIOL IMMUN, V18, P350, DOI 10.1046/j.0902-0055.2003.00094.x; Ittah M, 2008, EUR J IMMUNOL, V38, P1058, DOI 10.1002/eji.200738013; Kawakami A, 2007, J RHEUMATOL, V34, P1019; Kobayashi Y, 2004, CLIN EXP IMMUNOL, V136, P423, DOI 10.1111/j.1365-2249.2004.02467.x; Li J, 2002, AM J PHYSIOL-LUNG C, V283, pL690, DOI 10.1152/ajplung.00060.2002; Lisi S, 2012, LAB INVEST, V92, P615, DOI 10.1038/labinvest.2011.190; Ohta K, 2008, J DENT RES, V87, P1160; Qu WM, 2002, CLIN EXP IMMUNOL, V129, P27, DOI 10.1046/j.1365-2249.2002.01881.x; Shimizu S, 2012, J ORAL PATHOL MED, V41, P517, DOI 10.1111/j.1600-0714.2012.01136.x; Zheng LY, 2010, ORAL SURG ORAL MED O, V109, P844, DOI 10.1016/j.tripleo.2010.01.006	33	0	0	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1791-2997	1791-3004		MOL MED REP	Mol. Med. Rep.	NOV	2014	10	5					2377	2382		10.3892/mmr.2014.2507		6	Oncology; Medicine, Research & Experimental	Oncology; Research & Experimental Medicine	AS7GB	WOS:000344424000023		
J	Takahashi, Y; Makino, K; Nakamura, H; Hide, T; Yano, S; Kamada, H; Kuratsu, JI				Takahashi, Yoshinobu; Makino, Keishi; Nakamura, Hideo; Hide, Takuichiro; Yano, Shigetoshi; Kamada, Hajime; Kuratsu, Jun-Ichi			Clinical characteristics and pathogenesis of cerebellar glioblastoma	MOLECULAR MEDICINE REPORTS			English	Article						cerebellar; glioblastoma; p53; epidermal growth factor receptor; isocitrate dehydrogenase 1; hydrocephalus	NEUROFIBROMATOSIS TYPE-1 GENE; CODON 132 MUTATION; MALIGNANT ASTROCYTOMA; PILOCYTIC ASTROCYTOMAS; RADIATION-THERAPY; IDH1 MUTATIONS; BRAIN-TUMORS; MEDULLOBLASTOMA; MULTIFORME; CHILDREN	Cerebellar glioblastomas (GBMs) are rare, with neither their pathogenesis nor prognosis being completely understood. The present study aimed to clarify the clinical characteristics of cerebellar GBMs by comparison with supratentorial GBMs, focusing particularly on the pathogenesis. The clinical factors between cerebellar (n=10) and supratentorial (n=216) GBMs were compared. Additionally, p53 and epidermal growth factor receptor (EGFR) levels were investigated in six patients by immunostaining as well as the isocitrate dehydrogenase 1 (IDH1) status of five patients by direct sequencing. Eight males and two females participated in the present study, the mean age at diagnosis was 56.6 years and the range 37-75 years. Four patients presented with hydrocephalus and one with brainstem involvement, and two patients were diagnosed with neurofibromatosis type 1. Two patients had previously received radiotherapy, eight patients received postoperative radiotherapy and seven chemotherapy. The mean Karnofsky performance status (KPS) score was lower in patients with cerebellar GBMs compared to those with supratentorial GBM; however, the survival times did not differ between the two groups. All of the cases of six cerebellar GBMs were p53-positive and EGFR-negative, as detected by immunostaining, consistent with secondary GBM. However, no IDH1 mutations were detected in any of the five cases of cerebellar GBMs analyzed, indicating that these tumors were not of the secondary type. The KPS score with cerebellar GBMs may be lower due to hydrocephalus, which was ameliorated by surgery but may have impacted the survival rate. It was confirmed that cerebellar GBMs were identical to supratentorial GBMs with respect to its clinical features, with the possible exception of the KPS score. The present study's genetic analyses indicated that cerebellar GBMs may develop via a pathway different from that of either primary or secondary GBM.	[Takahashi, Yoshinobu; Makino, Keishi; Nakamura, Hideo; Hide, Takuichiro; Yano, Shigetoshi; Kuratsu, Jun-Ichi] Kumamoto Univ, Grad Sch Med Sci, Dept Neurosurg, Kumamoto 8608556, Japan; [Takahashi, Yoshinobu; Kamada, Hajime] Hokuto Hosp, Dept Neurosurg, Obihiro, Hokkaido 0800039, Japan	Takahashi, Y (reprint author), Hokuto Hosp, Dept Neurosurg, 7-5 Inada, Obihiro, Hokkaido 0800039, Japan.	yosinobu@hokuto7.or.jp					Akimoto J, 2009, BRAIN TUMOR PATHOL, V26, P59, DOI 10.1007/s10014-009-0248-x; Sanson M, 2009, J CLIN ONCOL, V27, P4150, DOI 10.1200/JCO.2009.21.9832; Lammert M, 2005, ARCH DERMATOL, V141, P71, DOI 10.1001/archderm.141.1.71; Brown PD, 2004, INT J RADIAT ONCOL, V58, P1153, DOI 10.1016/j.ijrobp.2003.09.020; Nobusawa S, 2009, CLIN CANCER RES, V15, P6002, DOI 10.1158/1078-0432.CCR-09-0715; EASTON DF, 1993, AM J HUM GENET, V53, P305; Roessler K, 2002, J NEURO-ONCOL, V58, P141, DOI 10.1023/A:1016053229688; Gravendeel LAM, 2010, HUM MUTAT, V31, pE1186, DOI 10.1002/humu.21201; Ichimura K, 2009, NEURO-ONCOLOGY, V11, P341, DOI 10.1215/15228517-2009-025; Zhu Y, 2005, CANCER CELL, V8, P119, DOI 10.1016/j.ccr.2005.07.004; Sonoda Y, 2009, CANCER SCI, V100, P1996, DOI 10.1111/j.1349-7006.2009.01270.x; Tsung AJ, 2011, J NEURO-ONCOL, V105, P555, DOI 10.1007/s11060-011-0617-2; Weller M, 2009, J CLIN ONCOL, V27, P5743, DOI 10.1200/JCO.2009.23.0805; Watanabe T, 2009, AM J PATHOL, V174, P1149, DOI 10.2353/ajpath.2009.080958; van den Bent MJ, 2010, CLIN CANCER RES, V16, P1597, DOI 10.1158/1078-0432.CCR-09-2902; Utsuki S, 2012, BRAIN TUMOR PATHOL, V29, P87, DOI 10.1007/s10014-011-0070-0; SALAZAR OM, 1981, INT J RADIAT ONCOL, V7, P1661; Ohgaki H, 2007, AM J PATHOL, V170, P1445, DOI 10.2353/ajpath.2007.070011; CAWTHON RM, 1990, CELL, V62, P193, DOI 10.1016/0092-8674(90)90253-B; Balss J, 2008, ACTA NEUROPATHOL, V116, P597, DOI 10.1007/s00401-008-0455-2; Canesso A, 2006, VIRCHOWS ARCH, V449, P248, DOI 10.1007/s00428-006-0224-3; COHEN MS, 1981, NEUROLOGY, V31, P616; Furuta T, 1998, CLIN NEUROL NEUROSUR, V100, P56, DOI 10.1016/S0303-8467(97)00122-4; GILLES FH, 1995, NEUROSURGERY, V37, P1056; Grahovac G, 2009, ACTA NEUROCHIR, V151, P653, DOI 10.1007/s00701-009-0286-5; Kleihues P, 1999, Neuro Oncol, V1, P44, DOI 10.1215/15228517-1-1-44; KLERIGA E, 1978, J NEUROSURG, V49, P445, DOI 10.3171/jns.1978.49.3.0445; Nakamizo A, 2001, ACTA NEUROCHIR, V143, P697, DOI 10.1007/s007010170048; OSUMI AK, 1994, CLIN NEUROPATHOL, V13, P281; Paulino AC, 2008, INT J RADIAT ONCOL, V71, P1381, DOI 10.1016/j.ijrobp.2007.12.018; PEARL GS, 1980, NEUROSURGERY, V6, P546; ROTH JG, 1960, J NEUROSURG, V17, P736, DOI 10.3171/jns.1960.17.4.0736; SAFNECK JR, 1992, CAN J NEUROL SCI, V19, P498; Saito T, 2006, ANTICANCER RES, V26, P1351; SCHMIDBAUER M, 1987, J NEUROSURG, V67, P915, DOI 10.3171/jns.1987.67.6.0915; Weber DC, 2006, INT J RADIAT ONCOL, V66, P179, DOI 10.1016/j.ijrobp.2006.04.035; XU GF, 1990, CELL, V63, P835, DOI 10.1016/0092-8674(90)90149-9	37	0	0	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1791-2997	1791-3004		MOL MED REP	Mol. Med. Rep.	NOV	2014	10	5					2383	2388		10.3892/mmr.2014.2549		6	Oncology; Medicine, Research & Experimental	Oncology; Research & Experimental Medicine	AS7GB	WOS:000344424000024		
J	de Castro, PA; Chen, CX; de Almeida, RSC; Freitas, FZ; Bertolini, MC; Morais, ER; Brown, NA; Ramalho, LNZ; Hagiwara, D; Mitchell, TK; Goldman, GH				de Castro, Patricia A.; Chen, Chenxi; Couto de Almeida, Ricardo Sergio; Freitas, Fernanda Z.; Bertolini, Maria C.; Morais, Enyara Rezende; Brown, Neil Andrew; Zambelli Ramalho, Leandra Naira; Hagiwara, Daisuke; Mitchell, Thomas K.; Goldman, Gustavo H.			ChIP-seq reveals a role for CrzA in the Aspergillus fumigatus high-osmolarity glycerol response (HOG) signalling pathway	MOLECULAR MICROBIOLOGY			English	Article							ACTIVATED PROTEIN-KINASE; HIGH-EFFICIENCY TRANSFORMATION; PATHOGEN-HOST INTERACTIONS; SACCHAROMYCES-CEREVISIAE; TRANSCRIPTION FACTOR; CANDIDA-ALBICANS; STRESS RESPONSES; OXIDATIVE STRESS; PHI-BASE; COCHLIOBOLUS-HETEROSTROPHUS	Aspergillus fumigatus is an opportunistic pathogen and allergen of mammals. Calcium signalling is essential for A. fumigatus pathogenicity and is regulated by the CrzA transcription factor. We used ChIP-seq (Chromatin Immunoprecipitation DNA sequencing) to explore CrzA gene targets in A. fumigatus. In total, 165 potential binding peaks including 102 directly regulated genes were identified, resulting in the prediction of the A[GT][CG]CA[AC][AG] CrzA-binding motif. The 102 CrzA putatively regulated genes exhibited a diverse array of functions. The phkB (Afu3g12530) histidine kinase and the sskB (Afu1g10940) MAP kinase kinase kinase of the HOG (high-osmolarity glycerol response) pathway were regulated by CrzA. Several members of the two-component system (TCS) and the HOG pathway were more sensitive to calcium. CrzA::GFP was translocated to the nucleus upon osmotic stress. CrzA is important for the phosphorylation of the SakA MAPK in response to osmotic shock. The sskB was more sensitive to CaCl2, NaCl, and paraquat stress, while being avirulent in a murine model of invasive pulmonary aspergillosis. The presence of CaCl2 and osmotic stresses resulted in synergistic inhibition of crzA and sskB growth. These results suggest there is a genetic interaction between the A. fumigatus calcineurin-CrzA and HOG pathway that is essential for full virulence.	[de Castro, Patricia A.; Couto de Almeida, Ricardo Sergio; Morais, Enyara Rezende; Brown, Neil Andrew; Goldman, Gustavo H.] Univ Sao Paulo, Fac Ciencias Farmaceut Ribeirao Preto, BR-14049 Ribeirao Preto, Brazil; [Zambelli Ramalho, Leandra Naira] Univ Sao Paulo, Fac Med Ribeirao Preto, BR-14049 Ribeirao Preto, Brazil; [Chen, Chenxi; Mitchell, Thomas K.] Ohio State Univ, Dept Plant Pathol, Columbus, OH 43210 USA; [Freitas, Fernanda Z.; Bertolini, Maria C.] Univ Estadual Paulista, Inst Quim, Araraquara, Brazil; [Hagiwara, Daisuke] Chiba Univ, Med Mycol Res Ctr, Chiba, Japan; [Goldman, Gustavo H.] Natl Lab Sci & Technol Bioethanol CTBE, Campinas, SP, Brazil	Goldman, GH (reprint author), Univ Sao Paulo, Fac Ciencias Farmaceut Ribeirao Preto, BR-14049 Ribeirao Preto, Brazil.	ggoldman@usp.br			Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) from Brazil; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) from Brazil; Ohio Agricultural Research and Development Center at the Ohio State University, USA	We would like to thank the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) and the Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP), both from Brazil, and Ohio Agricultural Research and Development Center at the Ohio State University, USA, for providing financial support. We also thank the four reviewers and the editor for their comments and suggestions.	Carafoli E, 2002, P NATL ACAD SCI USA, V99, P1115, DOI 10.1073/pnas.032427999; Juvvadi PR, 2003, ARCH MICROBIOL, V179, P416, DOI 10.1007/s00203-003-0546-3; Miyakawa T, 2007, BIOSCI BIOTECH BIOCH, V71, P633, DOI 10.1271/bbb.60495; Cyert MS, 2003, BIOCHEM BIOPH RES CO, V311, P1143, DOI 10.1016/S0006-291X(03)01552-3; Karababa M, 2006, MOL MICROBIOL, V59, P1429, DOI 10.1111/j.1365-2958.2005.05037.x; WARD MP, 1995, MOL CELL BIOL, V15, P6854; Rispail N, 2010, MOL PLANT PATHOL, V11, P395, DOI [10.1111/j.1364-3703.2010.00612.x, 10.1111/J.1364-3703.2010.00612.X]; Viladevall L, 2004, J BIOL CHEM, V279, P43614, DOI 10.1074/jbc.M403606200; Stathopoulos AM, 1997, GENE DEV, V11, P3432, DOI 10.1101/gad.11.24.3432; Bailey TL, 2006, NUCLEIC ACIDS RES, V34, pW369, DOI 10.1093/nar/gkl198; Nguyen TV, 2012, MOL PLANT MICROBE IN, V25, P1142, DOI 10.1094/MPMI-02-12-0047-R; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Semighini CP, 2002, APPL ENVIRON MICROB, V68, P1351, DOI 10.1128/AEM.68.3.1351-1357.2002; Ferreira MED, 2006, CURR GENET, V50, P32, DOI 10.1007/s00294-006-0073-2; Steinbach WJ, 2007, NAT REV MICROBIOL, V5, P418, DOI 10.1038/nrmicro1680; Goldman GH, 2003, EUKARYOT CELL, V2, P34, DOI 10.1128/EC.2.1.34-48.2003; Colot HV, 2006, P NATL ACAD SCI USA, V103, P10352, DOI 10.1073/pnas.0601456103; Greenberger PA, 2002, J ALLERGY CLIN IMMUN, V110, P685, DOI 10.1067/mai.2002.130179; Yoshimoto H, 2002, J BIOL CHEM, V277, P31079, DOI 10.1074/jbc.M202718200; Bahn YS, 2008, EUKARYOT CELL, V7, P2017, DOI 10.1128/EC.00323-08; BLOMBERG A, 1992, ADV MICROB PHYSIOL, V33, P145, DOI 10.1016/S0065-2911(08)60217-9; GIMENO CJ, 1994, MOL CELL BIOL, V14, P2100; Kojima K, 2006, MICROBIOL-SGM, V152, P591, DOI 10.1099/mic.0.28571-0; Lin CH, 2010, FUNGAL GENET BIOL, V47, P818, DOI 10.1016/j.fgb.2010.06.009; Alonso-Monge R, 1999, J BACTERIOL, V181, P3058; Steinbach WJ, 2006, EUKARYOT CELL, V5, P1091, DOI 10.1128/EC.00139-06; Takatsume Y, 2010, BIOCHEM J, V427, P275, DOI 10.1042/BJ20091334; Baldwin TK, 2006, MOL PLANT MICROBE IN, V19, P1451, DOI 10.1094/MPMI-19-1451; Du C, 2006, MED MYCOL, V44, P211, DOI 10.1080/13693780500338886; Zhang YJ, 2009, APPL ENVIRON MICROB, V75, P3787, DOI 10.1128/AEM.01913-08; Lawrence CL, 2004, MOL CELL BIOL, V24, P3307, DOI 10.1128/MCB.24.8.3307.3323.2004; Bahn YS, 2005, MOL BIOL CELL, V16, P2285, DOI 10.1091/mbc.E04-11-0987; Rep M, 2000, J BIOL CHEM, V275, P8290, DOI 10.1074/jbc.275.12.8290; Boyce KJ, 2011, MOL MICROBIOL, V82, P1164, DOI 10.1111/j.1365-2958.2011.07878.x; Yaakov G, 2009, MOL BIOL CELL, V20, P3572, DOI 10.1091/mbc.E09-02-0129; Thewes S, 2014, EUKARYOT CELL, V13, P694, DOI 10.1128/EC.00038-14; SCHIESTL RH, 1989, CURR GENET, V16, P339, DOI 10.1007/BF00340712; Fox DS, 2002, BIOESSAYS, V24, P894, DOI 10.1002/bies.10157; Haynes BC, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002411; Park PJ, 2009, NAT REV GENET, V10, P669, DOI 10.1038/nrg2641; Käfer E, 1977, Adv Genet, V19, P33, DOI 10.1016/S0065-2660(08)60245-X; Bilsland E, 2004, MOL MICROBIOL, V53, P1743, DOI 10.1111/j.1365-2958.2004.04238.x; Dagenais TRT, 2009, CLIN MICROBIOL REV, V22, P447, DOI 10.1128/CMR.00055-08; Degols G, 1997, MOL CELL BIOL, V17, P3356; Choi J, 2009, FUNGAL GENET BIOL, V46, P243, DOI 10.1016/j.fgb.2008.11.010; Soriani FM, 2008, MOL MICROBIOL, V67, P1274, DOI 10.1111/j.1365-2958.2008.06122.x; Li Ruiqiang, 2010, Genome Res, V20, P265, DOI 10.1101/gr.097261.109; Prokisch H, 1997, MOL GEN GENET, V256, P104; Winnenburg R, 2006, NUCLEIC ACIDS RES, V34, pD459, DOI 10.1093/nar/gkj047; Buske FA, 2010, BIOINFORMATICS, V26, P860, DOI 10.1093/bioinformatics/btq049; Cheetham J, 2011, J BIOL CHEM, V286, P42002, DOI 10.1074/jbc.M111.265231; Delgado-Jarana J, 2006, MICROBIOL-SGM, V152, P1687, DOI 10.1099/mic.0.28729-0; Dinamarco TM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037591; Ferreira MED, 2007, FUNGAL GENET BIOL, V44, P219, DOI 10.1016/j.fgb.2006.08.004; Gupta S, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r24; Hagiwara D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080881; Hagiwara D, 2008, CURR GENET, V54, P325, DOI 10.1007/s00294-008-0220-z; Hagiwara D, 2007, BIOSCI BIOTECH BIOCH, V71, P1003, DOI 10.1271/bbb.60665; HERRERAESTRELLA A, 1990, MOL MICROBIOL, V4, P839, DOI 10.1111/j.1365-2958.1990.tb00654.x; Igbaria A, 2008, MOL PLANT MICROBE IN, V21, P769, DOI 10.1094/MPMI-21-6-0769; Ji H, 2011, CURR PROTOC BIOINFOR, V2, DOI DOI 10.1002/0471250953.BIO213S33; Kim S, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000909; Kothe GO, 1998, FUNGAL GENET BIOL, V23, P248, DOI 10.1006/fgbi.1998.1037; Lim Jong-Sung, 2012, Genomics & Informatics, V10, P1, DOI 10.5808/GI.2012.10.1.1; Luo YY, 2012, CURR MICROBIOL, V64, P449, DOI 10.1007/s00284-012-0093-8; Ma DM, 2013, MYCOPATHOLOGIA, V175, P13, DOI 10.1007/s11046-012-9600-5; Malavazi I, 2009, FUNGAL GENET BIOL, V46, P791, DOI 10.1016/j.fgb.2009.06.009; May GS, 2005, MED MYCOL, V43, pS83, DOI 10.1080/13693780400024784; Nasmith CG, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002266; Nathues E, 2007, MOL PLANT PATHOL, V8, P653, DOI [10.1111/j.1364-3703.2007.00421.x, 10.1111/J.1364-3703.2007.00421.X]; Oide S, 2010, EUKARYOT CELL, V9, P1867, DOI 10.1128/EC.00150-10; RASMUSSEN C, 1994, EMBO J, V13, P3917; Schumacher J, 2008, EUKARYOT CELL, V7, P584, DOI 10.1128/EC.00426-07; Shitamukai A, 2004, J BIOL CHEM, V279, P3651, DOI 10.1074/jbc.M306098200; Soriani FM, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-12; Sotelo J, 2006, EUKARYOT CELL, V5, P1826, DOI 10.1128/EC.00225-06; Stathopoulos-Gerontides A, 1999, GENE DEV, V13, P798, DOI 10.1101/gad.13.7.798; Stie J, 2008, EUKARYOT CELL, V7, P177, DOI 10.1128/EC.00326-07; Viaud MC, 2002, PLANT CELL, V14, P917, DOI 10.1105/tpc.010389; Winkler A, 2002, STUD ECON TRANS, P1; Winnenburg R, 2008, NUCLEIC ACIDS RES, V36, pD572, DOI 10.1093/nar/gkm858	81	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0950-382X	1365-2958		MOL MICROBIOL	Mol. Microbiol.	NOV	2014	94	3					655	674		10.1111/mmi.12785		20	Biochemistry & Molecular Biology; Microbiology	Biochemistry & Molecular Biology; Microbiology	AS7XK	WOS:000344465000013		
J	Watanabe, T; Asano, N; Meng, G; Yamashita, K; Arai, Y; Sakurai, T; Kudo, M; Fuss, IJ; Kitani, A; Shimosegawa, T; Chiba, T; Strober, W				Watanabe, T.; Asano, N.; Meng, G.; Yamashita, K.; Arai, Y.; Sakurai, T.; Kudo, M.; Fuss, I. J.; Kitani, A.; Shimosegawa, T.; Chiba, T.; Strober, W.			NOD2 downregulates colonic inflammation by IRF4-mediated inhibition of K63-linked polyubiquitination of RICK and TRAF6	MUCOSAL IMMUNOLOGY			English	Article							TOLL-LIKE-RECEPTOR; CROHNS-DISEASE; BOWEL-DISEASE; DENDRITIC CELLS; PROINFLAMMATORY CYTOKINES; EXPERIMENTAL COLITIS; HOST-DEFENSE; RIP2; HOMEOSTASIS; ACTIVATION	It is well established that polymorphisms of the caspase activation and recruitment domain 15 (CARD15) gene, a major risk factor in Crohn's disease (CD), lead to loss of nucleotide-binding oligomerization domain 2 (NOD2) function. However, a molecular explanation of how such loss of function leads to increased susceptibility to CD has remained unclear. In a previous study exploring this question, we reported that activation of NOD2 in human dendritic cells by its ligand, muramyl dipeptide (MDP), negatively regulates Toll-like receptor (TLR)-mediated inflammatory responses. Here we show that NOD2 activation results in increased interferon regulatory factor 4 (IRF4) expression and binding to tumor necrosis factor receptor associated factor 6 (TRAF6) and RICK (receptor interacting serine-threonine kinase). We then show that such binding leads to IRF4-mediated inhibition of Lys63-linked polyubiquitination of TRAF6 and RICK and thus to downregulation of nuclear factor (NF)-kappa B activation. Finally, we demonstrate that protection of mice from the development of experimental colitis by MDP or IRF4 administration is accompanied by similar IRF4-mediated effects on polyubiquitination of TRAF6 and RICK in colonic lamina propria mononuclear cells. These findings thus define a mechanism of NOD2-mediated regulation of innate immune responses to intestinal microflora that could explain the relation of CARD15 polymorphisms and resultant NOD2 dysfunction to CD.	[Watanabe, T.] Kyoto Univ, Grad Sch Med, Ctr Innovat Immunoregulat Technol & Therapeut, Kyoto, Japan; [Watanabe, T.; Asano, N.; Meng, G.; Fuss, I. J.; Kitani, A.; Strober, W.] NIAID, Mucosal Immun Sect, Lab Host Def, NIH, Bethesda, MD 20892 USA; [Watanabe, T.; Chiba, T.] Kyoto Univ, Grad Sch Med, Dept Gastroenterol & Hepatol, Kyoto, Japan; [Asano, N.; Shimosegawa, T.] Tohoku Univ, Grad Sch Med, Div Gastroenterol, Sendai, Miyagi 980, Japan; [Yamashita, K.] Kyoto Univ, Grad Sch Med, Dept Hematol & Oncol, Kyoto, Japan; [Sakurai, T.; Kudo, M.] Kinki Univ, Sch Med, Dept Gastroenterol & Hepatol, Osakasayama, Japan	Watanabe, T (reprint author), Kyoto Univ, Grad Sch Med, Ctr Innovat Immunoregulat Technol & Therapeut, Kyoto, Japan.	tmhrwtnb@kuhp.kyoto-u.ac.jp; wstrober@niaid.nih.gov			Japan Society for the Promotion of Science [25293172, 21229009, 24229005, 24659363]; Japanese Society of Gastroenterology; Special Coordination Funds by the Ministry of Education, Culture, Sports, Science and Technology of Japan; Astellas Pharma in Creation of Innovation Centers for Advanced Interdisciplinary Research Areas Program; National Institutes of Health	This work was supported by Grant-in-Aid for Scientific Research (25293172, 21229009, 24229005, and 24659363) from the Japan Society for the Promotion of Science, the Japanese Society of Gastroenterology, and the Special Coordination Funds by the Ministry of Education, Culture, Sports, Science and Technology of Japan, and Astellas Pharma in Creation of Innovation Centers for Advanced Interdisciplinary Research Areas Program, and by the Intramural Research Program of the National Institutes of Health. We thank Ms M. Tosaka and Dr H. Ezoe for their support.	Abbott DW, 2007, MOL CELL BIOL, V27, P6012, DOI 10.1128/MCB.00270-07; Yeretssian G, 2011, NATURE, V474, P96, DOI 10.1038/nature09982; Honma K, 2005, P NATL ACAD SCI USA, V102, P16001, DOI 10.1073/pnas.0504226102; Bertrand MJM, 2009, IMMUNITY, V30, P789, DOI 10.1016/j.immuni.2009.04.011; Dorsch M, 2006, CELL SIGNAL, V18, P2223, DOI 10.1016/j.cellsig.2006.05.005; Tao MF, 2009, CURR BIOL, V19, P1255, DOI 10.1016/j.cub.2009.06.038; Strober W, 2011, GASTROENTEROLOGY, V140, P1756, DOI 10.1053/j.gastro.2011.02.016; Kim YG, 2008, IMMUNITY, V28, P246, DOI 10.1016/j.immuni.2007.12.012; Mudter J, 2011, INFLAMM BOWEL DIS, V17, P1343, DOI 10.1002/ibd.21476; Natkunam Y, 2001, MODERN PATHOL, V14, P686, DOI 10.1038/modpathol.3880373; Xu WD, 2012, AUTOIMMUN REV, V11, P918, DOI 10.1016/j.autrev.2012.08.011; Mudter J, 2008, J CLIN INVEST, V118, P2415, DOI 10.1172/JCI33227; Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Tsuji Y, 2012, IMMUNITY, V37, P326, DOI 10.1016/j.immuni.2012.05.024; Nembrini C, 2009, J BIOL CHEM, V284, P19183, DOI 10.1074/jbc.M109.006353; Wehkamp J, 2007, J IMMUNOL, V179, P3109; Watanabe T, 2008, J CLIN INVEST, V118, P545, DOI [10.1172/JCI33145, 10.1172/JC133145]; Hammer GE, 2011, NAT IMMUNOL, V12, P1184, DOI 10.1038/ni.2135; Meinzer U, 2012, CELL HOST MICROBE, V11, P337, DOI 10.1016/j.chom.2012.02.009; Ma A, 2012, NAT REV IMMUNOL, V12, P774, DOI 10.1038/nri3313; Strober W, 2007, J CLIN INVEST, V117, P514, DOI 10.1172/JCI30587; Tada H, 2005, INFECT IMMUN, V73, P7967, DOI 10.1128/IAI.73.12.7967-7976.2005; Biswas PS, 2010, J CLIN INVEST, V120, P3280, DOI 10.1172/JCI42856; Yang YB, 2007, J BIOL CHEM, V282, P36223, DOI 10.1074/jbc.M703079200; Cho JH, 2008, NAT REV IMMUNOL, V8, P458, DOI 10.1038/nri2340; van Heel DA, 2005, LANCET, V365, P1794, DOI 10.1016/S0140-6736(05)66582-8; Biswas PS, 2012, J EXP MED, V209, P581, DOI 10.1084/jem.20111195; Kobayashi KS, 2005, SCIENCE, V307, P731, DOI 10.1126/science.1104911; Hasegawa M, 2008, EMBO J, V27, P373, DOI 10.1038/sj.emboj.7601962; Strober W, 2011, MUCOSAL IMMUNOL, V4, P484, DOI 10.1038/mi.2011.29; Negishi H, 2005, P NATL ACAD SCI USA, V102, P15989, DOI 10.1073/pnas.0508327102; Strober W, 2006, NAT REV IMMUNOL, V6, P9, DOI 10.1038/nri1747; Castellaneta A, 2009, J IMMUNOL, V183, P6922, DOI 10.4049/jimmunol.0900582; Fichtner-Feigl S, 2005, J CLIN INVEST, V115, P3057, DOI 10.1172/JCI24792; De Vry CG, 2007, GUT, V56, P524, DOI 10.1136/gut.2006.096487; Hedl M, 2007, P NATL ACAD SCI USA, V104, P19440, DOI 10.1073/pnas.0706097104; Chen ZJJ, 2005, NAT CELL BIOL, V7, P758, DOI 10.1038/ncb0805-758; Abbott DW, 2004, CURR BIOL, V14, P2217, DOI 10.1016/j.cub.2004.12.032; Hedl M, 2010, GASTROENTEROLOGY, V140, P231; Inohara H., 2005, ANNU REV BIOCHEM, V74, P355; Kullberg BJ, 2008, IMMUNOLOGY, V123, P600, DOI 10.1111/j.1365-2567.2007.02735.x; Lassen S, 2010, J IMMUNOL, V185, P1976, DOI 10.4049/jimmunol.0904207; Werts C, 2011, J LEUKOCYTE BIOL, V90, P471, DOI 10.1189/jlb.0411183	43	3	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1933-0219	1935-3456		MUCOSAL IMMUNOL	Mucosal Immunol.	NOV	2014	7	6					1312	1325		10.1038/mi.2014.19		14	Immunology	Immunology	AS2ED	WOS:000344091700004		
J	Watanabe, K; Kouzaki, M; Moritani, T				Watanabe, Kohei; Kouzaki, Motoki; Moritani, Toshio			NON-UNIFORM SURFACE ELECTROMYOGRAPHIC RESPONSES TO CHANGE IN JOINT ANGLE WITHIN RECTUS FEMORIS MUSCLE	MUSCLE & NERVE			English	Article						bi-articular muscles; joint angle; M-wave; multichannel surface electromyography; neuromuscular compartment; quadriceps femoris	SPINDLES; ANATOMY; PATTERN; HUMANS; GAIT; MRI; EMG	Introduction: Our recent studies have demonstrated region-specific neural activation within the rectus femoris (RF) muscle. However, these studies involved a fixed joint angle or posture. In this study we investigated the effect of hip and knee joint angles on neural activation within RF using multichannel surface electromyography (SEMG). Methods: Eleven healthy men performed isometric maximal voluntary contraction (MVC) during knee extension and hip flexion at different hip or joint angles. During the contractions, SEMG of the RF was recorded using 46 electrode pairs covering most of the superficial area of the muscle. Results: During knee extension MVC, an increase in the hip joint angle was associated with a significant increase in SEMG amplitude in the proximal region and a decrease in the distal region (P<0.05). Higher SEMG amplitude during hip flexion MVC compared with knee extension MVC was observed in proximal regions with the flexed knee and hip joint angles. This task-dependent spatial distribution of SEMG amplitude was seen at the extended hip, but not at the extended knee. Conclusions: SEMG amplitudes within the RF muscle are not modified uniformly with changes in joint position. Muscle Nerve50: 794-802, 2014	[Watanabe, Kohei] Chukyo Univ, Sch Int Liberal Studies, Showa Ku, Nagoya, Aichi 4668666, Japan; [Kouzaki, Motoki] Kyoto Univ, Grad Sch Human & Environm Studies, Neurophysiol Lab, Kyoto, Japan; [Moritani, Toshio] Kyoto Univ, Grad Sch Human & Environm Studies, Appl Physiol Lab, Kyoto, Japan	Watanabe, K (reprint author), Chukyo Univ, Sch Int Liberal Studies, Showa Ku, Yagotohonmachi, Nagoya, Aichi 4668666, Japan.	wkohei@lets.chukyo-u.ac.jp					Solomonow M, 2001, SCAND J MED SCI SPOR, V11, P64, DOI 10.1034/j.1600-0838.2001.011002064.x; Watanabe K, 2012, J ELECTROMYOGR KINES, V22, P251, DOI 10.1016/j.jelekin.2011.11.004; Gyftopoulos S, 2008, AM J ROENTGENOL, V190, pW182, DOI 10.2214/AJR.07.2947; Akima H, 2004, EUR J APPL PHYSIOL, V91, P7, DOI 10.1007/s00421-003-0942-z; Farina D, 2001, IEEE ENG MED BIOL, V20, P62, DOI 10.1109/51.982277; Cordo PJ, 2002, J NEUROPHYSIOL, V87, P1186, DOI 10.1152/jn.00393.2001; Farina D, 2004, J APPL PHYSIOL, V96, P1486, DOI 10.1152/japplphysiol.01070.2003; Barr KM, 2010, GAIT POSTURE, V32, P363, DOI 10.1016/j.gaitpost.2010.06.010; Bordalo-Rodrigues Marcelo, 2005, Magn Reson Imaging Clin N Am, V13, P717, DOI 10.1016/j.mric.2005.08.005; Byrne CA, 2005, J ELECTROMYOGR KINES, V15, P564, DOI 10.1016/j.jelekin.2005.03.002; Dyhre-Poulsen P, 2000, J APPL PHYSIOL, V89, P2191; Hagio S, 2012, J BIOMECH, V45, P179, DOI 10.1016/j.jbiomech.2011.10.012; HASSELMAN CT, 1995, AM J SPORT MED, V23, P493, DOI 10.1177/036354659502300421; HERZOG W, 1991, MED SCI SPORT EXER, V23, P108; Kokkorogiannis T, 2004, J THEOR BIOL, V229, P263, DOI 10.1016/j.jtbi.2004.03.019; Kouzaki M, 2000, J APPL PHYSIOL, V89, P1420; Saitou K, 2000, J Hum Ergol (Tokyo), V29, P35; Sung DH, 2003, ARCH PHYS MED REHAB, V84, P1028, DOI 10.1016/S0003-9993(03)00029-7; Watanabe K, 2013, MUSCLE NERVE, V48, P226, DOI 10.1002/mus.23739; Yang DP, 1999, PLAST RECONSTR SURG, V104, P102, DOI 10.1097/00006534-199907000-00014	20	2	2	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0148-639X	1097-4598		MUSCLE NERVE	Muscle Nerve	NOV	2014	50	5					794	802		10.1002/mus.24232		9	Clinical Neurology; Neurosciences	Neurosciences & Neurology	AS6KY	WOS:000344373700011		
J	Sotome, K; Maekawa, N; Nakagiri, A; Lee, SS; Hattori, T				Sotome, Kozue; Maekawa, Nitato; Nakagiri, Akira; Lee, Su See; Hattori, Tsutomu			Taxonomic study of Asian species of poroid Auriculariales	MYCOLOGICAL PROGRESS			English	Article						Auriculariales; Phylogeny; Aporpium complex	PHYLOGENETIC-RELATIONSHIPS; BASIDIOMYCOTA; ELMERINA; GENUS; POLYPORACEAE; GENERA; TREMELLACEAE; APORPIUM; CLADES; FUNGI	A taxonomic study of poroid Asian species in the Auriculariales was conducted using phylogenetic and morphological methods. Phylogenetic analyses based on the LSU and ITS regions reveal that Elmerina was a polyphyletic genus. Moreover, E. hexagonoides collected from Malaysia and "E. hexagonoides" from Japan formed two distinct clades within a well-supported larger clade with Protomerulius caryae. These taxa comprise a different lineage from the type species of both Protomerulius and Protodaedalea, and we conclude that they are members of the genus Aporpium. The phylogenetic position of E. cladophora (type species of Elmerina) is still unclear, and we retain Aporpium and Protodaedalea as genera distinct from Elmerina. Aporpium strigosum sp. nov. is described to represent Japanese specimens misidentified as E. hexagonoides. Aporpium is characterized by resupinate to sessile basidiocarps, tough-fleshy to leathery context, poroid hymenophore, dimitic hyphal systems with unbranched skeletal hyphae, clavate to pyriform probasidia, and ellipsoid to cylindrical or allantoid basidiospores. Aporpium strigosum is similar to A. hexagonoides, but can be differentiated by the ochraceous to straw-colored basidiocarps, strigose pileus surface with long and stiff hairs, and the larger pores, basidia, and basidiospores.	[Sotome, Kozue; Maekawa, Nitato; Nakagiri, Akira] Tottori Univ, Fungus Mushroom Resource & Res Ctr, Tottori 6808553, Japan; [Lee, Su See] Forest Res Inst Malaysia, Kepong 52109, Selangor, Malaysia; [Hattori, Tsutomu] Forestry & Forest Prod Res Inst, Tsukuba, Ibaraki 6120855, Japan	Sotome, K (reprint author), Tottori Univ, Fungus Mushroom Resource & Res Ctr, Minami 4-101, Tottori 6808553, Japan.	ksotome@muses.tottori-u.ac.jp			Japan Society for the Promotion of Science [21405023]; Global COE Program "Advanced Utilization of Fungus/Mushroom Resources for Sustainable Society in Harmony with Nature", MEXT, Japan	We thank Mr. S. Kurogi, Mr. K. Maruyama, Mr. R. Nakano, Dr. X. H. Wang, and Mr. M. Shintani for kindly providing specimens and/or photographs. We are also grateful to Dr. H. Neda for providing an isolate. TH was financially supported by a Grant-in Aid for Scientific Research from the Japan Society for the Promotion of Science (No. 21405023). This study was partly supported by Global COE Program "Advanced Utilization of Fungus/Mushroom Resources for Sustainable Society in Harmony with Nature", MEXT, Japan.	BANDONI RJ, 1984, T MYCOL SOC JPN, V25, P489; Moncalvo JM, 2002, MOL PHYLOGENET EVOL, V23, P357, DOI 10.1016/S1055-7903(02)00027-1; RAJCHENBERG M, 1987, NORD J BOT, V7, P553, DOI 10.1111/j.1756-1051.1987.tb02023.x; GARDES M, 1993, MOL ECOL, V2, P113, DOI 10.1111/j.1365-294X.1993.tb00005.x; Miettinen O, 2012, ANN BOT FENN, V49, P359; Binder M, 2005, SYST BIODIVERS, V3, P113, DOI 10.1017/S1477200005001623; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI 10.1093/molbev/mst197; REID DA, 1992, PERSOONIA, V14, P465; Sotome K, 2008, MYCOLOGIA, V100, P603, DOI 10.3852/07-191R; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Sotome K, 2009, MYCOL PROG, V8, P123, DOI 10.1007/s11557-009-0584-6; BANDONI R, 1982, CAN J BOT, V60, P998; Bresadola G., 1912, ANN MYCOL, V10, P492; Choeyklin R, 2011, MYCOSPHERE, V2, P161; Corner EJH, 1989, NOVA HEDWIGIA, V96, P1; Dai YC, 2010, BIODIVERSITY WOOD IN; David A, 1976, GARD B SINGAP, V29, P151; David A, 1974, B TRIMEST SOC MYCOL, V90, P179; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.2307/2408678; Hattori Tsutomu, 2001, Mycoscience, V42, P423, DOI 10.1007/BF02464338; Hattori Tsutomu, 2003, Mycoscience, V44, P265, DOI 10.1007/s10267-003-0114-3; Holmgren P. K., 1990, INDEX HERBARIORUM 1; Hosaka Kentaro, 2008, Bulletin of the National Museum of Nature and Science Series B-Botany, V34, P161; IMAZEKI R., 1952, Bull. For. Exp. Stn., Meguro, Tokyo, V57, P87; Imazeki R, 1965, COLORED ILLUSTRATION, VII; Imazeki R., 1955, Revue de Mycologie, V20, P158; Imazeki R, 1988, FUNGI JAPAN; Nunez M, 1998, FOLIA CRYPTOGAMICA E, V33, P99; Nunez M, 2001, SYNOP FUNG, V2, P1; Nunez M, 1997, MYCOTAXON, V61, P177; PARMASTO E, 1984, NOVA HEDWIGIA, V39, P101; Ryardh L, 1991, SYNOPSIS FUNGORUM, V5; RYVARDEN L, 1975, Norwegian Journal of Botany, V22, P25; Singer Rolf., 1944, MYCOLOGIA, V36, P65, DOI 10.2307/3754880; Sotome Kozue, 2007, Mycoscience, V48, P42, DOI 10.1007/s10267-006-0328-2; Swofford DL, 2003, PAUP 4 0B10 PHYLOGEN; Taylor DL, 2003, AM J BOT, V90, P1168, DOI 10.3732/ajb.90.8.1168; TEIXEIRA AR, 1955, MYCOLOGIA, V47, P408, DOI 10.2307/3755461; Vilgalys R, 1990, J BACTERIOL, V172, P4239; Wei YL, 2008, MYCOTAXON, V105, P349; Weiss M, 2001, MYCOL RES, V105, P403, DOI 10.1017/S095375620100363X; White TJ, 1990, PCR PROTOCOLS GUIDE, P315, DOI DOI 10.1139/B07-071; Wu S, 1996, HIGHER FUNGI TAIWAN; Yamashita S, 2010, MYCOLOGIA, V102, P11, DOI 10.3852/09-008; Zhou LW, 2013, MYCOLOGIA, V105, P1219, DOI 10.3852/12-212	45	0	0	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1617-416X	1861-8952		MYCOL PROG	Mycol. Prog.	NOV	2014	13	4					987	997		10.1007/s11557-014-0984-0		11	Mycology	Mycology	AS5UP	WOS:000344335200005		
J	Baten, MA; Asano, T; Motohashi, K; Ishiguro, Y; Rahman, MZ; Inaba, S; Suga, H; Kageyama, K				Baten, Md Abdul; Asano, Takahiro; Motohashi, Keiichi; Ishiguro, Yasushi; Rahman, Mohammad Ziaur; Inaba, Shigeki; Suga, Haruhisa; Kageyama, Koji			Phylogenetic relationships among Phytopythium species, and re-evaluation of Phytopythium fagopyri comb. nov., recovered from damped-off buckwheat seedlings in Japan	MYCOLOGICAL PROGRESS			English	Article						Phytopythium; Re-evaluated species; Buckwheat	CYTOCHROME-OXIDASE-II; GENUS PYTHIUM; SEQUENCE DATA; MAFFT	We examined the phylogenetic relationships among Phytopythium species using the rDNA ITS region, the LSU rDNA region, and the mitochondrial coxI and coxII genes. The genus was resolved into three monophyletic clades (1-3). Clade 1 was the largest clade, composed of 12 known species. Clades 2 contained two known and one new species candidate and clade 3 contained two known species. Three isolates in clade 2 (FP1, HonMa, and a strain designated as P. helicoides CBS293.35) formed a monophyletic group with high bootstrap support. This monophyletic group was distinct from P. helicoides sensu stricto. All three isolates came from damped-off buckwheat seedlings. The isolates were morphologically identical with one another and were characterized by globose, sub-globose, or pyriform sporangia with apical papillae; internally or internally nested proliferating sporangia; simple sympodia; coiling antheridial stalks; and wavy, sessile, or clavate antheridial cells. The isolates grew at temperatures between 15 A degrees C and 40 A degrees C, and the optimum temperature was 30 A degrees C, with a radial growth rate of 20 mm/24 h. The phylogenetic and morphological analyses indicated that these isolates belong to a distinct species, which was previously under the genus Pythium, named here Phytopythium fagopyri comb. nov.	[Baten, Md Abdul] Gifu Univ, United Grad Sch Agr Sci, Gifu 5011193, Japan; [Ishiguro, Yasushi; Rahman, Mohammad Ziaur; Kageyama, Koji] Gifu Univ, River Basin Res Ctr, Gifu 5011193, Japan; [Asano, Takahiro] Inst Res & Innovat, Kashiwa, Chiba 2770861, Japan; [Motohashi, Keiichi] Tokyo Univ Agr, Fac Reg Environm Sci, Tokyo, Japan; [Inaba, Shigeki] Natl Inst Technol & Evolut, Kisarazu, Chiba 2920818, Japan; [Suga, Haruhisa] Gifu Univ, Life Sci Res Ctr, Gifu 5011193, Japan	Baten, MA (reprint author), Gifu Univ, United Grad Sch Agr Sci, Gifu 5011193, Japan.	baten@green.gifu-u.ac.jp					AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Tanabe AS, 2011, MOL ECOL RESOUR, V11, P914, DOI 10.1111/j.1755-0998.2011.03021.x; Katoh K, 2008, BRIEF BIOINFORM, V9, P286, DOI 10.1093/bib/bbn013; Robideau GP, 2011, MOL ECOL RESOUR, V11, P1002, DOI 10.1111/j.1755-0998.2011.03041.x; Vos RA, 2003, SYST BIOL, V52, P368, DOI 10.1080/10635150390196993; Belbahri L, 2006, FEMS MICROBIOL LETT, V255, P209, DOI 10.1111/j.1574-6968.2006.00059.x; Martin FN, 2003, MYCOLOGIA, V95, P269, DOI 10.2307/3762038; McLeod A, 2009, MYCOL RES, V113, P933, DOI 10.1016/j.mycres.2009.04.009; Levesque CA, 2004, MYCOL RES, V108, P1363, DOI 10.1017/S0953756204001431; Villa NO, 2006, MYCOLOGIA, V98, P410, DOI 10.3852/mycologia.98.3.410; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Bala K, 2010, PERSOONIA, V24, P137; Jobb G, 2004, BMC EVOL BIOL, V4, DOI 10.1186/1471-2148-4-18; KISHINO H, 1989, J MOL EVOL, V29, P170, DOI 10.1007/BF02100115; Matsumoto Chieko, 1999, Mycoscience, V40, P321, DOI 10.1007/BF02463876; Nechwatal J, 2005, FEMS MICROBIOLOGY LE, V255, P96; O'Dannell K, 1993, FUNGAL HOMOMORPH MIO, P225; Samson RA, 2004, STUD MYCOL, P1; SUGIURA N, 1978, COMMUN STAT A-THEOR, V7, P13, DOI 10.1080/03610927808827599; Swofford D. L., 2002, PAUP PHYLOGENETIC AN; TAKIMOTO S., 1935, Bull. Sci. Fak. Terk. Kyusu Univ., V6, P105; VANDERPLAATSNITERINK AJ, 1981, STUD MYCOL, P1; Waterhouse GM, 1967, MYCOL PAP, V109, P1; White TJ, 1990, PCR PROTOCOLS GUIDE, P315, DOI DOI 10.1139/B07-071	25	2	2	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1617-416X	1861-8952		MYCOL PROG	Mycol. Prog.	NOV	2014	13	4					1145	1156		10.1007/s11557-014-1003-1		12	Mycology	Mycology	AS5UP	WOS:000344335200021		
J	Kiryluk, K; Li, YF; Scolari, F; Sanna-Cherchi, S; Choi, M; Verbitsky, M; Fasel, D; Lata, S; Prakash, S; Shapiro, S; Fischman, C; Snyder, HJ; Appel, G; Izzi, C; Viola, BF; Dallera, N; Del Vecchio, L; Barlassina, C; Salvi, E; Bertinetto, FE; Amoroso, A; Savoldi, S; Rocchietti, M; Amore, A; Peruzzi, L; Coppo, R; Salvadori, M; Ravani, P; Magistroni, R; Ghiggeri, GM; Caridi, G; Bodria, M; Lugani, F; Allegri, L; Delsante, M; Maiorana, M; Magnano, A; Frasca, G; Boer, E; Boscutti, G; Ponticelli, C; Mignani, R; Marcantoni, C; Di Landro, D; Santoro, D; Pani, A; Polci, R; Feriozzi, S; Chicca, S; Galliani, M; Gigante, M; Gesualdo, L; Zamboli, P; Battaglia, GG; Garozzo, M; Maixnerova, D; Tesar, V; Eitner, F; Rauen, T; Floege, J; Kovacs, T; Nagy, J; Mucha, K; Paczek, L; Zaniew, M; Mizerska-Wasiak, M; Roszkowska-Blaim, M; Pawlaczyk, K; Gale, D; Barratt, J; Thibaudin, L; Berthoux, F; Canaud, G; Boland, A; Metzger, M; Panzer, U; Suzuki, H; Goto, S; Narita, I; Caliskan, Y; Xie, JY; Hou, P; Chen, N; Zhang, H; Wyatt, RJ; Novak, J; Julian, BA; Feehally, J; Stengel, B; Cusi, D; Lifton, RP; Gharavi, AG				Kiryluk, Krzysztof; Li, Yifu; Scolari, Francesco; Sanna-Cherchi, Simone; Choi, Murim; Verbitsky, Miguel; Fasel, David; Lata, Sneh; Prakash, Sindhuri; Shapiro, Samantha; Fischman, Clara; Snyder, Holly J.; Appel, Gerald; Izzi, Claudia; Viola, Battista Fabio; Dallera, Nadia; Del Vecchio, Lucia; Barlassina, Cristina; Salvi, Erika; Bertinetto, Francesca Eleonora; Amoroso, Antonio; Savoldi, Silvana; Rocchietti, Marcella; Amore, Alessandro; Peruzzi, Licia; Coppo, Rosanna; Salvadori, Maurizio; Ravani, Pietro; Magistroni, Riccardo; Ghiggeri, Gian Marco; Caridi, Gianluca; Bodria, Monica; Lugani, Francesca; Allegri, Landino; Delsante, Marco; Maiorana, Mariarosa; Magnano, Andrea; Frasca, Giovanni; Boer, Emanuela; Boscutti, Giuliano; Ponticelli, Claudio; Mignani, Renzo; Marcantoni, Carmelita; Di Landro, Domenico; Santoro, Domenico; Pani, Antonello; Polci, Rosaria; Feriozzi, Sandro; Chicca, Silvana; Galliani, Marco; Gigante, Maddalena; Gesualdo, Loreto; Zamboli, Pasquale; Battaglia, Giovanni Giorgio; Garozzo, Maurizio; Maixnerova, Dita; Tesar, Vladimir; Eitner, Frank; Rauen, Thomas; Floege, Juergen; Kovacs, Tibor; Nagy, Judit; Mucha, Krzysztof; Paczek, Leszek; Zaniew, Marcin; Mizerska-Wasiak, Malgorzata; Roszkowska-Blaim, Maria; Pawlaczyk, Krzysztof; Gale, Daniel; Barratt, Jonathan; Thibaudin, Lise; Berthoux, Francois; Canaud, Guillaume; Boland, Anne; Metzger, Marie; Panzer, Ulf; Suzuki, Hitoshi; Goto, Shin; Narita, Ichiei; Caliskan, Yasar; Xie, Jingyuan; Hou, Ping; Chen, Nan; Zhang, Hong; Wyatt, Robert J.; Novak, Jan; Julian, Bruce A.; Feehally, John; Stengel, Benedicte; Cusi, Daniele; Lifton, Richard P.; Gharavi, Ali G.			Discovery of new risk loci for IgA nephropathy implicates genes involved in immunity against intestinal pathogens	NATURE GENETICS			English	Article							GENOME-WIDE ASSOCIATION; INFLAMMATORY-BOWEL-DISEASE; LEUKEMIA INHIBITORY FACTOR; ULCERATIVE-COLITIS; CROHNS-DISEASE; SUSCEPTIBILITY LOCI; COMMON VARIANTS; DENDRITIC CELLS; VAV PROTEINS; KAPPA-B	We performed a genome-wide association study (GWAS) of IgA nephropathy (IgAN), the most common form of glomerulonephritis, with discovery and follow-up in 20,612 individuals of European and East Asian ancestry. We identified six new genome-wide significant associations, four in ITGAM-ITGAX, VAV3 and CARD9 and two new independent signals at HLA-DQB1 and DEFA. We replicated the nine previously reported signals, including known SNPs in the HLA-DQB1 and DEFA loci. The cumulative burden of risk alleles is strongly associated with age at disease onset. Most loci are either directly associated with risk of inflammatory bowel disease (IBD) or maintenance of the intestinal epithelial barrier and response to mucosal pathogens. The geospatial distribution of risk alleles is highly suggestive of multi-locus adaptation, and genetic risk correlates strongly with variation in local pathogens, particularly helminth diversity, suggesting a possible role for host-intestinal pathogen interactions in shaping the genetic landscape of IgAN.	[Kiryluk, Krzysztof; Li, Yifu; Sanna-Cherchi, Simone; Verbitsky, Miguel; Fasel, David; Lata, Sneh; Prakash, Sindhuri; Shapiro, Samantha; Fischman, Clara; Snyder, Holly J.; Appel, Gerald; Gharavi, Ali G.] Columbia Univ, Coll Phys & Surg, Dept Med, Div Nephrol, New York, NY 10027 USA; [Scolari, Francesco; Izzi, Claudia; Dallera, Nadia] Univ Brescia, Div Nephrol, Azienda Osped Spedali Civili Brescia, Montichiari Hosp, Brescia, Italy; [Scolari, Francesco; Dallera, Nadia] Univ Brescia, Dept Med & Surg Specialties, Brescia, Italy; [Choi, Murim; Lifton, Richard P.] Yale Univ, Sch Med, Dept Genet, New Haven, CT 06510 USA; [Choi, Murim] Seoul Natl Univ, Coll Med, Dept Biomed Sci, Seoul, South Korea; [Izzi, Claudia] Univ Brescia, Dept Obstet & Gynecol, Prenatal Diag Unit, Brescia, Italy; [Viola, Battista Fabio] Univ Brescia, Div Nephrol, Azienda Osped Spedali Civili Brescia, Spedali Civili Hosp, Brescia, Italy; [Del Vecchio, Lucia; Barlassina, Cristina; Salvi, Erika; Cusi, Daniele] Univ Milan, Div Renal, Dipartimento Med Chirurg & Odontoiatria, San Paolo Hosp,Sch Med, Milan, Italy; [Bertinetto, Francesca Eleonora; Amoroso, Antonio] Univ Hosp Turin, Citta Salute & Sci, Turin, Italy; [Bertinetto, Francesca Eleonora; Amoroso, Antonio] Univ Turin, Dept Med Sci, Turin, Italy; [Savoldi, Silvana; Rocchietti, Marcella] Osped Cirie, Nephrol & Dialysis Unit, Turin, Italy; [Savoldi, Silvana; Rocchietti, Marcella] Osped Chivasso, Turin, Italy; [Amore, Alessandro; Peruzzi, Licia; Coppo, Rosanna] Regina Margheritra Hosp, Nephrol Dialysis & Transplantat Unit, Turin, Italy; [Salvadori, Maurizio] Careggi Hosp, Div Nephrol & Renal Transplantat, Florence, Italy; [Ravani, Pietro] Univ Calgary, Dept Med, Calgary, AB, Canada; [Ravani, Pietro] Univ Calgary, Dept Community Hlth Sci, Calgary, AB, Canada; [Magistroni, Riccardo] Univ Modena & Reggio Emilia, Azienda Osped Univ Policlin Modena, Div Nephrol Dialysis & Transplantat, Modena, Italy; [Ghiggeri, Gian Marco; Caridi, Gianluca; Bodria, Monica; Lugani, Francesca] Giannina Gaslini Inst, Div Nephrol Dialysis & Transplantat, Genoa, Italy; [Allegri, Landino; Delsante, Marco; Maiorana, Mariarosa; Magnano, Andrea] Azienda Osped Univ, Div Nephrol, Parma, Italy; [Allegri, Landino; Delsante, Marco; Maiorana, Mariarosa; Magnano, Andrea] Univ Parma, Chair Nephrol, I-43100 Parma, Italy; [Frasca, Giovanni] Riuniti Hosp, Div Nephrol Dialysis & Renal Transplantat, Ancona, Italy; [Boer, Emanuela] Gorizia Hosp, Div Nephrol & Dialysis, Gorizia, Italy; [Boscutti, Giuliano] Azienda Osped Univ Osped Riuniti Trieste, Div Nephrol, Trieste, Italy; [Ponticelli, Claudio] Humanitas Clin & Res Ctr, Nephrol & Dialysis Unit, Milan, Italy; [Mignani, Renzo] Infermi Hosp, Div Nephrol & Dialysis, Rimini, Italy; [Marcantoni, Carmelita; Di Landro, Domenico] Cannizzaro Hosp, Div Nephrol, Catania, Italy; [Santoro, Domenico] Univ Messina, Chair Nephrol, Div Nephol & Dialysis, Azienda Osped Univ Policlin, Messina, Italy; [Pani, Antonello] G Brotzu Hosp, Dept Nephrol & Dialysis, Cagliari, Italy; [Polci, Rosaria; Feriozzi, Sandro] Hosp Viterbo, Viterbo, Italy; [Chicca, Silvana; Galliani, Marco] Sandro Pertini Hosp, Div Nephrol & Dialysis, Rome, Italy; [Gigante, Maddalena] Univ Foggia, Dept Med & Surg Sci, Foggia, Italy; [Gesualdo, Loreto] Univ Bari, Dept Emergency & Organ Transplantat, Nephrol Sect, Bari, Italy; [Zamboli, Pasquale] Univ Naples 2, Dept Nephrol, Naples, Italy; [Battaglia, Giovanni Giorgio; Garozzo, Maurizio] Osped Acireale, Unita Operat Nefrol & Dialisi, Acireale, Italy; [Maixnerova, Dita; Tesar, Vladimir] Charles Univ Prague, Fac Med 1, Dept Nephrol, Prague, Czech Republic; [Maixnerova, Dita; Tesar, Vladimir] Charles Univ Prague, Gen Univ Hosp, Prague, Czech Republic; [Eitner, Frank; Rauen, Thomas; Floege, Juergen] Univ Aachen, Dept Nephrol, Rhein Westfal Tech Hsch, Aachen, Germany; [Eitner, Frank] Bayer Pharma, Kidney Dis Res, Wuppertal, Germany; [Kovacs, Tibor; Nagy, Judit] Univ Pecs, Fac Med, Nephrol Ctr, Pecs, Hungary; [Kovacs, Tibor; Nagy, Judit] Univ Pecs, Fac Med, Dept Internal Med 2, Pecs, Hungary; [Mucha, Krzysztof; Paczek, Leszek] Med Univ Warsaw, Dept Immunol Transplantol & Internal Med, Warsaw, Poland; [Zaniew, Marcin] Krysiewicza Childrens Hosp, Poznan, Poland; [Mizerska-Wasiak, Malgorzata; Roszkowska-Blaim, Maria] Med Univ Warsaw, Dept Pediat & Nephrol, Warsaw, Poland; [Pawlaczyk, Krzysztof] Poznan Med Univ, Dept Nephrol Transplantol & Internal Med, Poznan, Poland; [Gale, Daniel] UCL, Ctr Nephrol, London, England; [Barratt, Jonathan; Feehally, John] Univ Hosp Leicester, John Walls Renal Unit, Leicester, Leics, England; [Barratt, Jonathan; Feehally, John] Univ Leicester, Dept Infect Immun & Inflammat, Leicester, Leics, England; [Thibaudin, Lise; Berthoux, Francois] Univ North Hosp, Dept Nephrol Dialysis & Renal Transplantat, St Etienne, France; [Canaud, Guillaume] Hop Necker Enfants Malad, Serv Nephrol Transplantat Adultes, Paris, France; [Boland, Anne] Univ Paris 05, INSERM, Inst Necker Enfants Malades, Sorbonne Paris Cite, Paris, France; [Boland, Anne] CEA, Ctr Natl Genotypage, Inst Genom, Evry, France; [Metzger, Marie; Stengel, Benedicte] INSERM, Ctr Res Epidemiol & Populat Hlth, Villejuif, France; [Metzger, Marie; Stengel, Benedicte] Univ Paris 11, Villejuif, France; [Panzer, Ulf] Univ Klinikum Hamburg Eppendorf, Med Klin 3, Hamburg, Germany; [Suzuki, Hitoshi] Juntendo Univ, Fac Med, Dept Internal Med, Div Nephrol, Tokyo, Japan; [Goto, Shin; Narita, Ichiei] Niigata Univ, Div Clin Nephrol & Rheumatol, Niigata, Japan; [Caliskan, Yasar] Istanbul Univ, Istanbul Fac Med, Div Nephrol, Istanbul, Turkey; [Xie, Jingyuan; Chen, Nan] Shanghai Jiao Tong Univ, Sch Med, Ruijin Hosp, Dept Nephrol, Shanghai 200030, Peoples R China; [Hou, Ping; Zhang, Hong] Peking Univ, Inst Nephrol, Peking Univ Hosp 1, Div Renal, Beijing 100871, Peoples R China; [Wyatt, Robert J.] Univ Tennessee, Hlth Sci Ctr, Div Pediat Nephrol, Memphis, TN USA; [Wyatt, Robert J.] Le Bonheur Childrens Hosp, Childrens Fdn Res Ctr, Memphis, TN USA; [Novak, Jan] Univ Alabama Birmingham, Dept Microbiol, Birmingham, AL 35294 USA; [Julian, Bruce A.] Univ Alabama Birmingham, Dept Med, Birmingham, AL 35294 USA; [Lifton, Richard P.] Yale Univ, Sch Med, Howard Hughes Med Inst, New Haven, CT 06510 USA	Gharavi, AG (reprint author), Columbia Univ, Coll Phys & Surg, Dept Med, Div Nephrol, New York, NY 10027 USA.	richard.lifton@yale.edu; ag2239@columbia.edu	Gale, Daniel/D-5594-2013; santoro, domenico/P-7902-2014; Salvi, Erika/C-1033-2015; Magistroni, Riccardo/F-3126-2014; santoro, domenico/L-2482-2013; Caridi, Gianluca/F-7052-2010; 	Salvi, Erika/0000-0002-2724-2291; Magistroni, Riccardo/0000-0002-3319-0248; santoro, domenico/0000-0002-4279-6559; Caridi, Gianluca/0000-0001-6700-3001; Wyatt, Robert/0000-0001-6077-0259; amoroso, antonio/0000-0002-9437-9407; Gigante, Maddalena/0000-0001-8228-7639	US National Institutes of Health (NIH) from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) [R01DK082753, R01DK095510]; Center for Glomerular Diseases at Columbia University; NIH/NIDDK [K23DK090207, R03DK099564, R21DK098531]; Carl W Gottschalk Research Scholar Grant from the American Society of Nephrology (ASN); American Heart Association (AHA) [13GRNT14680075]; Italian Ministry of Health and NIH Ricerca Finalizzata; Fondazione Malattie Renali nel Bambino; InterOmics (PB05 MIUR-CNR Italian Flagship Project);  [SROP-4.2.2/B-10/1/2010-0029]	We are grateful to all the study participants for their contribution to this work. This study was supported by US National Institutes of Health (NIH) grants R01DK082753 (A.G.G. and J. Novak) and R01DK095510 (A.G.G. and R.P.L.) from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) and by the Center for Glomerular Diseases at Columbia University. R.P.L. is an investigator of the Howard Hughes Medical Institute. K.K. is supported by NIH/NIDDK grants K23DK090207 and R03DK099564 and by a Carl W Gottschalk Research Scholar Grant from the American Society of Nephrology (ASN). S.S.-C. is supported by NIH/NIDDK grant R21DK098531 and by American Heart Association (AHA) grant 13GRNT14680075. G.M.G. is supported by the Joint Italian Ministry of Health and NIH Ricerca Finalizzata and by the Fondazione Malattie Renali nel Bambino. D.C. and the HYPERGENES Consortium are supported by InterOmics (PB05 MIUR-CNR Italian Flagship Project). Additionally, we would like to acknowledge individuals from the following organizations: the IgA Nephropathy Foundation of America for facilitating recruitment of individuals in the United States; the Columbia University Glomerular Center (New York), including). Radhalcrishnan, D. Cohen, C. Kunis, A. Bomback and P. Canetta, for referrals of IgAN cases; the Polish Registry of Congenital Malformations (PRCM; Poznan, Poland), including A. Materna-Kiryluk and A. Latos-Bielenska (supported by the Polish Ministry of Health), for facilitating the recruitment of the Polish IgAN cohort; J. Nagy at the University of Pecs, Hungary (supported by SROP-4.2.2/B-10/1/2010-0029); the GN-PROGRESS study, including F. Martinez, E Vrtovsnik and D. Droz, for adjudicating all IgAN cases as well as individual center investigators, including X. Belenfant (Hopital A Gregoire, Montreuil, France); B. Charpentier and A. Durrbach (Assistance Publique-Hopitaux de Paris (AP-HP) Hopital Bicetre, Kremlin-Bicetre, France); G. Rostoker (Hopital C Galien, Quincy/Senart, France); J. Rossert and C. facquot (AP-HP, Hopital Europeen G Pompidou, Paris); P. Lang and P. Remy (AP-HP HOpital H. Mondor, Creteil, France); O. Kourilsky (Hopital L. Michel, Evry, France); J.-P. Grunfeld and D. Chauveau (AP-HP Hopital Necker, Paris); G. Deray and H. Izzedine (AP-HP Hopital Pitie Salpetriere, Paris); C. Legendre and F. Martinez (AP-HP Hopital Saint-Louis, Paris); and P. Ronco and E. Rondeau (AP-HP Hopital Tenon, Paris). We would also like to thank L. Sturg from the Dalla Lana School of Public Health at the University of Toronto (Toronto) for contributing the R code for HD-GWAS analysis.	Ambruzs JM, 2014, CLIN J AM SOC NEPHRO, V9, P265, DOI 10.2215/CJN.04660513; Fujikawa K, 2003, J EXP MED, V198, P1595, DOI 10.1084/jem.20030874; van Egmond M, 1999, BLOOD, V93, P4387; Freudenberg J, 2011, ARTHRITIS RHEUM-US, V63, P884, DOI 10.1002/art.30235; Barry MA, 2013, ARCH DIS CHILD, V98, P635, DOI 10.1136/archdischild-2012-302338; Liu ZH, 2013, NAT REV NEPHROL, V9, P523, DOI 10.1038/nrneph.2013.146; Bevins CL, 2011, NAT REV MICROBIOL, V9, P356, DOI 10.1038/nrmicro2546; van Spriel AB, 2002, J IMMUNOL, V169, P3831; Liu JY, 2009, J CELL SCI, V122, P324, DOI 10.1242/jcs.033720; Kalabis J, 2003, FASEB J, V17, P1115, DOI 10.1096/fj.02-0852fje; Okada Y, 2011, GASTROENTEROLOGY, V141, P864, DOI 10.1053/j.gastro.2011.05.048; Yang WL, 2013, AM J HUM GENET, V92, P41, DOI 10.1016/j.ajhg.2012.11.018; Yang SK, 2013, INFLAMM BOWEL DIS, V19, P954, DOI 10.1097/MIB.0b013e3182802ab6; Fritz DK, 2011, J IMMUNOL, V186, P1107, DOI 10.4049/jimmunol.0903476; Visekruna A, 2006, J CLIN INVEST, V116, P3195, DOI 10.1172/JC128804; Fujimoto K, 2011, J IMMUNOL, V186, P6287, DOI 10.4049/jimmunol.1004036; Rockman SP, 2001, J GASTROEN HEPATOL, V16, P991, DOI 10.1046/j.1440-1746.2001.02588.x; Wehkamp J, 2005, P NATL ACAD SCI USA, V102, P18129, DOI 10.1073/pnas.0505256102; van Heel DA, 2007, NAT GENET, V39, P827, DOI 10.1038/ng2058; Uematsu S, 2008, NAT IMMUNOL, V9, P769, DOI 10.1038/ni.1622; Ferreira RC, 2010, NAT GENET, V42, P777, DOI 10.1038/ng.644; Teshima KM, 2006, GENOME RES, V16, P702, DOI 10.1101/gr.5105206; Barrett JC, 2009, NAT GENET, V41, P703, DOI 10.1038/ng.381; Vigorito E, 2005, BLOOD, V106, P2391, DOI 10.1182/blood-2004-12-4894; Radstake TRDJ, 2010, NAT GENET, V42, P426, DOI 10.1038/ng.565; McGovern DPB, 2010, NAT GENET, V42, P332, DOI 10.1038/ng.549; Rivas MA, 2011, NAT GENET, V43, P1066, DOI 10.1038/ng.952; Jostins L, 2012, NATURE, V491, P119, DOI 10.1038/nature11582; Castigli E, 2005, NAT GENET, V37, P829, DOI 10.1038/ng1601; Prunotto M, 2010, J AM SOC NEPHROL, V21, P507, DOI 10.1681/ASN.2008121259; Dubois PCA, 2010, NAT GENET, V42, P295, DOI 10.1038/ng.543; Gharavi AG, 2011, NAT GENET, V43, P321, DOI 10.1038/ng.787; Bertin J, 2000, J BIOL CHEM, V275, P41082, DOI 10.1074/jbc.C000726200; Imielinski M, 2009, NAT GENET, V41, P1335, DOI 10.1038/ng.489; Westra HJ, 2013, NAT GENET, V45, P1238, DOI 10.1038/ng.2756; Lanternier F, 2013, NEW ENGL J MED, V369, P1704, DOI 10.1056/NEJMoa1208487; Litinskiy MB, 2002, NAT IMMUNOL, V3, P822, DOI 10.1039/ni829; Sokol H, 2013, GASTROENTEROLOGY, V145, P591, DOI 10.1053/j.gastro.2013.05.047; Wyatt RJ, 2013, NEW ENGL J MED, V368, P2402, DOI 10.1056/NEJMra1206793; Pickrell JK, 2009, GENOME RES, V19, P826, DOI 10.1101/gr.087577.108; Cella M, 2009, NATURE, V457, P722, DOI 10.1038/nature07537; Feehally J, 2010, J AM SOC NEPHROL, V21, P1791, DOI 10.1681/ASN.2010010076; Franke A, 2010, NAT GENET, V42, P1118, DOI 10.1038/ng.717; Chu X, 2011, NAT GENET, V43, P897, DOI 10.1038/ng.898; Chen W, 2010, P NATL ACAD SCI USA, V107, P7401, DOI 10.1073/pnas.0912702107; Wu F, 2007, INFLAMM BOWEL DIS, V13, P807, DOI 10.1002/ibd.20110; McCarthy DD, 2011, J CLIN INVEST, V121, P3991, DOI 10.1172/JCI45563; Chu HT, 2012, SCIENCE, V337, P477, DOI 10.1126/science.1218831; Ernst M, 2001, J EXP MED, V194, P189, DOI 10.1084/jem.194.2.189; Kumar V, 2011, NAT GENET, V43, P455, DOI 10.1038/ng.809; Petukhova L, 2010, NATURE, V466, P113, DOI 10.1038/nature09114; Fairfax BP, 2012, NAT GENET, V44, P502, DOI 10.1038/ng.2205; Dixon AL, 2007, NAT GENET, V39, P1202, DOI 10.1038/ng2109; Schmidt N, 2010, GUT, V59, P896, DOI 10.1136/gut.2009.203554; Swat W, 2005, IMMUNOL RES, V32, P259, DOI 10.1385/IR:32:1-3:259; Barsoum R S, 1987, Nephrol Dial Transplant, V2, P488; Beaudoin M, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003723; CORBI AL, 1988, J EXP MED, V167, P1597, DOI 10.1084/jem.167.5.1597; Eriksson N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034442; Ferragine CE, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002136; Fumagalli M, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002355; Hafler DA, 2007, NEW ENGL J MED, V357, P851, DOI 10.1056/NEJMoa073493; Horn G, 2008, NEW ENGL J MED, V358, P900; Kiryluk K, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002765; Kunisawa J, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2718; Levison SE, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-127; Osman W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032683; Pritchard JK, 2010, CURR BIOL, V20, pR208, DOI 10.1016/j.cub.2009.11.055; Pullan RL, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-37; Smedby KE, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001378; Wellcome Trust Case Control Consortium, 2007, NATURE, V447, P661, DOI DOI 10.1038/NATURE05911; Yu XQ, 2012, NAT GENET, V44, P178, DOI 10.1038/ng.1047; Zhao J, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002079	73	19	19	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	NOV	2014	46	11					1187	1196		10.1038/ng.3118		10	Genetics & Heredity	Genetics & Heredity	AS2TI	WOS:000344131900009		
J	Eisfeld, AJ; Neumann, G; Kawaoka, Y				Eisfeld, Amie J.; Neumann, Gabriele; Kawaoka, Yoshihiro			Influenza A virus isolation, culture and identification	NATURE PROTOCOLS			English	Article							CANINE KIDNEY-CELLS; EMBRYONATED CHICKEN EGGS; AVIAN INFLUENZA; RECEPTOR SPECIFICITY; ESTABLISHED LINE; H7N9 VIRUS; RESPIRATORY DROPLET; MAMMALIAN-CELLS; FLOCKED SWABS; PLAQUE ASSAY	Influenza A viruses (IAVs) cause epidemics and pandemics that result in considerable financial burden and loss of human life. To manage annual IAV epidemics and prepare for future pandemics, an improved understanding of how IAVs emerge, transmit, cause disease and acquire pandemic potential is urgently needed. Fundamental techniques essential for procuring such knowledge are IAV isolation and culture from experimental and surveillance samples. Here we present a detailed protocol for IAV sample collection and processing, amplification in chicken eggs or mammalian cells, and identification from samples containing unknown pathogens. This protocol is robust, and it allows for the generation of virus cultures that can be used for downstream analyses. Once experimental or surveillance samples are obtained, virus cultures can be generated and the presence of IAVs can be verified in 3-5 d via reverse-transcription (RT)-PCR or hemagglutination assay. Increased time frames may be required for less experienced laboratory personnel, or when large numbers of samples will be processed.	[Eisfeld, Amie J.; Neumann, Gabriele; Kawaoka, Yoshihiro] Univ Wisconsin, Sch Vet Med, Influenza Res Inst, Dept Pathobiol Sci, Madison, WI 53706 USA; [Kawaoka, Yoshihiro] Japan Sci & Technol Agcy, Exploratory Res Adv Technol ERATO Infect Induced, Saitama, Japan; [Kawaoka, Yoshihiro] Univ Tokyo, Inst Med Sci, Dept Microbiol & Immunol, Div Virol, Tokyo, Japan; [Kawaoka, Yoshihiro] Univ Tokyo, Inst Med Sci, Int Res Ctr Infect Dis, Dept Special Pathogens, Tokyo, Japan	Kawaoka, Y (reprint author), Univ Wisconsin, Sch Vet Med, Influenza Res Inst, Dept Pathobiol Sci, Madison, WI 53706 USA.	kawaokay@svm.vetmed.wisc.edu			Ministry of Health, Labour and Welfare, Japan; ERATO (Japan Science and Technology Agency); US National Institute of Allergy and Infectious Diseases (NIAID) Public Health Service research; NIAID [HHSN266200700010C]	The authors are grateful to M. Hatta, S. Fan, J. Ping, Z. Najacht and A. Karasin for helpful discussions, to P. Jester and Z. Najacht for assistance with hemagglutination assay and RT-PCR figure components and to S. Watson for scientific editing of the manuscript. This work was supported by grants-in-aid from the Ministry of Health, Labour and Welfare, Japan, by ERATO (Japan Science and Technology Agency), by US National Institute of Allergy and Infectious Diseases (NIAID) Public Health Service research grants and by a NIAID-funded Center for Research on Influenza Pathogenesis grant (CRIP, HHSN266200700010C).	Al Johani S M, 2011, J Infect Public Health, V4, P7, DOI 10.1016/j.jiph.2010.10.004; Stevens J, 2010, J VIROL, V84, P8287, DOI 10.1128/JVI.00058-10; Imai M, 2012, NATURE, V486, P420, DOI 10.1038/nature10831; Hoffmann E, 2001, ARCH VIROL, V146, P2275, DOI 10.1007/s007050170002; Daley P, 2006, J CLIN MICROBIOL, V44, P2265, DOI 10.1128/JCM.02055-05; TOBITA K, 1975, MED MICROBIOL IMMUN, V162, P9, DOI 10.1007/BF02123572; Hirst GK, 1942, J EXP MED, V75, P49, DOI 10.1084/jem.75.1.49; Belser JA, 2013, NATURE, V501, P556, DOI 10.1038/nature12391; GAUSH CR, 1968, APPL MICROBIOL, V16, P588; Zhang QY, 2013, SCIENCE, V341, P410, DOI 10.1126/science.1240532; LAZAROWITZ SG, 1975, VIROLOGY, V68, P440, DOI 10.1016/0042-6822(75)90285-8; Ito T, 1997, VIROLOGY, V227, P493, DOI 10.1006/viro.1996.8323; Goodpasture EW, 1931, SCIENCE, V74, P371, DOI 10.1126/science.74.1919.371; Beato MS, 2012, VIROLOGY, V433, P522, DOI 10.1016/j.virol.2012.08.009; KATZ JM, 1989, J INFECT DIS, V160, P191; Chen LM, 2012, VIROLOGY, V422, P105, DOI 10.1016/j.virol.2011.10.006; van Elden LJR, 2001, J CLIN MICROBIOL, V39, P196, DOI 10.1128/JCM.39.1.196-200.2001; Herfst S, 2012, SCIENCE, V336, P1534, DOI 10.1126/science.1213362; Taubenberger JK, 2006, EMERG INFECT DIS, V12, P15; Skehel JJ, 2000, ANNU REV BIOCHEM, V69, P531, DOI 10.1146/annurev.biochem.69.1.531; GAUSH CR, 1966, P SOC EXP BIOL MED, V122, P931; Ito T, 1997, J VIROL, V71, P3357; Medeiros R, 2001, VIROLOGY, V289, P74, DOI 10.1006/viro.2001.1121; Hirst GK, 1941, SCIENCE, V94, P22, DOI 10.1126/science.94.2427.22; KODIHALLI S, 1995, J VIROL, V69, P4888; Walsh P, 2008, J CLIN MICROBIOL, V46, P2374, DOI 10.1128/JCM.00714-08; [Anonymous], 2014, WHO RISK ASS HUM INF; Fouchier RAM, 2000, J CLIN MICROBIOL, V38, P4096; Watanabe T, 2013, NATURE, V501, P551, DOI 10.1038/nature12392; Gao RB, 2013, NEW ENGL J MED, V368, P1888, DOI 10.1056/NEJMoa1304459; Zhu H, 2013, SCIENCE, V341, P183, DOI 10.1126/science.1239844; MEGURO H, 1979, J CLIN MICROBIOL, V9, P175; Hernes SS, 2011, EUR J CLIN MICROBIOL, V30, P159, DOI 10.1007/s10096-010-1064-2; GREIFF D, 1954, J EXP MED, V100, P89, DOI 10.1084/jem.100.1.89; KLENK HD, 1975, VIROLOGY, V68, P426, DOI 10.1016/0042-6822(75)90284-6; Tong SX, 2012, P NATL ACAD SCI USA, V109, P4269, DOI 10.1073/pnas.1116200109; Hurt AC, 2007, J CLIN VIROL, V39, P132, DOI 10.1016/j.jcv.2007.03.002; Rowe T, 1999, J CLIN MICROBIOL, V37, P937; DAVIES HW, 1978, B WORLD HEALTH ORGAN, V56, P991; Francis T, 1944, AM J PUBLIC HEALTH N, V34, P317, DOI 10.2105/AJPH.34.4.317; Gavin PJ, 2003, CLIN APPL IMMUNOL RE, V4, P151; Hatakeyama S, 2005, J CLIN MICROBIOL, V43, P4139, DOI 10.1128/JCM.43.8.4139-4146.2005; KOSTKA V, 1964, J BIOL CHEM, V239, P1799; Lee CW, 2006, CLIN VACCINE IMMUNOL, V13, P395, DOI 10.1128/CVI.13.3.395-402.2006; Lu B, 2006, VACCINE, V24, P6691, DOI 10.1016/j.vaccine.2006.05.062; Lu Bin, 2005, Journal of Virology, V79, P6763, DOI 10.1128/JVI.79.11.6763-6771.2005; Miller GL, 1944, J EXP MED, V80, P507, DOI 10.1084/jem.80.6.507; Munywoki PK, 2011, J CLIN MICROBIOL, V49, P3365, DOI 10.1128/JCM.02231-10; Nutter S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033097; Qi X, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f4752; Rahman M, 2007, DIAGN MICR INFEC DIS, V58, P413, DOI 10.1016/j.diagmicrobio.2007.03.011; St George K., 2012, INFLUENZA VIRUS METH; US Centers for Disease Control, 2009, BIOS MICR BIOM LAB B; US Centers for Disease Control, 2013, SEAS INFL ACT SURV; WADOWSKY RM, 1994, J CLIN MICROBIOL, V32, P1054; Wang X, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-354; WHO, 2014, INFL HUM AN INT SUMM; WHO, 2002, MAN AN INFL DIAGN SU; WIEBE JP, 1991, LIFE SCI, V48, P1511, DOI 10.1016/0024-3205(91)90275-G; Wiriyarat W, 2010, VET MICROBIOL, V146, P346, DOI 10.1016/j.vetmic.2010.05.031; World Health Organisation ( WHO), 2013, GLOB INFL SURV RESP; World Health Organization, 2006, SER DIAGN INFL MICR; World Health Organization, 2011, MAN LAB DIAGN VIR SU; World Health Organization, 2013, WHO COLL CTR INFL ES; World Health Organization, 2006, COLL PRES SHIPP SPEC; World Health Organization, 2013, WHO COLL CTR; World Health Organization, 2012, WHO INF MOL DIAGN IN	67	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1754-2189	1750-2799		NAT PROTOC	Nat. Protoc.	NOV	2014	9	11					2663	2681		10.1038/nprot.2014.180		19	Biochemical Research Methods	Biochemistry & Molecular Biology	AS4LT	WOS:000344248300011		
J	Nonaka, M; Kim, R; Sharry, S; Matsushima, A; Takemoto-Kimura, S; Bito, H				Nonaka, Mio; Kim, Ryang; Sharry, Stuart; Matsushima, Ayano; Takemoto-Kimura, Sayaka; Bito, Haruhiko			Towards a better understanding of cognitive behaviors regulated by gene expression downstream of activity-dependent transcription factors	NEUROBIOLOGY OF LEARNING AND MEMORY			English	Review						Activity-dependent transcription; CREB; CRTC1; SRF; MEF2; Npas4; DREAM; Memory; Virus vector	ELEMENT-BINDING PROTEIN; SERUM RESPONSE FACTOR; LONG-TERM-MEMORY; VIRAL-MEDIATED EXPRESSION; DOMINANT-NEGATIVE CREB; GENOME-WIDE ANALYSIS; FEAR MEMORY; NEURONAL-ACTIVITY; NEURAL CIRCUITS; DENTATE GYRUS	In the field of molecular and cellular neuroscience, it is not a trivial task to see the forest for the trees, where numerous, and seemingly independent, molecules often work in concert to control critical steps of synaptic plasticity and signalling. Here, we will first summarize our current knowledge on essential activity-dependent transcription factors (TFs) such as CREB, MEF2, Npas4 and SRF, then examine how various transcription cofactors (TcoFs) also contribute to defining the transcriptional outputs during learning and memory. This review finally attempts a provisory synthesis that sheds new light on some of the emerging principles of neuronal circuit dynamics driven by activity-regulated gene transcription to help better understand the intricate relationship between activity-dependent gene expression and cognitive behavior. (C) 2014 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-SA license (http://creativecommons.org/licenses/by-nc-sa/3.0/).	[Nonaka, Mio; Kim, Ryang; Sharry, Stuart; Matsushima, Ayano; Takemoto-Kimura, Sayaka; Bito, Haruhiko] Univ Tokyo, Dept Neurochem, Grad Sch Med, Bunkyo Ku, Tokyo 1130033, Japan; [Nonaka, Mio] Univ Edinburgh, Ctr Cognit & Neural Syst, Edinburgh EH8 9JZ, Midlothian, Scotland; [Kim, Ryang; Matsushima, Ayano; Bito, Haruhiko] CREST Japan Sci & Technol Agcy, Tokyo 1020076, Japan	Bito, H (reprint author), Univ Tokyo, Dept Neurochem, Grad Sch Med, 7-3-1 Hongo, Tokyo 1130033, Japan.	hbito@m.u-tokyo.ac.jp	Bito, Haruhiko/A-8635-2008		MEXT; JSPS; CREST-JST; JST-CONACyT SICP; Uehara Foundation; AXA Research Fund	We thank all members of the Bito laboratory for their support and discussion; and Y. Kondo, Y. Dobashi, R. Gyobu, and T. Kinbara for their assistance. This work was supported in part by Grants-in-Aid from MEXT and JSPS ("Research Activity Start-up" to M. N. and A. M., "WAKATE" to S. T.-K., and "Scientific Research on Innovative Areas" (CBSN and Memory Dynamism) (to H.B.), by a CREST-JST grant (to H.B.), by a JST-CONACyT SICP grant (to H.B.), and by grants from the Uehara Foundation (to H.B.) and from AXA Research Fund (A.M.).	Alexander JC, 2009, LEARN MEMORY, V16, P167, DOI 10.1101/lm.1261709; Ramos YFM, 2010, NUCLEIC ACIDS RES, V38, P5396, DOI 10.1093/nar/gkq184; Kim TK, 2010, NATURE, V465, P182, DOI 10.1038/nature09033; Mayford M, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0161; Castro J, 2013, CURR OPIN NEUROL, V26, P154, DOI 10.1097/WCO.0b013e32835f19a7; Adachi M, 2008, BIOL PSYCHIAT, V63, P642, DOI 10.1016/j.biopsych.2007.09.019; Czajkowski R, 2014, P NATL ACAD SCI USA, V111, P8661, DOI 10.1073/pnas.1313222111; Silva AJ, 1998, ANNU REV NEUROSCI, V21, P127, DOI 10.1146/annurev.neuro.21.1.127; Rashid AJ, 2014, GENES BRAIN BEHAV, V13, P118, DOI 10.1111/gbb.12058; Finkbeiner S, 1997, NEURON, V19, P1031, DOI 10.1016/S0896-6273(00)80395-5; Ebert DH, 2013, NATURE, V499, P341, DOI 10.1038/nature12348; Kalita K, 2012, INT J BIOCHEM CELL B, V44, P1444, DOI 10.1016/j.biocel.2012.05.008; Zhang XM, 2005, P NATL ACAD SCI USA, V102, P4459, DOI 10.1073/pnas.0501076102; Carrion AM, 1999, NATURE, V398, P80; Watts AG, 2011, J NEUROENDOCRINOL, V23, P754, DOI 10.1111/j.1365-2826.2011.02178.x; Berton O, 2006, SCIENCE, V311, P864, DOI 10.1126/science.1120972; Conkright MD, 2003, MOL CELL, V12, P413, DOI 10.1016/j.molcel.2003.08.013; Chen TW, 2013, NATURE, V499, P295, DOI 10.1038/nature12354; Silva AJ, 2009, SCIENCE, V326, P391, DOI 10.1126/science.1174519; Han JH, 2009, SCIENCE, V323, P1492, DOI 10.1126/science.1164139; Okuno H, 2012, CELL, V149, P886, DOI 10.1016/j.cell.2012.02.062; Stritt C, 2010, MOL CELL BIOL, V30, P1828, DOI 10.1128/MCB.01434-09; Ramanan N, 2005, NAT NEUROSCI, V8, P759, DOI 10.1038/nn1462; Lin YX, 2008, NATURE, V455, P1198, DOI 10.1038/nature07319; Bloodgood BL, 2013, NATURE, V503, P121, DOI 10.1038/nature12743; Vetere G, 2011, P NATL ACAD SCI USA, V108, P8456, DOI 10.1073/pnas.1016275108; Paul AP, 2010, J NEUROSCI, V30, P2513, DOI 10.1523/JNEUROSCI.5840-09.2010; YIN JCP, 1994, CELL, V79, P49, DOI 10.1016/0092-8674(94)90399-9; Han JH, 2007, SCIENCE, V316, P457, DOI 10.1126/science.1139438; Restivo L, 2009, HIPPOCAMPUS, V19, P228, DOI 10.1002/hipo.20527; Kim J, 2014, NAT NEUROSCI, V17, P65, DOI 10.1038/nn.3592; Suzuki A, 2011, J NEUROSCI, V31, P8786, DOI 10.1523/JNEUROSCI.3257-10.2011; West AE, 2001, P NATL ACAD SCI USA, V98, P11024, DOI 10.1073/pnas.191352298; Cohen S, 2011, NEURON, V72, P72, DOI 10.1016/j.neuron.2011.08.022; Josselyn SA, 2001, J NEUROSCI, V21, P2404; Guy J, 2011, ANNU REV CELL DEV BI, V27, P631, DOI 10.1146/annurev-cellbio-092910-154121; Bito H, 1996, CELL, V87, P1203, DOI 10.1016/S0092-8674(00)81816-4; Shepherd JD, 2006, NEURON, V52, P475, DOI 10.1016/j.neuron.2006.08.034; Garg SK, 2013, J NEUROSCI, V33, P13612, DOI 10.1523/JNEUROSCI.1854-13.2013; Ch'ng TH, 2012, CELL, V150, P207, DOI 10.1016/j.cell.2012.05.027; Barco A, 2011, MOL NEUROBIOL, V44, P330, DOI 10.1007/s12035-011-8209-x; Ramamoorthi K, 2011, SCIENCE, V334, P1669, DOI 10.1126/science.1208049; Altarejos JY, 2011, NAT REV MOL CELL BIO, V12, P141, DOI 10.1038/nrm3072; Impey S, 1996, NEURON, V16, P973, DOI 10.1016/S0896-6273(00)80120-8; Kathirvelu B, 2013, NEUROBIOL LEARN MEM, V99, P10, DOI 10.1016/j.nlm.2012.10.008; Green TA, 2010, BIOL PSYCHIAT, V67, P28, DOI 10.1016/j.biopsych.2009.06.022; Kawashima T, 2009, P NATL ACAD SCI USA, V106, P316, DOI 10.1073/pnas.0806518106; Jennings JH, 2014, CURR BIOL, V24, pR41, DOI 10.1016/j.cub.2013.11.042; Konermann S, 2013, NATURE, V500, P472, DOI 10.1038/nature12466; Chahrour M, 2008, SCIENCE, V320, P1224, DOI 10.1126/science.1153252; Posern G, 2006, TRENDS CELL BIOL, V16, P588, DOI 10.1016/j.tcb.2006.09.008; Martin KC, 1996, NEURON, V17, P567, DOI 10.1016/S0896-6273(00)80188-9; Ebert DH, 2013, NATURE, V493, P327, DOI 10.1038/nature11860; Cohen S, 2008, ANNU REV CELL DEV BI, V24, P183, DOI 10.1146/annurev.cellbio.24.110707.175235; Okuno H, 2011, NEUROSCI RES, V69, P175, DOI 10.1016/j.neures.2010.12.007; ANDRES V, 1995, J BIOL CHEM, V270, P23246; Mantamadiotis T, 2002, NAT GENET, V31, P47, DOI 10.1038/ng882; Garner AR, 2012, SCIENCE, V335, P1513, DOI 10.1126/science.1214985; Zhou Y, 2009, NAT NEUROSCI, V12, P1438, DOI 10.1038/nn.2405; Lu PPY, 2012, J NEUROSCI, V32, P8012, DOI 10.1523/JNEUROSCI.5633-11.2012; BOURTCHULADZE R, 1994, CELL, V79, P59, DOI 10.1016/0092-8674(94)90400-6; Hardingham GE, 1997, NATURE, V385, P260, DOI 10.1038/385260a0; Chowdhury S, 2006, NEURON, V52, P445, DOI 10.1016/j.neuron.2006.08.033; Yiu AP, 2014, NEURON, V83, P722, DOI 10.1016/j.neuron.2014.07.017; Kawashima T, 2013, NAT METHODS, V10, P889, DOI [10.1038/nmeth.2559, 10.1038/NMETH.2559]; Arthur JSC, 2004, J NEUROSCI, V24, P4324, DOI 10.1523/JNEUROSCI.5227-03.2004; Barrett RM, 2011, NEUROPSYCHOPHARMACOL, V36, P1545, DOI 10.1038/npp.2011.61; Spiegel I, 2014, CELL, V157, P1216, DOI 10.1016/j.cell.2014.03.058; Gruart A, 2012, J NEUROSCI, V32, P17431, DOI 10.1523/JNEUROSCI.4339-12.2012; Etkin A, 2006, NEURON, V50, P127, DOI 10.1016/j.neuron.2006.03.013; Liu X, 2012, NATURE, V484, P381, DOI 10.1038/nature11028; Cole CJ, 2012, NAT NEUROSCI, V15, P1255, DOI 10.1038/nn.3189; Flavell SW, 2008, NEURON, V60, P1022, DOI 10.1016/j.neuron.2008.11.029; Hommel JD, 2003, NAT MED, V9, P1539, DOI 10.1038/nm964; Kathirvelu B, 2013, HIPPOCAMPUS, V23, P1066, DOI 10.1002/hipo.22188; Benito E., 2014, MOL NEUROBIOLOGY; Besnard A, 2011, FRONT NEUROSCI-SWITZ, V5, DOI 10.3389/fnins.2011.00035; Dreyer JL, 2011, MOL BIOTECHNOL, V47, P169, DOI 10.1007/s12033-010-9334-x; Gadalla KKE, 2013, MOL THER, V21, P18, DOI 10.1038/mt.2012.200; Gau D, 2002, NEURON, V34, P245, DOI 10.1016/S0896-6273(02)00656-6; GINTY DD, 1994, CELL, V77, P713, DOI 10.1016/0092-8674(94)90055-8; GONZALEZ GA, 1989, CELL, V59, P675, DOI 10.1016/0092-8674(89)90013-5; Goodman RH, 1998, CURR OPIN NEUROBIOL, V8, P413, DOI 10.1016/S0959-4388(98)80069-X; Kalita K, 2006, J NEUROSCI, V26, P10020, DOI 10.1523/JNEUROSCI.2644-06.2006; Kawashima T, 2014, FRONT NEURAL CIRCUIT, V8, DOI 10.3389/fncir.2014.00037; Kids S., 2002, NAT NEUROSCI, V5, P348; Ledo F, 2000, BBA-MOL CELL RES, V1498, P162, DOI 10.1016/S0167-4889(00)00092-6; Ledo F, 2002, EMBO J, V21, P4583, DOI 10.1093/emboj/cdf440; Li SA, 2009, J NEUROSCI, V29, P2334, DOI 10.1523/JNEUROSCI.2296-08.2009; Maya-Vetencourt JF, 2013, NEURAL PLAST, V2013, DOI DOI 10.1155/2013/683909; Mellstrom B, 2014, MOL CELL BIOL, V34, P877, DOI 10.1128/MCB.00360-13; Naqvi S, 2014, BIOCHEM J, V458, P469, DOI 10.1042/BJ20131115; Nonaka M, 2009, J NEUROSCI, V29, P6389, DOI 10.1523/JNEUROSCI.1309-09.2009; Nonaka M., 2014, NEURON; Ploski JE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023760; Pulipparacharuvil S, 2008, NEURON, V59, P621, DOI 10.1016/j.neuron.2008.06.020; Ramirez Steve, 2013, Front Behav Neurosci, V7, P226, DOI 10.3389/fnbeh.2013.00226; Rodriguez-Tornos FM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053848; Sekeres MJ, 2012, J NEUROSCI, V32, P17857, DOI 10.1523/JNEUROSCI.1419-12.2012; SHENG M, 1991, SCIENCE, V252, P1427, DOI 10.1126/science.1646483; Smith-Hicks C, 2010, NAT NEUROSCI, V13, P1082, DOI 10.1038/nn.2611; Tabuchi A, 2005, J NEUROCHEM, V94, P169, DOI 10.1111/j.1471-4159.2005.03179.x; Varenika V, 2009, PROG BRAIN RES, V175, P163, DOI 10.1016/S0079-6123(09)17511-8; Vetere G, 2011, BEHAV BRAIN RES, V222, P394, DOI 10.1016/j.bbr.2011.04.004; West A. E., 2011, COLD SPRING HARBOR P, P3; Wilke SA, 2012, NEURAL DEV, V7, DOI 10.1186/1749-8104-7-9	106	0	0	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	1074-7427	1095-9564		NEUROBIOL LEARN MEM	Neurobiol. Learn. Mem.	NOV	2014	115				SI		21	29		10.1016/j.nlm.2014.08.010		9	Behavioral Sciences; Neurosciences; Psychology; Psychology, Multidisciplinary	Behavioral Sciences; Neurosciences & Neurology; Psychology	AS0FH	WOS:000343953100004		
J	Kuya, K; Shinohara, Y; Sakamoto, M; Iwata, N; Kishimoto, J; Fujii, S; Kaminou, T; Watanabe, T; Ogawa, T				Kuya, Keita; Shinohara, Yuki; Sakamoto, Makoto; Iwata, Naoki; Kishimoto, Junichi; Fujii, Shinya; Kaminou, Toshio; Watanabe, Takashi; Ogawa, Toshihide			CT angiography after carotid artery stenting: assessment of the utility of adaptive statistical iterative reconstruction and model-based iterative reconstruction	NEURORADIOLOGY			English	Article						CT angiography; Carotid artery stenting; Adaptive statistical iterative reconstruction; Model-based iterative reconstruction	COMPUTED-TOMOGRAPHY ANGIOGRAPHY; ISCHEMIC-STROKE; IN-VITRO; ENDARTERECTOMY; DISEASE; TRIAL; RISK; RESTENOSIS; PREVENTION; STENOSIS	Follow-up CT angiography (CTA) is routinely performed for post-procedure management after carotid artery stenting (CAS). However, the stent lumen tends to be underestimated because of stent artifacts on CTA reconstructed with the filtered back projection (FBP) technique. We assessed the utility of new iterative reconstruction techniques, such as adaptive statistical iterative reconstruction (ASIR) and model-based iterative reconstruction (MBIR), for CTA after CAS in comparison with FBP. In a phantom study, we evaluated the differences among the three reconstruction techniques with regard to the relationship between the stent luminal diameter and the degree of underestimation of stent luminal diameter. In a clinical study, 34 patients who underwent follow-up CTA after CAS were included. We compared the stent luminal diameters among FBP, ASIR, and MBIR, and performed visual assessment of low attenuation area (LAA) in the stent lumen using a three-point scale. In the phantom study, stent luminal diameter was increasingly underestimated as luminal diameter became smaller in all CTA images. Stent luminal diameter was larger with MBIR than with the other reconstruction techniques. Similarly, in the clinical study, stent luminal diameter was larger with MBIR than with the other reconstruction techniques. LAA detectability scores of MBIR were greater than or equal to those of FBP and ASIR in all cases. MBIR improved the accuracy of assessment of stent luminal diameter and LAA detectability in the stent lumen when compared with FBP and ASIR. We conclude that MBIR is a useful reconstruction technique for CTA after CAS.	[Kuya, Keita; Shinohara, Yuki; Fujii, Shinya; Ogawa, Toshihide] Tottori Univ, Fac Med, Dept Pathophysiol Therapeut Sci, Div Radiol, Yonago, Tottori 6838504, Japan; [Sakamoto, Makoto; Watanabe, Takashi] Tottori Univ, Fac Med, Dept Brain & Neurosci, Div Neurosurg, Yonago, Tottori 6838504, Japan; [Iwata, Naoki; Kishimoto, Junichi] Tottori Univ, Fac Med, Div Clin Radiol, Yonago, Tottori 6838504, Japan; [Kaminou, Toshio] Osaka Minami Med Ctr, Dept Radiol, Osaka, Japan	Kuya, K (reprint author), Tottori Univ, Fac Med, Dept Pathophysiol Therapeut Sci, Div Radiol, 36-1 Nishi Cho, Yonago, Tottori 6838504, Japan.	keita98_1_7@hotmail.co.jp					Machida H, 2013, AM J NEURORADIOL, V34, P971, DOI 10.3174/ajnr.A3320; Suzuki S, 2013, AM J ROENTGENOL, V200, P652, DOI 10.2214/AJR.12.8689; Katsura M, 2012, EUR RADIOL, V22, P1613, DOI 10.1007/s00330-012-2452-z; Clark DJ, 2006, J AM COLL CARDIOL, V47, P2390, DOI 10.1016/j.jacc.2006.01.076; Adams RJ, 2008, STROKE, V39, P1647, DOI 10.1161/STROKEAHA.107.189063; Brott TG, 2010, NEW ENGL J MED, V363, P11, DOI 10.1056/NEJMoa0912321; Goldstein LB, 2006, CIRCULATION, V113, pE873, DOI 10.1161/01.STR.0000223048.70103.F1; Fuchs TA, 2014, EUR HEART J, V35, P1131, DOI 10.1093/eurheartj/ehu053; Muller-Hulsbeck S, 2009, J ENDOVASC THER, V16, P168, DOI 10.1583/08-2539.1; Berg M, 2005, AM J NEURORADIOL, V26, P1022; Petty GW, 1999, STROKE, V30, P2513; Thibault JB, 2007, MED PHYS, V34, P4526, DOI 10.1118/1.2789499; Yadav JS, 2004, NEW ENGL J MED, V351, P1493, DOI 10.1056/NEJMoa040127; Lal BK, 2012, LANCET NEUROL, V11, P755, DOI 10.1016/S1474-4422(12)70159-X; Pickhardt PJ, 2012, AM J ROENTGENOL, V199, P1266, DOI 10.2214/AJR.12.9382; Hill MD, 2012, CIRCULATION, V126, P3054, DOI 10.1161/CIRCULATIONAHA.112.120030; Kohler M., 2011, RADIOL RES PRACT, V2011, DOI [10.1155/2011/103873, DOI 10.1155/2011/103873]; Lanzino G, 2009, MAYO CLIN PROC, V84, P362, DOI 10.1016/S0025-6196(11)60546-6; Lee YJ, 2013, J COMPUT ASSIST TOMO, V37, P402, DOI 10.1097/RCT.0b013e318289a9f9; Nishida J, 2014, RADIOLOGY, V270, P282, DOI 10.1148/radiol.13122019; Prakash P, 2010, RADIOLOGY, V256, P261, DOI 10.1148/radiol.10091487; Scheffel H, 2012, EUR J RADIOL, V81, pE363, DOI 10.1016/j.ejrad.2011.11.051; ROTHWELL PM, 1995, LANCET, V345, P209; Yanagawa M, 2010, ACAD RADIOL, V17, P1259, DOI 10.1016/j.acra.2010.05.014	24	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0028-3940	1432-1920		NEURORADIOLOGY	Neuroradiology	NOV	2014	56	11					947	953		10.1007/s00234-014-1415-2		7	Clinical Neurology; Neuroimaging; Radiology, Nuclear Medicine & Medical Imaging	Neurosciences & Neurology; Radiology, Nuclear Medicine & Medical Imaging	AS5ZW	WOS:000344345800004		
J	Iwata, T; Mori, T; Miyazaki, Y; Tanno, Y; Kasakura, S; Aoyagi, Y				Iwata, Tomonori; Mori, Takahisa; Miyazaki, Yuichi; Tanno, Yuhei; Kasakura, Shigen; Aoyagi, Yoshinori			Global Oxygen Extraction Fraction by Blood Sampling to Anticipate Cerebral Hyperperfusion Phenomenon After Carotid Artery Stenting	NEUROSURGERY			English	Article						Arteriovenous oxygen difference; Carotid artery stenting; Cerebral hyperperfusion phenomenon; Oxygen extraction fraction	POSITRON-EMISSION-TOMOGRAPHY; ENDARTERECTOMY; SPECT; FLOW; PET; HEMODYNAMICS; HEMORRHAGE; INHALATION; ACCURACY; HUMANS	BACKGROUND: Cerebral hyperperfusion syndrome sometimes occurs after carotid revascularization in patients with severe hemodynamic failure. To prevent cerebral hyperperfusion syndrome, cerebral hyperperfusion phenomenon (CHP) must be detected early. Single-photon emission computed tomography (SPECT) is useful for detecting CHP, but it is impractical on a daily basis. A tool with high availability to find CHP is desired. OBJECTIVE: To investigate whether global oxygen extraction fraction (OEF) by a blood sampling method is useful for indicating CHP after carotid artery stenting (CAS). METHODS: When patients underwent elective CAS from September 2010 to August 2012, we performed blood sampling for OEF calculation and SPECT before and immediately after elective CAS. Data were collected prospectively. OEF was calculated from the cerebral arteriovenous oxygen difference. Cerebral blood flow was measured in the affected middle cerebral artery (MCA) territory and in the ipsilateral cerebellum by SPECT. The ratio of MCA to cerebellar activity was defined as cerebral blood flow in the affected MCA territory divided by cerebral blood flow in the ipsilateral cerebellar hemisphere. Probable CHP was defined as >= 10% increase in the ratio of MCA to cerebellar activity after CAS. The relationship between peri-CAS OEF and probable CHP was evaluated. RESULTS: Of the 96 patients enrolled, 92 patients were analyzed. Probable CHP occurred in 17 patients. Post-CAS OEF was related to probable CHP (P < .01), but pre-CAS OEF was not. The receiver-operating characteristic curve showed that the cutoff value was 45% for probable CHP (P < .001). CONCLUSION: An increase in blood sampling OEF immediately after CAS was related to probable CHP; then the oxygen demand should be reduced.	[Iwata, Tomonori; Mori, Takahisa; Miyazaki, Yuichi; Tanno, Yuhei; Kasakura, Shigen; Aoyagi, Yoshinori] Shonan Kamakura Gen Hosp, Dept Stroke Treatment, Stroke Ctr, Kamakura, Kanagawa 2478533, Japan	Mori, T (reprint author), Shonan Kamakura Gen Hosp, Dept Stroke Treatment, Stroke Ctr, Okamoto 1370-1, Kamakura, Kanagawa 2478533, Japan.	morit-koc@umin.net					ALTMAN DI, 1991, J NUCL MED, V32, P1738; Kaku Y, 2004, AM J NEURORADIOL, V25, P1403; van Mook WNKA, 2005, LANCET NEUROL, V4, P877, DOI 10.1016/S1474-4422(05)70251-9; Ogasawara K, 2007, J NEUROSURG, V107, P1130, DOI 10.3171/JNS-07/12/1130; POWERS WJ, 1991, ANN NEUROL, V29, P231, DOI 10.1002/ana.410290302; Derdeyn CP, 2002, BRAIN, V125, P595, DOI 10.1093/brain/awf047; Buczek J, 2013, CEREBROVASC DIS, V35, P531, DOI 10.1159/000350736; Camargo EE, 2001, J NUCL MED, V42, P611; Franck G, 1986, Adv Neurol, V44, P935; Hattori N, 2004, J NUCL MED, V45, P765; Hino Akihiko, 2005, J Stroke Cerebrovasc Dis, V14, P234, DOI 10.1016/j.jstrokecerebrovasdis.2005.08.001; Iwata T, 2013, INT STROK C FEBR 6 8; Iwata T, 2013, J NEUROINTERV SURG, V5, P77, DOI 10.1136/neurintsurg-2012-010506; Kawai N, 2014, J STROKE CEREBROVASC, V23, pE55, DOI 10.1016/j.jstrokecerebrovasdis.2013.08.012; Kuroda Satoshi, 2011, Brain and Nerve (Tokyo), V63, P933; Maas MB, 2013, J NEUROL NEUROSUR PS, V84, P569, DOI 10.1136/jnnp-2012-303659; Matsubara S, 2009, J NEUROSURG, V111, P28, DOI 10.3171/2008.09.17663; Mori T, 1999, J ENDOVASC SURG, V6, P337, DOI 10.1583/1074-6218(1999)006<0337:IHACS>2.0.CO;2; Nakazaki Masahito, 2013, No Shinkei Geka, V41, P765; Ogura T, 2009, ANN NUCL MED, V23, P33, DOI 10.1007/s12149-008-0203-7; Okamoto K, 2002, CLIN NUCL MED, V27, P191, DOI 10.1097/00003072-200203000-00009; POWERS WJ, 1984, ANN NEUROL, V16, P546, DOI 10.1002/ana.410160504; POWERS WJ, 1989, ANN NEUROL, V25, P325, DOI 10.1002/ana.410250403; Wagner WH, 2005, ANN VASC SURG, V19, P479, DOI 10.1007/s10016-005-4644-3	24	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0148-396X	1524-4040		NEUROSURGERY	Neurosurgery	NOV	2014	75	5					546	551		10.1227/NEU.0000000000000485		6	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	AS2PD	WOS:000344121100009		
J	Palmiotti, G; Briggs, JB; Kugo, T; Trumble, E; Kahler, AC; Lancaster, D				Palmiotti, Giuseppe; Briggs, J. Blair; Kugo, Teruhiko; Trumble, Edward (Fitz); Kahler, Albert C. (Skip); Lancaster, Dale			Applications of Integral Benchmark Data	NUCLEAR SCIENCE AND ENGINEERING			English	Article							CORE PERFORMANCE PARAMETERS; BIAS FACTOR METHODS; PREDICTION ACCURACY; NEUTRONIC CHARACTERISTICS; REACTOR CORE; ENDF/B-VII.1; IMPROVEMENT; ADJUSTMENT; JENDL-4.0; ERROR	The International Reactor Physics Experiment Evaluation Project (IRPhEP) and the International Criticality Safety Benchmark Evaluation Project (ICSBEP) provide evaluated integral benchmark data that may be used for validation of reactor physics/nuclear criticality safety analytical methods and data, nuclear data testing, advanced modeling and simulation, and safety analysis licensing activities. The handbooks produced by these programs are used in over 30 countries. Five example applications are presented in this paper: (a) use of IRPhEP data in uncertainty analyses and cross-section adjustment, (b) uncertainty evaluation methods for reactor core design at Japan Atomic Energy Agency using reactor physics experimental data, (c) application of benchmarking data to a broad range of criticality safety problems, (d) cross-section data testing with ICSBEP benchmarks, and (e) use of the International Handbook of Evaluated Reactor Physics Benchmark Experiments to support the power industry.	[Palmiotti, Giuseppe; Briggs, J. Blair] Idaho Natl Lab, Nucl Syst Design & Anal Div, Idaho Falls, ID 83415 USA; [Kugo, Teruhiko] Japan Atom Energy Agcy, Nucl Sci & Engn Directorate, Tokai, Ibaraki 3191195, Japan; [Trumble, Edward (Fitz)] URS Profess Solut, Aiken, SC 29803 USA; [Kahler, Albert C. (Skip)] Los Alamos Natl Lab, Div Theoret, Los Alamos, NM 87545 USA; [Lancaster, Dale] NuclearConsultants Com, State Coll, PA 16801 USA	Palmiotti, G (reprint author), Idaho Natl Lab, Nucl Syst Design & Anal Div, POB 1625,MS 3860, Idaho Falls, ID 83415 USA.	giuseppe.palmiotti@inl.gov					[Anonymous], 2013, INT HDB EV CRIT SAF; [Anonymous], 2012, ANSIANS8242007 AM NU; [Anonymous], 2013, NPTR081421682NP; [Anonymous], 2014, INT HDB REACT PHYS B; [Anonymous], 2007, ANSIANS811998; [Anonymous], 2013, COMMUNICATION; [Anonymous], 2013, SPENT FUEL POOL MAN; BLANCO A. J., 2013, WCAP17728NP EL CO; CAPOTE NOY R., 2010, INDCNDS0586 INT AT E; Chiba G, 2011, J NUCL SCI TECHNOL, V48, P172, DOI 10.3327/jnst.48.172; COURCELLE A., 2006, SUMMARY REPORT WPEC; DE SAINT-JEAN C., 2014, COORDINATED EVALUATI; DRAGT JB, 1977, NUCL SCI ENG, V62, P117; HAZAMA T., 2004, P INT C PHYS FUEL CY; Herman M, 2008, NUCL DATA SHEETS, V109, P2752, DOI 10.1016/j.nds.2008.11.005; Hill I, 2014, NUCL SCI ENG, V178, P280, DOI 10.13182/NSE14-37; ILAS G., 2012, NUREGCR7107 US NUCL; Kahler AC, 2011, NUCL DATA SHEETS, V112, P2997, DOI 10.1016/j.nds.2011.11.003; KAMEI T, 1983, NUCL SCI ENG, V84, P83; Kugo T, 2007, J NUCL SCI TECHNOL, V44, P1509, DOI 10.3327/jnst.44.1509; Kugo T, 2008, J NUCL SCI TECHNOL, V45, P288, DOI 10.3327/jnst.45.288; LECLAIRE N., 2014, NUCL SCI ENG, V178; Nouri A, 2003, NUCL SCI ENG, V145, P11; OUISLOUMEN M., 2013, COMMUNICATION; Palmiotti G, 2014, NUCL DATA SHEETS, V118, P596, DOI 10.1016/j.nds.2014.04.145; Salvatores M, 2014, NUCL DATA SHEETS, V118, P38, DOI 10.1016/j.nds.2014.04.005; Sano T, 2006, J NUCL SCI TECHNOL, V43, P1465, DOI 10.3327/jnst.43.1465; Sugino K., 2012, 2012013 JAEA; TAKEDA T, 1989, NUCL SCI ENG, V103, P157; TERRY W. K., 2004, PRELIMINARY ASSESSME; van der Marck SC, 2012, NUCL DATA SHEETS, V113, P2935, DOI 10.1016/j.nds.2012.11.003; Yokoyama K, 2012, J NUCL SCI TECHNOL, V49, P1165, DOI 10.1080/00223131.2012.739020; ZHANG H., 2012, REV EXPT CASL NEUTRO	33	1	1	AMER NUCLEAR SOC	LA GRANGE PK	555 N KENSINGTON AVE, LA GRANGE PK, IL 60526 USA	0029-5639	1943-748X		NUCL SCI ENG	Nucl. Sci. Eng.	NOV	2014	178	3					295	310				16	Nuclear Science & Technology	Nuclear Science & Technology	AS0FX	WOS:000343954600004		
J	Ishikawa, M; Ikegami, T; Sanda, T				Ishikawa, Makoto; Ikegami, Tetsuo; Sanda, Toshio			ZPPR Benchmarks for Large LMFBR Core Physics from JUPITER Cooperative Program Between United States and Japan	NUCLEAR SCIENCE AND ENGINEERING			English	Article							REACTOR	Under the International Reactor Physics Experiment Evaluation Project (IRPhEP) framework, in the cooperative JUPITER program between the United States and Japan, benchmarks are established to study large fast breeder reactor (FBR) core physics utilizing nine Zero Power Plutonium Reactor (ZPPR) critical experimental cores. These benchmarks cover a wide variety of core concepts including homogeneous and heterogeneous configurations, clean and engineering mock-up cores of 600- to 1000-MW(electric) class sizes, and various core parameters such as criticality, reaction rate, and reactivity. Recently, detailed experimental information from original documents from Argonne National Laboratory has been scrutinized very carefully to establish the benchmark model and to evaluate quantitatively the experimental uncertainty. The benchmarks supply users with heterogeneous cell models and three-dimensional (3-D) core configurations, which are simplified to a degree that preserves the important physical features of the ZPPR cores such as plate heterogeneity, different drawer types, and 3-D core arrangement. Further, the benchmark handbook includes as-built information of the ZPPR cores as a complete set of electronic form; therefore, a user can develop his or her own benchmark model if necessaiy. The analysis of the benchmark with the deterministic or Monte Carlo method demonstrates its usefulness both for improving analytical methods and for validating nuclear data.	[Ishikawa, Makoto; Ikegami, Tetsuo; Sanda, Toshio] Japan Atom Energy Agcy, Nucl Sci & Engn Directorate, Tokai, Ibaraki 3191195, Japan	Ishikawa, M (reprint author), Japan Atom Energy Agcy, Nucl Sci & Engn Directorate, 2-4 Shirakata, Tokai, Ibaraki 3191195, Japan.	ishikawa.makoto@jaea.go.jp					Shibata K, 2011, J NUCL SCI TECHNOL, V48, P1, DOI 10.3327/jnst.48.1; BELL GI, 1967, NUCL SCI ENG, V28, P376; BENOIST P, 1968, NUCL SCI ENG, V34, P285; BRIGGS J. B., 2013, INT HDB EVALUATED RE; BRIGGS J. B., 2013, INT HDB EVALUATED CR; BRUMBACH S. B., 1990, P INT C PHYS REACT O, pV; BRUMBACH SB, 1989, NUCL SCI ENG, V103, P219; Carpenter S. G., 1980, Proceedings of the Conference, 1980 Advances in Reactor Physics and Shielding; Chiba G, 2006, J NUCL SCI TECHNOL, V43, P1395, DOI 10.3327/jnst.43.1395; COLLINS P. J., 1984, P TOPL M REACT PHYS, P647; Collins P. J., 1988, Proceedings of the 1988 International Reactor Physics Conference; Dean VAF, 2003, NUCL SCI ENG, V145, P20; Fowler T.B., 1971, ORNLTM2496; HAZAMA T., 2006, J NUCL SCI TECHNOL, V43, P908; HUMMEL H. H., 1970, REACTIVITY COEFFICIE, P38; ISHIKAWA M., 1992, TN941093010 PNC; LINEBERRY M. J., 1979, P FAST REACT PHYS AI, P187; McFarlane H. F., 1980, Proceedings of the Conference, 1980 Advances in Reactor Physics and Shielding; SANDA T., 1990, TN941090018 PNC; SHERAKATA K., 1984, P TOPL M REACT PHYS, P580; Shirakata K., 1988, Proceedings of the 1988 International Reactor Physics Conference; SUGINO K., 1996, TN945096052 PNC POW; TONE T, 1975, J NUCL SCI TECHNOL, V12, P467, DOI 10.3327/jnst.12.467; YAMAMOTO M., 1984, P TOPL M REACT PHYS, P773; YAMAMOTO T, 1986, J NUCL SCI TECHNOL, V23, P849, DOI 10.3327/jnst.23.849	25	0	0	AMER NUCLEAR SOC	LA GRANGE PK	555 N KENSINGTON AVE, LA GRANGE PK, IL 60526 USA	0029-5639	1943-748X		NUCL SCI ENG	Nucl. Sci. Eng.	NOV	2014	178	3					335	349				15	Nuclear Science & Technology	Nuclear Science & Technology	AS0FX	WOS:000343954600007		
J	Yokoyama, K; Ishikawa, M				Yokoyama, Kenji; Ishikawa, Makoto			Evaluation of Burnup Reactivity Coefficients Measured in Experimental Fast Reactor JOYO MK-I Duty Power Operation Cycles	NUCLEAR SCIENCE AND ENGINEERING			English	Article							PERTURBATION-THEORY	To provide a reactor physics benchmark for burnup reactivity coefficients, experimental data, showing the relationship between excess reactivity and accumulated thermal power acquired during the experimental fast reactor JOY MK-I duty power operation in the late 1970s, have been evaluated and analyzed. To improve the prediction accuracy of nuclear characteristics through the use of integral experimental data, nominal values and uncertainties, including correlations of the experimental data, were evaluated. All possible uncertainty factors were evaluated and quantified by utilizing knowledge obtained after the MK-I duty power operation and calculation results based on the latest reactor physics analysis methods. Meanwhile, the present evaluated data have been reviewed and approved by the International Reactor Physics Experiment Evaluation Project, with the expectation that these data will be widely used. In the present paper, the evaluation of nominal values and uncertainties is described with a focus on the measurement technique uncertainty, which is a dominant uncertainty factor of the burnup reactivity coefficient. In addition, new analysis results of the benchmark problem are shown by the use of the latest Japanese evaluated nuclear data JENDL-4.0.	[Yokoyama, Kenji; Ishikawa, Makoto] Japan Atom Energy Agcy, Nucl Sci & Engn Directorate, Tokai, Ibaraki 3191195, Japan	Yokoyama, K (reprint author), Japan Atom Energy Agcy, Nucl Sci & Engn Directorate, 2-4 Shirakata Shirane, Tokai, Ibaraki 3191195, Japan.	yokoyama.kenji09@jaea.go.jp					[Anonymous], 2010, NEANSCDOC20061 ORG E; [Anonymous], 2006, NEANESCDOC20061 ORG; DRAGT JB, 1977, NUCL SCI ENG, V62, P117; ENDOU A., 1979, TN9527903 PNC POW RE; Hazama T, 2006, J NUCL SCI TECHNOL, V43, P908, DOI 10.3327/jnst.43.908; HIROSE M., 1979, TN94179119 PNC POW R; IKEGAMI T., 1983, N9418312 PNC POW REA; ISHIKAWA M., 1980, TN94180211 PNC POW R; ISHIKAWA M., 1981, TN94181102 PNC POW R; ISHIKAWA M., 1980, TN9418033 PNC POW RE; Ishikawa M., 2002, J NUCL SCI TECHNOL S, V2, P1073; ISHIKAWA M., 1980, TN9418006 POW REACT; ISHIKAWA M., 1979, TN94179179 PNC POW R; SANDA T., 1979, SN94179191 PNC POW R; Sugino K., 2012, 2012013 JAEA; TAKEDA T, 1985, NUCL SCI ENG, V91, P1; TAKEDA T, 1989, NUCL SCI ENG, V103, P157; TERATA K., 1980, TN94180171 PNC POW N; WILLIAMS ML, 1979, NUCL SCI ENG, V70, P20; YAMAMOTO H., 1980, TN9418058 PNC POW RE; Yokoyama K, 2007, NUCL SCI ENG, V157, P249; Yokoyama K, 2014, ANN NUCL ENERGY, V66, P51, DOI 10.1016/j.anucene.2013.11.047	22	0	0	AMER NUCLEAR SOC	LA GRANGE PK	555 N KENSINGTON AVE, LA GRANGE PK, IL 60526 USA	0029-5639	1943-748X		NUCL SCI ENG	Nucl. Sci. Eng.	NOV	2014	178	3					350	362				13	Nuclear Science & Technology	Nuclear Science & Technology	AS0FX	WOS:000343954600008		
J	Kitamura, Y; Eguchi, Y				Kitamura, Yasunori; Eguchi, Yuta			Uncertainty Analysis of Temperature Effect on Reactivity in Very High Temperature Reactor Critical Assembly and Establishment of Biases for Benchmark Models	NUCLEAR SCIENCE AND ENGINEERING			English	Article							CORE	A series of integral reactor physics experiments conducted at the Very High Temperature Reactor Critical Assembly was analyzed to assemble it into a benchmark through an extensive peer-review process under the International Reactor Physics Experiment Evaluation Project. This benchmark provides the experimental data with respect to the criticalities of seven core configurations and the temperature effect on reactivity up to 200 degrees C with explicit experimental uncertainties newly evaluated. It further presents the benchmark models and corresponding values with some simplifications so that it can be used by reactor designers for validating the analytical tools employed to design next-generation reactors and for establishing the safety basis for operation of these reactors.	[Kitamura, Yasunori; Eguchi, Yuta] Japan Atom Energy Agcy, Nucl Sci & Engn Directorate, Tokai, Ibaraki 3191195, Japan	Kitamura, Y (reprint author), Japan Atom Energy Agcy, Nucl Sci & Engn Directorate, 2-4 Shirane, Tokai, Ibaraki 3191195, Japan.	kitamura.yasunori@jaea.go.jp					AKINO F, 1989, J ATOM ENERG SOC JPN, V31, P682; [Anonymous], 2013, INT HDB EV REACT PHY; Shibata K, 2011, J NUCL SCI TECHNOL, V48, P1, DOI 10.3327/jnst.48.1; Bess John D., 2013, Transactions of the American Nuclear Society, V108; Nagaya Y, 2005, 1348 JAERI; YAMANE T., 2012, COMMUNICATION; YAMANE T, 1990, J NUCL SCI TECHNOL, V27, P122; YASUDA H., 1990, P IAEA SPEC M UNC PH, P119; YASUDA H., 1987, 1305 JAERI	9	0	0	AMER NUCLEAR SOC	LA GRANGE PK	555 N KENSINGTON AVE, LA GRANGE PK, IL 60526 USA	0029-5639	1943-748X		NUCL SCI ENG	Nucl. Sci. Eng.	NOV	2014	178	3					401	413				13	Nuclear Science & Technology	Nuclear Science & Technology	AS0FX	WOS:000343954600012		
J	Bess, JD; Fujimoto, N				Bess, John D.; Fujimoto, Nozomu			Benchmark Evaluation of Start-Up and Zero-Power Measurements at the High-Temperature Engineering Test Reactor	NUCLEAR SCIENCE AND ENGINEERING			English	Article							CORE PHYSICS TESTS; NUCLEAR-DATA; HTTR; SCIENCE; CRITICALITY; TECHNOLOGY; LIBRARY	Benchmark models were developed to evaluate six cold-critical and two warm-critical, zero-power measurements of the high-temperature engineering test reactor (HTTR). Additional measurements of the subcritical configuration of the fully loaded core, core excess reactivity, shutdown margins, six isothermal temperature coefficients, and axial reaction-rate distributions were also evaluated as acceptable benchmark experiments. Insufficient information is publicly available to develop finely detailed models of the HTTR as much of the design information is still proprietary. The uncertainties in the benchmark models are judged to be of sufficient magnitude to encompass any biases and bias uncertainties incurred through the simplification process used to develop the benchmark models. However, use of the benchmark critical configurations of the HTTR for nuclear data adjustment is not recommended as the impact of these biases has not been addressed with rigorous detail. The impact of any simplification biases, if any, is not expected to significantly impact evaluation of the other reactor physics measurement calculations. Dominant uncertainties in the experimental k(eff) for all core configurations come from uncertainties in the impurity content of the various graphite blocks that compose the HTTR. Monte Carlo calculations of k(eff) are between 0.9% and 2.7% greater than the benchmark values. Reevaluation of the HTTR models as additional information becomes available could improve the quality of this benchmark and possibly reduce the computational biases. High-quality characterization of graphite impurities would significantly improve the quality of the HTTR benchmark assessment. Simulations of the other reactor physics measurements are in good agreement with the benchmark experiment values. The complete benchmark evaluation details are available in the 2014 edition of the International Handbook of Evaluated Reactor Physics Benchmark Experiments.	[Bess, John D.] Idaho Natl Lab, Idaho Falls, ID 83415 USA; [Fujimoto, Nozomu] Japan Atom Energy Agcy, Oarai Res & Dev Ctr, Dept HTTR, Oarai, Ibaraki 3111393, Japan	Bess, JD (reprint author), Idaho Natl Lab, POB 1625,MS 3855, Idaho Falls, ID 83415 USA.	john.bess@inl.gov			U.S. Department of Energy [DE-AC07-05ID14517]	The authors would like to thank J. W. Sterbentz and B. H. Dolphin from Idaho National Laboratory and L. Snoj from Jozef Stefan Institute for their review and support in developing a comprehensive benchmark evaluation. Extra gratitude is expressed for A. Zukeran, retired from JAEA, for his collaboration in obtaining and reviewing HTTR data, including translation from Japanese into English. Further appreciation is expressed to all the international participants in the International Reactor Physics Experiment Evaluation Project for all their well-spent time and effort. This paper was prepared at Idaho National Laboratory for the U.S. Department of Energy under contract DE-AC07-05ID14517.	Chadwick MB, 2011, NUCL DATA SHEETS, V112, P2887, DOI 10.1016/j.nds.2011.11.002; Shibata K, 2011, J NUCL SCI TECHNOL, V48, P1, DOI 10.3327/jnst.48.1; [Anonymous], 2014, INT HDB EV REACT PHY; Chadwick MB, 2006, NUCL DATA SHEETS, V107, P2931, DOI 10.1016/j.nds.2006.11.001; BESS I D., 2011, INT HDB EVALUATED RE; BESS J. D., 2010, INT HDB EVALUATED RE; Colak U, 2005, NUCL SCI ENG, V149, P131; Fujimoto N, 2000, J ATOM ENERG SOC JPN, V42, P458; FUJIMOTO N., 2001, 2000091 JAERI; Fujimoto N, 2005, NUCL SCI ENG, V150, P310; Goorley J T, 2013, LAUR1322934; Goto M, 2006, J NUCL SCI TECHNOL, V43, P1237, DOI 10.3327/jnst.43.1237; IAEA, 2003, IAEATECDOC1382; Koning A., 2006, 21 JEFF; Lemmel HD, 2001, IAEANDS100; MacFarlane R.E., 1994, LA12740M; Nojiri N, 2004, NUCL ENG DES, V233, P283, DOI 10.1016/j.nucengdes.2004.08.015; Ponornarev-Stepnoi NN, 2004, ATOM ENERGY+, V97, P669, DOI 10.1007/s10512-005-0046-4; SHIBATA K., 2002, J NUCL SCI TECHNOL, V39, P1125; SHIMAKAWA S., 2010, P 5 INT C HIGH TEM R; Shiozawa S, 2004, NUCL ENG DES, V233, P11, DOI 10.1016/j.nucengdes.2004.07.0l6; SUMITA J., 2006, 2006048 JAEA; TAKIKAWA N., 1993, IAEATECDOC690; X-5 Monte Carlo Team, 2003, LAUR031987; Yamashita K, 2000, J ATOM ENERG SOC JPN, V42, P30; ZIBI Z., 2010, P 5 INT C HIGH TEM R	26	0	0	AMER NUCLEAR SOC	LA GRANGE PK	555 N KENSINGTON AVE, LA GRANGE PK, IL 60526 USA	0029-5639	1943-748X		NUCL SCI ENG	Nucl. Sci. Eng.	NOV	2014	178	3					414	427				14	Nuclear Science & Technology	Nuclear Science & Technology	AS0FX	WOS:000343954600013		
J	Hokazono, K; Ueki, T; Nagayoshi, K; Nishioka, Y; Hatae, T; Koga, Y; Hirahashi, M; Oda, Y; Tanaka, M				Hokazono, Koji; Ueki, Takashi; Nagayoshi, Kinuko; Nishioka, Yasunobu; Hatae, Tatsunobu; Koga, Yutaka; Hirahashi, Minako; Oda, Yoshinao; Tanaka, Masao			A CpG island methylator phenotype of colorectal cancer that is contiguous with conventional adenomas, but not serrated polyps	ONCOLOGY LETTERS			English	Article						CpG island methylator phenotype; colorectal cancer; methylation; promoter CpG island; serrated pathway	POPULATION-BASED SAMPLE; COLON-CANCER; MICROSATELLITE-INSTABILITY; DNA METHYLATION; CHROMOSOMAL INSTABILITY; MOLECULAR-FEATURES; TUMOR-SUPPRESSOR; BRAF MUTATION; SURVIVAL; 5-FLUOROURACIL	A subset of colorectal cancers (CRCs) harbor the CpG island methylator phenotype (CIMP), with concurrent multiple promoter hypermethylation of tumor-related genes. A serrated pathway in which CIMP is developed from serrated polyps is proposed. The present study characterized CIMP and morphologically examined precursor lesions of CIMP. In total, 104 CRCs treated between January 1996 and December 2004 were examined. Aberrant promoter methylation of 15 cancer-related genes was analyzed. CIMP status was classified according to the number of methylated genes and was correlated with the clinicopathological features, including the concomitant polyps in and around the tumors. The frequency of aberrant methylation in each CRC showed a bimodal pattern, and the CRCs were classified as CIMP-high (CIMP-H), CIMP-low (CIMP-L) and CIMP-negative (CIMP-N). CIMP-H was associated with aberrant methylation of MLHI (P=0.005) and with an improved recurrence-free survival (RFS) rate following curative resection compared with CIMP-L/N (five-year RFS rate, 93.8 vs. 67.1%; P=0.044), while CIMP-N tumors were associated with frequent distant metastases at diagnosis (P=0.023). No concomitant serrated lesions were present in the tumors, whereas conventional adenoma was contiguous with 11(10.6%) of 104 CRCs, including four CIMP-H CRCs. CIMP-H was classified in CRCs by a novel CIMP marker panel and the presence of concomitant tumors revealed that certain CIMP-H CRCs may have arisen from conventional adenomas.	[Hokazono, Koji; Ueki, Takashi; Nagayoshi, Kinuko; Nishioka, Yasunobu; Hatae, Tatsunobu; Tanaka, Masao] Kyushu Univ, Dept Surg & Oncol, Grad Sch Med Sci, Fukuoka 8128582, Japan; [Koga, Yutaka; Hirahashi, Minako; Oda, Yoshinao] Kyushu Univ, Dept Anat Pathol, Grad Sch Med Sci, Fukuoka 8128582, Japan	Ueki, T (reprint author), Kyushu Univ, Dept Surg & Oncol, Grad Sch Med Sci, Higashi Ku, 3-1-1 Maidashi, Fukuoka 8128582, Japan.	tueki@surg1.med.kyushu-u.ac.jp					Ahn JB, 2011, CANCER-AM CANCER SOC, V117, P1847, DOI 10.1002/cncr.25737; Ang PW, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-227; Hawkins NJ, 2001, J NATL CANCER I, V93, P1307, DOI 10.1093/jnci/93.17.1307; Yamashita K, 2003, CANCER CELL, V4, P121, DOI 10.1016/S1535-6108(03)00190-9; Weisenberger DJ, 2006, NAT GENET, V38, P787, DOI 10.1038/ng1834; Ueki T, 2001, CANCER RES, V61, P8540; Barault L, 2008, CANCER RES, V68, P8541, DOI 10.1158/0008-5472.CAN-08-1171; Samowitz WS, 2005, CANCER RES, V65, P6063, DOI 10.1158/0008-5472.CAN-05-0404; Shen L, 2007, CLIN CANCER RES, V13, P6093, DOI 10.1158/1078-0432.CCR-07-1011; Sinicrope FA, 2011, JNCI-J NATL CANCER I, V103, P863, DOI 10.1093/jnci/djr153; Carethers JM, 2004, GASTROENTEROLOGY, V126, P394, DOI 10.1053/j.gastro.2003.12.023; Hawkins N, 2002, GASTROENTEROLOGY, V122, P1376, DOI 10.1053/gast.2002.32997; Li H, 2003, P NATL ACAD SCI USA, V100, P8412, DOI 10.1073/pnas.1430846100; Ogino S, 2007, J MOL DIAGN, V9, P305, DOI 10.2353/jmoldx.2007.060170; Goel A, 2007, GASTROENTEROLOGY, V132, P127, DOI 10.1053/j.gastro.2006.09.018; Toyota M, 1999, P NATL ACAD SCI USA, V96, P8681, DOI 10.1073/pnas.96.15.8681; Roth AD, 2010, J CLIN ONCOL, V28, P466, DOI 10.1200/JCO.2009.23.3452; Jover R, 2011, GASTROENTEROLOGY, V140, P1174, DOI 10.1053/j.gastro.2010.12.035; Park SJ, 2003, AM J PATHOL, V162, P815, DOI 10.1016/S0002-9440(10)63878-3; Arai E, 2012, CARCINOGENESIS, V33, P1487, DOI 10.1093/carcin/bgs177; Hutchins G, 2011, J CLIN ONCOL, V29, P1261, DOI 10.1200/JCO.2010.30.1366; Shen LL, 2007, P NATL ACAD SCI USA, V104, P18654, DOI 10.1073/pnas.0704652104; Matsuzaki K, 2005, CLIN CANCER RES, V11, P8564, DOI 10.1158/1708-0432.CCR-05-0859; Iacopetta B, 2008, INT J CLIN ONCOL, V13, P498, DOI 10.1007/s10147-008-0854-3; Rodriguez J, 2006, CANCER RES, V66, P8462, DOI 10.1158/0008-5472.CAN-06-0293; van Rijnsoever M, 2003, CLIN CANCER RES, V9, P2898; van Rijnsoever M, 2002, GUT, V51, P797, DOI 10.1136/gut.51.6.797; Ogino S, 2009, GUT, V58, P90, DOI 10.1136/gut.2008.155473; Ribic CM, 2003, NEW ENGL J MED, V349, P247, DOI 10.1056/NEJMoa022289; Samowitz WS, 2005, GASTROENTEROLOGY, V129, P837, DOI 10.1053/j.gastro.2005.06.020; He Lei, 2009, Human Genomics, V3, P195; Jass JR, 2007, HISTOPATHOLOGY, V50, P113, DOI 10.1111/j.1365-2559.2006.02549.x; Popat S, 2005, J CLIN ONCOL, V23, P609, DOI 10.1200/JCO.2005.01.186; Huang Y, 2006, CANCER LETT, V239, P168, DOI 10.1016/j.canlet.2005.07.032; Herman JG, 1996, P NATL ACAD SCI USA, V93, P9821, DOI 10.1073/pnas.93.18.9821; Ogino S, 2008, J NATL CANCER I, V100, P1734, DOI 10.1093/jnci/djn359; Arnold CN, 2004, CANCER BIOL THER, V3, P73, DOI 10.4161/cbt.3.1.590; Chan AOO, 2002, AM J PATHOL, V160, P529, DOI 10.1016/S0002-9440(10)64872-9; Derks S, 2008, CARCINOGENESIS, V29, P434, DOI 10.1093/carcin/bgm270; Etcheverry A, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-701; Gaiser T, 2013, INT J CANCER, V132, P1800, DOI 10.1002/ijc.27869; George SMC, 2000, CANCER, V89, P1901, DOI 10.1002/1097-0142(20001101)89:9<1901::AID-CNCR5>3.3.CO;2-R; Iacopetta B, 2006, INT J CANCER, V119, P2272, DOI 10.1002/ijc.22237; Shen L, 2002, CURR OPIN GASTROEN, V18, P68, DOI 10.1097/00001574-200201000-00012; Young J, 2006, CANCER EPIDEM BIOMAR, V15, P1778, DOI 10.1158/1055-9965.EPI-06-0164	45	0	0	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1792-1074	1792-1082		ONCOL LETT	Oncol. Lett.	NOV	2014	8	5					1937	1944		10.3892/ol.2014.2430		8	Oncology	Oncology	AS7GE	WOS:000344424300007		
J	Tomizawa, M; Shinozaki, F; Motoyoshi, Y; Sugiyama, T; Yamamoto, S; Sueishi, M				Tomizawa, Minoru; Shinozaki, Fuminobu; Motoyoshi, Yasufumi; Sugiyama, Takao; Yamamoto, Shigenori; Sueishi, Makoto			Picropodophyllin and sorafenib synergistically suppress the proliferation and motility of hepatocellular carcinoma cells	ONCOLOGY LETTERS			English	Article						insulin-like growth factor 1 receptor; scratch assay	ENDOTHELIAL GROWTH-FACTOR; FACTOR-I RECEPTOR; SERUM-FREE MEDIA; ANGIOGENESIS; INVOLVEMENT; EXPRESSION; APOPTOSIS; INVASION; THERAPY; PATHWAY	Resistance is one limitation of sorafenib in the treatment of hepatocellular carcinoma (HCC). Insulin-like growth factor-1 receptor (IGF-1R) is involved in cancer cell proliferation. To assess the potential synergistic antitumor effects of picropodophyllin (PPP), an IGF-1R inhibitor, HLF and PLC/PRL/5, HCC cells were treated with PPP alone or PPP in combination with sorafenib, a multikinase inhibitor. Normal human umbilical vein endothelial cells (HUVECs) were also used to analyze the antiangiogenic effects of the drugs. HCC cells and HUVECs were cultured on 96-well plates, and then treated with PPP, with and without the addition of sorafenib. A 3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium inner salt assay and hematoxylin and eosin staining were then performed 48 h later. The HCC cells were also analyzed using scratch assays and hematoxylin and eosin staining after 48 h. The proliferation of HLF, PLC/PRF/5 and HUVEC cells was suppressed by the combination of 0.2 mu M PPP and 3 mu M sorafenib more effectively than by 10 mu M sorafenib alone. The motility of HLF and PLC/PRF/5 cells was also suppressed to a greater extent with the combination of PPP at 0.2 mu M and sorafenib at 3 mu M than with sorafenib at 10 mu M alone. The cells that had been treated with 0.2 mu M PPP and 3 mu M sorafenib also exhibited pyknotic nuclei, which is characteristic of apoptosis. In conclusion, PPP enhanced sorafenib-mediated suppression of proliferation and motility in HCC cells. Therefore, the combination of PPP and sorafenib may exert antitumor and antiangiogenic effects.	[Tomizawa, Minoru] Natl Hosp Org, Shimoshizu Hosp, Dept Gastroenterol, Chiba 2840003, Japan; [Shinozaki, Fuminobu] Natl Hosp Org, Shimoshizu Hosp, Dept Radiol, Chiba 2840003, Japan; [Motoyoshi, Yasufumi] Natl Hosp Org, Shimoshizu Hosp, Dept Neurol, Chiba 2840003, Japan; [Motoyoshi, Yasufumi] Natl Hosp Org, Shimoshizu Hosp, Dept Neurol, Chiba 2840003, Japan; [Sugiyama, Takao; Sueishi, Makoto] Natl Hosp Org, Shimoshizu Hosp, Dept Rheumatol, Chiba 2840003, Japan; [Yamamoto, Shigenori] Natl Hosp Org, Shimoshizu Hosp, Dept Pediat, Chiba 2840003, Japan	Tomizawa, M (reprint author), Natl Hosp Org, Shimoshizu Hosp, Dept Gastroenterol, 934-5 Shikawatashi, Chiba 2840003, Japan.	nihminor-cib@umin.ac.jp			Japan Society for the Promotion of Science [23591002]	This study was supported in part by a Research Grant-in-Aid for Scientific Research (grant no. 23591002) from the Japan Society for the Promotion of Science.	Bai SM, 2009, J BIOL CHEM, V284, P32015, DOI 10.1074/jbc.M109.016774; El-Assal ON, 1998, HEPATOLOGY, V27, P1554, DOI 10.1002/hep.510270613; Shin JW, 2013, WORLD J GASTROENTERO, V19, P6144, DOI 10.3748/wjg.v19.i37.6144; Llovet JM, 2008, NEW ENGL J MED, V359, P378, DOI 10.1056/NEJMoa0708857; Girnita A, 2004, CANCER RES, V64, P236, DOI 10.1158/0008-5472.CAN-03-2522; Gedaly R, 2012, J SURG RES, V176, P542, DOI 10.1016/j.jss.2011.10.045; Xiong YQ, 2009, CLIN CANCER RES, V15, P4838, DOI 10.1158/1078-0432.CCR-08-2780; Chao Y, 2003, ANN SURG ONCOL, V10, P355, DOI 10.1245/ASO.2003.10.002; Huynh H, 2010, J HEPATOL, V52, P79, DOI 10.1016/j.jhep.2009.10.008; Liu L, 2006, CANCER RES, V66, P11851, DOI 10.1158/0008-5472.CAN-06-1377; Zhang X, 2012, HEPATOB PANCREAT DIS, V11, P458, DOI 10.1016/S1499-3872(12)60209-4; TOMIZAWA M, 1995, PATHOL INT, V45, P352, DOI 10.1111/j.1440-1827.1995.tb03468.x; Villanueva A, 2011, GASTROENTEROLOGY, V140, P1410, DOI 10.1053/j.gastro.2011.03.006; Bid HK, 2013, CLIN CANCER RES, V19, P2984, DOI 10.1158/1078-0432.CCR-12-2008; BROWN AL, 1986, J BIOL CHEM, V261, P3144; Ou DL, 2013, PLOS ONE, V8; Pennisi PA, 2002, CANCER RES, V62, P6529; Tomizawa M, 2010, EXP THER MED, V1, P863, DOI 10.3892/etm.2010.131; Tomizawa M, 2006, WORLD J GASTROENTERO, V12, P6531; Tomizawa M, 2008, MOL MED REP, V1, P685, DOI 10.3892/mmr_00000013; Tomizawa M, 2012, J CELL BIOCHEM, V113, P2714, DOI 10.1002/jcb.24149; Zhai Bo, 2013, World J Hepatol, V5, P345, DOI 10.4254/wjh.v5.i7.345	22	0	0	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1792-1074	1792-1082		ONCOL LETT	Oncol. Lett.	NOV	2014	8	5					2023	2026		10.3892/ol.2014.2484		4	Oncology	Oncology	AS7GE	WOS:000344424300023		
J	Takata, A; Takiguchi, S; Okada, K; Takahashi, T; Kurokawa, Y; Yamasaki, M; Miyata, H; Nakajima, K; Mori, M; Doki, Y				Takata, Akihiro; Takiguchi, Shuji; Okada, Kaoru; Takahashi, Tsuyoshi; Kurokawa, Yukinori; Yamasaki, Makoto; Miyata, Hiroshi; Nakajima, Kiyokazu; Mori, Masaki; Doki, Yuichiro			Expression of insulin-like growth factor-II mRNA-binding protein-3 as a marker for predicting clinical outcome in patients with esophageal squamous cell carcinoma	ONCOLOGY LETTERS			English	Article						insulin-like growth factor-II mRNA-binding protein-3; esophageal squamous cell carcinoma; immunohistochemistry	GASTRIC ADENOCARCINOMA; ONCOFETAL PROTEIN; CANCER; PROGRESSION; FAMILY; IMP-3; KOC; METASTASIS; PROGNOSIS; PROFILE	Insulin-like growth factor-II mRNA-binding protein-3 (IMP3) is an important factor in carcinogenesis, although its clinical significance in esophageal squamous cell carcinoma (ESCC) remains unknown. The present study investigated the associations between IMP3 expression and the clinicopathological parameters. IMP3 expression was assessed in 191 resected ESCC specimens, and the associations between IMP3 expression in ESCC, the clinicopathological parameters and patient prognosis were examined. Using immunohistochemistry, 113 (59.2%) tumors were identified as IMP3-positive. IMP3 positivity correlated significantly with high pathological (p)Stage, pT stage and pN stage. The IMP3-positive patients exhibited a poorer prognosis compared with the IMP3-negative patients. In univariate analyses, histology [hazard ratio (HR), 1.94; 95% confidence interval (CI), 1.18-3.49; P=0.0082], pT (HR, 2.34; 95% CI, 1.55-3.62; P<0.0001), pN (HR, 2.85; 95% CI, 1.81-4.69; P<0.0001), lymphatic invasion (HR, 2.08; 95% CI, 1.26-3.70; P=0.0036), venous invasion (HR, 1.79; 95% CI, 1.21-2.64; P=0.0039), neoadjuvant chemotherapy (NAC) (HR, 2.01; 95% CI, 1.35-3.00; P=0.0005) and IMP3 expression (HR, 2.12; 95% CI, 1.40-3.29; P=0.0003) were significantly associated with overall survival. Using multivariate analyses, histology (HR, 1.87; 95% CI, 1.13-3.29; P=0.014), pN (HR, 2.19; 95% CI, 1.36-3.66; P=0.0010), NAC (HR, 1.88; 95% CI, 1.24-2.86; P=0.0028) and IMP3 expression (HR, 1.84; 95% CI, 1.18-2.93; P=0.0064) were significant prognostic factors. IMP3 may therefore be a prognostic factor for patients with ESCC who have undergone a curative resection.	[Takata, Akihiro; Takiguchi, Shuji; Takahashi, Tsuyoshi; Kurokawa, Yukinori; Yamasaki, Makoto; Miyata, Hiroshi; Nakajima, Kiyokazu; Mori, Masaki; Doki, Yuichiro] Osaka Univ, Grad Sch Med, Dept Surg Gastroenterol, Suita, Osaka 5650871, Japan; [Okada, Kaoru] Nishinomiya Municipal Cent Hosp, Dept Surg, Nishinomiya, Hyogo 6638014, Japan	Takiguchi, S (reprint author), Osaka Univ, Grad Sch Med, Dept Surg Gastroenterol, 2-2,E2,Yamadaoka, Suita, Osaka 5650871, Japan.	stakiguchi@gesurg.med.osaka-u.ac.jp					Foulstone E, 2005, J PATHOL, V205, P145, DOI 10.1002/path.1712; Pryor JG, 2008, MODERN PATHOL, V21, P431, DOI 10.1038/modpathol.3801016; Gress TM, 1996, ONCOGENE, V13, P1819; Nielsen J, 1999, MOL CELL BIOL, V19, P1262; Yantiss RK, 2005, AM J SURG PATHOL, V29, P188, DOI 10.1097/01.pas.0000149688.98333.54; Zheng WX, 2008, AM J SURG PATHOL, V32, P304, DOI 10.1097/PAS.0b013e3181483ff8; Okada K, 2012, J SURG ONCOL, V105, P780, DOI 10.1002/jso.22108; Hoffmann NE, 2008, CANCER-AM CANCER SOC, V112, P1471, DOI [10.1002/cncr.23296, 10.1002/cncr23296]; Liao BS, 2005, J BIOL CHEM, V280, P18517, DOI 10.1074/jbc.M500270200; Vikesaa J, 2006, EMBO J, V25, P1456, DOI 10.1038/sj.emboj.7601039; Hammer NA, 2005, REPRODUCTION, V130, P203, DOI 10.1530/rep.1.00664; Mueller-Pillasch F, 1999, MECH DEVELOP, V88, P95, DOI 10.1016/S0925-4773(99)00160-4; Chao W, 2008, CYTOKINE GROWTH F R, V19, P111, DOI 10.1016/j.cytogfr.2008.01.005; Li DW, 2009, ANN SURG ONCOL, V16, P3499, DOI 10.1245/s10434-009-0648-5; Jiang Z, 2006, LANCET ONCOL, V7, P556, DOI 10.1016/S1470-2045(06)70732-X; Hansen TVO, 2004, MOL CELL BIOL, V24, P4448, DOI 10.1128/MCB.24.10.4448-4464.2004; Runge S, 2000, J BIOL CHEM, V275, P29562, DOI 10.1074/jbc.M001156200; Gu LJ, 2004, INT J ONCOL, V24, P671; Tamoto E, 2004, CLIN CANCER RES, V10, P3629, DOI 10.1158/1078-0432.CCR-04-0048; Doyle GAR, 1998, NUCLEIC ACIDS RES, V26, P5036, DOI 10.1093/nar/26.22.5036; Jeng YM, 2009, BRIT J SURG, V96, P66, DOI 10.1002/bjs.6438; Kono K, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-141; Mueller F, 2003, BRIT J CANCER, V88, P699, DOI 10.1038/sj.bjc.6600790; Nischalke HD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042141; Shimada H, 2003, SURGERY, V133, P486, DOI 10.1067/msy.2003.139; Simon R, 2007, HUM PATHOL, V38, P1178, DOI 10.1016/j.humpath.2007.02.001; Sobin LH, 2009, TNM CLASSIFICATION M, P66; Xu HD, 2007, HUM PATHOL, V38, P555, DOI 10.1016/j.humpath.2006.11.011; Yaniv K, 2002, GENE, V287, P49, DOI 10.1016/S0378-1119(01)00866-6; Yoshino K, 2012, DIS ESOPHAGUS	30	0	0	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1792-1074	1792-1082		ONCOL LETT	Oncol. Lett.	NOV	2014	8	5					2027	2031		10.3892/ol.2014.2465		5	Oncology	Oncology	AS7GE	WOS:000344424300024		
J	Ito, K; Asano, T; Tominaga, S; Yoshii, H; Sawazaki, H; Asano, T				Ito, Keiichi; Asano, Takako; Tominaga, Susumu; Yoshii, Hidehiko; Sawazaki, Harutake; Asano, Tomohiko			Erythropoietin production in renal cell carcinoma and renal cysts in autosomal dominant polycystic kidney disease in a chronic dialysis patient with polycythemia: A case report	ONCOLOGY LETTERS			English	Article						autosomal dominant polycystic kidney disease; erythropoietin; renal cell carcinoma; immunohistochemistry; polycythemia	HYPOXIA; HEMODIALYSIS; SITE	In patients undergoing chronic hemodialysis (HD), erythropoietin (EPO) production from the kidney generally decreases and renal anemia develops. Patients without anemia, but with high serum EPO (sEPO) levels are rare among HD patients. The current study presents the case of a 67-year-old female HD patient with autosomal dominant polycystic kidney disease (ADPKD) and renal cell carcinoma (RCC), manifesting polycythemia with elevated sEPO levels. A radical nephrectomy was performed, which diminished the polycythemia, but the sEPO levels remained high. To determine the origin of the EPO production, immunohistochemistry was performed to detect EPO in the RCC and the renal cysts of the surgically resected kidney. In addition, the sEPO and EPO levels in a renal cyst were determined by enzyme immunoassay. EPO expression was demonstrated in RCC and cyst epithelial cells using immunohistochemistry, revealing extremely high EPO levels in the cyst fluid. Due to the remission of polycythemia following the nephrectomy, EPO production from the resected kidney appeared to have been the cause of the polycythemia. Positive EPO staining of the renal cysts in the resected polycystic kidney and sustained sEPO elevation following nephrectomy led to the hypothesis of EPO production in the renal cysts of the contralateral polycystic kidney. Although the postoperative EPO level was higher than the normal range, the hematocrit (Hct) level gradually decreased and recombinant human EPO was required again three months following the nephrectomy. Eight months after the nephrectomy, the Hct level was 30.2% with the use of rHuEPO. In conclusion, EPO production from RCC and renal cysts in ADPKD appeared to cause polycythemia in the HD patient.	[Ito, Keiichi; Asano, Takako; Yoshii, Hidehiko; Sawazaki, Harutake; Asano, Tomohiko] Natl Def Med Coll, Dept Urol, Tokorozawa, Saitama 3598513, Japan; [Tominaga, Susumu] Natl Def Med Coll, Dept Pathol, Tokorozawa, Saitama 3598513, Japan	Ito, K (reprint author), Natl Def Med Coll, Dept Urol, 3-2 Namiki, Tokorozawa, Saitama 3598513, Japan.	itok@ndmc.ac.jp					LEVINE E, 1991, AM J ROENTGENOL, V156, P501; Semenza GL, 1999, ANNU REV CELL DEV BI, V15, P551, DOI 10.1146/annurev.cellbio.15.1.551; LACOMBE C, 1988, J CLIN INVEST, V81, P620, DOI 10.1172/JCI113363; Krieg M, 2000, ONCOGENE, V19, P5435, DOI 10.1038/sj.onc.1203938; Bunn HF, 1996, PHYSIOL REV, V76, P839; Wenger RH, 1997, BIOL CHEM, V378, P609; DASILVA JL, 1990, BLOOD, V75, P577; Yasuda Y, 2003, CARCINOGENESIS, V24, P1021, DOI 10.1093/carcin/bgg060; FERNANDEZ A, 1991, AM J NEPHROL, V11, P12, DOI 10.1159/000168265; Hama Y, 2005, BRIT J RADIOL, V78, P269, DOI 10.1259/bjr/28214940; Hanada T, 1998, Int J Urol, V5, P493, DOI 10.1111/j.1442-2042.1998.tb00397.x; HUGHSON MD, 1986, ARCH PATHOL LAB MED, V110, P592; Ito K, 2012, EXP THER MED, V3, P937, DOI 10.3892/etm.2012.513; JACOBS C, 1979, NEW ENGL J MED, V300, P1279; Leak B J, 2001, Urology, V57, P975, DOI 10.1016/S0090-4295(01)00910-4; LJUNGBERG B, 1992, EUR UROL, V21, P160; Ohi K, 1997, NIHON TOSEKI IGAKKAI, V30, P141; Ooki R, 1998, JIN TOUSEKI, V45, P709; Sakamoto S, 2003, INT J UROL, V10, P49, DOI 10.1046/j.1442-2042.2003.00568.x; SHALHOUB RJ, 1982, ANN INTERN MED, V97, P686; SHOHAT J, 1991, RENAL PHYSIOL BIOCH, V14, P103; Westenfelder C, 2000, KIDNEY INT, V58, P647, DOI 10.1046/j.1523-1755.2000.00211.x	22	0	0	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1792-1074	1792-1082		ONCOL LETT	Oncol. Lett.	NOV	2014	8	5					2032	2036		10.3892/ol.2014.2469		5	Oncology	Oncology	AS7GE	WOS:000344424300025		
J	Kim, H; Shoji, S; Tomonaga, T; Shima, M; Terachi, T; Uchida, T				Kim, Hakushi; Shoji, Sunao; Tomonaga, Tetsuro; Shima, Masanori; Terachi, Toshiro; Uchida, Toyoaki			Prostate cancer with cyst formation detected by whole body positron emission tomography/computed tomography: A case report	ONCOLOGY LETTERS			English	Article						prostate cancer; cyst formation; positron emission tomography/computed tomography		The present study reports a case of prostate adenocarcinoma with cyst formation. A 72-year-old male diagnosed with multiple lung metastases at a local clinic was referred to Tokai University Hachioji Hospital (Tokyo, Japan) for detection of a primary lesion. Whole body positron emission tomography/computed tomography showed strong accumulation of [F-18]-fluoro-deoxy-2-glucose (FDG) in the small pelvis, and pelvic magnetic resonance imaging revealed a 60x40-mm cystic lesion, with an irregular thickened wall, behind the prostate. The serum prostate-specific antigen (PSA) level was elevated to 211.99 ng/ml, therefore, the patient underwent a transperineal prostate needle biopsy, and was diagnosed with prostate adenocarcinoma with cyst formation. Androgen deprivation therapy was administered for 8 months following the diagnosis of prostate cancer; consequently, the cyst reduced in size and the serum PSA level decreased to 0.14 ng/ml. To the best of our knowledge, this is the first report of a malignant prostatic cyst detected by FDG-positron emission tomography/computed tomography.	[Kim, Hakushi; Shoji, Sunao; Tomonaga, Tetsuro; Shima, Masanori; Uchida, Toyoaki] Tokai Univ, Hachioji Hosp, Dept Urol, Hachioji, Tokyo 1920032, Japan; [Terachi, Toshiro] Tokai Univ, Dept Urol, Sch Med, Isehara, Kanagawa 2591193, Japan	Kim, H (reprint author), Tokai Univ, Hachioji Hosp, Dept Urol, 1838 Ishikawa Machi, Hachioji, Tokyo 1920032, Japan.	qblong888@gmail.com					Epstein JI, 2005, AM J SURG PATHOL, V29, P1228, DOI 10.1097/01.pas.0000173646.99337.b1; Minamimoto R, 2011, ANN NUCL MED, V25, P21, DOI 10.1007/s12149-010-0424-4; Chung HC, 2009, YONSEI MED J, V50, P174, DOI 10.3349/ymj.2009.50.1.174; Emmett JL, 1936, J UROLOGY, V36, P236; Han EJ, 2010, BRIT J RADIOL, V83, P915, DOI 10.1259/bjr/19887771; Hinev Alexander, 2012, Nephrourol Mon, V4, P644, DOI 10.5812/numonthly.4539; Itami Yoshitaka, 2012, Hinyokika Kiyo, V58, P349; Kim S C, 2001, Hinyokika Kiyo, V47, P653; Kojima K, 1996, Int J Urol, V3, P511, DOI 10.1111/j.1442-2042.1996.tb00588.x; Naoe M, 2004, INT J UROL, V11, P1036, DOI 10.1111/j.1442-2042.2004.00929.x; Niimi K, 2010, INT J CLIN ONCOL, V15, P93, DOI 10.1007/s10147-009-0004-6	11	1	1	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1792-1074	1792-1082		ONCOL LETT	Oncol. Lett.	NOV	2014	8	5					2037	2039		10.3892/ol.2014.2510		3	Oncology	Oncology	AS7GE	WOS:000344424300026		
J	Takagi, H; Azuma, K; Osaki, T; Itoh, N; Nakazumi, S; Taura, Y; Okamoto, Y				Takagi, Hidefumi; Azuma, Kazuo; Osaki, Tomohiro; Itoh, Norihiko; Nakazumi, Shinichi; Taura, Yasuho; Okamoto, Yoshiharu			High temperature hyperthermia treatment for canines exhibiting superficial tumors: A report of three cases	ONCOLOGY LETTERS			English	Article						high temperature hyperthermia; canine; spontaneous tumors	THERMAL ABLATION; ANTITUMOR IMMUNITY; MELANOMA; CANCER; RADIOTHERAPY; RESPONSES; ONCOLOGY; THERAPY; FUTURE	High temperature hyperthermia (HTH) treatment has previously been demonstrated to suppress tumor growth in a tumor-bearing rat model. In the present study, the effects of HTH therapy for the treatment of spontaneous tumors in canines was evaluated. In case 1, an 18-year-old female Papillon presented with a right forelimb rhabdomyosarcoma. Case 2 was a 13-year-old male English Cocker Spaniel with a right external auditory canal ceruminous adenocarcinoma and case 3 was a 14-year-old male Golden Retriever that exhibited a perianal gland adenocarcinoma, which surrounded the anus. HTH treatment was performed in all three cases for 10 min at 45-65 degrees C with or without the inhalation of isoflurane. In case 1, the tumor disappeared four weeks following HTH treatment. In case 2, the tumor volume had decreased by day 21, and in case 3, HTH was performed three times and the tumor disappeared following the third procedure. HTH is considered to be a simple procedure with no severe side effects. Consequently, this treatment modality is hypothesized to become a useful alternative therapy for superficial tumors in companion animals.	[Takagi, Hidefumi; Taura, Yasuho] Yamaguchi Univ, United Grad Sch Vet Sci, Dept Vet Clin Sci, Yamaguchi 7538515, Japan; [Takagi, Hidefumi] Takagi Anim Clin, Saijo, Ehime 7930035, Japan; [Azuma, Kazuo; Osaki, Tomohiro; Itoh, Norihiko; Okamoto, Yoshiharu] Tottori Univ, Sch Vet Med, Dept Vet Clin Sci, Fac Agr, Tottori 6808533, Japan; [Nakazumi, Shinichi] AdMeTech Co Ltd, Matsuyama, Ehime 7900054, Japan	Okamoto, Y (reprint author), Tottori Univ, Sch Vet Med, Dept Vet Clin Med, Fac Agr, 4-101 Koyama Minami, Tottori 6808533, Japan.	yokamoto@muses.tottori-u.ac.jp					Moroz P, 2002, INT J HYPERTHER, V18, P267, DOI 10.1080/02656730110108785; Baronzio G, 2006, IN VIVO, V20, P689; Wust P, 2002, LANCET ONCOL, V3, P487, DOI 10.1016/S1470-2045(02)00818-5; Zhang HG, 2008, CANCER LETT, V271, P191, DOI 10.1016/j.canlet.2008.05.026; Falk MH, 2001, INT J HYPERTHER, V17, P1, DOI 10.1080/02656730150201552; Mukhopadhaya A, 2007, CANCER RES, V67, P7798, DOI 10.1158/0008-5472.CAN-07-0203; Ito A, 2007, CANCER SCI, V98, P424, DOI 10.1111/j.1349-7006.2006.00382.x; Diederich CJ, 2005, INT J HYPERTHER, V21, P745, DOI 10.1080/02656730500271692; Roti JLR, 2008, INT J HYPERTHER, V24, P3, DOI 10.1080/02656730701769841; Zerbini A, 2006, CANCER RES, V66, P1139, DOI 10.1158/0008-5472.CAN-05-2244; Soares PIP, 2012, RECENT PAT ANTI-CANC, V7, P64; den Brok MHMGM, 2004, CANCER RES, V64, P4024, DOI 10.1158/0008-5472.CAN-03-3949; Haen SP, 2011, CLIN DEV IMMUNOL, DOI 10.1155/2011/160250; Baisi A, 2013, EUR J CARDIO-THORAC, V43, P683, DOI 10.1093/ejcts/ezs558; BREWER WG, 1982, J AM VET MED ASSOC, V181, P146; Gillette E L, 1982, Natl Cancer Inst Monogr, V61, P361; GRIER RL, 1980, J AM VET MED ASSOC, V177, P227; PAGE RL, 1990, VET CLIN N AM-SMALL, V20, P1075; Pennacchioli E, 2009, EXPERT REV ANTICANC, V9, P199, DOI 10.1586/14737140.9.2.199; Ross MI, 2008, INT J HYPERTHER, V24, P205, DOI 10.1080/02656730801944930; Stojkovic R, 2002, INT J HYPERTHER, V18, P62, DOI 10.1080/02656730110088373; Takagi H, 2014, ONCOL LETT, V7, P1007, DOI 10.3892/ol.2014.1852; Wiggermann P, 2012, MED SCI MONITOR, V18, pCR88	23	0	0	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1792-1074	1792-1082		ONCOL LETT	Oncol. Lett.	NOV	2014	8	5					2055	2058		10.3892/ol.2014.2496		4	Oncology	Oncology	AS7GE	WOS:000344424300030		
J	Akiba, J; Kawahara, A; Abe, H; Azuma, K; Yamaguchi, T; Taira, T; Fukumitsu, C; Takase, Y; Yasumoto, M; Umeno, Y; Todoroki, K; Kurita, T; Yamaguchi, R; Kage, M; Yano, H				Akiba, Jun; Kawahara, Akihiko; Abe, Hideyuki; Azuma, Koichi; Yamaguchi, Tomohiko; Taira, Tomoki; Fukumitsu, Chihiro; Takase, Yorihiko; Yasumoto, Makiko; Umeno, Yumi; Todoroki, Keita; Kurita, Takashi; Yamaguchi, Rin; Kage, Masayoshi; Yano, Hirohisa			Evaluation of immunohistochemistry using two different antibodies and procedures for primary lung adenocarcinoma harboring anaplastic lymphoma kinase rearrangement	ONCOLOGY LETTERS			English	Article						lung cancer; adenocarcinoma; anaplastic lymphoma kinase; fluorescence in situ hybridization; immunohistochemistry	EML4-ALK FUSION GENE; ALK REARRANGEMENT; BREAST-CANCER; GEFITINIB; IDENTIFICATION; CARCINOMAS; MUTATIONS; FEATURES; TRIAL; EGFR	Rearrangements of anaplastic lymphoma kinase (ALK) have been recently identified in non-small cell lung carcinomas. Previous studies have revealed characteristic features, including adenocarcinoma histology and mucin production, in ALK-positive lung carcinoma. The present study evaluated immunohistochemistry (IHC) in ALK-positive lung carcinoma using two different antibodies, clone 5A4 and D5F3, and compared the results. On the basis of the aforementioned characteristic features, out of 359 primary lung carcinomas, the ALK status of 14 adenocarcinomas was screened using the intercalated antibody-enhanced polymer (iAEP) method with antibody 5A4, and this was compared with the ALK status obtained using rabbit monoclonal antibody D5F3 and fluorescence in situ hybridization for ALK. Eight cases were demonstrated to be ALK-positive by IHC. Seven cases exhibited ALK rearrangement, which was demonstrated by fluorescence in situ hybridization. The IHC for ALK obtained using D5F3 was comparable with that of the iAEP and exhibited low heterogeneity. This finding suggests that IHC for ALK could be useful in limited tissue samples, such as biopsy specimens or cytology, for the screening of ALK-positive lung carcinoma. In the present study, it was demonstrated that IHC with ALK monoclonal antibody D5F3 was useful for screening lung adenocarcinoma harboring ALK rearrangement.	[Akiba, Jun; Yasumoto, Makiko; Umeno, Yumi; Todoroki, Keita; Kurita, Takashi; Yamaguchi, Rin; Yano, Hirohisa] Kurume Univ, Dept Pathol, Sch Med, Div Respirol Neurol & Rheumatol, Kurume, Fukuoka 8300011, Japan; [Kawahara, Akihiko; Abe, Hideyuki; Yamaguchi, Tomohiko; Taira, Tomoki; Fukumitsu, Chihiro; Takase, Yorihiko; Kage, Masayoshi] Kurume Univ Hosp, Dept Diagnost Pathol, Kurume, Fukuoka 8300011, Japan; [Azuma, Koichi] Kurume Univ, Dept Internal Med, Sch Med, Div Respirol Neurol & Rheumatol, Kurume, Fukuoka 8300011, Japan	Akiba, J (reprint author), Kurume Univ, Dept Pathol, Sch Med, 67 Asahi Machi, Kurume, Fukuoka 8300011, Japan.	akiba@med.kurume-u.ac.jp					Allred DC, 2000, AM J CLIN PATHOL, V113, P171, DOI 10.1309/9X6X-1EL6-5QB1-YLD2; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74; Rodig SJ, 2009, CLIN CANCER RES, V15, P5216, DOI 10.1158/1078-0432.CCR-09-0802; Pao W, 2004, P NATL ACAD SCI USA, V101, P13306, DOI 10.1073/pnas.0405220101; Christensen JG, 2007, MOL CANCER THER, V6, P3314, DOI 10.1158/1535-7163.MCT-07-0365; Takeuchi K, 2009, CLIN CANCER RES, V15, P3143, DOI 10.1158/1078-0432.CCR-08-3248; Soda M, 2007, NATURE, V448, P561, DOI 10.1038/nature05945; Shaw AT, 2009, J CLIN ONCOL, V27, P4247, DOI 10.1200/JCO.2009.22.6993; Travis WD, 2011, J THORAC ONCOL, V6, P244, DOI 10.1097/JTO.0b013e318206a221; Yoshida A, 2011, AM J SURG PATHOL, V35, P1226, DOI 10.1097/PAS.0b013e3182233e06; Park HS, 2012, LUNG CANCER, V77, P288, DOI 10.1016/j.lungcan.2012.03.004; Lindeman NI, 2013, ARCH PATHOL LAB MED, V137, P828, DOI 10.5858/arpa.2012-0720-OA; Vance GH, 2009, ARCH PATHOL LAB MED, V133, P611, DOI 10.1043/1543-2165-133.4.611; Roche PC, 2002, J NATL CANCER I, V94, P855; Fukuoka M, 2003, J CLIN ONCOL, V21, P2237, DOI 10.1200/JCO.2003.10.038; Wong DWS, 2009, CANCER, V115, P1723, DOI 10.1002/cncr.24181; Mino-Kenudson M, 2010, CLIN CANCER RES, V16, P1561, DOI 10.1158/1078-0432.CCR-09-2845; Elkin EB, 2004, J CLIN ONCOL, V22, P854, DOI 10.1200/JCO.2004.04.158; Yi ES, 2011, J THORAC ONCOL, V6, P459, DOI 10.1097/JTO.0b013e318209edb9; Azzoli CG, 2009, J CLIN ONCOL, V27, P6251, DOI 10.1200/JCO.2009.23.5622; Takahashi T, 2010, ANN SURG ONCOL, V17, P889, DOI 10.1245/s10434-009-0808-7; Conklin CMJ, 2013, J THORAC ONCOL, V8, P45, DOI 10.1097/JTO.0b013e318274a83e; Selinger CI, 2013, MODERN PATHOL, V26, P1545, DOI 10.1038/modpathol.2013.87; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; Baselga E, 2005, PEDIATR DERMATOL, V22, P213, DOI 10.1111/j.1525-1470.2005.22307.x; FDA, FDA SUMM SAF EFF DAT; Gouvea AP, 2006, APPL IMMUNOHISTO M M, V14, P103, DOI 10.1097/01.pai.0000155794.64525.11; Kawahara A, 2014, DIAGN CYTOPATHOL, V42, P460, DOI 10.1002/dc.22936; Kwak EL, 2010, NEW ENGL J MED, V363, P1693, DOI 10.1056/NEJMoa1006448; Li Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069016; Takamochi K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069794	31	2	2	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1792-1074	1792-1082		ONCOL LETT	Oncol. Lett.	NOV	2014	8	5					2155	2159		10.3892/ol.2014.2511		5	Oncology	Oncology	AS7GE	WOS:000344424300049		
J	Sekihara, K; Okuma, Y; Kawamoto, H; Hosomi, Y				Sekihara, Kuniko; Okuma, Yusuke; Kawamoto, Hiroshi; Hosomi, Yukio			Clinical outcome of thymic lymphoepithelioma-like carcinoma: Case report of a 14-year-old male	ONCOLOGY LETTERS			English	Article						thymic carcinoma; thymoma; lymphoepithelioma-like carcinoma; chemotherapy; Epstein-Barr virus infection	HYPERTROPHIC PULMONARY OSTEOARTHROPATHY; MALIGNANT THYMOMA; CHEMOTHERAPY; BOY; EXPRESSION; ONCOLOGY; CHILDREN; TUMORS	Thymic carcinoma is a rare type of cancer, which arises from the thymic epithelium and accounts for similar to 1-4% of anterior mediastinal tumors in the USA. It rarely occurs in children, and is rarer among adults. Thymic lymphoepithelioma-like carcinoma (LELC) is an uncommon subtype of thymic carcinoma in children, however, it is one of the common histological subtypes of thymic carcinoma in adults. In the present study, a 14-year-old male patient presented to the Tokyo Metropolitan Cancer and Infectious diseases Center, Komagome Hospital (Tokoyo, Japan) with chest pain due to a large anterior mediastinal mass. The patient was histologically diagnosed with thymic LELC via a needle biopsy specimen, which was obtained from the primary site and indicated the Epstein-Barr virus infection, whose markers are also associated with oncogenesis. Immunohistochemical analysis demonstrated positive staining for keratin (AE1/AE3), epithelial membrane antigen, and latent membrane protein-1 and negative staining for cluster of differentiation 5. Thus, the patient was diagnosed with metastatic thymic LELC. First-line chemotherapy comprising of a cisplatin- and adriamycin-based chemotherapy regimen achieved a partial response, however, the patient succumbed within 10 months of the initial diagnosis due to rapid disease progression and refractory to subsequent cycles of chemotherapy. Thus, the current study, as well as previously reported cases, demonstrates that pediatric patients with thymic LELC continue to have a poor prognosis.	[Sekihara, Kuniko; Okuma, Yusuke; Hosomi, Yukio] Komagome Hosp, Tokyo Metropolitan Canc & Infect Dis Ctr, Dept Thorac Oncol & Resp Med, Tokyo 1138677, Japan; [Sekihara, Kuniko] Natl Canc Ctr, Div Thorac Oncol, Tokyo 1040045, Japan; [Kawamoto, Hiroshi] Natl Canc Ctr, Dept Pediat, Tokyo 1040045, Japan	Okuma, Y (reprint author), Komagome Hosp, Tokyo Metropolitan Canc & Infect Dis Ctr, Dept Thorac Oncol & Resp Med, Bunkyo Ku, 3-18-22 Honkomagome, Tokyo 1138677, Japan.	y-okuma@cick.jp					Kunitoh H, 2009, BRIT J CANCER, V101, P1549, DOI 10.1038/sj.bjc.6605347; Agatsuma T, 2011, J THORAC ONCOL, V6, P2130, DOI 10.1097/JTO.0b013e31822e71c0; Yaris N, 2006, PEDIATR BLOOD CANCER, V47, P224, DOI 10.1002/pbc.20468; Okuma Y, 2010, LUNG CANCER, V70, P357, DOI 10.1016/j.lungcan.2010.09.004; Chen FF, 1998, CANCER, V82, P2334; Okuma Y, 2013, LUNG CANCER, V80, P75, DOI 10.1016/j.lungcan.2012.12.012; Engels EA, 2003, INT J CANCER, V105, P546, DOI 10.1002/ijc.11099; Ettinger DS, 2013, J NATL COMPR CANC NE, V11, P562; Eisenhauer EA, 2009, EUR J CANCER, V45, P228, DOI 10.1016/j.ejca.2008.10.026; WICK MR, 1982, MAYO CLIN PROC, V57, P653; Chalabreysse L, 2004, HISTOPATHOLOGY, V44, P367, DOI 10.1111/j.1365-2559.2004.01796.x; Di Cataldo A, 2000, PEDIATR HEMAT ONCOL, V17, P701; FUJII T, 1993, ACTA PATHOL JAPON, V43, P107; Hsueh C, 2006, J PEDIAT HEMATOL ONC, V28, P785, DOI 10.1097/MPH.0b013e31802d3a83; ILHAN I, 1994, MED PEDIATR ONCOL, V23, P140, DOI 10.1002/mpo.2950230214; Kilis-Pstrusinska K, 2008, PEDIATR NEPHROL, V23, P1001, DOI 10.1007/s00467-007-0666-0; Komatsu Y, 2006, ANTICANCER RES, V26, P4851; MARINO M, 1985, VIRCHOWS ARCH A, V407, P119, DOI 10.1007/BF00737071; Masaoka A, 2010, J THORAC ONCOL, V5, pS304, DOI 10.1097/JTO.0b013e3181f20c05; Niehues T, 1996, MED PEDIATR ONCOL, V26, P419, DOI 10.1002/(SICI)1096-911X(199606)26:6<419::AID-MPO10>3.0.CO;2-6; Rosai J, 1999, WHO INT HISTOLOGICAL, P5; SHIMOSATO Y, 1977, AM J SURG PATHOL, V1, P109, DOI 10.1097/00000478-197706000-00002; Stephan JL, 2000, J PEDIAT HEMATOL ONC, V22, P162, DOI 10.1097/00043426-200003000-00016; Tacyildiz N, 2007, PEDIATR HEMAT ONCOL, V24, P301, DOI 10.1080/08880010701440882; Travis WD, 2004, WHO CLASSIFICATION T, P145; WU TC, 1993, HUM PATHOL, V24, P235, DOI 10.1016/0046-8177(93)90031-B	26	0	0	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1792-1074	1792-1082		ONCOL LETT	Oncol. Lett.	NOV	2014	8	5					2183	2186		10.3892/ol.2014.2475		4	Oncology	Oncology	AS7GE	WOS:000344424300055		
J	Furubayashi, N; Negishi, T; Hirata, Y; Taguchi, K; Shimokawa, M; Nakamura, M				Furubayashi, Nobuki; Negishi, Takahito; Hirata, Yu; Taguchi, Kenichi; Shimokawa, Mototsugu; Nakamura, Motonobu			Positive resection margins may not reflect the true margin in patients undergoing radical prostatectomy	ONCOLOGY LETTERS			English	Article						prostate cancer; surgical margin; radical prostatectomy; ultrasensitive prostate-specific antigen; prostate-specific antigen nadir	ISUP CONSENSUS CONFERENCE; INTERNATIONAL-SOCIETY; SURGICAL MARGINS; ANTIGEN; CANCER; TUMOR; GENE; PROGRESSION; RECURRENCE; EXPRESSION	The aim of the present study was to evaluate the hypothesis that a positive resection margin (RM1) of an excised specimen may not reflect the true margin in patients that have undergone radical prostatectomy (RP). Between September 2003 and March 2011, 370 Japanese patients underwent an antegrade RP at the National Kyushu Cancer Center (Fukuoka, Japan), however, 95 of these patients were excluded from the study due to a history of receiving hormonal therapy or insufficient preoperative clinical data. The incidence of biochemical failure (BCF) was evaluated using multivariate analysis, which revealed that the preoperative prostate-specific antigen (PSA) level, pathological tumor stage, RP Gleason score and a PSA nadir <0.008 ng/ml were significant predictors (P=0.0065, 0.0006, 0.0002 and <0.0001, respectively). By contrast, an RM1 was not found to be a significant predictor of BCF, while the parameter with the highest hazard ratio (HR) was a PSA nadir <0.008 ng/ml (HR, 10.055; 95% confidence interval, 5.005-20.200). From the 56 cases that were RM1,41 cases (73.2%) exhibited a PSA nadir <0.008 ng/ml. There were 42 cases (75.0%) in which only one site was identified to be RM1; among these cases, no significant difference was observed between a PSA level <0.008 ng/ml and a PSA level >= 0.008 ng/ml at the RM1 site (apex, P=0.1460; base, P=0.1384; anterior, P=0.3870; and posterolateral, P=0.5040). There were 14 cases (25.0%) in which multiple sites were RM1; these cases were classified by the number of sites that were RM1 (one vs. multiple) and no significant difference was observed between a PSA level <0.008 ng/ml and a PSA level >= 0.008 ng/ml (P=0.6090). Based on these results, an RM1 of an excised specimen may not reflect the true Margin in patients that are treated with RP, specifically in cases where the PSA level is identified to decrease to below the postoperative measurement threshold value (PSA nadir <0.008 ng/ml).	[Furubayashi, Nobuki; Negishi, Takahito; Hirata, Yu; Nakamura, Motonobu] Kyushu Natl Canc Ctr, Dept Urol, Fukuoka 8111395, Japan; [Taguchi, Kenichi] Kyushu Natl Canc Ctr, Dept Pathol, Fukuoka 8111395, Japan; [Shimokawa, Mototsugu] Kyushu Natl Canc Ctr, Inst Clin Res, Fukuoka 8111395, Japan	Furubayashi, N (reprint author), Kyushu Natl Canc Ctr, Dept Urol, Minami Ku, Notame 3-1-1, Fukuoka 8111395, Japan.	furubayashi.n@nk-cc.go.jp					Epstein JI, 2005, AM J SURG PATHOL, V29, P1228, DOI 10.1097/01.pas.0000173646.99337.b1; Arora R, 2004, CANCER, V100, P2362, DOI 10.1002/cncr.20243; LEVESQUE M, 1995, J CLIN LAB ANAL, V9, P123, DOI 10.1002/jcla.1860090209; Tan PH, 2011, MODERN PATHOL, V24, P48, DOI 10.1038/modpathol.2010.155; STAMEY TA, 1989, J UROLOGY, V141, P1076; [Anonymous], 2005, SCAND J UROL NEPHR S, DOI DOI 10.1080/03008880510030932; Khalifeh A, 2013, J UROLOGY, V190, P1674, DOI 10.1016/j.juro.2013.05.110; YU H, 1995, CANCER RES, V55, P1603; Diamandis EP, 2000, TRENDS ENDOCRIN MET, V11, P54, DOI 10.1016/S1043-2760(99)00225-8; Blute ML, 2001, J UROLOGY, V165, P119, DOI 10.1097/00005392-200101000-00030; Ellis WJ, 1997, UROLOGY, V50, P573, DOI 10.1016/S0090-4295(97)00251-3; EPSTEIN JI, 1993, CANCER, V71, P3582, DOI 10.1002/1097-0142(19930601)71:11<3582::AID-CNCR2820711120>3.0.CO;2-Y; European Association of Urology, GUIDELINES PROSTATE; Freedland SJ, 2003, J UROLOGY, V169, P2136, DOI 10.1097/01.ju.0000065588.82511.06; Gretzer MB, 2002, UROLOGY, V60, P1034, DOI 10.1016/S0090-4295(02)01997-0; Kinoshita H, 2007, INT J UROL, V14, P930, DOI 10.1111/j.1442-2042.2007.01858.x; LEVESQUE M, 1995, J CLIN LAB ANAL, V9, P375, DOI 10.1002/jcla.1860090607; MONNE M, 1994, CANCER RES, V54, P6344; OESTERLING JE, 1988, J UROLOGY, V139, P766; PARTIN AW, 1990, J UROLOGY, V143, P747; Schmidt H, 2006, CANCER RES, V66, P8959, DOI 10.1158/0008-5472.CAN-06-1722; Sobin Leslie H, 2009, TNM CLASSIFICATION M; Wein AJ, 2011, CAMPBELL WALSH UROLO, P2748; YU H, 1995, CLIN CHEM, V41, P54; YU H, 1994, J CLIN LAB ANAL, V8, P251, DOI 10.1002/jcla.1860080412; YU H, 1995, CLIN CHEM, V41, P430	26	0	0	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1792-1074	1792-1082		ONCOL LETT	Oncol. Lett.	NOV	2014	8	5					2237	2242		10.3892/ol.2014.2491		6	Oncology	Oncology	AS7GE	WOS:000344424300065		
J	An, JL; Ji, QH; An, JJ; Masuda, S; Tsuneyama, K				An, Jun-Ling; Ji, Qiao-Hong; An, Ji-Jiang; Masuda, Shinji; Tsuneyama, Koichi			Clinicopathological analysis of CD8-positive lymphocytes in the tumor parenchyma and stroma of hepatocellular carcinoma	ONCOLOGY LETTERS			English	Article						hepatocellular carcinoma; tumor parenchyma; tumor stroma; CD4 T cells; CD8 T cells	INTERMITTENT MICROWAVE IRRADIATION; T-CELLS; OVARIAN-CANCER; IMMUNE-SYSTEM; RISK-FACTORS; PROGNOSIS; SURVIVAL; MICROENVIRONMENT; INFILTRATION; HEPATITIS	Tumor-infiltrating lymphocytes may be a manifestation of antitumor immunity. In the present study, hepatocellular carcinoma (HCC) and pericancerous non-tumor liver tissues samples were obtained from 86 surgical patients who had not received preoperative treatment. The cellular expression levels of CD4 and CD8 were immunohistochemically examined in the two tissue groups using tissue microarrays, to evaluate their clinicopathological relevance. Immunohistochemically, CD4 and CD8 T cells were observed in the tumor parenchyma and tumor stroma, and the intensity of CD4 and CD8 immunoreactivity was homogeneous in all HCC samples examined. Morphometrically, the average numbers of CD4- and CD8-positive T cells were significantly increased in the tumor stroma, compared with those in the tumor parenchyma (tumor stroma versus tumor parenchyma: 22 +/- 3.6 versus 7.4 +/- 0.9 in CD4, 32.8 +/- 4.2 versus 16 +/- 2.5 in CD8; both P<0.01). Furthermore, the average numbers of CD8-positive T cells in the tumor parenchyma and stroma were significantly increased, compared with the average numbers of CD4-positive cells (P<0.05). In addition, in the tumor parenchyma and stroma, the average numbers of CD8 T cells were significantly higher in patients with tumor diameters <= 5 cm compared with those in patients with tumor diameters 5 cm (diameter <= 5 cm versus diameter >5 cm: 18.1 +/- 3.3 versus 12.2 +/- 3.8 in tumor parenchyma, 36.5 +/- 4.8 versus 21.9 +/- 8.9 in tumor stroma; both P<0.05). In addition, CD8 expression was significantly enhanced in patients with chronic hepatitis and cirrhosis, Furthermore, a significant positive correlation was observed between CD4 and CD8 expression in the tumor parenchyma and stroma (both P<0.001). These observations suggest that tumor parenchyma- or stroma-infiltrating CD8 T cells may be involved in HCC tumor diameter control.	[An, Jun-Ling; Ji, Qiao-Hong] Henan Univ Sci & Technol, Dept Pathol & Pathophysiol, Coll Med, Luoyang 471003, Henan, Peoples R China; [An, Ji-Jiang] Songxian Peoples Hosp, Emergency Dept, Luoyang 471400, Henan, Peoples R China; [Masuda, Shinji] Koseiren Takaoka Hosp, Dept Diagnost Pathol, Toyama 9330335, Japan; [Tsuneyama, Koichi] Toyama Univ, Grad Sch Med & Pharmaceut Sci, Dept Diagnost Pathol, Toyama 9300194, Japan	Tsuneyama, K (reprint author), Toyama Univ, Grad Sch Med & Pharmaceut Sci, Dept Diagnost Pathol, 2630 Sugitani, Toyama 9300194, Japan.	ktsune@med.u-toyama.ac.jp					Kononen J, 1998, NAT MED, V4, P844, DOI 10.1038/nm0798-844; Dieu-Nosjean MC, 2008, J CLIN ONCOL, V26, P4410, DOI 10.1200/JCO.2007.15.0284; Blankenstein T, 2005, CURR OPIN IMMUNOL, V17, P180, DOI 10.1016/j.coi.2005.01.008; Kremsdorf D, 2006, ONCOGENE, V25, P3823, DOI 10.1038/sj.onc.1209559; Chew V, 2010, J HEPATOL, V52, P370, DOI 10.1016/j.jhep.2009.07.013; Wada Y, 1998, HEPATOLOGY, V27, P407, DOI 10.1002/hep.510270214; Galon J, 2006, SCIENCE, V313, P1960, DOI 10.1126/science.1129139; Levy I, 2002, GUT, V50, P881, DOI 10.1136/gut.50.6.881; Zhang B, 2008, CANCER RES, V68, P1563, DOI 10.1158/0008-5472.CAN-07-5324; Hatta H, 2006, PATHOL RES PRACT, V202, P439, DOI 10.1016/j.prp.2006.02.003; EDMONDSON HA, 1954, CANCER, V7, P462, DOI 10.1002/1097-0142(195405)7:3<462::AID-CNCR2820070308>3.0.CO;2-E; [Anonymous], 1989, JPN J SURG, V19, P98; Balkwill F, 2001, LANCET, V357, P539, DOI 10.1016/S0140-6736(00)04046-0; Sato E, 2005, P NATL ACAD SCI USA, V102, P18538, DOI 10.1073/pnas.0509182102; Finak G, 2008, NAT MED, V14, P518, DOI 10.1038/nm1764; Kobayashi N, 2007, CLIN CANCER RES, V13, P902, DOI 10.1158/1078-0432.CCR-06-2363; Lu XY, 2011, J CANCER RES CLIN, V137, P567, DOI 10.1007/s00432-010-0909-5; Liotta LA, 2001, NATURE, V411, P375, DOI 10.1038/35077241; Gao Q, 2007, J CLIN ONCOL, V25, P2586, DOI 10.1200/JCO.2006.09.4565; ISHAK K, 1995, J HEPATOL, V22, P696, DOI 10.1016/0168-8278(95)80226-6; Zhang L, 2003, NEW ENGL J MED, V348, P203, DOI 10.1056/NEJMoa020177; de Visser KE, 2006, NAT REV CANCER, V6, P24, DOI 10.1038/nrc1782; Schutte K, 2009, DIGEST DIS, V27, P80, DOI 10.1159/000218339; TOBE T, 1994, CANCER, V74, P2772, DOI 10.1002/1097-0142(19941115)74:10<2772::AID-CNCR2820741006>3.0.CO;2-V; Naugler WE, 2007, SCIENCE, V317, P121, DOI 10.1126/science.1140485; Connolly JL, 2000, HOLLAND FREI CANC ME, P384; Fattovich G, 2006, J HEPATOL, V44, P1013, DOI 10.1016/j.jhep.2006.04.001; Kashef E, 2001, SEMIN ONCOL, V28, P497, DOI 10.1053/sonc.2001.26952; Kumada T, 2004, MODERN PATHOL, V17, P1141, DOI 10.1038/modpathol.3800165; Naknmoto Y, 1998, J EXP MED, V188, P341; Parmiani G, 2006, J HEPATOL, V45, P178, DOI 10.1016/j.jhep.2006.06.005; SINGH S, 1992, J EXP MED, V175, P139, DOI 10.1084/jem.175.1.139; Spiotto Michael T, 2005, Cancer Immun, V5, P8; Zerbini A, 2004, J HEPATOL, V40, P102, DOI 10.1016/S0168-8278(03)00484-7	34	0	1	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1792-1074	1792-1082		ONCOL LETT	Oncol. Lett.	NOV	2014	8	5					2284	2290		10.3892/ol.2014.2516		7	Oncology	Oncology	AS7GE	WOS:000344424300073		
J	Yamamoto, H; Miyoshi, N; Mimori, K; Hitora, T; Tokuoka, M; Fujino, S; Ellis, HL; Ishii, H; Noura, S; Ohue, M; Yano, M; Doki, Y; Mori, M				Yamamoto, Hirofumi; Miyoshi, Norikatsu; Mimori, Koshi; Hitora, Toshiki; Tokuoka, Masayoshi; Fujino, Shiki; Ellis, Haley L.; Ishii, Hideshi; Noura, Shingo; Ohue, Masayuki; Yano, Masahiko; Doki, Yuichiro; Mori, Masaki			MACC1 expression levels as a novel prognostic marker for colorectal cancer	ONCOLOGY LETTERS			English	Article						metastasis-associated in colon cancer-1; prognosis; colorectal cancer	COLON-CANCER; RANDOMIZED-TRIAL; OPEN COLECTOMY; ASSISTED COLECTOMY; METASTASIS; MET; CLASSIFICATION; LEUCOVORIN; CARCINOMA; TARGET	Metastasis-associated in colon cancer-1 (MACC1) is key in promoting tumor proliferation and invasion, and is mediated by the hepatocyte growth factor (HGF) and mesenchymal-epithelial transition factor. Previous reports have revealed,,that MACC1 is a novel oncogene that is expressed in various types of gastrointestinal cancer. The present study comprised of 174 patients who underwent curative surgery for colorectal cancer (CRC). The correlation between gene expression and clinical parameters of the patients was assessed. It was identified that patients exhibiting high MACC1 expression levels were statistically more susceptible to distant metastases and a poor prognosis, and those exhibiting low MACC1 expression showed improved disease-free and overall survival than those with high expression. Therefore, the present data indicates that MACC1 expression levels may present as a prognostic factor in CRC patients.	[Yamamoto, Hirofumi; Doki, Yuichiro; Mori, Masaki] Osaka Univ, Grad Sch Med, Dept Surg Gastroenterol, Suita, Osaka 5650871, Japan; [Miyoshi, Norikatsu; Fujino, Shiki; Noura, Shingo; Ohue, Masayuki; Yano, Masahiko] Osaka Med Ctr Canc & Cardiovasc Dis, Dept Surg, Osaka 5378511, Japan; [Mimori, Koshi] Kyushu Univ, Dept Mol & Cellular Biol, Div Mol & Surg Oncol, Med Inst Bioregulat, Beppu, Osaka 8740838, Japan; [Hitora, Toshiki] Osaka Rosai Hosp, Dept Surg, Sakai, Osaka 5918025, Japan; [Tokuoka, Masayoshi] Yao Municipal Hosp, Dept Surg, Yao, Osaka 5810069, Japan; [Ellis, Haley L.] Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, New York, NY 10065 USA; [Ishii, Hideshi] Osaka Univ, Dept Frontier Sci Canc & Chemotherapy, Suita, Osaka 5650871, Japan	Miyoshi, N (reprint author), Osaka Med Ctr Canc & Cardiovasc Dis, Dept Surg, Higashinari Ku, 1-3-3 Nakamichi, Osaka 5378511, Japan.	miyosi-no@mc.pref.osaka.jp					Andre T, 2007, J CLIN ONCOL, V25, P3732, DOI 10.1200/JCO.2007.12.2234; Potempa S, 1998, MOL BIOL CELL, V9, P2185; Birchmeier C, 2003, NAT REV MOL CELL BIO, V4, P915, DOI 10.1038/nrm1261; Stein Ulrike, 2007, V176, P61; Stein U, 2013, EXPERT OPIN THER TAR, V17, P1039, DOI 10.1517/14728222.2013.815727; Jemal A, 2010, CA-CANCER J CLIN, V60, P277, DOI [10.3322/caac.20073, 10.1002/caac.20073]; Watanabe T, 2012, INT J CLIN ONCOL, V17, P1, DOI 10.1007/s10147-011-0315-2; Kornmann M, 2008, EJSO-EUR J SURG ONC, V34, P1316, DOI 10.1016/j.ejso.2008.01.019; Stein U, 2009, NAT MED, V15, P59, DOI 10.1038/nm.1889; Hodgson G, 2001, NAT GENET, V29, P459, DOI 10.1038/ng771; Mazzone M, 2006, FASEB J, V20, P1611, DOI 10.1096/fj.06-5947rev; Lacy AM, 2002, LANCET, V359, P2224, DOI 10.1016/S0140-6736(02)09290-5; Jayne DG, 2007, J CLIN ONCOL, V25, P3061, DOI 10.1200/JCO.2006.09.7758; Juneja M, 2013, MOL ONCOL, V7, P929, DOI 10.1016/j.molonc.2013.05.003; Hansen WJ, 1999, J CELL BIOL, V145, P265, DOI 10.1083/jcb.145.2.265; Wolpin BM, 2008, GASTROENTEROLOGY, V134, P1296, DOI 10.1053/j.gastro.2008.02.098; Sadanandam A, 2013, NAT MED, V19, P619, DOI 10.1038/nm.3175; Weeks JC, 2002, JAMA-J AM MED ASSOC, V287, P321, DOI 10.1001/jama.287.3.321; Bathe OF, 2004, BMC CANCER, V4, DOI 10.1186/1471-2407-4-32; Iijima M, 1996, ACTA MED OKAYAMA, V50, P73; Koshariya M, 2007, HEPATO-GASTROENTEROL, V54, P2232; Mimori K, 1997, BRIT J CANCER, V76, P531, DOI 10.1038/bjc.1997.420; MORI M, 1993, GASTROENTEROLOGY, V105, P820; Nelson H, 2004, NEW ENGL J MED, V350, P2050; Sattler Martin, 2007, Curr Oncol Rep, V9, P102, DOI 10.1007/s11912-007-0005-4; Sobin LH, 1997, CANCER, V80, P1803, DOI 10.1002/(SICI)1097-0142(19971101)80:9<1803::AID-CNCR16>3.0.CO;2-9; Zhang Y, 2012, MOL CANCER, V11, DOI 10.1186/1476-4598-11-23	27	1	2	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1792-1074	1792-1082		ONCOL LETT	Oncol. Lett.	NOV	2014	8	5					2305	2309		10.3892/ol.2014.2460		5	Oncology	Oncology	AS7GE	WOS:000344424300076		
J	Kurishima, K; Satoh, H; Kagohashi, K; Miyazaki, K; Tamura, T; Shiozawa, T; Ohara, G; Kawaguchi, M; Takayashiki, N; Hizawa, N				Kurishima, Koichi; Satoh, Hiroaki; Kagohashi, Katsunori; Miyazaki, Kunihiko; Tamura, Tomohiro; Shiozawa, Toshihiro; Ohara, Gen; Kawaguchi, Mio; Takayashiki, Norio; Hizawa, Nobuyuki			Superficial-type endobronchial metastases from colon cancer: A case report	ONCOLOGY LETTERS			English	Article						colon cancer; pulmonary metastasis; endobronchial metastasis	LUNG-CANCER; DIAGNOSIS; TUMORS	Certain internal malignancies, including colon cancer, can develop endobronchial metastasis. The present study reports a case of colon cancer with superficial-type endobronchial metastases in a 76-year-old male. Chest computed tomography revealed small masses and infiltrates in each lung, with bilateral hilar lymph node swelling. Superficial endobronchial tumors in each of the bronchi were unexpectedly found by bronchoscopic examination. A biopsy specimen obtained from the endobronchial tumor was diagnosed as colon cancer. Superficial-type endobronchial metastasis from colon cancer is extremely rare, however, such metastasis should be considered for patients who have a history of colon cancer. There should be no hesitation in performing a bronchoscopic biopsy as an additional examination.	[Kurishima, Koichi; Satoh, Hiroaki; Kagohashi, Katsunori; Ohara, Gen] Univ Tsukuba, Div Resp Med, Mito Med Ctr, Mito, Ibaraki 3100015, Japan; [Miyazaki, Kunihiko; Tamura, Tomohiro; Shiozawa, Toshihiro; Kawaguchi, Mio; Hizawa, Nobuyuki] Univ Tsukuba, Div Resp Med, Fac Med, Tsukuba, Ibaraki 3058575, Japan; [Takayashiki, Norio] Univ Tsukuba, Div Pathol, Mito Med Ctr, Mito, Ibaraki 3100015, Japan	Satoh, H (reprint author), Univ Tsukuba, Div Resp Med, Mito Med Ctr, Miya Machi 3-2-7, Mito, Ibaraki 3100015, Japan.	hirosato@md.tsukuba-ac.jp					SHAH H, 1995, CHEST, V107, P1744, DOI 10.1378/chest.107.6.1744; Kiryu T, 2001, CHEST, V119, P768, DOI 10.1378/chest.119.3.768; Seo JB, 2001, RADIOGRAPHICS, V21, P403; Lam B, 2006, EUR RESPIR J, V28, P915, DOI 10.1183/09031936.06.00131405; Katsimbri PP, 2000, LUNG CANCER-J IASLC, V28, P163, DOI 10.1016/S0169-5002(99)00134-8; Akoglu S, 2005, CLIN EXP METASTAS, V22, P587, DOI 10.1007/s10585-005-5787-x; Kim JS, 2000, YONSEI MED J, V41, P422; Yasufuku K, 2010, CLIN CHEST MED, V31, P39, DOI 10.1016/j.ccm.2009.08.004; BRAMAN SS, 1975, ARCH INTERN MED, V135, P543, DOI 10.1001/archinte.135.4.543; Itoi S, 2012, CENT EUR J MED, V7, P385, DOI 10.2478/s11536-011-0149-3; Koss MN, 1999, AM J SURG PATHOL, V23, P1514, DOI 10.1097/00000478-199912000-00009; LAU KY, 1992, THORAX, V47, P664, DOI 10.1136/thx.47.8.664; MURAKAMI S, 1995, ANN THORAC SURG, V60, P964, DOI 10.1016/0003-4975(95)00545-V; Oshikawa K, 1998, INTERNAL MED, V37, P349, DOI 10.2169/internalmedicine.37.349; Saida Y, 1996, RADIOLOGY, V201, P61; Shulman L, 2007, CURR OPIN PULM MED, V13, P271, DOI 10.1097/MCP.0b013e3281c9b0ee; The Japan Lung Cancer Society, 2010, GEN RUL CLIN PATH RE; Unger Michael, 2003, Chest Surg Clin N Am, V13, P129, DOI 10.1016/S1052-3359(02)00041-8; VANDENBRANDE P, 1991, RESP MED, V85, P107, DOI 10.1016/S0954-6111(06)80286-6; Wildbrett Peer, 2012, Afr J Paediatr Surg, V9, P159, DOI 10.4103/0189-6725.99406	20	0	0	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1792-1074	1792-1082		ONCOL LETT	Oncol. Lett.	NOV	2014	8	5					2310	2312		10.3892/ol.2014.2473		3	Oncology	Oncology	AS7GE	WOS:000344424300077		
J	Miyoshi, N; Yamamoto, H; Mimori, K; Yamashita, S; Miyazaki, S; Nakagawa, S; Ishii, H; Noura, S; Ohue, M; Yano, M; Doki, Y; Mori, M				Miyoshi, Norikatsu; Yamamoto, Hirofumi; Mimori, Koshi; Yamashita, Shinya; Miyazaki, Susumu; Nakagawa, Sumiko; Ishii, Hideshi; Noura, Shingo; Ohue, Masayuki; Yano, Masahiko; Doki, Yuichiro; Mori, Masaki			ANXA9 gene expression in colorectal cancer: A novel marker for prognosis	ONCOLOGY LETTERS			English	Article						ANXA9; prognosis; colorectal cancer	FACTOR RECEPTOR-KINASE; COLON-CANCER; RANDOMIZED-TRIAL; OPEN COLECTOMY; ASSISTED COLECTOMY; ANNEXIN; CLASSIFICATION; IDENTIFICATION; LEUCOVORIN; CARCINOMA	Annexin A9 (ANXA9) is involved with the interaction with membrane phospholipids in a Ca2+-dependent manner. A previous study has shown that ANXA9 expression is associated with bone metastasis in breast cancer, whereas its significance in colorectal cancer (CRC) is unknown. The present study was comprised of 100 patients who underwent surgery for CRC. The correlation between gene expression and the clinical parameters of the patients was assessed. Patients with high ANXA9 expression were statistically susceptible to a relatively worse prognosis, and those with low ANXA9 expression showed improved overall survival compared with those with high expression. In conclusion, the present data suggests that ANXA9 expression is a prognostic factor in CRC patients.	[Miyoshi, Norikatsu; Noura, Shingo; Ohue, Masayuki; Yano, Masahiko] Osaka Med Ctr Canc & Cardiovasc Dis, Dept Surg, Osaka 5378511, Japan; [Yamamoto, Hirofumi; Nakagawa, Sumiko] Osaka Univ, Grad Sch Med, Dept Surg Gastroenterol, Suita, Osaka 5650871, Japan; [Mimori, Koshi] Kyushu Univ, Dept Mol & Cellular Biol, Div Mol & Surg Oncol, Med Inst Bioregulat, Beppu, Oita 8740838, Japan; [Yamashita, Shinya; Doki, Yuichiro; Mori, Masaki] Natl Hosp Org Kure Med Ctr, Dept Surg, Kure, Hiroshima 7370023, Japan; [Miyazaki, Susumu] Osaka Gen Med Ctr, Dept Surg, Osaka 5588558, Japan; [Ishii, Hideshi] Osaka Univ, Dept Frontier Sci Canc & Chemotherapy, Suita, Osaka 5650871, Japan	Miyoshi, N (reprint author), Osaka Med Ctr Canc & Cardiovasc Dis, Dept Surg, Higashinari Ku, 1-3-3 Nakamichi, Osaka 5378511, Japan.	miyosi-no@mc.pref.osaka.jp					Andre T, 2007, J CLIN ONCOL, V25, P3732, DOI 10.1200/JCO.2007.12.2234; Stein Ulrike, 2007, V176, P61; Jemal A, 2010, CA-CANCER J CLIN, V60, P277, DOI [10.3322/caac.20073, 10.1002/caac.20073]; Watanabe T, 2012, INT J CLIN ONCOL, V17, P1, DOI 10.1007/s10147-011-0315-2; Kornmann M, 2008, EJSO-EUR J SURG ONC, V34, P1316, DOI 10.1016/j.ejso.2008.01.019; Gerke V, 2002, PHYSIOL REV, V82, P331, DOI 10.1152/physrev.00030.2001; Hodgson G, 2001, NAT GENET, V29, P459, DOI 10.1038/ng771; Lacy AM, 2002, LANCET, V359, P2224, DOI 10.1016/S0140-6736(02)09290-5; Jayne DG, 2007, J CLIN ONCOL, V25, P3061, DOI 10.1200/JCO.2006.09.7758; Smid M, 2006, J CLIN ONCOL, V24, P2261, DOI 10.1200/JCO.2005.03.8802; Hansen WJ, 1999, J CELL BIOL, V145, P265, DOI 10.1083/jcb.145.2.265; Wolpin BM, 2008, GASTROENTEROLOGY, V134, P1296, DOI 10.1053/j.gastro.2008.02.098; Sadanandam A, 2013, NAT MED, V19, P619, DOI 10.1038/nm.3175; Weeks JC, 2002, JAMA-J AM MED ASSOC, V287, P321, DOI 10.1001/jama.287.3.321; Bathe OF, 2004, BMC CANCER, V4, DOI 10.1186/1471-2407-4-32; Braun EL, 1998, J MOL EVOL, V47, P531, DOI 10.1007/PL00006409; FAVA RA, 1984, J BIOL CHEM, V259, P2636; Goebeler V, 2003, FEBS LETT, V546, P359, DOI 10.1016/S0014-5793(03)00634-3; Hawkins TE, 2000, CELL BIOCHEM BIOPHYS, V33, P275, DOI 10.1385/CBB:33:3:275; HUANG KS, 1986, CELL, V46, P191, DOI 10.1016/0092-8674(86)90736-1; Iijima M, 1996, ACTA MED OKAYAMA, V50, P73; Koshariya M, 2007, HEPATO-GASTROENTEROL, V54, P2232; Mimori K, 1997, BRIT J CANCER, V76, P531, DOI 10.1038/bjc.1997.420; MORGAN RO, 1995, MOL BIOL EVOL, V12, P967; Morgan RO, 1997, CELL MOL LIFE SCI, V53, P508, DOI 10.1007/s000180050064; Morgan RO, 1999, GENE, V227, P33, DOI 10.1016/S0378-1119(98)00597-6; MORI M, 1993, GASTROENTEROLOGY, V105, P820; Nelson H, 2004, NEW ENGL J MED, V350, P2050; Sobin LH, 1997, CANCER, V80, P1803, DOI 10.1002/(SICI)1097-0142(19971101)80:9<1803::AID-CNCR16>3.0.CO;2-9	29	1	1	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1792-1074	1792-1082		ONCOL LETT	Oncol. Lett.	NOV	2014	8	5					2313	2317		10.3892/ol.2014.2477		5	Oncology	Oncology	AS7GE	WOS:000344424300078		
J	Kimura, M; Usami, E; Iwai, M; Nakao, T; Yoshimura, T; Mori, H; Sugiyama, T; Teramachi, H				Kimura, Michio; Usami, Eiseki; Iwai, Mina; Nakao, Toshiya; Yoshimura, Tomoaki; Mori, Hiromi; Sugiyama, Tadashi; Teramachi, Hitomi			Oral anticancer agent medication adherence by outpatients	ONCOLOGY LETTERS			English	Article						adherence; compliance; oral anticancer agent; customer satisfaction	CHRONIC MYELOID-LEUKEMIA; BREAST-CANCER; PATIENT ADHERENCE; NONADHERENCE; CHEMOTHERAPY; PERSISTENCE; THERAPIES; COHORT	In the present study, medication adherence and factors affecting adherence were examined in patients taking oral anticancer agents. In June 2013, 172 outpatients who had been prescribed oral anticancer agents by Ogaki Municipal Hospital (Ogaki, Gifu, Japan) completed a questionnaire survey, with answers rated on a five-point Likert scale. The factors that affect medication adherence were evaluated using a customer satisfaction (CS) analysis. For patients with good and insufficient adherence to medication, the median ages were 66 years (range, 21-85 years) and 73 years (range, 30-90 years), respectively (P=0.0004), while the median dosing time was 131 days (range, 3-3,585 days) and 219 days (24-3,465 days), respectively (P=0.0447). In 36.0% (62 out of 172) of the cases, there was insufficient medication adherence; 64.5% of those cases (40 out of 62) showed good medication compliance (4-5 point rating score). However, these patients did not fully understand the effects or side-effects of the drugs, giving a score of three points or less. The percentage of patients with good medication compliance was 87.2% (150 out of 172). Through the CS analysis, three items, the interest in the drug, the desire to consult about the drug and the condition of the patient, were extracted as items for improvement. Overall, the medication compliance of the patients taking the oral anticancer agents was good, but the medication adherence was insufficient. To improve medication adherence, a better understanding of the effectiveness and necessity of drugs and their side-effects is required. In addition, the interest of patients in their medication should be encouraged and intervention should be tailored to the condition of the patient. These steps should lead to improved medication adherence.	[Kimura, Michio; Usami, Eiseki; Iwai, Mina; Nakao, Toshiya; Yoshimura, Tomoaki; Mori, Hiromi] Ogaki Municipal Hosp, Dept Pharm, Ogaki, Gifu 5038502, Japan; [Sugiyama, Tadashi] Gifu Pharmaceut Univ, Lab Clin Pharm Practice & Social Sci, Gifu, Japan; [Teramachi, Hitomi] Gifu Pharmaceut Univ, Lab Clin Pharm, Gifu, Japan	Kimura, M (reprint author), Ogaki Municipal Hosp, Dept Pharm, 4-86 Minaminokawa Cho, Ogaki, Gifu 5038502, Japan.	kimkim0305nao@yahoo.co.jp					McCowan C, 2008, BRIT J CANCER, V99, P1763, DOI 10.1038/sj.bjc.6604758; Marin D, 2010, J CLIN ONCOL, V28, P2381, DOI 10.1200/JCO.2009.26.3087; Noens L, 2009, BLOOD, V113, P5401, DOI 10.1182/blood-2008-12-196543; LEBOVITS AH, 1990, CANCER, V65, P17, DOI 10.1002/1097-0142(19900101)65:1<17::AID-CNCR2820650106>3.0.CO;2-I; Nilsson JLG, 2006, EUR J CANCER CARE, V15, P235, DOI 10.1111/j.1365-2354.2006.00645.x; Macintosh PW, 2007, EUR J CANCER CARE, V16, P380, DOI 10.1111/j.1365-2354.2006.00758.x; Ruddy K, 2009, CA-CANCER J CLIN, V59, P56, DOI 10.3322/caac.20004; Hershman DL, 2010, J CLIN ONCOL, V28, P4120, DOI 10.1200/JCO.2009.25.9655; Partridge AH, 2010, J CLIN ONCOL, V28, P2418, DOI 10.1200/JCO.2009.26.4671; Hasegawa K, 2008, IRYOUYAKUGAKU, V34, P800; Ziller V, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-407; LEE CR, 1992, J CLIN ONCOL, V10, P1007; Mayer EL, 2009, BREAST CANCER RES TR, V117, P615, DOI 10.1007/s10549-009-0366-5; Moore S, 2010, CLIN J ONCOL NURS, V14, P41, DOI 10.1188/10.CJON.41-47; Owashi T, 2008, GEKKAN YAKUJI, V50, P373; Reginster Jean-Yves, 2006, Bone, V38, pS18; Russmann Stefan, 2010, Ther Umsch, V67, P303, DOI 10.1024/0040-5930/a000054; Tsuboi K, 2012, IRYOUYAKUGAKU, V38, P522; Winkeljohn D, 2010, CLIN J ONCOL NURS, V14, P461, DOI 10.1188/10.CJON.461-466; Wu EQ, 2010, CURR MED RES OPIN, V26, P2861, DOI 10.1185/03007995.2010.533648	20	1	1	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1792-1074	1792-1082		ONCOL LETT	Oncol. Lett.	NOV	2014	8	5					2318	2324		10.3892/ol.2014.2480		7	Oncology	Oncology	AS7GE	WOS:000344424300079		
J	Yoshimura, Y; Takeda, Y; Fukuda, K; Kumaki, D; Tokito, S				Yoshimura, Yudai; Takeda, Yasunori; Fukuda, Kenjiro; Kumaki, Daisuke; Tokito, Shizuo			High-speed operation in printed organic inverter circuits with short channel length	ORGANIC ELECTRONICS			English	Article						Organic electronics; Integrated circuits; Printed electronics	THIN-FILM TRANSISTORS; LARGE-AREA; CONTACT RESISTANCE; ELECTRONICS; DISPLAY; DESIGN; LAYERS; GATE	We have demonstrated fast operation of printed organic inverter circuits. We employ a soluble organic semiconducting material which has high field-effect mobility and ink-jet printed source/drain electrodes with short channel length. Appropriate concentration of the semiconducting solution and modification layer of source/drain electrodes improve both mobility and on/off ratio. The fabricated transistors with a short channel length (4 mu m) exhibit excellent mobility (1.2 cm(2)/V s), high on/off ratio (>10(5)) and operational stability. The diode-load inverter with a narrow channel and low parasitic capacitance operate at 8 kHz at 20 V. These results will lead to significant progress in applications of printed organic circuits. (C) 2014 Elsevier B.V. All rights reserved.	[Fukuda, Kenjiro] Yamagata Univ, Grad Sch Sci & Engn, Yonezawa, Yamagata 9928510, Japan; Yamagata Univ, Res Ctr Organ Elect, Yonezawa, Yamagata 9928510, Japan	Fukuda, K (reprint author), Yamagata Univ, Grad Sch Sci & Engn, 4-3-16 Jonan, Yonezawa, Yamagata 9928510, Japan.	fukuda@yz.yamagata-u.ac.jp			Japan Science and Technology Agency (JST); KAKENHI [25820134]	This study was supported by the Japan Science and Technology Agency (JST) and a Grant-in-Aid for Scientific Research (KAKENHI; WAKATE B, Grant Number 25820134). We thank Merck for providing the materials (lisicon (R) S1200) and DIC Corporation for providing silver nanoparticle ink (JAGLT-01).	Naden AB, 2014, J MATER CHEM C, V2, P245, DOI 10.1039/c3tc31783h; Cantatore E, 2007, IEEE J SOLID-ST CIRC, V42, P84, DOI 10.1109/JSSC.2006.886556; Zirkl M, 2007, ADV MATER, V19, P2241, DOI 10.1002/adma.200700831; Steudel S, 2012, ORG ELECTRON, V13, P1729, DOI 10.1016/j.orgel.2012.05.034; Huang TC, 2011, IEEE T ELECTRON DEV, V58, P141, DOI 10.1109/TED.2010.2088127; Deegan RD, 1997, NATURE, V389, P827, DOI 10.1038/39827; Myny K, 2010, ORG ELECTRON, V11, P1176, DOI 10.1016/j.orgel.2010.04.013; Sele CW, 2005, ADV MATER, V17, P997, DOI 10.1002/adma.200401285; Kaltenbrunner M, 2013, NATURE, V499, P458, DOI 10.1038/nature12314; Takeda Y, 2013, ORG ELECTRON, V14, P3362, DOI 10.1016/j.orgel.2013.10.006; Crone B, 2000, NATURE, V403, P521, DOI 10.1038/35000530; Kitamura M, 2011, APPL PHYS EXPRESS, V4, DOI 10.1143/APEX.4.051601; Kang H, 2012, ADV MATER, V24, P3065, DOI 10.1002/adma.201200924; Kato Y, 2010, IEEE T ELECTRON DEV, V57, P995, DOI 10.1109/TED.2010.2044278; Nausieda I, 2010, IEEE T ELECTRON DEV, V57, P3027, DOI 10.1109/TED.2010.2072550; Rogers JA, 2001, P NATL ACAD SCI USA, V98, P4835, DOI 10.1073/pnas.091588098; Huebler AC, 2007, ORG ELECTRON, V8, P480, DOI 10.1016/j.orgel.2007.02.009; Voigt MM, 2010, ADV FUNCT MATER, V20, P239, DOI 10.1002/adfm.200901597; Fukuda K, 2012, ORG ELECTRON, V13, P3296, DOI 10.1016/j.orgel.2012.09.028; Klauk H, 2003, SOLID STATE ELECTRON, V47, P297, DOI 10.1016/S0038-1101(02)00210-1; Ante F, 2012, SMALL, V8, P73, DOI 10.1002/smll.201101677; Noda M, 2011, J SOC INF DISPLAY, V19, P316, DOI 10.1889/JSID19.4.316; Someya T, 2005, IEEE T ELECTRON DEV, V52, P2502, DOI 10.1109/TED.2005.857935; Diao Y, 2013, NAT MATER, V12, P665, DOI [10.1038/nmat3650, 10.1038/NMAT3650]; Fujisaki Y, 2013, APPL PHYS LETT, V102, DOI 10.1063/1.4802499; Bode D, 2010, APPL PHYS LETT, V96, DOI 10.1063/1.3373630; Fuketa H., 2014, IEEE ISSCC, P490; Fukuda K, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5147; Fukuda K, 2014, SCI REP-UK, V4, DOI 10.1038/srep03947; Gundlach DJ, 2006, J APPL PHYS, V100, DOI 10.1063/1.2215132; Guo D, 2007, J APPL PHYS, V102, DOI 10.1063/1.2753671; Jamesn M., 2012, SID INT S, V43, P422; Kitamura M, 2011, JPN J APPL PHYS, V50, DOI 10.1143/JJAP.50.01BC01; Lloyd G., 2010, P IDW, V10, P469; Myny K., 2011, ORG ELECTRON, V11, P1176; Smith J, 2008, APPL PHYS LETT, V93, DOI 10.1063/1.3050525; Suzuki K. Yutani, 2009, P IDW, P1581	37	3	3	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1566-1199	1878-5530		ORG ELECTRON	Org. Electron.	NOV	2014	15	11					2696	2701		10.1016/j.orgel.2014.08.001		6	Materials Science, Multidisciplinary; Physics, Applied	Materials Science; Physics	AS7GG	WOS:000344424500008		
J	Velusamy, DB; Kim, RH; Takaishi, K; Muto, T; Hashizume, D; Lee, S; Uchiyama, M; Aoyama, T; Ribierre, JC; Park, C				Velusamy, Dhinesh Babu; Kim, Richard Hahnkee; Takaishi, Kazuto; Muto, Tsuyoshi; Hashizume, Daisuke; Lee, Soyoon; Uchiyama, Masanobu; Aoyama, Tetsuya; Ribierre, Jean-Charles; Park, Cheolmin			Thin reduced graphene oxide interlayer with a conjugated block copolymer for high performance non-volatile ferroelectric polymer memory	ORGANIC ELECTRONICS			English	Article						Reduced graphene oxide; Conjugated block copolymer; Interlayer; Ferroelectric polymer; Polymer ferroelectric-gate field effect; transistor memory; Flexible non-volatile memory	FIELD-EFFECT TRANSISTOR; FILMS; SEMICONDUCTOR; THICKNESS; CRYSTALS; BEHAVIOR; DEVICE; LAYERS	Polymer ferroelectric-gate field effect transistors (Fe-FETs) employing ferroelectric polymer thin films as gate insulators are highly attractive as a next-generation non-volatile memory. For minimizing gate leakage current of a device which arises from electrically defective ferroelectric polymer layer in particular at low operation voltage, the materials design of interlayers between the ferroelectric insulator and gate electrode is essential. Here, we introduce a new solution-processed interlayer of conductive reduced graphene oxides (rGOs) modified with a conjugated block copolymer, poly(styrene-block-paraphenylene) (PS-b-PPP). A FeFET with a solution-processed p-type oligomeric semiconducting channel and ferroelectric poly(vinylidene fluoride-co-trifluoroethylene) (PVDF-TrFE) insulator exhibited characteristic source-drain current hysteresis arising from ferroelectric polarization switching of a PVDF-TrFE insulator. Our PS-b-PPP modified rGOs (PMrGOs) with conductive moieties embedded in insulating polymer matrix not only significantly reduced the gate leakage current but also efficiently lowered operation voltage of the device. In consequence, the device showed large memory gate voltage window and high ON/OFF source-drain current ratio with excellent data retention and read/write cycle endurance. Furthermore, our PMrGOs interlayers were successfully employed to FeFETs fabricated on mechanically flexible substrates with promising non-volatile memory performance under repetitive bending deformation. (C) 2014 Elsevier B.V. All rights reserved.	[Velusamy, Dhinesh Babu; Kim, Richard Hahnkee; Park, Cheolmin] Yonsei Univ, Dept Mat Sci & Engn, Seoul 120749, South Korea; [Takaishi, Kazuto; Muto, Tsuyoshi; Hashizume, Daisuke; Uchiyama, Masanobu; Aoyama, Tetsuya; Ribierre, Jean-Charles] RIKEN, Adv Sci Inst, Wako, Saitama, Japan; [Lee, Soyoon; Ribierre, Jean-Charles] Ewha Womans Univ, CNRS, Ewha Int Res Ctr, Dept Phys, Seoul, South Korea	Park, C (reprint author), Yonsei Univ, Dept Mat Sci & Engn, Seoul 120749, South Korea.	cmpark@yonsei.ac.kr	Uchiyama, Masanobu/B-7181-2015; TAKAISHI, Kazuto/J-5818-2015; Hashizume, Daisuke/D-3187-2013		Agency for Defence Development [UD110050GD]; National Research Foundation of Korea (NRF) - Korea government (MEST) [2014R1A2A1A01005046]; Second Stage of the Brain Korea 21 Project; Korea Science and Engineering Foundation (KOSEF) - Ministry of Science and Technology (MEST), Republic of Korea [R11-2007-050-03001-0]	This research was supported by the Agency for Defence Development (Grant No. UD110050GD) and by the National Research Foundation of Korea (NRF) grant funded by the Korea government (MEST) (No. 2014R1A2A1A01005046). This research was also supported by the Second Stage of the Brain Korea 21 Project in 2006 and a Korea Science and Engineering Foundation (KOSEF) grant funded by the Ministry of Science and Technology (MEST), Republic of Korea (No. R11-2007-050-03001-0).	Park YJ, 2010, IEEE T DIELECT EL IN, V17, P1135; Lee GG, 2011, APPL PHYS LETT, V99, DOI 10.1063/1.3608145; Hu ZJ, 2009, NAT MATER, V8, P62, DOI [10.1038/nmat2339, 10.1038/NMAT2339]; Hwang SK, 2012, ADV MATER, V24, P5910, DOI 10.1002/adma.201201831; Ribierre JC, 2010, APPL PHYS LETT, V96, DOI 10.1063/1.3310025; Xu HS, 2010, J APPL PHYS, V107, DOI 10.1063/1.3298463; Naber RCG, 2010, ADV MATER, V22, P933, DOI 10.1002/adma.200900759; Xu HS, 2011, J APPL POLYM SCI, V120, P1510, DOI 10.1002/app.33291; Urayama K, 2000, MACROMOLECULES, V33, P8269, DOI 10.1021/ma000855w; Velusamy DB, 2012, J MATER CHEM, V22, P25183, DOI 10.1039/c2jm35539f; Yoon SM, 2010, APPL PHYS LETT, V96, DOI 10.1063/1.3452339; Park YJ, 2008, MACROMOLECULES, V41, P8648, DOI 10.1021/ma801495k; Sekitani T, 2009, IEEE T ELECTRON DEV, V56, P1027, DOI 10.1109/TED.2009.2015169; Choi WJ, 2008, ELECTROCHEM SOLID ST, V11, pH47, DOI 10.1149/1.2822888; Zaitsu K, 2010, J APPL PHYS, V107, DOI 10.1063/1.3429079; Naber RCG, 2004, APPL PHYS LETT, V85, P2032, DOI 10.1063/1.1788885; Kang SJ, 2011, NANO LETT, V11, P138, DOI 10.1021/nl103094e; Unni KNN, 2004, APPL PHYS LETT, V85, P1823, DOI 10.1063/1.1788887; Jung HJ, 2009, MACROMOLECULES, V42, P4148, DOI 10.1021/ma900422n; Naber RCG, 2005, APPL PHYS LETT, V87, DOI 10.1063/1.2132062; Kang SJ, 2009, ADV FUNCT MATER, V19, P1609, DOI 10.1002/adfm.200801097; LOVINGER AJ, 1983, SCIENCE, V220, P1115, DOI 10.1126/science.220.4602.1115; Gerber A, 2010, J APPL PHYS, V107, DOI 10.1063/1.3437638; Xu HS, 2007, APPL PHYS LETT, V90, DOI 10.1063/1.2710477; Nguyen CA, 2008, ORG ELECTRON, V9, P1087, DOI 10.1016/j.orgel.2008.08.012; Xu HS, 2011, FERROELECTRICS, V413, P46, DOI 10.1080/00150193.2011.542702; Xia F, 2001, APPL PHYS LETT, V78, P1122, DOI 10.1063/1.1351848; Xu HS, 2009, J APPL PHYS, V105, DOI 10.1063/1.3075897; Yoon SM, 2010, ADV FUNCT MATER, V20, P921, DOI 10.1002/adfm.200902095; Fu WY, 2009, NANO LETT, V9, P921, DOI 10.1021/nl801656w; Naber RCG, 2005, NAT MATER, V4, P243, DOI 10.1038/nmat1329; Kang SJ, 2009, ADV FUNCT MATER, V19, P2812, DOI 10.1002/adfm.200900589; Zheng Y, 2009, APPL PHYS LETT, V94, DOI 10.1063/1.3119215; Lee WK, 2011, ADV FUNCT MATER, V21, P3843, DOI 10.1002/adfm.201101345; Ribierre JC, 2010, ADV MATER, V22, P4044, DOI 10.1002/adma.201001170; Chang JY, 2009, ORG ELECTRON, V10, P849, DOI 10.1016/j.orgel.2009.04.005; Heremans P., 2010, CHEM MATER, V23, P341; Kim RH, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4583; Lee K.H., 2010, ADV MATER, V21, P4287; Noh SH, 2007, APPL PHYS LETT, V90, DOI 10.1063/1.2749841; Park CH, 2010, J MATER CHEM, V20, P2638, DOI 10.1039/b921732k; Park Y.J., 2007, MACROMOLECULES, V41, P109; Salvatore G.A., 2008, ESSDERC 2008, V162; Woo Young K., 2009, IEEE ELECTR DEVICE L, V30, P822; YAMAUCHI N, 1986, JPN J APPL PHYS 1, V25, P590, DOI 10.1143/JJAP.25.590; Yamauchi N., 1984, JPN J APPL PHYS, V23, P671; Zhang QM, 2001, J APPL PHYS, V89, P2613, DOI 10.1063/1.1344585	47	1	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1566-1199	1878-5530		ORG ELECTRON	Org. Electron.	NOV	2014	15	11					2719	2727		10.1016/j.orgel.2014.07.035		9	Materials Science, Multidisciplinary; Physics, Applied	Materials Science; Physics	AS7GG	WOS:000344424500012		
J	Yang, JP; Sun, QJ; Yonezawa, K; Hinderhofer, A; Gerlach, A; Broch, K; Bussolotti, F; Gao, X; Li, YQ; Tang, JX; Schreiber, F; Ueno, N; Wang, SD; Kera, S				Yang, Jin-Peng; Sun, Qi-Jun; Yonezawa, Keiichirou; Hinderhofer, Alexander; Gerlach, Alexander; Broch, Katharina; Bussolotti, Fabio; Gao, Xu; Li, Yanqing; Tang, Jianxin; Schreiber, Frank; Ueno, Nobuo; Wang, Sui-Dong; Kera, Satoshi			Interface optimization using diindenoperylene for C-60 thin film transistors with high electron mobility and stability	ORGANIC ELECTRONICS			English	Article						Electron mobility; C-60; Organic thin film transistor; Highly sensitive ultraviolet photoelectron spectroscopy; Grazing incidence X-ray diffraction	FIELD-EFFECT TRANSISTORS; ORGANIC TRANSISTORS; GROWTH; SEMICONDUCTOR; TRANSPORT	C-60-based organic thin film transistors (OTFTs) with high electron mobility and high operational stability are achieved with (1 1 1) oriented C-60 films grown by using template effects of diindenoperylene (DIP) under layer on the SiO2 gate insulator. The electron mobility of the C60 transistor is significantly increased from 0.21 cm(2) V-1 s(-1) to 2.92 cm(2) V-1 S-1 by inserting the template-DIP layer. Moreover much higher operational stability is also observed for the DIP-template C-60 OTFTs. A grazing incidence X-ray diffraction and ultra-high-sensitivity photoelectron spectroscopy measurements indicate that the improved electron mobility and stability arise from the decreased density of trap states in the C-60 film due to increased (1 1 1) orientation of C-60-grains and their crystallinity on the DIP template. (C) 2014 Elsevier B.V. All rights reserved.	[Yang, Jin-Peng; Yonezawa, Keiichirou; Hinderhofer, Alexander; Bussolotti, Fabio; Ueno, Nobuo; Kera, Satoshi] Chiba Univ, Grad Sch Adv Integrat Sci, Chiba 2638522, Japan; [Sun, Qi-Jun; Gao, Xu; Li, Yanqing; Tang, Jianxin; Wang, Sui-Dong] Soochow Univ, Inst Funct Nano & Soft Mat FUNSOM, Suzhou 215123, Peoples R China; [Sun, Qi-Jun; Gao, Xu; Li, Yanqing; Tang, Jianxin; Wang, Sui-Dong] Soochow Univ, Collaborat Innovat Ctr Suzhou Nano Sci & Technol, Suzhou 215123, Peoples R China; [Gerlach, Alexander; Broch, Katharina; Schreiber, Frank] Univ Tubingen, Inst Appl Phys, D-72076 Tubingen, Germany	Wang, SD (reprint author), Soochow Univ, Inst Funct Nano & Soft Mat FUNSOM, Suzhou 215123, Peoples R China.	wangsd@suda.edu.cn; kera@ims.ac.jp	Wang, Sui-Dong/E-6063-2013; Ueno, Nobuo/F-4358-2014; Schreiber, Frank/J-3311-2014; Tang, Jianxin/A-1452-2013	Ueno, Nobuo/0000-0003-2051-1492; 	Global-COE Program of MEXT (Advanced School for Organic Electronics, Chiba University) [G03]; KAKENHI (JSPS) [24245034, 23360005]; joint JSPS-NSFC Project [612111116]; National Natural Science Foundation of China [61274019, 51033007]; Studienstiftung des Deutschen Volkes	This work was financially supported in part by the Global-COE Program of MEXT (G03: Advanced School for Organic Electronics, Chiba University), KAKENHI (JSPS Grant No. 24245034 and 23360005), joint JSPS-NSFC Project (Nos. 612111116) and the National Natural Science Foundation of China (Nos. 61274019 and 51033007). F.S. wishes to acknowledge the DFG. KB. was supported by the Studienstiftung des Deutschen Volkes and A.H. was supported by the JSPS. The authors are grateful to S. Leake and P. Willmott at the MS beamline of the Swiss Light for supporting the X-ray scattering experiments.	Chen Y, 2012, ADV MATER, V24, P2679, DOI 10.1002/adma.201200455; Miyadera T, 2008, APPL PHYS LETT, V93, DOI 10.1063/1.2949746; Zhong JQ, 2014, ACS NANO, V8, P1699, DOI 10.1021/nn406050e; Gruber M, 2013, ADV ENERGY MATER, V3, P1075, DOI 10.1002/aenm.201201012; Noever SJ, 2013, ADV MATER, V25, P2147, DOI 10.1002/adma.201203964; Wagner J, 2010, ADV FUNCT MATER, V20, P4295, DOI 10.1002/adfm.201001028; Calhoun MF, 2008, NAT MATER, V7, P84, DOI 10.1038/nmat2059; Klauk H, 2007, NATURE, V445, P745, DOI 10.1038/nature05533; Wang CL, 2012, CHEM REV, V112, P2208, DOI 10.1021/cr100380z; Kang JH, 2005, APPL PHYS LETT, V86, DOI 10.1063/1.1900944; Sekitani T, 2009, SCIENCE, V326, P1516, DOI 10.1126/science.1179963; Itaka K, 2006, ADV MATER, V18, P1713, DOI 10.1002/adma.200502752; Li HY, 2012, J AM CHEM SOC, V134, P2760, DOI 10.1021/ja210430b; Sueyoshi T, 2010, APPL PHYS LETT, V96, DOI 10.1063/1.3332577; Hinderhofer A, 2012, CHEMPHYSCHEM, V13, P628, DOI 10.1002/cphc.201100737; Gershenson ME, 2006, REV MOD PHYS, V78, P973, DOI 10.1103/RevModPhys.78.973; Horlet M, 2011, APPL PHYS LETT, V98, DOI 10.1063/1.3598423; Wilke A, 2011, APPL PHYS LETT, V98, DOI 10.1063/1.3571286; Ahn K, 2013, APPL PHYS LETT, V102, DOI 10.1063/1.4789873; Tsao HN, 2010, CHEM SOC REV, V39, P2372, DOI 10.1039/b918151m; Hinderhofer A, 2013, J PHYS CHEM C, V117, P1053, DOI 10.1021/jp3106056; Tripathi AK, 2006, APPL PHYS LETT, V89, DOI 10.1063/1.2338587; Wen YG, 2011, CHEM REV, V111, P3358, DOI 10.1021/cr1001904; Braga D, 2009, ADV MATER, V21, P1473, DOI 10.1002/adma.200802733; Banerjee R, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.185506; Hinderhofer A, 2011, J PHYS CHEM C, V115, P16155, DOI 10.1021/jp203003m; Wang SD, 2008, APPL PHYS LETT, V93, DOI 10.1063/1.2967193; Zhong JQ, 2012, ORG ELECTRON, V13, P2793, DOI 10.1016/j.orgel.2012.07.048; Bussolotti F, 2014, PHYS REV B, V89, DOI 10.1103/PhysRevB.89.115319; Bussolotti F, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.267602; Chen Y, 2012, PHYS CHEM CHEM PHYS, V14, P14142, DOI 10.1039/c2cp41823a; Gerstenberg MC, 2000, PHYS REV B, V61, P7678, DOI 10.1103/PhysRevB.61.7678; Hinderhofer A, 2010, EPL-EUROPHYS LETT, V91, DOI 10.1209/0295-5075/91/56002; Kao C.-Y., 2009, ADV FUNCT MATER, V19, P1; Li T., 2002, J APPL PHYS, V91, P7; Liu ZH, 2009, IEEE T ELECTRON DEV, V56, P176, DOI 10.1109/TED.2008.2010580; Olthof S, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.176601; Podzorov V, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.086602; Sze S. M., 1981, PHYS SEMICONDUCTOR D	39	4	4	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1566-1199	1878-5530		ORG ELECTRON	Org. Electron.	NOV	2014	15	11					2749	2755		10.1016/j.orgel.2014.07.010		7	Materials Science, Multidisciplinary; Physics, Applied	Materials Science; Physics	AS7GG	WOS:000344424500016		
J	Fujimoto, H; Potscavage, WJ; Edura, T; Adachi, C				Fujimoto, Hiroshi; Potscavage, William J., Jr.; Edura, Tomohiko; Adachi, Chihaya			Analysis of electron traps formed in organic films with a sputtered cathode	ORGANIC ELECTRONICS			English	Article						Organic light-emitting diode (OLED); Thermally stimulated current (TSC); Trapped charge limited current (TCLC); Damage free sputtering and Li-doped electron transport layer	THERMALLY STIMULATED CURRENT; LIGHT-EMITTING-DIODES; CHARGE-LIMITED CURRENTS; TRIS(8-HYDROXYQUINOLINE) ALUMINUM; TRANSPORT MATERIALS; DEVICES; SPECTROSCOPY; EFFICIENCY; MOBILITY; LAYERS	To understand why performance degradation is reduced for sputtered cathodes on organic devices when the electron transport layer (ETL) is doped with Li, we analyze electron-only devices using the thermally stimulated current (TSC) technique and modeling of temperature-dependent current-voltage characteristics with a trapped-charge-limited current (TCLC) model. The combined results suggest that the trap density measured by TSC might also include a portion of the density of the hopping sites in the lowest unoccupied molecular orbital levels, which contributes to charge transport. Compared to undoped devices, doped devices maintain a high density of hopping sites even when the Al is sputtered. We propose that the reduced effect of sputtering on electron injection and transport properties is because radical anions of Alq(3) might still be formed by the strong reducer Li even if the organic material is partially damaged. An additional TSC peak and increased driving voltage for doped tris(8-hydroxyquinoline)aluminum (Alq(3)) as an ETL with a sputtered cathode suggests the formation of new traps possibly because of damage even though the transport is better compared to the undoped device. Such traps are not found in doped bathophenanthroline (Bphen) as an ETL, which shows no change in driving voltage. (C) 2014 Elsevier B.V. All rights reserved.	[Fujimoto, Hiroshi; Potscavage, William J., Jr.; Edura, Tomohiko; Adachi, Chihaya] Kyushu Univ, Ctr Organ Photon & Elect Res OPERA, Nishi Ku, Fukuoka 8190395, Japan; [Fujimoto, Hiroshi; Adachi, Chihaya] Kyushu Univ, Dept Appl Chem, Nishi Ku, Fukuoka 8190395, Japan; [Adachi, Chihaya] Kyushu Univ, Int Inst Carbon Neutral Energy Res WPI I2CNER, Nishi Ku, Fukuoka 8190395, Japan; [Fujimoto, Hiroshi; Adachi, Chihaya] Fukuoka I3 Ctr Organ Photon & Elect Res I3 OPERA, Nishi Ku, Fukuoka 8190388, Japan	Adachi, C (reprint author), Kyushu Univ, Ctr Organ Photon & Elect Res OPERA, Nishi Ku, 744 Motooka, Fukuoka 8190395, Japan.	adachi@cstf.kyushu-u.ac.jp			Funding Program for World-Leading Innovative R&D on Science and Technology (FIRST); International Institute for Carbon Neutral Energy Research (WPI-I2CNER) - Ministry of Education, Culture, Sports, Science and Technology (MEXT)	This work was supported in part by the Funding Program for World-Leading Innovative R&D on Science and Technology (FIRST) and the International Institute for Carbon Neutral Energy Research (WPI-I<SUP>2</SUP>CNER) sponsored by Ministry of Education, Culture, Sports, Science and Technology (MEXT). H.F. also thanks Mr. Kohei Tsugita, prof. Kenichi Goushi, prof. Toshinori Matsushima, prof. Takeshi Komino and prof. Masayuki Yahiro from Kyushu University for their support in this study.	Burrows PE, 1996, J APPL PHYS, V79, P7991, DOI 10.1063/1.362350; Liu YF, 2014, ORG ELECTRON, V15, P478, DOI 10.1016/j.orgel.2013.11.035; Lo MF, 2010, APPL PHYS LETT, V97, DOI 10.1063/1.3497007; Renaud C, 2010, J APPL PHYS, V107, DOI 10.1063/1.3428962; Yan M, 2001, J MATER SCI, V36, P285, DOI 10.1023/A:1004843621542; Schmechel R, 2004, PHYS STATUS SOLIDI A, V201, P1215, DOI 10.1002/pssa.200404343; MONROE D, 1985, PHYS REV LETT, V54, P146, DOI 10.1103/PhysRevLett.54.146; KEPLER RG, 1995, APPL PHYS LETT, V66, P3618, DOI 10.1063/1.113806; Gil TH, 2009, PLASMA PROCESS POLYM, V6, pS808, DOI 10.1002/ppap.200932105; MARK P, 1962, J APPL PHYS, V33, P205, DOI 10.1063/1.1728487; Naka S, 2000, APPL PHYS LETT, V76, P197, DOI 10.1063/1.125701; LAURENT V, 1991, MAT SCI ENG A-STRUCT, V135, P89, DOI 10.1016/0921-5093(91)90542-U; Walzer K, 2007, CHEM REV, V107, P1233, DOI 10.1021/cr050156n; Fujimoto H, 2013, ORG ELECTRON, V14, P2994, DOI 10.1016/j.orgel.2013.08.020; Suzuki H, 1996, APPL PHYS LETT, V68, P2276, DOI 10.1063/1.115883; Brutting W, 2001, ORG ELECTRON, V2, P1, DOI 10.1016/S1566-1199(01)00009-X; Ding HJ, 2005, APPL PHYS LETT, V86, DOI 10.1063/1.1935750; Coehoorn R, 2005, PHYS REV B, V72, DOI 10.1103/PhysRevB.72.155206; ROSE A, 1955, PHYS REV, V97, P1538, DOI 10.1103/PhysRev.97.1538; Parthasarathy G, 2001, J APPL PHYS, V89, P4986, DOI 10.1063/1.1359161; Xu H, 2014, J MATER CHEM C, V2, P1255, DOI 10.1039/c3tc31710b; BANNISTER MK, 1989, CERAM INT, V15, P375, DOI 10.1016/0272-8842(89)90052-7; Baranovskii S.D., 2000, PHYS REV B, V62, P15; FANG ZQ, 1990, MAT SCI ENG B-SOLID, V5, P397, DOI 10.1016/0921-5107(90)90104-J; HINO T, 1975, J APPL PHYS, V46, P1956, DOI 10.1063/1.321873; Kato K., 1986, T I ELECT ENG JAPA A, V106, P384; MAETA S, 1979, JPN J APPL PHYS, V18, P1983, DOI 10.1143/JJAP.18.1983; MAETA S, 1980, JPN J APPL PHYS, V19, P597, DOI 10.1143/JJAP.19.597; MARTIN GM, 1976, J APPL PHYS, V47, P264, DOI 10.1063/1.322310; Matsudai M., 2013, SID 13, P720; Matsushima T, 2008, JPN J APPL PHYS, V47, P1748, DOI 10.1143/JJAP.47.1748; Nakahara M, 2007, JPN J APPL PHYS 2, V46, pL636, DOI 10.1143/JJAP.46.L636; Schmechel R, 2003, J APPL PHYS, V93, P4653, DOI 10.1063/1.1560571; Su SH, 2008, JPN J APPL PHYS, V47, P3193, DOI 10.1143/JJAP.47.3193; Sunaga Y., 2007, J VAC SOC JPN, V50, P28; TAK YH, 2013, SPIE P, V8829; von Malm N, 2002, SYNTHETIC MET, V126, P87, DOI 10.1016/S0379-6779(01)00549-5; Werner AG, 2001, J APPL PHYS, V90, P123, DOI 10.1063/1.1378813; Yoshida F., 1991, T IEE JAPAN A, V111-A	39	4	5	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1566-1199	1878-5530		ORG ELECTRON	Org. Electron.	NOV	2014	15	11					2783	2791		10.1016/j.orgel.2014.08.021		9	Materials Science, Multidisciplinary; Physics, Applied	Materials Science; Physics	AS7GG	WOS:000344424500021		
J	Nakanishi, R; Nogimura, A; Eguchi, R; Kanai, K				Nakanishi, Rie; Nogimura, Ayumi; Eguchi, Ritsuko; Kanai, Kaname			Electronic structure of fullerene derivatives in organic photovoltaics	ORGANIC ELECTRONICS			English	Article						Fullerene derivatives; Electronic structure; Organic photovoltaic (OPV); Ultraviolet photoelectron spectroscopy (UPS); Inverse photoemission spectroscopy (IPES)	HETEROJUNCTION SOLAR-CELLS; ACID METHYL-ESTER; CONVERSION EFFICIENCY; TANDEM POLYMER; ACCEPTOR; ADDUCT; FILMS	The electronic structures of the fullerene derivatives [6,6]-phenyl-C-61-butyric acid methyl ester (PCBM), [6,6]-diphenyl C-62 bis (butyric acid methyl ester) (bisPCBM), C-70, [6,6]-phenyl-C-71-butyric acid methyl ester (PC70BM), [6,6]-phenyl-C-61-butyric acid butyl ester (PCBB), [6,6]-phenyl-C-61-butyric acid octyl ester (PCBO), [6,6]-thienyl-C-61-butyric acid methyl ester (TCBM), and indene-C-60 bisadduct (ICBA), which are frequently used as n-type materials in organic photovoltaics, were studied by ultraviolet photoelectron spectroscopy and inverse photoemission spectroscopy. We also performed molecular orbital calculation based on density functional theory to understand the experimental results. The electronic structures near the energy gap of the compounds were found to be governed predominately by the fullerene backbone. The side chains also affected the electronic structures of the compounds. The ionization energy and electron affinity were strongly affected by the number of carbons and functional groups in the side chain. (C) 2014 Elsevier B.V. All rights reserved.	[Nakanishi, Rie; Nogimura, Ayumi; Kanai, Kaname] Tokyo Univ Sci, Fac Sci & Technol, Dept Phys, Noda, Chiba 2788510, Japan; [Eguchi, Ritsuko] Okayama Univ, Surface Sci Res Lab, Kita Ku, Okayama 7008530, Japan	Nakanishi, R (reprint author), Tokyo Univ Sci, Fac Sci & Technol, Dept Phys, 2641 Yamazaki, Noda, Chiba 2788510, Japan.	6213702@ed.tus.ac.jp	EGUCHI, Ritsuko/H-4129-2011		Ministry of Education, Culture, Sports, Science and Technology of Japan [24350013]	This work was supported by a Grant-in-Aid for Scientific Research (Grant No. 24350013) from the Ministry of Education, Culture, Sports, Science and Technology of Japan.	Akaike K, 2013, CHEM PHYS, V415, P31, DOI 10.1016/j.chemphys.2013.02.011; Akaike K, 2010, ADV FUNCT MATER, V20, P715, DOI 10.1002/adfm.200901585; Andersson LM, 2014, APPL PHYS LETT, V104, DOI 10.1063/1.4863438; Ratcliff EL, 2012, ORG ELECTRON, V13, P744, DOI 10.1016/j.orgel.2012.01.022; YU G, 1995, SCIENCE, V270, P1789, DOI 10.1126/science.270.5243.1789; He YJ, 2010, J AM CHEM SOC, V132, P1377, DOI 10.1021/ja908602j; Scharber MC, 2006, ADV MATER, V18, P789, DOI 10.1002/adma.200501717; Kim JY, 2007, SCIENCE, V317, P222, DOI 10.1126/science.1141711; Chu CW, 2006, APPL PHYS LETT, V88, DOI 10.1063/1.2194207; Li XH, 2012, ADV MATER, V24, P3046, DOI 10.1002/adma.201200120; Dou LT, 2012, NAT PHOTONICS, V6, P180, DOI 10.1038/NPHOTON.2011.356; Dennler G, 2009, ADV MATER, V21, P1323, DOI 10.1002/adma.200801283; Akaike K, 2008, J APPL PHYS, V104, DOI 10.1063/1.2957588; He ZC, 2012, NAT PHOTONICS, V6, P591, DOI 10.1038/NPHOTON.2012.190; Ishii H, 1999, ADV MATER, V11, P605, DOI 10.1002/(SICI)1521-4095(199906)11:8<605::AID-ADMA605>3.0.CO;2-Q; Lenes M, 2008, ADV MATER, V20, P2116, DOI 10.1002/adma.200702438; Guan ZL, 2011, J APPL PHYS, V110, DOI 10.1063/1.3626938; Lenes M, 2009, ADV FUNCT MATER, V19, P3002, DOI 10.1002/adfm.200900459; Brabec CJ, 2010, ADV MATER, V22, P3839, DOI 10.1002/adma.200903697; Zhao GJ, 2010, ADV FUNCT MATER, V20, P1480, DOI 10.1002/adfm.200902447; Wienk MM, 2003, ANGEW CHEM INT EDIT, V42, P3371, DOI 10.1002/anie.200351647; Park SH, 2009, NAT PHOTONICS, V3, P297, DOI 10.1038/NPHOTON.2009.69; Zhao GJ, 2010, ADV MATER, V22, P4355, DOI 10.1002/adma.201001339; HUMMELEN JC, 1995, J ORG CHEM, V60, P532, DOI 10.1021/jo00108a012; Shaheen SE, 2001, APPL PHYS LETT, V78, P841, DOI 10.1063/1.1345834; Brabec CJ, 2001, ADV FUNCT MATER, V11, P374, DOI 10.1002/1616-3028(200110)11:5<374::AID-ADFM374>3.3.CO;2-N; Akaike K, 2013, ORG ELECTRON, V14, P1, DOI 10.1016/j.orgel.2012.09.025; Nogimura A, 2013, ORG ELECTRON, V14, P3222, DOI 10.1016/j.orgel.2013.09.031; Yasuda T, 2012, J MATER CHEM, V22, P2539, DOI 10.1039/c2jm14671a	29	5	5	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1566-1199	1878-5530		ORG ELECTRON	Org. Electron.	NOV	2014	15	11					2912	2921		10.1016/j.orgel.2014.08.013		10	Materials Science, Multidisciplinary; Physics, Applied	Materials Science; Physics	AS7GG	WOS:000344424500037		
J	Mayr, C; Taneda, M; Adachi, C; Brutting, W				Mayr, Christian; Taneda, Masatsugu; Adachi, Chihaya; Bruetting, Wolfgang			Different orientation of the transition dipole moments of two similar Pt(II) complexes and their potential for high efficiency organic light-emitting diodes	ORGANIC ELECTRONICS			English	Article						Organic light-emitting diode; Molecular orientation; Platinum(II) complex; Light outcoupling; Optical simulation	PHOSPHORESCENT EMITTERS; QUANTUM EFFICIENCY; ENERGY-TRANSFER; THIN-FILM; ELECTROPHOSPHORESCENCE; 100-PERCENT; DEVICES; EMISSION; MOLECULE; OLEDS	The efficiency of organic light-emitting diodes (OLEDs) is especially limited by their low light outcoupling efficiency. An approach for its enhancement is the use of horizontally oriented emitter molecules with respect to the substrate. In this study we quantitatively determine the orientation of the optical transition dipole moments in doped films of two similar phosphorescent Pt(II) complexes having a linear molecular structure. These emitters are employed in OLED devices and their efficiency is analyzed by optical simulations. For an OLED with slightly more horizontally oriented emitter molecules an external quantum efficiency (eta(EQE)) of 15.8% at low current-density is realized, indicating a relative improvement of outcoupling efficiency of 5.3% compared to the isotropic case. However, a very similar complex adopting isotropic molecular orientation yields eta(EQE) of only 11.5% implying an imperfect charge carrier balance in the OLED device and a shift of the recombination zone. Furthermore, we highlight the enormous potential of horizontal molecular orientation of emitting molecules in OLEDs. (C) 2014 Elsevier B.V. All rights reserved.	[Mayr, Christian; Bruetting, Wolfgang] Univ Augsburg, Inst Phys, D-86159 Augsburg, Germany; [Taneda, Masatsugu; Adachi, Chihaya] Kyushu Univ, Ctr Organ Photon & Elect Res OPERA, Nishi Ku, Fukuoka 8190395, Japan; [Adachi, Chihaya] Kyushu Univ, Int Inst Carbon Neutral Energy Res, Nishi Ku, Fukuoka 8190395, Japan	Mayr, C (reprint author), Univ Augsburg, Inst Phys, Univ Str 1, D-86159 Augsburg, Germany.	Christian.Mayr@physik.uni-augsburg.de; adachi@cstf.kyushu-u.ac.jp; Wolfgang.Bruetting@physik.uni-augsburg.de	Bruetting, Wolfgang/H-5258-2013	Bruetting, Wolfgang/0000-0001-9895-8281	Deutsche Forschungsgemeinschaft (DFG) [Br 1728/13-1]; Bayerische Forschungsstiftung; Japanese Society for the Promotion of Science (JSPS); New Energy and Industrial Technology Development Organization (NEDO), BEANS project	We acknowledge financial support by the Deutsche Forschungsgemeinschaft (DFG, contract no. Br 1728/13-1), the Bayerische Forschungsstiftung and the Japanese Society for the Promotion of Science (JSPS). This work was supported by the New Energy and Industrial Technology Development Organization (NEDO), BEANS project.	Kim SY, 2013, ADV FUNCT MATER, V23, P3896, DOI 10.1002/adfm.201300104; O'Brien DF, 1999, APPL PHYS LETT, V74, P442, DOI 10.1063/1.123055; Reineke S, 2007, PHYS REV B, V75, DOI 10.1103/PhysRevB.75.125328; Flammich M, 2010, ORG ELECTRON, V11, P1039, DOI 10.1016/j.orgel.2010.03.002; Huang LM, 2013, J MATER CHEM C, V1, P7582, DOI 10.1039/c3tc31524j; Baldo MA, 1999, PHYS REV B, V60, P14422, DOI 10.1103/PhysRevB.60.14422; Wilson JS, 2001, NATURE, V413, P828, DOI 10.1038/35101565; Wang ZB, 2011, APPL PHYS LETT, V98, DOI 10.1063/1.3593495; Shore JD, 2005, APPL PHYS LETT, V86, DOI 10.1063/1.1925321; Segal M, 2003, PHYS REV B, V68, DOI 10.1103/PhysRevB.68.075211; WEBER WH, 1979, OPT LETT, V4, P236, DOI 10.1364/OL.4.000236; Kim KH, 2014, ADV MATER, V26, P3844, DOI 10.1002/adma.201305733; Adachi C, 2001, J APPL PHYS, V90, P5048, DOI 10.1063/1.1409582; Baldo MA, 2000, PHYS REV B, V62, P10967, DOI 10.1103/PhysRevB.62.10967; Yokoyama D, 2009, ORG ELECTRON, V10, P127, DOI 10.1016/j.orgel.2008.10.010; Frischeisen J, 2010, APPL PHYS LETT, V96, DOI 10.1063/1.3309705; Hudson ZM, 2010, ADV FUNCT MATER, V20, P3426, DOI 10.1002/adfm.201000904; Lamansky S, 2001, J AM CHEM SOC, V123, P4304, DOI 10.1021/ja003693s; Frischeisen J, 2011, J PHOTON ENERGY, V1, DOI 10.1117/1.3523314; Goushi K, 2004, J APPL PHYS, V95, P7798, DOI 10.1063/1.1751232; Turner E, 2013, INORG CHEM, V52, P7344, DOI 10.1021/ic302490c; Schmidt TD, 2011, APPL PHYS LETT, V99, DOI 10.1063/1.3653475; Yokoyama D, 2010, ADV FUNCT MATER, V20, P386, DOI 10.1002/adfm.200901684; Yokoyama D, 2011, J MATER CHEM, V21, P19187, DOI 10.1039/c1jm13417e; Baldo MA, 1998, NATURE, V395, P151; Baldo MA, 1999, APPL PHYS LETT, V75, P4, DOI 10.1063/1.124258; Pfeiffer M, 2003, ORG ELECTRON, V4, P89, DOI 10.1016/j.orgel.2003.08.004; Frischeisen J, 2011, ORG ELECTRON, V12, P809, DOI 10.1016/j.orgel.2011.02.005; Dalal SS, 2013, J PHYS CHEM B, V117, P15415, DOI 10.1021/jp405005n; Lee J, 2008, APPL PHYS LETT, V93, DOI 10.1063/1.2978235; Mayr C, 2014, ADV FUNCT MATER, V24, P5232, DOI 10.1002/adfm.201400495; Flammich M, 2011, ORG ELECTRON, V12, P1663, DOI 10.1016/j.orgel.2011.06.011; Yokoyama D, 2010, J APPL PHYS, V107, DOI 10.1063/1.3432568; Tsutsui T, 1997, PHILOS T R SOC A, V355, P801; Brutting W., 2012, PHYS STATUS SOLIDI A, V210, P44; Flammich M, 2011, ORG ELECTRON, V12, P83, DOI 10.1016/j.orgel.2010.09.019; Kawamura Y, 2005, APPL PHYS LETT, V86, DOI 10.1063/1.1862777; Meerholz K, 2001, ADV FUNCT MATER, V11, P251, DOI 10.1002/1616-3028(200108)11:4<251::AID-ADFM251>3.0.CO;2-Y; Nowy S, 2008, J APPL PHYS, V104, DOI 10.1063/1.3043800; Sun Y., 1999, PHYS REV B, V60, P14422; Taneda M, 2011, APPL PHYS EXPRESS, V4, DOI 10.1143/APEX.4.071602; TANG CW, 1987, APPL PHYS LETT, V51, P913, DOI 10.1063/1.98799	42	6	6	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1566-1199	1878-5530		ORG ELECTRON	Org. Electron.	NOV	2014	15	11					3031	3037		10.1016/j.orgel.2014.07.042		7	Materials Science, Multidisciplinary; Physics, Applied	Materials Science; Physics	AS7GG	WOS:000344424500052		
J	Nagasaki, Y; Lee, JH; Kubozono, Y; Kambe, T				Nagasaki, Yuya; Lee, Ji-Hyun; Kubozono, Yoshihiro; Kambe, Takashi			Dynamics of carrier injection in picene thin-film field-effect transistors with an ionic liquid sheet and ionic liquid gel	ORGANIC ELECTRONICS			English	Article						Picene; Electric double layer; Field-effect transistor; Electron spin resonance; Ionic liquid gel	ELECTRON-SPIN-RESONANCE; SUPERCONDUCTIVITY; INSULATOR; CAPACITANCE	We fabricated picene thin-film field-effect transistors (FETs) with an ionic liquid gel and ionic liquid sheet as the gate electrolyte, and then used electron spin resonance (ESR) to investigate the carrier injection process in the organic electric double layer (EDL) FET. The ESR spectra strongly depended on the morphology of gate electrolytes. Three types of carrier injection processes in the EDL-FET were observed by examining the applied-bias time, organic-layer thickness, and gate-voltage dependencies of the electric-field-induced ESR spectrum: (1) interface injection due to electrostatic EDL formation, (2) bulk injection due to penetration of ions (electrochemical bulk doping), and (3) electrochemical reaction. These findings are significant for designing novel materials using the EDL-FET technique because three different carrier injection processes may lead to different physical properties, even in the same organic material. (C) 2014 Elsevier B.V. All rights reserved.	[Nagasaki, Yuya; Lee, Ji-Hyun; Kambe, Takashi] Okayama Univ, Dept Phys, Okayama 7008530, Japan; [Kubozono, Yoshihiro] Okayama Univ, Res Lab Interface Sci, Okayama 7008530, Japan; [Kubozono, Yoshihiro] Okayama Univ, Res Ctr New Funct Mat Energy Prod Storage & Trans, Okayama 7008530, Japan	Kambe, T (reprint author), Okayama Univ, Dept Phys, Okayama 7008530, Japan.	kambe@science.okayama-u.ac.jp	KUBOZONO, Yoshihiro/B-2091-2011; KAMBE, Takashi/B-2117-2011		Japanese Ministry of Education, Culture, Sports, Science and Technology, Japan [23340104, 22244045]; LEMSUPER project (JST-EU Superconductor project) of the Japan Science and Technology Agency	This research is partly supported by a Grant-in-Aid for Scientific Research from the Japanese Ministry of Education, Culture, Sports, Science and Technology, Japan (23340104 and 22244045) and by the LEMSUPER project (JST-EU Superconductor project) of the Japan Science and Technology Agency.	Watanabe S, 2010, APPL PHYS LETT, V96, DOI 10.1063/1.3421538; Marumoto K, 2005, J PHYS SOC JPN, V74, P3066, DOI 10.1143/JPSJ.74.3066; Hultgren VM, 2002, ANAL CHEM, V74, P3151, DOI 10.1021/ac015729k; Kaji Y, 2011, ORG ELECTRON, V12, P2076, DOI 10.1016/j.orgel.2011.08.016; Hamedi M, 2009, ADV MATER, V21, P573, DOI 10.1002/adma.200802681; Ueno K, 2008, NAT MATER, V7, P855, DOI 10.1038/nmat2298; Lee KH, 2012, ADV MATER, V24, P4457, DOI 10.1002/adma.201200950; Lee J, 2009, J PHYS CHEM C, V113, P8972, DOI 10.1021/jp901426e; Bollinger AT, 2011, NATURE, V472, P458, DOI 10.1038/nature09998; Dhoot AS, 2010, ADV MATER, V22, P2529, DOI 10.1002/adma.200904024; Ye JT, 2012, SCIENCE, V338, P1193, DOI 10.1126/science.1228006; Ye JT, 2010, NAT MATER, V9, P125, DOI [10.1038/nmat2587, 10.1038/NMAT2587]; Ueno K, 2011, NAT NANOTECHNOL, V6, P408, DOI [10.1038/nnano.2011.78, 10.1038/NNANO.2011.78]; Kasahara Y, 2012, J PHYS CONF SER, V400, DOI 10.1088/1742-6596/400/2/022049; KINOSHITA N, 1985, J PHYS SOC JPN, V54, P4498, DOI 10.1143/JPSJ.54.4498; Nojima T, 2011, PHYS REV B, V84, DOI 10.1103/PhysRevB.84.020502; Okamoto H, 2014, SCI REP-UK, V4, DOI 10.1038/srep05330; Shimo Y., 2014, UNPUB; Shimoi Y, 2012, MOL CRYST LIQ CRYST, V566, P33, DOI 10.1080/15421406.2012.701113; Mitsuhashi R, 2010, NATURE, V464, P76, DOI 10.1038/nature08859; Takahashi Y, 2013, APPL PHYS EXPRESS, V6, DOI 10.7567/APEX.6.041603; Tsuji M, 2011, APPL PHYS EXPRESS, V4, DOI 10.1143/APEX.4.085702; Tsuji M, 2013, APPL PHYS LETT, V102, DOI 10.1063/1.4800550; Yuen JD, 2007, J AM CHEM SOC, V129, P14367, DOI 10.1021/ja0749845	24	2	2	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1566-1199	1878-5530		ORG ELECTRON	Org. Electron.	NOV	2014	15	11					3070	3075		10.1016/j.orgel.2014.08.043		6	Materials Science, Multidisciplinary; Physics, Applied	Materials Science; Physics	AS7GG	WOS:000344424500057		
J	Bisoyi, S; Zschieschang, U; Kang, MJ; Takimiya, K; Klauk, H; Tiwari, SP				Bisoyi, Sibani; Zschieschang, Ute; Kang, Myeong Jin; Takimiya, Kazuo; Klauk, Hagen; Tiwari, Shree Prakash			Bias-stress stability of low-voltage p-channel and n-channel organic thin-film transistors on flexible plastic substrates	ORGANIC ELECTRONICS			English	Article						Organic thin-film transistors; Bias stress; 10%-Current-decay lifetime	FIELD-EFFECT TRANSISTORS; AMOLED DISPLAY; DRIVEN; SEMICONDUCTOR; PERFORMANCE; INSTABILITY; OPERATION; MOBILITY; TFTS	The bias-stress stability of low-voltage organic p-channel and n-channel thin-film transistors (TFTs) based on five promising organic semiconductors and fabricated on flexible polyethylene naphthalate (PEN) substrates has been investigated. In particular, it has been studied to which extent the bias-stress-induced decay of the on-state drain current of the TFTs is affected by the choice of the semiconductor and by the gate-source and drain-source voltages applied during bias stress. It has been found that for at least some of the organic p-channel TFTs investigated in this study, the bias-stress stability is comparable to that of a-Si:H and metal-oxide TFTs, despite the fact that the organic TFTs were fabricated at significantly lower process temperatures, which is important in view of the fabrication of these devices on plastic substrates. (C) 2014 Elsevier B.V. All rights reserved.	[Bisoyi, Sibani; Tiwari, Shree Prakash] Indian Inst Technol, Ctr Informat & Commun Technol, Jodhpur 342011, Rajasthan, India; [Bisoyi, Sibani; Zschieschang, Ute; Klauk, Hagen] Max Planck Inst Solid State Res, D-70569 Stuttgart, Germany; [Kang, Myeong Jin] Hiroshima Univ, Dept Appl Chem, Higashihiroshima 7398527, Japan; [Takimiya, Kazuo] RIKEN, Ctr Emergent Matter Sci, Wako, Saitama 3510198, Japan	Bisoyi, S (reprint author), Indian Inst Technol, Ctr Informat & Commun Technol, Jodhpur 342011, Rajasthan, India.	sibani.bisoyi@iitj.ac.in; sptiwari@iitj.ac.in	Takimiya, Kazuo/A-5841-2010; 	Takimiya, Kazuo/0000-0002-6001-1129; Tiwari, Shree Prakash/0000-0001-8907-6113	BASF SE; German Ministry of Education and Research (BMBF) [13N10205, 13N12084, 13N10763, 1612000463]	This work was partially funded by BASF SE and by the German Ministry of Education and Research (BMBF) under Grants 13N10205, 13N12084 and 13N10763 (POLYTOS and KOSADIS; Research Network Forum Organic Electronics) and under Grant 1612000463 (KoSiF). The authors gratefully acknowledge BASF SE, Ludwigshafen, Germany, for providing the organic semiconductor NTCDI-Cl<INF>2</INF>-(CH<INF>2</INF>C<INF>3</INF>F<INF>7</INF>)<INF>2</INF> employed in this study. Sibani Bisoyi would like to thank Klaus von Klitzing for providing the opportunity to work at the Max Planck Institute for Solid State Research.	Glowacki ED, 2013, ADV MATER, V25, P1563, DOI 10.1002/adma.201204039; Doi I, 2012, CURR APPL PHYS, V12, pE2, DOI 10.1016/j.cap.2011.09.011; Yang S, 2011, IEEE ELECTR DEVICE L, V32, P1692, DOI 10.1109/LED.2011.2167122; Nakajima Y, 2009, J SOC INF DISPLAY, V17, P629, DOI 10.1889/JSID17.8.629; Steudel S, 2012, ORG ELECTRON, V13, P1729, DOI 10.1016/j.orgel.2012.05.034; Hwang DK, 2011, ORG ELECTRON, V12, P1108, DOI 10.1016/j.orgel.2011.04.002; Oh JH, 2010, ADV FUNCT MATER, V20, P2148, DOI 10.1002/adfm.201000425; Ling MM, 2006, ORG ELECTRON, V7, P568, DOI 10.1016/j.orgel.2006.09.003; Zhou LS, 2006, APPL PHYS LETT, V88, DOI 10.1063/1.2178213; Zaki T, 2014, IEEE T ELECTRON DEV, V61, P98, DOI 10.1109/TED.2013.2292390; Zschieschang U, 2012, J MATER CHEM, V22, P4273, DOI 10.1039/c1jm14917b; Meerheim R, 2011, J APPL PHYS, V109, DOI 10.1063/1.3590142; Yan Y, 2011, ORG ELECTRON, V12, P823, DOI 10.1016/j.orgel.2011.02.019; Zschieschang U, 2009, APPL PHYS A-MATER, V95, P139, DOI 10.1007/s00339-008-5019-8; Colleaux F, 2011, PHYS CHEM CHEM PHYS, V13, P14387, DOI 10.1039/c1cp20769e; Niimi K, 2011, ORG LETT, V13, P3430, DOI 10.1021/ol2010837; Bao ZA, 1998, J AM CHEM SOC, V120, P207, DOI 10.1021/ja9727629; Sekitani T, 2005, APPL PHYS LETT, V87, DOI 10.1063/1.2031932; Fujisaki Y, 2012, IEEE T ELECTRON DEV, V59, P3442, DOI 10.1109/TED.2012.2220968; Ante F, 2012, SMALL, V8, P73, DOI 10.1002/smll.201101677; Sirringhaus H, 2009, ADV MATER, V21, P3859, DOI 10.1002/adma.200901136; Noda M, 2011, J SOC INF DISPLAY, V19, P316, DOI 10.1889/JSID19.4.316; Tiwari SP, 2009, APPL PHYS LETT, V95, DOI 10.1063/1.3269579; Bobbert PA, 2012, ADV MATER, V24, P1146, DOI 10.1002/adma.201104580; Stolte M, 2012, PHYS CHEM CHEM PHYS, V14, P14181, DOI 10.1039/c2cp41552f; Kang MJ, 2011, ADV MATER, V23, P1222, DOI 10.1002/adma.201001283; Zschieschang U, 2011, ORG ELECTRON, V12, P1370, DOI 10.1016/j.orgel.2011.04.018; Salleo A, 2003, J APPL PHYS, V94, P471, DOI 10.1063/1.1581352; Kalb WL, 2007, PHYS REV B, V76, DOI 10.1103/PhysRevB.76.184112; Yokota T, 2013, ADV MATER, V25, P3639, DOI 10.1002/adma.201300941; Gomes HL, 2006, APPL PHYS LETT, V88, DOI 10.1063/1.2178410; Hausermann R, 2011, APPL PHYS LETT, V99, DOI 10.1063/1.3628297; Hekmatshoar B, 2008, APPL PHYS LETT, V93, DOI 10.1063/1.2963481; Hekmatshoar B, 2009, APPL PHYS LETT, V95, DOI 10.1063/1.3238559; Ishida K, 2011, IEEE J SOLID-ST CIRC, V46, P285, DOI 10.1109/JSSC.2010.2074330; Kalb WL, 2007, APPL PHYS LETT, V90, DOI 10.1063/1.2709894; Kraft U., 2014, 56 EL MAT C SA UNPUB; Levy DH, 2008, APPL PHYS LETT, V92, DOI 10.1063/1.2924768; Lu XB, 2011, APPL PHYS LETT, V98, DOI 10.1063/1.3599056; Park JH, 2013, ACS APPL MATER INTER, V5, P1625, DOI 10.1021/am3022703; Richards T, 2008, APPL PHYS LETT, V92, DOI 10.1063/1.2825584; Riedl T, 2007, PHYS STATUS SOLIDI-R, V1, P175, DOI 10.1002/pssr.200701129; Rodel R, 2013, APPL PHYS LETT, V102, DOI 10.1063/1.4811127; Street RA, 2006, J APPL PHYS, V100, DOI 10.1063/1.2398798; Suemori K, 2009, JPN J APPL PHYS, V48, DOI 10.1143/JJAP.48.04C170; Tiwari SP, 2009, J APPL PHYS, V106, DOI 10.1063/1.3204655; Wang SD, 2008, APPL PHYS LETT, V92, DOI 10.1063/1.2844857; Yagi I, 2008, J SOC INF DISPLAY, V16, P15, DOI 10.1889/1.2835023; Yamamoto T, 2007, J AM CHEM SOC, V129, P2224, DOI 10.1021/ja068429z; Zan HW, 2008, IEEE ELECTR DEVICE L, V29, P155, DOI 10.1109/LED.2007.914081; Zhang X.H., 2009, ORG ELECTRON, V10, P1133	51	1	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1566-1199	1878-5530		ORG ELECTRON	Org. Electron.	NOV	2014	15	11					3173	3182		10.1016/j.orgel.2014.08.057		10	Materials Science, Multidisciplinary; Physics, Applied	Materials Science; Physics	AS7GG	WOS:000344424500070		
J	Kapil, G; Pandey, SS; Ogomi, Y; Ma, TL; Hayase, S				Kapil, Gaurav; Pandey, Shyam S.; Ogomi, Yuhei; Ma, Tingli; Hayase, Shuzi			Titanium wire engineering and its effect on the performance of coil type cylindrical dye sensitized solar cells	ORGANIC ELECTRONICS			English	Article						Titanium (Ti) wires; TCO-less; Coil type cylindrical dye-sensitized solar cells (C-DSSCs); TiO2; H2O2 treatment	TIO2 NANOTUBE ARRAY; SURFACE; FABRICATION; EFFICIENCY; CONVERSION; SUBSTRATE; FTIR	This paper reports a comparative study of the photovoltaic characteristics of titanium (Ti) metal wires with different diameter and surface treatments towards their utilization as photoanodes for coil-based dye-sensitized solar cells. The surface property of the Ti wire, especially oxidized overlayer and surface treatments have been found to greatly influence the adhesion as well as optimum electrical contact between coated nanoporous titanium oxide (TiO2) and Ti-wires. Implication of adhesion of nanoporous TiO2 on the titanium wire and its influence on photovoltaic performance was analyzed using electrochemical impedance spectroscopy. Results of X-ray diffraction, X-ray photoelectron spectroscopy and scanning electron microscopy reveals the formation of anatase TiO2 nanosheets after the H2O2 surface treatment on the titanium wire resulting into enhancement in the extent of dye loading leading to enhanced photoconversion efficiency of 4.71% under simulated solar irradiation. (C 2014 Elsevier B.V. All rights reserved.	[Kapil, Gaurav; Pandey, Shyam S.; Ogomi, Yuhei; Ma, Tingli; Hayase, Shuzi] Kyushu Inst Technol, Grad Sch Life Sci & Syst Engn, Wakamatsu Ku, Kitakyushu, Fukuoka 8080196, Japan	Kapil, G (reprint author), Kyushu Inst Technol, Grad Sch Life Sci & Syst Engn, Wakamatsu Ku, 2-4 Hibikino, Kitakyushu, Fukuoka 8080196, Japan.	gauravkapil.ece@gmail.com; hayase@life.kyutech.ac.jp					Lee CH, 2011, J MATER CHEM, V21, P5114, DOI 10.1039/c0jm04099a; Lv ZB, 2012, NANOSCALE, V4, P1248, DOI 10.1039/c2nr11532h; Liu Y, 2010, APPL ENERG, V87, P436, DOI 10.1016/j.apenergy.2009.08.039; Ushiroda S, 2005, J AM CHEM SOC, V127, P5158, DOI 10.1021/ja044001t; VLACHOPOULOS N, 1988, J AM CHEM SOC, V110, P1216, DOI 10.1021/ja00212a033; Fan X, 2008, ADV MATER, V20, P592, DOI 10.1002/adma.200701249; Arshi N, 2013, B MATER SCI, V36, P807, DOI 10.1007/s12034-013-0552-2; Choi H, 2012, CURR APPL PHYS, V12, P737, DOI 10.1016/j.cap.2011.10.011; Usagawa J, 2013, PROG PHOTOVOLTAICS, V21, P517, DOI 10.1002/pip.1223; Erdem B, 2001, LANGMUIR, V17, P2664, DOI 10.1021/la0015213; Onoda K, 2007, SOL ENERG MAT SOL C, V91, P1176, DOI 10.1016/j.solmat.2006.12.017; Kumar PM, 2000, THIN SOLID FILMS, V358, P122, DOI 10.1016/S0040-6090(99)00722-1; Kim M, 2013, APPL PHYS LETT, V102, DOI 10.1063/1.4804987; Yun HG, 2008, APPL PHYS LETT, V93, DOI 10.1063/1.2996017; An J, 2012, SMALL, V8, P3427, DOI 10.1002/smll.201200802; Kapil G, 2014, RSC ADV, V4, P22959, DOI 10.1039/c4ra02999b; Lv ZB, 2011, PHYS CHEM CHEM PHYS, V13, P10076, DOI 10.1039/c1cp20543a; Ito S, 2008, THIN SOLID FILMS, V516, P4613, DOI 10.1016/j.tsf.2007.05.090; Kashiwa Y, 2008, APPL PHYS LETT, V92, DOI 10.1063/1.2837633; Tsai TY, 2013, PROG PHOTOVOLTAICS, V21, P226, DOI 10.1002/pip.1173; Lim Y.C., 2011, INT J PHOTO, V2012; Rajesh D, 2012, INDIAN J PHYS, V86, P681, DOI 10.1007/s12648-012-0122-2; Thamaphat K., 2008, KASETSART J NATURAL, V42, P357; Yu JF, 2011, NANOSCALE RES LETT, V6, DOI 10.1186/1556-276X-6-94	24	1	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1566-1199	1878-5530		ORG ELECTRON	Org. Electron.	NOV	2014	15	11					3399	3405		10.1016/j.orgel.2014.09.023		7	Materials Science, Multidisciplinary; Physics, Applied	Materials Science; Physics	AS7GG	WOS:000344424500097		
J	Tanikawa, C; Takada, K				Tanikawa, C.; Takada, K.			Objective classification of nose-lip-chin profiles and their relation to dentoskeletal traits	ORTHODONTICS & CRANIOFACIAL RESEARCH			English	Article						classification; facial profile; vector quantization	TISSUE CEPHALOMETRIC ANALYSIS; ORTHODONTIC TREATMENT; FACIAL PROFILE; INCISOR RETRACTION; SKELETAL; SHAPE; ESTHETICS; RELIABILITY; EXTRACTION; PREDICTION	Structured Abstract ObjectivesTo objectively classify the nose-lip-chin profiles of adult women and identify any associations between the nose-lip-chin profile patterns and dentoskeletal patterns. Setting and Sample PopulationLateral facial photographs and lateral cephalograms were obtained for 229 Japanese women who were being assessed for orthodontic treatment. MethodsA feature vector that was effective in distinguishing differences in nose-lip-chin profiles was extracted for each photograph. To categorize the records into an optimum number of subclasses according to nose-lip-chin profile configurations, a vector quantization method was applied to the feature vectors of all samples. Dentoskeletal patterns that corresponded to the nose-lip-chin profile subclasses were compared. ResultsEight profile patterns were identified, and the differences among patterns were notably maximized by the nasolabial angle, configuration and vertical length of the subnasal region, vertical thickness of the lip vermilion borders, sagittal position of the upper- and lower-lip vermilion borders and their relation to each other, labiomental angle, depth of the labiomental sulcus, degree of prominence of the chin, and degree of protrusion of the mandible. The dentoskeletal patterns showed significant differences between the classified profile patterns (p<0.01). ConclusionsA method to objectively classify the nose-lip-chin profiles of adult women was established, and the nose-lip-chin profile patterns were found to be associated with the dentoskeletal patterns.	[Tanikawa, C.] Osaka Univ, Grad Sch Dent, Ctr Adv Med Engn & Informat, Dept Orthodont, Osaka, Japan; [Takada, K.] Natl Univ Singapore, Fac Dent, Discipline Orthodont & Paediat Dent, Singapore 119083, Singapore	Takada, K (reprint author), Natl Univ Singapore, Fac Dent, 11 Lower Kent Ridge Rd, Singapore 119083, Singapore.	denkt@nus.edu.sg					SHROUT PE, 1979, PSYCHOL BULL, V86, P420, DOI 10.1037//0033-2909.86.2.420; Rose AD, 2003, AM J PHYS ANTHROPOL, V121, P172, DOI 10.1002/ajpa.10173; DROBOCKY OB, 1989, AM J ORTHOD DENTOFAC, V95, P220, DOI 10.1016/0889-5406(89)90052-8; PECK H, 1970, ANGLE ORTHOD, V40, P284; Ferrario VF, 1997, CLEFT PALATE-CRAN J, V34, P498, DOI 10.1597/1545-1569(1997)034<0498:SASOST>2.3.CO;2; LEGAN HL, 1980, J ORAL SURG, V38, P744; Takada K, 2009, ANGLE ORTHOD, V79, P885, DOI 10.2319/081908-436.1; Arnett GW, 1999, AM J ORTHOD DENTOFAC, V116, P239, DOI 10.1016/S0889-5406(99)70234-9; Blanchette ME, 1996, AM J ORTHOD DENTOFAC, V109, P116, DOI 10.1016/S0889-5406(96)70172-5; BURSTONE CJ, 1967, AMER J ORTHODONTICS, V53, P262, DOI 10.1016/0002-9416(67)90022-X; CHANG PC, 1986, IEEE T ACOUST SPEECH, V34, P679, DOI 10.1109/TASSP.1986.1164905; Erdinc AE, 2007, AM J ORTHOD DENTOFAC, V132, P324, DOI 10.1016/j.ajodo.2005.08.045; Farkas LG, 1994, ANTHROPOMETRY HEAD F; Fernandez-Riveiro P, 2002, AM J ORTHOD DENTOFAC, V122, P59, DOI 10.1067/mod.2002.125236; Godt A, 2007, EUR J ORTHODONT, V29, P648, DOI 10.1093/ejo/cjm073; Halazonetis DJ, 2007, AM J ORTHOD DENTOFAC, V132, P450, DOI 10.1016/j.ajodo.2005.10.033; HALAZONETIS DJ, 1991, AM J ORTHOD DENTOFAC, V99, P49, DOI 10.1016/S0889-5406(05)81680-4; HOLDAWAY RA, 1983, AM J ORTHOD DENTOFAC, V84, P1, DOI 10.1016/0002-9416(83)90144-6; JACOBS JD, 1978, AM J ORTHOD DENTOFAC, V74, P396, DOI 10.1016/0002-9416(78)90061-1; MAUCHAMP O, 1973, AM J ORTHOD DENTOFAC, V64, P83, DOI 10.1016/0002-9416(73)90282-0; MERRIFIE.LL, 1966, AMER J ORTHODONTICS, V52, P804, DOI 10.1016/0002-9416(66)90250-8; OLIVER BM, 1982, AM J ORTHOD DENTOFAC, V82, P141, DOI 10.1016/0002-9416(82)90492-4; PERKINS RA, 1993, AM J ORTHOD DENTOFAC, V103, P147, DOI 10.1016/S0889-5406(05)81764-0; Proffit WR, 2000, CONT ORTHODONTICS; RICKETTS RM, 1968, AMER J ORTHODONTICS, V54, P272, DOI 10.1016/S0002-9416(68)90278-9; Stoner MM, 1955, AM J ORTHOD, V45, P481; Subtelny JD, 1959, AM J ORTHOD, V45, P481; TAKADA K, 1984, AM J ORTHOD DENTOFAC, V86, P331, DOI 10.1016/0002-9416(84)90144-1; Tangchaitrong K, 2000, AM J PHYS ANTHROPOL, V113, P369, DOI 10.1002/1096-8644(200011)113:3<369::AID-AJPA7>3.3.CO;2-L; Tanikawa C, 2009, ANGLE ORTHOD, V79, P849, DOI 10.2319/103008-552.1; Tanikawa C, 2007, ANGLE ORTHOD, V77, P821, DOI 10.2319/061806-247.1; Tanikawa C, 2009, ANGLE ORTHOD, V79, P1037, DOI [10.2319/092908-508R.1, 10.2319/092908-508.1]; Utsuno H, 2010, FORENSIC SCI INT, V195, P165; Wada K, 1977, J OSAKA U DENT SOC, V22, P239	34	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1601-6335	1601-6343		ORTHOD CRANIOFAC RES	Orthod. Craniofac. Res.	NOV	2014	17	4					226	238		10.1111/ocr.12047		13	Dentistry, Oral Surgery & Medicine	Dentistry, Oral Surgery & Medicine	AS6GB	WOS:000344361300003		
J	Ishikawa, M; Yoshioka, K; Urano, K; Tanaka, Y; Hatanaka, T; Nii, A				Ishikawa, M.; Yoshioka, K.; Urano, K.; Tanaka, Y.; Hatanaka, T.; Nii, A.			Biocompatibility of cross-linked hyaluronate (Gel-200) for the treatment of knee osteoarthritis	OSTEOARTHRITIS AND CARTILAGE			English	Article						Osteoarthritis; Photo-gelation technology; Gel-200; Cross-linked hyaluronic acid; Biocompatibility	G-F 20; INTRAARTICULAR HYLAN GF-20; CONTROLLED-TRIAL; GUINEA-PIGS; G-F-20; INFLAMMATION; INJECTION; EFFICACY; SAFETY; ACID	Objective: To compare the biocompatibility and immunogenicity of two intra-articular hyaluronan formulations, Gel-200 (Gel-One (R)) and hylan G-F 20 (Synvisc (R) series). Experimental design: A comparison of the biocompatibility of Gel-200 and hylan G-F 20 was made using a rat subcutaneous air pouch model and the knee joint of normal rabbits. Immunogenicity was evaluated using a homologous passive cutaneous anaphylaxis (PCA) assay in guinea pigs. Results: In the air pouch model in rats, characteristic fibrous belts formed in the subcutaneous tissue. Injection of hylan G-F 20 into the air pouch induced granulomatous nodules primarily composed of macrophages, multinucleated giant cells, and eosinophils accompanied with the test material in the center of the nodules in the fibrous belt. Furthermore, the thickness of the fibrous belt in the hylan G-F 20 group increased significantly compared to the saline group. Injection of Gel-200 into the air pouch induced neither granulomatous inflammation nor significant thickening of fibrous belt, while foamy macrophages containing the test material were observed. Intra-articular injection of hylan G-F 20 into the rabbit knee joints induced granulomatous inflammation, eosinophil infiltration, and significant increase in the number of cells in the synovial fluid, while these findings were absent in the Gel-200 group. In the immunogenicity assay, hylan G-F 20 induced a positive PCA reaction, but the Gel-200 did not. Conclusion: Gel-200 showed more favorable biocompatibility and less immunogenicity compared to hylan G-F 20. Gel-200 is expected to be a single injection hyaluronan product with less safety concerns for the treatment of knee osteoarthritis (OA) pain. (C) 2014 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.	[Ishikawa, M.; Yoshioka, K.; Urano, K.; Tanaka, Y.; Hatanaka, T.; Nii, A.] Seikagaku Corp, Div Res & Dev, Cent Res Labs, Higashiyamato, Tokyo 2070021, Japan	Urano, K (reprint author), Seikagaku Corp, Cent Res Lab, 1253 Tateno 3-Chome, Higashiyamato, Tokyo 2070021, Japan.	kei.urano@seikagaku.co.jp					EDWARDS JCW, 1981, J PATHOL, V134, P147, DOI 10.1002/path.1711340205; Pagnano M, 2005, OSTEOARTHR CARTILAGE, V13, P751, DOI 10.1016/j.joca.2005.04.012; Beer K, 2007, DERMATOL SURG, V33, P928, DOI 10.1111/j.1524-4725.2007.33194.x; [Anonymous], 2004, CLIN ORTHOP RELA FEB, DOI DOI 10.1097/01.BLO.0000116314.20130.11; Strand V, 2012, OSTEOARTHR CARTILAGE, V20, P350, DOI 10.1016/j.joca.2012.01.013; Hamburger MI, 2003, SEMIN ARTHRITIS RHEU, V32, P296, DOI 10.1053/sarh.2002.50008; Robinson DS, 2000, BRIT MED BULL, V56, P956, DOI 10.1258/0007142001903625; Zhang W, 2008, OSTEOARTHR CARTILAGE, V16, P137, DOI [10.1016/j.joca.2007.12.013, 10.1016/j.joca.2010.01.013]; Mapp PI, 2013, OSTEOARTHR CARTILAGE, V21, P1336, DOI 10.1016/j.joca.2013.06.031; [Anonymous], 2000, ARTHRITIS RHEUM, V43, P1905; Wobig M, 1998, CLIN THER, V20, P410, DOI 10.1016/S0149-2918(98)80052-0; WATANABE N, 1977, J IMMUNOL METHODS, V14, P381, DOI 10.1016/0022-1759(77)90149-1; Xia Z, 2006, BIOMED MATER, V1, pR1, DOI 10.1088/1748-6041/1/1/R01; SANDERSON CJ, 1992, BLOOD, V79, P3101; Balazs EA, 1989, CELLULOSICS UTILIZAT, P233; Bucher W, 2002, ARTHRITIS RHEUM, V46, P2543, DOI 10.1002/art.10450; Chen AL, 2002, J BONE JOINT SURG AM, V84A, P1142; Choquet-Kastylevsky G, 1998, TOXICOLOGY, V129, P27, DOI 10.1016/S0300-483X(98)00060-2; Dragomir CL, 2012, OSTEOARTHR CARTILAGE, V20, P791, DOI 10.1016/j.joca.2012.03.020; Gil JT, 2003, ARTHRITIS RHEUM, V48, P866, DOI 10.1002/art.10821; Jackson DW, 2006, OSTEOARTHR CARTILAGE, V14, P1248, DOI 10.1016/j.joca.2006.05.015; Leopold SS, 2002, J BONE JOINT SURG AM, V84A, P1619; Martens PB, 2001, ARTHRITIS RHEUM, V44, P978, DOI 10.1002/1529-0131(200104)44:4<978::AID-ANR156>3.3.CO;2-E; Michou L, 2004, JOINT BONE SPINE, V71, P438, DOI 10.1016/j.jbspin.2003.09.006; Nagami Kazuyuki, 1995, Journal of Toxicological Sciences, V20, P579; Ohshima Y, 2004, JPN PHARMACOL THER, V32, P655; Ottaviani RA, 2007, J BONE JOINT SURG AM, V89A, P148, DOI 10.2106/JBJS.E.01135; Peyron J G, 1993, J Rheumatol Suppl, V39, P10; PUTTICK MPE, 1995, J RHEUMATOL, V22, P1311; Sasaki M, 2004, J RHEUMATOL, V31, P943; Sasaki M, 2003, TOXICOL PATHOL, V31, P321, DOI 10.1080/01926230390204360; Schiavinato A, 2002, CLIN EXP RHEUMATOL, V20, P445; Shichikawa K, 1983, Ryumachi, V23, P280; Waddell DD, 2014, J KNEE SURG, V27, P99, DOI 10.1055/s-0033-1348407; Wooley PH, 2012, J BIOMED MATER RES B, V100B, P808, DOI 10.1002/jbm.b.32514; Zardawi IM, 2001, PATHOLOGY, V33, P519	36	2	2	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1063-4584	1522-9653		OSTEOARTHR CARTILAGE	Osteoarthritis Cartilage	NOV	2014	22	11					1902	1909		10.1016/j.joca.2014.08.002		8	Orthopedics; Rheumatology	Orthopedics; Rheumatology	AS3NR	WOS:000344186000017		
J	Nakamura, K; Kitamura, K; Inoue, M; Sawada, N; Tsugane, S				Nakamura, K.; Kitamura, K.; Inoue, M.; Sawada, N.; Tsugane, S.			Physical activity and 10-year incidence of self-reported vertebral fractures in Japanese women: The Japan Public Health Center-based Prospective Study	OSTEOPOROSIS INTERNATIONAL			English	Article						Cohort studies; Metabolic equivalent; Motor activity; Osteoporotic fractures; Sedentary lifestyle; Spinal fractures	OSTEOPOROTIC FRACTURES; RISK-FACTORS; ASSOCIATION; POPULATION; MEN; PREVENTION; COHORT; TIME	This study assessed the effects of physical activity on a 10-year incidence of self-reported vertebral fractures in adult women of a large Japanese cohort. Medium levels of strenuous activity and long-duration sedentary activity were associated with a lower incidence of vertebral fractures; association patterns appear to be different from hip fractures. Physical activity helps prevent hip fracture, but little is known about the longitudinal association between physical activity and vertebral fractures. The purpose of this study was to evaluate the effects of physical activity on the 10-year incidence of symptomatic vertebral fractures using data from the Japan Public Health Center-based Prospective Study. Baseline studies were conducted in 1993-1994, and the follow-up study was conducted 10 years later. We analyzed 23,757 women aged 40-69 years. At baseline, physical activity was assessed as a predictor by using a questionnaire. Subjects were asked to report vertebral fractures that occurred during the 10-year follow-up period. Relative risks (RRs) adjusted for confounders were estimated by multiple logistic regression analysis. The 10-year cumulative incidence of vertebral fractures was 0.67 %. Those who engaged in strenuous physical activity of < 1 h/day had a significantly lower incidence of vertebral fractures than those who did not engage in such activity (RR = 0.52, 95 % CI 0.28-0.97), while those engaged in such activity a parts per thousand yen1 h/day did not (RR = 0.82, 95 % CI 0.58-1.14). Long-duration sedentary activity was associated with a low incidence of vertebral fractures (P for trend = 0.0002), but the frequencies of sports activities and metabolic equivalents were not (P for trend = 0.0729 and 0.4341, respectively). Strenuous activity and sedentary activity are associated with the incidence of vertebral fractures, although the association may not be linear. The pattern of association between physical activity and vertebral fractures appears to be different from that of hip fractures.	[Nakamura, K.; Kitamura, K.] Niigata Univ Grad Sch Med & Dent Sci, Dept Prevent Med, Chuo Ku, Niigata 9518510, Japan; [Inoue, M.; Sawada, N.; Tsugane, S.] Natl Canc Ctr, Epidemiol & Prevent Div, Res Ctr Canc Prevent & Screening, Chuo Ku, Tokyo 1040045, Japan; [Inoue, M.] Univ Tokyo, Grad Sch Med, AXA Dept Hlth & Human Secur, Bunkyo Ku, Tokyo 1130033, Japan	Nakamura, K (reprint author), Niigata Univ Grad Sch Med & Dent Sci, Dept Prevent Med, Chuo Ku, 1-757 Asahimachi Dori, Niigata 9518510, Japan.	kazun@med.niigata-u.ac.jp	Tsugane, Shocichiro/A-2424-2015		National Cancer Center Research and Development Fund [23-A31[toku]]	We thank all staff members in each study area and in the central offices for their cooperation and technical assistance. This study was supported by the National Cancer Center Research and Development Fund (23-A31[toku]) (since 2011) and a Grant-in-Aid for Cancer Research (from 1989 to 2010). The members of the Japan Public Health Center-based Prospective Study Group are shown in Appendix.	Ainsworth BE, 2000, MED SCI SPORT EXER, V32, pS457, DOI 10.1097/00005768-200009001-00004; Tremblay MS, 2010, APPL PHYSIOL NUTR ME, V35, P725, DOI 10.1139/H10-079; Nevitt MC, 2005, J BONE MINER RES, V20, P131, DOI 10.1359/JBMR.041003; Ross PD, 1995, INT J EPIDEMIOL, V24, P1171, DOI 10.1093/ije/24.6.1171; Schmitt NM, 2009, MATURITAS, V63, P34, DOI 10.1016/j.maturitas.2009.03.002; Samelson EJ, 2006, J BONE MINER RES, V21, P1207, DOI 10.1359/JBMR.060513; Inoue M, 2008, AM J EPIDEMIOL, V168, P391, DOI 10.1093/aje/kwn146; Moayyeri A, 2008, ANN EPIDEMIOL, V18, P827, DOI 10.1016/j.annepidem.2008.08.007; GARLAND DE, 1992, J ORTHOPAED RES, V10, P371, DOI 10.1002/jor.1100100309; Qu XH, 2014, J BONE MINER RES, V29, P202, DOI 10.1002/jbmr.2019; Strath SJ, 2013, CIRCULATION, V128, P2259, DOI 10.1161/01.cir.0000435708.67487.da; Sofi F, 2008, EUR J CARDIOV PREV R, V15, P247, DOI 10.1097/HJR.0b013e3282f232ac; Roy DK, 2003, OSTEOPOROSIS INT, V14, P19, DOI 10.1007/s00198-002-1317-8; Greendale GA, 2001, OSTEOPOROSIS, P819; Gregg EW, 1998, ANN INTERN MED, V129, P81; Hashimoto T, 1997, OSTEOPOROSIS INT, V7, P99, DOI 10.1007/BF03194353; Marcus R, 2001, OSTEOPOROSIS, P3; Nakamura Kazutoshi, 2011, Environmental Health and Preventive Medicine, V16, P129, DOI 10.1007/s12199-010-0166-x; Tsugane S, 2001, J Epidemiol, V11, pS24	19	0	0	SPRINGER LONDON LTD	LONDON	236 GRAYS INN RD, 6TH FLOOR, LONDON WC1X 8HL, ENGLAND	0937-941X	1433-2965		OSTEOPOROSIS INT	Osteoporosis Int.	NOV	2014	25	11					2565	2571		10.1007/s00198-014-2770-x		7	Endocrinology & Metabolism	Endocrinology & Metabolism	AS3HE	WOS:000344167500006		
J	Nomura, K; Oshima, H; Yamauchi, D; Hidaka, H; Kawase, T; Katori, Y				Nomura, Kazuhiro; Oshima, Hidetoshi; Yamauchi, Daisuke; Hidaka, Hiroshi; Kawase, Tetsuaki; Katori, Yukio			Ototoxic Effect of Ultrastop Antifog Solution Applied to the Guinea Pig Middle Ear	OTOLARYNGOLOGY-HEAD AND NECK SURGERY			English	Article						endoscope; endoscopic ear surgery; ethanol; hearing; inflammation	CONDUCTIVE HEARING-LOSS; ENDOSCOPY; SURGERY; ALCOHOL; AGENTS	Objectives. Recent advances in endoscopic technology have allowed its application to middle ear surgery. An antifog agent is necessary for endoscopy because moisture and blood may obscure visibility. Ultrastop is one of the most commonly used antifog agents. The current study examined the ototoxic effect of topical application of Ultrastop in the guinea pig ear. Study Design. A preliminary experimental animal study. Setting. University hospital. Subjects and Methods. Eighteen male Hartley guinea pigs (weight, 480-620 g) were divided into 3 groups to be treated with Ultrastop, gentamicin (50 mg/mL, positive control), or saline solution (negative control). After auditory brainstem responses were measured, topical solutions of 0.2 mL were applied through a small hole made at the tympanic bulla. Posttreatment auditory brainstem responses were obtained 14 days after the treatment. The extent of middle ear damage was investigated and scored. Results. The saline-treated group showed no deterioration in auditory brainstem response threshold. The Ultrastop-treated and gentamicin-treated groups showed severe deterioration in auditory brainstem response threshold. Middle ear examination revealed extensive changes in the Ultrastop-treated group and medium changes in the gentamicin-treated group. Conclusion. Ultrastop applied topically to the guinea pig middle ear caused significant middle ear inflammation and hearing impairment.	[Nomura, Kazuhiro; Oshima, Hidetoshi; Yamauchi, Daisuke; Hidaka, Hiroshi; Kawase, Tetsuaki; Katori, Yukio] Tohoku Univ, Grad Sch Med, Dept Otolaryngol Head & Neck Surg, Sendai, Miyagi 9808574, Japan	Nomura, K (reprint author), Tohoku Univ, Grad Sch Med, Dept Otolaryngol Head & Neck Surg, Aoba Ku, 1-1 Seiryo Machi, Sendai, Miyagi 9808574, Japan.	kazuhiroe@gmail.com			Ministry of Education, Culture, Sports, Science and Technology, Japan [24659743]	The fee for animals and chemicals was taken from Grant-in-Aid for Scientific Research Houga 24659743 issued by the Ministry of Education, Culture, Sports, Science and Technology, Japan.	Aktas S, 2013, INT J PEDIATR OTORHI, V77, P1465, DOI 10.1016/j.ijporl.2013.06.010; MCKENNAN KX, 1993, LARYNGOSCOPE, V103, P810; Kakehata S, 2006, OTOL NEUROTOL, V27, P14, DOI 10.1097/01.mao.0000181181.47495.a0; Migirov L, 2011, OTOL NEUROTOL, V32, P433, DOI 10.1097/MAO.0b013e3182096b39; Mansfield PD, 1997, J AM ANIM HOSP ASSOC, V33, P479; BOTTRILL ID, 1995, AM J OTOL, V16, P158; Kakehata S, 2004, LARYNGOSCOPE, V114, P1285, DOI 10.1097/00005537-200407000-00027; Knauth A, 2012, ANAESTHESIST, V61, P1036, DOI 10.1007/s00101-012-2116-z; Kojima H, 2014, LARYNGOSCOPE, V124, P266, DOI 10.1002/lary.24144; MORIZONO T, 1981, ACTA OTO-LARYNGOL, V92, P33, DOI 10.3109/00016488109133235; Ozturkcan S, 2008, EUR ARCH OTO-RHINO-L, V266, P663; Pawlowski KS, 2010, ARCH OTOLARYNGOL, V136, P481, DOI 10.1001/archoto.2010.54; Perez R, 2000, LARYNGOSCOPE, V110, P1522, DOI 10.1097/00005537-200009000-00021; POE DS, 1992, AM J OTOL, V13, P529; POE DS, 1992, LARYNGOSCOPE, V102, P993; PRYOR GT, 1985, PHARMACOL BIOCHEM BE, V23, P401, DOI 10.1016/0091-3057(85)90013-9; Roland PS, 2004, OTOLARYNG HEAD NECK, V130, pS51, DOI 10.1016/j.otohns.2003.12.010; Rosety M, 2001, HISTOL HISTOPATHOL, V16, P1091; Singer M M, 1993, Rev Environ Contam Toxicol, V133, P95; SPANDOW O, 1988, AM J OTOLARYNG, V9, P327, DOI 10.1016/S0196-0709(88)80041-3; Zettel ML, 2007, JARO-J ASSOC RES OTO, V8, P280, DOI 10.1007/s10162-007-0075-x	21	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	0194-5998	1097-6817		OTOLARYNG HEAD NECK	Otolaryngol. Head Neck Surg.	NOV	2014	151	5					840	844		10.1177/0194599814545749		5	Otorhinolaryngology; Surgery	Otorhinolaryngology; Surgery	AS6FO	WOS:000344360100022		
J	Shimosegawa, T				Shimosegawa, Tooru			2014 Japan Pancreas Society Presidential Address The American Pancreatic Association/Japan Pancreas Society Joint Meeting on the Big Island (the Second American Pancreatic Association/Japan Pancreas Society Joint Meeting)	PANCREAS			English	Editorial Material									[Shimosegawa, Tooru] Tohoku Univ, Grad Sch Med, Div Gastroenterol, Sendai, Miyagi 9808574, Japan	Shimosegawa, T (reprint author), Tohoku Univ, Grad Sch Med, Div Gastroenterol, Aoba Ku, 1-1 Seiryo Machi, Sendai, Miyagi 9808574, Japan.	tshimosegawa@int3.med.tohoku.ac.jp						0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0885-3177	1536-4828		PANCREAS	Pancreas	NOV	2014	43	8					1130	1130				1	Gastroenterology & Hepatology	Gastroenterology & Hepatology	AS6GO	WOS:000344362600002		
J	Tanaka, M				Tanaka, Masao			Intraductal Papillary Mucinous Neoplasms of the Pancreas	PANCREAS			English	Editorial Material							INTERNATIONAL CONSENSUS GUIDELINES; INVASIVE DUCTAL CARCINOMA; HIGH-GRADE DYSPLASIA; JUICE CYTOLOGY; FOLLOW-UP; QUANTITATIVE-ANALYSIS; PREDICTIVE FACTORS; RISK-ASSESSMENT; DUODENAL JUICE; ADDS VALUE		Kyushu Univ, Grad Sch Med Sci, Dept Surg & Oncol, Fukuoka 8128582, Japan	Tanaka, M (reprint author), Kyushu Univ, Grad Sch Med Sci, Dept Surg & Oncol, Fukuoka 8128582, Japan.	masaotan@med.kyushu-u.ac.jp					Niedergethmann M, 2008, WORLD J SURG, V32, P2253, DOI 10.1007/s00268-008-9692-8; Anand N, 2013, CLIN GASTROENTEROL H, V11, P913, DOI 10.1016/j.cgh.2013.02.010; Hashimoto Y, 2008, J GASTROINTEST SURG, V12, P17, DOI 10.1007/s11605-007-0383-9; Genevay M, 2011, ANN SURG, V254, P977, DOI 10.1097/SLA.0b013e3182383118; He J, 2013, J AM COLL SURGEONS, V216, P657, DOI 10.1016/j.jamcollsurg.2012.12.026; Kanda M, 2013, CLIN GASTROENTEROL H, V11, P719, DOI 10.1016/j.cgh.2012.11.016; Tanno S, 2010, PANCREATOLOGY, V10, P173, DOI 10.1159/000231982; Maker AV, 2011, CLIN CANCER RES, V17, P1502, DOI 10.1158/1078-0432.CCR-10-1561; Tsutsumi K, 2011, MODERN PATHOL, V24, P533, DOI 10.1038/modpathol.2010.218; Tanaka M, 2006, PANCREATOLOGY, V6, P17, DOI 10.1159/000090023; Yamaguchi K, 1997, INT J PANCREATOL, V22, P227; Hibi Y, 2007, PANCREAS, V34, P197, DOI 10.1097/MPA.0b013e31802dea0; Mori Y, 2013, PANCREAS, V42, P187, DOI 10.1097/MPA.0b013e3182649979; Hirooka Y, 2003, J GASTROEN HEPATOL, V18, P1323, DOI 10.1046/j.1440-1746.2003.03040.x; Ohtsuka T, 2012, SURGERY, V151, P76, DOI 10.1016/j.surg.2011.07.009; Hirono S, 2009, ARCH SURG-CHICAGO, V144, P345, DOI 10.1001/archsurg.2009.2; Akita H, 2011, AM J SURG, V202, P214, DOI 10.1016/j.amjsurg.2010.06.020; Okada KI, 2010, BIOMED RES-TOKYO, V31, P13; Kim KW, 2014, ANN SURG, V259, P72, DOI 10.1097/SLA.0b013e31829385f7; Wu J, 2011, P NATL ACAD SCI USA, V108, P21188, DOI 10.1073/pnas.1118046108; Ohno E, 2009, ANN SURG, V249, P628, DOI 10.1097/SLA.0b013e3181a189a8; Pedrazzoli S, 2011, ANN SURG, V254, P971, DOI 10.1097/SLA.0b013e3182383137; Ohtsuka T, 2012, AM J SURG, V204, P44, DOI 10.1016/j.amjsurg.2011.04.007; Bartsch DK, 2013, FAM CANCER, V12, P89, DOI 10.1007/s10689-012-9582-y; Maguchi H, 2011, PANCREAS, V40, P364, DOI 10.1097/MPA.0b013e31820a5975; Uehara H, 2008, GUT, V57, P1561, DOI 10.1136/gut.2007.145631; Nakata K, 2011, PANCREAS, V40, P581, DOI 10.1097/MPA.0b013e318214fa86; Shimizu Y, 2010, WORLD J SURG, V34, P2932, DOI 10.1007/s00268-010-0785-9; Tanaka M, 1997, GASTROINTEST ENDOSC, V46, P447, DOI 10.1016/S0016-5107(97)70039-7; Amato E, 2014, J PATHOL, V233, P217, DOI 10.1002/path.4344; Sadakari Y, 2010, PANCREAS, V39, P232, DOI 10.1097/MPA.0b013e3181bab60e; Shimizu Y, 2013, PANCREAS, V42, P883, DOI 10.1097/MPA.0b013e31827a7b84; Kang MJ, 2011, CLIN GASTROENTEROL H, V9, P87, DOI 10.1016/j.cgh.2010.09.008; Hara T, 2013, ANN SURG, V257, P1103, DOI 10.1097/SLA.0b013e318281b824; Arlix A, 2012, PANCREAS, V41, P295, DOI 10.1097/MPA.0b013e3182285cc8; Hirono S, 2012, ANN SURG, V255, P517, DOI 10.1097/SLA.0b013e3182444231; Uehara H, 2011, J GASTROENTEROL, V46, P657, DOI 10.1007/s00535-010-0343-0; Yamaguchi K, 2002, PANCREATOLOGY, V2, P484, DOI 10.1159/000064716; Tanaka M, 2012, PANCREATOLOGY, V12, P183, DOI 10.1016/j.pan.2012.04.004; Cooper CL, 2013, PATHOLOGY, V45, P286, DOI 10.1097/PAT.0b013e32835f2205; Wong J, 2013, J GASTROINTEST SURG, V17, P78, DOI 10.1007/s11605-012-2017-0; Yamaguchi T, 2005, CANCER, V104, P2830, DOI 10.1002/cncr.21565; Ohtsuka T, 2013, J HEPATO-BIL-PAN SCI, V20, P356, DOI 10.1007/s00534-012-0541-7; Tanno S, 2010, PANCREAS, V39, P36, DOI 10.1097/MPA.0b013e3181b91cd0; Ingkakul T, 2010, ANN SURG, V251, P70, DOI 10.1097/SLA.0b013e3181c5ddc3; Yamao K, 2011, PANCREAS, V40, P67, DOI 10.1097/MPA.0b013e3181f749d3; Ohuchida K, 2006, CLIN CANCER RES, V12, P2066, DOI 10.1158/1078-0432.CCR-05-1821; Corcos O, 2012, PANCREAS, V41, P169, DOI 10.1097/MPA.0b013e3182289356; Fujita H, 2008, CANCER SCI, V99, P2244, DOI 10.1111/j.1349-7006.2008.00930.x; Furukawa T, 2011, SCI REP-UK, V1, DOI 10.1038/srep00161; Iguchi H, 1996, GASTROENTEROLOGY, V110, P221, DOI 10.1053/gast.1996.v110.pm8536860; Inoue H, 2001, CANCER, V91, P35, DOI 10.1002/1097-0142(20010101)91:1<35::AID-CNCR5>3.0.CO;2-A; Kamata K, 2014, ENDOSCOPY, V46, P22, DOI 10.1055/s-0033-1353603; Masuda A, 2013, PANCREATOLOGY, V13, P583, DOI 10.1016/j.pan.2013.08.007; Mikata R, 2013, J GASTROENTEROL, V48, P866, DOI 10.1007/s00535-012-0684-y; Monzen M, 2013, PANCREATOLOGY, V13, P369, DOI 10.1016/j.pan.2013.06.003; Mori Yasuhisa, 2010, JOP, V11, P389; Nakata K, 2009, MODERN PATHOL, V22, P460, DOI 10.1038/modpathol.2008.205; Ono J, 2011, CYTOJOURNAL, V8, DOI 10.4103/1742-6413.90084; Pitman MB, 2008, PANCREATOLOGY, V8, P277, DOI 10.1159/000134276; Raman SP, 2013, AM J ROENTGENOL, V200, P563, DOI 10.2214/AJR.12.8924; Sai JK, 2009, GASTROINTEST ENDOSC, V69, P434, DOI 10.1016/j.gie.2008.04.050; Sakamoto H, 2009, WORLD J GASTROENTERO, V15, P5489, DOI 10.3748/wjg.15.5489; Shindo Koji, 2013, Case Rep Gastroenterol, V7, P449, DOI 10.1159/000355939; Tamura Koji, 2013, JOP, V14, P450, DOI 10.6092/1590-8577/1494; Tanaka M, 2011, NAT REV GASTRO HEPAT, V8, P56, DOI 10.1038/nrgastro.2010.193; Tanaka M, 2014, INTRADUCTAL PAPILLAR, P3; Tsutsumi K, 2012, ANN SURG ONCOL, V19, pS491, DOI 10.1245/s10434-011-1970-2; Wilentz RE, 1998, CANCER, V82, P96, DOI 10.1002/(SICI)1097-0142(19980101)82:1<96::AID-CNCR11>3.0.CO;2-8	69	1	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0885-3177	1536-4828		PANCREAS	Pancreas	NOV	2014	43	8					1136	1140				5	Gastroenterology & Hepatology	Gastroenterology & Hepatology	AS6GO	WOS:000344362600004		
J	Yuhara, H; Ogawa, M; Kawaguchi, Y; Igarashi, M; Mine, T				Yuhara, Hiroki; Ogawa, Masami; Kawaguchi, Yoshiaki; Igarashi, Muneki; Mine, Tetsuya			Smoking and Risk for Acute Pancreatitis A Systematic Review and Meta-Analysis	PANCREAS			English	Review						acute pancreatitis; smoking; meta-analysis	POPULATION-BASED-COHORT; CIGARETTE-SMOKING; METAANALYSIS; BIAS	We aimed to better understand the relationship between smoking and a risk for acute pancreatitis (AP) in existing observational studies. We identified studies by searching the PubMed, Scopus, and Web of Science databases (from inception through August 31, 2013) and by searching bibliographies of relevant articles. Summary relative risks (RRs) with 95% confidence intervals (CIs) were calculated with fixed-effects and random-effects models. A total of 5 studies met inclusion criteria for analysis. Both current smoking (summary RR, 1.74; 95% CI, 1.39-2.17; n = 5 studies) and former smoking (summary RR, 1.32; 95% CI, 1.03-1.71; n = 4 studies) were associated with an increased risk for AP. The positive association of current smoking and risk for AP remained when we limited the meta-analysis to studies that controlled for alcohol intake and body mass index (summary RR, 1.76; 95% CI, 1.31-2.36; n = 4 studies). Both current and former smoking are associated with increased risk for AP. Further investigations, both epidemiological and mechanistic, are needed to establish the extent to which the association can be explained by a causal link and whether smoking cessation can prevent the occurrence and development of AP.	[Yuhara, Hiroki; Ogawa, Masami; Kawaguchi, Yoshiaki; Igarashi, Muneki; Mine, Tetsuya] Tokai Univ, Sch Med, Dept Internal Med, Div Gastroenterol & Hepatol, Isehara, Kanagawa 2591193, Japan	Mine, T (reprint author), Tokai Univ, Sch Med, Dept Internal Med, Div Gastroenterol & Hepatol, 143 Shimokasuya, Isehara, Kanagawa 2591193, Japan.	tetsu-m@is.icc.u-tokai.ac.jp					Yadav D, 2006, PANCREAS, V33, P323, DOI 10.1097/01.mpa.0000236733.31617.52; Yang L, 2013, EUR J GASTROEN HEPAT, V25, P225, DOI 10.1097/MEG.0b013e32835af154; Lindkvist B, 2008, PANCREATOLOGY, V8, P63, DOI 10.1159/000114868; Fagenholz PJ, 2007, ANN EPIDEMIOL, V17, P491, DOI 10.1016/j.annepidem.2007.02.002; Gonzalez-Perez A, 2010, DIABETES CARE, V33, P2580, DOI [10.2337/dc10-0842, 10.2337/dc10.0842]; Tsuang W, 2009, AM J GASTROENTEROL, V104, P984, DOI 10.1038/ajg.2009.27; Blomgren KB, 2002, EUR J CLIN PHARMACOL, V58, P275, DOI 10.1007/s00228-002-0471-4; Frossard JL, 2008, LANCET, V371, P143, DOI 10.1016/S0140-6736(08)60107-5; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Yadav D, 2009, ARCH INTERN MED, V169, P1035, DOI 10.1001/archinternmed.2009.125; Egger M, 1997, BRIT MED J, V315, P629; Sadr-Azodi O, 2012, GUT, V61, P262, DOI 10.1136/gutjnl-2011-300566; Wittel UA, 2006, PANCREAS, V33, P364, DOI 10.1097/01.mpa.0000240601.80570.31; Malfertheiner P, 2006, AM J GASTROENTEROL, V101, P160, DOI 10.1111/j.1572-0241.2006.00402.x; Liberati A, 2009, ANN INTERN MED, V151, pW65; Andriulli A, 2010, PANCREAS, V39, P1205, DOI 10.1097/MPA.0b013e3181df27c0; Appelros S, 1999, BRIT J SURG, V86, P465; BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Guyatt GH, 2008, BRIT MED J, V336, P995, DOI 10.1136/bmj.39490.551019.BE; Jianyu-Hao, 2009, INHAL TOXICOL, V21, P1007, DOI 10.1080/08958370802665937; Maisonneuve P, 2006, PANCREAS, V33, P163, DOI 10.1097/01.mpa.0000227916.94073.fc; Rothman K, 2008, MODERN EPIDEMIOLOGY; Tolstrup JS, 2009, ARCH INTERN MED, V169, P603, DOI 10.1001/archinternmed.2008.601; Wells G, NEWCASTLE OTTAWA SCA; Wittel UA, 2008, LANGENBECK ARCH SURG, V393, P581, DOI 10.1007/s00423-007-0273-3	26	2	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0885-3177	1536-4828		PANCREAS	Pancreas	NOV	2014	43	8					1201	1207				7	Gastroenterology & Hepatology	Gastroenterology & Hepatology	AS6GO	WOS:000344362600012		
J	Aso, T; Ohtsuka, T; Matsunaga, T; Kimura, H; Watanabe, Y; Tamura, K; Ideno, N; Osoegawa, T; Takahata, S; Shindo, K; Ushijima, Y; Aishima, S; Oda, Y; Ito, T; Mizumoto, K; Tanaka, M				Aso, Teppei; Ohtsuka, Takao; Matsunaga, Taketo; Kimura, Hideyo; Watanabe, Yusuke; Tamura, Koji; Ideno, Noboru; Osoegawa, Takashi; Takahata, Shunnichi; Shindo, Koji; Ushijima, Yasuhiro; Aishima, Shinichi; Oda, Yoshinao; Ito, Tetsuhide; Mizumoto, Kazuhiro; Tanaka, Masao			"High-Risk Stigmata" of the 2012 International Consensus Guidelines Correlate With the Malignant Grade of Branch Duct Intraductal Papillary Mucinous Neoplasms of the Pancreas	PANCREAS			English	Article						IPMN; Fukuoka guidelines; high-risk stigmata	PREDICTIVE FACTORS; CYSTIC NEOPLASMS; MANAGEMENT; IPMN; CYTOLOGY; JUICE; MCN	Objectives: The 2012 international consensus guidelines for the management of intraductal papillary mucinous neoplasm (IPMN) of the pancreas stratified patients into 2 clinical categories, "high-risk stigmata" and "worrisome features," and recommended different therapeutic strategies for these groups. The aim of this study was to elucidate the significance of these categories in terms of predicting malignant IPMNs. Methods: The medical records of 100 consecutive patients who underwent pancreatectomy for IPMNs were retrospectively reviewed. Seventy patients with branch duct IPMNs (BD-IPMNs) were stratified into 3 groups. The relationships between the number of predictive factors and histopathologic grade were investigated. Results: The prevalence rates of malignant IPMN, invasive carcinoma, and lymph node metastasis in the high-risk group were 80%, 55%, and 20%, respectively, with these percentages significantly increasing in a stepwise manner according to the number of predictive factors. In contrast, there was no significant correlation between the number of worrisome features and grade of malignancy in patients stratified as having worrisome BD-IPMNs. Conclusions: The number of high-risk stigmata correlated significantly with the grade of malignancy of BD-IPMNs. The presence of at least 1 high-risk stigma in patients with BD-IPMNs indicates a need for pancreatectomy with lymphadenectomy.	[Aso, Teppei; Ohtsuka, Takao; Matsunaga, Taketo; Kimura, Hideyo; Watanabe, Yusuke; Tamura, Koji; Ideno, Noboru; Takahata, Shunnichi; Mizumoto, Kazuhiro; Tanaka, Masao] Kyushu Univ, Grad Sch Med Sci, Dept Surg & Oncol, Fukuoka 8128582, Japan; [Osoegawa, Takashi; Ito, Tetsuhide] Kyushu Univ, Grad Sch Med Sci, Dept Med & Bioregulatory Sci, Fukuoka 8128582, Japan; [Shindo, Koji; Aishima, Shinichi; Oda, Yoshinao] Kyushu Univ, Grad Sch Med Sci, Dept Anat Pathol, Fukuoka 8128582, Japan; [Ushijima, Yasuhiro] Kyushu Univ, Grad Sch Med Sci, Dept Clin Radiol, Fukuoka 8128582, Japan	Tanaka, M (reprint author), Kyushu Univ, Grad Sch Med Sci, Dept Surg & Oncol, Higashi Ku, 3-1-1 Maidashi, Fukuoka 8128582, Japan.	masaotan@med.kyushu-u.ac.jp					Abdeljawad K, 2014, GASTROINTEST ENDOSC, V79, P623, DOI 10.1016/j.gie.2013.08.024; Adsay NV, 2010, WHO CLASSIFICATION T, P304; Maire F, 2008, AM J GASTROENTEROL, V103, P2871, DOI 10.1111/j.1572-0241.2008.02114.x; Sadakari Y, 2010, SURGERY, V147, P812, DOI 10.1016/j.surg.2009.11.011; Tamura K, 2014, ANN SURG, V259, P360, DOI 10.1097/SLA.0b013e3182a690ff; Tanaka M, 2006, PANCREATOLOGY, V6, P17, DOI 10.1159/000090023; Weinberg BM, 2010, GASTROENTEROLOGY, V138, P531, DOI 10.1053/j.gastro.2009.10.001; Ohtsuka T, 2012, SURGERY, V151, P76, DOI 10.1016/j.surg.2011.07.009; Aso T, 2012, GASTROINTEST ENDOSC, V76, P313, DOI 10.1016/j.gie.2012.03.682; Murakami Y, 2007, J GASTROINTEST SURG, V11, P338, DOI 10.1007/s11605-006-0069-8; Yamaguchi K, 2005, PANCREATOLOGY, V5, P416, DOI 10.1159/000086555; Tanaka M, 2005, J GASTROENTEROL, V40, P669, DOI 10.1007/s00535-005-1646-4; Furukawa T, 2005, VIRCHOWS ARCH, V447, P794, DOI 10.1007/s00428-005-0039-7; Schmidt CM, 2007, ANN SURG, V246, P644, DOI 10.1097/SLA.0b013e318155a7b6; Hirono S, 2012, ANN SURG, V255, P517, DOI 10.1097/SLA.0b013e3182444231; Tanaka M, 2012, PANCREATOLOGY, V12, P183, DOI 10.1016/j.pan.2012.04.004; Hirota M, 2006, J HEPATO-BILIARY-PAN, V13, P33, DOI 10.1007/s00534-005-1049-1; Falconi M, 2001, BRIT J SURG, V88, P376, DOI 10.1046/j.1365-2168.2001.01720.x; Maker AV, 2008, ANN SURG ONCOL, V15, P3187, DOI 10.1245/s10434-008-0110-0; Schmidt CM, 2008, J GASTROINTEST SURG, V12, P243, DOI 10.1007/s11605-007-0404-8; Tanaka M, 2011, NAT REV GASTRO HEPAT, V8, P56, DOI 10.1038/nrgastro.2010.193; Tsutsumi K, 2011, PANCREATOLOGY, V10, P707	22	1	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0885-3177	1536-4828		PANCREAS	Pancreas	NOV	2014	43	8					1239	1243				5	Gastroenterology & Hepatology	Gastroenterology & Hepatology	AS6GO	WOS:000344362600017		
J	Hamada, S; Masamune, A; Kikuta, K; Hirota, M; Tsuji, I; Shimosegawa, T				Hamada, Shin; Masamune, Atsushi; Kikuta, Kazuhiro; Hirota, Morihisa; Tsuji, Ichiro; Shimosegawa, Tooru		Res Comm Intractable Dis Pancreas	Nationwide Epidemiological Survey of Acute Pancreatitis in Japan	PANCREAS			English	Article						acute pancreatitis; nationwide survey; Japan	MANAGEMENT; NECROSIS	Objectives: A nationwide epidemiological survey of acute pancreatitis (AP) was performed to estimate the number of patients with AP in 2011 in Japan and to clarify the clinical features. Methods: The first survey was performed by sending a questionnaire to randomly selected 4175 departments to determine the number of hospitalized patients with AP during 2011. The second survey was conducted by sending a questionnaire to departments in which hospitalized patients with AP were treated based on the first questionnaire. Evaluation of the AP severity was based on the revised severity scoring system of AP of the Japanese Ministry of Health, Labor and Welfare (2008). Results: The estimated total number of patients with AP in 2011 was 63,080 (95% confidence interval, 57,678-68,484), with an overall prevalence rate of 49.4 per 100,000 population. The male-to-female ratio was 1.9. The mean age was 58.5 in male and 65.3 in female patients. Alcoholic AP was the most common in male and gallstone AP was the most common in female patients. The overall mortality of AP was 2.6%, and in severe AP, 10.1%. Conclusions: The number of patients with AP is still increasing. The revised severity scoring system provided a more precise prediction of prognosis.	[Hamada, Shin; Masamune, Atsushi; Kikuta, Kazuhiro; Hirota, Morihisa; Shimosegawa, Tooru] Tohoku Univ, Grad Sch Med, Div Gastroenterol, Aoba Ku, Sendai, Miyagi 980, Japan; [Tsuji, Ichiro] Tohoku Univ, Grad Sch Med, Dept Publ Hlth & Forens Med, Div Epidemiol,Aoba Ku, Sendai, Miyagi 980, Japan	Shimosegawa, T (reprint author), Tohoku Univ, Grad Sch Med, Div Gastroenterol, Aoba Ku, 1-1 Seiryomachi, Sendai, Miyagi 980, Japan.	tshimosegawa@int3.med.tohoku.ac.jp					Yadav D, 2006, PANCREAS, V33, P323, DOI 10.1097/01.mpa.0000236733.31617.52; Spanier BWM, 2013, WORLD J GASTROENTERO, V19, P3018, DOI 10.3748/wjg.v19.i20.3018; Satoh K, 2011, PANCREAS, V40, P503, DOI 10.1097/MPA.0b013e318214812b; Yasuda I, 2013, ENDOSCOPY, V45, P627, DOI 10.1055/s-0033-1344027; Baron TH, 1996, GASTROENTEROLOGY, V111, P755, DOI 10.1053/gast.1996.v111.pm8780582; Takeda K, 2010, J HEPATO-BIL-PAN SCI, V17, P37, DOI 10.1007/s00534-009-0213-4; Sekimoto M, 2006, J HEPATO-BILIARY-PAN, V13, P10, DOI 10.1007/s00534-005-1047-3; Shen HN, 2012, PANCREAS, V41, P696, DOI 10.1097/MPA.0b013e31823db941; Schepers NJ, 2013, BEST PRACT RES CL GA, V27, P727, DOI 10.1016/j.bpg.2013.08.007; Vidarsdottir H, 2013, EUR J GASTROEN HEPAT, V25, P1068, DOI 10.1097/MEG.0b013e3283640fc8; Hashimoto S, 1991, Nihon Koshu Eisei Zasshi, V38, P880; Higuchi S, 2007, ADDICTION, V102, P1849, DOI 10.1111/j.1360-0443.2007.01902.x; National tax agency, SUMM LIQ TAX 2013; Ogawa M, 2002, PANCREAS, V25, P325, DOI 10.1097/00006676-200211000-00001; Otsuki M, 2006, WORLD J GASTROENTERO, V12, P3314; Piascik M, 2010, PANCREAS, V39, P863, DOI 10.1097/MPA.0b013e3181d37239; Takeda K, 2001, J Hepatobiliary Pancreat Surg, V8, P216, DOI 10.1007/s005340170019; Wakai K, 1997, J Epidemiol, V7, P221	18	9	9	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0885-3177	1536-4828		PANCREAS	Pancreas	NOV	2014	43	8					1244	1248				5	Gastroenterology & Hepatology	Gastroenterology & Hepatology	AS6GO	WOS:000344362600018		
J	Chiba, K; Kamisawa, T; Kuruma, S; Iwasaki, S; Tabata, T; Koizumi, S; Endo, Y; Kuwata, G; Fujiwara, T; Arakawa, T; Koizumi, K; Momma, K				Chiba, Kazuro; Kamisawa, Terumi; Kuruma, Sawako; Iwasaki, Susumu; Tabata, Taku; Koizumi, Satomi; Endo, Yuka; Kuwata, Go; Fujiwara, Takashi; Arakawa, Takeo; Koizumi, Koichi; Momma, Kumiko			Major and Minor Duodenal Papillae in Autoimmune Pancreatitis	PANCREAS			English	Article						autoimmune pancreatitis; major duodenal papilla; minor duodenal papilla; IgG4	AMPULLA; DISEASE	Objective: The objective of this study was to evaluate picture of the major and minor duodenal papillae in patients with autoimmune pancreatitis (AIP). Methods: Endoscopic features of the major and minor papillae were examined in 59 and 13 patients with AIP. After steroid therapy, changes of the major and minor papillae were observed in 5 and 6 patients. The major and minor papillae were observed with narrow band imaging in 24 and 6 patients. Biopsy specimens from the major (n = 50) and minor (n = 13) papillae were immunostained using an anti-IgG4 antibody. Results: Endoscopic features of the major and minor papillae were abnormal in 26 patients (44%; swelling [n = 20] and redness [n = 14]) and 5 patients (38%; swelling [n = 5]). Swelling of the pancreatic head, irregular narrowing of the main pancreatic duct of the pancreatic head, stenosis of the lower bile duct, and abundant infiltration of IgG4-positive plasma cells were more frequent in the patients with an abnormal major papilla compared with those with a normal major papilla. On narrow band imaging, dilated vessels were observed in abnormal papillae. After therapy, swelling of the major and minor papillae improved in all 4 and 2 patients. Conclusions: Endoscopic features of the major and minor papillae were abnormal in 44% and 38% of the patients with AIP.	[Chiba, Kazuro; Kamisawa, Terumi; Kuruma, Sawako; Iwasaki, Susumu; Tabata, Taku; Koizumi, Satomi; Endo, Yuka; Kuwata, Go; Fujiwara, Takashi; Arakawa, Takeo; Koizumi, Koichi; Momma, Kumiko] Tokyo Metropolitan Komagome Hosp, Dept Internal Med, Tokyo 1138677, Japan	Kamisawa, T (reprint author), Tokyo Metropolitan Komagome Hosp, Dept Internal Med, Bunkyo Ku, 3-18-22 Honkomagome, Tokyo 1138677, Japan.	kamisawa@cick.jp					ADDA G, 1984, ANAT CLIN, V5, P275, DOI 10.1007/BF01798752; Kamisawa T, 2013, GUT, V62, P1373, DOI 10.1136/gutjnl-2012-304224; Kamisawa T, 2010, NAT REV GASTRO HEPAT, V7, P401, DOI 10.1038/nrgastro.2010.81; Kamisawa T, 2008, GASTROINTEST ENDOSC, V68, P358, DOI 10.1016/j.gie.2008.02.018; Moon SH, 2010, GASTROINTEST ENDOSC, V71, P960, DOI 10.1016/j.gie.2009.12.004; Unno H, 2002, GASTROINTEST ENDOSC, V56, P880, DOI 10.1067/mge.2002.129605; Kamisawa T, 2006, WORLD J GASTROENTERO, V12, P2031; Shimosegawa T, 2011, PANCREAS, V40, P352, DOI 10.1097/MPA.0b013e3182142fd2; Hara S, 2013, SCAND J GASTROENTERO, V48, P856, DOI 10.3109/00365521.2012.737363; Hirano K, 2009, J GASTROENTEROL, V44, P765, DOI 10.1007/s00535-009-0052-8; Hisa T, 2008, GASTROINTEST ENDOSC, V68, P1229, DOI 10.1016/j.gie.2008.02.079; Itoi T, 2013, J GASTROENTEROL, V48, P504, DOI 10.1007/s00535-012-0652-6; Kamisawa T, 2001, DIG ENDOSC, V13, P82, DOI 10.1046/j.1443-1661.2001.00099.x; Kim MH, 2010, DIGEST SURG, V27, P110, DOI 10.1159/000286573; Kubota Kensuke, 2007, Pancreas, V35, pe51; Park JS, 2002, GASTROINTEST ENDOSC, V55, P877, DOI 10.1067/mge.2002.124559; Sepehr A, 2008, AM J SURG PATHOL, V32, P1770, DOI 10.1097/PAS.0b013e318185490a	17	1	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0885-3177	1536-4828		PANCREAS	Pancreas	NOV	2014	43	8					1299	1302				4	Gastroenterology & Hepatology	Gastroenterology & Hepatology	AS6GO	WOS:000344362600026		
J	Abe, T; Nakashima, H; Nakamura, M; Tanaka, M				Abe, T.; Nakashima, H.; Nakamura, M.; Tanaka, M.			Metachronous Pancreatic Ductal Adenocarcinoma (PDAC) After Resection of Branch Duct Intraductal Papillary Mucinous Neoplasms 3-Month Interval of Surveillance CT/MR Still Insufficient for Early Detection	PANCREAS			English	Meeting Abstract									[Abe, T.; Nakashima, H.; Nakamura, M.] Kawasaki Med Coll, Dept Digest Surg, Kurashiki, Okayama, Japan; [Tanaka, M.] Kyushu Univ, Dept Surg & Oncol, Grad Sch Med Sci, Fukuoka 812, Japan								0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0885-3177	1536-4828		PANCREAS	Pancreas	NOV	2014	43	8					1340	1340				1	Gastroenterology & Hepatology	Gastroenterology & Hepatology	AS6GO	WOS:000344362600035		
J	Abue, M; Yokoyama, M; Shibuya, R; Tamai, K; Sato, I; Tanaka, N; Yamaguch, K; Hamada, S; Shimosegawa, T; Sugamura, K; Satoh, K				Abue, M.; Yokoyama, M.; Shibuya, R.; Tamai, K.; Sato, I.; Tanaka, N.; Yamaguch, K.; Hamada, S.; Shimosegawa, T.; Sugamura, K.; Satoh, K.			The Evaluation of Circulating miR-483-3p and miR-21 in Plasma of Pancreatic Ductal Adenocarcinoma Patients	PANCREAS			English	Meeting Abstract									[Abue, M.; Yokoyama, M.; Shibuya, R.; Satoh, K.] Miyagi Canc Ctr, Res Inst, Div Canc Stem Cell, Notori, Japan; [Tamai, K.; Tanaka, N.] Miyagi Canc Ctr, Res Inst, Div Canc Biol & Therapeut, Notori, Japan; [Sato, I.] Miyagi Canc Ctr, Res Inst, Tissue Bank Ctr, Notori, Japan; [Yamaguch, K.; Sugamura, K.] Miyagi Canc Ctr, Res Inst, Div Mol & Cellular Biol, Notori, Japan; [Hamada, S.; Shimosegawa, T.] Tohoku Univ, Div Gastroenterol, Grad Sch Med, Sendai, Miyagi 980, Japan								0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0885-3177	1536-4828		PANCREAS	Pancreas	NOV	2014	43	8					1340	1340				1	Gastroenterology & Hepatology	Gastroenterology & Hepatology	AS6GO	WOS:000344362600037		
J	Aoki, H; Tada, Y; Iwao, T; Yoshida, K				Aoki, H.; Tada, Y.; Iwao, T.; Yoshida, K.			Retrospective Examination of Prediagnostic CT Findings of Pancreatic Cancer	PANCREAS			English	Meeting Abstract									[Aoki, H.; Yoshida, K.] Kawasaki Med Univ, Div Intervent Biliopancreatol, Okayama, Japan; [Tada, Y.; Iwao, T.] Adv Res Inst Gastroenterol Imaging, Fukushima, Japan								0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0885-3177	1536-4828		PANCREAS	Pancreas	NOV	2014	43	8					1342	1342				1	Gastroenterology & Hepatology	Gastroenterology & Hepatology	AS6GO	WOS:000344362600043		
J	Asari, S; Matsumoto, I; Toyama, H; Shinzeki, M; Goto, T; Ishida, J; Ajiki, T; Fukumoto, T; Ku, Y				Asari, S.; Matsumoto, I.; Toyama, H.; Shinzeki, M.; Goto, T.; Ishida, J.; Ajiki, T.; Fukumoto, T.; Ku, Y.			Preoperative Independent Prognostic Factors in Patients With Borderline Resectable Pancreatic Adenocarcinoma Following Curative Resection: Neutrophil-Lymphocyte Ratio and Platelet-Lymphocyte Ratio	PANCREAS			English	Meeting Abstract									[Asari, S.; Matsumoto, I.; Toyama, H.; Shinzeki, M.; Goto, T.; Ishida, J.; Ajiki, T.; Fukumoto, T.; Ku, Y.] Kobe Univ, Div Hepatobiliary Pancreat Surg, Dept Surg, Grad Sch Med, Kobe, Hyogo 657, Japan								0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0885-3177	1536-4828		PANCREAS	Pancreas	NOV	2014	43	8					1343	1343				1	Gastroenterology & Hepatology	Gastroenterology & Hepatology	AS6GO	WOS:000344362600047		
J	Cases, AI; Ohtsuka, T; Zheng, B; Horioka, K; Oda, Y; Mizumoto, K; Tanaka, M				Cases, A. I.; Ohtsuka, T.; Zheng, B.; Horioka, K.; Oda, Y.; Mizumoto, K.; Tanaka, M.			Glucagon-like Peptide 1 Receptor in Pancreatic Cancer	PANCREAS			English	Meeting Abstract									[Cases, A. I.; Ohtsuka, T.; Zheng, B.; Horioka, K.; Mizumoto, K.; Tanaka, M.] Kyushu Univ, Grad Sch Med Sci, Dept Surg & Oncol, Fukuoka 812, Japan; [Oda, Y.] Kyushu Univ, Grad Sch Med Sci, Dept Anat Pathol, Fukuoka 812, Japan								0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0885-3177	1536-4828		PANCREAS	Pancreas	NOV	2014	43	8					1346	1347				2	Gastroenterology & Hepatology	Gastroenterology & Hepatology	AS6GO	WOS:000344362600064		
J	Cheng, XB; Yamaguchi, K; Kohi, S; Higure, A; Sato, N				Cheng, X. B.; Yamaguchi, K.; Kohi, S.; Higure, A.; Sato, N.			Receptor for Hyaluronic Acid-Mediated Motility Expression in Human Pancreatic Cancer Cells and Tissues	PANCREAS			English	Meeting Abstract									[Cheng, X. B.; Yamaguchi, K.; Kohi, S.; Higure, A.; Sato, N.] Univ Occupat & Environm Hlth, Sch Med, Dept Surg 1, Kitakyushu, Fukuoka 807, Japan								0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0885-3177	1536-4828		PANCREAS	Pancreas	NOV	2014	43	8					1348	1349				2	Gastroenterology & Hepatology	Gastroenterology & Hepatology	AS6GO	WOS:000344362600072		
J	Chiba, N; Wakabayashi, T; Okihara, M; Tomita, K; Takano, K; Shimazu, M; Kawachi, S				Chiba, N.; Wakabayashi, T.; Okihara, M.; Tomita, K.; Takano, K.; Shimazu, M.; Kawachi, S.			Clinical Efficacy of Neoadjuvant Chemoradiation Therapy for Locally Advanced Pancreatic Cancer	PANCREAS			English	Meeting Abstract									[Chiba, N.; Wakabayashi, T.; Okihara, M.; Tomita, K.; Takano, K.; Shimazu, M.; Kawachi, S.] Tokyo Med Univ, Hachioji Med Ctr, Dept Digest & Transplantat Surg, Tokyo 1608402, Japan								0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0885-3177	1536-4828		PANCREAS	Pancreas	NOV	2014	43	8					1349	1349				1	Gastroenterology & Hepatology	Gastroenterology & Hepatology	AS6GO	WOS:000344362600074		
J	Date, K; Takahata, S; Tamura, K; Fujimoto, T; Kimura, H; Matsunaga, T; Watanabe, Y; Miyasaka, Y; Ohtsuka, T; Tanaka, M				Date, K.; Takahata, S.; Tamura, K.; Fujimoto, T.; Kimura, H.; Matsunaga, T.; Watanabe, Y.; Miyasaka, Y.; Ohtsuka, T.; Tanaka, M.			Endoscopic Transpapillary Drainage for Postoperative Pancreatic Fistula	PANCREAS			English	Meeting Abstract									[Date, K.; Takahata, S.; Tamura, K.; Fujimoto, T.; Kimura, H.; Matsunaga, T.; Watanabe, Y.; Miyasaka, Y.; Ohtsuka, T.; Tanaka, M.] Kyushu Univ, Dept Surg & Oncol, Fukuoka 812, Japan								0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0885-3177	1536-4828		PANCREAS	Pancreas	NOV	2014	43	8					1352	1352				1	Gastroenterology & Hepatology	Gastroenterology & Hepatology	AS6GO	WOS:000344362600086		
J	Desaki, R; Kishiwada, M; Mizuno, S; Murata, Y; Tanemura, A; Azumi, Y; Kuriyama, N; Usui, M; Sakurai, H; Isaji, S				Desaki, R.; Kishiwada, M.; Mizuno, S.; Murata, Y.; Tanemura, A.; Azumi, Y.; Kuriyama, N.; Usui, M.; Sakurai, H.; Isaji, S.			A New Surgical Technique of PD-SAR for Pancreatic Head-Body Cancer with Splenic Artery Invasion to Avoid Total Pancreatectomy, Based On the Preservation of Remnant Pancreatic Functions	PANCREAS			English	Meeting Abstract									[Desaki, R.; Kishiwada, M.; Mizuno, S.; Murata, Y.; Tanemura, A.; Azumi, Y.; Kuriyama, N.; Usui, M.; Sakurai, H.; Isaji, S.] Mie Univ Sch Med, Dept Hepatobiliary Pancreat & Transplant Surg, Tsu, Mie, Japan								0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0885-3177	1536-4828		PANCREAS	Pancreas	NOV	2014	43	8					1353	1354				2	Gastroenterology & Hepatology	Gastroenterology & Hepatology	AS6GO	WOS:000344362600093		
J	Eguchi, T; Hasegawa, T; Kurosawa, M; Yamashita, H; Fukuchi, T; Itou, D; Ashida, K				Eguchi, T.; Hasegawa, T.; Kurosawa, M.; Yamashita, H.; Fukuchi, T.; Itou, D.; Ashida, K.			Efficacy of Recombinant Human Soluble Thrombomodulin During the Clinical Course in Severe Acute Pancreatitis With Disseminated Intravascular Coagulation	PANCREAS			English	Meeting Abstract									[Eguchi, T.; Hasegawa, T.; Kurosawa, M.; Yamashita, H.; Fukuchi, T.; Itou, D.; Ashida, K.] Osaka Saiseikai Nakatsu Hosp, Dept Gastroenterol & Hepatol, Osaka, Japan								0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0885-3177	1536-4828		PANCREAS	Pancreas	NOV	2014	43	8					1355	1355				1	Gastroenterology & Hepatology	Gastroenterology & Hepatology	AS6GO	WOS:000344362600100		
J	Endo, A; Shimamura, H; Kanehara, K; Takeda, K				Endo, A.; Shimamura, H.; Kanehara, K.; Takeda, K.			3 Cases of Main Duct Type Intraductal Papillary-Mucinous Neoplasm Which Recurred in the Remnant Pancreas After the First Pancreatectomy	PANCREAS			English	Meeting Abstract									[Endo, A.; Shimamura, H.; Kanehara, K.; Takeda, K.] Natl Hosp Org, Dept Surg, Sendai Med Ctr, Sendai, Miyagi, Japan								0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0885-3177	1536-4828		PANCREAS	Pancreas	NOV	2014	43	8					1356	1356				1	Gastroenterology & Hepatology	Gastroenterology & Hepatology	AS6GO	WOS:000344362600104		
J	Fujimoto, T; Ohtsuka, T; Date, K; Kimura, H; Matsunaga, T; Watanabe, Y; Tamura, K; Takahata, S; Oda, Y; Tanaka, M				Fujimoto, T.; Ohtsuka, T.; Date, K.; Kimura, H.; Matsunaga, T.; Watanabe, Y.; Tamura, K.; Takahata, S.; Oda, Y.; Tanaka, M.			Early Stage Pancreatic Cancer in the Remnant Pancreas Diagnosed During Strict Surveillance After Resection of Main Duct Intraductal Papillary Mucinous Neoplasm: A Case Report	PANCREAS			English	Meeting Abstract									[Fujimoto, T.; Ohtsuka, T.; Date, K.; Kimura, H.; Matsunaga, T.; Watanabe, Y.; Tamura, K.; Takahata, S.; Tanaka, M.] Kyushu Univ, Dept Surg & Oncol, Grad Sch Med Sci, Fukuoka 812, Japan; [Oda, Y.] Kyushu Univ, Dept Anat Pathol, Grad Sch Med Sci, Fukuoka 812, Japan								0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0885-3177	1536-4828		PANCREAS	Pancreas	NOV	2014	43	8					1358	1358				1	Gastroenterology & Hepatology	Gastroenterology & Hepatology	AS6GO	WOS:000344362600112		
J	Fukase, K; Motoi, F; Katayose, Y; Unno, M				Fukase, K.; Motoi, F.; Katayose, Y.; Unno, M.			Surgical Resection for Initially Unresectable Pancreatic Cancer After Preoperative Therapy	PANCREAS			English	Meeting Abstract									[Fukase, K.; Motoi, F.; Unno, M.] Tohoku Univ, Dept Surg, Grad Sch Med, Sendai, Miyagi 980, Japan; [Katayose, Y.] Tohoku Univ, Grad Sch Med, Sendai, Miyagi 980, Japan			Unno, Michiaki/A-8633-2010	Unno, Michiaki/0000-0002-2145-6416				0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0885-3177	1536-4828		PANCREAS	Pancreas	NOV	2014	43	8					1358	1358				1	Gastroenterology & Hepatology	Gastroenterology & Hepatology	AS6GO	WOS:000344362600113		
J	Furukawa, T; Ameri, M; Sakamoto, H; Kuboki, Y; Hatori, T; Yamamoto, M; Sugiyama, M; Ohike, N; Yamaguchi, H; Shimizu, M; Shibata, N; Shimizu, K; Shiratori, K				Furukawa, T.; Ameri, M.; Sakamoto, H.; Kuboki, Y.; Hatori, T.; Yamamoto, M.; Sugiyama, M.; Ohike, N.; Yamaguchi, H.; Shimizu, M.; Shibata, N.; Shimizu, K.; Shiratori, K.			Whole Exome Sequencing Uncovered Unexpected Recurrent Mutations in BRCA2 and FAT in Pancreatic Acinar Cell Carcinoma	PANCREAS			English	Meeting Abstract									[Furukawa, T.; Ameri, M.; Sakamoto, H.; Kuboki, Y.] Tokyo Womens Med Univ, Inst Integrated Med Sci, Tokyo, Japan; [Hatori, T.; Yamamoto, M.] Tokyo Womens Med Univ, Dept Gastroenterol Surg, Tokyo, Japan; [Kuboki, Y.; Shimizu, K.; Shiratori, K.] Tokyo Womens Med Univ, Dept Gastroenterol, Tokyo, Japan; [Shibata, N.] Tokyo Womens Med Univ, Dept Pathol, Tokyo, Japan; [Sakamoto, H.; Sugiyama, M.] Kyorin Univ, Sch Med, Dept Surg, Mitaka, Tokyo 181, Japan; [Ohike, N.] Showa Univ, Sch Med, Dept Pathol, Tokyo 142, Japan; [Yamaguchi, H.; Shimizu, M.] Saitama Med Univ, Dept Pathol, Int Med Ctr, Hidaka, Japan								0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0885-3177	1536-4828		PANCREAS	Pancreas	NOV	2014	43	8					1358	1359				2	Gastroenterology & Hepatology	Gastroenterology & Hepatology	AS6GO	WOS:000344362600114		
J	Goto, T; Matsumoto, I; Shinzeki, M; Toyama, H; Asari, S; Kinoshita, H; Matsumoto, T; Kuramitsu, K; Tanaka, M; Kido, M; Ajiki, T; Fukumoto, T; Ku, Y				Goto, T.; Matsumoto, I.; Shinzeki, M.; Toyama, H.; Asari, S.; Kinoshita, H.; Matsumoto, T.; Kuramitsu, K.; Tanaka, M.; Kido, M.; Ajiki, T.; Fukumoto, T.; Ku, Y.			Pulmonary Embolism After Laparoscopic Distal Pancreatectomy: Report of a Case	PANCREAS			English	Meeting Abstract									[Goto, T.; Toyama, H.; Asari, S.; Kinoshita, H.; Matsumoto, T.; Kuramitsu, K.; Tanaka, M.; Kido, M.; Ajiki, T.; Fukumoto, T.; Ku, Y.] Kobe Univ, Div Hepatobiliary Pancreat Surg, Dept Surg, Grad Sch Med Sci, Kobe, Hyogo 657, Japan; [Matsumoto, I.] Kinki Univ Hosp, Dept Surg, Osaka, Japan; [Shinzeki, M.] Saiseikai Nakatsu Hosp, Dept Surg, Osaka, Japan								0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0885-3177	1536-4828		PANCREAS	Pancreas	NOV	2014	43	8					1361	1361				1	Gastroenterology & Hepatology	Gastroenterology & Hepatology	AS6GO	WOS:000344362600124		
J	Hamada, S; Masamune, A; Shimosegawa, T				Hamada, S.; Masamune, A.; Shimosegawa, T.			The MiR-365 Increases Gemcitabine Resistance by Regulating Cell Cycle and Apoptosis-related Molecules	PANCREAS			English	Meeting Abstract									[Hamada, S.; Masamune, A.; Shimosegawa, T.] Tohoku Univ, Grad Sch Med, Div Gastroenterol, Sendai, Miyagi 980, Japan								0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0885-3177	1536-4828		PANCREAS	Pancreas	NOV	2014	43	8					1362	1363				2	Gastroenterology & Hepatology	Gastroenterology & Hepatology	AS6GO	WOS:000344362600130		
J	Harada, T; Inoue, H; Yamada, R; Takei, Y				Harada, T.; Inoue, H.; Yamada, R.; Takei, Y.			Incidence of Thromboembolism and Significance of Plasma D-Dimer Levels in Pancreatic Cancer Patients	PANCREAS			English	Meeting Abstract									[Harada, T.; Inoue, H.; Yamada, R.; Takei, Y.] Mie Univ, Grad Sch Med, Dept Gastroenterol & Hepatol, Tsu, Mie, Japan								0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0885-3177	1536-4828		PANCREAS	Pancreas	NOV	2014	43	8					1363	1363				1	Gastroenterology & Hepatology	Gastroenterology & Hepatology	AS6GO	WOS:000344362600134		
J	Hari, Y; Harashima, N; Kidani, A; Hayashi, H; Kawabata, Y; Harada, M; Yano, S; Tajima, Y				Hari, Y.; Harashima, N.; Kidani, A.; Hayashi, H.; Kawabata, Y.; Harada, M.; Yano, S.; Tajima, Y.			Bcl-2 Family Inhibitors Effectively Sensitize Human Pancreatic Cancer Cells to TRAIL	PANCREAS			English	Meeting Abstract									[Hari, Y.; Kidani, A.; Hayashi, H.; Kawabata, Y.; Yano, S.; Tajima, Y.] Shimane Univ, Fac Med, Dept Digest & Gen Surg, Matsue, Shimane, Japan; [Harashima, N.; Harada, M.] Shimane Univ, Fac Med, Dept Immunol, Matsue, Shimane, Japan								0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0885-3177	1536-4828		PANCREAS	Pancreas	NOV	2014	43	8					1363	1364				2	Gastroenterology & Hepatology	Gastroenterology & Hepatology	AS6GO	WOS:000344362600135		
J	Hieda, N; Imaoka, H; Okuno, N; Yoshida, T; Sato, T; Tsutsumi, H; Hujiyoshi, T; Yogi, T; Ishihara, M; Tanaka, T; Hijioka, S; Hara, K; Tajika, M; Mizuno, N; Shimizu, Y; Niwa, Y; Yamao, K				Hieda, N.; Imaoka, H.; Okuno, N.; Yoshida, T.; Sato, T.; Tsutsumi, H.; Hujiyoshi, T.; Yogi, T.; Ishihara, M.; Tanaka, T.; Hijioka, S.; Hara, K.; Tajika, M.; Mizuno, N.; Shimizu, Y.; Niwa, Y.; Yamao, K.			Clinical Course of Poorly Differentiated Pancreatic Adenocarcinoma after Surgical Resection	PANCREAS			English	Meeting Abstract									[Hieda, N.; Imaoka, H.; Okuno, N.; Yoshida, T.; Sato, T.; Tsutsumi, H.; Hujiyoshi, T.; Yogi, T.; Hijioka, S.; Hara, K.; Mizuno, N.; Yamao, K.] Aichi Canc Ctr Hosp, Dept Gastroenterol, Nagoya, Aichi 464, Japan; [Ishihara, M.; Tanaka, T.; Tajika, M.; Niwa, Y.] Aichi Canc Ctr Hosp, Dept Endoscopy, Nagoya, Aichi 464, Japan; [Shimizu, Y.] Aichi Canc Ctr Hosp, Dept Gastrointestinal Surg, Nagoya, Aichi 464, Japan								0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0885-3177	1536-4828		PANCREAS	Pancreas	NOV	2014	43	8					1365	1366				2	Gastroenterology & Hepatology	Gastroenterology & Hepatology	AS6GO	WOS:000344362600143		
J	Hirose, K; Hattori, M; Tomita, M; Kanazawa, H; Isobe, S; Suzuki, Y; Ishihara, S; Horiguchi, A; Inui, K				Hirose, K.; Hattori, M.; Tomita, M.; Kanazawa, H.; Isobe, S.; Suzuki, Y.; Ishihara, S.; Horiguchi, A.; Inui, K.			Pancreatic Pseudocyst With Pseudoaneurysm Perforating to the Stomach: A Case Report	PANCREAS			English	Meeting Abstract									[Hirose, K.; Hattori, M.; Tomita, M.; Kanazawa, H.; Isobe, S.; Suzuki, Y.] Yamashita Hosp, Dept Gastroenterol, Ichinomiya, Japan; [Ishihara, S.; Horiguchi, A.] Fujita Hlth Univ, Dept Pancreatobiliary Surg, Toyoake, Aichi, Japan; [Inui, K.] Fujita Hlth Univ, Dept Gastroenterol, Teaching Hosp 2, Nagoya, Aichi, Japan								0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0885-3177	1536-4828		PANCREAS	Pancreas	NOV	2014	43	8					1366	1366				1	Gastroenterology & Hepatology	Gastroenterology & Hepatology	AS6GO	WOS:000344362600144		
J	Hisano, T; Nagasio, Y; Suzuki, T; Furukawa, M				Hisano, T.; Nagasio, Y.; Suzuki, T.; Furukawa, M.			Metallic Biliary Stenting vs. Surgical Bypass in the Palliative Management for Malignant Distal Biliary Obstruction in Unresectable Pancreatic Ductal Adenocarcinoma	PANCREAS			English	Meeting Abstract									[Hisano, T.; Nagasio, Y.; Suzuki, T.; Furukawa, M.] Kyushu Natl Canc Ctr, Dept Hepatobiliarypancreatol, Fukuoka, Japan								0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0885-3177	1536-4828		PANCREAS	Pancreas	NOV	2014	43	8					1366	1366				1	Gastroenterology & Hepatology	Gastroenterology & Hepatology	AS6GO	WOS:000344362600145		
J	Horiguchi, A; Ishihara, S; Ito, M; Asano, Y				Horiguchi, A.; Ishihara, S.; Ito, M.; Asano, Y.			Treitz Ligament Approach for Artery First PD	PANCREAS			English	Meeting Abstract									[Horiguchi, A.; Ishihara, S.; Ito, M.; Asano, Y.] Fujita Hlth Univ, Dept Gen Surg Pancreat Surg, Toyoake, Aichi, Japan								0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0885-3177	1536-4828		PANCREAS	Pancreas	NOV	2014	43	8					1367	1367				1	Gastroenterology & Hepatology	Gastroenterology & Hepatology	AS6GO	WOS:000344362600148		
J	Iizawa, Y; Azumi, Y; Kato, H; Tanemura, A; Murata, Y; Kuriyama, N; Kishiwada, M; Mizuno, S; Usui, M; Sakurai, H; Isaji, S				Iizawa, Y.; Azumi, Y.; Kato, H.; Tanemura, A.; Murata, Y.; Kuriyama, N.; Kishiwada, M.; Mizuno, S.; Usui, M.; Sakurai, H.; Isaji, S.			Short-Term and Long-Term Outcomes After Pancreaticoduodenectomy Using Pair-Watch Suturing Technique According To Remnant Pancreas Volume	PANCREAS			English	Meeting Abstract									[Iizawa, Y.; Azumi, Y.; Kato, H.; Tanemura, A.; Murata, Y.; Kuriyama, N.; Kishiwada, M.; Mizuno, S.; Usui, M.; Sakurai, H.; Isaji, S.] Mie Univ, Dept Hepatobiliary Pancreat & Transplant Surg, Grad Sch Med, Tsu, Mie 514, Japan								0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0885-3177	1536-4828		PANCREAS	Pancreas	NOV	2014	43	8					1368	1368				1	Gastroenterology & Hepatology	Gastroenterology & Hepatology	AS6GO	WOS:000344362600153		
J	Inui, K; Yoshino, J; Yamamoto, S; Miyoshi, H; Kobayashi, T; Katano, Y				Inui, K.; Yoshino, J.; Yamamoto, S.; Miyoshi, H.; Kobayashi, T.; Katano, Y.			Factors Associated With Failure in Endoscopic Treatment of Pancreatolithiasis	PANCREAS			English	Meeting Abstract									[Inui, K.; Yoshino, J.; Yamamoto, S.; Miyoshi, H.; Kobayashi, T.; Katano, Y.] Fujita Hlth Univ, Teaching Hosp 2, Dept Gastroenterol, Nagoya, Aichi, Japan								0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0885-3177	1536-4828		PANCREAS	Pancreas	NOV	2014	43	8					1368	1368				1	Gastroenterology & Hepatology	Gastroenterology & Hepatology	AS6GO	WOS:000344362600154		
J	Ishiwata, T; Yoshimura, H; Matsuda, Y; Murase, M; Suzuki, T; Kawamoto, Y; Kawahara, K; Ishiwata, S; Naito, Z				Ishiwata, T.; Yoshimura, H.; Matsuda, Y.; Murase, M.; Suzuki, T.; Kawamoto, Y.; Kawahara, K.; Ishiwata, S.; Naito, Z.			Decrease in Fibroblast Growth Factor Receptor-4 Levels Inhibited the Proliferation, Migration, and Invasion of Pancreatic Cancer	PANCREAS			English	Meeting Abstract									[Ishiwata, T.; Yoshimura, H.; Matsuda, Y.; Murase, M.; Suzuki, T.; Kawamoto, Y.; Kawahara, K.; Naito, Z.] Nippon Med Sch, Dept Integrated Diagnost Pathol, Grad Sch Med, Tokyo 113, Japan; [Matsuda, Y.] Tokyo Metropolitan Geriatr Hosp, Dept Pathol, Tokyo 173, Japan; [Matsuda, Y.] Inst Gerontol, Tokyo, Japan; [Ishiwata, S.] Kinki Univ, Div Clin Pharm, Fac Pharm, Lab Med Pharmaceut & Therapeut, Osaka, Japan								0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0885-3177	1536-4828		PANCREAS	Pancreas	NOV	2014	43	8					1369	1369				1	Gastroenterology & Hepatology	Gastroenterology & Hepatology	AS6GO	WOS:000344362600155		
J	Itakura, J; Watanabe, M; Maki, A; Amemiya, H; Kawaida, H; Kohno, H				Itakura, J.; Watanabe, M.; Maki, A.; Amemiya, H.; Kawaida, H.; Kohno, H.			Neuroendocrine Tumor of the Pancreas: A Clinicopathological Analysis of 36 Cases	PANCREAS			English	Meeting Abstract									[Itakura, J.; Watanabe, M.; Maki, A.; Amemiya, H.; Kawaida, H.; Kohno, H.] Univ Yamanashi, Dept Surg, Kofu, Yamanashi, Japan								0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0885-3177	1536-4828		PANCREAS	Pancreas	NOV	2014	43	8					1369	1369				1	Gastroenterology & Hepatology	Gastroenterology & Hepatology	AS6GO	WOS:000344362600156		
J	Ito, T; Kimura, Y; Imamura, M; Kyuno, T; Nobuoka, T; Hirata, K				Ito, T.; Kimura, Y.; Imamura, M.; Kyuno, T.; Nobuoka, T.; Hirata, K.			PPPD Is Not Inferior to SSPPD in Postoperative Oral Intake; Propensity Score Matching Analysis on 154 Consecutive Patients Who Underwent Pancreaticoduodenectomy	PANCREAS			English	Meeting Abstract									[Ito, T.; Kimura, Y.; Imamura, M.; Kyuno, T.; Nobuoka, T.; Hirata, K.] Sapporo Med Univ, Dept Surg Surg Oncol & Sci, Sapporo, Hokkaido, Japan								0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0885-3177	1536-4828		PANCREAS	Pancreas	NOV	2014	43	8					1369	1369				1	Gastroenterology & Hepatology	Gastroenterology & Hepatology	AS6GO	WOS:000344362600157		
J	Izumi, S; Ichihara, S; Kubo, T; Ohtani, H; Yano, M; Tanaka, N; Ohashi, R; Onoda, Y; Suzuka, I				Izumi, S.; Ichihara, S.; Kubo, T.; Ohtani, H.; Yano, M.; Tanaka, N.; Ohashi, R.; Onoda, Y.; Suzuka, I.			Smad4 is Associated With Differentiation of Pancreatic Ductal Adenocarcinomas	PANCREAS			English	Meeting Abstract									[Izumi, S.; Ichihara, S.; Kubo, T.; Ohtani, H.; Yano, M.; Tanaka, N.; Ohashi, R.; Onoda, Y.; Suzuka, I.] Kagawa Prefectural Cent Hosp, Dept Surg Gastroenterol, Takamatsu, Kagawa, Japan								0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0885-3177	1536-4828		PANCREAS	Pancreas	NOV	2014	43	8					1369	1369				1	Gastroenterology & Hepatology	Gastroenterology & Hepatology	AS6GO	WOS:000344362600158		
J	Kaise, T; Shimizu, K; Ajihara, K; Akao, J; Shioga, T; Nagao, K; Tahara, J; Takayama, Y; Shiratori, K; Izumo, W; Hatori, T; Furukawa, T				Kaise, T.; Shimizu, K.; Ajihara, K.; Akao, J.; Shioga, T.; Nagao, K.; Tahara, J.; Takayama, Y.; Shiratori, K.; Izumo, W.; Hatori, T.; Furukawa, T.			Increased Risk of Pancreatic Cancer in Patients With Intraductal Papillary Mucinous Neoplasms of the Pancreas and a Family History or Past History of Cancer of the Pancreas or Other Organs	PANCREAS			English	Meeting Abstract									[Kaise, T.; Shimizu, K.; Ajihara, K.; Akao, J.; Shioga, T.; Nagao, K.; Tahara, J.; Takayama, Y.; Shiratori, K.] Tokyo Womens Med Univ, Dept Gastroenterol, Tokyo, Japan; [Izumo, W.; Hatori, T.] Tokyo Womens Med Univ, Tokyo, Japan; [Furukawa, T.] Tokyo Womens Med Univ, Inst Integrated Med Sci, Tokyo, Japan								0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0885-3177	1536-4828		PANCREAS	Pancreas	NOV	2014	43	8					1373	1373				1	Gastroenterology & Hepatology	Gastroenterology & Hepatology	AS6GO	WOS:000344362600173		
J	Kamei, K; Matsumoto, I; Nakata, Y; Satoi, S; Ishikawa, H; Nakai, T; Takeyama, Y				Kamei, K.; Matsumoto, I.; Nakata, Y.; Satoi, S.; Ishikawa, H.; Nakai, T.; Takeyama, Y.			Pancreaticoduodenectomy With Preservation of Gastroduodenal Artery: Report of Two Cases	PANCREAS			English	Meeting Abstract									[Kamei, K.; Matsumoto, I.; Nakata, Y.; Satoi, S.; Ishikawa, H.; Nakai, T.; Takeyama, Y.] Kinki Univ, Dept Surg, Fac Med, Osaka, Japan								0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0885-3177	1536-4828		PANCREAS	Pancreas	NOV	2014	43	8					1373	1374				2	Gastroenterology & Hepatology	Gastroenterology & Hepatology	AS6GO	WOS:000344362600175		
J	Kanehara, K; Shimamura, H; Takeda, K				Kanehara, K.; Shimamura, H.; Takeda, K.			Strategy Against Venous Thromboembolism After Pancreatectomy, Especially Anticoagulant Therapy	PANCREAS			English	Meeting Abstract									[Kanehara, K.; Shimamura, H.; Takeda, K.] Sendai Med Ctr, Dept Surg, Sendai, Miyagi, Japan								0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0885-3177	1536-4828		PANCREAS	Pancreas	NOV	2014	43	8					1374	1374				1	Gastroenterology & Hepatology	Gastroenterology & Hepatology	AS6GO	WOS:000344362600176		
J	Kasuga, A; Ueno, H; Ikeda, M; Ueno, M; Mizuno, N; Ioka, T; Omuro, Y; Nakajima, TE; Furuse, J				Kasuga, A.; Ueno, H.; Ikeda, M.; Ueno, M.; Mizuno, N.; Ioka, T.; Omuro, Y.; Nakajima, T. E.; Furuse, J.			Efficacy, Safety and Pharmacokinetics (PK) of Weekly nab-paclitaxel (P) Plus Gemcitabine (G) in Japanese Patients (pts) With Metastatic Pancreatic Cancer (MPC): Phase I/II Trial	PANCREAS			English	Meeting Abstract									[Kasuga, A.; Furuse, J.] Kyorin Univ, Sch Med, Dept Med Oncol, Tokyo, Japan; [Ueno, H.] Natl Canc Ctr, Hepatobiliary & Pancreat Oncol Div, Tokyo, Japan; [Ikeda, M.] Natl Canc Ctr Hosp East, Dept Hepatobiliary & Pancreat Oncol, Tokyo, Japan; [Ueno, M.] Kanagawa Canc Ctr, Div Hepatobiliary & Pancreat Med Oncol, Yokohama, Kanagawa, Japan; [Mizuno, N.] Aichi Canc Ctr Hosp, Dept Gastroenterol, Nagoya, Aichi, Japan; [Ioka, T.] Osaka Med Ctr Canc & Cardiovasc Dis, Dept Hepatobiliary & Pancreat Oncol, Osaka, Japan; [Omuro, Y.] Tokyo Metropolitan Canc & Infect Dis Ctr Komagome, Dept Chemotherapy, Tokyo, Japan; [Nakajima, T. E.] St Marianna Univ Sch Med Hosp, Dept Med Oncol, Kawasaki, Kanagawa, Japan								0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0885-3177	1536-4828		PANCREAS	Pancreas	NOV	2014	43	8					1374	1374				1	Gastroenterology & Hepatology	Gastroenterology & Hepatology	AS6GO	WOS:000344362600179		
J	Katayose, Y; Sato, N; Motoi, F; Nakagawa, K; Yoshida, H; Morikawa, T; Hayashi, H; Mizuma, M; Fukase, K; Aoki, T; Kawaguchi, K; Naitoh, T; Unno, M				Katayose, Y.; Sato, N.; Motoi, F.; Nakagawa, K.; Yoshida, H.; Morikawa, T.; Hayashi, H.; Mizuma, M.; Fukase, K.; Aoki, T.; Kawaguchi, K.; Naitoh, T.; Unno, M.			Quality of Life (QOL) Evaluation for Pancreatic Tumor Surgery Patients at the Three and Six Months After Surgery in a Single Center	PANCREAS			English	Meeting Abstract									[Katayose, Y.; Motoi, F.; Nakagawa, K.; Yoshida, H.; Morikawa, T.; Hayashi, H.; Mizuma, M.; Fukase, K.; Aoki, T.; Kawaguchi, K.; Naitoh, T.; Unno, M.] Tohoku Univ, Grad Sch Med, Sendai, Miyagi 980, Japan; [Sato, N.] Tohoku Univ, Grad Sch Med, Dept Oncol Nursing, Sendai, Miyagi 980, Japan			Unno, Michiaki/A-8633-2010	Unno, Michiaki/0000-0002-2145-6416				0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0885-3177	1536-4828		PANCREAS	Pancreas	NOV	2014	43	8					1375	1375				1	Gastroenterology & Hepatology	Gastroenterology & Hepatology	AS6GO	WOS:000344362600180		
J	Kato, M; Ito, T				Kato, M.; Ito, T.			Clinical Characteristics of Hospitalized Acute Pancreatitis Patients in our Hospital	PANCREAS			English	Meeting Abstract									[Kato, M.; Ito, T.] JCHO Osaka Hosp, Dept Gastroenterol, Osaka, Japan								0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0885-3177	1536-4828		PANCREAS	Pancreas	NOV	2014	43	8					1375	1375				1	Gastroenterology & Hepatology	Gastroenterology & Hepatology	AS6GO	WOS:000344362600181		
J	Kato, S; Chinen, K; Kikuchi, K; Murakami, T; Kunishima, F				Kato, S.; Chinen, K.; Kikuchi, K.; Murakami, T.; Kunishima, F.			Efficacy of Repeated Cytology for Early Detection of Pancreatic Cancer: Two Cases Diagnosed Using Pancreatic Juice Cytology Obtained via Endoscopic Naso-Pancreatic Drainage Tube	PANCREAS			English	Meeting Abstract									[Kato, S.; Chinen, K.; Kikuchi, K.] Okinawa Chubu Hosp, Dept Gastroenterol, Uruma, Okinawa, Japan; [Murakami, T.] Okinawa Chubu Hosp, Dept Surg, Uruma, Okinawa, Japan; [Kunishima, F.] Okinawa Chubu Hosp, Dept Pathol, Uruma, Okinawa, Japan								0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0885-3177	1536-4828		PANCREAS	Pancreas	NOV	2014	43	8					1375	1375				1	Gastroenterology & Hepatology	Gastroenterology & Hepatology	AS6GO	WOS:000344362600182		
J	Katsuta, E; Kudo, A; Ohata, Y; Ueda, H; Sato, T; Oba, A; Akahoshi, K; Nakao, K; Furuyama, T; Ito, H; Matsumura, S; Aihara, A; Ban, D; Ochiai, T; Irie, T; Tanaka, S; Tanabe, M				Katsuta, E.; Kudo, A.; Ohata, Y.; Ueda, H.; Sato, T.; Oba, A.; Akahoshi, K.; Nakao, K.; Furuyama, T.; Ito, H.; Matsumura, S.; Aihara, A.; Ban, D.; Ochiai, T.; Irie, T.; Tanaka, S.; Tanabe, M.			Morphology of Pancreatic Neuroendocrine Tumor (P-NET)	PANCREAS			English	Meeting Abstract									[Katsuta, E.; Kudo, A.; Ohata, Y.; Ueda, H.; Sato, T.; Oba, A.; Akahoshi, K.; Nakao, K.; Furuyama, T.; Ito, H.; Matsumura, S.; Aihara, A.; Ban, D.; Ochiai, T.; Irie, T.; Tanaka, S.; Tanabe, M.] Tokyo Med & Dent Univ, Dept Hepatobiliary Pancreat Surg, Tokyo, Japan								0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0885-3177	1536-4828		PANCREAS	Pancreas	NOV	2014	43	8					1375	1375				1	Gastroenterology & Hepatology	Gastroenterology & Hepatology	AS6GO	WOS:000344362600183		
J	Kawaguchi, K; Motoi, F; Fukase, K; Katayose, Y; Unno, M				Kawaguchi, K.; Motoi, F.; Fukase, K.; Katayose, Y.; Unno, M.			Quantitative Targeted Proteomics in Pancreatic Cancer: Combination of Enzyme and Efflux Transporter Protein Expression are New Indicators for Gemcitabine Sensitivity	PANCREAS			English	Meeting Abstract									[Kawaguchi, K.; Motoi, F.; Fukase, K.; Katayose, Y.; Unno, M.] Tohoku Univ, Grad Sch Med, Dept Surg, Sendai, Miyagi 980, Japan; [Katayose, Y.; Unno, M.] Tohoku Univ, Grad Sch Med, Div Integrated Surg & Oncol, Sendai, Miyagi 980, Japan			Unno, Michiaki/A-8633-2010	Unno, Michiaki/0000-0002-2145-6416				0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0885-3177	1536-4828		PANCREAS	Pancreas	NOV	2014	43	8					1375	1376				2	Gastroenterology & Hepatology	Gastroenterology & Hepatology	AS6GO	WOS:000344362600184		
J	Kawaguchi, M; Takori, K; Nakamura, A; Uemura, T; Mizumoto, M; Masui, T; Mori, A; Okajima, H; Hiraoka, M; Uemoto, S				Kawaguchi, M.; Takori, K.; Nakamura, A.; Uemura, T.; Mizumoto, M.; Masui, T.; Mori, A.; Okajima, H.; Hiraoka, M.; Uemoto, S.			Neoadjuband Chemo-radiotherapy (NACRT) for Borderline Resectable Pancreatic Cancer	PANCREAS			English	Meeting Abstract									[Kawaguchi, M.; Takori, K.; Uemura, T.; Mizumoto, M.; Masui, T.; Mori, A.; Okajima, H.; Uemoto, S.] Kyoto Univ, HBP Surg & Transplantat, Kyoto, Japan; [Nakamura, A.; Hiraoka, M.] Kyoto Univ, Dept Radiotherapy, Kyoto, Japan								0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0885-3177	1536-4828		PANCREAS	Pancreas	NOV	2014	43	8					1376	1376				1	Gastroenterology & Hepatology	Gastroenterology & Hepatology	AS6GO	WOS:000344362600185		
J	Kawase, T; Nishina, S; Hara, Y; Kishi, F; Yoshida, K; Hino, K				Kawase, T.; Nishina, S.; Hara, Y.; Kishi, F.; Yoshida, K.; Hino, K.			Fibroblast Activation Protein Activates Proliferation and Invasion of Pancreatic Adenocarcinoma	PANCREAS			English	Meeting Abstract									[Kawase, T.; Nishina, S.; Hara, Y.; Kishi, F.; Yoshida, K.; Hino, K.] Kawasaki Med Univ, Dept Hepatol & Pancreatol, Kurashiki, Okayama, Japan								0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0885-3177	1536-4828		PANCREAS	Pancreas	NOV	2014	43	8					1376	1376				1	Gastroenterology & Hepatology	Gastroenterology & Hepatology	AS6GO	WOS:000344362600186		
J	Kikuta, K; Masamune, A; Hamada, S; Shimosegawa, T				Kikuta, K.; Masamune, A.; Hamada, S.; Shimosegawa, T.		Res Comm Intractable Dis Pancreas	The Impact of Diabetes Mellitus on Clinical Outcome of Acute Pancreatitis in Japan	PANCREAS			English	Meeting Abstract									[Kikuta, K.; Masamune, A.; Hamada, S.; Shimosegawa, T.] Tohoku Univ, Grad Sch Med, Div Gastroenterol, Sendai, Miyagi 980, Japan								0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0885-3177	1536-4828		PANCREAS	Pancreas	NOV	2014	43	8					1377	1377				1	Gastroenterology & Hepatology	Gastroenterology & Hepatology	AS6GO	WOS:000344362600190		
J	Kimura, H; Ohtsuka, T; Date, K; Fujimoto, T; Matsunaga, T; Watanabe, Y; Tamura, K; Miyasaka, Y; Yamada, D; Takahata, S; Igarashi, H; Ito, T; Oda, Y; Tanaka, M				Kimura, H.; Ohtsuka, T.; Date, K.; Fujimoto, T.; Matsunaga, T.; Watanabe, Y.; Tamura, K.; Miyasaka, Y.; Yamada, D.; Takahata, S.; Igarashi, H.; Ito, T.; Oda, Y.; Tanaka, M.			Recurrence After Curative Resection for Well-Differentiated Pancreatic Neuroendocrine Tumors	PANCREAS			English	Meeting Abstract									[Kimura, H.; Ohtsuka, T.; Date, K.; Fujimoto, T.; Matsunaga, T.; Watanabe, Y.; Tamura, K.; Miyasaka, Y.; Yamada, D.; Takahata, S.; Tanaka, M.] Kyushu Univ, Dept Surg & Oncol, Fukuoka 812, Japan; [Igarashi, H.; Ito, T.] Kyushu Univ, Dept Med & Bioregulatory Sci, Fukuoka 812, Japan; [Oda, Y.] Kyushu Univ, Dept Anat Pathol, Fukuoka 812, Japan								0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0885-3177	1536-4828		PANCREAS	Pancreas	NOV	2014	43	8					1379	1379				1	Gastroenterology & Hepatology	Gastroenterology & Hepatology	AS6GO	WOS:000344362600199		
J	Kimura, K; Amano, R; Yamazoe, S; Miura, K; Ohira, G; Nishio, K; Shibutani, M; Sakurai, K; Nagahara, H; Toyokawa, T; Kubo, N; Tanaka, H; Muguruma, K; Otani, H; Maeda, K; Ohira, M; Hirakawa, K				Kimura, K.; Amano, R.; Yamazoe, S.; Miura, K.; Ohira, G.; Nishio, K.; Shibutani, M.; Sakurai, K.; Nagahara, H.; Toyokawa, T.; Kubo, N.; Tanaka, H.; Muguruma, K.; Otani, H.; Maeda, K.; Ohira, M.; Hirakawa, K.			Importance of the Invasive Distance in Invasive IPMN as a Prognostic Factor	PANCREAS			English	Meeting Abstract									[Kimura, K.; Amano, R.; Yamazoe, S.; Miura, K.; Ohira, G.; Nishio, K.; Shibutani, M.; Sakurai, K.; Nagahara, H.; Toyokawa, T.; Kubo, N.; Tanaka, H.; Muguruma, K.; Otani, H.; Maeda, K.; Ohira, M.; Hirakawa, K.] Osaka City Univ, Grad Sch Med, Dept Surg Oncol, Osaka 558, Japan								0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0885-3177	1536-4828		PANCREAS	Pancreas	NOV	2014	43	8					1379	1379				1	Gastroenterology & Hepatology	Gastroenterology & Hepatology	AS6GO	WOS:000344362600198		
J	Kin, T; Maguchi, H; Takahashi, K; Katanuma, A; Osanai, M; Yane, K; Ikarashi, S; Sen-yo, M; Minami, R; Sano, I				Kin, T.; Maguchi, H.; Takahashi, K.; Katanuma, A.; Osanai, M.; Yane, K.; Ikarashi, S.; Sen-yo, M.; Minami, R.; Sano, I.			Neoadjuvant Chemotherapy With Gemcitabine and S-1 for Locally Advanced Pancreatic Cancer	PANCREAS			English	Meeting Abstract									[Kin, T.; Maguchi, H.; Takahashi, K.; Katanuma, A.; Osanai, M.; Yane, K.; Ikarashi, S.; Sen-yo, M.; Minami, R.; Sano, I.] Teine Keijinkai Hosp, Ctr Gastroenterol, Sapporo, Hokkaido, Japan								0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0885-3177	1536-4828		PANCREAS	Pancreas	NOV	2014	43	8					1379	1379				1	Gastroenterology & Hepatology	Gastroenterology & Hepatology	AS6GO	WOS:000344362600200		
J	Kishiwada, M; Kato, H; Murata, Y; Tanemura, A; Kuriyama, N; Azumi, Y; Mizuno, S; Usui, M; Sakurai, H; Isaji, S				Kishiwada, M.; Kato, H.; Murata, Y.; Tanemura, A.; Kuriyama, N.; Azumi, Y.; Mizuno, S.; Usui, M.; Sakurai, H.; Isaji, S.			Comparative Study on the Clinicopathological Effect Between Gemcitabine-Based and S-1/Gemcitabine-Based Chemoradiotherapy for Locally Advanced Pancreatic Ductal Adenocarcinoma	PANCREAS			English	Meeting Abstract									[Kishiwada, M.; Kato, H.; Murata, Y.; Tanemura, A.; Kuriyama, N.; Azumi, Y.; Mizuno, S.; Usui, M.; Sakurai, H.; Isaji, S.] Mie Univ, Sch Med, Tsu, Mie 514, Japan								0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0885-3177	1536-4828		PANCREAS	Pancreas	NOV	2014	43	8					1379	1380				2	Gastroenterology & Hepatology	Gastroenterology & Hepatology	AS6GO	WOS:000344362600201		
J	Kishiwada, M; Kato, H; Murata, Y; Tanemura, A; Kuriyama, N; Azumi, Y; Mizuno, S; Usui, M; Ssakurai, H; Isaji, S				Kishiwada, M.; Kato, H.; Murata, Y.; Tanemura, A.; Kuriyama, N.; Azumi, Y.; Mizuno, S.; Usui, M.; Ssakurai, H.; Isaji, S.			Improvement of the Chemoradiotherapy Followed by Surgery for Advanced Pancreatic Ductal Adenocarcinoma: Comparison of the Histopathological Effect Between Single-Agent Gemcitabine and S-1/Gemcitabine Combination Therapy	PANCREAS			English	Meeting Abstract									[Kishiwada, M.; Kato, H.; Murata, Y.; Tanemura, A.; Kuriyama, N.; Azumi, Y.; Mizuno, S.; Usui, M.; Ssakurai, H.; Isaji, S.] Mie Univ, Sch Med, Tsu, Mie 514, Japan								0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0885-3177	1536-4828		PANCREAS	Pancreas	NOV	2014	43	8					1380	1380				1	Gastroenterology & Hepatology	Gastroenterology & Hepatology	AS6GO	WOS:000344362600202		
J	Kobayashi, G; Noda, Y; Ito, K; Koshida, S; Kanno, Y; Ogawa, T; Masu, K; Michikawa, Y; Iwashita, Y; Fujita, N; Sawai, T				Kobayashi, G.; Noda, Y.; Ito, K.; Koshida, S.; Kanno, Y.; Ogawa, T.; Masu, K.; Michikawa, Y.; Iwashita, Y.; Fujita, N.; Sawai, T.			Clinicopathological Study of T1 Pancreatic Cancer	PANCREAS			English	Meeting Abstract									[Kobayashi, G.; Noda, Y.; Ito, K.; Koshida, S.; Kanno, Y.; Ogawa, T.; Masu, K.; Michikawa, Y.; Iwashita, Y.; Fujita, N.] Sendai City Med Ctr, Dept Gastroenterol, Sendai, Miyagi, Japan; [Sawai, T.] Sendai City Med Ctr, Dept Pathol, Sendai, Miyagi, Japan								0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0885-3177	1536-4828		PANCREAS	Pancreas	NOV	2014	43	8					1381	1381				1	Gastroenterology & Hepatology	Gastroenterology & Hepatology	AS6GO	WOS:000344362600205		
J	Koikawa, K; Nishihara, K; Akiyama, Y; Nakashima, Y; Matsunaga, H; Abe, Y; Nakano, T; Mitsuyama, S; Tanaka, M				Koikawa, K.; Nishihara, K.; Akiyama, Y.; Nakashima, Y.; Matsunaga, H.; Abe, Y.; Nakano, T.; Mitsuyama, S.; Tanaka, M.			Malignant Potential of Intraductal Papillary Mucinous Neoplasms of the Pancreas: Special Reference to Minimally Invasive Carcinoma	PANCREAS			English	Meeting Abstract									[Koikawa, K.; Nishihara, K.; Akiyama, Y.; Nakashima, Y.; Matsunaga, H.; Abe, Y.; Nakano, T.; Mitsuyama, S.] Kitakyushu Municipal Med Ctr, Dept Surg, Kitakyushu, Fukuoka, Japan; [Tanaka, M.] Kyushu Univ, Grad Sch Med Sci, Dept Surg Oncol, Fukuoka 812, Japan								0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0885-3177	1536-4828		PANCREAS	Pancreas	NOV	2014	43	8					1381	1381				1	Gastroenterology & Hepatology	Gastroenterology & Hepatology	AS6GO	WOS:000344362600206		
J	Kondo, S; Fujiki, K; Ko, SB; Yamamoto, A; Nakakuki, M; Ito, Y; Kitagawa, M; Naruse, S; Ishiguro, H				Kondo, S.; Fujiki, K.; Ko, S. B.; Yamamoto, A.; Nakakuki, M.; Ito, Y.; Kitagawa, M.; Naruse, S.; Ishiguro, H.			L1156F-CFTR Associated With Alcoholic Chronic Pancreatitis in Japanese	PANCREAS			English	Meeting Abstract									[Kondo, S.; Yamamoto, A.; Nakakuki, M.; Ishiguro, H.] Nagoya Univ, Grad Sch Med, Dept Human Nutr, Nagoya, Aichi 4648601, Japan; [Fujiki, K.; Kitagawa, M.] Nagoya Univ Arts & Sci, Dept Nutr, Nagoya, Aichi, Japan; [Ko, S. B.] Keio Univ, Sch Med, Dept Syst, Keio, Japan; [Ito, Y.] Nagoya Univ, Grad Sch Med, Div Med Res Engn, Nagoya, Aichi 4648601, Japan; [Naruse, S.] Miyoshi Municipal Hosp, Miyoshi, Japan								0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0885-3177	1536-4828		PANCREAS	Pancreas	NOV	2014	43	8					1381	1381				1	Gastroenterology & Hepatology	Gastroenterology & Hepatology	AS6GO	WOS:000344362600208		
J	Kosaka, H; Asano, Y; Suzumura, K; Sueoka, H; Uyama, N; Okada, T; Hirano, T; Iimuro, Y; Fujimoto, J				Kosaka, H.; Asano, Y.; Suzumura, K.; Sueoka, H.; Uyama, N.; Okada, T.; Hirano, T.; Iimuro, Y.; Fujimoto, J.			The Validation Analysis of Our Prediction Method for Postoperative Pancreatic Fistula After Pancreas Head Resection	PANCREAS			English	Meeting Abstract									[Kosaka, H.; Asano, Y.; Suzumura, K.; Sueoka, H.; Uyama, N.; Okada, T.; Hirano, T.; Iimuro, Y.; Fujimoto, J.] Hyogo Coll Med, Dept Surg, Nishinomiya, Hyogo, Japan								0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0885-3177	1536-4828		PANCREAS	Pancreas	NOV	2014	43	8					1382	1382				1	Gastroenterology & Hepatology	Gastroenterology & Hepatology	AS6GO	WOS:000344362600210		
J	Kurosawa, A; Miki, A; Nishimura, W; Kimura, T; Nanmoku, K; Sakuma, Y; Sanada, Y; Sasanuma, H; Morishima, K; Kasahara, N; Yagisawa, T; Sata, N; Yasuda, Y				Kurosawa, A.; Miki, A.; Nishimura, W.; Kimura, T.; Nanmoku, K.; Sakuma, Y.; Sanada, Y.; Sasanuma, H.; Morishima, K.; Kasahara, N.; Yagisawa, T.; Sata, N.; Yasuda, Y.			The Effect of Leptin for PDX-1 Promoter Activity in the Islet Beta Cell Specific Manner	PANCREAS			English	Meeting Abstract									[Kurosawa, A.; Miki, A.; Sakuma, Y.; Sanada, Y.; Sasanuma, H.; Morishima, K.; Kasahara, N.; Sata, N.; Yasuda, Y.] Jichi Med Univ, Dept Surg, Tochigi, Japan; [Kurosawa, A.; Miki, A.; Kimura, T.; Nanmoku, K.; Sakuma, Y.; Yagisawa, T.] Jichi Med Univ Hosp, Inst Kidney Dis, Surg Branch, Tochigi, Japan; [Nishimura, W.] Natl Ctr Global Hlth & Med, Diabet Res Ctr, Dept Metab Disorder, Tokyo, Japan								0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0885-3177	1536-4828		PANCREAS	Pancreas	NOV	2014	43	8					1383	1383				1	Gastroenterology & Hepatology	Gastroenterology & Hepatology	AS6GO	WOS:000344362600215		
J	Kyuno, T; Kimura, Y; Imamura, M; Ito, T; Nobuoka, T; Mizuguchi, T; Furuhata, T; Hirata, K				Kyuno, T.; Kimura, Y.; Imamura, M.; Ito, T.; Nobuoka, T.; Mizuguchi, T.; Furuhata, T.; Hirata, K.			The Clinical Implication of Repeat Pancreatectomy for Recurrent Pancreatic Cancer in the Remnant Pancreas After Initial Pancreatectomy	PANCREAS			English	Meeting Abstract									[Kyuno, T.; Kimura, Y.; Imamura, M.; Ito, T.; Nobuoka, T.; Mizuguchi, T.; Furuhata, T.; Hirata, K.] Sapporo Med Univ, Dept Surg Surg Oncol & Sci, Sapporo, Hokkaido, Japan								0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0885-3177	1536-4828		PANCREAS	Pancreas	NOV	2014	43	8					1383	1383				1	Gastroenterology & Hepatology	Gastroenterology & Hepatology	AS6GO	WOS:000344362600216		
J	Maguchi, H; Ohtsuka, T; Tanno, S; Kobayashi, G; Kimura, W; Yamaguchi, T; Hatori, T; Tada, M; Hijioka, S; Uehara, H; Hanada, K; Yamaguchi, K; Sugiyama, M; Tanaka, M				Maguchi, H.; Ohtsuka, T.; Tanno, S.; Kobayashi, G.; Kimura, W.; Yamaguchi, T.; Hatori, T.; Tada, M.; Hijioka, S.; Uehara, H.; Hanada, K.; Yamaguchi, K.; Sugiyama, M.; Tanaka, M.			Multicenter Prospective Surveillance Study of BD-IPMN in Japan: Objectives and Registration Status in 2014	PANCREAS			English	Meeting Abstract									[Maguchi, H.] Teine Keijinkai Hosp, Ctr Gastroenterol, Sapporo, Hokkaido, Japan								0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0885-3177	1536-4828		PANCREAS	Pancreas	NOV	2014	43	8					1386	1386				1	Gastroenterology & Hepatology	Gastroenterology & Hepatology	AS6GO	WOS:000344362600229		
J	Matsumoto, I; Shinzeki, M; Toyama, H; Asari, S; Goto, T; Shirakawa, S; Ajiki, T; Fukumoto, T; Ku, Y				Matsumoto, I.; Shinzeki, M.; Toyama, H.; Asari, S.; Goto, T.; Shirakawa, S.; Ajiki, T.; Fukumoto, T.; Ku, Y.			A Prospective Randomized Comparison Between Pylorus- and Subtotal Stomach-Preserving Pancreatoduodenectomy on Postoperative Delayed Gastric Emptying Occurrence and Long-Term Nutritional Status	PANCREAS			English	Meeting Abstract									[Matsumoto, I.] Kinki Univ, Fac Med, Dept Surg, Osaka, Japan; [Matsumoto, I.; Shinzeki, M.; Toyama, H.; Asari, S.; Goto, T.; Shirakawa, S.; Ajiki, T.; Fukumoto, T.; Ku, Y.] Kobe Univ, Grad Sch Med, Dept Surg, Div Hepatobiliarypancreat Surg, Kobe, Hyogo 657, Japan								0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0885-3177	1536-4828		PANCREAS	Pancreas	NOV	2014	43	8					1388	1389				2	Gastroenterology & Hepatology	Gastroenterology & Hepatology	AS6GO	WOS:000344362600238		
J	Matsumura, Y; Ito, T				Matsumura, Y.; Ito, T.			Severe Acute Pancreatitis as a Delayed Complication Following Radiofrequency Ablation (RFA) for Hepatocellular Carcinoma (HCC)	PANCREAS			English	Meeting Abstract									[Matsumura, Y.; Ito, T.] JCHO Osaka Hosp, Dept Gastroenterol, Osaka, Japan								0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0885-3177	1536-4828		PANCREAS	Pancreas	NOV	2014	43	8					1389	1389				1	Gastroenterology & Hepatology	Gastroenterology & Hepatology	AS6GO	WOS:000344362600239		
J	Matsunaga, T; Ohtsuka, T; Asano, K; Fujimoto, T; Date, K; Kimura, H; Watanabe, Y; Tamura, K; Ohuchida, K; Takahata, S; Mizumoto, K; Guha, S; Raimondo, M; Tanaka, M				Matsunaga, T.; Ohtsuka, T.; Asano, K.; Fujimoto, T.; Date, K.; Kimura, H.; Watanabe, Y.; Tamura, K.; Ohuchida, K.; Takahata, S.; Mizumoto, K.; Guha, S.; Raimondo, M.; Tanaka, M.			A Minimally Invasive Screening Test to Detect Pancreatic Ductal Adenocarcinoma Using Biomarkers in the Duodenal Gluid: an Up-to-Date Report	PANCREAS			English	Meeting Abstract									[Matsunaga, T.; Ohtsuka, T.; Fujimoto, T.; Date, K.; Kimura, H.; Watanabe, Y.; Tamura, K.; Ohuchida, K.; Takahata, S.; Mizumoto, K.; Tanaka, M.] Kyushu Univ, Dept Surg & Oncol, Fukuoka 812, Japan; [Asano, K.] Kyushu Univ, Dept Med & Clin Sci, Fukuoka 812, Japan; [Guha, S.] Univ Texas Med Sch, Div Gastroenterol Hepatol & Nutr, Houston, TX USA; [Guha, S.] Univ Texas Hlth Sci Ctr Houston, Houston, TX 77030 USA; [Raimondo, M.] Mayo Clin, Div Gastroenterol & Hepatol, Jacksonville, FL 32224 USA								0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0885-3177	1536-4828		PANCREAS	Pancreas	NOV	2014	43	8					1389	1389				1	Gastroenterology & Hepatology	Gastroenterology & Hepatology	AS6GO	WOS:000344362600240		
J	Matsushita, A; Nakamura, Y; Katsuno, A; Sumiyoshi, H; Kanda, T; Shimizu, T; Mizuguchi, Y; Yoshioka, M; Yamahatu, K; Yokoyama, T; Taniai, N; Mamada, Y; Uchida, E				Matsushita, A.; Nakamura, Y.; Katsuno, A.; Sumiyoshi, H.; Kanda, T.; Shimizu, T.; Mizuguchi, Y.; Yoshioka, M.; Yamahatu, K.; Yokoyama, T.; Taniai, N.; Mamada, Y.; Uchida, E.			The Oncologic and Long-Term Outcomes of Laparoscopic Pancreatectomy for Pancreatic Cancer	PANCREAS			English	Meeting Abstract									[Matsushita, A.; Nakamura, Y.; Katsuno, A.; Sumiyoshi, H.; Kanda, T.; Shimizu, T.; Mizuguchi, Y.; Yoshioka, M.; Taniai, N.; Mamada, Y.; Uchida, E.] Nippon Med Sch, Dept Gastrointestinal & Hepatobiliarypancreat Sur, Tokyo 113, Japan; [Yamahatu, K.] Chiba Hokusoh Hosp, Nippon Med Sch, Dept Surg, Chiba, Japan; [Yokoyama, T.] Tama Nagayama Hosp, Nippon Med Sch, Dept Surg, Tokyo, Japan								0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0885-3177	1536-4828		PANCREAS	Pancreas	NOV	2014	43	8					1389	1389				1	Gastroenterology & Hepatology	Gastroenterology & Hepatology	AS6GO	WOS:000344362600241		
J	Miki, A; Sakuma, Y; Aida, J; Izumiyama-Shimomura, N; Sanada, Y; Kawano, Y; Sasanuma, H; Morishima, K; Kasahara, N; Ishikawa, N; Nakamura, K; Matsuda, Y; Fukushima, N; Takubo, K; Sata, N; Yasuda, Y				Miki, A.; Sakuma, Y.; Aida, J.; Izumiyama-Shimomura, N.; Sanada, Y.; Kawano, Y.; Sasanuma, H.; Morishima, K.; Kasahara, N.; Ishikawa, N.; Nakamura, K.; Matsuda, Y.; Fukushima, N.; Takubo, K.; Sata, N.; Yasuda, Y.			Telomere Length Shortening Associated to the Malignant Potentials in Intraductal Papillary Mucinous Neoplasm (IPMN)	PANCREAS			English	Meeting Abstract									[Miki, A.; Sakuma, Y.; Sanada, Y.; Sasanuma, H.; Morishima, K.; Kasahara, N.; Sata, N.; Yasuda, Y.] Jichi Med Univ, Dept Surg, Shimotsuke, Tochigi, Japan; [Miki, A.; Aida, J.; Izumiyama-Shimomura, N.; Sanada, Y.; Kawano, Y.; Ishikawa, N.; Nakamura, K.; Matsuda, Y.; Takubo, K.] Tokyo Metropolitan Inst Gerontol, Res Team Geriatr Pathol, Tokyo, Japan; [Miki, A.; Aida, J.; Izumiyama-Shimomura, N.; Sanada, Y.; Kawano, Y.; Ishikawa, N.; Nakamura, K.; Matsuda, Y.; Takubo, K.] Tokyo Metropolitan Geriatr Hosp, Dept Pathol, Tokyo 173, Japan; [Fukushima, N.] Jichi Med Univ, Dept Pathol, Shimotsuke, Tochigi, Japan								0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0885-3177	1536-4828		PANCREAS	Pancreas	NOV	2014	43	8					1390	1391				2	Gastroenterology & Hepatology	Gastroenterology & Hepatology	AS6GO	WOS:000344362600246		
J	Minami, R; Maguchi, H; Kin, T; Takahashi, K; Katanuma, A; Osanai, M; Yane, K; Ikarashi, S; Sen-yo, M; Sano, I; Yamazaki, H				Minami, R.; Maguchi, H.; Kin, T.; Takahashi, K.; Katanuma, A.; Osanai, M.; Yane, K.; Ikarashi, S.; Sen-yo, M.; Sano, I.; Yamazaki, H.			Natural History of Branch Duct Intraductal Papillary Mucinous Neoplasms With or Without Mural Nodule	PANCREAS			English	Meeting Abstract									[Minami, R.; Maguchi, H.; Kin, T.; Takahashi, K.; Katanuma, A.; Osanai, M.; Yane, K.; Ikarashi, S.; Sen-yo, M.; Sano, I.; Yamazaki, H.] Teine Keijinkai Hosp, Ctr Gastroenterol, Sapporo, Hokkaido, Japan								0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0885-3177	1536-4828		PANCREAS	Pancreas	NOV	2014	43	8					1391	1391				1	Gastroenterology & Hepatology	Gastroenterology & Hepatology	AS6GO	WOS:000344362600247		
J	Miura, K; Kimura, K; Amano, R; Yamazoe, S; Ohira, G; Nishio, K; Shibutani, M; Sakurai, K; Nagahara, H; Toyokawa, T; Kubo, N; Tanaka, H; Muguruma, K; Otani, H; Yashiro, M; Maeda, K; Ohira, M; Hirakawa, K				Miura, K.; Kimura, K.; Amano, R.; Yamazoe, S.; Ohira, G.; Nishio, K.; Shibutani, M.; Sakurai, K.; Nagahara, H.; Toyokawa, T.; Kubo, N.; Tanaka, H.; Muguruma, K.; Otani, H.; Yashiro, M.; Maeda, K.; Ohira, M.; Hirakawa, K.			Significance of Ductal Region in Anaplastic Pancreatic Cancer	PANCREAS			English	Meeting Abstract									[Miura, K.; Kimura, K.; Amano, R.; Yamazoe, S.; Ohira, G.; Nishio, K.; Shibutani, M.; Sakurai, K.; Nagahara, H.; Toyokawa, T.; Kubo, N.; Tanaka, H.; Muguruma, K.; Otani, H.; Yashiro, M.; Maeda, K.; Ohira, M.; Hirakawa, K.] Osaka City Univ, Dept Surg Oncol, Grad Sch Med, Osaka 558, Japan								0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0885-3177	1536-4828		PANCREAS	Pancreas	NOV	2014	43	8					1391	1391				1	Gastroenterology & Hepatology	Gastroenterology & Hepatology	AS6GO	WOS:000344362600248		
J	Miura, Y; Sato, M; Yamamoto, M				Miura, Y.; Sato, M.; Yamamoto, M.			Intravenous Injection of Fiber-Redesigned Oncolytic Adenovirus Eliminates PDAC Tumors In Vivo	PANCREAS			English	Meeting Abstract									[Miura, Y.; Sato, M.; Yamamoto, M.] Univ Minnesota, Dept Surg, Minneapolis, MN 55455 USA; [Miura, Y.] Toyama Univ, Dept Med 3, Toyama 930, Japan								0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0885-3177	1536-4828		PANCREAS	Pancreas	NOV	2014	43	8					1391	1391				1	Gastroenterology & Hepatology	Gastroenterology & Hepatology	AS6GO	WOS:000344362600249		
J	Miwa, H; Sugimori, K; Ishii, T; Kaneko, T; Numata, K; Tanaka, K; Maeda, S				Miwa, H.; Sugimori, K.; Ishii, T.; Kaneko, T.; Numata, K.; Tanaka, K.; Maeda, S.			Complications Associated With Endoscopic Ultrasound-Guided Fine Needle Aspiration of Solid Pancreatic Lesions	PANCREAS			English	Meeting Abstract									[Miwa, H.; Maeda, S.] Yokohama City Univ, Sch Med, Div Gastroenterol, Yokohama, Kanagawa 232, Japan; [Sugimori, K.; Ishii, T.; Kaneko, T.; Numata, K.; Tanaka, K.] Yokohama City Univ, Med Ctr, Gastroenterol Ctr, Yokohama, Kanagawa 232, Japan								0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0885-3177	1536-4828		PANCREAS	Pancreas	NOV	2014	43	8					1391	1392				2	Gastroenterology & Hepatology	Gastroenterology & Hepatology	AS6GO	WOS:000344362600250		
J	Miyazawa, M; Tani, M; Kawai, M; Hirono, S; Okada, K; Shimizu, A; Kitahata, Y; Yamaue, H				Miyazawa, M.; Tani, M.; Kawai, M.; Hirono, S.; Okada, K.; Shimizu, A.; Kitahata, Y.; Yamaue, H.			Phase I Clinical Trial Using Peptide Vaccine for Human Vascular Endothelial Growth Factor Receptor 2 in Combination With Gemcitabine for Patients With Advanced Pancreatic Cancer	PANCREAS			English	Meeting Abstract									[Miyazawa, M.; Tani, M.; Kawai, M.; Hirono, S.; Okada, K.; Shimizu, A.; Kitahata, Y.; Yamaue, H.] Wakayama Med Univ, Sch Med, Dept Surg 2, Wakayama, Japan								0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0885-3177	1536-4828		PANCREAS	Pancreas	NOV	2014	43	8					1392	1392				1	Gastroenterology & Hepatology	Gastroenterology & Hepatology	AS6GO	WOS:000344362600251		
J	Mizukami, H; Tanaka, JI				Mizukami, H.; Tanaka, J. -I.			A Case of Surgical Resection for Pancreatic Gastrinoma and Synchronized Multiple Liver Metastasis	PANCREAS			English	Meeting Abstract									[Mizukami, H.; Tanaka, J. -I.] Showa Univ, Fujigaoka Hosp, Yokohama, Kanagawa 227, Japan								0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0885-3177	1536-4828		PANCREAS	Pancreas	NOV	2014	43	8					1392	1392				1	Gastroenterology & Hepatology	Gastroenterology & Hepatology	AS6GO	WOS:000344362600252		
J	Monma, H; Harashima, N; Hari, Y; Kishi, S; Tajima, Y; Harada, M				Monma, H.; Harashima, N.; Hari, Y.; Kishi, S.; Tajima, Y.; Harada, M.			Autophagy Inhibitors Enhance TRAIL-Induced Antitumor Effects on Human Pancreatic Cancer Cells	PANCREAS			English	Meeting Abstract									[Monma, H.; Kishi, S.] Hyogo Prefectural Kakogawa Med Ctr, Dept Surg, Kobe, Hyogo, Japan; [Monma, H.; Hari, Y.; Tajima, Y.] Shimane Univ, Fac Med, Dept Surg, Matsue, Shimane, Japan; [Harashima, N.; Hari, Y.; Harada, M.] Shimane Univ, Fac Med, Dept Immunol, Matsue, Shimane, Japan								0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0885-3177	1536-4828		PANCREAS	Pancreas	NOV	2014	43	8					1392	1392				1	Gastroenterology & Hepatology	Gastroenterology & Hepatology	AS6GO	WOS:000344362600254		
J	Morvaridi, SK; Kanzaki, H; Edderkaoui, M; Pandol, SJ; Murali, R				Morvaridi, S. K.; Kanzaki, H.; Edderkaoui, M.; Pandol, S. J.; Murali, R.			Osteoprotegerin is a Pro-tumorigenic Factor for Pancreatic Cancer	PANCREAS			English	Meeting Abstract									[Morvaridi, S. K.; Kanzaki, H.; Edderkaoui, M.; Pandol, S. J.; Murali, R.] Cedars Sinai Med Ctr, Dept Biomed Sci, Los Angeles, CA 90048 USA; [Morvaridi, S. K.; Edderkaoui, M.; Pandol, S. J.] Cedars Sinai Med Ctr, Dept Med, Los Angeles, CA 90048 USA; [Kanzaki, H.] Okayama Univ Hosp, Dept Pharm, Okayama, Japan								0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0885-3177	1536-4828		PANCREAS	Pancreas	NOV	2014	43	8					1392	1393				2	Gastroenterology & Hepatology	Gastroenterology & Hepatology	AS6GO	WOS:000344362600255		
J	Murakami, T; Mori, R; Matsuyama, R; Homma, Y; Nakazawa, M; Tanaka, Y; Miyake, K; Sawada, Y; Oota, Y; Hiroshima, Y; Kumamoto, T; Ueda, M; Takeda, K; Ichikawa, Y; Tanaka, K; Endo, I				Murakami, T.; Mori, R.; Matsuyama, R.; Homma, Y.; Nakazawa, M.; Tanaka, Y.; Miyake, K.; Sawada, Y.; Oota, Y.; Hiroshima, Y.; Kumamoto, T.; Ueda, M.; Takeda, K.; Ichikawa, Y.; Tanaka, K.; Endo, I.			Local Immunological Effect of Neoadjuvant Chemoradiotherapy in Patients With Borderline Resectable Pancreatic Cancer	PANCREAS			English	Meeting Abstract									[Murakami, T.; Mori, R.; Matsuyama, R.; Homma, Y.; Tanaka, Y.; Miyake, K.; Sawada, Y.; Oota, Y.; Hiroshima, Y.; Kumamoto, T.; Ueda, M.; Takeda, K.; Ichikawa, Y.; Tanaka, K.; Endo, I.] Yokohama City Univ, Grad Sch Med, Dept Surg Gastroenterol, Yokohama, Kanagawa 232, Japan; [Nakazawa, M.] Yokohama City Univ, Grad Sch Med, Dept Expt Anim Med, Yokohama, Kanagawa 232, Japan								0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0885-3177	1536-4828		PANCREAS	Pancreas	NOV	2014	43	8					1394	1394				1	Gastroenterology & Hepatology	Gastroenterology & Hepatology	AS6GO	WOS:000344362600260		
J	Murata, Y; Usui, M; Mizuno, S; Tanemura, A; Kato, H; Kuriyama, N; Azumi, Y; Kishiwada, M; Sakurai, H; Isaji, S				Murata, Y.; Usui, M.; Mizuno, S.; Tanemura, A.; Kato, H.; Kuriyama, N.; Azumi, Y.; Kishiwada, M.; Sakurai, H.; Isaji, S.			Pancreatoduodenectomy With Resection of the Splenic Artery and Left Gastric Artery for Pancreatic Head and Body Cancer: Preservation of the Remnant Pancreatic Function via the Blood Supply From the Posterior Epiploic Artery	PANCREAS			English	Meeting Abstract									[Murata, Y.; Usui, M.; Mizuno, S.; Tanemura, A.; Kato, H.; Kuriyama, N.; Azumi, Y.; Kishiwada, M.; Sakurai, H.; Isaji, S.] Mie Univ, Sch Med, Dept Hepatobiliary Pancreat & Transplant Surg, Tsu, Mie 514, Japan								0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0885-3177	1536-4828		PANCREAS	Pancreas	NOV	2014	43	8					1394	1394				1	Gastroenterology & Hepatology	Gastroenterology & Hepatology	AS6GO	WOS:000344362600261		
J	Nakamura, T; Ambo, Y; Takada, M; Nakamura, F; Kashimura, N; Hirano, S				Nakamura, T.; Ambo, Y.; Takada, M.; Nakamura, F.; Kashimura, N.; Hirano, S.			Reduction of the Incidence of Delayed Gastric Emptying in Side-to-Side Gastrojejunostomy in Subtotal Stomach-Preserving Pancreaticoduodenectomy	PANCREAS			English	Meeting Abstract									[Nakamura, T.; Hirano, S.] Hokkaido Univ, Grad Sch Med, Dept Gastroenterol Surg 2, Sapporo, Hokkaido, Japan; [Ambo, Y.; Takada, M.; Nakamura, F.; Kashimura, N.] Teine Keijinkai Hosp, Dept Surg, Teine Ku, Sapporo, Hokkaido, Japan								0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0885-3177	1536-4828		PANCREAS	Pancreas	NOV	2014	43	8					1395	1395				1	Gastroenterology & Hepatology	Gastroenterology & Hepatology	AS6GO	WOS:000344362600264		
J	Naruse, S; Ishiguro, H; Yamamoto, A; Kondo, S; Nakakuki, M; Hoshino, M; Fujiki, K; Kitagawa, M; Yoshimura, K; Shimosegawa, T				Naruse, S.; Ishiguro, H.; Yamamoto, A.; Kondo, S.; Nakakuki, M.; Hoshino, M.; Fujiki, K.; Kitagawa, M.; Yoshimura, K.; Shimosegawa, T.			Incidence and Exocrine Pancreatic Function of Cystic Fibrosis in Japan	PANCREAS			English	Meeting Abstract									[Naruse, S.; Hoshino, M.] Miyoshi Municipal Hosp, Dept Med, Miyoshi, Japan; [Naruse, S.; Hoshino, M.] Miyoshi Municipal Hosp, Dept Pediat, Miyoshi, Japan; [Ishiguro, H.; Yamamoto, A.; Kondo, S.; Nakakuki, M.] Nagoya Univ, Grad Sch Med, Human Nutr Lab, Nagoya, Aichi 4648601, Japan; [Fujiki, K.; Kitagawa, M.] Nagoya Univ Art & Sci, Nagoya, Aichi, Japan; [Yoshimura, K.] Omori Red Cross Hosp, Tokyo, Japan; [Shimosegawa, T.] Tohoku Univ, Grad Sch Med, Div Gastroenterol, Sendai, Miyagi 980, Japan								0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0885-3177	1536-4828		PANCREAS	Pancreas	NOV	2014	43	8					1395	1395				1	Gastroenterology & Hepatology	Gastroenterology & Hepatology	AS6GO	WOS:000344362600265		
J	Okada, T; Iimuro, Y; Hirano, T; Asano, Y; Suzumura, K; Nakamura, I; Kondo, Y; Kosaka, H; Hai, S; Sueoka, H; Fujimoto, J				Okada, T.; Iimuro, Y.; Hirano, T.; Asano, Y.; Suzumura, K.; Nakamura, I.; Kondo, Y.; Kosaka, H.; Hai, S.; Sueoka, H.; Fujimoto, J.			The Drain Management after Laparoscopic Distal Pancreatectomy	PANCREAS			English	Meeting Abstract									[Okada, T.; Iimuro, Y.; Hirano, T.; Asano, Y.; Suzumura, K.; Nakamura, I.; Kondo, Y.; Kosaka, H.; Hai, S.; Sueoka, H.; Fujimoto, J.] Hyogo Coll Med, Dept Surg, Nishinomiya, Hyogo 6638501, Japan								0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0885-3177	1536-4828		PANCREAS	Pancreas	NOV	2014	43	8					1397	1397				1	Gastroenterology & Hepatology	Gastroenterology & Hepatology	AS6GO	WOS:000344362600274		
J	Okamura, Y; Sugiura, T; Ito, T; Yamamoto, Y; Uesaka, K				Okamura, Y.; Sugiura, T.; Ito, T.; Yamamoto, Y.; Uesaka, K.			Prognostic Factors of Intraductal Papillary Mucinous Carcinoma	PANCREAS			English	Meeting Abstract									[Okamura, Y.; Sugiura, T.; Ito, T.; Yamamoto, Y.; Uesaka, K.] Shizuoka Canc Ctr Hosp, Div Hepatobiliary Pancreat Surg, Shizuoka, Japan								0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0885-3177	1536-4828		PANCREAS	Pancreas	NOV	2014	43	8					1397	1398				2	Gastroenterology & Hepatology	Gastroenterology & Hepatology	AS6GO	WOS:000344362600275		
J	Ota, S; Mizuguchi, T; Nishimura, M; Ishii, M; Okita, K; Nishidate, T; Nobuoka, T; Kimura, Y; Niitsu, Y; Hirata, K				Ota, S.; Mizuguchi, T.; Nishimura, M.; Ishii, M.; Okita, K.; Nishidate, T.; Nobuoka, T.; Kimura, Y.; Niitsu, Y.; Hirata, K.			Vitamin A-Binding Liposome Containing Heat Shock Protein 47 siRNA Regulates Pancreatic Regeneration	PANCREAS			English	Meeting Abstract									[Ota, S.; Mizuguchi, T.; Ishii, M.; Okita, K.; Nishidate, T.; Nobuoka, T.; Kimura, Y.; Hirata, K.] Sapporo Med Univ, Dept Surg, Sapporo, Hokkaido, Japan; [Ota, S.; Nishimura, M.; Niitsu, Y.] Sapporo Med Univ, Dept Mol Target, Sapporo, Hokkaido, Japan								0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0885-3177	1536-4828		PANCREAS	Pancreas	NOV	2014	43	8					1398	1398				1	Gastroenterology & Hepatology	Gastroenterology & Hepatology	AS6GO	WOS:000344362600276		
J	Sakagami, J; Kataoka, K; Yasuda, H; Sogame, Y; Kato, R; Doi, T; Itoh, Y				Sakagami, J.; Kataoka, K.; Yasuda, H.; Sogame, Y.; Kato, R.; Doi, T.; Itoh, Y.			Initial Change in Mesenteric Blood Flow as Studied by Pulse Doppler and Contrast-Enhanced US in Acute Pancreatitis	PANCREAS			English	Meeting Abstract									[Sakagami, J.; Kataoka, K.; Yasuda, H.; Sogame, Y.; Kato, R.; Doi, T.; Itoh, Y.] Kyoto Prefectural Univ Med, Dept Gastroenterol & Hepatol, Kyoto, Japan								0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0885-3177	1536-4828		PANCREAS	Pancreas	NOV	2014	43	8					1403	1403				1	Gastroenterology & Hepatology	Gastroenterology & Hepatology	AS6GO	WOS:000344362600298		
J	Sakuraba, S; Toyoki, Y; Ishido, K; Kudo, D; Kimura, N; Hakamada, K				Sakuraba, S.; Toyoki, Y.; Ishido, K.; Kudo, D.; Kimura, N.; Hakamada, K.			Surgical Treatment of Solid-Pseudopapillary Neoplasm of the Pancreas: A Single Institution Experience	PANCREAS			English	Meeting Abstract									[Sakuraba, S.; Toyoki, Y.; Ishido, K.; Kudo, D.; Kimura, N.; Hakamada, K.] Hirosaki Univ, Grad Sch Med, Dept Surg Gastroenterol, Hirosaki, Aomori, Japan								0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0885-3177	1536-4828		PANCREAS	Pancreas	NOV	2014	43	8					1403	1403				1	Gastroenterology & Hepatology	Gastroenterology & Hepatology	AS6GO	WOS:000344362600299		
J	Sanuki, T; Kinoshita, M; Sakai, H; Yamada, Y; Sasaki, A; Tanaka, K; Yoshie, T; Hori, J; Sawa, H; Kuroda, D; Kanzawa, M; Zen, Y				Sanuki, T.; Kinoshita, M.; Sakai, H.; Yamada, Y.; Sasaki, A.; Tanaka, K.; Yoshie, T.; Hori, J.; Sawa, H.; Kuroda, D.; Kanzawa, M.; Zen, Y.			Endoscopic Retrograde Cholangiopancreatography Brush Cytology for Invasive Pancreatic Ductal Cancer: A Method to Improve the Diagnostic Accuracy Rate	PANCREAS			English	Meeting Abstract									[Sanuki, T.; Kinoshita, M.; Sakai, H.; Yamada, Y.; Sasaki, A.; Tanaka, K.; Yoshie, T.; Hori, J.] Kita Harima Med Ctr, Dept Gastroenterol, Ono, Hokkaido, Japan; [Sawa, H.; Kuroda, D.] Kita Harima Med Ctr, Dept Surg, Ono, Hokkaido, Japan; [Kanzawa, M.; Zen, Y.] Kita Harima Med Ctr, Dept Diagnost Pathol, Ono, Hokkaido, Japan								0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0885-3177	1536-4828		PANCREAS	Pancreas	NOV	2014	43	8					1404	1404				1	Gastroenterology & Hepatology	Gastroenterology & Hepatology	AS6GO	WOS:000344362600302		
J	Sasaki, Y; Nagata, H; Shinkai, T; Nakada, S; Shinzato, Y; Tamae, T; Maeshiro, K				Sasaki, Y.; Nagata, H.; Shinkai, T.; Nakada, S.; Shinzato, Y.; Tamae, T.; Maeshiro, K.			A Case of Chronic Pancreatitis in Child With the Point Mutation in SPINK1	PANCREAS			English	Meeting Abstract									[Sasaki, Y.; Nagata, H.; Shinkai, T.; Nakada, S.; Shinzato, Y.; Tamae, T.; Maeshiro, K.] Okinawa Chubu Tokusyukai Hosp, Okinawa, Japan								0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0885-3177	1536-4828		PANCREAS	Pancreas	NOV	2014	43	8					1404	1405				2	Gastroenterology & Hepatology	Gastroenterology & Hepatology	AS6GO	WOS:000344362600305		
J	Satoh, A; Asonuma, S; Umemura, K; Hirota, M; Konishi, H; Arai, T; Tamagawa, H; Takahashi, K; Onuma, M; Miura, M				Satoh, A.; Asonuma, S.; Umemura, K.; Hirota, M.; Konishi, H.; Arai, T.; Tamagawa, H.; Takahashi, K.; Onuma, M.; Miura, M.			Endoscopic Papillary Large Balloon Dilatation for Removal of Common Bile Duct Stones Does Not Increase the Risk of Post-ERCP Pancreatitis	PANCREAS			English	Meeting Abstract									[Satoh, A.; Asonuma, S.; Umemura, K.; Tamagawa, H.; Takahashi, K.; Onuma, M.; Miura, M.] South Miyagi Med Ctr, Dept Gastroenterol, Ohgawara, Japan; [Satoh, A.; Konishi, H.; Arai, T.] Kurihara Cent Hosp, Dept Internal Med, Kurihara, Japan; [Hirota, M.] Tohoku Univ, Grad Sch Med, Div Gastroenterol, Sendai, Miyagi 980, Japan								0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0885-3177	1536-4828		PANCREAS	Pancreas	NOV	2014	43	8					1405	1405				1	Gastroenterology & Hepatology	Gastroenterology & Hepatology	AS6GO	WOS:000344362600306		
J	Sawa, H; Sanuki, T; Fukuoka, E; Murata, K; Mii, Y; Otsubo, D; Oka, S; Iwatani, Y; Kuroda, D				Sawa, H.; Sanuki, T.; Fukuoka, E.; Murata, K.; Mii, Y.; Otsubo, D.; Oka, S.; Iwatani, Y.; Kuroda, D.			Two Cases of Pancreatic Neuroendocrine Tumor Diagnosed by Endoscopic Ultrasonography-Fine Needle Aspiration Biopsy	PANCREAS			English	Meeting Abstract									[Sawa, H.; Fukuoka, E.; Murata, K.; Mii, Y.; Otsubo, D.; Oka, S.; Iwatani, Y.; Kuroda, D.] Kita Harima Med Ctr, Dept Surg, Ono, Hokkaido, Japan; [Sanuki, T.] Kita Harima Med Ctr, Dept Gastroenterol, Ono, Hokkaido, Japan								0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0885-3177	1536-4828		PANCREAS	Pancreas	NOV	2014	43	8					1405	1405				1	Gastroenterology & Hepatology	Gastroenterology & Hepatology	AS6GO	WOS:000344362600307		
J	Shimamura, H; Endo, A; Kanehara, K; Kodama, H; Takeda, K				Shimamura, H.; Endo, A.; Kanehara, K.; Kodama, H.; Takeda, K.			Standardization of Distal Pancreatectomy	PANCREAS			English	Meeting Abstract									[Shimamura, H.; Endo, A.; Kanehara, K.; Kodama, H.; Takeda, K.] Sendai Med Ctr, Dept Surg, Sendai, Miyagi, Japan								0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0885-3177	1536-4828		PANCREAS	Pancreas	NOV	2014	43	8					1406	1407				2	Gastroenterology & Hepatology	Gastroenterology & Hepatology	AS6GO	WOS:000344362600313		
J	Shimizu, A; Tani, M; Kawai, M; Hirono, S; Okada, K; Miyazawa, M; Kitahata, Y; Yamaue, H				Shimizu, A.; Tani, M.; Kawai, M.; Hirono, S.; Okada, K.; Miyazawa, M.; Kitahata, Y.; Yamaue, H.			Treatment Strategy for Patients With SMA Plexus Invasion on Preoperative CT Diagnosis in Pancreatic Head Cancer	PANCREAS			English	Meeting Abstract									[Shimizu, A.; Tani, M.; Kawai, M.; Hirono, S.; Okada, K.; Miyazawa, M.; Kitahata, Y.; Yamaue, H.] Wakayama Med Univ, Sch Med, Dept Surg 2, Wakayama, Japan								0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0885-3177	1536-4828		PANCREAS	Pancreas	NOV	2014	43	8					1407	1407				1	Gastroenterology & Hepatology	Gastroenterology & Hepatology	AS6GO	WOS:000344362600314		
J	Shimizu, Y; Yamaue, H; Maguchi, H; Yamao, K; Hirono, S; Osanai, M; Hijioka, S; Kanemitsu, Y; Sano, T; Senda, Y; Bhatia, V; Yanagisawa, A				Shimizu, Y.; Yamaue, H.; Maguchi, H.; Yamao, K.; Hirono, S.; Osanai, M.; Hijioka, S.; Kanemitsu, Y.; Sano, T.; Senda, Y.; Bhatia, V.; Yanagisawa, A.			Validation of a Nomogram for Predicting the Probability of Carcinoma in Patients with Intraductal Papillary-Mucinous Neoplasm in 180 Pancreatic Resection Patients at 3 High Volume Centers	PANCREAS			English	Meeting Abstract									[Shimizu, Y.; Sano, T.; Senda, Y.] Aichi Canc Ctr Hosp, Dept Surg Gastroenterol, Nagoya, Aichi 464, Japan; [Yamaue, H.; Hirono, S.] Wakayama Med Univ, Dept Surg 2, Sch Med, Wakayama, Japan; [Maguchi, H.; Osanai, M.] Teine Keijinkai Hosp, Ctr Gastroenterol, Sapporo, Hokkaido, Japan; [Yamao, K.; Hijioka, S.] Aichi Canc Ctr Hosp, Dept Gastroenterol, Nagoya, Aichi 464, Japan; [Kanemitsu, Y.] Natl Canc Ctr, Colorectal Surg Div, Tokyo, Japan; [Bhatia, V.] Inst Liver & Biliary Sci, Dept Med Hepatol, Delhi, India; [Yanagisawa, A.] Kyoto Prefectural Univ Med, Dept Pathol, Kyoto 602, Japan								0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0885-3177	1536-4828		PANCREAS	Pancreas	NOV	2014	43	8					1407	1407				1	Gastroenterology & Hepatology	Gastroenterology & Hepatology	AS6GO	WOS:000344362600315		
J	Shinchi, H; Takao, S; Maemura, K; Mataki, Y; Kurahara, H; Hiwatashi, K; Ino, S; Sakoda, M; Ueno, S; Natsugoe, S				Shinchi, H.; Takao, S.; Maemura, K.; Mataki, Y.; Kurahara, H.; Hiwatashi, K.; Ino, S.; Sakoda, M.; Ueno, S.; Natsugoe, S.			Oral S-1 With Concurrent Radiotherapy Versus S-1 Alone in Patients With Locally Unresectable Pancreatic Cancer	PANCREAS			English	Meeting Abstract									[Shinchi, H.] Kagoshima Univ, Sch Hlth Sci, Kagoshima 890, Japan; [Takao, S.] Kagoshima Univ, Frontier Sci Res Ctr, Kagoshima 890, Japan; [Maemura, K.; Mataki, Y.; Kurahara, H.; Hiwatashi, K.; Ino, S.; Sakoda, M.; Natsugoe, S.] Kagoshima Univ, Dept Surg Gastroenterol, Kagoshima 890, Japan; [Ueno, S.] Kagoshima Univ, Dept Clin Oncol, Kagoshima 890, Japan								0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0885-3177	1536-4828		PANCREAS	Pancreas	NOV	2014	43	8					1407	1407				1	Gastroenterology & Hepatology	Gastroenterology & Hepatology	AS6GO	WOS:000344362600316		
J	Shirakawa, S; Lee, D; Tsuchida, S; Teramura, K				Shirakawa, S.; Lee, D.; Tsuchida, S.; Teramura, K.			Locally Advanced Cancer of the Pancreatic Tail Adjacent to Malignant Lymphoma of the Spleen	PANCREAS			English	Meeting Abstract									[Shirakawa, S.; Lee, D.; Tsuchida, S.] Yodogawa Christians Hosp, Dept Surg, Osaka, Japan; [Teramura, K.] Yodogawa Christians Hosp, Osaka, Japan								0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0885-3177	1536-4828		PANCREAS	Pancreas	NOV	2014	43	8					1407	1408				2	Gastroenterology & Hepatology	Gastroenterology & Hepatology	AS6GO	WOS:000344362600317		
J	Sugiyama, M; Suzuki, Y; Yokoyama, M; Nakazato, T; Abe, N; Masaki, T; Mori, T				Sugiyama, M.; Suzuki, Y.; Yokoyama, M.; Nakazato, T.; Abe, N.; Masaki, T.; Mori, T.			Technical Refinement of Pancreatoduodenectomy	PANCREAS			English	Meeting Abstract									[Sugiyama, M.; Suzuki, Y.; Yokoyama, M.; Nakazato, T.; Abe, N.; Masaki, T.; Mori, T.] Kyorin Univ Sch Med, Dept Surg, Tokyo, Japan								0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0885-3177	1536-4828		PANCREAS	Pancreas	NOV	2014	43	8					1411	1412				2	Gastroenterology & Hepatology	Gastroenterology & Hepatology	AS6GO	WOS:000344362600334		
J	Suzuki, S; Goto, Y; Kajiyama, H; Takemura, A; Konishi, S; Shimazaki, J; Motohashi, G; Nakachi, T; Tabuchi, T; Nishida, K; Ubukata, H; Tabuchi, T; Harada, N				Suzuki, S.; Goto, Y.; Kajiyama, H.; Takemura, A.; Konishi, S.; Shimazaki, J.; Motohashi, G.; Nakachi, T.; Tabuchi, T.; Nishida, K.; Ubukata, H.; Tabuchi, T.; Harada, N.			Prognostic Significance of Preoperative Neutrophil-to-Lymphocyte Ratio in Pancreatic Cancer	PANCREAS			English	Meeting Abstract									[Suzuki, S.; Goto, Y.; Kajiyama, H.; Takemura, A.; Konishi, S.; Shimazaki, J.; Motohashi, G.; Nakachi, T.; Tabuchi, T.; Nishida, K.; Ubukata, H.; Tabuchi, T.] Tokyo Med Univ, Ibaraki Med Ctr, Dept Surg Gastroenterol, Ibaraki, Japan; [Harada, N.] Hachioji Digest Dis Hosp, Tokyo, Japan								0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0885-3177	1536-4828		PANCREAS	Pancreas	NOV	2014	43	8					1412	1412				1	Gastroenterology & Hepatology	Gastroenterology & Hepatology	AS6GO	WOS:000344362600335		
J	Suzuki, Y; Sugiyama, M; Inui, K; Igarashi, Y; Ohara, H; Tazuma, S; Tsuji, T; Miyakawa, H; Atomi, Y				Suzuki, Y.; Sugiyama, M.; Inui, K.; Igarashi, Y.; Ohara, H.; Tazuma, S.; Tsuji, T.; Miyakawa, H.; Atomi, Y.			Management for Pancreatolithiasis: A Japanese Multicenter Study	PANCREAS			English	Meeting Abstract									[Suzuki, Y.; Sugiyama, M.; Atomi, Y.] Kyorin Univ Sch Med, Dept Surg, Tokyo, Japan; [Inui, K.] Fujita Hlth Univ, Teaching Hosp 2, Dept Internal Med, Nagoya, Aichi, Japan; [Igarashi, Y.] Toho Univ, Div Gastroenterol & Hepatol, Dept Internal Med, Omori Med Ctr, Tokyo, Japan; [Ohara, H.] Nagoya City Univ Grad Sch Med Sci, Dept Gastroenterol & Metab, Nagoya, Aichi, Japan; [Tazuma, S.] Hiroshima Univ, Grad Sch Biomed Sci, Dept Gen Med & Clin Pharmacotherapy, Hiroshima, Japan; [Tsuji, T.] Saitama Cooperat Hosp, Dept Gastroenterol, Saitama, Japan; [Miyakawa, H.] Sapporo Kesei Hosp, Dept Gastroenterol, Sapporo, Hokkaido, Japan								0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0885-3177	1536-4828		PANCREAS	Pancreas	NOV	2014	43	8					1412	1412				1	Gastroenterology & Hepatology	Gastroenterology & Hepatology	AS6GO	WOS:000344362600336		
J	Suzumura, K; Asano, Y; Kosaka, H; Iimuro, Y; Hirano, T; Okada, T; Uyama, N; Nakamura, I; Kondo, Y; Hai, S; Sueoka, H; Yada, A; Ohashi, K; Okamoto, T; Kurimoto, A; Fujimoto, J				Suzumura, K.; Asano, Y.; Kosaka, H.; Iimuro, Y.; Hirano, T.; Okada, T.; Uyama, N.; Nakamura, I.; Kondo, Y.; Hai, S.; Sueoka, H.; Yada, A.; Ohashi, K.; Okamoto, T.; Kurimoto, A.; Fujimoto, J.			Preoperative CA19-9 is a Predictive Value for Early Recurrence After Resection of Pancreatic Adenocarcinoma	PANCREAS			English	Meeting Abstract									[Suzumura, K.; Asano, Y.; Kosaka, H.; Iimuro, Y.; Hirano, T.; Okada, T.; Uyama, N.; Nakamura, I.; Kondo, Y.; Hai, S.; Sueoka, H.; Yada, A.; Ohashi, K.; Okamoto, T.; Kurimoto, A.; Fujimoto, J.] Hyogo Coll Med, Dept Surg, Nishinomiya, Hyogo, Japan								0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0885-3177	1536-4828		PANCREAS	Pancreas	NOV	2014	43	8					1412	1412				1	Gastroenterology & Hepatology	Gastroenterology & Hepatology	AS6GO	WOS:000344362600337		
J	Tada, Y; Yoshida, K; Iwao, T				Tada, Y.; Yoshida, K.; Iwao, T.			EUS-Assisted Cholangiopancreatography Reduces Post-ERCP	PANCREAS			English	Meeting Abstract									[Tada, Y.; Iwao, T.] Aizu Cent Hosp, Div Gastroenterol, Kurashiki, Okayama, Japan; [Yoshida, K.] Kawasaki Med Univ, Div Intervent Biliopancreatol, Kurashiki, Okayama, Japan								0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0885-3177	1536-4828		PANCREAS	Pancreas	NOV	2014	43	8					1413	1413				1	Gastroenterology & Hepatology	Gastroenterology & Hepatology	AS6GO	WOS:000344362600342		
J	Tahara, J; Kaise, T; Shioga, T; Takayama, Y; Shimizu, K; Shiratori, K				Tahara, J.; Kaise, T.; Shioga, T.; Takayama, Y.; Shimizu, K.; Shiratori, K.			Long-Term Corticosteroid Therapy of Autoimmune Pancreatitis	PANCREAS			English	Meeting Abstract									[Tahara, J.; Kaise, T.; Shioga, T.; Takayama, Y.; Shimizu, K.; Shiratori, K.] Tokyo Womens Med Univ, Dept Gastroenterol, Tokyo, Japan								0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0885-3177	1536-4828		PANCREAS	Pancreas	NOV	2014	43	8					1413	1414				2	Gastroenterology & Hepatology	Gastroenterology & Hepatology	AS6GO	WOS:000344362600343		
J	Takada, M; Ambo, Y; Nakamura, F; Kashimura, N				Takada, M.; Ambo, Y.; Nakamura, F.; Kashimura, N.			The Clip & Wrap Method for the Stump of Gastroduodenal Artery Reduced Delayed Arterial Hemorrhage After Pancreatoduodenectomy	PANCREAS			English	Meeting Abstract									[Takada, M.; Ambo, Y.; Nakamura, F.; Kashimura, N.] Teine Keijinkai Hosp, Dept Surg, Sapporo, Hokkaido, Japan								0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0885-3177	1536-4828		PANCREAS	Pancreas	NOV	2014	43	8					1414	1414				1	Gastroenterology & Hepatology	Gastroenterology & Hepatology	AS6GO	WOS:000344362600344		
J	Takahashi, K; Hisaka, T; Horiuchi, H; Ishikawa, H; Nakayama, M; Nakashima, O; Kawahara, A; Kage, A; Yano, H; Akagi, Y; Yonemoto, K; Kinoshita, H; Shirozu, K				Takahashi, K.; Hisaka, T.; Horiuchi, H.; Ishikawa, H.; Nakayama, M.; Nakashima, O.; Kawahara, A.; Kage, A.; Yano, H.; Akagi, Y.; Yonemoto, K.; Kinoshita, H.; Shirozu, K.			Neoplastic Spindle Cells are an Independent Prognostic Factor in Pancreatic Cancer	PANCREAS			English	Meeting Abstract									[Takahashi, K.; Hisaka, T.; Horiuchi, H.; Ishikawa, H.; Akagi, Y.; Kinoshita, H.; Shirozu, K.] Kurume Univ Sch Med, Dept Surg, Kurume, Fukuoka, Japan; [Nakayama, M.; Nakashima, O.; Yano, H.] Kurume Univ Sch Med, Dept Pathol, Kurume, Fukuoka, Japan; [Kawahara, A.; Kage, A.] Kurume Univ Sch Med, Dept Diagnost Pathol, Kurume, Fukuoka, Japan; [Yonemoto, K.] Kurume Univ Sch Med, Biostat Ctr, Kurume, Fukuoka, Japan								0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0885-3177	1536-4828		PANCREAS	Pancreas	NOV	2014	43	8					1414	1414				1	Gastroenterology & Hepatology	Gastroenterology & Hepatology	AS6GO	WOS:000344362600345		
J	Takahashi, M; Kyoden, Y; Kanemoto, H; Oba, N; Watanabe, M; Ohata, K; Takagi, M				Takahashi, M.; Kyoden, Y.; Kanemoto, H.; Oba, N.; Watanabe, M.; Ohata, K.; Takagi, M.			Influence of Preoperative Visceral Fat Area on Outcomes after Pancreaticoduodenectomy for Patients with Pancreatic Adenocarcinoma	PANCREAS			English	Meeting Abstract									[Takahashi, M.; Kyoden, Y.; Kanemoto, H.; Oba, N.; Watanabe, M.; Ohata, K.; Takagi, M.] Shizuoka Prefectural Gen Hosp, Dept Surg, Shizuoka, Japan								0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0885-3177	1536-4828		PANCREAS	Pancreas	NOV	2014	43	8					1414	1414				1	Gastroenterology & Hepatology	Gastroenterology & Hepatology	AS6GO	WOS:000344362600346		
J	Takahata, S; Miyasaka, Y; Yamada, D; Ohtsuka, T; Tanaka, M				Takahata, S.; Miyasaka, Y.; Yamada, D.; Ohtsuka, T.; Tanaka, M.			Morphology-Based Pancreas Head Resection for Pancreas Tumors With Circumportal Pancreas	PANCREAS			English	Meeting Abstract									[Takahata, S.; Miyasaka, Y.; Yamada, D.; Ohtsuka, T.; Tanaka, M.] Kyushu Univ, Dept Surg & Oncol, Fukuoka 812, Japan								0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0885-3177	1536-4828		PANCREAS	Pancreas	NOV	2014	43	8					1414	1414				1	Gastroenterology & Hepatology	Gastroenterology & Hepatology	AS6GO	WOS:000344362600347		
J	Tamae, T; Uejyo, A; Iha, K; Miyagi, K; Ikemura, R; Nakasone, Y; Ikehara, Y; Eguchi, M; Nishijima, I; Kawamoto, H; Tedokon, Y				Tamae, T.; Uejyo, A.; Iha, K.; Miyagi, K.; Ikemura, R.; Nakasone, Y.; Ikehara, Y.; Eguchi, M.; Nishijima, I.; Kawamoto, H.; Tedokon, Y.			A Case of Intraductal Papillary-Mucinous NeoplasmsWith Developing Acute Pancreatitis	PANCREAS			English	Meeting Abstract									[Tamae, T.; Uejyo, A.; Iha, K.; Miyagi, K.; Ikemura, R.; Nakasone, Y.; Ikehara, Y.; Eguchi, M.; Nishijima, I.; Kawamoto, H.; Tedokon, Y.] Chubutokushukai Hosp, Dept Surg, Okinawa, Japan								0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0885-3177	1536-4828		PANCREAS	Pancreas	NOV	2014	43	8					1415	1415				1	Gastroenterology & Hepatology	Gastroenterology & Hepatology	AS6GO	WOS:000344362600349		
J	Tamura, K; Ohtsuka, T; Taketo, M; Date, K; Fujimoto, T; Kimura, H; Watanabe, Y; Miyazaki, T; Ohuchida, K; Takahata, S; Oda, Y; Mizumoto, K; Tanaka, M				Tamura, K.; Ohtsuka, T.; Taketo, M.; Date, K.; Fujimoto, T.; Kimura, H.; Watanabe, Y.; Miyazaki, T.; Ohuchida, K.; Takahata, S.; Oda, Y.; Mizumoto, K.; Tanaka, M.			Assessment of Clonality of Multisegmental Main Duct Intraductal Papillary Mucinous Neoplasms of the Pancreas Based on GNAS Mutation Analysis	PANCREAS			English	Meeting Abstract									[Tamura, K.; Ohtsuka, T.; Taketo, M.; Date, K.; Fujimoto, T.; Kimura, H.; Watanabe, Y.; Ohuchida, K.; Takahata, S.; Mizumoto, K.; Tanaka, M.] Kyushu Univ, Grad Sch Med Sci, Dept Surg & Oncol, Fukuoka 812, Japan; [Miyazaki, T.; Oda, Y.] Kyushu Univ, Grad Sch Med Sci, Dept Anat Pathol, Fukuoka 812, Japan								0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0885-3177	1536-4828		PANCREAS	Pancreas	NOV	2014	43	8					1415	1415				1	Gastroenterology & Hepatology	Gastroenterology & Hepatology	AS6GO	WOS:000344362600350		
J	Tanemura, A; Okuda, Y; Desaki, R; Iizawa, Y; Takahashi, N; Kato, H; Murata, Y; Azumi, Y; Kuriyama, N; Kishiwada, M; Mizuno, S; Usui, M; Sakurai, H; Isaji, S				Tanemura, A.; Okuda, Y.; Desaki, R.; Iizawa, Y.; Takahashi, N.; Kato, H.; Murata, Y.; Azumi, Y.; Kuriyama, N.; Kishiwada, M.; Mizuno, S.; Usui, M.; Sakurai, H.; Isaji, S.			Usability of the First Jejunal Artery for Hepatic Arterial Reconstruction in Pancreatoduodenectomy With Combined Resection of the Hepatic Artery	PANCREAS			English	Meeting Abstract									[Tanemura, A.; Okuda, Y.; Desaki, R.; Iizawa, Y.; Takahashi, N.; Kato, H.; Murata, Y.; Azumi, Y.; Kuriyama, N.; Kishiwada, M.; Mizuno, S.; Usui, M.; Sakurai, H.; Isaji, S.] Mie Univ, Dept Hepatobiliary Pancreat & Transplant Surg, Grad Sch Med, Tsu, Mie 514, Japan								0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0885-3177	1536-4828		PANCREAS	Pancreas	NOV	2014	43	8					1415	1415				1	Gastroenterology & Hepatology	Gastroenterology & Hepatology	AS6GO	WOS:000344362600352		
J	Tedokon, Y; Uejyo, A; Kawamoto, H; Nisijima, I; Eguchi, M; Nakasone, Y; Ikehara, Y; Ikemura, R; Tamae, T; Miyagi, K; Iha, K				Tedokon, Y.; Uejyo, A.; Kawamoto, H.; Nisijima, I.; Eguchi, M.; Nakasone, Y.; Ikehara, Y.; Ikemura, R.; Tamae, T.; Miyagi, K.; Iha, K.			A Case of Lymphoepithelial Cyst of the Pancreas	PANCREAS			English	Meeting Abstract									[Tedokon, Y.; Uejyo, A.; Kawamoto, H.; Nisijima, I.; Eguchi, M.; Nakasone, Y.; Ikehara, Y.; Ikemura, R.; Tamae, T.; Miyagi, K.; Iha, K.] Chubu Tokusyukai Hosp, Dept Surg, Okinawa, Japan								0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0885-3177	1536-4828		PANCREAS	Pancreas	NOV	2014	43	8					1416	1416				1	Gastroenterology & Hepatology	Gastroenterology & Hepatology	AS6GO	WOS:000344362600354		
J	Todaka, A; Fukutomi, A; Uesaka, K; Sugiura, T; Yasui, H				Todaka, A.; Fukutomi, A.; Uesaka, K.; Sugiura, T.; Yasui, H.			Post-Operative Treatment for Resected Pancreatic Cancer With Positive Peritoneal Cytology	PANCREAS			English	Meeting Abstract									[Todaka, A.; Fukutomi, A.; Yasui, H.] Shizuoka Canc Ctr, Div Gastrointestinal Oncol & Endoscopy, Shizuoka, Japan; [Uesaka, K.; Sugiura, T.] Shizuoka Canc Ctr, Dept Hepatobiliary Pancreat Surg, Shizuoka, Japan								0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0885-3177	1536-4828		PANCREAS	Pancreas	NOV	2014	43	8					1417	1417				1	Gastroenterology & Hepatology	Gastroenterology & Hepatology	AS6GO	WOS:000344362600359		
J	Toyoki, Y; Ishido, K; Kudo, D; Kimura, N; Sakuraba, S; Hakamada, K				Toyoki, Y.; Ishido, K.; Kudo, D.; Kimura, N.; Sakuraba, S.; Hakamada, K.			Delayed Gastric Emptying by Straight Stomach Reconstruction After Pylorus-Preserving Pancreaticoduodenectomy	PANCREAS			English	Meeting Abstract									[Toyoki, Y.; Ishido, K.; Kudo, D.; Kimura, N.; Sakuraba, S.; Hakamada, K.] Hirosaki Univ, Grad Sch Med, Dept Surg Gastroenterol, Hirosaki, Aomori, Japan								0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0885-3177	1536-4828		PANCREAS	Pancreas	NOV	2014	43	8					1417	1417				1	Gastroenterology & Hepatology	Gastroenterology & Hepatology	AS6GO	WOS:000344362600360		
J	Uchida, K; Fukui, Y; Yanagawa, M; Mitsuyama, T; Sumimoto, K; Ikeura, T; Sakaguchi, Y; Shimatani, M; Fukui, T; Matsushita, M; Takaoka, M; Nishio, A; Satoi, S; Kwon, AH; Okazaki, K				Uchida, K.; Fukui, Y.; Yanagawa, M.; Mitsuyama, T.; Sumimoto, K.; Ikeura, T.; Sakaguchi, Y.; Shimatani, M.; Fukui, T.; Matsushita, M.; Takaoka, M.; Nishio, A.; Satoi, S.; Kwon, A. H.; Okazaki, K.			The Role of Innate Immunity in the Pathogenesis of Type 1 Autoimmune Pancreatitis	PANCREAS			English	Meeting Abstract									[Uchida, K.; Fukui, Y.; Yanagawa, M.; Mitsuyama, T.; Sumimoto, K.; Ikeura, T.; Sakaguchi, Y.; Shimatani, M.; Fukui, T.; Matsushita, M.; Takaoka, M.; Nishio, A.; Okazaki, K.] Kansai Med Univ, Dept Gastroenterol & Hepatol, Hirakata, Osaka, Japan; [Satoi, S.; Kwon, A. H.] Kansai Med Univ, Dept Surg, Hirakata, Osaka, Japan								0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0885-3177	1536-4828		PANCREAS	Pancreas	NOV	2014	43	8					1418	1418				1	Gastroenterology & Hepatology	Gastroenterology & Hepatology	AS6GO	WOS:000344362600364		
J	Wada, K; Sano, K; Amano, H; Miura, F; Toyota, N; Ito, H; Aoyagi, Y; Shibuya, M; Ikeda, Y; Kainuma, M; Takahashi, K				Wada, K.; Sano, K.; Amano, H.; Miura, F.; Toyota, N.; Ito, H.; Aoyagi, Y.; Shibuya, M.; Ikeda, Y.; Kainuma, M.; Takahashi, K.			Conversion Surgery for Locally-Advanced Unresectable Pancreatic Cancer: Is There Any Role?	PANCREAS			English	Meeting Abstract									[Wada, K.; Sano, K.; Amano, H.; Miura, F.; Toyota, N.; Ito, H.; Aoyagi, Y.; Shibuya, M.; Ikeda, Y.; Kainuma, M.; Takahashi, K.] Teikyo Univ, Sch Med, Dept Surg, Tokyo 173, Japan								0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0885-3177	1536-4828		PANCREAS	Pancreas	NOV	2014	43	8					1419	1419				1	Gastroenterology & Hepatology	Gastroenterology & Hepatology	AS6GO	WOS:000344362600368		
J	Watanabe, Y; Ohtsuka, T; Matsunaga, T; Kimura, H; Tamura, K; Ideno, N; Aso, T; Miyasaka, Y; Yamada, D; Ueda, J; Takahata, S; Igarashi, H; Inoguchi, T; Ito, T; Tanaka, M				Watanabe, Y.; Ohtsuka, T.; Matsunaga, T.; Kimura, H.; Tamura, K.; Ideno, N.; Aso, T.; Miyasaka, Y.; Yamada, D.; Ueda, J.; Takahata, S.; Igarashi, H.; Inoguchi, T.; Ito, T.; Tanaka, M.			Adequate Patient Selection for Total Pancreatectomy Based on Postoperative Assessments of Short- and Long-Term Outcomes	PANCREAS			English	Meeting Abstract									[Watanabe, Y.; Ohtsuka, T.; Matsunaga, T.; Kimura, H.; Tamura, K.; Ideno, N.; Aso, T.; Miyasaka, Y.; Yamada, D.; Ueda, J.; Takahata, S.; Tanaka, M.] Kyushu Univ, Dept Surg & Oncol, Fukuoka 812, Japan; [Igarashi, H.; Inoguchi, T.; Ito, T.] Kyushu Univ, Dept Med & Bioregulatory Sci, Fukuoka 812, Japan								0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0885-3177	1536-4828		PANCREAS	Pancreas	NOV	2014	43	8					1421	1421				1	Gastroenterology & Hepatology	Gastroenterology & Hepatology	AS6GO	WOS:000344362600374		
J	Yamada, M; Murata, M; Takahashi, H; Asai, K; Saso, K; Yagi, T; Katsuyama, S; Sawami, H; Takayama, O; Tanaka, N; Baba, M; Yamamoto, M; Hiratsuka, M; Song, M; Kimura, H; Fukuda, H				Yamada, M.; Murata, M.; Takahashi, H.; Asai, K.; Saso, K.; Yagi, T.; Katsuyama, S.; Sawami, H.; Takayama, O.; Tanaka, N.; Baba, M.; Yamamoto, M.; Hiratsuka, M.; Song, M.; Kimura, H.; Fukuda, H.			A Case of Mixed Ductal-Neuroendocrine Carcinoma: Immunohistochemical Analysis for Histogenesis	PANCREAS			English	Meeting Abstract									[Yamada, M.; Murata, M.; Takahashi, H.; Asai, K.; Saso, K.; Yagi, T.; Katsuyama, S.; Sawami, H.; Takayama, O.; Tanaka, N.; Baba, M.; Yamamoto, M.; Hiratsuka, M.] Itami City Hosp, Dept Surg, Itami, Hyogo, Japan; [Song, M.; Kimura, H.; Fukuda, H.] Itami City Hosp, Dept Pathol, Itami, Hyogo, Japan								0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0885-3177	1536-4828		PANCREAS	Pancreas	NOV	2014	43	8					1424	1425				2	Gastroenterology & Hepatology	Gastroenterology & Hepatology	AS6GO	WOS:000344362600390		
J	Yamada, R; Mizuno, S; Inoue, H; Murata, Y; Kuriyama, N; Azumi, Y; Kishiwada, M; Usui, M; Sakurai, Y; Isaji, S				Yamada, R.; Mizuno, S.; Inoue, H.; Murata, Y.; Kuriyama, N.; Azumi, Y.; Kishiwada, M.; Usui, M.; Sakurai, Y.; Isaji, S.			Can hENT1 Expression in EUS-FNAB Samples be the Prognostic Factor of Pancreatic Ductal Adenocarcinoma Before Gemcitabine-based Chemoradiotherapy?	PANCREAS			English	Meeting Abstract									[Yamada, R.; Inoue, H.] Mie Univ, Dept Gastroenterol & Hepatol, Tsu, Mie, Japan; [Mizuno, S.; Murata, Y.; Kuriyama, N.; Azumi, Y.; Kishiwada, M.; Usui, M.; Sakurai, Y.; Isaji, S.] Mie Univ, Dept Surg, Tsu, Mie, Japan								0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0885-3177	1536-4828		PANCREAS	Pancreas	NOV	2014	43	8					1425	1425				1	Gastroenterology & Hepatology	Gastroenterology & Hepatology	AS6GO	WOS:000344362600391		
J	Yamaguchi, H; Shimizu, M; Koyama, I; Hatori, T; Yamamoto, M; Shimizu, K; Shiratori, K; Furukawa, T				Yamaguchi, H.; Shimizu, M.; Koyama, I.; Hatori, Takashi; Yamamoto, M.; Shimizu, K.; Shiratori, K.; Furukawa, T.			Histological Invasive Patterns of Intraductal Tubulopapillary Neoplasms of the Pancreas	PANCREAS			English	Meeting Abstract									[Yamaguchi, H.; Shimizu, M.] Saitama Med Univ, Int Med Ctr, Dept Pathol, Hidaka, Japan; [Koyama, I.] Saitama Med Univ, Int Med Ctr, Dept Surg, Hidaka, Japan; [Hatori, Takashi; Yamamoto, M.; Shimizu, K.; Shiratori, K.] Tokyo Womens Med Univ, Inst Gastroenterol, Tokyo, Japan; [Furukawa, T.] Tokyo Womens Med Univ, Inst Integrated Med Sci, Tokyo, Japan								0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0885-3177	1536-4828		PANCREAS	Pancreas	NOV	2014	43	8					1425	1425				1	Gastroenterology & Hepatology	Gastroenterology & Hepatology	AS6GO	WOS:000344362600392		
J	Yamazaki, H; Maguchi, H; Takahashi, K; Katanuma, A; Osanai, M; Yane, K; Kin, T; Ikarashi, S; Senyo, M; Minami, R; Sano, I				Yamazaki, H.; Maguchi, H.; Takahashi, K.; Katanuma, A.; Osanai, M.; Yane, K.; Kin, T.; Ikarashi, S.; Senyo, M.; Minami, R.; Sano, I.			Clinicopathological Features of Recurrent Intraductal Papillary Mucinous Neoplasms of Remnant Pancreases	PANCREAS			English	Meeting Abstract									[Yamazaki, H.; Maguchi, H.; Takahashi, K.; Katanuma, A.; Osanai, M.; Yane, K.; Kin, T.; Ikarashi, S.; Senyo, M.; Minami, R.; Sano, I.] Teine Keijinkai Hosp, Ctr Gastroenterol, Sapporo, Hokkaido, Japan								0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0885-3177	1536-4828		PANCREAS	Pancreas	NOV	2014	43	8					1425	1425				1	Gastroenterology & Hepatology	Gastroenterology & Hepatology	AS6GO	WOS:000344362600393		
J	Yamazoe, S; Amano, R; Kimura, K; Hirata, K; Miura, K; Hirakawa, K				Yamazoe, S.; Amano, R.; Kimura, K.; Hirata, K.; Miura, K.; Hirakawa, K.			Persisting Elevation of Postoperative CRP Predicts Outcome of Patients With Curative Distal Pancreatectomy for Pancreatic Cancer	PANCREAS			English	Meeting Abstract									[Yamazoe, S.; Amano, R.; Kimura, K.; Hirata, K.; Miura, K.; Hirakawa, K.] Osaka City Univ, Grad Sch Med, Dept Surg 1, Dept Surg Oncol, Osaka 558, Japan								0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0885-3177	1536-4828		PANCREAS	Pancreas	NOV	2014	43	8					1425	1426				2	Gastroenterology & Hepatology	Gastroenterology & Hepatology	AS6GO	WOS:000344362600394		
J	Yang, J; Guha, S; Matsunaga, T; Ohtsuka, T; Asano, K; Fujimoto, T; Date, K; Kimura, H; Watanabe, Y; Tamura, K; Ohuchida, K; Takahata, S; Mizumoto, K; Skinner, V; Wallace, M; Woodward, T; Li, M; Tanaka, M; Raimondo, M				Yang, J.; Guha, S.; Matsunaga, T.; Ohtsuka, T.; Asano, K.; Fujimoto, T.; Date, K.; Kimura, H.; Watanabe, Y.; Tamura, K.; Ohuchida, K.; Takahata, S.; Mizumoto, K.; Skinner, V.; Wallace, M.; Woodward, T.; Li, M.; Tanaka, M.; Raimondo, M.			NGAL in Pancreatic Juice (PJ) Helps to Discriminate Pancreatic Cancer (PC) Patients from Healthy Controls (HC): Report From a Prospective Trial	PANCREAS			English	Meeting Abstract									[Yang, J.; Guha, S.; Li, M.] UT Med Sch & Hlth Sci Ctr, Houston, TX USA; [Matsunaga, T.; Ohtsuka, T.; Asano, K.; Fujimoto, T.; Date, K.; Kimura, H.; Watanabe, Y.; Tamura, K.; Ohuchida, K.; Takahata, S.; Mizumoto, K.; Tanaka, M.] Kyushu Univ, Fukuoka 812, Japan; [Skinner, V.; Wallace, M.; Woodward, T.; Raimondo, M.] Mayo Clin, Jacksonville, FL 32224 USA								0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0885-3177	1536-4828		PANCREAS	Pancreas	NOV	2014	43	8					1426	1426				1	Gastroenterology & Hepatology	Gastroenterology & Hepatology	AS6GO	WOS:000344362600396		
J	Yano, M; Hara, Y; Arihara, H; Horita, Y; Matsuda, K; Matsuda, M; Sakai, A; Noda, Y				Yano, M.; Hara, Y.; Arihara, H.; Horita, Y.; Matsuda, K.; Matsuda, M.; Sakai, A.; Noda, Y.			Validation of International Consensus Guidelines for the Resection of IPMN at Our Hospital	PANCREAS			English	Meeting Abstract									[Yano, M.; Hara, Y.; Arihara, H.; Horita, Y.; Matsuda, K.; Matsuda, M.; Sakai, A.; Noda, Y.] Toyama Prefectural Cent Hosp, Dept Internal Med Gastroenterol, Toyama, Japan								0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0885-3177	1536-4828		PANCREAS	Pancreas	NOV	2014	43	8					1426	1427				2	Gastroenterology & Hepatology	Gastroenterology & Hepatology	AS6GO	WOS:000344362600398		
J	Yasuda, H; Kato, R; Doi, T; Sogame, Y; Sakagami, J; Kataoka, K; Itoh, Y				Yasuda, H.; Kato, R.; Doi, T.; Sogame, Y.; Sakagami, J.; Kataoka, K.; Itoh, Y.			A Step-up Approach for Infected Walled-off Necrosis: Experience of Four Patients Treated by Endoscopic Transgastric Necrosectomy	PANCREAS			English	Meeting Abstract									[Yasuda, H.; Kato, R.; Doi, T.; Sogame, Y.; Sakagami, J.; Kataoka, K.; Itoh, Y.] Kyoto Prefectural Univ Med, Dept Med, Div Gastroenterol & Hepatol, Kyoto, Japan								0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0885-3177	1536-4828		PANCREAS	Pancreas	NOV	2014	43	8					1427	1427				1	Gastroenterology & Hepatology	Gastroenterology & Hepatology	AS6GO	WOS:000344362600399		
J	Yasuda, T; Aota, T; Masuda, T; Nozawa, A; Tanaka, T; Hamada, T; Okuda, T; Tsukazaki, T				Yasuda, T.; Aota, T.; Masuda, T.; Nozawa, A.; Tanaka, T.; Hamada, T.; Okuda, T.; Tsukazaki, T.			Laparoscopic Cholecystectomy for Severe Acute Gallstone Pancreatitis: Our Experiences at a Municipal Hospital and Review of Literatures	PANCREAS			English	Meeting Abstract									[Yasuda, T.; Aota, T.; Masuda, T.; Nozawa, A.; Tanaka, T.; Hamada, T.; Okuda, T.; Tsukazaki, T.] Tsukazaki Hosp, Himeji, Hyogo, Japan								0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0885-3177	1536-4828		PANCREAS	Pancreas	NOV	2014	43	8					1427	1427				1	Gastroenterology & Hepatology	Gastroenterology & Hepatology	AS6GO	WOS:000344362600400		
J	Yokoyama, M; Shibuya, R; Shiroki, T; Tanuma, N; Tamai, K; Yamaguchi, K; Tanaka, N; Sugamura, K; Satoh, K				Yokoyama, M.; Shibuya, R.; Shiroki, T.; Tanuma, N.; Tamai, K.; Yamaguchi, K.; Tanaka, N.; Sugamura, K.; Satoh, K.			Pyruvate Kinase Type M2 (PKM2) Is Selectively Expressed and Involved in Survival and Development in Pancreatic Ductal Adenocarcinoma Cells	PANCREAS			English	Meeting Abstract									[Yokoyama, M.; Shibuya, R.; Shiroki, T.; Satoh, K.] Miyagi Canc Ctr, Res Inst, Div Canc Stem Cell, Notori, Japan; [Tanuma, N.] Miyagi Canc Ctr, Res Inst, Div Canc Chemotherapy, Notori, Japan; [Tamai, K.] Miyagi Canc Ctr, Res Inst, Div Canc Biol & Therapeut, Notori, Japan; [Yamaguchi, K.; Tanaka, N.; Sugamura, K.] Miyagi Canc Ctr, Res Inst, Div Mol & Cellular Biol, Notori, Japan								0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0885-3177	1536-4828		PANCREAS	Pancreas	NOV	2014	43	8					1427	1428				2	Gastroenterology & Hepatology	Gastroenterology & Hepatology	AS6GO	WOS:000344362600402		
J	Yoshioka, W; Akiyama, T; Tanaka, K; Kumagai, T; Kawaguchi, Y; Kawazoe, S				Yoshioka, W.; Akiyama, T.; Tanaka, K.; Kumagai, T.; Kawaguchi, Y.; Kawazoe, S.			Relationship Between Body Mass Index and Severity of Acute Pancreatitis in Japanese Patients	PANCREAS			English	Meeting Abstract									[Yoshioka, W.; Akiyama, T.; Tanaka, K.; Kumagai, T.; Kawaguchi, Y.; Kawazoe, S.] Saga Ken Med Ctr Koseikan, Dept Hepatobiliary & Pancreatol, Saga, Japan								0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0885-3177	1536-4828		PANCREAS	Pancreas	NOV	2014	43	8					1428	1428				1	Gastroenterology & Hepatology	Gastroenterology & Hepatology	AS6GO	WOS:000344362600403		
J	Mori, M; Onodera, M; Morimoto, A; Kosaka, Y; Morio, T; Notario, GF; Sharma, S; Saji, T				Mori, Masaaki; Onodera, Masafumi; Morimoto, Akira; Kosaka, Yoshiyuki; Morio, Tomohiro; Notario, Gerard F.; Sharma, Shringi; Saji, Tsutomu			PALIVIZUMAB USE IN JAPANESE INFANTS AND CHILDREN WITH IMMUNOCOMPROMISED CONDITIONS	PEDIATRIC INFECTIOUS DISEASE JOURNAL			English	Article						immunocompromised; palivizumab; pediatric; prophylaxis; respiratory syncytial virus	RESPIRATORY SYNCYTIAL VIRUS; MONOCLONAL-ANTIBODY; DOWN-SYNDROME	A total of 27/28 (96%) immunocompromised Japanese children received >= 4 doses of palivizumab. No respiratory syncytial virus-associated hospitalizations occurred. Mean palivizumab trough concentrations were 59.0 and 91.8 mu g/mL 30 days after the 1st and 4th doses, respectively. Of 28 subjects, 27 (96%) experienced >= 1 adverse event and 7 (25%) experienced >= 1 serious adverse event, none of which was considered related to palivizumab.	[Mori, Masaaki] Yokohama City Univ, Med Ctr, Dept Pediat, Yokohama, Kanagawa 2320024, Japan; [Onodera, Masafumi] Natl Ctr Child Hlth & Dev, Dept Human Genet, Tokyo, Japan; [Morimoto, Akira] Jichi Med Univ, Dept Pediat, Sch Med, Shimotsuke, Japan; [Kosaka, Yoshiyuki] Hyogo Prefectural Kobe Childrens Hosp, Dept Hematol & Oncol, Kobe, Hyogo, Japan; [Morio, Tomohiro] Tokyo Med & Dent Univ, Dept Pediat & Dev Biol, Grad Sch Med & Dent Sci, Tokyo, Japan; [Notario, Gerard F.] AbbVie Inc, Virol, N Chicago, IL USA; [Sharma, Shringi] AbbVie Inc, Clin Pharmacol & Pharmacometr, N Chicago, IL USA; [Saji, Tsutomu] Toho Univ, Dept Pediat, Med Ctr Omori Hosp, Tokyo, Japan	Mori, M (reprint author), Yokohama City Univ, Med Ctr, Dept Pediat, Minami Ku, 4-57 Urafune, Yokohama, Kanagawa 2320024, Japan.	mmori@med.yokohama-cu.ac.jp			AbbVie Inc; AbbVie GK; Pfizer; MSD; Dainippon Sumitomo; Astellas; Japan Blood Products Organization; Nihon Pharmaceutical Co., Ltd; Baxter; KAKETSUKEN; GlaxoSmithKline; Ono Pharmaceutical Co., Ltd; Novo Nordisk; Asahi Kasei; Chugai Pharmaceutical; CSL Behring; Eisai; Toray; Dainippon Sumitomo Pharma; Teijin Pharma	This work was supported by AbbVie Inc. AbbVie Inc. participated in the design and conduct of the study; the interpretation of data; the review and approval of the manuscript and funded medical writing support.; M. M. has received research funding and consulting fees from AbbVie GK, Pfizer and MSD and has received lecturer fees from AbbVie GK, Pfizer, Dainippon Sumitomo and Astellas. A. M. has received research funding from AbbVie GK and has received speaker fees from Japan Blood Products Organization, Nihon Pharmaceutical Co., Ltd. and Baxter. M.O. and T. S. have received research funding from AbbVie GK. Y.K. has received research funding from AbbVie GK, KAKETSUKEN, MSD, GlaxoSmithKline and Ono Pharmaceutical Co., Ltd. and has received consulting fees from Baxter, Novo Nordisk and Asahi Kasei. T. M. has received research funding and speaker fees from AbbVie GK, Chugai Pharmaceutical, CSL Behring, Eisai, Toray, Dainippon Sumitomo Pharma and Teijin Pharma. G.F.N. and S. S. are employees of AbbVie Inc. and may hold AbbVie Inc. stock or options.	Bocchini JA, 2009, PEDIATRICS, V124, P1694, DOI 10.1542/peds.2009-2345; Bloemers BLP, 2007, PEDIATRICS, V120, pE1076, DOI 10.1542/peds.2007-0788; Zachariah P, 2012, J PEDIATR-US, V160, P827, DOI 10.1016/j.jpeds.2011.11.004; Bloemers BLP, 2011, J IMMUNOL, V186, P4500, DOI 10.4049/jimmunol.1001700; Boeckh M, 2001, J INFECT DIS, V184, P350, DOI 10.1086/322043; Michaels MG, 2009, PEDIATR TRANSPLANT, V13, P451, DOI 10.1111/j.1399-3046.2008.01017.x; Mori M, 2011, J INFECT CHEMOTHER, V17, P254, DOI 10.1007/s10156-010-0121-1; Sommer Constanze, 2011, Open Microbiol J, V5, P144, DOI 10.2174/1874285801105010144; Takeuchi Y, 2002, JAPANESE J CHEMOTHER, V50, P215; Null D, 1998, PEDIATRICS, V102, P531	10	1	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0891-3668	1532-0987		PEDIATR INFECT DIS J	Pediatr. Infect. Dis. J.	NOV	2014	33	11					1183	1185		10.1097/INF.0000000000000392		3	Immunology; Infectious Diseases; Pediatrics	Immunology; Infectious Diseases; Pediatrics	AS6DH	WOS:000344354400023		
J	Terui, K; Taguchi, T; Goishi, K; Hayakawa, M; Tazuke, Y; Yokoi, A; Takayasu, H; Okuyama, H; Yoshida, H; Usui, N				Terui, Keita; Taguchi, Tomoaki; Goishi, Keiji; Hayakawa, Masahiro; Tazuke, Yuko; Yokoi, Akiko; Takayasu, Hajime; Okuyama, Hiroomi; Yoshida, Hideo; Usui, Noriaki		Japanese Congenital Diaphragmatic	Prognostic factors of gastroesophageal reflux disease in congenital diaphragmatic hernia: a multicenter study	PEDIATRIC SURGERY INTERNATIONAL			English	Article						Congenital diaphragmatic hernia; Gastroesophageal reflux; Diaphragm; Fundoplication; Long-term care	REPAIR	Gastroesophageal reflux disease (GERD) is one of the concomitant problems in infants with congenital diaphragmatic hernia (CDH). We assessed risk factors of GERD in CDH patients. The retrospective observational study for CDH infants was conducted. Cases of CDH who were born between January 2006 and December 2010, were operated in the 9 participating institutions, and survived to discharge were included. Completion of medical therapy for GERD and incidence of surgery were primary outcomes. Kaplan-Meier survival analysis and Cox proportional hazards regression were used. In 182 cases of CDH, the medical therapies for GERD were performed in 23.8 % (40/168), and were completed in 60.0 % (24/40). Prenatal detection of CDH (HR 5.87, CI 1.6-18.8, p = 0.012) and tube feeding at discharge (HR 5.04, 95 % CI 1.3-33.1, p = 0.016) were significantly correlated with unsuccessful weaning from medical therapy. Surgery for GERD was performed in 10.7 % (18/169). Gestational age (HR 4.78, 95 % CI 1.5-21.1, p = 0.006) and diaphragmatic defect of more than 75 % (HR 4.3, 95 % CI 1.6-12.9, p = 0.005) were significantly correlated with need for antireflux surgery. Diaphragmatic defect of more than 75 % was risk factor of future need for antireflux surgery.	[Terui, Keita; Yoshida, Hideo] Chiba Univ, Grad Sch Med, Dept Pediat Surg, Chuou ku, Chiba 2608677, Japan; [Taguchi, Tomoaki] Kyushu Univ, Grad Sch Med Sci, Dept Pediat Surg Reprod & Dev Med, Kyushu, Japan; [Goishi, Keiji] Natl Ctr Child Hlth & Dev, Dept Maternal & Perinatal Med, Div Neonatol, Tokyo, Japan; [Hayakawa, Masahiro] Nagoya Univ Hosp, Div Neonatol, Ctr Maternal Neonatal Care, Nagoya, Aichi, Japan; [Tazuke, Yuko; Usui, Noriaki] Osaka Med Ctr, Dept Pediat Surg, Osaka, Japan; [Tazuke, Yuko; Usui, Noriaki] Res Inst Maternal & Child Hlth, Osaka, Japan; [Yokoi, Akiko] Kobe Childrens Hosp, Dept Pediat Surg, Kobe, Hyogo, Japan; [Takayasu, Hajime] Univ Tsukuba, Fac Med, Dept Pediat Surg, Tsukuba, Ibaraki, Japan; [Okuyama, Hiroomi] Osaka Univ, Grad Sch Med, Dept Pediat Surg, Osaka, Japan; [Okuyama, Hiroomi] Hyogo Coll Med Univ, Dept Pediat Surg, Kobe, Hyogo, Japan	Terui, K (reprint author), Chiba Univ, Grad Sch Med, Dept Pediat Surg, Chuou ku, 1-8-1 Inohana, Chiba 2608677, Japan.	kta@cc.rim.or.jp			Ministry of Health, Labor and Welfare of Japan	This work was supported by a grant from the Ministry of Health, Labor and Welfare of Japan (Health and Labor Sciences Research Grants for Research on Intrac Diseases). The authors gratefully acknowledge the contributions of all the pediatric surgery and/or tertiary perinatal care centers for the collection of data for this study. We are grateful to Dr. Yasunori Sato (Clinical Research Center, Chiba University Hospital) for his supervising in statistical analyses.	Abdullah F, 2009, PEDIATR SURG INT, V25, P1059, DOI 10.1007/s00383-009-2473-0; Campanozzi A, 2009, PEDIATRICS, V123, P779, DOI 10.1542/peds.2007-3569; Lightdale JR, 2013, PEDIATRICS, V131, pE1684, DOI 10.1542/peds.2013-0421; Leeuwen L, 2014, J PAEDIATR CHILD H, V50, P667, DOI 10.1111/jpc.12508; Peetsold MG, 2010, J PEDIATR GASTR NUTR, V51, P448, DOI 10.1097/MPG.0b013e3181d1b149; Bagolan Pietro, 2007, Semin Pediatr Surg, V16, P134, DOI 10.1053/j.sempedsurg.2007.01.009; Dariel A, 2010, J PEDIATR-US, V157, P688, DOI 10.1016/j.jpeds.2010.06.009; Diamond IR, 2007, J PEDIATR SURG, V42, P1066, DOI 10.1016/j.jpedsurg.2007.01.046; Kamiyama M, 2002, J PEDIATR SURG, V37, P1681, DOI 10.1053/jpsu.2002.36693; KIEFFER J, 1995, J PEDIATR SURG, V30, P1330, DOI 10.1016/0022-3468(95)90497-2; Koivusalo AI, 2008, J PEDIATR SURG, V43, P279, DOI 10.1016/j.jpedsurg.2007.10.014; Maier S, 2011, J PEDIATR SURG, V46, P1510, DOI 10.1016/j.jpedsurg.2011.03.085; Muratore CS, 2001, J PEDIATR SURG, V36, P1171, DOI 10.1053/jpsu.2001.25746; Nagata K, 2013, J PEDIATR SURG, V48, P738, DOI 10.1016/j.jpedsurg.2012.12.017; NAGAYA M, 1994, J PEDIATR SURG, V29, P1447, DOI 10.1016/0022-3468(94)90141-4; SIGALET DL, 1994, J PEDIATR SURG, V29, P1262, DOI 10.1016/0022-3468(94)90819-2; Su W, 2007, J PEDIATR SURG, V42, P1639, DOI 10.1016/j.jpedsurg.2007.05.016; Usui N, 2011, PEDIATR SURG INT, V27, P39, DOI 10.1007/s00383-010-2725-z	18	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0179-0358	1437-9813		PEDIATR SURG INT	Pediatr. Surg. Int.	NOV	2014	30	11					1129	1134		10.1007/s00383-014-3594-7		6	Pediatrics; Surgery	Pediatrics; Surgery	AS5UX	WOS:000344335900008		
J	Kubota, M; Nakaya, K; Arai, Y; Ohyama, T; Yokota, N; Nagai, Y				Kubota, Masayuki; Nakaya, Kengo; Arai, Yuhki; Ohyama, Toshiyuki; Yokota, Naoki; Nagai, Yu			The area and attachment abnormalities of the gubernaculum in patients with undescended testes in comparison with those with retractile testes	PEDIATRIC SURGERY INTERNATIONAL			English	Article						Undescended testis; Gubernaculum; Testicular descent	TESTICULAR DESCENT; HORMONAL-CONTROL; MODEL	In order to evaluate the gubernaculum (GN) abnormalities quantitatively in patients with undescended testes (UDT), the area and attachment site of the gubernaculum were evaluated. Sixty-seven testes from 61 patients with an undescended testis treated in the past 11 years at our institution were examined. Using intraoperative photographs or DVDs, the area of the GN inside the processus vaginalis was measured, and the ratio to that of the testis was determined. When the GN was attached to the vas deferens, the GN distance from the testis was also measured, and the ratio to that of the transverse length of the testis (deviation index) was calculated. Reference values were obtained from 23 testes from 15 patients with mobile testes. In cases with mobile testes, the GN attached to the bottom of the testis, and involved the lower pole of the epididymis. Even though the GN was attached to the bottom of the testis in 43 testes in the UDT patients (64 %), the GN was found to be elongated. The mean GN area ratio was 1.58 (1SD, 0.6) in the UDT cases, in comparison to 0.47 (0.2) in the cases with mobile testes. The GN was attached to the vas deferens in 24 testes (36 %). The deviation index was 1.34 (1.0), but the GN area ratio of these cases was 1.56 (0.7), which was similar to that of the GN attached to the bottom of the testis. The present study revealed that an increase in the GN area ratio was the most common imaging abnormality in cases with UDT.	[Kubota, Masayuki; Nakaya, Kengo; Arai, Yuhki; Ohyama, Toshiyuki; Yokota, Naoki; Nagai, Yu] Niigata Univ, Grad Sch Med & Dent Sci, Dept Pediat Surg, Chuo Ku, Niigata 9518510, Japan	Kubota, M (reprint author), Niigata Univ, Grad Sch Med & Dent Sci, Dept Pediat Surg, Chuo Ku, 1-757 Asahimachi Dori, Niigata 9518510, Japan.	mkubota@med.niigata-u.ac.jp			Japan Society for the Promotion of Science [24659773]	The authors would like to thank Mr. Brian Quinn for his critical reading of this manuscript. Grant Support: Grant-in-aid for Exploratory Research (No. 24659773) from the Japan Society for the Promotion of Science.	Abe T, 1996, J PEDIATR SURG, V31, P652, DOI 10.1016/S0022-3468(96)90667-3; HEYNS CF, 1987, J ANAT, V153, P93; HUTSON JM, 1986, J PEDIATR SURG, V21, P195, DOI 10.1016/S0022-3468(86)80830-2; Barteczko KJ, 2000, ADV ANAT EMBRYOL CEL, V156, P1; El Zoghbi CS, 2007, INT BRAZ J UROL, V33, P230; El Zoghbi Charbel S, 2007, Int Braz J Urol, V33, P223, DOI 10.1590/S1677-55382007000200014; Favorito LA, 2003, J UROLOGY, V170, P554, DOI 10.1097/01.ju.0000070436.98851.46; HUTSON JM, 1985, LANCET, V2, P419; Kubota M, 2007, PEDIATR SURG INT, V23, P633, DOI 10.1007/s00383-007-1935-5; Niikura H, 2008, CLIN ANAT, V21, P547, DOI 10.1002/ca.20675; SCORER CG, 1962, BRIT J SURG, V49, P357; SPENCER JR, 1993, J UROLOGY, V149, P618; Vigueras RM, 2003, ARCH MED RES, V34, P166, DOI 10.1016/S0188-4409(03)00040-7	13	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0179-0358	1437-9813		PEDIATR SURG INT	Pediatr. Surg. Int.	NOV	2014	30	11					1149	1154		10.1007/s00383-014-3597-4		6	Pediatrics; Surgery	Pediatrics; Surgery	AS5UX	WOS:000344335900011		
J	Watanuki, Y; Kageyama, K; Takayasu, S; Matsuzaki, Y; Iwasaki, Y; Daimon, M				Watanuki, Yutaka; Kageyama, Kazunori; Takayasu, Shinobu; Matsuzaki, Yasushi; Iwasaki, Yasumasa; Daimon, Makoto			Ultraviolet B radiation-stimulated urocortin 1 is involved in tyrosinase-related protein 1 production in human melanoma HMV-II cells	PEPTIDES			English	Article						Corticotropin-releasing factor; Urocortin 1; Nurr-1; Nur77; Tyrosinase-related protein 1	CORTICOTROPIN-RELEASING HORMONE; FISH UROTENSIN-I; HPA AXIS; DIFFERENTIAL EXPRESSION; HUMAN KERATINOCYTES; HUMAN MELANOCYTES; SKIN; ACID; PEPTIDES; SYSTEM	Ultraviolet B (UVB) radiation stimulates cutaneous melanin pigmentation. The melanosomal enzyme tyrosinase-related protein 1 (TRP1) is involved in the modulation of pigment production in response to this stressor. Recent molecular and biochemical analyses have revealed the presence of corticotropin-releasing factor (CRF) and urocortin 1 (Ucn1), together with their corresponding receptors, in mammalian skin. Although CRF and Ucn1 are thought to have potent effects on the skin system, their possible roles and regulations have yet to be determined fully. Our previous findings in human melanoma HMV-II cells suggest that both CRF and Ucn1 regulate TRP1 gene expression via Nurr-1/Nur77, transcription factors that constitute the nuclear receptor 4a subgroup of orphan nuclear receptors. HMV-II cells were found to express mainly Ucn1 mRNA. This study aimed to explore the effects of UVB on Ucn1 mRNA and TRP1 protein levels in HMV-II cells. UVB (30 mJ/cm(2)) increased Nurr-1, Nur77, and Ucn1 mRNA levels. UVB also increased TRP1 protein levels. Ucn1 knockdown inhibited the UVB-induced increases in TRP1 protein levels. These data suggest that UVB-stimulated Ucn1 contributes to TRP1 production via the transcription of both Nurr-1 and Nur77. Ucn1, produced in melanoma cells, acts on melanoma cells themselves in an autocrine manner. (C) 2014 Elsevier Inc. All rights reserved.	[Watanuki, Yutaka; Kageyama, Kazunori; Takayasu, Shinobu; Daimon, Makoto] Hirosaki Univ, Grad Sch Med, Dept Endocrinol & Metab, Hirosaki, Aomori 0368562, Japan; [Kageyama, Kazunori] Hirosaki Univ, Sch Med & Hosp, Dept Endocrinol Metab & Infect Dis, Hirosaki, Aomori 0368563, Japan; [Matsuzaki, Yasushi] Hirosaki Univ, Grad Sch Med, Dept Dermatol, Hirosaki, Aomori 0368562, Japan; [Iwasaki, Yasumasa] Kochi Univ, Hlth Care Ctr, Kochi 7808520, Japan	Kageyama, K (reprint author), Hirosaki Univ, Grad Sch Med, Dept Endocrinol & Metab, 5 Zaifu Cho, Hirosaki, Aomori 0368562, Japan.	kkageyama@hkg.odn.ne.jp					Skobowiat C, 2013, GENE, V530, P1, DOI 10.1016/j.gene.2013.08.035; Skobowiat C, 2011, AM J PHYSIOL-ENDOC M, V301, pE484, DOI [10.1152/ajpendo.00217.2011., 10.1152/ajpendo.00217.2011]; Slominski A, 2004, PHYSIOL REV, V84, P1155, DOI 10.1152/physrev.00044.2003; SCHAUER E, 1994, J CLIN INVEST, V93, P2258, DOI 10.1172/JCI117224; Slominski A, 2000, PHYSIOL REV, V80, P979; Slominski A, 2006, J CELL PHYSIOL, V206, P780, DOI 10.1002/jcp.20530; Slominski AT, 1999, ANN NY ACAD SCI, V885, P287; Kenny EE, 2012, SCIENCE, V336, P554, DOI 10.1126/science.1217849; Suda T, 2004, PEPTIDES, V25, P1689, DOI 10.1016/j.peprides.2004.03.027; Zbytek B, 2006, MOL ENDOCRINOL, V20, P2539, DOI 10.1210/me.2006-0116; Kauser S, 2006, FASEB J, V20, P882, DOI 10.1096/fj.05-5257com; Sato H, 2002, PIGM CELL RES, V15, P98, DOI 10.1034/j.1600-0749.2002.1o063.x; MOURI T, 1993, NEUROENDOCRINOLOGY, V57, P34, DOI 10.1159/000126339; Chakraborty AK, 1996, BBA-MOL CELL RES, V1313, P130, DOI 10.1016/0167-4889(96)00063-8; VALE W, 1981, SCIENCE, V213, P1394, DOI 10.1126/science.6267699; Slominski A, 2004, ENDOCRINOLOGY, V145, P941, DOI 10.1210/en.2003-0851; VAUGHAN J, 1995, NATURE, V378, P287, DOI 10.1038/378287a0; Ito N, 2005, FASEB J, V19, P1332, DOI 10.1096/fj.04-1968fje; Slominski A, 2007, MOL CELL ENDOCRINOL, V265, P143, DOI 10.1016/j.mce.2006.12.012; Slominski A, 2005, AM J PHYSIOL-ENDOC M, V288, pE701, DOI 10.1152/ajpendo.00519.2004; DAVIS IJ, 1994, MOL CELL BIOL, V14, P3469; GILLIES GE, 1982, NATURE, V299, P355, DOI 10.1038/299355a0; Jahn O, 2004, NEUROPHARMACOLOGY, V47, P233, DOI 10.1016/j.neuropharm.2004.03.018; Kageyama K, 1999, ENDOCRINOLOGY, V140, P5651, DOI 10.1210/en.140.12.5651; Kim MH, 2006, BRIT J DERMATOL, V155, P910, DOI 10.1111/j.1365-2133.2006.07442.x; Kimura K, 2012, J DERMATOL SCI, V66, P64, DOI 10.1016/j.jdermsci.2012.02.006; Pagida MA, 2013, NEUROSCI LETT, V554, P47, DOI 10.1016/j.neulet.2013.08.054; Watanuki Y, 2013, MOL CELL ENDOCRINOL, V370, P42, DOI 10.1016/j.mce.2013.01.022; Yamada M, 2011, J DERMATOL SCI, V64, P217, DOI 10.1016/j.jdermsci.2011.09.005; Yang Y, 2007, EXP DERMATOL, V16, P22, DOI 10.1111/j.1600-0625.2006.00511.x	30	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0196-9781	1873-5169		PEPTIDES	Peptides	NOV	2014	61						93	97		10.1016/j.peptides.2014.09.009		5	Biochemistry & Molecular Biology; Pharmacology & Pharmacy	Biochemistry & Molecular Biology; Pharmacology & Pharmacy	AS4GU	WOS:000344232700014		
J	Koshino, Y; Yamanaka, M; Ezawa, Y; Ishida, T; Kobayashi, T; Samukawa, M; Saito, H; Takeda, N				Koshino, Yuta; Yamanaka, Masanori; Ezawa, Yuya; Ishida, Tomoya; Kobayashi, Takumi; Samukawa, Mina; Saito, Hiroshi; Takeda, Naoki			Lower limb joint motion during a cross cutting movement differs in individuals with and without chronic ankle instability	PHYSICAL THERAPY IN SPORT			English	Article						Ankle sprain; Biomechanics; Neuromuscular control; Proximal joints	FUNCTIONAL INSTABILITY; MUSCLE-ACTIVITY; LOWER-EXTREMITY; KINEMATICS; LEG; WALKING; SPRAIN; INJURY; PATTERNS; GAIT	Objective: To compare the kinematics of lower limb joints between individuals with and without chronic ankle instability (CAI) during cross-turn and -cutting movements. Design: Cross-sectional study. Setting: Motion analysis laboratory. Participants: Twelve subjects with CAI and twelve healthy controls. Main outcome measures: Hip flexion, adduction, and internal rotation, knee flexion, and ankle dorsiflexion and inversion angles were calculated in the 200 ms before initial ground contact and from initial ground contact to toe-off (stance phase) in a cross-turn movement during gait and a cross-cutting movement from a forward jump, and compared across the two groups. Results: In the cross-cutting movement, the CAI group exhibited greater hip and knee flexion than the control group during the stance phase, and more hip abduction during the period before initial contact and the stance phase. In the cross-turn movement the joint kinematics were similar in the two groups. Conclusions: CAI subjects exhibited an altered pattern of the proximal joint kinematics during a cross-cutting movement. It is important for clinicians to assess the function of the hip and knee as well as the ankle, and to incorporate coordination training for the entire lower limb into rehabilitation after lateral ankle sprains. (C) 2013 Elsevier Ltd. All rights reserved.	[Koshino, Yuta; Ezawa, Yuya; Ishida, Tomoya] Hokkaido Univ, Grad Sch Hlth Sci, Kita Ku, Sapporo, Hokkaido 0600812, Japan; [Koshino, Yuta] NTT East Japan Sapporo Hosp, Rehabil Ctr, Chuo Ku, Sapporo, Hokkaido 0600812, Japan; [Yamanaka, Masanori; Samukawa, Mina; Saito, Hiroshi] Hokkaido Univ, Fac Hlth Sci, Dept Rehabil Sci, Kita Ku, Sapporo, Hokkaido 0600812, Japan; [Yamanaka, Masanori; Kobayashi, Takumi] Hokkaido Univ, Fac Hlth Sci, Hokuto Endowed Chair Prevent Joint Dis, Kita Ku, Sapporo, Hokkaido 0600812, Japan; [Ishida, Tomoya] Hokushin Orthoped Hosp, Dept Rehabil, Shiroishi Ku, Sapporo, Hokkaido 0030823, Japan; [Takeda, Naoki] Hokuto Hosp, Dept Orthoped Surg, Obihiro, Hokkaido 0800833, Japan	Yamanaka, M (reprint author), Hokkaido Univ, Fac Hlth Sci, Kita Ku, North 15,West 5, Sapporo, Hokkaido 0600812, Japan.	yamanaka@hs.hokudai.ac.jp					Hertel J, 2000, SPORTS MED, V29, P361, DOI 10.2165/00007256-200029050-00005; Dayakidis MK, 2006, CLIN BIOMECH, V21, P405, DOI 10.1016/j.clinbiomech.2005.11.010; Valderrabano V, 2006, AM J SPORT MED, V34, P612, DOI 10.1177/0363546505281813; McKay GD, 2001, BRIT J SPORT MED, V35, P103, DOI 10.1136/bjsm.35.2.103; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BRM.41.4.1149; Huang PY, 2011, SCAND J MED SCI SPOR, V21, pE461, DOI 10.1111/j.1600-0838.2011.01367.x; de Leva P, 1996, J BIOMECH, V29, P1223, DOI 10.1016/0021-9290(95)00178-6; Drewes LK, 2009, J SCI MED SPORT, V12, P685, DOI 10.1016/j.jsams.2008.07.003; Delahunt E, 2010, MED SCI SPORT EXER, V42, P2106, DOI 10.1249/MSS.0b013e3181de7a8a; Brown C, 2008, CLIN BIOMECH, V23, P822, DOI 10.1016/j.clinbiomech.2008.02.013; Hass CJ, 2010, AM J SPORT MED, V38, P829, DOI 10.1177/0363546509351562; Van Deun S, 2007, AM J SPORT MED, V35, P274, DOI 10.1177/0363546506294470; Monaghan K, 2006, CLIN BIOMECH, V21, P168, DOI 10.1016/j.clinbiomech.2005.09.004; Lu TW, 1999, J BIOMECH, V32, P129, DOI 10.1016/S0021-9290(98)00158-4; Chinn L, 2013, PHYS THER SPORT, V14, P232, DOI 10.1016/j.ptsp.2012.10.001; Kipp K, 2012, CLIN BIOMECH, V27, P706, DOI 10.1016/j.clinbiomech.2012.02.005; Hiller CE, 2006, ARCH PHYS MED REHAB, V87, P1235, DOI 10.1016/j.apmr.2006.05.022; BECKMAN SM, 1995, ARCH PHYS MED REHAB, V76, P1138, DOI 10.1016/S0003-9993(95)80123-5; WALKER PS, 1988, J BIOMECH, V21, P965, DOI 10.1016/0021-9290(88)90135-2; Brown C, 2011, AM J SPORT MED, V39, P1769, DOI 10.1177/0363546511408872; Wikstrom EA, 2010, MED SCI SPORT EXER, V42, P197, DOI 10.1249/MSS.0b013e3181ad1e2f; Delahunt E, 2007, SCAND J MED SCI SPOR, V17, P641, DOI 10.1111/j.1600-0838.2006.00612.x; Gerber JP, 1998, FOOT ANKLE INT, V19, P653; Woods C, 2003, BRIT J SPORT MED, V37, P233, DOI 10.1136/bjsm.37.3.233; Brown CN, 2011, J ATHL TRAINING, V46, P461; Lin CF, 2011, AM J SPORT MED, V39, P2007, DOI 10.1177/0363546511406868; Caulfield BM, 2002, INT J SPORTS MED, V23, P64, DOI 10.1055/s-2002-19272; Fong DTP, 2007, SPORTS MED, V37, P73, DOI 10.2165/00007256-200737010-00006; Gribble PA, 2013, J ORTHOP SPORT PHYS, V43, P585, DOI 10.2519/jospt.2013.0303; Delahunt E, 2006, J ORTHOP RES, V24, P1991, DOI 10.1002/jor.20235; Drewes LK, 2009, J SPORT REHABIL, V18, P375; Webster KA, 2013, PHYS THER SPORT, V14, P17, DOI 10.1016/j.ptsp.2012.02.002; Delahunt E, 2006, AM J SPORT MED, V34, P1970, DOI 10.1177/0363546506290989; Ford KR, 2005, MED SCI SPORT EXER, V37, P124, DOI 10.1249/01.MSS.0000150087.95953.C3; Suda EY, 2011, PHYS THER SPORT, V12, P164, DOI 10.1016/j.ptsp.2011.01.003; DELP SL, 1990, IEEE T BIO-MED ENG, V37, P757, DOI 10.1109/10.102791; Delp S.L., 1990, THESIS STANFORD U; Gribble P, 2010, Scand J Med Sci Sports, V20, pe63, DOI 10.1111/j.1600-0838.2009.00899.x; Houck J, 2003, GAIT POSTURE, V18, P126, DOI 10.1016/S0966-6362(02)00188-1; Inman VT, 1976, JOINTS ANKLE; KADABA MP, 1990, J ORTHOPAED RES, V8, P383, DOI 10.1002/jor.1100080310; Kerr R, 2009, J ORTHOP RES, V27, P318, DOI 10.1002/jor.20744; O'Connor KM, 2009, MED SCI SPORT EXER, V41, P867, DOI 10.1249/MSS.0b013e31818f8743; Rein S, 2010, FOOT ANKLE INT, V31, P423, DOI 10.3113/FAI.2010.0423; YEUNG MS, 1994, BRIT J SPORT MED, V28, P112	45	0	0	CHURCHILL LIVINGSTONE	EDINBURGH	JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE, LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND	1466-853X			PHYS THER SPORT	Phys. Ther. Sport	NOV	2014	15	4					242	248		10.1016/j.ptsp.2013.12.001		7	Rehabilitation; Sport Sciences	Rehabilitation; Sport Sciences	AS7NP	WOS:000344442900005		
J	Hori, K; Takehiro, S; Shimizu, H				Hori, K.; Takehiro, S.; Shimizu, H.			Waves and linear stability of magnetoconvection in a rotating cylindrical annulus	PHYSICS OF THE EARTH AND PLANETARY INTERIORS			English	Article						Magnetoconvection; Rotating cylindrical annulus; Wave; Thermal boundary condition; Geomagnetic secular variation	GEOMAGNETIC SECULAR VARIATION; CONVECTION-DRIVEN DYNAMOS; SPHERICAL FLUID SHELLS; MAGNETIC-FIELD; EARTHS CORE; HEAT-FLUX; INSULATING BOUNDARIES; THERMAL-CONVECTION; SYSTEMS; CONDUCTIVITY	Magnetohydrodynamic (MHD) waves in a rapidly rotating planetary core can cause the magnetic secular variation. To strengthen our understanding of the physical basis, we revisit the linear stability analyses of thermal convection in a quasi-geostrophic rotating cylindrical annulus with an applied toroidal magnetic field, and we extend the investigation of the oscillatory modes to a broader range of the parameters. Particular attention is paid to influence of thermal boundary conditions, either fixed temperature or heat-flux conditions. While the non-dissipative approximation yields a slow wave propagating retrograde, termed as a Magnetic-Coriolis (MC) Rossby wave, dissipative effects produce a variety of waves. When magnetic diffusion is stronger than thermal diffusion, this can cause a very slow wave propagating prograde. Retrograde-traveling slow waves appear when magnetic diffusion is weaker. Emergence of the slow modes allows convection to occur at lower critical Rayleigh numbers than in the nonmagnetic case. When magnetic diffusion is strong, the onset of the convection occurs with the prograde-propagating slow wave, whereas when it is weak, a slow MC-Rossby mode yields the critical convection. Fixed heat-flux boundary conditions have profound effects on the marginal curves, which monotonically increase with the azimuthal wavenumber, and favor larger length scales at the onset of the convection, provided there is sufficient field strength that the Coriolis force is balanced with the Lorentz force. The effect, however, becomes less clear as magnetic diffusion is weakened and various MHD waves emerge. (C) 2014 Elsevier B.V. All rights reserved.	[Hori, K.; Shimizu, H.] Univ Tokyo, Earthquake Res Inst, Bunkyo Ku, Tokyo 1130032, Japan; [Takehiro, S.] Kyoto Univ, Math Sci Res Inst, Kyoto 6068501, Japan; [Hori, K.] Nagoya Univ, Solar Terr Environm Lab, Chikusa Ku, Nagoya, Aichi 4648601, Japan	Hori, K (reprint author), Nagoya Univ, Solar Terr Environm Lab, Chikusa Ku, Nagoya, Aichi 4648601, Japan.	khori@eri.u-tokyo.ac.jp			Japan Society for the Promotion of Science [26800232]	We thank A. Sakuraba and C. Finlay for helpful discussions. Comments by two anonymous reviewers helped to improve the manuscript. This work was partly supported by the Japan Society for the Promotion of Science under a grant-in-aid for young scientists (B) No. 26800232.	AITKEN MJ, 1964, NATURE, V201, P659, DOI 10.1038/201659a0; Sakuraba A, 2009, NAT GEOSCI, V2, P802, DOI 10.1038/NGEO643; de Koker N, 2012, P NATL ACAD SCI USA, V109, P4070, DOI 10.1073/pnas.1111841109; BUSSE FH, 1970, J FLUID MECH, V44, P441, DOI 10.1017/S0022112070001921; Aubert J, 2013, NATURE, V502, P219, DOI 10.1038/nature12574; CHAPMAN CJ, 1980, J FLUID MECH, V101, P759, DOI 10.1017/S0022112080001917; BULLARD EC, 1950, PHILOS TR R SOC S-A, V243, P67, DOI 10.1098/rsta.1950.0014; FEARN DR, 1979, P ROY SOC LOND A MAT, V369, P227, DOI 10.1098/rspa.1979.0161; Takehiro SI, 2002, GEOPHYS ASTRO FLUID, V96, P439, DOI 10.1080/0309192021000036996; Finlay CC, 2003, SCIENCE, V300, P2084, DOI 10.1126/science.1083324; Pozzo M, 2012, NATURE, V485, P355, DOI 10.1038/nature11031; MALKUS WVR, 1967, J FLUID MECH, V28, P793, DOI 10.1017/S0022112067002447; Braginsky SI, 1999, PHYS EARTH PLANET IN, V111, P21, DOI 10.1016/S0031-9201(98)00143-5; Christensen UR, 2003, PHYS EARTH PLANET IN, V138, P39, DOI 10.1016/S0031-9201(03)00064-5; Jones CA, 2003, P ROY SOC A-MATH PHY, V459, P773, DOI 10.1098/rspa.2002.1048; BUSSE FH, 1980, J FLUID MECH, V96, P243, DOI 10.1017/S0022112080002091; Busse FH, 2006, GEOPHYS ASTRO FLUID, V100, P341, DOI 10.1080/03091920600784873; Hori K, 2012, PHYS EARTH PLANET IN, V196, P32, DOI 10.1016/j.pepi.2012.02.002; Canet E, 2014, PHYS EARTH PLANET IN, V229, P1, DOI 10.1016/j.pepi.2013.12.006; Finlay CC, 2010, SPACE SCI REV, V155, P177, DOI 10.1007/s11214-010-9691-6; BRAGINSKY SI, 1984, GEOPHYS ASTRO FLUID, V30, P1, DOI 10.1080/03091928408210077; Kono M, 2002, REV GEOPHYS, V40, DOI 10.1029/2000RG000102; Braginskiy S. I., 1967, Geomagnetism and Aeronomy, V7; BUSSE FH, 1976, PHYS EARTH PLANET IN, V12, P350, DOI 10.1016/0031-9201(76)90030-3; BUSSE FH, 1986, J FLUID MECH, V173, P545, DOI 10.1017/S002211208600126X; BUSSE FH, 1993, PHYS EARTH PLANET IN, V80, P13, DOI 10.1016/0031-9201(93)90069-L; BUSSE FH, 1990, EUR J MECH B-FLUID, V9, P225; CHANDRASEKHAR S., 1961, HYDRODYNAMIC HYDROMA; Dumberry M, 2007, EARTH PLANET SC LETT, V254, P146, DOI 10.1016/j.epsl.2006.11.026; Fearn D. R., 1979, Geophysical and Astrophysical Fluid Dynamics, V14, DOI 10.1080/03091927908244534; Finlay C. C., 2008, DYNAMOS, P403; Gibbons SJ, 2007, GEOPHYS ASTRO FLUID, V101, P347, DOI 10.1080/03091920701472550; Gillet N, 2007, J FLUID MECH, V580, P123, DOI 10.1017/S0022112007005289; HIDE R, 1966, PHILOS TR R SOC S-A, V259, P615, DOI 10.1098/rsta.1966.0026; Holme R., 2007, CORE DYNAMICS TREATI, V8, P107; Hori K, 2010, PHYS EARTH PLANET IN, V182, P85, DOI 10.1016/j.pepi.2010.06.011; ISHIWATARI M, 1994, J FLUID MECH, V281, P33, DOI 10.1017/S0022112094003022; JAKEMAN E, 1968, PHYS FLUIDS, V11, P10, DOI 10.1063/1.1691741; Jones CA., 2007, CORE DYNAMICS, V8, P131; Petry M, 1997, EUR J MECH B-FLUID, V16, P817; RIAHI N, 1982, Z ANGEW MATH PHYS, V33, P81, DOI 10.1007/BF00948314; Sakuraba A, 2002, GEOPHYS ASTRO FLUID, V96, P291, DOI 10.1080/03091920290024234; SOWARD AM, 1979, PHYS EARTH PLANET IN, V20, P134, DOI 10.1016/0031-9201(79)90036-0; Stevenson D. J., 1979, Geophysical and Astrophysical Fluid Dynamics, V12, DOI 10.1080/03091927908242681; YOSHIDA S, 1993, J GEOMAGN GEOELECTR, V45, P1497; Yukutake T., 1962, B EARTHQ RES I TOKYO, V40, P1; Zhang K, 2002, MATH COMPUT MODEL, V36, P389, DOI 10.1016/S0895-7177(02)00133-4; Zhang K, 1996, P ROY SOC A-MATH PHY, V452, P981, DOI 10.1098/rspa.1996.0049	48	2	2	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0031-9201	1872-7395		PHYS EARTH PLANET IN	Phys. Earth Planet. Inter.	NOV	2014	236						16	35		10.1016/j.pepi.2014.07.010		20	Geochemistry & Geophysics	Geochemistry & Geophysics	AS3XB	WOS:000344207400003		
J	Shimono, H; Ozaki, Y; Jagadish, KSV; Sakai, H; Usui, Y; Hasegawa, T; Kumagai, E; Nakano, H; Yoshinaga, S				Shimono, Hiroyuki; Ozaki, Youhei; Jagadish, Krishna S. V.; Sakai, Hidemitsu; Usui, Yasuhiro; Hasegawa, Toshihiro; Kumagai, Etsushi; Nakano, Hiroshi; Yoshinaga, Satoshi			Planting geometry as a pre-screening technique for identifying CO2 responsive rice genotypes: a case study of panicle number	PHYSIOLOGIA PLANTARUM			English	Article							ATMOSPHERIC CARBON-DIOXIDE; SPRING WHEAT CULTIVARS; ELEVATED CO2; INTRASPECIFIC VARIATION; YIELD ENHANCEMENT; WINTER-WHEAT; GROWTH; ENRICHMENT; FIELD; DENSITY	Identifying CO2 responsive genotypes is a major target for enhancing crop productivity under future global elevated atmospheric CO2 concentration ([CO2]). However, [CO2]-fumigation facilities are extremely expensive and are not easily accessible, and are limited in space for large-scale screening. Hence, reliable donors for initiating [CO2]-responsive breeding programs are not in place for crops, including rice. We propose a simple and novel phenotyping method for identifying [CO2]-responsive genotypes, and quantify the responsiveness to low planting density over 4-year trials across both temperate and tropical conditions. Panicle number per plant is the key determinant of grain yield and hence was the focus trait across all our trials. In temperate climate, a 3-season field screening using 127 diverse rice genotypes and employing two planting densities (normal and low density) was conducted. Two japonica genotypes were selected based on their higher responsiveness to low planting density as candidates for validating the proposed phenotyping protocol as a pre-screen for [CO2]-responsiveness. The approach using the two selected candidates and three standard genotypes was confirmed using a free-air CO2 enrichment facility and temperature gradient chambers under elevated [CO2]. In tropical climate, we grew three rice cultivars, previously identified for their [CO2]-responsiveness, at two planting densities. The experiments provided confirmation that responsiveness to low planting density was correlated with that of [CO2]-responsiveness across both the temperate and tropical conditions. The planting density would be useful pre-screening method for testing large panels of diverse germplasm at low cost complemented by available CO2-control facilities for final validation of candidates from the pre-screens.	[Shimono, Hiroyuki; Ozaki, Youhei] Iwate Univ, Fac Agr, Crop Sci Lab, Morioka, Iwate 0208550, Japan; [Jagadish, Krishna S. V.] Int Rice Res Inst, Crop & Environm Sci Div, Manila, Philippines; [Sakai, Hidemitsu; Usui, Yasuhiro; Hasegawa, Toshihiro] Natl Inst Agroenvironm Sci, Agrometeorol Div, Ibaraki 3058604, Japan; [Kumagai, Etsushi] NARO Tohoku Agr Res Ctr, Agroenvironm Div, Morioka, Iwate 0200198, Japan; [Nakano, Hiroshi] NARO Inst Crop Sci, Rice Res Div, Tsukuba, Ibaraki 3058518, Japan; [Yoshinaga, Satoshi] NARO Hokuriku Agr Res Ctr, Land Farming Div, Niigata 9430193, Japan	Shimono, H (reprint author), Iwate Univ, Fac Agr, Crop Sci Lab, Morioka, Iwate 0208550, Japan.	shimn@iwate-u.ac.jp			Ministry of Agriculture, Forestry and Fisheries, Japan;  [22114515]	We thank the members of our laboratory in Iwate University, Mr Nakamura of Taiyo Keiki Co. Ltd. in Japan, Mr Anicio Macahia IRRI, Philippines and Mr S. S. for their technical assistance. Thanks to Dr Lewis H. Ziska, Beltsville Agricultural Research Center, USDA-ARS, for valuable comments on the initial draft of the manuscript. This work was partially supported by the Ministry of Agriculture, Forestry and Fisheries, Japan, through a research project entitled 'Development of technologies for mitigation and adaptation to climate change in Agriculture, Forestry and Fisheries' and in part by a Grant-in-Aid for Scientific Research on Innovative Areas (no. 22114515).	Shimono H, 2009, J EXP BOT, V60, P523, DOI 10.1093/jxb/ern288; Ziska LH, 2012, P ROY SOC B-BIOL SCI, V279, P4097, DOI 10.1098/rspb.2012.1005; De Bruin JL, 2009, CROP SCI, V49, P2225, DOI 10.2135/cropsci2009.02.0063; Kimball BA, 2002, ADV AGRON, V77, P293, DOI 10.1016/S0065-2113(02)77017-X; Kim HY, 2003, FIELD CROP RES, V83, P261, DOI 10.1016/S0378-4290(03)00076-5; Ebana K, 2008, BREEDING SCI, V58, P281, DOI 10.1270/jsbbs.58.281; Spink JH, 2000, ANN APPL BIOL, V137, P179, DOI 10.1111/j.1744-7348.2000.tb00049.x; Kojima Y, 2005, BREEDING SCI, V55, P431, DOI 10.1270/jsbbs.55.431; Ainsworth EA, 2004, AGR FOREST METEOROL, V122, P85, DOI 10.1016/j.agrformet.2003.09.002; Manderscheid R, 1997, AGR ECOSYST ENVIRON, V64, P65, DOI 10.1016/S0167-8809(97)00020-0; Tausz M, 2013, ENVIRON EXP BOT, V88, P71, DOI 10.1016/j.envexpbot.2011.12.005; Baker JT, 1997, GLOB CHANGE BIOL, V3, P119, DOI 10.1046/j.1365-2486.1997.00058.x; Ziska LH, 2008, FIELD CROP RES, V108, P54, DOI 10.1016/j.fcr.2008.03.006; Hasegawa T, 2013, FUNCT PLANT BIOL, V40, P148, DOI 10.1071/FP12357; Ziska LH, 2007, NEW PHYTOL, V175, P607, DOI 10.1111/j.1469-8137.2007.02180.x; Ziska LH, 1996, J EXP BOT, V47, P1353, DOI 10.1093/jxb/47.9.1353; Baker JT, 2004, AGR FOREST METEOROL, V122, P129, DOI 10.1016/j.agrformet.2003.09.012; Ziska LH, 2000, AUST J PLANT PHYSIOL, V27, P979, DOI 10.1071/PP00043; Cox WJ, 2010, AGRON J, V102, P1238, DOI 10.2134/agronj2010.0047; DOMINGUEZ C, 1978, AGRON J, V70, P801; FAO, 2009, FAO NEWSL, V44; Matsumoto T, 2005, NATURE, V436, P793, DOI 10.1038/nature03895; Mayeux HS, 1997, GLOBAL CHANGE BIOL, V3, P269, DOI 10.1046/j.1365-2486.1997.00074.x; Moya TB, 1998, GLOB CHANGE BIOL, V4, P645, DOI 10.1046/j.1365-2486.1998.00180.x; Nakamura Hirofumi, 2012, Journal of Agricultural Meteorology, V68, P15, DOI 10.2480/agrmet.68.1.2; Okada M., 2000, Biotronics, V29, P43; Shimono H, 2013, ENVIRON EXP BOT, V87, P227, DOI 10.1016/j.envexpbot.2012.11.008; Shimono H, 2011, AGR ECOSYST ENVIRON, V141, P240, DOI 10.1016/j.agee.2011.02.028; Shimono H, 2008, GLOBAL CHANGE BIOL, V14, P276, DOI 10.1111/j.1365-2486.2007.01498.x; Soloman S. D., 2007, CLIMATE CHANGE 2007, P1; Thilakarathne CL, 2013, FUNCT PLANT BIOL, V40, P185, DOI 10.1071/FP12057; Whaley JM, 2000, ANN APPL BIOL, V137, P165, DOI 10.1111/j.1744-7348.2000.tb00048.x; Yang LX, 2009, AGR ECOSYST ENVIRON, V129, P193, DOI 10.1016/j.agee.2008.08.016; Ziska LH, 2004, GLOBAL CHANGE BIOL, V10, P1810, DOI 10.1111/j.1365-2486.2004.00840.x; Ziska LH, 2001, CROP SCI, V41, P385; Ziska LH, 2007, CROP SCI, V47, P1547, DOI 10.2135/cropsci2006.09.0616	36	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0031-9317	1399-3054		PHYSIOL PLANTARUM	Physiol. Plant.	NOV	2014	152	3					520	528		10.1111/ppl.12202		9	Plant Sciences	Plant Sciences	AS0MY	WOS:000343972500010		
J	Miyagawa, M; Satou, T; Yukimune, C; Ishibashi, A; Seimiya, H; Yamada, H; Hasegawa, T; Koike, K				Miyagawa, Michiyo; Satou, Tadaaki; Yukimune, Chihiro; Ishibashi, Ayumi; Seimiya, Haruna; Yamada, Hideo; Hasegawa, Toshio; Koike, Kazuo			Anxiolytic-Like Effect of Illicium verum Fruit Oil, trans-Anethole and Related Compounds in Mice	PHYTOTHERAPY RESEARCH			English	Article						Illicium verum; trans-anethole; anxiolytic-like effect; structure-activity relationship	STAR ANISE FRUITS; GAS-CHROMATOGRAPHY; MASS-SPECTROMETRY	The fruit of Illicium verum Hook. f. (star anise) is used by many as a spice. The fragrance of I. verum fruit is characteristically anise-like. In this study, hexane-extracted I. verum fruit oil (IVO), trans-anethole as the main component, and related compounds (propiophenone, 4-methoxy-propiophenone, trans--methylstyrene) were analyzed in order to clarify the emotional effect of inhaling the fragrance of I. verum fruit. As a result, although 4L/L air IVO did not exhibit an anxiolytic-like effect, 1L/L air trans-anethole exhibited a significant effect (p<0.05). Moreover, the anxiolytic-like effect of 1L/L air trans-anethole was significantly greater than 1L/L air propiophenone and 1L/L air 4-methoxy-propiophenone (p<0.05). Thus, the anxiolytic-like effect of trans-anethole was confirmed, and it is proposed that the methoxyl group and 1-propenyl group in the para position of the benzene ring are necessary for the effect. Copyright (c) 2014 John Wiley & Sons, Ltd.	[Miyagawa, Michiyo; Satou, Tadaaki; Yukimune, Chihiro; Ishibashi, Ayumi; Koike, Kazuo] Toho Univ, Fac Pharmaceut Sci, Chiba 2748510, Japan; [Seimiya, Haruna; Hasegawa, Toshio] Saitama Univ, Grad Sch Sci & Engn, Dept Chem, Sakura Ku, Saitama 3888570, Japan; [Yamada, Hideo] Yamada Matsu Co Ltd, Kyoto 6028014, Japan	Satou, T (reprint author), Toho Univ, Fac Pharmaceut Sci, Chiba 2748510, Japan.	satou@phar.toho-u.ac.jp		Satou, Tadaaki/0000-0002-0963-8487			Adamss RP., 2009, IDENTIFICATION ESSEN; Tuan DQ, 1997, J FOOD ENG, V31, P47, DOI 10.1016/S0260-8774(96)00030-1; Domiciano TP, 2013, N-S ARCH PHARMACOL, V386, P331, DOI 10.1007/s00210-012-0820-5; DELLAGRECA M, 1992, PHYTOCHEMISTRY, V31, P4119; Huang YF, 2010, MOLECULES, V15, P7558, DOI 10.3390/molecules15117558; Soares PMG, 2007, LIFE SCI, V81, P1085, DOI 10.1016/j.lfs.2007.08.027; LISTER RG, 1987, PSYCHOPHARMACOLOGY, V92, P180; Cais M, 2013, INT J FOOD SCI TECH, V48, P2324; Chouksey D, 2013, ASIAN PAC J TROP MED, V6, P869, DOI 10.1016/S1995-7645(13)60155-8; Cus JQ, 1990, J ESSENT OIL RES, V2, P91; Des M, 2002, PHYTOTHER RES, V16, P94; Freire RS, 2005, BIOORGAN MED CHEM, V13, P4353, DOI 10.1016/j.bmc.2005.03.058; Gholivand MB, 2009, ANAL LETT, V42, P1382, DOI 10.1080/00032710902961081; Hasegawa T, 2014, NAT PROD COMMUN, V9, P251; Howes MJR, 2009, J AGR FOOD CHEM, V57, P5783, DOI 10.1021/jf9009153; Lees OS, 2007, J MICROBIOL BIOTECHN, V17, P1568; Padmashree A, 2007, FOOD CHEM, V104, P59, DOI 10.1016/j.foodchem.2006.10.074; Peng WX, 2013, J PURE APPL MICROBIO, V7, P2017; Satou T, 2013, PHYTOTHER RES, V27, P306, DOI 10.1002/ptr.4723; Singh G, 2006, J SCI FOOD AGR, V86, P111, DOI 10.1002/jsfa.2277; Yang JF, 2010, J MED FOOD, V13, P1254, DOI 10.1089/jmf.2010.1086	21	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0951-418X	1099-1573		PHYTOTHER RES	Phytother. Res.	NOV	2014	28	11					1710	1712		10.1002/ptr.5190		3	Chemistry, Medicinal; Pharmacology & Pharmacy	Pharmacology & Pharmacy	AS5QE	WOS:000344324100019		
J	Okamoto, N; Aoto, T; Uhara, H; Yamazaki, S; Akutsu, H; Umezawa, A; Nakauchi, H; Miyachi, Y; Saida, T; Nishimura, EK				Okamoto, Natsuko; Aoto, Takahiro; Uhara, Hisashi; Yamazaki, Satoshi; Akutsu, Hidenori; Umezawa, Akihiro; Nakauchi, Hiromitsu; Miyachi, Yoshiki; Saida, Toshiaki; Nishimura, Emi K.			A melanocyte-melanoma precursor niche in sweat glands of volar skin	PIGMENT CELL & MELANOMA RESEARCH			English	Article						mitochondrial dynamics; melanogenesis; Drp1; Opa1; ROS-ERK; MITF	MITOCHONDRIAL MORPHOLOGY; TRANSCRIPTION FACTOR; GENETIC-DISORDERS; MEMBRANE FUSION; DOWN-REGULATION; MELANOGENESIS; PIGMENTATION; CELLS; INHIBITION; MITF	Mitochondrial dynamics control mitochondrial functions as well as their morphology. However, the role of mitochondrial dynamics in melanogenesis is largely unknown. Here, we show that mitochondrial dynamics regulate melanogenesis by modulating the ROS-ERK signaling pathway. Genetic and chemical inhibition of Drp1, a mitochondrial fission protein, increased melanin production and mitochondrial elongation in melanocytes and melanoma cells. In contrast, down-regulation of OPA1, a mitochondria fusion regulator, suppressed melanogensis but induced massive mitochondrial fragmentation in hyperpigmented cells. Consistently, treatment with CCCP, a mitochondrial fission chemical inducer, also efficiently repressed melanogenesis. Furthermore, we found that ROS production and ERK phosphorylation were increased in cells with fragmented mitochondria. And inhibition of ROS or ERK suppressed the antimelanogenic effect of mitochondrial fission in -MSH-treated cells. In addition, the activation of ROS-ERK pathway by mitochondrial fission induced phosphorylation of serine73 on MITF accelerating its proteasomal degradation. In conclusion, mitochondrial dynamics may regulate melanogenesis by modulating ROS-ERK signaling pathway.	[Okamoto, Natsuko; Aoto, Takahiro; Nishimura, Emi K.] Tokyo Med & Dent Univ, Med Res Inst, Dept Stem Cell Biol, Tokyo, Japan; [Okamoto, Natsuko; Miyachi, Yoshiki] Kyoto Univ, Dept Dermatol, Grad Sch Med, Kyoto, Japan; [Uhara, Hisashi; Saida, Toshiaki] Shinshu Univ, Sch Med, Dept Dermatol, Matsumoto, Nagano 390, Japan; [Yamazaki, Satoshi; Nakauchi, Hiromitsu] Univ Tokyo, Inst Med Sci, Div Stem Cell Therapy, Ctr Stem Cell Biol & Med, Tokyo, Japan; [Akutsu, Hidenori; Umezawa, Akihiro] Natl Res Inst Child Hlth & Dev, Dept Reprod Biol, Tokyo, Japan	Nishimura, EK (reprint author), Tokyo Med & Dent Univ, Med Res Inst, Dept Stem Cell Biol, Tokyo, Japan.	nishscm@tmd.ac.jp			JSPS Funding Program for Next Generation World-leading Researchers (NEXT Program)	We thank Dr. Ian Jackson (Roslin Institute) for the Dct-LacZ mice; Dr. Vincent Hearing (National Cancer Institute) for antibodies; Dr. David Fisher (Harvard Medical School) for antibodies; Dr. Shinichi Nishikawa (RIKEN C. D. B.) for plasmid; Dr. Ryuhei Okuyama (Shinsyu University) for his support; Dr. Robert Hoffman (University of California, San Diego) for his critical reading of the manuscript; Dr. Hatsune Makino (National Research Institute for Child Health and Development) for her support for human samples; Dr. Ken Inomata for his support for experiments; and Dr. Hideaki Tanizaki and Dr. Yo Kaku for skin excision surgery at Kyoto University. E.K.N is supported by JSPS Funding Program for Next Generation World-leading Researchers (NEXT Program) and Grant-in-Aid for Scientific Research on Innovative Areas.	Briganti S, 2003, PIGM CELL RES, V16, P101, DOI 10.1034/j.1600-0749.2003.00029.x; Cassidy-Stone A, 2008, DEV CELL, V14, P193, DOI [10.1016/j.devcel.2007.11.019, 10.1016/j.devce1.2007.11.019]; Liu JJ, 2010, PIGM CELL MELANOMA R, V23, P741, DOI 10.1111/j.1755-148X.2010.00775.x; Yang YM, 2011, PHYTOTHER RES, V25, P1166, DOI 10.1002/ptr.3417; SPRITZ RA, 1994, ADV HUM GENET, V22, P1; Tondera D, 2009, EMBO J, V28, P1589, DOI 10.1038/emboj.2009.89; Westermann B, 2010, NAT REV MOL CELL BIO, V11, P872, DOI 10.1038/nrm3013; Yamaguchi Y, 2007, J BIOL CHEM, V282, P27557, DOI 10.1074/jbc.R700026200; Park SJ, 2014, J BIOL CHEM, V289, P2195, DOI 10.1074/jbc.M113.492587; Dessinioti C, 2009, EXP DERMATOL, V18, P741, DOI 10.1111/j.1600-0625.2009.00896.x; Liesa M, 2009, PHYSIOL REV, V89, P799, DOI 10.1152/physrev.00030.2008; Chang CR, 2007, J BIOL CHEM, V282, P21583, DOI 10.1074/jbc.C700083200; D'Orazio J, 2011, CELL CYCLE, V10, P8, DOI 10.4161/cc.10.1.14292; Flaherty KT, 2012, NAT REV CANCER, V12, P349, DOI 10.1038/nrc3218; Song ZY, 2009, MOL BIOL CELL, V20, P3525, DOI 10.1091/mbc.E09-03-0252; Merkwirth C, 2008, GENE DEV, V22, P476, DOI 10.1101/gad.460708; Xu WD, 2000, EXP CELL RES, V255, P135, DOI 10.1006/excr.2000.4803; Liu F, 2009, J INVEST DERMATOL, V129, P422, DOI 10.1038/jid.2008.255; Yu TZ, 2006, P NATL ACAD SCI USA, V103, P2653, DOI 10.1073/pnas.0511154103; Vachtenheim J, 2010, EXP DERMATOL, V19, P617, DOI 10.1111/j.1600-0625.2009.01053.x; Schallreuter KU, 2008, EXP DERMATOL, V17, P395, DOI 10.1111/j.1600-0625.2007.00675.x; Kim SH, 2013, BIOORG MED CHEM LETT, V23, P4332, DOI 10.1016/j.bmcl.2013.05.094; Torres M, 2003, BIOFACTORS, V17, P287; Widlund HR, 2003, ONCOGENE, V22, P3035, DOI 10.1038/sj.onc.1206443; Loson OC, 2013, MOL BIOL CELL, V24, P659, DOI 10.1091/mbc.E12-10-0721; Nappi AJ, 1996, MELANOMA RES, V6, P341, DOI 10.1097/00008390-199610000-00001; Satooka H, 2012, BIOORGAN MED CHEM, V20, P1090, DOI 10.1016/j.bmc.2011.11.030; Meeusen S, 2006, CELL, V127, P383, DOI 10.1016/j.cell.2006.09.021; Cho DH, 2010, CELL MOL LIFE SCI, V67, P3435, DOI 10.1007/s00018-010-0435-2; Englaro W, 1998, J BIOL CHEM, V273, P9966, DOI 10.1074/jbc.273.16.9966; Swalwell H, 2012, FREE RADICAL BIO MED, V52, P626, DOI 10.1016/j.freeradbiomed.2011.11.019; Wu M, 2000, GENE DEV, V14, P301; Kim Eun Sung, 2014, Exp Dermatol, V23, P204, DOI 10.1111/exd.12337; Chang TS, 2005, BIOSCI BIOTECH BIOCH, V69, P1999, DOI 10.1271/bbb.69.1999; Ishihara N, 2003, BIOCHEM BIOPH RES CO, V301, P891, DOI 10.1016/S0006-291X(03)00050-0; Detmer SA, 2007, NAT REV MOL CELL BIO, V8, P870, DOI 10.1038/nrm2275; Jheng HF, 2012, MOL CELL BIOL, V32, P309, DOI 10.1128/MCB.05603-11; Lin JY, 2007, NATURE, V445, P843, DOI 10.1038/nature05660; Eves PC, 2006, PEPTIDES, V27, P444, DOI 10.1016/j.peptides.2005.01.027; Cunha ES, 2012, EXP CELL RES, V318, P1913, DOI 10.1016/j.yexcr.2012.05.019; Daniele T, 2014, CURR BIOL, V24, P393, DOI 10.1016/j.cub.2014.01.007; Huang HC, 2012, BMC COMPLEM ALTERN M, V12, DOI 10.1186/1472-6882-12-72; Jimenez-Cervantes C, 2001, J CELL SCI, V114, P2335; Lee TH, 2014, BIOMOL THER, V22, P35, DOI 10.4062/biomolther.2013.081; Makino A, 2010, DIABETOLOGIA, V53, P1783, DOI 10.1007/s00125-010-1770-4; Snyder JR, 2005, CHEM BIOL, V12, P477, DOI 10.1016/j.chembiol.2005.02.014; Son Y., 2011, J SIGNAL TRANSDUCT, V2011, DOI DOI 10.1155/2011/792639; Zanchetta LM, 2011, INT J RADIAT BIOL, V87, P506, DOI 10.3109/09553002.2011.556175	48	4	4	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1755-1471	1755-148X		PIGM CELL MELANOMA R	Pigment Cell Melanoma Res.	NOV	2014	27	6					1039	1050		10.1111/pcmr.12298		12	Oncology; Cell Biology; Dermatology	Oncology; Cell Biology; Dermatology	AS6BG	WOS:000344349300010		
J	Makino-Okamura, C; Niki, Y; Takeuchi, S; Nishigori, C; Declercq, L; Yaroch, DB; Saito, N				Makino-Okamura, Chieko; Niki, Yoko; Takeuchi, Seiji; Nishigori, Chikako; Declercq, Lieve; Yaroch, Daniel B.; Saito, Naoaki			Heparin inhibits melanosome uptake and inflammatory response coupled with phagocytosis through blocking PI3k/Akt and MEK/ERK signaling pathways in human epidermal keratinocytes	PIGMENT CELL & MELANOMA RESEARCH			English	Article						vitiligo; mouse model; T-cell receptor; IL-17; stem cell factor; pigmentation	REGULATORY T-CELLS; TCR TRANSGENIC MICE; STEM-CELL; AUTOIMMUNE VITILIGO; MOUSE MODEL; GENERALIZED VITILIGO; SELF-TOLERANCE; MAST-CELLS; SKIN; TH17	To generate a mouse model of spontaneous epidermal depigmentation, parental h3TA2 mice, expressing both a human-derived, tyrosinase-reactive T-cell receptor on T cells and the matching HLA-A2 transgene, were crossed to keratin 14-promoter driven, stem cell factor transgenic (K14-SCF) mice with intra-epidermal melanocytes. In resulting Vitesse mice, spontaneous skin depigmentation precedes symmetrical and sharply demarcated patches of graying hair. Whereas the SCF transgene alone dictates a greater retinoic acid receptor-related orphan receptor gamma (RORt)(+) T-cell compartment, these cells displayed markedly increased IL-17 expression within Vitesse mice. Similar to patient skin, regulatory T cells were less abundant compared with K14-SCF mice, with the exception of gradually appearing patches of repigmenting skin. The subtle repigmentation observed likely reflects resilient melanocytes that coexist with skin-infiltrating, melanocyte-reactive T cells. Similar repigmenting lesions were found in a different TCR transgenic model of vitiligo developed on an SCF transgenic background, supporting a role for SCF in repigmentation.	[Makino-Okamura, Chieko; Niki, Yoko; Saito, Naoaki] Kobe Univ, Biosignal Res Ctr, Kobe Skin Res Dept, Kobe, Hyogo 657, Japan; [Takeuchi, Seiji; Nishigori, Chikako] Kobe Univ, Div Dermatol, Dept Internal Related, Grad Sch Med, Kobe, Hyogo 657, Japan; [Declercq, Lieve] Estee Lauder Co, Biol Res Dept Europe & Asia, Oevel, Belgium; [Yaroch, Daniel B.] Estee Lauder Co, Basic Sci Res, Melville, NY USA	Saito, N (reprint author), Kobe Univ, Biosignal Res Ctr, Kobe Skin Res Dept, Kobe, Hyogo 657, Japan.	naosaito@kobe-u.ac.jp					Abu Tahir M, 2010, AUTOIMMUN REV, V9, P516, DOI 10.1016/j.autrev.2010.02.013; Taieb A, 2009, NEW ENGL J MED, V360, P160, DOI 10.1056/NEJMcp0804388; Nichols LA, 2007, J IMMUNOL, V179, P993; Harrington LE, 2005, NAT IMMUNOL, V6, P1123, DOI 10.1038/ni1254; NATALI PG, 1989, P NATL ACAD SCI USA, V86, P6719, DOI 10.1073/pnas.86.17.6719; Colella TA, 2000, J EXP MED, V191, P1221, DOI 10.1084/jem.191.7.1221; Overwijk WW, 2003, J EXP MED, V198, P569, DOI 10.1084/jem.20030590; Gjerdrum LM, 2008, EUR J HAEMATOL, V80, P483, DOI 10.1111/j.1600-0609.2008.01064.x; Ray P, 2008, CELL CYCLE, V7, P2826, DOI 10.4161/cc.7.18.6752; Stockinger B, 2011, SEMIN IMMUNOL, V23, P99, DOI 10.1016/j.smim.2011.01.008; LEPOOLE IC, 1993, J INVEST DERMATOL, V100, P816, DOI 10.1111/1523-1747.ep12476645; Denman CJ, 2008, J INVEST DERMATOL, V128, P2041, DOI 10.1038/jid.2008.45; Chatterjee S, 2014, J INVEST DERMATOL, V134, P1285, DOI 10.1038/jid.2013.540; Harris JE, 2012, J INVEST DERMATOL, V132, P1869, DOI 10.1038/jid.2011.463; Yamaguchi Y, 2009, BIOFACTORS, V35, P193, DOI 10.1002/biof.29; Yi HF, 2012, J IMMUNOL, V189, P4295, DOI 10.4049/jimmunol.1200086; Das PK, 2001, TRENDS IMMUNOL, V22, P130, DOI 10.1016/S1471-4906(00)01844-5; Yang J, 2011, RHEUMATOLOGY, V50, P1366, DOI 10.1093/rheumatology/ker116; Botchkareva NV, 2001, FASEB J, V15, P645, DOI 10.1096/fj.00-0368com; Kunisada T, 1998, J EXP MED, V187, P1565, DOI 10.1084/jem.187.10.1565; Muranski P, 2008, BLOOD, V112, P362, DOI 10.1182/blood-2007-11-120998; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Lee PP, 1999, NAT MED, V5, P677; Meyer KC, 2008, BRIT J DERMATOL, V159, P1077, DOI 10.1111/j.1365-2133.2008.08818.x; Jin Y, 2010, NEW ENGL J MED, V362, P1686, DOI 10.1056/NEJMoa0908547; Tarbox JA, 2014, J CLIN IMMUNOL, V34, P594, DOI 10.1007/s10875-014-0038-z; Guan YT, 2006, J NEUROIMMUNOL, V178, P40, DOI 10.1016/j.neuroim.2006.05.019; Tripathi RK, 1999, PIGM CELL RES, V12, P187, DOI 10.1111/j.1600-0749.1999.tb00512.x; Nishimura MI, 1999, CANCER RES, V59, P6230; Fisher M, 2002, B WORLD HEALTH ORGAN, V80, P908; Ezzedine K, 2012, PIGM CELL MELANOMA R, V25, pE1, DOI 10.1111/j.1755-148X.2012.00997.x; Gregg RK, 2010, J IMMUNOL, V184, P1909, DOI 10.4049/jimmunol.0902778; Berti S, 2011, EUR J DERMATOL, V21, P800, DOI 10.1684/ejd.2011.1459; BOISSY RE, 1987, AM J PATHOL, V127, P380; Brusko TM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011726; Buggiani G, 2012, DERMATOL THER, V25, P472, DOI 10.1111/j.1529-8019.2012.01484.x; Carter EL, 2008, J INVEST DERMATOL, V128, P1861, DOI 10.1038/sj.jid.5701247; Cedercreutz K, 2010, J DERMATOL NURS ASS, V2, P265; Dwivedi M, 2013, PIGM CELL MELANOMA R, V26, DOI 10.1111/pcmr.12105; Falabella R, 2009, PIGM CELL MELANOMA R, V22, P42, DOI 10.1111/j.1755-148X.2008.00528.x; Fongers A, 2009, BRIT J DERMATOL, V161, P1105, DOI 10.1111/j.1365-2133.2009.09367.x; Gawkrodger DJ, 2010, POSTGRAD MED J, V86, P466, DOI 10.1136/pgmj.2009.093278; Gorczynski RM, 2011, TRANSPL IMMUNOL, V25, P187, DOI 10.1016/j.trim.2011.07.006; GOUDIE RB, 1990, LANCET, V335, P316; Grishkan IV, 2013, CELL IMMUNOL, V284, P68, DOI 10.1016/j.cellimm.2013.06.011; Kang HK, 2012, J IMMUNOL, V188, P5970, DOI 10.4049/jimmunol.1200452; Klarquist J, 2010, PIGM CELL MELANOMA R, V23, P276, DOI 10.1111/j.1755-148X.2010.00688.x; Kong N, 2012, ARTHRITIS RHEUM-US, V64, P2548, DOI 10.1002/art.34513; Kotobuki Y, 2012, PIGM CELL MELANOMA R, V25, DOI 10.1111/j.1755-148X.2011.00945.x; Le Poole IC, 2008, J AM ACAD DERMATOL, V59, P967; Le Poole I C, 1993, Exp Dermatol, V2, P145; LERNER AB, 1986, J INVEST DERMATOL, V87, P299, DOI 10.1111/1523-1747.ep12524353; LesPoole I. C., 1996, AM J PATHOL, V148, P1219; Longley BJ, 1997, P NATL ACAD SCI USA, V94, P9017, DOI 10.1073/pnas.94.17.9017; Mak SS, 2006, DEV BIOL, V291, P144, DOI 10.1016/j.ydbio.2005.12.025; Mehrotra S, 2012, J IMMUNOL, V189, P1627, DOI 10.4049/jimmunol.1103271; Menendez P, 2005, STEM CELL REV, V1, P151, DOI 10.1385/SCR:1:2:151; MISFELDT ML, 1994, VET IMMUNOL IMMUNOP, V43, P167, DOI 10.1016/0165-2427(94)90133-3; Oyarbide-Valencia K, 2006, AUTOIMMUN REV, V5, P486, DOI 10.1016/j.autrev.2006.03.012; Parsad Davinder, 2003, Health Qual Life Outcomes, V1, P58, DOI 10.1186/1477-7525-1-58; Quandt D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093293; Sukseree S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038933; Vanover JC, 2009, PIGM CELL MELANOMA R, V22, P827, DOI 10.1111/j.1755-148X.2009.00617.x; vansden Wijngaard R., 2001, LAB INVEST, V81, P1061; Wang CQF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018907; Yagi H, 1997, EUR J DERMATOL, V7, P19; Yang YS, 2010, INT J DERMATOL, V49, P317, DOI 10.1111/j.1365-4632.2009.04332.x	67	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1755-1471	1755-148X		PIGM CELL MELANOMA R	Pigment Cell Melanoma Res.	NOV	2014	27	6					1063	1074		10.1111/pcmr.12284		12	Oncology; Cell Biology; Dermatology	Oncology; Cell Biology; Dermatology	AS6BG	WOS:000344349300012		
J	Ito, S; Gerwat, W; Kolbe, L; Yamashita, T; Ojika, M; Wakamatsu, K				Ito, Shosuke; Gerwat, Wolfram; Kolbe, Ludger; Yamashita, Toshiharu; Ojika, Makoto; Wakamatsu, Kazumasa			Human tyrosinase is able to oxidize both enantiomers of rhododendrol	PIGMENT CELL & MELANOMA RESEARCH			English	Article						melanoma; NRAS; trametinib; ERK; AZD6244	BRAF INHIBITOR THERAPY; MEK INHIBITION; OPEN-LABEL; MELANOMA; NRAS; RESISTANCE; MUTATIONS; SURVIVAL; ESCAPE	The MEK inhibitor MEK162 is the first targeted therapy agent with clinical activity in patients whose melanomas harbor NRAS mutations; however, median PFS is 3.7months, suggesting the rapid onset of resistance in the majority of patients. Here, we show that treatment of NRAS-mutant melanoma cell lines with the MEK inhibitors AZD6244 or trametinib resulted in a rebound activation of phospho-ERK (pERK). Functionally, the recovery of signaling was associated with the maintenance of cyclin-D1 expression and therapeutic escape. The combination of a MEK inhibitor with an ERK inhibitor suppressed the recovery of cyclin-D1 expression and was associated with a significant enhancement of apoptosis and the abrogation of clonal outgrowth. The MEK/ERK combination strategy induced greater levels of apoptosis compared with dual MEK/CDK4 or MEK/PI3K inhibition across a panel of cell lines. These data provide the rationale for further investigation of vertically co-targeting the MAPK pathway as a potential treatment option for NRAS-mutant melanoma patients.	[Ito, Shosuke; Wakamatsu, Kazumasa] Fujita Hlth Univ, Dept Chem, Sch Hlth Sci, Toyoake, Aichi, Japan; [Gerwat, Wolfram; Kolbe, Ludger] Beiersdorf AG, Res & Dev, Hamburg, Germany; [Yamashita, Toshiharu] Sapporo Med Univ, Dept Dermatol, Sch Med, Sapporo, Hokkaido, Japan; [Ojika, Makoto] Nagoya Univ, Grad Sch Bioagr Sci, Dept Appl Mol Biosci, Nagoya, Aichi 4648601, Japan	Ito, S (reprint author), Fujita Hlth Univ, Dept Chem, Sch Hlth Sci, Toyoake, Aichi, Japan.	sito@fujita-hu.ac.jp			Japan Society for the Promotion of Science (JSPS) [23591659, 26461705]	The authors thank members of the Special Committee on the Safety of Cosmetics Containing Rhododenol (the Japanese Dermatological Association) for their helpful discussions and encouragements. This work was supported, in part, by a Japan Society for the Promotion of Science (JSPS) grant (No. 23591659 and 26461705) given to SI and KW. The authors wish to acknowledge Kanebo Cosmetics Inc. for the gift of RS-rhododendrol.	Ascierto PA, 2013, LANCET ONCOL, V14, P249, DOI 10.1016/S1470-2045(13)70024-X; Shi HB, 2014, CANCER DISCOV, V4, P80, DOI 10.1158/2159-8290.CD-13-0642; Ishii N, 2013, CANCER RES, V73, P4050, DOI 10.1158/0008-5472.CAN-12-3937; Hauschild A, 2012, LANCET, V380, P358, DOI 10.1016/S0140-6736(12)60868-X; Chapman PB, 2011, NEW ENGL J MED, V364, P2507, DOI 10.1056/NEJMoa1103782; Ma XH, 2014, J CLIN INVEST, V124, P1406, DOI 10.1172/JCI70454; Lito P, 2014, CANCER CELL, V25, P697, DOI 10.1016/j.ccr.2014.03.011; Kwong LN, 2012, NAT MED, V18, P1503, DOI 10.1038/nm.2941; Posch C, 2013, P NATL ACAD SCI USA, V110, P4015, DOI 10.1073/pnas.1216013110; Aronov AM, 2009, J MED CHEM, V52, P6362, DOI 10.1021/jm900630q; Lito P, 2012, CANCER CELL, V22, P668, DOI 10.1016/j.ccr.2012.10.009; Flaherty KT, 2012, NEW ENGL J MED, V367, P1694, DOI 10.1056/NEJMoa1210093; Paraiso KHT, 2010, BRIT J CANCER, V102, P1724, DOI 10.1038/sj.bjc.6605714; Rebecca VW, 2014, MOL CELL PROTEOMICS, V13, P1844, DOI 10.1074/mcp.M113.037424	14	4	4	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1755-1471	1755-148X		PIGM CELL MELANOMA R	Pigment Cell Melanoma Res.	NOV	2014	27	6					1149	1153		10.1111/pcmr.12303		5	Oncology; Cell Biology; Dermatology	Oncology; Cell Biology; Dermatology	AS6BG	WOS:000344349300020		
J	Galvan, I; Wakamatsu, K; Alonso-Alvarez, C				Galvan, Ismael; Wakamatsu, Kazumasa; Alonso-Alvarez, Carlos			Black bib size is associated with feather content of pheomelanin in male house sparrows	PIGMENT CELL & MELANOMA RESEARCH			English	Letter							CANCER GENOMICS; MELANOMA; MELANOCYTES; CELLS; BRAF; RAF		[Galvan, Ismael] Estn Biol Donana CSIC, Dept Ecol Evolutiva, Seville, Spain; [Wakamatsu, Kazumasa] Fujita Hlth Univ Sch Hlth Sci, Dept Chem, Toyoake, Aichi, Japan; [Alonso-Alvarez, Carlos] Inst Invest Recursos Cineget IREC CSIC UCLM JCCM, Ciudad Real, Spain	Galvan, I (reprint author), Estn Biol Donana CSIC, Dept Ecol Evolutiva, Seville, Spain.	galvan@ebd.csic.es	Galvan, Ismael/H-8602-2015	Galvan, Ismael/0000-0002-6523-8592			Adameyko I, 2010, CELL MOL LIFE SCI, V67, P3037, DOI 10.1007/s00018-010-0390-y; Walker GJ, 2011, PIGM CELL MELANOMA R, V24, P1158, DOI 10.1111/j.1755-148X.2011.00923.x; Whiteman DC, 2011, PIGM CELL MELANOMA R, V24, P879, DOI 10.1111/j.1755-148X.2011.00880.x; Aoki H, 2009, DEVELOPMENT, V136, P2511, DOI 10.1242/dev.037168; McMahon M, 2011, PIGM CELL MELANOMA R, V24, P361, DOI 10.1111/j.1755-148X.2010.00824.x; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Sommer L, 2011, PIGM CELL MELANOMA R, V24, P411, DOI 10.1111/j.1755-148X.2011.00834.x; Heidorn SJ, 2010, CELL, V140, P209, DOI 10.1016/j.cell.2009.12.040; Pedersen M, 2013, CANCER DISCOV, V3, P458, DOI 10.1158/2159-8290.CD-12-0464; Wan PTC, 2004, CELL, V116, P855, DOI 10.1016/S0092-8674(04)00215-6; Damsky WE, 2010, PIGM CELL MELANOMA R, V23, P853, DOI 10.1111/j.1755-148X.2010.00777.x; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Larue L, 2007, PIGM CELL RES, V20, P485, DOI 10.1111/j.1600-0749.2007.00411.x; Sanchez-Laorden B, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2004815	14	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1755-1471	1755-148X		PIGM CELL MELANOMA R	Pigment Cell Melanoma Res.	NOV	2014	27	6					1159	1161		10.1111/pcmr.12293		3	Oncology; Cell Biology; Dermatology	Oncology; Cell Biology; Dermatology	AS6BG	WOS:000344349300022		
J	Tanoi, K; Kobayashi, NI; Saito, T; Iwata, N; Kamada, R; Iwata, R; Suzuki, H; Hirose, A; Ohmae, Y; Sugita, R; Nakanishi, TM				Tanoi, Keitaro; Kobayashi, Natsuko I.; Saito, Takayuki; Iwata, Naoko; Kamada, Risa; Iwata, Ren; Suzuki, Hisashi; Hirose, Atsushi; Ohmae, Yoshimi; Sugita, Ryohei; Nakanishi, Tomoko M.			Effects of magnesium deficiency on magnesium uptake activity of rice root, evaluated using (28) Mg as a tracer	PLANT AND SOIL			English	Article						Radioisotope; Kinetic study; Magnesium; Mg-28; Rice; Uptake	ARABIDOPSIS-THALIANA; PHYSIOLOGICAL CHARACTERIZATION; SALMONELLA-TYPHIMURIUM; TRANSPORT-SYSTEM; PLANT; GENE; FAMILY; EXPRESSION; POTASSIUM; KINETICS	The mechanisms underlying magnesium (Mg) uptake by plant roots remain to be fully elucidated. In particular, there is little information about the effects of Mg deficiency on Mg uptake activity. A Mg uptake kinetic study is essential for better understanding the Mg uptake system. We performed a Mg uptake tracer experiment in rice plants using (28) Mg. Mg uptake was mediated by high- and low-affinity transport systems. The K (m) value of the high-affinity transport system was approximately 70 mu M under Mg-deficient conditions. The Mg uptake activity was promoted by Mg deficiency, which in turn fell to the basal level after 5- min of Mg resupply. The induced uptake rate was inhibited by ionophore treatment, suggesting that an energy-dependent uptake system is enhanced by Mg deficiency. The Mg uptake changes rapidly with Mg conditions in rice, as revealed by a (28) Mg tracer experiment. This technique is expected to be applicable for Mg uptake analyses, particularly in mutants or other lines.	[Tanoi, Keitaro; Kobayashi, Natsuko I.; Saito, Takayuki; Iwata, Naoko; Kamada, Risa; Hirose, Atsushi; Ohmae, Yoshimi; Sugita, Ryohei; Nakanishi, Tomoko M.] Univ Tokyo, Grad Sch Agr & Life Sci, Bunkyo Ku, Tokyo 1138657, Japan; [Iwata, Ren] Tohoku Univ, Ctr Cyclotron & Radioisotope, Aoba Ku, Sendai, Miyagi 9808578, Japan; [Suzuki, Hisashi] Natl Inst Radiol Sci, Inage Ku, Chiba 2638555, Japan	Tanoi, K (reprint author), Univ Tokyo, Grad Sch Agr & Life Sci, Bunkyo Ku, 1-1-1 Yayoi, Tokyo 1138657, Japan.	uktanoi@mail.ecc.u-tokyo.ac.jp; anikoba@mail.ecc.u-tokyo.ac.jp; tsaito.mailbox@gmail.com; rfmdelac@gmail.com; kamadarisa647@gmail.com; rencyric@cyric.tohoku.ac.jp; hisashi@nirs.go.jp; hirose.atsushi@nifty.com; ayoshimi@mail.ecc.u-tokyo.ac.jp; ryo818@hotmail.co.jp; atomoko@mail.ecc.u-tokyo.ac.jp	Tanoi, Keitaro/N-7462-2015	Tanoi, Keitaro/0000-0001-7545-2771	Japan Society for the Promotion of Science [24780056]; Funding Program for Next Generation World-Leading Researchers (NEXT Program) [GS-007]	This work was supported by the Japan Society for the Promotion of Science[Grant-in-Aid for Young Scientists (B) Grant No. 24780056] to K. T. and by the Funding Program for Next Generation World-Leading Researchers (NEXT Program)[GS-007] to T.M.N.	Hermans C, 2010, NEW PHYTOL, V187, P119, DOI 10.1111/j.1469-8137.2010.03258.x; Shaul O, 1999, EMBO J, V18, P3973, DOI 10.1093/emboj/18.14.3973; Chen ZC, 2012, PLANT PHYSIOL, V159, P1624, DOI 10.1104/pp.112.199778; Bose J, 2013, PLANT CELL PHYSIOL, V54, P1093, DOI 10.1093/pcp/pct064; Cakmak I, 2008, PHYSIOL PLANTARUM, V133, P692, DOI 10.1111/j.1399-3054.2007.01042.x; Hermans C, 2004, PLANTA, V220, P344, DOI 10.1007/s00425-004-1340-4; Gebert M, 2009, PLANT CELL, V21, P4018, DOI 10.1105/tpc.109.070557; Dann CE, 2007, CELL, V130, P878, DOI 10.1016/j.cell.2007.06.051; Gansel X, 2001, PLANT J, V26, P143, DOI 10.1046/j.1365-313x.2001.01016.x; Gierth M, 2005, PLANT PHYSIOL, V137, P1105, DOI 10.1104/pp.104.057216; Kobayashi NI, 2013, PHYSIOL PLANTARUM, V148, P490, DOI 10.1111/ppl.12003; Shaul O, 2002, BIOMETALS, V15, P309; Hattori M, 2007, NATURE, V448, P1072, DOI 10.1038/nature06093; SNAVELY MD, 1989, J BACTERIOL, V171, P4761; Muchhal US, 1996, P NATL ACAD SCI USA, V93, P10519, DOI 10.1073/pnas.93.19.10519; Yoshimoto N, 2002, PLANT J, V29, P465, DOI 10.1046/j.0960-7412.2001.01231.x; Takano J, 2006, PLANT CELL, V18, P1498, DOI 10.1105/tpc.106.041640; Hawkesford M, 2012, MARSCHNER'S MINERAL NUTRITION OF HIGHER PLANTS, 3RD EDITION, P135, DOI 10.1016/B978-0-12-384905-2.00006-6; White PJ, 2012, PLANT SOIL, V357, P1, DOI 10.1007/s11104-012-1128-4; Takano J, 2005, P NATL ACAD SCI USA, V102, P12276, DOI 10.1073/pnas.0502060102; Saito T, 2013, PLANT CELL PHYSIOL, V54, P1673, DOI 10.1093/pcp/pct112; Maguire ME, 2002, BIOMETALS, V15, P203, DOI 10.1023/A:1016058229972; MAAS EV, 1971, PLANT PHYSIOL, V47, P357, DOI 10.1104/pp.47.3.357; Tanoi K, 2011, SOIL SCI PLANT NUTR, V57, P265, DOI 10.1080/00380768.2011.576397; Hermans C, 2010, NEW PHYTOL, V187, P132, DOI 10.1111/j.1469-8137.2010.03257.x; Connolly E.L., 2002, GENOME BIOL, V3; Hermans C, 2005, J EXP BOT, V56, P2153, DOI 10.1093/jxb/eri215; HMIEL SP, 1986, J BACTERIOL, V168, P1444; IWATA R, 1992, J RADIOAN NUCL CH AR, V159, P233, DOI 10.1007/BF02040716; JOSEPH RA, 1976, PHYSIOL PLANTARUM, V36, P233, DOI 10.1111/j.1399-3054.1976.tb04419.x; Kucharski LM, 2000, J BIOL CHEM, V275, P16767, DOI 10.1074/jbc.M001507200; Legett JE, 1969, PLANT PHYSIOL, V44, P1182; Li LG, 2001, PLANT CELL, V13, P2761, DOI 10.1105/tpc.13.12.2761; Mao D, 2014, PLANT CELL IN PRESS; RENGEL Z, 1989, PLANT PHYSIOL, V91, P1407, DOI 10.1104/pp.91.4.1407; STEUCEK GL, 1970, PLANT PHYSIOL, V46, P50, DOI 10.1104/pp.46.1.50; Tanoi K, 2013, J RADIOANAL NUCL CH, V296, P749, DOI 10.1007/s10967-012-2219-7	37	2	2	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0032-079X	1573-5036		PLANT SOIL	Plant Soil	NOV	2014	384	1-2					69	77		10.1007/s11104-014-2197-3		9	Agronomy; Plant Sciences; Soil Science	Agriculture; Plant Sciences	AS5WA	WOS:000344336200006		
J	Tsunoda, T; Kachi, N; Suzuki, JI				Tsunoda, Tomonori; Kachi, Naoki; Suzuki, Jun-Ichirou			Interactive effects of soil nutrient heterogeneity and belowground herbivory on the growth of plants with different root foraging traits	PLANT AND SOIL			English	Article						Grubs; Lolium perenne; Nutrient patches; Plant-soil interactions; Plantago lanceolata; Root herbivore	LOLIUM-PERENNE; NITROGEN CAPTURE; JAPANESE-BEETLE; RESPONSES; COMMUNITIES; GRASSLAND; BIOMASS; SYSTEM; PROLIFERATION; AVAILABILITY	Plants with precise root foraging patterns can proliferate roots preferentially in nutrient-rich soil patches. When nutrients are distributed heterogeneously, this trait is often competitively advantageous in pot experiments but not field experiments. We hypothesized that this difference is due to belowground herbivory under field conditions. We performed pot experiments using seedlings of Lolium perenne (a more precise root foraging species) and Plantago lanceolata (a less precise root foraging species). The experiment had a two-way factorial randomized block design, with nutrient distribution pattern (homogeneous or heterogeneous) and belowground herbivore (present or absent) as the two factors. Each pot contained one seedling of each species. With no herbivore present, plant biomass was smaller in the heterogeneous nutrient treatment than in the homogeneous treatment in P. lanceolata, but not in L. perenne. Under homogeneous nutrient distribution, plant biomass was lower in both species with a herbivore present than with no herbivore. Under heterogeneous nutrient distribution, biomass reduction due to herbivory occurred only in L. perenne. Roots of the precise root foraging species were grazed more under the heterogeneous nutrient distribution, suggesting that the herbivore more efficiently foraged for roots in nutrient-rich soil patches.	[Tsunoda, Tomonori; Kachi, Naoki; Suzuki, Jun-Ichirou] Tokyo Metropolitan Univ, Dept Biol Sci, Hachioji, Tokyo 1920397, Japan	Tsunoda, T (reprint author), Tokyo Metropolitan Univ, Dept Biol Sci, 1-1 Minamiosawa, Hachioji, Tokyo 1920397, Japan.	ttsunoda@tmu.ac.jp					Robinson D, 1999, P ROY SOC B-BIOL SCI, V266, P431; James SE, 2003, J ECOL, V91, P234, DOI 10.1046/j.1365-2745.2003.00758.x; Blossey B, 2003, ANNU REV ENTOMOL, V48, P521, DOI 10.1146/annurev.ento.48.091801.112700; Wijesinghe DK, 2001, J ECOL, V89, P972, DOI 10.1046/j.0022-0477.2001.00618.x; Cain ML, 1999, OECOLOGIA, V118, P397, DOI 10.1007/s004420050741; DREW MC, 1975, NEW PHYTOL, V75, P479, DOI 10.1111/j.1469-8137.1975.tb01409.x; Farley RA, 1999, J ECOL, V87, P688, DOI 10.1046/j.1365-2745.1999.00390.x; Potter DA, 2002, ANNU REV ENTOMOL, V47, P175, DOI 10.1146/annurev.ento.47.091201.145153; Joshi J, 2000, J ECOL, V88, P634, DOI 10.1046/j.1365-2745.2000.00487.x; Stevens GN, 2006, NEW PHYTOL, V171, P127, DOI 10.1111/j.1469-8137.2006.01731.x; JACKSON RB, 1993, J ECOL, V81, P683, DOI 10.2307/2261666; Jackson RB, 1997, P NATL ACAD SCI USA, V94, P7362, DOI 10.1073/pnas.94.14.7362; de Kroon H, 2012, J ECOL, V100, P6, DOI 10.1111/j.1365-2745.2011.01906.x; Stevens GN, 2006, ECOLOGY, V87, P616, DOI 10.1890/05-0809; Coverdale TC, 2012, ECOLOGY, V93, P2085, DOI 10.1890/12-0010.1; Hutchings MJ, 2003, ECOLOGY, V84, P2322, DOI 10.1890/02-0290; HUTCHINGS MJ, 1994, ADV ECOL RES, V25, P159, DOI 10.1016/S0065-2504(08)60215-9; Lundholm JT, 2003, J ECOL, V91, P966, DOI 10.1046/j.1365-2745.2003.00826.x; Bliss KM, 2002, NEW PHYTOL, V154, P409, DOI 10.1046/j.1469-8137.2002.00389.x; Brown V.K., 1990, Advances in Ecological Research, V20, P1, DOI 10.1016/S0065-2504(08)60052-5; CRUTCHFIELD BA, 1994, J ENTOMOL SCI, V29, P398; Einsmann JC, 1999, J ECOL, V87, P609, DOI 10.1046/j.1365-2745.1999.00376.x; Gerber E, 2007, BIOL CONTROL, V42, P355, DOI 10.1016/j.biocontrol.2007.06.005; Grime J.P., 1988, COMP PLANT ECOLOGY F; Hodge A, 2003, NEW PHYTOL, V157, P303, DOI 10.1046/j.1469-8137.2003.00662.x; Hodge A, 1999, PLANT CELL ENVIRON, V22, P811, DOI 10.1046/j.1365-3040.1999.00454.x; Johnson SN, 2008, ROOT FEEDERS: AN ECOSYSTEM PERSPECTIVE, P1, DOI 10.1079/9781845934613.0000; KACHI N, 1985, J ECOL, V73, P887, DOI 10.2307/2260155; Kachi N, 1983, THESIS U TOKYO; Maestre FT, 2005, NEW PHYTOL, V168, P637, DOI 10.1111/j.1469-8137.2005.01547.x; Nakamura R, 2008, J PLANT RES, V121, P547, DOI 10.1007/s10265-008-0183-7; R Development Core Team, 2012, R LANG ENV STAT COMP; Rajaniemi TK, 2004, OECOLOGIA, V141, P519, DOI 10.1007/s00442-004-1666-4; ROBINSON D, 1983, NEW PHYTOL, V94, P263, DOI 10.1111/j.1469-8137.1983.tb04499.x; Sakai K, 2007, ATLAS JAPANESE SCARA, V2; Stevens GN, 2008, ROOT FEEDERS: AN ECOSYSTEM PERSPECTIVE, P171, DOI 10.1079/9781845934613.0171; STRONG DR, 1995, OECOLOGIA, V104, P85, DOI 10.1007/BF00365566; Sun Y, 2011, PLANT SOIL, V347, P351, DOI 10.1007/s11104-011-0854-3; Townsend C, 2003, ESSENTIALS ECOLOGY; Tsunoda T, 2014, ECOL RES, V29, P351, DOI 10.1007/s11284-014-1133-6	40	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0032-079X	1573-5036		PLANT SOIL	Plant Soil	NOV	2014	384	1-2					327	334		10.1007/s11104-014-2215-5		8	Agronomy; Plant Sciences; Soil Science	Agriculture; Plant Sciences	AS5WA	WOS:000344336200024		
J	Hossain, MA; Ye, W; Munemasa, S; Nakamura, Y; Mori, IC; Murata, Y				Hossain, M. A.; Ye, W.; Munemasa, S.; Nakamura, Y.; Mori, I. C.; Murata, Y.			Cyclic adenosine 5 '-diphosphoribose (cADPR) cyclic guanosine 3 ',5 '-monophosphate positively function in Ca2+ elevation in methyl jasmonate-induced stomatal closure, cADPR is required for methyl jasmonate-induced ROS accumulation NO production in guard cells	PLANT BIOLOGY			English	Article						Abscisic acid; Arabidopsis thaliana; cyclic adenosine 5-diphosphoribose; cyclic guanosine 3; 5-monophosphate; methyl jasmonate	OXYGEN SPECIES PRODUCTION; DEPENDENT PROTEIN-KINASE; ENDOGENOUS ABSCISIC-ACID; NITRIC-OXIDE PRODUCTION; SIGNALING PATHWAYS; CYTOSOLIC CA2+; NADPH OXIDASE; ADP-RIBOSE; ARABIDOPSIS-THALIANA; PLASMA-MEMBRANE	Methyl jasmonate (MeJA) signalling shares several signal components with abscisic acid (ABA) signalling in guard cells. Cyclic adenosine 5-diphosphoribose (cADPR) and cyclic guanosine 3,5-monophosphate (cGMP) are second messengers in ABA-induced stomatal closure. In order to clarify involvement of cADPR and cGMP in MeJA-induced stomatal closure in Arabidopsis thaliana (Col-0), we investigated effects of an inhibitor of cADPR synthesis, nicotinamide (NA), and an inhibitor of cGMP synthesis, LY83583 (LY, 6-anilino-5,8-quinolinedione), on MeJA-induced stomatal closure. Treatment with NA and LY inhibited MeJA-induced stomatal closure. NA inhibited MeJA-induced reactive oxygen species (ROS) accumulation and nitric oxide (NO) production in guard cells. NA and LY suppressed transient elevations elicited by MeJA in cytosolic free Ca2+ concentration ([Ca2+](cyt)) in guard cells. These results suggest that cADPR and cGMP positively function in [Ca2+](cyt) elevation in MeJA-induced stomatal closure, are signalling components shared with ABA-induced stomatal closure in Arabidopsis, and that cADPR is required for MeJA-induced ROS accumulation and NO production in Arabidopsis guard cells.	[Hossain, M. A.; Ye, W.; Munemasa, S.; Nakamura, Y.; Murata, Y.] Okayama Univ, Grad Sch Environm & Life Sci, Okayama 7008530, Japan; [Mori, I. C.] Okayama Univ, Inst Plant Sci & Resources, Kurashiki, Okayama, Japan	Murata, Y (reprint author), Okayama Univ, Grad Sch Environm & Life Sci, 1-1-1 Tsushima Naka, Okayama 7008530, Japan.	muta@cc.okayama-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan	This research was supported in part by Grants for Scientific Research on Priority Areas from the Ministry of Education, Culture, Sports, Science and Technology of Japan.	Munemasa S, 2007, PLANT PHYSIOL, V143, P1398, DOI 10.1104/pp.106.091298; Dubovskaya LV, 2011, NEW PHYTOL, V191, P57, DOI 10.1111/j.1469-8137.2011.03661.x; Bright J, 2006, PLANT J, V45, P113, DOI 10.1111/j.1365-313X.2005.02615.x; SCHROEDER JI, 1989, NATURE, V338, P427, DOI 10.1038/338427a0; Munemasa S, 2011, PLANT PHYSIOL, V155, P553, DOI 10.1104/pp.110.162750; Uraji M, 2012, PLANT PHYSIOL, V159, P450, DOI 10.1104/pp.112.195578; Suhita D, 2003, PLANT SCI, V164, P481, DOI 10.1016/S0168-9452(02)00432-6; Allen GJ, 1999, PLANT J, V19, P735, DOI 10.1046/j.1365-313x.1999.00574.x; Neill S, 2008, J EXP BOT, V59, P165, DOI 10.1093/jxb/erm293; Kwak JM, 2003, EMBO J, V22, P2623, DOI 10.1093/emboj/cdg277; Cousson A, 1998, PLANTA, V206, P308, DOI 10.1007/s004250050405; Gehring CA, 1997, ANN BOT-LONDON, V80, P485, DOI 10.1006/anbo.1997.0471; ALLEN GJ, 1995, SCIENCE, V268, P735, DOI 10.1126/science.7732384; Turner JG, 2002, PLANT CELL, V14, pS153, DOI 10.1105/tpc.000679; Melotto M, 2006, CELL, V126, P969, DOI 10.1016/j.cell.2006.06.054; Murata Y, 2001, PLANT CELL, V13, P2513, DOI 10.1105/tpc.13.11.2513; Ye WX, 2013, PLANT PHYSIOL, V163, P591, DOI 10.1104/pp.113.224055; Suhita D, 2004, PLANT PHYSIOL, V134, P1536, DOI 10.1104/pp.103.032250; Gonugunta VK, 2008, PLANT CELL ENVIRON, V31, P1717, DOI 10.1111/j.1365-3040.2008.01872.x; Pharmawati M, 2001, PLANT PHYSIOL BIOCH, V39, P385, DOI 10.1016/S0981-9428(01)01252-9; Ye WX, 2013, J PLANT PHYSIOL, V170, P1212, DOI 10.1016/j.jplph.2013.03.011; Joudoi T, 2013, PLANT CELL, V25, P558, DOI 10.1105/tpc.112.105049; Sagi M, 2001, PLANT PHYSIOL, V126, P1281, DOI 10.1104/pp.126.3.1281; Ma W, 2008, PLANT PHYSIOL, V148, P818, DOI 10.1104/pp.108.125104; Hossain MA, 2011, PLANT PHYSIOL, V156, P430, DOI 10.1104/pp.111.172254; Shimazaki K, 2007, ANNU REV PLANT BIOL, V58, P219, DOI 10.1146/annurev.arplant.57.032905.105434; Qi Z, 2010, P NATL ACAD SCI USA, V107, P21193, DOI 10.1073/pnas.1000191107; Garcia-Mata C, 2003, P NATL ACAD SCI USA, V100, P11116, DOI 10.1073/pnas.1434381100; Klusener B, 2002, PLANT PHYSIOL, V130, P2152, DOI 10.1104/pp.012187; Kobayashi M, 2007, PLANT CELL, V19, P1065, DOI 10.1105/tpc.106.048884; Neill SJ, 2002, PLANT PHYSIOL, V128, P13, DOI 10.1104/pp.128.1.13; Pei ZM, 2000, NATURE, V406, P731, DOI 10.1038/35021067; Garcia-Mata C, 2007, NITRIC OXIDE-BIOL CH, V17, P143, DOI 10.1016/j.niox.2007.08.001; Hossain MA, 2011, J PLANT PHYSIOL, V168, P1901, DOI 10.1016/j.jplph.2011.05.004; Islam MM, 2009, PLANT CELL PHYSIOL, V50, P1171, DOI 10.1093/pcp/pcp066; Israelsson M, 2006, CURR OPIN PLANT BIOL, V9, P654, DOI 10.1016/j.pbi.2006.09.006; Jacob T, 1999, P NATL ACAD SCI USA, V96, P12192, DOI 10.1073/pnas.96.21.12192; Leckie CP, 1998, P NATL ACAD SCI USA, V95, P15837, DOI 10.1073/pnas.95.26.15837; Liechti R, 2002, SCIENCE, V296, P1649, DOI 10.1126/science.1071547; Liu X, 2002, ACTA BOT SIN, V44, P164; MacRobbie EAC, 2000, P NATL ACAD SCI USA, V97, P12361, DOI 10.1073/pnas.220417197; MULSCH A, 1988, J PHARMACOL EXP THER, V247, P283; RAGHAVENDRA AS, 1987, PLANT PHYSIOL, V83, P732, DOI 10.1104/pp.83.4.732; Saito N, 2008, PLANT CELL PHYSIOL, V49, P1396, DOI 10.1093/pcp/pcn106; Sethi JK, 1996, BIOCHEM J, V319, P613; Wu JY, 2011, PLANT CELL REP, V30, P1193, DOI 10.1007/s00299-011-1027-9	46	0	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1435-8603	1438-8677		PLANT BIOLOGY	Plant Biol.	NOV	2014	16	6					1140	1144		10.1111/plb.12175		5	Plant Sciences	Plant Sciences	AS9XE	WOS:000344591000015		
J	Hand, C; Maki, S; Reed, BM				Hand, Charles; Maki, Shinya; Reed, Barbara M.			Modeling optimal mineral nutrition for hazelnut micropropagation	PLANT CELL TISSUE AND ORGAN CULTURE			English	Article						Corylus; Growth medium; Micropropagation; Mineral nutrition; Minor nutrients; Nitrogen nutrition	IMPROVED SHOOT MULTIPLICATION; IN-VITRO PROPAGATION; CORYLUS-AVELLANA L; TISSUE-CULTURES; HYBRID HAZELNUT; HIGHER-PLANTS; GROWTH; INVITRO; L.	Micropropagation of hazelnut (Corylus avellana L.) is typically difficult because of the wide variation in response among cultivars. This study was designed to determine the required mineral nutrient concentrations for micropropagation of C. avellana cultivars using a response surface design analysis. Driver and Kuniyuki Walnut (DKW) medium mineral nutrients were separated into five factors: NH4NO3, Ca(NO3)(2), mesos (MgSO4 and KH2PO4), K2SO4, and minor nutrients (boron, copper, manganese, molybdenum, and zinc) ranging from 0.5x to 2x the standard DKW medium concentrations with 33 treatments for use in modeling. Overall quality and shoot length for all cultivars were influenced by ammonium and nitrate nitrogen, mesos and minors. Reduced Ca(NO3)(2) improved multiplication while higher amounts increased shoot length for most cultivars. Uptake of nutrients varied among the cultivars. Calcium and magnesium concentrations were greater in the shoots that grew well compared to poorly-growing and control treatments. All five cultivars showed improved growth on some treatments and the models indicated that shoots grown on an optimized medium would be even better. This model indicates that NH4NO3, Ca(NO3)(2), mesos, and minors all had significant effects on hazelnut growth and multiplication and should be optimized in future experiments.	[Hand, Charles] Oregon State Univ, Dept Hort, Corvallis, OR 97331 USA; [Maki, Shinya] Niihama Natl Coll Technol, Dept Appl Chem & Biotechnol, Niihama, Japan; [Reed, Barbara M.] ARS, USDA, Corvallis, OR 97333 USA	Reed, BM (reprint author), ARS, USDA, 33447 Peoria Rd, Corvallis, OR 97333 USA.	Barbara.Reed@ars.usda.gov		Reed, Barbara/0000-0003-0079-8473	Oregon Hazelnut Commission; USDA-ARS CRIS [5358-21000-044-00D]	This study was part of a MS thesis by CH and was supported by the Oregon Hazelnut Commission and USDA-ARS CRIS 5358-21000-044-00D.	ALKAI H, 1984, AGRONOMIE, V4, P399, DOI 10.1051/agro:19840412; Anderson WC, 1984, COMB P INT PLANT PRO, V33, P132; Nas MN, 2004, SCI HORTIC-AMSTERDAM, V101, P189, DOI 10.1016/j.scienta.2003.10.004; Reed BM, 2013, IN VITRO CELL DEV-PL, V49, P699, DOI 10.1007/s11627-013-9556-2; Niedz RP, 2007, IN VITRO CELL DEV-PL, V43, P370, DOI 10.1007/s11627-007-9062-5; Niedz RP, 2007, SCI HORTIC-AMSTERDAM, V112, P349, DOI 10.1016/j.scienta.2006.12.044; Adelberg JW, 2010, IN VITRO CELL DEV-PL, V46, P95, DOI 10.1007/s11627-009-9247-1; LEIFERT C, 1995, CRIT REV PLANT SCI, V14, P83, DOI 10.1080/713608070; WILLIAMS RR, 1993, AUST J BOT, V41, P237, DOI 10.1071/BT9930237; DRIVER JA, 1984, HORTSCIENCE, V19, P507; Bacchetta L, 2008, HORTSCIENCE, V43, P562; Reed BM, 2013, IN VITRO CELL DEV-PL, V49, P343, DOI 10.1007/s11627-013-9504-1; Tester M, 2003, ANN BOT-LONDON, V91, P503, DOI 10.1093/aob/mcg058; Poothong S, 2014, SCI HORTIC-AMSTERDAM, V165, P132, DOI 10.1016/j.scienta.2013.10.040; Bassil N, 1992, ACTA HORTIC, V300, P137; Damiano C, 2005, ACTA HORTIC, P221; Diaz Sala C, 1990, PLANT CELL TISS ORG, V23, P151; Garrison W, 2013, CAN J PLANT SCI, V93, P511, DOI 10.4141/CJPS2012-218; Hand CR, 2013, THESIS OREG STATE, P108; Jyoti J, 2013, THESIS U GUELPH GUEL, P170; Lloyd G, 1981, COMB P INT PLANT PRO, V30, P421; Marschner H, 1995, MINERAL NUTR HIGHER, P1; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Nas MN, 2001, ACTA HORTIC, P251; Niedz RP, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-126; Niedz RP, 2006, NAT METHODS, V3, P417, DOI 10.1035/nmeth0606-417; Perez-Tornero O, 2000, J HORTIC SCI BIOTECH, V75, P283; Wada S, 2013, IN VITRO CELL DEV-PL, V49, P356, DOI 10.1007/s11627-013-9508-x; YU XL, 1993, PLANT CELL REP, V12, P256, DOI 10.1007/BF00237130; Yu Xiaoling, 1995, Hortscience, V30, P120	30	2	3	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0167-6857	1573-5044		PLANT CELL TISS ORG	Plant Cell Tissue Organ Cult.	NOV	2014	119	2					411	425		10.1007/s11240-014-0544-y		15	Biotechnology & Applied Microbiology; Plant Sciences	Biotechnology & Applied Microbiology; Plant Sciences	AS3ML	WOS:000344181700016		
J	Tanaka, T; Sato, T				Tanaka, Takayuki; Sato, Toshiyuki			Species richness of seed plants and ferns along a temperate elevational gradient in central Japan	PLANT ECOLOGY			English	Article						Diversity; Elevation; Fern; Japan; Seed plant; Species richness	HIGH MOUNTAINS; GEOMETRIC CONSTRAINTS; HENGDUAN MOUNTAINS; GLOBAL ANALYSIS; ALPINE PLANT; RANGE SIZE; COSTA-RICA; PATTERNS; DIVERSITY; NEPAL	We evaluated richness patterns of all vascular plants in central Japan with respect to spatial and climatic factors. This evaluation was performed by analysing a database that contained information on 150,806 herbarium specimens from this region. We analysed the area-corrected and rarefied species richness of all vascular plants, seed plants and ferns at 100-m elevational bands. The area-corrected species richness showed an asymmetric hump-shaped pattern for total and seed plants with a plateau in a higher elevation, whereas fern species richness showed a decreasing pattern. The rarefied species richness showed a low-plateau pattern in all cases because of the low threshold; however, species richness by rarefaction of specimens down to a higher threshold supported the area-corrected pattern. Thus, we concluded that total and seed plant richness showed a hump-shaped pattern, and that fern richness showed a decreasing pattern. Area, temperature and precipitation were significantly correlated with species richness, and climatic factors explained more variation in species richness of ferns compared with that of seed plants. When the species were divided based on range size, climatic factors explained more variation in small-ranged species richness than spatial factors, whereas spatial factors did so in large-ranged species richness. In addition, small-ranged species richness of seed plants showed a bimodal pattern with peaks at low elevation and high elevation probably because the mountains in central Japan play a role as refugia for Japanese alpine plants during climatic oscillations, or an artefact.	[Tanaka, Takayuki] Shinshu Univ, Interdisciplinary Grad Sch Sci & Technol, Dept Mt & Environm Sci, Matsumoto, Nagano 3908621, Japan; [Sato, Toshiyuki] Shinshu Univ, Fac Sci, Dept Biol, Matsumoto, Nagano 3908621, Japan	Tanaka, T (reprint author), Shinshu Univ, Interdisciplinary Grad Sch Sci & Technol, Dept Mt & Environm Sci, 3-1-1 Asahi, Matsumoto, Nagano 3908621, Japan.	tanakanaka8150@gmail.com; toshibo@shinshu-u.ac.jp					Lomolino MV, 2001, GLOBAL ECOL BIOGEOGR, V10, P3, DOI 10.1046/j.1466-822x.2001.00229.x; Colwell RK, 2000, TRENDS ECOL EVOL, V15, P70, DOI 10.1016/S0169-5347(99)01767-X; Bhattarai KR, 2003, GLOBAL ECOL BIOGEOGR, V12, P327, DOI 10.1046/j.1466-822X.2003.00044.x; Grytnes JA, 2006, J BIOGEOGR, V33, P1838, DOI 10.1111/j.1365-2699.2006.01554.x; RAHBEK C, 1995, ECOGRAPHY, V18, P200, DOI 10.1111/j.1600-0587.1995.tb00341.x; Brehm G, 2007, GLOBAL ECOL BIOGEOGR, V16, P205, DOI 10.1111/j.1466-822x.2006.00281.x; McCain CM, 2007, GLOBAL ECOL BIOGEOGR, V16, P1, DOI 10.1111/j.1466-822X.2006.00263.x; Kessler M, 2001, BIODIVERS CONSERV, V10, P1897, DOI 10.1023/A:1013130902993; Olszewski TD, 2004, OIKOS, V104, P377, DOI 10.1111/j.0030-1299.2004.12519.x; Hemp A, 2002, PLANT ECOL, V159, P211, DOI 10.1023/A:1015569125417; Brose U, 2003, ECOLOGY, V84, P2364, DOI 10.1890/02-0558; Kessler M, 2011, GLOBAL ECOL BIOGEOGR, V20, P868, DOI 10.1111/j.1466-8238.2011.00653.x; Gotelli NJ, 2001, ECOL LETT, V4, P379, DOI 10.1046/j.1461-0248.2001.00230.x; Grau O, 2007, J BIOGEOGR, V34, P1907, DOI 10.1111/j.1365-2699.2007.01745.x; McCain CM, 2010, GLOBAL ECOL BIOGEOGR, V19, P541, DOI 10.1111/j.1466-8238.2010.00528.x; Acharya KP, 2011, J BIOGEOGR, V38, P1821, DOI 10.1111/j.1365-2699.2011.02511.x; Kessler M, 2000, J BIOGEOGR, V27, P275, DOI 10.1046/j.1365-2699.2000.00399.x; Wu YJ, 2013, J BIOGEOGR, V40, P2310, DOI 10.1111/jbi.12177; Grytnes JA, 2002, AM NAT, V159, P294, DOI 10.1086/338542; Herzog SK, 2005, ECOGRAPHY, V28, P209, DOI 10.1111/j.0906-7590.2005.03935.x; Kluge J, 2006, GLOBAL ECOL BIOGEOGR, V15, P358, DOI 10.1111/j.1466-822x.2006.00223.x; Rahbek C, 1997, AM NAT, V149, P875, DOI 10.1086/286028; Bhattarai KR, 2004, J BIOGEOGR, V31, P389; Jetz W, 2002, SCIENCE, V297, P1548, DOI 10.1126/science.1072779; McCain CM, 2009, GLOBAL ECOL BIOGEOGR, V18, P346, DOI 10.1111/j.1466-8238.2008.00443.x; Takahashi K, 2005, ECOL RES, V20, P445, DOI 10.1007/s11284-005-0060-y; Karger DN, 2011, J BIOGEOGR, V38, P1177, DOI 10.1111/j.1365-2699.2010.02468.x; Milne RI, 2002, ADV BOT RES, V38, P281, DOI 10.1016/S0065-2296(02)38033-9; Rangel TF, 2010, ECOGRAPHY, V33, P46, DOI 10.1111/j.1600-0587.2009.06299.x; Wang ZH, 2007, DIVERS DISTRIB, V13, P845, DOI 10.1111/j.1472-4642.2007.00335.x; Arrhenius O, 1921, J ECOL, V9, P95, DOI 10.2307/2255763; BARRINGTON DS, 1993, J BIOGEOGR, V20, P275, DOI 10.2307/2845635; Colwell RK, 2004, AM NAT, V163, P1; Colwell RK, 2006, RANGEMODEL MONTE CAR; Fu CZ, 2007, BIODIVERS CONSERV, V16, P707, DOI 10.1007/s10531-005-4382-4; Fujii N, 1999, J PLANT RES, V112, P87, DOI 10.1007/PL00013866; Grytnes JA, 2008, FOLIA GEOBOT, V43, P357, DOI 10.1007/s12224-008-9017-6; Ikeda H, 2009, BIOL J LINN SOC, V97, P403, DOI 10.1111/j.1095-8312.2009.01177.x; Ikeda H, 2007, J BIOGEOGR, V34, P169, DOI 10.1111/j.1365-2699.2006.01577.x; Ikeda H, 2008, PLANT SYST EVOL, V272, P197, DOI 10.1007/s00606-007-0637-8; Ikeda H, 2006, MOL ECOL, V15, P3731, DOI 10.1111/j.1365-294X.2006.03054.x; Iwatsuki K, 1994, VEGETATION E N AM, P89; Iwatsuki K, 1995, FLORA JAPAN, VI; KANAI H, 2006, J JPN BOT, V81, P54; Kessler M, 2009, BASIC APPL ECOL, V10, P295, DOI 10.1016/j.baae.2008.10.006; Kessler M., 2010, FERN ECOLOGY, P22; Kessler M, 2001, CONSERV BIOL, V15, P634, DOI 10.1046/j.1523-1739.2001.015003634.x; Kluge J, 2008, BASIC APPL ECOL, V9, P35, DOI 10.1016/j.baae.2006.11.004; Koidzumi G, 1919, BOT MAG TOKYO, V33, P193; Korner C., 1999, ALPINE PLANT LIFE FU; Kubota Y, 2014, J BIOGEOGR, V41, P1267, DOI 10.1111/jbi.12290; Mittermeier R. A., 2005, HOTSPOTS REVISITED E; Ohwi J., 1965, FLORA JAPAN; R Development Core Team, 2009, R LANG ENV STAT COMP; Rahbek C, 2005, ECOL LETT, V8, P224, DOI 10.1111/j.1461-0248.2004.00701.x; Rosenzweig M. L., 1995, SPECIES DIVERSITY SP; Shimizu T, 1997, FLORA NAGANO PREFECT; Tanaka T, 2014, PLANT SYST EVOL, V300, P2041, DOI 10.1007/s00606-014-1036-6; Tanaka T, 2013, PLANT ECOL, V214, P1189, DOI 10.1007/s11258-013-0243-5; Zhang DC, 2009, BIODIVERS CONSERV, V18, P699, DOI 10.1007/s10531-008-9534-x	60	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	1385-0237	1573-5052		PLANT ECOL	Plant Ecol.	NOV	2014	215	11					1299	1311		10.1007/s11258-014-0388-x		13	Plant Sciences; Ecology; Forestry	Plant Sciences; Environmental Sciences & Ecology; Forestry	AS3CR	WOS:000344154400007		
J	Abe, H; Takahashi, T; Hasegawa, M				Abe, Harue; Takahashi, Toshimori; Hasegawa, Masami			Effects of volcanic disturbance on the reproductive success of Eurya japonica and its reproductive mutualisms	PLANT ECOLOGY			English	Article						Forest recovery; Frugivorous bird; Fruit set; Natural disturbance; Pollination; Seed dispersal	BROAD-LEAVED FOREST; CAMELLIA-JAPONICA; ZOSTEROPS-JAPONICA; SEED PRODUCTION; FRUIT ABORTION; THEACEAE; FLOWER; ECOSYSTEM; GROWTH; PLANTS	Ecological observation of surviving organisms and their interactions during and after volcanic activity provides an indispensable opportunity to study how organisms respond to environmental devastation. Eurya japonica satisfies the criteria as a facilitator plant species in recovering forest on the volcanic Miyake Island, which erupted in 2000, because this species is more resistant to volcanic gases than other tree species on the island. We examined the effects of volcanic disturbance on reproductive success of E. japonica and compared the visitation frequencies of pollinator insects and frugivorous birds at nine sites showing different degrees of disturbance. The leaf health was strongly decreased by frequent volcanic gas exposure, whereas flower bud formation was not suppressed. The fruit abortion rate did not differ among sites, whereas the fruit set rate significantly decreased with increasing volcanic damage. The frequencies of pollinator and frugivorous bird visits were higher in heavily damaged areas. These results indicate that the pollination and seed-dispersal system of E. japonica was potentially maintained under volcanic disturbance, though the final reproductive success decreased.	[Abe, Harue] Niigata Univ, Ctr Sustainable Agr & Forestry, Fac Agr, Niigata 9522206, Japan; [Takahashi, Toshimori] Utsunomiya Univ, Ctr Educ & Res Community Collaborat, Utsunomiya, Tochigi 3218505, Japan; [Hasegawa, Masami] Toho Univ, Lab Geog Ecol, Funabashi, Chiba 2748510, Japan	Abe, H (reprint author), Niigata Univ, Ctr Sustainable Agr & Forestry, Fac Agr, 94-2 Koda, Niigata 9522206, Japan.	apodemusnyagis@gmail.com					Abe H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062696; Abe H, 2006, ECOL RES, V21, P732, DOI 10.1007/s11284-006-0179-5; Abe H, 2008, ECOL RES, V23, P141, DOI 10.1007/s11284-007-0345-4; Abe H, 2011, SINGLE-POLLEN GENOTYPING, P47, DOI 10.1007/978-4-431-53901-8_5; Aizen MA, 2007, ECOLOGY, V88, P81; Tsuji K, 2013, ENTOMOL SCI, V16, P291, DOI 10.1111/ens.12019; STEPHENSON AG, 1981, ANNU REV ECOL SYST, V12, P253, DOI 10.1146/annurev.es.12.110181.001345; BAWA KS, 1984, AM J BOT, V71, P736, DOI 10.2307/2443371; TURNER MG, 1989, ANNU REV ECOL SYST, V20, P171, DOI 10.1146/annurev.es.20.110189.001131; Sekercioglu CH, 2006, TRENDS ECOL EVOL, V21, P464, DOI 10.1016/j.tree.2006.05.007; Manabe T, 1997, J VEG SCI, V8, P761, DOI 10.2307/3237020; Tilman D, 2006, NATURE, V441, P629, DOI 10.1038/nature04742; BRONSTEIN JL, 1995, BIOTROPICA, V27, P373, DOI 10.2307/2388922; Hargreaves AL, 2009, BIOL REV, V84, P259, DOI 10.1111/j.1469-185X.2008.00074.x; Tsuji K, 2010, OIKOS, V119, P1848, DOI 10.1111/j.1600-0706.2010.18585.x; CASPER BB, 1988, AM NAT, V132, P318, DOI 10.1086/284855; Chung MG, 1996, CAN J FOREST RES, V26, P537; Chung MG, 2000, SILVAE GENET, V49, P1; Forestry and Forest Products Research Institute, 2006, MIYAK SINR FUKK TAIS; Garcia D, 2013, ECOGRAPHY, V36, P197, DOI 10.1111/j.1600-0587.2012.07519.x; Iwatsuki K, 2006, FLORA JAPAN A; Johnson EA, 2007, PLANT DISTURBANCE EC, P720; KIKKAWA J, 1981, Journal of the Yamashina Institute for Ornithology, V13, P60; Kamijo T, 2008, J DISASTER RES, V3, P226; Kamijo T, 2003, GLOBAL ENV RES, V7, P69; Kamijo T, 2002, FOLIA GEOBOT, V37, P71, DOI 10.1007/BF02803192; Kunitake YK, 2004, PLANT SPEC BIOL, V19, P197, DOI 10.1111/j.1442-1984.2004.00115.x; Manabe T, 1993, J JPN SOC REVEGET TE, V18, P154; MENGE BA, 1987, AM NAT, V130, P730, DOI 10.1086/284741; MIZUI N, 1991, Plant Species Biology, V6, P39, DOI 10.1111/j.1442-1984.1991.tb00208.x; Mori AS, 2012, BIOL REV, V88, P349; Naeem S, 2009, BIODIVERSITY ECOSYST; Sperens U, 1996, ECOSCIENCE, V3, P325; STEPHENSON AG, 1986, EVOLUTION, V40, P453, DOI 10.2307/2408568; Sugimura Y, 2003, BUNRUI, V3, P95; Suzuki AA, 2005, AM J BOT, V92, P2003, DOI 10.3732/ajb.92.12.2003; Takahashi T, 2008, J JPN I LANDSC ARCHI, V46, P7; Tokyo City, 2005, MIYAK RYOK MAN MIYAK; Wilson AL, 2009, PLANT ECOL, V203, P173, DOI 10.1007/s11258-008-9524-9; Yamanishi Aki, 2005, Journal of Agricultural Meteorology, V60, P1183; Yamanishi A, 2003, J JPN I LANDSCAPE AR, V66, P473; YOUNG AM, 1985, EXPERIENTIA, V41, P760, DOI 10.1007/BF02012584; YUMOTO T, 1988, Ecological Research, V3, P117, DOI 10.1007/BF02346934; ZIMMERMAN M, 1988, J ECOL, V76, P777, DOI 10.2307/2260573	44	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	1385-0237	1573-5052		PLANT ECOL	Plant Ecol.	NOV	2014	215	11					1361	1372		10.1007/s11258-014-0393-0		12	Plant Sciences; Ecology; Forestry	Plant Sciences; Environmental Sciences & Ecology; Forestry	AS3CR	WOS:000344154400012		
J	Del Vecchio, HA; Ying, S; Park, J; Knowles, VL; Kanno, S; Tanoi, K; She, YM; Plaxton, WC				Del Vecchio, Hernan A.; Ying, Sheng; Park, Joonho; Knowles, Vicki L.; Kanno, Satomi; Tanoi, Keitaro; She, Yi-Min; Plaxton, William C.			The cell wall-targeted purple acid phosphatase AtPAP25 is critical for acclimation of Arabidopsis thaliana to nutritional phosphorus deprivation	PLANT JOURNAL			English	Article						Arabidopsis thaliana (thale cress); functional genomics; cell-wall proteome; phosphorus nutrition; purple acid phosphatase	MOLECULAR CHARACTERIZATION; PROTEOMIC ANALYSIS; SUSPENSION CELLS; TOBACCO CELLS; EXPRESSION; OLIGOSACCHARIDES; PHOSPHORYLATION; PROTEINS; GENES; ROLES	Plant purple acid phosphatases (PAPs) belong to a relatively large gene family whose individual functions are poorly understood. Three PAP isozymes that are up-regulated in the cell walls of phosphate (Pi)-starved (-Pi) Arabidopsis thaliana suspension cells were purified and identified by MS as AtPAP12 (At2g27190), AtPAP25 (At4g36350) and AtPAP26 (At5g34850). AtPAP12 and AtPAP26 were previously isolated from the culture medium of -Pi cell cultures, and shown to be secreted by roots of Arabidopsis seedlings to facilitate Pi scavenging from soil-localized organophosphates. AtPAP25 exists as a 55kDa monomer containing complex NX(S/T) glycosylation motifs at Asn172, Asn367 and Asn424. Transcript profiling and immunoblotting with anti-AtPAP25 immune serum indicated that AtPAP25 is exclusively synthesized under -Pi conditions. Coupled with potent mixed-type inhibition of AtPAP25 by Pi (I-50=50m), this indicates a tight feedback control by Pi that prevents AtPAP25 from being synthesized or functioning as a phosphatase except when Pi levels are quite low. Promoter-GUS reporter assays revealed AtPAP25 expression in shoot vascular tissue of -Pi plants. Development of an atpap25 T-DNA insertion mutant was arrested during cultivation on soil lacking soluble Pi, but rescued upon Pi fertilization or complementation with AtPAP25. Transcript profiling by quantitative RT-PCR indicated that Pi starvation signaling was attenuated in the atpap25 mutant. AtPAP25 exhibited near-optimal phosphatase activity with several phosphoproteins and phosphoamino acids as substrates. We hypothesize that AtPAP25 plays a key signaling role during Pi deprivation by functioning as a phosphoprotein phosphatase rather than as a non-specific scavenger of Pi from extracellular P-monoesters.	[Del Vecchio, Hernan A.; Ying, Sheng; Knowles, Vicki L.; Plaxton, William C.] Queens Univ, Dept Biol, Kingston, ON K7L 3N6, Canada; [Park, Joonho] Seoul Natl Univ Sci & Technol, Dept Fine Chem, Seoul 139743, South Korea; [Kanno, Satomi; Tanoi, Keitaro] Univ Tokyo, Grad Sch Agr & Life Sci, Bunkyo Ku, Tokyo 1138657, Japan; [She, Yi-Min] Chinese Acad Sci, Shanghai Ctr Plant Stress Biol, Shanghai 201602, Peoples R China; [Plaxton, William C.] Queens Univ, Dept Biomed & Mol Sci, Kingston, ON K7L 3N6, Canada	Plaxton, WC (reprint author), Queens Univ, Dept Biol, Kingston, ON K7L 3N6, Canada.	plaxton@queensu.ca	Plaxton, William/O-3353-2013; Tanoi, Keitaro/N-7462-2015	Tanoi, Keitaro/0000-0001-7545-2771	Natural Sciences and Engineering Research Council of Canada; Queen's Research Chairs program	We are grateful to Tom McKnight (Dept. of Biology, Texas A & M University, College Station, TX) for the gift of anti-recombinant At-PAP12 immune serum. Financial support was generously provided by grants from the Natural Sciences and Engineering Research Council of Canada and the Queen's Research Chairs program to W.C.P.	Albenne C, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00111; Tran HT, 2008, PROTEOMICS, V8, P4317, DOI 10.1002/pmic.200800292; Zhang W, 2008, PLANT PHYSIOL, V146, P431, DOI 10.1104/pp.107.109934; Robinson WD, 2012, NEW PHYTOL, V196, P1024, DOI 10.1111/nph.12006; Shane MW, 2014, J EXP BOT, V65, P6097, DOI 10.1093/jxb/eru348; Chivasa S, 2002, ELECTROPHORESIS, V23, P1754, DOI 10.1002/1522-2683(200206)23:11<1754::AID-ELPS1754>3.0.CO;2-E; Gregory AL, 2009, BIOCHEM J, V420, P57, DOI 10.1042/BJ20082397; Borderies G, 2003, ELECTROPHORESIS, V24, P3421, DOI 10.1002/elps.200305608; Wang LS, 2011, PLANT PHYSIOL, V157, P1283, DOI 10.1104/pp.111.183723; Kaida R, 2010, PLANT PHYSIOL, V153, P603, DOI 10.1104/pp.110.154138; Wang LS, 2014, J INTEGR PLANT BIOL, V56, P299, DOI 10.1111/jipb.12184; Tran HT, 2010, PLANT SCI, V179, P14, DOI 10.1016/j.plantsci.2010.04.005; Sugiyama N, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.32; VARKI A, 1993, GLYCOBIOLOGY, V3, P97, DOI 10.1093/glycob/3.2.97; Shin H, 2006, PLANT J, V45, P712, DOI 10.1111/j.1365-313X.2005.02629.x; BROOKS SPJ, 1992, BIOTECHNIQUES, V13, P906; CORNISHB.A, 1974, BIOCHEM J, V137, P143; Ha S, 2014, CRIT REV BIOTECHNOL, V34, P16, DOI 10.3109/07388551.2013.783549; Hurley BA, 2010, PLANT PHYSIOL, V153, P1112, DOI 10.1104/pp.110.153270; Kaida R, 2009, PLANT PHYSIOL, V150, P1822, DOI 10.1104/pp.109.139287; Olczak M, 2003, ACTA BIOCHIM POL, V50, P1245; Olczak M, 2007, ARCH BIOCHEM BIOPHYS, V461, P247, DOI 10.1016/j.abb.2007.02.005; Robinson WD, 2012, J EXP BOT, V63, P6531, DOI 10.1093/jxb/ers309; STAHL B, 1994, EUR J BIOCHEM, V220, P321, DOI 10.1111/j.1432-1033.1994.tb18628.x; Tran HT, 2010, PLANT CELL ENVIRON, V33, P1789, DOI 10.1111/j.1365-3040.2010.02184.x; Veljanovski V, 2006, PLANT PHYSIOL, V142, P1282, DOI 10.1104/pp.106.087171; Zamani K, 2014, GENE EXPR PATTERNS, V14, P9, DOI 10.1016/j.gep.2013.08.001; Zhu HF, 2005, PLANT MOL BIOL, V59, P581, DOI 10.1007/s11103-005-0183-0	28	3	3	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0960-7412	1365-313X		PLANT J	Plant J.	NOV	2014	80	4					569	581		10.1111/tpj.12663		13	Plant Sciences	Plant Sciences	AS6KS	WOS:000344373200001		
J	Pitaksaringkarn, W; Matsuoka, K; Asahina, M; Miura, K; Sage-Ono, K; Ono, M; Yokoyama, R; Nishitani, K; Ishii, T; Iwai, H; Satoh, S				Pitaksaringkarn, Weerasak; Matsuoka, Keita; Asahina, Masashi; Miura, Kenji; Sage-Ono, Kimiyo; Ono, Michiyuki; Yokoyama, Ryusuke; Nishitani, Kazuhiko; Ishii, Tadashi; Iwai, Hiroaki; Satoh, Shinobu			XTH20 and XTH19 regulated by ANAC071 under auxin flow are involved in cell proliferation in incised Arabidopsis inflorescence stems	PLANT JOURNAL			English	Article						incision of stem; pith cell proliferation; transcription factors; XTH; auxin; tissue reunion	NAC TRANSCRIPTION FACTORS; GRAFT-UNION DEVELOPMENT; ENDOXYLOGLUCAN TRANSFERASE; TISSUE REUNION; MATRIX POLYSACCHARIDES; FUNCTIONAL-ANALYSIS; THALIANA; XYLOGLUCAN; EXPRESSION; GROWTH	One week after partial incision of Arabidopsis inflorescence stems, the repair process in damaged tissue includes pith cell proliferation. Auxin is a key factor driving this process, and ANAC071, a transcription factor gene, is upregulated in the distal region of the incised stem. Here we show that XTH20 and the closely related XTH19, members of xyloglucan endotransglucosylase/hydrolases family catalyzing molecular grafting and/or hydrolysis of cell wall xyloglucans, were also upregulated in the distal part of the incised stem, similar to ANAC071. XTH19 was expressed in the proximal incision region after 3days or after auxin application to the decapitated stem. Horizontal positioning of the plant with the incised side up resulted in decreased Pro(DR5):GUS, ANAC071, XTH20, and XTH19 expression and reduced pith cell proliferation. In incised stems of Pro(35S):ANAC071-SRDX plants, expression of XTH20 and XTH19 was substantially and moderately decreased, respectively. XTH20 and XTH19 expression and pith cell proliferation were suppressed in anac071 plants and were increased in Pro(35S):ANAC071 plants. Pith cell proliferation was also inhibited in the xth20xth19 double mutant. Furthermore, ANAC071 bound to the XTH20 and XTH19 promoters to induce their expression. This study revealed XTH20 and XTH19 induction by auxin via ANAC071 in the distal part of an incised stem and their involvement in cell proliferation in the tissue reunion process.	[Pitaksaringkarn, Weerasak; Matsuoka, Keita; Miura, Kenji; Sage-Ono, Kimiyo; Ono, Michiyuki; Ishii, Tadashi; Iwai, Hiroaki; Satoh, Shinobu] Univ Tsukuba, Grad Sch Life & Environm Sci, Tsukuba, Ibaraki 3058572, Japan; [Asahina, Masashi] Teikyo Univ, Dept Biosci, Utsunomiya, Tochigi 3208551, Japan; [Yokoyama, Ryusuke; Nishitani, Kazuhiko] Tohoku Univ, Grad Sch Life Sci, Dept Dev Biol & Neurosci, Sendai, Miyagi 9808578, Japan	Satoh, S (reprint author), Univ Tsukuba, Grad Sch Life & Environm Sci, Tsukuba, Ibaraki 3058572, Japan.	satoh.shinobu.ga@u.tsukuba.ac.jp	Miura, Kenji/C-2803-2011	Miura, Kenji/0000-0003-1262-2176	 [21027004];  [24114006]	Special thanks to Dr. Nobutaka Mitsuda and Dr. Masaru Ohme-Takagi of the National Institute of Advanced Industrial Science and Technology for providing ANAC071-SRDX transgenic Arabidopsis and Mr. Takashi Yamazaki, Mr. Katsuya Azuma, and Mrs. Rieko Nozawa for technical assistance. This work was supported in part by a Grant-in-Aid for Scientific Research on Priority Areas (21027004) and on Innovative Areas (24114006) to S.S.	Robert HS, 2009, NAT CHEM BIOL, V5, P325, DOI 10.1038/nchembio.170; Vanzin GF, 2002, P NATL ACAD SCI USA, V99, P3340, DOI 10.1073/pnas.052450699; Ooka H, 2003, DNA RES, V10, P239, DOI 10.1093/dnares/10.6.239; Vissenberg K, 2005, PLANT CELL PHYSIOL, V46, P192, DOI 10.1093/pcp/pci013; Rose JKC, 2002, PLANT CELL PHYSIOL, V43, P1421, DOI 10.1093/pcp/pcf171; Satoh S, 2006, J PLANT RES, V119, P179, DOI 10.1007/s10265-005-0257-8; Teale WD, 2006, NAT REV MOL CELL BIO, V7, P847, DOI 10.1038/nrm2020; NISHITANI K, 1992, J BIOL CHEM, V267, P21058; Yin H, 2012, J EXP BOT, V63, P4219, DOI 10.1093/jxb/ers109; Mitsuda N, 2005, PLANT CELL, V17, P2993, DOI 10.1105/tpc.105.036004; Xie Q, 2000, GENE DEV, V14, P3024, DOI 10.1101/gad.852200; Leon J, 2001, J EXP BOT, V52, P1, DOI 10.1093/jexbot/52.354.1; Berleth T, 2000, TRENDS PLANT SCI, V5, P387, DOI 10.1016/S1360-1385(00)01725-8; Tran LSP, 2004, PLANT CELL, V16, P2481, DOI 10.1105/tpc.104.022699; DUBOIS M, 1956, ANAL CHEM, V28, P350, DOI 10.1021/ac60111a017; Kehr J, 2008, J EXP BOT, V59, P85, DOI 10.1093/jxb/erm176; Alonso JM, 2003, SCIENCE, V301, P653, DOI 10.1126/science.1086391; Cho HT, 2000, P NATL ACAD SCI USA, V97, P9783, DOI 10.1073/pnas.160276997; Zhong R, 2007, PLANT CELL, V19, P2776, DOI 10.1105/tpc.107.053678; Atmodjo MA, 2011, P NATL ACAD SCI USA, V108, P20225, DOI 10.1073/pnas.1112816108; Harholt J, 2006, PLANT PHYSIOL, V140, P49, DOI 10.1104/pp.105.072744; Bu QY, 2008, CELL RES, V18, P756, DOI 10.1038/cr.2008.53; SELVENDRAN RR, 1987, METHOD BIOCHEM ANAL, V32, P25, DOI 10.1002/9780470110539.ch2; GALAMBOS JT, 1967, ANAL BIOCHEM, V19, P119, DOI 10.1016/0003-2697(67)90141-8; Ishii T, 2001, PLANT PHYSIOL, V126, P1698, DOI 10.1104/pp.126.4.1698; Kubo M, 2005, GENE DEV, V19, P1855, DOI 10.1101/gad.1331305; ZABLACKIS E, 1995, PLANT PHYSIOL, V107, P1129, DOI 10.1104/pp.107.4.1129; Olsen AN, 2005, TRENDS PLANT SCI, V10, P79, DOI 10.1016/j.tplants.2004.12.010; Turnbull CGN, 2002, PLANT J, V32, P255, DOI 10.1046/j.1365-313X.2002.01419.x; Asahina M, 2002, PLANT PHYSIOL, V129, P201, DOI 10.1104/pp.010886; Asahina M, 2011, P NATL ACAD SCI USA, V108, P16128, DOI 10.1073/pnas.1110443108; Asahina M, 2006, J PLANT RES, V119, P337, DOI 10.1007/s10265-006-0278-y; Flaishman MA, 2003, J PLANT GROWTH REGUL, V22, P253, DOI 10.1007/s00344-003-0030-y; Flaishman MA, 2008, J PLANT GROWTH REGUL, V27, P231, DOI 10.1007/s00344-008-9050-y; Fry SC, 2004, NEW PHYTOL, V161, P641, DOI 10.1111/j.1469-8137.2003.00980.x; Hyodo H, 2003, PLANT MOL BIOL, V52, P473, DOI 10.1023/A:1023904217641; Jefferson RA, 1987, PLANT MOL BIOL REP, V5, P387, DOI 10.1007/BF02667740; MOORE PJ, 1988, PLANTA, V174, P433, DOI 10.1007/BF00634471; OKAZAWA K, 1993, J BIOL CHEM, V268, P25364; Osato Y, 2006, J PLANT RES, V119, P153, DOI 10.1007/s10265-006-0262-6; Pitaksaringkarn W, 2014, PLANT BIOTECHNOL-NAR, V31, P49, DOI 10.5511/plantbiotechnology.13.1028b; Yokoyama R, 2001, PLANT CELL PHYSIOL, V42, P292, DOI 10.1093/pcp/pce034; York W. S., 1985, METHOD ENZYMOL, V118, P3, DOI DOI 10.1016/0076-6879(86)18062-1	43	3	3	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0960-7412	1365-313X		PLANT J	Plant J.	NOV	2014	80	4					604	614		10.1111/tpj.12654		11	Plant Sciences	Plant Sciences	AS6KS	WOS:000344373200004		
J	Tanaka, T; Isaka, Y; Hattori, M; Sato, T				Tanaka, Takayuki; Isaka, Yuichi; Hattori, Mitsuru; Sato, Toshiyuki			Ecological and phylogenetic approaches for diversification of apogamous ferns in Japan	PLANT SYSTEMATICS AND EVOLUTION			English	Article						Apogamy; Apomixis; Diversification; Environmental gradient; Fern; Monsoon	EAST-ASIAN MONSOON; POLYSTICHUM DRYOPTERIDACEAE; GEOGRAPHICAL PARTHENOGENESIS; ASEXUAL REPRODUCTION; SEQUENCE DATA; BIODIVERSITY; TOLERANCE; GAMETOPHYTES; SPOROPHYTES; PATTERNS	It has long been argued that related asexual and sexual taxa have different distribution patterns. In general, apomictic angiosperms are believed to occur preferentially at higher latitudes and elevations compared to their sexual relatives. It is thus expected that the frequency of apomixis increases with latitude or from warmer to colder climatic regions. However, despite the significant role played by apogamy in fern evolution and diversification, the distribution pattern of apogamous ferns and lycophytes has received little attention. To clarify the ecological diversity pattern and evolutional diversification of apogamous ferns, we analysed a variety of apogamous fern species with reference to latitude, elevation and climatic factors, and reconstructed the ancestral state and estimated the divergence time of Japanese apogamous ferns. Our results on the distribution of apogamous ferns along these two gradients suggest a decline in the proportion of apogamous ferns towards high latitudes and elevations. Temperature was correlated with the proportion of apogamous ferns along both gradients, and the seasonality of precipitation was correlated with the proportion of apogamous ferns along latitude. Reconstruction of ancestral state and estimates of divergence time showed that the crown groups of apogamous ferns diversified less than 15 Ma. The results of our ecological and phylogenetic approaches reinforce the hypothesis based on previously reported phylogenetic results in which the apogamous ferns appears to be correlated with strongly seasonal climates such as the Asia monsoon.	[Tanaka, Takayuki; Isaka, Yuichi] Shinshu Univ, Interdisciplinary Grad Sch Sci & Technol, Dept Mt & Environm Sci, Matsumoto, Nagano 3908621, Japan; [Hattori, Mitsuru; Sato, Toshiyuki] Shinshu Univ, Dept Biol, Fac Sci, Matsumoto, Nagano 3908621, Japan	Tanaka, T (reprint author), Shinshu Univ, Interdisciplinary Grad Sch Sci & Technol, Dept Mt & Environm Sci, 3-1-1 Asahi, Matsumoto, Nagano 3908621, Japan.	11sc003h@shinshu-u.ac.jp			Nagano Society for The Promotion of Science	We greatly appreciate the valuable suggestions and discussions offered by Associate Professor K. Shimano (Shinshu University) and Associate Professor K. Takahashi (Shinshu University). We also thank Y. Obana and T. Yokoi for the many useful comments on this study. These research results were aided by funding from Nagano Society for The Promotion of Science.	BAKER HG, 1955, EVOLUTION, V9, P347, DOI 10.2307/2405656; Schneller J, 2010, PLANT SYST EVOL, V286, P1, DOI 10.1007/s00606-009-0264-7; Schneider H, 2004, NATURE, V428, P553, DOI 10.1038/nature02361; Tanabe AS, 2011, MOL ECOL RESOUR, V11, P914, DOI 10.1111/j.1755-0998.2011.03021.x; Horandl E, 2011, TAXON, V60, P390; Lu JM, 2006, BOT J LINN SOC, V150, P221, DOI 10.1111/j.1095-8339.2006.00462.x; Little DP, 2003, AM J BOT, V90, P508, DOI 10.3732/ajb.90.3.508; Kelly CK, 1996, PHILOS T R SOC B, V351, P1261, DOI 10.1098/rstb.1996.0109; Chase JM, 2002, NATURE, V416, P427, DOI 10.1038/416427a; van Dijk PJ, 2003, PHILOS T ROY SOC B, V358, P1113, DOI 10.1098/rstb.2003.1302; BAYER RJ, 1983, EVOLUTION, V37, P555, DOI 10.2307/2408268; dos Santos APM, 2012, ANN BOT-LONDON, V110, P667, DOI 10.1093/aob/mcs125; Ohsawa M, 1995, VEGETATIO, V121, P3, DOI 10.1007/BF00044667; Haag CR, 2004, ANN ZOOL FENN, V41, P539; Li CX, 2008, J PLANT RES, V121, P19, DOI 10.1007/s10265-007-0120-1; Qian W, 2002, THEOR APPL CLIMATOL, V73, P151, DOI 10.1007/s00704-002-0679-3; Pearson RG, 2003, GLOBAL ECOL BIOGEOGR, V12, P361, DOI 10.1046/j.1466-822X.2003.00042.x; Kawai H, 2003, NATURE, V421, P287, DOI 10.1038/nature01310; SATO T, 1981, CAN J BOT, V59, P604; Gaston KJ, 2000, NATURE, V405, P220, DOI 10.1038/35012228; HAMILTON WD, 1980, OIKOS, V35, P282, DOI 10.2307/3544435; Wang B, 2002, J CLIMATE, V15, P386, DOI 10.1175/1520-0442(2002)015<0386:RSOTAP>2.0.CO;2; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; Schuettpelz E, 2009, P NATL ACAD SCI USA, V106, P11200, DOI 10.1073/pnas.0811136106; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Wan SM, 2007, PALAEOGEOGR PALAEOCL, V254, P561, DOI 10.1016/j.palaeo.2007.07.009; Takahashi K, 2005, ECOL RES, V20, P445, DOI 10.1007/s11284-005-0060-y; BIERZYCHUDEK P, 1985, EXPERIENTIA, V41, P1255, DOI 10.1007/BF01952068; Grusz AL, 2009, AM J BOT, V96, P1636, DOI 10.3732/ajb.0900019; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Asker S. E., 1992, APOMIXIS PLANTS; Beck JB, 2011, EVOLUTION, V65, P3217, DOI 10.1111/j.1558-5646.2011.01362.x; BELL PR, 1992, INT J PLANT SCI, V153, pS123, DOI 10.1086/297070; Breman JW, 2009, ANN APPL BIOL, V155, P219, DOI 10.1111/j.1744-7348.2009.00332.x; Chao Y-S, 2012, J BOT, V2012, P1; Driscoll HE, 2007, AM J BOT, V94, P1413, DOI 10.3732/ajb.94.8.1413; DVORAK J, 1978, CROP SCI, V18, P477; Ebihara A., 2011, B NATL MUSEUM NATU B, V37, P63; Ebihara A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015136; ESTOQUE MA, 1976, TELLUS, V28, P243; Gabancho LR, 2010, PLANT SYST EVOL, V289, P137, DOI 10.1007/s00606-010-0339-5; Guo QF, 2003, ECOGRAPHY, V26, P129, DOI 10.1034/j.1600-0587.2003.03379.x; Horandl E, 2006, NEW PHYTOL, V171, P525, DOI 10.1111/j.1469-8137.2006.01769.x; Horandl E, 2009, HEREDITY, V103, P445, DOI 10.1038/hdy.2009.85; JAENIKE J, 1978, Evolutionary Theory, V3, P191; Kearney M, 2005, TRENDS ECOL EVOL, V20, P495, DOI 10.1016/j.tree.2005.06.005; Kurata S, 1979, ILLUSTRATIONS PTERID; Liu H, 2012, J BOT, V2012, P1; Lovis J.D., 1977, ADV BOT RES, V4, P229; Lu JM, 2007, SYST BOT, V32, P26, DOI 10.1600/036364407780360193; Maddison W. P., 2001, MESQUITE MODULAR SYS; Mogie M, 1992, EVOLUTION ASEXUAL RE; Mogie M, 2013, BIOL J LINN SOC, V109, P487, DOI 10.1111/bij.12055; MOGIE M, 1990, EVOLUTION, V44, P1707, DOI 10.2307/2409349; Rathinasabapathi B, 2006, NEW PHYTOL, V172, P385, DOI 10.1111/j.1469-8137.2006.01889.x; Sakai A, 1987, FROST SURVIVAL PLANT; SATO T, 1982, OECOLOGIA, V55, P53, DOI 10.1007/BF00386718; Stebbins GL, 1950, VARIATION EVOLUTION; Takamiya M, 1996, INDEX CHROMOSOMES JA; Tanaka T, 2013, PLANT ECOL, V214, P1189, DOI 10.1007/s11258-013-0243-5; WALKER TG, 1985, P ROY SOC EDINB B, V86, P59; Wang L, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-210; WHITTIER D P, 1968, American Fern Journal, V58, P12; WHITTIER DP, 1970, PHYTOMORPHOLOGY, V20, P30; Zhisheng An, 2001, Nature (London), V411, P62, DOI 10.1038/35075035	65	1	1	SPRINGER WIEN	WIEN	SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA	0378-2697	1615-6110		PLANT SYST EVOL	Plant Syst. Evol.	NOV	2014	300	9					2041	2050		10.1007/s00606-014-1036-6		10	Plant Sciences; Evolutionary Biology	Plant Sciences; Evolutionary Biology	AS3KB	WOS:000344175100009		
J	Bai, SL; Saito, T; Honda, C; Hatsuyama, Y; Ito, A; Moriguchi, T				Bai, Songling; Saito, Takanori; Honda, Chikako; Hatsuyama, Yoshimichi; Ito, Akiko; Moriguchi, Takaya			An apple B-box protein, MdCOL11, is involved in UV-B- and temperature-induced anthocyanin biosynthesis	PLANTA			English	Article						Anthocyanin; Apple (Malus x domestica) peel; B-box protein (BBX); MdMYBA; Temperature; Ultra-violet (UV)-B	MYB TRANSCRIPTION FACTOR; GENE-EXPRESSION; PROANTHOCYANIDIN BIOSYNTHESIS; REGULATORY COMPLEX; RED COLORATION; ARABIDOPSIS; LIGHT; HY5; ACCUMULATION; FRUIT	Main conclusion Our studies showed that an apple B-box protein, MdCOL11, the homolog of AtBBX22, is involved in UV-B- and temperature-induced anthocyanin biosynthesis in apple peel. Anthocyanin is responsible for the red pigmentation in apple peel and a R2R3 MYB gene, MdMYBA/1/10, a homolog of MdMYBA, controls its accumulation. Arabidopsis PAP1 is under the control of a series of upstream factors involved in light signal transduction and photomorphogenesis, such as ELONGATED HYPOCOTYL 5 (HY5) and B-box family (BBX) proteins. In this study, we identified and characterized the homolog of Arabidopsis BBX22 in apple, designated as MdCOL11. Overexpression of MdCOL11 in Arabidopsis enhanced the accumulation of anthocyanin. In apples, MdCOL11 was differentially expressed in all tissues, with the highest expression in petals and the lowest expression in the xylem. Transcripts of MdCOL11 noticeably accumulated at the ripening stage, concomitant with increases in the expressions of anthocyanin biosynthesis-related genes. In an in vitro treatment experiment, MdCOL11 was upregulated in an ultra-violet (UV)-B- and temperature-dependent manner, together with the inductions of anthocyanin biosynthesis-related genes and anthocyanin accumulation in apple peel. Furthermore, a dual-luciferase assay indicated that (1) MdCOL11 regulated the expression of MdMYBA and (2) MdCOL11 was a target of MdHY5. Taken together, our results suggest that MdCOL11 is involved in MdHY5-mediated signal transduction and regulates anthocyanin accumulation in apple peel, which sheds new light on anthocyanin accumulation in apples.	[Bai, Songling; Saito, Takanori; Ito, Akiko; Moriguchi, Takaya] NARO Inst Fruit Tree Sci, Tsukuba, Ibaraki 3058605, Japan; [Honda, Chikako] NARO Inst Fruit Tree Sci, Morioka, Iwate 0200123, Japan; [Hatsuyama, Yoshimichi] Aomori Prefectural Ind Technol Res Ctr, Hirosaki Ind Res Inst, Hirosaki, Aomori 0368363, Japan	Moriguchi, T (reprint author), NARO Inst Fruit Tree Sci, Tsukuba, Ibaraki 3058605, Japan.	takaya@affrc.go.jp			Japan Society for the Promotion of Science [24-02214]	We thank Dr. Ting Peng (National Navel Orange Engineering Research Center, College of Navel Orange, Gannan Normal University, China) for her critical assessment and valuable suggestions. This study was partly supported by the Japan Society for the Promotion of Science (No. 24-02214).	Ang LH, 1998, MOL CELL, V1, P213, DOI 10.1016/S1097-2765(00)80022-2; Khanna R, 2009, PLANT CELL, V21, P3416, DOI 10.1105/tpc.109.069088; DIXON RA, 1995, PLANT CELL, V7, P1085, DOI 10.1105/tpc.7.7.1085; Lin-Wang K, 2011, PLANT CELL ENVIRON, V34, P1176, DOI 10.1111/j.1365-3040.2011.02316.x; Chalker-Scott L, 1999, PHOTOCHEM PHOTOBIOL, V70, P1, DOI 10.1562/0031-8655(1999)070<0001:ESOAIP>2.3.CO;2; Cheng FS, 1996, THEOR APPL GENET, V93, P222, DOI 10.1007/BF00225749; Nakagawa T, 2007, J BIOSCI BIOENG, V104, P34, DOI 10.1263/jbb.104.34; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Pang YZ, 2009, PLANT PHYSIOL, V151, P1114, DOI 10.1104/pp.109.144022; Osterlund MT, 2000, NATURE, V405, P462, DOI 10.1038/35013076; Ubi BE, 2006, PLANT SCI, V170, P571, DOI 10.1016/j.plantsci.2005.10.009; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Maier A, 2013, PLANT J, V74, P638, DOI 10.1111/tpj.12153; Koes R, 2005, TRENDS PLANT SCI, V10, P236, DOI 10.1016/j.tplants.2005.03.002; DENG XW, 1991, GENE DEV, V5, P1172, DOI 10.1101/gad.5.7.1172; Bai SL, 2011, J EXP BOT, V62, P4561, DOI 10.1093/jxb/err163; MARTIN C, 1991, PLANT J, V1, P37, DOI 10.1111/j.1365-313X.1991.00037.x; Takos AM, 2006, PLANT PHYSIOL, V142, P1216, DOI 10.1104/pp.106.088104; Akagi T, 2012, PLANT PHYSIOL, V158, P1089, DOI 10.1104/pp.111.191205; Rowan DD, 2009, NEW PHYTOL, V182, P102, DOI 10.1111/j.1469-8137.2008.02737.x; Peng T, 2013, PHYSIOL PLANTARUM, V148, P432, DOI 10.1111/ppl.12002; Steyn WJ, 2009, PHYSIOL PLANTARUM, V136, P461, DOI 10.1111/j.1399-3054.2009.01246.x; Higo K, 1999, NUCLEIC ACIDS RES, V27, P297, DOI 10.1093/nar/27.1.297; Zhang H, 2011, NUCLEIC ACIDS RES, V39, pD1114, DOI 10.1093/nar/gkq1141; Zhang YQ, 2011, J PLANT PHYSIOL, V168, P367, DOI 10.1016/j.jplph.2010.07.025; Xie XB, 2012, PLANT CELL ENVIRON, V35, P1884, DOI 10.1111/j.1365-3040.2012.02523.x; Lescot M, 2002, NUCLEIC ACIDS RES, V30, P325, DOI 10.1093/nar/30.1.325; Lee J, 2007, PLANT CELL, V19, P731, DOI 10.1105/tpc.106.047688; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Ban Y, 2007, PLANT CELL PHYSIOL, V48, P958, DOI 10.1093/pcp/pcm066; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI 10.1093/molbev/mst197; Espley RV, 2009, PLANT CELL, V21, P168, DOI 10.1105/tpc.108.059329; Espley RV, 2007, PLANT J, V49, P414, DOI 10.1111/j.1365-313X.2006.02964.x; Rizzini L, 2011, SCIENCE, V332, P103, DOI 10.1126/science.1200660; Oyama T, 1997, GENE DEV, V11, P2983, DOI 10.1101/gad.11.22.2983; Osterlund MT, 1998, PLANT J, V16, P201, DOI 10.1046/j.1365-313x.1998.00290.x; Velasco R, 2010, NAT GENET, V42, P833, DOI 10.1038/ng.654; Yamane T, 2006, AM J ENOL VITICULT, V57, P54; Ramsay NA, 2005, TRENDS PLANT SCI, V10, P63, DOI 10.1016/j.tplants.2004.12.011; Griffiths S, 2003, PLANT PHYSIOL, V131, P1855, DOI 10.1104/pp.102.016188; Eddy SR, 1998, BIOINFORMATICS, V14, P755, DOI 10.1093/bioinformatics/14.9.755; Holm M, 2002, GENE DEV, V16, P1247, DOI 10.1101/gad.969702; Shin DH, 2013, FEBS LETT, V587, P1543, DOI 10.1016/j.febslet.2013.03.037; Favory JJ, 2009, EMBO J, V28, P591, DOI 10.1038/emboj.2009.4; Lau OS, 2012, TRENDS PLANT SCI, V17, P584, DOI 10.1016/j.tplants.2012.05.004; Catala R, 2011, P NATL ACAD SCI USA, V108, P16475, DOI 10.1073/pnas.1107161108; Chagne D, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-212; Chang CSJ, 2008, PLANT J, V54, P205, DOI 10.1111/j.1365-313X.2008.03401.x; Chang CSJ, 2011, PLANT PHYSIOL, V156, P228, DOI 10.1104/pp.111.175042; Crifo T, 2012, J AGR FOOD CHEM, V60, P476, DOI 10.1021/jf203891e; Datta S, 2008, PLANT CELL, V20, P2324, DOI 10.1105/tpc.108.061747; Datta S, 2007, PLANT CELL, V19, P3242, DOI 10.1105/tpc.107.054791; Fox J, 2005, J STAT SOFTW, V14; Gangappa SN, 2014, TRENDS PLANT SCI, V19, P460, DOI 10.1016/j.tplants.2014.01.010; Gasic K., 2004, Plant Molecular Biology Reporter, V22, P437, DOI 10.1007/BF02772687; Gonzalez A, 2009, NEW PHYTOL, V182, P1, DOI 10.1111/j.1469-8137.2009.02771.x; Li JG, 2010, PLANT CELL, V22, P3634, DOI 10.1105/tpc.110.075788; Shin J, 2007, PLANT J, V49, P981, DOI 10.1111/j.1365-313X.2006.03021.x; Xie L, 2013, PLANT GROWTH REGUL, V69, P295, DOI 10.1007/s10725-012-9772-5	59	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0032-0935	1432-2048		PLANTA	Planta	NOV	2014	240	5					1051	1062		10.1007/s00425-014-2129-8		12	Plant Sciences	Plant Sciences	AR9SC	WOS:000343915200013		
J	Takahashi, A; Umezaki, M; Yoshida, Y; Kuzuya, A; Ohya, Y				Takahashi, Akihiro; Umezaki, Masaya; Yoshida, Yasuyuki; Kuzuya, Akinori; Ohya, Yuichi			A macromolecular prodrug-type injectable polymer composed of poly(depsipeptide-co-lactide)-g-PEG for sustained release of drugs	POLYMERS FOR ADVANCED TECHNOLOGIES			English	Article; Proceedings Paper	12th Conference on Polymers for Advanced Technologies (PAT)	2013	Belin, GERMANY			injectable polymers; macromolecular prodrug; temperature-responsive sol-to-gel transition; controlled release; graft copolymer	POLY(ETHYLENE GLYCOL); BIOMEDICAL MATERIALS; TRIBLOCK COPOLYMERS; HYDROLYTIC DEGRADATION; POLY(PROPYLENE GLYCOL); BIODEGRADABLE POLYMERS; MULTIBLOCK COPOLYMERS; POLY(ESTER URETHANE)S; ANTITUMOR-ACTIVITY; AQUEOUS-SOLUTIONS	We propose a macromolecular prodrug strategy of an injectable polymer (IP) system for continuous and sustained release of water-soluble low-molecular-weight drugs. A biodegradable graft copolymer-type IP covalently immobilizing model drugs via hydrolyzable ester bonds was synthesized through the coupling reaction of poly(depsipeptide-co-dl-lactide), P(DG-dl-LA), having reactive carboxylic acid side-chain groups with the amino derivative of a model drug (levofloxacin [LEV]) and monomethoxy-poly(ethylene glycol) (PEG). The solution of the obtained graft copolymer-type IP/model drug conjugate exhibited a temperature-responsive sol-to-gel transition between room temperature and body temperature in phosphate buffer solution, similar to P(GD-dl-LA)-g-PEG without LEV. The immobilization of the LEV molecule onto P(DG-dl-LA)-g-PEG did not have a significant influence on the sol-to-gel transition behavior, physical properties, or in vitro degradation rates of the hydrogels. The in vitro release of LEV derivatives from the P(DG-dl-LA)-g-PEG/LEV hydrogel in phosphate buffer solution was continuous for 11weeks, which corresponded to the degradation period of the hydrogel, and slower than that from the control hydrogels prepared from P(DG-dl-LA)-g-PEG and PLGA-b-PEG-b-PLGA that physically entrapped LEV molecules. These results suggest that the covalent attachment strategy is effective in achieving sustained release of low-molecular-weight drugs in IP systems and can be applied to drug delivery devices for highly bioactive drugs. Copyright (c) 2014 John Wiley & Sons, Ltd.	[Umezaki, Masaya; Yoshida, Yasuyuki; Kuzuya, Akinori; Ohya, Yuichi] Kansai Univ, Dept Chem & Mat Engn, Fac Chem Mat & Bioengn, Suita, Osaka 5648680, Japan; [Takahashi, Akihiro; Kuzuya, Akinori; Ohya, Yuichi] Kansai Univ, ORDIST, Suita, Osaka 5648680, Japan	Ohya, Y (reprint author), Kansai Univ, Dept Chem & Mat Engn, Fac Chem Mat & Bioengn, 3-3-35 Yamate, Suita, Osaka 5648680, Japan.	yohya@kansai-u.ac.jp					Qiao MX, 2005, INT J PHARM, V294, P103, DOI 10.1016/j.ijpharm.2005.01.017; Nagahama K, 2007, BIOMACROMOLECULES, V8, P3938, DOI 10.1021/bm700921h; Jeong B, 2000, MACROMOLECULES, V33, P8317, DOI 10.1021/ma000638v; Frick A, 1998, EUR J PHARM BIOPHARM, V46, P305, DOI 10.1016/S0939-6411(98)00041-1; Loh XJ, 2007, BIOMATERIALS, V28, P4113, DOI 10.1016/j.biomaterials.2007.05-016; Velthoen IW, 2011, REACT FUNCT POLYM, V71, P245, DOI 10.1016/j.reactfunctpolym.2010.08.007; Hwang MJ, 2005, BIOMACROMOLECULES, V6, P885, DOI 10.1021/bm049347a; Loh XJ, 2008, BIOMATERIALS, V29, P3185, DOI 10.1016/j.biomaterials.2008.04.015; Fujiwara T, 2001, MACROMOL BIOSCI, V1, P204, DOI 10.1002/1616-5195(20010701)1:5<204::AID-MABI204>3.0.CO;2-H; Yu L, 2006, ANGEW CHEM INT EDIT, V45, P2232, DOI 10.1002/anie.200503575; Chung HJ, 2008, J CONTROL RELEASE, V127, P22, DOI 10.1016/j.jconrel.2007.12.008; [Anonymous], 2008, INT J PHARMACEUT; Tasaka F, 2001, MACROMOLECULES, V34, P5494, DOI 10.1021/ma010067m; Moon HJ, 2012, CHEM SOC REV, V41, P4860, DOI 10.1039/c2cs35078e; Loh XJ, 2008, BIOMATERIALS, V29, P2164, DOI 10.1016/j.biomaterials.2008.01.016; Yu L, 2008, CHEM SOC REV, V37, P1473, DOI 10.1039/b713009k; Nagahama K, 2008, J POLYM SCI POL CHEM, V46, P6317, DOI 10.1002/pola.22943; Klouda L, 2008, EUR J PHARM BIOPHARM, V68, P34, DOI 10.1016/j.ejpb.2007.02.025; MATSUMURA Y, 1986, CANCER RES, V46, P6387; Jeong B, 1997, NATURE, V388, P860; Loh XJ, 2007, BIOMACROMOLECULES, V8, P585, DOI 10.1021/bm0607933; Hyun H, 2007, BIOMACROMOLECULES, V8, P1093, DOI 10.1021/bm060771u; Nagahama K, 2013, REACT FUNCT POLYM, V73, P979, DOI 10.1016/j.reactfunctpolym.2012.11.003; Daga A, 2002, GENE THER, V9, P915, DOI 10.1038/sj.gt.3301727; Fish DN, 1997, CLIN PHARMACOKINET, V32, P101, DOI 10.2165/00003088-199732020-00002; Huynh DP, 2006, POLYMER, V47, P7918, DOI 10.1016/j.polymer.2006.09.021; Ichinose K, 2000, ANTI-CANCER DRUG, V11, P33, DOI 10.1097/00001813-200001000-00006; Jeong B, 2000, J CONTROL RELEASE, V63, P155, DOI 10.1016/S0168-3659(99)00194-7; Jeong B, 2001, CHEM COMMUN, P1516, DOI 10.1039/b102819g; Lee DS, 2001, MACROMOL RAPID COMM, V22, P587, DOI 10.1002/1521-3927(20010501)22:8<587::AID-MARC587>3.0.CO;2-8; Lee J, 2006, BIOMACROMOLECULES, V7, P1729, DOI 10.1021/bm0600062; Maeda H., 1989, CRIT REV THER DRUG, V6, P1939; Nagahama K, 2009, POLYMER, V50, P3547, DOI 10.1016/j.polymer.2009.05.045; Nagahama K, 2008, ADV FUNCT MATER, V18, P1220, DOI 10.1002/adfm.200700587; Nguyen Minh Khanh, 2010, Macromol Biosci, V10, P563, DOI 10.1002/mabi.200900402; Ohya Y, 2003, J BIOMED MATER RES A, V65A, P79, DOI 10.1002/jbm.a.10446; OHYA Y, 1991, J CONTROL RELEASE, V17, P259, DOI 10.1016/0168-3659(91)90144-3; OUCHI T, 1995, PROG POLYM SCI, V20, P211, DOI 10.1016/0079-6700(94)00031-V; Ouchi T, 1997, J POLYM SCI POL CHEM, V35, P377; Ouchi T, 1998, J POLYM SCI POL CHEM, V36, P1283, DOI 10.1002/(SICI)1099-0518(199806)36:8<1283::AID-POLA11>3.0.CO;2-2; Park MH, 2012, ACCOUNTS CHEM RES, V45, P424, DOI 10.1021/ar200162j; Takahashi A., 2014, J BIOMAT SCI-POLYM E, V2013, P869150, DOI [10.1080/09205063, DOI 10.1080/09205063.2013]	42	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1042-7147	1099-1581		POLYM ADVAN TECHNOL	Polym. Adv. Technol.	NOV	2014	25	11			SI		1226	1233		10.1002/pat.3265		8	Polymer Science	Polymer Science	AS0UU	WOS:000343994800006		
J	Shiraishi, Y; Akiyama, M; Sato, T; Hattori, M; Komatsu, T				Shiraishi, Yuta; Akiyama, Motofusa; Sato, Takaaki; Hattori, Minoru; Komatsu, Teruyuki			Size-dependent dextran loading in protein nanotube with an interior wall of concanavalin A	POLYMERS FOR ADVANCED TECHNOLOGIES			English	Article; Proceedings Paper	12th Conference on Polymers for Advanced Technologies (PAT)	2013	Belin, GERMANY			dextran; nanotubes; human serum albumin; concanavalin A; layer-by-layer assembly		This paper describes the synthesis and structure of protein nanotube (NT) with a lectin interior surface and its size-dependent dextran loading ability in aqueous medium. The NTs were prepared using an alternating layer-by-layer build-up assembly of poly-l-arginine (PLA) and human serum albumin (HSA) in a track-etched polycarbonate (PC) membrane (pore diameter, 400nm), subsequently coating concanavalin A (ConA) as the last layer. Dissolution of the PC template yielded (PLA/HSA)(2)PLA/ConA NTs with 419 +/- 14nm outer diameter and 50 +/- 7nm wall thickness. In a 2-[4-(2-hydroxyethyl)-1-piperazinyl]ethanesulfonic acid (HEPES) buffered solution, the NTs captured fluorescein isothiocyanate (FITC)-labeled dextran [molecular weight 4kDa, FITC-Dex(4k)] efficiently into the pores. The ratio of the bound FITC-Dex(4kDa)/ConA was estimated to be 2.1 (mol/mol). Two of four glucosyl-residue binding sites of ConA on the wall presumably faced to the aqueous inner phase of the tube, and they can bind FITC-Dex(4k). On the one hand, only half amount of FITC-Dex was loaded into the channels when the molecular weight of the dextran is greater than 20kDa. Small-angle X-ray scattering measurements revealed that the radius of gyration (R-g) of the FITC-Dex(4k) is 1.45nm (5.0mg/ml), which is satisfactorily small to interact with the each binding site of ConA independently. In contrast, the R-g values of FITC-Dex(20k) and FITC-Dex(40k) were 3.75nm (5.0mg/ml) and 6.62nm (4.0mg/ml), respectively. These large dextrans probably formed an equivalent complex with ConA on the tube wall. Copyright (c) 2014 John Wiley & Sons, Ltd.	[Shiraishi, Yuta; Akiyama, Motofusa; Komatsu, Teruyuki] Chuo Univ, Dept Appl Chem, Fac Sci & Engn, Bunkyo Ku, Tokyo 1128551, Japan; [Sato, Takaaki; Hattori, Minoru] Shinshu Univ, Fac Text Sci & Technol, Div Chem & Mat, Ueda, Nagano 3868567, Japan	Komatsu, T (reprint author), Chuo Univ, Dept Appl Chem, Fac Sci & Engn, Bunkyo Ku, 1-13-27 Kasuga, Tokyo 1128551, Japan.	komatsu@kc.chuo-u.ac.jp	Akiyama, Motofusa/E-4101-2015				Komatsu T, 2011, J AM CHEM SOC, V133, P3246, DOI 10.1021/ja1096122; Komatsu T, 2011, CHEM-EUR J, V17, P1849, DOI 10.1002/chem.201001937; Naismith JH, 1996, J BIOL CHEM, V271, P972; Qu X, 2010, ACS NANO, V4, P563, DOI 10.1021/nn901474y; Azzaroni O, 2011, SOFT MATTER, V7, P8709, DOI 10.1039/c1sm05561e; Tian Y, 2006, BIOMACROMOLECULES, V7, P2539, DOI 10.1021/bm0604121; Shimizu T, 2008, B CHEM SOC JPN, V81, P1554, DOI 10.1246/bcsj.81.1554; Landoulsi J, 2009, BIOMACROMOLECULES, V10, P1021, DOI 10.1021/bm900245h; Hou SF, 2005, NANO LETT, V5, P231, DOI 10.1021/nl048305p; Yu AM, 2005, CHEM MATER, V17, P171, DOI 10.1021/cm048659h; Reches M, 2006, NAT NANOTECHNOL, V1, P195, DOI 10.1038/nnano.2006.139; Komatsu T, 2012, NANOSCALE, V4, P1910, DOI 10.1039/c1nr11224d; Bouckaert J, 2000, J BIOL CHEM, V275, P19778, DOI 10.1074/jbc.M001251200; Duff MR, 2006, ANGEW CHEM INT EDIT, V45, P137, DOI 10.1002/anie.200502344; Komatsu T, 2011, POLYM ADVAN TECHNOL, V22, P1315, DOI 10.1002/pat.1921; Lacowicz J. R., 1993, ANAL CHIM ACTA, V271, P155	16	3	3	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1042-7147	1099-1581		POLYM ADVAN TECHNOL	Polym. Adv. Technol.	NOV	2014	25	11			SI		1247	1251		10.1002/pat.3299		5	Polymer Science	Polymer Science	AS0UU	WOS:000343994800009		
J	Muller, AJ; Lorenzo, AT; Hirao, A				Mueller, Alejandro J.; Lorenzo, Arnaldo T.; Hirao, Akira			Crystallization behavior of polyethylene/polystyrene A(m)B(n) miktoarm star copolymers	POLYMERS FOR ADVANCED TECHNOLOGIES			English	Article; Proceedings Paper	12th Conference on Polymers for Advanced Technologies (PAT)	2013	Belin, GERMANY			polyethylene block copolymers; miktoarm star copolymers; crystallization	BENZYL BROMIDE MOIETIES; BLOCK-COPOLYMERS; FRACTIONATED CRYSTALLIZATION; POLYMER CRYSTALLIZATION; THERMAL FRACTIONATION; TRIBLOCK COPOLYMERS; BRANCHED POLYMERS; POLYSTYRENE; NUCLEATION; ARCHITECTURE	A(m)B(n) miktoarm star copolymers composed of polyethylene (PE) and polystyrene (PS) arms were synthesized by the Pd-catalyzed hydrogenation of A(m)B(n) miktoarm stars consisting of PS and polybutadiene obtained by means of living anionic polymerization. From transmission electron microscopy, it was found that the (PSm)-b-(PEn) miktoarm star copolymer samples exhibited more confined morphologies than those expected for their PS-b-PE linear diblock analogs, a result that indicated more entropic restrictions for chain stretching in the stars. This enhancement in confinement produced by the change in chain topology strongly affected the overall crystallization kinetics of the PE component, especially when it constituted the minor phase. As confinement increased, the supercooling needed for crystallization increased, and the Avrami index was dramatically reduced, since nucleation became the rate-determining step of the overall crystallization process. Copyright (c) 2014 John Wiley & Sons, Ltd.	[Mueller, Alejandro J.] Univ Basque Country UPV EHU, Fac Chem, Inst Polymer Mat POLYMAT, Donostia San Sebastian 20018, Spain; [Mueller, Alejandro J.] Univ Basque Country UPV EHU, Fac Chem, Polymer Sci & Technol Dept, Donostia San Sebastian 20018, Spain; [Mueller, Alejandro J.] Ikerbasque, Basque Fdn Sci, E-48011 Bilbao, Spain; [Mueller, Alejandro J.; Lorenzo, Arnaldo T.] Univ Simon Bolivar, Dept Ciencia Mat, Grp Polimeros USB, Caracas 1080A, Venezuela; [Hirao, Akira] Tokyo Inst Technol, Grad Sch Sci & Engn, Dept Organ & Polymer Mat Dept, Meguro Ku, Tokyo 1528552, Japan; [Hirao, Akira] Natl Taiwan Univ, Inst Polymer Sci & Engn, Taipei 10617, Taiwan; [Hirao, Akira] Soochow Univ, Coll Chem Chem Engn & Mat Sci, Suzhou 215123, Peoples R China	Muller, AJ (reprint author), Univ Basque Country UPV EHU, Fac Chem, Inst Polymer Mat POLYMAT, Paseo Manuel de Lardizabal 3, Donostia San Sebastian 20018, Spain.	alejandrojesus.muller@ehu.es	Lorenzo, Arnaldo /G-5932-2010; Muller, Alejandro/A-1415-2008	Lorenzo, Arnaldo /0000-0002-4524-3626; Muller, Alejandro/0000-0001-7009-7715			Allgaier J, 1996, MACROMOLECULES, V29, P1794, DOI 10.1021/ma951356b; Dyer C, 2013, MACROMOLECULES, V46, P2023, DOI 10.1021/ma202650a; Castillo RV, 2009, PROG POLYM SCI, V34, P516, DOI 10.1016/j.progpolymsci.2009.03.002; Arnal ML, 1998, MACROMOL CHEM PHYSIC, V199, P2275, DOI 10.1002/(SICI)1521-3935(19981001)199:10<2275::AID-MACP2275>3.3.CO;2-R; Cai YL, 2005, MACROMOLECULES, V38, P271, DOI 10.1021/ma048511j; Liu H, 2007, J POLYM SCI POL CHEM, V45, P1446, DOI 10.1002/pola.21915; DELACRUZ MO, 1986, MACROMOLECULES, V19, P2501; Galante MJ, 1996, J THERM ANAL, V47, P913, DOI 10.1007/BF01979439; Babin J, 2008, MACROMOLECULES, V41, P1384, DOI 10.1021/ma702071y; Lorenzo AT, 2006, MACROMOL CHEM PHYS, V207, P39, DOI 10.1002/macp.200500437; Balsamo V, 2004, EUR POLYM J, V40, P1033, DOI 10.1016/j.eurpolymj.2004.01.009; Michell RM, 2013, POLYMER, V54, P4059, DOI 10.1016/j.polymer.2013.05.029; Khanna K, 2010, POLYM CHEM-UK, V1, P1171, DOI 10.1039/c0py00082e; Hadjichristidis N, 2005, PROG POLYM SCI, V30, P725, DOI 10.1016/j.progpolymsci.2005.04.001; Zhang WD, 2009, J POLYM SCI POL CHEM, V47, P6908, DOI 10.1002/pola.23730; Lorenzo AT, 2007, POLYM TEST, V26, P222, DOI 10.1016/j.polymertesting.2006.10.005; FILLON B, 1993, J POLYM SCI POL PHYS, V31, P1383, DOI 10.1002/polb.1993.090311013; Pispas S, 2000, MACROMOLECULES, V33, P1741, DOI 10.1021/ma991636h; Hirao A, 2002, MACROMOLECULES, V35, P7224, DOI 10.1021/ma0202888; Muller AJ, 2005, PROG POLYM SCI, V30, P559, DOI 10.1016/j.progpolymsci.2005.03.001; Muller AJ, 2011, EUR POLYM J, V47, P614, DOI 10.1016/j.eurpolymj.2010.09.027; Isono T, 2013, MACROMOLECULES, V46, P1461, DOI 10.1021/ma3026578; Muller AJ, 2005, ADV POLYM SCI, V190, P1, DOI 10.1007/12_001; MILNER ST, 1994, MACROMOLECULES, V27, P2333, DOI 10.1021/ma00086a057; Barner L., 2008, MACROMOL RAPID COMM, V29, P539; Gao HF, 2006, MACROMOLECULES, V39, P3154, DOI 10.1021/ma060223v; Hadjichristidis N., 2002, BLOCK COPOLYMERS SYN; Hamley IW, 1998, PHYS BLOCK COPOLYMER; Hawker C. J., 2001, CHEM REV, V101, P3664; Hirao A, 2003, MACROMOLECULES, V36, P9742, DOI 10.1021/ma035264v; Hsieh H. L., 1996, ANIONIC POLYM PRINCI, P333; Huang CI, 2010, MACROMOLECULES, V43, P9117, DOI 10.1021/ma100765t; Lee W, 2002, J POLYM SCI POL PHYS, V40, P519, DOI 10.1002/polb.10121; Li QB, 2006, BIOMACROMOLECULES, V7, P2377, DOI 10.1021/bm060372l; Lorenzo AT, 2007, J POLYM SCI POL CHEM, V45, P5387, DOI 10.1002/pola.22283; Lorenzo AT, 2009, MACROMOLECULES, V42, P8353, DOI 10.1021/ma901289t; Lorenzo AT, 2008, J POLYM SCI POL PHYS, V46, P1478, DOI 10.1002/polb.21483; Mandelkern L., 2004, PHYS PROPERTIES POLY; Muller Alejandro J, 2009, Macromolecular Symposia, V277, DOI 10.1002/masy.200950325; Muller AJ, 2013, HANDBOOK OF POLYMER CRYSTALLIZATION, P347; Muller A. J., 2007, LECT NOTE PHYS, V714; Muller AJ, 2002, MACROMOLECULES, V35, P3048, DOI 10.1021/ma012026w; Shultz J. M., 2001, POLYM CRYSTALLIZATIO; Tselikas Y, 1996, J CHEM PHYS, V105, P2456, DOI 10.1063/1.472113; Wu Z. M., 2010, J POLYM SCI A, V48, P3223; Zhang YF, 2009, J POLYM SCI POL CHEM, V47, P3066, DOI 10.1002/pola.23388	46	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1042-7147	1099-1581		POLYM ADVAN TECHNOL	Polym. Adv. Technol.	NOV	2014	25	11			SI		1257	1263		10.1002/pat.3308		7	Polymer Science	Polymer Science	AS0UU	WOS:000343994800011		
J	Aoto, K; Dufour, P; Yang, HY; Glatz, JP; Kim, Y; Ashurko, Y; Hill, R; Uto, N				Aoto, Kazumi; Dufour, Philippe; Yang Hongyi; Glatz, Jean Paul; Kim, Yeong-il; Ashurko, Yury; Hill, Robert; Uto, Nariaki			A summary of sodium-cooled fast reactor development	PROGRESS IN NUCLEAR ENERGY			English	Article						Sodium-Cooled Fast Reactor; Closed fuel cycle; Minor actinide management; Improved safety performance; Long term development experience; Generation IV International Forum		Much of the basic technology for the Sodium-cooled fast Reactor (SFR) has been established through long term development experience with former fast reactor programs, and is being confirmed by the Phenix end-of-life tests in France, the restart of Monju in Japan, the lifetime extension of BN-600 in Russia, and the startup of the China Experimental Fast Reactor in China. Planned startup in 2014 for new SFRs: BN-800 in Russia and PFBR in India, will further enhance the confirmation of the SFR basic technology. Nowadays, the SFR development has advanced to aiming at establishment of the Generation-IV system which is dedicated to sustainable energy generation and actinide management, and several advanced SFR concepts are under development such as PRISM, JSFR, ASTRID, PGSFR, BN-1200, and CFR-600. Generation-IV International Forum is an international collaboration framework where various R&D activities are progressing on design of system and component, safety and operation, advanced fuel, and actinide cycle for the Generation-IV SFR development, and will play a beneficial role of promoting them thorough providing an opportunity to share the past experience and the latest data of design and R&D among countries developing SFR. (C) 2014 Elsevier Ltd. All rights reserved.	[Aoto, Kazumi] Japan Atom Energy Agcy, Chiyoda Ku, Tokyo 1008577, Japan; [Dufour, Philippe] French Alternat Energies & Atom Energy Commiss CE, Cadarache, France; [Yang Hongyi] CIAE, Beijing, Peoples R China; [Glatz, Jean Paul] European Commiss, Joint Res Ctr, Karlsruhe, Germany; [Kim, Yeong-il] Korea Atom Energy Res Inst, Taejon, South Korea; [Ashurko, Yury] Inst Phys & Power Engn, Obninsk, Russia; [Hill, Robert] Argonne Natl Lab, Argonne, IL 60439 USA; [Uto, Nariaki] Japan Atom Energy Agcy, Oarai, Ibaraki, Japan	Aoto, K (reprint author), Japan Atom Energy Agcy, Chiyoda Ku, 2-2-2 Uchisaiwai, Tokyo 1008577, Japan.	aoto.kazumi@jaea.go.jp					[Anonymous], 1994, NUREG1368; Tsuboi Y, 2012, NUCL TECHNOL, V178, P201; Aoto K., 2013, P INT C FAST REACT R; Cacuci D. G, 2010, HDB NUCL ENG; Coz P.L., 2013, P 2013 INT C ADV NUC; Hahn D., 2012, GIF S P SAN DIEG CAL; International Atomic Energy Agency, 2006, IAEATECDOC1531; International Atomic Energy Agency, 2012, IAEATECDOC1691; International Atomic Energy Agency, 2007, HYDR PROD OTH IND AP; Kim Y.I., 2013, P INT C FAST REACT R; Kondo S., 2013, P INT C FAST REACT R; Seong S.H., 2013, T KOR NUCL SOC AUT M; United Kingdom Nuclear Decommissioning Authority, 2014, SMSTSB1PLUT002A UK N; United States Nuclear Regulatory Commission, 1983, NUREG0968; Vasilyev B.A., 2013, P INT C FAST REACT R	15	2	2	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0149-1970			PROG NUCL ENERG	Prog. Nucl. Energy	NOV	2014	77						247	265		10.1016/j.pnucene.2014.05.008		19	Nuclear Science & Technology	Nuclear Science & Technology	AS3WT	WOS:000344206700025		
J	Futterer, MA; Fu, L; Sink, C; de Groot, S; Pouchon, M; Kim, YW; Carre, F; Tachibana, Y				Futterer, Michael A.; Fu, Li; Sink, Carl; de Groot, Sander; Pouchon, Manuel; Kim, Yong Wan; Carre, Frank; Tachibana, Yukio			Status of the very high temperature reactor system	PROGRESS IN NUCLEAR ENERGY			English	Article						Generation IV international forum; Very high temperature reactor; Materials; Fuel; Hydrogen production; International cooperation	HTR-PM; EXPERIENCE; PROJECT	The purpose of this paper is to provide an update on the international effort in the development of the Very High Temperature Reactor system pursued through international collaboration in the Generation IV International Forum (GIF) and an outlook for further activities. The initial motivations to develop this reactor type are recalled, a historical overview is given about technology developments and test reactors since 1945 and several of the targeted non-electric applications of VHTR power are addressed. Cooperation in the frame of GIF is clearly beneficial for all project partners. Initially, a wealth of historical experience was collected and shared in the form of documents, dedicated workshops or fuel and material samples. This exchange included properties data, fabrication, irradiation and post-irradiation testing methods, quality assurance, design and analysis tools and methods, as well as the experience in building and operating related equipment. In the further course of the project execution, time, effort and scarce facilities (such as irradiation space or hot cell equipment) are shared, they accelerate progress and create synergies. Recent highlights from currently active GIF VHTR R&D projects (Materials, Fuel and Fuel Cycle, Hydrogen Production) are then provided and placed into the context of the GIF VHTR signatories' national programs. The majority of these currently focus on licensing requirements for demonstrators of near term process steam production scenarios while more aggressive, longer term and higher temperature applications are mainly pursued to enable thermochemical production of bulk hydrogen. Based on the VHTR's high technology readiness level, orientations for future R&D are outlined which would contribute to enhancing the system's market readiness level. These include work on System Integration and Assessment, Safety Analysis and Demonstration, Waste Minimization and Cost Reductions. The inherent safety characteristics of the VHTR are a precious asset for it to become a strong response to today's concerns of nuclear safety, energy security and climate change. (C) 2014 Published by Elsevier Ltd.	[Futterer, Michael A.] Inst Energy & Transport, Joint Res Ctr, Commiss European Communities, NL-1755 ZG Petten, Netherlands; [Fu, Li] Tsinghua Univ, INEI, Beijing 100084, Peoples R China; [Sink, Carl] US DOE, Washington, DC 20585 USA; [de Groot, Sander] NRG, NL-1755 ZG Petten, Netherlands; [Pouchon, Manuel] Paul Scherrer Inst, CH-5232 Villigen, Switzerland; [Kim, Yong Wan] Korea Atom Energy Res Inst, Taejon 305353, South Korea; [Carre, Frank] CEA, F-91191 Gif Sur Yvette, France; [Tachibana, Yukio] JAEA, Oarai, Ibaraki 3111393, Japan	Futterer, MA (reprint author), Inst Energy & Transport, Joint Res Ctr, Commiss European Communities, NL-1755 ZG Petten, Netherlands.	michael.fuetterer@ec.europa.eu; lifu@mail.tsinghua.edu.cn; carl.sink@nuclear.energy.gov; s.degroot@nrg.eu; manuel.pouchon@psi.ch; ywkim@kaeri.re.kr; franck.carre@cea.fr; tachibana.yukio@jaea.gojp	Pouchon, Manuel Alexandre/J-7213-2015				Angulo C, 2012, NUCL ENG DES, V251, P30, DOI 10.1016/j.nucengdes.2011.12.025; Zhang ZY, 2006, NUCL ENG DES, V236, P485, DOI 10.1016/j.nucengdes.2005.11.024; BAUMER R, 1991, ENERGY, V16, P59, DOI 10.1016/0360-5442(91)90087-3; Kunitomi K, 2004, NUCL ENG DES, V233, P309, DOI 10.1016/j.nucengdes.2004.08.026; Zhang ZY, 2009, NUCL ENG DES, V239, P1212, DOI 10.1016/j.nucengdes.2009.02.023; [Anonymous], 2012, INLEXT1226732; [Anonymous], 1988, HOCHT MOD KRAFTW KUR; REUTLER H, 1984, NUCL ENG DES, V78, P129, DOI 10.1016/0029-5493(84)90298-X; Beck J.M., 2010, INLEXT1019329; Bredimas A., 2012, P HTR 2012 TOK JAP O; GIF Technology Roadmap, 2013, GIF TECHN R IN PRESS; HARTH R, 1990, NUCL ENG DES, V121, P173, DOI 10.1016/0029-5493(90)90102-4; Hino R., 2011, NUCL HYDROGEN PRODUC; Konefal J., 2008, MPR3181; Kunitomi K., 2013, TWGGCR M IAEA; LaBar MP, 2002, GAA23952; Lommers LJ, 2012, NUCL ENG DES, V251, P292, DOI 10.1016/j.nucengdes.2011.10.030; Matzner D., 2008, FUTURE ENERGY; Neef J., 1979, NUCL ENGRG DES, V54, P157; Pohl P., 2008, NEA173902 OECDNEA; Price MST, 2012, NUCL ENG DES, V251, P60, DOI 10.1016/j.nucengdes.2011.12.024; SCHULTEN R, 1976, CHEM-ING-TECH, V48, P375, DOI 10.1002/cite.330480507; Shropshire D., 2013, P JOINT NEA IAEA EXP; Styring P., 2011, CARBON CAPTURE UTILI; Thomas S, 2011, ENERG POLICY, V39, P2431, DOI 10.1016/j.enpol.2011.01.066; Uranium 2011, 2012, RES PROD DEM JOINT R; Verfondern K., 2007, IAEA P IAEA CN 152 5; Verfondern K., 2007, IAEA P IAEA CN 152 1; Wu ZX, 2002, NUCL ENG DES, V218, P25, DOI 10.1016/S0029-5493(02)00182-6; Yujie Dong, 2012, IAEA COURS HIGH TEMP, P22	30	3	3	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0149-1970			PROG NUCL ENERG	Prog. Nucl. Energy	NOV	2014	77						266	281		10.1016/j.pnucene.2014.01.013		16	Nuclear Science & Technology	Nuclear Science & Technology	AS3WT	WOS:000344206700026		
J	Schulenberg, T; Leung, LKH; Oka, Y				Schulenberg, Thomas; Leung, Laurence K. H.; Oka, Yoshiaki			Review of R&D for supercritical water cooled reactors	PROGRESS IN NUCLEAR ENERGY			English	Article						Conceptual design; Supercritical water; Materials; Heat transfer; Fuel qualification		The Supercritical Water-Cooled Reactor (SCWR) is a high temperature, high pressure water-cooled reactor that operates above the thermodynamic critical point (374 degrees C, 22.1 MPa) of water. In general terms, the conceptual designs of SCWRs can be grouped into two main categories: pressure vessel concepts proposed first by Japan and more recently by a Euratom partnership, and pressure tube concepts proposed by Canada, generically called the Canadian SCWR. Other than the specifics of the core design, these concepts have many similar features, like outlet pressure and temperatures, steam cycle options, materials, or heat transfer characteristics. Therefore, the R&D needs for each reactor type are common, which enables collaborative research to be pursued. The paper provides an overview on research and development performed so far on the SCWR within the Generation IV International Forum. (C) 2014 Elsevier Ltd. All rights reserved.	[Schulenberg, Thomas] Karlsruhe Inst Technol, D-76021 Karlsruhe, Germany; [Leung, Laurence K. H.] Atom Energy Canada Ltd, Ottawa, ON K1A 0S4, Canada; [Oka, Yoshiaki] Waseda Univ, Tokyo, Japan	Schulenberg, T (reprint author), Karlsruhe Inst Technol, D-76021 Karlsruhe, Germany.	schulenberg@kit.edu; leungl@aecl.ca; okay@waseda.jp			European Commission as part of their project SCWR-FQT [269908]; SUSEN Project of the European Regional Development Fund (ERDF) [CZ.1.05/2.1.00/03.0108]; Natural Resources Canada through the Office of Energy Research and Development; Atomic Energy of Canada Limited; Natural Sciences and Engineering Research Council of Canada; Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT)	Work related to the FQT loop was has been partially financially supported by the European Commission as part of their project SCWR-FQT, contract number 269908, and by the SUSEN Project CZ.1.05/2.1.00/03.0108 realized in the framework of the European Regional Development Fund (ERDF).; Funding to the Canada Gen-IV National Program was provided by Natural Resources Canada through the Office of Energy Research and Development, Atomic Energy of Canada Limited, and Natural Sciences and Engineering Research Council of Canada.; Japanese studies of the paper are financially supported by the projects of "Research and Development of the Super Fast Reactor" entrusted to University of Tokyo between 2005 and 2010 and Waseda University between 2010 and 2014 by the Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT).	[Anonymous], 2002, US DOE NUCL EN RES A; [Anonymous], 2010, JAPAN J          DEC, P26; Guzonas DA, 2012, CORROS SCI, V65, P48, DOI 10.1016/j.corsci.2012.08.006; T'Joen C, 2012, NUCL ENG DES, V242, P221, DOI 10.1016/j.nucengdes.2011.10.055; Boczar G.P., 2002, IAEATECDOC1319, P10; Chandra L., 2010, P NUTHOS 8 SHANGH CH; Chow C.K., 2007, P 3 INT S SCWR DES T; Duffey R.B., 2003, P IAEA CN 108 5P IAE; Dyck G.R., 2004, P PAC BAS NUCL C TEC; Guzonas D., 2008, P INT C WAT CHEM NUC; Higuchi S., 2010, P ICAPP10 SAN DIEG J; Hopwood J.M., 2006, P PAC BAS NUCL C SYD, P42; Hyland B., 2009, P GLOB 2009 PAR FRAN; Jeddi L., 2011, P 5 INT S SCWR ISSCW; Kaneda J., 2007, P ICAPP 2007 NIC FRA; Komita H., 2003, NURETH10 SEOUL OCT 5; Liu Q., 2013, P GLOB 2013 SALT LAK; Magill M., 2011, P 5 INT S SCWR ISSCW; McDonald M. H., 2011, P 5 INT S SCWR ISSCW; Nava-Dominguez A., 2013, P 6 INT S SUP WAT CO; Oka Y, 2010, SUPER LIGHT WATER REACTORS AND SUPER FAST REACTORS: SUPERCRITICAL-PRESSURE LIGHT WATER COOLED REACTORS, P1, DOI 10.1007/978-1-4419-6035-1; Oka Y., 2013, ISSCWR 6 SHENGZH CHI; Oka Y., 2000, SCR 2000 TOK NOV 6 8; Pioro I.L., 2008, P 6 INT C HEAT TRANS; Roelofs F., 2011, P NURETH 14 TOR ONT; Ruzickova M., 2011, P ISSCWR 5 VANC BRIT; Sakurai S., 2009, P GLO 2009 SEPT 6 11; Schulenberg T., 2013, P ISSCWR 6 SHENZH GU; Schulenberg T., 2012, HIGH PERFORMANCE LIG; Shan J., 2011, P 5 INT S SCWR ISSCW; Wu Gang, 2011, Nuclear Engineering and Design, V241, DOI 10.1016/j.nucengdes.2011.07.007; Wu J, 2014, NUCL ENG DES, V267, P100, DOI 10.1016/j.nucengdes.2013.12.002; Wu J., 2013, J NUCL SCI TEC UNPUB; Yetisir M., 2013, P 6 INT S SUP WAT CO	34	2	2	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0149-1970			PROG NUCL ENERG	Prog. Nucl. Energy	NOV	2014	77						282	299		10.1016/j.pnucene.2014.02.021		18	Nuclear Science & Technology	Nuclear Science & Technology	AS3WT	WOS:000344206700027		
J	Alemberti, A; Smirnov, V; Smith, CF; Takahashi, M				Alemberti, Alessandro; Smirnov, Valery; Smith, Craig F.; Takahashi, Minoru			Overview of lead-cooled fast reactor activities	PROGRESS IN NUCLEAR ENERGY			English	Review						LFR; Lead; Fast reactors		The lead-cooled fast reactor (LFR) features a fast neutron spectrum, high temperature operation, and cooling by molten lead or lead-bismuth eutectic (LBE), low-pressure, chemically inert liquids with very good thermodynamic properties. It would have multiple applications including production of electricity, hydrogen and process heat. System concepts represented in plans of the Generation IV International Forum (GIF) System Research Plan (SRP) are based on Europe's ELFR lead-cooled system, Russia's BREST-OD-300 and the SSTAR system concept designed in the US. The LFR has excellent materials management capabilities since it operates in the fast neutron spectrum and uses a closed fuel cycle enhanced by the fertile conversion of uranium. It can also be used as a burner to consume actinides from spent LWR fuel and as a burner/breeder with thorium matrices. An important feature of the LFR is the enhanced safety that results from the choice of molten lead as a chemically inert and low-pressure coolant. In terms of sustainability, lead is abundant and hence available, even in case of deployment of a large number of reactors. More importantly, as with other fast systems, fuel sustainability is greatly enhanced by the conversion capabilities of the LFR fuel cycle. Because they incorporate a liquid coolant with a very high margin to boiling and benign interaction with air or water, LFR concepts offer substantial potential in terms of safety, design simplification, proliferation resistance and the resulting economic performance. An important factor is the potential for benign end state to severe accidents. The LFR has development needs in the areas of fuels, materials performance, and corrosion control. During the next 5 years progress is expected on materials, system design, and operating parameters. Significant test and demonstration activities are underway and planned during this time frame. (C) 2013 Elsevier Ltd. All rights reserved.	[Alemberti, Alessandro] Ansaldo Nucl, Genoa, Italy; [Smirnov, Valery] NIKIET, Moscow, Russia; [Smith, Craig F.] Naval Postgrad Sch, Monterey, CA USA; [Takahashi, Minoru] Tokyo Inst Technol, Tokyo 152, Japan	Alemberti, A (reprint author), Ansaldo Nucl, Genoa, Italy.	alessandro.alemberti@ann.ansaldo.it; sval@nikiet.ru; cfsmith@nps.edu; mtakahas@nr.titech.acjp					Alemberti, 2013, INT C FAST REACT NUC; Alemberti, 2012, IAEA TECHN M IMP FUK; Alemberti Alessandro, 2013, GIF S P; Takahashi M, 2005, PROG NUCL ENERG, V47, P190, DOI 10.1016/j.pnucene.2005.05.020; Artioli C, 2010, ANN NUCL ENERGY, V37, P915, DOI 10.1016/j.anucene.2010.03.016; Cinotti L., 2008, P INT C PHYS REACT P; De Bruyn Didier, 2007, ACCAPP07; GIF-LFR Provisional System Steering Committee (PSSC), 2013, SYST RES PL IN PRESS; Hwang I.S., 2006, ICAPP 06 REN NV US J; Kim W.J., 2006, ICAPP 06 REN NV US J; Sekimoto H., 2008, P WORKSH ADV REACT I; Short M.P., 2010, MITANPTR131; Smith CF, 2008, J NUCL MATER, V376, P255, DOI 10.1016/j.jnucmat.2008.02.049; Smith R.R., 1978, INT S DES CONSTR OP; Takahashi M., 2012, 11 LFR PROV SSC M FI; Toshinsky G.I., 2011, P ICAPP 2011 NIC FRA; U.S. Nuclear Energy Research Advisory Committee (NERAC) Generation IV International Forum (GIF), 2002, GIF00200 NERAC; Waltar Alan E., 2012, FAST SPECTUM REACTOR; Wu Y, 2013, INT C FAST REACT REL	19	4	4	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0149-1970			PROG NUCL ENERG	Prog. Nucl. Energy	NOV	2014	77						300	307		10.1016/j.pnucene.2013.11.011		8	Nuclear Science & Technology	Nuclear Science & Technology	AS3WT	WOS:000344206700028		
J	Serp, J; Allibert, M; Benes, O; Delpech, S; Feynberg, O; Ghetta, V; Heuer, D; Holcomb, D; Ignatiev, V; Kloosterman, JL; Luzzi, L; Merle-Lucotte, E; Uhlir, J; Yoshioka, R; Dai, ZM				Serp, Jerome; Allibert, Michel; Benes, Ondrej; Delpech, Sylvie; Feynberg, Olga; Ghetta, Veronique; Heuer, Daniel; Holcomb, David; Ignatiev, Victor; Kloosterman, Jan Leen; Luzzi, Lelio; Merle-Lucotte, Elsa; Uhlir, Jan; Yoshioka, Ritsuo; Dai Zhimin			The molten salt reactor (MSR) in generation IV: Overview and perspectives	PROGRESS IN NUCLEAR ENERGY			English	Article						Molten salt reactor; Gen IV; Nuclear systems; Neutronic performance; Fuel cycle	HIGH-TEMPERATURE REACTOR; FUEL-CYCLE; CORE PHYSICS; THORIUM; DESIGN; SYSTEM	Molten Salt Reactors (MSR) with the fuel dissolved in the liquid salt and fluoride-salt-cooled High-temperature Reactors (FHR) have many research themes in common. This paper gives an overview of the international R&D efforts on these reactor types carried out in the framework of Generation-IV. Many countries worldwide contribute to this reactor technology, among which the European Union, France, Japan, Russia and the USA, and for the past few years China and India have also contributed. In general, the international R&D focuses on three main lines of research. The USA focuses on the FHR, which will be a nearer-term application of liquid salt as a reactor coolant, while China also focuses on solid fuel reactors as a precursor to molten salt reactors with liquid fuel and a thermal neutron spectrum. The EU, France and Russia are focusing on the development of a fast spectrum molten salt reactor capable of either breeding or transmutation of actinides from spent nuclear fuel. Future research topics focus on liquid salt technology and materials behavior, the fuel and fuel cycle chemistry and modeling, and the numerical simulation and safety design aspects of the reactor. MSR development attracts more and more attention every year, because it is generally considered as most sustainable of the six Generation-IV designs with intrinsic safety features. Continuing joint efforts are needed to advance common molten salt reactor technologies. (C) 2014 Elsevier Ltd. All rights reserved.	[Serp, Jerome] CEA Marcoule, Radiochem & Proc Dept, Nucl Energy Div, SCPS LEPS, F-30207 Bagnols Sur Ceze, France; [Benes, Ondrej] Commiss European Communities, Joint Res Ctr, Inst Transuranium Elements, D-76125 Karlsruhe, Germany; [Delpech, Sylvie] Univ Paris, IPNO, Grp Radiochim, F-91406 Orsay, France; [Allibert, Michel; Ghetta, Veronique; Heuer, Daniel; Merle-Lucotte, Elsa] UJF Grenoble, INP, IN2P3 CNRS, LPSC, F-38026 Grenoble, France; [Holcomb, David] Oak Ridge Natl Lab, Oak Ridge, TN USA; [Ignatiev, Victor] Kurchatov Inst, Natl Res Ctr, Moscow, Russia; [Kloosterman, Jan Leen] Delft Univ Technol, Dept Radiat Sci & Technol, NL-2629 JB Delft, Netherlands; [Luzzi, Lelio] Politecn Milan, Dept Energy, Nucl Engn Div, I-20133 Milan, Italy; [Uhlir, Jan] Res Ctr Rez, CZ-25068 Rez, Czech Republic; [Yoshioka, Ritsuo] Int Thorium Molten Salt Forum, Tokyo, Japan; [Dai Zhimin] Chinese Acad Sci, Shanghai 201800, Peoples R China	Serp, J (reprint author), CEA Marcoule, Radiochem & Proc Dept, Nucl Energy Div, SCPS LEPS, F-30207 Bagnols Sur Ceze, France.	jerome.serp@cea.fr; mallibert@orange.fr; ondrej.benes@ec.europa.eu; delpech@ipno.in2p3.fr; olga.fein@yandex.ru; Veronique.Ghetta@lpsc.in2p3.fr; Daniel.Heuer@lpsc.in2p3.fr; HolcombDE@oml.gov; ignatiev@vver.kiae.ru; J.L.Kloosterman@tudelft.nl; lelio.luzzi@polimi.it; elsa.merle@lpsc.in2p3.fr; jan.Uhlir@cvrez.cz; yoshioka@nifty.ne.jp; daizm@sinap.ac.cn					Anheier N.C., 2013, PNNL22622; Fiorina C, 2013, PROG NUCL ENERG, V68, P153, DOI 10.1016/j.pnucene.2013.06.006; MACPHERSON HG, 1985, NUCL SCI ENG, V90, P374; Fiorina C, 2014, ANN NUCL ENERGY, V64, P485, DOI 10.1016/j.anucene.2013.08.003; Mathieu L, 2009, NUCL SCI ENG, V161, P78; Yoder GL, 2014, ANN NUCL ENERGY, V64, P511, DOI 10.1016/j.anucene.2013.08.008; Furukawa K, 2008, ENERG CONVERS MANAGE, V49, P1832, DOI 10.1016/j.enconman.2007.09.027; Ignatiev V, 2014, ANN NUCL ENERGY, V64, P408, DOI 10.1016/j.anucene.2013.09.004; Zagnit'ko AV, 2012, RUSS J PHYS CHEM A+, V86, P533, DOI 10.1134/S0036024412040322; Benes O, 2009, J FLUORINE CHEM, V130, P22, DOI 10.1016/j.jfluchem.2008.07.014; [Anonymous], 2013, COMMUNICATION; Forsberg C, 2005, PROG NUCL ENERG, V47, P32, DOI 10.1016/j.pnucene.2005.05.002; [Anonymous], 2011, [No title captured], Patent No. 1158572; LeBlanc D, 2010, NUCL ENG DES, V240, P1644, DOI 10.1016/j.nucengdes.2009.12.033; Hargraves R, 2010, AM SCI, V98, P304; Delpech S, 2009, J FLUORINE CHEM, V130, P11, DOI 10.1016/j.jfluchem.2008.07.009; Ignatiev VV, 2012, ATOM ENERGY+, V112, P157, DOI 10.1007/s10512-012-9537-2; Delpech S, 2013, PURE APPL CHEM, V85, P71, DOI 10.1351/PAC-CON-12-04-06; Aufiero M., 2013, CHEM ENG SCI UNPUB; Aufiero M, 2013, J NUCL MATER, V441, P473, DOI 10.1016/j.jnucmat.2013.06.026; Aufiero M, 2014, ANN NUCL ENERGY, V65, P78, DOI 10.1016/j.anucene.2013.10.015; Baldwin C.A., 2012, P HTR 2012 TOK JAP O; Benes O., 2012, NUCL MAT, V3, P359; BETTIS ES, 1957, NUCL SCI ENG, V2, P804; Briggs R B, 1966, ORNL3936; Brovchenko M., 2013, THESIS GRENOBLE I TE; Brovchenko M, 2013, NUCL SCI ENG, V175, P329; Brovchenko M., 2012, PHYSOR 2012 ADV REAC; Delpech S., 2010, MATER TODAY, V13, P36; Doligez X, 2014, ANN NUCL ENERGY, V64, P430, DOI 10.1016/j.anucene.2013.09.009; Engel J.R., 1980, ORNLTM7207; Engel J.R., 1979, ORNLTM6415; Guerrieri C., 2012, P 20 INT C NUCL ENG; Haubenreich Paul N., 1970, NUCL APPL TECHNOL, V8; Heuer D, 2014, ANN NUCL ENERGY, V64, P421, DOI 10.1016/j.anucene.2013.08.002; Holcomb D. E., 2013, ORNLTM2013401; Ignatiev V., 2012, MAT PERFORMANCE CORR, V5, P221; Ignatiev V., 2007, P ICAPP, P7548; Ignatiev V, 2013, J NUCL MATER, V441, P592, DOI 10.1016/j.jnucmat.2013.05.007; Katoh Y., 2013, J NUCL MAT; Vergnes J, 2002, NUCL ENG DES, V216, P43, DOI 10.1016/S0029-5493(02)00026-2; Mathieu L, 2006, PROG NUCL ENERG, V48, P664, DOI 10.1016/j.pnucene.2006.07.005; McNeese L.E., 1971, ORNLTM3137; Merle-Lucotte E., 2013, P INT C FAST REACT R; Mitachi K., 2013, AUT M AESJ, pG08; Nagy K., 2012, THESIS TU DELFT NETH; Renault C., 2005, 0305ST101 MOST EUR C; Rosenthal M.W., 1970, NUCL APPL TECHNOL, V8, P102; Rubiolo P., 2013, P INT C MOLT SALTS N; Uhlff J., 2012, P ICAPP 12 CHIC US J; Uhlir J., 2013, P THEC 2013 GEN SWIT; U.S. Atomic Energy Commission Division of Reactor Technology, 1972, WASH, P3; Varma V. K., 2012, ORNLTM2012320; Yoshioka R., 2013, MOLTEN SALTS CHEM LA	54	11	12	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0149-1970			PROG NUCL ENERG	Prog. Nucl. Energy	NOV	2014	77						308	319		10.1016/j.pnucene.2014.02.014		12	Nuclear Science & Technology	Nuclear Science & Technology	AS3WT	WOS:000344206700029		
J	Myo, T; Kikuchi, Y; Mosui, H; Kato, K				Myo, Takayuki; Kikuchi, Yuma; Mosui, Hiroshi; Kato, Kiyoshi			Recent development of complex scaling method for many-body resonances and continua in light nuclei	PROGRESS IN PARTICLE AND NUCLEAR PHYSICS			English	Review						Complex scaling method; Resonances; Level density; Extended completeness relation; Halo nuclei	INTERACTION CROSS-SECTIONS; SCALED SPECTRUM COMPLETENESS; GAUSSIAN EXPANSION METHOD; NEUTRON HALO NUCLEI; SHELL-MODEL; LEVEL DENSITY; GROUND-STATE; O-16(P,GAMMA)F-17 REACTION; MATTER DISTRIBUTION; DISPERSION FORMULA	The complex scaling method (CSM) is a useful similarity transformation of the Schrodinger equation, in which bound-state spectra are not changed but continuum spectra are separated into resonant and non-resonant continuum ones. Because the asymptotic wave functions of the separated resonant states are regularized by the CSM, many-body resonances can be obtained by solving an eigenvalue problem with the L-2 basis functions. Applying this method to a system consisting of a core and valence nucleons, we investigate many-body resonant states in weakly bound nuclei very far from the stability lines. Non-resonant continuum states are also obtained with the discretized eigenvalues on the rotated branch cuts. Using these complex eigenvalues and eigenstates in CSM, we construct the extended completeness relations and Green's functions to calculate strength functions and breakup cross sections. Various kinds of theoretical calculations and comparisons with experimental data are presented. (C) 2014 Elsevier B.V. All rights reserved.	[Myo, Takayuki] Osaka Inst Technol, Fac Engn, Osaka 5358585, Japan; [Myo, Takayuki] Osaka Univ, RCNP, Ibaraki 5670047, Japan; [Kikuchi, Yuma] RIKEN, Inst Phys & Chem Res, Nishina Ctr Accelerator Based Sci, Wako, Saitama 3510198, Japan; [Mosui, Hiroshi] Kitami Inst Technol, Informat Proc Ctr, Kitami, Hokkaido 0908507, Japan; [Kato, Kiyoshi] Hokkaido Univ, Fac Sci, Nucl React Data Ctr, Sapporo, Hokkaido 0600810, Japan	Myo, T (reprint author), Osaka Inst Technol, Fac Engn, Asahi Ku, 5-16-1 Omiya, Osaka 5358585, Japan.	myo@ge.oitac.jp					Abu-Ibrahim B, 2009, J PHYS SOC JPN, V78, DOI 10.1143/JPSJ.78.044201; Adahchour A, 2006, PHYS LETT B, V639, P447, DOI 10.1016/j.physletb.2006.05.092; AJZENBERGSELOVE F, 1987, NUCL PHYS A, V475, P1, DOI 10.1016/0375-9474(87)90205-3; Akaishi Y, 2004, NUCL PHYS A, V738, P80, DOI 10.1016/j.nuclphysa.2004.04.015; Alkhazov GD, 1997, PHYS REV LETT, V78, P2313, DOI 10.1103/PhysRevLett.78.2313; SIMON B, 1972, COMMUN MATH PHYS, V27, P1, DOI 10.1007/BF01649654; AGUILAR J, 1971, COMMUN MATH PHYS, V22, P269, DOI 10.1007/BF01877510; ZHUKOV MV, 1993, PHYS REP, V231, P151, DOI 10.1016/0370-1573(93)90141-Y; Rotureau J, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.110603; Nielsen E, 2001, PHYS REP, V347, P373, DOI 10.1016/S0370-1573(00)00107-1; Carbonell J, 2014, PROG PART NUCL PHYS, V74, P55, DOI 10.1016/j.ppnp.2013.10.003; Kikuchi Y, 2011, PHYS REV C, V84, DOI 10.1103/PhysRevC.84.064610; Ho YK, 2012, FEW-BODY SYST, V53, P437, DOI 10.1007/s00601-012-0320-7; Aumann T, 1999, PHYS REV C, V59, P1252, DOI 10.1103/PhysRevC.59.1252; BERTULANI CA, 1988, PHYS REP, V163, P299, DOI 10.1016/0370-1573(88)90142-1; Mougeot X, 2012, PHYS LETT B, V718, P441, DOI 10.1016/j.physletb.2012.10.054; WIGNER EP, 1947, PHYS REV, V72, P29, DOI 10.1103/PhysRev.72.29; KANADA H, 1979, PROG THEOR PHYS, V61, P1327, DOI 10.1143/PTP.61.1327; NEWTON RG, 1960, J MATH PHYS, V1, P319, DOI 10.1063/1.1703665; Michel N, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.042502; Simon H, 1999, PHYS REV LETT, V83, P496, DOI 10.1103/PhysRevLett.83.496; Efros VD, 2007, J PHYS G NUCL PARTIC, V34, pR459, DOI 10.1088/0954-3899/34/12/R02; Myo T, 2007, PHYS REV C, V76, DOI 10.1103/PhysRevC.76.024305; Kobayashi N, 2012, PHYS REV C, V86, DOI 10.1103/PhysRevC.86.054604; Siegert AJF, 1939, PHYS REV, V56, P750, DOI 10.1103/PhysRev.56.750; Kikuchi Y, 2013, PHYS REV C, V87, DOI 10.1103/PhysRevC.87.034606; Kurokawa C, 2007, NUCL PHYS A, V792, P87, DOI 10.1016/j.nuclphysa.2007.05.007; AJZENBERGSELOVE F, 1986, NUCL PHYS A, V460, P1, DOI 10.1016/0375-9474(86)90038-2; Morlock R, 1997, PHYS REV LETT, V79, P3837, DOI 10.1103/PhysRevLett.79.3837; Odsuren M, 2014, PHYS REV C, V89, DOI 10.1103/PhysRevC.89.034322; Kruppa AT, 2014, PHYS REV C, V89, DOI 10.1103/PhysRevC.89.014330; Sanchez R, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.033002; AUSTERN N, 1987, PHYS REP, V154, P125, DOI 10.1016/0370-1573(87)90094-9; BALSLEV E, 1971, COMMUN MATH PHYS, V22, P280, DOI 10.1007/BF01877511; Kiselev OA, 2005, EUR PHYS J A, V25, P215, DOI 10.1140/epjad/i2005-06-156-3; Myo T, 2012, PHYS REV C, V85, DOI 10.1103/PhysRevC.85.034338; Suzuki R, 2005, PROG THEOR PHYS, V113, P1273, DOI 10.1143/PTP.113.1273; Myo T, 2008, PROG THEOR PHYS, V119, P561, DOI 10.1143/PTP.119.561; Itoh M, 2011, PHYS REV C, V84, DOI 10.1103/PhysRevC.84.054308; HUMBLET J, 1961, NUCL PHYS, V26, P529, DOI 10.1016/0029-5582(61)90207-3; Nakamura T, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.262501; TANG YC, 1978, PHYS REP, V47, P167, DOI 10.1016/0370-1573(78)90175-8; SHLOMO S, 1992, NUCL PHYS A, V539, P17, DOI 10.1016/0375-9474(92)90233-A; Kapur PL, 1938, PROC R SOC LON SER-A, V166, P0277, DOI 10.1098/rspa.1938.0093; Dobrovolsky AV, 2006, NUCL PHYS A, V766, P1, DOI 10.1016/j.nuclphysa.2005.11.016; Hagen G, 2009, PHYS REV C, V80, DOI 10.1103/PhysRevC.80.021306; Zinser M, 1997, NUCL PHYS A, V619, P151, DOI 10.1016/S0375-9474(97)00134-6; Kruppa AT, 1999, PHYS REV A, V59, P3556, DOI 10.1103/PhysRevA.59.3556; SHIMOURA S, 1995, PHYS LETT B, V348, P29, DOI 10.1016/0370-2693(95)00131-4; SCHMID EW, 1961, NUCL PHYS, V26, P463, DOI 10.1016/0029-5582(61)90105-5; Tanihata I, 2013, PROG PART NUCL PHYS, V68, P215, DOI 10.1016/j.ppnp.2012.07.001; CSOTO A, 1994, PHYS REV C, V49, P3035, DOI 10.1103/PhysRevC.49.3035; FANO U, 1961, PHYS REV, V124, P1866, DOI 10.1103/PhysRev.124.1866; Hiyama E, 2003, PROG PART NUCL PHYS, V51, P223, DOI 10.1016/S0146-6410(03)00082-6; VOLKOV AB, 1965, NUCL PHYS, V74, P33, DOI 10.1016/0029-5582(65)90244-0; Tanaka K, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.062701; Michel N, 2003, PHYS REV C, V67, DOI 10.1103/PhysRevC.67.054311; Skaza F, 2006, PHYS REV C, V73, DOI 10.1103/PhysRevC.73.044301; Okolowicz J, 2003, PHYS REP, V374, P271, DOI 10.1016/S0370-1573(02)00366-6; Myo T, 1998, PROG THEOR PHYS, V99, P801, DOI 10.1143/PTP.99.801; Pieper SC, 2001, ANNU REV NUCL PART S, V51, P53, DOI 10.1146/annurev.nucl.51.101701.132506; TANIHATA I, 1985, PHYS REV LETT, V55, P2676, DOI 10.1103/PhysRevLett.55.2676; Myo T, 2011, PHYS REV C, V84, DOI 10.1103/PhysRevC.84.064306; Aoyama S, 2006, PROG THEOR PHYS, V116, P1, DOI 10.1143/PTP.116.1; Yamada T, 2008, PROG THEOR PHYS, V120, P1139, DOI 10.1143/PTP.120.1139; Ozawa A, 2001, NUCL PHYS A, V693, P32, DOI 10.1016/S0375-9474(01)01152-6; Baroni S, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.022505; Aoyama S., 1995, Progress of Theoretical Physics, V93, DOI 10.1143/PTP.93.99; Arai K, 1999, PHYS REV C, V60; Bachelet C, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.182501; Baye D, 1998, PHYS REV C, V58, P545, DOI 10.1103/PhysRevC.58.545; Beck F, 2007, PHYS LETT B, V645, P128, DOI 10.1016/j.physletb.2006.12.036; Bennaceur K, 2000, NUCL PHYS A, V671, P203, DOI 10.1016/S0375-9474(99)00851-9; Berggren T, 1996, PHYS LETT B, V373, P1, DOI 10.1016/0370-2693(96)00132-3; BERGGREN T, 1968, NUCL PHYS A, VA109, P265, DOI 10.1016/0375-9474(68)90593-9; BERGGREN T, 1970, PHYS LETT B, VB 33, P547, DOI 10.1016/0370-2693(70)90344-8; BERGGREN T, 1993, PHYS REV C, V47, P768, DOI 10.1103/PhysRevC.47.768; Betan RI, 2004, PHYS LETT B, V584, P48, DOI 10.1016/j.physletb.2004.01.042; Betan RI, 2003, PHYS REV C, V67, DOI 10.1103/PhysRevC.67.014322; Betan RMI, 2014, PHYS LETT B, V730, P18, DOI 10.1016/j.physletb.2014.01.020; BLUE RA, 1965, PHYS REV, V137, pB284, DOI 10.1103/PhysRev.137.B284; BOCHKAREV OV, 1989, NUCL PHYS A, V505, P215, DOI 10.1016/0375-9474(89)90371-0; Bohm A., 1978, LECT NOTES PHYS, V78; Charity RJ, 2011, PHYS REV C, V84, DOI 10.1103/PhysRevC.84.014320; Charity RJ, 2010, PHYS REV C, V82, DOI 10.1103/PhysRevC.82.041304; Chulkov C.V., 2005, NUCL PHYS A, V759, P43; DETERAMOND GF, 1987, PHYS REV C, V36, P691; Dufour M, 2005, PHYS REV C, V72, DOI 10.1103/PhysRevC.72.015801; Egorova I.A., 2012, PHYS REV LETT, V109; ESBENSEN H, 1992, NUCL PHYS A, V542, P310, DOI 10.1016/0375-9474(92)90219-A; Furutani H., 1980, PROG THEOR PHYS SUPP, V68, P193, DOI 10.1143/PTPS.68.193; Garrido E., 2003, NUCL PHYS A, V722, P221; Gaudefroy L, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.202503; Gel'fand I. M., 1961, GEN FUNCTIONS, V4; Giraud BG, 2003, ANN PHYS-NEW YORK, V308, P115, DOI 10.1016/S0003-4916(03)00134-9; Giraud BG, 2004, J PHYS A-MATH GEN, V37, P11575, DOI 10.1088/0305-4470/37/48/004; Goldzak T, 2010, PHYS REV A, V82, DOI 10.1103/PhysRevA.82.052105; Goldzak T, 2012, MOL PHYS, V110, P537, DOI 10.1080/00268976.2012.662599; Griiebler W., 1975, NUCL PHYS A, V242, P265; GYARMATI B, 1971, NUCL PHYS A, VA160, P523, DOI 10.1016/0375-9474(71)90095-9; GYARMATI B, 1972, PHYS LETT B, VB 41, P110, DOI 10.1016/0370-2693(72)90438-8; CSOTO A, 1990, PHYS REV A, V41, P3469, DOI 10.1103/PhysRevA.41.3469; Hagen G, 2007, PHYS LETT B, V656, P169, DOI 10.1016/j.physletb.2007.07.072; Hagen G, 2004, J PHYS A-MATH GEN, V37, P8991, DOI 10.1088/0305-4470/37/38/006; Hagen G, 2005, PHYS REV C, V71, DOI 10.1103/PhysRevC.71.044314; Hagino K, 2009, PHYS REV C, V80, DOI 10.1103/PhysRevC.80.031301; Hagino K, 2005, PHYS REV C, V72, DOI 10.1103/PhysRevC.72.044321; HASEGAWA A, 1971, PROG THEOR PHYS, V45, P1786, DOI 10.1143/PTP.45.1786; Hatano N., ARXIV14056683; HO YK, 1983, PHYS REP, V99, P1, DOI 10.1016/0370-1573(83)90112-6; Homma M, 1997, PROG THEOR PHYS, V97, P561, DOI 10.1143/PTP.97.561; Hoop B., 1966, NUCL PHYS, V83, P65; Horiuchi H, 2012, PROG THEOR PHYS SUPP, P1; Horiuchi W, 2013, PHYS REV C, V87, DOI 10.1103/PhysRevC.87.034001; Betan RI, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.042501; Ieki K., 1993, PHYS REV LETT, V70, P730; Igashira M., 1995, ASTRON J, V441, pL89; Ikeda K, 2004, NUCL PHYS A, V738, P73, DOI 10.1016/j.nuclphysa.2004.04.014; Iwata Y, 2000, PHYS REV C, V62; Jaganathen Y, 2012, J PHYS CONF SER, V403, DOI 10.1088/1742-6596/403/1/012022; JOHNSON CH, 1967, PHYS REV, V162, P890, DOI 10.1103/PhysRev.162.890; KAMIMURA M, 1986, PROG THEOR PHYS SUPP, P1; Kanada-En'yo Y, 2007, PHYS REV C, V76, DOI 10.1103/PhysRevC.76.044323; KANEKO T, 1991, PHYS REV C, V44, P1588, DOI 10.1103/PhysRevC.44.1588; Kanungo, 2011, PHYS REV C, V84; Kato K., 2010, AIP C P, V1238, P181; Kato K, 1999, PROG THEOR PHYS, V101, P119, DOI 10.1143/PTP.101.119; Keeley N, 2007, PHYS LETT B, V646, P222, DOI 10.1016/j.physletb.2007.01.035; KIENER J, 1991, PHYS REV C, V44, P2195, DOI 10.1103/PhysRevC.44.2195; Kikuchi Y, 2010, PHYS REV C, V81, DOI 10.1103/PhysRevC.81.044308; Kikuchi Y, 2013, PHYS REV C, V88, DOI 10.1103/PhysRevC.88.021602; Kikuchi Y, 2009, PROG THEOR PHYS, V122, P499; Klaiman S, 2010, J PHYS B-AT MOL OPT, V43, DOI 10.1088/0953-4075/43/18/185205; Klaiman S, 2011, J CHEM PHYS, V134, DOI 10.1063/1.3577997; Korsheninnikov AA, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.082501; Kruppa A.T., 1998, PHYS LETT B, V431, P384; Kruppa AT, 2007, PHYS REV C, V75, DOI 10.1103/PhysRevC.75.044602; KRUPPA AT, 1988, PHYS REV C, V37, P383, DOI 10.1103/PhysRevC.37.383; Kukulin V.I., 1984, NUCL PHYS A, V417, P128; Lane A.M., 1958, REV MOD PHYS, V30, P257; Levine R.D., 1969, QUANTUM MECH MOL RAT, P101; Mahaux C., 1969, SHELL MODEL APPROACH; Masui H, 2000, NUCL PHYS A, V673, P207, DOI 10.1016/S0375-9474(00)00148-2; Masui H, 2006, PHYS REV C, V73, DOI 10.1103/PhysRevC.73.034318; Masui H, 2014, PHYS REV C, V89, DOI 10.1103/PhysRevC.89.044317; Masui H, 2012, NUCL PHYS A, V895, P1, DOI 10.1016/j.nuclphysa.2012.09.004; Masui H, 2007, PHYS REV C, V75, DOI 10.1103/PhysRevC.75.034316; Matsumoto T, 2010, PHYS REV C, V82, DOI 10.1103/PhysRevC.82.051602; Matsuo M, 2005, PHYS REV C, V71, DOI 10.1103/PhysRevC.71.064326; Maurin K, 1968, GEN EIGENFUNCTION EX; Michel N, 2004, PHYS REV C, V70, DOI 10.1103/PhysRevC.70.064313; Michel N., 2008, J PHYS G, V36; Moiseyev N., 1998, Physics Reports, V302, DOI 10.1016/S0370-1573(98)00002-7; Moiseyev N, 2011, NONHERMITIAN QUANTUM; Mueller P, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.252501; Myo T, 2011, PHYS REV C, V84, DOI 10.1103/PhysRevC.84.034315; Myo T, 2003, PHYS LETT B, V576, P281, DOI 10.1016/j.physletb.2003.10.011; Myo T, 2005, PROG THEOR PHYS, V113, P763, DOI 10.1143/PTP.113.763; Myo T, 2007, PHYS REV C, V76, DOI 10.1103/PhysRevC.76.054309; Myo T, 2012, PHYS REV C, V86, DOI 10.1103/PhysRevC.86.024318; Myo T, 2009, PHYS REV C, V80, DOI 10.1103/PhysRevC.80.014315; Myo T, 2001, PHYS REV C, V63, DOI 10.1103/PhysRevC.63.054313; Myo T, 2010, PHYS LETT B, V691, P150, DOI 10.1016/j.physletb.2010.06.034; Myo T, 2009, PROG THEOR PHYS, V121, P511, DOI 10.1143/PTP.121.511; Nakada H, 2006, NUCL PHYS A, V764, P117, DOI 10.1016/j.nuclphysa.2005.09.007; Nakamura T, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.252502; Ogata K, 2013, PHYS REV C, V88, DOI 10.1103/PhysRevC.88.024616; Ogawa Y, 2006, PHYS REV C, V73, DOI 10.1103/PhysRevC.73.034301; Ohtsubo S., 2013, PHYS, V2013; OSBORN TA, 1976, ANN PHYS-NEW YORK, V101, P119, DOI 10.1016/0003-4916(76)90277-3; Puchalski M, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.133001; ROBERTSON RGH, 1981, PHYS REV LETT, V47, P1867, DOI 10.1103/PhysRevLett.47.1867; ROMO WJ, 1968, NUCL PHYS A, VA116, P617, DOI 10.1016/0375-9474(68)90395-3; Saito S., 1977, PROG THEOR PHYS    S, V62, P11, DOI 10.1143/PTPS.62.11; SCHMELZB.PA, 1972, NUCL PHYS A, VA184, P193, DOI 10.1016/0375-9474(72)90453-8; Stammbach Th., 1972, NUCL PHYS A, V180, P225; STRUTINS.VM, 1967, NUCL PHYS A, VA 95, P420, DOI 10.1016/0375-9474(67)90510-6; Sugimoto S, 2004, NUCL PHYS A, V740, P77, DOI 10.1016/j.nuclphysa.2004.05.009; Suzuki R, 2008, PROG THEOR PHYS, V119, P949, DOI 10.1143/PTP.119.949; SUZUKI Y, 1988, PHYS REV C, V38, P410, DOI 10.1103/PhysRevC.38.410; Takechi M, 2012, PHYS LETT B, V707, P357, DOI 10.1016/j.physletb.2011.12.028; TANIHATA I, 1992, PHYS LETT B, V289, P261, DOI 10.1016/0370-2693(92)91216-V; Tanihata I, 1996, J PHYS G NUCL PARTIC, V22, P157, DOI 10.1088/0954-3899/22/2/004; TANIHATA I, 1988, PHYS LETT B, V206, P592, DOI 10.1016/0370-2693(88)90702-2; Taylor J.R., 1972, SCATTERING THEORY, P249; Tilley D.R., 1993, NUCL PHYS A, V565, P1; Tostevin JA, 1997, NUCL PHYS A, V616, pC418; TSANG TY, 1975, NUCL PHYS A, V247, P43, DOI 10.1016/0375-9474(75)90275-4; Volya A, 2006, PHYS REV C, V74, DOI 10.1103/PhysRevC.74.064314; Volya A, 2009, PHYS REV C, V79, DOI 10.1103/PhysRevC.79.044308; Wang J, 2002, PHYS REV C, V65, DOI 10.1103/PhysRevC.65.034306; Yahiro M., 2012, PROG THEOR EXP PHYS; Yamamoto K, 2009, PROG THEOR PHYS, V121, P375, DOI 10.1143/PTP.121.375; Zei'dovich Ya.B., 1961, SOV PHYS JETP, V12	194	9	9	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0146-6410	1873-2224		PROG PART NUCL PHYS	Prog. Part. Nucl. Phys.	NOV	2014	79						1	56		10.1016/j.ppnp.2014.08.001		56	Physics, Nuclear; Physics, Particles & Fields	Physics	AS7NL	WOS:000344442500001		
J	Mori, T; Ootani, W				Mori, T.; Ootani, W.			Flavour violating muon decays	PROGRESS IN PARTICLE AND NUCLEAR PHYSICS			English	Review						Muon; Flavour; Rare decay; Experimental method; Lepton flavour violation	SEARCH; CONVERSION; E(+)GAMMA; DETECTOR; PHYSICS; MESON; MU(+); LIMIT	We review experimental searches for flavour violating muon decays that are strongly suppressed to negligible levels in the standard model but are predicted to occur at measurable rates in many of the proposed new physics scenarios. Present and future experimental programs are presented and discussed together with newly developed experimental techniques that enable these experiments to explore extremely rare processes. (C) 2014 Elsevier B.V. All rights reserved.	[Mori, T.; Ootani, W.] Univ Tokyo, Int Ctr Elementary Particle Phys, Bunkyo Ku, Tokyo 1130033, Japan	Mori, T (reprint author), Univ Tokyo, Int Ctr Elementary Particle Phys, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.	mori@icepp.s.u-tokyo.ac.jp			JSPS KAKENHI [22000004, 26000004]	We wish to thank S. Mihara and H. Nishiguchi for their useful comments, and R. Sawada for preparing a few inspiring figures. This work was supported by JSPS KAKENHI Grant Numbers 22000004 and 26000004.	Adam J, 2013, EUR PHYS J C, V73, DOI 10.1140/epjc/s10052-013-2365-2; Adam J, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.171801; Adinolfl M., 2002, NUCL INSTRUM METH A, V448, P51; Ahmed M, 2002, PHYS REV D, V65, DOI 10.1103/PhysRevD.65.112002; Amaldi U., 1991, PPE91233 CERN; Isidori G, 2007, PHYS REV D, V75, DOI 10.1103/PhysRevD.75.115019; FUKUGITA M, 1986, PHYS LETT B, V174, P45, DOI 10.1016/0370-2693(86)91126-3; Feldman GJ, 1998, PHYS REV D, V57, P3873, DOI 10.1103/PhysRevD.57.3873; Bennett GW, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.161802; Marciano WJ, 2008, ANNU REV NUCL PART S, V58, P315, DOI 10.1146/annurev.nucl.58.110707.171126; BELLGARDT U, 1988, NUCL PHYS B, V299, P1, DOI 10.1016/0550-3213(88)90462-2; ALBRECHT H, 1987, PHYS LETT B, V192, P245, DOI 10.1016/0370-2693(87)91177-4; Bertl W, 2006, EUR PHYS J C, V47, P337, DOI 10.1140/epjc/s2006-02582-x; BOUCHIAT C, 1957, PHYS REV, V106, P170, DOI 10.1103/PhysRev.106.170; CHRISTENSON JH, 1964, PHYS REV LETT, V13, P138, DOI 10.1103/PhysRevLett.13.138; Brooks ML, 1999, PHYS REV LETT, V83, P1521, DOI 10.1103/PhysRevLett.83.1521; KOBAYASHI M, 1973, PROG THEOR PHYS, V49, P652, DOI 10.1143/PTP.49.652; GLASHOW SL, 1970, PHYS REV D, V2, P1285, DOI 10.1103/PhysRevD.2.1285; Raidal M, 2008, EUR PHYS J C, V57, P13, DOI 10.1140/epjc/s10052-008-0715-2; AMALDI U, 1991, PHYS LETT B, V260, P447, DOI 10.1016/0370-2693(91)91641-8; Adam J, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.201801; Bernstein RH, 2013, PHYS REP, V532, P27, DOI 10.1016/j.physrep.2013.07.002; Hagiwara K, 2011, J PHYS G NUCL PARTIC, V38, DOI 10.1088/0954-3899/38/8/085003; Grossheim A, 2009, PHYS REV D, V80, DOI 10.1103/PhysRevD.80.052012; Antognini A, 2013, SCIENCE, V339, P417, DOI 10.1126/science.1230016; Kuno Y, 2001, REV MOD PHYS, V73, P151, DOI 10.1103/RevModPhys.73.151; Czarnecki A, 2011, PHYS REV D, V84, DOI 10.1103/PhysRevD.84.013006; Antusch S, 2006, J HIGH ENERGY PHYS, DOI 10.1088/1126-6708/2006/11/090; Aubert B, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.021802; Bachman M., 1997, BNL PROPOSAL E, V940; Baldini A., 2002, RES PROPOSAL INFN; Baldini A. M., 2013, ARXIV13017225 MEG II; Barbieri R., 1995, NUCL PHYS B, V445, P219; Barbieri R., 1994, PHYS LETT B, V338, P212; Bennett GW, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.101804; Bennett G.W., 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.129903; Beringer J., 2012, PHYS REV D, V86; BERTL W, 1985, NUCL PHYS B, V260, P1, DOI 10.1016/0550-3213(85)90308-6; Cheng C.-h., 2013, ARXIV13097679; COMET collaboration, 2014, COMET PHAS 1 TECHN D; COMET collaboration, PROP J PARC 50 GEV P; Czarnecki A, 1998, AIP CONF PROC, V435, P409, DOI 10.1063/1.56214; de Gouvea A, 2010, ANNU REV NUCL PART S, V60, P513, DOI 10.1146/annurev-nucl-100809-131949; DeeMe Collaboration, 2010, DEEME KEK J PARC PRO; Derwent P., 2013, PROJECT IMPROVEMENT; DZHILKIBAEV RM, 1989, SOV J NUCL PHYS+, V49, P384; Gell-Mann M., 1979, SUPERGRAVITY; Hayasaka K, 2008, PHYS LETT B, V666, P16, DOI 10.1016/j.physletb.2008.06.056; Hisano J., 1995, PHYS REV D, V59; Kaulard J, 1998, PHYS LETT B, V422, P334, DOI 10.1016/S0370-2693(97)01423-8; Kettle P.-R., 2010, LTP FILZB M JUN; Kitano R, 2002, PHYS REV D, V66, DOI 10.1103/PhysRevD.66.096002; Koike M, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.121601; Kuno Y., 2006, J PARC LETT INTENT; Kuno Y., 2013, PROG THEOR EXP PHYS; Kuno Y, 1997, PHYS REV D, V55, pR2517; MICHEL L, 1950, P PHYS SOC LOND A, V63, P514, DOI 10.1088/0370-1298/63/5/311; Mihara S, 2013, ANNU REV NUCL PART S, V63, P531, DOI 10.1146/annurev-nucl-102912-144530; Mori T., 1999, RES PROPOSAL P SCHER; Mu2e Collaboration, 2014, ARXIV12117019 MU2E; Mu3e Collaboration, 2012, RES PROP PSI; Bennett GW, 2006, PHYS REV D, V73, DOI 10.1103/PhysRevD.73.072003; Nishiguchi H., 2014, 37 INT C HIGH EN PHY; Peric I, 2007, NUCL INSTRUM METH A, V582, P876, DOI 10.1016/j.nima.2007.07.115; PIFER AE, 1976, NUCL INSTRUM METHODS, V135, P39, DOI 10.1016/0029-554X(76)90823-5; Stoykov A., 2011, 6 INT C NEW DEV PHOT; Stoykov A, 2012, NUCL INSTRUM METH A, V695, P202, DOI 10.1016/j.nima.2011.11.011; van der Schaaf A., 1998, COMMUNICATION; Wilmann L., 1999, PHYS REV LETT, V82, P49; Yanagida T., 1979, P WORKSH UN THEOR BA	70	3	3	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0146-6410	1873-2224		PROG PART NUCL PHYS	Prog. Part. Nucl. Phys.	NOV	2014	79						57	94		10.1016/j.ppnp.2014.09.001		38	Physics, Nuclear; Physics, Particles & Fields	Physics	AS7NL	WOS:000344442500002		
J	Namekata, K; Kimura, A; Kawamura, K; Harada, C; Harada, T				Namekata, Kazuhiko; Kimura, Atsuko; Kawamura, Kazuto; Harada, Chikako; Harada, Takayuki			Dock GEFs and their therapeutic potential: Neuroprotection and axon regeneration	PROGRESS IN RETINAL AND EYE RESEARCH			English	Article						Dock3; Guanine exchange factors; Glaucoma; Neuroprotection; Axon regeneration; Optic nerve; Retinal ganglion cells	NUCLEOTIDE EXCHANGE FACTOR; NORMAL-TENSION GLAUCOMA; ADENOMATOUS POLYPOSIS-COLI; RHO-FAMILY GTPASES; PRIMARY-OPEN-ANGLE; NEURAL CELL-DEATH; REGULATES NEURITE DIFFERENTIATION; PRESENILIN BINDING-PROTEIN; ALDRICH-SYNDROME PROTEIN; NMDA RECEPTOR	The dedicator of cytokinesis (Dock) family is composed of atypical guanine exchange factors (GEFs) that activate the Rho GTPases Rac1 and Cdc42. Rho GTPases are best documented for their roles in actin polymerization and they regulate important cellular functions, including morphogenesis, migration, neuronal development, and cell division and adhesion. To date, 11 Dock family members have been identified and their roles have been reported in diverse contexts. There has been increasing interest in elucidating the roles of Dock proteins in recent years and studies have revealed that they are potential therapeutic targets for various diseases, including glaucoma, Alzheimer's disease, cancer, attention deficit hyperactivity disorder and combined immunodeficiency. Among the Dock proteins, Dock3 is predominantly expressed in the central nervous system and recent studies have revealed that Dock3 plays a role in protecting retinal ganglion cells from neurotoxicity and oxidative stress as well as in promoting optic nerve regeneration. In this review, we discuss the current understanding of the 11 Dock GEFs and their therapeutic potential, with a particular focus on Dock3 as a novel target for the treatment of glaucoma and other neurodegenerative diseases. (C) 2014 Elsevier Ltd. All rights reserved.	[Namekata, Kazuhiko; Kimura, Atsuko; Kawamura, Kazuto; Harada, Chikako; Harada, Takayuki] Tokyo Metropolitan Inst Med Sci, Visual Res Project, Setagaya Ku, Tokyo 1568506, Japan	Harada, T (reprint author), Tokyo Metropolitan Inst Med Sci, Visual Res Project, Setagaya Ku, 2-1-6 Kamikitazawa, Tokyo 1568506, Japan.	harada-tk@igakuken.or.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan; Funding Program for Next Generation World-Leading Researchers (NEXT Program)	This study was supported by the Ministry of Education, Culture, Sports, Science and Technology of Japan (KN, AK, CH, TH) and the Funding Program for Next Generation World-Leading Researchers (NEXT Program) (TH).	Anderson MG, 2006, BMC BIOL, V4, DOI 10.1186/1741-7007-4-20; Park D, 2007, NATURE, V450, P430, DOI 10.1038/nature06329; De Strooper B, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006304; Ham H, 2013, J IMMUNOL, V190, P3661, DOI 10.4049/jimmunol.1202792; Lin Q, 2006, J BIOL CHEM, V281, P35253, DOI 10.1074/jbc.M606248200; Meller N, 2005, J CELL SCI, V118, P4937, DOI 10.1242/jcs.02671; Yurkewicz L, 2005, J NEUROTRAUM, V22, P1428, DOI 10.1089/neu.2005.22.1428; Yin YQ, 2006, NAT NEUROSCI, V9, P843, DOI 10.1038/nn1701; Shankar GM, 2007, J NEUROSCI, V27, P2866, DOI 10.1523/JNEUROSCI.4970-06.2007; Mou F, 2012, J EXP MED, V209, P741, DOI 10.1084/jem.20111692; Nishikimi A, 2005, FEBS LETT, V579, P1039, DOI 10.1016/j.febslet.2005.01.006; Namekata K, 2013, CELL DEATH DIFFER, V20, P1250, DOI 10.1038/cdd.2013.91; Namekata K, 2012, J NEUROSCI, V32, P264, DOI 10.1523/JNEUROSCI.4884-11.2012; Waters JE, 2008, J CELL SCI, V121, P2892, DOI 10.1242/jcs.030353; KLEIN BEK, 1992, OPHTHALMOLOGY, V99, P1499; Liang XB, 2005, J NEUROSCI, V25, P10180, DOI 10.1523/JNEUROSCI.3591-05.2005; Ju WK, 2009, INVEST OPHTH VIS SCI, V50, P707, DOI 10.1167/iovs.08-2499; Kozma R, 1997, MOL CELL BIOL, V17, P1201; Grimsley CM, 2004, J BIOL CHEM, V279, P6087, DOI 10.1074/jbc.M307087200; Rossman KL, 2005, NAT REV MOL CELL BIO, V6, P167, DOI 10.1038/nrm1587; Yoshimura T, 2005, CELL, V120, P137, DOI 10.1016/j.cell.2004.11.012; Stevenson C, 2014, J IMMUNOL, V192, P6062, DOI 10.4049/jimmunol.1303348; Sobczyk A, 2005, J NEUROSCI, V25, P6037, DOI 10.1523/JNEUROSCI.1221-05.2005; Kulkarni K, 2011, J BIOL CHEM, V286, P25341, DOI 10.1074/jbc.M111.236455; Feng HZ, 2012, P NATL ACAD SCI USA, V109, P3018, DOI 10.1073/pnas.1121457109; Yang YT, 2012, NAT NEUROSCI, V15, P1201, DOI 10.1038/nn.3171; Takenawa T, 2007, NAT REV MOL CELL BIO, V8, P37, DOI 10.1038/nrm2069; Randall KL, 2011, J EXP MED, V208, P2305, DOI 10.1084/jem.20110345; Harada C, 2010, CELL DEATH DIFFER, V17, P1751, DOI 10.1038/cdd.2010.62; Sun F, 2011, NATURE, V480, P372, DOI 10.1038/nature10594; DANCESCU M, 1992, J EXP MED, V176, P1319, DOI 10.1084/jem.176.5.1319; Inoue T, 2013, PROG RETIN EYE RES, V37, P1, DOI 10.1016/j.preteyeres.2013.05.002; Czugala M, 2012, EUR J HUM GENET, V20, P389, DOI 10.1038/ejhg.2011.203; Zeron MM, 2002, NEURON, V33, P849, DOI 10.1016/S0896-6273(02)00615-3; Dulak AM, 2013, NAT GENET, V45, P478, DOI 10.1038/ng.2591; Tolias KF, 2005, NEURON, V45, P525, DOI 10.1016/j.neuron.2005.01.024; Engelhardt KR, 2009, J ALLERGY CLIN IMMUN, V124, P1289, DOI 10.1016/j.jaci.2009.10.038; Nutt JG, 2008, MOVEMENT DISORD, V23, P1860, DOI 10.1002/mds.22169; Chen Q, 2009, J NEUROSCI, V29, P118, DOI 10.1523/JNEUROSCI.3985-08.2009; Jabara HH, 2012, NAT IMMUNOL, V13, P612, DOI 10.1038/ni.2305; Osborne NN, 2009, ACTA OPHTHALMOL, V87, P450, DOI 10.1111/j.1755-3768.2008.01459.x; Atorf J, 2013, DOC OPHTHALMOL, V126, P221, DOI 10.1007/s10633-013-9380-3; Li DW, 2014, MOL MED REP, V9, P2043, DOI 10.3892/mmr.2014.2080; Hirata E, 2012, J CELL SCI, V125, P858, DOI 10.1242/jcs.089995; Zhou FQ, 2004, NEURON, V42, P897, DOI 10.1016/j.neuron.2004.05.011; Hasegawa H, 1996, MOL CELL BIOL, V16, P1770; Namekata K, 2012, GENES CELLS, V17, P688, DOI 10.1111/j.1365-2443.2012.01616.x; Gumienny TL, 2001, CELL, V107, P27, DOI 10.1016/S0092-8674(01)00520-7; Ren M, 2003, P NATL ACAD SCI USA, V100, P6210, DOI 10.1073/pnas.0937423100; Le Floc'h A, 2013, J EXP MED, V210, P2721, DOI 10.1084/jem.20131324; Upadhyay G, 2008, ONCOGENE, V27, P5845, DOI 10.1038/onc.2008.202; Dong LD, 2013, NEURAL PLAST, DOI 10.1155/2013/670254; Feng HZ, 2011, J CLIN INVEST, V121, P4670, DOI 10.1172/JCI58559; Lu MJ, 2005, CURR BIOL, V15, P371, DOI 10.1016/j.cub.2005.01.050; Hammarlund M, 2009, SCIENCE, V323, P802, DOI 10.1126/science.1165527; Cole AR, 2013, FEBS J, V280, P5213, DOI 10.1111/febs.12407; Soleman S, 2013, NEUROSCIENCE, V253, P194, DOI 10.1016/j.neuroscience.2013.08.050; de Lima S, 2012, P NATL ACAD SCI USA, V109, P9149, DOI 10.1073/pnas.1119449109; Kurimoto T, 2010, J NEUROSCI, V30, P15654, DOI 10.1523/JNEUROSCI.4340-10.2010; Harada T, 2007, J CLIN INVEST, V117, P1763, DOI 10.1172/JCI30178; Kashiwa A, 2000, J NEUROCHEM, V75, P109, DOI 10.1046/j.1471-4159.2000.0750109.x; Katoh H, 2003, NATURE, V424, P461, DOI 10.1038/nature01817; Komander D, 2008, MOL BIOL CELL, V19, P4837, DOI 10.1091/mbc.E08-04-0345; Karnoub AE, 2008, NAT REV MOL CELL BIO, V9, P517, DOI 10.1038/nrm2438; Tanihara H, 2013, AM J OPHTHALMOL, V156, P731, DOI 10.1016/j.ajo.2013.05.016; Yashiro K, 2008, NEUROPHARMACOLOGY, V55, P1081, DOI 10.1016/j.neuropharm.2008.07.046; Roche KW, 2001, NAT NEUROSCI, V4, P794, DOI 10.1038/90498; Hiramoto-Yamaki N, 2010, J CELL BIOL, V190, P461, DOI 10.1083/jcb.201005141; Harada T, 1998, P NATL ACAD SCI USA, V95, P4663, DOI 10.1073/pnas.95.8.4663; Paoletti P, 2013, NAT REV NEUROSCI, V14, P383, DOI 10.1038/nrn3504; BOURNE HR, 1990, NATURE, V348, P125, DOI 10.1038/348125a0; Iwase A, 2004, OPHTHALMOLOGY, V111, P1641, DOI 10.1016/j.ophtha.2004.03.029; Hanawa-Suetsugu K, 2012, P NATL ACAD SCI USA, V109, P3305, DOI 10.1073/pnas.1113512109; Harada Y, 2012, BLOOD, V119, P4451, DOI 10.1182/blood-2012-01-407098; Heasman SJ, 2008, NAT REV MOL CELL BIO, V9, P690, DOI 10.1038/nrm2476; Kitamura Y, 2003, J PHARMACOL SCI, V92, P115; Medina M, 2014, EXPERT OPIN THER TAR, V18, P69, DOI 10.1517/14728222.2013.843670; Ittner LM, 2010, CELL, V142, P387, DOI 10.1016/j.cell.2010.06.036; Laurin M, 2008, P NATL ACAD SCI USA, V105, P15446, DOI 10.1073/pnas.0805546105; de Silva MG, 2003, J MED GENET, V40, P733, DOI 10.1136/jmg.40.10.733; Sengottuvel V, 2011, J NEUROSCI, V31, P2688, DOI 10.1523/JNEUROSCI.4885-10.2011; Amadoro G, 2006, P NATL ACAD SCI USA, V103, P2892, DOI 10.1073/pnas.0511065103; Kubo T, 2007, CURR PHARM DESIGN, V13, P2493; Gadea G, 2008, CURR BIOL, V18, P1456, DOI 10.1016/j.cub.2008.08.053; Laurin M, 2013, P NATL ACAD SCI USA, V110, P7434, DOI 10.1073/pnas.1213050110; Cote JF, 2007, TRENDS CELL BIOL, V17, P383, DOI 10.1016/j.tcb.2007.05.001; Harada C, 2006, AM J PATHOL, V168, P261, DOI 10.2353/ajpath.2006.050765; Thrasher AJ, 2010, NAT REV IMMUNOL, V10, P182, DOI 10.1038/nri2724; Nava C, 2014, EUR J HUM GENET, V22, P71, DOI 10.1038/ejhg.2013.88; Pankratz N, 2012, ANN NEUROL, V71, P370, DOI 10.1002/ana.22687; Namekata K, 2010, P NATL ACAD SCI USA, V107, P7586, DOI 10.1073/pnas.0914514107; Yajnik V, 2003, CELL, V112, P673, DOI 10.1016/S0092-8674(03)00155-7; Park KK, 2008, SCIENCE, V322, P963, DOI 10.1126/science.1161566; Jungmichel S, 2014, CELL REP, V6, P578, DOI 10.1016/j.celrep.2013.12.038; Fournier AE, 2003, J NEUROSCI, V23, P1416; Sanal O, 2012, J CLIN IMMUNOL, V32, P698, DOI 10.1007/s10875-012-9664-5; Geraldo S, 2009, J CELL SCI, V122, P3595, DOI 10.1242/jcs.042309; Eickholt BJ, 2002, J CELL BIOL, V157, P211, DOI 10.1083/jcb.200201098; Shaheen R, 2011, AM J HUM GENET, V89, P328, DOI 10.1016/j.ajhg.2011.07.009; Watabe-Uchida M, 2006, NEURON, V51, P727, DOI 10.1016/j.neuron.2006.07.020; Hamoud N, 2014, P NATL ACAD SCI USA, V111, P3745, DOI 10.1073/pnas.1313886111; Yang J, 2009, SCIENCE, V325, P1398, DOI 10.1126/science.1174468; Vives V, 2011, J BONE MINER RES, V26, P1099, DOI 10.1002/jbmr.282; Alexander MS, 2014, J CLIN INVEST, V124, P2651, DOI 10.1172/JCI73579; Gherghel D, 2013, INVEST OPHTH VIS SCI, V54, P3333, DOI 10.1167/iovs.12-11256; Alkelai A, 2012, INT J NEUROPSYCHOPH, V15, P459, DOI 10.1017/S1461145711000903; Hellal F, 2011, SCIENCE, V331, P928, DOI 10.1126/science.1201148; Meller N, 2002, NAT CELL BIOL, V4, P639, DOI 10.1038/ncb835; Katome T, 2013, CELL DEATH DIFFER, V20, P270, DOI 10.1038/cdd.2012.122; Mony L, 2009, BRIT J PHARMACOL, V157, P1301, DOI 10.1111/j.1476-5381.2009.00304.x; Purro SA, 2008, J NEUROSCI, V28, P8644, DOI 10.1523/JNEUROSCI.2320-08.2008; Hardingham GE, 2010, NAT REV NEUROSCI, V11, P682, DOI 10.1038/nrn2911; Zhou L, 2011, J BIOL CHEM, V286, P25211, DOI 10.1074/jbc.M111.235028; Kuramoto K, 2009, J NEUROSCI RES, V87, P1794, DOI 10.1002/jnr.21997; Bonomi L, 1998, OPHTHALMOLOGY, V105, P209, DOI 10.1016/S0161-6420(98)92665-3; Crawford G, 2013, BLOOD, V122, P2052, DOI 10.1182/blood-2013-02-482331; Yelo E, 2008, MOL IMMUNOL, V45, P3411, DOI 10.1016/j.molimm.2008.04.003; Li XL, 2008, NAT NEUROSCI, V11, P28, DOI 10.1038/nn2022; NOBES CD, 1995, CELL, V81, P53, DOI 10.1016/0092-8674(95)90370-4; Maes Michael, 2012, Inflammopharmacology, V20, P127, DOI 10.1007/s10787-011-0111-7; Watkins TA, 2013, P NATL ACAD SCI USA, V110, P4039, DOI 10.1073/pnas.1211074110; Miyamoto Y, 2007, EXP CELL RES, V313, P791, DOI 10.1016/j.yexcr.2006.11.017; Randall KL, 2009, NAT IMMUNOL, V10, P1283, DOI 10.1038/ni.1820; Yokota Y, 2009, NEURON, V61, P42, DOI 10.1016/j.neuron.2008.10.053; Cote JF, 2005, NAT CELL BIOL, V7, P797, DOI 10.1038/ncb1280; Hur EM, 2010, NAT REV NEUROSCI, V11, P539, DOI 10.1038/nrn2870; DeRosse P, 2008, SCHIZOPHRENIA BULL, V34, P1047, DOI 10.1093/schbul/sbn076; Zhang Q, 2009, NEW ENGL J MED, V361, P2046, DOI 10.1056/NEJMoa0905506; Fukui Y, 2001, NATURE, V412, P826, DOI 10.1038/35090591; Bai N, 2013, MOL BRAIN, V6, DOI 10.1186/1756-6606-6-34; Bai N, 2013, MOL BRAIN, V6, DOI 10.1186/1756-6606-6-22; Bertrand J, 2005, J NEUROSCI, V25, P1113, DOI 10.1523/JNEUROSCI.3931-04.2005; Biersmith B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016120; Blasius AL, 2009, P NATL ACAD SCI USA, V106, P2706, DOI 10.1073/pnas.0813208106; Chen Q, 2001, AM J PATHOL, V159, P1597, DOI 10.1016/S0002-9440(10)63005-2; Chen Q, 2002, J CELL BIOL, V158, P79, DOI 10.1083/jcb.200110151; Cimino PJ, 2013, EXP MOL PATHOL, V94, P366, DOI 10.1016/j.yexmp.2013.01.002; Cimino PJ, 2009, AM J PATHOL, V175, P1622, DOI 10.2353/ajpath.2009.090443; Cook D.R., 2013, ONCOGENE, V16, P1; Cox AD, 2010, SMALL GTPASES, V1, P2, DOI DOI 10.4161/SGTP.1.1.12178.PMID:21686117; Detera-Wadleigh SD, 2007, PSYCHIAT GENET, V17, P274, DOI 10.1097/YPG.0b013e328133f352; Eguchi K, 2013, EXP CELL RES, V319, P2179, DOI 10.1016/j.yexcr.2013.05.024; Gao C, 2011, REV NEUROSCI, V23, P1; Griggs BL, 2008, GENOMICS, V91, P195, DOI 10.1016/j.ygeno.2007.10.011; Li HY, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2680; Hochreiter-Hufford AE, 2013, NATURE, V497, P263, DOI 10.1038/nature12135; Iida F, 1997, EXP EYE RES, V64, P107, DOI 10.1006/exer.1996.0192; Koester MP, 2007, J NEUROSCI, V27, P12590, DOI 10.1523/JNEUROSCI.2250-07.2007; Laurin M, 2014, GENE DEV, V28, P533, DOI 10.1101/gad.236349.113; Li JB, 2014, CELL BIOCHEM BIOPHYS, V68, P275, DOI 10.1007/s12013-013-9707-4; Makino Y, 2006, J CELL SCI, V119, P923, DOI 10.1242/jcs.02797; McCubrey J.A., 2014, ONCOTARGET, V5, P881; Meller N, 2004, J BIOL CHEM, V279, P37470, DOI 10.1074/jbc.M404535200; Miletic AV, 2006, J BIOL CHEM, V281, P38257, DOI 10.1074/jbc.M608913200; Miyamoto Y, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003661; Namekata K, 2004, J BIOL CHEM, V279, P14331, DOI 10.1074/jbc.M311275200; Neubrand VE, 2010, J CELL SCI, V123, P2110, DOI 10.1242/jcs.064055; Ogawa K., 2014, J EXP MED; Omi N, 2008, EXP EYE RES, V86, P828, DOI 10.1016/j.exer.2008.02.011; Orlic-Milacic M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091742; Pagnamenta AT, 2010, BIOL PSYCHIAT, V68, P320, DOI 10.1016/j.biopsych.2010.02.002; Palomo V, 2011, CURR MED CHEM, V18, P3028; Patel M, 2010, CURR BIOL, V20, P2021, DOI 10.1016/j.cub.2010.10.028; Patel M., 2011, SMALL GTPASES, V2, P268; Pertz OC, 2008, P NATL ACAD SCI USA, V105, P1931, DOI 10.1073/pnas.0706545105; Picard M, 2009, CELL SIGNAL, V21, P1961, DOI 10.1016/j.cellsig.2009.09.004; Pochwat B, 2014, EXPERT OPIN INV DRUG, V12, P1; Premkumar L, 2010, J BIOL CHEM, V285, P13211, DOI 10.1074/jbc.M110.102517; Sakabe I, 2012, IMMUN AGEING, V9, DOI 10.1186/1742-4933-9-2; Sakai Y, 2013, BLOOD, V122, P386, DOI 10.1182/blood-2012-12-475897; Sakthivel KM, 2012, ASIAN PAC J CANCER P, V13, P1719, DOI 10.7314/APJCP.2012.13.5.1719; Sanui T, 2003, IMMUNITY, V19, P119, DOI 10.1016/S1074-7613(03)00169-9; SAVIO T, 1990, P NATL ACAD SCI USA, V87, P4130, DOI 10.1073/pnas.87.11.4130; Schwechter B, 2013, P NATL ACAD SCI USA, V110, P14462, DOI 10.1073/pnas.1304340110; Semba K, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.296; Semba K, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.306; Sengottuvel Vetrivel, 2011, Commun Integr Biol, V4, P391, DOI 10.4161/cib.4.4.15552; Tachi N, 2012, BIOCHEM J, V442, P413, DOI 10.1042/BJ20100993; Terasawa M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046277; Ueda S, 2013, MOL BIOL CELL, V24, P1602, DOI 10.1091/mbc.E12-11-0782; Valvezan AJ, 2012, FRONT MOL NEUROSCI, V5, DOI 10.3389/fnmol.2012.00001; Wahl Anna-Sophia, 2014, Front Hum Neurosci, V7, P911, DOI 10.3389/fnhum.2013.00911; Wang Sean K, 2014, Clin Ophthalmol, V8, P883, DOI 10.2147/OPTH.S41000; Wu X, 2011, BIOCHEMISTRY-US, V50, P1070, DOI 10.1021/bi100971y; Xiao YG, 2013, J BIOL CHEM, V288, P20034, DOI 10.1074/jbc.M113.458612; Yamauchi J, 2008, J CELL BIOL, V181, P351, DOI 10.1083/jcb.200709033	186	10	10	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	1350-9462			PROG RETIN EYE RES	Prog. Retin. Eye Res.	NOV	2014	43						1	16		10.1016/j.preteyeres.2014.06.005		16	Ophthalmology	Ophthalmology	AS7NH	WOS:000344442100001		
J	Ishibashi, Y; Tobisawa, Y; Hatakeyama, S; Ohashi, T; Tanaka, M; Narita, S; Koie, T; Habuchi, T; Nishimura, SI; Ohyama, C; Yoneyama, T				Ishibashi, Yusuke; Tobisawa, Yuki; Hatakeyama, Shingo; Ohashi, Tetsu; Tanaka, Masakazu; Narita, Shintaro; Koie, Takuya; Habuchi, Tomonori; Nishimura, Shin-Ichiro; Ohyama, Chikara; Yoneyama, Tohru			SerumTri- and Tetra-Antennary N-Glycan is a Potential Predictive Biomarker for Castration-Resistant Prostate Cancer	PROSTATE			English	Article						serum N-glycan; androgen deprivation therapy; biomarker; castration-resistant prostate cancer; glycoblotting	HEPATOCELLULAR-CARCINOMA; ACETYLGLUCOSAMINYLTRANSFERASE-V; PANCREATIC-CANCER; OPEN-LABEL; EXPRESSION; FUCOSYLATION; STATISTICS; GLYCOME; MARKER	BACKGROUND. The U.S. FDA has approved several novel systemic agents including abiraterone acetate and taxoid cabazitaxel for metastatic castration-resistant prostate cancer (CRPC) result in a complicated decision-making while selecting an appropriate treatment. Therefore, a predictive biomarker for CRPC would provide useful information to physicians. The aim of this study is to evaluate the diagnostic potential of serum N-glycan profiling in CRPC. METHODS. Serum N-glycomics was performed in 80 healthy volunteers and 286 benign prostatic hyperplasia, 258 early-stage PC, 46 PC with androgen deprivation therapy (ADT), and 68 CRPC patients using the glycoblotting method. A total of 36 types of N-glycan levels in each patient were analyzed using logistic regression analysis and receiver operating characteristic curves. We also examined the expression of N-glycan branching enzyme genes in PC cell lines using quantitative RT-PCR. RESULTS. We observed that tri- and tetra-antennary N-glycans were significantly higher in CRPC patients than in any other groups. The longitudinal follow-up of tri- and tetra-antennary N-glycan levels revealed that one PC with ADT patient showed an increase that was more than the cut-off level and two consecutive increases in tri- and tetra-antennary N-glycan levels 3 months apart; resulted in biochemical recurrence despite the castrate level of testosterone, and the patient was defined as CRPC. Expression of N-glycan branching enzyme genes were significantly upregulated in CRPC cell lines. CONCLUSIONS. These results suggest that the overexpression of tri- and tetra-antennary N-glycan may be associated with the castration-resistant status in PC and may be a potential predictive biomarker for CRPC. (C) 2014 Wiley Periodicals, Inc.	[Ishibashi, Yusuke; Tobisawa, Yuki; Hatakeyama, Shingo; Koie, Takuya; Ohyama, Chikara; Yoneyama, Tohru] Hirosaki Univ, Grad Sch Med, Dept Urol, Hirosaki, Aomori 0368562, Japan; [Ohashi, Tetsu; Nishimura, Shin-Ichiro] Hokkaido Univ, Grad Sch Life Sci, Sapporo, Hokkaido, Japan; [Ohashi, Tetsu; Nishimura, Shin-Ichiro] Hokkaido Univ, Frontier Res Ctr Postgenome Sci & Technol, Sapporo, Hokkaido, Japan; [Tanaka, Masakazu] Med Chem Pharmaceut Co Ltd, Sapporo, Hokkaido, Japan; [Narita, Shintaro; Habuchi, Tomonori] Akita Univ, Grad Sch Med, Dept Urol, Akita 010, Japan; [Ohyama, Chikara; Yoneyama, Tohru] Hirosaki Univ, Grad Sch Med, Dept Adv Transplant & Regenerat Med, Hirosaki, Aomori 0368562, Japan	Yoneyama, T (reprint author), Hirosaki Univ, Grad Sch Med, Dept Adv Transplant & Regenerat Med, 5 Zaifu Cho, Hirosaki, Aomori 0368562, Japan.	tohruyon@cc.hirosaki-u.ac.jp			Japan Society for the Promotion of Science [24659708]	Grant sponsor: Japan Society for the Promotion of Science; Grant number: 24659708.	Tsui KH, 2008, ANTICANCER RES, V28, P1993; Furukawa JI, 2008, ANAL CHEM, V80, P1094, DOI 10.1021/ac702124d; Hatakeyama S, 2010, INT J CANCER, V127, P1052, DOI 10.1002/ijc.25117; Okuyama N, 2006, INT J CANCER, V118, P2803, DOI 10.1002/ijc.21728; Tombal B, 2014, LANCET ONCOL, V15, P592, DOI 10.1016/S1470-2045(14)70129-9; Nouso K, 2013, J GASTROENTEROL, V48, P1171, DOI 10.1007/s00535-012-0732-7; Jemal A, 2011, CA-CANCER J CLIN, V61, P69, DOI 10.3322/caac.20107; Kamiyama T, 2013, HEPATOLOGY, V57, P2314, DOI 10.1002/hep.26262; Ishimura H, 2006, CLIN CANCER RES, V12, P2506, DOI 10.1158/1078-0432.CCR-05-1938; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; de Bono JS, 2010, LANCET, V376, P1147, DOI 10.1016/S0140-6736(10)61389-X; Miura Y, 2010, ANAL CHEM, V82, P10021, DOI 10.1021/ac101599p; D'Arrigo A, 2005, INT J CANCER, V115, P256, DOI 10.1002/ijc.20883; Akobeng AK, 2007, ACTA PAEDIATR, V96, P644, DOI 10.1111/j.1651-2227.2006.00178.x; De Bono JS, 2011, NEW ENGL J MED, V364, P1995, DOI 10.1056/NEJMoa1014618; Toren PJ, 2013, ASIAN J ANDROL, V15, P342, DOI 10.1038/aja.2013.38; Kirby M, 2011, INT J CLIN PRACT, V65, P1180, DOI 10.1111/j.1742-1241.2011.02799.x; Kantoff PW, 2010, NEW ENGL J MED, V363, P411, DOI 10.1056/NEJMoa1001294; Kyselova Z, 2007, J PROTEOME RES, V6, P1822, DOI 10.1021/pr060664t; Hagisawa S, 2005, GLYCOBIOLOGY, V15, P1016, DOI 10.1093/glycob/cwi086; Amano M, 2010, MOL CELL PROTEOMICS, V9, P523, DOI 10.1074/mcp.M900559-MCP200; Beheshti Zavareh R, 2012, PLOS ONE, V7; Hatakeyama S, 2013, SCI WORLD J, V5, P1; Hatakeyama S, 2013, J UROLOGY, V191, P805; Hirst CJ, 2012, CANCER EPIDEMIOL, V36, pE349, DOI 10.1016/j.canep.2012.07.012; Miyahara K, 2014, HEPATOLOGY, V59, P355, DOI 10.1002/hep.26531; Moriwaki K, 2007, GLYCOBIOLOGY, V17, P1311, DOI 10.1093/glycob/cwm094; SAITO S, 1991, INT J CANCER, V49, P329; Takeuchi M, 2013, J GLYCOMICS LIPIDOMI, V3, P1	29	2	2	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0270-4137	1097-0045		PROSTATE	Prostate	NOV	2014	74	15					1521	1529		10.1002/pros.22869		9	Endocrinology & Metabolism; Urology & Nephrology	Endocrinology & Metabolism; Urology & Nephrology	AS1OT	WOS:000344050800007		
J	Kawasaki, H; Kretsinger, RH				Kawasaki, Hiroshi; Kretsinger, Robert H.			Structural differences among subfamilies of EF-hand proteins-A view from the pseudo two-fold symmetry axis	PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS			English	Article						EF-hand; EF-lobe; symmetry; calcium; structural comparison; evolution; function	CALCIUM-BINDING PROTEINS; CRYSTAL-STRUCTURE; ANGSTROM RESOLUTION; TARGET RECOGNITION; PARVALBUMIN CALCIUM; REGULATORY DOMAIN; DIVERSITY; EVOLUTION; COMPLEX; SUPERFAMILY	We have analyzed the conformations of EF-lobes, adjacent pairs of EF-hand domains, in a coordinate system based on the approximate two-fold (z) axis that relates the two EF-hands. Two parameters - dE(O), the azimuthal angle between the y-axis and the projection of the offset vector to helix E onto the yz-plane, and dF(O), the difference angle between the two helices (F1 and F2) of odd and even domainscharacterize the openness of a single EF-hand domain and of an EF-lobe, respectively. We describe and compare values of dE(O) and of dF(O) for EF-hand proteins of five subfamiliesCTER, CPV, S100, PARV, CALPin calci- and apo- forms, with and without bound target proteins. Each subfamily has characteristic changes associated with binding calcium and/or target proteins. Proteins 2014; 82:2915-2924. (c) 2014 Wiley Periodicals, Inc.	[Kawasaki, Hiroshi] Yokohama City Univ, Grad Sch Med Life Sci, Dept Med Life Sci, Tsurumi Ku, Yokohama, Kanagawa 2300045, Japan; [Kretsinger, Robert H.] Univ Virginia, Dept Biol, Charlottesville, VA 22904 USA	Kawasaki, H (reprint author), Yokohama City Univ, Grad Sch Med Life Sci, Dept Med Life Sci, Tsurumi Ku, Suehiro Cho I-7-29, Yokohama, Kanagawa 2300045, Japan.	kawasaki@yokohama-cu.ac.jp; rhk5i@virginia.edu	Kawasaki, Hiroshi/C-3048-2011	Kawasaki, Hiroshi/0000-0002-2517-159X			Maki M, 2002, BBA-PROTEINS PROTEOM, V1600, P51, DOI 10.1016/S1570-9639(02)00444-2; Donato R, 2013, CURR MOL MED, V13, P24; Olinger E, 2012, NEPHROL DIAL TRANSPL, V27, P3988, DOI 10.1093/ndt/gfs457; Kojetin DJ, 2006, NAT STRUCT MOL BIOL, V13, P641, DOI 10.1038/nsmb1112d; KAWASAKI H, 1994, PROTEIN PROFILE, V1, P343; Becker S, 1998, NATURE, V394, P145, DOI 10.1038/28101; Bourne Y, 2003, EMBO J, V22, P1, DOI 10.1093/emboj/cdg005; Essen LO, 1996, NATURE, V380, P595, DOI 10.1038/380595a0; Hoeflich KP, 2002, CELL, V108, P739, DOI 10.1016/S0092-8674(02)00682-7; Yap KL, 1999, PROTEINS, V37, P499, DOI 10.1002/(SICI)1097-0134(19991115)37:3<499::AID-PROT17>3.0.CO;2-Y; Ames JB, 2012, BBA-GEN SUBJECTS, V1820, P1205, DOI 10.1016/j.bbagen.2011.10.003; Kawasaki H, 1998, BIOMETALS, V11, P277, DOI 10.1023/A:1009282307967; Clapham DE, 2007, CELL, V131, P1047, DOI 10.1016/j.cell.2007.11.028; Chen XM, 1998, CELL, V93, P827, DOI 10.1016/S0092-8674(00)81443-9; Huang X, 2000, NAT STRUCT BIOL, V7, P634, DOI 10.1038/77923; Hohenester E, 1997, EMBO J, V16, P3778, DOI 10.1093/emboj/16.13.3778; Vetter SW, 2003, EUR J BIOCHEM, V270, P404, DOI 10.1046/j.1432-1033.2003.03414.x; Head JF, 2000, NATURE, V405, P372, DOI 10.1038/35012659; BOURNE Y, 1995, CELL, V83, P503, DOI 10.1016/0092-8674(95)90128-0; Babini E, 2005, J PROTEOME RES, V4, P1961, DOI 10.1021/pr050148n; Bhattacharya S, 2004, BBA-MOL CELL RES, V1742, P69, DOI 10.1016/j.bbamcr.2004.09.002; Croall DE, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-6-218; Houdusse A, 1996, STRUCTURE, V4, P21, DOI 10.1016/S0969-2126(96)00006-8; Kawasaki H, 2012, PROTEINS, V80, P2592, DOI 10.1002/prot.24143; Meng WY, 1999, NATURE, V398, P84; Nakayama S, 2000, CALCIUM HOMEOSTASIS, P29; NAKAYAMA S, 1992, J MOL EVOL, V34, P416, DOI 10.1007/BF00162998; Ohtsuki I, 2007, ADV EXP MED BIOL, V592, P21; PERMYAKOV EA, 1991, BIOCHIM BIOPHYS ACTA, V1076, P67, DOI 10.1016/0167-4838(91)90220-T; Rezvanpour A, 2009, GEN PHYSIOL BIOPHYS, V28, pF39; Schwaller B, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a004051; SHAW GS, 1990, SCIENCE, V249, P280, DOI 10.1126/science.2374927; SWAIN AL, 1989, J BIOL CHEM, V264, P16620; Theret I, 2000, BIOCHEMISTRY-US, V39, P7920, DOI 10.1021/bi000360z; Tsigelny I, 2000, PROTEIN SCI, V9, P180; TUFTY RM, 1975, SCIENCE, V187, P167, DOI 10.1126/science.1111094; VIJAYKUMAR S, 1992, J MOL BIOL, V224, P413, DOI 10.1016/0022-2836(92)91004-9; Wang X, 2005, PROTEIN SCI, V14, P2447, DOI 10.1110/ps.051595805; Wojcik J, 1997, BIOCHEMISTRY-US, V36, P680, DOI 10.1021/bi961821c; Yap KL, 2002, CALCIUM BIND PROTEIN, V2, P317	40	4	4	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0887-3585	1097-0134		PROTEINS	Proteins	NOV	2014	82	11					2915	2924		10.1002/prot.24562		10	Biochemistry & Molecular Biology; Biophysics	Biochemistry & Molecular Biology; Biophysics	AS6MT	WOS:000344378300005		
J	Mori, Y; Okumura, H				Mori, Yoshiharu; Okumura, Hisashi			Molecular dynamics of the structural changes of helical peptides induced by pressure	PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS			English	Article						AK16 peptide; C-peptide; generalized-ensemble algorithm; simulated tempering; pressure dependence; salt bridge	MULTIBARIC-MULTITHERMAL ENSEMBLE; MONTE-CARLO METHOD; HISTOGRAM ANALYSIS METHOD; REPLICA-EXCHANGE METHOD; TRP-CAGE MINIPROTEIN; PARTICLE MESH EWALD; MOLAR VOLUME CHANGE; AQUEOUS-SOLUTION; COIL TRANSITION; MULTICANONICAL ENSEMBLE	An AK16 peptide and a C-peptide analog are experimentally known to form more helical structures under high-pressure conditions than those at atmospheric pressure, even though most proteins usually unfold at high pressure. To understand the pressure-induced structural changes of the two peptides, molecular dynamics simulations with the simulated tempering method for the isobaric-isothermal ensemble were performed in a wide pressure range from 0.1 MPa to 1.4 GPa. We found that the fraction of the folded state decreases once and then increases with increasing pressure for both peptides. The partial molar volume change of both peptides from the folded state to the unfolded state increases monotonically from a negative value to a positive value as pressure increases. By calculating the radius of gyration and interatomic distances of the AK16 peptide and the C-peptide analog, we found that these peptides are compressed under high-pressure conditions, which causes the folded state to be more stable at high pressure. Furthermore, we found that the salt bridge of the C-peptide analog is broken under high pressure. Proteins 2014; 82:2970-2981. (c) 2014 Wiley Periodicals, Inc.	[Mori, Yoshiharu; Okumura, Hisashi] Inst Mol Sci, Dept Theoret & Computat Mol Sci, Okazaki, Aichi 4448585, Japan; [Okumura, Hisashi] Inst Mol Sci, Res Ctr Computat Sci, Okazaki, Aichi 4448585, Japan; [Okumura, Hisashi] Grad Univ Adv Studies, Dept Struct Mol Sci, Okazaki, Aichi 4448585, Japan	Okumura, H (reprint author), Inst Mol Sci, Res Ctr Computat Sci, 38 Nishigo Naka, Okazaki, Aichi 4448585, Japan.	hokumura@ims.ac.jp					Roche J, 2012, P NATL ACAD SCI USA, V109, P6945, DOI 10.1073/pnas.1200915109; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Day R, 2008, PROTEINS, V70, P1175, DOI 10.1002/prot.21562; Nakajima N, 1997, J PHYS CHEM B, V101, P817, DOI 10.1021/jp962142e; Hansmann UHE, 1996, CHEM PHYS LETT, V259, P321, DOI 10.1016/0009-2614(96)00761-0; English CA, 2014, PHYS CHEM CHEM PHYS, V16, P2748, DOI [10.1039/c3cp54339k, 10.1039/c3cp54339h]; Itoh SG, 2013, J CHEM THEORY COMPUT, V9, P570, DOI 10.1021/ct3007919; Mackerell AD, 2004, J COMPUT CHEM, V25, P1400, DOI 10.1002/jcc.20065; Refaee M, 2003, J MOL BIOL, V327, P857, DOI 10.1016/S0022-2836(03)00209-2; Day R, 2010, PROTEINS, V78, P1889, DOI 10.1002/prot.22702; Nisius L, 2012, NAT CHEM, V4, P711, DOI [10.1038/nchem.1396, 10.1038/NCHEM.1396]; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; CHAKRABARTTY A, 1995, ADV PROTEIN CHEM, V46, P141, DOI 10.1016/S0065-3233(08)60334-4; Silva JL, 2001, TRENDS BIOCHEM SCI, V26, P612, DOI 10.1016/S0968-0004(01)01949-1; Imai T, 2005, BIOPOLYMERS, V79, P97, DOI 10.1002/bip.20337; Okumura H, 2012, PROTEINS, V80, P2397, DOI 10.1002/prot.24125; BERG BA, 1992, PHYS REV LETT, V68, P9, DOI 10.1103/PhysRevLett.68.9; Paschek D, 2005, P NATL ACAD SCI USA, V102, P6765, DOI 10.1073/pnas.0408527102; Rouget JB, 2011, J AM CHEM SOC, V133, P6020, DOI 10.1021/ja200228w; Best RB, 2009, J PHYS CHEM B, V113, P9004, DOI 10.1021/jp901540t; [Anonymous], 2010, PYMOL MOL GRAPH SYST, V1.3r1; Quigley D, 2004, J CHEM PHYS, V120, P11432, DOI 10.1063/1.1755657; Imai T, 2007, PROTEIN SCI, V16, P1927, DOI 10.1110/ps.072909007; Joosten RP, 2011, NUCLEIC ACIDS RES, V39, pD411, DOI 10.1093/nar/gkq1105; SHOEMAKER KR, 1985, P NATL ACAD SCI USA, V82, P2349, DOI 10.1073/pnas.82.8.2349; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Mitsutake A, 2001, BIOPOLYMERS, V60, P96, DOI 10.1002/1097-0282(2001)60:2<96::AID-BIP1007>3.0.CO;2-F; Mori Y, 2013, J PHYS CHEM LETT, V4, P2079, DOI 10.1021/jz400769w; Yamazaki T, 2007, J PHYS CHEM B, V111, P1206, DOI 10.1021/jp064615f; Mori Y, 2010, J PHYS SOC JPN, V79, DOI 10.1143/JPSJ.79.074003; HOOVER WG, 1985, PHYS REV A, V31, P1695, DOI 10.1103/PhysRevA.31.1695; NOSE S, 1984, J CHEM PHYS, V81, P511; SHOEMAKER KR, 1987, NATURE, V326, P563, DOI 10.1038/326563a0; Shirts MR, 2008, J CHEM PHYS, V129, DOI 10.1063/1.2978177; Okabe T, 2001, CHEM PHYS LETT, V335, P435, DOI 10.1016/S0009-2614(01)00055-0; SCHOLTZ JM, 1992, ANNU REV BIOPH BIOM, V21, P95, DOI 10.1146/annurev.bb.21.060192.000523; Luo PZ, 1999, P NATL ACAD SCI USA, V96, P4930, DOI 10.1073/pnas.96.9.4930; BERG BA, 1991, PHYS LETT B, V267, P249, DOI 10.1016/0370-2693(91)91256-U; Schroer MA, 2010, BIOPHYS J, V99, P3430, DOI 10.1016/j.bpj.2010.09.046; CHAKRABARTTY A, 1994, PROTEIN SCI, V3, P843; Hukushima K, 1996, J PHYS SOC JPN, V65, P1604, DOI 10.1143/JPSJ.65.1604; LYUBARTSEV AP, 1992, J CHEM PHYS, V96, P1776, DOI 10.1063/1.462133; KUMAR S, 1992, J COMPUT CHEM, V13, P1011, DOI 10.1002/jcc.540130812; Sugita Y, 1999, CHEM PHYS LETT, V314, P141, DOI 10.1016/S0009-2614(99)01123-9; Chodera JD, 2007, J CHEM THEORY COMPUT, V3, P26, DOI 10.1021/ct0502864; MARINARI E, 1992, EUROPHYS LETT, V19, P451, DOI 10.1209/0295-5075/19/6/002; Pace CN, 1998, BIOPHYS J, V75, P422; Wilton DJ, 2008, PROTEINS, V71, P1432, DOI 10.1002/prot.21832; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; FELLER SE, 1995, J CHEM PHYS, V103, P4613, DOI 10.1063/1.470648; FERRENBERG AM, 1989, PHYS REV LETT, V63, P1195, DOI 10.1103/PhysRevLett.63.1195; Hatch HW, 2014, J PHYS CHEM B, V118, P7761, DOI 10.1021/jp410651u; HAWLEY SA, 1971, BIOCHEMISTRY-US, V10, P2436, DOI 10.1021/bi00789a002; Imai T, 2010, J PHYS CHEM B, V114, P2281, DOI 10.1021/jp909701j; Imamura H, 2009, PROTEINS, V75, P911, DOI 10.1002/prot.22302; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Kato M, 2011, 11 ANN M PROT SCI SO; Kitahara R, 2003, P NATL ACAD SCI USA, V100, P3167, DOI 10.1073/pnas.0630309100; Kitahara R, 2001, BIOCHEMISTRY-US, V40, P13556, DOI 10.1021/bi010922u; Kitahara R, 2005, J MOL BIOL, V347, P277, DOI 10.1016/j.jmb.2005.01.052; Lim D, 1998, CHEM COMMUN, P2375, DOI 10.1039/a805367g; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; METROPOLIS N, 1953, J CHEM PHYS, V21, P1087, DOI 10.1063/1.1699114; Mitsutake A, 2012, BIOMOLECULAR SIMULAT, P153; Mitsutake A, 2010, PHYSCS PROC, V4, P89, DOI 10.1016/j.phpro.2010.08.012; Mitsutake A, 2009, J CHEM PHYS, V130, DOI 10.1063/1.3127783; MIYAMOTO S, 1992, J COMPUT CHEM, V13, P952, DOI 10.1002/jcc.540130805; Mori Y, 2010, J PHYS SOC JPN, V79, DOI 10.1143/JPSJ.79.074001; Mori Y, 2012, MOL SIMULAT, V38, P452, DOI 10.1080/08927022.2011.651139; Mori Y, 2011, P 4 JAP RUSS INT WOR, P46; Moye-Sherman D, 1998, J AM CHEM SOC, V120, P9435, DOI 10.1021/ja981153d; Nishikawa T, 2000, PROG THEOR PHYS SUPP, P270; Okumura H, 2007, B CHEM SOC JPN, V80, P1114, DOI 10.1246/bcsj.80.1114; Okumura H, 2008, J PHYS CHEM B, V112, P12038, DOI 10.1021/jp712109q; Okumura H, 2004, CHEM PHYS LETT, V383, P391, DOI 10.1016/j.cplett.2003.10.152; Okumura H, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.026702; Okumura H, 2006, J COMPUT CHEM, V27, P379, DOI 10.1002/jcc.20351; Okumura H, 2004, CHEM PHYS LETT, V391, P248, DOI 10.1016/j.cplett.2004.04.073; OSTERHOUT JJ, 1989, BIOCHEMISTRY-US, V28, P7059, DOI 10.1021/bi00443a042; Paschek D, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.238105; Roche J, 2012, BIOCHEMISTRY-US, V51, P9535, DOI 10.1021/bi301071z; Sugita Y, 2002, LECT NOTES COMPUTATI, P303; Takekiyo T, 2004, BIOPOLYMERS, V73, P283, DOI 10.1002/bip.10548; Takekiyo T, 2005, BBA-PROTEINS PROTEOM, V1750, P1, DOI 10.1016/j.bbapap.2005.02.014; Williamson MP, 2003, PROTEIN SCI, V12, P1971, DOI 10.1110/ps.0242103; Yoda T, 2004, CHEM PHYS LETT, V386, P460, DOI 10.1016/j.cplett.2004.01.078	87	3	3	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0887-3585	1097-0134		PROTEINS	Proteins	NOV	2014	82	11					2970	2981		10.1002/prot.24654		12	Biochemistry & Molecular Biology; Biophysics	Biochemistry & Molecular Biology; Biophysics	AS6MT	WOS:000344378300010		
J	Nagasato, C; Kajimura, N; Terauchi, M; Mineyuki, Y; Motomura, T				Nagasato, Chikako; Kajimura, Naoko; Terauchi, Makoto; Mineyuki, Yoshinobu; Motomura, Taizo			Electron tomographic analysis of cytokinesis in the brown alga Silvetia babingtonii (Fucales, Phaeophyceae)	PROTOPLASMA			English	Article						Brown algae; Cell partition membrane; Cytokinesis; Electron tomography; Flat cisternae; Golgi-derived vesicles	CELL PLATE FORMATION; SCYTOSIPHON-LOMENTARIA SCYTOSIPHONALES; ENDOPLASMIC-RETICULUM; FUCOID ZYGOTES; MICROTUBULE ORGANIZATION; ASYMMETRIC DIVISION; ANIMAL-CELLS; F-ACTIN; ESTABLISHMENT; PLASMODESMATA	In brown algae, membrane resources for the new cell partition during cytokinesis are mainly flat cisternae (FCs) and Golgi-derived vesicles. We used electron tomography coupled with rapid freezing/freeze substitution of zygotes to clarify the structure of transient membrane compartments during cytokinesis in Silvetia zygotes. After mitosis, an amorphous membranous structure, considered to be an FC intermediate was observed near endoplasmic reticulum clusters, lying between two daughter nuclei. FCs were arrayed at the cytokinetic plane, and a tubular membranous network was formed around them. This network might be formed by the consecutive fusion of spherical vesicles that are linked to the edges of FCs to form a membranous network (MN). At the initial stage of the formation of a membranous sac (MS) from the MN, the MS had flat and swollen parts, with the latter showing membranous tunnels. Coated pits were detected with high frequency at the swollen parts of the MS. This observation indicated that membranous tunnels disappeared by recycling of excess membrane via endocytosis, and the swollen part became flat. The MN appeared at the edges of the growing MS. MN and the MN-MS complex were observed along the cytokinetic plane in several spaces. The MS expanded by the incorporation of MN or other MS in its neighborhood. With the maturation of the new cell partition membrane, the thickness of the MS became constant and the membrane cavity disappeared. The changes in the surface area and volume of the transient membrane compartment during cytokinesis were analyzed from the tomographic data.	[Nagasato, Chikako; Motomura, Taizo] Hokkaido Univ, Field Sci Ctr Northern Biosphere, Muroran Marine Stn, Muroran, Hokkaido 0510013, Japan; [Kajimura, Naoko] Osaka Univ, Grad Sch Frontier Biosci, Suita, Osaka 5650871, Japan; [Kajimura, Naoko] JEOL Ltd, Yodogawa Ku, Osaka 5320011, Japan; [Terauchi, Makoto] Hokkaido Univ, Grad Sch Environm Sci, Sapporo, Hokkaido 0600810, Japan; [Mineyuki, Yoshinobu] Univ Hyogo, Grad Sch Life Sci, Dept Sci, Himeji, Hyogo 6712280, Japan	Nagasato, C (reprint author), Hokkaido Univ, Field Sci Ctr Northern Biosphere, Muroran Marine Stn, Muroran, Hokkaido 0510013, Japan.	nagasato@fsc.hokudai.ac.jp			JSPS KAKENHI [21770065, 22370034, 25291087]; Ministry of Education, Culture, Sports, Science and Technology, Japan, at the Research Center for Ultrahigh Voltage Electron Microscopy, Osaka University (Handai multi-functional Nano-Foundry)	This study was supported by the JSPS KAKENHI grant numbers 21770065, 22370034, and 25291087. This work was supported by the Nanotechnology Network Project of the Ministry of Education, Culture, Sports, Science and Technology, Japan, at the Research Center for Ultrahigh Voltage Electron Microscopy, Osaka University (Handai multi-functional Nano-Foundry). We thank Dr. M. Takeuchi from the University of Tokyo for the technical advice.	ALLEN VW, 1992, DEVELOPMENT, V115, P873; Piel M, 2001, SCIENCE, V291, P1550, DOI 10.1126/science.1057330; Nagasato C, 2002, PROTOPLASMA, V219, P140, DOI 10.1007/s007090200015; Staehelin LA, 1997, PLANT J, V11, P1151, DOI 10.1046/j.1365-313X.1997.11061151.x; Mastronarde DN, 1997, J STRUCT BIOL, V120, P343, DOI 10.1006/jsbi.1997.3919; Kremer JR, 1996, J STRUCT BIOL, V116, P71, DOI 10.1006/jsbi.1996.0013; SAMUELS AL, 1995, J CELL BIOL, V130, P1345, DOI 10.1083/jcb.130.6.1345; Lauber MH, 1997, J CELL BIOL, V139, P1485, DOI 10.1083/jcb.139.6.1485; Nagasato C, 2002, J CELL SCI, V115, P2541; REYNOLDS ES, 1963, J CELL BIOL, V17, P208, DOI 10.1083/jcb.17.1.208; Shibata Y, 2009, ANNU REV CELL DEV BI, V25, P329, DOI 10.1146/annurev.cellbio.042308.113324; Barr FA, 2007, CELL, V131, P847, DOI 10.1016/j.cell.2007.11.011; Skop AR, 2004, SCIENCE, V305, P61, DOI 10.1126/science.1097931; English AR, 2009, CURR OPIN CELL BIOL, V21, P596, DOI 10.1016/j.ceb.2009.04.004; Segui-Simarro JM, 2004, PLANT CELL, V16, P836, DOI 10.1105/tpc.017749; TERASAKI M, 1986, J CELL BIOL, V103, P1557, DOI 10.1083/jcb.103.4.1557; Otegui MS, 2001, PLANT CELL, V13, P2033, DOI 10.1105/tpc.13.9.2033; Bisgrove SR, 1998, DEV BIOL, V194, P246, DOI 10.1006/dbio.1997.8832; Bisgrove SR, 2004, PROTOPLASMA, V223, P163, DOI 10.1007/s00709-004-0038-6; Bisgrove SR, 2003, PLANT CELL, V15, P854, DOI 10.1105/tpc.009415; Bouget FY, 1996, PLANT CELL, V8, P189; BRAWLEY SH, 1985, J CELL BIOL, V100, P1173, DOI 10.1083/jcb.100.4.1173; BRAWLEY SH, 1977, J CELL SCI, V24, P275; Bringmann H, 2005, NATURE, V436, P731, DOI 10.1038/nature03823; BYERS B, 1968, PROTOPLASMA, V66, P413, DOI 10.1007/BF01255868; Dreier L, 2000, J CELL BIOL, V148, P883, DOI 10.1083/jcb.148.5.883; Du YR, 2004, J CELL SCI, V117, P2871, DOI 10.1242/jcs.01286; Elad N, 2011, J CELL SCI, V124, P207, DOI 10.1242/jcs.073486; Glotzer M, 2009, CURR BIOL, V19, P162; Hable WE, 2003, PROTOPLASMA, V221, P193, DOI 10.1007/s0070-002-0081-0; HEPLER PK, 1982, PROTOPLASMA, V111, P121, DOI 10.1007/BF01282070; Karyophyllis D, 2000, EUR J PHYCOL, V35, P25, DOI 10.1017/S0967026200002602; KATSAROS C, 1992, PROTOPLASMA, V169, P75, DOI 10.1007/BF01343372; Katsaros C, 2009, BOT MAR, V52, P150, DOI 10.1515/BOT.2009.016; KATSAROS C, 1983, J PHYCOL, V19, P16, DOI 10.1111/j.0022-3646.1983.00016.x; LACLAIRE JW, 1981, BIOL CELL, V40, P139; MARKEY DR, 1975, PROTOPLASMA, V85, P219, DOI 10.1007/BF01567948; Motomura T, 1994, PROTOPLASMA, V178, P94; MULLINS JM, 1982, J CELL BIOL, V94, P654, DOI 10.1083/jcb.94.3.654; MULLINS JM, 1977, J CELL BIOL, V73, P672, DOI 10.1083/jcb.73.3.672; Nagasato C, 2009, J PHYCOL, V45, P404, DOI 10.1111/j.1529-8817.2009.00655.x; Nagasato C, 2010, PLANTA, V232, P287, DOI 10.1007/s00425-010-1188-8; Nagasato C, 1999, DEV BIOL, V208, P200, DOI 10.1006/dbio.1998.9183; Otegui MS, 2004, PLANTA, V218, P501, DOI 10.1007/s00425-003-1125-1; Panstruga R, 2007, ANNU REV CELL DEV BI, V23, P47; Provasoli L, 1968, CULTURES COLLECTIONS, P63; RAPPAPORT R, 1986, INT REV CYTOL, V105, P245, DOI 10.1016/S0074-7696(08)61065-7; RAWLENCE D J, 1973, Phycologia, V12, P17, DOI 10.2216/i0031-8884-12-1-17.1; Sato T, 1968, J Electron Microsc (Tokyo), V17, P158; Schiel A, 2011, J CELL SCI, V124, P1411; SCHOPFER CR, 1991, J CELL SCI, V100, P717; Terauchi M, 2012, PLANTA, V236, P1013, DOI 10.1007/s00425-012-1656-4	52	3	3	SPRINGER WIEN	WIEN	SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA	0033-183X	1615-6102		PROTOPLASMA	Protoplasma	NOV	2014	251	6					1347	1357		10.1007/s00709-014-0635-y		11	Plant Sciences; Cell Biology	Plant Sciences; Cell Biology	AS5WD	WOS:000344336500006		
J	Mostofa, MG; Seraj, ZI; Fujita, M				Mostofa, Mohammad Golam; Seraj, Zeba Islam; Fujita, Masayuki			Exogenous sodium nitroprusside and glutathione alleviate copper toxicity by reducing copper uptake and oxidative damage in rice (Oryza sativa L.) seedlings	PROTOPLASMA			English	Article						Cu toxicity; Oxidative stress; Nitric oxide; Glutathione; Antioxidant system; Cu homeostasis	NITRIC-OXIDE; SALICYLIC-ACID; IRON-DEFICIENCY; SPINACH-CHLOROPLASTS; HYDROGEN-PEROXIDE; STRESS TOLERANCE; REDUCTASE; LEAVES; PLANTS; BARLEY	Nitric oxide (NO) and glutathione (GSH) regulate a variety of physiological processes and stress responses; however, their involvement in mitigating Cu toxicity in plants has not been extensively studied. This study investigated the interactive effect of exogenous sodium nitroprusside (SNP) and GSH on Cu homeostasis and Cu-induced oxidative damage in rice seedlings. Hydroponically grown 12-day-old seedlings were subjected to 100 mu M CuSO4 alone and in combination with 200 mu M SNP (an NO donor) and 200 mu M GSH. Cu exposure for 48 h resulted in toxicity symptoms such as stunted growth, chlorosis, and rolling in leaves. Cu toxicity was also manifested by a sharp increase in lipoxygenase (LOX) activity, lipid peroxidation (MDA), hydrogen peroxide (H2O2), proline (Pro) content, and rapid reductions in biomass, chlorophyll (Chl), and relative water content (RWC). Cu-caused oxidative stress was evident by overaccumulation of reactive oxygen species (ROS; superoxide (O-2 (aEuro cent aEuro")) and H2O2). Ascorbate (AsA) content decreased while GSH and phytochelatin (PC) content increased significantly in Cu-stressed seedlings. Exogenous SNP, GSH, or SNP + GSH decreased toxicity symptoms and diminished a Cu-induced increase in LOX activity, O-2 (aEuro cent aEuro"), H2O2, MDA, and Pro content. They also counteracted a Cu-induced increase in superoxide dismutase (SOD), ascorbate peroxidase (APX), glutathione reductase (GR), monodehydroascorbate reductase (MDHAR), and glyoxalase I and glyoxalase II activities, which paralleled changes in ROS and MDA levels. These seedlings also showed a significant increase in catalase (CAT), glutathione peroxidase (GPX), dehydroascorbate reductase (DHAR), glutathione S-transferase (GST) activities, and AsA and PC content compared with the seedlings stressed with Cu alone. Cu analysis revealed that SNP and GSH restricted the accumulation of Cu in the roots and leaves of Cu-stressed seedlings. Our results suggest that Cu exposure provoked an oxidative burden while reduced Cu uptake and modulating the antioxidant defense and glyoxalase systems by adding SNP and GSH play an important role in alleviating Cu toxicity. Furthermore, the protective action of GSH and SNP + GSH was more efficient than SNP alone.	[Mostofa, Mohammad Golam; Fujita, Masayuki] Kagawa Univ, Fac Agr, Dept Appl Biol Sci, Lab Plant Stress Responses, Miki, Kagawa 7610795, Japan; [Mostofa, Mohammad Golam] Bangabandhu Shiekh Mujibur Rahman Agr Univ, Dept Biochem & Mol Biol, Gazipur 1706, Bangladesh; [Seraj, Zeba Islam] Univ Dhaka, Dept Biochem & Mol Biol, Dhaka 1000, Bangladesh	Fujita, M (reprint author), Kagawa Univ, Fac Agr, Dept Appl Biol Sci, Lab Plant Stress Responses, Miki, Kagawa 7610795, Japan.	mostofabmb@gmail.com; fujita@ag.kagawa-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan	M. G. Mostofa thankfully acknowledges the financial support from the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan.	Wang YS, 2005, PLANT CELL PHYSIOL, V46, P1915, DOI 10.1093/pcp/pci202; NAKANO Y, 1981, PLANT CELL PHYSIOL, V22, P867; Graziano M, 2007, PLANT J, V52, P949, DOI 10.1111/j.1365-313X.2007.03283.x; Noctor G, 2002, J EXP BOT, V53, P1283, DOI 10.1093/jexbot/53.372.1283; Hossain MA, 2009, AUST J CROP SCI, V3, P53; Hossain Mohammad Anwar, 2010, Physiology and Molecular Biology of Plants, V16, P259, DOI 10.1007/s12298-010-0028-4; Singla-Pareek SL, 2006, PLANT PHYSIOL, V140, P613, DOI 10.1104/pp.105.073734; Choudhary SP, 2012, J EXP BOT, V63, P5659, DOI 10.1093/jxb/ers219; Singh VP, 2013, PLANT PHYSIOL BIOCH, V71, P155, DOI 10.1016/j.plaphy.2013.07.003; BATES LS, 1973, PLANT SOIL, V39, P205, DOI 10.1007/BF00018060; Mishra A, 1999, BIOL PLANTARUM, V42, P409, DOI 10.1023/A:1002469303670; Singh HP, 2009, NITRIC OXIDE-BIOL CH, V20, P289, DOI 10.1016/j.niox.2009.02.004; Xiong J, 2010, ARCH BIOCHEM BIOPHYS, V497, P13, DOI 10.1016/j.abb.2010.02.014; ARNON DI, 1949, PLANT PHYSIOL, V24, P1, DOI 10.1104/pp.24.1.1; Kholodova V, 2011, ENVIRON EXP BOT, V71, P382, DOI 10.1016/j.envexpbot.2011.02.007; Sun BT, 2007, J PLANT PHYSIOL, V164, P536, DOI 10.1016/j.jplph.2006.02.011; El-Shabrawi H, 2010, PROTOPLASMA, V245, P85, DOI 10.1007/s00709-010-0144-6; Chen WW, 2010, PLANT PHYSIOL, V154, P810, DOI 10.1104/pp.110.161109; Cobbett C, 2002, ANNU REV PLANT BIOL, V53, P159, DOI 10.1146/annurev.arplant.53.100301.135154; Thounaojam TC, 2012, PLANT PHYSIOL BIOCH, V53, P33, DOI 10.1016/j.plaphy.2012.01.006; Beligni MV, 2002, PLANT CELL ENVIRON, V25, P737, DOI 10.1046/j.1365-3040.2002.00857.x; Bhuiyan MAH, 2010, J HAZARD MATER, V179, P1065, DOI 10.1016/j.jhazmat.2010.03.114; Laspina NV, 2005, PLANT SCI, V169, P323, DOI 10.1016/j.plantsci.2005.02.007; Chen F, 2010, PLANT PHYSIOL BIOCH, V48, P663, DOI 10.1016/j.plaphy.2010.05.001; Nagajyoti PC, 2010, ENVIRON CHEM LETT, V8, P199, DOI 10.1007/s10311-010-0297-8; Wang LN, 2010, J PLANT PHYSIOL, V167, P1298, DOI 10.1016/j.jplph.2010.04.007; Gill SS, 2010, PLANT PHYSIOL BIOCH, V48, P909, DOI 10.1016/j.plaphy.2010.08.016; Metwally A, 2003, PLANT PHYSIOL, V132, P272, DOI 10.1104/pp.102.018457; GRIFFITH OW, 1980, ANAL BIOCHEM, V106, P207, DOI 10.1016/0003-2697(80)90139-6; Dutilleul C, 2003, PLANT PHYSIOL, V131, P264, DOI 10.1104/pp.011155; HEATH RL, 1968, ARCH BIOCHEM BIOPHYS, V125, P189, DOI 10.1016/0003-9861(68)90654-1; Singh HP, 2008, ENVIRON EXP BOT, V63, P158, DOI 10.1016/j.envexpbot.2007.12.005; Elia AC, 2003, ECOTOX ENVIRON SAFE, V55, P162, DOI 10.1016/S0147-6513(02)00123-9; Anjum NA, 2012, ENVIRON EXP BOT, V75, P307, DOI 10.1016/j.envexpbot.2011.07.002; Yruela I, 2009, FUNCT PLANT BIOL, V36, P409, DOI 10.1071/FP08288; Mostofa MG, 2013, ECOTOXICOLOGY, V22, P959, DOI 10.1007/s10646-013-1073-x; Zhang H, 2008, RUSS J PLANT PHYSL+, V55, P469, DOI 10.1134/S1021443708040067; Burkhead JL, 2009, NEW PHYTOL, V182, P799, DOI 10.1111/j.1469-8137.2009.02846.x; HOSSAIN MA, 1984, PLANT CELL PHYSIOL, V25, P385; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1006/abio.1976.9999; Jozefczak M, 2012, INT J MOL SCI, V13, P3145, DOI 10.3390/ijms13033145; Saito R, 2011, PLANT CELL ENVIRON, V34, P1454, DOI 10.1111/j.1365-3040.2011.02344.x; Chen CT, 2004, PLANT SCI, V166, P103, DOI 10.1016/j.plantsci.2003.08.015; FOYER CH, 1976, PLANTA, V133, P21, DOI 10.1007/BF00386001; Mostofa MG, 2014, PLANT GROWTH REGUL, V73, P31, DOI 10.1007/s10725-013-9865-9; Berg J.M., 1994, PRINCIPLES BIOINORGA; Cai Y, 2010, BIOL TRACE ELEM RES, V143, P1159; Chino M., 1981, Heavy metal pollution in soils of Japan, P65; Contreras L, 2009, AQUAT TOXICOL, V94, P94, DOI 10.1016/j.aquatox.2009.06.004; De Vos RCH, 1992, PLANT PHYSIOL, V98, P853; Demirevska-Kepova K, 2004, ENVIRON EXP BOT, V52, P253, DOI 10.1016/j.envexpbot.2004.02.004; DODERER A, 1992, BIOCHIM BIOPHYS ACTA, V1120, P97, DOI 10.1016/0167-4838(92)90429-H; Hoque TS, 2012, J PLANT PHYSIOL, V169, P979, DOI 10.1016/j.jplph.2012.02.007; Hossain M.A., 2013, J PLANT SCI MOL BREE, V2, P1, DOI DOI 10.7243/2050-2389-2-2; Hossain M.A., 2013, MOL PLANT BREED, V4, P50, DOI DOI 10.5376/MPB.2013.04.0007; Hossain MA, 2012, J BOT, V2012, P1, DOI DOI 10.1155/2012/872875; Jones JB, 1998, PLANT NUTR MANUAL, P55; KANG YJ, 1987, CELL BIOL TOXICOL, V3, P347, DOI 10.1007/BF00119909; Kazemi N, 2010, SCI HORTIC-AMSTERDAM, V126, P402, DOI 10.1016/j.scienta.2010.07.037; Li Y, 2009, ACTA PHYSIOL PLANT, V31, P55; Marschner P, 2012, MARSCHNER'S MINERAL NUTRITION OF HIGHER PLANTS, 3RD EDITION, P1; Panda P, 2011, ACTA PHYSIOL PLANT, V33, P1737, DOI 10.1007/s11738-011-0710-3; Siddiqui MH, 2011, PROTOPLASMA, V248, P447; Thounaojam TC, 2014, PROTOPLASMA, V251, P61, DOI 10.1007/s00709-013-0525-8; Wendehenne D, 2005, BMC PLANT BIOL S1, V5, pS35, DOI [10.1186/ 1471-2229-5-S1-S35, DOI 10.1186/1471-2229-5-SL-S35, DOI 10.1186/1471-2229-5-S1-S35]; Yadav Sudesh Kumar, 2005, Physiology and Molecular Biology of Plants, V11, P1; Yruela Inmaculada, 2005, Brazilian Journal of Plant Physiology, V17, P145, DOI 10.1590/S1677-04202005000100012; Yu CC, 2005, J PLANT PHYSL, V162, P319	68	6	6	SPRINGER WIEN	WIEN	SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA	0033-183X	1615-6102		PROTOPLASMA	Protoplasma	NOV	2014	251	6					1373	1386		10.1007/s00709-014-0639-7		14	Plant Sciences; Cell Biology	Plant Sciences; Cell Biology	AS5WD	WOS:000344336500008		
J	Umeda, M; Kawakami, N				Umeda, Maki; Kawakami, Norito			Cross-cultural measurement equivalence of the Japanese version of Revised Conflict Tactics Scales Short Form among Japanese men and women	PSYCHIATRY AND CLINICAL NEUROSCIENCES			English	Article						cultural characteristics; domestic violence; Japan; reproducibility of result	INTIMATE PARTNER VIOLENCE; AGGRESSION QUESTIONNAIRE; PSYCHOLOGICAL DISTRESS; GENERAL-POPULATION; DOMESTIC VIOLENCE; HEALTH; ABUSE; MULTICOUNTRY; YOKOHAMA; ILLNESS	AimThe Revised Conflict Tactics Scales Short Form (CTS2SF) is an instrument used to measure intimate partner violence (IPV) perpetration and victimization over the past 12 months. MethodsThe CTS2SF was translated into Japanese, and the reliability (internal consistency and 4-week test-retest reliability) and the concurrent and factor-based validity were examined using two waves of Internet surveys over an interval of 4 weeks. Participants of the survey were 393 Japanese men and women who were registrants of an Internet survey company. ResultsCronbach's was greater than 0.5 for most scales, while it was low (=0.18) for sexual coercion by partner. The test-retest reliability of the binary variable for the presence or absence of IPV was high (Yule's Q, 0.79-1.00), and moderate between the scores (Spearman's rank correlation, 0.38:0.70). Concordance with the Buss-Perry Aggression Questionnaire, Violence Against Women Screen, and Kessler 6 generally indicated good concurrent validity. The results of the exploratory factor analysis confirmed the three-factor structure of the Japanese version of the CTS2SF. ConclusionAlthough the internal consistency reliability was limited for some sub-scales, its moderate internal consistency and test-retest reliability and good factor-based validity highlighted the benefit of using the Japanese version of the CTS2SF in a large-scale community survey where a shorter scale is required to assess IPV.	[Umeda, Maki; Kawakami, Norito] Univ Tokyo, Grad Sch Med, Dept Mental Hlth, Tokyo 1130033, Japan	Umeda, M (reprint author), Univ Tokyo, Grad Sch Med, Dept Mental Hlth, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.	makiumeda-tky@umin.ac.jp			Ministry of Education, Culture, Sports, Science and Technology, Japan [20240062]	This study was supported by a Grant-in-Aid for Scientific Research (A) 2009-2013 (No. 20240062) from the Ministry of Education, Culture, Sports, Science and Technology, Japan. There is no conflict of interest. Material from the CTS2 'short form' (c) 2003 by Western Psychological Services. Translated and adapted by M. Umeda, the University of Tokyo, for specific, limited research use under license of the publisher, WPS, 625 Alaska Avenue, Torrance, California 90503, U.S.A. (rights@wpspublish.com). No additional reproduction, in whole or in part, by any medium or for any purpose, may be made without prior, written authorization of WPS. All rights reserved.	Kessler RC, 2003, ARCH GEN PSYCHIAT, V60, P184, DOI 10.1001/archpsyc.60.2.184; Garcia-Moreno C, 2006, LANCET, V368, P1260, DOI 10.1016/S0140-6736(06)69523-8; Ellsberg M, 2008, LANCET, V371, P1165, DOI 10.1016/S0140-6736(08)60522-X; Kessler RC, 2002, PSYCHOL MED, V32, P959, DOI 10.1017/S0033291702006074; Straus MA, 1996, J FAM ISSUES, V17, P283, DOI 10.1177/019251396017003001; HUDSON WW, 1981, J MARRIAGE FAM, V43, P873, DOI 10.2307/351344; Furukawa TA, 2008, INT J METH PSYCH RES, V17, P152, DOI 10.1002/mpr.257; Yoshihama M, 2002, AM J COMMUN PSYCHOL, V30, P429, DOI 10.1023/A:1015393204820; Boyle MH, 2009, SOC SCI MED, V69, P691, DOI 10.1016/j.socscimed.2009.06.039; Bauer NS, 2013, JAMA PEDIATR, V167, P341, DOI 10.1001/jamapediatrics.2013.780; Kessler RC, 2010, INT J METH PSYCH RES, V19, P4, DOI 10.1002/mpr.310; Straus MA, 2004, CROSS-CULT RES, V38, P407, DOI 10.1177/1069397104269543; Ando A, 1999, JPN J PSYCHOL, V70, P384; BUSS AH, 1992, J PERS SOC PSYCHOL, V63, P452, DOI 10.1037//0022-3514.63.3.452; Dussich JPJ, 2001, INT J OFFENDER THER, V45, P278, DOI 10.1177/0306624X01453002; Ishii T, 2003, PSYCHIAT MED, V45, P817; Ishii T, 2002, P ANN CONV JAP PSYCH, P277; Japan. Cabinet Office, 2012, REP INT PARTN VIOL; Kataoka Y, 2005, JAPAN J NURSING SCI, V25, P51; Kataoka Y, 2005, JAPAN J PUBLIC HLTH, V52, P785; Macromill, 2012, LIF STYL SURV MACR R; MARSHALL LL, 1992, J FAM VIOLENCE, V7, P103, DOI 10.1007/BF00978700; Moraes Claudia Leite, 2002, Cad Saude Publica, V18, P783, DOI 10.1590/S0102-311X2002000300027; Oram S, 2014, EPIDEMIOL PSYCH SCI, V23, P361, DOI 10.1017/S2045796013000450; Rani Manju, 2004, Afr J Reprod Health, V8, P116, DOI 10.2307/3583398; Smith P H, 1995, Womens Health, V1, P273; Straus M. A., 2003, CONFLICT TACTICS SCA; Straus Murray A, 2004, Violence Vict, V19, P507, DOI 10.1891/088667004780927800; Straus MA, TRANSLATIONS CONFLIC; Yoshihama M, 2002, SOC WORK, V47, P389; Yoshihama M, 2009, AM J PUBLIC HEALTH, V99, P647, DOI 10.2105/AJPH.2007.118976; Yoshihama M, 2010, SOC SCI MED, V71, P1199, DOI 10.1016/j.socscimed.2010.06.018	32	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1323-1316	1440-1819		PSYCHIAT CLIN NEUROS	Psychiatry Clin. Neurosci.	NOV	2014	68	11					804	811		10.1111/pcn.12194		8	Clinical Neurology; Neurosciences; Psychiatry	Neurosciences & Neurology; Psychiatry	AS6XR	WOS:000344403100004		
J	Takeuchi, N; Fujita, K; Aizen, VB; Narama, C; Yokoyama, Y; Okamoto, S; Naoki, K; Kubota, J				Takeuchi, Nozomu; Fujita, Koji; Aizen, Vladimir B.; Narama, Chiyuki; Yokoyama, Yusuke; Okamoto, Sachiko; Naoki, Kazuhiro; Kubota, Jumpei			The disappearance of glaciers in the Tien Shan Mountains in Central Asia at the end of Pleistocene	QUATERNARY SCIENCE REVIEWS			English	Article						Bolling-Allerod; Glaciers; Ice core; Holocene; Deglaciation	ICE-CORE RECORD; ENVIRONMENTAL-CHANGES; QUATERNARY GLACIATION; TAKLAMAKAN DESERT; CLIMATE-CHANGE; HOLOCENE; CHINA; INSTABILITY; EVOLUTION; DEPOSITS	Glaciers in Central Asia are among the largest ice masses in the Eurasian continent and have supplied vital water to local inhabitants for thousands of years. The glaciers in this region are generally believed to be remnants of the last deglaciation, however, glacier variability in the central Asian mountains since the Last Glacial Maximum (LGM) has not been well documented. Here, we report an 86.87 m-deep ice core record drilled on an ice cap in the Tien Shan Mountains of Central Asia. Radiocarbon dating of organic soil from the bottom of the ice-core borehole showed that the age of the soil was 12,656 - 12,434 cal years before present, coincident with the beginning of the Younger Dryas cold period (YD). This result indicates that the ice cap did not exist in the Bolling-Allerod period (BA), which was the warm period before the YD, and that the BA climate was significantly warmer than at present. It also indicates that the ice cap has never entirely disappeared in any warm periods throughout the Holocene. We estimated that during the BA its extent was 43% or less of the present glacier coverage in the mountains. Our results suggest that this region at the end of Pleistocene was considerably warmer than at present, and that most of the present glaciers in this region are not relics of the Last Glacial period, but are composed of ice formed during the YD and Holocene. (C) 2014 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).	[Takeuchi, Nozomu] Chiba Univ, Grad Sch Sci, Dept Earth Sci, Chiba 2638522, Japan; [Fujita, Koji; Okamoto, Sachiko] Nagoya Univ, Grad Sch Environm Studies, Nagoya, Aichi 4648601, Japan; [Aizen, Vladimir B.] Univ Idaho, Coll Sci, Moscow, ID 83843 USA; [Narama, Chiyuki] Niigata Univ, Dept Environm Sci, Niigata 9502181, Japan; [Yokoyama, Yusuke] Univ Tokyo, Atmosphere & Ocean Res Inst, Chiba 2778564, Japan; [Naoki, Kazuhiro] Tokai Univ, Res & Informat Ctr, Tokyo 1510063, Japan; [Kubota, Jumpei] Res Inst Humanity & Nat, Kyoto 6038047, Japan	Takeuchi, N (reprint author), Chiba Univ, Grad Sch Sci, Dept Earth Sci, Chiba 2638522, Japan.	ntakeuch@faculty.chiba-u.jp	Fujita, Koji/E-6104-2010; 	Fujita, Koji/0000-0003-3753-4981; Takeuchi, Nozomu/0000-0002-3267-5534	Research Institute for Humanity and Nature (RIHN), Japan [R-03]; JSPS KAKENHI-A [26247078]	We thank Dr. B. Moldobekov and Prof. C. Reigber of the Central Asian Institute for Applied Geosciences (CAIAG), Kyrgyzstan, and V. Denisov and other members of the Top Asia tourist company for their logistic support of the fieldwork. We also thank Dr. Vladimir Shatravin of the Institute of Water Problems and Hydropower, National Academy of Sciences, Kyrgyzstan for information on paleo-geomorphology in Tien Shan Mountains, Dr. Arwyn Edwards for English correction, and anonymous reviewers for valuable suggestions, which significantly improved this manuscript. This study was a part of the Ili Projects (R-03, 2006-2012) funded by the Research Institute for Humanity and Nature (RIHN), Japan, and partly supported by JSPS KAKENHI-A (No. 26247078).	Yang XP, 2006, QUATERNARY SCI REV, V25, P923, DOI 10.1016/j.quascirev.2005.06.008; Yang B, 2009, QUATERN INT, V194, P68, DOI 10.1016/j.quaint.2007.11.020; Alley RB, 1997, GEOLOGY, V25, P483, DOI 10.1130/0091-7613(1997)025<0483:HCIAPW>2.3.CO;2; Sorg A, 2012, NAT CLIM CHANGE, V2, P725, DOI [10.1038/nclimate1592, 10.1038/NCLIMATE1592]; Aizen VB, 1997, J CLIMATE, V10, P1393, DOI 10.1175/1520-0442(1997)010<1393:CAHCIT>2.0.CO;2; Barnett TP, 2005, NATURE, V438, P303, DOI 10.1038/nature04141; Stuiver M, 1995, QUATERNARY RES, V44, P341, DOI 10.1006/qres.1995.1079; Narama C, 2007, QUAT GEOCHRONOL, V2, P249, DOI 10.1016/j.quageo.2006.06.007; Zech R, 2012, QUATERNARY RES, V77, P281, DOI 10.1016/j.yqres.2011.11.008; Seong YB, 2009, GEOL SOC AM BULL, V121, P348, DOI 10.1130/B26339.1; Tian LD, 2007, J GEOPHYS RES-ATMOS, V112, DOI 10.1029/2006JD007718; Yang XP, 2010, QUATERNARY RES, V73, P1, DOI 10.1016/j.yqres.2009.10.011; Thompson LG, 1997, SCIENCE, V276, P1821, DOI 10.1126/science.276.5320.1821; Kalnay E, 1996, B AM METEOROL SOC, V77, P437, DOI 10.1175/1520-0477(1996)077<0437:TNYRP>2.0.CO;2; Reimer PJ, 2009, RADIOCARBON, V51, P1111; Herzschuh U, 2006, QUATERNARY SCI REV, V25, P163, DOI 10.1016/j.quascirev.2005.02.006; Herren PA, 2013, QUATERNARY SCI REV, V69, P59, DOI 10.1016/j.quascirev.2013.02.025; Numaguti A, 1999, J GEOPHYS RES-ATMOS, V104, P1957, DOI 10.1029/1998JD200026; DANSGAARD W, 1993, NATURE, V364, P218, DOI 10.1038/364218a0; Fujita K, 2007, HYDROL PROCESS, V21, P2892, DOI 10.1002/hyp.6504; THOMPSON LG, 1989, SCIENCE, V246, P474, DOI 10.1126/science.246.4929.474; Liu Z, 2009, SCIENCE, V325, P310, DOI 10.1126/science.1171041; Feng ZD, 2006, HOLOCENE, V16, P119, DOI 10.1191/0959683606hl912xx; Fujita K, 2011, CRYOSPHERE, V5, P539, DOI 10.5194/tc-5-539-2011; Grosswald M., 1994, GEOJOURNAL, V33, P273, DOI 10.1007/BF00812878; Koppes M, 2008, QUATERNARY SCI REV, V27, P846, DOI 10.1016/j.quascirev.2008.01.009; Kreutz KJ, 2001, J GLACIOL, V47, P548, DOI 10.3189/172756501781831819; Lee XQ, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2002JD002181; Maksimov E.V., 1987, TERMINAL MORAINES 7, V1, P28; Maksimov E.V., 1980, HIST GLACIATION KYRG, P184; Melnikova A.P., 1987, THESIS MOSCOW STATE, P23; Osmonov A.O., 1991, CENTRAL TIEN SHAN GL, P40; Penck A, 1909, ALPEN EISZEITALTER, V3; Pomortcev O.A., 1980, THESIS LENINGRAD STA, P25; Romanovskiy V.V., 2007, CLIMATE GLACIERS LAK, V162; Sevastyanov D.V., 1974, IZV VGO, V106; Shakun JD, 2010, QUATERNARY SCI REV, V29, P1801, DOI 10.1016/j.quascirev.2010.03.016; Shatravin V.I., 1994, GEOLOGY CENOZOIC SEI, P15; Shatravin V.I., 1992, THESIS I GEOLOGY ARC, P21; Shatravin V.I., 2012, ANDEAN ASIA MOUNTAIN, P123; Shatravin V.I., 2007, CLIMATE GLACIERS LAK, P74; Shatravin V.I., 1994, GEOLOGY CENOZOIC SEI, P3; Shitnikov A.V., 1957, NEWS W GEOGRAPHICAL, V16, P337; Sigl M, 2009, J GLACIOL, V55, P985; Solomina O.N., 1999, EURASIA MOUNTAIN GLA, P180; Stein A, 1925, GEOGR J, V65, P377, DOI 10.2307/1782547; Takeuchi N., 2004, POLAR METEOROL GLACI, V18, P121; Thompson L.G., 1997, MAT GLYATSIOL ISSLED, V81, P100; Yang X, 2006, LAND DEGRAD DEV, V17, P381, DOI 10.1002/ldr.744; Yang X, 2001, ENVIRON GEOL, V41, P314, DOI 10.1007/s002540100388	50	3	3	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0277-3791			QUATERNARY SCI REV	Quat. Sci. Rev.	NOV 1	2014	103						26	33		10.1016/j.quascirev.2014.09.006		8	Geography, Physical; Geosciences, Multidisciplinary	Physical Geography; Geology	AS3YM	WOS:000344211000003		
J	Brabcova, KP; Sihver, L; Yasuda, N; Matuo, Y; Stepan, V; Davidkova, M				Brabcova, Katerina Pachnerova; Sihver, Lembit; Yasuda, Nakahiro; Matuo, Youichirou; Stepan, Vaclav; Davidkova, Marie			Clustered DNA damage on subcellular level: effect of scavengers	RADIATION AND ENVIRONMENTAL BIOPHYSICS			English	Article						Clustered damage; Indirect effects; Heavy ion; Plasmid in liquid water; Scavenger	QUANTITATIVE-ANALYSIS; IONIZING-RADIATION; OXIDATIVE DAMAGE; PLASMID DNA; HUMAN-CELLS; GAMMA-RAYS; REPAIR; IRRADIATION; LESIONS; YIELDS	Clustered DNA damages are induced by ionizing radiation, particularly of high linear energy transfer (LET). Compared to isolated DNA damage sites, their biological effects can be more severe. We investigated a clustered DNA damage induced by high LET radiation (C 290 MeV u(-1) and Fe 500 MeV u(-1)) in pBR322 plasmid DNA. The plasmid is dissolved in pure water or in aqueous solution of one of the three scavengers (coumarin-3-carboxylic acid, dimethylsulfoxide, and glycylglycine). The yield of double strand breaks (DSB) induced in the DNA plasmid-scavenger system by heavy ion radiation was found to decrease with increasing scavenging capacity due to reaction with hydroxyl radical, linearly with high correlation coefficients. The yield of non-DSB clusters was found to occur twice as much as the DSB. Their decrease with increasing scavenging capacity had lower linear correlation coefficients. This indicates that the yield of non-DSB clusters depends on more factors, which are likely connected to the chemical properties of individual scavengers.	[Brabcova, Katerina Pachnerova; Sihver, Lembit] Chalmers, Dept Appl Phys, S-41296 Gothenburg, Sweden; [Brabcova, Katerina Pachnerova; Stepan, Vaclav; Davidkova, Marie] ASCR, Inst Nucl Phys, Dept Radiat Dosimetry, Prague 18000, Czech Republic; [Yasuda, Nakahiro; Matuo, Youichirou] Univ Fukui, Res Inst Nucl Engn, Tsuruga, Fukui 9140055, Japan; [Stepan, Vaclav] Univ Bordeaux, CENBG, Ctr Etud Nucl Bordeaux Gradignan, CNRS,IN2P3, F-33175 Gradignan, France	Brabcova, KP (reprint author), Chalmers, Dept Appl Phys, Fys Grarden 4, S-41296 Gothenburg, Sweden.	brabcova.katerina@gmail.com	Davidkova, Marie/G-7845-2014; Stepan, Vaclav/G-7865-2014	Stepan, Vaclav/0000-0002-7696-2877	ESA-ESTEC NPI [4000101677/10/NL/PA-NPI 120-2009]; NIRS-HIMAC [13J401]; Ministry of Education, Youth and Sports of the Czech Republic [LD12008]	K. Pachnerova Brabcova and L. Sihver greatly acknowledge the support by the ESA-ESTEC NPI program No. 4000101677/10/NL/PA-NPI 120-2009. This work was performed as a part of accelerator experiments of the Research Project (13J401) at NIRS-HIMAC. We would like to express our thanks to the staff of NIRS-HIMAC for their kind support throughout the experiments for sample irradiation. M. Davidkova and V. Stepan greatly acknowledge the support by the Ministry of Education, Youth and Sports of the Czech Republic, project No. LD12008.	Akimoto T, 2000, CHEM PHARM BULL, V48, P467; Shikazono N, 2009, J RADIAT RES, V50, P27, DOI 10.1269/jrr.08086; Tsao D, 2007, RADIAT RES, V168, P87, DOI 10.1667/RR0865.1; Prise KM, 1999, CARCINOGENESIS, V20, P905, DOI 10.1093/carcin/20.5.905; Leloup C, 2005, INT J RADIAT BIOL, V81, P41, DOI 10.1080/09553000400017895; Keszenman DJ, 2010, RADIAT RES, V174, P238, DOI 10.1667/RR2093.1; Sutherland BM, 2000, P NATL ACAD SCI USA, V97, P103, DOI 10.1073/pnas.97.1.103; Sui L, 2013, CHINESE SCI BULL, V58, P3217, DOI 10.1007/s11434-013-5940-x; COWAN R, 1987, J THEOR BIOL, V127, P229, DOI 10.1016/S0022-5193(87)80133-9; LAVERNE JA, 1993, RADIAT RES, V135, P16, DOI 10.2307/3578391; Coudore F, 1997, FEBS LETT, V414, P581, DOI 10.1016/S0014-5793(97)01077-6; Asaithamby A, 2011, P NATL ACAD SCI USA, V108, P8293, DOI 10.1073/pnas.1016045108; Terato H, 2008, J RADIAT RES, V49, P133, DOI 10.1269/jrr.07089; Milligan JR, 2000, INT J RADIAT BIOL, V76, P1475; Dizdaroglu M, 2012, FREE RADICAL RES, V46, P382, DOI 10.3109/10715762.2011.653969; Maeyama T, 2011, RADIAT PHYS CHEM, V80, P535, DOI 10.1016/j.radphyschem.2010.11.013; Hada M, 2006, RADIAT RES, V165, P223, DOI 10.1667/RR3498.1; Hada M, 2008, J RADIAT RES, V49, P203, DOI 10.1269/jrr.07123; Baldacchino G, 2009, CHEM PHYS LETT, V468, P275, DOI 10.1016/j.cplett.2008.12.006; Georgakilas AG, 2013, RADIAT RES, V180, P100, DOI 10.1667/RR3041.1; BOITEUX S, 1993, J PHOTOCH PHOTOBIO B, V19, P87, DOI 10.1016/1011-1344(93)87101-R; BOLCH WE, 1990, RADIAT RES, V121, P248, DOI 10.2307/3577773; Dang HM, 2011, EUR PHYS J D, V63, P359, DOI 10.1140/epjd/e2011-10679-1; Eccles JL, 2011, MUTAT RES, V711, P134; KLIMCZAK U, 1993, INT J RADIAT BIOL, V64, P497, DOI 10.1080/09553009314551711; Kouass Sahbani S., 2014, RADIAT RES, V181, P99; Pang DL, 2011, J RADIAT RES, V52, P309, DOI 10.1269/jrr.10147; Smialek MA, 2012, J PHYS CONF SER, V373, DOI 10.1088/1742-6596/373/1/012013; Stepan V, 2014, EUR PHYS J D, V68, DOI 10.1140/epjd/e2014-50068-8; Terato Hiroaki, 2004, Biol Sci Space, V18, P206, DOI 10.2187/bss.18.206; von Sonntag C, 2006, FREE RADICAL INDUCED; Ward JF, 1985, RADIAT RES, V104, P103; Yamashita S, 2012, FREE RADICAL RES, V46, P861, DOI 10.3109/10715762.2012.684879	33	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0301-634X	1432-2099		RADIAT ENVIRON BIOPH	Radiat. Environ. Biophys.	NOV	2014	53	4					705	712		10.1007/s00411-014-0557-2		8	Biology; Biophysics; Environmental Sciences; Radiology, Nuclear Medicine & Medical Imaging	Life Sciences & Biomedicine - Other Topics; Biophysics; Environmental Sciences & Ecology; Radiology, Nuclear Medicine & Medical Imaging	AS3KZ	WOS:000344177800008		
J	Mano, S; Suto, Y				Mano, Shuhei; Suto, Yumiko			A Bayesian hierarchical method to account for random effects in cytogenetic dosimetry based on calibration curves	RADIATION AND ENVIRONMENTAL BIOPHYSICS			English	Article						Dicentric chromosome assay; Calibration; Random effects; Bayesian hierarchical model	BIOLOGICAL DOSIMETRY; DOSE-RESPONSE; GAMMA-RAYS; RADIATION; BIODOSIMETRY; LYMPHOCYTES; EXPOSURE; DAMAGE; ASSAY	The dicentric chromosome assay (DCA) is one of the most sensitive and reliable methods of inferring doses of radiation exposure in patients. In DCA, one calibration curve is prepared in advance by in vitro irradiation to blood samples from one or sometimes multiple healthy donors in considering possible inter-individual variability. Although the standard method has been demonstrated to be quite accurate for actual dose estimates, it cannot account for random effects, which come from such as the blood donor used to prepare the calibration curve, the radiation-exposed patient, and the examiners. To date, it is unknown how these random effects impact on the standard method of dose estimation. We propose a novel Bayesian hierarchical method that incorporates random effects into the dose estimation. To demonstrate dose estimation by the proposed method and to assess the impact of inter-individual variability in samples from multiple donors on the estimation, peripheral blood samples from 13 occupationally non-exposed, non-smoking, healthy individuals were collected and irradiated with gamma rays. The results clearly showed significant inter-individual variability and the standard method using a sample from a single donor gave anti-conservative confidence interval of the irradiated dose. In contrast, the Bayesian credible interval for irradiated dose calculated by the proposed method using samples from multiple donors properly covered the actual doses. Although the classical confidence interval of calibration curve with accounting inter-individual variability in samples from multiple donors was roughly coincident with the Bayesian credible interval, the proposed method has better reasoning and potential for extensions.	[Mano, Shuhei] Inst Stat Math, Dept Math Anal & Stat Inference, Tachikawa, Tokyo 1908562, Japan; [Suto, Yumiko] Natl Inst Radiol Sci, Res Ctr Radiat Emergency Med, Chiba 260, Japan	Mano, S (reprint author), Inst Stat Math, Dept Math Anal & Stat Inference, 10-3 Midori Cho, Tachikawa, Tokyo 1908562, Japan.	smano@ism.ac.jp			Research Organization of Information and Systems; Institute of Statistical Mathematics [2012-ISM CRP -4302]; International Atomic Energy Agency [IAEA CRP E.3.50.08]	We would like to thank Dr. Masanari Itokawa (Tokyo Metropolitan Institute of Medical Science, Tokyo, Japan) for arranging blood sample collection from volunteer donors and Dr. Momoki Hirai (National Institute of Radiological Sciences, Chiba, Japan) for useful discussions. We would also like to thank the reviewer for many useful comments and suggestions. This work was supported by the Research Organization of Information and Systems (Grant awarded by the president) and by the Institute of Statistical Mathematics cooperative research program (Grant No. 2012-ISM CRP -4302). This project was partly supported by International Atomic Energy Agency (IAEA CRP E.3.50.08).	Ainsbury EA, 2014, RADIAT PROT DOSIM, V162, P185, DOI 10.1093/rpd/nct301; Al-Hadyan K, 2014, BIO-TECHNOL, DOI [10.1007/s13205-014-0217-x, DOI 10.1007/S13205-014-0217-X]; Spiegelhalter DJ, 2002, J ROY STAT SOC B, V64, P583, DOI 10.1111/1467-9868.00353; Vinnikov VA, 2013, RADIAT PROT DOSIM, V154, P186, DOI 10.1093/rpd/ncs200; Romm H, 2009, ANN I SUPER SANITA, V45, P251; BENDER MA, 1988, MUTAT RES, V196, P103, DOI 10.1016/0165-1110(88)90017-6; Deperas J, 2007, RADIAT PROT DOSIM, V124, P115, DOI 10.1093/rpd/ncm137; Ainsbury EA, 2013, MUTAT RES-GEN TOX EN, V756, P184, DOI 10.1016/j.mrgentox.2013.06.005; BARQUINERO JF, 1995, MUTAT RES-FUND MOL M, V326, P65, DOI 10.1016/0027-5107(94)00150-4; Thierens H, 2005, RADIAT PROT DOSIM, V113, P408, DOI 10.1093/rpd/nch483; Brown PJ, 1994, MEASUREMENT; Gilks W. R, 1996, MARKOV CHAIN MONTE C; Groer PG, 1987, PROBABILITY BAYESIAN; International Atomic Energy Agency, 2011, CYT DOS APPL PREP RE; KAKATI S, 1986, CANCER GENET CYTOGEN, V22, P137, DOI 10.1016/0165-4608(86)90173-1; Nelder J., 1989, GEN LINEAR MODELS; Prasanna PGS, 2013, CYTOGENETIC BIODOSIM, P272; Suto Y, 2010, RAD CYTOGENETICS DIC; Suto Y, 2013, HEALTH PHYS, V105, P366, DOI 10.1097/HP.0b013e3182995e42; Szluinska M, 2005, STAT METHODS BIOL DO; THIERENS H, 1991, HEALTH PHYS, V61, P623, DOI 10.1097/00004032-199111000-00005; VANBUUL PPW, 1980, MUTAT RES, V70, P61, DOI 10.1016/0027-5107(80)90058-5	22	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0301-634X	1432-2099		RADIAT ENVIRON BIOPH	Radiat. Environ. Biophys.	NOV	2014	53	4					775	780		10.1007/s00411-014-0563-4		6	Biology; Biophysics; Environmental Sciences; Radiology, Nuclear Medicine & Medical Imaging	Life Sciences & Biomedicine - Other Topics; Biophysics; Environmental Sciences & Ecology; Radiology, Nuclear Medicine & Medical Imaging	AS3KZ	WOS:000344177800016		
J	Hanamura, H; Hattori, R; Maruyama, R; Nemoto, N				Hanamura, Hitoshi; Hattori, Ryoichi; Maruyama, Ryo; Nemoto, Nobukatsu			Synthesis and characterization of poly(tetramethylsilarylenesiloxane) derivatives bearing benzodithiophene moieties	REACTIVE & FUNCTIONAL POLYMERS			English	Article						Benzodithiophene; Heat-resistant polymer; Photoluminescence; Polysiloxane; Poly(tetramethylsilarylenesiloxane)	THERMAL CHARACTERIZATION; ELECTRONIC-PROPERTIES; CONJUGATED POLYMERS; SOLAR-CELLS; POLYSILOXANE; FLUORESCENCE; SEMICONDUCTOR; OLIGOSILANES; CHEMISTRY; STATE	Poly(tetramethylsilarylenesiloxane) derivatives bearing benzo[1,2-b;4,5-b']dithiophene (P1) and benzo[2,1-b;3,4-b']dithiophene (P2) moieties were prepared via polycondensation of the corresponding disilanol monomers, that is, 2,6-bis(dimethylhydroxysilyl)benzo[1,2-b;4,5-b']dithiophene (M1) and 2,7-bis(dimethylhydroxysilyl)benzo[2,1-b;3,4-b']dithiophene (M2), respectively. It was deduced that P1 is a crystalline polymer while P2 is an amorphous one from the results of differential scanning calorimetry (DSC). Bathochromic and hyperchromic effects were observed in the absorption and fluorescence spectra when dimethylsilyl substituents were introduced on the benzo[1,2-b;4,5-b']dithiophene and benzo[2,1-b;3,4-b']dithiophene skeletons. The fluorescence quantum yields (Phi(F)s) were not improved by the introduction of dimethylsilyl groups onto the benzo[1,2-b;4,5-b']dithiophene and benzo[2,1-b;3,4-b']dithiophene skeletons, whereas the improvement in the Phi(F)s was remarkable in the case of poly(tetramethylsilarylenesiloxane) derivatives that possessed the corresponding fused benzene ring systems, i.e., poly(tetramethyl-2,6-silanthrylenesiloxane) and poly(tetramethyl-1,8-silphenanthrylenesiloxane). (C) 2014 Elsevier B.V. All rights reserved.	[Hanamura, Hitoshi; Hattori, Ryoichi; Maruyama, Ryo; Nemoto, Nobukatsu] Nihon Univ, Coll Engn, Dept Chem Biol & Appl Chem, Koriyama, Fukushima 9638642, Japan	Nemoto, N (reprint author), Nihon Univ, Coll Engn, Dept Chem Biol & Appl Chem, Koriyama, Fukushima 9638642, Japan.	nemoto.nobukatsu@nihon-u.ac.jp					Katz HE, 2001, ACCOUNTS CHEM RES, V34, P359, DOI 10.1021/ar990114j; Roncali J, 1997, CHEM REV, V97, P173, DOI 10.1021/cr950257t; Laquindanum JG, 1997, ADV MATER, V9, P36, DOI 10.1002/adma.19970090106; DECLERCQ D, 1993, J AM CHEM SOC, V115, P5702, DOI 10.1021/ja00066a040; Shao Y, 2006, PHYS CHEM CHEM PHYS, V8, P3172, DOI 10.1039/b517914a; Li XC, 1998, J AM CHEM SOC, V120, P2206, DOI 10.1021/ja9735968; Grimsdale AC, 2009, CHEM REV, V109, P897, DOI 10.1021/cr000013v; Kyushin S, 1996, ORGANOMETALLICS, V15, P1067, DOI 10.1021/om950776m; Saragi TPI, 2007, CHEM REV, V107, P1011, DOI 10.1021/cr0501341; Imai K, 2009, POLYM J, V41, P584, DOI 10.1295/polymj.PJ2009045; Sondergaard R, 2012, ADV ENERGY MATER, V2, P415, DOI 10.1002/aenm.201100517; Takimiya K, 2005, J ORG CHEM, V70, P10569, DOI 10.1021/jo051812m; Grimsdale AC, 2006, ADV POLYM SCI, V199, P1, DOI 10.1007/12_076; WUDL F, 1984, J ORG CHEM, V49, P3382, DOI 10.1021/jo00192a027; Ponomarenko SA, 2011, ADV POLYM SCI, V235, P33, DOI 10.1007/12_2009_48; Leng HF, 2012, REACT FUNCT POLYM, V72, P206, DOI 10.1016/j.reactfunctpolym.2012.01.002; Zhou HX, 2010, ACS APPL MATER INTER, V2, P1377, DOI 10.1021/am1000344; Brook M. A., 2000, SILICON ORGANIC ORGA; Coppo P, 2005, J MATER CHEM, V15, P1123, DOI 10.1039/b412143k; Day GM, 2003, ACS SYM SER, V838, P127; EATON DF, 1988, PURE APPL CHEM, V60, P1107, DOI 10.1351/pac198860071107; Hanamura H, 2011, POLYMER, V52, P5282, DOI 10.1016/j.polymer.2011.09.031; Hattori Y, 2008, POLYMER, V49, P2825, DOI 10.1016/j.polymer.2008.04.053; Imai K, 2010, TETRAHEDRON, V66, P8012, DOI 10.1016/j.tet.2010.08.010; Imai K, 2012, POLYM BULL, V68, P1589, DOI 10.1007/s00289-011-0639-0; Imai K, 2011, POLYM J, V43, P58, DOI 10.1038/pj.2010.104; Karatsu T, 2008, J PHOTOCH PHOTOBIO C, V9, P111, DOI 10.1016/j.jphotochemrev.2008.06.001; Kitamura N, 2003, APPL ORGANOMET CHEM, V17, P840, DOI 10.1002/aoc.542; KRAAK A, 1968, TETRAHEDRON, V24, P3381, DOI 10.1016/S0040-4020(01)92636-5; Maeda H, 2001, CHEM LETT, P1224; MARK JE, 1990, ADV CHEM SER, V224, P47; Nagai K, 1996, J POLYM SCI POL PHYS, V34, P2059; Nemoto N, 2008, POLYM BULL, V61, P165, DOI 10.1007/s00289-008-0944-4; Otomo Y, 2005, POLYMER, V46, P9714, DOI 10.1016/j.polymer.2005.08.063; Rao HX, 2011, REACT FUNCT POLYM, V71, P537, DOI 10.1016/j.reactfunctpolym.2011.01.001; Sato I, 2007, POLYM BULL, V59, P607, DOI 10.1007/s00289-007-0804-7; SHIZUKA H, 1984, J CHEM SOC FARAD T 1, V80, P341, DOI 10.1039/f19848000341; TAKIMIYA K, 1993, CHEM LETT, P365, DOI 10.1246/cl.1993.365; Wu HM, 2012, REACT FUNCT POLYM, V72, P897, DOI 10.1016/j.reactfunctpolym.2012.07.006; WUDL F, 1979, J ORG CHEM, V44, P2491, DOI 10.1021/jo01328a034; Xiao SQ, 2008, MACROMOLECULES, V41, P5688, DOI 10.1021/ma800776q; Zhang RZ, 1997, MACROMOLECULES, V30, P2513, DOI 10.1021/ma9618484	42	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1381-5148	1873-166X		REACT FUNCT POLYM	React. Funct. Polym.	NOV	2014	84						60	67		10.1016/j.reactfunctpolym.2014.09.007		8	Chemistry, Applied; Engineering, Chemical; Polymer Science	Chemistry; Engineering; Polymer Science	AS7NM	WOS:000344442600008		
J	Suemizu, H; Sota, S; Kuronuma, M; Shimizu, M; Yamazaki, H				Suemizu, Hiroshi; Sota, Shigeto; Kuronuma, Miyuki; Shimizu, Makiko; Yamazaki, Hiroshi			Pharmacokinetics and effects on serum cholinesterase activities of organophosphorus pesticides acephate and chlorpyrifos in chimeric mice transplanted with human hepatocytes	REGULATORY TOXICOLOGY AND PHARMACOLOGY			English	Article						Transplanted human liver cells; Serum cholinesterase activities; Lowest-observed-adverse-effect level; Physiologically based pharmacokinetic model; Allometric scaling	TK-NOG MICE; IN-VIVO EXPERIMENTS; PHARMACODYNAMIC MODEL; PLASMA-CONCENTRATIONS; HUMAN CYTOCHROME-P450; BLOOD-CONCENTRATIONS; RAT; INHIBITION; METABOLISM; LIVER	Organophosphorus pesticides acephate and chlorpyrifos in foods have potential to impact human health. The aim of the current study was to investigate the pharmacokinetics of acephate and chlorpyrifos orally administered at lowest-observed-adverse-effect-level doses in chimeric mice transplanted with human hepatocytes. Absorbed acephate and its metabolite methamidophos were detected in serum from wild type mice and chimeric mice orally administered 150 mg/kg. Approximately 70% inhibition of cholinesterase was evident in plasma of chimeric mice with humanized liver (which have higher serum cholinesterase activities than wild type mice) 1 day after oral administrations of acephate. Adjusted animal biomonitoring equivalents from chimeric mice studies were scaled to human biomonitoring equivalents using known species allometric scaling factors and in vitro metabolic clearance data with a simple physiologically based pharmacokinetic (PBPK) model. Estimated plasma concentrations of acephate and chlorpyrifos in humans were consistent with reported concentrations. Acephate cleared similarly in humans and chimeric mice but accidental/incidental overdose levels of chlorpyrifos cleared (dependent on liver metabolism) more slowly from plasma in humans than it did in mice. The data presented here illustrate how chimeric mice transplanted with human hepatocytes in combination with a simple PBPK model can assist evaluations of toxicological potential of organophosphorus pesticides. (C) 2014 Elsevier Inc. All rights reserved.	[Suemizu, Hiroshi; Kuronuma, Miyuki] Cent Inst Expt Anim, Kawasaki Ku, Kawasaki, Kanagawa 2100821, Japan; [Sota, Shigeto; Shimizu, Makiko; Yamazaki, Hiroshi] Shows Pharmaceut Univ, Lab Drug Metab & Pharmacokinet, Machida, Tokyo 1948543, Japan	Yamazaki, H (reprint author), Shows Pharmaceut Univ, Lab Drug Metab & Pharmacokinet, 3-3165 Higashi Tamagawa, Machida, Tokyo 1948543, Japan.	hyamazak@ac.shoyaku.ac.jp	Yamazaki, Hiroshi/A-6081-2011	Yamazaki, Hiroshi/0000-0002-1068-4261	Food Safety Commission of Japan [1103]; Ministry of Education, Culture, Sports, Science and Technology of Japan; JCIA's LRI program	The authors thank Drs. Yasuhiko Ando, Shingo Kojima, Sayako Nishiyama, Ryohji Takano, and None Murayama for their technical assistance and David Smallbones for his English language advice. This work was supported in part by The Food Safety Commission of Japan (1103 to H.S. and H.Y.); the Ministry of Education, Culture, Sports, Science and Technology of Japan; and JCIA's LRI program.	AMIDON GL, 1988, PHARMACEUT RES, V5, P651, DOI 10.1023/A:1015927004752; Tang J, 2001, DRUG METAB DISPOS, V29, P1201; RENWICK AG, 1993, FOOD ADDIT CONTAM, V10, P275; Kato M, 2008, PHARM RES-DORDR, V25, P1891, DOI 10.1007/s11095-008-9607-2; Raghu P, 2014, FOOD CHEM, V142, P188, DOI 10.1016/j.foodchem.2013.07.047; Timchalk C, 2002, TOXICOL SCI, V66, P34, DOI 10.1093/toxsci/66.1.34; Lowe ER, 2009, TOXICOL SCI, V108, P258, DOI 10.1093/toxsci/kfp034; Yamazaki H, 2013, CHEM RES TOXICOL, V26, P486, DOI 10.1021/tx400008g; Montesano MA, 2007, J EXPO SCI ENV EPID, V17, P321, DOI 10.1038/sj.jes.7500550; Smith JN, 2011, DRUG METAB DISPOS, V39, P1353, DOI 10.1124/dmd.111.038745; Edwards SW, 2008, TOXICOL SCI, V106, P312, DOI 10.1093/toxsci/kfn190; Yamazaki H, 2012, CHEM RES TOXICOL, V25, P274, DOI 10.1021/tx300009j; Hasegawa M, 2011, BIOCHEM BIOPH RES CO, V405, P405, DOI 10.1016/j.bbrc.2011.01.042; Foxenberg RJ, 2011, TOXICOLOGY, V285, P57, DOI 10.1016/j.tox.2011.04.002; Chang Arthur, 2009, J Med Toxicol, V5, P68; DREVENKAR V, 1993, CHEM-BIOL INTERACT, V87, P315, DOI 10.1016/0009-2797(93)90059-8; Emoto C, 2009, XENOBIOTICA, V39, P227, DOI 10.1080/00498250802668863; GARGAS ML, 1995, TOXICOL APPL PHARM, V134, P185, DOI 10.1006/taap.1995.1183; Higuchi Y, 2014, XENOBIOTICA, V44, P146, DOI 10.3109/00498254.2013.836257; Hinderliter PM, 2011, REGUL TOXICOL PHARM, V61, P82, DOI 10.1016/j.yrtph.2011.06.004; Joint FAO/WHO Meeting, 2003, PEST RES FOOD 2002, P3; Mahajna M, 1997, CHEM RES TOXICOL, V10, P64, DOI 10.1021/tx9601420; Marty MS, 2012, REGUL TOXICOL PHARM, V63, P209, DOI 10.1016/j.yrtph.2012.03.015; Reiss R, 2012, REGUL TOXICOL PHARM, V63, P124, DOI 10.1016/j.yrtph.2012.03.008; Smith JN, 2014, REGUL TOXICOL PHARM, V69, P580, DOI 10.1016/j.yrtph.2013.10.005; Takano R, 2010, REGUL TOXICOL PHARM, V58, P252, DOI 10.1016/j.yrtph.2010.06.008; Timchalk C, 2008, NEUROTOXICOLOGY, V29, P428, DOI 10.1016/j.neuro.2008.02.004; Tsukada A, 2013, REGUL TOXICOL PHARM, V65, P316, DOI 10.1016/j.yrtph.2013.01.008; Yamashita M, 2014, REGUL TOXICOL PHARM, V70, P214, DOI 10.1016/j.yrtph.2014.06.028; Yamazaki H, 2010, INT J ENV RES PUB HE, V7, P3406, DOI 10.3390/ijerph7093406	30	5	6	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0273-2300	1096-0295		REGUL TOXICOL PHARM	Regul. Toxicol. Pharmacol.	NOV	2014	70	2					468	473		10.1016/j.yrtph.2014.08.010		6	Medicine, Legal; Pharmacology & Pharmacy; Toxicology	Legal Medicine; Pharmacology & Pharmacy; Toxicology	AS0FN	WOS:000343953700005		
J	Okamoto, T; Ikenoue, T; Matsui, K; Miyazaki, M; Tsuzuku, Y; Nishizawa, Y; Kubota, M				Okamoto, Takayuki; Ikenoue, Tatsuyoshi; Matsui, Kosuke; Miyazaki, Mikiko; Tsuzuku, Yuko; Nishizawa, Yoshiko; Kubota, Minoru			Free air on CT and the risk of peritonitis in peritoneal dialysis patients: a retrospective study	RENAL FAILURE			English	Article						Computed tomography; peritoneal dialysis/AE; peritonitis; pneumoperitoneum	SINGLE-CENTER; INFECTIONS RECOMMENDATIONS; PNEUMOPERITONEUM; EXPERIENCE; PREDICTORS; DIAGNOSIS; OUTCOMES; UPDATE; IMPACT	Background: Intra-abdominal free air is found frequently in patients undergoing peritoneal dialysis (PD). Some studies have investigated an association between intra-abdominal free air and peritonitis in PD patients. However, most used chest X-rays, which are of limited sensitivity, and the association was not made clear. We conducted a retrospective study of the association between peritonitis and intra-abdominal free air using computed tomography. Methods: The presence and volume of free air, and its relationship with other variables, were assessed on review of routine examinations in 108 patients. Correlations between the presence of free air and age, duration of PD, continuous ambulatory versus automated PD, presence or absence of a person who assisted in bag changes, exit-site infection, tunnel infection and peritonitis were assessed. Results: Free air was detected in 29 patients (27.1%). The prevalence of peritonitis was higher in the free air (+) group than in the free air (-) group: 1/40.2 patient-months for free air (+) versus 1/96.9 patient-months for free air (-). The risk ratio of free air for peritonitis was 2.41 (95% confidence interval: 2.28-2.55) and was similar when corrected for age, gender, albumin, diabetes mellitus and body mass index. Conclusion: Free air is an independent risk factor for peritonitis in PD patients. This suggests that bag change procedures should be re-evaluated, and patients re-educated, when necessary.	[Okamoto, Takayuki; Matsui, Kosuke; Miyazaki, Mikiko; Tsuzuku, Yuko; Nishizawa, Yoshiko; Kubota, Minoru] Oji Hosp, Dept Nephrol, Tokyo, Japan; [Ikenoue, Tatsuyoshi] Fujiidera Keijinkai Clin, Dept Nephrol, Fujiidera, Japan	Okamoto, T (reprint author), Kyoritsu Hosp, Dept Nephrol, 16-5 Chuo Cho, Kawanishi, Hyogo 1628666, Japan.	otaka816@gmail.com					Li PKT, 2010, PERITON DIALYSIS INT, V30, P393, DOI 10.3747/pdi.2010.00049; WINEK TG, 1988, ARCH SURG-CHICAGO, V123, P709; Han SH, 2007, PERITON DIALYSIS INT, V27, P432; Piraino B, 2005, PERITON DIALYSIS INT, V25, P107; Edey M, 2010, NEPHROL DIAL TRANSPL, V25, P1272, DOI 10.1093/ndt/gfp641; Braccini G, 1996, ABDOM IMAGING, V21, P404, DOI 10.1007/s002619900092; Bernardini J, 2006, PERITON DIALYSIS INT, V26, P625; Chen SC, 2002, BRIT J SURG, V89, P351, DOI 10.1046/j.0007-1323.2001.02013.x; Boehm M, 2005, PEDIATR NEPHROL, V20, P1478, DOI 10.1007/s00467-005-1953-2; Buoncristiani U, 2007, CONTRIB NEPHROL, V154, P103; Chen CH, 2001, HEPATO-GASTROENTEROL, V48, P1393; Curtin LR, 1995, DIRECT STANDARDIZATI; DALY BD, 1991, POSTGRAD MED J, V67, P999; Ergun T, 2012, EUR J RADIOL, V81, P13, DOI 10.1016/j.ejrad.2010.10.012; Fouque D, 2008, KIDNEY INT, V73, P391, DOI 10.1038/sj.ki.5002585; Freitas Cristina, 2009, Adv Perit Dial, V25, P26; Friedrich AKU, 2014, J INTENSIVE CARE MED, V29, P247, DOI 10.1177/0885066613476465; Goffin E, 2004, PERITON DIALYSIS INT, V24, P433; Hall G, 2004, NEPHROL NURS J, V31, P159; Hall Gayle, 2004, Nephrol Nurs J, V31, P149; Holloway M, 2001, PERITON DIALYSIS INT, V21, P401; Hsieh YP, 2014, PERITON DIALYSIS INT, V34, P85, DOI 10.3747/pdi.2012.00075; KIEFER T, 1993, AM J KIDNEY DIS, V22, P30; Lampainen E, 1986, ASAIO Trans, V32, P581, DOI 10.1097/00002480-198609000-00043; LEE FT, 1994, J COMPUT ASSIST TOMO, V18, P439, DOI 10.1097/00004728-199405000-00018; Li PKT, 2002, AM J KIDNEY DIS, V40, P373, DOI 10.1053/ajkd.2002.34522; Lobo João Victor Duarte, 2010, J Bras Nefrol, V32, P156, DOI 10.1590/S0101-28002010000200004; Nessim SJ, 2010, NEPHROL DIAL TRANSPL, V25, P2310, DOI 10.1093/ndt/gfq002; Oguro S, 2010, EUR RADIOL, V20, P1396, DOI 10.1007/s00330-009-1670-5; Prasad N, 2003, PERITON DIALYSIS INT, V23, pS144; Renaud CJ, 2011, NEPHROLOGY, V16, P174, DOI 10.1111/j.1440-1797.2010.01370.x; Stanley IR, 2002, ANAESTHESIA, V57, P57; Stegmayr B, 2002, INT J ARTIF ORGANS, V25, P365; Yang ZK, 2012, PERITON DIALYSIS INT, V32, P60, DOI 10.3747/pdi.2010.00208	34	0	0	INFORMA HEALTHCARE	LONDON	TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND	0886-022X	1525-6049		RENAL FAILURE	Ren. Fail.	NOV	2014	36	10					1492	1496		10.3109/0886022X.2014.958953		5	Urology & Nephrology	Urology & Nephrology	AS6SA	WOS:000344391400004		
J	Jaros, J; Kusano, T				Jaros, Jaroslav; Kusano, Takasi			Decreasing Regularly Varying Solutions of Sublinearly Perturbed Superlinear Thomas-Fermi Equation	RESULTS IN MATHEMATICS			English	Article						Thomas-Fermi equation; mixed nonlinearities; asymptotic behavior; regularly varying functions		We consider the perturbed Thomas-Fermi equation x '' = p(t)vertical bar vertical bar x vertical bar(gamma-1)x + q(t)vertical bar x vertical bar(delta-1)x, (A) where delta and gamma are positive constants with delta < 1 < gamma and p(t) and q(t) are positive continuous functions on [a, infinity), a > 0. Our aim here is to establish criteria for the existence of positive solutions of (A) decreasing to zero as t -> infinity in the case where p(t) and q(t) are regularly varying functions (in the sense of Karamata). Generalization of the obtained results to equations of the form (r(t)x')' = p(t)vertical bar x vertical bar(gamma-1) vertical bar q(t)vertical bar x vertical bar(delta-1)x, (B) is also given.	[Jaros, Jaroslav] Comenius Univ, Fac Math Phys & Informat, Dept Math Anal & Numer Math, Bratislava 84248, Slovakia; [Kusano, Takasi] Hiroshima Univ, Fac Sci, Dept Math, Higashihiroshima 7398526, Japan	Jaros, J (reprint author), Comenius Univ, Fac Math Phys & Informat, Dept Math Anal & Numer Math, Bratislava 84248, Slovakia.	jaros@fmph.uniba.sk; kusanot@zj8.so-net.ne.jp					Kusano T, 2012, NONLINEAR ANAL-THEOR, V75, P2474, DOI 10.1016/j.na.2011.10.039; Avakumovic V. G., 1947, PUBL I MATH-BEOGRAD, V1, P101; Bingham N. H., 1987, ENCY MATH ITS APPL, V27; Haupt O., 1938, DIFFERENTIAL INTEGRA; Jaros J., 2004, B T 129 ACAD S SMNSM, V29, P25; Maric V., 1726, LECT NOTES MATH, V1726; Seneta E., 1976, LECT NOTES MATH, V508	7	0	0	SPRINGER BASEL AG	BASEL	PICASSOPLATZ 4, BASEL, 4052, SWITZERLAND	1422-6383	1420-9012		RESULTS MATH	Results Math.	NOV	2014	66	3-4					273	289		10.1007/s00025-014-0376-4		17	Mathematics, Applied; Mathematics	Mathematics	AS6AD	WOS:000344346500001		
J	Sakaki, M				Sakaki, Makoto			Four Classes of Surfaces with Constant Mean Curvature in S-3 x R and H-3 x R	RESULTS IN MATHEMATICS			English	Article						Surface; mean curvature vector; product space; minimal; complete	MINIMAL-SURFACES	Deforming rotation surfaces with constant mean curvature in S-3 and H-3 to S-3 x R and H-3 x R respectvely, we give four classes of surfaces with mean curvature vector of constant length in S-3 x R and H-3 x R. We have complete minimal surfaces in S-3 x R and H-3 x R. Also we obtain minimal 2-tori in S-3 x S-1, some of which are embedded.	Hirosaki Univ, Grad Sch Sci & Technol, Hirosaki, Aomori 0368561, Japan	Sakaki, M (reprint author), Hirosaki Univ, Grad Sch Sci & Technol, Hirosaki, Aomori 0368561, Japan.	sakaki@cc.hirosaki-u.ac.jp					Abresch U, 2004, ACTA MATH-DJURSHOLM, V193, P141, DOI 10.1007/BF02392562; DOCARMO M, 1983, T AM MATH SOC, V277, P685; Daniel B, 2009, T AM MATH SOC, V361, P6255; Chen Q, 2010, RESULTS MATH, V57, P319, DOI 10.1007/s00025-010-0031-7; Fetcu D, 2012, MICH MATH J, V61, P715; Kim YW, 2009, PAC J MATH, V242, P281; Kim YW, 2012, B AUST MATH SOC, V86, P135, DOI 10.1017/S0004972711003042; MORI H, 1981, INDIANA U MATH J, V30, P787, DOI 10.1512/iumj.1981.30.30057; Sa Earp R., 2005, ILLINOIS J MATH, V49, P1323; Sa Earp R., 2008, J AUST MATH SOC, V85, P113, DOI 10.1017/S1446788708000013; Sakaki M., 2011, TSUKUBA J MATH, V35, P215; Sakaki M., 2013, SOME CLASSES S UNPUB	12	1	1	SPRINGER BASEL AG	BASEL	PICASSOPLATZ 4, BASEL, 4052, SWITZERLAND	1422-6383	1420-9012		RESULTS MATH	Results Math.	NOV	2014	66	3-4					343	362		10.1007/s00025-014-0380-8		20	Mathematics, Applied; Mathematics	Mathematics	AS6AD	WOS:000344346500004		
J	Kajikiya, R				Kajikiya, Ryuji			Three Positive Solutions of the One-Dimensional Generalized Henon Equation	RESULTS IN MATHEMATICS			English	Article						Henon equation; Emden-Fowler equation; least energy solution; multiple positive solutions; variational method	LEAST-ENERGY SOLUTIONS; GROUND-STATES; ELLIPTIC-EQUATIONS; ASYMPTOTIC PROFILE; GROWTH	We study the one-dimensional generalized Henon equation under the Dirichlet boundary condition. It is known that there exist at least three positive solutions if the coefficient function is even. In this paper, without the assumption of evenness, we prove the existence of at least three positive solutions.	Saga Univ, Fac Sci & Engn, Dept Math, Saga 8408502, Japan	Kajikiya, R (reprint author), Saga Univ, Fac Sci & Engn, Dept Math, Saga 8408502, Japan.	kajikiya@ms.saga-u.ac.jp			Japan Society for the Promotion of Science [24540179]	R. Kajikiya was supported in part by the Grant-in-Aid for Scientific Research (C) (No. 24540179), Japan Society for the Promotion of Science.	Ambrosetti A., 1973, Journal of Functional Analysis, V14, DOI 10.1016/0022-1236(73)90051-7; Esposito P, 2006, J ANAL MATH, V100, P249, DOI 10.1007/BF02916763; Pistoia A, 2007, MATH Z, V256, P75, DOI 10.1007/s00209-006-0060-9; Badiale M, 2004, ADV NONLINEAR STUD, V4, P453; Hirano N, 2009, J DIFFER EQUATIONS, V247, P1311, DOI 10.1016/j.jde.2009.06.008; Byeon J, 2006, ANN I H POINCARE-AN, V23, P803, DOI 10.1016/j.anihpc.2006.04.001; Byeon J, 2011, DISCRETE CONT DYN-A, V30, P1055, DOI 10.3934/dcds.2011.30.1055; Byeon J, 2005, J DIFFER EQUATIONS, V216, P78, DOI 10.1016/j.jde.2005.02.018; Barutello V, 2008, J MATH ANAL APPL, V341, P720, DOI 10.1016/j.jmaa.2007.10.052; Serra E, 2005, CALC VAR PARTIAL DIF, V23, P301, DOI 10.1007/s00526-004-0302-9; Cao DM, 2003, J MATH ANAL APPL, V278, P1, DOI 10.1016/S0022-247X(02)00292-5; Chern JL, 2003, J DIFFER EQUATIONS, V187, P240, DOI 10.1016/S0022-0396(02)00080-3; Smets D, 2002, COMMUN CONTEMP MATH, V4, P467, DOI 10.1142/S0219199702000725; Calanchi M, 2008, J DIFFER EQUATIONS, V245, P1507, DOI 10.1016/j.jde.2008.06.018; BREZIS H, 1986, NONLINEAR ANAL-THEOR, V10, P55, DOI 10.1016/0362-546X(86)90011-8; Kajikiya R, 2012, J DIFFER EQUATIONS, V252, P1987, DOI 10.1016/j.jde.2011.08.032; Kajikiya R, 2012, P AM MATH SOC, V140, P1353; Moore R. A., 1959, T AM MATH SOC, V93, P30, DOI 10.2307/1993421; Rabinowitz P.H., 1986, CBMS REGIONAL C SER, V65; Ribarska N., 1995, SERDICA MATH J, V21, P239; Struwe M., 1996, VARIATIONAL METHODS; SZULKIN A, 1988, ANN I H POINCARE-AN, V5, P119	22	0	0	SPRINGER BASEL AG	BASEL	PICASSOPLATZ 4, BASEL, 4052, SWITZERLAND	1422-6383	1420-9012		RESULTS MATH	Results Math.	NOV	2014	66	3-4					427	459		10.1007/s00025-014-0385-3		33	Mathematics, Applied; Mathematics	Mathematics	AS6AD	WOS:000344346500009		
J	Muto, G; Yamashita, H; Takahashi, Y; Miyata, Y; Morooka, M; Minamimoto, R; Kubota, K; Kaneko, H; Kano, T; Mimori, A				Muto, Go; Yamashita, Hiroyuki; Takahashi, Yuko; Miyata, Yoko; Morooka, Miyako; Minamimoto, Ryogo; Kubota, Kazuo; Kaneko, Hiroshi; Kano, Toshikazu; Mimori, Akio			Large vessel vasculitis in elderly patients: early diagnosis and steroid-response evaluation with FDG-PET/CT and contrast-enhanced CT	RHEUMATOLOGY INTERNATIONAL			English	Article						Large vessel vasculitis; Fluorine-18 fluorodeoxyglucose positron emission tomography/computed tomography; Contrast-enhanced CT; Inflammation of unknown origin	GIANT-CELL ARTERITIS; POSITRON-EMISSION-TOMOGRAPHY; RHEUMATOLOGY 1990 CRITERIA; TAKAYASU ARTERITIS; POLYMYALGIA-RHEUMATICA; AORTITIS; CLASSIFICATION; REGISTRATION; INFLAMMATION; MANAGEMENT	Large vessel vasculitis (LVV) is an often-reported cause of inflammation of unknown origin (IUO) in elderly people. The objective of this study was to describe the usefulness of fluorine-18 fluorodeoxyglucose positron emission tomography/computed tomography (FDG-PET/CT) and contrast-enhanced CT in early diagnosis and treatment follow-up of patients with LVV presenting as elderly onset IUO. We retrospectively compared contrast-enhanced CT findings and FDG-PET/CT findings of the patients diagnosed with LVV and 11 controls; all subjects were 50 years of age or older. We evaluated maximum standardised uptake value (SUVmax) and PET score of the aortic wall for quantitative comparison of FDG-PET/CT findings. We measured the aortic wall thickness (W) and its ratio against the radius (W/R) for quantitative comparison of aortic wall thickening by contrast-enhanced CT. After steroid treatment, we compared these values with those pre-treatment. Of 124 patients who were hospitalised due to advanced age and IUO, 88 underwent FDG-PET/CT and contrast-enhanced CT. Abnormal findings were observed on images from 78 patients. The findings were indicative of LVV in 13 patients (10.5 %), of whom more than half had only non-specific symptoms. Patients with LVV had significantly higher aortic wall SUVmax (3.85 vs. 1.95), PET scores by FDG-PET/CT, and aortic wall thicknesses by contrast-enhanced CT (3.8 vs. 2.6 mm) than controls. Significant improvement in aortic wall thickening was evidenced by reduced PET scores and by contrast-enhanced CT findings in patients who were followed up after treatment. LVV is an important cause of IUO with non-specific symptoms in elderly patients. Imaging examination comprising contrast-enhanced CT and FDG-PET/CT is useful for early diagnosis and early treatment evaluation of LVV, allowing for amelioration of reversible aortic wall thickening.	[Muto, Go; Yamashita, Hiroyuki; Takahashi, Yuko; Kaneko, Hiroshi; Kano, Toshikazu; Mimori, Akio] Natl Ctr Global Hlth & Med, Div Rheumat Dis, Shinjuku Ku, Tokyo 1628655, Japan; [Miyata, Yoko; Morooka, Miyako; Minamimoto, Ryogo; Kubota, Kazuo] Natl Ctr Global Hlth & Med, Dept Radiol, Shinjuku Ku, Tokyo 1628655, Japan	Muto, G (reprint author), Natl Ctr Global Hlth & Med, Div Rheumat Dis, Shinjuku Ku, 1-21-1 Toyama, Tokyo 1628655, Japan.	gomuto@z6.keio.jp; hiroyuki_yjp2005@yahoo.co.jp			Ministry of Health, Labor, and Welfare of Japan	This study was supported by Grants-in-Aid for Research on Intractable Diseases from the Ministry of Health, Labor, and Welfare of Japan. We thank R. K. for statistical assistance; and J.K., T. U., and Y.M. for critical suggestions.	Fuchs M, 2012, EUR J NUCL MED MOL I, V39, P344, DOI 10.1007/s00259-011-1967-x; Brack A, 1999, ARTHRITIS RHEUM, V42, P311, DOI 10.1002/1529-0131(199902)42:2<311::AID-ANR14>3.0.CO;2-F; WAHL RL, 1993, J NUCL MED, V34, P1190; Blockmans D, 2000, AM J MED, V108, P246, DOI 10.1016/S0002-9343(99)00424-6; AREND WP, 1990, ARTHRITIS RHEUM, V33, P1129; Treglia G, 2011, CLIN RHEUMATOL, V30, P1265, DOI 10.1007/s10067-011-1828-9; Yamashita H, 2012, MOD RHEUMATOL, V22, P942, DOI 10.1007/s10165-012-0689-7; Ferda J, 2010, EUR J RADIOL, V73, P518, DOI 10.1016/j.ejrad.2008.12.014; Gonzalez-Gay MA, 2001, SEMIN ARTHRITIS RHEU, V30, P249, DOI 10.1053/sarh.2001.16650; Liang KP, 2009, J RHEUMATOL, V36, P2290, DOI 10.3899/jrheum.090081; Gotthardt M, 2010, J NUCL MED, V51, P1937, DOI 10.2967/jnumed.110.076232; HUNDER GG, 1990, ARTHRITIS RHEUM, V33, P1122; Miller DV, 2006, AM J SURG PATHOL, V30, P1150; Mukhtyar C, 2009, ANN RHEUM DIS, V68, P318, DOI 10.1136/ard.2008.088351; Vanderschueren S, 2003, ARCH INTERN MED, V163, P1033, DOI 10.1001/archinte.163.9.1033; Zerizer I, 2010, EUR J RADIOL, V73, P504, DOI 10.1016/j.ejrad.2010.01.021; KERR GS, 1994, ANN INTERN MED, V120, P919; Schmidt WA, 2008, RHEUMATOLOGY, V47, P96, DOI 10.1093/rheumatology/kem322; Nuenninghoff DM, 2003, ARTHRITIS RHEUM, V48, P3522, DOI 10.1002/art.11353; de Leeuw K, 2004, CLIN EXP RHEUMATOL, V22, pS21; Rojo-Leyva F, 2000, ARTHRITIS RHEUM, V43, P901, DOI 10.1002/1529-0131(200004)43:4<901::AID-ANR23>3.0.CO;2-U; Kubota K, 2011, ANN NUCL MED, V25, P355, DOI 10.1007/s12149-011-0470-6; JENNETTE JC, 1994, ARTHRITIS RHEUM, V37, P187, DOI 10.1002/art.1780370206; Besson Florent L, 2011, Eur J Nucl Med Mol Imaging, V38, P1764, DOI 10.1007/s00259-011-1830-0; Blockmans D, 2006, ARTHRIT RHEUM-ARTHR, V55, P131, DOI 10.1002/art.21699; Brodmann M, 2004, RHEUMATOLOGY, V43, P241, DOI 10.1093/rheumatology/keh025; CORREIA JA, 1990, J NUCL MED, V31, P1227; Durack D T, 1991, Curr Clin Top Infect Dis, V11, P35; Ezeonyeji AN, 2011, CLIN RHEUMATOL, V30, P259, DOI 10.1007/s10067-010-1616-y; GERBER NJ, 1984, EUR NEUROL, V23, P410, DOI 10.1159/000115723; Hayakawa I, 2012, INTERNAL MED, V51, P3431, DOI 10.2169/internalmedicine.51.8414; Hernandez-Rodriguez J, 2008, CURR OPIN RHEUMATOL, V20, P40, DOI 10.1097/BOR.0b013e3282f176a0; KUBOTA R, 1992, J NUCL MED, V33, P1972; Kawashima M, 1999, Nihon Rinsho Meneki Gakkai Kaishi, V22, P317; Kerr LD, 2000, J THORAC CARDIOV SUR, V120, P813, DOI 10.1067/mtc.2000.107832; Lensen KJDF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058917; Shreve PD, 2000, J NUCL MED, V41, P1380; Treglia G, 2010, ITAL J MED, V4, P84; WEBER DA, 1994, SEMIN NUCL MED, V24, P311, DOI 10.1016/S0001-2998(05)80021-2	39	2	2	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	0172-8172	1437-160X		RHEUMATOL INT	Rheumatol. Int.	NOV	2014	34	11					1545	1554		10.1007/s00296-014-2985-3		10	Rheumatology	Rheumatology	AS5WR	WOS:000344337900009		
J	Kamata, Y; Minota, S				Kamata, Yasuyuki; Minota, Seiji			Effects of phosphodiesterase type 5 inhibitors on Raynaud's phenomenon	RHEUMATOLOGY INTERNATIONAL			English	Article						Connective tissue diseases; Raynaud's phenomenon; Sildenafil; Tadalafil; Vardenafil	SILDENAFIL; THERAPY; DISEASE	Raynaud's phenomenon (RP) is commonly observed in fingers and toes of patients with connective tissue diseases (CTDs). However, existing vasodilators have very limited efficacy. In this study, phosphodiesterase type 5 inhibitors (PDE-5Is) were administered to evaluate efficacy on RP. Three patients with mixed connective tissue disease and three patients with systemic sclerosis having RP were enrolled. Oral sildenafil, vardenafil, or tadalafil was administered. The fingertip temperature was measured by thermography before and 120 min after administration. To evaluate longer effects, vardenafil was administered daily for 12 weeks; the fingertip temperature was measured by thermography before and 12 weeks after administration. As compared with the pre-administration of sildenafil, vardenafil, and tadalafil, the mean fingertip temperature increased by 2.17, 3.47, and 3.59 A degrees C, respectively, in 120 min. In the 12-week trial with vardenafil in 3 patients, the mean fingertip temperature increased by 3.04, 7.96, and 3.32 A degrees C from baseline in each patient. PDE-5Is significantly increased fingertip temperature within 120 min, and the effect of vardenafil lasted for 12 weeks under daily use. PDE-5Is were safe and would be an effective treatment for RP with CTDs.	[Kamata, Yasuyuki; Minota, Seiji] Jichi Med Univ, Div Rheumatol & Clin Immunol, Shimotsuke, Tochigi 3290498, Japan	Kamata, Y (reprint author), Jichi Med Univ, Div Rheumatol & Clin Immunol, 3311-1 Yakushiji, Shimotsuke, Tochigi 3290498, Japan.	y.kamata@jichi.ac.jp; sminota@jichi.ac.jp					Abrams D, 2000, Heart, V84, pE4, DOI 10.1136/heart.84.2.e4; WOLLERSHEIM H, 1993, EUR HEART J, V14, P147; Roustit M, 2012, CLIN PHARMACOL THER, V91, P813, DOI 10.1038/clpt.2011.302; BEAVO JA, 1995, PHYSIOL REV, V75, P725; Fries R, 2005, CIRCULATION, V112, P2980, DOI 10.1161/CIRCULATIONHA.104.523324; Roustit M, 2013, ANN RHEUM DIS, V72, P1696, DOI 10.1136/annrheumdis-2012-202836; Wright PJ, 2006, INT J CLIN PRACT, V60, P967, DOI 10.1111/j.1742-1241.2006.01049.x; DINERMAN JL, 1993, CIRC RES, V73, P217; Kamata Y, 2005, ANN RHEUM DIS, V64, P1236, DOI 10.1136/ard.2004.029074; Kirby JD, 1980, LANCET, V30, P453; LANGEVITZ P, 1989, J RHEUMATOL, V16, P1433; Padma-Nathan H, 2004, J SEX MED, V1, P128, DOI 10.1111/j.1743-6109.2004.04021.x; Sanchez LS, 1998, PEDIATR RES, V43, P163, DOI 10.1203/00006450-199802000-00002; Smith CD, 1982, LANCET, V11, P1299	14	0	0	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	0172-8172	1437-160X		RHEUMATOL INT	Rheumatol. Int.	NOV	2014	34	11					1623	1626		10.1007/s00296-014-3025-z		4	Rheumatology	Rheumatology	AS5WR	WOS:000344337900021		
J	Kurita, D; Miller, MR; Muto, A; Buskirk, AR; Himeno, H				Kurita, Daisuke; Miller, Mickey R.; Muto, Akira; Buskirk, Allen R.; Himeno, Hyouta			Rejection of tmRNA.SmpB after GTP hydrolysis by EF-Tu on ribosomes stalled on intact mRNA	RNA-A PUBLICATION OF THE RNA SOCIETY			English	Article						trans-translation; SmpB; tmRNA; ribosome; translation	VITRO TRANS-TRANSLATION; ELONGATION-FACTOR TU; ESCHERICHIA-COLI; STOP CODONS; BACILLUS-SUBTILIS; STRUCTURAL BASIS; TAGGED PROTEINS; QUALITY-CONTROL; TAGGING SYSTEM; EARLY-STAGE	Messenger RNAs lacking a stop codon trap ribosomes at their 3' ends, depleting the pool of ribosomes available for protein synthesis. In bacteria, a remarkable quality control system rescues and recycles stalled ribosomes in a process known as trans-translation. Acting as a tRNA, transfer-messenger RNA (tmRNA) is aminoacylated, delivered by EF-Tu to the ribosomal A site, and accepts the nascent polypeptide. Translation then resumes on a reading frame within tmRNA, encoding a short peptide tag that targets the nascent peptide for degradation by proteases. One unsolved issue in trans-translation is how tmRNA and its protein partner SmpB preferentially recognize stalled ribosomes and not actively translating ones. Here, we examine the effect of the length of the 3' extension of mRNA on each step of trans-translation by pre-steady-state kinetic methods and fluorescence polarization binding assays. Unexpectedly, EF-Tu activation and GTP hydrolysis occur rapidly regardless of the length of the mRNA, although the peptidyl transfer to tmRNA decreases as the mRNA 3' extension increases and the tmRNA.SmpB binds less tightly to the ribosome with an mRNA having a long 3' extension. From these results, we conclude that the tmRNA.SmpB complex dissociates during accommodation due to competition between the downstream mRNA and the C-terminal tail for the mRNA channel. Rejection of the tmRNA.SmpB complex during accommodation is reminiscent of the rejection of near-cognate tRNA from the ribosome in canonical translation.	[Kurita, Daisuke; Muto, Akira; Himeno, Hyouta] Hirosaki Univ, Fac Agr & Life Sci, Dept Biochem & Mol Biol, Hirosaki, Aomori 0368561, Japan; [Kurita, Daisuke; Miller, Mickey R.; Buskirk, Allen R.] Brigham Young Univ, Dept Chem & Biochem, Provo, UT 84602 USA	Himeno, H (reprint author), Hirosaki Univ, Fac Agr & Life Sci, Dept Biochem & Mol Biol, Hirosaki, Aomori 0368561, Japan.	buskirk@chem.byu.edu; himeno@cc.hirosaki-u.ac.jp			Japan Society for the Promotion of Science [23780099, 23380045, 23380054]	We thank the staff of the Gene Research Center of Hirosaki University for the use of the facility. This work was supported by a Grant-in-Aid for Young Scientists from the Japan Society for the Promotion of Science (D.K., no. 23780099), and Grants-in-Aid for Scientific Research from the Japan Society for the Promotion of Science (A.M., no. 23380045; H.H., no. 23380054).	Barends S, 2001, J MOL BIOL, V314, P9, DOI 10.1006/jmbi.2001.5114; Becker T, 2011, NAT STRUCT MOL BIOL, V18, P715, DOI 10.1038/nsmb.2057; Garza-Sanchez F, 2008, J MOL BIOL, V378, P505, DOI 10.1016/j.jmb.2008.02.065; KOMINE Y, 1994, P NATL ACAD SCI USA, V91, P9223, DOI 10.1073/pnas.91.20.9223; Shoemaker CJ, 2012, NAT STRUCT MOL BIOL, V19, P594, DOI 10.1038/nsmb.2301; Passmore LA, 2007, MOL CELL, V26, P41, DOI 10.1016/j.molcel.2007.03.018; Karzai AW, 1999, EMBO J, V18, P3793, DOI 10.1093/emboj/18.13.3793; Shimizu Y, 2012, J MOL BIOL, V423, P624, DOI 10.1016/j.jmb.2012.08.007; Keiler KC, 1996, SCIENCE, V271, P990, DOI 10.1126/science.271.5251.990; Gagnon MG, 2012, SCIENCE, V335, P1370, DOI 10.1126/science.1217443; Pisareva VP, 2011, EMBO J, V30, P1804, DOI 10.1038/emboj.2011.93; Roche ED, 1999, EMBO J, V18, P4579, DOI 10.1093/emboj/18.16.4579; Gottesman S, 1998, GENE DEV, V12, P1338, DOI 10.1101/gad.12.9.1338; Dong HJ, 1996, J MOL BIOL, V260, P649, DOI 10.1006/jmbi.1996.0428; Hayes CS, 2003, MOL CELL, V12, P903, DOI 10.1016/S1097-2765(03)00385-X; MOAZED D, 1991, P NATL ACAD SCI USA, V88, P3725, DOI 10.1073/pnas.88.9.3725; Youngman EM, 2004, CELL, V117, P589, DOI 10.1016/S0092-8674(04)00411-8; Chadani Y, 2011, MOL MICROBIOL, V80, P772, DOI 10.1111/j.1365-2958.2011.07607.x; Asano K, 2005, NUCLEIC ACIDS RES, V33, P5544, DOI 10.1093/nar/gki871; Barends S, 2000, BIOCHEMISTRY-US, V39, P2652, DOI 10.1021/bi992439d; Bessho Y, 2007, P NATL ACAD SCI USA, V104, P8293, DOI 10.1073/pnas.0700402104; Chadani Y, 2010, MOL MICROBIOL, V78, P796, DOI 10.1111/j.1365-2958.2010.07375.x; Choy JS, 2007, J BACTERIOL, V189, P6564, DOI 10.1128/JB.00860-07; Collier J, 2002, MOL MICROBIOL, V45, P745, DOI 10.1046/j.1365-2958.2002.03045.x; Garza-Sanchez F, 2009, MOL MICROBIOL, V73, P882, DOI 10.1111/j.1365-2958.2009.06813.x; Gillet R, 2007, J BIOL CHEM, V282, P6356, DOI 10.1074/jbc.M609658200; de Novoa PG, 2004, NUCLEIC ACIDS RES, V32, pD104, DOI 10.1093/nar/gkh102; Gutmann S, 2003, NATURE, V424, P5503; Hanawa-Suetsugu K, 2002, NUCLEIC ACIDS RES, V30, P1620, DOI 10.1093/nar/30.7.1620; Handa Y., 2010, NUCLEIC ACIDS RES, V39, P1739, DOI 10.1093/nar/gkq1097; Hayes CS, 2002, P NATL ACAD SCI USA, V99, P3440, DOI 10.1073/pnas.052707199; Herman C, 1998, GENE DEV, V12, P1348, DOI 10.1101/gad.12.9.1348; Himeno H, 1997, J MOL BIOL, V268, P803, DOI 10.1006/jmbi.1997.1011; Huang CH, 2000, EMBO J, V19, P1098, DOI 10.1093/emboj/19.5.1098; Ivanova N, 2004, J MOL BIOL, V338, P33, DOI 10.1016/j.jmb.2004.02.043; Janssen BD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081319; Kogure H, 2014, NUCLEIC ACIDS RES, V42, P3152, DOI 10.1093/nar/gkt1280; Konno T, 2007, RNA, V13, P1723, DOI 10.1261/rna.604907; Kurita D, 2007, NUCLEIC ACIDS RES, V35, P7248, DOI 10.1093/nar/gkm677; Kurita D, 2010, RNA, V16, P980, DOI 10.1261/rna.1916610; LEE SY, 1978, J BACTERIOL, V133, P1015; Li X, 2007, MOL MICROBIOL, V63, P116, DOI 10.1111/j.1365-2958.2006.05498.x; Luidalepp Hannes, 2005, RNA Biol, V2, P70, DOI 10.4161/rna.2.2.2020; Miller MR, 2014, RNA, V20, P228, DOI 10.1261/rna.042226.113; Miller MR, 2011, RNA, V17, P1727, DOI 10.1261/rna.2821711; Muto A, 2000, GENES CELLS, V5, P627, DOI 10.1046/j.1365-2443.2000.00356.x; Neubauer C, 2012, SCIENCE, V335, P1366, DOI 10.1126/science.1217039; Ramadoss NS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057537; Ramrath DJF, 2012, NATURE, V485, P526, DOI 10.1038/nature11006; Roche ED, 2001, J BIOL CHEM, V276, P28509, DOI 10.1074/jbc.M103864200; Shimizu Y, 2006, J BIOL CHEM, V281, P15987, DOI 10.1074/jbc.M512165200; Shoemaker CJ, 2011, P NATL ACAD SCI USA, V108, P1392; Sunohara T, 2004, J BIOL CHEM, V279, P15368, DOI 10.1074/jbc.M312805200; Takada K, 2007, RNA, V13, P503, DOI 10.1261/rna.363207; Thibonnier M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003810; USHIDA C, 1994, NUCLEIC ACIDS RES, V22, P3392, DOI 10.1093/nar/22.16.3392; Zaher HS, 2009, CELL, V136, P46	57	3	3	COLD SPRING HARBOR LAB PRESS, PUBLICATIONS DEPT	COLD SPRING HARBOR	1 BUNGTOWN RD, COLD SPRING HARBOR, NY 11724 USA	1355-8382	1469-9001		RNA	RNA-Publ. RNA Soc.	NOV	2014	20	11					1706	1714		10.1261/rna.045773.114		9	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	AS1UA	WOS:000344065900006		
J	Gao, L; Lin, WR; Sun, DS; Wang, HC				Gao, Lu; Lin, Weiren; Sun, Dongsheng; Wang, Hongcai			Experimental Anelastic Strain Recovery Compliance of Three Typical Rocks	ROCK MECHANICS AND ROCK ENGINEERING			English	Article						Anelastic strain recovery; Compliance; In situ stress; Uniaxial compressive strength; Young's modulus	IN-SITU STRESS; CORES	The experimental determination of anelastic strain recovery (ASR) compliances for three types of rocks (granite, marble, and sandstone) was performed in the laboratory. Preloading of specimens for uniaxial compression creep tests was at 50 % of the uniaxial compressive strength (UCS) for each rock type. We obtained the shear mode Jas(t) and volumetric mode Jav(t) ASR compliances and calculated the ratio of Jas(t) to Jav(t). The Kelvin model for rock rheology was then applied in numerical simulations and the results were in good agreement with the measured data for Jas(t) and Jav(t). These results showed that both the magnitude and rate of increase of the ASR compliances are strongly dependent on the rock type, and the values of the Jas(t)/Jav(t) ratio for a loading of 50 % of the UCS showed a trend leading to different constants for each of the three rock types. Further experimental and numerical analyses showed approximate power-law relationships between the ASR compliances at 50 % of UCS, and both the UCS and the tangential Young's modulus at 50 % of UCS (E (t50)). These relationships may be useful for the preliminary estimation of ASR compliances.	[Gao, Lu] China Univ Geosci, Sch Sci, Beijing 100083, Peoples R China; [Lin, Weiren] Japan Agcy Marine Earth Sci & Technol JAMSTEC, Kochi Inst Core Sample Res, Nankoku, Kochi 7838502, Japan; [Lin, Weiren] China Univ Geosci, Minist Educ, Key Lab Tecton & Petr Resources, Wuhan 430074, Peoples R China; [Sun, Dongsheng; Wang, Hongcai] Chinese Acad Geol Sci, Minist Land & Resources, Key Lab Neotecton & Geohazard, Beijing 100081, Peoples R China; [Sun, Dongsheng; Wang, Hongcai] Chinese Acad Geol Sci, Inst Geomech, Beijing 100081, Peoples R China	Lin, WR (reprint author), Japan Agcy Marine Earth Sci & Technol JAMSTEC, Kochi Inst Core Sample Res, 200 Monobe Otsu, Nankoku, Kochi 7838502, Japan.	lin@jamstec.go.jp			Research Fund for the Doctoral Program of Higher Education of China [20110022120002]; Sinoprobe Deep Exploration in China Project [SinoProbe-07]; Japan Society for the Promotion of Science; JSPS [25287134]; (Ministry of Education, Culture, Sports, Science and Technology; MEXT), Japan [21107006]	We thank Lianjie Wang, Bojing Zhu, Junwei Cui, and Wei Wang for their very helpful comments and suggestions during the preparation of this paper. We gratefully acknowledge Giovanni Barla, the editor of RMRE, and two anonymous reviewers for their careful reading and constructive comments that helped us to improve this manuscript. This research was supported by the Research Fund for the Doctoral Program of Higher Education of China, Project No. 20110022120002, and the Sinoprobe Deep Exploration in China Project (SinoProbe-07). Weiren Lin acknowledges the support of the Grant-in-Aid for Scientific Research No. 25287134 (Japan Society for the Promotion of Science; JSPS) and 21107006 (Ministry of Education, Culture, Sports, Science and Technology; MEXT), Japan.	American Society for Testing and Materials, 1999, STAND TEST METH LAB, P6; MATSUKI K, 1993, INT J ROCK MECH MIN, V30, P1019, DOI 10.1016/0148-9062(93)90064-K; Haimson BC, 2003, INT J ROCK MECH MIN, V40, P1011, DOI 10.1016/j.ijrmms.2003.08.002; Matsuki K, 2008, INT J ROCK MECH MIN, V45, P952, DOI 10.1016/j.ijrmms.2007.10.005; Lin WR, 2006, TECTONOPHYSICS, V426, P221, DOI 10.1016/j.tecto.2006.02.019; RUTTER EH, 1994, J STRUCT GEOL, V16, P1431, DOI 10.1016/0191-8141(94)90007-8; Ljunggren C, 2003, INT J ROCK MECH MIN, V40, P975, DOI 10.1016/j.ijrmms.2003.07.003; EISSA EA, 1988, INT J ROCK MECH MIN, V25, P479, DOI 10.1016/0148-9062(88)90987-4; Blanton TL, 1983, SPE DOE S LOW PERM D, P213; Byrne TB, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL040749; Flugge W, 1967, VISCOELASTICITY; ISRM Comission on Standardization of Laboratory and Field Test, 1979, INT J ROCK MECH MIN, V16, P135; Ito T, 2006, EARTH PLANETS SPACE, V58, P963; Jiang Y, 2011, P 12 INT C ROCK MECH, P655; Kanagawa T, 1987, P 7 JAP S ROCK MECH, P193; [LIN Weiren 林为人], 2008, [岩石力学与工程学报, Chinese Journal of Rock Mechanics and Engineering], V27, P2387; Matsuki K, 1992, J MINING MAT PROCESS, V108, P41; Matthew M, 2011, J STRUCT GEOL, V33, P713; Rivas T, 2000, BUILD ENVIRON, V35, P387, DOI 10.1016/S0360-1323(99)00037-2; Strickland F.G., 1980, P 21 US S ROCK MECH, P523; [孙东生 Sun Dongsheng], 2012, [地球物理学进展, Progress in Geophysiscs], V27, P1101; Teufel LW, 1982, P 23 US S ROCK MECH, P238; Voight B, 1968, FELSMECH INGENIEURGE, V6, P201; Wang LJ, 2012, CHINESE J GEOPHYS-CH, V55, P1674, DOI 10.6038/j.issn.0001-5733.2012.05.024; Warpinski NR, 1989, SPE PROD ENG, V4, P272; WOLTER KE, 1989, ROCK MECH ROCK ENG, V22, P273, DOI 10.1007/BF01262283; Yamamoto K., 1990, Tohoku Geophysical Journal, Science Reports of the Tohoku University, Fifth Series, V33	27	0	0	SPRINGER WIEN	WIEN	SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA	0723-2632	1434-453X		ROCK MECH ROCK ENG	Rock Mech. Rock Eng.	NOV	2014	47	6					1987	1995		10.1007/s00603-013-0526-0		9	Engineering, Geological; Geosciences, Multidisciplinary	Engineering; Geology	AS6UK	WOS:000344397400002		
J	Zhao, ZH; Li, B; Jiang, YJ				Zhao, Zhihong; Li, Bo; Jiang, Yujing			Effects of Fracture Surface Roughness on Macroscopic Fluid Flow and Solute Transport in Fracture Networks	ROCK MECHANICS AND ROCK ENGINEERING			English	Article						Roughness; Rock fracture; Fracture network; Flow; Solute transport; Anisotropy	ROCK JOINTS; PERMEABILITY; SHEARING; MASSES; MODEL		[Zhao, Zhihong] Stockholm Univ, Dept Geol Sci, Bolin Ctr Climate Res, S-10691 Stockholm, Sweden; [Li, Bo; Jiang, Yujing] Nagasaki Univ, Grad Sch Engn, Nagasaki 8528521, Japan	Zhao, ZH (reprint author), Stockholm Univ, Dept Geol Sci, Bolin Ctr Climate Res, S-10691 Stockholm, Sweden.	zhihong.zhao@geo.su.se			Bolin Centre for Climate Research at Stockholm University, Sweden; National Natural Science Foundation of China [51279097];  [24760690]	Z.Z. was financially supported by the Bolin Centre for Climate Research at Stockholm University, Sweden. B. L. was partially funded by Grant-in-Aid for Young Scientists (B) (No. 24760690), Japan, and the National Natural Science Foundation of China (No. 51279097). Dr. Lanru Jing from the Royal Institute of Technology (KTH), Stockholm, Sweden, is acknowledged for the constructive comments and discussion. The two anonymous reviewers are acknowledged for their valuable comments.	Min KB, 2004, INT J ROCK MECH MIN, V41, P1191, DOI 10.1016/j.ijrmms.2004.05.005; Grasselli G, 2002, INT J ROCK MECH MIN, V39, P789, DOI 10.1016/S1365-1609(02)00070-9; Renshaw CE, 1995, J GEOPHYS RES-SOL EA, V100, P24629, DOI 10.1029/95JB02159; YU XB, 1991, INT J ROCK MECH MIN, V28, P333, DOI 10.1016/0148-9062(91)90598-G; Zhao ZH, 2011, COMPUT GEOTECH, V38, P113, DOI 10.1016/j.compgeo.2010.10.001; Min KB, 2004, HYDROGEOL J, V12, P497, DOI 10.1007/s10040-004-0331-7; Boutt DF, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL027275; Zimmerman RW, 1996, TRANSPORT POROUS MED, V23, P1; TSANG YW, 1983, J GEOPHYS RES, V88, P2359, DOI 10.1029/JB088iB03p02359; Baghbanan A, 2008, INT J ROCK MECH MIN, V45, P1320, DOI 10.1016/j.ijrmms.2008.01.015; TSE R, 1979, INT J ROCK MECH MIN, V16, P303, DOI 10.1016/0148-9062(79)90241-9; BARTON N, 1973, ENG GEOL, V7, P287, DOI 10.1016/0013-7952(73)90013-6; Itasca Consulting Group Inc, 2004, UDEC US GUID VER 4 0; Iwano M, 1995, THESIS MIT; Johnson J, 2006, J GEOPHYS RES-SOL EA, V111, DOI 10.1029/2005JB004087; Li B, 2008, INT J ROCK MECH MIN, V45, P362, DOI 10.1016/j.ijrmms.2007.06.004; Li B, 2013, J MMIJ, V129, P479; Mandelbrot B. B., 1983, FRACTAL GEOMETRY NAT; Moreno L, 2006, J CONTAM HYDROL, V86, P215, DOI 10.1016/j.jconhyd.2006.03.004; Myers NO, 1962, WEAR, V5, P182, DOI 10.1016/0043-1648(62)90002-9; Olsson R, 2001, INT J ROCK MECH MIN, V38, P317, DOI 10.1016/S1365-1609(00)00079-4; Xiong XB, 2011, INT J ROCK MECH MIN, V48, P1292, DOI 10.1016/j.ijrmms.2011.09.009	22	0	0	SPRINGER WIEN	WIEN	SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA	0723-2632	1434-453X		ROCK MECH ROCK ENG	Rock Mech. Rock Eng.	NOV	2014	47	6					2279	2286		10.1007/s00603-013-0497-1		8	Engineering, Geological; Geosciences, Multidisciplinary	Engineering; Geology	AS6UK	WOS:000344397400024		
J	Yang, QQ; Cai, F; Su, ZM; Ugai, KZ; Xu, LY; Huang, RQ; Xu, Q				Yang, Qingqing; Cai, Fei; Su, Zhiman; Ugai, Keizo; Xu, Lingyu; Huang, Runqiu; Xu, Qiang			Numerical Simulation of Granular Flows in a Large Flume Using Discontinuous Deformation Analysis	ROCK MECHANICS AND ROCK ENGINEERING			English	Article						Discontinuous deformation analysis; Large flume test; Rock avalanche; Mass-front velocity; Deposit morphology			[Yang, Qingqing] Southwest Jiaotong Univ, Fac Geosci & Environm Engn, Chengdu 610031, Peoples R China; [Yang, Qingqing] Southwest Jiaotong Univ, MOE Key Lab High Speed Railway Engn, Chengdu 610031, Peoples R China; [Cai, Fei; Ugai, Keizo; Xu, Lingyu] Gunma Univ, Dept Civil & Environm Engn, Kiryu, Gumma 3768515, Japan; [Cai, Fei; Huang, Runqiu; Xu, Qiang] Chengdu Univ Technol, State Key Lab Geohazard Prevent & Geoenvironm Pro, Chengdu 610059, Peoples R China; [Su, Zhiman] Chinese Acad Sci, Inst Mt Hazards & Environm, Chengdu 610041, Peoples R China; [Xu, Lingyu] Dalian Univ Technol, Dept Hydraul Engn, Dalian 116024, Peoples R China	Yang, QQ (reprint author), Southwest Jiaotong Univ, Fac Geosci & Environm Engn, Chengdu 610031, Peoples R China.	yangqq_71@126.com			Chinese State Key Basic Research Program [2013CB733201]	The authors would like to acknowledge Dr. Genhua Shi for kindly providing his DDA code for this study, as well as Dr. Lu Zheng and Dr. Zusong Wu of Kyushu University in Japan for their helpful discussions and suggestions. This research was partly supported by the Chinese State Key Basic Research Program (project 2013CB733201).	Hungr O, 2001, ENVIRON ENG GEOSCI, V7, P221; CUNDALL PA, 1979, GEOTECHNIQUE, V29, P47; Tommasi P, 2008, ROCK MECH ROCK ENG, V41, P37, DOI 10.1007/s00603-007-0133-z; Chen GQ, 2013, ROCK MECH ROCK ENG, V46, P527, DOI 10.1007/s00603-012-0360-9; Yang QQ, 2011, ENG GEOL, V122, P249, DOI 10.1016/j.enggeo.2011.06.006; Valentino R, 2008, ROCK MECH ROCK ENG, V41, P153, DOI 10.1007/s00603-006-0126-3; Calvetti F, 2000, ITAL GEOTECH J, V2, P21; Gonzales E, 2002, P 1 INT PFC S NUM MO, P307; Ma GC, 2011, J ROCK MECH GEOTECH, V3, P57; Shi G., 1988, THESIS U CALIFORNIA	10	0	0	SPRINGER WIEN	WIEN	SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA	0723-2632	1434-453X		ROCK MECH ROCK ENG	Rock Mech. Rock Eng.	NOV	2014	47	6					2299	2306		10.1007/s00603-013-0489-1		8	Engineering, Geological; Geosciences, Multidisciplinary	Engineering; Geology	AS6UK	WOS:000344397400026		
J	Larsen, M; Rantala, R; Koudenburg, OA; Gulis, G				Larsen, Maja; Rantala, Riikka; Koudenburg, Okje Anna; Gulis, Gabriel			Intersectoral action for health: The experience of a Danish municipality	SCANDINAVIAN JOURNAL OF PUBLIC HEALTH			English	Article						Collaboration; health policy; intersectoral action for health; health in all policies; health promotion; public health; municipality	POLICIES	Background:The aim was to build up evidence on intersectoral action for health at local government level by identifying both challenges and facilitating factors in collaboration between sectors when developing and implementing an intersectoral health policy in Varde, Denmark. Methods: The study was carried out in 2011 using the case-study method. Approximately 500 pages of documents from the period 2007-2011 were analysed, and semi-structured interviews were carried out with nine key informants. Results: The following challenges were identified: the policy was perceived as an additional task by employees outside the health sector; initially no direct funding was allocated to intersectoral projects; the level of ambition was not balanced between sectors; there was a lack of ownership of the policy; baseline measures were lacking and the policy had no clear objectives. Facilitating factors were considered to be: significant political support; public involvement; use of local media; establishment of a Fund for Health'; establishment of Health Networks' within sectors; and collaboration with a research group. Conclusions: Important practical lessons can be drawn from this experience for other cities planning to introduce similar formal intersectoral health policies. In order to increase the chance of successful intersectoral action in further development and implementation of the intersectoral health policy in Varde in the future, the challenges and facilitating factors identified in this study should be considered. More evidence is required on the long-term health impacts of such policies.	[Larsen, Maja; Koudenburg, Okje Anna; Gulis, Gabriel] Univ Southern Denmark, Inst Publ Hlth, Unit Hlth Promot Res, DK-6700 Esbjerg, Denmark; [Rantala, Riikka] World Hlth Org, Ctr Hlth Dev, Kobe, Hyogo, Japan	Larsen, M (reprint author), Univ Southern Denmark, Inst Publ Hlth, Unit Hlth Promot Res, Niels Bohrs Vej 9, DK-6700 Esbjerg, Denmark.	malarsen@health.sdu.dk			World Health Organization Centre for Health Development [200317003]	The study is supported by a grant from the World Health Organization Centre for Health Development for documenting case studies on intersectoral action for health in urban settings [grant number 200317003].	Aarestrup AK, 2007, MUNICIPAL HLTH POLIC; Andersen PT, 2009, SCAND J PUBLIC HEALT, V38, P246; [Anonymous], 2010, AD STAT HLTH ALL POL; [Anonymous], 2011, INT ACT HLTH PATH PO; [Anonymous], 2011, WORLD C SOC DET HLTH; Kickbusch I, 2010, HEALTH PROMOT INT, V25, P261, DOI 10.1093/heapro/daq055; Shankardass K, 2012, INT J PUBLIC HEALTH, V57, P25, DOI 10.1007/s00038-011-0302-4; [Anonymous], 2011, UN GEN ASS 66 SESS; Ollila E, 2011, SCAND J PUBLIC HEALT, V39, P11, DOI 10.1177/1403494810379895; [Anonymous], 2010, HIDD CIT UNM OV HLTH; Bambra C., 2005, SOCIAL POLICY SOC, V4, P31, DOI 10.1017/S1474746404002143; Christensen AI, 2010, HVORDAN HAR TRIVSEL; Dahlgren G, 1991, POLICIES STRATEGIES; Esping-Andersen G., 1990, 3 WORLDS WELFARE CAP; Esping-Andersen G., 1999, SOCIAL FDN POSTINDUS; Kemm J., 2006, HLTH ALL POLICIES PR; Larsen M, 2013, SCAND J PUBLIC HEALT, V41, P778, DOI 10.1177/1403494813496602; Larsen M, 2012, INT J PUBLIC HEALTH, V57, P477, DOI 10.1007/s00038-011-0324-y; Olejaz M., 2012, HLTH SYST TRANSIT, V14, P1; Kreisel W., 1998, World Health Statistics Quarterly, V51, P75; Stahl T., 2006, HLTH ALL POLICIES PR; Varde municipality, 2008, HLTH POL 2008 2012; WHO, 2014, SOC DET HLTH INT; WHO (World Health Organisation), 2006, BAS DOC S; World Health Organisation (WHO), 2008, HLTH EQ INT ACT AN 1; World Health Organization, 2010, URB HEART URB HLTH E; Yin R.K., 2009, CASE STUDY RES DESIG	27	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1403-4948	1651-1905		SCAND J PUBLIC HEALT	Scand. J. Public Health	NOV	2014	42	7					649	657		10.1177/1403494814544397		9	Public, Environmental & Occupational Health	Public, Environmental & Occupational Health	AS1UG	WOS:000344066600014		
J	Zhang, MW; Yang, B; Wang, CZ; Takagi, TS				Zhang, Mingwu; Yang, Bo; Wang, Chunzhi; Takagi, Tsuyoshi			Unbounded anonymous hierarchical IBE with continual-key-leakage tolerance	SECURITY AND COMMUNICATION NETWORKS			English	Article						hierarchical IBE; key leakage; unbounded delegation; anonymity; orthogonal subgroup	IDENTITY-BASED ENCRYPTION; BOUNDED-RETRIEVAL MODEL; DUAL SYSTEM ENCRYPTION; RESILIENT; CRYPTOGRAPHY; SCHEMES; HIBE	Modern cryptographic schemes are constructed under the fundamental assumption that secret keys are perfectly hidden from all possible attackers. In practice, however, keys and internal states may partially be leaked. Recently, cryptographic construction with key-leakage resilience has been a crucial research topic. In this work, we proposed an anonymous hierarchical identity-based encryption that can tolerate partial leakage of secret keys. Our results were as follows. First, we provided a tolerance for continual key leakage that can capture both memory leakage and continual leakage. We extended a dual-system encryption mechanism in orthogonal subgroups to achieve key-leakage resilience and implicitly employed an update algorithm to guard against continual leakage. Second, the delegation depth is unbounded, which means that no predetermined depth was imposed in the setup algorithm, thus making the scheme very flexible in practice. We employed a secret-sharing approach to split the master key into multiple shares in key components corresponding to the elements. Third, we analyzed and discussed the performance of allowable leakage-tolerance bounds and the leakage rate of the proposed scheme and gave an evaluation that attains about 40-70% leakage rate under the Advanced Encryption Standard 112 security level. Copyright (c) 2013 John Wiley & Sons, Ltd.	[Zhang, Mingwu; Wang, Chunzhi] Hubei Univ Technol, Sch Comp Sci, Wuhan 430068, Peoples R China; [Yang, Bo] Shaanxi Normal Univ, Sch Comp, Xian 710062, Peoples R China; [Zhang, Mingwu; Takagi, Tsuyoshi] Kyushu Univ, Inst Math Ind, Fukuoka 8190395, Japan	Zhang, MW (reprint author), Hubei Univ Technol, Sch Comp Sci, Wuhan 430068, Peoples R China.	csmwzhang@gmail.com	Zhang, Mingwu/Q-1571-2015		National Natural Science Foundation of China [61272404, 61370224, 61173164, 61170135]; Guangdong Natural Science Foundation [S2012010010383]	This work is supported by the National Natural Science Foundation of China under grants 61272404, 61370224, 61173164 and 61170135, and the Guangdong Natural Science Foundation under grant S2012010010383.	Abdalla M, 2012, LNCS, V7533, P78; Akavik A, 2009, LECT NOTES COMPUT SC, V5444, P474; Alwen J, 2009, LECT NOTES COMPUT SC, V5677, P36, DOI 10.1007/978-3-642-03356-8_3; Dodis Y, 2010, LECT NOTES COMPUT SC, V5978, P361; Brakerski Z, 2010, ANN IEEE SYMP FOUND, P501, DOI 10.1109/FOCS.2010.55; Boyen X, 2006, LECT NOTES COMPUT SC, V4117, P290; Alwen J, 2010, LECT NOTES COMPUT SC, V6110, P113; Gentry C, 2009, LECT NOTES COMPUT SC, V5444, P437; Dodis Y, 2011, ANN IEEE SYMP FOUND, P688, DOI 10.1109/FOCS.2011.35; Boneh D, 2005, LECT NOTES COMPUT SC, V3494, P440; Kiltz E, 2010, LECT NOTES COMPUT SC, V6477, P595, DOI 10.1007/978-3-642-17373-8_34; Zhang MW, 2013, COMPUT J, V56, P464, DOI 10.1093/comjnl/bxs133; Lewko A, 2011, LECT NOTES COMPUT SC, V6632, P547, DOI 10.1007/978-3-642-20465-4_30; Lewko A, 2010, LECT NOTES COMPUT SC, V5978, P455; Waters B, 2009, LECT NOTES COMPUT SC, V5677, P619, DOI 10.1007/978-3-642-03356-8_36; Naor M, 2009, LECT NOTES COMPUT SC, V5677, P18, DOI 10.1007/978-3-642-03356-8_2; Boneh D, 2008, LECT NOTES COMPUT SC, V5350, P455, DOI 10.1007/978-3-540-89255-7_28; Bonehs D, 2004, CRYPTO, P443; Chow S.M., 2010, ACM C COMP COMM SEC, P152; Dziembowski S, 2011, LECT NOTES COMPUT SC, V7073, P702, DOI 10.1007/978-3-642-25385-0_38; Lewko A, 2011, LECT NOTES COMPUT SC, V6597, P70, DOI 10.1007/978-3-642-19571-6_6; Okamoto T., 2012, LNCS, V7658, P349; Okamoto T., 2012, LECT NOTES COMPUTER, V7237, P591; Seos JH, 2009, LNCS, V5443, P215; Yangs B, 2012, LNCS, V7496, P125; Yuen T.H., 2012, LNCS, V7237, P117; Zhang MW, 2011, LECT NOTES COMPUT SC, V6980, P154	27	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1939-0114	1939-0122		SECUR COMMUN NETW	Secur. Commun. Netw.	NOV	2014	7	11					1974	1987		10.1002/sec.912		14	Computer Science, Information Systems; Telecommunications	Computer Science; Telecommunications	AS5PJ	WOS:000344322100026		
J	Kinuhata, S; Hayashi, T; Sato, KK; Uehara, S; Oue, K; Endo, G; Kambe, H; Fukuda, K				Kinuhata, Shigeki; Hayashi, Tomoshige; Sato, Kyoko Kogawa; Uehara, Shinichiro; Oue, Keiko; Endo, Ginji; Kambe, Hiroshi; Fukuda, Kanji			Sleep duration and the risk of future lipid profile abnormalities in middle-aged men: the Kansai Healthcare Study	SLEEP MEDICINE			English	Article						Sleep duration; Lifestyle; Lipids; Lipoproteins; Dyslipidemia; Epidemiology; Prospective cohort study	METABOLIC SYNDROME; BLOOD-PRESSURE; ADULTS; ASSOCIATIONS; METAANALYSIS; CHOLESTEROL; DISEASE; OBESITY; WORKERS; CARDIA	Background: Although short sleep duration has been reported to be associated with future cardiometabolic diseases, it is not fully understood whether sleep duration is prospectively associated with the risk of each lipid profile abnormality. Methods: Subjects were nondiabetic Japanese, 40-55 years of age, who were not taking oral lipid-lowering medications: for the incidence of low high-density lipoprotein cholesterol (HDL-C), 7627 men with an HDL-C level >= 40 mg/dL; for high triglycerides, 6973 men with a triglyceride level <200 mg/dL; for high low-density lipoprotein cholesterol (LDL-C), 7273 men with an LDL-C level <160 mg/dL; for high non-HDL-C, 7415 men with a non-HDL-C level <190 mg/dL; and for high total cholesterol (TC), 7196 men with a TC level <240 mg/dL. Lipid profile abnormalities were defined according to the Adult Treatment Panel III guidelines of the National Cholesterol Education Program. Results: During the 6-year observation period, there were 1022 cases of low HDL-C. Multiple-adjusted hazard ratios for low HDL-C were 0.79 (95% confidence interval, 0.64-0.97) for sleep durations of 5 to <7 h and 0.62 (0.46-0.83) for >= 7 h comparedwith <5 h. There were 1473 cases of high triglycerides. Multipleadjusted hazard ratios for high triglycerides were 0.81 (0.68-0.98) for sleep durations of 5 to <7 h and 0.90 (0.72-1.13) for >= 7 h compared with <5 h. However, no association between sleep duration and the risk of future high LDL-C, non-HDL-C, or TC was observed. Conclusions: Moderate and/or long sleep durations decreased the risk of future low HDL-C and high triglycerides. (C) 2014 Elsevier B.V. All rights reserved.	[Kinuhata, Shigeki; Hayashi, Tomoshige; Sato, Kyoko Kogawa; Uehara, Shinichiro; Endo, Ginji] Osaka City Univ, Grad Sch Med, Dept Prevent Med & Environm Hlth, Osaka 5458585, Japan; [Oue, Keiko; Kambe, Hiroshi; Fukuda, Kanji] Nippon Telegraph & Tel West Corp, Kansai Hlth Adm Ctr, Osaka, Japan	Hayashi, T (reprint author), Osaka City Univ, Grad Sch Med, Dept Prevent Med & Environm Hlth, Abeno Ku, 1-4-3 Asahi Machi, Osaka 5458585, Japan.	thayashi@med.osaka-cu.ac.jp	Hayashi, Tomoshige/N-8508-2015		Ministry of Health, Labour and Welfare of Japan; Health and Labour Sciences Research Grant (Research on Occupational Safety and Health) from the Ministry of Health, Labour and Welfare of Japan [H1403]	This work was supported by a Health and Labour Sciences Research Grant (Research on Occupational Safety and Health H1403) from the Ministry of Health, Labour and Welfare of Japan, and by facilities and services provided by Kansai Health Administration Center at Nippon Telegraph and Telephone West Corporation. The funding source had no role in the collection of data or in the decision to submit the manuscript for publication.	American Diabetes Association, 2007, DIABETES CARE S1, V30, pS42, DOI DOI 10.2337/DC07-S042; Arora T, 2011, DIABETES CARE, V34, P2317, DOI 10.2337/dc11-0647; Gangwisch JE, 2006, HYPERTENSION, V47, P833, DOI 10.1161/01.HYP.0000217362.34748.e0; Cappuccio FP, 2008, SLEEP, V31, P619; Kita T, 2012, DIABETES CARE, V35, P313, DOI 10.2337/dc11-1455; Sato KK, 2008, DIABETES CARE, V31, P1230, DOI 10.2337/dc07-2184; Kohyama J, 2011, J PHYSIOL ANTHROPOL, V30, P1, DOI 10.2114/jpa2.30.1; BOLLEN KA, 1985, SOCIOL METHOD RES, V13, P510, DOI 10.1177/0049124185013004004; Lauderdale DS, 2006, AM J EPIDEMIOL, V164, P5, DOI 10.1093/aje/kwj199; Broussard JL, 2012, ANN INTERN MED, V157, P549, DOI 10.7326/0003-4819-157-8-201210160-00005; Hall MH, 2008, SLEEP, V31, P635; van Den Berg JF, 2008, PSYCHOSOM MED, V70, P1005, DOI 10.1097/PSY.0b013e318186e656; Amagai Y, 2010, J EPIDEMIOL, V20, P106, DOI 10.2188/jea.JE20090053; Nielsen LS, 2011, OBES REV, V12, P78, DOI 10.1111/j.1467-789X.2010.00724.x; Gallicchio L, 2009, J SLEEP RES, V18, P148, DOI 10.1111/j.1365-2869.2008.00732.x; Gangwisch JE, 2010, SLEEP, V33, P956; Walsleben JA, 2004, SLEEP, V27, P293; Kashiwagi A, 2012, J DIABETES INVEST, V3, P39, DOI 10.1111/j.2040-1124.2012.00207.x; Bin YS, 2012, SLEEP MED REV, V16, P223, DOI 10.1016/j.smrv.2011.07.003; Petrov MER, 2013, SLEEP, V36, P1587, DOI 10.5665/sleep.3104; Chobanian AV, 2003, JAMA-J AM MED ASSOC, V289, P2560, DOI 10.1001/jama.289.19.2560; Kaneita Y, 2008, SLEEP, V31, P645; Lockley SW, 1999, J SLEEP RES, V8, P175, DOI 10.1046/j.1365-2869.1999.00155.x; HAFFNER SM, 1992, DIABETES, V41, P715, DOI 10.2337/diabetes.41.6.715; Cleves M, 2010, INTRO SURVIVAL ANAL, P203; FRIEDEWA.WT, 1972, CLIN CHEM, V18, P499; Katz MH, 2006, MULTIVARIABLE ANAL P, P71; Katz MH, 2006, MULTIVARIABLE ANAL P, P139; Koh H, 2011, HYPERTENS RES, V34, P536, DOI 10.1038/hr.2011.2; Nishiura C, 2010, J EPIDEMIOL, V20, P385, DOI 10.2188/jea.JE20100019; Rashid S, 2003, CLIN BIOCHEM, V36, P421, DOI 10.1016/S0009-9120(03)00078-X; Third report of the National Cholesterol Education Program (NCEP), 2002, CIRCULATION, V106, P3143; YAMADA N, 1994, DIABETES CARE, V17, P107, DOI 10.2337/diacare.17.2.107	33	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1389-9457	1878-5506		SLEEP MED	Sleep Med.	NOV	2014	15	11					1379	1385		10.1016/j.sleep.2014.06.011		7	Clinical Neurology	Neurosciences & Neurology	AS4IH	WOS:000344237200016		
J	Kawada, T				Kawada, Tomoyuki			Persistent insomnia symptoms and its predictors by questionnaire survey	SLEEP MEDICINE			English	Letter							OPERATING CHARACTERISTIC CURVES; AREAS; RISK		Nippon Med Sch, Dept Hyg & Publ Hlth, Bunkyo Ku, Tokyo 1138602, Japan	Kawada, T (reprint author), Nippon Med Sch, Dept Hyg & Publ Hlth, Bunkyo Ku, 1-1-5 Sendagi, Tokyo 1138602, Japan.	kawada@nms.ac.jp					Suh S, 2014, SLEEP MED, V15, P180, DOI 10.1016/j.sleep.2013.09.024; Robbins J, 2007, JAMA-J AM MED ASSOC, V298, P2389, DOI 10.1001/jama.298.20.2389; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; HANLEY JA, 1983, RADIOLOGY, V148, P839	4	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1389-9457	1878-5506		SLEEP MED	Sleep Med.	NOV	2014	15	11					1427	1428		10.1016/j.sleep.2014.05.031		4	Clinical Neurology	Neurosciences & Neurology	AS4IH	WOS:000344237200027		
J	Goennenwein, SB; Maekawa, S; Bauer, GEW				Goennenwein, S. T. B.; Maekawa, S.; Bauer, G. E. W.			Spin mechanics Preface	SOLID STATE COMMUNICATIONS			English	Editorial Material							CURRENT GENERATION; MAGNETIZATION; CALORITRONICS; ROTATION; DRIVEN		[Goennenwein, S. T. B.] Bayer Akad Wissensch, Walther Messner Inst, D-85748 Garching, Germany; [Goennenwein, S. T. B.] Nanosyst Initiat Munich, D-80799 Munich, Germany; [Goennenwein, S. T. B.] Tech Univ Munich, Dept Phys, D-85748 Garching, Germany; [Maekawa, S.] Japan Atom Energy Agcy, Adv Sci Res Ctr, Tokai, Ibaraki 3191195, Japan; [Maekawa, S.] Japan Sci & Technol Agcy, CREST, Tokyo 1020075, Japan; [Bauer, G. E. W.] Tohoku Univ, Inst Mat Res, Sendai, Miyagi 9808577, Japan; [Bauer, G. E. W.] Tohoku Univ, WPI AIMR, Sendai, Miyagi 9808577, Japan; [Bauer, G. E. W.] Delft Univ Technol, Kavli Inst NanoSci, NL-2628 CJ Delft, Netherlands	Goennenwein, SB (reprint author), Bayer Akad Wissensch, Walther Messner Inst, D-85748 Garching, Germany.	goennenwein@wmi.badw.de	Bauer, Gerrit/F-8273-2010	Bauer, Gerrit/0000-0002-3615-8673			Adachi H, 2014, SOLID STATE COMMUN, V198, P22, DOI 10.1016/j.ssc.2014.02.030; Bauer GEW, 2012, NAT MATER, V11, P391, DOI [10.1038/nmat3301, 10.1038/NMAT3301]; Ramesh R, 2007, NAT MATER, V6, P21, DOI 10.1038/nmat1805; Chudo H, 2014, APPL PHYS EXPRESS, V7, DOI 10.7567/APEX.7.063004; Klein O, 2008, PHYS REV B, V78, DOI 10.1103/PhysRevB.78.144410; Barnett SJ, 1915, PHYS REV, V6, P239, DOI 10.1103/PhysRev.6.239; O'Connell AD, 2010, NATURE, V464, P697, DOI 10.1038/nature08967; Wallis TM, 2006, APPL PHYS LETT, V89, DOI 10.1063/1.2355445; Mohanty P, 2004, PHYS REV B, V70, DOI 10.1103/PhysRevB.70.195301; Kiselev SI, 2003, NATURE, V425, P380, DOI 10.1038/nature01967; Fiebig M, 2005, J PHYS D APPL PHYS, V38, pR123, DOI 10.1088/0022-3727/38/8/R01; Miron IM, 2010, NAT MATER, V9, P230, DOI [10.1038/nmat2613, 10.1038/NMAT2613]; Bauer GEW, 2010, PHYS REV B, V81, DOI 10.1103/PhysRevB.81.024427; Brandl F, 2014, SOLID STATE COMMUN, V198, P13, DOI 10.1016/j.ssc.2013.12.019; De A, 2014, SOLID STATE COMMUN, V198, P66, DOI 10.1016/j.ssc.2013.08.004; Didier N, 2014, SOLID STATE COMMUN, V198, P61, DOI 10.1016/j.ssc.2014.02.029; Einstein A., 1915, Verhandlungen der Deutschen Physikalischen Gesellschaft, V17; Geprags S, 2014, SOLID STATE COMMUN, V198, P7, DOI 10.1016/j.ssc.2013.07.019; Gui YS, 2014, SOLID STATE COMMUN, V198, P45, DOI 10.1016/j.ssc.2014.07.026; Ieda J, 2014, SOLID STATE COMMUN, V198, P52, DOI [10.1016/j.ssc.2014.02.003, 10.1010/j.ssc.2014.02.003]; Jin HY, 2014, SOLID STATE COMMUN, V198, P40, DOI 10.1016/j.ssc.2013.12.027; Keslittiar H., 2014, SOLID STATE COMMUN, V108, P30; Lim SH, 2014, EPL-EUROPHYS LETT, V105, DOI 10.1209/0295-5075/105/37009; Losby JE, 2014, SOLID STATE COMMUN, V198, P3, DOI 10.1016/j.ssc.2013.08.006; Maekawa S., 2012, SPIN CURRENT; Matsuo M, 2014, SOLID STATE COMMUN, V198, P57, DOI 10.1016/j.ssc.2013.08.005; Nunez AS, 2014, SOLID STATE COMMUN, V198, P18, DOI 10.1016/j.ssc.2013.10.018; Rasura A., 2014, SOLID STATE COMMUN, V103, P35; Richardson OW, 1908, PHYS REV, V26, P248, DOI 10.1103/PhysRevSeriesI.26.248; SCOTT GG, 1962, REV MOD PHYS, V34, P102, DOI 10.1103/RevModPhys.34.102; Uchida K, 2014, SOLID STATE COMMUN, V198, P26, DOI 10.1016/j.ssc.2013.10.012	31	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0038-1098	1879-2766		SOLID STATE COMMUN	Solid State Commun.	NOV	2014	198				SI		1	2		10.1016/j.ssc.2014.07.021		2	Physics, Condensed Matter	Physics	AS4EN	WOS:000344226100001		
J	Adachi, H; Maekawa, S				Adachi, Hiroto; Maekawa, Sadamichi			Theory of the acoustic spin pumping	SOLID STATE COMMUNICATIONS			English	Article						Magnetically ordered materials; Thermoelectricity; Magnetocalorics	THERMAL CONDUCTIVITY; MAGNETIC TRANSITION	Spin pumping refers to the spin current injection driven by magnetization dynamics from a ferromagnet into adjacent nonmagnetic conductors. Conventionally, ferromagnetic resonance is used to drive the magnetization dynamics and the spin pumping. Recently a new type of spin pumping driven by acoustic waves, i.e., the acoustic spin pumping, has been reported. We present a linear-response theory of the acoustic spin pumping. (C) 2014 Elsevier Ltd. All rights reserved.	[Adachi, Hiroto; Maekawa, Sadamichi] Japan Atom Energy Agcy, Adv Sci Res Ctr, Tokai, Ibaraki 3191195, Japan; [Adachi, Hiroto; Maekawa, Sadamichi] Japan Sci & Technol Agcy, CREST, Tokyo 1020075, Japan	Adachi, H (reprint author), Japan Atom Energy Agcy, Adv Sci Res Ctr, Tokai, Ibaraki 3191195, Japan.	adachi.hiroto@jaea.go.jp	ADACHI, Hiroto/C-7889-2012	ADACHI, Hiroto/0000-0002-6844-6477	Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan	We are grateful to E. Saitoh and K. Uchida. This work was financially supported by a Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan.	Adachi H, 2011, PHYS REV B, V83, DOI 10.1103/PhysRevB.83.094410; Ando K, 2011, NAT MATER, V10, P655, DOI [10.1038/nmat3052, 10.1038/NMAT3052]; Uchida K, 2012, J APPL PHYS, V111, DOI 10.1063/1.4716012; COHEN MH, 1962, PHYS REV LETT, V8, P316, DOI 10.1103/PhysRevLett.8.316; Jaworski CM, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.186601; Uchida K, 2010, NAT MATER, V9, P894, DOI [10.1038/nmat2856, 10.1038/NMAT2856]; Brataas A, 2012, NAT MATER, V11, P372, DOI [10.1038/nmat3311, 10.1038/NMAT3311]; Jungwirth T, 2012, NAT MATER, V11, P382, DOI [10.1038/nmat3279, 10.1038/NMAT3279]; Uchida K, 2008, NATURE, V455, P778, DOI 10.1038/nature07321; Zhang S, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.127204; Jaworski CM, 2010, NAT MATER, V9, P898, DOI [10.1038/nmat2860, 10.1038/NMAT2860]; Weiler M, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.106602; Uchida K, 2011, NAT MATER, V10, P737, DOI [10.1038/nmat3099, 10.1038/NMAT3099]; Adachi H, 2013, REP PROG PHYS, V76, DOI 10.1088/0034-4885/76/3/036501; Adachi H, 2010, APPL PHYS LETT, V97, DOI 10.1063/1.3529944; Tserkovnyak Y, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.117601; KITTEL C, 1958, PHYS REV, V110, P836, DOI 10.1103/PhysRev.110.836; Saitoh E, 2006, APPL PHYS LETT, V88, DOI 10.1063/1.2199473; BENNETT HS, 1967, PHYS REV, V155, P553, DOI 10.1103/PhysRev.155.553; KAWASAKI K, 1963, PROG THEOR PHYS, V29, P801, DOI 10.1143/PTP.29.801; Lifshitzm E.M., 1982, PHYS KINETICS; LUTHI B, 1970, J PHYS CHEM SOLIDS, V31, P1741, DOI 10.1016/0022-3697(70)90164-2; Ma S.-K., 1976, MODERN THEORY CRITIC; Maekawa S., 2002, SPIN DEPENDENT TRANS; Maekawa S., 1976, AIP C P, V29, P542; STERN H, 1965, J PHYS CHEM SOLIDS, V26, P153, DOI 10.1016/0022-3697(65)90082-X	26	2	2	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0038-1098	1879-2766		SOLID STATE COMMUN	Solid State Commun.	NOV	2014	198				SI		22	25		10.1016/j.ssc.2014.02.030		4	Physics, Condensed Matter	Physics	AS4EN	WOS:000344226100006		
J	Uchida, K; Qiu, ZY; Kikkawa, T; Saitoh, E				Uchida, Ken-ichi; Qiu, Zhiyong; Kikkawa, Takashi; Saitoh, Eiji			Pure detection of the acoustic spin pumping in Pt/YIG/PZT structures	SOLID STATE COMMUNICATIONS			English	Article						Insulators; Magnetically ordered materials; Phonons; Spin dynamics		The acoustic spin pumping (ASP) stands for the generation of a spin voltage from sound waves in a ferromagnet/paramagnet junction. In this letter, we propose and demonstrate a method for pure detection of the ASP, which enables the separation of sound-wave-driven spin currents from the spin Seebeck effect due to the heating of a sample caused by a sound-wave injection. Our demonstration using a Pt/YIG/PZT sample shows that the ASP signal in this structure measured by a conventional method is considerably offset by the heating signal and that the pure ASP signal is one order of magnitude greater than that reported in the previous study. (C) 2013 Elsevier Ltd. All rights reserved	[Uchida, Ken-ichi; Kikkawa, Takashi; Saitoh, Eiji] Tohoku Univ, Inst Mat Res, Sendai, Miyagi 9808577, Japan; [Uchida, Ken-ichi] Japan Sci & Technol Agcy, PRESTO, Kawaguchi, Saitama 3320012, Japan; [Qiu, Zhiyong; Saitoh, Eiji] Tohoku Univ, WPI Adv Inst Mat Res, Sendai, Miyagi 9808577, Japan; [Saitoh, Eiji] Japan Atom Energy Agcy, Adv Sci Res Ctr, Tokai, Ibaraki 3191195, Japan; [Saitoh, Eiji] Japan Sci & Technol Agcy, CREST, Tokyo 1020076, Japan	Uchida, K (reprint author), Tohoku Univ, Inst Mat Res, Sendai, Miyagi 9808577, Japan.	kuchida@imr.tohoku.ac.jp	Uchida, Ken-ichi/H-3098-2011; Saitoh, Eiji/C-1004-2011; Qiu, Zhiyong/P-5746-2014; Kikkawa, Takashi/P-9016-2015	Qiu, Zhiyong/0000-0002-7796-3978; Kikkawa, Takashi/0000-0002-7789-604X	PRESTO-JST "Phase Interfaces for Highly Efficient Energy Utilization"; CREST-JST "Creation of Nanosystems with Novel Functions through Process Integration"; MEXT, Japan [25707029, 24244051]; LC-IMR of Tohoku University; Murata Science Foundation; Mazda Foundation; Sumitomo Foundation	The authors thank S. Maekawa, H. Adachi, and H. Nakayama for valuable discussions. This work was supported by PRESTO-JST "Phase Interfaces for Highly Efficient Energy Utilization", CREST-JST "Creation of Nanosystems with Novel Functions through Process Integration", Grant-in-Aid for Young Scientists (A) (25707029) from MEXT, Japan, Grant-in-Aid for Scientific Research (A) (24244051) from MEXT, Japan, LC-IMR of Tohoku University, The Murata Science Foundation, The Mazda Foundation, and The Sumitomo Foundation.	Qu D, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.067206; Uchida K, 2012, J APPL PHYS, V111, DOI 10.1063/1.4716012; Uchida K, 2010, APPL PHYS LETT, V97, DOI 10.1063/1.3507386; Kimura T, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.156601; Ramos R, 2013, APPL PHYS LETT, V102, DOI 10.1063/1.4793486; Kirihara A, 2012, NAT MATER, V11, P686, DOI [10.1038/nmat3360, 10.1038/NMAT3360]; Matsuo M, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.076601; Nakayama H, 2012, PHYS REV B, V85, DOI 10.1103/PhysRevB.85.144408; Matsuo M, 2011, PHYS REV B, V84, DOI 10.1103/PhysRevB.84.104410; Weiler M, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.176601; Uchida K, 2011, NAT MATER, V10, P737, DOI [10.1038/nmat3099, 10.1038/NMAT3099]; Adachi H, 2013, REP PROG PHYS, V76, DOI 10.1088/0034-4885/76/3/036501; Azevedo A, 2005, J APPL PHYS, V97, DOI 10.1063/1.1855251; Uchida K, 2010, APPL PHYS LETT, V97, DOI 10.1063/1.3533397; Meier D, 2013, PHYS REV B, V87, DOI 10.1103/PhysRevB.87.054421; Ando K, 2011, J APPL PHYS, V109, DOI 10.1063/1.3587173; Jiao HJ, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.217602; GANGULY AK, 1976, J APPL PHYS, V47, P2696, DOI 10.1063/1.322991; Saitoh E, 2006, APPL PHYS LETT, V88, DOI 10.1063/1.2199473; CALLEN HB, 1948, PHYS REV, V73, P1349, DOI 10.1103/PhysRev.73.1349; Maekawa S., 1976, AIP C P, V29, P542; Matsuo M, 2013, PHYS REV B, V87, DOI 10.1103/PhysRevB.87.180402; MATTHEWS H, 1962, PHYS REV LETT, V8, P397, DOI 10.1103/PhysRevLett.8.397; Uchida K, 2013, PHYS REV B, V87, DOI 10.1103/PhysRevB.87.104412; Uchida K, 2012, J APPL PHYS, V111, DOI 10.1063/1.3688332; Uchida K, 2011, APPL PHYS LETT, V99, DOI [10.1063/1.3662032, 10.1063/1.3662931]; Weiler M, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.117601; Zolfagharkhani G, 2008, NAT NANOTECHNOL, V3, P720, DOI 10.1038/nnano.2008.311	28	1	1	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0038-1098	1879-2766		SOLID STATE COMMUN	Solid State Commun.	NOV	2014	198				SI		26	29		10.1016/j.ssc.2013.10.012		4	Physics, Condensed Matter	Physics	AS4EN	WOS:000344226100007		
J	Keshtgar, H; Zareyan, M; Bauer, GEW				Keshtgar, Hedyeh; Zareyan, Malek; Bauer, Gerrit E. W.			Acoustic parametric pumping of spin waves	SOLID STATE COMMUNICATIONS			English	Article						Parametric excitation; Instability threshold; Magnetoelastic effects; Spin pumping	FERROMAGNETIC RESONANCE; MAGNETIZATION; EXCITATION; FIELD	Recent experiments demonstrated generation of spin currents by ultrasound. We can understand this acoustically induced spin pumping in terms of the coupling between magnetization and lattice waves. Here we study the parametric excitation of magnetization by longitudinal acoustic waves and calculate the acoustic threshold power. The induced magnetization dynamics can be detected by the spin pumping into an adjacent normal metal that displays the inverse spin Hall effect. (C) 2014 Elsevier Ltd. All rights reserved.	[Keshtgar, Hedyeh; Zareyan, Malek] Inst Adv Studies Basic Sci, Zanjan 45195, Iran; [Bauer, Gerrit E. W.] Tohoku Univ, Inst Mat Res, Sendai, Miyagi 9808577, Japan; [Bauer, Gerrit E. W.] Tohoku Univ, WPI AIMR, Sendai, Miyagi 9808577, Japan; [Bauer, Gerrit E. W.] Delft Univ Technol, Kavli Inst NanoSci, NL-2628 CJ Delft, Netherlands	Keshtgar, H (reprint author), Inst Adv Studies Basic Sci, POB 45195-1159, Zanjan 45195, Iran.	keshtgar@iasbs.ac.ir	Bauer, Gerrit/F-8273-2010	Bauer, Gerrit/0000-0002-3615-8673	FOM Foundation; Marie Curie ITN Spinicur; Reimei program of the Japan Atomic Energy Agency; EU RTN Spinicur; ICC-IMR, DFG Priority Programme 1538 "Spin-Caloric Transport";  [25247056];  [252209]	We would like to thank Akash Kamra and Yaroslav Blanter for illuminating discussions. This work was supported by the FOM Foundation, Marie Curie ITN Spinicur, Reimei program of the Japan Atomic Energy Agency, EU RTN Spinicur, the ICC-IMR, DFG Priority Programme 1538 "Spin-Caloric Transport", and Grand-in-Aid for Scientific Research Nr. 25247056 and 252209. M.Z. thanks G.E.W. Bauer for the hospitality and support during his visit to the Institute for Materials Research of Tohoku University in Sendai.	SUHL H, 1957, J PHYS CHEM SOLIDS, V1, P209, DOI 10.1016/0022-3697(57)90010-0; Weiler M, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.176601; MORGENTHALER FR, 1960, J APPL PHYS, V31, pS95, DOI 10.1063/1.1984617; Tserkovnyak Y, 2005, REV MOD PHYS, V77, P1375, DOI 10.1103/RevModPhys.77.1375; Holstein T, 1940, PHYS REV, V58, P1098, DOI 10.1103/PhysRev.58.1098; Weiler M, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.176601; Uchida K, 2011, NAT MATER, V10, P737, DOI [10.1038/nmat3099, 10.1038/NMAT3099]; Berger L, 1996, PHYS REV B, V54, P9353, DOI 10.1103/PhysRevB.54.9353; Tserkovnyak Y, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.117601; GILBERT TL, 1955, PHYS REV, V100, P1243; KITTEL C, 1958, PHYS REV, V110, P836, DOI 10.1103/PhysRev.110.836; Saitoh E, 2006, APPL PHYS LETT, V88, DOI 10.1063/1.2199473; Brataas A., ARXIV11080385; COMSTOCK RL, 1963, J APPL PHYS, V34, P1461, DOI 10.1063/1.1729600; JOSEPH RI, 1963, J APPL PHYS, V34, P2686, DOI 10.1063/1.1729791; MATTHEWS H, 1964, PHYS REV LETT, V13, P614, DOI 10.1103/PhysRevLett.13.614; McLachlan NW, 1947, THEORY APPL MATHIEU; SCHLOMANN E, 1960, J APPL PHYS, V31, pS386; Slonczewski JC, 1996, J MAGN MAGN MATER, V159, pL1, DOI 10.1016/0304-8853(96)00062-5; Uchida K., 2012, J APPL PHYS, V111; Zakharov V. E., 1975, Soviet Physics - Uspekhi, V17, DOI 10.1070/PU1975v017n06ABEH004404	21	2	2	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0038-1098	1879-2766		SOLID STATE COMMUN	Solid State Commun.	NOV	2014	198				SI		30	34		10.1016/j.ssc.2013.12.026		5	Physics, Condensed Matter	Physics	AS4EN	WOS:000344226100008		
J	Kamra, A; Bauer, GEW				Kamra, Akashdeep; Bauer, Gerrit E. W.			Actuation, propagation, and detection of transverse magnetoelastic waves in ferromagnets	SOLID STATE COMMUNICATIONS			English	Article						Ferromagnets; Ultrasound; Magnetoelastic coupling; Spin pumping	YTTRIUM IRON-GARNET	We study propagation of ultrasonic waves through a ferromagnetic medium with special attention to the boundary conditions at the interface with an ultrasonic actuator. In analogy to charge and spin transport in conductors, we formulate the energy transport through the system as a scattering problem. We find that the magneto-elastic coupling leads to a non-vanishing magnetic (elastic) energy accompanying the acoustic (spin) waves with a resonantly enhanced effect around the anti-crossing in the dispersion relations. We demonstrate the physics of excitating magnetization dynamics via acoustic waves injected around the ferromagnetic resonance frequency. (C) 2013 Elsevier Ltd. All rights reserved.	[Kamra, Akashdeep; Bauer, Gerrit E. W.] Delft Univ Technol, Kavli Inst NanoSci, NL-2628 CJ Delft, Netherlands; [Bauer, Gerrit E. W.] Tohoku Univ, WPI AIMR, Inst Mat Res, Sendai, Miyagi 9808577, Japan	Kamra, A (reprint author), Delft Univ Technol, Kavli Inst NanoSci, Lorentzweg 1, NL-2628 CJ Delft, Netherlands.	a.kamra@tudelft.nl	Bauer, Gerrit/F-8273-2010	Bauer, Gerrit/0000-0002-3615-8673	FOM Foundation; Marie Curie ITN Spinicur; Reimei program of the Japan Atomic Energy Agency; EU-ICT-7 "MACALO"; ICC-IMR, DFG Priority Programme 1538 "Spin-Caloric Transport";  [25247056]	The authors thank Peng Yan and Sebastian Gonnenwein for useful discussions. This work was supported by the FOM Foundation, Marie Curie ITN Spinicur, Reimei program of the Japan Atomic Energy Agency, EU-ICT-7 "MACALO", the ICC-IMR, DFG Priority Programme 1538 "Spin-Caloric Transport", and Grand-in-Aid for Scientific Research A (Kakenhi) 25247056.	Akhiezer A. I., 1968, SPIN WAVES; Barnett SJ, 1935, REV MOD PHYS, V7, P0129, DOI 10.1103/RevModPhys.7.129; Hoffmann A, 2013, IEEE T MAGN, V49, P5172, DOI 10.1109/TMAG.2013.2262947; Barnett SJ, 1915, PHYS REV, V6, P239, DOI 10.1103/PhysRev.6.239; Weiler M, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.176601; Uchida K, 2011, NAT MATER, V10, P737, DOI [10.1038/nmat3099, 10.1038/NMAT3099]; [Anonymous], YIG CRYST SPEC SHEET; Tserkovnyak Y, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.117601; Jiao HJ, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.217602; KITTEL C, 1958, PHYS REV, V110, P836, DOI 10.1103/PhysRev.110.836; FENG I, 1982, J APPL PHYS, V53, P177, DOI 10.1063/1.331582; Boemmel H., 1959, PHYS REV LETT, V3, P83; Chikazumi S., 1997, PHYS FERROMAGNETISM; Datta S., 2003, ELECT TRANSPORT MESO; EGGERS FG, 1963, J APPL PHYS, V34, P1180, DOI 10.1063/1.1729423; HANSEN P, 1973, PHYS REV B, V8, P246, DOI 10.1103/PhysRevB.8.246; Kittel C., 1915, DTSCH PHYS GES VERH, V17, P152; Nazarov Y., 2009, QUANTUM TRANSPORT IN; TIERSTEN HF, 1964, J MATH PHYS, V5, P1298, DOI 10.1063/1.1704239	19	1	1	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0038-1098	1879-2766		SOLID STATE COMMUN	Solid State Commun.	NOV	2014	198				SI		35	39		10.1016/j.ssc.2013.10.007		5	Physics, Condensed Matter	Physics	AS4EN	WOS:000344226100009		
J	Ieda, J; Matsuo, M; Maekawa, S				Ieda, Jun'ichi; Matsuo, Mamoru; Maekawa, Sadamichi			Theory of mechanical spin current generation via spin-rotation coupling	SOLID STATE COMMUNICATIONS			English	Article						Nonmagnetic conductors; Spin current; Spin-rotation coupling; Surface acoustic waves	ROOM-TEMPERATURE; RELATIVITY	The spin rotation coupling (SRC) is responsible for angular momentum conversion between the electron spin and rotational deformations of elastic media, whereby spin current generation from mechanical motions is theoretically predicted. Here a surface acoustic wave (SAW) is considered as an example of such elastic deformations. We formulate the spin diffusion equation that is extended to include the influence of the SRC, and from the solution we rind that larger spin currents can be obtained in materials with longer spin lifetimes. This distinct feature arises from the fact that the present method is of "purely" mechanical origin, i.e., it relies on neither equilibrium magnetization nor spin-orbit coupling, offering a new route to building the so-called "rare-metal-free" spintronics devices. (C) 2014 Elsevier Ltd. All rights reserved	[Ieda, Jun'ichi; Matsuo, Mamoru; Maekawa, Sadamichi] Japan Atom Energy Agcy, Adv Sci Res Ctr, Tokai, Ibaraki 3191195, Japan; [Ieda, Jun'ichi; Matsuo, Mamoru; Maekawa, Sadamichi] Japan Sci & Technol Agcy, CREST, Tokyo 1020075, Japan	Ieda, J (reprint author), Japan Atom Energy Agcy, Adv Sci Res Ctr, Tokai, Ibaraki 3191195, Japan.	ieda.junichi@jaea.go.jp			MEXT	The authors thank E. Saitoh, K. Harii, K. Uchida, S. Takahashi, and K. Sekiguchi for valuable discussions. This study was supported by a Grant-in-Aid for Scientific Research from MEXT.	ANANDAN J, 1992, PHYS REV LETT, V68, P3809, DOI 10.1103/PhysRevLett.68.3809; FROHLICH J, 1993, REV MOD PHYS, V65, P733, DOI 10.1103/RevModPhys.65.733; Kimura T, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.156601; Matsuo M, 2013, PHYS REV B, V87, DOI 10.1103/PhysRevB.87.115301; de Sitter W, 1916, MON NOT R ASTRON SOC, V77, P0155; Matsuo M, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.076601; MASHHOON B, 1988, PHYS REV LETT, V61, P2639, DOI 10.1103/PhysRevLett.61.2639; HEHL FW, 1990, PHYS REV D, V42, P2045, DOI 10.1103/PhysRevD.42.2045; Everitt CWF, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.221101; Barnett SJ, 1915, PHYS REV, V6, P239, DOI 10.1103/PhysRev.6.239; Jedema FJ, 2001, NATURE, V410, P345, DOI 10.1038/35066533; Weiler M, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.176601; Uchida K, 2011, NAT MATER, V10, P737, DOI [10.1038/nmat3099, 10.1038/NMAT3099]; DEOLIVEIRA CG, 1962, NUOVO CIMENTO, V24, P672; Sanada H, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.216602; Liu LQ, 2012, SCIENCE, V336, P555, DOI 10.1126/science.1218197; Thirring H, 1918, PHYS Z, V19, P33; Wallis TM, 2006, APPL PHYS LETT, V89, DOI 10.1063/1.2355445; Mohanty P, 2004, PHYS REV B, V70, DOI 10.1103/PhysRevB.70.195301; Kato YK, 2004, SCIENCE, V306, P1910, DOI 10.1126/science.1105514; Saitoh E, 2006, APPL PHYS LETT, V88, DOI 10.1063/1.2199473; Bauer GEW, 2010, PHYS REV B, V81, DOI 10.1103/PhysRevB.81.024427; BERTOTTI B, 1987, PHYS REV LETT, V58, P1062, DOI 10.1103/PhysRevLett.58.1062; Bretzel S, 2009, APPL PHYS LETT, V95, DOI 10.1063/1.3232221; Calero C, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.166603; Chudnovsky EM, 2010, PHYS REV B, V81, DOI 10.1103/PhysRevB.81.214423; Chudnovsky EM, 2005, PHYS REV B, V72, DOI 10.1103/PhysRevB.72.094426; Einstein A., 1915, Verhandlungen der Deutschen Physikalischen Gesellschaft, V17; Hernandez-Minguez A, 2010, APPL PHYS LETT, V97, DOI 10.1063/1.3524218; Jaafar R, 2009, PHYS REV B, V79, DOI 10.1103/PhysRevB.79.104410; Jaafar R, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.227202; Kovalev AA, 2003, APPL PHYS LETT, V83, P1584, DOI 10.1063/1.1603338; Kovalev AA, 2007, PHYS REV B, V75, DOI 10.1103/PhysRevB.75.014430; Kovalev AA, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.147203; Kovalev AA, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.167201; Landau L. D., 1959, THEORY ELASTICITY; Lendinez S, 2010, PHYS REV B, V82, DOI 10.1103/PhysRevB.82.174418; Lense J., 1918, Physikalische Zeitschrift, V19; LOVE A. E., 1967, TREATISE MATH THEORY; Maekawa S., 2006, CONCEPTS SPIN ELECT; Maekawa S., 2012, SPIN CURRENT; MASHHOON B, 1992, PHYS REV LETT, V68, P3812, DOI 10.1103/PhysRevLett.68.3812; Matsuo M, 2014, SOLID STATE COMMUN, V198, P57, DOI 10.1016/j.ssc.2013.08.005; Matsuo M, 2013, PHYS REV B, V87, DOI 10.1103/PhysRevB.87.180402; Rauch H, 2000, NEUTRON INTERFEROMET; Rudolf D., 2012, NAT COMMUN, V3, P2029; SCHIFF LI, 1960, PHYS REV LETT, V4, P215, DOI 10.1103/PhysRevLett.4.215; SUZUKI Y, 1992, PHYS REV LETT, V68, P3355, DOI 10.1103/PhysRevLett.68.3355; Uchida K, 2012, J APPL PHYS, V111, DOI 10.1063/1.3688332; Uchida K, 2011, APPL PHYS LETT, V99, DOI [10.1063/1.3662032, 10.1063/1.3662931]; Zolfagharkhani G, 2008, NAT NANOTECHNOL, V3, P720, DOI 10.1038/nnano.2008.311	51	1	1	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0038-1098	1879-2766		SOLID STATE COMMUN	Solid State Commun.	NOV	2014	198				SI		52	56		10.1010/j.ssc.2014.02.003		5	Physics, Condensed Matter	Physics	AS4EN	WOS:000344226100012		
J	Matsuo, M; Ieda, J; Maekawa, S				Matsuo, Mamoru; Ieda, Jun'ichi; Maekawa, Sadamichi			Theory of mechanical spin current generation via spin-orbit coupling	SOLID STATE COMMUNICATIONS			English	Article						Nonmagnetic conductors; Spin current; Spin-orbit coupling		We theoretically investigate mechanical spin current generation via spin-orbit coupling on the basis of the generally covariant Dirac equation. In accelerating systems, the spin-orbit coupling is modified by inertial effects. Due to the augmented coupling, spin current is generated frorn rigid rotation and vibration. Renormalization of the inertial effects due to the interband mixing is also discussed by using the k.p perturbation. (C) 2013 Elsevier Ltd. All rights reserved.	[Matsuo, Mamoru; Ieda, Jun'ichi; Maekawa, Sadamichi] Japan Atom Energy Agcy, Adv Sci Res Ctr, Tokai, Ibaraki 3191195, Japan; [Matsuo, Mamoru; Ieda, Jun'ichi; Maekawa, Sadamichi] Japan Sci & Technol Agcy, CREST, Sanbancho, Tokyo 1020075, Japan	Matsuo, M (reprint author), Japan Atom Energy Agcy, Adv Sci Res Ctr, Tokai, Ibaraki 3191195, Japan.	matsuo.mamoru@jaea.go.jp	Ieda, Jun'ichi/A-3345-2009	Ieda, Jun'ichi/0000-0001-6069-8533	MEXT, Japan	We are grateful to E. Saitoh, K. Harii, and S. Takahashi for valuable discussions. This work was supported by a Grant-in-Aid for Scientific Research from MEXT, Japan and the Next Generation Supercomputer Project, Nanoscience Program from MEXT, Japan,	RUGAR D, 1992, NATURE, V360, P563, DOI 10.1038/360563a0; Takahashi S, 2008, SCI TECHNOL ADV MAT, V9, DOI 10.1088/1468-6996/9/1/014105; Matsuo M, 2013, PHYS REV B, V87, DOI 10.1103/PhysRevB.87.115301; Matsuo M, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.076601; Tolman RC, 1916, PHYS REV, V8, P8, DOI 10.1103/PhysRev.8.8; HEHL FW, 1990, PHYS REV D, V42, P2045, DOI 10.1103/PhysRevD.42.2045; Uchida K, 2008, NATURE, V455, P778, DOI 10.1038/nature07321; Calero C, 2007, PHYS REV B, V76, DOI 10.1103/PhysRevB.76.094419; Barnett SJ, 1915, PHYS REV, V6, P239, DOI 10.1103/PhysRev.6.239; Hirohata A, 2001, PHYS REV B, V63, DOI 10.1103/PhysRevB.63.104425; Matsuo M, 2011, PHYS REV B, V84, DOI 10.1103/PhysRevB.84.104410; Vila L, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.226604; Uchida K, 2011, NAT MATER, V10, P737, DOI [10.1038/nmat3099, 10.1038/NMAT3099]; BRILL DR, 1957, REV MOD PHYS, V29, P465, DOI 10.1103/RevModPhys.29.465; O'Connell AD, 2010, NATURE, V464, P697, DOI 10.1038/nature08967; FOLDY LL, 1950, PHYS REV, V78, P29, DOI 10.1103/PhysRev.78.29; Wallis TM, 2006, APPL PHYS LETT, V89, DOI 10.1063/1.2355445; Calero C, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.047201; Mohanty P, 2004, PHYS REV B, V70, DOI 10.1103/PhysRevB.70.195301; Tserkovnyak Y, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.117601; Barnes SE, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.246601; Kato YK, 2004, SCIENCE, V306, P1910, DOI 10.1126/science.1105514; KANE EO, 1957, J PHYS CHEM SOLIDS, V1, P249, DOI 10.1016/0022-3697(57)90013-6; Saitoh E, 2006, APPL PHYS LETT, V88, DOI 10.1063/1.2199473; Bauer GEW, 2010, PHYS REV B, V81, DOI 10.1103/PhysRevB.81.024427; Birrell N.D., 1982, QUANTUM FIELDS CURVE; Bretzel S, 2009, APPL PHYS LETT, V95, DOI 10.1063/1.3232221; Calero C, 2005, PHYS REV B, V72, DOI 10.1103/PhysRevB.72.024409; Calero C, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.166603; Chudnovsky EM, 2002, PHYS REV B, V66, DOI 10.1103/PhysRevB.66.054412; Chudnovsky EM, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.120405; Chudnovsky EM, 2010, PHYS REV B, V81, DOI 10.1103/PhysRevB.81.214423; Chudnovsky EM, 2005, PHYS REV B, V72, DOI 10.1103/PhysRevB.72.094426; Einstein A., 1915, Verhandlungen der Deutschen Physikalischen Gesellschaft, V17; Ieda J., 2013, SOLID STATE COMMUN, V198, P52; Jaafar R, 2009, PHYS REV B, V79, DOI 10.1103/PhysRevB.79.104410; Jaafar R, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.227202; Kim GH, 2009, PHYS REV B, V79, DOI 10.1103/PhysRevB.79.134404; Kovalev AA, 2003, APPL PHYS LETT, V83, P1584, DOI 10.1063/1.1603338; Kovalev AA, 2007, PHYS REV B, V75, DOI 10.1103/PhysRevB.75.014430; Kovalev AA, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.147203; Kovalev AA, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.167201; Lendinez S, 2010, PHYS REV B, V82, DOI 10.1103/PhysRevB.82.174418; Maekawa S., 2012, SPIN CURRENT; Matsuo M, 2013, PHYS REV B, V87, DOI 10.1103/PhysRevB.87.180402; Matsuo M, 2011, APPL PHYS LETT, V98, DOI 10.1063/1.3597220; Tani S., 1951, Progress of Theoretical Physics, V6, DOI 10.1143/PTP.6.267; Tejada J, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.027202; Weiler M, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.117601; Winkler R., 2006, SPIN ORBIT COUPLING; Zolfagharkhani G, 2008, NAT NANOTECHNOL, V3, P720, DOI 10.1038/nnano.2008.311	51	2	2	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0038-1098	1879-2766		SOLID STATE COMMUN	Solid State Commun.	NOV	2014	198				SI		57	60		10.1016/j.ssc.2013.08.005		4	Physics, Condensed Matter	Physics	AS4EN	WOS:000344226100013		
J	Yamamoto, R; Moongyu, C				Yamamoto, Riken; Moongyu, Choi			Seoul Gangnam District A3 BL Housing	SPACE			English	Article									[Yamamoto, Riken] Riken Yamamoto & Field Shop, Kanagawa, Japan; [Yamamoto, Riken] Kogakuin Univ, Tokyo 160, Japan; [Yamamoto, Riken] Yokohama Natl Univ, Yokohama, Kanagawa, Japan; [Yamamoto, Riken] Saitama Prefectural Univ, Koshigaya, Saitama, Japan; [Yamamoto, Riken] Future Univ Hakodate, Hakodate, Hokkaido, Japan; [Yamamoto, Riken] Yokosuka Museum Art, Yokosuka, Kanagawa, Japan; [Yamamoto, Riken] Pangyo Housing, Pangyo, North Korea; [Yamamoto, Riken] Tianjin Lib, Tianjin, Peoples R China; [Moongyu, Choi] Ga A Architects, Seoul, South Korea; [Moongyu, Choi] Dalki Theme Pk, Paju, South Korea; [Moongyu, Choi] Arumdri Media, Seoul, South Korea; [Moongyu, Choi] Booksea Publishing, Gyeonggi, South Korea; [Moongyu, Choi] Taehaksa, Seoul, South Korea								0	0	0	SPACE MAGAZINE	SEOUL	52-20 YEONHUI-RO, SEODAEMUN-GU, SEOUL, 120-830, SOUTH KOREA	1228-2472			SPACE	Space	NOV	2014		564					62	65				4	Architecture	Architecture	AS5LZ	WOS:000344313600020		
J	Murakami, H				Murakami, Hidetoshi			A saddlepoint approximation to the distribution of the sum of independent non-identically uniform random variables	STATISTICA NEERLANDICA			English	Article						independent and non-identically distributed; saddlepoint approximation; sum of uniform random variables		Calculating the probability of the corresponding significance point is important for finite sample sizes. However, it is difficult to evaluate this probability when the sample sizes are moderate to large. Under these circumstances, consideration of a more accurate approximation for the distribution function is extremely important. Herein, we performed a saddlepoint approximation in the upper tails for the distribution of the sum of independent non-identically uniform random variables under finite sample sizes. Saddlepoint approximation results were compared with those for a normal approximation. Additionally, the order of errors of the saddlepoint approximation was derived. (c) 2014 The Authors. Statistica Neerlandica (c) 2014 VVS.	Natl Def Acad, Dept Math, Yokosuka, Kanagawa 2398686, Japan	Murakami, H (reprint author), Natl Def Acad, Dept Math, 1-10-20 Hashirimizu, Yokosuka, Kanagawa 2398686, Japan.	murakami@gug.math.chuo-u.ac.jp			JSPS, KAKENHI [26730025]	The author would like to thank the editor and the referee for their valuable comments and suggestions. The author also appreciates that this research is supported by the Grant-in-Aid for Young Scientists B of JSPS, KAKENHI Number 26730025.	Huzurbazar S, 1999, AM STAT, V53, P225, DOI 10.2307/2686101; LUGANNANI R, 1980, ADV APPL PROBAB, V12, P475, DOI 10.2307/1426607; MITRA SK, 1971, SIAM J APPL MATH, V20, P195, DOI 10.1137/0120026; DANIELS HE, 1987, INT STAT REV, V55, P37, DOI 10.2307/1403269; Billingsley P., 1995, PROBABILITY MEASURE; Bradley DM, 2002, ANN I STAT MATH, V54, P689, DOI 10.1023/A:1022483715767; Butler R. W., 2007, SADDLEPOINT APPROXIM; DANIELS HE, 1954, ANN MATH STAT, V25, P631, DOI 10.1214/aoms/1177728652; Eisinga R, 2013, STAT NEERL, V67, P190, DOI 10.1111/stan.12002; Gillespie CS, 2007, MATH BIOSCI, V208, P359, DOI 10.1016/j.mbs.2006.08.026; Habibi R, 2005, COMMUN STAT-THEOR M, V34, P1935, DOI 10.1080/03610920500201145; Jensen J. L., 1995, SADDLEPOINT APPROXIM; Kolassa J., 2006, SERIES APPROXIMATION; Mood A. M., 1974, INTRO THEORY STAT; OLDS EG, 1952, ANN MATH STAT, V23, P282, DOI 10.1214/aoms/1177729446; ROACH SA, 1963, BIOMETRIKA, V50, P508, DOI 10.2307/2333917; Sadooghi-Alvandi SM, 2009, STAT PAP, V50, P171, DOI 10.1007/s00362-007-0049-4	17	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0039-0402	1467-9574		STAT NEERL	Stat. Neerl.	NOV	2014	68	4					267	275		10.1111/stan.12032		9	Statistics & Probability	Mathematics	AS3GL	WOS:000344165500002		
J	Okada, Y; Kohara, K; Ochi, M; Nagai, T; Tabara, Y; Igase, M; Miki, T				Okada, Yoko; Kohara, Katsuhiko; Ochi, Masayuki; Nagai, Tokihisa; Tabara, Yasuharu; Igase, Michiya; Miki, Tetsuro			Mechanical Stresses, Arterial Stiffness, and Brain Small Vessel Diseases Shimanami Health Promoting Program Study	STROKE			English	Article						brain small vessel disease; carotid artery; mechanical stress; vascular stiffness	WHITE-MATTER HYPERINTENSITIES; PULSE-WAVE VELOCITY; SYSTOLIC BLOOD-PRESSURE; SHEAR-STRESS; RISK-FACTORS; J-SHIPP; COGNITIVE IMPAIRMENT; ISCHEMIC-STROKE; CAROTID-ARTERY; ASSOCIATION	Background and Purpose Arterial stiffness, a risk factor of brain small vessel diseases (SVD), causes hemodynamic changes. Mechanical stresses, circumferential wall tension (WT), and shear stress (SS) may change with arterial stiffness and be related to SVD. We investigated the associations between mechanical stresses and arterial stiffness and SVD. Methods A total of 1296 subjects without apparent cardiovascular diseases were recruited. Brachial-to-ankle pulse wave velocity (baPWV) was measured as an arterial stiffness index. Silent lacunar infarction and deep subcortical white matter hyperintensity were evaluated as SVD indices. Circumferential WT and SS at peak systole and end diastole were measured at the common carotid artery. Second peak of systolic blood pressure was obtained from the radial waveform and used as a central systolic blood pressure substitute. Results baPWV was associated positively with WT (P<0.0001) and negatively with SS (P=0.0007) even after correction for confounding parameters including baPWV. SVD was associated with significantly higher WT (P<0.0001) and lower SS (P<0.0001). After adjustment for confounding parameters (including baPWV), second peak of systolic blood pressure WT (odds ratio, 1.30; P=0.0017) and end diastolic WT (odds ratio, 1.60; P=0.0038) were related to presence of silent lacunar infarction, whereas peak systolic (odds ratio, 0.95; P=0.014) and end diastolic SS (odds ratio, 0.94; P=0.014) were associated with presence of deep subcortical white matter hyperintensity grade >3. Regression lines between blood pressure and WT were significantly steeper in subjects with SVD than without SVD (=0.02; P<0.0001). Conclusions These findings indicate that SVD is phenotype-specifically associated with alterations in WT and SS independently of arterial stiffness.	[Okada, Yoko; Kohara, Katsuhiko; Ochi, Masayuki; Nagai, Tokihisa; Igase, Michiya; Miki, Tetsuro] Ehime Univ, Grad Sch Med, Dept Geriatr & Neurol, Toon City, Ehime 7910295, Japan; [Tabara, Yasuharu] Kyoto Univ, Grad Sch Med, Dept Med Genet, Kyoto, Japan	Kohara, K (reprint author), Ehime Univ, Grad Sch Med, Dept Geriatr & Neurol, Toon City, Ehime 7910295, Japan.	koharak@m.ehime-u.ac.jp			Japanese Ministry of Education, Culture, Sports, Science, and Technology [23390188, 30260384]; Mitsui Sumitomo Insurance Welfare Foundation in Japan	This work was supported in part by Grants-in-Aid for Scientific Research from the Japanese Ministry of Education, Culture, Sports, Science, and Technology (No. 23390188 and 30260384), and a research fund from the Mitsui Sumitomo Insurance Welfare Foundation in Japan.	Lu DS, 2011, J R SOC INTERFACE, V8, P1379, DOI 10.1098/rsif.2011.0177; Henskens LHG, 2008, HYPERTENSION, V52, P1120, DOI 10.1161/HYPERTENSIONAHA.108.119024; Togay-Isikay C, 2005, ACTA NEUROL BELG, V105, P68; Adib-Samii P, 2013, STROKE, V44, P1609, DOI 10.1161/STROKEAHA.113.679936; Davies PF, 2009, NAT CLIN PRACT CARD, V6, P16, DOI 10.1038/ncpcardio1397; Ando J, 2013, CARDIOVASC RES, V99, P260, DOI 10.1093/cvr/cvt084; Roman MJ, 2014, HYPERTENSION, V63, P1148, DOI 10.1161/HYPERTENSIONAHA.114.03361; Kalaria RN, 2012, STROKE, V43, P2526, DOI 10.1161/STROKEAHA.112.655803; Rosano C, 2013, HYPERTENSION, V61, P160, DOI 10.1161/HYPERTENSIONAHA.112.198069; Gouw AA, 2011, J NEUROL NEUROSUR PS, V82, P126, DOI 10.1136/jnnp.2009.204685; Conijn MMA, 2011, STROKE, V42, P3105, DOI 10.1161/STROKEAHA.110.594853; Hoefer IE, 2013, CARDIOVASC RES, V99, P276, DOI 10.1093/cvr/cvt089; Poels MMF, 2012, STROKE, V43, P2637, DOI 10.1161/STROKEAHA.111.642264; Topakian R, 2010, J NEUROL NEUROSUR PS, V81, P192, DOI 10.1136/jnnp.2009.172072; Carallo C, 1999, HYPERTENSION, V34, P217; Ochi M, 2010, ATHEROSCLEROSIS, V212, P327, DOI 10.1016/j.atherosclerosis.2010.05.026; Ciccone MM, 2012, INT J CARDIOL, V158, P123, DOI 10.1016/j.ijcard.2012.04.052; O'Rourke MF, 2005, HYPERTENSION, V46, P200, DOI 10.1161/01.HYP.0000168052.00426.65; DESIMONE G, 1990, CIRCULATION, V81, P107; Tabara Y, 2013, EUR J NEUROL, V20, P860, DOI 10.1111/j.1468-1331.2012.03879.x; Tomiyama H, 2003, ATHEROSCLEROSIS, V166, P303, DOI 10.1016/S0021-9150(02)00332-5; Tamariz LJ, 2008, AM J EPIDEMIOL, V168, P1153, DOI 10.1093/aje/kwn243; Uetani E, 2014, DIABETES CARE, V37, P396, DOI 10.2337/dc13-1658; Ciccone MM, 2014, J ATHEROSCLER THROMB, V21, P56; Debette S, 2010, BRIT MED J, V341, DOI 10.1136/bmj.c3666; Gemignani T, 2012, ATHEROSCLEROSIS, V224, P118, DOI 10.1016/j.atherosclerosis.2012.06.069; Irace C, 2004, STROKE, V35, P464, DOI 10.1161/01.STR.0000111597.34179.47; Jiang YN, 2000, STROKE, V31, P2319; Kohara K, 2012, INT J CARDIOL, V158, P146, DOI 10.1016/j.ijcard.2012.04.033; Kohara K, 2009, J HUM HYPERTENS, V23, P538, DOI 10.1038/jhh.2008.154; Kohara K, 2012, CURR HYPERTENS REV, V8, P100; Mutsaerts HJMM, 2011, STROKE, V42, P3497, DOI 10.1161/STROKEAHA.111.614453; Ochi N, 2010, AM J HYPERTENS, V23, P889, DOI 10.1038/ajh.2010.60; Singer J, 2014, AGEING RES REV, V15, P16, DOI 10.1016/j.arr.2014.02.002; Takazawa K, 2012, J HYPERTENS, V30, P908, DOI 10.1097/HJH.0b013e3283524910	35	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0039-2499	1524-4628		STROKE	Stroke	NOV	2014	45	11					3287	3292		10.1161/STROKEAHA.114.006539		6	Clinical Neurology; Peripheral Vascular Disease	Neurosciences & Neurology; Cardiovascular System & Cardiology	AS6CD	WOS:000344351500036		
J	Urfer, R; Moebius, HJ; Skoloudik, D; Santamarina, E; Sato, W; Mita, S; Muir, KW				Urfer, Roman; Moebius, Hans J.; Skoloudik, David; Santamarina, Estevo; Sato, Wakao; Mita, Shiro; Muir, Keith W.		Cutamesine Stroke Recovery Study	Phase II Trial of the Sigma-1 Receptor Agonist Cutamesine (SA4503) for Recovery Enhancement After Acute Ischemic Stroke	STROKE			English	Article						clinical trial; randomized controlled trial; SA 4503; stroke	COLONY-STIMULATING FACTOR; PLASTICITY; LIGAND; SCALE; ERYTHROPOIETIN; CHAPERONES	Background and Purpose The sigma-1 receptor (Sig-1R) agonist cutamesine (SA4503) enhanced functional recovery after experimental stroke with a treatment initiation window of 48 hours and chronic treatment for 28 days. We conducted a phase 2 clinical trial exploring the safety, tolerability, dose range, and functional effects of cutamesine in patients with ischemic stroke. Methods Subjects were randomized between 48 and 72 hours after stroke to receive cutamesine 1 mg/d, 3 mg/d, or placebo for 28 days. Effects on safety and function were assessed at baseline, at end of treatment (day 28), and at end of follow-up (day 56). Results In 60 patients, treatment with both cutamesine dosages was safe and well tolerated without significant differences in numbers of treatment emergent or serious adverse events. No significant effect was observed on the primary efficacy measure (change in National Institutes of Health Stroke Scale from baseline to day 56) or modified Rankin Scale and Barthel Index scores. Post hoc analysis of moderately and severely affected patients (baseline National Institutes of Health Stroke Scale, 7 and 10) showed greater National Institutes of Health Stroke Scale improvements in the 3 mg/d cutamesine group when compared with placebo (P=0.034 and P=0.038, respectively). A trend toward a higher proportion being able to complete a 10m timed walk was observed for cutamesine-treated subjects. Conclusions Cutamesine was safe and well tolerated at both dosage levels. Although no significant effects on functional end points were seen in the population as a whole, greater improvement in National Institutes of Health Stroke Scale scores among patients with greater pretreatment deficits seen in post hoc analysis warrants further investigation. Additional studies should focus on the patient population with moderate-to-severe stroke. Clinical Trial Registration URL: http://www.clinicaltrials.gov/show/NCT00639249. Unique identifier: NCT00639249. The EudraCT number is 2007-004840-60 (https://www.clinicaltrialsregister.eu/ctr-search/trial/2007-004840-60/GB).	[Urfer, Roman; Sato, Wakao; Mita, Shiro] Ms Sci Corp, Kobe, Hyogo, Japan; [Moebius, Hans J.] Moebius Consult GmbH, Zurich, Switzerland; [Skoloudik, David] Univ Hosp Ostrava, Dept Neurol, Ostrava, Czech Republic; [Santamarina, Estevo] Hosp Valle De Hebron, Neurovasc Unit, Barcelona, Spain; [Muir, Keith W.] Univ Glasgow, So Gen Hosp, Inst Neurosci & Psychol, Glasgow G51 4TF, Lanark, Scotland	Muir, KW (reprint author), Univ Glasgow, So Gen Hosp, Inst Neurosci & Psychol, Glasgow G51 4TF, Lanark, Scotland.	keith.muir@glasgow.ac.uk			M's Science Corporation	This study was funded by M's Science Corporation.	Ruscher K, 2011, BRAIN, V134, P732, DOI 10.1093/brain/awq367; Carmichael ST, 2008, STROKE, V39, P1380, DOI 10.1161/STROKEAHA.107.499962; Hayashi T, 2007, CELL, V131, P596, DOI 10.1016/j.cell.2007.08.036; Tsai SY, 2009, P NATL ACAD SCI USA, V106, P22468, DOI 10.1073/pnas.0909089106; Sprigg N, 2006, STROKE, V37, P2979, DOI 10.1161/01.STR.0000248763.49831.c3; Fujimoto M, 2012, SYNAPSE, V66, P630, DOI 10.1002/syn.21549; BROTT T, 1989, STROKE, V20, P864; Meunier J, 2010, J PHARMACOL EXP THER, V332, P388, DOI 10.1124/jpet.109.160960; Pekna M, 2012, STROKE, V43, P2819, DOI 10.1161/STROKEAHA.112.654228; Ringelstein EB, 2013, STROKE, V44, P2681, DOI 10.1161/STROKEAHA.113.001531; Schabitz WR, 2010, STROKE, V41, P2545, DOI 10.1161/STROKEAHA.110.579508; Ehrenreich H, 2009, STROKE, V40, pE647, DOI 10.1161/STROKEAHA.109.564872; [Anonymous], 1996, GUID IND E6 GOOD CLI; Murphy TH, 2009, NAT REV NEUROSCI, V10, P861, DOI 10.1038/nrn2735; Ehrenreich H, 2002, MOL MED, V8, P495; Hayashi T, 2011, EXPERT OPIN THER TAR, V15, P557, DOI 10.1517/14728222.2011.560837; Matsuno K, 1996, EUR J PHARMACOL, V306, P271, DOI 10.1016/0014-2999(96)00201-4; Chollet F, 2011, LANCET NEUROL, V10, P123, DOI 10.1016/S1474-4422(10)70314-8; Su TP, 2010, TRENDS PHARMACOL SCI, V31, P557, DOI 10.1016/j.tips.2010.08.007; Bruno A, 2009, J STROKE CEREBROVASC, V18, P56, DOI 10.1016/j.jstrokecerebrovasdis.2008.09.002; Cramer SC, 2011, REGENESIS INVESTIGAT; Cramer SC, 2010, STROKE, V41, P927, DOI 10.1161/STROKEAHA.109.574343; Han J, 2012, STROKE, V43, P1918, DOI 10.1161/STROKEAHA.111.641878; Kikuchi-Utsumi K, 2008, NEUROSCI LETT, V440, P19, DOI 10.1016/j.neulet.2008.05.055; MAHONEY F I, 1965, Md State Med J, V14, P61; RANKIN J, 1957, Scott Med J, V2, P200; VANMARWIJK HWJ, 1995, BRIT J GEN PRACT, V45, P195	27	3	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0039-2499	1524-4628		STROKE	Stroke	NOV	2014	45	11					3304	3310		10.1161/STROKEAHA.114.005835		7	Clinical Neurology; Peripheral Vascular Disease	Neurosciences & Neurology; Cardiovascular System & Cardiology	AS6CD	WOS:000344351500039		
J	Hattori, Y; Okamoto, Y; Maki, T; Yamamoto, Y; Oishi, N; Yamahara, K; Nagatsuka, K; Takahashi, R; Kalaria, RN; Fukuyama, H; Kinoshita, M; Ihara, M				Hattori, Yorito; Okamoto, Yoko; Maki, Takakuni; Yamamoto, Yumi; Oishi, Naoya; Yamahara, Kenichi; Nagatsuka, Kazuyuki; Takahashi, Ryosuke; Kalaria, Raj N.; Fukuyama, Hidenao; Kinoshita, Makoto; Ihara, Masafumi			Silent Information Regulator 2 Homolog 1 Counters Cerebral Hypoperfusion Injury by Deacetylating Endothelial Nitric Oxide Synthase	STROKE			English	Article						carotid artery stenosis; cerebral ischemia; dementia; endothelial nitric oxide synthase; mouse; SIRT1	AMYOTROPHIC-LATERAL-SCLEROSIS; CELLULAR PRION PROTEIN; EXTENDS LIFE-SPAN; ALZHEIMERS-DISEASE; MOUSE MODEL; NEURODEGENERATIVE DISEASE; SACCHAROMYCES-CEREVISIAE; SIRT1 DEACETYLASE; ISCHEMIC DAMAGE; BRAIN	Background and Purpose Silent information regulator 2 homolog 1 (SIRT1) is a protein deacetylase that has been reported to suppress neurodegenerative and cardiovascular diseases in model organisms. We hypothesized that neurovascular protection is one of the diverse actions of SIRT1. This study was designed to determine whether SIRT1 protects against the consequences of cerebral hypoperfusion in vivo. MethodsSirt1-overexpressing (Sirt1-Tg) mice driven by a prion promoter and their wild-type littermates were subjected to bilateral common carotid artery stenosis using external microcoils. Using Sirt1-Tg mice, we assessed the effect of SIRT1 on cerebral blood flow, cerebral angioarchitecture, histological and ultrastructural changes, and spatial working memory at several time points. We also evaluated the effects of preadministration of SIRT1 inhibitors or endothelial nitric oxide synthase inhibitors on cerebral blood flow after bilateral common carotid artery stenosis in Sirt1-Tg mice. Levels of acetylated and nonacetylated endothelial nitric oxide synthase were measured semiquantitatively with immunoblotting. Results Cerebral hypoperfusion induced by bilateral common carotid artery stenosis caused memory impairment and histological changes in wild-type littermates. However, these phenotypes were rescued in Sirt1-Tg mice, where cerebral blood flow was maintained even poststenosis. Electron microscopic analyses showed irregularities in the vascular endothelia, such as tight junction openings in wild-type mice, which were absent in Sirt1-Tg littermates. Brain endothelial nitric oxide synthase was acetylated after cerebral hypoperfusion in wild-type littermates but remained unacetylated in Sirt1-Tg mice. Moreover, treatment with SIRT1 inhibitors and endothelial nitric oxide synthase inhibitors abolished the vasculoprotective effects of SIRT1. Conclusions Our results indicate that neurovascular endothelial SIRT1 potentiation upregulates the nitric oxide system and counters cerebral hypoperfusion injury. This novel cerebral blood flow-preserving mechanism offers potential molecular targets for future therapeutic intervention.	[Hattori, Yorito; Takahashi, Ryosuke] Kyoto Univ, Grad Sch Med, Dept Neurol, Kyoto, Japan; [Oishi, Naoya; Fukuyama, Hidenao] Kyoto Univ, Grad Sch Med, Human Brain Res Ctr, Kyoto, Japan; [Hattori, Yorito; Yamamoto, Yumi; Yamahara, Kenichi; Ihara, Masafumi] Natl Cerebral & Cardiovasc Ctr, Dept Regenerat Med & Tissue Engn, Osaka 5658565, Japan; [Okamoto, Yoko] Natl Cerebral & Cardiovasc Ctr, Dept Pathol, Osaka 5658565, Japan; [Nagatsuka, Kazuyuki; Ihara, Masafumi] Natl Cerebral & Cardiovasc Ctr, Dept Stroke & Cerebrovasc Dis, Osaka 5658565, Japan; [Maki, Takakuni] Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02114 USA; [Maki, Takakuni] Massachusetts Gen Hosp, Dept Neurol, Boston, MA 02114 USA; [Maki, Takakuni] Harvard Univ, Sch Med, Boston, MA USA; [Takahashi, Ryosuke; Kinoshita, Makoto] Japan Sci Technol Corp, CREST, Saitama, Japan; [Kalaria, Raj N.] Newcastle Univ, Inst Ageing & Hlth, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Kinoshita, Makoto] Nagoya Univ, Grad Sch Sci, Div Biol Sci, Nagoya, Aichi 4648601, Japan	Ihara, M (reprint author), Natl Cerebral & Cardiovasc Ctr, Dept Stroke & Cerebrovasc Dis, Osaka 5658565, Japan.	ihara@ncvc.go.jp		Ihara, Masafumi/0000-0002-7102-4048	Ministry of Health, Labour, and Welfare [0605-1]; Ministry of Education, Culture, Sports, Science, and Technology [23390233]; Takeda Science Foundation; Japan Science Technology Corporation; Alzheimer's Research UK;  [2311531];  [25116514];  [25893301]	We gratefully acknowledge grant support from the Ministry of Health, Labour, and Welfare (Dr Ihara, no. 0605-1), the Ministry of Education, Culture, Sports, Science, and Technology (Dr Ihara, Grant-in-Aid for Scientific Research (B), no. 23390233; Dr Hattori, Grant-in-Aid for Research Activity Start-up, no. 25893301; Dr Kinoshita, Grant-in-Aid for Scientific Research on Innovative Areas, no. 2311531 and 25116514), the Takeda Science Foundation (Dr Ihara), Japan Science Technology Corporation (Dr Takahashi), and Alzheimer's Research UK (Dr Kalaria).	Duan WZ, 2013, FRONT AGING NEUROSCI, V5, DOI 10.3389/fnagi.2013.00036; Yeung F, 2004, EMBO J, V23, P2369, DOI 10.1038/sj.emboj.7600244; Kalaria RN, 2012, J NEUROL SCI, V322, P141, DOI 10.1016/j.jns.2012.07.032; Min SW, 2010, NEURON, V67, P953, DOI 10.1016/j.neuron.2010.08.044; Donmez G, 2010, CELL, V142, P320, DOI 10.1016/j.cell.2010.06.020; Mawuenyega KG, 2010, SCIENCE, V330, P1774, DOI 10.1126/science.1197623; Kalaria RN, 2010, NUTR REV, V68, pS74, DOI 10.1111/j.1753-4887.2010.00352.x; Arunachalam G, 2010, BIOCHEM BIOPH RES CO, V393, P66, DOI 10.1016/j.bbrc.2010.01.080; Shibata M, 2004, STROKE, V35, P2598, DOI 10.1161/01.STR.0000143725.19053.60; Mattagajasingh I, 2007, P NATL ACAD SCI USA, V104, P14855, DOI 10.1073/pnas.0704329104; Sperling R, 2012, LANCET NEUROL, V11, P241, DOI 10.1016/S1474-4422(12)70015-7; Hawkes CA, 2011, ACTA NEUROPATHOL, V121, P431, DOI 10.1007/s00401-011-0801-7; Kalaria RN, 1999, ALZ DIS ASSOC DIS, V13, pS115, DOI 10.1097/00002093-199912003-00017; Wang RS, 2013, CELL METAB, V17, P685, DOI [10.1016/j.cmet.2013.03.016, 10.1016/cmet.2013.03.016]; Imai S, 2000, NATURE, V403, P795; Zhang F, 2011, PROG NEUROBIOL, V95, P373, DOI 10.1016/j.pneurobio.2011.09.001; Dvir-Ginzberg M, 2011, ARTHRITIS RHEUM-US, V63, P2363, DOI 10.1002/art.30279; Carare RO, 2013, NEUROPATH APPL NEURO, V39, P593, DOI 10.1111/nan.12042; Howitz KT, 2003, NATURE, V425, P191, DOI 10.1038/nature01960; Shibata M, 2007, STROKE, V38, P2826, DOI 10.1161/STROKEAHA.107.490151; Della-Morte D, 2009, NEUROSCIENCE, V159, P993, DOI 10.1016/j.neuroscience.2009.01.017; Simak J, 2002, TRANSFUSION, V42, P334, DOI 10.1046/j.1537-2995.2002.00072.x; Rogina B, 2004, P NATL ACAD SCI USA, V101, P15998, DOI 10.1073/pnas.0404184101; Kim D, 2007, EMBO J, V26, P3169, DOI 10.1038/sj.emboj.7601758; de la Torre JC, 2002, STROKE, V33, P1152, DOI 10.1161/01.STR.0000014421.15948.67; Wareski P, 2009, J BIOL CHEM, V284, P21379, DOI 10.1074/jbc.M109.018911; Snowdon DA, 1997, JAMA-J AM MED ASSOC, V277, P813, DOI 10.1001/jama.277.10.813; Fujita Y, 2010, STROKE, V41, P2938, DOI 10.1161/STROKEAHA.110.596379; Satoh A, 2013, CELL METAB, V18, P416, DOI 10.1016/j.cmet.2013.07.013; Arbel-Ornath M, 2013, ACTA NEUROPATHOL, V126, P353, DOI 10.1007/s00401-013-1145-2; KLAR AJS, 1979, GENETICS, V93, P37; Tissenbaum HA, 2001, NATURE, V410, P227, DOI 10.1038/35065638; Hawkes CA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041636; Hernandez-Jimenez M, 2013, STROKE, V44, P2333, DOI 10.1161/STROKEAHA.113.001715; Kalaria RN, 2013, NAT REV NEUROL, V9, P487, DOI 10.1038/nrneurol.2013.164; Osuka K, 2004, STROKE, V35, P2582, DOI 10.1161/01.STR.0000143454.14159.28; Pflanzner T, 2012, J CEREBR BLOOD F MET, V32, P628, DOI 10.1038/jcbfm.2012.7; Starke R, 2002, BRIT J HAEMATOL, V119, P863, DOI 10.1046/j.1365-2141.2002.03847.x; Toledo JB, 2013, BRAIN, V136, P2697, DOI 10.1093/brain/awt188; Watanabe S, 2014, MOL BRAIN, V7, DOI 10.1186/s13041-014-0062-1	40	4	4	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0039-2499	1524-4628		STROKE	Stroke	NOV	2014	45	11					3403	3411		10.1161/STROKEAHA.114.006265		9	Clinical Neurology; Peripheral Vascular Disease	Neurosciences & Neurology; Cardiovascular System & Cardiology	AS6CD	WOS:000344351500053		
J	Nozaki, H; Nishizawa, M; Onodera, O				Nozaki, Hiroaki; Nishizawa, Masatoyo; Onodera, Osamu			Features of Cerebral Autosomal Recessive Arteriopathy With Subcortical Infarcts and Leukoencephalopathy	STROKE			English	Article						cerebral autosomal recessive arteriopathy with subcortical infarcts and leukoencephalopathy; cerebral small vessel diseases; HtrA1 protein; human; myocytes; smooth muscle; TGF-	SMALL-VESSEL DISEASE; HTRA1 MUTATIONS; CARASIL; ALOPECIA; FAMILY; PROTEOLYSIS; EXPRESSION; TGF-BETA-1; PATHOLOGY; PROTEASES		[Nozaki, Hiroaki] Niigata Univ, Fac Med, Sch Hlth Sci, Dept Med Technol, Niigata 9518585, Japan; [Nishizawa, Masatoyo] Niigata Univ, Brain Res Inst, Clin Neurosci Branch, Dept Neurol, Niigata 9518585, Japan; [Onodera, Osamu] Niigata Univ, Dept Mol Neurosci, Resource Branch Brain Dis, Brain Res Inst, Niigata 9518585, Japan	Onodera, O (reprint author), Niigata Univ, Dept Mol Neurosci, Resource Branch Brain Dis, Brain Res Inst, Niigata 9518585, Japan.	onodera@bri.niigata-u.ac.jp	Onodera, Osamu/K-7327-2013	Onodera, Osamu/0000-0003-3354-5472	Takeda Science Foundation; Japan Society for the Promotion of Science; Research Committee for Hereditary Cerebral Small Vessel Disease; Ministry of Health, Labor, and Welfare, Japan; Yujin Society	This work was supported by a grant-in-aid for Medical Research from Takeda Science Foundation, a grant-in-aid for Scientific Research (B) from the Japan Society for the Promotion of Science, a grant-in-aid for the Research Committee for Hereditary Cerebral Small Vessel Disease, a grant-in-aid for Comprehensive Research on Disability from Health and Welfare from the Ministry of Health, Labor, and Welfare, Japan, and a Yujin Memorial Grant from Yujin Society.	Hankey GJ, 2014, LANCET NEUROL, V13, P178, DOI 10.1016/S1474-4422(13)70255-2; FUKUTAKE T, 1995, EUR NEUROL, V35, P69, DOI 10.1159/000117096; Oide T, 2008, NEUROPATHOLOGY, V28, P132, DOI 10.1111/j.1440-1789.2007.00864.x; Shiga A, 2011, HUM MOL GENET, V20, P1800, DOI 10.1093/hmg/ddr063; Clausen T, 2002, MOL CELL, V10, P443, DOI 10.1016/S1097-2765(02)00658-5; Launay S, 2008, CELL DEATH DIFFER, V15, P1408, DOI 10.1038/cdd.2008.82; Pantoni L, 2010, LANCET NEUROL, V9, P689, DOI 10.1016/S1474-4422(10)70104-6; Truebestein L, 2011, NAT STRUCT MOL BIOL, V18, P386, DOI 10.1038/nsmb.2013; Iadecola C, 2013, NEURON, V80, P844, DOI 10.1016/j.neuron.2013.10.008; ten Dijke P, 2007, NAT REV MOL CELL BIO, V8, P857, DOI 10.1038/nrm2262; Mendioroz M, 2010, NEUROLOGY, V75, P2033, DOI 10.1212/WNL.0b013e3181ff96ac; Hara K, 2009, NEW ENGL J MED, V360, P1729, DOI 10.1056/NEJMoa0801560; Clausen T, 2011, NAT REV MOL CELL BIO, V12, P152, DOI 10.1038/nrm3065; Grau S, 2005, P NATL ACAD SCI USA, V102, P6021, DOI 10.1073/pnas.0501823102; Arima K, 2003, NEUROPATHOLOGY, V23, P327, DOI 10.1046/j.1440-1789.2003.00519.x; Tiaden AN, 2013, AM J PATHOL, V182, P1482, DOI 10.1016/j.ajpath.2013.02.003; Eigenbrot C, 2012, STRUCTURE, V20, P1040, DOI 10.1016/j.str.2012.03.021; Yanagawa S, 2002, NEUROLOGY, V58, P817; Bianchi S, 2014, NEUROLOGY, V82, P898, DOI 10.1212/WNL.0000000000000202; Holm TM, 2011, SCIENCE, V332, P358, DOI 10.1126/science.1192149; Antic M, 2013, CURR OPIN PHARMACOL, V13, P455, DOI 10.1016/j.coph.2013.05.016; Fukutake T, 2011, J STROKE CEREBROVASC, V20, P85, DOI 10.1016/j.jstrokecerebrovasdis.2010.11.008; Jakobsson L, 2013, EXP CELL RES, V319, P1264, DOI 10.1016/j.yexcr.2013.02.015; Shi ML, 2011, NATURE, V474, P343, DOI 10.1038/nature10152; Oka C, 2004, DEVELOPMENT, V131, P1041, DOI 10.1242/dev.00999; Arisato T, 1993, Rinsho Shinkeigaku, V33, P400; Bayrakli F, 2014, TURK NEUROSURG, V24, P67, DOI 10.5137/1019-5149.JTN.6226-12.1; Beck K, 2012, CELL TISSUE RES, V347, P187, DOI 10.1007/s00441-011-1228-0; Brooke BS, 2008, NEW ENGL J MED, V358, P2787, DOI 10.1056/NEJMoa0706585; Caplan LR, 2010, J NEUROL SCI, V299, P9, DOI 10.1016/j.jns.2010.08.041; CHEN YQ, 2013, J HENAN NORM UNIV, V41, P1; De Luca A, 2004, J HISTOCHEM CYTOCHEM, V52, P1609, DOI 10.1369/jhc.4A6330.2004; Falcone GJ, 2014, LANCET NEUROL, V13, P405, DOI 10.1016/S1474-4422(14)70029-8; Graham JR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074094; Iwasaki Y, 1997, NEUROL MED, V47, P593; Liu X, 2001, P NATL ACAD SCI USA, V98, P9139, DOI 10.1073/pnas.161016098; MAEDA S, 1976, Folia Psychiatrica et Neurologica Japonica, V30, P165; Nishimoto Y, 2011, J NEUROL NEUROSUR PS, V82, P860, DOI 10.1136/jnnp.2010.240051; Nishimoto Y, 2011, NEUROLOGY, V76, P1353, DOI 10.1212/WNL.0b013e318215281d; Okeda R, 2004, NEUROPATHOLOGY, V24, P21, DOI 10.1111/j.1440-1789.2003.00534.x; Shirata A, 2004, J MOV DISORD DISABIL, V14, P71; Shizuma N, 1993, NEUROL MED, V39, P406; Singhal S, 2005, AM J NEURORADIOL, V26, P2481; Usuki F, 2013, P NATL ACAD SCI USA, V110, P15037, DOI 10.1073/pnas.1300654110; Wang XL, 2012, CNS NEUROSCI THER, V18, P867, DOI 10.1111/j.1755-5949.2012.00373.x	45	7	7	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0039-2499	1524-4628		STROKE	Stroke	NOV	2014	45	11					3447	3453		10.1161/STROKEAHA.114.004236		7	Clinical Neurology; Peripheral Vascular Disease	Neurosciences & Neurology; Cardiovascular System & Cardiology	AS6CD	WOS:000344351500063		
J	Ritsuno, H; Sakamoto, N; Osada, T; Goto, SP; Murakami, T; Ueyama, H; Mori, H; Matsumoto, K; Beppu, K; Shibuya, T; Nagahara, A; Ogihara, T; Watanabe, S				Ritsuno, Hideaki; Sakamoto, Naoto; Osada, Taro; Goto, Shingo P.; Murakami, Takashi; Ueyama, Hiroya; Mori, Hiroki; Matsumoto, Kenshi; Beppu, Kazuko; Shibuya, Tomoyoshi; Nagahara, Akihito; Ogihara, Tatsuo; Watanabe, Sumio			Prospective clinical trial of traction device-assisted endoscopic submucosal dissection of large superficial colorectal tumors using the S-O clip	SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES			English	Article						S-O clip; Traction device; Colorectal ESD; Superficial colorectal tumors	EARLY GASTRIC-CANCER; MUCOSAL RESECTION; NEOPLASIA; STANDARDIZATION; LESIONS; KNIFE; FLAT; ESD	Endoscopic submucosal dissection (ESD) allows en bloc resection of superficial colorectal tumors regardless of size. However, ESD is technically difficult, hazardous, and time consuming. New devices may help overcome these drawbacks. We focused on traction methods and designed a new traction device, the "S-O clip." Its main advantage is that it allows direct visualization of the cutting line during submucosal dissection. Moreover, it can be used at any location without withdrawing the endoscope. The purpose of this study was to evaluate the efficacy and safety of traction device-assisted ESD for large colorectal tumors using the S-O clip. Between August 2010 and December 2011, ESD was performed in 70 patients with a superficial colorectal tumor a parts per thousand yen20 mm in diameter in our department. Patients were randomized into two groups: 27 cases in the S-O clip-assisted ESD group and 23 cases in the conventional ESD group. Included in the analysis were patient's gender and age, tumor form, size, and location, rate of en bloc resection, procedure time, presence or absence of intraoperative perforation or delayed bleeding, and pathological findings. Subgroup analysis stratified by these factors and multivariate analyses were conducted. In the S-O clip-assisted ESD group, all 27 tumors were resected en bloc without any complications. Although a micro perforation occurred in one patient in the conventional ESD group, further surgical treatment was not required. None of the other 22 cases in the conventional ESD group experienced complications. The mean procedure time for the S-O clip-assisted ESD group was significantly shorter than for the conventional ESD group (37.4 +/- A 32.6 vs. 67.1 +/- A 44.1 min, p = 0.03). No significant between-group differences were found for the other factors. Our results demonstrated that S-O clip-assisted ESD is safe and fast for en bloc resection of large superficial colorectal tumors.	[Ritsuno, Hideaki; Sakamoto, Naoto; Osada, Taro; Goto, Shingo P.; Murakami, Takashi; Ueyama, Hiroya; Mori, Hiroki; Matsumoto, Kenshi; Beppu, Kazuko; Shibuya, Tomoyoshi; Nagahara, Akihito; Ogihara, Tatsuo; Watanabe, Sumio] Juntendo Univ, Sch Med, Dept Gastroenterol, Bunkyo Ku, Tokyo 1138421, Japan	Sakamoto, N (reprint author), Juntendo Univ, Sch Med, Dept Gastroenterol, Bunkyo Ku, 2-1-1 Hongo, Tokyo 1138421, Japan.	sakamoto@juntendo.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan [23591023]	This work was supported in part by Grant-in-Aid for Scientific Research (C) (No. 23591023 to T.O. and N.S.) from the Ministry of Education, Culture, Sports, Science and Technology of Japan.	Saito Y, 2010, SURG ENDOSC, V24, P343, DOI 10.1007/s00464-009-0562-8; Cao Y, 2009, ENDOSCOPY, V41, P751, DOI 10.1055/s-0029-1215053; Kudo S, 2001, ENDOSCOPY, V33, P367; Imaeda H, 2009, DIGEST ENDOSC, V21, P122, DOI 10.1111/j.1443-1661.2009.00842.x; Saito Y, 2012, DIGEST ENDOSC, V24, P67, DOI 10.1111/j.1443-1661.2012.01282.x; Tanaka S, 2007, GASTROINTEST ENDOSC, V66, P100, DOI 10.1016/j.gie.2007.02.032; Saito Y, 2010, GASTROINTEST ENDOSC, V72, P1217, DOI 10.1016/j.gie.2010.08.004; Mannen K, 2010, J GASTROENTEROL, V45, P30, DOI 10.1007/s00535-009-0137-4; Sano Y, 2009, GASTROINTEST ENDOSC, V69, P278, DOI 10.1016/j.gie.2008.04.066; Lee EJ, 2012, SURG ENDOSC, V26, P1587, DOI 10.1007/s00464-011-2075-5; Sakamoto N, 2009, GASTROINTEST ENDOSC, V69, P1370, DOI 10.1016/j.gie.2008.12.245; Fujishiro M, 2006, WORLD J GASTROENTERO, V12, P5108; Lee EJ, 2013, SURG ENDOSC, V27, P31, DOI 10.1007/s00464-012-2403-4; Imagawa A, 2006, ENDOSCOPY, V38, P987, DOI 10.1055/s-2006-944716; Ohkuwa M, 2001, ENDOSCOPY, V33, P221, DOI 10.1055/s-2001-12805; Conio M, 2006, AM J GASTROENTEROL, V101, P653, DOI 10.1111/j.1572-0241.2006.00424.x; Fujiya M, 2009, DIGEST ENDOSC, V21, pS28, DOI 10.1111/j.1443-1661.2009.00861.x; Gotoda T, 2009, GASTROINTEST ENDOSC, V69, P10, DOI 10.1016/j.gie.2008.03.1127; Kondo H, 2004, GASTROINTEST ENDOSC, V59, P284, DOI 10.1016/S0016-5107(03)02533-1; KUDO S, 1993, ENDOSCOPY, V25, P455, DOI 10.1055/s-2007-1010367; Neuhaus H, 2006, ENDOSCOPY, V38, P1016, DOI 10.1055/s-2006-944830; Onozato Y, 2006, ENDOSCOPY, V38, P980, DOI 10.1055/s-2006-944809; Saito Y, 2005, GASTROINTEST ENDOSC, V62, P297, DOI 10.1016/S0016-5107(05)00546-8; Sakamoto N, 2008, Endoscopy, V40 Suppl 2, pE94, DOI 10.1055/s-2007-995603; Uraoka T, 2010, DIGEST ENDOSC, V22, P186, DOI 10.1111/j.1443-1661.2010.00992.x	25	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0930-2794	1432-2218		SURG ENDOSC	Surg. Endosc.	NOV	2014	28	11					3143	3149		10.1007/s00464-014-3572-0		7	Surgery	Surgery	AS3HL	WOS:000344168200015		
J	Hiraki, M; Takemasa, I; Uemura, M; Haraguchi, N; Nishimura, J; Hata, T; Mizushima, T; Yamamoto, H; Doki, Y; Mori, M				Hiraki, Masayuki; Takemasa, Ichiro; Uemura, Mamoru; Haraguchi, Naotsugu; Nishimura, Junichi; Hata, Taishi; Mizushima, Tsunekazu; Yamamoto, Hirofumi; Doki, Yuichiro; Mori, Masaki			Evaluation of invasiveness in single-site laparoscopic colectomy, using "the PainVision (TM) system" for quantitative analysis of pain sensation	SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES			English	Article						Single-site laparoscopic colectomy; Colon cancer; Postoperative pain; Pain Vision (TM); Visual analog scale (VAS)	SHORT-TERM OUTCOMES; OPEN SURGERY; COLORECTAL-CANCER; CONTROLLED-TRIAL; COLON-CANCER; INCISION; CHOLECYSTECTOMY; SCALES; 3-PORT	Single-site laparoscopic colectomy (SLC) is increasingly performed for colon cancer. There are few reports on invasiveness in SLC. This study aimed to evaluate the postoperative pain from SLC, as compared to conventional multiport laparoscopic colectomy (MLC). We compared postoperative pain among patients from the SLC group (n = 11) with those from the MLC group (n = 11) who underwent laparoscopic surgery for colon cancer at our institution between May and October 2013. Patients were specifically matched for gender, age, body mass index, tumor size, and performance status. Postoperative pain was evaluated at rest and during mobilization, using a visual analog scale (VAS) on postoperative days (PODs) 1-7, and by postoperative frequency of analgesics; pain intensity was evaluated at rest, using the Pain Vision (TM) system on PODs 1-7. Other operative outcomes of the two groups were also recorded. Patient demographics, operative outcomes, time duration before first flatus, and C-reactive protein and WBC count on POD 1 showed no significant differences between groups. Results of sequential VAS during mobilization until POD 7 were significantly less in the SLC group than in the MLC group (p = 0.009). However, sequential VAS at rest did not differ between the two groups (p = 0.11). Measured with the Pain Vision (TM) system, the difference in pain intensity at rest was statistically significant for the postoperative period (p = 0.003). Total requests for analgesics until POD 7 were reduced in the SLC group compared to that in the MLC group, but lacked statistical significance (three vs. seven, respectively, p = 0.07). In both quantitative and objective measurements using the Pain Vision (TM) system, SLC significantly reduced postoperative pain. SLC is a promising procedure, associated with less invasiveness than MLC.	[Hiraki, Masayuki; Takemasa, Ichiro; Uemura, Mamoru; Haraguchi, Naotsugu; Nishimura, Junichi; Hata, Taishi; Mizushima, Tsunekazu; Yamamoto, Hirofumi; Doki, Yuichiro; Mori, Masaki] Osaka Univ, Grad Sch Med, Dept Surg Gastroenterol, Suita, Osaka 5650871, Japan	Takemasa, I (reprint author), Osaka Univ, Grad Sch Med, Dept Surg Gastroenterol, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan.	mhiraki@gesurg.med.osaka-u.ac.jp; itakemasa@gesurg.med.osaka-u.ac.jp	Nishimura, Junichi/K-8390-2015	Nishimura, Junichi/0000-0001-8220-3423			DeLoach LJ, 1998, ANESTH ANALG, V86, P102, DOI 10.1097/00000539-199801000-00020; Champagne BJ, 2012, ANN SURG, V255, P66, DOI 10.1097/SLA.0b013e3182378442; Moraca RJ, 2003, ANN SURG, V238, P663, DOI 10.1097/01.sla.0000094300.36689.ad; Bucher P, 2008, INT J COLORECTAL DIS, V23, P1013, DOI 10.1007/s00384-008-0519-8; BABUL N, 1993, ANN PHARMACOTHER, V27, P9; Poon JTC, 2012, SURG ENDOSC, V26, P2729, DOI 10.1007/s00464-012-2262-z; Fung AKY, 2012, BRIT J SURG, V99, P1353, DOI 10.1002/bjs.8834; Remzi FH, 2008, COLORECTAL DIS, V10, P823, DOI 10.1111/j.1463-1318.2008.01660.x; MCCORMACK HM, 1988, PSYCHOL MED, V18, P1007; Fleshman J, 2007, ANN SURG, V246, P655, DOI 10.1097/SLA.0b013e318155a762; Makino T, 2012, ANN SURG, V255, P667, DOI 10.1097/SLA.0b013e31823fbae7; Matsumura H, 2012, INT WOUND J, V9, P451, DOI 10.1111/j.1742-481X.2011.00911.x; Jayne DG, 2010, BRIT J SURG, V97, P1638, DOI 10.1002/bjs.7160; Chew MH, 2013, SURG ENDOSC, V27, P471, DOI 10.1007/s00464-012-2460-8; Kim SJ, 2011, ANN SURG, V254, P933, DOI 10.1097/SLA.0b013e318237826b; Tjandra JJ, 2006, COLORECTAL DIS, V8, P375, DOI 10.1111/j.1463-1318.2006.00974.x; Chen WTL, 2011, SURG ENDOSC, V25, P1887, DOI 10.1007/s00464-010-1481-4; Osada K, 2011, INT J RHEUM DIS, V14, P74, DOI 10.1111/j.1756-185X.2010.01585.x; Stener-Victorin E, 2002, ANESTH ANALG, V95, P151, DOI 10.1097/00000539-200207000-00027; Buunen M, 2009, LANCET ONCOL, V10, P44, DOI DOI 10.1016/S1470-2045(08)70310-3; Cerci C, 2007, HEPATO-GASTROENTEROL, V54, P15; Gupta Aman, 2005, Trop Gastroenterol, V26, P149; Jacobs M, 1991, Surg Laparosc Endosc, V1, P144; Jefferson JK, 1998, PAIN DIGEST, V8, P219; Kumar Manoj, 2007, JSLS, V11, P358; LAHODA R, 1977, INT J CLIN PHARM BI, V15, P51; Leblancs F, 2010, DIAGN THER ENDOSC, V2010; Lee HJ, 2014, TRIALS, V15, DOI 10.1186/1745-6215-15-105; Lu CC, 2012, COLORECTAL DIS, V14, pE171, DOI 10.1111/j.1463-1318.2011.02825.x; Ota S, 2009, PAIN CLINIC, V30, P209; Papaconstantinou HT, 2011, J AM COLL SURGEONS, V213, P72, DOI 10.1016/j.jamcollsurg.2011.02.010; Poon CM, 2003, SURG ENDOSC, V17, P1624, DOI 10.1007/s00464-002-8718-9; Schwenk W, 2005, COCHRANE DB SYST REV, V20; SEYMOUR RA, 1982, EUR J CLIN PHARMACOL, V23, P441, DOI 10.1007/BF00605995; Shimazu H, 2004, 11TH INTERNATIONAL PAIN CLINIC: WORLD SOCIETY OF PAIN CLINICIANS, P451; Takemasa I, 2013, SURG ENDOSC, V28, P1110; Takemasa I, 2010, SURG ENDOSC, V24, P2321, DOI 10.1007/s00464-010-0948-7; Trichak S, 2003, SURG ENDOSC, V17, P1434, DOI 10.1007/s00464-002-8713-1; Bonjer HJ, 2005, LANCET ONCOL, V6, P477, DOI 10.1016/S1470-2045(05)70221-7	39	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0930-2794	1432-2218		SURG ENDOSC	Surg. Endosc.	NOV	2014	28	11					3216	3223		10.1007/s00464-014-3594-7		8	Surgery	Surgery	AS3HL	WOS:000344168200025		
J	Aoki, H; Yamashita, H; Mori, T; Fukuyo, T; Chiba, T				Aoki, Hisae; Yamashita, Hiromasa; Mori, Toshiyuki; Fukuyo, Tsuneo; Chiba, Toshio			Ultrahigh sensitivity endoscopic camera using a new CMOS image sensor Providing with clear images under low illumination in addition to fluorescent images	SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES			English	Article						CMOS; Fluorescent image; Laparoscopic surgery; High sensitivity	SURGERY; ANATOMY	We developed a new ultrahigh-sensitive CMOS camera using a specific sensor that has a wide range of spectral sensitivity characteristics. The objective of this study is to present our updated endoscopic technology that has successfully integrated two innovative functions; ultrasensitive imaging as well as advanced fluorescent viewing. Two different experiments were conducted. One was carried out to evaluate the function of the ultrahigh-sensitive camera. The other was to test the availability of the newly developed sensor and its performance as a fluorescence endoscope. In both studies, the distance from the endoscopic tip to the target was varied and those endoscopic images in each setting were taken for further comparison. In the first experiment, the 3-CCD camera failed to display the clear images under low illumination, and the target was hardly seen. In contrast, the CMOS camera was able to display the targets regardless of the camera-target distance under low illumination. Under high illumination, imaging quality given by both cameras was quite alike. In the second experiment as a fluorescence endoscope, the CMOS camera was capable of clearly showing the fluorescent-activated organs. The ultrahigh sensitivity CMOS HD endoscopic camera is expected to provide us with clear images under low illumination in addition to the fluorescent images under high illumination in the field of laparoscopic surgery.	[Aoki, Hisae] Murayama Med Ctr, Natl Hosp Org, Dept Surg, Musashimurayama, Tokyo 2080011, Japan; [Aoki, Hisae; Mori, Toshiyuki] Kyorin Univ, Dept Surg, Tokyo, Japan; [Yamashita, Hiromasa; Chiba, Toshio] Natl Ctr Child Hlth & Dev, Clin Res Ctr, Tokyo, Japan; [Fukuyo, Tsuneo] Shinko Opt Co Ltd, Tokyo, Japan	Aoki, H (reprint author), Murayama Med Ctr, Natl Hosp Org, Dept Surg, 2-37-1 Gakuen, Musashimurayama, Tokyo 2080011, Japan.	hisae.aoki.m.d@gmail.com; chiba-t@sea.plala.or.jp			Health and Labour Sciences Research Grants [H24-Area-Norm-007]	A part of this work was supported by the Health and Labour Sciences Research Grants (H24-Area-Norm-007).	Tanaka E, 2008, SURGERY, V144, P39, DOI 10.1016/j.surg.2008.03.017; Mitsuhashi N, 2008, J HEPATO-BILIARY-PAN, V15, P508, DOI 10.1007/s00534-007-1307-5; Kimura T, 2007, GASTROINTEST ENDOSC, V66, P37, DOI 10.1016/j.gie.2007.01.009; Miyashiro I, 2008, ANN SURG ONCOL, V15, P1640, DOI 10.1245/s10434-008-9872-7; Bhoyrul S, 1995, FUNDAMENTALS LAPAROS, P1; Demling L, 1985, ENDOSCOPY, V5, P167; Harada K, 2009, MINIM INVASIV THER, V18, DOI 10.1080/13645700802655661; Hindle AK, 2009, SURG ENDOSC, V23, P1720, DOI 10.1007/s00464-008-0219-z; Matsuda Tadashi, 2013, Asian J Endosc Surg, V6, P68, DOI 10.1111/ases.12032; Matsunaga Y, 1998, I IMAGE INFORM TELEV, V52, P1171; Matsunaga Y, 1999, I IMAGE INFORM TELEV, V53, P184; Mori T, 1995, FUNDAMENTALS LAPAROS, P1; Stiles BM, 2006, SURG ENDOSC, V20, P1291, DOI 10.1007/s00464-005-0664-x; Sumi H, 2010, FUNDAM REV, V3, P44; Tagaya T, 2010, J HEPATOBILIARY PANC, V17, P595; Underwood RA, 2004, LAPAROSCOPIC SURG, P1	16	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0930-2794	1432-2218		SURG ENDOSC	Surg. Endosc.	NOV	2014	28	11					3240	3248		10.1007/s00464-014-3590-y		9	Surgery	Surgery	AS3HL	WOS:000344168200028		
J	Shimizu, S; Kudo, K; Antoku, Y; Hu, M; Okamura, K; Nakashima, N				Shimizu, Shuji; Kudo, Kuriko; Antoku, Yasuaki; Hu, Min; Okamura, Koji; Nakashima, Naoki			Ten-Year Experience of Remote Medical Education in Asia	TELEMEDICINE AND E-HEALTH			English	Article						remote education; Internet; research and education network; telemedicine; digital video transport system	TELEMEDICINE; SURGERY; SYSTEM; HEALTH	Background: Moving images are often essential in medical education, to learn new procedures and advanced skills, but, in the past, high-quality movie transmission was technically much more challenging than transmitting still pictures because of technological limitations and cost. Materials and Methods: We established a new system, taking advantage of two advanced technologies, the digital video transport system (DVTS) and the research and education network (REN), which enabled satisfactory telemedicine on a routine basis. Results: Between 2003 and 2013, we organized 360 programs connecting 221 hospitals or facilities in 34 countries in Asia and beyond. The two main areas were endoscopy and surgery, with 113 (31%) and 106 (29%) events, respectively. Teleconferences made up 76% of the total events, with the remaining 24% being live demonstrations. Multiple connections were more popular (63%) than one-to-one connections (37%). With continuous technological development, new high-definition H.323 and Vidyo((R)) (Hackensack, NJ) systems were used in 47% and 39% of events in 2011 and 2012, respectively. The evaluation by questionnaires was favorable on image and sound quality as well as programs. Conclusions: Remote medical education with moving images was well accepted in Asia with changing needs and developing technologies.	[Shimizu, Shuji] Kyushu Univ Hosp, Dept Endoscop Diagnost & Therapeut, Fukuoka 8128582, Japan; [Shimizu, Shuji; Kudo, Kuriko; Antoku, Yasuaki; Hu, Min; Okamura, Koji; Nakashima, Naoki] Kyushu Univ Hosp, Telemed Dev Ctr Asia, Fukuoka 8128582, Japan; [Antoku, Yasuaki; Hu, Min; Nakashima, Naoki] Kyushu Univ Hosp, Med Informat Ctr, Fukuoka 8128582, Japan; [Okamura, Koji] Kyushu Univ, Res Inst Informat Technol, Fukuoka 812, Japan	Shimizu, S (reprint author), Kyushu Univ Hosp, Telemed Dev Ctr Asia, Higashi Ku, 3-1-1 Maidashi, Fukuoka 8128582, Japan.	shimizu@med.kyushu-u.ac.jp	Nakashima, Naotoshi/C-8791-2009		Japan Society for the Promotion of Science [23256005]	The authors are grateful for the cooperation and expertise of the entire medical and engineering staff in supporting program organization and network preparations at all the hospitals and institutions involved. We are particularly grateful to the APAN-NOC and TEIN-NOC teams for intensive network preparations. This project was funded in part by Grant-in-Aid number 23256005 for Scientific Research from the Japan Society for the Promotion of Science.	Mars M, 2012, TELEMED E-HEALTH, V18, P32, DOI 10.1089/tmj.2011.0146; Weinstein RS, 2012, APMIS, V120, P256, DOI 10.1111/j.1600-0463.2011.02866.x; Cao Minh Duc, 2012, Korean J Radiol, V13 Suppl 1, pS21, DOI 10.3348/kjr.2012.13.S1.S21; JENNINGS DM, 1986, SCIENCE, V231, P943, DOI 10.1126/science.231.4741.943; Liu WL, 2011, TELEMED E-HEALTH, V17, P358, DOI 10.1089/tmj.2010.0193; Rabenstein T, 2002, ENDOSCOPY, V34, P703, DOI 10.1055/s-2002-33568; Rafiq A, 2004, ANN SURG, V239, P567, DOI 10.1097/01.sla.0000118749.24645.45; Saliba V, 2012, INT J MED INFORM, V81, P793, DOI 10.1016/j.ijmedinf.2012.08.003; Shimizu S, 2008, TELEMEDICINE 21 CENT, P143; Shimizu S, 2009, TELEMED J E-HEALTH, V15, P112, DOI 10.1089/tmj.2008.0067; Shimizu S, 2006, SURG ENDOSC, V20, P167, DOI 10.1007/s00464-005-0282-7; Shimizu S, 2011, ADV TELEMEDICINE TEC, P87; Shimizu S, 2010, SURGERY, V147, P597, DOI 10.1016/j.surg.2009.11.001; SMITH A, 2012, SIGHT SOUND, V22, P82; Wootton R, 2011, BMC HEALTH SERV RES, V11, DOI 10.1186/1472-6963-11-185	15	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	1530-5627	1556-3669		TELEMED E-HEALTH	Telemed. e-Health	NOV 1	2014	20	11					1021	1026		10.1089/tmj.2014.0018		6	Health Care Sciences & Services	Health Care Sciences & Services	AS8BZ	WOS:000344476600008		
J	Sato, S; Itamochi, H				Sato, Seiya; Itamochi, Hiroaki			Neoadjuvant chemotherapy in advanced ovarian cancer: latest results and place in therapy	THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY			English	Article						advanced ovarian cancer; interval debulking surgery; neoadjuvant chemotherapy	ADVANCED-STAGE OVARIAN; PRIMARY DEBULKING SURGERY; QUALITY-OF-LIFE; GYNECOLOGIC-ONCOLOGY-GROUP; PRIMARY CYTOREDUCTIVE SURGERY; PLATINUM-BASED CHEMOTHERAPY; RANDOMIZED PHASE-III; CLEAR-CELL CARCINOMA; LONG-TERM SURVIVAL; INTERVAL DEBULKING	Approximately 70% of women with epithelial ovarian cancer (EOC) are diagnosed with advanced stage disease, which is associated with high morbidity and mortality. The standard approach to treating patients with advanced EOC remains primary debulking surgery (PDS) followed by chemotherapy. EOC is one of the most sensitive of all solid tumors to cytotoxic drugs, with over 80% of women showing a response to standard chemotherapy combined with taxane and platinum. Furthermore, residual disease is a major prognostic factor for survival. On the basis of the clinical features, neoadjuvant chemotherapy (NACT) followed by interval debulking surgery (IDS) is considered to be an alternative treatment option to standard treatment in patients unable to undergo complete resection during PDS. Noninferiority of NACT-IDS to PDS has been demonstrated in some randomized controlled trials and meta-analyses. NACT would also lead to improved quality of life (QOL) of patients, however there are still problems to be solved in the treatment strategy. The uncertainty of perioperative visual assessment of tumor dissemination after NACT has been reported. In addition, several papers have shown the possibility that NACT induces platinum resistance. Furthermore, a notable risk associated with NACT is that patients with significant side effects and refractory disease will lose the opportunity for debulking surgery. Appropriate selection of the patient cohort for NACT is an important issue. Bevacizumab (Bev) is active in patients with advanced EOC. However, the use of Bev is not recommended in the neoadjuvant setting. Bev has a specific adverse event profile that needs to be considered, especially for surgical management, such as gastrointestinal perforation, hemorrhage, and thromboembolic events. NACT could be an alternative treatment option in patients with stage III or IV EOC. However, further studies are needed to clarify the precise role of NACT in the management of advanced EOC.	[Sato, Seiya; Itamochi, Hiroaki] Tottori Univ, Dept Obstet & Gynecol, Sch Med, Yonago, Tottori 6838504, Japan	Itamochi, H (reprint author), Tottori Univ, Dept Obstet & Gynecol, Sch Med, 36-1 Nishicho, Yonago, Tottori 6838504, Japan.	itamochi@med.tottori-u.ac.jp					Shimada M, 2009, GYNECOL ONCOL, V113, P331, DOI 10.1016/j.ygyno.2009.02.010; du Bois A, 2005, ANN ONCOL, V16, P7, DOI 10.1093/annonc/mdi961; Samrao D, 2012, TRANSL ONCOL, V5, P469, DOI 10.1593/tlo.12265; du Bois A, 2009, CANCER, V115, P1234, DOI 10.1002/cncr.24149; Bristow RE, 2006, GYNECOL ONCOL, V103, P1070, DOI 10.1016/j.ygyno.2006.06.025; Chi DS, 2006, GYNECOL ONCOL, V103, P559, DOI 10.1016/j.ygyno.2006.03.051; Miranda VD, 2014, GYNECOL ONCOL, V132, P287, DOI 10.1016/j.ygyno.2013.12.002; Lim MC, 2010, ONKOLOGIE, V33, P324, DOI 10.1159/000313823; Fago-Olsen CL, 2014, GYNECOL ONCOL, V132, P292, DOI 10.1016/j.ygyno.2013.11.035; Vergote I, 2011, J CLIN ONCOL, V29, P4076, DOI 10.1200/JCO.2011.36.9785; HOSKINS WJ, 1994, AM J OBSTET GYNECOL, V170, P974; Heintz APM, 2006, INT J GYNECOL OBSTET, V95, pS161, DOI 10.1016/S0020-7292(06)60033-7; Rose PG, 2004, NEW ENGL J MED, V351, P2489, DOI 10.1056/NEJMoa041125; Bristow RE, 2002, J CLIN ONCOL, V20, P1248, DOI 10.1200/JCO.20.5.1248; Vergote I, 1998, GYNECOL ONCOL, V71, P431, DOI 10.1006/gyno.1998.5213; Wenzel L, 2005, J CLIN ONCOL, V23, P5605, DOI 10.1200/JCO.2005.08.147; Jemal A, 2010, CA-CANCER J CLIN, V60, P277, DOI [10.3322/caac.20073, 10.1002/caac.20073]; Muraji M, 2013, GYNECOL ONCOL, V131, P531, DOI 10.1016/j.ygyno.2013.09.030; Schwartz PE, 1999, GYNECOL ONCOL, V72, P93, DOI 10.1006/gyno.1998.5236; Wright JD, 2014, CANCER-AM CANCER SOC, V120, P1246, DOI 10.1002/cncr.28508; Greimel E, 2013, GYNECOL ONCOL, V131, P437, DOI 10.1016/j.ygyno.2013.08.014; Vergote I, 2013, GYNECOL ONCOL, V128, P6, DOI 10.1016/j.ygyno.2012.09.013; HOSKINS WJ, 1992, GYNECOL ONCOL, V47, P159, DOI 10.1016/0090-8258(92)90100-W; Worley MJ, 2013, GYNECOL ONCOL, V129, P69, DOI 10.1016/j.ygyno.2013.01.012; Goff BA, 1996, GYNECOL ONCOL, V60, P412, DOI 10.1006/gyno.1996.0065; Ferlay J, 2010, Eur J Cancer, V46, P765, DOI 10.1016/j.ejca.2009.12.014; Cannistra SA, 2004, NEW ENGL J MED, V351, P2519, DOI 10.1056/NEJMra041842; Kang S, 2009, ANN SURG ONCOL, V16, P2315, DOI 10.1245/s10434-009-0558-6; Chang SJ, 2012, GYNECOL ONCOL, V125, P483, DOI 10.1016/j.ygyno.2012.02.024; Vergote I, 2011, EUR J CANCER, V47, pS88, DOI 10.1016/S0959-8049(11)70152-6; van Meurs HS, 2013, EUR J CANCER, V49, P3191, DOI 10.1016/j.ejca.2013.06.013; Rauh-Hain JA, 2013, GYNECOL ONCOL, V129, P63, DOI 10.1016/j.ygyno.2013.01.009; Eisenkop SM, 1998, GYNECOL ONCOL, V69, P103, DOI 10.1006/gyno.1998.4955; Cannistra SA, 2007, J CLIN ONCOL, V25, P5180, DOI 10.1200/JCO.2007.12.0782; Rauh-Hain JA, 2012, ANN SURG ONCOL, V19, P959, DOI 10.1245/s10434-011-2100-x; Benedet JL, 2000, INT J GYNECOL OBSTET, V70, P209; Rustin G, 2011, LANCET, V377, P380, DOI 10.1016/S0140-6736(11)60126-8; Itamochi H, 2002, JPN J CANCER RES, V93, P723; Milam MR, 2011, INT J GYNECOL CANCER, V21, P66, DOI 10.1097/IGC.0b013e3182013e2f; Chi DS, 2012, GYNECOL ONCOL, V124, P10, DOI 10.1016/j.ygyno.2011.08.014; VANDERBURG MEL, 1995, NEW ENGL J MED, V332, P629, DOI 10.1056/NEJM199503093321002; Han ES, 2007, GYNECOL ONCOL, V105, P3, DOI 10.1016/j.ygyno.2007.01.038; Sato S, 2009, CANCER SCI, V100, P546, DOI 10.1111/j.1349-7006.2008.01065.x; Hynninen J, 2013, GYNECOL ONCOL, V128, P229, DOI 10.1016/j.ygyno.2012.11.007; Burger RA, 2011, NEW ENGL J MED, V365, P2473, DOI 10.1056/NEJMoa1104390; Chi DS, 2009, GYNECOL ONCOL, V112, P6, DOI 10.1016/j.ygyno.2008.10.010; Garcia AA, 2008, J CLIN ONCOL, V26, P76, DOI 10.1200/JCO.2007.12.1939; Aletti GD, 2006, GYNECOL ONCOL, V100, P283, DOI 10.1016/j.ygyno.2005.08.027; Bezjak A, 2004, J CLIN ONCOL, V22, P4595, DOI 10.1200/JCO.2004.08.080; Chereau E, 2013, INT J GYNECOL CANCER, V23, P1326, DOI 10.1097/IGC.0b013e31829dc923; Cornelis S, 2012, INT J GYNECOL CANCER, V22, P407, DOI 10.1097/IGC.0b013e31823ea1d8; Du Bois A, 2005, INT J GYNECOL CANCER, V15, P42, DOI 10.1111/j.1525-1438.2005.15356.x; Glasgow MA, 2013, J SURG ONCOL, V107, P195, DOI 10.1002/jso.23171; Greimel ER, 2006, J CLIN ONCOL, V24, P579, DOI 10.1200/JCO.2005.02.4067; Hershman D, 2004, GYNECOL ONCOL, V94, P540, DOI 10.1016/j.ygyno.2004.04.022; JACOB JH, 1991, GYNECOL ONCOL, V42, P146, DOI 10.1016/0090-8258(91)90335-3; Kawaguchi M, 2005, ANTICANCER RES, V25, P3547; Kehoe S, 2013, J CLIN ONCOL, V31; Le T, 2007, GYNECOL ONCOL, V106, P160, DOI 10.1016/j.ygyno.2007.03.029; Lu Y, 2014, GYNECOL ONCOL, V134, P78, DOI 10.1016/j.ygyno.2014.02.029; Matsuo K, 2010, ARCH GYNECOL OBSTET, V281, P325, DOI 10.1007/s00404-009-1121-1; Matsuo K, 2010, AM J CLIN ONCOL-CANC, V33, P358, DOI 10.1097/COC.0b013e3181af30d3; McLean KA, 2010, GYNECOL ONCOL, V118, P43, DOI 10.1016/j.ygyno.2010.03.002; Naniwa J, 2007, INT J GYNECOL CANCER, V17, P76, DOI 10.1111/j.1525-1438.2006.00752.x; Perren TJ, 2011, NEW ENGL J MED, V365, P2484, DOI 10.1056/NEJMoa1103799; Pignata S, 2011, J CLIN ONCOL, V29, P3628, DOI 10.1200/JCO.2010.33.8566; Sato S, 2012, CURR OPIN OBSTET GYN, V24, P8, DOI 10.1097/GCO.0b013e32834daeed; Schwartz PE, 2008, ONCOLOGY-NY, V22, P1118; Schwartz PE, 2009, CURR ONCOL REP, V11, P457; SCHWARTZ PE, 1994, GYNECOL ONCOL, V53, P33, DOI 10.1006/gyno.1994.1083; Stoeckle E, 2014, ANN SURG ONCOL, V21, P629, DOI 10.1245/s10434-013-3278-x; Sugiyama T, 2002, ONCOLOGY-BASEL, V63, P16, DOI 10.1159/000065715; Talukdar S, 2014, GYNECOL ONCOL, V132, P28, DOI 10.1016/j.ygyno.2013.10.009; Vergote I, 2010, NEW ENGL J MED, V363, P943, DOI 10.1056/NEJMoa0908806; Vergote IB, 2000, SEMIN ONCOL, V27, P31; Wang YY, 2013, INT J CLIN EXP PATHO, V6, P2121; Winter WE, 2007, J CLIN ONCOL, V25, P3621, DOI 10.1200/JCO.2006.10.2517; World Health Organization, 2011, GLOB CANC FACTS FIG; Wright JD, 2008, BRIT J CANCER, V98, P1197, DOI 10.1038/sj.bjc.6604298; Zhang GN, 2014, GYNECOL ONCOL, V132, P752, DOI 10.1016/j.ygyno.2014.01.028	80	2	2	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1758-8340	1758-8359		THER ADV MED ONCOL	Ther. Adv. Med. Oncol.	NOV	2014	6	6					293	304		10.1177/1758834014544891		12	Oncology	Oncology	AS4PU	WOS:000344259800004		
J	Yamane, H; Ochi, N; Isozaki, H; Yamagishi, T; Honda, Y; Takigawa, N				Yamane, Hiromichi; Ochi, Nobuaki; Isozaki, Hideko; Yamagishi, Tomoko; Honda, Yoshihiro; Takigawa, Nagio			Skin involvement in diffuse large B-cell lymphoma detected using positron emission tomography	THORACIC CANCER			English	Editorial Material						Diffuse large B-cell lymphoma; fluorodeoxyglucose-avid lymphoma; fluorodeoxyglucose-positron emission tomography; skin involvement			[Yamane, Hiromichi; Ochi, Nobuaki; Isozaki, Hideko; Yamagishi, Tomoko; Honda, Yoshihiro; Takigawa, Nagio] Kawasaki Med Univ, Dept Gen Internal Med 4, Okayama 7008505, Japan	Yamane, H (reprint author), Kawasaki Med Univ, Dept Gen Internal Med 4, Kita Ku, 2-1-80 Nakasange, Okayama 7008505, Japan.	hiromichi.ya@gmail.com					Weiler-Sagie M, 2010, J NUCL MED, V51, P25, DOI 10.2967/jnumed.109.067892; Paes FM, 2010, RADIOGRAPHICS, V30, P269, DOI 10.1148/rg.301095088; Elstrom R, 2003, BLOOD, V101, P3875, DOI 10.1182/blood-2002-09-2778	3	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1759-7706	1759-7714		THORAC CANCER	Thorac. Cancer	NOV	2014	5	6					581	582		10.1111/1759-7714.12149		2	Oncology; Respiratory System	Oncology; Respiratory System	AS5OY	WOS:000344321000016		
J	Nakano, Y; Tho, NV; Coxson, HO				Nakano, Yasutaka; Nguyen Van Tho; Coxson, Harvey O.			Is the 'spatially matched central airways' relevant to studies of airway dimensions in COPD?	THORAX			English	Letter									[Nakano, Yasutaka; Nguyen Van Tho] Shiga Univ Med Sci, Dept Resp Med, Otsu, Shiga 5202192, Japan; [Coxson, Harvey O.] Vancouver Gen Hosp, Dept Radiol, Vancouver, BC V5Z 1M9, Canada	Nakano, Y (reprint author), Shiga Univ Med Sci, Dept Resp Med, Seta Tsukinowa Cho, Otsu, Shiga 5202192, Japan.	nakano@belle.shiga-med.ac.jp		Tho, Nguyen Van/0000-0003-4004-9872			[Anonymous], 2014, THORAX, V69, P987; Hsia CCW, 2010, AM J RESP CRIT CARE, V181, P394, DOI 10.1164/rccm.200809-1522ST; Washko GR, 2014, J APPL PHYSIOL, V116, P668, DOI 10.1152/japplphysiol.00004.2013	3	1	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0040-6376	1468-3296		THORAX	Thorax	NOV	2014	69	11								10.1136/thoraxjnl-2014-206118		2	Respiratory System	Respiratory System	AS2HX	WOS:000344101700018		
J	Haugen, B; McDermott, M; Carrothers, TC; Daniels, GH; Ross, DS; Klibanski, A; Crowley, WF; Bigos, ST; Wartofsky, L; Cooper, DS; Ladenson, PW; Hershman, JM; Brent, G; Shupnik, P; Samuels, MH; Nagataki, S; Pacini, F; Maciel, RMB; Singer, P; Donelson, CH; Ridgway, H				Haugen, Bryan; McDermott, Michael; Carrothers, Terri C.; Daniels, Gilbert H.; Ross, Douglas S.; Klibanski, Anne; Crowley, William F., Jr.; Bigos, S. Thomas; Wartofsky, Leonard; Cooper, David S.; Ladenson, Paul W.; Hershman, Jerome M.; Brent, Gregory; Shupnik, Peggy; Samuels, Mary H.; Nagataki, Shigenobu; Pacini, Furio; Maciel, Rui M. B.; Singer, Peter; Donelson, Carla Hamre; Ridgway, Hap		Colorado Grp; Massachusetts Gen Hosp Grp	E. Chester Ridgway, MD, MACP (1942-2014) IN MEMORIAM	THYROID			English	Biographical-Item									[Haugen, Bryan; McDermott, Michael; Carrothers, Terri C.] Univ Colorado, Sch Med, Aurora, CO 80045 USA; [Haugen, Bryan] Univ Colorado, Sch Med, Div Endocrinol Metab & Diabet, Aurora, CO USA; [Daniels, Gilbert H.] Mass Gen Hosp, Boston, MA USA; [Daniels, Gilbert H.; Ross, Douglas S.] Massachusetts Gen Hosp, Boston, MA 02114 USA; [Daniels, Gilbert H.; Ross, Douglas S.; Klibanski, Anne; Crowley, William F., Jr.] Harvard Univ, Sch Med, Boston, MA USA; [Klibanski, Anne] Massachusetts Gen Hosp, Partners HealthCare, Boston, MA 02114 USA; [Klibanski, Anne] Massachusetts Gen Hosp, Neuroendocrine Unit, Boston, MA 02114 USA; [Crowley, William F., Jr.] Massachusetts Gen Hosp, Harvard Reprod Endocrine Unit, Boston, MA 02114 USA; [Bigos, S. Thomas] Togus Vet Affairs Med Ctr, Endocrine Serv, Augusta, ME USA; [Wartofsky, Leonard] MedStar Washington Hosp Ctr, Washington, DC USA; [Wartofsky, Leonard] Georgetown Univ, Sch Med, Washington, DC USA; [Cooper, David S.; Ladenson, Paul W.] Johns Hopkins Univ, Sch Med, Baltimore, MD USA; [Hershman, Jerome M.] Univ Calif Los Angeles, David Geffen Sch Med, Vet Affairs Greater Los Angeles Healthcare Syst, Los Angeles, CA 90095 USA; [Brent, Gregory] Univ Calif Los Angeles, David Geffen Sch Med, Vet Affairs Greater Los Angeles Healthcare Syst, Dept Med, Los Angeles, CA 90095 USA; [Shupnik, Peggy] Univ Virginia, Sch Med, Charlottesville, VA 22908 USA; [Samuels, Mary H.] Oregon Hlth & Sci Univ, Div Endocrinol Diabet & Clin Nutr, Portland, OR 97201 USA; [Samuels, Mary H.] Oregon Hlth & Sci Univ, Clin & Translat Res Ctr, Portland, OR 97201 USA; [Nagataki, Shigenobu] Nagasaki Univ, Tokyo, Japan; [Nagataki, Shigenobu] AOTA, Tokyo, Japan; [Nagataki, Shigenobu] Radiat Effects Assoc, Tokyo, Japan; [Pacini, Furio] Univ Siena, European Thyroid Assoc, I-53100 Siena, Italy; [Pacini, Furio] Univ Siena, Dept Endocrinol & Metab, I-53100 Siena, Italy; [Maciel, Rui M. B.] Univ Fed Sao Paulo, Lab Mol & Translat Endocrinol, Div Endocrinol, Dept Med,Escola Paulista Med, Sao Paulo, Brazil; [Singer, Peter] Univ So Calif, Keck Sch Med, Los Angeles, CA 90033 USA	Haugen, B (reprint author), Univ Colorado, Sch Med, Aurora, CO 80045 USA.	Bryan.haugen@ucdenver.edu; Michael.mcdermott@ucdenver.edu; Terri.carrothers@ucdenver.edu; gdaniels@partners.org; dross@partners.org; aklibanski@partners.org; wcrowley@partners.org; BIGOS_STHOMAS@comcast.net; Leonard.Wartofsky@Medstar.net; DSCooper@jhmi.edu; ladenson@jhmi.edu; jhershmn@g.ucla.edu; gbrent@ucla.edu; mas3x@virginia.edu; samuelsm@ohsu.edu; shigenobu.nagataki@nifty.com; pacini8@unisi.it; Rui.Maciel@grupofleury.com.br; psinger@med.usc.edu; carladonelson@aol.com; rockinrrranch@wildblue.net					RIDGWAY EC, PUBLICATION LIST	1	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	1050-7256	1557-9077		THYROID	Thyroid	NOV 1	2014	24	11					1555	1565		10.1089/thy.2014.2411		11	Endocrinology & Metabolism	Endocrinology & Metabolism	AS9EZ	WOS:000344547100001		
J	Iwasaki, J; Iida, T; Mizumoto, M; Uemura, T; Yagi, S; Hori, T; Ogawa, K; Fujimoto, Y; Mori, A; Kaido, T; Uemoto, S				Iwasaki, Junji; Iida, Taku; Mizumoto, Masaki; Uemura, Tadahiro; Yagi, Shintaro; Hori, Tomohide; Ogawa, Kohei; Fujimoto, Yasuhiro; Mori, Akira; Kaido, Toshimi; Uemoto, Shinji			Donor morbidity in right and left hemiliver living donor liver transplantation: the impact of graft selection and surgical innovation on donor safety	TRANSPLANT INTERNATIONAL			English	Article						biliary complication; hilar dissection; liver transplantation; living donor; morbidity	SINGLE-CENTER ANALYSIS; LEFT-LOBE GRAFT; BILIARY COMPLICATIONS; ADULT; SURVIVAL; PATIENT; MORTALITY; DONATION; LESSONS; RISK	This study investigated adequate liver graft selection for donor safety by comparing postoperative donor liver function and morbidity between the right and left hemilivers (RL and LL, respectively) of living donors. Between April 2006 and March 2012, RL (n=168) and LL (n=140) donor operations were performed for liver transplantation at Kyoto University Hospital. Postoperative hyperbilirubinemia and coagulopathy persisted in RL donors, whereas the liver function of LL donors normalized more rapidly. The overall complication rate of the RL donors was significantly higher than that of the LL donors (59.5% vs. 30.7%; P<0.001). There were no significant differences in severe complications worse than Clavien grade IIIa or in biliary complication rates between the two donor groups. In April 2006, we introduced an innovative surgical procedure: hilar dissection preserving the blood supply to the bile duct during donor hepatectomy. Compared with our previous outcomes (1990-2006), the biliary complication rate of the RL donors decreased from 12.2% to 7.2%, and the severity of these complications was significantly lower. In conclusion, LL donors demonstrated good recovery in postoperative liver function and lower morbidity, and our surgical innovations reduced the severity of biliary complications in living donors.	[Iwasaki, Junji; Iida, Taku; Mizumoto, Masaki; Uemura, Tadahiro; Yagi, Shintaro; Hori, Tomohide; Ogawa, Kohei; Fujimoto, Yasuhiro; Mori, Akira; Kaido, Toshimi; Uemoto, Shinji] Kyoto Univ, Grad Sch Med, Dept Surg, Div Hepatobiliary Pancreat & Transplant Surg, Kyoto, Japan	Iida, T (reprint author), 54 Kawara Cho,Sakyo Ku, Kyoto, Japan.	itaku@kuhp.kyoto-u.ac.jp					Hashikura Y, 2009, TRANSPLANTATION, V88, P110, DOI 10.1097/TP.0b013e3181aaccb0; Dindo D, 2004, ANN SURG, V240, P205, DOI 10.1097/01.sla.0000133083.54934.ae; Li C, 2011, HEPATOB PANCREAT DIS, V10, P248; YAMAOKA Y, 1994, TRANSPLANTATION, V57, P1127, DOI 10.1097/00007890-199404150-00024; Yoshizumi T, 2012, TRANSPLANTATION, V93, P93, DOI 10.1097/TP.0b013e318238dacd; Hwang S, 2006, LIVER TRANSPLANT, V12, P920, DOI 10.1002/lt.20734; Kiuchi T, 1999, TRANSPLANTATION, V67, P321, DOI 10.1097/00007890-199901270-00024; STRONG RW, 1990, NEW ENGL J MED, V322, P1505, DOI 10.1056/NEJM199005243222106; Kasahara M, 2005, AM J TRANSPLANT, V5, P1339, DOI 10.1111/j.1600-6143.2005.00817; Iwasaki M, 2004, TRANSPLANTATION, V78, P1501, DOI 10.1097/01.TP.0000140499.23683.0D; HASHIKURA Y, 1994, LANCET, V343, P1233, DOI 10.1016/S0140-6736(94)92450-3; Middleton PF, 2006, LIVER TRANSPLANT, V12, P24, DOI 10.1002/lt.20663; Yoshizumi T, 2008, TRANSPL INT, V21, P81, DOI 10.1111/j.1432-2277.2007.00561.x; Kaido T, 2013, AM J TRANSPLANT, V13, P1549, DOI 10.1111/ajt.12221; Ogura Y, 2010, LIVER TRANSPLANT, V16, P718, DOI 10.1002/lt.22059; Soejima Y, 2012, AM J TRANSPLANT, V12, P1877, DOI 10.1111/j.1600-6143.2012.04022.x; Trotter JF, 2006, LIVER TRANSPLANT, V12, P1485, DOI 10.1002/lt.20875; Iida T, 2010, TRANSPLANTATION, V89, P1276, DOI 10.1097/TP.0b013e3181d66c55; Inomata Y, 2000, TRANSPLANTATION, V69, P258, DOI 10.1097/00007890-200001270-00011; Lee KW, 2004, LIVER TRANSPLANT, V10, P1158, DOI 10.1002/lt.20230; Ito T, 2003, TRANSPLANTATION, V76, P158, DOI 10.1097/01.TP.0000072372.42396.47; RAIA S, 1989, LANCET, V2, P497; Asakuma M, 2007, AM J TRANSPLANT, V7, P1788, DOI 10.1111/j.1600-6143.2007.01849.x; Broering DC, 2004, ANN SURG, V240, P1013, DOI 10.1097/01.sla.0000146146.97485.6c; Fujita S, 2000, TRANSPLANT INT, V13, P333, DOI 10.1111/j.1432-2277.2000.tb01006.x; Hayashi PH, 2003, LIVER TRANSPLANT, V9, P737, DOI 10.1053/jlts.2003.50122; Iida T, 2010, TRANSPLANTATION, V89, P1163, DOI 10.1097/TP.0b013e3181d2feac; Kousoulas L, 2011, TRANSPL INT, V24, P251, DOI 10.1111/j.1432-2277.2010.01183.x; Li HY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074081; Li HY, 2012, HEPATO-GASTROENTEROL, V59, P2050, DOI 10.5754/hge12261; Liu CL, 2003, LIVER TRANSPLANT, V9, P863, DOI 10.1053/jlts.2003.50163; Lo CM, 2003, TRANSPLANTATION, V75, pS12, DOI 10.1097/01.TP.0000046534.45645.47; Ringe B, 2008, TRANSPLANTATION, V85, P790, DOI 10.1097/TP.0b013e318167345e; Russo MW, 2004, AM J TRANSPLANT, V4, P427, DOI 10.1111/j.1600-6143.2004.00336.x; Shin M, 2012, TRANSPLANTATION, V93, P942, DOI 10.1097/TP.0b013e31824ad5de; Shio S, 2008, AM J GASTROENTEROL, V103, P1393, DOI 10.1111/j.1572-0241.2008.01786.x; Taketomi A, 2009, TRANSPLANTATION, V87, P445, DOI 10.1097/TP.0b013e3181943d46	37	3	3	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0934-0874	1432-2277		TRANSPL INT	Transpl. Int.	NOV	2014	27	11					1205	1213		10.1111/tri.12414		9	Surgery; Transplantation	Surgery; Transplantation	AS4JA	WOS:000344239600017		
J	Belgiawan, PF; Schmocker, JD; Abou-Zeid, M; Walker, J; Lee, TC; Ettema, DF; Fujii, S				Belgiawan, Prawira Fajarindra; Schmoecker, Jan-Dirk; Abou-Zeid, Maya; Walker, Joan; Lee, Tzu-Chang; Ettema, Dick F.; Fujii, Satoshi			Car ownership motivations among undergraduate students in China, Indonesia, Japan, Lebanon, Netherlands, Taiwan, and USA	TRANSPORTATION			English	Article						Car ownership motivations; Developed versus developing countries; Attitudes towards cars; Social norms	VEHICLE OWNERSHIP; EMPIRICAL-ANALYSIS; MOBILITY; DUTCH	"Peak car" and related discussions suggest that especially younger people (age cohort until 30) have less desire to drive and purchase cars. This might though only be true for a limited range of developed countries. This study aims to understand the role of personal background and the country context influencing future car ownership decisions of younger people in seven countries (China, Indonesia, Japan, Lebanon, Netherlands, Taiwan, and USA). The main foci of this research are undergraduate students where it is expected that their current attitudes and habits will influence their travel behavior after they graduate and obtain a job. A web survey asked students about their attitudes towards car and public transportation, social norms, their socio-demographic situations, current mobility patterns and the intention to own a car after graduation. We conducted a descriptive analysis as well as correlation analysis of the survey data focusing on explaining intentions to own a car in the future. We find that there is a significant difference between developing and developed countries; students in developed countries have less desire to purchase cars. Expectations of others appears an important determinant of purchase intentions whereas income and the symbolic affective meaning of the car are less correlated with intentions.	[Belgiawan, Prawira Fajarindra; Schmoecker, Jan-Dirk; Fujii, Satoshi] Kyoto Univ, Dept Urban Management, Nishikyo Ku, Kyoto 6158540, Japan; [Abou-Zeid, Maya] Amer Univ Beirut, Dept Civil & Environm Engn, Beirut, Lebanon; [Walker, Joan] Univ Calif Berkeley, Dept Civil & Environm Engn, Berkeley, CA 94720 USA; [Walker, Joan] Univ Calif Berkeley, Ctr Global Metropolitan Studies, Berkeley, CA 94720 USA; [Lee, Tzu-Chang] Natl Cheng Kung Univ, Dept Urban Planning, Tainan 70101, Taiwan; [Ettema, Dick F.] Univ Utrecht, Fac Geosci, Utrecht, Netherlands	Belgiawan, PF (reprint author), Kyoto Univ, Dept Urban Management, Nishikyo Ku, Kyoto 6158540, Japan.	belgiawan@trans.kuciv.kyoto-u.ac.jp		Belgiawan, Prawira Fajarindra/0000-0002-2017-787X	Lotte International Scholarship Foundation; UC Berkeley Global Metropolitan Studies; National Science Foundation; Dean's Office of the Faculty of Engineering and Architecture at AUB	The authors would like to thank Lotte International Scholarship Foundation for supporting this study through a personal scholarship to the first author of this paper as well as UC Berkeley Global Metropolitan Studies, the National Science Foundation, and the Dean's Office of the Faculty of Engineering and Architecture at AUB for supporting this work. We also kindly acknowledge the help of Mr. Zhang Dong, Tongji University with data collection in China.	Kuhnimhof T, 2013, TRANSPORT REV, V33, P325, DOI 10.1080/01441647.2013.801928; Abou-Zeid M, 2013, TRANSP LETT, V5, P115, DOI 10.1179/1942786713Z.00000000011; AJZEN I, 1991, ORGAN BEHAV HUM DEC, V50, P179, DOI 10.1016/0749-5978(91)90020-T; Simma A, 2003, TRANSPORT RES REC, P22; MANSKI CF, 1980, TRANSPORT RES A-POL, V14, P349, DOI 10.1016/0191-2607(80)90054-0; Gaker D, 2010, TRANSP RES RECORD, P47, DOI 10.3141/2156-06; Oliver JD, 2010, J CONSUM MARK, V27, P96, DOI 10.1108/07363761011027204; Belgiawan P. F., 2012, P 32 JAP SOC TRAFF E, P259; CIALDINI RB, 1990, J PERS SOC PSYCHOL, V58, P1015, DOI 10.1037/0022-3514.58.6.1015; Directorate-General of Budget Accounting and Statistics Taiwan (DGBAS), 2013, NAT STAT; Goetzke F., 2011, 90 ANN M TRANSP RES; IMF, 2013, WOR ECON OUTLOOK, P1; Indonesia Central Agency of Statistics, 2013, NUMB MOT VEH TYP IND; Institute for Mobility Research, 2013, MOB Y EM TRAV PATT G; International Transport Forum, 2011, TRANSP OUTL M NEEDS; Khan A., 1986, TRAFFIC ENG CONTROL, V27, P554; Lanzendorf M., 2003, 10 INT C TRAV BEH RE; Metropolitan Transportation Commission, 2013, SAN FRANC BAY AR REG; Millstein S. G., 1990, THRESHOLD DEV ADOLES, P431; Ministry of Environment, 2013, PART A4 TRANSP SECT; Ministry of Environment, 2011, LEB 2 NAT COMM UN FR; Nakkash T., 1999, P WORKSH LAND TRANSP; Numbeo Doo, 2013, COST LIV 2013; Oak Ridge National Laboratory, 2013, CAR REG SEL COUNTR 1; Rasouli S., 2013, 92 ANN M TRANSP RES; Sillaparcharn P, 2007, TRANSP RES RECORD, P98, DOI 10.3141/2038-13; Statistics Netherlands, 2013, MOT VEH GEN OV PER P; Steg L, 2005, TRANSPORT RES A-POL, V39, P147, DOI 10.1016/j.tra.2004.07.001; TANNER JC, 1978, J ROY STAT SOC A STA, V141, P14, DOI 10.2307/2344775; United Nations Department of Economic and Social Affairs Population Division, 2013, WORLD POP PROSP 2012; Urban Construction and Communications Commission, 2010, REP 4 COMPR TRANSP S; Van H. T., 2011, J E ASIA SOC TRANSP, V9, P411; van der Waard J, 2013, TRANSPORT REV, V33, P343, DOI 10.1080/01441647.2013.801046; MANNERING F, 1985, RAND J ECON, V16, P215, DOI 10.2307/2555411; World Bank, 2013, PASS CARS PER 1 000; Zhu C, 2012, J TRANSP GEOGR, V24, P315, DOI 10.1016/j.jtrangeo.2012.03.011	36	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0049-4488	1572-9435		TRANSPORTATION	Transportation	NOV	2014	41	6					1227	1244		10.1007/s11116-014-9548-z		18	Engineering, Civil; Transportation; Transportation Science & Technology	Engineering; Transportation	AS6UZ	WOS:000344398800006		
J	Kato, K				Kato, Kumiko			Comparison of two handheld applanation tonometers and the association of central corneal thickness, age, and intraocular pressure in normal and diseased canine eyes	VETERINARY OPHTHALMOLOGY			English	Article						applanation tonometer; central corneal thickness; diseased eyes; dog; intraocular pressure; normal eyes	SOFT CONTACT-LENSES; TONO-PEN XL(R); REBOUND TONOMETER; ULTRASONIC PACHYMETRY; DOGS; CATS; HORSES; TONOVET(R); ACCURACY	Objective To compare the intraocular pressure (IOP) measurements from two applanation tonometers (Tono-Pen XL (R) and AccuPen (R)) in normal and diseased canine eyes (including corneal disease, cataract, glaucoma, uveitis, and noninflammatory intraocular disease) and evaluate the associations among the central corneal thickness (CCT), IOP measurements, and age. Animals studied Sixty-eight normal and 191 diseased eyes. Procedure A topical anesthetic agent was applied to each eye. One minute later, IOP was measured with the Tono-Pen XL (R) and then the AccuPen (R), and then CCT was measured with an ultrasonic pachymeter. Measurements for the right eye were always taken first. Results The Tono-Pen XL (R) successfully measured IOP in all eyes, whereas the AccuPen (R) registered measurements in only 98.4% of diseased eyes. The AccuPen (R) measurements were significantly lower than the Tono-Pen XL (R) measurements in both normal and diseased eyes. The CCT did not affect the Tono-Pen XL (R) or AccuPen (R) measurements in normal or diseased eyes. Spearman's correlation coefficient by rank analysis of CCT and IOP yielded correlation coefficients (r) of 0.144 and 0.101 for the Tono-Pen XL (R), and 0.108 and 0.175 for the AccuPen (R) in normal and diseased eyes, respectively. In normal canine eyes, age correlated inversely with the CCT (r = -0.128) and IOP as measured using the Tono-Pen XL (R) (r = -0.446) and AccuPen (R) (r = -0.427). Conclusions The AccuPen (R) measurements were slightly but significantly lower than the Tono-Pen XL (R) measurements in both normal and diseased canine eyes. The CCT affected the results of neither tonometer regardless of disease, while both IOP and CCT tended to decrease with age in normal eyes.	Kumi Anim Hosp, Dept Ophthalmol, Saitama, Japan	Kato, K (reprint author), Kumi Anim Hosp, Dept Ophthalmol, Saitama, Japan.	55kumi.k@gmail.com					Airiani S, 2006, AM J OPHTHALMOL, V142, P164, DOI 10.1016/j.ajo.2006.01.043; Stodtmeister R, 1998, ACTA OPHTHALMOL SCAN, V76, P319, DOI 10.1034/j.1600-0420.1998.760313.x; Rusanen E, 2010, VET OPHTHALMOL, V13, P31, DOI 10.1111/j.1463-5224.2009.00752.x; Iester M, 2001, EYE, V15, P52; PRIEHS DR, 1990, AM J VET RES, V51, P1547; Brandt JD, 2001, OPHTHALMOLOGY, V108, P1779, DOI 10.1016/S0161-6420(01)00760-6; WHITACRE MM, 1993, AM J OPHTHALMOL, V115, P592; Shah S, 1999, OPHTHALMOLOGY, V106, P2154, DOI 10.1016/S0161-6420(99)90498-0; Andrade SF, 2012, VET OPHTHALMOL, V15, P14, DOI 10.1111/j.1463-5224.2011.00926.x; Kingman S, 2004, B WORLD HEALTH ORGAN, V82, P887; Passaglia CL, 2004, VET OPHTHALMOL, V7, P261, DOI 10.1111/j.1463-5224.2004.04038.x; Knollinger AM, 2005, JAVMA-J AM VET MED A, V227, P244, DOI 10.2460/javma.2005.227.244; FRENKEL REP, 1988, ARCH OPHTHALMOL-CHIC, V106, P750; MILLER PE, 1991, AM J VET RES, V52, P1917; Bhan A, 2002, INVEST OPHTH VIS SCI, V43, P1389; Kroll MM, 2001, J AM VET MED ASSOC, V219, P1406, DOI 10.2460/javma.2001.219.1406; Gunvant P, 2005, J GLAUCOMA, V14, P337, DOI 10.1097/01.ijg.0000176940.81799.33; Herndon LW, 2006, CURR OPIN OPHTHALMOL, V17, P115, DOI 10.1097/01.icu.0000193093.05927.a1; Park YW, 2011, VET OPHTHALMOL, V14, P169, DOI 10.1111/j.1463-5224.2010.00859.x; Broadwater JJ, 2007, VET OPHTHALMOL, V10, P269, DOI 10.1111/j.1463-5224.2007.00548.x; Leiva M, 2006, VET OPHTHALMOL, V9, P17, DOI 10.1111/j.1463-5224.2005.00429.x; WHITACRE MM, 1993, SURV OPHTHALMOL, V38, P1, DOI 10.1016/0039-6257(93)90053-A; Doughty MJ, 2000, SURV OPHTHALMOL, V44, P367, DOI 10.1016/S0039-6257(00)00110-7; DZIEZYC J, 1992, J AM VET MED ASSOC, V201, P430; Gorig C, 2006, AM J VET RES, V67, P134, DOI 10.2460/ajvr.67.1.134; Ahn JT, 2012, VET OPHTHALMOL, V15, P83, DOI 10.1111/j.1463-5224.2011.00979.x; Pereira FQ, 2011, VET OPHTHALMOL, V14, P321, DOI 10.1111/j.1463-5224.2011.00879.x; Boehm AG, 2005, INVESTIGATIVE OPHTHA, V46; BOOTHE WA, 1988, ARCH OPHTHALMOL-CHIC, V106, P1214; Bunce C, 2009, AM J OPHTHALMOL, V148, P1; Damji KF, 2000, J GLAUCOMA, V9, P205; Ekesten B., 1992, Progress in Veterinary & Comparative Ophthalmology, V2, P37; Gelatt KN, 2007, VET OPHTHALMOLOGY, P753; GILGER BC, 1991, AM J VET RES, V52, P1570; GOLDMANN H, 1957, Ophthalmologica, V134, P221; Guttman C, 2010, OPHTHALMOLOGY TIMES, V35, P14; Hikoya A, 2009, JPN J OPHTHALMOL, V53, P7, DOI 10.1007/s10384-008-0619-6; Jeong MB, 2007, VET OPHTHALMOL, V10, P376, DOI 10.1111/j.1463-5224.2007.00573.x; Kohlhaas M, 2006, J REFRACT SURG, V22, P263; KRAKAU CET, 1971, ACTA OPHTHALMOL, V49, P611; Labelle AL, 2012, VET OPHTHALMOL, V15, P5, DOI 10.1111/j.1463-5224.2011.00899.x; Lee GA, 2002, CLIN EXP OPHTHALMOL, V30, P334, DOI 10.1046/j.1442-9071.2002.00551.x; Gelatt K. N., 1998, Veterinary Ophthalmology, V1, P109, DOI 10.1046/j.1463-5224.1998.00024.x; Madjlessi F, 2000, OPHTHALMOLOGE, V97, P478, DOI 10.1007/s003470070078; MILLER PE, 1990, AM J VET RES, V51, P935; Miller P. E., 1991, Progress in Veterinary & Comparative Ophthalmology, V1, P171; MILLER PE, 1995, AM J VET RES, V56, P1418; MINCKLER DS, 1987, AM J OPHTHALMOL, V104, P168; Montiani-Ferreira F, 2003, VET OPHTHALMOL, V6, P19, DOI 10.1046/j.1463-5224.2003.00196.x; Ogbuehi KC, 2012, CONTACT LENS ANTERIO, V35, P199, DOI 10.1016/j.clae.2012.05.004; Rehany U, 2000, J CATARACT REFR SURG, V26, P1823, DOI 10.1016/S0886-3350(00)00763-X; ROOTMAN DS, 1988, ARCH OPHTHALMOL-CHIC, V106, P1697; Rosa N, 2011, OPTOMETRY VISION SCI, V88, P640, DOI 10.1097/OPX.0b013e3182114303; Slack JM, 2012, VET REC, V171, P15; Tang JH, 2011, INVEST OPHTH VIS SCI, V52, P7866, DOI 10.1167/iovs.11-7407; Thomas J, 2006, J REFRACT SURG, V22, P671; Tofflemire KL, 2011, VET OPHTHALMOLOGY, V14, P413; WHITACRE MM, 1991, AM J OPHTHALMOL, V111, P59; Yeung K K, 2000, Optometry, V71, P49	59	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1463-5216	1463-5224		VET OPHTHALMOL	Vet. Ophthalmol.	NOV	2014	17	6					417	425		10.1111/vop.12151		9	Veterinary Sciences	Veterinary Sciences	AS4KM	WOS:000344244500006		
J	Usui, M; Uchida, I; Tamura, Y				Usui, M.; Uchida, I.; Tamura, Y.			Selection of macrolide-resistant Campylobacter in pigs treated with macrolides	VETERINARY RECORD			English	Article							FOOD-PRODUCING ANIMALS; ANTIMICROBIAL RESISTANCE; COLI; INFECTIONS; PATTERN; JEJUNI; JAPAN; FARMS		[Usui, M.; Tamura, Y.] Rakuno Gakuen Univ, Sch Vet Med, Ebetsu, Hokkaido 069, Japan; [Uchida, I.] Natl Inst Anim Hlth, Hokkaido Res Stn, Dairy Hyg Res Div, Sapporo, Hokkaido, Japan	Tamura, Y (reprint author), Rakuno Gakuen Univ, Sch Vet Med, 582 Midorimachi, Ebetsu, Hokkaido 069, Japan.	tamuray@rakuno.ac.jp			Ministry of Agriculture, Forestry and Fisheries of Japan	We thank the staff of the Research Institute for Animal Science in Biochemistry and Toxicology for supporting the investigation. This study was supported by a grant from the Ministry of Agriculture, Forestry and Fisheries of Japan.	Mead PS, 1999, EMERG INFECT DIS, V5, P607; Allos BM, 2001, CLIN INFECT DIS, V32, P1201; Juntunen P, 2010, VET MICROBIOL, V146, P90, DOI 10.1016/j.vetmic.2010.04.027; Little CL, 2008, FOOD MICROBIOL, V25, P538, DOI 10.1016/j.fm.2008.01.001; Asai T, 2005, JPN J INFECT DIS, V58, P369; ALLOS BM, 1995, CLIN INFECT DIS, V20, P1092; EFSA, 2013, EFSA J, V11, P3129, DOI DOI 10.2903/J.EFSA.2013.3129; Harada K, 2006, J VET MED SCI, V68, P1109, DOI 10.1292/jvms.68.1109; Ishihara K, 2004, INT J ANTIMICROB AG, V24, P261, DOI 10.1016/j.ijantimicag.2004.03.017; Ministry of Agriculture Forestry and Fisheries [MAFF], 2012, SAL AM MED QUAS MED; NID National Institute of Infectious Disease and Tuberculosis and Infectious Diseases Control Division M.o.H. Labour and Welfare, 2010, INFECT AGENTS SURVEI, P1; NVAL National Veterinary Assay Laboratory M.o.A. Forestry and Fisheries, 2011, REP JAP VET ANT RES; Tam CC, 2003, J INFECTION, V47, P28, DOI 10.1016/S0163-4453(03)00042-2; TAMURA Y., 2003, OIE INT STANDARDS AN, P206; Weijtens MJBM, 1999, J APPL MICROBIOL, V86, P63, DOI 10.1046/j.1365-2672.1999.00636.x	15	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0042-4900	2042-7670		VET REC	Vet. Rec.	NOV 1	2014	175	17								10.1136/vr.102681		2	Veterinary Sciences	Veterinary Sciences	AS2DH	WOS:000344089100018		
J	Sano, M; Homma, T; Hayashi, E; Noda, H; Amano, Y; Tsujimura, R; Yamada, T; Quattrochi, B; Nemoto, N				Sano, Makoto; Homma, Taku; Hayashi, Emiko; Noda, Hiroko; Amano, Yusuke; Tsujimura, Ryusuke; Yamada, Tsutomu; Quattrochi, Brian; Nemoto, Norimichi			Clinicopathological characteristics of anaplastic carcinoma of the pancreas with rhabdoid features	VIRCHOWS ARCHIV			English	Article						Undifferentiated carcinoma; Pleomorphic carcinoma; Rhabdoid feature; Autophagy; Chemoresistance	SOFT-TISSUE SARCOMAS; EPITHELIOID SARCOMA; INI1 EXPRESSION; TUMORS; INCLUSIONS; P62; ADENOCARCINOMA; PHENOTYPE; CELLS	Undifferentiated (anaplastic) carcinoma with rhabdoid features is a rare and aggressive subtype of pancreatic carcinoma. Here, we report the clinical, histological, and immunohistochemical phenotypes in six autopsy cases of anaplastic carcinoma with rhabdoid features. The patients ranged between 44 and 76 years of age (median, 61 years) and consisted of four males and two females. All patients except one case died within 3 months of diagnosis, as these tumors were found at an advanced stage and were chemoresistant. At autopsy, tumor masses measuring 4-22 cm in maximum diameter were mainly located in the pancreatic body and tail. Microscopically, all cases showed anaplastic carcinoma with rhabdoid features that were discohesive with round to polygonal eosinophilic cytoplasm with occasional inclusions, and that had vesicular nuclei, and prominent nucleoli. Immunohistochemistry showed that the rhabdoid cells, particularly the inclusions, were strongly positive for pan-cytokeratin (AE1/AE3) and vimentin. Meanwhile, downregulation or aberrant cytoplasmic localization with focal aggregation of E-cadherin, beta-catenin, and EMA were frequently observed in the rhabdoid cells. Moreover, the intracytoplasmic inclusions were labeled with selective autophagy-related molecules including p62/SQSTM1, ubiquitin, and kelch-like ECH-associated protein 1 (KEAP1). In addition, nuclear factor erythroid 2-related factor 2 (NRF2) and overexpression of its target molecule multidrug resistance-associated protein 1 (MRP1) were commonly observed in the rhabdoid cells. Therefore, these results suggest that p62-mediated aggregation of ubiquitinated intermediate filaments and membranous proteins is an important phenomenon in the rhabdoid phenotype. Indeed, the ubiquitinated aggregates of p62 and KEAP1 would induce activation of NRF2 and upregulation of MRP1, leading to potential chemoresistance of anaplastic carcinoma with rhabdoid features.	[Sano, Makoto; Homma, Taku; Noda, Hiroko; Amano, Yusuke; Tsujimura, Ryusuke; Yamada, Tsutomu; Nemoto, Norimichi] Nihon Univ, Sch Med, Div Pathol, Dept Pathol & Microbiol,Itabashi Ku, Tokyo 1738610, Japan; [Hayashi, Emiko] Tokai Univ, Inst Innovat Sci & Technol, Isehara, Kanagawa 2591193, Japan; [Quattrochi, Brian] Univ Massachusetts, Sch Med, Program Gene Funct & Express, Worcester, MA 01605 USA	Sano, M (reprint author), Nihon Univ, Sch Med, Div Pathol, Dept Pathol & Microbiol,Itabashi Ku, 30-1 Oyaguchi Kamimachi, Tokyo 1738610, Japan.	sano.makoto@nihon-u.ac.jp					Al-Nafussi A, 1999, PATHOL INT, V49, P160, DOI 10.1046/j.1440-1827.1999.00839.x; Perez-Montiel MD, 2003, AM J SURG PATHOL, V27, P642, DOI 10.1097/00000478-200305000-00007; Hornick JL, 2009, AM J SURG PATHOL, V33, P542, DOI 10.1097/PAS.0b013e3181882c54; Matsumoto G, 2011, MOL CELL, V44, P279, DOI 10.1016/j.molcel.2011.07.039; Kuusisto E, 2001, NEUROREPORT, V12, P2085, DOI 10.1097/00001756-200107200-00009; Bourdeaut F, 2007, J PATHOL, V211, P323, DOI 10.1002/path.2103; Hollmann TJ, 2011, AM J SURG PATHOL, V35, pE47, DOI 10.1097/PAS.0b013e31822b325b; CHETTY R, 1993, VIRCHOWS ARCH A, V422, P179, DOI 10.1007/BF01607171; Cheng JX, 2008, MODERN PATHOL, V21, P647, DOI 10.1038/modpathol.2008.44; TSUNEYOSHI M, 1987, VIRCHOWS ARCH A, V411, P509, DOI 10.1007/BF00713281; HAAS JE, 1981, HUM PATHOL, V12, P646, DOI 10.1016/S0046-8177(81)80050-0; Oda Y, 2006, PATHOL INT, V56, P287, DOI 10.1111/j.1440-1827.2006.01962.x; Zatloukal K, 2002, AM J PATHOL, V160, P255, DOI 10.1016/S0002-9440(10)64369-6; Tafe LJ, 2010, MODERN PATHOL, V23, P781, DOI 10.1038/modpathol.2010.41; Arlt A, 2013, ONCOGENE, V32, P4825, DOI 10.1038/onc.2012.493; Roberts CWM, 2000, P NATL ACAD SCI USA, V97, P13796, DOI 10.1073/pnas.250492697; Tamboli P, 2004, HUM PATHOL, V35, P8, DOI 10.1016/j.humpath.2003.07.019; Hong YB, 2010, PANCREAS, V39, P463, DOI 10.1097/MPA.0b013e3181c31314; Denk H, 2006, J PATHOL, V208, P653, DOI 10.1002/path.1946; Izumi T, 2006, MODERN PATHOL, V19, P820, DOI 10.1038/modpathol.3800599; Jamali Mina, 2007, JOP, V8, P330; Kloppel G, 2000, WHO CLASSIFICATION T; Komatsu M, 2011, AUTOPHAGY, V7, P1088, DOI 10.4161/auto.7.9.16474; Kuroda N, 2000, PATHOL INT, V50, P57, DOI 10.1046/j.1440-1827.2000.00996.x; Kuroda N, 2007, MED MOL MORPHOL, V40, P168, DOI 10.1007/s00795-006-0349-0; Lister A, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-37; Nishihara K, 1997, ARCH PATHOL LAB MED, V121, P1104; Saito T, 2001, PATHOL INT, V51, P532, DOI 10.1046/j.1440-1827.2001.01232.x; Serra S, 2006, ENDOCR PATHOL, V17, P75, DOI 10.1385/EP:17:1:75	29	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0945-6317	1432-2307		VIRCHOWS ARCH	Virchows Arch.	NOV	2014	465	5					531	538		10.1007/s00428-014-1631-5		8	Pathology	Pathology	AS6WD	WOS:000344399200005		
J	Shibuya, R; Matsuyama, A; Nakamoto, M; Shiba, E; Kasai, T; Hisaoka, M				Shibuya, Ryo; Matsuyama, Atsuji; Nakamoto, Mitsuhiro; Shiba, Eisuke; Kasai, Takahiko; Hisaoka, Masanori			The combination of CD99 and NKX2.2, a transcriptional target of EWSR1-FLI1, is highly specific for the diagnosis of Ewing sarcoma	VIRCHOWS ARCHIV			English	Article						Ewing sarcoma; Immunohistochemistry; NKX2.2; NR0B1; E2F3; EZH2	SARCOMA/PRIMITIVE NEUROECTODERMAL TUMOR; MESENCHYMAL PROGENITOR CELLS; NUCLEAR RECEPTOR DAX-1; ROUND-CELL; PROSTATE-CANCER; IMMUNOHISTOCHEMICAL DETECTION; MONOCLONAL-ANTIBODY; FAMILY TUMORS; EXPRESSION; E2F3	Ewing sarcoma (ES) is a high-grade malignant neoplasm primarily affecting children and young adults. The diagnosis of ES is often difficult because of its broad differential diagnosis comprising a diverse group of small round cell tumors (SRCTs). Although the identification of tumor type-specific fusion genes by molecular testing is the gold standard for the diagnosis of ES, such approaches are not always available in a routine pathology practice. Thus, a reliable immunohistochemical marker is required. A recent study using a limited number of tumor samples has shown that NKX2.2, a putative transcriptional target of EWSR1-FLI1, is a useful marker for the diagnosis of ES. In the present study, the immunohistochemical expression of NKX2.2 was evaluated on 46 genetically confirmed ES and 85 non-ES SRCTs, together with comparative assessment of CD99 and other molecular targets of EWSR1-FLI1, including NR0B1, E2F3, and EZH2. NKX2.2 was expressed in 37 (80 %) of the ES samples with a mostly diffuse and strong staining pattern, and 14 (16 %) of the non-ES SRCTs, including olfactory neuroblastomas, extraskeletal myxoid chondrosarcoma, mesenchymal chondrosarcoma, small cell carcinomas, and Merkel cell carcinoma, also expressed this marker. The sensitivity and specificity of the NKX2.2 expression in this cohort were 80 and 84 %, respectively. The specificity when combined with CD99 was 98 %, with exceptional expression of both markers in only two non-ES SRCTs, including one case each of mesenchymal chondrosarcoma and small cell carcinoma. NR0B1, E2F3, and EZH2 were less sensitive for specific markers for ES when applied singly or in any combination. In conclusion, the study reinforces that NKX2.2 is a useful immunohistochemical marker for ES, and that the combination of CD99 and NKX2.2 is a powerful diagnostic tool that can differentiate ES from other SRCTs.	[Shibuya, Ryo; Matsuyama, Atsuji; Nakamoto, Mitsuhiro; Shiba, Eisuke; Kasai, Takahiko; Hisaoka, Masanori] Univ Occupat & Environm Hlth, Sch Med, Dept Pathol & Oncol, Yahatanishi Ku, Kitakyushu, Fukuoka 8078555, Japan	Matsuyama, A (reprint author), Univ Occupat & Environm Hlth, Sch Med, Dept Pathol & Oncol, Yahatanishi Ku, 1-1 Iseigaoka, Kitakyushu, Fukuoka 8078555, Japan.	amatsu@med.uoeh-u.ac.jp					Abd-Elaziz M, 2003, CANCER SCI, V94, P980, DOI 10.1111/j.1349-7006.2003.tb01388.x; Wang L, 2012, GENE CHROMOSOME CANC, V51, P127, DOI 10.1002/gcc.20937; Riggi N, 2008, CANCER RES, V68, P2176, DOI 10.1158/0008-5472.CAN-07-1761; Briscoe J, 1999, NATURE, V398, P622; Sparmann A, 2006, NAT REV CANCER, V6, P846, DOI 10.1038/nrcd1991; Riggi N, 2005, CANCER RES, V65, P11459, DOI 10.1158/0008-5472.CAN-05-1696; Kinsey M, 2006, MOL CANCER RES, V4, P851, DOI 10.1158/1541-7786.MCR-06-0090; Foster CS, 2004, ONCOGENE, V23, P5871, DOI 10.1038/sj.onc.1207800; Kort EJ, 2008, CANCER RES, V68, P4034, DOI 10.1158/0008-5472.CAN-08-0592; Wang WL, 2012, MODERN PATHOL, V25, P1378, DOI 10.1038/modpathol.2012.97; Feber A, 2004, ONCOGENE, V23, P1627, DOI 10.1038/sj.onc.1207274; Yoshida A, 2012, AM J SURG PATHOL, V36, P993, DOI 10.1097/PAS.0b013e31824ee43c; Folpe AL, 2000, AM J SURG PATHOL, V24, P1657, DOI 10.1097/00000478-200012000-00010; Richter GHS, 2009, P NATL ACAD SCI USA, V106, P5324, DOI 10.1073/pnas.0810759106; Sainz-Jaspeado M, 2011, ONCOTARGET, V2, P305; Bilke S, 2013, GENOME RES, V23, P1797, DOI 10.1101/gr.151340.112; Smith R, 2006, CANCER CELL, V9, P405, DOI 10.1016/j.ccr.2006.04.004; Llombart-Bosch A, 2009, VIRCHOWS ARCH, V455, P397, DOI 10.1007/s00428-009-0842-7; Antonescu C, 2014, HISTOPATHOLOGY, V64, P26, DOI 10.1111/his.12281; Humbert PO, 2000, GENE DEV, V14, P690; Pierron G, 2012, NAT GENET, V44, P461, DOI 10.1038/ng.1107; Changchien YC, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-216; Cheung IY, 2007, CLIN CANCER RES, V13, P6978, DOI 10.1158/1078-0432.CCR-07-1417; Ciarapica R, 2009, CELL CYCLE, V8, P172, DOI 10.4161/cc.8.1.7292; Fletcher Ch, 2013, WHO CLASSIFICATION T; Goldblum JR, 2014, ENZINGER WEISSS SOFT; Kauer M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005415; Kinsey M, 2009, CANCER RES, V69, P9047, DOI 10.1158/0008-5472.CAN-09-1540; Kovar H, 2010, GENOME MED, V2, DOI 10.1186/gm129; Kovar Heinrich, 2012, Front Oncol, V2, P54, DOI 10.3389/fonc.2012.00054; Lee AF, 2011, APPL IMMUNOHISTO M M, V19, P233, DOI 10.1097/PAI.0b013e3181fd6697; Madhavan J, 2009, MOL VIS, V15, P235; Mhawech-Fauceglia P, 2006, HISTOPATHOLOGY, V49, P569, DOI 10.1111/j.1365-2559.2006.02535.x; Miyagawa Y, 2008, MOL CELL BIOL, V28, P2125, DOI 10.1128/MCB.00740-07; Muller S, 2005, MODERN PATHOL, V18, P1088, DOI 10.1038/modpathol.3800391; Nakamura Y, 2009, ENDOCR J, V56, P39; Niakan KK, 2005, MOL GENET METAB, V86, P70, DOI 10.1016/j.ymgme.2005.07.019; Oda T, 2009, AM J PATHOL, V175, P1235, DOI 10.2353/ajpath.2009.090010; Owen LA, 2008, PLOS ONE, V3, pe1965; Rossi S, 2004, MODERN PATHOL, V17, P547, DOI 10.1038/modpathol.3800065; Saito S, 2005, CANCER SCI, V96, P645, DOI 10.1111/j.1349-7006.2005.00101.x; Sasaki H, 2010, ONCOL REP, V23, P677, DOI 10.3892/or_00000684; Tomlins SA, 2013, AM J CLIN PATHOL, V139, P771, DOI 10.1309/AJCPN4L1BMRQPEIT; Wehrli BM, 2003, HUM PATHOL, V34, P263, DOI 10.1053/hupa.2003.41	44	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0945-6317	1432-2307		VIRCHOWS ARCH	Virchows Arch.	NOV	2014	465	5					599	605		10.1007/s00428-014-1627-1		7	Pathology	Pathology	AS6WD	WOS:000344399200012		
J	Kurisaki-Arakawa, A; Akaike, K; Hara, K; Arakawa, A; Takahashi, M; Mitani, K; Yao, T; Saito, T				Kurisaki-Arakawa, Aiko; Akaike, Keisuke; Hara, Kieko; Arakawa, Atsushi; Takahashi, Michiko; Mitani, Keiko; Yao, Takashi; Saito, Tsuyoshi			A case of dedifferentiated solitary fibrous tumor in the pelvis with TP53 mutation	VIRCHOWS ARCHIV			English	Article						Solitary fibrous tumor; STAT6; NAB2-STAT6; Dedifferentiation	ADENOID CYSTIC CARCINOMA; OF-THE-LITERATURE; GIANT-CELL TUMOR; TERM-FOLLOW-UP; CLINICOPATHOLOGICAL FEATURES; P53 EXPRESSION; FUSION; GENE; LIPOSARCOMA; CHONDROSARCOMA	Solitary fibrous tumors (SFTs), initially observed in the pleura, were later found to develop in almost any extrapleural site. Dedifferentiation within SFTs was characterized only recently. We report a case of dedifferentiated SFT arising within the pelvis of a 70-year-old Japanese woman. Macroscopically, the resected tumor measured 17 x 17 x 13 cm. Histologically, the tumor displayed distinct heterologous osteosarcomatous and chondrosarcomatous components on a background of conventional SFT. Immunohistochemistry uncovered a loss of CD34 expression in the dedifferentiated area, whereas the nuclear expression of signal transducer and activator of transcription-6 (STAT6) and NGFI-A-binding protein 2 (NAB2) was maintained in both components. The p53 mutation 158 CGC > CAC (A158H) was found only in the dedifferentiated component. Furthermore, a fusion gene of NAB2(exon6)-STAT6(exon18) was detected in both the conventional and dedifferentiated components. The patient died of the disease 4 months after surgery. This case identifies a possible role of p53 dysfunction in the dedifferentiation process of SFT as reported in other sarcomas.	[Kurisaki-Arakawa, Aiko; Akaike, Keisuke; Hara, Kieko; Arakawa, Atsushi; Takahashi, Michiko; Mitani, Keiko; Yao, Takashi; Saito, Tsuyoshi] Juntendo Univ, Sch Med, Dept Human Pathol, Bunkyo Ku, Tokyo 113, Japan	Saito, T (reprint author), Juntendo Univ, Sch Med, Dept Human Pathol, Bunkyo Ku, 2-1-1 Hongo, Tokyo 113, Japan.	tysaitou@juntendo.ac.jp			Ministry of Education, Science, Sports and Culture, Tokyo, Japan [26670286]	This work was supported in part by a Grant-in-Aid for General Scientific Research from the Ministry of Education, Science, Sports and Culture (#26670286 to Tsuyoshi Saito), Tokyo, Japan.	Mosquera JM, 2009, AM J SURG PATHOL, V33, P1314; Robinson DR, 2013, NAT GENET, V45, P180, DOI 10.1038/ng.2509; Romero-Perez L, 2013, MODERN PATHOL, V26, P1514, DOI 10.1038/modpathol.2013.93; Chmielecki J, 2013, NAT GENET, V45, P131, DOI 10.1038/ng.2522; Mohajeri A, 2013, GENE CHROMOSOME CANC, V52, P873, DOI 10.1002/gcc.22083; Hasegawa T, 1999, HUM PATHOL, V30, P1464, DOI 10.1016/S0046-8177(99)90169-7; Seethala RR, 2007, AM J SURG PATHOL, V31, P1683; Soares P, 2011, CURR GENOMICS, V12, P609, DOI 10.2174/138920211798120853; Schirosi L, 2008, AM J SURG PATHOL, V32, P1627, DOI 10.1097/PAS.0b013e31817a8a89; Are C, 2006, ANN SURG ONCOL, V13, P453, DOI 10.1245/ASO.2006.05.042; Barthelmess S, 2014, AM J PATHOL, V184, P1209, DOI 10.1016/j.ajpath.2013.12.016; EVANS HL, 1979, AM J SURG PATHOL, V3, P507, DOI 10.1097/00000478-197912000-00004; Oda K, 2000, CELL, V102, P849, DOI 10.1016/S0092-8674(00)00073-8; Yokoi T, 1998, HISTOPATHOLOGY, V32, P423; Doyle LA, 2014, MODERN PATHOL, V27, P390, DOI 10.1038/modpathol.2013.164; GOODLAD JR, 1991, HISTOPATHOLOGY, V19, P515, DOI 10.1111/j.1365-2559.1991.tb01499.x; Schweizer L, 2013, ACTA NEUROPATHOL, V125, P651, DOI 10.1007/s00401-013-1117-6; Boyd C, 2012, AM J SURG PATHOL, V36, P368, DOI 10.1097/PAS.0b013e31823732a9; Gold JS, 2002, CANCER, V94, P1057, DOI 10.1002/cncr.10328; Muller PAJ, 2013, NAT CELL BIOL, V15, P2, DOI 10.1038/ncb2641; Pilotti S, 1997, J PATHOL, V181, P14; Evans HL, 2007, AM J SURG PATHOL, V31, P1, DOI 10.1097/01.pas.0000213406.95440.7a; Morimitsu Y, 2000, APMIS, V108, P617, DOI 10.1034/j.1600-0463.2000.d01-105.x; Cheuk W, 1999, AM J SURG PATHOL, V23, P465, DOI 10.1097/00000478-199904000-00012; Collini P, 2012, AM J SURG PATHOL, V36, P1202, DOI 10.1097/PAS.0b013e31825748f0; DAHLIN DC, 1971, CANCER, V28, P461, DOI 10.1002/1097-0142(197108)28:2<461::AID-CNCR2820280227>3.0.CO;2-U; Dei Tos Angelo P., 1997, Journal of Pathology, V181, P8, DOI 10.1002/(SICI)1096-9896(199701)181:1<8::AID-PATH700>3.0.CO;2-#; Fletcher CDM, 2013, WHO CLASSIFICATION T, P10; FRASSICA FJ, 1986, J BONE JOINT SURG AM, V68A, P1197; Kusafuka K, 2008, ORAL SURG ORAL MED O, V106, P85, DOI 10.1016/j.tripleo.2008.01.013; Masuda Y, 2014, INT J CLIN EXP PATHO, V7, P386; Saito T, 2011, PATHOL RES PRACT, V207, P664, DOI 10.1016/j.prp.2011.07.009; Saito T, 2011, HUM PATHOL, V42, P727, DOI 10.1016/j.humpath.2010.08.008; Segura-Sanchez J, 2006, ANTICANCER RES, V26, P4937; SIMMS WW, 1995, CANCER, V76, P223, DOI 10.1002/1097-0142(19950715)76:2<223::AID-CNCR2820760210>3.0.CO;2-4; Subramaniam MM, 2011, HISTOPATHOLOGY, V59, P1269, DOI 10.1111/j.1365-2559.2011.03997.x; Tsuji S, 1998, AM J PATHOL, V153, P1807, DOI 10.1016/S0002-9440(10)65695-7; Yoshida A, 2014, AM J SURG PATHOL, V38, P552, DOI 10.1097/PAS.0000000000000137	38	3	3	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0945-6317	1432-2307		VIRCHOWS ARCH	Virchows Arch.	NOV	2014	465	5					615	621		10.1007/s00428-014-1625-3		7	Pathology	Pathology	AS6WD	WOS:000344399200014		
J	Komoda, K; Ishibashi, K; Kawamura-Nagaya, K; Ishikawa, M				Komoda, Keisuke; Ishibashi, Kazuhiro; Kawamura-Nagaya, Kazue; Ishikawa, Masayuki			Possible involvement of eEF1A in Tomato spotted wilt virus RNA synthesis	VIROLOGY			English	Article						Tomato spotted wilt virus; Bunyavirus; Transcription; Replication; Host factor; Cell-free system; eEF1A	VESICULAR STOMATITIS-VIRUS; MESSENGER-RNA; IN-VITRO; TRANSLATIONAL REQUIREMENT; INFECTED CELLS; 5 ENDS; FRANKLINIELLA-OCCIDENTALIS; BASE COMPLEMENTARITY; ELONGATION-FACTORS; CAP DONORS	Tomato spotted wilt virus (TSWV) is a negative-strand RNA virus in the family Bunyaviridae and propagates in both insects and plants. Although TSWV can infect a wide range of plant species, host factors involved in viral RNA synthesis of TSWV in plants have not been characterized. In this report, we demonstrate that the cell-free extract derived from one of the host plants can activate mRNA transcriptional activity of TSWV. Based on activity-guided fractionation of the cell-free extract, we identified eukaryotic elongation factor (eEF) 1A as a possible host factor facilitating TSWV transcription and replication. The RNA synthesis-supporting activity decreased in the presence of an eEF1A inhibitor, suggesting that eEF1A plays an important role in RNA synthesis of TSWV. (C) 2014 Elsevier Inc. All rights reserved.	[Komoda, Keisuke; Ishibashi, Kazuhiro; Kawamura-Nagaya, Kazue; Ishikawa, Masayuki] Natl Inst Agrobiol Sci, Div Plant Sci, Tsukuba, Ibaraki, Japan	Komoda, K (reprint author), Univ Tokyo, Grad Sch Agr & Life Sci, Dept Appl Biol Chem, Lab Struct Biol & Food Biotechnol,Bunkyo Ku, 1-1-1 Yayoi, Tokyo 1138657, Japan.	a-komoda@mail.ecc.u-tokyo.ac.jp	Komoda, Keisuke/O-9651-2015	Komoda, Keisuke/0000-0002-9563-1061	JSPS KAKENHI [07J03587, 23658043]	We thank Genebank of the National Institute of Agrobiological Sciences for providing TSWV-infected Pericallis x hybrida leaves (MAFF number: 260050) and the Drug Synthesis and Chemistry Branch, Developmental Therapeutics Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute for providing DB. We also thank Dr. Shinya Tsuda (National Agricultural Research Center, Tsukuba, Ibaraki, Japan) for supplying us with Nicotiana rustica seeds, and Dr. Karen S. Browning (The University of Texas at Austin) for the kind gift of antibodies against eEF1A. We would like to express our appreciation to Dr. Tetsuo Meshi and Dr. Yuka Hagiwara-Komoda for their careful reading, insightful comments, and editing some parts of this manuscript. We would particularly like to thank Eiko Matsumoto-Yokoyama for the preparation of TSWV virions. We also thank members of our laboratory for productive discussions. This work was supported by JSPS KAKENHI Grant numbers 07J03587 (Grant-in-Aid for JSPS Fellows to K. Komoda) and 23658043 (Grant-in-Aid for Challenging Exploratory Research to M.I.).	ADKINS S, 1995, VIROLOGY, V207, P308, DOI 10.1006/viro.1995.1083; WIJKAMP I, 1993, J GEN VIROL, V74, P341, DOI 10.1099/0022-1317-74-3-341; van Knippenberg I, 2005, VIROLOGY, V335, P122, DOI 10.1016/j.virol.2005.01.041; Barr JN, 2007, RNA, V13, P731, DOI 10.1261/rna.436607; Mateyak MK, 2010, J BIOL CHEM, V285, P21209, DOI 10.1074/jbc.R110.113795; BOULOY M, 1978, P NATL ACAD SCI USA, V75, P4886, DOI 10.1073/pnas.75.10.4886; BELLOCQ C, 1987, J VIROL, V61, P3960; Li ZH, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001175; Matsuda D, 2004, VIROLOGY, V321, P47, DOI 10.1016/j.virol.2003.10.028; PLOTCH SJ, 1981, CELL, V23, P847, DOI 10.1016/0092-8674(81)90449-9; Li DS, 2013, MICROBIOL MOL BIOL R, V77, P253, DOI 10.1128/MMBR.00059-12; Marklewitz M, 2013, J VIROL, V87, P12850, DOI 10.1128/JVI.01862-13; Barr JN, 2002, BBA-GENE STRUCT EXPR, V1577, P337, DOI 10.1016/S0167-4781(02)00462-1; Davis WG, 2007, J VIROL, V81, P10172, DOI 10.1128/JVI.00531-07; Mir MA, 2008, P NATL ACAD SCI USA, V105, P19294, DOI 10.1073/pnas.0807211105; ABRAHAM G, 1983, J GEN VIROL, V64, P1277, DOI 10.1099/0022-1317-64-6-1277; Warren K, 2012, P NATL ACAD SCI USA, V109, P9587, DOI 10.1073/pnas.1204673109; GERMAN TL, 1992, ANNU REV PHYTOPATHOL, V30, P315, DOI 10.1146/annurev.py.30.090192.001531; Kikkert M, 1998, PHYTOPATHOLOGY, V88, P63, DOI 10.1094/PHYTO.1998.88.1.63; DEHAAN P, 1990, J GEN VIROL, V71, P1001, DOI 10.1099/0022-1317-71-5-1001; GONSALVES D, 1986, PLANT DIS, V70, P501, DOI 10.1094/PD-70-501; Scholthof KBG, 2011, MOL PLANT PATHOL, V12, P938, DOI [10.1111/j.1364-3703.2011.00752.x, 10.1111/J.1364-3703.2011.00752.X]; Parrella G, 2003, J PLANT PATHOL, V85, P227; de Medeiros RB, 2005, P NATL ACAD SCI USA, V102, P1175, DOI 10.1073/pnas.0406668102; Vera MD, 2002, MED RES REV, V22, P102, DOI 10.1002/med.10003; Bandla MD, 1998, PHYTOPATHOLOGY, V88, P98, DOI 10.1094/PHYTO.1998.88.2.98; Bellocq C, 1987, J Virol, V61, P87; BLUMENTH.T, 1972, P NATL ACAD SCI USA, V69, P1313, DOI 10.1073/pnas.69.5.1313; Clabbers MTB, 2014, BIOINFORMATICS, V30, P1800, DOI 10.1093/bioinformatics/btu122; DEHAAN P, 1991, J GEN VIROL, V72, P2207, DOI 10.1099/0022-1317-72-9-2207; Duijsings D, 1999, J VIROL, V73, P5172; Duijsings D, 2001, EMBO J, V20, P2545, DOI 10.1093/emboj/20.10.2545; Geerts-Dimitriadou C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031013; Geerts-Dimitriadou C, 2011, VIROLOGY, V409, P17, DOI 10.1016/j.virol.2010.09.003; Gursinsky T, 2009, VIROLOGY, V390, P250, DOI 10.1016/j.virol.2009.05.009; Ikegami T, 2005, J VIROL, V79, P12106, DOI 10.1128/JVI.79.18.12106-12111.2005; Iwakawa HO, 2007, VIROLOGY, V369, P168, DOI 10.1016/j.virol.2007.07.016; JIN H, 1993, J GEN VIROL, V74, P2293, DOI 10.1099/0022-1317-74-10-2293; King AM, 2012, VIRUS TAXONOMY; Komoda K, 2007, J VIROL, V81, P2584, DOI 10.1128/JVI.01921-06; Komoda K, 2004, P NATL ACAD SCI USA, V101, P1863, DOI 10.1073/pnas.0307131101; KORMELINK R, 1992, J GEN VIROL, V73, P2125, DOI 10.1099/0022-1317-73-8-2125; Kormelink R., 1992, J GEN VIROL, V73, P687; Medeiros RB, 2000, VIRUS RES, V67, P109, DOI 10.1016/S0168-1702(00)00123-4; PATTERSON JL, 1984, J VIROL, V49, P680; PATTNAIK AK, 1983, J VIROL, V47, P452; PLOTCH SJ, 1979, P NATL ACAD SCI USA, V76, P1618, DOI 10.1073/pnas.76.4.1618; Qanungo KR, 2004, P NATL ACAD SCI USA, V101, P5952, DOI 10.1073/pnas.0401449101; Raju R, 1987, J Virol, V61, P96; SIMONS JF, 1991, J VIROL, V65, P4741; Sun YJ, 1997, PLANT PHYSIOL, V115, P1101, DOI 10.1104/pp.115.3.1101; Takeshita K., 2010, P NATL ACAD SCI USA, V107, P15733; Tsuda Shinya, 1992, Annals of the Phytopathological Society of Japan, V58, P393; van Knippenberg I, 2005, VIRUS RES, V110, P125, DOI 10.1016/j.virusres.2005.01.012; van Knippenberg I, 2004, J GEN VIROL, V85, P1335, DOI 10.1099/vir.0.19767-0; van Knippenberg I, 2002, VIROLOGY, V303, P278, DOI 10.1006/viro.2002.1632; vanPoelwijk F, 1996, ARCH VIROL, V141, P177; VIALAT P, 1992, J VIROL, V66, P685; Yamaji Y, 2010, ARCH VIROL, V155, P263, DOI 10.1007/s00705-009-0571-x	59	0	0	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0042-6822			VIROLOGY	Virology	NOV	2014	468						81	87		10.1016/j.virol.2014.07.053		7	Virology	Virology	AS7KF	WOS:000344434400010		
J	Li, CH; Pham, VH; Abe, K; Lu, L				Li, Chunhua; Pham, Van H.; Abe, Kenji; Lu, Ling			Nine additional complete genome sequences of HCV genotype 6 from Vietnam including new subtypes 6xb and 6xc	VIROLOGY			English	Article						HCV; Full-length genome; Genotype 6; Sequence	HEPATITIS-C VIRUS; THAI BLOOD-DONORS; GENETIC DIVERSITY; SOUTHEAST-ASIA; RISK-FACTORS; VARIANTS; CORE; ASSAY; PREVALENCE; SYSTEM	We completely sequenced nine HCV-6 variants from Vietnam. They are grouped into six lineages beyond the 24 assigned subtypes, 6a-6xa, and 14 unclassified lineages that have been recently described with full-length genomes. Co-analysis with reference sequences in the NS5B region identified additional 22 such lineages, which made the total taxonomic number of HCV-6 increased to 66 that might be recognized at the subtype level. Because two of these six lineages revealed in this study each had > 3 epidemiologically unlinked isolates identified, we proposed to assign them new subtypes 6xb and 6xc in following the eXtended format recently recommended in the expanded HCV nomenclature. (C) 2014 Elsevier Inc. All rights reserved.	[Li, Chunhua; Lu, Ling] Univ Kansas, Med Ctr, Ctr Viral Oncol, Dept Pathol & Lab Med, Kansas City, KS 66160 USA; [Pham, Van H.; Abe, Kenji] Univ Med & Pharm Ho Chi Minh City, Sch Med, Ctr Mol Biomed, Ho Chi Minh City, Vietnam; [Pham, Van H.; Abe, Kenji] NK BIOTEK Lab, Mol Diagnost Sect, Ho Chi Minh City, Vietnam; [Abe, Kenji] Natl Inst Infect Dis, Dept Pathol, Tokyo 1628640, Japan	Lu, L (reprint author), Univ Kansas, Med Ctr, Ctr Viral Oncol, Dept Pathol & Lab Med, MS 3046,3901 Rainbow Blvd, Kansas City, KS 66160 USA.	llu@kumc.edu			National Institute of Allergy and Infectious Diseases [5 R01 AI080734-03A]	The study described was supported by a grant from the National Institute of Allergy and Infectious Diseases (5 R01 AI080734-03A). The funding agencies had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Simmonds P, 2004, J GEN VIROL, V85, P3173, DOI 10.1099/vir.0.80401-0; Simmonds P, 2005, HEPATOLOGY, V42, P962, DOI 10.1002/hep.20819; Kuiken C, 2005, BIOINFORMATICS, V21, P379, DOI 10.1093/bioinformatics/bth485; Salemi M, 2002, J MOL EVOL, V54, P62, DOI 10.1007/s00239-001-0018-9; Pham VH, 2011, JPN J INFECT DIS, V64, P537; Martin DP, 2010, BIOINFORMATICS, V26, P2462, DOI 10.1093/bioinformatics/btq467; Shinji T, 2004, ACTA MED OKAYAMA, V58, P135; Murphy DG, 2007, J CLIN MICROBIOL, V45, P1102, DOI 10.1128/JCM.02366-06; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI 10.1093/molbev/mst197; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; An YL, 2014, VIROLOGY, V464, P21, DOI 10.1016/j.virol.2014.06.011; Koletzki D, 2010, CLIN CHEM LAB MED, V48, P1095, DOI 10.1515/CCLM.2010.236; Wang HR, 2013, J GEN VIROL, V94, P76, DOI 10.1099/vir.0.047506-0; Bernier L, 1996, J CLIN MICROBIOL, V34, P2815; Kuiken C, 2006, HEPATOLOGY, V44, P1355, DOI 10.1002/hep.21377; Li C., 2014, VIROLOGY IN PRESS; Lu L, 2007, J GEN VIROL, V88, P1505, DOI 10.1099/vir.0.82604-0; Mellor J, 1996, J CLIN MICROBIOL, V34, P417; Nguyen NH, 2010, HEPATOL INT, V4, P523, DOI 10.1007/s12072-010-9181-7; Noppornpath S, 2008, J GEN VIROL, V89, P1276, DOI 10.1099/vir.0.83593-0; Noppornpanth S, 2006, J CLIN MICROBIOL, V44, P3969, DOI 10.1128/JCM.01122-06; Pybus OG, 2009, J VIROL, V83, P1071, DOI 10.1128/JVI.01501-08; Smith DB, 2014, HEPATOLOGY, V59, P318, DOI 10.1002/hep.26744; STUYVER L, 1995, VIRUS RES, V38, P137, DOI 10.1016/0168-1702(95)00052-R; Thaikruea L, 2004, TRANSFUSION, V44, P1433, DOI 10.1111/j.1537-2995.2004.04073.x; Theamboonlers A, 2002, ACTA VIROL, V46, P169; Tippmann HF, 2004, BRIEF BIOINFORM, V5, P82, DOI 10.1093/bib/5.1.82; Tokita H, 1998, J GEN VIROL, V79, P1847; TOKITA H, 1994, P NATL ACAD SCI USA, V91, P11022, DOI 10.1073/pnas.91.23.11022	29	1	1	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0042-6822			VIROLOGY	Virology	NOV	2014	468						172	177		10.1016/j.virol.2014.08.006		6	Virology	Virology	AS7KF	WOS:000344434400020		
J	Li, CH; Yuan, MQ; Lu, L; Lu, T; Xia, WJ; Pham, VH; Vo, AXD; Nguyen, MH; Abe, K				Li, Chunhua; Yuan, Manqiong; Lu, Ling; Lu, Teng; Xia, Wenjie; Pham, Van H.; Vo, An X. D.; Nguyen, Mindie H.; Abe, Kenji			The genetic diversity and evolutionary history of hepatitis C virus in Vietnam	VIROLOGY			English	Article						HCV; Genotype; Sequence; BEAST; Evolution; Vietnam	INJECTION-DRUG USERS; HO-CHI-MINH; BLOOD-DONORS; GENOTYPE 6; HIGH PREVALENCE; RISK-FACTORS; HEPATOCELLULAR-CARCINOMA; MOLECULAR EPIDEMIOLOGY; SEQUENCE-ANALYSIS; B-VIRUS	Vietnam has a unique history in association with foreign countries, which may have resulted in multiple introductions of the alien HCV strains to mix with those indigenous ones. In this study, we characterized the HCV sequences in Core-E1 and NS5B regions from 236 Vietnamese individuals. We identified multiple HCV lineages; 6a, 6e, 6h, 6k, 6l, 6o, 6p, and two novel variants may represent the indigenous strains; 1a was probably introduced from the US; 1b and 2a possibly originated in East Asia; while 2i, 2j, and 2m were likely brought by French explorers. We inferred the evolutionary history for four major subtypes: 1a, 1b, 6a, and 6e. The obtained Bayesian Skyline Plots (BSPs) consistently showed the rapid HCV population growth from 1955 to 1963 until 1984 or after, corresponding to the era of the Vietnam War. We also estimated HCV growth rates and reconstructed phylogeographic trees for comparing subtypes 1a, 1b, and HCV-2. (C) 2014 Elsevier Inc. All rights reserved.	[Li, Chunhua; Lu, Ling; Lu, Teng] Univ Kansas, Med Ctr, Ctr Viral Oncol, Dept Pathol & Lab Med, Kansas City, KS 66103 USA; [Yuan, Manqiong] Sch Publ Hlth, State Key Lab Mol Vaccinol & Mol Diagnost, Xiamen 361102, Fujian, Peoples R China; [Lu, Teng] Univ So Calif, Los Angeles, CA USA; [Xia, Wenjie] Guangzhou Blood Ctr, Guangzhou, Guangdong, Peoples R China; [Pham, Van H.; Abe, Kenji] Univ Med & Pharm Ho Chi Minh City, Sch Med, Ctr Mol Biomed, Ho Chi Minh City, Vietnam; [Pham, Van H.; Vo, An X. D.; Abe, Kenji] NK BIOTEK Lab, Mol Diagnost Sect, Ho Chi Minh City, Vietnam; [Nguyen, Mindie H.] Stanford Univ, Med Ctr, Div Gastroenterol & Hepatol, Palo Alto, CA 94304 USA; [Abe, Kenji] Natl Inst Infect Dis, Dept Pathol, Tokyo 1628640, Japan	Lu, L (reprint author), Univ Kansas, Med Ctr, Ctr Viral Oncol, Dept Pathol & Lab Med, Kansas City, KS 66103 USA.	llu@kumc.edu; kenjiabe@nih.go.jp			Division of Intramural Research, National Institute of Allergy and Infectious Diseases [5 R01 AI080734-03A]; Ministry of Education, Culture, Sports, Science and Technology of Japan [25305006]	The study described was supported by a grant from Division of Intramural Research, National Institute of Allergy and Infectious Diseases (5 R01 AI080734-03A for Dr. Ling Lu) and in part by grants-in-aid for Science Research of the Ministry of Education, Culture, Sports, Science and Technology of Japan (No. 25305006 for Dr. Kenji Abe). The funding agencies had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams NJ, 1997, BIOCHEM BIOPH RES CO, V234, P393, DOI 10.1006/bbrc.1997.6627; Ahmad W, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-293; Akkarathamrongsin S, 2011, INTERVIROLOGY, V54, P10, DOI 10.1159/000318884; Akkarathamrongsin S, 2010, J MED VIROL, V82, P257, DOI 10.1002/jmv.21680; Nainan OV, 2006, GASTROENTEROLOGY, V131, P478, DOI 10.1053/j.gastro.2006.06.007; Noppornpanth S, 2006, J VIROL, V80, P7569, DOI 10.1128/JVI.00312-06; Pham DA, 2009, ASIAN PAC J ALLERGY, V27, P153; Parker J, 2008, INFECT GENET EVOL, V8, P239, DOI 10.1016/j.meegid.2007.08.001; Pybus OG, 2003, MOL BIOL EVOL, V20, P381, DOI 10.1093/molbev/msg043; Pybus OG, 2007, INT J PARASITOL, V37, P839, DOI 10.1016/j.ijpara.2007.04.009; Lu L, 2005, J MED VIROL, V75, P538, DOI 10.1002/jmv.20307; Simmonds P, 2005, HEPATOLOGY, V42, P962, DOI 10.1002/hep.20819; Nakano T, 2004, J INFECT DIS, V190, P1098, DOI 10.1086/422606; Waheed Y, 2009, WORLD J GASTROENTERO, V15, P5647, DOI 10.3748/wjg.15.5647; BUKH J, 1992, P NATL ACAD SCI USA, V89, P4942, DOI 10.1073/pnas.89.11.4942; Drummond AJ, 2012, MOL BIOL EVOL, V29, P1969, DOI 10.1093/molbev/mss075; Garten RJ, 2005, CLIN INFECT DIS, V41, pS18, DOI 10.1086/429491; PAWLOTSKY JM, 1995, J INFECT DIS, V171, P1607; Hubschen JM, 2011, CLIN MICROBIOL INFEC, V17, pE30, DOI 10.1111/j.1469-0691.2011.03665.x; Shepard CW, 2005, LANCET INFECT DIS, V5, P558, DOI 10.1016/S1473-3099(05)70216-4; Pham VH, 2011, JPN J INFECT DIS, V64, P537; Fried MW, 2002, NEW ENGL J MED, V347, P975, DOI 10.1056/NEJMoa020047; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Shinji T, 2004, ACTA MED OKAYAMA, V58, P135; Perz JF, 2006, J HEPATOL, V45, P529, DOI 10.1016/j.jhep.2006.05.013; SLATKIN M, 1989, GENETICS, V123, P603; Murphy DG, 2007, J CLIN MICROBIOL, V45, P1102, DOI 10.1128/JCM.02366-06; NAKATA S, 1994, J GASTROEN HEPATOL, V9, P416, DOI 10.1111/j.1440-1746.1994.tb01265.x; Fu Y, 2011, J VIRAL HEPATITIS, V18, P42, DOI 10.1111/j.1365-2893.2010.01280.x; Tanaka Y, 2006, GASTROENTEROLOGY, V130, P703, DOI 10.1053/j.gastro.2006.01.032; Guerra J, 2012, J VIRAL HEPATITIS, V19, P560, DOI 10.1111/j.1365-2893.2011.01576.x; Sievert W, 2011, LIVER INT, V31, P61, DOI 10.1111/j.1478-3231.2011.02540.x; Alter MJ, 2007, WORLD J GASTROENTERO, V13, P2436; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Tanimoto T, 2010, J MED VIROL, V82, P1355, DOI 10.1002/jmv.21787; Pybus OG, 2009, NAT REV GENET, V10, P540, DOI 10.1038/nrg2583; Dubois F, 1997, HEPATOLOGY, V25, P1490, DOI 10.1002/hep.510250630; Koletzki D, 2010, CLIN CHEM LAB MED, V48, P1095, DOI 10.1515/CCLM.2010.236; Markov PV, 2012, J VIROL, V86, P7677, DOI 10.1128/JVI.06910-11; Esteban JI, 2008, J HEPATOL, V48, P148, DOI 10.1016/j.jhep.2007.07.033; Lu L, 2013, J VIROL, V87, P12041, DOI 10.1128/JVI.01773-13; Apichartpiyakul C, 1999, JPN J INFECT DIS, V52, P121; Dunford L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041266; Fu YS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0028006; Holland PV, 1996, J CLIN MICROBIOL, V34, P2372; Jahan S, 2012, INFECT AGENTS CANCER, V7, DOI 10.1186/1750-9378-7-2; Jutavijittum P, 2009, SE ASIAN J TROP MED, V40, P471; Katayama Y, 1996, MICROBIOL IMMUNOL, V40, P525; Kendrick D., 1964, EXPERIENCES KOREAN S; Li CH, 2012, J GEN VIROL, V93, P1173, DOI 10.1099/vir.0.038315-0; Lu L, 2008, J GEN VIROL, V89, P444, DOI 10.1099/vir.0.83460-0; Lwin AA, 2007, HEPATOL RES, V37, P337, DOI 10.1111/j.1872-034X.2007.00053.x; Magiorkinis G, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000198; Maramag F., 2006, J GASTROENTEROL, V2, P30; Neel S., 1991, MED SUPPORT US ARMY; Newman R.M., 2012, J INFECT DIS, V208, P17; Nguyen VTT, 2007, HEPATOL INT, V1, P387, DOI 10.1007/s12072-007-9008-3; Ohno T, 1997, J CLIN MICROBIOL, V35, P201; POWER JP, 1995, LANCET, V345, P1211, DOI 10.1016/S0140-6736(95)91993-7; Pybus OG, 2009, J VIROL, V83, P1071, DOI 10.1128/JVI.01501-08; Pybus Oliver G., 2005, Infection Genetics and Evolution, V5, P131, DOI 10.1016/j.meegid.2004.08.001; R Core Team, 2013, R LANG ENV STAT COMP; Rosen HR, 1999, AM J GASTROENTEROL, V94, P3015; Sistayanarain A, 2011, MOL BIOL REP, V38, P4287, DOI 10.1007/s11033-010-0552-x; Smith DB, 2014, HEPATOLOGY, V59, P318, DOI 10.1002/hep.26744; Songsivilai S, 1997, AM J TROP MED HYG, V57, P66; Stimson G. V., 1993, Bulletin on Narcotics, V45, P3; Sulbaran MZ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014315; TOKITA H, 1994, P NATL ACAD SCI USA, V91, P11022, DOI 10.1073/pnas.91.23.11022; Tran HTT, 2003, HEPATOL RES, V26, P275, DOI 10.1016/S1386-6346(03)00166-9; Tucker S.C., 1999, VIETNAM, P22; Yuan MQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064698	72	3	3	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0042-6822			VIROLOGY	Virology	NOV	2014	468						197	206		10.1016/j.virol.2014.07.026		10	Virology	Virology	AS7KF	WOS:000344434400023		
J	Park, ES; Suzuki, M; Kimura, M; Maruyama, K; Mizutani, H; Saito, R; Kubota, N; Furuya, T; Mizutani, T; Imaoka, K; Morikawa, S				Park, Eun-Sil; Suzuki, Michio; Kimura, Masanobu; Maruyama, Keiji; Mizutani, Hiroshi; Saito, Ryuichi; Kubota, Nami; Furuya, Tetsuya; Mizutani, Tetsuya; Imaoka, Koichi; Morikawa, Shigeru			Identification of a natural recombination in the F and H genes of feline morbillivirus	VIROLOGY			English	Article						Feline morbillivirus; Fusion protein; Hemagglutinin protein; Recombination	CANINE-DISTEMPER VIRUS; NEIGHBOR-JOINING METHOD; HOMOLOGOUS RECOMBINATION; HEMAGGLUTININ GENE; MOSAIC STRUCTURE; SEQUENCES; INFECTION; PHYLOGENIES; ALIGNMENTS; OUTBREAK	Feline morbillivirus (FmoPV) has recently been identified in Hong Kong and Japan. FmoPV is considered to belong to the genus Morbillivirus, in the family Paramyxoviridae. In this study, the complete nucleotide sequences of three strains of FmoPV detected in cats in Japan were determined. Among the six genes in FmoPV; N, P/V/C, M, F, H and L, the P gene showed the highest polymorphism in the nucleotide and putative amino acid sequences among the FmoPV strains. There was no geographical association in terms of the FmoPV phylogeny; however, from extensive phylogenetic and recombination analyses, we found that one Japanese FmoPV strain, MiJP003, was a probable recombinant between two virus strains in the independent lineages found in Japan and Hong Kong, respectively. The recombination was considered to have occurred within the F and H genes. Such recombination is thought to be involved in the evolution of FmoPV. (C) 2014 Elsevier Inc. All rights reserved.	[Park, Eun-Sil; Suzuki, Michio; Kimura, Masanobu; Imaoka, Koichi; Morikawa, Shigeru] Natl Inst Infect Dis, Dept Vet Sci, Tokyo 1628640, Japan; [Maruyama, Keiji; Mizutani, Hiroshi; Saito, Ryuichi; Kubota, Nami] Tokyo Metropolitan Anim Care & Consultat Ctr, Jounanjima Branch Off, Tokyo 1430002, Japan; [Furuya, Tetsuya; Mizutani, Tetsuya] Tokyo Univ Agr & Technol, Res & Educ Ctr Prevent Global Infect Dis Anim, Tokyo 1838509, Japan	Morikawa, S (reprint author), Natl Inst Infect Dis, Dept Vet Sci, Tokyo 1628640, Japan.	morikawa@nih.go.jp	Furuya, Tetsuya/J-5916-2013; MIZUTANI, Tetsuya/G-1086-2013	MIZUTANI, Tetsuya/0000-0003-2570-0452	Ministry of Health, Labor and Welfare of Japan [H25-shinkou-ippan-008]	This work was supported by a grant-in-aid from the Ministry of Health, Labor and Welfare of Japan (grants H25-shinkou-ippan-008).	Han GZ, 2008, VIRUS RES, V136, P198, DOI 10.1016/j.virusres.2008.04.022; Han GZ, 2011, VIRUSES-BASEL, V3, P1358, DOI 10.3390/v3081358; McGuire G, 2000, BIOINFORMATICS, V16, P130, DOI 10.1093/bioinformatics/16.2.130; Furuya T, 2014, ARCH VIROL, V159, P371, DOI 10.1007/s00705-013-1813-5; Saliki JT, 2002, ANN NY ACAD SCI, V969, P51; Padidam M, 1999, VIROLOGY, V265, P218, DOI 10.1006/viro.1999.0056; Martin D, 2000, BIOINFORMATICS, V16, P562, DOI 10.1093/bioinformatics/16.6.562; Gibbs MJ, 2001, SCIENCE, V293, P1842, DOI 10.1126/science.1061662; Rubio-Guerri C, 2013, VET MICROBIOL, V165, P109, DOI 10.1016/j.vetmic.2012.12.031; Posada D, 2001, P NATL ACAD SCI USA, V98, P13757, DOI 10.1073/pnas.241370698; SMITH JM, 1992, J MOL EVOL, V34, P126; Birch J, 2013, J VIROL, V87, P4756, DOI 10.1128/JVI.02792-12; Martin DP, 2005, AIDS RES HUM RETROV, V21, P98, DOI 10.1089/aid.2005.21.98; YOSHIKAWA Y, 1989, VET MICROBIOL, V20, P193, DOI 10.1016/0378-1135(89)90043-6; Archer AM, 2002, VIROLOGY, V304, P274, DOI 10.1006/viro.2002.1695; Boni MF, 2007, GENETICS, V176, P1035, DOI 10.1534/genetics.106.068874; Sakaguchi S, 2014, J GEN VIROL, V95, P1464, DOI 10.1099/vir.0.065029-0; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI 10.1093/molbev/mst197; Sakai K, 2013, J VIROL, V87, P1105, DOI 10.1128/JVI.02419-12; Wittmann TJ, 2007, P NATL ACAD SCI USA, V104, P17123, DOI 10.1073/pnas.0704076104; Woo PCY, 2012, P NATL ACAD SCI USA, V109, P5435, DOI 10.1073/pnas.1119972109; Tamura K, 2004, P NATL ACAD SCI USA, V101, P11030, DOI 10.1073/pnas.0404206101; Holmes EC, 1999, MOL BIOL EVOL, V16, P405; Lole KS, 1999, J VIROL, V73, P152; Gibbs MJ, 2000, BIOINFORMATICS, V16, P573, DOI 10.1093/bioinformatics/16.7.573; Han GZ, 2008, VIROLOGY, V371, P54, DOI 10.1016/j.virol.2007.09.038; RoelkeParker ME, 1996, NATURE, V379, P441, DOI 10.1038/379441a0; Baron MD, 2011, BIOLOGY OF PARAMYXOVIRUSES, P293; Bevan S., 2001, BIOL PARAMYXOVIRUSES, P275; Chare Elizabeth R., 2003, Journal of General Virology, V84, P2691, DOI 10.1099/vir.0.19277-0; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.2307/2408678; Felsenstein J., 1989, CLADISTICS, V5, P164, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Hall T. A., 1999, NUCL ACIDS S SER, V4, P95, DOI DOI 10.1111/J.1469-8137.2009.02874.X; He CQ, 2009, MOL BIOL EVOL, V26, P177, DOI 10.1093/molbev/msn238; He CQ, 2008, VIROLOGY, V380, P12, DOI 10.1016/j.virol.2008.07.014; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Lemey P, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-126; Lo MK, 2011, BIOLOGY OF PARAMYXOVIRUSES, P211; Lukashev AN, 2005, J GEN VIROL, V86, P2333, DOI 10.1099/vir.0.80974-0; Mazzariol S, 2013, J CLIN MICROBIOL, V51, P708, DOI 10.1128/JCM.02710-12; SAITOU N, 1987, MOL BIOL EVOL, V4, P406; Sakai K, 2013, J VIROL, V87, P7170, DOI 10.1128/JVI.03479-12; Schneider-Schaulies S, 2011, BIOLOGY OF PARAMYXOVIRUSES, P245; Takeda M., 2012, FRONT MICROBIOL; Weiller GF, 1998, MOL BIOL EVOL, V15, P326; Zhang R, 2010, VIRUS RES, V151, P45, DOI 10.1016/j.virusres.2010.03.015	46	1	1	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0042-6822			VIROLOGY	Virology	NOV	2014	468						524	531		10.1016/j.virol.2014.09.003		8	Virology	Virology	AS7KF	WOS:000344434400055		
J	Sipiran, I; Meruane, R; Bustos, B; Schreck, T; Li, B; Lu, YJ; Johan, H				Sipiran, Ivan; Meruane, Rafael; Bustos, Benjamin; Schreck, Tobias; Li, Bo; Lu, Yijuan; Johan, Henry			A benchmark of simulated range images for partial shape retrieval	VISUAL COMPUTER			English	Article						Partial shape retrieval; Performance evaluation; Benchmarking		In this paper, we address the evaluation of algorithms for partial shape retrieval using a large-scale simulated benchmark of partial views which are used as queries. Since the scanning of real objects is a time-consuming task, we create a simulation that generates a set of views from a target model and at different levels of complexity (amount of missing data). In total, our benchmark contains 7,200 partial views. Furthermore, we propose the use of weighted effectiveness measures based on the complexity of a query. With these characteristics, we aim at jointly evaluating the effectiveness, efficiency and robustness of existing algorithms. As a result of our evaluation, we found that a combination of methods provides the best effectiveness, mainly due to the complementary information that they deliver. The obtained results open new questions regarding the difficulty of the partial shape retrieval problem. As a consequence, potential future directions are also identified.	[Sipiran, Ivan; Schreck, Tobias] Univ Konstanz, Dept Comp & Informat Sci, Constance, Germany; [Meruane, Rafael; Bustos, Benjamin] Univ Chile, Dept Comp Sci, Santiago, Chile; [Li, Bo; Lu, Yijuan] Texas State Univ, Dept Comp Sci, San Marcos, TX USA; [Johan, Henry] Fraunhofer IDM NTU, Singapore, Singapore; [Bustos, Benjamin] PRISMA Res Grp, Santiago, Chile; [Li, Bo] Texas State Univ, San Marcos, TX USA; [Li, Bo] Natl Inst Stand & Technol, Gaithersburg, MD USA; [Johan, Henry] Univ Tokyo, Dept Complex Sci & Engn, Tokyo 1138654, Japan; [Johan, Henry] Nanyang Technol Univ, Sch Comp Engn, Singapore 639798, Singapore	Sipiran, I (reprint author), Univ Konstanz, Dept Comp & Informat Sci, Constance, Germany.	ivan.sipiran@gmail.com; rmeruane@dcc.uchile.cl; bebustos@dcc.uchile.cl; tobias.schreck@uni-konstanz.de; b_l58@txstate.edu; lu@txstate.edu; hjohan@fraunhofer.sg	Bustos, Benjamin/G-1170-2010	Bustos, Benjamin/0000-0002-3955-361X	EC FP7 STREP Project PRESIOUS [600533]; FONDECYT (Chile) [1140783]; Army Research Office [W911NF-12-1-0057]; Texas State University Research Enhancement Program (REP); NSF [CRI 1305302]; Fraunhofer IDM@NTU - National Research Foundation (NRF)	The work of Ivan Sipiran and Tobias Schreck was supported by EC FP7 STREP Project PRESIOUS, Grant No. 600533. Benjamin Bustos has been partially funded by FONDECYT (Chile) Project 1140783. This work of Bo Li and Yijuan Lu has been supported by the Army Research Office grant W911NF-12-1-0057, Texas State University Research Enhancement Program (REP), and NSF CRI 1305302 to Yijuan Lu. Henry Johan is supported by Fraunhofer IDM@NTU, which is funded by the National Research Foundation (NRF) and managed through the multi-agency Interactive & Digital Media Programme Office (IDMPO) hosted by the Media Development Authority of Singapore (MDA).	Belongie S, 2002, IEEE T PATTERN ANAL, V24, P509, DOI 10.1109/34.993558; Lai K, 2011, IEEE INT CONF ROBOT, P1817; Sipiran I, 2011, VISUAL COMPUT, V27, P963, DOI 10.1007/s00371-011-0610-y; Li B, 2013, MULTIMED TOOLS APPL, V65, P363, DOI 10.1007/s11042-012-1009-0; Osada R, 2002, ACM T GRAPHIC, V21, P807, DOI 10.1145/571647.571648; Beecks C., 2009, P ACM INT C MULT, P697, DOI 10.1145/1631272.1631391; Biasotti S., 2012, P EUR WORKSH 3D OBJ, P101; Bronstein AM, 2011, ACM T GRAPHIC, V30, DOI 10.1145/1899404.1899405; Browatzki B., 2011, IEEE ICCV WORKSH, P1189; Bustos B., 2012, 3D IMAGING ANAL APPL, P265; Dutagaci H, 2009, P 2 EUR WORKSH 3D OB, P69; Dutagaci H, 2010, P 3 EUR WORKSH OD OB, P109; Frome A., 2004, P EUR C COMP VIS ECC; Johnson A., 1997, THESIS CARNEGIE MELL; Leow WK, 2004, COMPUT VIS IMAGE UND, V94, P67, DOI 10.1016/j.cviu.2003.10.010; Li B, 2010, LECT NOTES COMPUT SC, V5916, P185; Li B, 2013, P EUR WORKSH 3D OBJ, P49; Li B, 2012, P EUR WORKSH 3D OBJ, P109; Liu Y., 2006, P IEEE C COMP VIS PA; Rusu R. B., 2009, ROB AUT 2009 ICRA 09, P3212; Rusu R.B., 2011, INT C ROB AUT SHANGH; Rusu RB, 2009, 2009 IEEE-RSJ INTERNATIONAL CONFERENCE ON INTELLIGENT ROBOTS AND SYSTEMS, P7, DOI 10.1109/IROS.2009.5354763; Sipiran I, 2013, COMPUT GRAPH-UK, V37, P460, DOI 10.1016/j.cag.2013.04.002; Sipiran I, 2013, P 6 EUR WORKSH 3D OB, P81; Takahashi S., 2005, IEEE VISUALIZATION, P63, DOI 10.1109/VIS.2005.4; Veltkamp R., 2007, TECHNICAL REPORT; Vranic D.V., 2005, P IEEE INT C MULT EX	27	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0178-2789	1432-2315		VISUAL COMPUT	Visual Comput.	NOV	2014	30	11					1293	1308		10.1007/s00371-014-0937-2		16	Computer Science, Software Engineering	Computer Science	AS3HX	WOS:000344169300008		
J	Epstein, J; Ganz, PR; Seitz, R; Jutzi, M; Schaerer, C; Michaud, G; Agbanyo, F; Smith, G; Prosser, I; Heiden, M; Saint-Marie, I; Oualikene-Gonin, W; Hamaguchi, I; Yasuda, N				Epstein, J.; Ganz, P. R.; Seitz, R.; Jutzi, M.; Schaerer, C.; Michaud, G.; Agbanyo, F.; Smith, G.; Prosser, I.; Heiden, M.; Saint-Marie, I.; Oualikene-Gonin, W.; Hamaguchi, I.; Yasuda, N.			A shared regulatory perspective on deferral from blood donation of men who have sex with men (MSM)	VOX SANGUINIS			English	Article						blood collection; donors; epidemiology; motivation; recruitment; transfusion medicine (in general)	HAD SEX; RISK; ENGLAND; IMPACT; VIRUS; AUSTRALIA; BENEFITS; DONORS	National Regulatory Authorities (NRAs) establish deferral criteria for donors with risk factors for transfusion transmissible infections (TTI). In most jurisdictions, epidemiological data show that men who have sex with men (MSM) have a significantly higher rate of TTI than the general population. Nevertheless, changes from an indefinite donor deferral for MSM have been considered in many countries in response to concerns over a perceived discrimination and questioning of the scientific need. Changes to MSM donor deferral criteria should be based on sound scientific evidence. Safety of transfusion recipients should be the first priority, and stakeholder input should be sought.	[Epstein, J.; Michaud, G.] US FDA, Off Blood Res & Review, Ctr Biol Evaluat & Res, Silver Spring, MD 20993 USA; [Ganz, P. R.; Agbanyo, F.] Hlth Canada, Ctr Blood & Tissues Evaluat, Biol & Genet Therapies Directorate, Ottawa, ON K1A 0L2, Canada; [Seitz, R.; Heiden, M.] Paul Ehrlich Inst, Div Haematol Transfus Med, Langen, Germany; [Jutzi, M.; Schaerer, C.] Swiss Agcy Therapeut Prod, Swissmed, Bern, Switzerland; [Smith, G.; Prosser, I.] Therapeut Goods Adm, Off Sci Evaluat, Woden, ACT, Australia; [Saint-Marie, I.; Oualikene-Gonin, W.] French Natl Agcy Med & Hlth Prod Safety, Div Adv Therapies Prod Human Origin & Vaccines, St Denis, France; [Hamaguchi, I.] Natl Inst Infect Dis, Dept Safety Res Blood & Biol Prod, Tokyo, Japan; [Yasuda, N.] Minist Hlth Labour & Welf, Chiyoda Ku, Tokyo, Japan	Epstein, J (reprint author), US FDA, Off Blood Res & Review, Ctr Biol Evaluat & Res, WO71-4230,10903 New Hampshire Ave, Silver Spring, MD 20993 USA.	jay.epstein@fda.hhs.gov					Anderson SA, 2009, TRANSFUSION, V49, P1102, DOI 10.1111/j.1537-2995.2009.02124.x; Seed CR, 2014, VOX SANG, V106, P14, DOI 10.1111/vox.12093; Schroder KEE, 2003, ANN BEHAV MED, V26, P104, DOI 10.1207/S15324796ABM2602_03; Leiss W, 2008, TRANSFUS MED REV, V22, P35, DOI 10.1016/j.tmrv.2007.09.002; Davison KL, 2011, VOX SANG, V101, P291, DOI 10.1111/j.1423-0410.2011.01491.x; Germain M, 2014, VOX SANG, V106, P372, DOI 10.1111/vox.12109; Benjamin RJ, 2011, VOX SANG, V101, P339, DOI 10.1111/j.1423-0410.2011.01489.x; Sanchez AM, 2005, TRANSFUSION, V45, P404, DOI 10.1111/j.1537-2995.2005.03421.x; Chudy M, 2012, TRANSFUSION, V52, P431, DOI 10.1111/j.1537-2995.2011.03281.x; Busch MP, 2003, JAMA-J AM MED ASSOC, V289, P959, DOI 10.1001/jama.289.8.959; Seed CR, 2010, TRANSFUSION, V50, P2722, DOI 10.1111/j.1537-2995.2010.02793.x; Soldan K, 2003, VOX SANG, V84, P274, DOI 10.1046/j.1423-0410.2003.00296.x; [Anonymous], PAPHTS1128R CD PTS; Brooks J, 2009, BMJ-BRIT MED J, V338, P572; Centers for Disease Control and Prevention, 2008, MMWR-MORBID MORTAL W, V57, P681; European Centre for Disease Prevention and Control/WHO Regional Office for Europe, 2011, HIV AIDS SURV EUR 20; Germain M, 2003, TRANSFUSION, V43, P25, DOI 10.1046/j.1537-2995.2003.00281.x; Hurley R, 2009, BMJ-BRIT MED J, V338, P568; LINDEN JV, 1994, TRANSFUSION, V34, P1016, DOI 10.1046/j.1537-2995.1994.341195065028.x; Public Health Agency of Canada, 2008, SUMM EST HIV PREV IN; Roehr B, 2009, BMJ-BRIT MED J, V338, P572; Soldan K, 2003, VOX SANG, V84, P265, DOI 10.1046/j.1423-0410.2003.00295.x; Spencer B, 2006, TRANSFUSION, V46, P869, DOI 10.1111/j.1537-2995.2006.00814.x; Vamvakas EC, 2009, TRANSFUS MED REV, V23, P85, DOI 10.1016/j.tmrv.2008.12.007; Vamvakas EC, 2009, TRANSFUSION, V49, P1037, DOI 10.1111/j.1537-2995.2009.02175.x; Vaner Bij AK, 2006, TRANSFUSION, V46, P1729; Wainberg MA, 2010, CAN MED ASSOC J, V182, P1321, DOI 10.1503/cmaj.091476	27	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0042-9007	1423-0410		VOX SANG	Vox Sang.	NOV	2014	107	4					416	419		10.1111/vox.12166		4	Hematology	Hematology	AS4EY	WOS:000344227100014		
J	Yang, B; Gao, JT; Zhou, YZ; Jiang, XH				Yang, Bin; Gao, Juntao; Zhou, Yuezhi; Jiang, Xiaohong			Delay control in MANETs with erasure coding and f-cast relay	WIRELESS NETWORKS			English	Article						Mobile ad hoc networks; Two-hop relay; Erasure coding; Packet redundancy; Delay	AD-HOC NETWORKS; THROUGHPUT TRADEOFFS; WIRELESS NETWORKS; MOBILE NETWORKS; CAPACITY; IMPROVES	Packet delay control in mobile ad hoc networks (MANETs) is critical to support delay-sensitive applications in such networks. By combining erasure coding and packet redundancy techniques, this paper proposes a general two-hop relay algorithm 2HR-(x, tau, f) for a flexible control of packet delivery delay in MANETs, where a group of x packets in source node are first encoded into x . tau encoded packets based erasure coding, and each encoded packet is then delivered to at most f distinct relay nodes (f-cast) that will help to forward the encoded packet to destination node. To understand the delay performance in a 2HR-(x, tau, f) MANET, we then develop a discrete time multi-dimensional Markov chain model to depict the packet delivery process in the network, based on which closed-form results on mean and variance of packet delivery delay are further derived. Finally, extensive simulation and theoretical results are provided to illustrate the efficiency of our delay models as well as the capability of the 2HR-(x, tau, f) algorithm in delay control.	[Yang, Bin; Jiang, Xiaohong] Future Univ Hakodate, Sch Syst Informat Sci, Hakodate, Hokkaido 0418655, Japan; [Yang, Bin] Chuzhou Univ, Sch Comp & Informat Engn, Chuzhou 239000, Peoples R China; [Gao, Juntao] Nara Inst Sci & Technol, Sch Informat Sci, Nara 6300192, Japan; [Zhou, Yuezhi] Tsinghua Univ, Dept Comp Sci & Technol, Beijing 100084, Peoples R China	Yang, B (reprint author), Future Univ Hakodate, Sch Syst Informat Sci, Hakodate, Hokkaido 0418655, Japan.	yangbinchi@gmail.com; gaojuntao223@gmail.com; zhouyz@mail.tsinghua.edu.cn; jiang@fun.ac.jp			Significant Natural Science Foundation of the Education Department of Anhui Province [KJ2011ZD06]; Natural Science Foundation of Chuzhou University [2012kj002Z]; Chuzhou University Excellent Young Talents Fund Project [2013RC005]	This work is supported in part by the Significant Natural Science Foundation of the Education Department of Anhui Province under Grant No. KJ2011ZD06, the Key Program of Natural Science Foundation of Chuzhou University under Grant No. 2012kj002Z and the Chuzhou University Excellent Young Talents Fund Project under Grant No. 2013RC005.	Altman E, 2013, IEEE T WIREL COMMUN, V12, P725, DOI 10.1109/TWC.2012.122212.120196; Garetto M, 2010, IEEE T INFORM THEORY, V56, P5016, DOI 10.1109/TIT.2010.2059510; Bulut E, 2010, IEEE ACM T NETWORK, V18, P1530, DOI 10.1109/TNET.2010.2043744; Urgaonkar R, 2011, IEEE ACM T NETWORK, V19, P1137, DOI 10.1109/TNET.2010.2103367; Gupta P, 2000, IEEE T INFORM THEORY, V46, P388, DOI 10.1109/18.825799; Sharma G, 2007, IEEE ACM T NETWORK, V15, P981, DOI 10.1109/TNET.2007.905154; Kannhavong B, 2007, IEEE WIREL COMMUN, V14, P85, DOI 10.1109/MWC.2007.4396947; Altman E, 2011, IEEE ACM T NETWORK, V19, P1, DOI 10.1109/TNET.2010.2091968; Wang ZH, 2012, IEEE J SEL AREA COMM, V30, P289, DOI 10.1109/JSAC.2012.120207; Ying L, 2008, IEEE T INFORM THEORY, V54, P4119, DOI 10.1109/TIT.2008.928247; Garetto M, 2009, IEEE ACM T NETWORK, V17, P1888, DOI 10.1109/TNET.2009.2015572; Andrews J, 2008, IEEE COMMUN MAG, V46, P94, DOI 10.1109/MCOM.2008.4689214; Liu JJ, 2012, IEEE ACM T NETWORK, V20, P1950, DOI 10.1109/TNET.2012.2187923; Goldsmith A, 2011, IEEE COMMUN MAG, V49, P195, DOI 10.1109/MCOM.2011.5762818; Li P, 2012, IEEE T MOBILE COMPUT, V11, P427, DOI 10.1109/TMC.2011.54; Kong ZN, 2012, IEEE T INFORM THEORY, V58, P6894, DOI 10.1109/TIT.2012.2208573; Neely MJ, 2005, IEEE T INFORM THEORY, V51, P1917, DOI 10.1109/TIT.2005.847717; Groenevelt R, 2005, PERFORM EVALUATION, V62, P210, DOI 10.1016/j.peva.2005.07.018; Boche H, 2011, IEEE ACM T NETWORK, V19, P589, DOI 10.1109/TNET.2010.2083683; Chen L., 2006, P ACM SIGCOMM WORKSH; Ciullo D., 2010, P INFOCOM; Gamal A. E., 2006, IEEE T INFORM THEORY, V52, P2568, DOI DOI 10.1109/TIT.2006.874379; Grinstead C., 1997, INTRO PROBABILITY; Grossglauser M., 2001, P INFOCOM; Hanbali A. A., 2007, P IFIP NETW; Hanbali A.A., 2008, PERFORM EVALUATION, V65, P463; Kannhavong B, 2007, INT J COMMUN SYST, V20, P1245, DOI 10.1002/dac.870; Li P., 2010, P INFOCOM; Liao Y., 2006, P IWCMC; Liu J., 2011, P GLOB; Liu J., 2012, P INFOCOM; Liu JJ, 2011, IEEE T WIREL COMMUN, V10, P2738, DOI 10.1109/TWC.2011.062111.101976; Panagakis A., 2007, P WIOPT; Rizzo L., 1997, Computer Communication Review, V27; Sharma G., 2004, P WIOPT; Spyropoulos T., 2005, P ACM SIGCOMM WORKS; Tsapeli F., 2012, P WWIC; Wang Y., 2005, P ACM SIGCOMM WDTN; Zhang C., 2009, P INFOCOM; Zhou S., 2010, P INFOCOM; Zhou Y., 2014, IEEE T NETW SERV MAN, V11, P46	41	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	1022-0038	1572-8196		WIREL NETW	Wirel. Netw.	NOV	2014	20	8					2617	2631		10.1007/s11276-014-0767-1		15	Computer Science, Information Systems; Engineering, Electrical & Electronic; Telecommunications	Computer Science; Engineering; Telecommunications	AR9UZ	WOS:000343925600031		
J	Tanaka, Y; Inamori, M; Sanada, Y				Tanaka, Yuki; Inamori, Mamiko; Sanada, Yukitoshi			Two Step Timing Synchronization Scheme for OFDM Signal in General Purpose Processor Based Software Defined Radio Receiver	WIRELESS PERSONAL COMMUNICATIONS			English	Article						Software defined radio; IEEE802.11g; General purpose processors; OFDM; Timing synchronization	ARCHITECTURE	Software defined radio (SDR) is a technology that allows a single terminal to support various kinds of wireless systems by changing its software to reconfigure itself. A general purpose processor (GPP) based SDR receiver platform named Sora has been recently developed by Microsoft. In the GPP based SDR receiver, timing synchronization of an OFDM signal consumes a significant amount of computational resources in the GPP. In this paper, a timing synchronization scheme which uses delayed correlation and matched filtering for the GPP based SDR platform is evaluated. The two stage timing synchronization scheme reduces the computational complexity by limiting the timing range of matched filtering. The proposed scheme reduces the amount of data transmission between the memory and the GPP of the SDR platform. It is shown through an experiment that the proposed scheme reduces the number of cycles for timing synchronization by up to 30 %.	[Tanaka, Yuki; Inamori, Mamiko; Sanada, Yukitoshi] Keio Univ, Dept Elect & Elect Engn, Kohoku Ku, Yokohama, Kanagawa 2238522, Japan; [Inamori, Mamiko] Keio Univ, Yokohama, Kanagawa 2238522, Japan; [Sanada, Yukitoshi] Tokyo Inst Technol, Fac Engn, Tokyo, Japan; [Sanada, Yukitoshi] Sony Comp Sci Labs Inc, Adv Telecommun Lab, Tokyo, Japan; [Sanada, Yukitoshi] Keio Univ, Fac Sci & Engn, Yokohama, Kanagawa 2238522, Japan	Sanada, Y (reprint author), Keio Univ, Dept Elect & Elect Engn, Kohoku Ku, 3-14-1 Hiyoshi, Yokohama, Kanagawa 2238522, Japan.	ytanaka@snd.elec.keio.ac.jp; inamori@tokai-u.jp; sanada@elec.keio.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology of Japan [25426382]	This work is supported in part by a Grant-in-Aid for Scientific Research (C) under Grant No. 25426382 from the Ministry of Education, Culture, Sports, Science, and Technology of Japan.	Tan K, 2011, COMMUN ACM, V54, P99, DOI 10.1145/1866739.1866760; [Anonymous], 80211G IEEE; Bose V, 1999, IEEE J SEL AREA COMM, V17, P591, DOI 10.1109/49.761038; Cummings M, 1999, IEEE COMMUN MAG, V37, P108, DOI 10.1109/35.747258; Heiskala J., 2001, OFDM WIRELESS LANS T; Joint Technical Committee of Committee T1 R1P1.4 and TIA TR46.3.3/TR45.4. 4 on Wireless Access, 1994, JTCAIR940117238R4; Khurram M., 2006, IEEE GCC C MARCH, P1; MITOLA J, 1995, IEEE COMMUN MAG, V33, P26, DOI 10.1109/35.393001; Schmid T., 2007, WINETCH 07 JAN, P59; Tan K., 2011, MSRTR201114 SOR COR; Tan K., 2009, 6 USENIX S NETW SYST; Tsurumi H, 1999, IEEE COMMUN MAG, V37, P90, DOI 10.1109/35.747255; Yip KW, 2003, IEEE T CONSUM ELECTR, V49, P107	13	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0929-6212	1572-834X		WIRELESS PERS COMMUN	Wirel. Pers. Commun.	NOV	2014	79	1					363	374		10.1007/s11277-014-1860-6		12	Telecommunications	Telecommunications	AS3NC	WOS:000344183900021		
J	Uchida, S; Sato, A; Inamori, M; Sanada, Y; Ghavami, M				Uchida, Shoya; Sato, Akihiro; Inamori, Mamiko; Sanada, Yukitoshi; Ghavami, Mohammad			Signal Detection Performance of Overlapped FFT Scheme with Additional Frames Consisting of Non-continuous Samples in Indoor Environment	WIRELESS PERSONAL COMMUNICATIONS			English	Article						Cognitive radio; Overlapped FFT; Spectrum sensing	COGNITIVE RADIO	Overlapped FFT has been proposed as a signal detection scheme in dynamic spectrum access to reduce the variance of the noise and improve the detection probability. However, the improvement of the detection probability in the conventional overlapped FFT is bounded with the upper limit of the overlap ratio. This paper proposes a new overlapped FFT scheme using additional frames. In the proposed scheme, in addition to the original FFT frames, new frames that consist of multiple subframes with non-continuous samples are constructed and included. It can realize the increase of the number of the FFT frames and the improvement of the detection probability compared with the conventional scheme. Numerical results through computer simulation show that the proposed scheme improves the detection probability by up to 0.07. On indoor channel models the proposed scheme also improves the detection probability. In addition, it is clarified that as the delay spread increases the detection probability reduces due to the correlation between the frames.	[Uchida, Shoya; Sato, Akihiro; Sanada, Yukitoshi] Keio Univ, Dept Elect & Elect Engn, Kohoku Ku, Yokohama, Kanagawa 2238522, Japan; [Inamori, Mamiko] Tokai Univ, Dept Elect & Elect Engn, Hiratsuka, Kanagawa 2591292, Japan; [Ghavami, Mohammad] London S Bank Univ, Dept Engn & Design, London, England; [Inamori, Mamiko] Keio Univ, Yokohama, Kanagawa 2238522, Japan; [Sanada, Yukitoshi] Tokyo Inst Technol, Tokyo, Japan; [Sanada, Yukitoshi] Sony Comp Sci Labs Inc, Adv Telecommun Lab, Paris, France; [Sanada, Yukitoshi] Keio Univ, Fac Sci & Engn, Yokohama, Kanagawa 2238522, Japan; [Ghavami, Mohammad] Yokohama Natl Univ, Yokohama, Kanagawa, Japan; [Ghavami, Mohammad] Sony Comp Sci Labs, Tokyo, Japan	Sanada, Y (reprint author), Keio Univ, Dept Elect & Elect Engn, Kohoku Ku, 3-14-1 Hiyoshi, Yokohama, Kanagawa 2238522, Japan.	uchida@snd.elec.keio.ac.jp; asato@snd.elec.keio.ac.jp; inamori@tokai-u.jp; sanada@elec.keio.ac.jp; ghavamim@lsbu.ac.uk					Haykin S, 2005, IEEE J SEL AREA COMM, V23, P201, DOI 10.1109/JSAC.2004.839380; Yucek T, 2009, IEEE COMMUN SURV TUT, V11, P116, DOI 10.1109/SURV.2009.090109; Zhao Q, 2007, IEEE SIGNAL PROC MAG, V24, P79; [Anonymous], 2011, 190062011 IEEE; Tandra R, 2008, IEEE J-STSP, V2, P4, DOI 10.1109/JSTSP.2007.914879; [Anonymous], 2011, 802222011 IEEE; Chong J. W., 2008, SPAWC 2008; Fan H., 2006, INT C RAD OCT, P1; Hu Z., 2011, 7 INT C MOB AD HOC S; Joint Technical Committee of Committee T1 R1P1.4 and TIA TR46.3.3/TR45.4. 4 on Wireless Access, 1994, JTCAIR940117238R4; Macaluso I, 2012, IEEE VEH TECHNOL MAG, V7, P85, DOI 10.1109/MVT.2012.2190188; Maranda BH, 1996, IEEE T AERO ELEC SYS, V32, P1452, DOI 10.1109/7.543866; Matsudo T., 2012, 565 URSI COMM F M; Mitra III J., 1999, IEEE PERS COMMUN, V6, P13; Mitra III J., 1999, 1999 IEEE INT WORKSH, P3; Proakis J., 1989, DIGITAL COMMUNICATIO; Takai R, 2014, WIRELESS PERS COMMUN, V77, P553, DOI 10.1007/s11277-013-1522-0; Tomioka T., 2009, IEEE 69 VEH TECHN C; Van Loan C. F., 1996, MATRIX COMPUTATIONS; Wang SC, 2010, IEEE T INSTRUM MEAS, V59, P1424, DOI 10.1109/TIM.2009.2038294	20	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0929-6212	1572-834X		WIRELESS PERS COMMUN	Wirel. Pers. Commun.	NOV	2014	79	2					987	1002		10.1007/s11277-014-1899-4		16	Telecommunications	Telecommunications	AS3NJ	WOS:000344184700012		
J	Moscholios, ID; Kallos, GA; Vassilakis, VG; Logothetis, MD				Moscholios, I. D.; Kallos, G. A.; Vassilakis, V. G.; Logothetis, M. D.			Congestion Probabilities in CDMA-Based Networks Supporting Batched Poisson Input Traffic	WIRELESS PERSONAL COMMUNICATIONS			English	Article						CDMA; Time-call congestion; Batched Poisson; Recursive formula; Call admission	SHARED RESOURCE ENVIRONMENT; INTERFERENCE CANCELLATION; BLOCKING; UPLINK; REQUIREMENTS; CAPACITY	We propose a new multirate teletraffic loss model for the calculation of time and call congestion probabilities in CDMA-based networks that accommodate calls of different service-classes. The call arrival process follows a batched Poisson process, which is more "peaked" and "bursty" than the ordinary Poisson process. The call-admission-control policy is based on the partial batch blocking discipline. This policy accepts a part of the batch (one or more calls) and discards the rest, if the available resources are not enough to accept the whole batch. The proposed model takes into account multiple access interference, both the notion of local (soft) and hard blocking, the user's activity, as well as interference cancellation. Although the analysis of the model does not lead to a product form solution of the steady state probabilities, we show that the call-level performance metrics, time and call congestion probabilities can be efficiently calculated based on approximate but recursive formulas. The accuracy of the proposed formulas are verified through simulation and found to be quite satisfactory. Comparison of the proposed model with that of Poisson input shows the necessity of the new model. We also show the consistency of the new model over changes of its parameters.	[Moscholios, I. D.] Univ Peloponnese, Dept Informat & Telecommun, Tripolis 22100, Greece; [Kallos, G. A.] BT Technol, Serv & Operat, Ipswich IP5 3RE, Suffolk, England; [Vassilakis, V. G.] Univ Surrey, Dept Elect Engn, Guildford GU2 7XH, Surrey, England; [Logothetis, M. D.] Univ Patras, WCL, Dept Elect & Comp Engn, Patras 26504, Greece; [Moscholios, I. D.] Univ Peloponnese, Dept Telecommun Sci & Technol, Tripolis 22100, Greece; [Kallos, G. A.] British Telecommun Adastral Pk, Ipswich, Suffolk, England; [Logothetis, M. D.] Univ Patras, Lab Wire Commun, GR-26110 Patras, Greece; [Logothetis, M. D.] NTTs Telecommun Networks Labs, Tokyo, Japan; [Logothetis, M. D.] Univ Patras, Dept Elect & Comp Engn, GR-26110 Patras, Greece	Moscholios, ID (reprint author), Univ Peloponnese, Dept Informat & Telecommun, Tripolis 22100, Greece.	idm@uop.gr; george.kallos@bt.com; v.vasilakis@surrey.ac.uk; mlogo@upatras.gr					Akimaru H., 1999, TELETRAFFIC THEORY A; Chen H. H., 2007, NEXT GENERATION CDMA; DELBROUCK LEN, 1983, IEEE T COMMUN, V31, P1209, DOI 10.1109/TCOM.1983.1095768; Fazel K., 2008, MULTICARRIER SPREAD; Hamalainen S, 1996, IEEE ISSSTA '96 - IEEE FOURTH INTERNATIONAL SYMPOSIUM ON SPREAD SPECTRUM TECHNIQUES & APPLICATIONS, PROCEEDINGS, VOLS 1-3, P339; Holma H., 2007, W CDMA UMTS HSPA EVO; Iversen V., 2004, P ITC SPEC SEM ANTW, P223; Iversen VB, 2010, LECT NOTES COMPUT SC, V6294, P160, DOI 10.1007/978-3-642-14891-0_15; Kallos GA, 2011, EUR T TELECOMMUN, V22, P25, DOI 10.1002/ett.1446; KAUFMAN JS, 1981, IEEE T COMMUN, V29, P1474, DOI 10.1109/TCOM.1981.1094894; Kaufman JS, 1996, PERFORM EVALUATION, V24, P249, DOI 10.1016/0166-5316(94)00029-8; Li DB, 2003, IEEE COMMUN MAG, V41, P114; Moscholios, 2012, P IEEE ICC 2012 OTT; Moscholios M. I., 2010, COMPUT COMMUN, V33, pS167; Moscholios M. I., 2013, ANN TELECOMMUN, V68, P327; Patel S., 2012, INT J COMPUTER APPL, V54, P6; Pinter SZ, 2010, IEEE T COMMUN, V58, P1803, DOI 10.1109/TCOMM.2010.06.090114; Popova L., 2006, P ISWCS 06 VAL SPAIN; Roberts J. W., 1981, Performance of Data Communication Systems and their Applications. Proceedings of the International Conference; Rosa C, 2005, IEEE VTS VEH TECHNOL, P1758; Ross K., 1995, MULTISERVICE LOSS MO; Staehle D, 2003, TELETRAF SCI ENG, V5A-B, P81; Staehle D., 2002, P IEEE 55 VEH TECHN, P1640; Stasiak M., 2011, MODELING DIMENSIONIN; van Doom EA, 1993, IEEE ACM T NETWORK, V1, P664, DOI 10.1109/90.266054; Varshney U, 2012, IT PROF, V14, P34, DOI 10.1109/MITP.2012.71	26	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0929-6212	1572-834X		WIRELESS PERS COMMUN	Wirel. Pers. Commun.	NOV	2014	79	2					1163	1186		10.1007/s11277-014-1923-8		24	Telecommunications	Telecommunications	AS3NJ	WOS:000344184700022		
J	Imashuku, S; Matsuoka, S; Yokoi, K; Kawai, J				Imashuku, Susumu; Matsuoka, Shunsuke; Yokoi, Ken; Kawai, Jun			Mechanical stress X-ray emission from crystal sugar	X-RAY SPECTROMETRY			English	Article							AUDIO DIGITIZER; TRIBOLUMINESCENCE	We report a new phenomenon of generating X-rays by fracturing a well-known material, crystal sugar, in a vacuum. The generated X-rays had a maximum energy of 250keV and peak energy of 5keV. The X-ray pulses continued for 4x10(-3)s. Copyright (c) 2014 John Wiley & Sons, Ltd.	[Imashuku, Susumu; Matsuoka, Shunsuke; Yokoi, Ken; Kawai, Jun] Kyoto Univ, Dept Mat Sci & Engn, Sakyo Ku, Kyoto 6068501, Japan	Imashuku, S (reprint author), Kyoto Univ, Dept Mat Sci & Engn, Sakyo Ku, Kyoto 6068501, Japan.	imashuku.susumu.2m@kyoto-u.ac.jp					WALTON AJ, 1977, ADV PHYS, V26, P887, DOI 10.1080/00018737700101483; Bacon F., 1620, NOVUM ORGANUM, P129; Chandra BP, 1998, LUMINESCENCE OF SOLIDS, P361; Eddingsaas NC, 2006, NATURE, V444, P163, DOI 10.1038/444163a; Nakaye Y, 2011, X-RAY SPECTROM, V40, P446, DOI 10.1002/xrs.1367; Nakaye Y, 2010, X-RAY SPECTROM, V39, P318, DOI 10.1002/xrs.1269; ZINK JI, 1978, ACCOUNTS CHEM RES, V11, P289, DOI 10.1021/ar50128a001	7	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0049-8246	1097-4539		X-RAY SPECTROM	X-Ray Spectrom.	NOV-DEC	2014	43	6					367	369		10.1002/xrs.2566		3	Spectroscopy	Spectroscopy	AS3LG	WOS:000344178700010		
J	Ueno, K				Ueno, Koichi			Expression and Function of the Histamine Receptors in Dermal and Articular Tissues	YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN			Japanese	Review						histamine; H-4 receptor; expression; rheumatoid arthritis; bone metabolism; dermal tissue	KAPPA-B LIGAND; RHEUMATOID SYNOVIAL-CELLS; H-4 RECEPTOR; H4 RECEPTOR; OSTEOCLAST DIFFERENTIATION; ADJUVANT ARTHRITIS; DENDRITIC CELLS; BONE-MARROW; MAST-CELLS; T-CELL	Histamine was first identified in 1910 as a physiologically active amine. It is now recognized for its multiple regulatory activities in the digestive, neuronal, and immune systems, and new roles are still being elucidated. Histamine exerts its effects through four distinct receptor subtypes. The histamine H-4 receptor was identified in 2000 and is the most recently identified of the four histamine receptors. It is expressed primarily in immune cells and is involved in physiologic functions related to inflammation and allergy. Recently, the H-4 receptor was highlighted as a promising therapeutic target in atopic dermatitis, asthma, and chronic arthritis. In fact, some H-4 receptor antagonists have reached clinical trials for the treatment of asthma, atopic dermatitis, and allergic rhinitis. Based on an initial assessment of its distribution, the H-4 receptor has been referred to as the histamine receptor of the hematopoietic system. However, the H-4 receptor has also been implicated in the regulation of other non-hematopoietic systems. Here, I review the expression and function of the identified histamine receptors, including the H-4 receptor with a focus on articular and dermal tissues. In articular tissue, H-4 receptor expression has been detected in synovial cells. Chondrocytes, a major cell source for cartilage tissue engineering, also express the H-4 receptor. In skin, the H-4 receptor is expressed in both the epidermis and dermis, with stronger receptor expression in the epidermis. Further understanding of the functions of H-4 receptors in non-hematopoietic cells might lead to novel treatments for diseases with unmet medical needs.	Chiba Univ, Grad Sch Pharmaceut Sci, Dept Geriatr Pharmacol & Therapeut, Chuo Ku, Chiba 2608675, Japan	Ueno, K (reprint author), Chiba Univ, Grad Sch Pharmaceut Sci, Dept Geriatr Pharmacol & Therapeut, Chuo Ku, 1-8-1 Inohana, Chiba 2608675, Japan.	kueno@chiba-u.jp					Abe Toru, 2005, Nihon Rinsho, V63 Suppl 1, P431; ALHABOUBI HA, 1982, EUR J PHARMACOL, V78, P175, DOI 10.1016/0014-2999(82)90234-5; Zampeli E, 2009, BRIT J PHARMACOL, V157, P24, DOI 10.1111/j.1476-5381.2009.00151.x; Hofstra CL, 2003, J PHARMACOL EXP THER, V305, P1212, DOI 10.1124/jpet.102.046581; Oda T, 2000, J BIOL CHEM, V275, P36781, DOI 10.1074/jbc.M006480200; Dunford PJ, 2006, J IMMUNOL, V176, P7062; Lubberts E, 2005, ARTHRITIS RES THER, V7, P29, DOI 10.1186/ar1478; Simonet WS, 1997, CELL, V89, P309, DOI 10.1016/S0092-8674(00)80209-3; Fu Q, 2002, J BIOL CHEM, V277, P48868, DOI 10.1074/jbc.M208494200; Jutel M, 2001, NATURE, V413, P420, DOI 10.1038/35096564; Gutzmer R, 2005, J IMMUNOL, V174, P5224; Shibata T, 2002, J BONE MINER RES, V17, P622, DOI 10.1359/jbmr.2002.17.4.622; Glatzer F, 2013, J ALLERGY CLIN IMMUN, V132, P1358, DOI 10.1016/j.jaci.2013.06.023; Takeuchi T, 2001, BIOCHEM PHARMACOL, V61, P579, DOI 10.1016/S0006-2952(00)00591-8; Takeshita K, 2003, J PHARMACOL EXP THER, V307, P1072, DOI 10.1124/jpet.103.057489; Nigrovic PA, 2005, ARTHRITIS RES THER, V7, P1, DOI 10.1186/ar1446; Damaj BB, 2007, J IMMUNOL, V179, P7907; O'Brien CA, 1999, J BIOL CHEM, V274, P19301, DOI 10.1074/jbc.274.27.19301; de Saint-Vis B, 1998, IMMUNITY, V9, P325, DOI 10.1016/S1074-7613(00)80615-9; Varga C, 2005, EUR J PHARMACOL, V522, P130, DOI 10.1016/j.ejphar.2005.08.045; Fonseca JE, 2002, ARTHRITIS RHEUM-US, V46, P1210, DOI 10.1002/art.10207; Crotti TN, 2002, ANN RHEUM DIS, V61, P1047, DOI 10.1136/ard.61.12.1047; Packard KA, 2003, INT IMMUNOPHARMACOL, V3, P909, DOI 10.1016/S1567-5769(02)00235-7; Lippert U, 2004, J INVEST DERMATOL, V123, P116, DOI 10.1111/j.0022-202X.2004.22721.x; Woolf AD, 2003, B WORLD HEALTH ORGAN, V81, P646; DAYER JM, 1976, P NATL ACAD SCI USA, V73, P945, DOI 10.1073/pnas.73.3.945; Nakamura T, 2000, BIOCHEM BIOPH RES CO, V279, P615, DOI 10.1006/bbrc.2000.4008; Gantner F, 2002, J PHARMACOL EXP THER, V303, P300, DOI 10.1124/jpet.102.036939; Takami M, 2000, ENDOCRINOLOGY, V141, P4711, DOI 10.1210/en.141.12.4711; Gschwandtner M, 2013, ALLERGY, V68, P37, DOI 10.1111/all.12051; Takeshita K, 2004, J PHARMACOL EXP THER, V310, P272, DOI 10.1124/jpet.103.063776; Ikawa Y, 2008, J TOXICOL SCI, V33, P503, DOI 10.2131/jts.33.503; Baeten D, 2004, ARTHRITIS RHEUM, V50, P444, DOI 10.1002/art.20012; Berger I, 2005, HISTOPATHOLOGY, V46, P490, DOI 10.1111/j.1365-2559.2005.01959.x; Coge F, 2001, BIOCHEM BIOPH RES CO, V284, P301, DOI 10.1006/bbrc.2001.4976; Deyama Y, 2002, BIOCHEM BIOPH RES CO, V298, P240, DOI 10.1016/S0006-291X(02)02440-3; Dijkstra D, 2008, J INVEST DERMATOL, V128, P1696, DOI 10.1038/sj.jid.5701250; Fitzpatrick LA, 2003, P NATL ACAD SCI USA, V100, P6027, DOI 10.1073/pnas.0934373100; Fonseca JE, 2005, CLIN EXP RHEUMATOL, V23, P185; FREWIN DB, 1986, J RHEUMATOL, V13, P13; Grzybowska-Kowalczyk A, 2008, INFLAMM RES, V57, pS63, DOI 10.1007/s00011-007-0631-1; Hamann J, 1999, ARTHRITIS RHEUM, V42, P650, DOI 10.1002/1529-0131(199904)42:4<650::AID-ANR7>3.0.CO;2-S; Hossain A, 2001, J AUTOIMMUN, V17, P289, DOI 10.1006/jaut.2001.0552; Ikawa Yoshiko, 2007, Journal of Toxicological Sciences, V32, P555, DOI 10.2131/jts.32.555; Ikawa Y, 2005, BIOL PHARM BULL, V28, P2016, DOI 10.1248/bpb.28.2016; Ishida H., 1998, NIHON NAIKA GAKKAI Z, V87, P147; Japan Osteoporosis Society, 2004, OSTEOPOROSIS JPN, V12, P191; Jutel M, 2001, INT ARCH ALLERGY IMM, V124, P190, DOI 10.1159/000053707; Kanematsu M, 2002, BONE, V30, P553, DOI 10.1016/S8756-3282(02)00680-4; Kodama S., 2006, J CHUGOKU SHIKOKU OR, V18, P87; KONTTINEN YT, 1989, J RHEUMATOL, V16, P339; Lesclous P, 2004, BONE, V34, P91, DOI 10.1016/j.bone.2003.08.007; Maslinska D, 2006, INFLAMM RES, V55, pS77, DOI 10.1007/s00011-005-0051-z; Matsuzaki S., 2003, SHINSHU MED J, V51, P9; NAGATA Y, 1991, Medical Journal of Kinki University, V16, P117; Ochi Takahiro, 2005, Nihon Rinsho, V63 Suppl 1, P439; Oda T, 2001, Nihon Yakurigaku Zasshi, V118, P36; Ohki E, 2007, BIOL PHARM BULL, V30, P2217, DOI 10.1248/bpb.30.2217; Ohnishi H, 2008, J ALLERGY CLIN IMMUN, V121, P864, DOI 10.1016/j.jaci.2008.01.035; Onodera K, 1999, Nihon Yakurigaku Zasshi, V114, P89; Page G, 2002, J IMMUNOL, V168, P5333; PELCZARS.A, 1969, J PHARM PHARMACOL, V21, P692; PERMIN H, 1981, ALLERGY, V36, P435, DOI 10.1111/j.1398-9995.1981.tb01852.x; SAEKI K, 1976, ARCH INT PHARMACOD T, V222, P132; Steenbakkers PGA, 2003, J IMMUNOL, V170, P5719; Suwa E, 2014, EXP DERMATOL, V23, P138, DOI 10.1111/exd.12313; Tanaka Masao, 2005, Nihon Rinsho, V63 Suppl 1, P80; Tanaka S., 2005, JPN J IMMUNOL, V28, P291, DOI 10.2177/jsci.28.291; Tanaka S, 1992, Nihon Rinsho, V50, P455; TAYLOR DJ, 1986, ARTHRITIS RHEUM, V29, P160, DOI 10.1002/art.1780290202; Watanabe T., 2003, INFECT INFLAMMATION, V33, P24; Yamaura K, 2012, RHEUMATOL INT, V32, P3309, DOI 10.1007/s00296-011-2069-6; Yamaura K, 2013, LIFE SCI, V92, P108, DOI 10.1016/j.lfs.2012.10.030; Yamaura K, 2003, J PHARMACOL SCI, V92, P43; Yamaura K, 2009, J TOXICOL SCI, V34, P427; Yasuda H, 1999, BONE, V25, P109, DOI 10.1016/S8756-3282(99)00121-0; Yoshida K, 2002, P NATL ACAD SCI USA, V99, P4580, DOI 10.1073/pnas.062053399	77	0	0	PHARMACEUTICAL SOC JAPAN	TOKYO	2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN	0031-6903			YAKUGAKU ZASSHI	Yakugaku Zasshi-J. Pharm. Soc. Jpn.	NOV	2014	134	11					1093	1108				16	Pharmacology & Pharmacy	Pharmacology & Pharmacy	AS0JU	WOS:000343964400001		
J	Hirose, J				Hirose, Junzo			Coordination Chemical Studies on the Zinc Enzymes	YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN			Japanese	Review						zinc-peptidase; chelating agent; coordination geometry; metal dissociation constant	DIPEPTIDYL-PEPTIDASE-III; BOVINE CARBONIC-ANHYDRASE; ERYTHROCYTE SUPEROXIDE-DISMUTASE; CIRCULAR DICHROIC SPECTRA; METAL-BINDING SITE; CARBOXYPEPTIDASE-A; AMINOPEPTIDASE-B; TERNARY COMPLEX; RAT-LIVER; COBALT(II) COMPLEXES	The metal dissociation constants of bovine carbonic anhydrase II, bovine carboxypeptidase A, rat aminopeptidase B, and rat dipeptidyl peptidase III were measured using metal buffer solutions. The zinc dissociation constants of bovine carbonic anhydrase II, bovine carboxypeptidase A, rat aminopeptidase B, and rat dipeptidyl peptidase III were 5.8 X 10(-14), 3.5 X 10(-12), 3.7 X 10(-13), and 1.9 X 10(-13) M, respectively. The ternary complex between metal derivatives of bovine carbonic anhydrase and various chelating agents were characterized using the kinetic method and visible and magnetic circular dichroism spectra. The coordination geometry of the ternary complex was in the equilibrium state between the five and the tetrahedral coordination geometry. The equilibrium state depends on the character of ligands. Dipeptidyl peptidase III which has an abnormal zinc binding motif (HEXXXH) was characterized using the point mutation and computer simulation methods. The abnormal zinc binding motif (HEXXXH) of rat dipeptidyl peptidase III has a large helix part. It is generally known that the cupric derivatives of the zinc peptidase loses enzyme activity, but the cupric derivative of dipeptidyl peptidase III surprisingly has enzyme activity. The measurement of the electron paramagnetic resonance spectra of the cupric rat dipeptidyl peptidase III in the presence of the substrate showed that the coordination geometry is very flexible. The flexibility of the coordination geometry in the cupric rat dipeptidyl peptidase III is important for the expression of enzyme activity. Docking simulation was used to identify the substrate binding site of aminopeptidase B, which is a powerful tool to estimate substrate binding residues in enzymes.	Fukuyama Univ, Fac Pharmaceut Sci, Fukuyama, Hiroshima 7200292, Japan	Hirose, J (reprint author), Fukuyama Univ, Fac Pharmaceut Sci, 1 Sanzo,Gakuen Cho, Fukuyama, Hiroshima 7200292, Japan.	hirose123j@sky.bbexcite.jp					ALBERT A, 1946, Med J Aust, V2, P566; Baral PK, 2008, J BIOL CHEM, V283, P22316, DOI 10.1074/jbc.M803522200; Fukasawa KM, 1999, BIOCHEM J, V339, P497, DOI 10.1042/0264-6021:3390497; Fukasawa KM, 2006, BIOCHEMISTRY-US, V45, P11425, DOI 10.1021/bi0604577; LINDSKOG S, 1964, BIOCHIM BIOPHYS ACTA, V85, P462, DOI 10.1016/0926-6569(64)90310-4; KIDANI Y, 1977, J BIOCHEM-TOKYO, V81, P1383; Fukasawa KM, 1996, J BIOL CHEM, V271, P30731, DOI 10.1074/jbc.271.48.30731; Bertini I., 1986, ZINC ENZYMES, P27; BERTINI I, 1988, INORG CHEM, V27, P2405, DOI 10.1021/ic00287a009; BERTINI I, 1993, INORG CHEM, V32, P1106, DOI 10.1021/ic00059a014; BERTINI I, 1978, J AM CHEM SOC, V100, P4873, DOI 10.1021/ja00483a038; BERTINI I, 1988, INORG CHEM, V27, P1081, DOI 10.1021/ic00279a029; Fukasawa K, 1999, BIOCHEMISTRY-US, V38, P8299, DOI 10.1021/bi9904959; Fukasawa K, 1998, BIOCHEM J, V329, P275; Fukasawa KM, 2011, J AMINO ACIDS, V2011; Fukasawa KM, 2010, BBA-PROTEINS PROTEOM, V1804, P2063, DOI 10.1016/j.bbapap.2010.06.015; GERBER K, 1975, BIOINORG CHEM, V4, P153, DOI 10.1016/S0006-3061(00)81024-8; GomezOrtiz M, 1997, FEBS LETT, V400, P336, DOI 10.1016/S0014-5793(96)01412-3; HIROSE J, 1981, J INORG BIOCHEM, V14, P313, DOI 10.1016/S0162-0134(00)80288-3; HIROSE J, 1985, BIOCHEMISTRY-US, V24, P3495, DOI 10.1021/bi00335a016; Hirose J, 2012, ARCH BIOCHEM BIOPHYS, V525, P71, DOI 10.1016/j.abb.2012.05.018; Hirose J, 2006, BIOL PHARM BULL, V29, P2378, DOI 10.1248/bpb.29.2378; HIROSE J, 1978, CHEM PHARM BULL, V26, P1768; HIROSE J, 1984, BIOCHEMISTRY-US, V23, P3149, DOI 10.1021/bi00309a007; Hirose J, 2001, BIOCHEMISTRY-US, V40, P11860, DOI 10.1021/bi0110903; HIROSE J, 1987, BIOCHEMISTRY-US, V26, P6561, DOI 10.1021/bi00394a041; HIROSE J, 1984, CHEM PHARM BULL, V32, P2481; HIROSE J, 1983, CHEM LETT, P1429, DOI 10.1246/cl.1983.1429; Hirose J, 2004, ARCH BIOCHEM BIOPHYS, V431, P1, DOI 10.1016/j.abb.2004.07.033; KIDANI Y, 1984, ANN NY ACAD SCI, V429, P140, DOI 10.1111/j.1749-6632.1984.tb12325.x; KIDANI Y, 1977, CHEM LETT, P475, DOI 10.1246/cl.1977.475; KIDANI Y, 1976, J BIOCHEM-TOKYO, V79, P43; HIROSE J, 1980, BIOCHIM BIOPHYS ACTA, V622, P71, DOI 10.1016/0005-2795(80)90159-2; KIDANI Y, 1978, BIOCHEM BIOPH RES CO, V82, P506, DOI 10.1016/0006-291X(78)90903-8; Kodera A., 2013, THESIS FUKUYAMA U; Larsen K. S., BIOCHEMISTRY, V28; LARSEN KS, 1991, BIOCHEMISTRY-US, V30, P2613, DOI 10.1021/bi00224a007; OZAKI S, 1988, INORG CHEM, V27, P3746, DOI 10.1021/ic00294a015; Sugimoto A, 2010, BIOL PHARM BULL, V33, P301; Sugimoto A, 2008, BIOL PHARM BULL, V31, P796, DOI 10.1248/bpb.31.796; Vallee B. L., 1980, ADV INORG BIOCHEM, V2, P27	41	0	0	PHARMACEUTICAL SOC JAPAN	TOKYO	2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN	0031-6903			YAKUGAKU ZASSHI	Yakugaku Zasshi-J. Pharm. Soc. Jpn.	NOV	2014	134	11					1109	1124				16	Pharmacology & Pharmacy	Pharmacology & Pharmacy	AS0JU	WOS:000343964400002		
J	Kuraishi, Y				Kuraishi, Yasushi			A Memoir of My Research on Pain and Analgesia for 39 Years	YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN			Japanese	Review						neuropathic pain; descending noradrenergic system; nociceptive transmitter; cancer pain	SPINAL DORSAL HORN; GENE-RELATED PEPTIDE; NUCLEUS-RETICULARIS GIGANTOCELLULARIS; HERPES-SIMPLEX-VIRUS; PRIMARY SENSORY NEURONS; BULBOSPINAL NORADRENERGIC SYSTEM; ORTHOTOPIC MELANOMA INOCULATION; DELAYED POSTHERPETIC PAIN; CAPSAICIN-EVOKED RELEASE; EXCITATORY AMINO-ACIDS	This review describes my research for the past 39 years regarding the pharmacology of pain and analgesia. We have demonstrated that the descending noradrenergic system is involved in the analgesic effect of morphine injected into the nucleus reticularis gigantocellularis, and that noradrenaline exerts antinociception mediated by alpha-adrenoceptors. We have found that noxious mechanical and thermal stimuli to the skin increase the release of substance P and somatostatin, respectively, from the dorsal horn in situ, and that noradrenaline inhibits the release of substance P and glutamate from primary afferents. We developed an animal model of cancer pain using melanoma cells. We have shown that the suppression of cancer pain results in the inhibition of tumor growth and lung metastasis, and that melanoma cells release several algogenic substances including ATP, endothelin-1, and bradykinin. We investigated neuropathic allodynia induced by the chemotherapeutic drugs paciltaxel, oxaliplatin, vincristine, and bortezomib. Single administration of these drugs caused allodynia with similar time-courses. However, antiallodynic actions of adjuvant analgesics, including gabapentin and limaprost, were dependent on the chemotherapeutic drugs used. Limaprost experiments have revealed that a decrease in peripheral blood flow is involved in allodynia exacerbation after the administration of paciltaxel and oxaliplatin. We have developed animal models of herpetic pain and postherpetic neuralgia using herpes simplex virus 1. We have demonstrated that nitric oxide, prostaglandin E-2, and galectin-3 are involved in herpetic allodynia, that risk factors associated with postherpetic allodynia include severe herpetic pain, nociceptin, and major histocompatibility complex, and that deafferentation and nitric oxide are involved in postherpetic allodynia.	Toyama Univ, Grad Sch Med & Pharmaceut Sci, Lab Appl Pharmacol, Toyama 9300194, Japan	Kuraishi, Y (reprint author), Toyama Univ, Grad Sch Med & Pharmaceut Sci, Lab Appl Pharmacol, 2630 Sugitani, Toyama 9300194, Japan.	kuraisiy@pha.u-toyama.ac.jp					Adhikari S., 2013, ACTA DERM-VENEREOL, V93, pP616; AKAIKE A, 1978, NEUROPHARMACOLOGY, V17, P775, DOI 10.1016/0028-3908(78)90093-X; ANDOH T, 1995, NEUROSCI LETT, V190, P101, DOI 10.1016/0304-3940(95)11512-U; Andoh T, 2008, BIOL PHARM BULL, V31, P520, DOI 10.1248/bpb.31.520; Gotoh Y, 2011, NEUROPHARMACOLOGY, V61, P825, DOI 10.1016/j.neuropharm.2011.05.030; DUGGAN AW, 1988, BRAIN RES, V451, P261, DOI 10.1016/0006-8993(88)90771-8; Abe T, 2005, EUR J NEUROSCI, V22, P1445, DOI 10.1111/j.1460-9568.2005.04340.x; Kitamura R, 2014, J PHARMACOL SCI, V124, P502, DOI 10.1254/jphs.13274FP; Nishioka M, 2011, INT J CLIN ONCOL, V16, P322, DOI 10.1007/s10147-010-0183-1; Okano K, 1998, JPN J PHARMACOL, V76, P15, DOI 10.1254/jjp.76.15; JU G, 1987, CELL TISSUE RES, V247, P417; Hidaka T, 2009, EUR J PAIN, V13, P22, DOI 10.1016/j.ejpain.2008.03.003; KURAISHI Y, 1989, PEPTIDES, V10, P447, DOI 10.1016/0196-9781(89)90057-0; Field MJ, 2006, P NATL ACAD SCI USA, V103, P17537, DOI 10.1073/pnas.0409066103; KURAISHI Y, 1983, BRAIN RES, V273, P245, DOI 10.1016/0006-8993(83)90849-1; Fujita M, 2010, EUR J PAIN, V14, P588, DOI 10.1016/j.ejpain.2009.10.010; Luo ZD, 2001, J NEUROSCI, V21, P1868; SATOH M, 1992, PAIN, V49, P273, DOI 10.1016/0304-3959(92)90151-Z; KOLTZENBURG M, 1992, PAIN, V51, P207, DOI 10.1016/0304-3959(92)90262-A; Jung BF, 2004, NEUROLOGY, V62, P1545; Fujita M, 2008, J PHARMACOL SCI, V106, P257, DOI 10.1254/jphs.FP0072051; Tanabe M, 2008, J NEUROSCI RES, V86, P3258, DOI 10.1002/jnr.21786; REDDY SVR, 1980, BRAIN RES, V189, P391; Wacnik PW, 2001, J NEUROSCI, V21, P9355; Gauchan P, 2009, J PHARMACOL SCI, V109, P469, DOI 10.1254/jphs.08325SC; OCHOA JL, 1993, ANN NEUROL, V33, P465, DOI 10.1002/ana.410330509; Kaku H, 2012, EXP THER MED, V3, P60, DOI 10.3892/etm.2011.375; BARON R, 1993, BRAIN, V116, P1477, DOI 10.1093/brain/116.6.1477; Tohda C, 2001, J NEUROCHEM, V76, P1628, DOI 10.1046/j.1471-4159.2001.00193.x; Sevcik MA, 2005, J PAIN, V6, P771, DOI 10.1016/j.jpain.2005.06.010; NAGY JI, 1981, BRAIN RES, V211, P497, DOI 10.1016/0006-8993(81)90980-X; Quasthoff S, 2002, J NEUROL, V249, P9, DOI 10.1007/PL00007853; Bahar MA, 2013, EVID-BASED COMPL ALT, DOI 10.1155/2013/849754; BASBAUM AI, 1976, P NATL ACAD SCI USA, V73, P4685, DOI 10.1073/pnas.73.12.4685; Fujita M, 2010, EUR J NEUROSCI, V31, P1629, DOI 10.1111/j.1460-9568.2010.07185.x; Gauchan P, 2009, BIOL PHARM BULL, V32, P732, DOI 10.1248/bpb.32.732; Gotoh Y, 2011, J PHARMACOL SCI, V115, P417, DOI 10.1254/jphs.10305SC; Hamilton SG, 2000, BRAIN, V123, P1238, DOI 10.1093/brain/123.6.1238; Harimaya Y, 2002, CANCER LETT, V187, P121, DOI 10.1016/S0304-3835(02)00360-9; HOKFELT T, 1976, NEUROSCIENCE, V1, P131, DOI 10.1016/0306-4522(76)90008-7; Inomata Y, 2013, ANESTH ANALG, V116, P722, DOI 10.1213/ANE.0b013e31827d139a; KAWAMURA M, 1989, BRAIN RES, V497, P199, DOI 10.1016/0006-8993(89)90990-6; Kitamura R., 2013, Journal of Traditional Medicines, V30, P183; KURAISHI Y, 1991, NEUROSCI RES, V11, P276, DOI 10.1016/0168-0102(91)90010-V; KURAISHI Y, 1985, BRAIN RES, V359, P177, DOI 10.1016/0006-8993(85)91426-X; KURAISHI Y, 1979, NEUROPHARMACOLOGY, V18, P107, DOI 10.1016/0028-3908(79)90016-9; Kuraishi Y, 2004, LIFE SCI, V74, P2619, DOI 10.1016/j.lfs.2004.01.005; KURAISHI Y, 1982, LIFE SCI, V30, P2071; Kuraishi Y, 1987, Pain Headache, V9, P101; KURAISHI Y, 1985, BRAIN RES, V326, P168, DOI 10.1016/0006-8993(85)91398-8; KURAISHI Y, 1985, BRAIN RES, V325, P294, DOI 10.1016/0006-8993(85)90326-9; KURAISHI Y, 1988, NEUROSCI LETT, V92, P325, DOI 10.1016/0304-3940(88)90611-8; KURAISHI Y, 1983, LIFE SCI, V33, P693, DOI 10.1016/0024-3205(83)90597-0; Kuraishi Y., 2014, CURRENT TOPICS BEHAV, P1; Kuraishi Y, 2003, BIOL PHARM BULL, V26, P550; KURAISHI Y, 1991, PAIN, V44, P321, DOI 10.1016/0304-3959(91)90103-5; KURAISHI Y, 1979, BRAIN RES, V174, P333, DOI 10.1016/0006-8993(79)90857-6; KURAISHI Y, 1984, BRAIN RES BULL, V12, P123, DOI 10.1016/0361-9230(84)90223-5; KURAISHI Y, 1989, NEUROSCIENCE, V30, P241, DOI 10.1016/0306-4522(89)90369-2; KURAISHI Y, 1978, BIOCHEM PHARMACOL, V27, P2756; LEWIS JW, 1983, PEPTIDES, V4, P635, DOI 10.1016/0196-9781(83)90010-4; Ma QP, 2000, NEUROSCIENCE, V101, P699, DOI 10.1016/S0306-4522(00)00419-X; MORTON CR, 1989, BRAIN RES, V488, P89, DOI 10.1016/0006-8993(89)90696-3; NAGY JI, 1980, BRAIN RES, V186, P435, DOI 10.1016/0006-8993(80)90987-7; NANAYAMA T, 1989, NEUROSCI RES, V6, P569, DOI 10.1016/0168-0102(89)90045-X; Nishikawa Y, 2009, NEUROREPORT, V20, P1077, DOI 10.1097/WNR.0b013e32832e0cc1; Oaklander A. L., 2001, PAIN, V92, P139; OHNO H, 1988, BRAIN RES, V474, P197, DOI 10.1016/0006-8993(88)90685-3; OHNO H, 1990, NEUROSCI RES, V8, P179, DOI 10.1016/0168-0102(90)90019-B; Omori Y, 2009, J PHARMACOL SCI, V109, P532, DOI 10.1254/jphs.08319FP; PAGE GG, 1993, PAIN, V54, P21, DOI 10.1016/0304-3959(93)90095-7; Pappagallo M, 2000, ANESTHESIOLOGY, V92, P691, DOI 10.1097/00000542-200003000-00013; RUSIN KI, 1993, BRAIN RES BULL, V30, P329, DOI 10.1016/0361-9230(93)90261-9; Sasaki A, 2013, NEUROREPORT, V24, P137, DOI 10.1097/WNR.0b013e32835df4d9; Sasaki A, 2008, NEUROREPORT, V19, P83, DOI 10.1097/WNR.0b013e3282f35839; Sasaki A, 2003, J PHARMACOL SCI, V92, P329; Sasaki A, 2007, NEUROSCIENCE, V150, P459, DOI 10.1016/j.neuroscience.2007.09.067; Sasaki A, 2008, J PHARMACOL SCI, V108, P266, DOI 10.1254/jphs.08154FP; Sasaki A, 2013, NEUROREPORT, V24, P652, DOI 10.1097/WNR.0b013e32836352d8; Sasaki M, 1998, NEUROREPORT, V9, P3219, DOI 10.1097/00001756-199810050-00016; Sasamura T, 2002, EUR J PHARMACOL, V441, P185, DOI 10.1016/S0014-2999(02)01450-4; Sato-Takeda M, 2004, PAIN, V110, P329, DOI 10.1016/j.pain.2004.04.010; Sato-Takeda M, 2006, ANESTHESIOLOGY, V104, P1063, DOI 10.1097/00000542-200605000-00024; SHAVIT Y, 1987, Brain Behavior and Immunity, V1, P318, DOI 10.1016/0889-1591(87)90034-1; SHIOMI H, 1974, BRIT J PHARMACOL, V52, P519; Shiraki K, 1998, NEUROSCI RES, V31, P235, DOI 10.1016/S0168-0102(98)00050-9; SUGIMOTO M, 1986, NEUROPHARMACOLOGY, V25, P481, DOI 10.1016/0028-3908(86)90171-1; TAKAGI H, 1975, LIFE SCI, V17, P67, DOI 10.1016/0024-3205(75)90237-4; TAKAGI H, 1979, EUR J PHARMACOL, V54, P99, DOI 10.1016/0014-2999(79)90412-6; TAKAGI H, 1977, EUR J PHARMACOL, V45, P91, DOI 10.1016/0014-2999(77)90064-4; Takasaki I, 2000, JPN J PHARMACOL, V83, P319, DOI 10.1254/jjp.83.319; Takasaki I, 2006, EUR J PHARMACOL, V550, P62, DOI 10.1016/j.ejphar.2006.08.041; Takasaki I, 2002, ANESTHESIOLOGY, V96, P1168, DOI 10.1097/00000542-200205000-00021; Takasaki I, 2000, PAIN, V86, P95, DOI 10.1016/S0304-3959(00)00240-2; Takasaki I, 2005, NEUROPHARMACOLOGY, V49, P283, DOI 10.1016/j.neuropharm.2004.12.025; Takasaki I, 2012, PAIN, V153, P585, DOI 10.1016/j.pain.2011.11.022; TISEO PJ, 1990, J PHARMACOL EXP THER, V252, P539; Tohda C, 1996, NEUROSCI RES, V24, P183, DOI 10.1016/0168-0102(95)00983-3; UEDA M, 1994, NEUROSCI RES, V20, P231, DOI 10.1016/0168-0102(94)90092-2; UEDA M, 1995, NEUROSCI LETT, V188, P137, DOI 10.1016/0304-3940(95)11397-F; UEDA M, 1993, NEUROSCI LETT, V155, P179, DOI 10.1016/0304-3940(93)90702-M; Unezaki S, 2012, MOL PAIN, V8, DOI 10.1186/1744-8069-8-59; Zhang H. W., 2001, PAIN RES, V16, P43; Zhang HW, 2003, J PHARMACOL SCI, V91, P167	104	0	0	PHARMACEUTICAL SOC JAPAN	TOKYO	2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN	0031-6903			YAKUGAKU ZASSHI	Yakugaku Zasshi-J. Pharm. Soc. Jpn.	NOV	2014	134	11					1125	1142				18	Pharmacology & Pharmacy	Pharmacology & Pharmacy	AS0JU	WOS:000343964400003		
J	Yamada, Y				Yamada, Yuma			Development of the MITO-Porter, a Nano Device for Mitochondrial Drug Delivery via Membrane Fusion	YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN			Japanese	Review						MITO-Porter; mitochondria; drug delivery system (DDS); nano device; mitochondrial medicine; mitocondrial gene therapy	LIPOSOME-BASED CARRIER; TARGETING SIGNAL PEPTIDE; PLASMID DNA; FUSOGENIC ENVELOPES; BONGKREKIC ACID; DISEASE; PROTEIN; SYSTEM; CELLS; MACROMOLECULE	Many human diseases have been reported to be associated with mitochondrial dysfunction. Therefore, mitochondrial therapy would be expected to be useful and productive in the treatment of various diseases. To achieve such an innovative therapy, it will be necessary to deliver therapeutic agents into mitochondria. However, only a limited number of methods are available for accomplishing this. We previously developed the MITO-Porter, a liposome-based carrier that permits macromolecular cargos to be transported into mitochondria via membrane fusion. Intracellular observations using the green fluorescence protein as a model macromolecule confirmed the mitochondrial delivery of a macromolecule by the MITO-Porter. Moreover, when we attempted the mitochondrial delivery of bongkrekic acid (BKA), an antiapoptosis agent, the MITO-Porter enhanced the antiapoptosis effect compared with naked BKA. To construct a device with enhanced performance, the MITO-Porter was coated with cell membrane-fusogenic outer envelopes to produce the dual function (DF) -MITO-Porter. Intracellular observations indicated that the DF-MITO-Porter was more effective in delivering exogenous macromolecules into mitochondria than the conventional MITO-Porter. Furthermore, when biomacromolecules were delivered using the DF-MITO-Porter to estimate the mitochondrial gene targeting of the carrier, the results confirmed that the MITO-Porter system has the potential for use in therapies aimed at mitochondrial DNA. This paper sumarizes our findings on mitochondrial drug delivery systems that are directed toward mitochondrial medicine development and mitochondrial gene therapy. It is expected that the MITO-Porter system will open new research areas in mitochondrial drug delivery systems and have a significant impact on the medical and life sciences.	Hokkaido Univ, Fac Pharmaceut Sci, Lab Mol Design Pharmaceut, Kita Ku, Sapporo, Hokkaido 0600812, Japan	Yamada, Y (reprint author), Hokkaido Univ, Fac Pharmaceut Sci, Lab Mol Design Pharmaceut, Kita Ku, Kita 12 Nishi 6, Sapporo, Hokkaido 0600812, Japan.	u-ma@pharm.hokudai.ac.jp					Flierl A, 2003, MOL THER, V7, P550, DOI 10.1016/S1525-0016(03)00037-6; Khalil IA, 2006, J BIOL CHEM, V281, P3544, DOI 10.1074/jbc.M503202200; Yamada Y, 2012, BIOMATERIALS, V33, P1589, DOI 10.1016/j.biomaterials.2011.10.082; Schatz G, 1996, J BIOL CHEM, V271, P31763; D'Souza GGM, 2003, J CONTROL RELEASE, V92, P189, DOI 10.1016/S0168-3659(03)00297-9; Yasuzaki Y, 2013, J CONTROL RELEASE, V172, P805, DOI 10.1016/j.jconrel.2013.09.029; Schapira AHV, 2012, LANCET, V379, P1825, DOI 10.1016/S0140-6736(11)61305-6; Liu F, 1999, GENE THER, V6, P1258, DOI 10.1038/sj.gt.3300947; Weissig V, 2001, J CONTROL RELEASE, V75, P401, DOI 10.1016/S0168-3659(01)00392-3; Futaki S, 2001, J BIOL CHEM, V276, P5836, DOI 10.1074/jbc.M007540200; Kajimoto K, 2014, J CONTROL RELEASE, V190, P593, DOI 10.1016/j.jconrel.2014.03.058; Biswas S, 2014, ADV DRUG DELIVER REV, V66, P26, DOI 10.1016/j.addr.2013.11.004; Chan DC, 2006, CELL, V125, P1241, DOI 10.1016/j.cell.2006.06.010; Zhang EL, 2011, DRUG DISCOV TODAY, V16, P140, DOI 10.1016/j.drudis.2010.12.006; Owen R, 2000, HUM GENE THER, V11, P2067, DOI 10.1089/104303400750001381; IGARASHI R, 1992, J PHARMACOL EXP THER, V262, P1214; Kogure K, 2004, J CONTROL RELEASE, V98, P317, DOI 10.1016/j.jconrel.2004.04.024; Yamada Y, 2012, METHOD ENZYMOL, V509, P301, DOI 10.1016/B978-0-12-391858-1.00015-0; Weissig V, 2011, PHARM RES-DORDR, V28, P2657, DOI 10.1007/s11095-011-0556-9; Smith RAJ, 1999, EUR J BIOCHEM, V263, P709, DOI 10.1046/j.1432-1327.1999.00543.x; Yamada Y, 2008, ADV DRUG DELIVER REV, V60, P1439, DOI 10.1016/j.addr.2008.04.016; James AM, 2007, J BIOL CHEM, V282, P14708, DOI 10.1074/jbc.M611463200; BRUIJN JD, 1973, TETRAHEDRON, V29, P1541; D'Souza GGM, 2005, MITOCHONDRION, V5, P352, DOI 10.1016/j.mito.2005.07.001; ENDO T, 1995, J BIOCHEM, V118, P753; Furukawa R, 2011, BIOCHEM BIOPH RES CO, V404, P796, DOI 10.1016/j.bbrc.2010.12.062; Furukawa R, 2012, FEBS OPEN BIO, V2, P145, DOI 10.1016/j.fob.2012.06.001; Kawamura E, 2013, MITOCHONDRION, V13, P610, DOI [10.1016/j.mito.2013.08.010, 10.1016/j.mito2013.08.010]; Kawamura E, 2013, J BIOSCI BIOENG, V116, P634, DOI 10.1016/j.jbiosc.2013.05.001; Wallace DC, 2005, GENE, V354, P169, DOI 10.1016/j.gene.2005.05.001; Yamada Y, 2012, J NANOPART RES, V14, DOI 10.1007/s11051-012-1013-3; Yamada Y, 2012, YAKUGAKU ZASSHI, V132, P1111; Yamada Y, 2013, J PHARM SCI-US, V102, P1008, DOI 10.1002/jps.23442; Yamada Y, 2011, MOL THER, V19, P1449, DOI 10.1038/mt.2011.99; Yamada Y, 2008, BBA-BIOMEMBRANES, V1778, P423, DOI 10.1016/j.bbamem.2007.11.002; Yamada Y, 2014, METHODS MOL BIOL, V1141, P57, DOI 10.1007/978-1-4939-0363-4_2; Yamada Y, 2013, MITOCHONDRION, V13, P526, DOI 10.1016/j.mito.2012.09.001; Yamada Y, 2007, MITOCHONDRION, V7, P63, DOI 10.1016/j.mito.2006.12.003; Yasuzaki Y, 2010, BIOCHEM BIOPH RES CO, V397, P181, DOI 10.1016/j.bbrc.2010.05.070	39	0	0	PHARMACEUTICAL SOC JAPAN	TOKYO	2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN	0031-6903			YAKUGAKU ZASSHI	Yakugaku Zasshi-J. Pharm. Soc. Jpn.	NOV	2014	134	11					1143	1155				13	Pharmacology & Pharmacy	Pharmacology & Pharmacy	AS0JU	WOS:000343964400004		
J	Saitoh, T				Saitoh, Tatsuya			Role of Intracellular Degradation System in Regulation of Innate Immune Response	YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN			Japanese	Review						cytokine and interferon; innate immunity; intracellular degradation system; organelle; pattern-recognition receptor; signal transduction	NEUTROPHIL EXTRACELLULAR TRAPS; HUMAN IMMUNODEFICIENCY VIRUS-1; PLASMACYTOID DENDRITIC CELLS; GENOME-WIDE ASSOCIATION; INFLAMMASOME ACTIVATION; ANTIVIRAL RESPONSE; CROHN-DISEASE; PROTEIN; AUTOPHAGY; PATHOGENESIS	Innate immunity is induced after sensing microbial components by pattern-recognition receptors and functions as a first line of host defense against microbes. However, innate immunity is also induced after sensing host-derived stimulatory substances such as monosodium urate crystals and causes the development of inflammatory diseases, such as gout. Therefore, a better understanding of innate immunity is required for the development of effective therapeutic treatments for infectious and inflammatory diseases. This paper summarizes recent findings on regulation of the innate immune response. Accumulating evidence has shown that the intracellular degradation system is critically involved in various cellular processes. We focused on the intracellular degradation system and have revealed the molecular mechanisms underlying regulation of the innate immune response. Ubiquitin-proteasome, autophagy and phagocyte-specific proteases most certainly regulate the innate immune response induced by infection of microbes and exposure to host-derived stimulatory substances. Therefore, intracellular degradation systems would be attractive therapeutic targets for the treatment of immune-related diseases.	Osaka Univ, Microbial Dis Res Inst, Dept Host Def, Suita, Osaka 5650871, Japan	Saitoh, T (reprint author), Osaka Univ, Microbial Dis Res Inst, Dept Host Def, 3-1 Yamada Oka, Suita, Osaka 5650871, Japan.	tatsuya@biken.osaka-u.ac.jp					Brinkmann V, 2012, J CELL BIOL, V198, P773, DOI 10.1083/jcb.201203170; Lee H, 2013, P NATL ACAD SCI USA, V110, P12379, DOI 10.1073/pnas.1310604110; KLEBANOFF SJ, 1992, J CLIN INVEST, V89, P2014, DOI 10.1172/JCI115810; Rioux JD, 2007, NAT GENET, V39, P596, DOI 10.1038/ng2032; Lupfer C, 2013, NAT IMMUNOL, V14, P480, DOI 10.1038/ni.2563; Desmet CJ, 2012, NAT REV IMMUNOL, V12, P479, DOI 10.1038/nri3247; Cai X, 2014, MOL CELL, V54, P289, DOI 10.1016/j.molcel.2014.03.040; Misawa T, 2013, NAT IMMUNOL, V14, P454, DOI 10.1038/ni.2550; Gao GX, 2002, SCIENCE, V297, P1703, DOI 10.1126/science.1074276; Kawai T, 2009, INT IMMUNOL, V21, P317, DOI 10.1093/intimm/dxp017; Lu KP, 2007, NAT REV MOL CELL BIO, V8, P904, DOI 10.1038/nrm2261; Meunier E, 2014, NATURE, V509, P366, DOI 10.1038/nature13157; Saitoh T, 2011, IMMUNITY, V34, P352, DOI 10.1016/j.immuni.2011.03.010; Saitoh T, 2012, CELL HOST MICROBE, V12, P109, DOI 10.1016/j.chom.2012.05.015; Saitoh T, 2009, P NATL ACAD SCI USA, V106, P20842, DOI 10.1073/pnas.0911267106; Hampe J, 2007, NAT GENET, V39, P207, DOI 10.1038/ng1954; Chang TL, 2004, AIDS REV, V6, P161; Latz E, 2013, NAT REV IMMUNOL, V13, P397, DOI 10.1038/nri3452; Mizushima N, 2011, CELL, V147, P728, DOI 10.1016/j.cell.2011.10.026; Razani B, 2012, CELL METAB, V15, P534, DOI 10.1016/j.cmet.2012.02.011; Saitoh T, 2006, NAT IMMUNOL, V7, P598, DOI 10.1038/ni1347; Nakahira K, 2011, NAT IMMUNOL, V12, P222, DOI 10.1038/ni.1980; Wen HT, 2011, NAT IMMUNOL, V12, P408, DOI 10.1038/ni.2022; Saitoh T, 2008, NATURE, V456, P264, DOI 10.1038/nature07383; HASELTINE WA, 1988, J ACQ IMMUN DEF SYND, V1, P217; Kumagai Y, 2009, J IMMUNOL, V182, P3960, DOI 10.4049/jimmunol.0804315; SCHIFF RD, 1986, CRIT REV ONCOL HEMAT, V5, P257, DOI 10.1016/S1040-8428(86)80041-5; Urban CF, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000639	28	0	0	PHARMACEUTICAL SOC JAPAN	TOKYO	2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN	0031-6903			YAKUGAKU ZASSHI	Yakugaku Zasshi-J. Pharm. Soc. Jpn.	NOV	2014	134	11					1157	1164				8	Pharmacology & Pharmacy	Pharmacology & Pharmacy	AS0JU	WOS:000343964400005		
J	Matsumoto, K				Matsumoto, Kenjiro			Immunohistochemical Analysis of Altered Serotonin Signaling and Transient Receptor Potential Vanilloid 1 Channels in Experimental Colitis Mice	YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN			Japanese	Review						enteric nervous system; inflammatory bowel disease; serotonin; transient receptor potential vanilloid type 1; visceral hypersensitivity	INFLAMMATORY-BOWEL-DISEASE; EXPRESSION; CAPSAICIN; TRPV1; HYPERSENSITIVITY; INTESTINE; SYSTEM; MOUSE; PAIN	Primary afferent nerve fibers are highly associated with visceral hypersensitivity state of inflammatory bowel disease. Hypersensitivity of afferent fibers occurs during inflammation, and therefore to gain insight into the alteration of receptors and channels, we examined receptors such as 5-HT receptors and transient receptor potential vanilloid type 1 (TRPV1), which are expressed in primary afferent neurons. The current study was designed to investigate the time-dependent dynamic changes of 5-HT3 receptors, 5-HT4 receptors, TRPV1 channels, and 5-HT regulatory factors in DSS-induced colitis model mice. Colitis was induced by 3% dextran sulfate sodium (DSS) solution given as drinking water in C57BL/6J mice. Immunohistochemical analysis and visceromotor responses to colorectal distension were measured during induction of DSS colitis (day 0, 4 and 7). Progress of the inflammation led to down regulation of serotonin transporter immunoreactivities with concomitant increases in 5-HT and tryptophan hydroxylase-1 positive cell numbers. TRPV1-expressing nerve fibers gradually increased during DSS treatment. Abundant non-neuronal TRPV1-immunopositive cell like structure was observed on day 7 of DSS treatment, but not on day 4. The number of 5-HT3 receptor-expressing nerve fibers increased in mucosa on day 7. On the other hand, 5-HT4 receptor-expressing nerve fibers decreased on day 7. TRPV1 antagonist and 5-HT3 receptor antagonist attenuated the visceral hyperalgesia to control level in the DSS-induced colitis model. We made the novel observations of increased neuronal/non-neuronal TRPV1 channel and 5-HT3 receptor expression, and decreased 5-HT4 receptor expression in mucosa. Moreover, we show that a correlation existed between the mucosal changes and visceral hypersensitivity in experimental colitis.	Josai Int Univ, Fac Pharmaceut Sci, Pharmacol Lab, Togane, Chiba 2838555, Japan	Matsumoto, K (reprint author), Josai Int Univ, Fac Pharmaceut Sci, Pharmacol Lab, 1 Gumyo, Togane, Chiba 2838555, Japan.	kenjiro@mb.kyoto-phu.ac.jp					Akbar A, 2010, GUT, V59, P767, DOI 10.1136/gut.2009.194449; Coates MD, 2004, GASTROENTEROLOGY, V126, P1657, DOI 10.1053/j.gastro.2004.03.013; Caterina MJ, 1997, NATURE, V389, P816; Furness JB, 2004, PROG NEUROBIOL, V72, P143, DOI 10.1016/j.pneurobio.2003.12.004; Amaya F, 2004, EUR J NEUROSCI, V20, P2303, DOI 10.1111/j.1460-9568.2004.03701.x; Matsumoto K, 2011, NEUROSCIENCE, V172, P518, DOI 10.1016/j.neuroscience.2010.10.024; Bertrand PP, 2010, AM J PHYSIOL-GASTR L, V298, pG446, DOI 10.1152/ajpgi.00318.2009; De Schepper HU, 2008, ALIMENT PHARM THERAP, V27, P621, DOI 10.1111/j.1365-2036.2008.03624.x; Gershon MD, 2007, GASTROENTEROLOGY, V132, P397, DOI 10.1053/j.gastro.2006.11.002; Gershon MD, 2005, J CLIN GASTROENTEROL, V39, pS184, DOI 10.1097/01.mcg.0000156403.37240.30; Gonlachanvit S, 2007, ALIMENT PHARM THERAP, V26, P617, DOI 10.1111/j.1365-2036.2007.03396.x; Matsumoto K, 2009, AM J PHYSIOL-GASTR L, V297, pG348, DOI 10.1152/ajpgi.90578.2008; Matsumoto K, 2012, LAB INVEST, V92, P769, DOI 10.1038/labinvest.2012.14; Zeng FN, 2010, GASTROENTEROLOGY, V138, P1491, DOI 10.1053/j.gastro.2009.11.048	14	0	0	PHARMACEUTICAL SOC JAPAN	TOKYO	2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN	0031-6903			YAKUGAKU ZASSHI	Yakugaku Zasshi-J. Pharm. Soc. Jpn.	NOV	2014	134	11					1165	1170				6	Pharmacology & Pharmacy	Pharmacology & Pharmacy	AS0JU	WOS:000343964400006		
J	Koyama, R				Koyama, Ryuta			Cellular and Molecular Mechanisms Underlying Aberrant Network Reorganization in the Epileptic Brain	YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN			Japanese	Review						dentate gyrus; epilepsy; mossy fiber sprouting; ectopic granule cell; axon guidance; neuronal migration	TEMPORAL-LOBE EPILEPSY; ECTOPIC GRANULE CELLS; ACID-TREATED RATS; DENTATE GYRUS; FEBRILE SEIZURES; SYNAPTIC REORGANIZATION; NEUROTROPHIC FACTOR; ANIMAL-MODELS; MOSSY FIBERS; HIPPOCAMPUS	Well-refined wiring of neural circuits is fundamental to proper brain function. Aberrantly formed neural circuits may induce epileptiform discharges of neurons. Therefore, elucidating the cellular and molecular mechanisms that underlie the development of aberrant neural circuitry will advance the understanding and prevention of epilepsy. The dentate gyrus has been suggested to serve as a gate that prevents the propagation of epileptiform activity from the entorhinal cortex to the hippocampus. Within the dentate gyrus is the dentate granule cell layer, which consists of densely packed granule cells that maintain intrinsically low-firing properties and rarely exhibit burst discharges synchronized with other neurons. Additionally, granule cells form abundant synaptic inputs to inhibitory interneurons in the dentate hilus, a fraction of which provide feedback inhibition back to the granule cells. Network reorganization of the dentate gyrus in patients with temporal lobe epilepsy and in corresponding animal models was reported. Specifically, mossy fiber sprouting and the emergence of ectopic granule cells contribute to the observed phenotypes. This paper reviews the expanding literature on the cellular and molecular mechanisms underlying the formation of aberrant hippocampal networks and their role in epileptogenesis.	Univ Tokyo, Grad Sch Pharmaceut Sci, Chem Pharmacol Lab, Bunkyo Ku, Tokyo 1130033, Japan	Koyama, R (reprint author), Univ Tokyo, Grad Sch Pharmaceut Sci, Chem Pharmacol Lab, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.	rkoyama@mol.f.u-tokyo.ac.jp					Bender RA, 2003, HIPPOCAMPUS, V13, P399, DOI 10.1002/hipo.10089; Bell B, 2011, NAT REV NEUROL, V7, P154, DOI 10.1038/nrneurol.2011.3; Chevassus-au-Louis N, 1999, EPILEPSIA, V40, P811, DOI 10.1111/j.1528-1157.1999.tb00786.x; Toyoda I, 2005, EPILEPSIA, V46, P1017, DOI 10.1111/j.1528-1167.2005.04605.x; Heinemann U, 1992, Epilepsy Res Suppl, V7, P273; Koyama R, 2004, J NEUROSCI, V24, P7215, DOI 10.1523/JNEUROSCI.2045-04.2004; Wuarin JP, 2001, J NEUROPHYSIOL, V85, P1067; TAUCK DL, 1985, J NEUROSCI, V5, P1016; Scharfman HE, 2002, EXP NEUROL, V174, P201, DOI 10.1006/exnr.2002.7869; Longo B, 2003, EXP NEUROL, V181, P57, DOI 10.1016/S0014-4886(02)00046-8; Bumanglag AV, 2008, J COMP NEUROL, V510, P561, DOI 10.1002/cne.21801; Binder DK, 2001, TRENDS NEUROSCI, V24, P47, DOI 10.1016/S0166-2236(00)01682-9; SUTULA T, 1988, SCIENCE, V239, P1147, DOI 10.1126/science.2449733; Liu GM, 2013, NEURON, V79, P31, DOI 10.1016/j.neuron.2013.04.027; Nissinen J, 2001, HIPPOCAMPUS, V11, P299, DOI 10.1002/hipo.1044; Tao K, 2014, DEV NEUROBIOL, V74, P557, DOI 10.1002/dneu.22149; Haas CA, 2010, EXP BRAIN RES, V200, P141, DOI 10.1007/s00221-009-1948-5; Goffin K, 2007, EXP NEUROL, V205, P501, DOI 10.1016/j.expneurol.2007.03.008; Koyama R, 2012, NAT MED, V18, P1271, DOI 10.1038/nm.2850; SLOVITER RS, 1992, NEUROSCI LETT, V137, P91, DOI 10.1016/0304-3940(92)90306-R; Russo E, 2010, EPILEPSIA, V51, P1560, DOI 10.1111/j.1528-1167.2009.02400.x; Lothman E W, 1992, Epilepsy Res Suppl, V7, P301; Buckmaster PS, 2002, J NEUROSCI, V22, P6650; Muramatsu R, 2007, NEUROSCIENCE, V148, P593, DOI 10.1016/j.neuroscience.2007.06.040; Koyama R, 2004, CURR NEUROVASC RES, V1, P3, DOI 10.2174/1567202043480242; Muramatsu R, 2008, EXP NEUROL, V211, P503, DOI 10.1016/j.expneurol.2008.02.026; Notenboom RGE, 2010, EUR J NEUROSCI, V32, P749, DOI 10.1111/j.1460-9568.2010.07321.x; Koyama R, 2010, J PHARMACOL SCI, V113, P14, DOI 10.1254/jphs.09R19FM; Lynch M, 2000, J NEUROPHYSIOL, V83, P693; Scharfman H, 2007, DEV NEUROSCI-BASEL, V29, P14, DOI 10.1159/000096208; Kwak SE, 2008, BRAIN RES, V1216, P1, DOI 10.1016/j.brainres.2008.04.026; CAVAZOS JE, 1991, J NEUROSCI, V11, P2795; Amaral DG, 2007, PROG BRAIN RES, V163, P3, DOI 10.1016/S0079-6123(07)63001-5; Blumenfeld H, 2008, EPILEPSIA, V49, P400, DOI 10.1111/j.1528-1167.2007.01458.x; HOUSER CR, 1990, BRAIN RES, V535, P195, DOI 10.1016/0006-8993(90)91601-C; Cavazos JE, 2003, J COMP NEUROL, V458, P272, DOI 10.1002/cne.10581; Gomez-Lira G, 2002, EXP NEUROL, V177, P276, DOI 10.1006/exnr.2002.7986; Koyama R, 2005, NEUROSCIENTIST, V11, P282, DOI 10.1177/1073858405278266; Koyama R, 2002, J PHYSIOL-LONDON, V539, P157, DOI 10.1013/jphysiol.2001.013505; Koyama R, 2004, DEV BIOL, V267, P29, DOI 10.1016/j.ydbio.2003.11.008; MARGERIS.JH, 1966, BRAIN, V89, P499, DOI 10.1093/brain/89.3.499; Miles R, 2012, JASPERS BASIC MECH E; Muramatsu R, 2010, BRAIN, V133, P60, DOI 10.1093/brain/awp266; Myers CE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068208; Okazaki MM, 1999, J NEUROPHYSIOL, V81, P1645; Patrylo PR, 1999, EPILEPSY RES, V36, P31, DOI 10.1016/S0920-1211(99)00022-4; Sloviter R. S., 2012, JASPERS BASIC MECH E; SLOVITER RS, 1987, SCIENCE, V235, P73, DOI 10.1126/science.2879352; Wasterlain C G, 1999, Adv Neurol, V79, P829	49	0	0	PHARMACEUTICAL SOC JAPAN	TOKYO	2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN	0031-6903			YAKUGAKU ZASSHI	Yakugaku Zasshi-J. Pharm. Soc. Jpn.	NOV	2014	134	11					1171	1177				7	Pharmacology & Pharmacy	Pharmacology & Pharmacy	AS0JU	WOS:000343964400007		
J	Taketomi, Y				Taketomi, Yoshitaka			Emerging Roles of Phospholipase A(2)s in Mast Cell Biology	YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN			Japanese	Review						phospholipase A(2); lipid mediator; mast cell; maturation; degranulation; anaphylaxis	EICOSANOID GENERATION; MOUSE; DEGRANULATION; MATURATION; RECEPTOR; GRANULE; D-2; INFLAMMATION; KINASE; MICE	Tissue-resident mast cells are derived from circulating committed progenitors, which are originated from pluripotent hematopoietic stem cells in bone marrow. These progenitors migrate into extravascular tissues, where they undergo differentiation and maturation into tissue-specific mast cell phenotypes. When activated by antigen or microenvironmental factors, mast cells release various biologically active products, including pre-formed mediators stored in secretory granules, de novo synthesized lipid mediators, and newly transcribed cytokines and chemokines; thereby promoting anaphylactic inflammation as well as other acute and chronic inflammatory diseases. Here, Twill highlight the newest understanding of the phospholipase A(2) (PLA(2)) -driven lipid networks in the maturation and effector functions of mast cells and attendant allergic responses. Group III secreted PLA(2), the sole mammalian homolog of the potent extrinsic anaphylaxis inducer bee venom PLA(2), regulates mast cell maturation through the paracrine prostaglandin D-2 (PGD(2)) circuit. While cytosolic PLA(2)alpha is essential for the generation of PGD(2) and leukotriene C-4 by mast cells, it is also functionally coupled, through the arachidonic acid transfer mechanism, with PGE(2) synthase in stromal fibroblasts to provide anti-anaphylactic PGE(2). In addition, the roles of two particular mast cell maturation-responsible genes, NDRG1 and NLRP3, in mast cells will be discussed.	Tokyo Metropolitan Inst Med Sci, Lipid Metab Project, Setagaya Ku, Tokyo 1568555, Japan	Taketomi, Y (reprint author), Tokyo Metropolitan Inst Med Sci, Lipid Metab Project, Setagaya Ku, 2-1-6 Kamikitazawa, Tokyo 1568555, Japan.	taketomi-ys@igakuken.or.jp					LIN LL, 1993, CELL, V72, P269, DOI 10.1016/0092-8674(93)90666-E; Nakazawa S, 2014, EUR J IMMUNOL, V44, P204, DOI 10.1002/eji.201343838; Agostini L, 2004, IMMUNITY, V20, P319, DOI 10.1016/S1074-7613(04)00046-9; Fujishima H, 1999, P NATL ACAD SCI USA, V96, P4803, DOI 10.1073/pnas.96.9.4803; Taketomi Y, 2013, NAT IMMUNOL, V14, P554, DOI 10.1038/ni.2586; Humphries DE, 1999, NATURE, V400, P769, DOI 10.1038/23481; Kaieda S, 2010, J BIOL CHEM, V285, P21478, DOI 10.1074/jbc.M110.114991; Forsberg E, 1999, NATURE, V400, P773; Kikawada E, 2007, BLOOD, V110, P561, DOI 10.1182/blood-2006-10-052258; Liu J, 2009, NAT MED, V15, P940, DOI 10.1038/nm.1994; Kokame K, 1996, J BIOL CHEM, V271, P29659; ZSEBO KM, 1990, CELL, V63, P213, DOI 10.1016/0092-8674(90)90302-U; Sun JS, 2007, NAT MED, V13, P719, DOI 10.1038/nm1601; Iwanaga K, 2014, CANCER RES, V74, P3011, DOI 10.1158/0008-5472.CAN-13-2792; Abrink M, 2004, J BIOL CHEM, V279, P40897, DOI 10.1074/jbc.M405856200; Kunikata T, 2005, NAT IMMUNOL, V6, P524, DOI 10.1038/ni1188; Murakami M, 2011, PROG LIPID RES, V50, P152, DOI 10.1016/j.plipres.2010.12.001; Gurish MF, 2012, IMMUNITY, V37, P25, DOI 10.1016/j.immuni.2012.07.003; Murata T, 2011, P NATL ACAD SCI USA, V108, P19802, DOI 10.1073/pnas.1110011108; Nakamura Y, 2009, J EXP MED, V206, P1037, DOI 10.1084/jem.20082179; Palm NW, 2013, IMMUNITY, V39, P976, DOI 10.1016/j.immuni.2013.10.006; Valentin E, 2000, J BIOL CHEM, V275, P7492, DOI 10.1074/jbc.275.11.7492; Morimoto K, 2014, J IMMUNOL, V192, P1130, DOI 10.4049/jimmunol.1300290; Stahelin RV, 2003, J BIOL CHEM, V278, P12452, DOI 10.1074/jbc.M212864200; Yamamoto Y, 2011, AM J PATHOL, V179, P302, DOI 10.1016/j.ajpath.2011.03.047; Lundequist A, 2010, J IMMUNOL, V184, P433, DOI 10.4049/jimmunol.0902835; Abraham SN, 2010, NAT REV IMMUNOL, V10, P440, DOI 10.1038/nri2782; Yao CC, 2009, NAT MED, V15, P633, DOI 10.1038/nm.1968; Murray JT, 2004, BIOCHEM J, V384, P477, DOI 10.1042/BJ20041057; MACPHEE M, 1995, CELL, V81, P957, DOI 10.1016/0092-8674(95)90015-2; Diaz BL, 2006, BBA-MOL CELL BIOL L, V1761, P1489, DOI 10.1016/j.bbalip.2006.09.009; Enomoto A, 2000, J IMMUNOL, V165, P4007; Granata F, 2010, BIOCHIMIE, V92, P588, DOI 10.1016/j.biochi.2010.02.030; Hoffman H. M., 2001, NAT GENT, V29, P301; Honda T, 2009, J ALLERGY CLIN IMMUN, V124, P809, DOI 10.1016/j.jaci.2009.04.029; Kanaoka Y., 2001, J BIOL CHEM, V168, P443; MURAKAMI M, 1993, J IMMUNOL, V151, P5675; Murakami M, 2001, J BIOL CHEM, V276, P10083, DOI 10.1074/jbc.M007877200; MURAKAMI M, 1992, EUR J BIOCHEM, V209, P257, DOI 10.1111/j.1432-1033.1992.tb17284.x; Nakamura Y, 2012, IMMUNITY, V37, P85, DOI 10.1016/j.immuni.2012.04.013; Nakatani N, 2000, BIOCHEM J, V352, P311, DOI 10.1042/0264-6021:3520311; Ogasawara T, 1997, J IMMUNOL, V158, P393; Ohtsu H., 2001, FEBS LETT, V305, P181; Schmid E, 2013, AM J PHYSIOL-CELL PH, V304, pC49, DOI 10.1152/ajpcell.00179.2012; Starkl P, 2013, NAT IMMUNOL, V14, P527, DOI 10.1038/ni.2612; Taketomi Y., 2003, BIOCHEM BIOPH RES CO, V134, P699; Taketomi Y, 2007, J IMMUNOL, V178, P7042; Triggiani M, 2009, J ALLERGY CLIN IMMUN, V124, P558, DOI 10.1016/j.jaci.2009.04.035; Ueno N, 2011, J BIOL CHEM, V286, P37249, DOI 10.1074/jbc.M111.290312; Ueno N, 2008, BBA-MOL CELL BIOL L, V1781, P415, DOI 10.1016/j.bbalip.2008.06.011	50	0	0	PHARMACEUTICAL SOC JAPAN	TOKYO	2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN	0031-6903			YAKUGAKU ZASSHI	Yakugaku Zasshi-J. Pharm. Soc. Jpn.	NOV	2014	134	11					1179	1189				11	Pharmacology & Pharmacy	Pharmacology & Pharmacy	AS0JU	WOS:000343964400008		
J	Min, JZ				Min, Jun Zhe			Development of a Highly Sensitive Separation Method for the Analysis of Metabolites in Human Nails and Applications in the Diagnosis of Chronic Disease	YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN			Japanese	Review						human nail; D,L-amino acid; polyamine; 3-deoxyglucosone; diabetes; lung cancer	ADVANCED MAILLARD REACTION; FLIGHT MASS-SPECTROMETRY; IN-VIVO DETERMINATION; LIQUID-CHROMATOGRAPHY; PROTEIN GLYCATION; POLYAMINES; PLASMA; 3-DEOXYGLUCOSONE; INTERMEDIATE; PRODUCTS	We have recently developed target-specific derivatization methods for determining the metabolites in human nails. The nails can be used to obtain physiologic information and may serve as noninvasive biosamples for the diagnosis of chronic disease. Certain endogenous biogenic D,L-amino acids, polyamines, and advanced glycation end-products (AGEs) have been detected in human nails. By identifying biological trace components in human samples, we tested the possibility of using these new methods to diagnose chronic disease, i.e., diabetes and lung cancer. When comparing the index from diabetic patients to that from healthy volunteers, there was no significant difference in the content of L-amino acids, methylglyoxal, and glyoxal in the nails. However, a statistically significant correlation was observed between the D/L-amino acid concentration ratios (Ala, Val, Ile, Leu; p<0.01), and 3-deoxyglucosone concentrations (p<0.001). Additionally, in the lung cancer patient group, as compared with healthy volunteers, the concentrations of spermine showed a statistically significant (p<0.05) correlation. This review describes our current target-specific derivatization UPLC-EST-MS methods for the determination of metabolites and related compounds, e.g., D,L-amino acids, polyamines, and AGEs, in human nails. Advanced applications of human nails as new, noninvasively obtained biosamples for the diagnosis of chronic disease are also described.	[Min, Jun Zhe] Univ Shizuoka, Sch Pharmaceut Sci, Lab Analyt & Bioanalyt Chem, Suruga Ku, Shizuoka 4228526, Japan; [Min, Jun Zhe] Yanbian Univ, Key Lab Nat Resource Changbai Mt Funct Mol, Minist Educ, Coll Pharm, Yanji 133002, Jilin Province, Peoples R China	Min, JZ (reprint author), Univ Shizuoka, Sch Pharmaceut Sci, Lab Analyt & Bioanalyt Chem, Suruga Ku, 52-1 Yada, Shizuoka 4228526, Japan.	junzhe@u-shizuoka-ken.ac.jp					Palmeri A, 2000, CLIN PHARMACOKINET, V38, P95, DOI 10.2165/00003088-200038020-00001; Byun JA, 2008, BIOMED CHROMATOGR, V22, P73, DOI 10.1002/bmc.898; Min JZ, 2014, BIOMED CHROMATOGR, V28, P492, DOI 10.1002/bmc.3059; Min JZ, 2011, CLIN CHIM ACTA, V412, P98, DOI 10.1016/j.cca.2010.09.018; YAMADA H, 1994, J BIOL CHEM, V269, P20275; Irving RC, 2007, FORENSIC SCI INT, V166, P58, DOI 10.1016/j.forsciint.2006.03.027; Min JZ, 2011, J CHROMATOGR B, V879, P3220, DOI 10.1016/j.jchromb.2011.02.016; Morikawa A, 2007, BIOCHEM BIOPH RES CO, V355, P872, DOI 10.1016/j.bbrc.2007.02.056; Min JZ, 2012, ANAL BIOCHEM, V424, P187, DOI 10.1016/j.ab.2012.02.025; Gerner EW, 2004, NAT REV CANCER, V4, P781, DOI 10.1038/nrc1454; Niwa T, 2006, MASS SPECTROM REV, V25, P713, DOI 10.1002/mas.20089; Odani H, 1999, BIOCHEM BIOPH RES CO, V256, P89, DOI 10.1006/bbrc.1999.0221; Casero RA, 2009, BIOCHEM J, V421, P323, DOI 10.1042/BJ20090598; Hegele J, 2008, ANAL CHIM ACTA, V617, P85, DOI 10.1016/j.aca.2007.12.027; Min JZ, 2010, ANAL METHODS-UK, V2, P1233, DOI 10.1039/c0ay00373e; Biemel KM, 2003, BIOCONJUGATE CHEM, V14, P619, DOI 10.1021/bc025653e; Min J.Z., 2014, CHROMATOGRAPHY, V35, P23; Miyagi Y., 2011, PLOS ONE, V6, P1; Mochida T, 2011, MOL GENET METAB, V103, P406, DOI 10.1016/j.ymgme.2011.05.002; NIWA T, 1993, BIOCHEM BIOPH RES CO, V196, P837, DOI 10.1006/bbrc.1993.2325; Odani H, 1999, J CHROMATOGR B, V731, P131, DOI 10.1016/S0378-4347(99)00206-6; Sugiura K, 2008, J CHROMATOGR A, V1205, P94, DOI 10.1016/j.chroma.2008.08.026; Umemori Y, 2010, CLIN CHIM ACTA, V411, P1894, DOI 10.1016/j.cca.2010.07.018	23	1	1	PHARMACEUTICAL SOC JAPAN	TOKYO	2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN	0031-6903			YAKUGAKU ZASSHI	Yakugaku Zasshi-J. Pharm. Soc. Jpn.	NOV	2014	134	11					1191	1198				8	Pharmacology & Pharmacy	Pharmacology & Pharmacy	AS0JU	WOS:000343964400009		
J	Kurio, W; Konishi, M; Okuno, T; Nakao, T; Kimura, T; Tsuji, T; Yamamuro, A; Yamamoto, Y; Nishikawa, T; Yanada, K; Yasuhara, T; Kohno, T; Ogita, K; Sone, T				Kurio, Wasako; Konishi, Motomi; Okuno, Tomofumi; Nakao, Teruyuki; Kimura, Tomoki; Tsuji, Takumi; Yamamuro, Akiko; Yamamoto, Yumi; Nishikawa, Tomoe; Yanada, Kazuo; Yasuhara, Tomohisa; Kohno, Takeyuki; Ogita, Kiyokazu; Sone, Tomomichi			A Self-improvement and Participatory Career Development Education Program Involving Internships and Volunteer Training Experience for Pharmacy Students: Results Verified in a Follow-up Survey Three Years after Participation	YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN			Japanese	Article						careers education; participatory practice; pharmaceutical education; internship		The Faculty of Pharmaceutical Sciences, Setsunan University, offers the Self-improvement and Participatory Career Development Education Program: Internship and Volunteer Training Experience for Pharmacy Students to third-year students. We previously reported that the training experience was effective in cultivating important attributes among students, such as a willingness to learn the aims of pharmacists, an awareness of their own role as healthcare workers, and a desire to reflect on their future careers and lives. A follow-up survey of the participants was carried out three years after the training experience. The questionnaire verified that the training experience affected attendance at subsequent lectures and course determination after graduation. We confirmed the relationship between the participants' degree of satisfaction with the training experience and increased motivation for attending subsequent lectures. Through the training experience, participants discovered future targets and subjects of study. In addition, they became more interested in subsequent classroom lessons and their future. The greater the participants' degree of satisfaction with their training experience, the more interest they took in practical training and future courses. The present study clarified that the training experience was effective in cultivating important attributes such as a willingness to learn and an interest in future courses. Moreover, the training positively affected the course determination after graduation.	[Kurio, Wasako; Konishi, Motomi; Okuno, Tomofumi; Nakao, Teruyuki; Kimura, Tomoki; Tsuji, Takumi; Yamamuro, Akiko; Yamamoto, Yumi; Nishikawa, Tomoe; Yanada, Kazuo; Yasuhara, Tomohisa; Kohno, Takeyuki; Ogita, Kiyokazu; Sone, Tomomichi] Setsunan Univ, Fac Pharmaceut Sci, Hirakata, Osaka 5730101, Japan	Kurio, W (reprint author), Setsunan Univ, Fac Pharmaceut Sci, 45-1 Nagaotoge Cho, Hirakata, Osaka 5730101, Japan.	kurio@pharm.setsunan.ac.jp					Central Council for Education, 2008, TURN CONSTR COLL PRO, P1; Central Council for Education, 2004, IMPR FULLN PHARM ED, P1; Kurio W., 2012, JPN J PHARM HLTH CAR, V38, P757; Ministry of Economy, 2006, OFF B EC TRAD IND, P4; Ministry of Economy, 2006, ROUMU GYOUSEI INFO, V314, P14; Ministry of Economy, 2007, ROUMU GYOUSEI INFO, V329, P2; Setsunan University, 2009, SYLLABUS 2009 FAC PH, P1; Wiedenmayer K., 2011, DEV PHARM PRACTICE F, P1	8	1	1	PHARMACEUTICAL SOC JAPAN	TOKYO	2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN	0031-6903			YAKUGAKU ZASSHI	Yakugaku Zasshi-J. Pharm. Soc. Jpn.	NOV	2014	134	11					1199	1208				10	Pharmacology & Pharmacy	Pharmacology & Pharmacy	AS0JU	WOS:000343964400010		
J	Yamada, K; Kinoshita, M; Jo, Y; Inoue, T; Aoshima, M; Hasegawa, K; Sei, K; Kita, S; Kakehi, K				Yamada, Keita; Kinoshita, Mitsuhiro; Jo, Yoshio; Inoue, Toshiki; Aoshima, Motonori; Hasegawa, Kiyotaka; Sei, Kazuo; Kita, Soichiro; Kakehi, Kazuaki			Structural Analysis of Carboxymethyl Cellulose Used as an Antiadhesive Material for Surgical Wound Healing	YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN			Japanese	Article						anti-adhesive material; carboxymethyl cellulose; monosaccharide analysis; ethyl 4-aminobenzoate; LC-fluorescent detection-MS; NMR	ADHESIONS; SPECTROMETRY; PREVENTION	Carboxymethyl cellulose (CMC) is one of the most important cellulose derivatives and used in the fields of food, pharmaceuticals, cosmetics, and paint. Fibrous CMC is used an antiadhesive material to prevent postoperative wound adhesions. The degree of substitution and distribution of the substituent (i.e., the carboxymethyl group) are the most important parameters for the function of CMC. Thus, CMC used for antiadhesive material must be carefully evaluated, because the CMC product is retained in patients' bodies over the long term. Although identification tests of CMC are defined in the Japanese Pharmacopoeia, it is difficult to evaluate its structure using those tests. In the present study, we propose improved methods for evaluating CMC products by. analyzing monosaccharides after hydrolysis.	[Yamada, Keita] Osaka Ohtani Univ, Fac Pharm, Lab Toxicol, Tondabayashi, Osaka 5848640, Japan; [Kinoshita, Mitsuhiro; Kakehi, Kazuaki] Kinki Univ, Sch Pharm, Dept Biopharmaco Informat, Higashiosaka, Osaka 5778502, Japan; [Jo, Yoshio; Inoue, Toshiki; Aoshima, Motonori; Hasegawa, Kiyotaka; Sei, Kazuo; Kita, Soichiro] HOGY Med Co Ltd, Dept Res & Dev, Ushi Ku, Ibaraki 3001283, Japan	Yamada, K (reprint author), Osaka Ohtani Univ, Fac Pharm, Lab Toxicol, 3-11-1 Nishikiori Kita, Tondabayashi, Osaka 5848640, Japan.	m-kino@phar.kindai.ac.jp					Ahn JH, 2012, LARYNGOSCOPE, V122, P912, DOI 10.1002/lary.23213; RYAN CK, 1995, AM J SURG, V169, P154, DOI 10.1016/S0002-9610(99)80125-1; Pabst M, 2009, ANAL BIOCHEM, V384, P263, DOI 10.1016/j.ab.2008.09.041; HO FFL, 1980, ANAL CHEM, V52, P913, DOI 10.1021/ac50056a032; Becker JM, 1996, J AM COLL SURGEONS, V183, P297; Baakdah Hanadi, 2005, Surg Technol Int, V14, P185; BLYTHE RH, 1949, J AM PHARM ASSOC SCI, V38, P59; Cohen A, 2004, J CHROMATOGR A, V1029, P87, DOI 10.1016/j.chroma.2003.12.010; COURTOIS JE, 1982, B ACAD NAT MED PARIS, V166, P853; Enebro J, 2009, CARBOHYD RES, V344, P2173, DOI 10.1016/j.carres.2009.08.009; MENZIES D, 1990, ANN ROY COLL SURG, V72, P60; Sjoberg J, 2004, CARBOHYD RES, V339, P2037, DOI 10.1016/j.carres.2004.06.003	12	0	0	PHARMACEUTICAL SOC JAPAN	TOKYO	2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN	0031-6903			YAKUGAKU ZASSHI	Yakugaku Zasshi-J. Pharm. Soc. Jpn.	NOV	2014	134	11					1209	1217				9	Pharmacology & Pharmacy	Pharmacology & Pharmacy	AS0JU	WOS:000343964400011		
J	Tanaka, I; Watanabe, K; Nakaminami, H; Azuma, C; Noguchi, N				Tanaka, Ippei; Watanabe, Kiyoshi; Nakaminami, Hidemasa; Azuma, Chihiro; Noguchi, Norihisa			Disinfection Efficacy of Hand Hygiene Based on Chlorhexidine Gluconate Content and Usage of Alcohol-based Hand-rubbing Solution	YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN			Japanese	Article						alcohol-based hand-rubbing; chlorhexidine gluconate; surgical hand hygiene; antiseptics		Recently, the procedure for surgical hand hygiene has been switching to a two-stage method and hand-rubbing method from the traditional hand-scrubbing method. Both the two-stage and hand-rubbing methods use alcohol-based hand-rubbing after hand washing. The former requires 5 min of antiseptic hand washing, and the latter 1 min of nonantiseptic hand washing. For a prolonged bactericidal effect in terms of surgical hand hygiene, chlorhexidine gluconate (CHG) has been noted due to its residual activity. However, no detailed study comparing the disinfection efficacy and prolonged effects according to different contents of CHG and the usage of alcohol-based hand-rubbing has been conducted. The glove juice method is able to evaluate disinfection efficacy and prolonged effects of the disinfectants more accurately because it can collect not only transitory bacteria but also normal inhabitants on hands. In the present study, we examined the disinfection efficacy and prolonged effects on alcohol-based hand-rubbing containing CHG by six hand-rubbing methods and three two-stage methods using the glove juice method. In both methods, 3 mL (one pump dispenser push volume) alcohol-based hand-rubbing solution containing 1% (w/v) CHG showed the highest disinfection efficacy and prolonged effects, and no significant difference was found between the hand-rubbing and two-stage methods. In the two methods of hand hygiene, the hand-rubbing method was able to save time and cost. Therefore, the data strongly suggest that the hand-rubbing method using a one pump dispenser push volume of alcohol-based hand-rubbing solution containing 1% (w/v) CHG is suitable for surgical hand hygiene.	[Tanaka, Ippei; Nakaminami, Hidemasa; Azuma, Chihiro; Noguchi, Norihisa] Tokyo Univ Pharm & Life Sci, Sch Pharm, Dept Microbiol, Hachioji, Tokyo 1920392, Japan; [Watanabe, Kiyoshi] Hachioji Pharmaceut Ctr, Hachioji, Tokyo 1930944, Japan	Tanaka, I (reprint author), Tokyo Univ Pharm & Life Sci, Sch Pharm, Dept Microbiol, 1432-1 Horinouchi, Hachioji, Tokyo 1920392, Japan.	noguchin@toyaku.ac.jp					LARSON EL, 1995, AM J INFECT CONTROL, V23, P251, DOI 10.1016/0196-6553(95)90070-5; Parienti JJ, 2002, JAMA-J AM MED ASSOC, V288, P722, DOI 10.1001/jama.288.6.722; ASTM Standard, 1996, STAND TEST METH EV S; Boyce John M, 2002, MMWR Recomm Rep, V51, P1; Chisaki Y., 2013, JPN J PHARM HLTH CAR, V39, P251; Fukata T., 2006, J JPN SOC SURG INFEC, V3, P515; Imamura Y., 2007, JPN J ENV INFECT, V22, P28; Ishiwata N., 2009, JPN J ENV INFECT, V24, P319; Kobayashi Y., 2010, OKAYAMA IGAKKAI ZASS, V122, P225, DOI 10.4044/joma.122.225; Kumagai A., 2012, JPN J ENV INFECT, V27, P375; Kunisada T., 1999, JPN SOC ENV INFECT, V14, P127; Nishimura C, 1998, J NEW REM CLIN, V47, P749; Shiraishi T., 2008, JPN J ENV INFECT, V23, P124; Sugawara E., 2008, J HEALTHCARE ASS INF, V1, P53; WALSH B, 1987, J HOSP INFECT, V9, P30, DOI 10.1016/0195-6701(87)90091-0; Watanabe K., 2013, JPN J PHARM HLTH CAR, V39, P304; Yoshida Pharmaceutical, 2012, SHOUD TEXT; Yoshida R., 2009, J HEALTHCARE ASS INF, V2, P66	18	1	1	PHARMACEUTICAL SOC JAPAN	TOKYO	2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN	0031-6903			YAKUGAKU ZASSHI	Yakugaku Zasshi-J. Pharm. Soc. Jpn.	NOV	2014	134	11					1219	1225				7	Pharmacology & Pharmacy	Pharmacology & Pharmacy	AS0JU	WOS:000343964400012		
J	Yamaguchi, T; Akiyama, S; Sagara, H; Tanaka, A; Miyauchi, Y; Araki, H; Shibata, K; Izushi, F; Namba, H				Yamaguchi, Takumi; Akiyama, Shinji; Sagara, Hidenori; Tanaka, Akihiro; Miyauchi, Yoshirou; Araki, Hiroaki; Shibata, Kazuhiko; Izushi, Fumio; Namba, Hiroyuki			Effects of Practical Training to Increase Motivation for Learning and Related Factors	YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN			Japanese	Article						practical training; model core curriculum; pharmaceutical education system		Under the six-year pharmaceutical education system that was initiated in April 2006, students who had completed the course in March 2012 became the first graduates. The six-year system encourages students to develop a well-rounded personality, a deep sense of ethics, knowledge required for health care professionals, abilities to identify and solve problems, and practical skills required in clinical settings, as well as basic knowledge and skills. Under the new education system based on the "pharmaceutical education model core curriculums" and "practical training model core curriculums", general pharmaceutical education is implemented in each college, and five-month practical training is conducted in clinical settings. Clinical tasks experienced by students for the first time are expected to significantly influence their motivation to learn and future prospects. In the present survey research, students who had completed practical training evaluated the training program, and correspondence and logistic regression analyses of the results were conducted to examine the future effects and influences of the training on the students. The results suggest that the students viewed the practical training program positively. In addition, clinical experience during the training sessions not only influenced their decisions on future careers, but also significantly increased their motivation to learn. Furthermore, their motivation for learning was increased most by the enthusiasm of pharmacists who advised them in clinical settings, rather than the training program itself. To improve pharmaceutical clinical learning, it is important to develop teaching and working environments for pharmacists in charge of advising students in clinical training.	[Yamaguchi, Takumi; Akiyama, Shinji; Sagara, Hidenori; Shibata, Kazuhiko; Izushi, Fumio; Namba, Hiroyuki] Matsuyama Univ, Ctr Clin Pharm, Matsuyama, Ehime 7908578, Japan; [Tanaka, Akihiro; Araki, Hiroaki] Ehime Univ Hosp, Div Pharm, Toon, Ehime 7910295, Japan; [Tanaka, Akihiro; Araki, Hiroaki] Ehime Soc Hosp Pharm, Toon, Ehime 7910295, Japan; [Miyauchi, Yoshirou] Ehime Pharmaceut Assoc, Matsuyama, Ehime 7900003, Japan	Yamaguchi, T (reprint author), Matsuyama Univ, Ctr Clin Pharm, 4-2 Bunkyo Cho, Matsuyama, Ehime 7908578, Japan.	tyamagu@cc.matsuyama-u.ac.jp					American Association of Colleges of Pharmacy, ASS MAN ADV PHARM PR; Yamaguchi T, 2013, YAKUGAKU ZASSHI, V133, P1249; Council on Pharmaceutical Education, YAK JITS; Ministry of Education Culture Sports Science and Technology, YAK KYOUIK MOD COR C; Nagasato A., 2013, J JPN SOC HOSP PHARM, V49, P861; Nakamura M., 2013, B SHOWA PHARM U, V47, P33; The Daniel K. Inouye College of Pharmacy at UH Hilo, 2014, ADV PHARM PRACT EXP; The Pharmaceutical Society of Japan, 2014, JITS JISSH MOD COR C; The Pharmaceutical Society of Japan, 2014, YAK KYOUIK MOD COR C; Turner J. C., 2007, AM J PHARM EDUC, V71, P46; Yoshida Y., 2013, 133 ANN M PHARM SOC, P238	11	0	0	PHARMACEUTICAL SOC JAPAN	TOKYO	2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN	0031-6903			YAKUGAKU ZASSHI	Yakugaku Zasshi-J. Pharm. Soc. Jpn.	NOV	2014	134	11					1227	1235				9	Pharmacology & Pharmacy	Pharmacology & Pharmacy	AS0JU	WOS:000343964400013		
J	Pal, C; Tomosaburo, O; Vimalathithan, K; Jeyabharath, M; Muthukumar, M; Satheesh, N; Narahari, S				Pal, Chinmoy; Tomosaburo, Okabe; Vimalathithan, K.; Jeyabharath, M.; Muthukumar, M.; Satheesh, N.; Narahari, S.			Effect of weight, height and BMI on injury outcome in side impact crashes without airbag deployment	ACCIDENT ANALYSIS AND PREVENTION			English	Article						BMI; Side impact; Lower extremity injury; Thoracic injury; Abdomen injury; Head injury	MOTOR-VEHICLE CRASHES	A comprehensive analysis is performed to evaluate the effect of weight, height and body mass index (BMI) of occupants on side impact injuries at different body regions. The accident dataset for this study is based on the National Automotive Sampling System-Crashworthiness Data System (NASS-CDS) for accident year 2000-08. The mean BMI values for driver and front passenger are estimated from all types of crashes using NASS database, which clearly indicates that mean BMI has been increasing over the years in the USA. To study the effect of BMI in side impact injuries, BMI was split into three groups namely (1) thin (BMI < 21), (2) normal (BMI 24-27), (3) obese (BMI > 30). For more clear identification of the effect of BMI in side impact injuries, a minimum gap of three BMI is set in between each adjacent BMI groups. Car model years from MY1995-1999 to MY2000-2008 are chosen in order to identify the degree of influence of older and newer generation of cars in side impact injuries. Impact locations particularly side-front (F), side-center (P) and side-distributed (Y) are chosen for this analysis. Direction of force (DOF) considered for both near side and far side occupants are 8 o'clock, 9 o'clock, 10 o'clock and 2 o'clock, 3 o'clock and 4 o'clock respectively. Age <60 years is also one of the constraints imposed on data selection to minimize the effect of bone strength on the occurrence of occupant injuries. AIS2+ and AIS3+ injury risk in all body regions have been plotted for the selected three BMI groups of occupant, delta-V 0-60 kmph, two sets (old and new) of car model years. The analysis is carried with three approaches: (a) injury risk percentage based on simple graphical method with respect to a single variable, (b) injury distribution method where the injuries are marked on the respective anatomical locations and (c) logistic regression, a statistical method, considers all the related variables together. Lower extremity injury risk appears to be high for thin BMI group. It is found that BMI does not have much influence on head injuries but it is influenced more by the height of the occupant. Results of logistic analysis suggest that BMI, height and weight may have significant contribution towards side impact injuries across different body regions. (C) 2014 Elsevier Ltd. All rights reserved.	[Pal, Chinmoy; Tomosaburo, Okabe] Nissan Motor Co Ltd, Yokohama, Kanagawa, Japan; [Vimalathithan, K.; Jeyabharath, M.; Muthukumar, M.; Satheesh, N.; Narahari, S.] Renault Nissan Technol Business Ctr India, Madras, Tamil Nadu, India	Jeyabharath, M (reprint author), Renault Nissan Technol Business Ctr India, Madras, Tamil Nadu, India.	jeyabharath.manoharan@rntbci.com					[Anonymous], 2001, P 17 INT TECHN C ESV; Arbabi S, 2003, J TRAUMA, V54, P1090, DOI 10.1097/01.TA.0000064449.11809.48; Augenstein Jeffrey, 2003, Annu Proc Assoc Adv Automot Med, V47, P561; HALAND Y, 1993, ACCIDENT ANAL PREV, V25, P199, DOI 10.1016/0001-4575(93)90060-A; SIEGEL JH, 1993, J TRAUMA, V34, P736, DOI 10.1097/00005373-199305000-00017; Jakobsson, 2005, IRCOBI C PRAG CZECH; Jillian E.Urban, 2012, UNDERSTANDING BRAIN; Lai XH, 2012, ACCIDENT ANAL PREV, V48, P442, DOI 10.1016/j.aap.2012.02.023; Mock CN, 2002, ACCIDENT ANAL PREV, V34, P221, DOI 10.1016/S0001-4575(01)00017-3; National Highway Traffic Safety Administration, 2005, HS8106312005 NHTSA U; Pal C., 2014, 2014010522 SAE, DOI [10. 427112014-01-0522., DOI 10.427/2014-01-0522]; Samaha R. R., 2003, P 18 C ENH SAF VEH N; Shankuan Zhu, 2006, AM J PUBLIC HEALTH, V96, P734; Shankuan Zhu, 2010, PLOS MED, V7; Terrel M., 2003, P 18 C ESV NAG JAP	15	2	2	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0001-4575	1879-2057		ACCIDENT ANAL PREV	Accid. Anal. Prev.	NOV	2014	72						193	209		10.1016/j.aap.2014.06.020		17	Ergonomics; Public, Environmental & Occupational Health; Social Sciences, Interdisciplinary; Transportation	Engineering; Public, Environmental & Occupational Health; Social Sciences - Other Topics; Transportation	AR8SC	WOS:000343843700020		
J	Fujita, G; Okamura, K; Kihira, M; Kosuge, R				Fujita, Goro; Okamura, Kazuko; Kihira, Makoto; Kosuge, Ritsu			Factors contributing to driver choice after hitting a pedestrian in Japan	ACCIDENT ANALYSIS AND PREVENTION			English	Article						Alcohol; Hit-and-run; Logistic regression; Pedestrian; Road safety	HIT-AND-RUN; RISK-TAKING BEHAVIOR; FATALITIES; ACCIDENTS; INJURY; CRIME; ROAD	In Japan, where pedestrian deaths account for a third of road traffic fatalities, 7.4% of victims die from hit-and-run accidents. To identify determinants for drivers considering leaving an accident scene after hitting a pedestrian, environment-related, driver-related, and pedestrian-related factors were examined using Japanese national police data. Results generally confirmed the conceptual framework of previous studies, which examined hit-and-run behavior based on a classic economic cost-benefit approach. However, results suggest that effects of road-related factors and harsher legal punishments have limited influence for reducing hit-and-run likelihood after a driver hits a pedestrian. Measures to prevent hit-and-run accidents are presented herein. (C) 2014 Published by Elsevier Ltd.	[Fujita, Goro; Okamura, Kazuko; Kihira, Makoto; Kosuge, Ritsu] Natl Res Inst Police Sci, Kashiwa, Chiba 2770882, Japan	Fujita, G (reprint author), Natl Res Inst Police Sci, 6-3-1 Kashiwanoha, Kashiwa, Chiba 2770882, Japan.	fujita@nrips.go.jp					Aidoo EN, 2013, ACCIDENT ANAL PREV, V53, P23, DOI 10.1016/j.aap.2012.12.021; Castella J, 2004, ACCIDENT ANAL PREV, V36, P947, DOI 10.1016/j.aap.2003.10.003; SOLNICK SJ, 1994, J STUD ALCOHOL, V55, P679; Machin MA, 2008, ACCIDENT ANAL PREV, V40, P541, DOI 10.1016/j.aap.2007.08.010; Goldenbeld C, 2007, ACCIDENT ANAL PREV, V39, P1121, DOI 10.1016/j.aap.2007.02.012; Ryb GE, 2006, ACCIDENT ANAL PREV, V38, P567, DOI 10.1016/j.aap.2005.12.001; Shimamura M, 2005, ACCIDENT ANAL PREV, V37, P5, DOI 10.1016/j.aap.2004.05.003; Moller M, 2008, ACCIDENT ANAL PREV, V40, P209, DOI 10.1016/j.aap.2007.05.007; Vandenbroucke JP, 2007, ANN INTERN MED, V147, pW163; NAGIN DS, 1993, LAW SOC REV, V27, P467, DOI 10.2307/3054102; Dahlen ER, 2005, ACCIDENT ANAL PREV, V37, P341, DOI 10.1016/j.aap.2004.10.006; Turner C, 2004, ACCIDENT ANAL PREV, V36, P93, DOI 10.1016/S0001-4575(02)00131-8; Cabinet Office, 2006, WHIT PAP TRAFF SAF J; CALES RH, 1984, ANN EMERG MED, V13, P1, DOI 10.1016/S0196-0644(84)80375-3; Clarke R., 1997, SITUATIONAL CRIME PR; CLARKE RVG, 1980, BRIT J CRIMINOL, V20, P136; Gottfredson M. R., 1990, GEN THEORY CRIME; Hagita K., 2010, ASIAN TRANSP STUD, V1, P123; Hara A., 2009, J SOC AUTOMOT ENG JP, V63, P35; Japan Automobile Manufacturers Association, 2013, MOT VEH STAT JAP; Kim K, 2008, TRANSP RES RECORD, P114, DOI 10.3141/2083-13; MacLeod KE, 2012, ACCIDENT ANAL PREV, V45, P366, DOI 10.1016/j.aap.2011.08.001; National Police Agency, 2013, TRAFF ACC SIT MONTHL; Okamura K, 2010, ACCIDENT ANAL PREV, V42, P403, DOI 10.1016/j.aap.2009.09.001; Pieske O, 2010, UNFALLCHIRURG, V113, P350, DOI 10.1007/s00113-010-1774-z; SOLNICK SJ, 1995, ACCIDENT ANAL PREV, V27, P643, DOI 10.1016/0001-4575(95)00012-O; Statistics Bureau Ministry of Internal Affairs and Communication, 2011, POP HOUS JAP 2010; Tay R, 2009, ACCIDENT ANAL PREV, V41, P227, DOI 10.1016/j.aap.2008.11.002; Tay R., 2010, CAN J TRANSP, V4, P2; Tay R, 2008, ACCIDENT ANAL PREV, V40, P1330, DOI 10.1016/j.aap.2008.02.003	30	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0001-4575	1879-2057		ACCIDENT ANAL PREV	Accid. Anal. Prev.	NOV	2014	72						277	286		10.1016/j.aap.2014.07.002		10	Ergonomics; Public, Environmental & Occupational Health; Social Sciences, Interdisciplinary; Transportation	Engineering; Public, Environmental & Occupational Health; Social Sciences - Other Topics; Transportation	AR8SC	WOS:000343843700027		
J	Kojima, H				Kojima, Hirohisa			Calculation and fitting of boundaries between elliptic and hyperbolic singularities of pyramid-type control moment gyros	ACTA ASTRONAUTICA			English	Article						Control moment gyros; Elliptic and hyperbolic singularities; Curve fitting	STEERING LOGIC; NULL MOTION; SYSTEMS; LAWS	There exists a singularity problem in control moment gyros (CMGs). CMG singularities are classified into two types: hyperbolic and elliptic. Several gimbal steering control methods have been presented to avoid CMG singularities. Hyperbolic singularities can be avoided by null motion, but elliptic singularities cannot. The existing steering control methods are rarely designed by explicitly taking the singularity type into account. In order to effectively avoid elliptic singularities by perturbing gimbal angles, it is desirable to calculate and record the boundaries between elliptic and hyperbolic singularities in advance so that the determined boundaries can be utilized for developing model predictive steering control. To this end, the boundaries between elliptic and hyperbolic singularities of CMGs are calculated and represented in the form of fitted curves. Several numerical examples are presented to determine the perturbation gimbal angles for avoiding elliptic singularities without using singular value decomposition. (C) 2014 IAA. Published by Elsevier Ltd. All rights reserved.	Tokyo Metropolitan Univ, Dept Aerosp Engn, Hino, Tokyo 1910065, Japan	Kojima, H (reprint author), Tokyo Metropolitan Univ, Dept Aerosp Engn, 6-6 Asahigaoka, Hino, Tokyo 1910065, Japan.	hkojima@tmu.ac.jp		Kojima, Hirohisa/0000-0002-8704-9362	Japan Society for the Promotion of Science [22560783]	This study was partially supported by a Grant-in-Aid for Scientific Research (C) (No. 22560783) from the Japan Society for the Promotion of Science.	Kurokawa H, 2007, J GUID CONTROL DYNAM, V30, P1331, DOI 10.2514/1.27316; Wie B, 2005, J GUID CONTROL DYNAM, V28, P948, DOI 10.2514/1.10136; Wie B, 2004, J GUID CONTROL DYNAM, V27, P271, DOI 10.2514/1.9167; Ford KA, 2000, J GUID CONTROL DYNAM, V23, P648, DOI 10.2514/2.4610; MARGULIES G, 1978, J ASTRONAUT SCI, V26, P159; BEDROSSIAN NS, 1990, J GUID CONTROL DYNAM, V13, P1096, DOI 10.2514/3.20584; BEDROSSIAN NS, 1990, J GUID CONTROL DYNAM, V13, P1083, DOI 10.2514/3.20582; Fleming A, 2006, ADV ASTRONAUT SCI, V123, P2681; Hart E. P., 1968, IEEE T SYST SCI CYB, VSSC-4, P100; Higashi M., 1990, JPN SOC PRECIS ENG, V56, P92; Kojima H., 2009, T JAPAN SOC AERONAUT, V7, P19, DOI DOI 10.2322/TSTJ.7.19; Kojima H, 2013, ACTA ASTRONAUT, V85, P120, DOI 10.1016/j.actaastro.2012.12.019; Kurokawa H, 1997, J GUID CONTROL DYNAM, V20, P445, DOI 10.2514/2.4095; Kurokawa H., 1998, 175 MECH ENG LAB; Leve A.F., 2010, J GUIDANCE CONTROL D, V33, P1202; Marquart D., 1963, SIAM J APPL MATH, V11, P431, DOI DOI 10.1137/0111030; McMahon J, 2009, J GUID CONTROL DYNAM, V32, P1938, DOI 10.2514/1.45433; OH HS, 1991, J ASTRONAUT SCI, V39, P183; PARADISO JA, 1992, J GUID CONTROL DYNAM, V15, P1236, DOI 10.2514/3.20974; Sato S., 2013, T JPN MECH ENG C, V79, P1526; Schaub H, 2000, J GUID CONTROL DYNAM, V23, P11, DOI 10.2514/2.4514; Takada K, 2010, J GUID CONTROL DYNAM, V33, P1442, DOI 10.2514/1.48381; Takada K, 2009, T JPN SOC AERONAUT S, V52, P1, DOI 10.2322/tjsass.52.1; VADALI SR, 1990, J GUID CONTROL DYNAM, V13, P1090, DOI 10.2514/3.20583; Wie B, 2001, J GUID CONTROL DYNAM, V24, P865, DOI 10.2514/2.4799; Wie B., 2008, AIAA ED SERIES, VSecond	26	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0094-5765	1879-2030		ACTA ASTRONAUT	Acta Astronaut.	NOV	2014	104	1			SI		33	44		10.1016/j.actaastro.2014.07.013		12	Engineering, Aerospace	Engineering	AR8RH	WOS:000343841700004		
